Citrus Sinensis ID: 018785
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 350 | 2.2.26 [Sep-21-2011] | |||||||
| O49839 | 426 | Protein kinase 2A, chloro | yes | no | 0.922 | 0.758 | 0.624 | 1e-121 | |
| O49840 | 426 | Protein kinase 2B, chloro | no | no | 0.84 | 0.690 | 0.681 | 1e-119 | |
| P43293 | 389 | Probable serine/threonine | no | no | 0.922 | 0.830 | 0.598 | 1e-117 | |
| Q8H186 | 389 | Probable receptor-like pr | no | no | 0.871 | 0.784 | 0.611 | 1e-110 | |
| O48814 | 395 | Serine/threonine-protein | no | no | 0.868 | 0.769 | 0.602 | 1e-110 | |
| P46573 | 412 | Protein kinase APK1B, chl | no | no | 0.834 | 0.708 | 0.627 | 1e-109 | |
| Q06548 | 410 | Protein kinase APK1A, chl | no | no | 0.834 | 0.712 | 0.613 | 1e-108 | |
| Q9LFP7 | 493 | Probable receptor-like pr | no | no | 0.842 | 0.598 | 0.614 | 1e-104 | |
| Q9SRH7 | 490 | Receptor-like serine/thre | no | no | 0.842 | 0.602 | 0.610 | 1e-102 | |
| Q8GXZ3 | 410 | Serine/threonine-protein | no | no | 0.825 | 0.704 | 0.600 | 2e-98 |
| >sp|O49839|APK2A_ARATH Protein kinase 2A, chloroplastic OS=Arabidopsis thaliana GN=APK2A PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 433 bits (1114), Expect = e-121, Method: Compositional matrix adjust.
Identities = 208/333 (62%), Positives = 253/333 (75%), Gaps = 10/333 (3%)
Query: 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLT 76
K ATKNF D LLGEGGFGCVFKGWIDQ + ++PGSGIVVA+K+LK E FQGHKEWLT
Sbjct: 80 KNATKNFRQDNLLGEGGFGCVFKGWIDQTSLTASRPGSGIVVAVKQLKPEGFQGHKEWLT 139
Query: 77 EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 136
EV YLGQL H NLV L+GYC+E +NRLLVYEFMPKGSLENHLFR+G QP++W R+K+A+
Sbjct: 140 EVNYLGQLSHPNLVLLVGYCAEGENRLLVYEFMPKGSLENHLFRRGAQPLTWAIRMKVAV 199
Query: 137 DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 196
A+GL+FLH + VIYRD KA+N+LLD++FNAKLSDFGLA+ GPTGDNTHVST+++GT
Sbjct: 200 GAAKGLTFLHEAKSQVIYRDFKAANILLDADFNAKLSDFGLAKAGPTGDNTHVSTKVIGT 259
Query: 197 RGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDS 256
GYAAPEYVATG LT KSDVYSFGVVLLEL+SGRRA+D GG E +LV+WA P+L D
Sbjct: 260 HGYAAPEYVATGRLTAKSDVYSFGVVLLELISGRRAMDNSNGG-NEYSLVDWATPYLGDK 318
Query: 257 RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL--------- 307
R++ RIMDT+LGGQY +K A A + LQCL+ D K RP M +VL +LEQL
Sbjct: 319 RKLFRIMDTKLGGQYPQKGAFTAANLALQCLNPDAKLRPKMSEVLVTLEQLESVAKPGTK 378
Query: 308 HTSKDMPRTPPPAKLHHHHHHHNHHQGIKHTNP 340
HT + PR + + ++H + + H P
Sbjct: 379 HTQMESPRFHHSSVMQKSPVRYSHDRPLLHMTP 411
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|O49840|APK2B_ARATH Protein kinase 2B, chloroplastic OS=Arabidopsis thaliana GN=APK2B PE=1 SV=1 | Back alignment and function description |
|---|
Score = 428 bits (1100), Expect = e-119, Method: Compositional matrix adjust.
Identities = 201/295 (68%), Positives = 241/295 (81%), Gaps = 1/295 (0%)
Query: 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLT 76
K AT+NF D LLGEGGFG VFKGWID T +KPGSGIVVA+K+LK E +QGHKEWLT
Sbjct: 77 KNATRNFRPDSLLGEGGFGYVFKGWIDGTTLTASKPGSGIVVAVKKLKTEGYQGHKEWLT 136
Query: 77 EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 136
EV YLGQL H NLVKL+GYC E +NRLLVYEFMPKGSLENHLFR+G QP++W R+K+AI
Sbjct: 137 EVNYLGQLSHPNLVKLVGYCVEGENRLLVYEFMPKGSLENHLFRRGAQPLTWAIRMKVAI 196
Query: 137 DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 196
A+GL+FLH + VIYRD KA+N+LLD+ FN+KLSDFGLA+ GPTGD THVST+++GT
Sbjct: 197 GAAKGLTFLHDAKSQVIYRDFKAANILLDAEFNSKLSDFGLAKAGPTGDKTHVSTQVMGT 256
Query: 197 RGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDS 256
GYAAPEYVATG LT KSDVYSFGVVLLELLSGRRA+D+ + G+ EQ+LV+WA P+L D
Sbjct: 257 HGYAAPEYVATGRLTAKSDVYSFGVVLLELLSGRRAVDKSKVGM-EQSLVDWATPYLGDK 315
Query: 257 RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSK 311
R++ RIMDTRLGGQY +K A A++ LQCL+ D K RP M +VL L+QL ++K
Sbjct: 316 RKLFRIMDTRLGGQYPQKGAYTAASLALQCLNPDAKLRPKMSEVLAKLDQLESTK 370
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P43293|NAK_ARATH Probable serine/threonine-protein kinase NAK OS=Arabidopsis thaliana GN=NAK PE=2 SV=2 | Back alignment and function description |
|---|
Score = 422 bits (1084), Expect = e-117, Method: Compositional matrix adjust.
Identities = 195/326 (59%), Positives = 254/326 (77%), Gaps = 3/326 (0%)
Query: 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLT 76
K AT+NF D ++GEGGFGCVFKGWID+++ AP+KPG+GIV+A+KRL E FQGH+EWL
Sbjct: 62 KSATRNFRPDSVVGEGGFGCVFKGWIDESSLAPSKPGTGIVIAVKRLNQEGFQGHREWLA 121
Query: 77 EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGV--QPISWPTRVKI 134
E+ YLGQL H NLVKLIGYC E ++RLLVYEFM +GSLENHLFR+G QP+SW TRV++
Sbjct: 122 EINYLGQLDHPNLVKLIGYCLEEEHRLLVYEFMTRGSLENHLFRRGTFYQPLSWNTRVRM 181
Query: 135 AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 194
A+ ARGL+FLH VIYRD KASN+LLDSN+NAKLSDFGLARDGP GDN+HVSTR++
Sbjct: 182 ALGAARGLAFLHNAQPQVIYRDFKASNILLDSNYNAKLSDFGLARDGPMGDNSHVSTRVM 241
Query: 195 GTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLR 254
GT+GYAAPEY+ATGHL+ KSDVYSFGVVLLELLSGRRA+D+++ + E LV+WA P+L
Sbjct: 242 GTQGYAAPEYLATGHLSVKSDVYSFGVVLLELLSGRRAIDKNQ-PVGEHNLVDWARPYLT 300
Query: 255 DSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDMP 314
+ RR+LR+MD RL GQYS A +A + L C+ +D K+RP+M +++ ++E+LH K+
Sbjct: 301 NKRRLLRVMDPRLQGQYSLTRALKIAVLALDCISIDAKSRPTMNEIVKTMEELHIQKEAS 360
Query: 315 RTPPPAKLHHHHHHHNHHQGIKHTNP 340
+ ++ + + Q + + P
Sbjct: 361 KEQQNPQISIDNIINKSPQAVNYPRP 386
|
May play a role in the regulation of plant growth and development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8H186|Y3545_ARATH Probable receptor-like protein kinase At3g55450 OS=Arabidopsis thaliana GN=At3g55450 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 397 bits (1021), Expect = e-110, Method: Compositional matrix adjust.
Identities = 189/309 (61%), Positives = 237/309 (76%), Gaps = 4/309 (1%)
Query: 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLT 76
K+AT+NF SD ++GEGGFGCVF+GW+D+ T PTK SG+V+A+KRL + FQGH+EWLT
Sbjct: 55 KLATRNFRSDSVVGEGGFGCVFRGWLDETTLTPTKSSSGLVIAVKRLNPDGFQGHREWLT 114
Query: 77 EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKG---VQPISWPTRVK 133
E+ YLGQL H NLVKLIGYC E + RLLVYEFM KGSLENHLF G +P+SW R+K
Sbjct: 115 EINYLGQLSHPNLVKLIGYCLEDEQRLLVYEFMHKGSLENHLFANGNKDFKPLSWILRIK 174
Query: 134 IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRI 193
+A+D A+GL+FLH VIYRD+KASN+LLDS+FNAKLSDFGLARDGP G+ ++VSTR+
Sbjct: 175 VALDAAKGLAFLHSDPVKVIYRDIKASNILLDSDFNAKLSDFGLARDGPMGEQSYVSTRV 234
Query: 194 VGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 253
+GT GYAAPEYV+TGHL +SDVYSFGVVLLELL GR+ALD +R EQ LV+WA P+L
Sbjct: 235 MGTFGYAAPEYVSTGHLNARSDVYSFGVVLLELLCGRQALDHNRPA-KEQNLVDWARPYL 293
Query: 254 RDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDM 313
R+VL I+DTRL QY + A +A++ +QCL +PK+RP+M V+ +L QL S
Sbjct: 294 TSRRKVLLIVDTRLNSQYKPEGAVRLASIAVQCLSFEPKSRPTMDQVVRALVQLQDSVVK 353
Query: 314 PRTPPPAKL 322
P P K+
Sbjct: 354 PANVDPLKV 362
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O48814|BIK1_ARATH Serine/threonine-protein kinase BIK1 OS=Arabidopsis thaliana GN=BIK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 397 bits (1020), Expect = e-110, Method: Compositional matrix adjust.
Identities = 185/307 (60%), Positives = 241/307 (78%), Gaps = 3/307 (0%)
Query: 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLT 76
K+AT+NF D ++GEGGFGCVFKGW+D++T PTKPG+G+V+A+K+L E FQGH+EWLT
Sbjct: 61 KLATRNFRPDSVIGEGGFGCVFKGWLDESTLTPTKPGTGLVIAVKKLNQEGFQGHREWLT 120
Query: 77 EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGV--QPISWPTRVKI 134
E+ YLGQL H NLVKLIGYC E ++RLLVYEFM KGSLENHLFR+G +P+ W RV +
Sbjct: 121 EINYLGQLSHPNLVKLIGYCLEDEHRLLVYEFMQKGSLENHLFRRGAYFKPLPWFLRVNV 180
Query: 135 AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 194
A+D A+GL+FLH VIYRD+KASN+LLD+++NAKLSDFGLARDGP GD ++VSTR++
Sbjct: 181 ALDAAKGLAFLHSDPVKVIYRDIKASNILLDADYNAKLSDFGLARDGPMGDLSYVSTRVM 240
Query: 195 GTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLR 254
GT GYAAPEY+++GHL +SDVYSFGV+LLE+LSG+RALD +R E+ LV+WA P+L
Sbjct: 241 GTYGYAAPEYMSSGHLNARSDVYSFGVLLLEILSGKRALDHNRPA-KEENLVDWARPYLT 299
Query: 255 DSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDMP 314
R+VL I+D RL QY +EA +A+V +QCL +PK+RP+M V+ +L+QL + P
Sbjct: 300 SKRKVLLIVDNRLDTQYLPEEAVRMASVAVQCLSFEPKSRPTMDQVVRALQQLQDNLGKP 359
Query: 315 RTPPPAK 321
P K
Sbjct: 360 SQTNPVK 366
|
Required to activate the resistance responses to necrotrophic pathogens. Phosphorylates FLS2 and BAK1. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P46573|APK1B_ARATH Protein kinase APK1B, chloroplastic OS=Arabidopsis thaliana GN=APK1B PE=2 SV=2 | Back alignment and function description |
|---|
Score = 394 bits (1013), Expect = e-109, Method: Compositional matrix adjust.
Identities = 185/295 (62%), Positives = 234/295 (79%), Gaps = 3/295 (1%)
Query: 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLT 76
K AT+NF D +LGEGGFG VFKGWID+ T +KPG+G+V+A+K+L + +QGH+EWL
Sbjct: 63 KAATRNFRPDSVLGEGGFGSVFKGWIDEQTLTASKPGTGVVIAVKKLNQDGWQGHQEWLA 122
Query: 77 EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKG--VQPISWPTRVKI 134
EV YLGQ H NLVKLIGYC E ++RLLVYEFMP+GSLENHLFR+G QP+SW R+K+
Sbjct: 123 EVNYLGQFSHPNLVKLIGYCLEDEHRLLVYEFMPRGSLENHLFRRGSYFQPLSWTLRLKV 182
Query: 135 AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 194
A+ A+GL+FLH + +VIYRD K SN+LLDS +NAKLSDFGLA+DGPTGD +HVSTRI+
Sbjct: 183 ALGAAKGLAFLHNAETSVIYRDFKTSNILLDSEYNAKLSDFGLAKDGPTGDKSHVSTRIM 242
Query: 195 GTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLR 254
GT GYAAPEY+ATGHLT KSDVYS+GVVLLE+LSGRRA+D++R EQ LVEWA P L
Sbjct: 243 GTYGYAAPEYLATGHLTTKSDVYSYGVVLLEVLSGRRAVDKNRPP-GEQKLVEWARPLLA 301
Query: 255 DSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHT 309
+ R++ R++D RL QYS +EA VA + L+CL + K RP+M +V++ LE + T
Sbjct: 302 NKRKLFRVIDNRLQDQYSMEEACKVATLALRCLTFEIKLRPNMNEVVSHLEHIQT 356
|
Possible bi-functional kinase. In vitro, it exhibits serine/threonine activity. In vivo, can phosphorylate tyrosine residues of limited substrates. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q06548|APK1A_ARATH Protein kinase APK1A, chloroplastic OS=Arabidopsis thaliana GN=APK1A PE=2 SV=1 | Back alignment and function description |
|---|
Score = 393 bits (1009), Expect = e-108, Method: Compositional matrix adjust.
Identities = 181/295 (61%), Positives = 235/295 (79%), Gaps = 3/295 (1%)
Query: 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLT 76
K AT+NF D +LGEGGFGCVFKGWID+ + ++PG+G+V+A+K+L + +QGH+EWL
Sbjct: 62 KSATRNFRPDSVLGEGGFGCVFKGWIDEKSLTASRPGTGLVIAVKKLNQDGWQGHQEWLA 121
Query: 77 EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGV--QPISWPTRVKI 134
EV YLGQ H +LVKLIGYC E ++RLLVYEFMP+GSLENHLFR+G+ QP+SW R+K+
Sbjct: 122 EVNYLGQFSHRHLVKLIGYCLEDEHRLLVYEFMPRGSLENHLFRRGLYFQPLSWKLRLKV 181
Query: 135 AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 194
A+ A+GL+FLH + VIYRD K SN+LLDS +NAKLSDFGLA+DGP GD +HVSTR++
Sbjct: 182 ALGAAKGLAFLHSSETRVIYRDFKTSNILLDSEYNAKLSDFGLAKDGPIGDKSHVSTRVM 241
Query: 195 GTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLR 254
GT GYAAPEY+ATGHLT KSDVYSFGVVLLELLSGRRA+D++R E+ LVEWA P+L
Sbjct: 242 GTHGYAAPEYLATGHLTTKSDVYSFGVVLLELLSGRRAVDKNRPS-GERNLVEWAKPYLV 300
Query: 255 DSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHT 309
+ R++ R++D RL QYS +EA VA + L+CL + K RP+M +V++ LE + +
Sbjct: 301 NKRKIFRVIDNRLQDQYSMEEACKVATLSLRCLTTEIKLRPNMSEVVSHLEHIQS 355
|
Possible bi-functional kinase. In vitro, it exhibits serine/threonine activity. In vivo, can phosphorylate tyrosine residues of limited substrates. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LFP7|Y5158_ARATH Probable receptor-like protein kinase At5g15080 OS=Arabidopsis thaliana GN=At5g15080 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 377 bits (969), Expect = e-104, Method: Compositional matrix adjust.
Identities = 183/298 (61%), Positives = 223/298 (74%), Gaps = 3/298 (1%)
Query: 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLT 76
K++T+NF + LLGEGGFGCVFKGWI++N AP KPG+G+ VA+K L + QGHKEWL
Sbjct: 136 KLSTRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNPDGLQGHKEWLA 195
Query: 77 EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 136
E+ +LG L H NLVKL+GYC E D RLLVYEFMP+GSLENHLFR+ + P+ W R+KIA+
Sbjct: 196 EINFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSL-PLPWSIRMKIAL 254
Query: 137 DVARGLSFLHGLDAN-VIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVG 195
A+GLSFLH VIYRD K SN+LLD+++NAKLSDFGLA+D P THVSTR++G
Sbjct: 255 GAAKGLSFLHEEALKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPDEGKTHVSTRVMG 314
Query: 196 TRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRD 255
T GYAAPEYV TGHLT KSDVYSFGVVLLE+L+GRR++D++R E LVEWA P L D
Sbjct: 315 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPN-GEHNLVEWARPHLLD 373
Query: 256 SRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDM 313
RR R++D RL G +S K AQ V + QCL DPK RP M DV+ +L+ L KDM
Sbjct: 374 KRRFYRLLDPRLEGHFSIKGAQKVTQLAAQCLSRDPKIRPKMSDVVEALKPLPHLKDM 431
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SRH7|Y3130_ARATH Receptor-like serine/threonine-protein kinase At3g01300 OS=Arabidopsis thaliana GN=At3g01300 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 372 bits (956), Expect = e-102, Method: Compositional matrix adjust.
Identities = 182/298 (61%), Positives = 219/298 (73%), Gaps = 3/298 (1%)
Query: 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLT 76
K+AT+NF + LLGEGGFGCVFKGW+++N AP KPG+G+ VA+K L + QGHKEWL
Sbjct: 130 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNPDGLQGHKEWLA 189
Query: 77 EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 136
E+ YLG L H NLVKL+GYC E D RLLVYEFMP+GSLENHLFR+ + P+ W R+KIA+
Sbjct: 190 EINYLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSL-PLPWSIRMKIAL 248
Query: 137 DVARGLSFLHGLDAN-VIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVG 195
A+GLSFLH VIYRD K SN+LLD +NAKLSDFGLA+D P THVSTR++G
Sbjct: 249 GAAKGLSFLHEEALKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDAPDEGKTHVSTRVMG 308
Query: 196 TRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRD 255
T GYAAPEYV TGHLT KSDVYSFGVVLLE+L+GRR++D++R E LVEWA P L D
Sbjct: 309 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPN-GEHNLVEWARPHLLD 367
Query: 256 SRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDM 313
RR R++D RL G +S K AQ V + QCL D K RP M +V+ L+ L KDM
Sbjct: 368 KRRFYRLLDPRLEGHFSVKGAQKVTQLAAQCLSRDSKIRPKMSEVVEVLKPLPHLKDM 425
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8GXZ3|Y5102_ARATH Serine/threonine-protein kinase At5g01020 OS=Arabidopsis thaliana GN=At5g01020 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 359 bits (921), Expect = 2e-98, Method: Compositional matrix adjust.
Identities = 176/293 (60%), Positives = 217/293 (74%), Gaps = 4/293 (1%)
Query: 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVI 79
TK+F DY+LGEGGFG V+KG+ID N K + VA+K L E QGH+EWLTEV
Sbjct: 66 TKSFRPDYILGEGGFGTVYKGYIDDNLRVGLK---SLPVAVKVLNKEGLQGHREWLTEVN 122
Query: 80 YLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVA 139
+LGQLRH NLVKLIGYC E D+RLLVYEFM +GSLENHLFRK P+SW R+ IA+ A
Sbjct: 123 FLGQLRHPNLVKLIGYCCEDDHRLLVYEFMLRGSLENHLFRKTTAPLSWSRRMMIALGAA 182
Query: 140 RGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGY 199
+GL+FLH + VIYRD K SN+LLDS++ AKLSDFGLA+ GP GD THVSTR++GT GY
Sbjct: 183 KGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGY 242
Query: 200 AAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRV 259
AAPEYV TGHLT +SDVYSFGVVLLE+L+GR+++D+ R EQ LV+WA P L D R++
Sbjct: 243 AAPEYVMTGHLTARSDVYSFGVVLLEMLTGRKSVDKTRPS-KEQNLVDWARPKLNDKRKL 301
Query: 260 LRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKD 312
L+I+D RL QYS + AQ ++ CL +PK RP M DV+ +LE L + D
Sbjct: 302 LQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCTGD 354
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 350 | ||||||
| 224104557 | 340 | predicted protein [Populus trichocarpa] | 0.882 | 0.908 | 0.832 | 1e-146 | |
| 296083955 | 422 | unnamed protein product [Vitis vinifera] | 0.914 | 0.758 | 0.785 | 1e-144 | |
| 225435985 | 403 | PREDICTED: protein kinase 2B, chloroplas | 0.914 | 0.794 | 0.785 | 1e-144 | |
| 449463895 | 403 | PREDICTED: protein kinase 2B, chloroplas | 0.877 | 0.761 | 0.742 | 1e-139 | |
| 357493723 | 407 | Protein kinase 2B [Medicago truncatula] | 0.882 | 0.759 | 0.763 | 1e-138 | |
| 356574647 | 382 | PREDICTED: protein kinase 2A, chloroplas | 0.891 | 0.816 | 0.742 | 1e-132 | |
| 356549815 | 382 | PREDICTED: protein kinase 2A, chloroplas | 0.86 | 0.787 | 0.777 | 1e-132 | |
| 242039753 | 433 | hypothetical protein SORBIDRAFT_01g02240 | 0.84 | 0.678 | 0.705 | 1e-121 | |
| 357113846 | 421 | PREDICTED: protein kinase 2B, chloroplas | 0.84 | 0.698 | 0.708 | 1e-121 | |
| 308080840 | 436 | uncharacterized LOC100502290 [Zea mays] | 0.86 | 0.690 | 0.688 | 1e-121 |
| >gi|224104557|ref|XP_002313478.1| predicted protein [Populus trichocarpa] gi|222849886|gb|EEE87433.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 522 bits (1345), Expect = e-146, Method: Compositional matrix adjust.
Identities = 258/310 (83%), Positives = 282/310 (90%), Gaps = 1/310 (0%)
Query: 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLT 76
K ATKNF S+ LLGEGGFGCVFKGWID NTFAPTKPGSG++VA+K+LK ES QGHKEWLT
Sbjct: 17 KNATKNFRSETLLGEGGFGCVFKGWIDLNTFAPTKPGSGVIVAVKKLKPESCQGHKEWLT 76
Query: 77 EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 136
EV YLGQL HENLVKLIGYCSESDNRLLVYEFMPKGSLE HLFRKGVQPI+W R+ IAI
Sbjct: 77 EVTYLGQLHHENLVKLIGYCSESDNRLLVYEFMPKGSLEQHLFRKGVQPITWTMRMNIAI 136
Query: 137 DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 196
DVARGLSFLHGLDANVIYRDLKASNVLLDS++NAKLSDFGLARDGPTGDNTHVST+++GT
Sbjct: 137 DVARGLSFLHGLDANVIYRDLKASNVLLDSDYNAKLSDFGLARDGPTGDNTHVSTKVLGT 196
Query: 197 RGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRD 255
RGYAAPEYVAT GHLTPKSDVYS+GVVLLELLSGRRA+DE+RGG ++TLV+WA PFL D
Sbjct: 197 RGYAAPEYVATAGHLTPKSDVYSYGVVLLELLSGRRAMDEERGGFDDETLVDWAKPFLID 256
Query: 256 SRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDMPR 315
SRRVLRIMDTRLGGQY KK AQA AA+ LQCLH DPKNRP M+DVLT+LE+L TSKD+PR
Sbjct: 257 SRRVLRIMDTRLGGQYPKKAAQAAAALALQCLHTDPKNRPPMIDVLTTLEKLITSKDIPR 316
Query: 316 TPPPAKLHHH 325
T P KL +H
Sbjct: 317 TARPVKLDNH 326
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|296083955|emb|CBI24343.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 518 bits (1335), Expect = e-144, Method: Compositional matrix adjust.
Identities = 252/321 (78%), Positives = 285/321 (88%), Gaps = 1/321 (0%)
Query: 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLT 76
K A+KNF S+ LLGEGGFGCVFKGW+D+NT APTKPG+G+VVAIK+LK ESFQGHKEWL
Sbjct: 74 KNASKNFRSESLLGEGGFGCVFKGWLDENTLAPTKPGTGMVVAIKKLKTESFQGHKEWLA 133
Query: 77 EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 136
EV YLGQL HENLVKLIGYCSES+NRLLVYEFM KGSLENHLF+KGVQPI+W TR+ IAI
Sbjct: 134 EVNYLGQLHHENLVKLIGYCSESENRLLVYEFMSKGSLENHLFKKGVQPITWATRMSIAI 193
Query: 137 DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 196
DVA+G+SFLH LDANVIYRDLKASN+LLDS+F AKLSDFGLARDGPTGDNTHVSTR+VGT
Sbjct: 194 DVAQGISFLHSLDANVIYRDLKASNILLDSDFKAKLSDFGLARDGPTGDNTHVSTRVVGT 253
Query: 197 RGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDS 256
RGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRA+D+++ G E+TLV+WA PFL D+
Sbjct: 254 RGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAMDDEKAGGVEETLVDWAKPFLSDN 313
Query: 257 RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDMPRT 316
RRVLRIMDTRLGGQYSKK AQA A++ LQCLH DPKNRP M DVL +LE+L TSKD+PRT
Sbjct: 314 RRVLRIMDTRLGGQYSKKGAQAAASLALQCLHTDPKNRPLMTDVLAALERLPTSKDIPRT 373
Query: 317 PPPAKLHHHHHHHNHHQGIKH 337
P P ++ +H H+ + G H
Sbjct: 374 PSP-RVEYHIMKHSSNPGHTH 393
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225435985|ref|XP_002272310.1| PREDICTED: protein kinase 2B, chloroplastic-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 518 bits (1334), Expect = e-144, Method: Compositional matrix adjust.
Identities = 252/321 (78%), Positives = 285/321 (88%), Gaps = 1/321 (0%)
Query: 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLT 76
K A+KNF S+ LLGEGGFGCVFKGW+D+NT APTKPG+G+VVAIK+LK ESFQGHKEWL
Sbjct: 74 KNASKNFRSESLLGEGGFGCVFKGWLDENTLAPTKPGTGMVVAIKKLKTESFQGHKEWLA 133
Query: 77 EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 136
EV YLGQL HENLVKLIGYCSES+NRLLVYEFM KGSLENHLF+KGVQPI+W TR+ IAI
Sbjct: 134 EVNYLGQLHHENLVKLIGYCSESENRLLVYEFMSKGSLENHLFKKGVQPITWATRMSIAI 193
Query: 137 DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 196
DVA+G+SFLH LDANVIYRDLKASN+LLDS+F AKLSDFGLARDGPTGDNTHVSTR+VGT
Sbjct: 194 DVAQGISFLHSLDANVIYRDLKASNILLDSDFKAKLSDFGLARDGPTGDNTHVSTRVVGT 253
Query: 197 RGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDS 256
RGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRA+D+++ G E+TLV+WA PFL D+
Sbjct: 254 RGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAMDDEKAGGVEETLVDWAKPFLSDN 313
Query: 257 RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDMPRT 316
RRVLRIMDTRLGGQYSKK AQA A++ LQCLH DPKNRP M DVL +LE+L TSKD+PRT
Sbjct: 314 RRVLRIMDTRLGGQYSKKGAQAAASLALQCLHTDPKNRPLMTDVLAALERLPTSKDIPRT 373
Query: 317 PPPAKLHHHHHHHNHHQGIKH 337
P P ++ +H H+ + G H
Sbjct: 374 PSP-RVEYHIMKHSSNPGHTH 393
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449463895|ref|XP_004149666.1| PREDICTED: protein kinase 2B, chloroplastic-like [Cucumis sativus] gi|449515432|ref|XP_004164753.1| PREDICTED: protein kinase 2B, chloroplastic-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 499 bits (1285), Expect = e-139, Method: Compositional matrix adjust.
Identities = 234/315 (74%), Positives = 270/315 (85%), Gaps = 8/315 (2%)
Query: 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLT 76
K ATKNF S+ LLGEGGFGCVFKGWID++++ PTKPG+GIVVA+K+LK ES QG+KEWL
Sbjct: 88 KNATKNFRSESLLGEGGFGCVFKGWIDEHSYLPTKPGTGIVVAVKKLKRESLQGYKEWLA 147
Query: 77 EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 136
EV YLGQLRHENLV+LIGYCSESDNRLLVYE+MPKGSLENHLFRKGV PISW R+ IA+
Sbjct: 148 EVNYLGQLRHENLVRLIGYCSESDNRLLVYEYMPKGSLENHLFRKGVTPISWRVRMDIAV 207
Query: 137 DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 196
DVARGL+FLH + NVIYRDLKASN+LLDS FNAKLSDFGLAR+GPTGD THVSTR++GT
Sbjct: 208 DVARGLAFLHSSEPNVIYRDLKASNILLDSEFNAKLSDFGLAREGPTGDKTHVSTRVMGT 267
Query: 197 RGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDS 256
RGYAAPEYVATGHLTPKSDVYSFGVVLLELLSG+RALD ++ G E+TLV+W P L D
Sbjct: 268 RGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGKRALDHEKVGRVEETLVDWGKPLLSDG 327
Query: 257 RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDMPRT 316
+R+LRIMDTR+GGQYS+KEAQA A++ L CLH DPKNRPSM +VL LE+LHT+KD+ T
Sbjct: 328 KRMLRIMDTRMGGQYSRKEAQAAASLALNCLHTDPKNRPSMAEVLDELERLHTAKDILGT 387
Query: 317 P--------PPAKLH 323
P PP++
Sbjct: 388 PNAHAIRRTPPSRFQ 402
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357493723|ref|XP_003617150.1| Protein kinase 2B [Medicago truncatula] gi|355518485|gb|AET00109.1| Protein kinase 2B [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 496 bits (1278), Expect = e-138, Method: Compositional matrix adjust.
Identities = 236/309 (76%), Positives = 268/309 (86%)
Query: 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLT 76
K AT+NF + L+GEGGFG V+KGWID+NT APTKPG+GIVVAIK+LK ESFQGHKEWL
Sbjct: 64 KEATRNFRQENLIGEGGFGFVYKGWIDENTGAPTKPGNGIVVAIKKLKPESFQGHKEWLA 123
Query: 77 EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 136
EV YLGQL HENLVKLIGYCSE NRLLVYEFM KGSLENHLFRKGVQPISW TR+ IAI
Sbjct: 124 EVNYLGQLHHENLVKLIGYCSEGKNRLLVYEFMQKGSLENHLFRKGVQPISWMTRISIAI 183
Query: 137 DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 196
VARGL+FLH LDANVIYRDLKASN+LLDS+FNA LSDFGLARDGPTGDNTHVSTRI+GT
Sbjct: 184 GVARGLAFLHSLDANVIYRDLKASNILLDSDFNANLSDFGLARDGPTGDNTHVSTRIIGT 243
Query: 197 RGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDS 256
GYAAPEYVATGHLT +SDVYSFGVVLLELL+GRR +++DR E+TLV+WA PFL DS
Sbjct: 244 HGYAAPEYVATGHLTLRSDVYSFGVVLLELLTGRRVVEDDRQVYTEETLVDWAMPFLSDS 303
Query: 257 RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDMPRT 316
RR+LRIMDT+LGGQYSKK AQA AA+VL+CL+ DPK+RP+MV+VL +LE LH+S P+
Sbjct: 304 RRILRIMDTKLGGQYSKKGAQAAAALVLKCLNTDPKHRPTMVNVLAALEALHSSNSFPKK 363
Query: 317 PPPAKLHHH 325
P +H+
Sbjct: 364 PKSGTDNHN 372
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356574647|ref|XP_003555457.1| PREDICTED: protein kinase 2A, chloroplastic-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 479 bits (1232), Expect = e-132, Method: Compositional matrix adjust.
Identities = 236/318 (74%), Positives = 269/318 (84%), Gaps = 6/318 (1%)
Query: 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLT 76
K ATKNF + L+GEGGFG VFKGWID+NT+ PTKPG+GIVVAIK LK ESFQGHKEWL
Sbjct: 66 KEATKNFRQENLIGEGGFGRVFKGWIDENTYGPTKPGTGIVVAIKNLKPESFQGHKEWLQ 125
Query: 77 EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 136
EV YLGQL+HENLVKLIGYC E NRLLVYEFM KGSLENHLFRKGVQP++W TRV IAI
Sbjct: 126 EVNYLGQLQHENLVKLIGYCLEGKNRLLVYEFMQKGSLENHLFRKGVQPMAWVTRVNIAI 185
Query: 137 DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 196
VARGL+ LH LD NVI+RDLKASN+LLDS+FNAKLSDFGLARDGPTGDNTHVSTR++GT
Sbjct: 186 GVARGLTLLHSLDQNVIFRDLKASNILLDSDFNAKLSDFGLARDGPTGDNTHVSTRVLGT 245
Query: 197 RGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDS 256
+GYAAPEYVATGHLTP+SDVYS+GVVLLELL+GRRA+++DR G +E+TLV+WA PFL D+
Sbjct: 246 QGYAAPEYVATGHLTPRSDVYSYGVVLLELLTGRRAVEDDRPGFSEETLVDWAKPFLSDN 305
Query: 257 RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDMPRT 316
RRVLRIMDT+LGGQYSKK AQA AA+ LQCL++DPK RP MV+VL +LE L++S RT
Sbjct: 306 RRVLRIMDTKLGGQYSKKGAQAAAALALQCLNIDPKFRPPMVEVLAALEALNSSNSFTRT 365
Query: 317 PPPAKLHHHHHHHNHHQG 334
P H H G
Sbjct: 366 P------KHESHATKQSG 377
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356549815|ref|XP_003543286.1| PREDICTED: protein kinase 2A, chloroplastic-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 478 bits (1231), Expect = e-132, Method: Compositional matrix adjust.
Identities = 234/301 (77%), Positives = 264/301 (87%)
Query: 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLT 76
K ATKNF + L+GEGGFG VFKGWID+NT+ PTKPG+GIVVAIK LK ESFQGHKEWL
Sbjct: 66 KEATKNFRRENLIGEGGFGRVFKGWIDENTYGPTKPGTGIVVAIKNLKPESFQGHKEWLQ 125
Query: 77 EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 136
EV YLG L+HENLVKLIGYC E NRLLVYEFM KGSLENHLFRKGVQP++W TRV IAI
Sbjct: 126 EVNYLGMLQHENLVKLIGYCLEGKNRLLVYEFMQKGSLENHLFRKGVQPMAWVTRVNIAI 185
Query: 137 DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 196
VARGL+FLH LD NVI+RDLKASN+LLDS+FNAKLSDFGLARDGPTGDNTHVSTR++GT
Sbjct: 186 GVARGLTFLHSLDQNVIFRDLKASNILLDSDFNAKLSDFGLARDGPTGDNTHVSTRVIGT 245
Query: 197 RGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDS 256
+GYAAPEYVATGHLTP+SDVYSFGVVLLELL+GRRA+++D G +E+TLV+WA PFL D+
Sbjct: 246 QGYAAPEYVATGHLTPRSDVYSFGVVLLELLTGRRAVEDDGPGFSEETLVDWAKPFLNDN 305
Query: 257 RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDMPRT 316
RRVLRIMDTRLGGQYSKK AQA AA+ LQCL+ DPK RP MV+VL +LE L++S RT
Sbjct: 306 RRVLRIMDTRLGGQYSKKGAQAAAALALQCLNTDPKFRPPMVEVLAALEALNSSNSFTRT 365
Query: 317 P 317
P
Sbjct: 366 P 366
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|242039753|ref|XP_002467271.1| hypothetical protein SORBIDRAFT_01g022400 [Sorghum bicolor] gi|241921125|gb|EER94269.1| hypothetical protein SORBIDRAFT_01g022400 [Sorghum bicolor] | Back alignment and taxonomy information |
|---|
Score = 441 bits (1134), Expect = e-121, Method: Compositional matrix adjust.
Identities = 208/295 (70%), Positives = 245/295 (83%), Gaps = 1/295 (0%)
Query: 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLT 76
K A+KNF SD L+GEGGFG VFKGWID+ T AP+KPGSG+VVAIK+LK E FQGHKEWLT
Sbjct: 78 KSASKNFRSDSLIGEGGFGYVFKGWIDEQTLAPSKPGSGMVVAIKKLKPEGFQGHKEWLT 137
Query: 77 EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 136
EV YLGQL H+NLVKLIGYCS+ DNRLLVYE+MPKGSLENHLFR+G P+ W R+K+AI
Sbjct: 138 EVDYLGQLHHQNLVKLIGYCSDGDNRLLVYEYMPKGSLENHLFRRGADPLPWGIRLKVAI 197
Query: 137 DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 196
A+GLSFLH + VIYRD KASN+LLD+ FNAKLSDFGLA+ GPTGD THVST+++GT
Sbjct: 198 GAAKGLSFLHDAENQVIYRDFKASNILLDTEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 257
Query: 197 RGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDS 256
RGYAAPEYVATG L+ K+DVYSFGVVLLELL+GRRALD+ + ++EQ LVEWA P+L D
Sbjct: 258 RGYAAPEYVATGRLSVKADVYSFGVVLLELLTGRRALDKSK-PVSEQNLVEWAKPYLGDK 316
Query: 257 RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSK 311
RR+ RIMD++LGGQY KK A AVA + LQC+ D KNRP+M +V+ LEQL K
Sbjct: 317 RRLYRIMDSKLGGQYPKKGAHAVAGIALQCIRNDGKNRPAMSEVVEKLEQLQDPK 371
|
Source: Sorghum bicolor Species: Sorghum bicolor Genus: Sorghum Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357113846|ref|XP_003558712.1| PREDICTED: protein kinase 2B, chloroplastic-like [Brachypodium distachyon] | Back alignment and taxonomy information |
|---|
Score = 441 bits (1134), Expect = e-121, Method: Compositional matrix adjust.
Identities = 209/295 (70%), Positives = 243/295 (82%), Gaps = 1/295 (0%)
Query: 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLT 76
K ATKNF D LLGEGGFG VFKGWID++T AP+KPGSG+VVA+K+LK E FQGHKEWLT
Sbjct: 81 KNATKNFRPDSLLGEGGFGHVFKGWIDEHTLAPSKPGSGMVVAVKKLKPEGFQGHKEWLT 140
Query: 77 EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 136
EV YLGQL H NLVKLIGYC++ DNRLLVYEFMPKGSLENHLFR+G P+SW R+K+AI
Sbjct: 141 EVNYLGQLHHANLVKLIGYCTDGDNRLLVYEFMPKGSLENHLFRRGADPLSWAIRLKVAI 200
Query: 137 DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 196
ARGLSFLH + VIYRD KASN+LLDS FN+KLSDFGLA+ GPTGD THVST+++GT
Sbjct: 201 GAARGLSFLHDAENQVIYRDFKASNILLDSEFNSKLSDFGLAKAGPTGDRTHVSTQVMGT 260
Query: 197 RGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDS 256
GYAAPEY+ATG L+ K+DVYSFGVVLLELL+GRRALD+ + G+ EQ LV+WA P LRD
Sbjct: 261 HGYAAPEYIATGRLSAKADVYSFGVVLLELLTGRRALDKSKPGI-EQNLVDWAKPHLRDK 319
Query: 257 RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSK 311
RR+ R+MDT+LGGQY KK A A+A + LQC+ D K RP M +VL LEQL SK
Sbjct: 320 RRLYRVMDTKLGGQYPKKGAHAIANLALQCICNDAKMRPQMSEVLEELEQLQESK 374
|
Source: Brachypodium distachyon Species: Brachypodium distachyon Genus: Brachypodium Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|308080840|ref|NP_001183697.1| uncharacterized LOC100502290 [Zea mays] gi|238013964|gb|ACR38017.1| unknown [Zea mays] gi|414871478|tpg|DAA50035.1| TPA: putative protein kinase superfamily protein [Zea mays] | Back alignment and taxonomy information |
|---|
Score = 440 bits (1131), Expect = e-121, Method: Compositional matrix adjust.
Identities = 208/302 (68%), Positives = 247/302 (81%), Gaps = 1/302 (0%)
Query: 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLT 76
+ A++NF SD LLGEGGFG VFKGWID+ T AP+KPGSG+VVAIK+LK E FQGHKEWLT
Sbjct: 77 RTASRNFRSDSLLGEGGFGYVFKGWIDEQTLAPSKPGSGMVVAIKKLKPEGFQGHKEWLT 136
Query: 77 EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 136
EV YLGQL H+NLVKLIGYC++ D+RLLVYE+MPKGSLENHLFR+G P+SW TR+K+AI
Sbjct: 137 EVDYLGQLHHQNLVKLIGYCTDGDHRLLVYEYMPKGSLENHLFRRGADPLSWGTRLKVAI 196
Query: 137 DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 196
A+GLSFLH + VIYRD KASN+LLDS FNAKLSDFGLA+ GPTGD THVST+++GT
Sbjct: 197 GAAKGLSFLHDAENQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 256
Query: 197 RGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDS 256
RGYAAPEYVATG L+ K+DVYSFGVVLLELL+GRRALD+ + L EQ LVEWA P+L D
Sbjct: 257 RGYAAPEYVATGRLSVKADVYSFGVVLLELLTGRRALDKSK-PLTEQNLVEWARPYLSDK 315
Query: 257 RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDMPRT 316
RR+ RIMD++LGGQY KK A AVA + LQC+ + K RP+M +V+ LEQL +
Sbjct: 316 RRLYRIMDSKLGGQYPKKGAHAVAGIALQCIRNEGKMRPAMSEVVEKLEQLQDPRYNVAA 375
Query: 317 PP 318
PP
Sbjct: 376 PP 377
|
Source: Zea mays Species: Zea mays Genus: Zea Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 350 | ||||||
| TAIR|locus:2012492 | 426 | APK2A "protein kinase 2A" [Ara | 0.834 | 0.685 | 0.682 | 9e-109 | |
| TAIR|locus:2058847 | 426 | APK2B "protein kinase 2B" [Ara | 0.84 | 0.690 | 0.677 | 1e-107 | |
| TAIR|locus:2205050 | 387 | AT1G69790 [Arabidopsis thalian | 0.848 | 0.767 | 0.661 | 1.9e-106 | |
| TAIR|locus:2180127 | 389 | NAK [Arabidopsis thaliana (tax | 0.922 | 0.830 | 0.595 | 6.5e-106 | |
| TAIR|locus:2205714 | 412 | AT1G26970 [Arabidopsis thalian | 0.905 | 0.769 | 0.621 | 5.3e-104 | |
| TAIR|locus:2039772 | 395 | BIK1 "botrytis-induced kinase1 | 0.868 | 0.769 | 0.596 | 5.6e-100 | |
| TAIR|locus:2053240 | 423 | PK1B "protein kinase 1B" [Arab | 0.834 | 0.690 | 0.620 | 1.3e-98 | |
| TAIR|locus:2147805 | 493 | AT5G15080 [Arabidopsis thalian | 0.842 | 0.598 | 0.610 | 4.2e-95 | |
| TAIR|locus:2100282 | 490 | AT3G01300 [Arabidopsis thalian | 0.842 | 0.602 | 0.607 | 4.8e-94 | |
| TAIR|locus:2095517 | 453 | AT3G28690 [Arabidopsis thalian | 0.84 | 0.649 | 0.595 | 4.3e-93 |
| TAIR|locus:2012492 APK2A "protein kinase 2A" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1075 (383.5 bits), Expect = 9.0e-109, P = 9.0e-109
Identities = 200/293 (68%), Positives = 238/293 (81%)
Query: 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLT 76
K ATKNF D LLGEGGFGCVFKGWIDQ + ++PGSGIVVA+K+LK E FQGHKEWLT
Sbjct: 80 KNATKNFRQDNLLGEGGFGCVFKGWIDQTSLTASRPGSGIVVAVKQLKPEGFQGHKEWLT 139
Query: 77 EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 136
EV YLGQL H NLV L+GYC+E +NRLLVYEFMPKGSLENHLFR+G QP++W R+K+A+
Sbjct: 140 EVNYLGQLSHPNLVLLVGYCAEGENRLLVYEFMPKGSLENHLFRRGAQPLTWAIRMKVAV 199
Query: 137 DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 196
A+GL+FLH + VIYRD KA+N+LLD++FNAKLSDFGLA+ GPTGDNTHVST+++GT
Sbjct: 200 GAAKGLTFLHEAKSQVIYRDFKAANILLDADFNAKLSDFGLAKAGPTGDNTHVSTKVIGT 259
Query: 197 RGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDS 256
GYAAPEYVATG LT KSDVYSFGVVLLEL+SGRRA+D GG E +LV+WA P+L D
Sbjct: 260 HGYAAPEYVATGRLTAKSDVYSFGVVLLELISGRRAMDNSNGG-NEYSLVDWATPYLGDK 318
Query: 257 RRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVLTSLEQLHT 309
R++ RIMDT+LGGQY +K A LQCL+ D K RP M +VL +LEQL +
Sbjct: 319 RKLFRIMDTKLGGQYPQKGAFTAANLALQCLNPDAKLRPKMSEVLVTLEQLES 371
|
|
| TAIR|locus:2058847 APK2B "protein kinase 2B" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1065 (380.0 bits), Expect = 1.0e-107, P = 1.0e-107
Identities = 200/295 (67%), Positives = 238/295 (80%)
Query: 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLT 76
K AT+NF D LLGEGGFG VFKGWID T +KPGSGIVVA+K+LK E +QGHKEWLT
Sbjct: 77 KNATRNFRPDSLLGEGGFGYVFKGWIDGTTLTASKPGSGIVVAVKKLKTEGYQGHKEWLT 136
Query: 77 EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 136
EV YLGQL H NLVKL+GYC E +NRLLVYEFMPKGSLENHLFR+G QP++W R+K+AI
Sbjct: 137 EVNYLGQLSHPNLVKLVGYCVEGENRLLVYEFMPKGSLENHLFRRGAQPLTWAIRMKVAI 196
Query: 137 DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 196
A+GL+FLH + VIYRD KA+N+LLD+ FN+KLSDFGLA+ GPTGD THVST+++GT
Sbjct: 197 GAAKGLTFLHDAKSQVIYRDFKAANILLDAEFNSKLSDFGLAKAGPTGDKTHVSTQVMGT 256
Query: 197 RGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDS 256
GYAAPEYVATG LT KSDVYSFGVVLLELLSGRRA+D+ + G+ EQ+LV+WA P+L D
Sbjct: 257 HGYAAPEYVATGRLTAKSDVYSFGVVLLELLSGRRAVDKSKVGM-EQSLVDWATPYLGDK 315
Query: 257 RRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVLTSLEQLHTSK 311
R++ RIMDTRLGGQY +K A LQCL+ D K RP M +VL L+QL ++K
Sbjct: 316 RKLFRIMDTRLGGQYPQKGAYTAASLALQCLNPDAKLRPKMSEVLAKLDQLESTK 370
|
|
| TAIR|locus:2205050 AT1G69790 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1053 (375.7 bits), Expect = 1.9e-106, P = 1.9e-106
Identities = 199/301 (66%), Positives = 243/301 (80%)
Query: 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLT 76
K AT+NF + ++GEGGFGCV+KGWI + + +P+KPGSG+VVA+K+LK+E FQGHKEWLT
Sbjct: 78 KTATRNFKPNSMIGEGGFGCVYKGWIGERSLSPSKPGSGMVVAVKKLKSEGFQGHKEWLT 137
Query: 77 EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 136
EV YLG+L H NLVKLIGYC E + RLLVYE+MPKGSLENHLFR+G +PI W TR+K+A
Sbjct: 138 EVHYLGRLHHMNLVKLIGYCLEGEKRLLVYEYMPKGSLENHLFRRGAEPIPWKTRMKVAF 197
Query: 137 DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 196
ARGLSFLH +A VIYRD KASN+LLD +FNAKLSDFGLA+ GPTGD THV+T+++GT
Sbjct: 198 SAARGLSFLH--EAKVIYRDFKASNILLDVDFNAKLSDFGLAKAGPTGDRTHVTTQVIGT 255
Query: 197 RGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDS 256
+GYAAPEY+ATG LT KSDVYSFGVVLLELLSGR LD+ + G+ E+ LV+WA P+L D
Sbjct: 256 QGYAAPEYIATGRLTSKSDVYSFGVVLLELLSGRPTLDKSKVGV-ERNLVDWAIPYLVDR 314
Query: 257 RRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVLTSLEQLHTS-KDMPR 315
R+V RIMDT+LGGQY K A L+CL+ +PK RP M DVL++L+QL TS K M
Sbjct: 315 RKVFRIMDTKLGGQYPHKGACAAANIALRCLNTEPKLRPDMADVLSTLQQLETSSKKMGS 374
Query: 316 T 316
T
Sbjct: 375 T 375
|
|
| TAIR|locus:2180127 NAK [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1048 (374.0 bits), Expect = 6.5e-106, P = 6.5e-106
Identities = 194/326 (59%), Positives = 249/326 (76%)
Query: 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLT 76
K AT+NF D ++GEGGFGCVFKGWID+++ AP+KPG+GIV+A+KRL E FQGH+EWL
Sbjct: 62 KSATRNFRPDSVVGEGGFGCVFKGWIDESSLAPSKPGTGIVIAVKRLNQEGFQGHREWLA 121
Query: 77 EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGV--QPISWPTRVKI 134
E+ YLGQL H NLVKLIGYC E ++RLLVYEFM +GSLENHLFR+G QP+SW TRV++
Sbjct: 122 EINYLGQLDHPNLVKLIGYCLEEEHRLLVYEFMTRGSLENHLFRRGTFYQPLSWNTRVRM 181
Query: 135 AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 194
A+ ARGL+FLH VIYRD KASN+LLDSN+NAKLSDFGLARDGP GDN+HVSTR++
Sbjct: 182 ALGAARGLAFLHNAQPQVIYRDFKASNILLDSNYNAKLSDFGLARDGPMGDNSHVSTRVM 241
Query: 195 GTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLR 254
GT+GYAAPEY+ATGHL+ KSDVYSFGVVLLELLSGRRA+D+++ + E LV+WA P+L
Sbjct: 242 GTQGYAAPEYLATGHLSVKSDVYSFGVVLLELLSGRRAIDKNQP-VGEHNLVDWARPYLT 300
Query: 255 DSRRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVLTSLEQLHTSKDMP 314
+ RR+LR+MD RL GQYS A L C+ +D K+RP+M +++ ++E+LH K+
Sbjct: 301 NKRRLLRVMDPRLQGQYSLTRALKIAVLALDCISIDAKSRPTMNEIVKTMEELHIQKEAS 360
Query: 315 RTPPPAKLXXXXXXXXXXQGIKHTNP 340
+ ++ Q + + P
Sbjct: 361 KEQQNPQISIDNIINKSPQAVNYPRP 386
|
|
| TAIR|locus:2205714 AT1G26970 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1030 (367.6 bits), Expect = 5.3e-104, P = 5.3e-104
Identities = 200/322 (62%), Positives = 246/322 (76%)
Query: 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLT 76
K AT+NF D ++GEGGFG V+KGWID+ T +P+KPGSG+VVA+K+LK E FQGH++WL
Sbjct: 77 KTATRNFRPDSVIGEGGFGYVYKGWIDERTLSPSKPGSGMVVAVKKLKEEGFQGHRQWLA 136
Query: 77 EVIYLGQLRHENLVKLIGYCSESDN-RLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIA 135
EV LG+L H NLVKLIGYCS+ D+ RLLVYE+MPKGSLENHLFR+G +PI W TR+K+A
Sbjct: 137 EVDCLGRLHHMNLVKLIGYCSKGDHIRLLVYEYMPKGSLENHLFRRGAEPIPWRTRIKVA 196
Query: 136 IDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVG 195
I ARGL+FLH +A VIYRD KASN+LLDS FNAKLSDFGLA+ GPTGD THVST+++G
Sbjct: 197 IGAARGLAFLH--EAQVIYRDFKASNILLDSEFNAKLSDFGLAKVGPTGDRTHVSTQVMG 254
Query: 196 TRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRD 255
T+GYAAPEYVATG +T KSDVYSFGVVLLELLSGR +D+ + G+ E+ LV+WA P+L D
Sbjct: 255 TQGYAAPEYVATGRITAKSDVYSFGVVLLELLSGRLTVDKTKVGV-ERNLVDWAIPYLGD 313
Query: 256 SRRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVLTSLEQLH-TSKDMP 314
R+V RIMDT+LGGQY K A LQCL+ +PK RP M DVL++LE+L T K
Sbjct: 314 KRKVFRIMDTKLGGQYPHKGACLTANTALQCLNQEPKLRPKMSDVLSTLEELEMTLKSGS 373
Query: 315 RTPPPAKLXXXXXXXXXXQGIK 336
+ KL Q ++
Sbjct: 374 ISNSVMKLTSSSSSFTAKQRVR 395
|
|
| TAIR|locus:2039772 BIK1 "botrytis-induced kinase1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 992 (354.3 bits), Expect = 5.6e-100, P = 5.6e-100
Identities = 183/307 (59%), Positives = 237/307 (77%)
Query: 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLT 76
K+AT+NF D ++GEGGFGCVFKGW+D++T PTKPG+G+V+A+K+L E FQGH+EWLT
Sbjct: 61 KLATRNFRPDSVIGEGGFGCVFKGWLDESTLTPTKPGTGLVIAVKKLNQEGFQGHREWLT 120
Query: 77 EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGV--QPISWPTRVKI 134
E+ YLGQL H NLVKLIGYC E ++RLLVYEFM KGSLENHLFR+G +P+ W RV +
Sbjct: 121 EINYLGQLSHPNLVKLIGYCLEDEHRLLVYEFMQKGSLENHLFRRGAYFKPLPWFLRVNV 180
Query: 135 AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 194
A+D A+GL+FLH VIYRD+KASN+LLD+++NAKLSDFGLARDGP GD ++VSTR++
Sbjct: 181 ALDAAKGLAFLHSDPVKVIYRDIKASNILLDADYNAKLSDFGLARDGPMGDLSYVSTRVM 240
Query: 195 GTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLR 254
GT GYAAPEY+++GHL +SDVYSFGV+LLE+LSG+RALD +R E+ LV+WA P+L
Sbjct: 241 GTYGYAAPEYMSSGHLNARSDVYSFGVLLLEILSGKRALDHNRPA-KEENLVDWARPYLT 299
Query: 255 DSRRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVLTSLEQLHTSKDMP 314
R+VL I+D RL QY +EA +QCL +PK+RP+M V+ +L+QL + P
Sbjct: 300 SKRKVLLIVDNRLDTQYLPEEAVRMASVAVQCLSFEPKSRPTMDQVVRALQQLQDNLGKP 359
Query: 315 RTPPPAK 321
P K
Sbjct: 360 SQTNPVK 366
|
|
| TAIR|locus:2053240 PK1B "protein kinase 1B" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 979 (349.7 bits), Expect = 1.3e-98, P = 1.3e-98
Identities = 183/295 (62%), Positives = 231/295 (78%)
Query: 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLT 76
K AT+NF D +LGEGGFG VFKGWID+ T +KPG+G+V+A+K+L + +QGH+EWL
Sbjct: 74 KAATRNFRPDSVLGEGGFGSVFKGWIDEQTLTASKPGTGVVIAVKKLNQDGWQGHQEWLA 133
Query: 77 EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKG--VQPISWPTRVKI 134
EV YLGQ H NLVKLIGYC E ++RLLVYEFMP+GSLENHLFR+G QP+SW R+K+
Sbjct: 134 EVNYLGQFSHPNLVKLIGYCLEDEHRLLVYEFMPRGSLENHLFRRGSYFQPLSWTLRLKV 193
Query: 135 AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 194
A+ A+GL+FLH + +VIYRD K SN+LLDS +NAKLSDFGLA+DGPTGD +HVSTRI+
Sbjct: 194 ALGAAKGLAFLHNAETSVIYRDFKTSNILLDSEYNAKLSDFGLAKDGPTGDKSHVSTRIM 253
Query: 195 GTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLR 254
GT GYAAPEY+ATGHLT KSDVYS+GVVLLE+LSGRRA+D++R EQ LVEWA P L
Sbjct: 254 GTYGYAAPEYLATGHLTTKSDVYSYGVVLLEVLSGRRAVDKNRPP-GEQKLVEWARPLLA 312
Query: 255 DSRRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVLTSLEQLHT 309
+ R++ R++D RL QYS +EA L+CL + K RP+M +V++ LE + T
Sbjct: 313 NKRKLFRVIDNRLQDQYSMEEACKVATLALRCLTFEIKLRPNMNEVVSHLEHIQT 367
|
|
| TAIR|locus:2147805 AT5G15080 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 946 (338.1 bits), Expect = 4.2e-95, P = 4.2e-95
Identities = 182/298 (61%), Positives = 221/298 (74%)
Query: 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLT 76
K++T+NF + LLGEGGFGCVFKGWI++N AP KPG+G+ VA+K L + QGHKEWL
Sbjct: 136 KLSTRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNPDGLQGHKEWLA 195
Query: 77 EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 136
E+ +LG L H NLVKL+GYC E D RLLVYEFMP+GSLENHLFR+ + P+ W R+KIA+
Sbjct: 196 EINFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSL-PLPWSIRMKIAL 254
Query: 137 DVARGLSFLHGLDAN-VIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVG 195
A+GLSFLH VIYRD K SN+LLD+++NAKLSDFGLA+D P THVSTR++G
Sbjct: 255 GAAKGLSFLHEEALKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPDEGKTHVSTRVMG 314
Query: 196 TRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRD 255
T GYAAPEYV TGHLT KSDVYSFGVVLLE+L+GRR++D++R E LVEWA P L D
Sbjct: 315 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPN-GEHNLVEWARPHLLD 373
Query: 256 SRRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVLTSLEQLHTSKDM 313
RR R++D RL G +S K AQ QCL DPK RP M DV+ +L+ L KDM
Sbjct: 374 KRRFYRLLDPRLEGHFSIKGAQKVTQLAAQCLSRDPKIRPKMSDVVEALKPLPHLKDM 431
|
|
| TAIR|locus:2100282 AT3G01300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 936 (334.5 bits), Expect = 4.8e-94, P = 4.8e-94
Identities = 181/298 (60%), Positives = 217/298 (72%)
Query: 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLT 76
K+AT+NF + LLGEGGFGCVFKGW+++N AP KPG+G+ VA+K L + QGHKEWL
Sbjct: 130 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNPDGLQGHKEWLA 189
Query: 77 EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 136
E+ YLG L H NLVKL+GYC E D RLLVYEFMP+GSLENHLFR+ + P+ W R+KIA+
Sbjct: 190 EINYLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSL-PLPWSIRMKIAL 248
Query: 137 DVARGLSFLHGLDAN-VIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVG 195
A+GLSFLH VIYRD K SN+LLD +NAKLSDFGLA+D P THVSTR++G
Sbjct: 249 GAAKGLSFLHEEALKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDAPDEGKTHVSTRVMG 308
Query: 196 TRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRD 255
T GYAAPEYV TGHLT KSDVYSFGVVLLE+L+GRR++D++R E LVEWA P L D
Sbjct: 309 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPN-GEHNLVEWARPHLLD 367
Query: 256 SRRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVLTSLEQLHTSKDM 313
RR R++D RL G +S K AQ QCL D K RP M +V+ L+ L KDM
Sbjct: 368 KRRFYRLLDPRLEGHFSVKGAQKVTQLAAQCLSRDSKIRPKMSEVVEVLKPLPHLKDM 425
|
|
| TAIR|locus:2095517 AT3G28690 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 927 (331.4 bits), Expect = 4.3e-93, P = 4.3e-93
Identities = 177/297 (59%), Positives = 218/297 (73%)
Query: 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLT 76
K+AT+NF + LLGEGGFGCVFKGWI++N AP KPG+G+ VA+K L + QGHKEWL
Sbjct: 97 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNPDGLQGHKEWLA 156
Query: 77 EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 136
E+ +LG L H +LVKL+GYC E D RLLVYEFMP+GSLENHLFR+ + P+ W R+KIA+
Sbjct: 157 EINFLGNLVHPSLVKLVGYCMEEDQRLLVYEFMPRGSLENHLFRRTL-PLPWSVRMKIAL 215
Query: 137 DVARGLSFLHG-LDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVG 195
A+GL+FLH + VIYRD K SN+LLD +NAKLSDFGLA+D P +HVSTR++G
Sbjct: 216 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDAPDEKKSHVSTRVMG 275
Query: 196 TRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRD 255
T GYAAPEYV TGHLT KSDVYSFGVVLLE+L+GRR++D+ R EQ LVEW P L D
Sbjct: 276 TYGYAAPEYVMTGHLTTKSDVYSFGVVLLEILTGRRSVDKSRPN-GEQNLVEWVRPHLLD 334
Query: 256 SRRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVLTSLEQLHTSKD 312
+R R++D RL G YS K AQ QCL+ D K RP M +V+ +L+ L KD
Sbjct: 335 KKRFYRLLDPRLEGHYSIKGAQKATQVAAQCLNRDSKARPKMSEVVEALKPLPNLKD 391
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| O49839 | APK2A_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.6246 | 0.9228 | 0.7582 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 350 | |||
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-62 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-61 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 9e-59 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-58 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-56 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 4e-56 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 6e-54 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 8e-39 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-38 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 9e-36 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 7e-34 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-33 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-33 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 8e-33 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 5e-32 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 5e-32 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 7e-32 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 4e-31 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 5e-31 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 5e-31 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-30 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-30 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-30 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-30 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-29 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-29 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 6e-29 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 7e-29 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-28 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-28 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-28 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-28 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-28 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 8e-28 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 8e-28 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-27 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-27 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-27 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 4e-27 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 9e-27 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 9e-27 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-26 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-26 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 8e-26 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 9e-26 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-25 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-25 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 4e-25 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 5e-25 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 6e-25 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 8e-25 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-24 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-24 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-24 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 3e-24 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-24 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 5e-24 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 7e-24 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-23 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-23 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-23 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-23 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-23 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-23 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-23 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-23 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 6e-23 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 6e-23 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 7e-23 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-22 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-22 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-22 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-22 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-22 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-22 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-22 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-22 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-22 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-22 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 5e-22 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 5e-22 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 6e-22 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-21 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-21 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-21 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-21 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-21 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-21 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 6e-21 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 6e-21 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 7e-21 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 8e-21 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 9e-21 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-20 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-20 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 4e-20 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 5e-20 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 6e-20 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 8e-20 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 8e-20 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-19 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-19 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-19 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-19 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 5e-19 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 5e-19 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-18 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-18 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-18 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-18 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-18 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-18 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-18 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-18 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-18 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 4e-18 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 5e-18 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 5e-18 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 6e-18 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 7e-18 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 8e-18 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 9e-18 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-17 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-17 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-17 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-17 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-17 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-17 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-17 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-17 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 4e-17 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 4e-17 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 5e-17 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 7e-17 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 7e-17 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 7e-17 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 9e-17 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-16 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-16 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-16 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-16 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-16 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-16 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-16 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-16 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 3e-16 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-16 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-16 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 4e-16 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-16 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 4e-16 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 5e-16 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 5e-16 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 5e-16 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 5e-16 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 5e-16 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 6e-16 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 6e-16 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 9e-16 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 9e-16 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-15 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-15 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-15 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-15 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-15 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-15 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-15 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-15 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-15 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-15 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-15 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 3e-15 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 3e-15 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-15 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-15 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 4e-15 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 4e-15 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 4e-15 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 8e-15 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 8e-15 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 9e-15 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-14 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-14 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-14 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-14 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-14 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-14 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-14 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-14 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-14 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-14 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-14 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-14 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-14 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 4e-14 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 4e-14 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 4e-14 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 5e-14 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 6e-14 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 6e-14 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 9e-14 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-13 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-13 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-13 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-13 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-13 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-13 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 4e-13 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 4e-13 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 5e-13 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 7e-13 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 7e-13 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 7e-13 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 7e-13 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 9e-13 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 9e-13 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-12 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-12 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-12 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-12 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-12 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-12 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-12 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-12 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-12 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 4e-12 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 4e-12 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 5e-12 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 5e-12 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 6e-12 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 7e-12 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 8e-12 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-11 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-11 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-11 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-11 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-11 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-11 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-11 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-11 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-11 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-11 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-11 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-11 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 4e-11 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 5e-11 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 5e-11 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 6e-11 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-10 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-10 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-10 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-10 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-10 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-10 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-10 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-10 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 4e-10 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 6e-10 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 7e-10 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 8e-10 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 9e-10 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-09 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-09 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-09 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-09 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-09 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 4e-09 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 4e-09 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 4e-09 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 4e-09 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 5e-09 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 5e-09 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 6e-09 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 8e-09 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 9e-09 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-08 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-08 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-08 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-08 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-08 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 4e-08 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 5e-08 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 5e-08 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 5e-08 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 6e-08 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 8e-08 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 2e-07 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-07 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-07 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-07 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 4e-07 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 5e-07 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 6e-07 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-06 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 4e-06 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 5e-06 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 5e-06 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 8e-06 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-05 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 7e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-04 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-04 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-04 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 4e-04 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 5e-04 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 0.001 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 0.002 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 199 bits (509), Expect = 2e-62
Identities = 91/278 (32%), Positives = 147/278 (52%), Gaps = 28/278 (10%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAE-SFQGHKEWLTEVIYLGQLRHE 87
LGEG FG V+KG + G + VA+K LK + S Q +E+L E + +L H
Sbjct: 7 LGEGAFGEVYKGTLK-----GKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHG 147
N+VKL+G C+E + ++V E+MP G L ++L + + +S + A+ +ARG+ +L
Sbjct: 62 NIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE- 120
Query: 148 LDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT 207
N I+RDL A N L+ N K+SDFGL+RD D V + R + APE +
Sbjct: 121 -SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIR-WMAPESLKE 178
Query: 208 GHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTR 266
G T KSDV+SFGV+L E+ + G +E G++ ++E+ L+ R+ + +
Sbjct: 179 GKFTSKSDVWSFGVLLWEIFTLG----EEPYPGMSNAEVLEY----LKKGYRLPKPPNCP 230
Query: 267 LGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL 304
+ ++LQC DP++RP+ +++ L
Sbjct: 231 ----------PELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 196 bits (502), Expect = 2e-61
Identities = 89/278 (32%), Positives = 145/278 (52%), Gaps = 29/278 (10%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAE-SFQGHKEWLTEVIYLGQLRHE 87
LGEG FG V+KG + + VA+K LK + S Q +E+L E + +L H
Sbjct: 7 LGEGAFGEVYKGKLK-----GKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHG 147
N+VKL+G C+E + +V E+M G L ++L RK +S + A+ +ARG+ +L
Sbjct: 62 NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYL-RKNRPKLSLSDLLSFALQIARGMEYLE- 119
Query: 148 LDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT 207
N I+RDL A N L+ N K+SDFGL+RD D + R + APE +
Sbjct: 120 -SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIR-WMAPESLKE 177
Query: 208 GHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTR 266
G T KSDV+SFGV+L E+ + G ++ G++ + ++E+ L++ R+ + +
Sbjct: 178 GKFTSKSDVWSFGVLLWEIFTLG----EQPYPGMSNEEVLEY----LKNGYRLPQPPNCP 229
Query: 267 LGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL 304
+ ++LQC DP++RP+ +++ L
Sbjct: 230 ----------PELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 190 bits (484), Expect = 9e-59
Identities = 91/278 (32%), Positives = 138/278 (49%), Gaps = 34/278 (12%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES--FQGHKEWLTEVIYLGQLRH 86
LG G FG V+K G+G +VA+K LK S + + E+ L +L H
Sbjct: 7 LGSGSFGTVYKA---------KHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSH 57
Query: 87 ENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLH 146
N+V+LI + D+ LV E+ G L ++L R G P+S KIA+ + RGL +LH
Sbjct: 58 PNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGG--PLSEDEAKKIALQILRGLEYLH 115
Query: 147 GLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVA 206
+I+RDLK N+LLD N K++DFGLA+ ++ ++T VGT Y APE +
Sbjct: 116 --SNGIIHRDLKPENILLDENGVVKIADFGLAKKL-LKSSSSLTT-FVGTPWYMAPEVLL 171
Query: 207 TG-HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDT 265
G PK DV+S GV+L ELL+G+ + L + + RI+
Sbjct: 172 GGNGYGPKVDVWSLGVILYELLTGK--------------PPFSGENILDQLQLIRRILGP 217
Query: 266 RLGGQYSKK--EAQAVAAVVLQCLHMDPKNRPSMVDVL 301
L K ++ ++ +CL+ DP RP+ ++L
Sbjct: 218 PLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEIL 255
|
Length = 260 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 188 bits (480), Expect = 3e-58
Identities = 87/284 (30%), Positives = 141/284 (49%), Gaps = 40/284 (14%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAE-SFQGHKEWLTEVIYLGQLRHE 87
LGEG FG V+KG + G+ VA+K LK S + +E+L E + +L H
Sbjct: 7 LGEGAFGEVYKGTLK-----GDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHP 61
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHG 147
N+V+L+G C++ + +V E+MP G L + L RK + ++ +++A+ +A+G+ +L
Sbjct: 62 NIVRLLGVCTQGEPLYIVTEYMPGGDLLDFL-RKHGEKLTLKDLLQMALQIAKGMEYLE- 119
Query: 148 LDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRG---YAAPEY 204
N ++RDL A N L+ N K+SDFGL+RD D G + + APE
Sbjct: 120 -SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRG---GGKLPIKWMAPES 175
Query: 205 VATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADP----FLRDSRRVL 260
+ G T KSDV+SFGV+L E+ + L EQ ++ L D R+
Sbjct: 176 LKDGKFTSKSDVWSFGVLLWEIFT-----------LGEQPYPGMSNEEVLELLEDGYRLP 224
Query: 261 RIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL 304
R + + ++LQC DP++RP+ +++ L
Sbjct: 225 RPENC----------PDELYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 185 bits (471), Expect = 1e-56
Identities = 90/293 (30%), Positives = 141/293 (48%), Gaps = 49/293 (16%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAE-SFQGHKEWLTEVIYLGQLRHE 87
LGEG FG V+KG K G VA+K LK + S + K++L E + +L H
Sbjct: 3 LGEGAFGEVYKG------KLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHP 56
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHL-------FRKGVQPISWPTRVKIAIDVAR 140
N+V+L+G C+E + LV E+M G L ++L +S + AI +A+
Sbjct: 57 NVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAK 116
Query: 141 GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVST-RIVGTRGY 199
G+ +L ++RDL A N L+ + K+SDFGL+RD D T + R +
Sbjct: 117 GMEYLASK--KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR-W 173
Query: 200 AAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRG-----GLAEQTLVEWADPFLR 254
APE + G T KSDV+SFGV+L E+ + G GL+ + ++E +LR
Sbjct: 174 MAPESLKDGIFTSKSDVWSFGVLLWEIFT--------LGATPYPGLSNEEVLE----YLR 221
Query: 255 DSRRVLRIMDTRLGGQYSKKE--AQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 305
G + K E + ++L C +DP++RP+ +++ LE
Sbjct: 222 K------------GYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 181 bits (462), Expect = 4e-56
Identities = 85/279 (30%), Positives = 124/279 (44%), Gaps = 67/279 (24%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKE-WLTEVIYLGQLRHE 87
LGEGGFG V+ + G VAIK +K E E L E+ L +L H
Sbjct: 1 LGEGGFGTVYLARDKKT---------GKKVAIKIIKKEDSSSLLEELLREIEILKKLNHP 51
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHG 147
N+VKL G + ++ LV E+ GSL++ L +S ++I + + GL +LH
Sbjct: 52 NIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENE-GKLSEDEILRILLQILEGLEYLH- 109
Query: 148 LDANVIYRDLKASNVLLDS-NFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPE-YV 205
+I+RDLK N+LLDS N KL+DFGL++ + + IVGT Y APE +
Sbjct: 110 -SNGIIHRDLKPENILLDSDNGKVKLADFGLSKL--LTSDKSLLKTIVGTPAYMAPEVLL 166
Query: 206 ATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDT 265
G+ + KSD++S GV+L EL P L+D
Sbjct: 167 GKGYYSEKSDIWSLGVILYEL------------------------PELKD---------- 192
Query: 266 RLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL 304
++ + L DP+ RPS ++L L
Sbjct: 193 ----------------LIRKMLQKDPEKRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 177 bits (452), Expect = 6e-54
Identities = 78/281 (27%), Positives = 121/281 (43%), Gaps = 42/281 (14%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKE-WLTEVIYLGQLRH 86
LGEG FG V+ D+ T G +VAIK +K + + +E L E+ L +L+H
Sbjct: 6 KLGEGSFGKVYLA-RDKKT--------GKLVAIKVIKKKKIKKDRERILREIKILKKLKH 56
Query: 87 ENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLH 146
N+V+L + D LV E+ G L + L ++G +S + L +LH
Sbjct: 57 PNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRG--RLSEDEARFYLRQILSALEYLH 114
Query: 147 GLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVA 206
+++RDLK N+LLD + + KL+DFGLAR D T VGT Y APE +
Sbjct: 115 --SKGIVHRDLKPENILLDEDGHVKLADFGLARQ---LDPGEKLTTFVGTPEYMAPEVLL 169
Query: 207 TGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTR 266
D++S GV+L ELL+G+ PF ++L +
Sbjct: 170 GKGYGKAVDIWSLGVILYELLTGKP-------------------PF-PGDDQLLELFKKI 209
Query: 267 LGGQYSKKEA-----QAVAAVVLQCLHMDPKNRPSMVDVLT 302
+ ++ + L DP+ R + + L
Sbjct: 210 GKPKPPFPPPEWDISPEAKDLIRKLLVKDPEKRLTAEEALQ 250
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 8e-39
Identities = 71/272 (26%), Positives = 124/272 (45%), Gaps = 39/272 (14%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHEN 88
+G+GGFG V+K + +G VAIK +K ES + ++ + E+ L + +H N
Sbjct: 8 IGKGGFGEVYKARHKR---------TGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPN 58
Query: 89 LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL 148
+VK G + D +V EF GSL++ L + Q ++ + ++ +GL +LH
Sbjct: 59 IVKYYGSYLKKDELWIVMEFCSGGSLKD-LLKSTNQTLTESQIAYVCKELLKGLEYLHSN 117
Query: 149 DANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG 208
+I+RD+KA+N+LL S+ KL DFGL+ + +VGT + APE +
Sbjct: 118 --GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARN---TMVGTPYWMAPEVINGK 172
Query: 209 HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLG 268
K+D++S G+ +EL G+ P + + +
Sbjct: 173 PYDYKADIWSLGITAIELAEGK--------------------PPYSELPPMKALFKIATN 212
Query: 269 GQY----SKKEAQAVAAVVLQCLHMDPKNRPS 296
G +K + + +CL +P+ RP+
Sbjct: 213 GPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPT 244
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 4e-38
Identities = 69/273 (25%), Positives = 127/273 (46%), Gaps = 33/273 (12%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIK--RLKAESFQGHKEWLTEVIYLGQLR 85
LLG G FG V+ +D++T G ++A+K L +S + + E+ L L+
Sbjct: 7 LLGRGSFGSVYLA-LDKDT--------GELMAVKSVELSGDSEEELEALEREIRILSSLQ 57
Query: 86 HENLVKLIG-YCSESDNRLLVY-EFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLS 143
H N+V+ G E N L ++ E++ GSL + L + G + P K + GL+
Sbjct: 58 HPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLA 115
Query: 144 FLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPE 203
+LH +++RD+K +N+L+DS+ KL+DFG A+ + + + GT + APE
Sbjct: 116 YLH--SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPE 173
Query: 204 YVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIM 263
+ +D++S G ++E+ +G+ E +A + +I
Sbjct: 174 VIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAA----------------LYKIG 217
Query: 264 DTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPS 296
+ + + ++ + +CL DPK RP+
Sbjct: 218 SSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPT 250
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 9e-36
Identities = 84/283 (29%), Positives = 132/283 (46%), Gaps = 46/283 (16%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHE 87
+G+G FG V G + K VA+K LK +S + +L E + LRH
Sbjct: 13 TIGKGEFGDVMLG-----DYRGQK------VAVKCLKDDS-TAAQAFLAEASVMTTLRHP 60
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHG 147
NLV+L+G + + +V E+M KGSL ++L +G I+ ++ A+DV G+ +L
Sbjct: 61 NLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEE 120
Query: 148 LDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT 207
N ++RDL A NVL+ + AK+SDFGLA++ G S ++ + APE +
Sbjct: 121 --KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG---QDSGKL--PVKWTAPEALRE 173
Query: 208 GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRL 267
+ KSDV+SFG++L E+ S R P+ R L+ + +
Sbjct: 174 KKFSTKSDVWSFGILLWEIYSFGRV------------------PYPRIP---LKDVVPHV 212
Query: 268 GGQYSKKEA-----QAVAAVVLQCLHMDPKNRPSMVDVLTSLE 305
Y + EA V V+ C +DP RP+ + L
Sbjct: 213 EKGY-RMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLA 254
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 125 bits (317), Expect = 7e-34
Identities = 81/287 (28%), Positives = 133/287 (46%), Gaps = 21/287 (7%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGH-KEWLTEVIYLGQLRHE 87
LGEG FG V D P +G VA+K L + H ++ E+ L L HE
Sbjct: 12 LGEGHFGKVELCRYD-----PLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHE 66
Query: 88 NLVKLIGYCSESDNR--LLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFL 145
N+VK G C + R L+ E++P GSL ++L ++ I+ + + + +G+ +L
Sbjct: 67 NIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYL-QRHRDQINLKRLLLFSSQICKGMDYL 125
Query: 146 HGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVST--RIVGTRGYAAPE 203
I+RDL A N+L++S K+SDFGLA+ P + + Y APE
Sbjct: 126 G--SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APE 182
Query: 204 YVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIM 263
+ T + SDV+SFGV L EL + D + AE + R+L ++
Sbjct: 183 CLRTSKFSSASDVWSFGVTLYELFT---YGDPSQSPPAEFLRMIGIAQGQMIVTRLLELL 239
Query: 264 DTRLGGQYSKKEA--QAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLH 308
G + + + V ++ C +P++RPS D++ +++L
Sbjct: 240 KE--GERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (312), Expect = 2e-33
Identities = 69/206 (33%), Positives = 109/206 (52%), Gaps = 19/206 (9%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLR 85
L+G G FG V+KG ++ T G VAIK++ E + K + E+ L L+
Sbjct: 7 LIGRGAFGVVYKG-LNLET--------GDFVAIKQISLEKIKEEALKSIMQEIDLLKNLK 57
Query: 86 HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI-DVARGLSF 144
H N+VK IG SD+ ++ E+ GSL + + G P S V + + V +GL++
Sbjct: 58 HPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPES---LVAVYVYQVLQGLAY 114
Query: 145 LHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEY 204
LH + VI+RD+KA+N+L + KL+DFG+A D + +VGT + APE
Sbjct: 115 LH--EQGVIHRDIKAANILTTKDGVVKLADFGVATK--LNDVSKDDASVVGTPYWMAPEV 170
Query: 205 VATGHLTPKSDVYSFGVVLLELLSGR 230
+ + SD++S G ++ELL+G
Sbjct: 171 IEMSGASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 2e-33
Identities = 90/307 (29%), Positives = 150/307 (48%), Gaps = 51/307 (16%)
Query: 9 DPSASMISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF 68
DPS I K+ +G G FG V +G + P K I VAIK LKA S
Sbjct: 2 DPSYVTIEKV----------IGGGEFGEVCRGRLKL----PGKKE--IDVAIKTLKAGSS 45
Query: 69 QGHK-EWLTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPIS 127
+ ++LTE +GQ H N+++L G ++S +++ E+M GSL+ L R+ +
Sbjct: 46 DKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFL-RENDGKFT 104
Query: 128 WPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNT 187
V + +A G+ +L + N ++RDL A N+L++SN K+SDFGL+R + T
Sbjct: 105 VGQLVGMLRGIASGMKYLS--EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEAT 162
Query: 188 HVSTRIVGTRG------YAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGL 240
+ T+G + APE +A T SDV+SFG+V+ E++S G R +
Sbjct: 163 YT------TKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPY----WDM 212
Query: 241 AEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDV 300
+ Q +++ + D R+ MD A+ ++L C D RP+ +
Sbjct: 213 SNQDVIK----AVEDGYRLPPPMDC----------PSALYQLMLDCWQKDRNERPTFSQI 258
Query: 301 LTSLEQL 307
+++L+++
Sbjct: 259 VSTLDKM 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 8e-33
Identities = 66/205 (32%), Positives = 108/205 (52%), Gaps = 24/205 (11%)
Query: 29 LGEGGFGCVFKG-WIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHE 87
LG G FG V++G W ++ + VAIK LK++ +++ EV L +LRH+
Sbjct: 14 LGSGYFGEVWEGLWKNR-----------VRVAIKILKSDDLLKQQDFQKEVQALKRLRHK 62
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHG 147
+L+ L CS + ++ E M KGSL L Q + + + +A VA G+++L
Sbjct: 63 HLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE- 121
Query: 148 LDANVIYRDLKASNVLLDSNFNAKLSDFGLAR----DGPTGDNTHVSTRIVGTRGYAAPE 203
+ N I+RDL A N+L+ + K++DFGLAR D + + + + APE
Sbjct: 122 -EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYK------WTAPE 174
Query: 204 YVATGHLTPKSDVYSFGVVLLELLS 228
+ G + KSDV+SFG++L E+ +
Sbjct: 175 AASHGTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 123 bits (308), Expect = 5e-32
Identities = 84/331 (25%), Positives = 130/331 (39%), Gaps = 35/331 (10%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEW---LTEVIYLGQL 84
LGEG FG V+ + VA+K L + KE L E+ L L
Sbjct: 7 KLGEGSFGEVYLARDRKL------------VALKVLAKKLESKSKEVERFLREIQILASL 54
Query: 85 RHE-NLVKLIGYCSESDNRLLVYEFMPKGSLENHL-FRKGVQPISWPTRVKIAIDVARGL 142
H N+VKL + + + LV E++ GSLE+ L P+S + I + L
Sbjct: 55 NHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSAL 114
Query: 143 SFLHGLDANVIYRDLKASNVLLDSN-FNAKLSDFGLAR----DGPTGDNTHVSTRIVGTR 197
+LH +I+RD+K N+LLD + KL DFGLA+ G T + + VGT
Sbjct: 115 EYLH--SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTP 172
Query: 198 GYAAPEYVA---TGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLR 254
GY APE + + + SD++S G+ L ELL+G + ++ A ++
Sbjct: 173 GYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILEL-- 230
Query: 255 DSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDMP 314
+ + + SK A + ++ + L DPKNR S L L +
Sbjct: 231 PTPSLASPLSPSNPELISK----AASDLLKKLLAKDPKNRLSSSSDL--SHDLLAHLKLK 284
Query: 315 RTPPPAKLHHHHHHHNHHQGIKHTNPPRKTS 345
+ L +
Sbjct: 285 ESDLSDLLKPDDSAPLRLSLPPSLEALISSL 315
|
Length = 384 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 5e-32
Identities = 85/283 (30%), Positives = 134/283 (47%), Gaps = 39/283 (13%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKE-WLTEVIYLGQLRH 86
+G+G FG V+KG + NT VA+K ++ K +L E L Q H
Sbjct: 2 KIGKGNFGDVYKGVLKGNT----------EVAVKTCRSTLPPDLKRKFLQEAEILKQYDH 51
Query: 87 ENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLH 146
N+VKLIG C + +V E +P GSL L +K + ++ +++++D A G+ +L
Sbjct: 52 PNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNR-LTVKKLLQMSLDAAAGMEYLE 110
Query: 147 GLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR----GYAAP 202
N I+RDL A N L+ N K+SDFG++R+ G T VS G + + AP
Sbjct: 111 S--KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYT-VSD---GLKQIPIKWTAP 164
Query: 203 EYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRI 262
E + G T +SDV+S+G++L E S D G++ Q E + R
Sbjct: 165 EALNYGRYTSESDVWSYGILLWETFSLG---DTPYPGMSNQQTRERIESGYRMPA----- 216
Query: 263 MDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 305
+ + + ++LQC DP+NRPS ++ L+
Sbjct: 217 ---------PQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 7e-32
Identities = 89/279 (31%), Positives = 140/279 (50%), Gaps = 40/279 (14%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAE-SFQGHKEWLTEVIYLGQLRHE 87
LG G FG V KG K G + VA+K LK E G KE+L E + QL H
Sbjct: 3 LGHGNFGSVVKGVYL------MKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHP 56
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHG 147
+V+LIG C + + +LV E P G L +L ++ P+S ++A VA G+++L
Sbjct: 57 CIVRLIGVC-KGEPLMLVMELAPLGPLLKYLKKRREIPVS--DLKELAHQVAMGMAYLES 113
Query: 148 LDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR---GYAAPEY 204
+ ++RDL A NVLL + AK+SDFG++R G + + +T R + APE
Sbjct: 114 --KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATT--AGRWPLKWYAPEC 169
Query: 205 VATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIM 263
+ G + KSDV+S+GV L E S G + E +G AE V+ ++
Sbjct: 170 INYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG--AE----------------VIAML 211
Query: 264 DTRLGGQYSKKE--AQAVAAVVLQCLHMDPKNRPSMVDV 300
++ G + + E Q + +++L C P++RP+ ++
Sbjct: 212 ES--GERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSEL 248
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 4e-31
Identities = 85/294 (28%), Positives = 135/294 (45%), Gaps = 42/294 (14%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPG-SGIVVAIKRLK-AESFQGHKEWLTEVIYLGQLRH 86
LGEG FG VF G +P +VA+K LK S K++ E L +H
Sbjct: 13 LGEGAFGKVFLG-----ECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQH 67
Query: 87 ENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKG------VQPISWPTR------VKI 134
EN+VK G C+E D ++V+E+M G L L G P S ++I
Sbjct: 68 ENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQI 127
Query: 135 AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS-TRI 193
A+ +A G+ +L + ++RDL N L+ + K+ DFG++RD T D V +
Sbjct: 128 AVQIASGMVYLASQ--HFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTM 185
Query: 194 VGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPF 252
+ R + PE + T +SDV+SFGVVL E+ + G++ GL+ + ++E
Sbjct: 186 LPIR-WMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPW----YGLSNEEVIECI--- 237
Query: 253 LRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQ 306
R+L+ T V ++L C DP+ R ++ D+ L++
Sbjct: 238 --TQGRLLQRPRTC---------PSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 5e-31
Identities = 83/298 (27%), Positives = 137/298 (45%), Gaps = 49/298 (16%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGH--KEWLTEVIYLGQLR 85
+LGEG FG V +G + Q+ + K VA+K +K + +E+L+E +
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLK------VAVKTMKLDIHTYSEIEEFLSEAACMKDFD 59
Query: 86 HENLVKLIGYCSESDNR------LLVYEFMPKGSLENHLF--RKGVQPISWPTR--VKIA 135
H N++KLIG C E+ + +++ FM G L + L R G P P + +K
Sbjct: 60 HPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFM 119
Query: 136 IDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGD---NTHVSTR 192
+D+A G+ +L + N I+RDL A N +L + ++DFGL++ +GD ++
Sbjct: 120 VDIALGMEYLS--NRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKM 177
Query: 193 IVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPF 252
V + A E +A T KSDV++FGV + E+ + RG QT P
Sbjct: 178 PV---KWIAIESLADRVYTSKSDVWAFGVTMWEIAT--------RG----QT----PYPG 218
Query: 253 LRDSRRVLRIMDTRLGGQYSKKEAQA---VAAVVLQCLHMDPKNRPSMVDVLTSLEQL 307
+ + I D G K+ + ++ C DPK+RP+ + LE +
Sbjct: 219 VENH----EIYDYLRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 5e-31
Identities = 82/295 (27%), Positives = 136/295 (46%), Gaps = 50/295 (16%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIV-VAIKRL-KAESFQGHKEWLTEVIYLGQLRH 86
LG+G FG V++G G VAIK + + S + E+L E + +
Sbjct: 14 LGQGSFGMVYEGLAKG-----VVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNC 68
Query: 87 ENLVKLIGYCSESDNRLLVYEFMPKGSLENHL--------FRKGVQPISWPTRVKIAIDV 138
++V+L+G S L+V E M KG L+++L G+ P + +++A ++
Sbjct: 69 HHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEI 128
Query: 139 ARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR- 197
A G+++L ++RDL A N ++ + K+ DFG+ RD R G
Sbjct: 129 ADGMAYLAAK--KFVHRDLAARNCMVAEDLTVKIGDFGMTRD----IYETDYYRKGGKGL 182
Query: 198 ---GYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLR 254
+ APE + G T KSDV+SFGVVL E+ + LAEQ P+
Sbjct: 183 LPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT-----------LAEQ-------PYQG 224
Query: 255 DS-RRVLR-IMDTRLGGQYSKKEA--QAVAAVVLQCLHMDPKNRPSMVDVLTSLE 305
S VL+ ++D GG E + ++ C +PK RP+ +++++SL+
Sbjct: 225 LSNEEVLKFVID---GGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 1e-30
Identities = 71/291 (24%), Positives = 119/291 (40%), Gaps = 57/291 (19%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKR--LKAESFQGHKEWLTEVIYLGQLR 85
+G+G FG V+ + G + +K L S + ++ L EV L +L
Sbjct: 7 QIGKGSFGKVYLV---------RRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLN 57
Query: 86 HENLVKLIGYCSESDNRLLVYEFMPKGSLENHL--FRKGVQPISWPTRVKIAIDVARGLS 143
H N++K E +V E+ G L + +K +P + + + L
Sbjct: 58 HPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALK 117
Query: 144 FLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPE 203
+LH +++RD+K N+ L SN KL DFG+++ ++ +VGT Y +PE
Sbjct: 118 YLH--SRKILHRDIKPQNIFLTSNGLVKLGDFGISKV--LSSTVDLAKTVVGTPYYLSPE 173
Query: 204 ------YVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSR 257
Y KSD++S G VL EL + + PF ++
Sbjct: 174 LCQNKPY------NYKSDIWSLGCVLYELCTLKH-------------------PFEGENL 208
Query: 258 R--VLRIMD---TRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303
L+I+ + QYS + + +V L DP+ RPS+ +L S
Sbjct: 209 LELALKILKGQYPPIPSQYSSE----LRNLVSSLLQKDPEERPSIAQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 1e-30
Identities = 67/215 (31%), Positives = 105/215 (48%), Gaps = 21/215 (9%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAE-SFQGHKEWLTEVIYLGQLRHE 87
LGEG FG V+KG + P + S VAIK LK + +E+ E + L+H
Sbjct: 13 LGEGAFGKVYKGEL----TGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHP 68
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRK--------------GVQPISWPTRVK 133
N+V L+G C++ +++E++ G L L R + +
Sbjct: 69 NIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLH 128
Query: 134 IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRI 193
IAI +A G+ +L + ++RDL A N L+ K+SDFGL+RD + D V ++
Sbjct: 129 IAIQIAAGMEYLSS--HHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKS 186
Query: 194 VGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 228
+ + PE + G T +SD++SFGVVL E+ S
Sbjct: 187 LLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 2e-30
Identities = 74/211 (35%), Positives = 109/211 (51%), Gaps = 31/211 (14%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLK-----AESFQGHKEWLTEVIYLGQ 83
LG G FG V+ G + T VA+K LK E+F L E + +
Sbjct: 14 LGAGQFGEVWMGTWNGTT----------KVAVKTLKPGTMSPEAF------LQEAQIMKK 57
Query: 84 LRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLS 143
LRH+ LV+L CSE + +V E+M KGSL + L + + P V +A +A G++
Sbjct: 58 LRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMA 117
Query: 144 FLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR---GYA 200
+L N I+RDL A N+L+ N K++DFGLAR ++ + R G + +
Sbjct: 118 YLE--SRNYIHRDLAARNILVGENLVCKIADFGLAR---LIEDDEYTAR-EGAKFPIKWT 171
Query: 201 APEYVATGHLTPKSDVYSFGVVLLELLS-GR 230
APE G T KSDV+SFG++L E+++ GR
Sbjct: 172 APEAANYGRFTIKSDVWSFGILLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 3e-30
Identities = 83/300 (27%), Positives = 142/300 (47%), Gaps = 42/300 (14%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPT-------KPGSGIVVAIKRLKAESFQGHK-EWLTEVIY 80
LGEG FG V + PT + G ++VA+K L+ ++ + + ++L EV
Sbjct: 13 LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKI 72
Query: 81 LGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSL----ENHLFRKGVQP----------- 125
L +L+ N+++L+G C + D ++ E+M G L +H +
Sbjct: 73 LSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCL 132
Query: 126 --ISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPT 183
IS+ + + +A+ +A G+ +L L N ++RDL N L+ N K++DFG++R+
Sbjct: 133 PAISYSSLLHVALQIASGMKYLSSL--NFVHRDLATRNCLVGENLTIKIADFGMSRNLYA 190
Query: 184 GDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQ 243
GD + R V + A E + G T SDV++FGV L E+L + + G L ++
Sbjct: 191 GDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKE--QPYGELTDE 248
Query: 244 TLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEA---QAVAAVVLQCLHMDPKNRPSMVDV 300
++E A F RD R + Y + Q + ++LQC D + RPS D+
Sbjct: 249 QVIENAGEFFRDQGRQV----------YLFRPPPCPQGLYELMLQCWSRDCRERPSFSDI 298
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 1e-29
Identities = 87/287 (30%), Positives = 136/287 (47%), Gaps = 23/287 (8%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKE-WLTEVIYLGQLRHE 87
LGEG FG V D P G+G +VA+K LK E Q + W E+ L L HE
Sbjct: 12 LGEGHFGKVSLYCYD-----PANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHE 66
Query: 88 NLVKLIGYCSESDNR--LLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFL 145
N+VK G CSE + L+ E++P GSL ++L + ++ + A + G+++L
Sbjct: 67 NIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPK---HKLNLAQLLLFAQQICEGMAYL 123
Query: 146 HGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTH-VSTRIVGTRGYAAPEY 204
H + I+RDL A NVLLD++ K+ DFGLA+ P G + V + A E
Sbjct: 124 HS--QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVEC 181
Query: 205 VATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMD 264
+ + SDV+SFGV L ELL+ + E ++ + V+R+++
Sbjct: 182 LKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEE--MIGPKQGQM----TVVRLIE 235
Query: 265 TRLGGQY---SKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLH 308
G K Q V ++ C + K RP+ ++ L+++H
Sbjct: 236 LLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 3e-29
Identities = 67/206 (32%), Positives = 106/206 (51%), Gaps = 21/206 (10%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHEN 88
LG G FG V++G + T VA+K LK + K++L E + +LRH
Sbjct: 14 LGAGQFGEVWEGLWNNTT----------PVAVKTLKPGTMDP-KDFLAEAQIMKKLRHPK 62
Query: 89 LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL 148
L++L C+ + +V E M GSL +L + + P + +A VA G+++L
Sbjct: 63 LIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE-- 120
Query: 149 DANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR---GYAAPEYV 205
N I+RDL A NVL+ N K++DFGLAR ++ + + G + + APE
Sbjct: 121 AQNYIHRDLAARNVLVGENNICKVADFGLAR--VIKEDIYEAR--EGAKFPIKWTAPEAA 176
Query: 206 ATGHLTPKSDVYSFGVVLLELLS-GR 230
+ KSDV+SFG++L E+++ GR
Sbjct: 177 LYNRFSIKSDVWSFGILLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (281), Expect = 6e-29
Identities = 70/206 (33%), Positives = 106/206 (51%), Gaps = 20/206 (9%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEW---LTEVIYLGQLR 85
LG+G FG V K +G + A+K LK + KE LTE L ++
Sbjct: 1 LGKGSFGKVL---------LVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRIN 51
Query: 86 HENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSF 144
H +VKL Y +++ +L LV E+ P G L +HL ++G R A ++ L +
Sbjct: 52 HPFIVKLH-YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEER-ARFYAA-EIVLALEY 108
Query: 145 LHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEY 204
LH L +IYRDLK N+LLD++ + KL+DFGLA++ + + + GT Y APE
Sbjct: 109 LHSLG--IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT--FCGTPEYLAPEV 164
Query: 205 VATGHLTPKSDVYSFGVVLLELLSGR 230
+ D +S GV+L E+L+G+
Sbjct: 165 LLGKGYGKAVDWWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 7e-29
Identities = 80/298 (26%), Positives = 148/298 (49%), Gaps = 34/298 (11%)
Query: 29 LGEGGFG----CVFKG---WIDQNTFAPTKPGSGIVVAIKRLKAESFQGHK-EWLTEVIY 80
LGEG FG C +G ++D++ ++VA+K L+ ++ + + ++L E+
Sbjct: 13 LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72
Query: 81 LGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFR---------KGVQPISWPTR 131
+ +L+ N+++L+ C SD ++ E+M G L L R V IS+ T
Sbjct: 73 MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTL 132
Query: 132 VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVST 191
+ +A +A G+ +L L N ++RDL N L+ N+ K++DFG++R+ +GD +
Sbjct: 133 IFMATQIASGMKYLSSL--NFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQG 190
Query: 192 RIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADP 251
R V + + E + G T SDV++FGV L E+L+ + ++ L+++ ++E
Sbjct: 191 RAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCK--EQPYSQLSDEQVIENTGE 248
Query: 252 FLRDSRRVLRIMDTRLGGQYSKKEA---QAVAAVVLQCLHMDPKNRPSMVDVLTSLEQ 306
F RD R + Y K A ++ ++L C + K RPS ++ +L +
Sbjct: 249 FFRDQGRQV----------YLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 1e-28
Identities = 80/289 (27%), Positives = 121/289 (41%), Gaps = 38/289 (13%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKA--ESFQGHKEWLTEVIYLGQLR 85
++GEG +G V K ++ T G +VAIK+ K + K L EV L QLR
Sbjct: 8 VVGEGAYGVVLKC-RNKAT--------GEIVAIKKFKESEDDEDVKKTALREVKVLRQLR 58
Query: 86 HENLVKLIGYCSESDNRLLVYEFMPKGSLEN-HLFRKGVQPISWPTRVKIAIDVARGLSF 144
HEN+V L LV+E++ + LE G+ P + R + + +++
Sbjct: 59 HENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDA--VR-SYIWQLLQAIAY 115
Query: 145 LHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPE- 203
H N+I+RD+K N+L+ + KL DFG AR + + T V TR Y APE
Sbjct: 116 CHSH--NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPL-TDYVATRWYRAPEL 172
Query: 204 YVATGHLTPKSDVYSFGVVLLELLSGRRAL-----DEDR--------GGLAE-QTLVEWA 249
V + DV++ G ++ ELL G L D D+ G L + +
Sbjct: 173 LVGDTNYGKPVDVWAIGCIMAELLDGE-PLFPGDSDIDQLYLIQKCLGPLPPSHQELFSS 231
Query: 250 DPFLRDSRRVLRIMDTRLGGQ--YSKKEAQAVAAVVLQCLHMDPKNRPS 296
+P + Y K + + CL MDPK R +
Sbjct: 232 NPRFAGVA--FPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLT 278
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 2e-28
Identities = 88/286 (30%), Positives = 144/286 (50%), Gaps = 36/286 (12%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPG-SGIVVAIKRLKAESFQGHK-EWLTEVIYLGQLR 85
++G G FG VF+G + PG + VAIK LK + + ++L+E +GQ
Sbjct: 12 VIGAGEFGEVFRGILKM-------PGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFS 64
Query: 86 HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFL 145
H N+++L G ++ +++ E+M G+L+ +L R S V + +A G+ +L
Sbjct: 65 HHNIIRLEGVVTKFKPAMIITEYMENGALDKYL-RDHDGEFSSYQLVGMLRGIAAGMKYL 123
Query: 146 HGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR---DGPTGDNTHVSTRIVGTRGYAAP 202
D N ++RDL A N+L++SN K+SDFGL+R D P G T +I + AP
Sbjct: 124 S--DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKI--PIRWTAP 179
Query: 203 EYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLR 261
E +A T SDV+SFG+V+ E++S G R + ++ +++ + D R+
Sbjct: 180 EAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWD----MSNHEVMK----AINDGFRLPA 231
Query: 262 IMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 307
MD AV ++LQC D RP VD++ L++L
Sbjct: 232 PMDC----------PSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 2e-28
Identities = 84/280 (30%), Positives = 138/280 (49%), Gaps = 40/280 (14%)
Query: 29 LGEGGFGCVFKG-WIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHE 87
+G G FG V+ G W+++ VAIK ++ E ++++ E + +L H
Sbjct: 12 IGSGQFGLVWLGYWLEKRK-----------VAIKTIR-EGAMSEEDFIEEAQVMMKLSHP 59
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHG 147
LV+L G C+E LV+EFM G L ++L R S T + + +DV G+++L
Sbjct: 60 KLVQLYGVCTERSPICLVFEFMEHGCLSDYL-RAQRGKFSQETLLGMCLDVCEGMAYLE- 117
Query: 148 LDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR---GYAAPEY 204
+NVI+RDL A N L+ N K+SDFG+ R D+ + S+ GT+ +++PE
Sbjct: 118 -SSNVIHRDLAARNCLVGENQVVKVSDFGMTR--FVLDDQYTSST--GTKFPVKWSSPEV 172
Query: 205 VATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMD 264
+ + KSDV+SFGV++ E+ S + E+R + +VE R+
Sbjct: 173 FSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENR---SNSEVVE-------TINAGFRLYK 222
Query: 265 TRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL 304
RL +Q+V ++ C P++RPS +L L
Sbjct: 223 PRLA-------SQSVYELMQHCWKERPEDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 3e-28
Identities = 76/279 (27%), Positives = 125/279 (44%), Gaps = 37/279 (13%)
Query: 27 YLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKR--LKAESFQGHKEWLTEVIYLGQL 84
+G+G FG VFK + V A+K+ L + + +E + E L +L
Sbjct: 6 NKIGKGSFGVVFKV---------VRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKL 56
Query: 85 RHENLVKLIGYCSESDNRLL--VYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGL 142
+++ Y S D L V E+ G L L + +P+ + I + GL
Sbjct: 57 DSSYIIRY--YESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGL 114
Query: 143 SFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAP 202
+ LH +++RD+K+ N+ LD+ N K+ D G+A+ DNT+ + IVGT Y +P
Sbjct: 115 AHLH--SKKILHRDIKSLNLFLDAYDNVKIGDLGVAK--LLSDNTNFANTIVGTPYYLSP 170
Query: 203 EYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRI 262
E KSDV++ GVVL E +G+ D + G L+ +++R
Sbjct: 171 ELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG----ALI----------LKIIRG 216
Query: 263 MDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL 301
+ + YS Q +A ++ QCL D + RP +L
Sbjct: 217 VFPPVSQMYS----QQLAQLIDQCLTKDYRQRPDTFQLL 251
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 4e-28
Identities = 68/211 (32%), Positives = 107/211 (50%), Gaps = 25/211 (11%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKE-----WLTEVIYLG 82
LGEG + V+K D+ T G +VAIK++K + K+ L E+ L
Sbjct: 7 KLGEGTYAVVYKA-RDKET--------GRIVAIKKIKLGERKEAKDGINFTALREIKLLQ 57
Query: 83 QLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVK-IAIDVARG 141
+L+H N++ L+ N LV+EFM LE + + ++ P +K + RG
Sbjct: 58 ELKHPNIIGLLDVFGHKSNINLVFEFME-TDLE-KVIKDKSIVLT-PADIKSYMLMTLRG 114
Query: 142 LSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAA 201
L +LH +++RDLK +N+L+ S+ KL+DFGLAR + N ++ ++V TR Y A
Sbjct: 115 LEYLH--SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGS-PNRKMTHQVV-TRWYRA 170
Query: 202 PE--YVATGHLTPKSDVYSFGVVLLELLSGR 230
PE + A H D++S G + ELL
Sbjct: 171 PELLFGAR-HYGVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 8e-28
Identities = 78/281 (27%), Positives = 127/281 (45%), Gaps = 39/281 (13%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKA-ESFQGHKEWLTEVIYLGQLRHE 87
LG+G G V+K PT G + A+K++ + K+ L E+ L
Sbjct: 9 LGQGSSGVVYKV-----RHKPT----GKIYALKKIHVDGDEEFRKQLLRELKTLRSCESP 59
Query: 88 NLVKLIG-YCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLH 146
+VK G + E + + V E+M GSL + K V I P IA + +GL +LH
Sbjct: 60 YVVKCYGAFYKEGEISI-VLEYMDGGSLAD--LLKKVGKIPEPVLAYIARQILKGLDYLH 116
Query: 147 GLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD-GPTGDNTHVSTRIVGTRGYAAPEYV 205
++I+RD+K SN+L++S K++DFG+++ T D + VGT Y +PE +
Sbjct: 117 T-KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTF---VGTVTYMSPERI 172
Query: 206 ATGHLTPKSDVYSFGVVLLELLSGRRA-LDEDRGGLAE--QTLVEWADPFLRDSRRVLRI 262
+ +D++S G+ LLE G+ L + E Q + + P L
Sbjct: 173 QGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPA------- 225
Query: 263 MDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303
++S + ++A CL DPK RPS ++L
Sbjct: 226 ------EEFSPEFRDFISA----CLQKDPKKRPSAAELLQH 256
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 8e-28
Identities = 72/209 (34%), Positives = 112/209 (53%), Gaps = 31/209 (14%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLK----AESFQGHKEWLTEVIYLGQL 84
+GEG FG V +G +G VA+K +K A++F L E + +L
Sbjct: 14 IGEGEFGAVLQG-----------EYTGQKVAVKNIKCDVTAQAF------LEETAVMTKL 56
Query: 85 RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSF 144
H+NLV+L+G + +V E M KG+L N L +G +S ++ ++DVA G+ +
Sbjct: 57 HHKNLVRLLGVILH-NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEY 115
Query: 145 LHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTG-DNTHVSTRIVGTRGYAAPE 203
L +++RDL A N+L+ + AK+SDFGLAR G G DN+ + + + APE
Sbjct: 116 LE--SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK------WTAPE 167
Query: 204 YVATGHLTPKSDVYSFGVVLLELLSGRRA 232
+ + KSDV+S+GV+L E+ S RA
Sbjct: 168 ALKHKKFSSKSDVWSYGVLLWEVFSYGRA 196
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 1e-27
Identities = 82/285 (28%), Positives = 129/285 (45%), Gaps = 39/285 (13%)
Query: 28 LLGEGGFGCVFKG-WIDQNTFAPTKPGSGIVVAIKRLKAESFQG-HKEWLTEVIYLGQLR 85
LG+G FG V +G W G I VA+K LK++ ++L E + L
Sbjct: 2 KLGDGSFGVVRRGEWSTSG-------GKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLD 54
Query: 86 HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFL 145
HENL++L G + ++V E P GSL + L + + T A+ +A G+ +L
Sbjct: 55 HENLIRLYGVVL-THPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYL 113
Query: 146 HGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVST--RIVGTRGYAAPE 203
I+RDL A N+LL S+ K+ DFGL R P ++ +V V + APE
Sbjct: 114 E--SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPF-AWCAPE 170
Query: 204 YVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFL-RDSRRVLR 261
+ T + SDV+ FGV L E+ + G +P+ ++L+
Sbjct: 171 SLRTRTFSHASDVWMFGVTLWEMFTYGE-------------------EPWAGLSGSQILK 211
Query: 262 IMDTRLGGQYSKKEA--QAVAAVVLQCLHMDPKNRPSMVDVLTSL 304
+D G + + EA Q + V+LQC +P +RP+ + L
Sbjct: 212 KIDKE-GERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 3e-27
Identities = 75/284 (26%), Positives = 144/284 (50%), Gaps = 27/284 (9%)
Query: 29 LGEGGFG----CVFKGWID-QNTFAPTKPGSGIVVAIKRLKAESFQ-GHKEWLTEVIYLG 82
LGEG FG C +G + AP G ++VA+K L+A+ + ++L E+ +
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72
Query: 83 QLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQP----------ISWPTRV 132
+L++ N+++L+G C D ++ E+M G L L ++ ++ +S +
Sbjct: 73 RLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLL 132
Query: 133 KIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR 192
+A+ +A G+ +L L N ++RDL N L+ +++ K++DFG++R+ +GD + R
Sbjct: 133 YMAVQIASGMKYLASL--NFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGR 190
Query: 193 IVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPF 252
V + A E + G T SDV++FGV L E+ + + ++ L+++ ++E F
Sbjct: 191 AVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCK--EQPYSLLSDEQVIENTGEF 248
Query: 253 LRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPS 296
R+ R + + T L V ++++C D K+RP+
Sbjct: 249 FRNQGRQIYLSQTPLC-------PSPVFKLMMRCWSRDIKDRPT 285
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 3e-27
Identities = 74/283 (26%), Positives = 124/283 (43%), Gaps = 47/283 (16%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHEN 88
+GEG G V+K T +G VAIK+++ Q + + E++ + +H N
Sbjct: 27 IGEGASGEVYKA---------TDRATGKEVAIKKMRLRK-QNKELIINEILIMKDCKHPN 76
Query: 89 LVKLIGYCSESDNRL-LVYEFMPKGSL----ENHLFRKGVQPISWPTRVKIAIDVARGLS 143
+V + L +V E+M GSL + R I++ + +V +GL
Sbjct: 77 IVDYYD-SYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAY-----VCREVLQGLE 130
Query: 144 FLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPE 203
+LH NVI+RD+K+ N+LL + + KL+DFG A + S +VGT + APE
Sbjct: 131 YLHSQ--NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS--VVGTPYWMAPE 186
Query: 204 YVATGHL-TPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRI 262
V PK D++S G++ +E+ G + A + P L++ +
Sbjct: 187 -VIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKW--- 242
Query: 263 MDTRLGGQYSK--KEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303
S K+ + +CL DP+ RPS ++L
Sbjct: 243 ---------SPEFKD------FLNKCLVKDPEKRPSAEELLQH 270
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 4e-27
Identities = 69/206 (33%), Positives = 101/206 (49%), Gaps = 25/206 (12%)
Query: 29 LGEGGFGCVFKG-WIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHE 87
LG G FG V G W + I VAIK ++ E +++ E + +L H
Sbjct: 12 LGSGQFGVVHLGKWRGK-----------IDVAIKMIR-EGAMSEDDFIEEAKVMMKLSHP 59
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHL-FRKGVQPISWPTRVKIAIDVARGLSFLH 146
NLV+L G C++ +V E+M G L N+L RKG W + + DV + +L
Sbjct: 60 NLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEW--LLDMCSDVCEAMEYLE 117
Query: 147 GLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR---GYAAPE 203
I+RDL A N L+ + K+SDFGLAR D+ + S+ GT+ +A PE
Sbjct: 118 --SNGFIHRDLAARNCLVGEDNVVKVSDFGLAR--YVLDDQYTSS--QGTKFPVKWAPPE 171
Query: 204 YVATGHLTPKSDVYSFGVVLLELLSG 229
+ KSDV+SFGV++ E+ S
Sbjct: 172 VFDYSRFSSKSDVWSFGVLMWEVFSE 197
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 9e-27
Identities = 86/286 (30%), Positives = 134/286 (46%), Gaps = 50/286 (17%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHEN 88
+G+G FG V G G VA+K +K ++ + +L E + QLRH N
Sbjct: 14 IGKGEFGDVMLG-----------DYRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSN 60
Query: 89 LVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHG 147
LV+L+G E L +V E+M KGSL ++L +G + +K ++DV + +L
Sbjct: 61 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEA 120
Query: 148 LDANVIYRDLKASNVLLDSNFNAKLSDFGLARD-GPTGDNTHVSTRIVGTRGYAAPEYVA 206
N ++RDL A NVL+ + AK+SDFGL ++ T D + + + APE +
Sbjct: 121 --NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK------WTAPEALR 172
Query: 207 TGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTR 266
+ KSDV+SFG++L E+ S R P+ R L+ + R
Sbjct: 173 EKKFSTKSDVWSFGILLWEIYSFGRV------------------PY---PRIPLKDVVPR 211
Query: 267 LGGQYSKKEA-----QAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 307
+ Y K +A V V+ QC H+D RPS + + LE +
Sbjct: 212 VEKGY-KMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 9e-27
Identities = 70/212 (33%), Positives = 110/212 (51%), Gaps = 25/212 (11%)
Query: 29 LGEGGFGCVFKG-WIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRH 86
LG G FG V+KG WI P I VAIK L+ E+ + +KE L E + + H
Sbjct: 15 LGSGAFGTVYKGVWI------PEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDH 68
Query: 87 ENLVKLIGYCSESDNRLLVYEFMPKGSL----ENHLFRKGVQPI-SWPTRVKIAIDVARG 141
++V+L+G C S L+ + MP G L NH G Q + +W + +A+G
Sbjct: 69 PHVVRLLGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNW------CVQIAKG 121
Query: 142 LSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNT-HVSTRIVGTRGYA 200
+S+L + +++RDL A NVL+ + + K++DFGLA+ + H V + +
Sbjct: 122 MSYLE--EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIK-WM 178
Query: 201 APEYVATGHLTPKSDVYSFGVVLLELLS-GRR 231
A E + T KSDV+S+GV + EL++ G +
Sbjct: 179 ALESILHRIYTHKSDVWSYGVTVWELMTFGAK 210
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 2e-26
Identities = 88/285 (30%), Positives = 136/285 (47%), Gaps = 43/285 (15%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSG-IVVAIKRL-KAESFQGHKEWLTEVIYLGQLR 85
LG G FG V++G PGSG I VA+K L K + Q KE+L E +
Sbjct: 2 FLGSGAFGEVYEG----TATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFN 57
Query: 86 HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWP-----TRVKIAIDVAR 140
H N+VKL+G C ++ + ++ E M G L ++L V+ P + I +DVA+
Sbjct: 58 HPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAK 117
Query: 141 GLSFLHGLDANVIYRDLKASNVLL-----DSNFNAKLSDFGLARDGPTGDNTHV-STRIV 194
G +L + I+RDL A N L+ D++ K+ DFGLARD D ++
Sbjct: 118 GCVYLE--QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLL 175
Query: 195 GTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPF-L 253
R + APE + G T +SDV+SFGV++ E+L+ L +Q P+
Sbjct: 176 PVR-WMAPESLLDGKFTTQSDVWSFGVLMWEILT-----------LGQQ-------PYPA 216
Query: 254 RDSRRVLRIMDTRLGGQYSKKE--AQAVAAVVLQCLHMDPKNRPS 296
+++ VL+ + GG+ K E + ++ C DP RP+
Sbjct: 217 LNNQEVLQHVTA--GGRLQKPENCPDKIYQLMTNCWAQDPSERPT 259
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 2e-26
Identities = 88/298 (29%), Positives = 136/298 (45%), Gaps = 49/298 (16%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGH--KEWLTEVIYLGQLR 85
+LG+G FG V + ++ GS VA+K LKA+ F +E+L E + +
Sbjct: 6 MLGKGEFGSV------REAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFD 59
Query: 86 HENLVKLIGYC--SESDNRL----LVYEFMPKGSLENHLF--RKGVQPISWP--TRVKIA 135
H N++KLIG S + RL ++ FM G L L R G +P + P T V+
Sbjct: 60 HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFM 119
Query: 136 IDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVG 195
ID+A G+ +L N I+RDL A N +L+ N ++DFGL++ +GD
Sbjct: 120 IDIASGMEYLS--SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177
Query: 196 TRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTL---VEWADPF 252
+ A E +A T SDV++FGV + E+++ RG QT VE ++
Sbjct: 178 PVKWLALESLADNVYTTHSDVWAFGVTMWEIMT--------RG----QTPYAGVENSE-- 223
Query: 253 LRDSRRVLRIMDTRLGGQYSKKEAQAVAAV---VLQCLHMDPKNRPSMVDVLTSLEQL 307
I + + G K+ + V + QC +PK RPS + LE +
Sbjct: 224 ---------IYNYLIKGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 8e-26
Identities = 71/202 (35%), Positives = 106/202 (52%), Gaps = 15/202 (7%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHK-EWLTEVIYLGQLRH 86
LLG+G FG VFKG + T VA+K K + Q K ++L+E L Q H
Sbjct: 2 LLGKGNFGEVFKGTLKDKT----------PVAVKTCKEDLPQELKIKFLSEARILKQYDH 51
Query: 87 ENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLH 146
N+VKLIG C++ +V E +P G + L RK + VK A+D A G+++L
Sbjct: 52 PNIVKLIGVCTQRQPIYIVMELVPGGDFLSFL-RKKKDELKTKQLVKFALDAAAGMAYLE 110
Query: 147 GLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVA 206
N I+RDL A N L+ N K+SDFG++R G + + + + + APE +
Sbjct: 111 --SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIK-WTAPEALN 167
Query: 207 TGHLTPKSDVYSFGVVLLELLS 228
G + +SDV+S+G++L E S
Sbjct: 168 YGRYSSESDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 9e-26
Identities = 70/211 (33%), Positives = 106/211 (50%), Gaps = 26/211 (12%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVI----YLGQL 84
LG G FG V ++ + +K + + VA+K LK + +E L + +LG
Sbjct: 43 LGAGAFGKV----VEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGN- 97
Query: 85 RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSF 144
HEN+V L+G C+ L++ E+ G L N L RK ++ + + VA+G++F
Sbjct: 98 -HENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAF 156
Query: 145 LHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYA---- 200
L N I+RDL A NVLL K+ DFGLARD D+ +V +G A
Sbjct: 157 LAS--KNCIHRDLAARNVLLTHGKIVKICDFGLARD-IMNDSNYVV------KGNARLPV 207
Query: 201 ---APEYVATGHLTPKSDVYSFGVVLLELLS 228
APE + T +SDV+S+G++L E+ S
Sbjct: 208 KWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 1e-25
Identities = 79/303 (26%), Positives = 140/303 (46%), Gaps = 43/303 (14%)
Query: 29 LGEGGFGCV-------FKGWIDQNTFAPTKPGSGIVVAIKRLKA-ESFQGHKEWLTEVIY 80
LGEG FG V + + ++ + ++VA+K L+ S +++L EV
Sbjct: 13 LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKI 72
Query: 81 LGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRK----------GVQPISWPT 130
L +L N+ +L+G C+ ++ E+M G L N +K + +S+ T
Sbjct: 73 LSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDL-NQFLQKHVAETSGLACNSKSLSFST 131
Query: 131 RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 190
+ +A +A G+ +L L N ++RDL N L+ N+ K++DFG++R+ + D V
Sbjct: 132 LLYMATQIASGMRYLESL--NFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQ 189
Query: 191 TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS--GRRALDEDRGGLAEQTLVEW 248
R + A E V G T KSDV++FGV L E+L+ + + L +Q ++E
Sbjct: 190 GRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEH----LTDQQVIEN 245
Query: 249 ADPFLRD-SRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 307
A F RD R++ K+ + ++L+C D ++RP + ++
Sbjct: 246 AGHFFRDDGRQIYLPRPPN-----CPKD---IYELMLECWRRDEEDRP-------TFREI 290
Query: 308 HTS 310
H
Sbjct: 291 HLF 293
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-25
Identities = 81/311 (26%), Positives = 136/311 (43%), Gaps = 50/311 (16%)
Query: 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIV-VAIKRLKAESFQGH-KEWLTEVI 79
N LGEG FG V K T K +G VA+K LK + ++ L+E
Sbjct: 1 NLVLGKTLGEGEFGKVVKA-----TAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFN 55
Query: 80 YLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHL--------------------- 118
L Q+ H +++KL G CS+ LL+ E+ GSL + L
Sbjct: 56 LLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSY 115
Query: 119 -FRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL 177
+ ++ + A ++RG+ +L + +++RDL A NVL+ K+SDFGL
Sbjct: 116 LDNPDERALTMGDLISFAWQISRGMQYLAEM--KLVHRDLAARNVLVAEGRKMKISDFGL 173
Query: 178 ARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDED 236
+RD D+ ++ + A E + T +SDV+SFGV+L E+++ G
Sbjct: 174 SRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP-- 231
Query: 237 RGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPS 296
G+A + L L+ R+ R + ++ + ++L C +P RP+
Sbjct: 232 --GIAPERLFN----LLKTGYRMER----------PENCSEEMYNLMLTCWKQEPDKRPT 275
Query: 297 MVDVLTSLEQL 307
D+ LE++
Sbjct: 276 FADISKELEKM 286
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 4e-25
Identities = 70/210 (33%), Positives = 106/210 (50%), Gaps = 28/210 (13%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGH-KEWLTEVIYLGQLR 85
+GEG +G V+K D+ T G +VAIK++K F +G K L E+ L +L
Sbjct: 7 IGEGTYGVVYKAR-DKLT--------GEIVAIKKIK-LRFESEGIPKTALREIKLLKELN 56
Query: 86 HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVK-IAIDVARGLSF 144
H N++KL+ + LV+EFM L L + + + + +K + +GL+F
Sbjct: 57 HPNIIKLLDVFRHKGDLYLVFEFM-DTDLY-KLIKDRQRGLP-ESLIKSYLYQLLQGLAF 113
Query: 145 LHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR--DGPTGDNTHVSTRIVGTRGYAAP 202
H +++RDLK N+L+++ KL+DFGLAR P TH V TR Y AP
Sbjct: 114 CH--SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHY----VVTRWYRAP 167
Query: 203 E--YVATGHLTPKSDVYSFGVVLLELLSGR 230
E G+ + D++S G + ELLS R
Sbjct: 168 ELLLGDKGY-STPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 5e-25
Identities = 63/216 (29%), Positives = 112/216 (51%), Gaps = 37/216 (17%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEW------LTEVIYLG 82
+GEG +G V+K ++ T G +VA+K+++ E +++ + E+ L
Sbjct: 7 IGEGTYGQVYKA-RNKKT--------GELVALKKIRME----NEKEGFPITAIREIKLLQ 53
Query: 83 QLRHENLVKLIG-YCSESDNRL-LVYEFMP---KGSLENHLFRKGVQPISWPTRVK-IAI 136
+LRH N+V+L S+ + +V+E+M G L++ + + +++K
Sbjct: 54 KLRHPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVK-----FT-ESQIKCYMK 107
Query: 137 DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 196
+ GL +LH +++RD+K SN+L++++ KL+DFGLAR T N+ T V T
Sbjct: 108 QLLEGLQYLHS--NGILHRDIKGSNILINNDGVLKLADFGLARP-YTKRNSADYTNRVIT 164
Query: 197 RGYAAPEYV--ATGHLTPKSDVYSFGVVLLELLSGR 230
Y PE + AT P+ D++S G +L EL G+
Sbjct: 165 LWYRPPELLLGAT-RYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 6e-25
Identities = 87/296 (29%), Positives = 143/296 (48%), Gaps = 50/296 (16%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAE--SFQGHKEWLTEVIYLGQLRH 86
LGEG FG V +G ++Q+ S + VA+K +K + +++L+E + + + H
Sbjct: 7 LGEGEFGSVMEGQLNQDD-------SILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDH 59
Query: 87 ENLVKLIGYCSESDNR------LLVYEFMPKGSLENHLF--RKGVQPISWPTR--VKIAI 136
N+++LIG C ++ +++ FM G L + L R G P PT+ VK
Sbjct: 60 PNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMT 119
Query: 137 DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 196
D+A G+ +L + I+RDL A N +L+ N N ++DFGL++ GD + RI
Sbjct: 120 DIASGMEYLS--SKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGD-YYRQGRIAKM 176
Query: 197 R-GYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRG-----GLAEQTLVEWAD 250
+ A E +A T KSDV+SFGV + E+ + RG G+ + +
Sbjct: 177 PVKWIAIESLADRVYTTKSDVWSFGVTMWEIAT--------RGQTPYPGVENSEIYD--- 225
Query: 251 PFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQ 306
+LR R+ + D L G YS ++ C ++PK+RPS + LE+
Sbjct: 226 -YLRQGNRLKQPPDC-LDGLYS---------LMSSCWLLNPKDRPSFETLRCELEK 270
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 8e-25
Identities = 72/214 (33%), Positives = 120/214 (56%), Gaps = 24/214 (11%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSG-IVVAIKRLKA-ESFQGHKEWLTEVIYLGQLR 85
++G G FG V +G + PG I VAIK LK+ + + +++L+E +GQ
Sbjct: 11 VIGAGEFGEVCRGRLKL-------PGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD 63
Query: 86 HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQ--PISWPTRVKIAIDVARGLS 143
H N++ L G ++S +++ EFM G+L++ L + Q I V + +A G+
Sbjct: 64 HPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQL---VGMLRGIAAGMK 120
Query: 144 FLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR--DGPTGDNTHVSTRIVGTR---G 198
+L + N ++RDL A N+L++SN K+SDFGL+R + T D T+ S+ +G +
Sbjct: 121 YLS--EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSS--LGGKIPIR 176
Query: 199 YAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRR 231
+ APE +A T SDV+S+G+V+ E++S G R
Sbjct: 177 WTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGER 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 1e-24
Identities = 79/281 (28%), Positives = 124/281 (44%), Gaps = 52/281 (18%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES-FQGHKEWLTEVIYLGQLRHE 87
LG G G V K +P +G ++A+K ++ E K+ L E+ L +
Sbjct: 9 LGAGNSGVVSK--------VLHRP-TGKIMAVKTIRLEINEAIQKQILRELDILHKCNSP 59
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHG 147
+V G + + + E+M GSL+ + ++ I KIA+ V +GL++LH
Sbjct: 60 YIVGFYGAFYNNGDISICMEYMDGGSLDK-ILKEVQGRIPERILGKIAVAVLKGLTYLHE 118
Query: 148 LDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV--------GTRGY 199
+I+RD+K SN+L++S KL DFG VS ++V GT Y
Sbjct: 119 -KHKIIHRDVKPSNILVNSRGQIKLCDFG------------VSGQLVNSLAKTFVGTSSY 165
Query: 200 AAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRV 259
APE + + KSD++S G+ L+EL +GR DP +
Sbjct: 166 MAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYP------------PENDPPDGIFELL 213
Query: 260 LRIMDT---RL-GGQYSKKEAQAVAAVVLQCLHMDPKNRPS 296
I++ RL G++S + Q V CL DP+ RPS
Sbjct: 214 QYIVNEPPPRLPSGKFS-PDFQ---DFVNLCLIKDPRERPS 250
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-24
Identities = 76/299 (25%), Positives = 129/299 (43%), Gaps = 44/299 (14%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAE-SFQGHKEWLTEVIYLGQLRHE 87
+G+G FG VF+ P +P + +VA+K LK E S ++ E + + H
Sbjct: 13 IGQGAFGRVFQA--RAPGLLPYEPFT--MVAVKMLKEEASADMQADFQREAALMAEFDHP 68
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQ--------------------PIS 127
N+VKL+G C+ L++E+M G L L + + P+S
Sbjct: 69 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLS 128
Query: 128 WPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNT 187
++ IA VA G+++L + ++RDL N L+ N K++DFGL+R+ + D
Sbjct: 129 CTEQLCIAKQVAAGMAYLS--ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY 186
Query: 188 HVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVE 247
S + PE + T +SDV+++GVVL E+ S + G E+ +
Sbjct: 187 KASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS--YGMQPYYGMAHEEVIY- 243
Query: 248 WADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQ 306
++RD VL D + ++ C P +RPS + L++
Sbjct: 244 ----YVRDG-NVLSCPDNC---------PLELYNLMRLCWSKLPSDRPSFASINRILQR 288
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 99.4 bits (247), Expect = 3e-24
Identities = 88/283 (31%), Positives = 136/283 (48%), Gaps = 38/283 (13%)
Query: 26 DYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLR 85
D LG+G FG V+ G + T VAIK LK + + +L E + +LR
Sbjct: 11 DVKLGQGCFGEVWMGTWNGTT----------KVAIKTLKPGTMMP-EAFLQEAQIMKKLR 59
Query: 86 HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFL 145
H+ LV L SE + +V EFM KGSL + L + + P V +A +A G++++
Sbjct: 60 HDKLVPLYAVVSE-EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYI 118
Query: 146 HGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR---GYAAP 202
+ N I+RDL+A+N+L+ N K++DFGLAR DN + + + G + + AP
Sbjct: 119 ERM--NYIHRDLRAANILVGDNLVCKIADFGLAR--LIEDNEYTARQ--GAKFPIKWTAP 172
Query: 203 EYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRI 262
E G T KSDV+SFG++L EL++ R G+ + ++E + R
Sbjct: 173 EAALYGRFTIKSDVWSFGILLTELVTKGRV---PYPGMVNREVLEQVERGYR-------- 221
Query: 263 MDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 305
M G S E ++ C DP RP+ + + LE
Sbjct: 222 MPCPQGCPESLHE------LMKLCWKKDPDERPTFEYIQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 3e-24
Identities = 88/297 (29%), Positives = 140/297 (47%), Gaps = 50/297 (16%)
Query: 28 LLGEGGFGCVFKG-WIDQNTFAPTKPGSGIVVAIKRL-KAESFQGHKEWLTEVIYLGQLR 85
++G+G FGCV+ G ID + G I A+K L + + +++L E I +
Sbjct: 2 VIGKGHFGCVYHGTLIDSD-------GQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFS 54
Query: 86 HENLVKLIGYCSESDNR-LLVYEFMPKGSLENHLFRKGVQPISWPTRVK----IAIDVAR 140
H N++ L+G C S+ L+V +M G L + R PT VK + VA+
Sbjct: 55 HPNVLSLLGICLPSEGSPLVVLPYMKHGDLR-NFIRS---ETHNPT-VKDLIGFGLQVAK 109
Query: 141 GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD--GPTGDNTHVSTRIVGTRG 198
G+ +L ++RDL A N +LD +F K++DFGLARD + H T
Sbjct: 110 GMEYL--ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVK 167
Query: 199 YAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPF-----L 253
+ A E + T T KSDV+SFGV+L EL++ RG + D F L
Sbjct: 168 WMALESLQTQKFTTKSDVWSFGVLLWELMT--------RGAPPYPDV----DSFDITVYL 215
Query: 254 RDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 310
RR+L+ +Y + V+L C H P+ RP+ ++++ +EQ+ ++
Sbjct: 216 LQGRRLLQ-------PEYC---PDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFST 262
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 3e-24
Identities = 64/202 (31%), Positives = 107/202 (52%), Gaps = 21/202 (10%)
Query: 29 LGEGGFGCVFKG-WIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHE 87
LG G +G V++G W + + VA+K LK ++ + E+L E + +++H
Sbjct: 14 LGGGQYGEVYEGVWKKYS----------LTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHP 62
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHG 147
NLV+L+G C+ ++ EFM G+L ++L Q ++ + +A ++ + +L
Sbjct: 63 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 122
Query: 148 LDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR---GYAAPEY 204
N I+RDL A N L+ N K++DFGL+R TGD T G + + APE
Sbjct: 123 --KNFIHRDLAARNCLVGENHLVKVADFGLSR-LMTGD---TYTAHAGAKFPIKWTAPES 176
Query: 205 VATGHLTPKSDVYSFGVVLLEL 226
+A + KSDV++FGV+L E+
Sbjct: 177 LAYNKFSIKSDVWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 5e-24
Identities = 82/272 (30%), Positives = 134/272 (49%), Gaps = 40/272 (14%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHEN 88
LG G FG V+ G + NT VA+K LK + + +L E + +LRH+
Sbjct: 14 LGNGQFGEVWMGTWNGNT----------KVAVKTLKPGTMSP-ESFLEEAQIMKKLRHDK 62
Query: 89 LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL 148
LV+L SE + +V E+M KGSL + L + + P V +A VA G++++ +
Sbjct: 63 LVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM 121
Query: 149 DANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR---GYAAPEYV 205
N I+RDL+++N+L+ K++DFGLAR DN + + + G + + APE
Sbjct: 122 --NYIHRDLRSANILVGDGLVCKIADFGLAR--LIEDNEYTARQ--GAKFPIKWTAPEAA 175
Query: 206 ATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL-RDSRRVLRIMD 264
G T KSDV+SFG++L EL++ R P+ ++R VL ++
Sbjct: 176 LYGRFTIKSDVWSFGILLTELVTKGRV------------------PYPGMNNREVLEQVE 217
Query: 265 TRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPS 296
+ ++ ++LQC DP+ RP+
Sbjct: 218 RGYRMPCPQDCPISLHELMLQCWKKDPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 98.6 bits (245), Expect = 7e-24
Identities = 72/206 (34%), Positives = 112/206 (54%), Gaps = 21/206 (10%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHEN 88
LG+G FG V+ G + T VAIK LK + + +L E + +LRHE
Sbjct: 14 LGQGCFGEVWMGTWNGTT----------RVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEK 62
Query: 89 LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL 148
LV+L SE + +V E+M KGSL + L + + + P V +A +A G++++ +
Sbjct: 63 LVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM 121
Query: 149 DANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR---GYAAPEYV 205
N ++RDL+A+N+L+ N K++DFGLAR DN + + + G + + APE
Sbjct: 122 --NYVHRDLRAANILVGENLVCKVADFGLAR--LIEDNEYTARQ--GAKFPIKWTAPEAA 175
Query: 206 ATGHLTPKSDVYSFGVVLLELLSGRR 231
G T KSDV+SFG++L EL + R
Sbjct: 176 LYGRFTIKSDVWSFGILLTELTTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 1e-23
Identities = 88/293 (30%), Positives = 143/293 (48%), Gaps = 46/293 (15%)
Query: 26 DYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKA-ESFQGHKEWLTEVIYLGQL 84
+ ++G G FG V G + P K I VAIK LKA + + +++L+E +GQ
Sbjct: 9 EKVIGAGEFGEVCSGRLK----LPGK--REIPVAIKTLKAGYTEKQRRDFLSEASIMGQF 62
Query: 85 RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSF 144
H N++ L G ++S ++V E+M GSL+ L RK + V + +A G+ +
Sbjct: 63 DHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFL-RKHDGQFTVIQLVGMLRGIASGMKY 121
Query: 145 LHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR---DGPTGDNTHVSTRIVGTRG--- 198
L D ++RDL A N+L++SN K+SDFGL+R D P T TRG
Sbjct: 122 LS--DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYT--------TRGGKI 171
Query: 199 ---YAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLR 254
+ APE +A T SDV+S+G+V+ E++S G R E ++ Q +++ +
Sbjct: 172 PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWE----MSNQDVIKAIE---- 223
Query: 255 DSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 307
+ R+ MD A+ ++L C D RP +++ L++L
Sbjct: 224 EGYRLPAPMDC----------PAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 98.1 bits (244), Expect = 2e-23
Identities = 72/204 (35%), Positives = 103/204 (50%), Gaps = 12/204 (5%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWL-TEVIYLGQLRHE 87
LGEG FG V + + P +G VA+K LK ES H L E+ L L HE
Sbjct: 12 LGEGHFGKV-----ELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHE 66
Query: 88 NLVKLIGYCSESDNR--LLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFL 145
N+VK G C+E L+ EF+P GSL+ +L R I+ ++K A+ + +G+ +L
Sbjct: 67 NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRN-KNKINLKQQLKYAVQICKGMDYL 125
Query: 146 HGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTH-VSTRIVGTRGYAAPEY 204
++RDL A NVL++S K+ DFGL + T + V + + APE
Sbjct: 126 G--SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPEC 183
Query: 205 VATGHLTPKSDVYSFGVVLLELLS 228
+ SDV+SFGV L ELL+
Sbjct: 184 LIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 2e-23
Identities = 63/213 (29%), Positives = 103/213 (48%), Gaps = 19/213 (8%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHEN 88
LGEG FG VF + + P + ++VA+K LK S +++ E L L+H++
Sbjct: 13 LGEGAFGKVFLA--ECHNLLPEQ--DKMLVAVKALKEASESARQDFQREAELLTVLQHQH 68
Query: 89 LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKG-------------VQPISWPTRVKIA 135
+V+ G C+E L+V+E+M G L L G ++ + IA
Sbjct: 69 IVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIA 128
Query: 136 IDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVG 195
+A G+ +L L + ++RDL N L+ K+ DFG++RD + D V R +
Sbjct: 129 SQIASGMVYLASL--HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 186
Query: 196 TRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 228
+ PE + T +SD++SFGVVL E+ +
Sbjct: 187 PIRWMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 2e-23
Identities = 73/234 (31%), Positives = 112/234 (47%), Gaps = 18/234 (7%)
Query: 75 LTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 134
+E+ +G+L+H N+VKLIG C L++E++ +L L + +SW R KI
Sbjct: 731 SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL-----RNLSWERRRKI 785
Query: 135 AIDVARGLSFLH-GLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRI 193
AI +A+ L FLH V+ +L +++D L R G +
Sbjct: 786 AIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL------RLSLPGLLCTDTKCF 839
Query: 194 VGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 253
+ + Y APE T +T KSD+Y FG++L+ELL+G+ D + G ++VEWA
Sbjct: 840 ISS-AYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGV--HGSIVEWARYCY 896
Query: 254 RDSRRVLRIMDTRLGGQYSKKEAQAVAA--VVLQCLHMDPKNRPSMVDVLTSLE 305
D + I D + G S + + V + L C DP RP DVL +LE
Sbjct: 897 SDCHLDMWI-DPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLE 949
|
Length = 968 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 96.9 bits (241), Expect = 3e-23
Identities = 85/284 (29%), Positives = 131/284 (46%), Gaps = 46/284 (16%)
Query: 29 LGEGGFGCVFKG-WIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHE 87
LG G FG V G W Q VAIK +K E E++ E + +L HE
Sbjct: 12 LGTGQFGVVKYGKWRGQYD-----------VAIKMIK-EGSMSEDEFIEEAKVMMKLSHE 59
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHL--FRKGVQPISWPTRVKIAIDVARGLSFL 145
LV+L G C++ +V E+M G L N+L K QP +++ DV G+++L
Sbjct: 60 KLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQL---LEMCKDVCEGMAYL 116
Query: 146 HGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR---GYAAP 202
I+RDL A N L+D K+SDFGL+R D+ + S+ VG++ ++ P
Sbjct: 117 E--SKQFIHRDLAARNCLVDDQGCVKVSDFGLSR--YVLDDEYTSS--VGSKFPVRWSPP 170
Query: 203 EYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLR 261
E + + KSDV++FGV++ E+ S G+ + VE LR R L
Sbjct: 171 EVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYER----FNNSETVEKVSQGLRLYRPHL- 225
Query: 262 IMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 305
++ V A++ C H + RP+ +L+S+E
Sbjct: 226 -------------ASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 3e-23
Identities = 74/291 (25%), Positives = 132/291 (45%), Gaps = 39/291 (13%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRL---KAESFQGHKEWLTEVIYLGQL 84
LG G FG VF + G +V +K L K E+ Q E+ E+ +L
Sbjct: 12 TLGRGEFGEVFLAKAK----GIEEEGGETLVLVKALQKTKDENLQ--SEFRRELDMFRKL 65
Query: 85 RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLF--RKGV-----QPISWPTRVKIAID 137
H+N+V+L+G C E++ ++ E+ G L+ L + P+S +V +
Sbjct: 66 SHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQ 125
Query: 138 VARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR 197
+A G+ L +A ++RDL A N L+ S K+S L++D + + ++ R
Sbjct: 126 IALGMDHLS--NARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLR 183
Query: 198 GYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPF--LRD 255
+ APE V + KSDV+SFGV++ E+ + E PF L D
Sbjct: 184 -WLAPEAVQEDDFSTKSDVWSFGVLMWEVFT-----------QGEL-------PFYGLSD 224
Query: 256 SRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQ 306
+ R+ +L + + ++ +C ++PK+RPS +++++L +
Sbjct: 225 EEVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 96.9 bits (242), Expect = 3e-23
Identities = 55/225 (24%), Positives = 93/225 (41%), Gaps = 35/225 (15%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAE---SFQGHKEWLTEVIYLGQL 84
++GEG F V + + AIK L + K E L +L
Sbjct: 8 IIGEGSFSTVVLA---------KEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRL 58
Query: 85 -RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLS 143
H ++KL + +N V E+ P G L ++ + G + A ++ L
Sbjct: 59 NGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGS--LDEKCTRFYAAEILLALE 116
Query: 144 FLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGD----NTHVSTRI------ 193
+LH +I+RDLK N+LLD + + K++DFG A+ N +T I
Sbjct: 117 YLHSK--GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEK 174
Query: 194 --------VGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR 230
VGT Y +PE + SD+++ G ++ ++L+G+
Sbjct: 175 NRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 3e-23
Identities = 74/257 (28%), Positives = 113/257 (43%), Gaps = 32/257 (12%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLR 85
LG+GGFG V A +G + A K+L + +G + L E L ++
Sbjct: 1 LGKGGFGEVC---------ACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVS 51
Query: 86 HENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSF 144
+V L Y E+ + L LV M G L+ H++ G + A + GL
Sbjct: 52 SRFIVSL-AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEH 110
Query: 145 LHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEY 204
LH ++YRDLK NVLLD + N ++SD GLA + G GT GY APE
Sbjct: 111 LHQR--RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGR---AGTPGYMAPEV 165
Query: 205 VATGHLTPKSDVYSFGVVLLELLSGR-----RALDEDRGGLAEQTL---VEWADPFLRDS 256
+ D ++ G L E+++GR R ++ L +TL VE+ D F ++
Sbjct: 166 LQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEA 225
Query: 257 RRVLRIM-----DTRLG 268
+ + + + RLG
Sbjct: 226 KDLCEALLQKDPEKRLG 242
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 96.6 bits (241), Expect = 6e-23
Identities = 58/205 (28%), Positives = 97/205 (47%), Gaps = 17/205 (8%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQG--HKEWLTEVIYLGQLRH 86
+GEG G VFK + G VA+K++ +G + L E+ L +H
Sbjct: 8 IGEGAHGIVFKAKDRET---------GETVALKKVALRRLEGGIPNQALREIKALQACQH 58
Query: 87 ENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLH 146
+VKL+ +LV E+MP L L R +P+ + +G++++H
Sbjct: 59 PYVVKLLDVFPHGSGFVLVMEYMP-SDLSEVL-RDEERPLPEAQVKSYMRMLLKGVAYMH 116
Query: 147 GLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYV- 205
+++RDLK +N+L+ ++ K++DFGLAR + S + V TR Y APE +
Sbjct: 117 AN--GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQ-VATRWYRAPELLY 173
Query: 206 ATGHLTPKSDVYSFGVVLLELLSGR 230
P D+++ G + ELL+G
Sbjct: 174 GARKYDPGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.4 bits (241), Expect = 6e-23
Identities = 65/211 (30%), Positives = 111/211 (52%), Gaps = 30/211 (14%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLT-----EVIYLGQ 83
LGEG +G V+K D+ T G +VA+K+++ ++ +E + E+ L +
Sbjct: 7 LGEGTYGVVYKAR-DKKT--------GEIVALKKIRLDN---EEEGIPSTALREISLLKE 54
Query: 84 LRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVK-IAIDVARGL 142
L+H N+VKL+ LV+E+ L+ +L ++ P+S P +K I + RGL
Sbjct: 55 LKHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRP-GPLS-PNLIKSIMYQLLRGL 111
Query: 143 SFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD--GPTGDNTHVSTRIVGTRGYA 200
++ H +++RDLK N+L++ + KL+DFGLAR P TH V T Y
Sbjct: 112 AYCH--SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHE----VVTLWYR 165
Query: 201 APE-YVATGHLTPKSDVYSFGVVLLELLSGR 230
APE + + H + D++S G + E+++G+
Sbjct: 166 APEILLGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 7e-23
Identities = 67/214 (31%), Positives = 105/214 (49%), Gaps = 20/214 (9%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHEN 88
LGEG FG VF + +PTK ++VA+K LK + K++ E L L+HE+
Sbjct: 13 LGEGAFGKVFLA--ECYNLSPTK--DKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 68
Query: 89 LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGV--------QP------ISWPTRVKI 134
+VK G C + D ++V+E+M G L L G QP + + I
Sbjct: 69 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 128
Query: 135 AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 194
A +A G+ +L + ++RDL N L+ +N K+ DFG++RD + D V +
Sbjct: 129 ASQIASGMVYL--ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 186
Query: 195 GTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 228
+ PE + T +SDV+SFGV+L E+ +
Sbjct: 187 LPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 1e-22
Identities = 67/206 (32%), Positives = 109/206 (52%), Gaps = 22/206 (10%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHEN 88
LG G FG V+ G+ + +T VAIK LK S + +L E + QL+H
Sbjct: 14 LGAGQFGEVWMGYYNGHT----------KVAIKSLKQGSMS-PEAFLAEANLMKQLQHPR 62
Query: 89 LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL 148
LV+L ++ + ++ E+M GSL + L ++ + +A +A G++F+
Sbjct: 63 LVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE-- 119
Query: 149 DANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR---GYAAPEYV 205
N I+RDL+A+N+L+ K++DFGLAR DN + + G + + APE +
Sbjct: 120 RKNYIHRDLRAANILVSETLCCKIADFGLAR--LIEDNEYTARE--GAKFPIKWTAPEAI 175
Query: 206 ATGHLTPKSDVYSFGVVLLELLS-GR 230
G T KSDV+SFG++L E+++ GR
Sbjct: 176 NYGTFTIKSDVWSFGILLTEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.6 bits (241), Expect = 1e-22
Identities = 72/215 (33%), Positives = 109/215 (50%), Gaps = 31/215 (14%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGH---KEWLTEVIYLGQL 84
+GEG +G V A KP +G+ VAIK++ F+ + L E+ L +
Sbjct: 12 YIGEGAYGMVCS--------ATHKP-TGVKVAIKKI--SPFEHQTFCQRTLREIKILRRF 60
Query: 85 RHENLVKL------IGYCSESDNRLLVYEFMPKGSLENHLFRK-GVQPISWPTRVKIAID 137
+HEN++ + + S +D +V E M E L++ Q +S
Sbjct: 61 KHENIIGILDIIRPPSFESFND-VYIVQELM-----ETDLYKLIKTQHLSNDHIQYFLYQ 114
Query: 138 VARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR-DGPTGDNTHVSTRIVGT 196
+ RGL ++H ANV++RDLK SN+LL++N + K+ DFGLAR P D+T T V T
Sbjct: 115 ILRGLKYIHS--ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVAT 172
Query: 197 RGYAAPEYVATGHLTPKS-DVYSFGVVLLELLSGR 230
R Y APE + K+ D++S G +L E+LS R
Sbjct: 173 RWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 1e-22
Identities = 81/292 (27%), Positives = 143/292 (48%), Gaps = 42/292 (14%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRL-KAESFQGHKEWLTEVIYLGQLRHE 87
LG+G FG V++G K VAIK + +A S + E+L E + +
Sbjct: 14 LGQGSFGMVYEGIAK----GVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 69
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLF--------RKGVQPISWPTRVKIAIDVA 139
++V+L+G S+ L++ E M +G L+++L P S +++A ++A
Sbjct: 70 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIA 129
Query: 140 RGLSFLHGLDAN-VIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRG 198
G+++L +AN ++RDL A N ++ +F K+ DFG+ RD D + +
Sbjct: 130 DGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 186
Query: 199 YAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL-RDSR 257
+ +PE + G T SDV+SFGVVL E+ + LAEQ P+ +
Sbjct: 187 WMSPESLKDGVFTTYSDVWSFGVVLWEIAT-----------LAEQ-------PYQGMSNE 228
Query: 258 RVLR-IMDTRLGGQYSKKE--AQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQ 306
+VLR +M+ GG K + + ++ C +PK RPS +++++S+++
Sbjct: 229 QVLRFVME---GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 96.1 bits (240), Expect = 1e-22
Identities = 72/220 (32%), Positives = 114/220 (51%), Gaps = 42/220 (19%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLT-------EVIYL 81
LG+G +G V+K ID+ T VVA+K++ ++F+ T E+++L
Sbjct: 15 LGKGAYGIVWKA-IDRRT--------KEVVALKKI-FDAFRN----ATDAQRTFREIMFL 60
Query: 82 GQLR-HENLVKLIG-YCSESDNRL-LVYEFMPKGSLENHL---FRKGV-QPISWPTRVKI 134
+L H N+VKL+ +E+D + LV+E+M E L R + + + + I
Sbjct: 61 QELGDHPNIVKLLNVIKAENDKDIYLVFEYM-----ETDLHAVIRANILEDVH---KRYI 112
Query: 135 AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTH---VST 191
+ + L ++H NVI+RDLK SN+LL+S+ KL+DFGLAR + V T
Sbjct: 113 MYQLLKALKYIHS--GNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLT 170
Query: 192 RIVGTRGYAAPE-YVATGHLTPKSDVYSFGVVLLELLSGR 230
V TR Y APE + + T D++S G +L E+L G+
Sbjct: 171 DYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 1e-22
Identities = 80/291 (27%), Positives = 128/291 (43%), Gaps = 42/291 (14%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRL-KAESFQGHKEWLTEVIYLGQLRHE 87
LG G FG V++G + VA+K L ++ S Q ++L E + + + H+
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQ----VAVKTLPESCSEQDESDFLMEALIMSKFNHQ 69
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKG----VQPISWPTR--VKIAIDVARG 141
N+V+LIG E R ++ E M G L++ L R+ +P S + + A DVA+G
Sbjct: 70 NIVRLIGVSFERLPRFILLELMAGGDLKSFL-RENRPRPERPSSLTMKDLLFCARDVAKG 128
Query: 142 LSFLHGLDANVIYRDLKASNVLLDSNFN---AKLSDFGLARDGPTGDNTHVSTRIVGTRG 198
+L + + I+RD+ A N LL AK++DFG+ARD R +
Sbjct: 129 CKYLE--ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIK 186
Query: 199 YAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSR 257
+ PE G T K+DV+SFGV+L E+ S G P+ R
Sbjct: 187 WMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYM-------------------PY--PGR 225
Query: 258 RVLRIMDTRLGG---QYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 305
+M+ GG K V ++ C P++RP+ +L ++
Sbjct: 226 TNQEVMEFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 2e-22
Identities = 66/213 (30%), Positives = 104/213 (48%), Gaps = 30/213 (14%)
Query: 28 LLGEGGFGCVFKGW-IDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRH 86
LLG G FG V++G +D F K V++ + K+ E+ L +L+H
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVK-----EVSLADDGQTGQEAVKQLEQEIALLSKLQH 61
Query: 87 ENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQP---ISWPTRVKIAIDVARGLS 143
N+V+ +G E DN + E +P GSL L + G P I TR + GL
Sbjct: 62 PNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTR-----QILLGLE 116
Query: 144 FLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVST-----RIVGTRG 198
+LH D N ++RD+K +N+L+D+N KL+DFG+A+ V G+
Sbjct: 117 YLH--DRNTVHRDIKGANILVDTNGVVKLADFGMAK--------QVVEFSFAKSFKGSPY 166
Query: 199 YAAPEYVA-TGHLTPKSDVYSFGVVLLELLSGR 230
+ APE +A G +D++S G +LE+ +G+
Sbjct: 167 WMAPEVIAQQGGYGLAADIWSLGCTVLEMATGK 199
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 2e-22
Identities = 63/203 (31%), Positives = 108/203 (53%), Gaps = 20/203 (9%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHEN 88
LG G FG V+ G+ + +T VA+K LK + + +L E + L+H+
Sbjct: 14 LGAGQFGEVWMGYYNNST----------KVAVKTLKPGTMS-VQAFLEEANLMKTLQHDK 62
Query: 89 LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL 148
LV+L ++ + ++ E+M KGSL + L + P + + +A G++++
Sbjct: 63 LVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE-- 120
Query: 149 DANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR---GYAAPEYV 205
N I+RDL+A+NVL+ + K++DFGLAR DN + + G + + APE +
Sbjct: 121 RKNYIHRDLRAANVLVSESLMCKIADFGLAR--VIEDNEYTARE--GAKFPIKWTAPEAI 176
Query: 206 ATGHLTPKSDVYSFGVVLLELLS 228
G T KSDV+SFG++L E+++
Sbjct: 177 NFGSFTIKSDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 2e-22
Identities = 79/296 (26%), Positives = 138/296 (46%), Gaps = 39/296 (13%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHE 87
LG+G FG V D P + +G VVA+K+L+ + + +++ E+ L L+H+
Sbjct: 11 QLGKGNFGSVELCRYD-----PLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHD 65
Query: 88 NLVKLIGYCSESDNR--LLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFL 145
N+VK G C + R LV E++P GSL ++L +K + + + A + +G+ +L
Sbjct: 66 NIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYL-QKHRERLDHRKLLLYASQICKGMEYL 124
Query: 146 HGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRG--YAAPE 203
++RDL N+L++S K+ DFGL + P D + R G + APE
Sbjct: 125 GSK--RYVHRDLATRNILVESENRVKIGDFGLTKVLPQ-DKEYYKVREPGESPIFWYAPE 181
Query: 204 YVATGHLTPKSDVYSFGVVLLELLS------------GRRALDEDRGGLAEQTLVEWADP 251
+ + SDV+SFGVVL EL + R ++ +G + L+E
Sbjct: 182 SLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIE---- 237
Query: 252 FLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 307
L+++ R+ + A++ +C + DP RPS ++ +E +
Sbjct: 238 LLKNNGRLPAPPGC----------PAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 2e-22
Identities = 70/287 (24%), Positives = 123/287 (42%), Gaps = 39/287 (13%)
Query: 28 LLGEGGFGCVFKG-WIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKE-WLTEVIYLGQLR 85
+GEG FG V++G ++ I VA+K K + +E +L E + Q
Sbjct: 13 CIGEGQFGDVYQGVYMSPE-------NEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFD 65
Query: 86 HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFL 145
H ++VKLIG +E + +V E P G L ++L + + + + + ++ L++L
Sbjct: 66 HPHIVKLIGVITE-NPVWIVMELAPLGELRSYL-QVNKYSLDLASLILYSYQLSTALAYL 123
Query: 146 HGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYV 205
++RD+ A NVL+ S KL DFGL+R S + + + APE +
Sbjct: 124 ESK--RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIK-WMAPESI 180
Query: 206 ATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPF--LRDSRRVLRIM 263
T SDV+ FGV + E+L G PF ++++ + RI
Sbjct: 181 NFRRFTSASDVWMFGVCMWEILM--------LG----------VKPFQGVKNNDVIGRIE 222
Query: 264 DTRLGGQYSKKE--AQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLH 308
+ G + + +++ +C DP RP ++ L +
Sbjct: 223 N---GERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDIL 266
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 94.2 bits (234), Expect = 2e-22
Identities = 69/203 (33%), Positives = 105/203 (51%), Gaps = 15/203 (7%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQG-HKEWLTEVIYLGQLRHE 87
LG G FGCV KG + K I VAIK LK E+ + E + E + QL +
Sbjct: 3 LGSGNFGCVKKG-----VYKMRK--KQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNP 55
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHG 147
+V++IG C E++ +LV E G L L K + I+ V++ V+ G+ +L G
Sbjct: 56 YIVRMIGVC-EAEALMLVMEMASGGPLNKFLSGKKDE-ITVSNVVELMHQVSMGMKYLEG 113
Query: 148 LDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT--RGYAAPEYV 205
N ++RDL A NVLL + AK+SDFGL++ D+++ R G + APE +
Sbjct: 114 --KNFVHRDLAARNVLLVNQHYAKISDFGLSK-ALGADDSYYKARSAGKWPLKWYAPECI 170
Query: 206 ATGHLTPKSDVYSFGVVLLELLS 228
+ +SDV+S+G+ + E S
Sbjct: 171 NFRKFSSRSDVWSYGITMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 93.4 bits (232), Expect = 5e-22
Identities = 81/280 (28%), Positives = 127/280 (45%), Gaps = 40/280 (14%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHEN 88
LG G FG V G K + I VAIK + E ++++ E + +L H
Sbjct: 12 LGSGQFGVVHLG----------KWRAQIKVAIKAIN-EGAMSEEDFIEEAKVMMKLSHPK 60
Query: 89 LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL 148
LV+L G C++ +V EFM G L N+L R+ +S + + DV G+ +L
Sbjct: 61 LVQLYGVCTQQKPLYIVTEFMENGCLLNYL-RQRQGKLSKDMLLSMCQDVCEGMEYLE-- 117
Query: 149 DANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR---GYAAPEYV 205
+ I+RDL A N L+ S K+SDFG+ R D+ + S+ G + ++ PE
Sbjct: 118 RNSFIHRDLAARNCLVSSTGVVKVSDFGMTR--YVLDDEYTSS--SGAKFPVKWSPPEVF 173
Query: 206 ATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDT 265
+ KSDV+SFGV++ E+ + E PF + S + M +
Sbjct: 174 NFSKYSSKSDVWSFGVLMWEVFT------------------EGKMPFEKKSNYEVVEMIS 215
Query: 266 RLGGQYSKKEA-QAVAAVVLQCLHMDPKNRPSMVDVLTSL 304
R Y K A V V+ C H P+ RP+ ++L ++
Sbjct: 216 RGFRLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 94.0 bits (233), Expect = 5e-22
Identities = 67/211 (31%), Positives = 101/211 (47%), Gaps = 17/211 (8%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHEN 88
LGEG FG VF + P + I+VA+K LK S K++ E L L+HE+
Sbjct: 13 LGEGAFGKVFLA--ECYNLCPEQ--DKILVAVKTLKDASDNARKDFHREAELLTNLQHEH 68
Query: 89 LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPI-----SWPTRVK------IAID 137
+VK G C E D ++V+E+M G L L G + + P + IA
Sbjct: 69 IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQ 128
Query: 138 VARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR 197
+A G+ +L + ++RDL N L+ N K+ DFG++RD + D V +
Sbjct: 129 IAAGMVYL--ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 186
Query: 198 GYAAPEYVATGHLTPKSDVYSFGVVLLELLS 228
+ PE + T +SDV+S GVVL E+ +
Sbjct: 187 RWMPPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 6e-22
Identities = 84/308 (27%), Positives = 131/308 (42%), Gaps = 68/308 (22%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLK--AESFQGHKEWLTEVIYLGQLR 85
LL EG FG +F G + + V +K +K A Q L E L L
Sbjct: 13 LLQEGTFGRIFYGILIDEKPGKEEE-----VFVKTVKDHASEIQVTL-LLQESCLLYGLS 66
Query: 86 HENLVKLIGYCSE-SDNRLLVYEFMPKGSLENHL------FRKGVQPISWPTRVKIAIDV 138
H+N++ ++ C E + ++Y +M G+L+ L Q +S V +AI +
Sbjct: 67 HQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQI 126
Query: 139 ARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD-GPT-----GDNTHVSTR 192
A G+S+LH VI++D+ A N ++D K++D L+RD P GDN + +
Sbjct: 127 ACGMSYLHKR--GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVK 184
Query: 193 IVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPF 252
+ A E + + SDV+SFGV+L EL++ L + VE DPF
Sbjct: 185 ------WMALESLVNKEYSSASDVWSFGVLLWELMT-----------LGQTPYVE-IDPF 226
Query: 253 -----LRDSRRVLRIMDTRLGGQYSKKEAQAVA------AVVLQCLHMDPKNRPSMVDVL 301
L+D R+ AQ + AV+ C +DP+ RPS ++
Sbjct: 227 EMAAYLKDGYRL----------------AQPINCPDELFAVMACCWALDPEERPSFSQLV 270
Query: 302 TSLEQLHT 309
L H
Sbjct: 271 QCLTDFHA 278
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 92.3 bits (230), Expect = 1e-21
Identities = 69/209 (33%), Positives = 99/209 (47%), Gaps = 26/209 (12%)
Query: 32 GGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGH---KEWLTEVIYLGQLRHEN 88
G +G VF K +G + AIK +K + LTE L Q +
Sbjct: 4 GAYGRVFLA---------KKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPY 54
Query: 89 LVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHG 147
+VKL Y + L LV E++P G L + L G R+ IA ++ L +LH
Sbjct: 55 VVKLY-YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDV-ARIYIA-EIVLALEYLHS 111
Query: 148 LDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS------TRIVGTRGYAA 201
+I+RDLK N+L+DSN + KL+DFGL++ G +++ RIVGT Y A
Sbjct: 112 N--GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIA 169
Query: 202 PEYV-ATGHLTPKSDVYSFGVVLLELLSG 229
PE + GH + D +S G +L E L G
Sbjct: 170 PEVILGQGH-SKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 92.3 bits (230), Expect = 1e-21
Identities = 74/289 (25%), Positives = 119/289 (41%), Gaps = 48/289 (16%)
Query: 27 YLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGH-KEWLT-EVIYLGQL 84
+G+G FG V K K G ++ K + + K+ L EV L +L
Sbjct: 6 ETIGKGSFGTVRK--------VRRKS-DGKILVWKEIDYGNMTEKEKQQLVSEVNILREL 56
Query: 85 RHENLVKLIGYCSESDNRLL--VYEFMPKGSLENHL--FRKGVQPISWPTRVKIAIDVAR 140
+H N+V+ + N+ L V E+ G L + +K + I +I +
Sbjct: 57 KHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLL 116
Query: 141 GLSFLHGLDAN---VIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR 197
L H V++RDLK +N+ LD+N N KL DFGLA+ G ++ + VGT
Sbjct: 117 ALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAK--ILGHDSSFAKTYVGTP 174
Query: 198 GYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSR 257
Y +PE + KSD++S G ++ EL + PF ++
Sbjct: 175 YYMSPEQLNHMSYDEKSDIWSLGCLIYELCALS-------------------PPFTARNQ 215
Query: 258 RVLRIM-----DTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL 301
L R+ +YS + V+ L++DP RPS ++L
Sbjct: 216 LQLASKIKEGKFRRIPYRYSS----ELNEVIKSMLNVDPDKRPSTEELL 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.5 bits (228), Expect = 3e-21
Identities = 81/287 (28%), Positives = 126/287 (43%), Gaps = 58/287 (20%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLT-EVIYLGQLRH 86
+G+G FG V+K ID+ T VVAIK + E + E + E+ +L Q R
Sbjct: 8 CIGKGSFGEVYKA-IDKRT--------NQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRS 58
Query: 87 ENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLH 146
+ K G + ++ E+ GS L + G + I +V GL +LH
Sbjct: 59 PYITKYYGSFLKGSKLWIIMEYCGGGSCL-DLLKPG--KLDETYIAFILREVLLGLEYLH 115
Query: 147 GLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR---IVGTRGYAAPE 203
I+RD+KA+N+LL + KL+DFG++ G T ++ VGT + APE
Sbjct: 116 E--EGKIHRDIKAANILLSEEGDVKLADFGVS-----GQLTSTMSKRNTFVGTPFWMAPE 168
Query: 204 YVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRD--SRRVLR 261
+ K+D++S G+ +EL G +P L D RVL
Sbjct: 169 VIKQSGYDEKADIWSLGITAIELAKG--------------------EPPLSDLHPMRVLF 208
Query: 262 IM-----DTRLGGQYSK--KEAQAVAAVVLQCLHMDPKNRPSMVDVL 301
++ + G ++SK K+ V CL+ DPK RPS ++L
Sbjct: 209 LIPKNNPPSLEGNKFSKPFKD------FVSLCLNKDPKERPSAKELL 249
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 3e-21
Identities = 62/213 (29%), Positives = 111/213 (52%), Gaps = 24/213 (11%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRL------KAESFQGHKEWLTEVIYL 81
+LG+G +G V+ G +Q G ++A+K++ + + +++ EV L
Sbjct: 7 VLGKGAYGTVYCGLTNQ----------GQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLL 56
Query: 82 GQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARG 141
L+H N+V+ +G C + + + EF+P GS+ + L R G P+ P K + G
Sbjct: 57 KSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFG--PLPEPVFCKYTKQILDG 114
Query: 142 LSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD----GPTGDNTHVSTRIVGTR 197
+++LH + V++RD+K +NV+L N KL DFG AR G G ++++ + GT
Sbjct: 115 VAYLH--NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTP 172
Query: 198 GYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR 230
+ APE + KSD++S G + E+ +G+
Sbjct: 173 YWMAPEVINESGYGRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 3e-21
Identities = 64/209 (30%), Positives = 96/209 (45%), Gaps = 24/209 (11%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKR-LKAESFQGHKEWLTEVIYLGQLRHE 87
LGEG G V K + G++ A+K + K+ L E+ +
Sbjct: 9 LGEGAGGSVTKCRLKNT---------GMIFALKTITTDPNPDLQKQILRELEINKSCKSP 59
Query: 88 NLVKLIG-YCSESDNRL-LVYEFMPKGSLENHL--FRKGVQPISWPTRVKIAIDVARGLS 143
+VK G + ES + + + E+ GSL++ +K I KIA V +GLS
Sbjct: 60 YIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLS 119
Query: 144 FLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGD--NTHVSTRIVGTRGYAA 201
+LH +I+RD+K SN+LL KL DFG+ +G+ N+ T GT Y A
Sbjct: 120 YLH--SRKIIHRDIKPSNILLTRKGQVKLCDFGV-----SGELVNSLAGT-FTGTSFYMA 171
Query: 202 PEYVATGHLTPKSDVYSFGVVLLELLSGR 230
PE + + SDV+S G+ LLE+ R
Sbjct: 172 PERIQGKPYSITSDVWSLGLTLLEVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.4 bits (228), Expect = 3e-21
Identities = 66/219 (30%), Positives = 101/219 (46%), Gaps = 46/219 (21%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEW-----LTEVIYLGQ 83
LG+G FG V+ ++ T G +VAIK++K + W L EV L +
Sbjct: 7 LGDGTFGSVYLA-RNKET--------GELVAIKKMKKKF----YSWEECMNLREVKSLRK 53
Query: 84 L-RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLF-----RKGVQPISWPTRVKIAID 137
L H N+VKL E+D V+E+M E +L+ RKG +P S I
Sbjct: 54 LNEHPNIVKLKEVFRENDELYFVFEYM-----EGNLYQLMKDRKG-KPFSESVIRSIIYQ 107
Query: 138 VARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS-----TR 192
+ +GL+ +H +RDLK N+L+ K++DFGLAR + T
Sbjct: 108 ILQGLAHIH--KHGFFHRDLKPENLLVSGPEVVKIADFGLAR--------EIRSRPPYTD 157
Query: 193 IVGTRGYAAPEYV-ATGHLTPKSDVYSFGVVLLELLSGR 230
V TR Y APE + + + D+++ G ++ EL + R
Sbjct: 158 YVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 6e-21
Identities = 78/283 (27%), Positives = 133/283 (46%), Gaps = 33/283 (11%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES-FQGHKEWLTEVIYLGQLRHE 87
+G G FG V G + S V +K L+A + +L EV +L H
Sbjct: 3 IGNGWFGKVLLGEAHRGM-------SKARVVVKELRASATPDEQLLFLQEVQPYRELNHP 55
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLF--RKGVQPISWP-TRVKIAIDVARGLSF 144
N+++ +G C ES LLV EF P G L+N+L R V ++ ++A +VA GL +
Sbjct: 56 NVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLW 115
Query: 145 LHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEY 204
LH A+ I+ DL N L ++ + K+ D+GLA + D + APE
Sbjct: 116 LH--QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPEL 173
Query: 205 VATGH-------LTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSR 257
V T KS+++S GV + EL + A D+ L+++ +++ +R+
Sbjct: 174 VEIRGQDLLPKDQTKKSNIWSLGVTMWELFT---AADQPYPDLSDEQVLKQV---VRE-- 225
Query: 258 RVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDV 300
+ +++ +L +YS + + V+Q +DP+ RP+ +V
Sbjct: 226 QDIKLPKPQLDLKYSDRWYE-----VMQFCWLDPETRPTAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 6e-21
Identities = 83/298 (27%), Positives = 129/298 (43%), Gaps = 48/298 (16%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRL--KAESFQGHKEWLTEVIYLGQLR 85
L+GEG +G V K +G +VAIK+ + K + E+ L QLR
Sbjct: 8 LVGEGSYGMVMKC---------KHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLR 58
Query: 86 HENLVKLIGYCSESDNRLLVYEFMPKGSLEN-HLFRKGVQPISWPTRVKIAIDVARGLSF 144
HENLV LI LV+EF+ L++ + G + K + RG+ F
Sbjct: 59 HENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNG---LDESRVRKYLFQILRGIEF 115
Query: 145 LHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR--DGPTGDNTHVSTRIVGTRGYAAP 202
H N+I+RD+K N+L+ + KL DFG AR P G+ V T V TR Y AP
Sbjct: 116 CH--SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP-GE---VYTDYVATRWYRAP 169
Query: 203 EYVATGHLTPKS-DVYSFGVVLLELLSGRRALDEDR------------GGLAE--QTLVE 247
E + ++ D+++ G ++ E+L+G D G L Q + +
Sbjct: 170 ELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQ 229
Query: 248 WADPFLRDSRRVLRIMDTR----LGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL 301
F +R+ + + L ++ K + + QCL +DP +RPS +L
Sbjct: 230 KNPLFA-----GMRLPEVKEIEPLEKRFPKLSGLVL-DLAKQCLRIDPDDRPSSSQLL 281
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 91.4 bits (228), Expect = 7e-21
Identities = 72/216 (33%), Positives = 106/216 (49%), Gaps = 26/216 (12%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRL-KAESFQGH-KEWLTEVIYLGQLR 85
+G G +G V +D+ T G VAIK++ K L E+ L LR
Sbjct: 7 PIGSGAYGVVCSA-VDKRT--------GRKVAIKKISNVFDDLIDAKRILREIKLLRHLR 57
Query: 86 HENLVKLIGY----CSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVK-IAIDVA 139
HEN++ L+ E N + +V E M + + + + QP++ ++ +
Sbjct: 58 HENIIGLLDILRPPSPEDFNDVYIVTELME--TDLHKVIKSP-QPLT-DDHIQYFLYQIL 113
Query: 140 RGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR-DGPTGDNTHVSTRIVGTRG 198
RGL +LH ANVI+RDLK SN+L++SN + K+ DFGLAR P D T V TR
Sbjct: 114 RGLKYLHS--ANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRW 171
Query: 199 YAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRAL 233
Y APE + + T D++S G + ELL R+ L
Sbjct: 172 YRAPELLLSSSRYTKAIDIWSVGCIFAELL-TRKPL 206
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 8e-21
Identities = 82/296 (27%), Positives = 143/296 (48%), Gaps = 41/296 (13%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRL-KAESFQGHKEWLTEVIYLGQLRHE 87
LG+G FG V++G N K + VA+K + ++ S + E+L E +
Sbjct: 14 LGQGSFGMVYEG----NARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH 69
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHL--FR------KGVQPISWPTRVKIAIDVA 139
++V+L+G S+ L+V E M G L+++L R G P + +++A ++A
Sbjct: 70 HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 129
Query: 140 RGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGY 199
G+++L+ ++RDL A N ++ +F K+ DFG+ RD D + + +
Sbjct: 130 DGMAYLNA--KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 187
Query: 200 AAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPF--LRDSR 257
APE + G T SD++SFGVVL E+ S LAEQ P+ L + +
Sbjct: 188 MAPESLKDGVFTTSSDMWSFGVVLWEITS-----------LAEQ-------PYQGLSNEQ 229
Query: 258 RVLRIMDTRLGGQYSKKE--AQAVAAVVLQCLHMDPKNRPSMVDVLTSL-EQLHTS 310
+ +MD GG + + + V ++ C +PK RP+ ++++ L + LH S
Sbjct: 230 VLKFVMD---GGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPS 282
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 9e-21
Identities = 66/219 (30%), Positives = 101/219 (46%), Gaps = 26/219 (11%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQL--- 84
LGEG FG V K P VA+K LK ++ + K+ V + +
Sbjct: 19 PLGEGAFGQVVKA----EAVGLDNPNETSTVAVKMLKDDATE--KDLSDLVSEMEMMKMI 72
Query: 85 -RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHL--------------FRKGVQPISWP 129
+H+N++ L+G C++ +V E+ G+L + L R + ++
Sbjct: 73 GKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQK 132
Query: 130 TRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHV 189
V A VARG+ FL I+RDL A NVL+ + K++DFGLARD D
Sbjct: 133 DLVSFAYQVARGMEFLA--SKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRK 190
Query: 190 STRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 228
+T + APE + T +SDV+SFGV+L E+ +
Sbjct: 191 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 2e-20
Identities = 60/183 (32%), Positives = 88/183 (48%), Gaps = 15/183 (8%)
Query: 57 VVAIKRLKAESFQGH-KEWLTEVIYLGQLRHENLVKLIGYCSESDNRLL--VYEFMPKGS 113
VAIKR+ E Q E EV + Q H N+VK Y S L V ++ GS
Sbjct: 28 KVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKY--YTSFVVGDELWLVMPYLSGGS 85
Query: 114 LEN---HLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNA 170
L + + +G + +V +GL +LH I+RD+KA N+LL + +
Sbjct: 86 LLDIMKSSYPRGGLD--EAIIATVLKEVLKGLEYLH--SNGQIHRDIKAGNILLGEDGSV 141
Query: 171 KLSDFGL-ARDGPTGDNTH-VSTRIVGTRGYAAPEYVATGH-LTPKSDVYSFGVVLLELL 227
K++DFG+ A GD T V VGT + APE + H K+D++SFG+ +EL
Sbjct: 142 KIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELA 201
Query: 228 SGR 230
+G
Sbjct: 202 TGA 204
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 3e-20
Identities = 69/222 (31%), Positives = 107/222 (48%), Gaps = 38/222 (17%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKA-ESFQGHKEWLTEVIYLGQL-R 85
++GEG FG V + I K G + AIK LK S H+++ E+ L +L
Sbjct: 9 VIGEGNFGQVIRAMI-------KKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGH 61
Query: 86 HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGV--------------QPISWPTR 131
H N++ L+G C + E+ P G+L + L + V ++
Sbjct: 62 HPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQL 121
Query: 132 VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVST 191
++ A DVA G+ +L + I+RDL A NVL+ N +K++DFGL+R G+ +V
Sbjct: 122 LQFASDVATGMQYLS--EKQFIHRDLAARNVLVGENLASKIADFGLSR----GEEVYVKK 175
Query: 192 RIVGTRGYAAPEYVATGHL-----TPKSDVYSFGVVLLELLS 228
T G ++A L T KSDV+SFGV+L E++S
Sbjct: 176 ----TMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 4e-20
Identities = 73/284 (25%), Positives = 135/284 (47%), Gaps = 40/284 (14%)
Query: 26 DYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLR 85
+ LG G FG V+ +++T VA+K +K S + +L E + L+
Sbjct: 11 EKKLGAGQFGEVWMATYNKHT----------KVAVKTMKPGSMS-VEAFLAEANVMKTLQ 59
Query: 86 HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFL 145
H+ LVKL ++ + ++ EFM KGSL + L P + + +A G++F+
Sbjct: 60 HDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI 118
Query: 146 HGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR---GYAAP 202
N I+RDL+A+N+L+ ++ K++DFGLAR DN + + G + + AP
Sbjct: 119 E--QRNYIHRDLRAANILVSASLVCKIADFGLAR--VIEDNEYTARE--GAKFPIKWTAP 172
Query: 203 EYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL-RDSRRVLR 261
E + G T KSDV+SFG++L+E+++ R P+ + V+R
Sbjct: 173 EAINFGSFTIKSDVWSFGILLMEIVTYGRI------------------PYPGMSNPEVIR 214
Query: 262 IMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 305
++ + + + ++++C P+ RP+ + + L+
Sbjct: 215 ALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLD 258
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 5e-20
Identities = 71/214 (33%), Positives = 107/214 (50%), Gaps = 21/214 (9%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEW-LTEVIYLGQL 84
+LG+G FG V A K G+ + A+K LK + E +TE L
Sbjct: 2 VLGKGSFGKVL--------LAELK-GTDELYAVKVLKKDVILQDDDVECTMTEKRVLALA 52
Query: 85 -RHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGL 142
+H L +L C ++ +RL V E++ G L H+ R G P A ++ GL
Sbjct: 53 GKHPFLTQLHS-CFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDE--PRARFYAAEIVLGL 109
Query: 143 SFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAP 202
FLH + +IYRDLK NVLLDS + K++DFG+ ++G G T ++ GT Y AP
Sbjct: 110 QFLH--ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT--TSTFCGTPDYIAP 165
Query: 203 EYVATGHLTPKSDVYSFGVVLLELLSGRRALDED 236
E ++ P D ++ GV+L E+L+G+ + D
Sbjct: 166 EILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 6e-20
Identities = 70/222 (31%), Positives = 107/222 (48%), Gaps = 38/222 (17%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQG-HKEWLTEVIYLGQL-R 85
++GEG FG V K I K G + AIKR+K + + H+++ E+ L +L
Sbjct: 14 VIGEGNFGQVLKARI-------KKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 66
Query: 86 HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGV--------------QPISWPTR 131
H N++ L+G C L E+ P G+L + L + V +S
Sbjct: 67 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126
Query: 132 VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVST 191
+ A DVARG+ +L I+RDL A N+L+ N+ AK++DFGL+R G +V
Sbjct: 127 LHFAADVARGMDYLS--QKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVKK 180
Query: 192 RIVGTRGYAAPEYVATGHL-----TPKSDVYSFGVVLLELLS 228
T G ++A L T SDV+S+GV+L E++S
Sbjct: 181 ----TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 87.6 bits (218), Expect = 8e-20
Identities = 69/218 (31%), Positives = 98/218 (44%), Gaps = 49/218 (22%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQ----- 83
LG G FG V K SG A+K L K +++ L Q
Sbjct: 9 LGTGSFGRVM--------LVRHKG-SGKYYALKIL-------SKA---KIVKLKQVEHVL 49
Query: 84 --------LRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIA 135
+RH LV L G + N LV E++P G L +HL + G P R A
Sbjct: 50 NEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPV-ARFYAA 108
Query: 136 IDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR--- 192
V L +LH LD ++YRDLK N+LLDS+ K++DFG A+ V R
Sbjct: 109 -QVVLALEYLHSLD--IVYRDLKPENLLLDSDGYIKITDFGFAK--------RVKGRTYT 157
Query: 193 IVGTRGYAAPEYV-ATGHLTPKSDVYSFGVVLLELLSG 229
+ GT Y APE + + G+ D ++ G+++ E+L+G
Sbjct: 158 LCGTPEYLAPEIILSKGYGKA-VDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 8e-20
Identities = 61/203 (30%), Positives = 107/203 (52%), Gaps = 12/203 (5%)
Query: 28 LLGEGGFGCVFKG-WIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTE-VIYLGQLR 85
LLG G FG V KG WI P I VAIK ++ S + + +T+ ++ +G L
Sbjct: 14 LLGSGVFGTVHKGIWI------PEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLD 67
Query: 86 HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFL 145
H +V+L+G C + +L V + P GSL +H+ R+ + + + +A+G+ +L
Sbjct: 68 HAYIVRLLGICPGASLQL-VTQLSPLGSLLDHV-RQHRDSLDPQRLLNWCVQIAKGMYYL 125
Query: 146 HGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYV 205
+ +++R+L A N+LL S+ +++DFG+A D + + + A E +
Sbjct: 126 E--EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESI 183
Query: 206 ATGHLTPKSDVYSFGVVLLELLS 228
G T +SDV+S+GV + E++S
Sbjct: 184 LFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 2e-19
Identities = 61/209 (29%), Positives = 91/209 (43%), Gaps = 21/209 (10%)
Query: 27 YLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIK---RLKAESFQGHKEWLTEVIYLGQ 83
++G+G FG V I Q K + + A+K + K + L E L +
Sbjct: 6 RVIGKGAFGKV---CIVQ------KRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQE 56
Query: 84 LRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI-DVARGL 142
L H LV L + +N LV + + G L HL +K +VK I ++ L
Sbjct: 57 LNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFS---EEQVKFWICEIVLAL 113
Query: 143 SFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAP 202
+LH +I+RD+K N+LLD + ++DF +A T T GT GY AP
Sbjct: 114 EYLH--SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT---TSTSGTPGYMAP 168
Query: 203 EYVATGHLTPKSDVYSFGVVLLELLSGRR 231
E + + D +S GV E L G+R
Sbjct: 169 EVLCRQGYSVAVDWWSLGVTAYECLRGKR 197
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 2e-19
Identities = 58/207 (28%), Positives = 103/207 (49%), Gaps = 19/207 (9%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHEN 88
LG+G FG V+K +G+ A K ++ ES + ++++ E+ L + +H N
Sbjct: 13 LGDGAFGKVYKA---------QHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPN 63
Query: 89 LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL 148
+V L + ++ EF G+L++ + + + ++ P + + L+FLH
Sbjct: 64 IVGLYEAYFYENKLWILIEFCDGGALDS-IMLELERGLTEPQIRYVCRQMLEALNFLH-- 120
Query: 149 DANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVA-- 206
VI+RDLKA N+LL + + KL+DFG++ + + +GT + APE VA
Sbjct: 121 SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT--FIGTPYWMAPEVVACE 178
Query: 207 TGHLTP---KSDVYSFGVVLLELLSGR 230
T P K+D++S G+ L+EL
Sbjct: 179 TFKDNPYDYKADIWSLGITLIELAQME 205
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 86.5 bits (215), Expect = 3e-19
Identities = 63/211 (29%), Positives = 101/211 (47%), Gaps = 32/211 (15%)
Query: 31 EGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKE-----WLTEVIYLGQLR 85
EG +G V++ D+ T G +VA+K+LK E KE L E+ L +L+
Sbjct: 15 EGTYGVVYRA-RDKKT--------GEIVALKKLKMEK---EKEGFPITSLREINILLKLQ 62
Query: 86 HENLVKL--IGYCSESDNRLLVYEFMP---KGSLENHLFRKGVQPISWPTRVKIAIDVAR 140
H N+V + + S D +V E++ K +E QP + + +
Sbjct: 63 HPNIVTVKEVVVGSNLDKIYMVMEYVEHDLKSLMETM-----KQPFLQSEVKCLMLQLLS 117
Query: 141 GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYA 200
G++ LH D +++RDLK SN+LL++ K+ DFGLAR G T++V T Y
Sbjct: 118 GVAHLH--DNWILHRDLKTSNLLLNNRGILKICDFGLAR--EYGSPLKPYTQLVVTLWYR 173
Query: 201 APE-YVATGHLTPKSDVYSFGVVLLELLSGR 230
APE + + D++S G + ELL+ +
Sbjct: 174 APELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 3e-19
Identities = 75/289 (25%), Positives = 125/289 (43%), Gaps = 55/289 (19%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKE-WLTEVIYLGQLR 85
LG+G +G V+K + A+K + S Q +E + E+ L +
Sbjct: 7 KLGKGSYGSVYK---------VKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVN 57
Query: 86 HENLVKLIGYCSES---DNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRV--KIAIDVA 139
H N+ I Y E+ N+L +V E+ P G L + ++ + P + +I I +
Sbjct: 58 HPNI---ISY-KEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLL 113
Query: 140 RGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGY 199
RGL LH + +++RDLK++N+LL +N K+ D G+++ T+I GT Y
Sbjct: 114 RGLQALH--EQKILHRDLKSANILLVANDLVKIGDLGISK---VLKKNMAKTQI-GTPHY 167
Query: 200 AAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPF----LRD 255
APE + KSD++S G +L E+ + PF ++D
Sbjct: 168 MAPEVWKGRPYSYKSDIWSLGCLLYEMATFAP-------------------PFEARSMQD 208
Query: 256 SR-RVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303
R +V R + YS Q + + L + PK RP+ +L S
Sbjct: 209 LRYKVQRGKYPPIPPIYS----QDLQNFIRSMLQVKPKLRPNCDKILAS 253
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 5e-19
Identities = 66/276 (23%), Positives = 120/276 (43%), Gaps = 35/276 (12%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHEN 88
LG+G FG + + T+ S +V L S + ++ L E++ L L+H N
Sbjct: 8 LGKGAFG-------EATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPN 60
Query: 89 LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL 148
++ + + + L+ E+ G+L + + R+ Q + + +S++H
Sbjct: 61 IIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH-- 118
Query: 149 DANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG 208
A +++RD+K N+ L KL DFG+++ G ++ +VGT Y +PE
Sbjct: 119 KAGILHRDIKTLNIFLTKAGLIKLGDFGISKI--LGSEYSMAETVVGTPYYMSPELCQGV 176
Query: 209 HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMD---T 265
KSD+++ G VL ELL+ +R D V++I+ T
Sbjct: 177 KYNFKSDIWALGCVLYELLTLKRTFDAT-----------------NPLNLVVKIVQGNYT 219
Query: 266 RLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL 301
+ YS + ++V L DP+ RP+ +VL
Sbjct: 220 PVVSVYS----SELISLVHSLLQQDPEKRPTADEVL 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 5e-19
Identities = 63/207 (30%), Positives = 108/207 (52%), Gaps = 14/207 (6%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAE-SFQGHKEWLTEVIYLGQLRH 86
+LG G FG + +G + P+K + VAI L+A S + + +L E + LGQ H
Sbjct: 12 ILGTGRFGELCRGCLK----LPSK--RELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDH 65
Query: 87 ENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLH 146
N+V+L G + + ++V E+M G+L++ L RK + + + +A G+ +L
Sbjct: 66 SNIVRLEGVITRGNTMMIVTEYMSNGALDSFL-RKHEGQLVAGQLMGMLPGLASGMKYLS 124
Query: 147 GLDANVIYRDLKASNVLLDSNFNAKLSDFG-LARDGPTGDNTHVSTRIVGTRGYAAPEYV 205
+ +++ L A VL++S+ K+S F L D T +S + +AAPE +
Sbjct: 125 --EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVL--WAAPEAI 180
Query: 206 ATGHLTPKSDVYSFGVVLLELLS-GRR 231
H + SDV+SFG+V+ E++S G R
Sbjct: 181 QYHHFSSASDVWSFGIVMWEVMSYGER 207
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 1e-18
Identities = 69/251 (27%), Positives = 100/251 (39%), Gaps = 35/251 (13%)
Query: 51 KPGSGIVVAIKRLKAESFQGHKEWLTEV-----IYLGQLRHENLVKLIGYCSESDNRLLV 105
K +G AIK LK + +T V I + Q + KL D LV
Sbjct: 17 KRSTGDYFAIKVLKKSDMIAKNQ-VTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLV 75
Query: 106 YEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLD 165
E++ G + + G P W + +V G+ LH +I+RD+K N+L+D
Sbjct: 76 MEYLNGGDCASLIKTLGGLPEDWAK--QYIAEVVLGVEDLH--QRGIIHRDIKPENLLID 131
Query: 166 SNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLE 225
+ KL+DFGL+R+G + + VGT Y APE + SD +S G V+ E
Sbjct: 132 QTGHLKLTDFGLSRNG------LENKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFE 185
Query: 226 LLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVL- 284
L G AE + I+ R+ KE + AV L
Sbjct: 186 FLFGYPPFH------AETPDAVFD-----------NILSRRINWPEEVKEFCSPEAVDLI 228
Query: 285 -QCLHMDPKNR 294
+ L MDP R
Sbjct: 229 NRLLCMDPAKR 239
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 1e-18
Identities = 66/205 (32%), Positives = 98/205 (47%), Gaps = 17/205 (8%)
Query: 29 LGEGGFG--CVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRH 86
LG+GGFG C + +A K + KRLK +S G K L E L ++
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKK------LDKKRLKKKS--GEKMALLEKEILEKVNS 52
Query: 87 ENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFL 145
+V L Y ES L LV M G L+ H++ G + + + + + G+ L
Sbjct: 53 PFIVNL-AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHL 111
Query: 146 HGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYV 205
H +D ++YRD+K NVLLD N +LSD GLA + G T+ GT GY APE +
Sbjct: 112 HSMD--IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTI---TQRAGTNGYMAPEIL 166
Query: 206 ATGHLTPKSDVYSFGVVLLELLSGR 230
+ D ++ G + E+++GR
Sbjct: 167 KEEPYSYPVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 83.8 bits (208), Expect = 1e-18
Identities = 69/212 (32%), Positives = 90/212 (42%), Gaps = 33/212 (15%)
Query: 29 LGEGGFGCVF--KGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIY-----L 81
LG GGFG V K TFA +V Q H I+ L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETG------QQEH-------IFSEKEIL 47
Query: 82 GQLRHENLVKLIGYCSESDNRLLVY---EFMPKGSLENHLFRKGVQPISWPTRVKIAIDV 138
+ H +VKL Y + D + +Y E+ G L L +G+ + R IA V
Sbjct: 48 EECNHPFIVKL--YRTFKDKKY-IYMLMEYCLGGELWTILRDRGLFD-EYTARFYIAC-V 102
Query: 139 ARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRG 198
+LH +IYRDLK N+LLDSN KL DFG A+ +G T GT
Sbjct: 103 VLAFEYLHNR--GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT---FCGTPE 157
Query: 199 YAAPEYVATGHLTPKSDVYSFGVVLLELLSGR 230
Y APE + D +S G++L ELL+GR
Sbjct: 158 YVAPEIILNKGYDFSVDYWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 1e-18
Identities = 76/284 (26%), Positives = 136/284 (47%), Gaps = 33/284 (11%)
Query: 28 LLGEGGFGCVFKG-WIDQNTFAPTKPGSGIVVAIKRLKAE-SFQGHKEWLTEVIYLGQLR 85
+LG G FG V+KG WI P I VAIK L+ S + +KE L E + +
Sbjct: 14 VLGSGAFGTVYKGIWI------PDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVG 67
Query: 86 HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFL 145
+ +L+G C S +L V + MP G L +++ R+ I + + +A+G+S+L
Sbjct: 68 SPYVCRLLGICLTSTVQL-VTQLMPYGCLLDYV-RENKDRIGSQDLLNWCVQIAKGMSYL 125
Query: 146 HGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNT-HVSTRIVGTRGYAAPEY 204
+ +++RDL A NVL+ S + K++DFGLAR + H V + + A E
Sbjct: 126 E--EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIK-WMALES 182
Query: 205 VATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIM 263
+ T +SDV+S+GV + EL++ G + D G+ + + + + R + + +
Sbjct: 183 ILHRRFTHQSDVWSYGVTVWELMTFGAKPYD----GIPAREIPDLLEKGERLPQPPICTI 238
Query: 264 DTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 307
D V ++++C +D + RP +++ ++
Sbjct: 239 D--------------VYMIMVKCWMIDSECRPRFRELVDEFSRM 268
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 1e-18
Identities = 72/217 (33%), Positives = 95/217 (43%), Gaps = 44/217 (20%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKA--ESFQGHKEWLTEVIYLGQLRH 86
+GEG +G VFK +G +VAIK+ + K L E+ L QL+H
Sbjct: 9 IGEGSYGVVFKC---------RNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKH 59
Query: 87 ENLVKLIGYCSESDNRLLVYEFM-----------PKGSLENHLFRKGVQPISWPTRVKIA 135
NLV LI LV+E+ P+G + HL +K I W T
Sbjct: 60 PNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRG-VPEHLIKK----IIWQT----- 109
Query: 136 IDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR--DGPTGDNTHVSTRI 193
+ ++F H N I+RD+K N+L+ KL DFG AR GP D T
Sbjct: 110 ---LQAVNFCHKH--NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDY---- 160
Query: 194 VGTRGYAAPEY-VATGHLTPKSDVYSFGVVLLELLSG 229
V TR Y APE V P DV++ G V ELL+G
Sbjct: 161 VATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 2e-18
Identities = 65/219 (29%), Positives = 107/219 (48%), Gaps = 26/219 (11%)
Query: 29 LGEGGFGCVFKG---WIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQL- 84
LGEG FG V ID++ KP + VA+K LK ++ + L + + ++
Sbjct: 23 LGEGCFGQVVMAEALGIDKD-----KPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI 77
Query: 85 -RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHL--------------FRKGVQPISWP 129
+H+N++ L+G C++ ++ E+ KG+L +L R + +++
Sbjct: 78 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFK 137
Query: 130 TRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHV 189
V VARG+ +L I+RDL A NVL+ N K++DFGLARD D
Sbjct: 138 DLVSCTYQVARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKK 195
Query: 190 STRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 228
+T + APE + T +SDV+SFGV++ E+ +
Sbjct: 196 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 2e-18
Identities = 73/282 (25%), Positives = 120/282 (42%), Gaps = 42/282 (14%)
Query: 26 DYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLR 85
LGEG +G V+K +G VVAIK + + +E + E+ L Q
Sbjct: 8 LEKLGEGSYGSVYKA---------IHKETGQVVAIKVV--PVEEDLQEIIKEISILKQCD 56
Query: 86 HENLVKLIGYCSESDNRLLVYEFMPKGSLEN--HLFRKGVQPISWPTRVKIAI---DVAR 140
+VK G ++ + +V E+ GS+ + + K + T +IA +
Sbjct: 57 SPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTL------TEEEIAAILYQTLK 110
Query: 141 GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYA 200
GL +LH I+RD+KA N+LL+ AKL+DFG++ G D ++GT +
Sbjct: 111 GLEYLH--SNKKIHRDIKAGNILLNEEGQAKLADFGVS--GQLTDTMAKRNTVIGTPFWM 166
Query: 201 APEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVL 260
APE + K+D++S G+ +E+ G+ + A + P L D
Sbjct: 167 APEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSD----- 221
Query: 261 RIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLT 302
+K + V +CL DP+ RPS + +L
Sbjct: 222 -----------PEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 3e-18
Identities = 82/313 (26%), Positives = 131/313 (41%), Gaps = 62/313 (19%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQG--HKEWLTEVIYLGQLRH 86
LGEG FG V+K Q +G VVA+K++ + + L E+ L +L+H
Sbjct: 16 LGEGTFGEVYKA--RQIK-------TGRVVALKKILMHNEKDGFPITALREIKILKKLKH 66
Query: 87 ENLVKLIGYCSE-----SDNRLLVYEFMP------KGSLENHLFRKGVQPISWPTRVK-I 134
N+V LI E R VY P G LEN + +++K
Sbjct: 67 PNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLT------ESQIKCY 120
Query: 135 AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR---------DGPTGD 185
+ + G+++LH + ++++RD+KA+N+L+D+ K++DFGLAR G G
Sbjct: 121 MLQLLEGINYLH--ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGG 178
Query: 186 NTHVSTRIVGTRGYAAPEYVA-TGHLTPKSDVYSFGVVLLELLSGRRAL----DEDR--- 237
T T +V TR Y PE + T D++ G V E+ + R L D D+
Sbjct: 179 GTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHL 238
Query: 238 -----GGLAEQTLVEWAD----PFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLH 288
G E+T W + R ++ R G + ++ + L
Sbjct: 239 IFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPE-----GLDLLSKLLS 293
Query: 289 MDPKNRPSMVDVL 301
+DP R + D L
Sbjct: 294 LDPYKRLTASDAL 306
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 3e-18
Identities = 62/218 (28%), Positives = 113/218 (51%), Gaps = 30/218 (13%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKR--LKAESFQG---HKEWLT----EV 78
L+G G FG V+ G SG ++A+K+ L + S + L E+
Sbjct: 7 LIGSGSFGSVYLGMNAS---------SGELMAVKQVELPSVSASSKDRKRSMLDALAREI 57
Query: 79 IYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI-D 137
L +L+HEN+V+ +G ++D+ + E++P GS+ L G T V+ +
Sbjct: 58 ALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFE---ETLVRNFVRQ 114
Query: 138 VARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD-----GPTGDNTHVSTR 192
+ +GL++LH +I+RD+K +N+L+D+ K+SDFG+++ T N +
Sbjct: 115 ILKGLNYLHNRG--IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPS- 171
Query: 193 IVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR 230
+ G+ + APE V T K+D++S G +++E+L+G+
Sbjct: 172 LQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 4e-18
Identities = 75/259 (28%), Positives = 118/259 (45%), Gaps = 44/259 (16%)
Query: 54 SGIVVAIKRLKAESFQG-HKEWLTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKG 112
+G V+A K + + K+ L E+ + + R +V G +N + EFM G
Sbjct: 29 TGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCG 88
Query: 113 SLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKL 172
SL+ +++KG PI KIA+ V GL++L+ + +++RD+K SN+L++S KL
Sbjct: 89 SLDR-IYKKG-GPIPVEILGKIAVAVVEGLTYLYNVH-RIMHRDIKPSNILVNSRGQIKL 145
Query: 173 SDFGLARDGPTGD--NTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR 230
DFG+ +G+ N+ ++ VGT Y +PE + G T KSDV+S G+ ++EL G+
Sbjct: 146 CDFGV-----SGELINS-IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGK 199
Query: 231 RALDE----DRGGLAE-------QTLVEWADPFLRDSR--RVLRIMDTRLGGQYSKKEAQ 277
D G Q +V+ P L S LR
Sbjct: 200 FPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDLRDF-------------- 245
Query: 278 AVAAVVLQCLHMDPKNRPS 296
V CL DP RP+
Sbjct: 246 -----VDACLLKDPTERPT 259
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 5e-18
Identities = 66/185 (35%), Positives = 94/185 (50%), Gaps = 18/185 (9%)
Query: 58 VAIKRLKAESFQGH---KEWLTEVIYLGQLRHENLVKLIGY----CSESDNRL-LVYEFM 109
VAIK++ A +F K L E+ L L HEN++ + E+ N + +VYE M
Sbjct: 33 VAIKKI-ANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELM 91
Query: 110 PKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFN 169
+ H + Q +S + RGL ++H ANV++RDLK SN+LL++N +
Sbjct: 92 ---DTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIH--SANVLHRDLKPSNLLLNANCD 146
Query: 170 AKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYV-ATGHLTPKSDVYSFGVVLLELLS 228
K+ DFGLAR T + T V TR Y APE + T DV+S G + ELL
Sbjct: 147 LKICDFGLAR--TTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELL- 203
Query: 229 GRRAL 233
GR+ L
Sbjct: 204 GRKPL 208
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 5e-18
Identities = 65/209 (31%), Positives = 110/209 (52%), Gaps = 14/209 (6%)
Query: 23 FCSDYLLGEGGFGCVFKG-WIDQNTFAPTKPGSGIVVAIKRLK-AESFQGHKEWLTEVIY 80
F +LG G FG V+KG WI P I VAIK L+ A S + +KE L E
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWI------PEGEKVKIPVAIKELREATSPKANKEILDEAYV 62
Query: 81 LGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVAR 140
+ + + ++ +L+G C S +L + + MP G L +++ R+ I + + +A+
Sbjct: 63 MASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAK 120
Query: 141 GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR-DGPTGDNTHVSTRIVGTRGY 199
G+++L + +++RDL A NVL+ + + K++DFGLA+ G H V + +
Sbjct: 121 GMNYLE--ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIK-W 177
Query: 200 AAPEYVATGHLTPKSDVYSFGVVLLELLS 228
A E + T +SDV+S+GV + EL++
Sbjct: 178 MALESILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 6e-18
Identities = 58/217 (26%), Positives = 107/217 (49%), Gaps = 27/217 (12%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKR--LKAESFQGHKEWL--------TE 77
L+G+G +G V+ ++ T G ++A+K+ L A H +E
Sbjct: 8 LIGKGTYGRVYLA-LNVTT--------GEMMAVKQVELPATIAGRHDSRQKDMVKALRSE 58
Query: 78 VIYLGQLRHENLVKLIGYCSESDNRLLVY-EFMPKGSLENHLFRKGVQPISWPTRVKIAI 136
+ L L H N+V+ +G ++ L ++ E++P GS+ + L G
Sbjct: 59 IETLKDLDHLNIVQYLG-FETTEEYLSIFLEYVPGGSIGSCLRTYG--RFEEQLVRFFTE 115
Query: 137 DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 196
V GL++LH +++RDLKA N+L+D++ K+SDFG+++ + + + G+
Sbjct: 116 QVLEGLAYLH--SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGS 173
Query: 197 RGYAAPEYVATGH--LTPKSDVYSFGVVLLELLSGRR 231
+ APE + + + K D++S G V+LE+ +GRR
Sbjct: 174 VFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 7e-18
Identities = 71/222 (31%), Positives = 106/222 (47%), Gaps = 38/222 (17%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKA-ESFQGHKEWLTEVIYLGQL-R 85
++GEG FG V K I K G + AIKR+K S H+++ E+ L +L
Sbjct: 2 VIGEGNFGQVLKARI-------KKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 54
Query: 86 HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGV--------------QPISWPTR 131
H N++ L+G C L E+ P G+L + L + V +S
Sbjct: 55 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 114
Query: 132 VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVST 191
+ A DVARG+ +L I+RDL A N+L+ N+ AK++DFGL+R G +V
Sbjct: 115 LHFAADVARGMDYLS--QKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVKK 168
Query: 192 RIVGTRGYAAPEYVATGHL-----TPKSDVYSFGVVLLELLS 228
T G ++A L T SDV+S+GV+L E++S
Sbjct: 169 ----TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 8e-18
Identities = 74/257 (28%), Positives = 100/257 (38%), Gaps = 79/257 (30%)
Query: 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIY 80
+F ++G G FG V+ +G V A+K L+ ++I
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVR---------DKDTGQVYAMKVLRKS----------DMIK 41
Query: 81 LGQLRH---EN----------LVKLIGYCSESDNRLL--VYEFMPKGSLENHLFRKGVQP 125
Q+ H E +VKL Y S D L V E+MP G L N L RK V P
Sbjct: 42 RNQIAHVRAERDILADADSPWIVKL--YYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFP 99
Query: 126 ISWPTRVKI-----AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD 180
R I A+D L F+H RD+K N+L+D++ + KL+DFGL +
Sbjct: 100 EET-ARFYIAELVLALDSVHKLGFIH--------RDIKPDNILIDADGHIKLADFGLCKK 150
Query: 181 GPTG----------------DNTHVSTR-----------IVGTRGYAAPEYVATGH-LTP 212
DN V R VGT Y APE V G
Sbjct: 151 MNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPE-VLRGTPYGL 209
Query: 213 KSDVYSFGVVLLELLSG 229
+ D +S GV+L E+L G
Sbjct: 210 ECDWWSLGVILYEMLYG 226
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 9e-18
Identities = 73/277 (26%), Positives = 129/277 (46%), Gaps = 48/277 (17%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAE-SFQGHKEWLTEVIYLGQLRHE 87
LG G G V+K + + ++A+K + + + + K+ ++E+ L +
Sbjct: 9 LGHGNGGTVYKAYH---------LLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSP 59
Query: 88 NLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLH 146
++ G +NR+ + EFM GSL+ ++RK I +IA+ V +GL++L
Sbjct: 60 YIIGFYG-AFFVENRISICTEFMDGGSLD--VYRK----IPEHVLGRIAVAVVKGLTYLW 112
Query: 147 GLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVA 206
L +++RD+K SN+L+++ KL DFG++ ++ VGT Y APE ++
Sbjct: 113 SL--KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS----IAKTYVGTNAYMAPERIS 166
Query: 207 TGHLTPKSDVYSFGVVLLELLSGR---RALDEDRGGLAE----QTLVEWADPFLRDSRRV 259
SDV+S G+ +EL GR + +++G L Q +V+ P L
Sbjct: 167 GEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPV---- 222
Query: 260 LRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPS 296
GQ+S+K + QC+ PK RP+
Sbjct: 223 ---------GQFSEKFVHFIT----QCMRKQPKERPA 246
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 1e-17
Identities = 83/283 (29%), Positives = 124/283 (43%), Gaps = 42/283 (14%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIK--RLKAESFQGHKEWLTEVIYLGQLR 85
L+G G +G V++G PT G VVA+K L EV L QLR
Sbjct: 8 LIGRGAYGAVYRG-----KHVPT----GRVVALKIINLDTPDDDVSDIQ-REVALLSQLR 57
Query: 86 H---ENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARG 141
N+ K G RL ++ E+ GS+ L + G PI+ I +V
Sbjct: 58 QSQPPNITKYYG-SYLKGPRLWIIMEYAEGGSVRT-LMKAG--PIAEKYISVIIREVLVA 113
Query: 142 LSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAA 201
L ++H VI+RD+KA+N+L+ + N KL DFG+A N+ + VGT + A
Sbjct: 114 LKYIH--KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ--NSSKRSTFVGTPYWMA 169
Query: 202 PEYVATGHL-TPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVL 260
PE + G K+D++S G+ + E+ +G + A + + P L D+
Sbjct: 170 PEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDN---- 225
Query: 261 RIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303
YSK + VAA CL +PK R S ++L S
Sbjct: 226 ---------GYSKLLREFVAA----CLDEEPKERLSAEELLKS 255
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 1e-17
Identities = 64/204 (31%), Positives = 101/204 (49%), Gaps = 17/204 (8%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQG--HKEWLTEVIYLGQLRH 86
LG G FG V KG T VA+K LK ++ E L E + QL +
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKT-------VAVKILKNDNNDPALKDELLREANVMQQLDN 55
Query: 87 ENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLH 146
+V++IG C E+++ +LV E G L + F + + ++ ++ V+ G+ +L
Sbjct: 56 PYIVRMIGIC-EAESWMLVMELAELGPL--NKFLQKNKHVTEKNITELVHQVSMGMKYLE 112
Query: 147 GLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT--RGYAAPEY 204
+ N ++RDL A NVLL + AK+SDFGL++ D + + G + APE
Sbjct: 113 --ETNFVHRDLAARNVLLVTQHYAKISDFGLSK-ALGADENYYKAKTHGKWPVKWYAPEC 169
Query: 205 VATGHLTPKSDVYSFGVVLLELLS 228
+ + KSDV+SFGV++ E S
Sbjct: 170 MNYYKFSSKSDVWSFGVLMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 2e-17
Identities = 61/216 (28%), Positives = 103/216 (47%), Gaps = 20/216 (9%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQL--RH 86
LGEG FG V + + ++P + VA+K LK + L + L +L +H
Sbjct: 20 LGEGCFGQVVRA--EAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKH 77
Query: 87 ENLVKLIGYCSESDNRLLVYEFMPKGSLENHL--------------FRKGVQPISWPTRV 132
+N++ L+G C++ ++ E+ KG+L L + + +S+ V
Sbjct: 78 KNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLV 137
Query: 133 KIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR 192
A VARG+ +L I+RDL A NVL+ + K++DFGLAR D ++
Sbjct: 138 SCAYQVARGMEYLE--SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSN 195
Query: 193 IVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 228
+ APE + T +SDV+SFG+++ E+ +
Sbjct: 196 GRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 3e-17
Identities = 68/215 (31%), Positives = 103/215 (47%), Gaps = 22/215 (10%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKE---WLTEVIYLGQL 84
+LG+G FG V + G+ + AIK LK + + + E L
Sbjct: 7 VLGKGSFGKVMLA---------ERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALP 57
Query: 85 RHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLS 143
+ + C ++ +RL V E++ G L H+ + G P V A ++A GL
Sbjct: 58 GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG--KFKEPHAVFYAAEIAIGLF 115
Query: 144 FLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR-IVGTRGYAAP 202
FLH +IYRDLK NV+LD+ + K++DFG+ ++ G T TR GT Y AP
Sbjct: 116 FLH--SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT---TRTFCGTPDYIAP 170
Query: 203 EYVATGHLTPKSDVYSFGVVLLELLSGRRALD-ED 236
E +A D ++FGV+L E+L+G+ D ED
Sbjct: 171 EIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED 205
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 3e-17
Identities = 59/216 (27%), Positives = 103/216 (47%), Gaps = 23/216 (10%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLK-AESFQGHKEWLTEVIYLGQLRHE 87
LGE FG ++KG + + P + +V AIK LK + Q E+ E + +L H
Sbjct: 13 LGECAFGKIYKG----HLYLPGMDHAQLV-AIKTLKDINNPQQWGEFQQEASLMAELHHP 67
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQP---------------ISWPTRV 132
N+V L+G ++ +++E++ +G L L + + +
Sbjct: 68 NIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFL 127
Query: 133 KIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR 192
IAI +A G+ +L +++DL A N+L+ + K+SD GL+R+ + D V +
Sbjct: 128 HIAIQIAAGMEYLS--SHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPK 185
Query: 193 IVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 228
+ + PE + G + SD++SFGVVL E+ S
Sbjct: 186 SLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 3e-17
Identities = 79/275 (28%), Positives = 121/275 (44%), Gaps = 42/275 (15%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ---GHKEWLTEVIYLGQL 84
+LG+GGFG V A +G + A K+L+ + + G L E L ++
Sbjct: 7 VLGKGGFGEVC---------ACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKV 57
Query: 85 RHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLS 143
+V L Y E+ + L LV M G L+ H++ G V A ++ GL
Sbjct: 58 NSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLE 116
Query: 144 FLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPE 203
LH ++YRDLK N+LLD + + ++SD GLA P G + R VGT GY APE
Sbjct: 117 DLH--QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGR-VGTVGYMAPE 171
Query: 204 YVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIM 263
V T D ++ G +L E+++G+ PF + +++ R
Sbjct: 172 VVKNERYTFSPDWWALGCLLYEMIAGQ-------------------SPFQQRKKKIKREE 212
Query: 264 DTRL----GGQYSKKEAQAVAAVVLQCLHMDPKNR 294
RL +YS+K + ++ L DPK R
Sbjct: 213 VERLVKEVQEEYSEKFSPDARSLCKMLLCKDPKER 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 3e-17
Identities = 79/271 (29%), Positives = 122/271 (45%), Gaps = 34/271 (12%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ---GHKEWLTEVIYLGQL 84
+LG+GGFG V A +G + A K+L+ + + G L E L ++
Sbjct: 7 VLGKGGFGEVC---------ACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV 57
Query: 85 RHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLS 143
+V L Y E+ + L LV M G L+ H++ G V A ++ GL
Sbjct: 58 NSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLE 116
Query: 144 FLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPE 203
LH ++YRDLK N+LLD + ++SD GLA + P G+ + R VGT GY APE
Sbjct: 117 DLH--RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET--IRGR-VGTVGYMAPE 171
Query: 204 YVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIM 263
V T D + G ++ E++ G+ + + E+ E + RRV
Sbjct: 172 VVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRK----EKVKREEVE------RRVKEDQ 221
Query: 264 DTRLGGQYSKKEAQAVAAVVLQCLHMDPKNR 294
+ YS+K ++A ++ Q L DP R
Sbjct: 222 EE-----YSEKFSEAARSICRQLLTKDPGFR 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 3e-17
Identities = 80/274 (29%), Positives = 123/274 (44%), Gaps = 35/274 (12%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLT-EVIYLGQLRHE 87
+G+G FG V+KG ID T VVAIK + E + E + E+ L Q
Sbjct: 12 IGKGSFGEVYKG-IDNRTKE--------VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 62
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHG 147
+ + G + ++ E++ GS + L + G P+ I ++ +GL +LH
Sbjct: 63 YITRYYGSYLKGTKLWIIMEYLGGGSALD-LLKPG--PLEETYIATILREILKGLDYLH- 118
Query: 148 LDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT 207
I+RD+KA+NVLL + KL+DFG+A G D VGT + APE +
Sbjct: 119 -SERKIHRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIKQ 175
Query: 208 GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRL 267
K+D++S G+ +EL G + D + L+ P L
Sbjct: 176 SAYDFKADIWSLGITAIELAKGEPP-NSDLHPMRVLFLIPKNSP-------------PTL 221
Query: 268 GGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL 301
GQYSK + V A CL+ DP+ RP+ ++L
Sbjct: 222 EGQYSKPFKEFVEA----CLNKDPRFRPTAKELL 251
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 4e-17
Identities = 64/216 (29%), Positives = 105/216 (48%), Gaps = 20/216 (9%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQL--RH 86
LGEG FG V + KP VA+K LK+++ + L + + ++ +H
Sbjct: 26 LGEGCFGQVVMA--EAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 83
Query: 87 ENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRK--------------GVQPISWPTRV 132
+N++ L+G C++ ++ E+ KG+L +L + + +S+ V
Sbjct: 84 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLV 143
Query: 133 KIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR 192
A VARG+ +L I+RDL A NVL+ + K++DFGLARD D +T
Sbjct: 144 SCAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 201
Query: 193 IVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 228
+ APE + T +SDV+SFGV+L E+ +
Sbjct: 202 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 4e-17
Identities = 72/298 (24%), Positives = 121/298 (40%), Gaps = 41/298 (13%)
Query: 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHK---EWLT 76
NF + +G+G F V+K G VVA+K+++ K + L
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKA---ICLL------DGRVVALKKVQIFEMMDAKARQDCLK 51
Query: 77 EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHL--FRKGVQPISWPTRVKI 134
E+ L QL H N++K + E++ +V E G L + F+K + I T K
Sbjct: 52 EIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKY 111
Query: 135 AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 194
+ + L +H +++RD+K +NV + + KL D GL R T + +V
Sbjct: 112 FVQLCSALEHMH--SKRIMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAAHSLV 167
Query: 195 GTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLR 254
GT Y +PE + KSD++S G +L E + PF
Sbjct: 168 GTPYYMSPERIHENGYNFKSDIWSLGCLLYE-------------------MAALQSPFYG 208
Query: 255 DSRRVLRIMDTRLGGQYSKKEAQAVAA----VVLQCLHMDPKNRPSMVDVLTSLEQLH 308
D + + Y A + +V +C++ DP+ RP + VL +++H
Sbjct: 209 DKMNLYSLCKKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 5e-17
Identities = 52/188 (27%), Positives = 92/188 (48%), Gaps = 16/188 (8%)
Query: 58 VAIKRLKAESFQGHKE---WLTEVIYLGQLRHENLVKLIGYCSESDNRLL-VYEFMPKGS 113
VAIK L+ ++ + + + E +L H N+V L+ L V+E++P +
Sbjct: 6 VAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRT 65
Query: 114 LENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLL---DSNFNA 170
L L G P ++ + V L+ H + +++RDLK N+++ +A
Sbjct: 66 LREVLAADGALPAG--ETGRLMLQVLDALACAH--NQGIVHRDLKPQNIMVSQTGVRPHA 121
Query: 171 KLSDFGLARDGP-TGDNTHV----STRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLE 225
K+ DFG+ P D +T ++GT Y APE + +TP SD+Y++G++ LE
Sbjct: 122 KVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLE 181
Query: 226 LLSGRRAL 233
L+G+R +
Sbjct: 182 CLTGQRVV 189
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 7e-17
Identities = 73/274 (26%), Positives = 120/274 (43%), Gaps = 40/274 (14%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHK-EWLTEVIYLGQLRHE 87
+G G FG VF G + + VA+K + K ++L E L Q H
Sbjct: 3 IGRGNFGEVFSGRLRADN---------TPVAVKSCRETLPPDLKAKFLQEARILKQYSHP 53
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHG 147
N+V+LIG C++ +V E + G L +G + + +++ + A G+ +L
Sbjct: 54 NIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPR-LKVKELIQMVENAAAGMEYLE- 111
Query: 148 LDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVST---RIVGTRGYAAPEY 204
+ I+RDL A N L+ K+SDFG++R+ D + ST + + + + APE
Sbjct: 112 -SKHCIHRDLAARNCLVTEKNVLKISDFGMSRE--EEDGVYASTGGMKQIPVK-WTAPEA 167
Query: 205 VATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMD 264
+ G + +SDV+SFG++L E S A P+ S + R
Sbjct: 168 LNYGRYSSESDVWSFGILLWEAFS------------------LGAVPYANLSNQQTREAI 209
Query: 265 TRLGGQYSKKE--AQAVAAVVLQCLHMDPKNRPS 296
+ G + E AV ++ +C DP RPS
Sbjct: 210 EQ-GVRLPCPELCPDAVYRLMERCWEYDPGQRPS 242
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 7e-17
Identities = 81/271 (29%), Positives = 121/271 (44%), Gaps = 34/271 (12%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ---GHKEWLTEVIYLGQL 84
+LG+GGFG V A +G + A KRL+ + + G L E L ++
Sbjct: 7 VLGKGGFGEVC---------ACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKV 57
Query: 85 RHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLS 143
+ +V L Y E+ + L LV M G L+ H++ G + A ++ GL
Sbjct: 58 NSQFVVNL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLE 116
Query: 144 FLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPE 203
LH N +YRDLK N+LLD + ++SD GLA P G++ + R VGT GY APE
Sbjct: 117 DLH--RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES--IRGR-VGTVGYMAPE 171
Query: 204 YVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIM 263
+ T D + G ++ E++ G+ G E+ E D RRVL
Sbjct: 172 VLNNQRYTLSPDYWGLGCLIYEMIEGQSPFR----GRKEKVKREEVD------RRVLETE 221
Query: 264 DTRLGGQYSKKEAQAVAAVVLQCLHMDPKNR 294
+ YS K ++ ++ L DPK R
Sbjct: 222 EV-----YSAKFSEEAKSICKMLLTKDPKQR 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 7e-17
Identities = 66/222 (29%), Positives = 103/222 (46%), Gaps = 50/222 (22%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHK--EWLTEVIYLGQLRH 86
+GEG +G V++ SG +VA+K+++ ++ + L E+ L LRH
Sbjct: 15 IGEGTYGIVYRARDTT---------SGEIVALKKVRMDNERDGIPISSLREITLLLNLRH 65
Query: 87 ENLVKL---------------IGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTR 131
N+V+L + YC + LL + MP P S +
Sbjct: 66 PNIVELKEVVVGKHLDSIFLVMEYCEQDLASLL--DNMP-------------TPFSES-Q 109
Query: 132 VK-IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 190
VK + + + RGL +LH + +I+RDLK SN+LL K++DFGLAR G
Sbjct: 110 VKCLMLQLLRGLQYLH--ENFIIHRDLKVSNLLLTDKGCLKIADFGLAR--TYGLPAKPM 165
Query: 191 TRIVGTRGYAAPEYV--ATGHLTPKSDVYSFGVVLLELLSGR 230
T V T Y APE + T + T D+++ G +L ELL+ +
Sbjct: 166 TPKVVTLWYRAPELLLGCTTY-TTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 9e-17
Identities = 59/209 (28%), Positives = 104/209 (49%), Gaps = 23/209 (11%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGH-----KEWLTEVIYLG 82
LLG+G FG V+ + D +T G +A+K++ + E+ L
Sbjct: 9 LLGQGAFGRVYLCY-DVDT--------GRELAVKQVPFDPDSPETKKEVNALECEIQLLK 59
Query: 83 QLRHENLVKLIGYCSESDNRLLVY-EFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARG 141
L+HE +V+ G C D L ++ E+MP GS+++ L G ++ K + G
Sbjct: 60 NLQHERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYG--ALTETVTRKYTRQILEG 116
Query: 142 LSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPT--GDNTHVSTRIVGTRGY 199
+ +LH +++RD+K +N+L DS N KL DFG ++ T T + + + GT +
Sbjct: 117 VEYLH--SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKS-VTGTPYW 173
Query: 200 AAPEYVATGHLTPKSDVYSFGVVLLELLS 228
+PE ++ K+DV+S G ++E+L+
Sbjct: 174 MSPEVISGEGYGRKADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 1e-16
Identities = 58/261 (22%), Positives = 117/261 (44%), Gaps = 33/261 (12%)
Query: 53 GSGIVVAIKRLK------AESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSESDNRLLVY 106
+G ++A+K++ +E + + E+ + +L H ++++++G E + L
Sbjct: 23 KTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFV 82
Query: 107 EFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS 166
E+M GS+ + L + G + + RGLS+LH + +I+RD+K +N+L+DS
Sbjct: 83 EWMAGGSVSHLLSKYG--AFKEAVIINYTEQLLRGLSYLH--ENQIIHRDVKGANLLIDS 138
Query: 167 N-FNAKLSDFG----LARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGV 221
+++DFG LA G +++GT + APE + DV+S G
Sbjct: 139 TGQRLRIADFGAAARLAAKGTGAG--EFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGC 196
Query: 222 VLLELLSGRRALDEDRGGLAEQTLVEW-ADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVA 280
V++E+ + + W A+ + +I + + +
Sbjct: 197 VIIEMATAK---------------PPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLR 241
Query: 281 AVVLQCLHMDPKNRPSMVDVL 301
V L+CL + P++RP ++L
Sbjct: 242 DVTLRCLELQPEDRPPSRELL 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 1e-16
Identities = 71/229 (31%), Positives = 99/229 (43%), Gaps = 37/229 (16%)
Query: 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLK---------AESFQGHK 72
+ +LG G FG V A K +G + AIK LK ES K
Sbjct: 2 RCLA--VLGRGHFGKVL--------LAEYKK-TGELYAIKALKKGDIIARDEVESLMCEK 50
Query: 73 EWLTEVIYLGQLRHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTR 131
RH LV L C ++++ + V E+ G L H+ S P
Sbjct: 51 RIFETA---NSERHPFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIHTD---VFSEPRA 103
Query: 132 VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGP-TGDNTHVS 190
V A V GL +LH + ++YRDLK N+LLD+ K++DFGL ++G GD T S
Sbjct: 104 VFYAACVVLGLQYLH--ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRT--S 159
Query: 191 TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR---RALDED 236
T GT + APE + T D + GV++ E+L G DE+
Sbjct: 160 T-FCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE 207
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 2e-16
Identities = 74/284 (26%), Positives = 126/284 (44%), Gaps = 50/284 (17%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLT--EVIYLGQLRH 86
+GEG FG ++ A K S V IK + ++ + EVI L +++H
Sbjct: 8 IGEGSFGKIY--------LAKAKSDSEHCV-IKEIDLTKMPVKEKEASKKEVILLAKMKH 58
Query: 87 ENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFR-KGV-----QPISWPTRVKIAIDVAR 140
N+V E+ +V E+ G L + R +GV Q +SW + ++
Sbjct: 59 PNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSW------FVQISL 112
Query: 141 GLSFLHGLDANVIYRDLKASNVLLDSN-FNAKLSDFGLARDGPTGDNTHVSTRIVGTRGY 199
GL +H D +++RD+K+ N+ L N AKL DFG+AR D+ ++ VGT Y
Sbjct: 113 GLKHIH--DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQ--LNDSMELAYTCVGTPYY 168
Query: 200 AAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDS--R 257
+PE K+D++S G VL EL + + PF ++ +
Sbjct: 169 LSPEICQNRPYNNKTDIWSLGCVLYELCTLKH-------------------PFEGNNLHQ 209
Query: 258 RVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL 301
VL+I S ++ + +++ Q + P++RPS+ +L
Sbjct: 210 LVLKICQGYF-APISPNFSRDLRSLISQLFKVSPRDRPSITSIL 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 2e-16
Identities = 66/206 (32%), Positives = 112/206 (54%), Gaps = 19/206 (9%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEW-LTEVIYLGQLRHE 87
LGEG + V+KG +N +G +VA+K + ++ +G + E+ + +L+HE
Sbjct: 8 LGEGTYATVYKG---RNRT------TGEIVALKEIHLDAEEGTPSTAIREISLMKELKHE 58
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVK-IAIDVARGLSFLH 146
N+V+L + +LV+E+M K L+ ++ GV+ P VK + +G++F H
Sbjct: 59 NIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH 117
Query: 147 GLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVA 206
+ V++RDLK N+L++ KL+DFGLAR NT S +V T Y AP+ V
Sbjct: 118 --ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT-FSNEVV-TLWYRAPD-VL 172
Query: 207 TGHLTPKS--DVYSFGVVLLELLSGR 230
G T + D++S G ++ E+++GR
Sbjct: 173 LGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 2e-16
Identities = 72/232 (31%), Positives = 112/232 (48%), Gaps = 23/232 (9%)
Query: 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKE---WLTEV 78
+F +LG+G FG V A K G+ + AIK LK + + + E
Sbjct: 1 DFNFLMVLGKGSFGKVM--------LAERK-GTDELYAIKILKKDVVIQDDDVECTMVEK 51
Query: 79 IYLGQLRHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAID 137
L + + C ++ +RL V E++ G L H+ + G P V A +
Sbjct: 52 RVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVG--KFKEPQAVFYAAE 109
Query: 138 VARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR-IVGT 196
++ GL FLH +IYRDLK NV+LDS + K++DFG+ ++ V+TR GT
Sbjct: 110 ISVGLFFLH--RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG---VTTRTFCGT 164
Query: 197 RGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALD-EDRGGLAEQTLVE 247
Y APE +A D +++GV+L E+L+G+ D ED L Q+++E
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELF-QSIME 215
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 2e-16
Identities = 77/291 (26%), Positives = 126/291 (43%), Gaps = 55/291 (18%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIK--RLKAESFQGHKEWLTEVIYLGQLRH 86
+G G FG V+ ++ +T G ++A+K R++ + KE E+ L L+H
Sbjct: 8 IGGGTFGKVYTA-VNLDT--------GELMAVKEIRIQDNDPKTIKEIADEMKVLELLKH 58
Query: 87 ENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLH 146
NLVK G + + E+ G+LE L + RV + + GL++LH
Sbjct: 59 PNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHV-IRV-YTLQLLEGLAYLH 116
Query: 147 GLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR---DGPTGDNTHVSTRIVGTRGYAAPE 203
+++RD+K +N+ LD N KL DFG A + T V + + GT Y APE
Sbjct: 117 --SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQS-LAGTPAYMAPE 173
Query: 204 YVATGHLTPK---SDVYSFGVVLLELLSGRR---ALDEDRGGLAEQTLVEWADPFLRDSR 257
+ G +D++S G V+LE+ +G+R LD E+
Sbjct: 174 VITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN-----------EFQ-------- 214
Query: 258 RVLRIMDTRLGGQY------SKKEAQAVAAVVLQCLHMDPKNRPSMVDVLT 302
IM +G + S + + + +CL DPK RP+ ++L
Sbjct: 215 ----IM-FHVGAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 3e-16
Identities = 79/274 (28%), Positives = 122/274 (44%), Gaps = 35/274 (12%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLT-EVIYLGQLRHE 87
+G+G FG VFKG ID T VVAIK + E + E + E+ L Q
Sbjct: 12 IGKGSFGEVFKG-IDNRTQQ--------VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 62
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHG 147
+ K G + ++ E++ GS + L R G P + ++ +GL +LH
Sbjct: 63 YVTKYYGSYLKGTKLWIIMEYLGGGSALD-LLRAG--PFDEFQIATMLKEILKGLDYLH- 118
Query: 148 LDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT 207
I+RD+KA+NVLL + KL+DFG+A G D VGT + APE +
Sbjct: 119 -SEKKIHRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIQQ 175
Query: 208 GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRL 267
K+D++S G+ +EL G + D + L+ +P L
Sbjct: 176 SAYDSKADIWSLGITAIELAKGEPP-NSDMHPMRVLFLIPKNNP-------------PTL 221
Query: 268 GGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL 301
G++SK + + A CL+ DP RP+ ++L
Sbjct: 222 TGEFSKPFKEFIDA----CLNKDPSFRPTAKELL 251
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 3e-16
Identities = 70/283 (24%), Positives = 121/283 (42%), Gaps = 45/283 (15%)
Query: 28 LLGEGGFGCVF--KGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEW--LTEVIYLGQ 83
++G G FG V + DQ +V IK++ E + E L
Sbjct: 7 VVGRGAFGIVHLCRRKADQK-----------LVIIKQIPVEQMTKDERLAAQNECQVLKL 55
Query: 84 LRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLS 143
L H N+++ E ++V E+ P G+L ++ ++ + T + + + L
Sbjct: 56 LSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALH 115
Query: 144 FLHGLDANVIYRDLKASNVLLDSNFNA-KLSDFGLARDGPTGDNTHVSTRIVGTRGYAAP 202
+H +++RDLK N+LLD + K+ DFG+++ + T +VGT Y +P
Sbjct: 116 HVH--TKLILHRDLKTQNILLDKHKMVVKIGDFGISKI--LSSKSKAYT-VVGTPCYISP 170
Query: 203 EYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRI 262
E KSD+++ G VL EL S +RA + A P L VL+I
Sbjct: 171 ELCEGKPYNQKSDIWALGCVLYELASLKRAFE------AANL------PAL-----VLKI 213
Query: 263 MDTR---LGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLT 302
M + +YS + ++L L++DP RP + ++
Sbjct: 214 MSGTFAPISDRYSPD----LRQLILSMLNLDPSKRPQLSQIMA 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 3e-16
Identities = 63/210 (30%), Positives = 98/210 (46%), Gaps = 20/210 (9%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAE-SFQGHKEWLTEVIYLGQLRHE 87
+G G FG V G ++ + P + V +K L+ S Q ++L E L+H
Sbjct: 3 IGNGWFGKVILGEVNSG-YTPAQ------VVVKELRVSASVQEQMKFLEEAQPYRSLQHS 55
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWP---TRVKIAIDVARGLSF 144
NL++ +G C+E LLV EF P G L+ +L + P T ++A ++A GL
Sbjct: 56 NLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLH 115
Query: 145 LHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEY 204
LH N I+ DL N LL ++ K+ D+GL+ + D ++ + APE
Sbjct: 116 LH--KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPEL 173
Query: 205 VATGH-------LTPKSDVYSFGVVLLELL 227
V H T +S+V+S GV + EL
Sbjct: 174 VDEVHGNLLVVDQTKESNVWSLGVTIWELF 203
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 3e-16
Identities = 80/274 (29%), Positives = 120/274 (43%), Gaps = 35/274 (12%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLT-EVIYLGQLRHE 87
+G+G FG VFKG ID T VVAIK + E + E + E+ L Q
Sbjct: 12 IGKGSFGEVFKG-IDNRTQK--------VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 62
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHG 147
+ K G + ++ E++ GS + L G P+ I ++ +GL +LH
Sbjct: 63 YVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPG--PLDETQIATILREILKGLDYLH- 118
Query: 148 LDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT 207
I+RD+KA+NVLL + KL+DFG+A G D VGT + APE +
Sbjct: 119 -SEKKIHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIKQ 175
Query: 208 GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRL 267
K+D++S G+ +EL G E + L+ +P L
Sbjct: 176 SAYDSKADIWSLGITAIELAKGEPPHSELH-PMKVLFLIPKNNP-------------PTL 221
Query: 268 GGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL 301
G YSK + V A CL+ +P RP+ ++L
Sbjct: 222 EGNYSKPLKEFVEA----CLNKEPSFRPTAKELL 251
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 3e-16
Identities = 60/206 (29%), Positives = 104/206 (50%), Gaps = 25/206 (12%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHEN 88
LG+G FG V+K QN +G++ A K + +S + ++++ E+ L H N
Sbjct: 13 LGDGAFGKVYKA---QNK------ETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 63
Query: 89 LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL 148
+VKL+ +N ++ EF G+++ + +P++ P + L++LH
Sbjct: 64 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELE-RPLTEPQIRVVCKQTLEALNYLH-- 120
Query: 149 DANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR---IVGTRGYAAPEYV 205
+ +I+RDLKA N+L + + KL+DFG+ + NT R +GT + APE V
Sbjct: 121 ENKIIHRDLKAGNILFTLDGDIKLADFGV-----SAKNTRTIQRRDSFIGTPYWMAPEVV 175
Query: 206 --ATGHLTP---KSDVYSFGVVLLEL 226
T P K+DV+S G+ L+E+
Sbjct: 176 MCETSKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 4e-16
Identities = 73/294 (24%), Positives = 125/294 (42%), Gaps = 44/294 (14%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES-FQGHKEWLTEVIYLGQLRHE 87
LGE FG V+KG + F VAIK LK ++ +E+ E + +L+H
Sbjct: 13 LGEDRFGKVYKG----HLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHP 68
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLF-----------------RKGVQPISWPT 130
N+V L+G ++ +++ + L L + ++P
Sbjct: 69 NIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEP---AD 125
Query: 131 RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 190
V I +A G+ FL +V+++DL NVL+ N K+SD GL R+ D +
Sbjct: 126 FVHIVTQIAAGMEFLS--SHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLM 183
Query: 191 TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD 250
+ + +PE + G + SD++S+GVVL E+ S + G + Q ++E
Sbjct: 184 GNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGL---QPYCGYSNQDVIE--- 237
Query: 251 PFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL 304
+ +R+VL D Y ++L+C + P RP D+ + L
Sbjct: 238 --MIRNRQVLPCPDDCPAWVY---------TLMLECWNEFPSRRPRFKDIHSRL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 4e-16
Identities = 71/206 (34%), Positives = 106/206 (51%), Gaps = 18/206 (8%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLT--EVIYLGQLR 85
+LG+G FG VF T P +G + A+K LK + + T E L ++
Sbjct: 3 VLGQGSFGKVFL------VRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVN 56
Query: 86 HENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSF 144
H +VKL Y +++ +L L+ +F+ G L L K V + +A ++A L
Sbjct: 57 HPFIVKL-HYAFQTEGKLYLILDFLRGGDLFTRL-SKEVMFTEEDVKFYLA-ELALALDH 113
Query: 145 LHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEY 204
LH L +IYRDLK N+LLD + KL+DFGL+++ + S GT Y APE
Sbjct: 114 LHSL--GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYMAPEV 169
Query: 205 V-ATGHLTPKSDVYSFGVVLLELLSG 229
V GH T +D +SFGV++ E+L+G
Sbjct: 170 VNRRGH-TQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 4e-16
Identities = 56/207 (27%), Positives = 95/207 (45%), Gaps = 28/207 (13%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHEN 88
+GEG G V T +G VA+K++ Q + EV+ + +H N
Sbjct: 27 IGEGSTGIVC---------IATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPN 77
Query: 89 LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVK------IAIDVARGL 142
+V++ D +V EF+ G+L + I TR+ + + V + L
Sbjct: 78 IVEMYSSYLVGDELWVVMEFLEGGALTD---------IVTHTRMNEEQIATVCLAVLKAL 128
Query: 143 SFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAP 202
SFLH VI+RD+K+ ++LL S+ KLSDFG +VGT + AP
Sbjct: 129 SFLHA--QGVIHRDIKSDSILLTSDGRVKLSDFGFC--AQVSKEVPRRKSLVGTPYWMAP 184
Query: 203 EYVATGHLTPKSDVYSFGVVLLELLSG 229
E ++ + D++S G++++E++ G
Sbjct: 185 EVISRLPYGTEVDIWSLGIMVIEMVDG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 5e-16
Identities = 65/207 (31%), Positives = 96/207 (46%), Gaps = 26/207 (12%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQG---HKEWLTEVIYLGQLR 85
+G G FG V DQ T G VAIK++ + F K E+ L LR
Sbjct: 18 VGMGAFGLVCSAR-DQLT--------GQNVAIKKI-MKPFSTPVLAKRTYRELKLLKHLR 67
Query: 86 HENLVKLIG-YCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSF 144
HEN++ L + S ++ V E + G+ + L P+ + RGL +
Sbjct: 68 HENIISLSDIFISPLEDIYFVTELL--GTDLHRLLTSR--PLEKQFIQYFLYQILRGLKY 123
Query: 145 LHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEY 204
+H A V++RDLK SN+L++ N + K+ DFGLAR T V TR Y APE
Sbjct: 124 VH--SAGVVHRDLKPSNILINENCDLKICDFGLAR-----IQDPQMTGYVSTRYYRAPEI 176
Query: 205 VATGH-LTPKSDVYSFGVVLLELLSGR 230
+ T + D++S G + E+L G+
Sbjct: 177 MLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 5e-16
Identities = 74/281 (26%), Positives = 126/281 (44%), Gaps = 46/281 (16%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWL-TEVIYLGQLRHE 87
+G+G G V+ ID T G VAIK++ + Q KE + E++ + + +H
Sbjct: 27 IGQGASGTVYTA-IDVAT--------GQEVAIKQMNLQQ-QPKKELIINEILVMRENKHP 76
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQP--ISWPTRVKIAIDVARGLSFL 145
N+V + D +V E++ GSL + + + I+ R + + L FL
Sbjct: 77 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR-----ECLQALEFL 131
Query: 146 HGLDANVIYRDLKASNVLLDSNFNAKLSDFGL-ARDGPTGDNTHVSTRIVGTRGYAAPEY 204
H VI+RD+K+ N+LL + + KL+DFG A+ P + +VGT + APE
Sbjct: 132 HS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAPEV 186
Query: 205 VATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSR-RVLRIM 263
V PK D++S G++ +E +VE P+L ++ R L ++
Sbjct: 187 VTRKAYGPKVDIWSLGIMAIE-------------------MVEGEPPYLNENPLRALYLI 227
Query: 264 DTRLGGQYSKKEAQAVA--AVVLQCLHMDPKNRPSMVDVLT 302
T + E + + +CL MD + R S ++L
Sbjct: 228 ATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 5e-16
Identities = 77/275 (28%), Positives = 120/275 (43%), Gaps = 42/275 (15%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ---GHKEWLTEVIYLGQL 84
+LG+GGFG V A +G + A K+L+ + + G L E L ++
Sbjct: 7 VLGKGGFGEVC---------ACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKV 57
Query: 85 RHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLS 143
+V L Y E+ + L LV M G L+ H++ G + A ++ GL
Sbjct: 58 NSRFVVSL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLE 116
Query: 144 FLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPE 203
L ++YRDLK N+LLD + ++SD GLA P G+ V R VGT GY APE
Sbjct: 117 DLQ--RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET--VRGR-VGTVGYMAPE 171
Query: 204 YVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRI- 262
+ T D + G ++ E++ G+ PF + RV R
Sbjct: 172 VINNEKYTFSPDWWGLGCLIYEMIQGQ-------------------SPFRKRKERVKREE 212
Query: 263 MDTRLGG---QYSKKEAQAVAAVVLQCLHMDPKNR 294
+D R+ +YS+K ++ ++ L +PK R
Sbjct: 213 VDRRVKEDQEEYSEKFSEDAKSICRMLLTKNPKER 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 5e-16
Identities = 64/212 (30%), Positives = 98/212 (46%), Gaps = 31/212 (14%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQG--H-KEWLTEVIYLGQLR 85
+G G +G V D +G VAIK+L + FQ H K E+ L +
Sbjct: 23 VGSGAYGQVCSA-FDT--------KTGRKVAIKKL-SRPFQSAIHAKRTYRELRLLKHMD 72
Query: 86 HENLVKLIG-YCSESDNR-----LLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVA 139
HEN++ L+ + S LV M G+ N++ + Q +S + +
Sbjct: 73 HENVIGLLDVFTPASSLEDFQDVYLVTHLM--GADLNNIVKC--QKLSDDHIQFLVYQIL 128
Query: 140 RGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGY 199
RGL ++H A +I+RDLK SN+ ++ + K+ DFGLAR T V TR Y
Sbjct: 129 RGLKYIHS--AGIIHRDLKPSNIAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWY 181
Query: 200 AAPEYVAT-GHLTPKSDVYSFGVVLLELLSGR 230
APE + H D++S G ++ ELL+G+
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 5e-16
Identities = 68/209 (32%), Positives = 107/209 (51%), Gaps = 20/209 (9%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIK--RLKAESFQGHKEWLTEVIYLGQLRH 86
+GEG +G V+K A K +G VVA+K RL E+ + E+ L +L H
Sbjct: 8 IGEGTYGVVYK--------ARNKL-TGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 58
Query: 87 ENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFL 145
N+VKL+ ++N+L LV+EF+ + L+ + + I P + +GL+F
Sbjct: 59 PNIVKLLDVI-HTENKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFC 116
Query: 146 HGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPE-Y 204
H V++RDLK N+L+++ KL+DFGLAR G T V T Y APE
Sbjct: 117 HS--HRVLHRDLKPQNLLINTEGAIKLADFGLAR--AFGVPVRTYTHEVVTLWYRAPEIL 172
Query: 205 VATGHLTPKSDVYSFGVVLLELLSGRRAL 233
+ + + D++S G + E+++ RRAL
Sbjct: 173 LGCKYYSTAVDIWSLGCIFAEMVT-RRAL 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 6e-16
Identities = 63/216 (29%), Positives = 104/216 (48%), Gaps = 20/216 (9%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQL--RH 86
LGEG FG V + KP + VA+K LK ++ L + + ++ +H
Sbjct: 20 LGEGCFGQVVMA--EAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKH 77
Query: 87 ENLVKLIGYCSESDNRLLVYEFMPKGSLENHL--------------FRKGVQPISWPTRV 132
+N++ L+G C++ ++ E+ KG+L +L + + +++ V
Sbjct: 78 KNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLV 137
Query: 133 KIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR 192
A VARG+ +L I+RDL A NVL+ + K++DFGLARD D +T
Sbjct: 138 SCAYQVARGMEYL--ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTN 195
Query: 193 IVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 228
+ APE + T +SDV+SFGV+L E+ +
Sbjct: 196 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 6e-16
Identities = 61/203 (30%), Positives = 104/203 (51%), Gaps = 12/203 (5%)
Query: 28 LLGEGGFGCVFKG-WIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLR 85
+LG G FG V+KG W+ P I VAIK L + + + E++ E + + +
Sbjct: 14 VLGSGAFGTVYKGIWV------PEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMD 67
Query: 86 HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFL 145
H +LV+L+G C S LV + MP G L +++ I + + +A+G+ +L
Sbjct: 68 HPHLVRLLGVCL-SPTIQLVTQLMPHGCLLDYVHEHK-DNIGSQLLLNWCVQIAKGMMYL 125
Query: 146 HGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYV 205
+ +++RDL A NVL+ S + K++DFGLAR + + + + A E +
Sbjct: 126 E--ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI 183
Query: 206 ATGHLTPKSDVYSFGVVLLELLS 228
T +SDV+S+GV + EL++
Sbjct: 184 HYRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 9e-16
Identities = 46/124 (37%), Positives = 73/124 (58%), Gaps = 7/124 (5%)
Query: 107 EFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS 166
E M GSL+ L + G P + ++ IA V RGL++L +++RD+K SN+L++S
Sbjct: 79 EHMDGGSLDQVLKKAGRIPENILGKISIA--VLRGLTYLRE-KHKIMHRDVKPSNILVNS 135
Query: 167 NFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLEL 226
KL DFG++ G D+ ++ VGTR Y +PE + H T +SD++S G+ L+E+
Sbjct: 136 RGEIKLCDFGVS--GQLIDS--MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEM 191
Query: 227 LSGR 230
GR
Sbjct: 192 AIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 9e-16
Identities = 80/260 (30%), Positives = 121/260 (46%), Gaps = 36/260 (13%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQL 84
++G GGFG V+ K +G + A+K L + QG L E I L +
Sbjct: 1 IIGRGGFGEVY---------GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLV 51
Query: 85 RHEN--LVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARG 141
+ + + Y + ++L + + M G L HL + GV S A ++ G
Sbjct: 52 STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV--FSEAEMRFYAAEIILG 109
Query: 142 LSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAA 201
L +H + V+YRDLK +N+LLD + + ++SD GLA D + H S VGT GY A
Sbjct: 110 LEHMH--NRFVVYRDLKPANILLDEHGHVRISDLGLACDF-SKKKPHAS---VGTHGYMA 163
Query: 202 PEYVATGHLTPKS-DVYSFGVVLLELLSG----RRALDEDRGGLAEQTL---VEWADPFL 253
PE + G S D +S G +L +LL G R+ +D+ + TL VE D F
Sbjct: 164 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFS 223
Query: 254 RDSRRVL-----RIMDTRLG 268
+ R +L R ++ RLG
Sbjct: 224 PELRSLLEGLLQRDVNRRLG 243
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 1e-15
Identities = 71/223 (31%), Positives = 98/223 (43%), Gaps = 36/223 (16%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLK---------AESFQGHKEWLTEV 78
+LG+G FG V + G G A+K LK E K L
Sbjct: 2 VLGKGSFGKVLLAELK---------GKGEYFAVKALKKDVVLIDDDVECTMVEKRVLA-- 50
Query: 79 IYLGQLRHEN--LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 136
L EN L L ++ V EF+ G L H+ KG + T A
Sbjct: 51 -----LAWENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFY--AA 103
Query: 137 DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 196
++ GL FLH +IYRDLK NV+LD + + K++DFG+ ++ GDN ++ GT
Sbjct: 104 EIVCGLQFLH--SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR--ASTFCGT 159
Query: 197 RGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL---DED 236
Y APE + T D +SFGV+L E+L G+ DED
Sbjct: 160 PDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED 202
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 1e-15
Identities = 67/205 (32%), Positives = 95/205 (46%), Gaps = 23/205 (11%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEW---LTEVIYLGQLR 85
+G+GG+G VF K +G +VA+KR+K E LTE L +
Sbjct: 9 VGQGGYGQVF---------LAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTK 59
Query: 86 HENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSF 144
E LVKL+ Y + D L L E++P G L GV R +A +
Sbjct: 60 SEWLVKLL-YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLS-EDHARFYMAEMFE-AVDA 116
Query: 145 LHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEY 204
LH L I+RDLK N L+D++ + KL+DFGL++ T N+ +VG+ Y APE
Sbjct: 117 LHEL--GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANS-----VVGSPDYMAPEV 169
Query: 205 VATGHLTPKSDVYSFGVVLLELLSG 229
+ D +S G +L E L G
Sbjct: 170 LRGKGYDFTVDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 1e-15
Identities = 56/211 (26%), Positives = 95/211 (45%), Gaps = 25/211 (11%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHE 87
+LG+G +G V+ + +AIK + + + E+ L+H
Sbjct: 15 VLGKGTYGIVYAARDLSTQ---------VRIAIKEIPERDSRYVQPLHEEIALHSYLKHR 65
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRK-GVQPISWPTRVKIAIDVARGLSFLH 146
N+V+ +G SE+ + E +P GSL L K G + T + + GL +LH
Sbjct: 66 NIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH 125
Query: 147 GLDANVIYRDLKASNVLLDSNFNA-KLSDFG----LARDGPTGDNTHVSTRIVGTRGYAA 201
D +++RD+K NVL+++ K+SDFG LA P + GT Y A
Sbjct: 126 --DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP------CTETFTGTLQYMA 177
Query: 202 PEYVATGH--LTPKSDVYSFGVVLLELLSGR 230
PE + G +D++S G ++E+ +G+
Sbjct: 178 PEVIDKGPRGYGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 1e-15
Identities = 64/208 (30%), Positives = 104/208 (50%), Gaps = 22/208 (10%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIK--RLKAESFQGHKEWLTEVIYLGQLRH 86
+GEG +G V+KG +G +VA+K RL++E + E+ L +L+H
Sbjct: 8 IGEGTYGVVYKG---------RNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQH 58
Query: 87 ENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI-DVARGLSF 144
N+V L + ++RL L++EF+ L+ +L VK + + +G+ F
Sbjct: 59 PNIVCLQDVLMQ-ESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILF 116
Query: 145 LHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEY 204
H V++RDLK N+L+D+ KL+DFGLAR G V T V T Y APE
Sbjct: 117 CHS--RRVLHRDLKPQNLLIDNKGVIKLADFGLAR--AFGIPVRVYTHEVVTLWYRAPEV 172
Query: 205 V--ATGHLTPKSDVYSFGVVLLELLSGR 230
+ + + TP D++S G + E+ + +
Sbjct: 173 LLGSPRYSTP-VDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 1e-15
Identities = 68/226 (30%), Positives = 104/226 (46%), Gaps = 23/226 (10%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKE---WLTEVIYLGQL 84
LLG+G FG V + +G A+K L+ E E +TE L
Sbjct: 2 LLGKGTFGKVI---------LVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 52
Query: 85 RHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKI-AIDVARGL 142
RH L L Y ++ +RL V E+ G L HL R+ V R + ++ L
Sbjct: 53 RHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFT---EERARFYGAEIVSAL 108
Query: 143 SFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAP 202
+LH +V+YRD+K N++LD + + K++DFGL ++G + T + GT Y AP
Sbjct: 109 EYLH--SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYLAP 164
Query: 203 EYVATGHLTPKSDVYSFGVVLLELLSGRRAL-DEDRGGLAEQTLVE 247
E + D + GVV+ E++ GR ++D L E L+E
Sbjct: 165 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME 210
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 2e-15
Identities = 60/209 (28%), Positives = 103/209 (49%), Gaps = 17/209 (8%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLT---EVIYLGQL 84
LLG+G FG V+ + D +T G + + ES + KE E+ L L
Sbjct: 9 LLGQGAFGRVYLCY-DVDT------GRELAAKQVQFDPESPETSKEVSALECEIQLLKNL 61
Query: 85 RHENLVKLIGYCSESDNRLLV--YEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGL 142
+HE +V+ G + + L E+MP GS+++ L K ++ K + G+
Sbjct: 62 QHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQL--KAYGALTESVTRKYTRQILEGM 119
Query: 143 SFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR-IVGTRGYAA 201
S+LH +++RD+K +N+L DS N KL DFG ++ T + R + GT + +
Sbjct: 120 SYLHS--NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMS 177
Query: 202 PEYVATGHLTPKSDVYSFGVVLLELLSGR 230
PE ++ K+DV+S G ++E+L+ +
Sbjct: 178 PEVISGEGYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 2e-15
Identities = 72/225 (32%), Positives = 103/225 (45%), Gaps = 21/225 (9%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKE---WLTEVIYLGQL 84
LLG+G FG V + SG A+K LK E E LTE L
Sbjct: 2 LLGKGTFGKVI---------LVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNT 52
Query: 85 RHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLS 143
RH L L Y ++ +RL V E++ G L HL R+ V S ++ L
Sbjct: 53 RHPFLTSL-KYSFQTKDRLCFVMEYVNGGELFFHLSRERV--FSEDRTRFYGAEIVSALD 109
Query: 144 FLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPE 203
+LH ++YRDLK N++LD + + K++DFGL ++G T T + GT Y APE
Sbjct: 110 YLH--SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT--FCGTPEYLAPE 165
Query: 204 YVATGHLTPKSDVYSFGVVLLELLSGRRAL-DEDRGGLAEQTLVE 247
+ D + GVV+ E++ GR ++D L E L+E
Sbjct: 166 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME 210
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 2e-15
Identities = 65/206 (31%), Positives = 97/206 (47%), Gaps = 19/206 (9%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKE---WLTEVIYLGQL 84
+LG+G FG V A K SG + A+K LK + + +TE L
Sbjct: 2 VLGKGSFGKVM--------LARLKE-SGRLYAVKVLKKDVILQDDDVECTMTEKRILSLA 52
Query: 85 RHENLVKLIGYCSESDNRLL-VYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLS 143
R+ + + C ++ +RL V EF+ G L H+ + + A ++ L
Sbjct: 53 RNHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHI--QKSRRFDEARARFYAAEITSALM 110
Query: 144 FLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPE 203
FLH D +IYRDLK NVLLD + KL+DFG+ ++G N ++ GT Y APE
Sbjct: 111 FLH--DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIF--NGKTTSTFCGTPDYIAPE 166
Query: 204 YVATGHLTPKSDVYSFGVVLLELLSG 229
+ P D ++ GV+L E+L G
Sbjct: 167 ILQEMLYGPSVDWWAMGVLLYEMLCG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 3e-15
Identities = 66/216 (30%), Positives = 105/216 (48%), Gaps = 29/216 (13%)
Query: 26 DYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGH---KEWLTEVIYLG 82
D +G G FG V W + T P G VA+K++ FQ K E+ L
Sbjct: 5 DRPIGYGAFGVV---W------SVTDPRDGKRVALKKM-PNVFQNLVSCKRVFRELKMLC 54
Query: 83 QLRHENLVKLI-----GYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI- 136
+H+N++ + + + +V E M + L + QP+S VK+ +
Sbjct: 55 FFKHDNVLSALDILQPPHIDPFEEIYVVTELM-QSDLHKIIVSP--QPLS-SDHVKVFLY 110
Query: 137 DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 196
+ RGL +LH A +++RD+K N+L++SN K+ DFGLAR ++ H++ +V T
Sbjct: 111 QILRGLKYLHS--AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV-T 167
Query: 197 RGYAAPEYVATG--HLTPKSDVYSFGVVLLELLSGR 230
+ Y APE + G H T D++S G + ELL R
Sbjct: 168 QYYRAPE-ILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 3e-15
Identities = 63/213 (29%), Positives = 97/213 (45%), Gaps = 19/213 (8%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKE---WLTEVIYLGQL 84
+LG+G FG V G+ V AIK LK + + +TE L
Sbjct: 2 VLGKGSFGKVMLA---------ELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALA 52
Query: 85 RHENLVKLIGYCSESDNRLL-VYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLS 143
+ + C ++ +RL V E++ G L + R + P A +V L
Sbjct: 53 AKHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRS--RKFDEPRSRFYAAEVTLALM 110
Query: 144 FLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPE 203
FLH VIYRDLK N+LLD+ + KL+DFG+ ++G T +T GT Y APE
Sbjct: 111 FLH--RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT--TTTFCGTPDYIAPE 166
Query: 204 YVATGHLTPKSDVYSFGVVLLELLSGRRALDED 236
+ P D ++ GV++ E+++G+ + D
Sbjct: 167 ILQELEYGPSVDWWALGVLMYEMMAGQPPFEAD 199
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 3e-15
Identities = 72/285 (25%), Positives = 119/285 (41%), Gaps = 39/285 (13%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ-GHKEWLTEVIYLGQLRH 86
+G G FG V K SG ++A+KR+++ + K L ++ + +
Sbjct: 11 EIGRGAFGTVNKML---------HKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSD 61
Query: 87 -ENLVKLIGYCSESDNRLLVYEFMPKGSLEN-HLFRKGVQPISWPTRV--KIAIDVARGL 142
+VK G + + E M SL+ + + V P + KIA+ + L
Sbjct: 62 CPYIVKFYGALFREGDCWICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKAL 120
Query: 143 SFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGD--NTHVSTRIVGTRGYA 200
++L + +I+RD+K SN+LLD N N KL DFG++ G ++ TR G R Y
Sbjct: 121 NYLKE-ELKIIHRDVKPSNILLDRNGNIKLCDFGIS-----GQLVDSIAKTRDAGCRPYM 174
Query: 201 APEYVATGHLTP---KSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSR 257
APE + +SDV+S G+ L E+ +G+ + + T V DP
Sbjct: 175 APERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDP------ 228
Query: 258 RVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLT 302
I+ ++S + CL D RP ++L
Sbjct: 229 ---PILSNSEEREFSPSFVNFINL----CLIKDESKRPKYKELLE 266
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 3e-15
Identities = 69/212 (32%), Positives = 98/212 (46%), Gaps = 41/212 (19%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEW---LTEVIYLGQLR 85
+G G FG V+ FA + VVAIK++ Q +++W + EV +L QLR
Sbjct: 23 IGHGSFGAVY--------FA-RDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLR 73
Query: 86 HENLVKLIGYCSESDNRLLVYEFMPKGS----LENHLFRKGVQPISWPTRVKIAI---DV 138
H N ++ G LV E+ GS LE H +K +Q V+IA
Sbjct: 74 HPNTIEYKGCYLREHTAWLVMEYC-LGSASDILEVH--KKPLQ------EVEIAAICHGA 124
Query: 139 ARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR-DGPTGDNTHVSTRIVGTR 197
+GL++LH I+RD+KA N+LL KL+DFG A P + VGT
Sbjct: 125 LQGLAYLHSH--ERIHRDIKAGNILLTEPGTVKLADFGSASLVSP-------ANSFVGTP 175
Query: 198 GYAAPEYVAT---GHLTPKSDVYSFGVVLLEL 226
+ APE + G K DV+S G+ +EL
Sbjct: 176 YWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 3e-15
Identities = 75/279 (26%), Positives = 119/279 (42%), Gaps = 42/279 (15%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEW---LTEVIYLGQLR 85
+G G FG V+ FA T + VVA+K++ Q +++W + EV +L QL+
Sbjct: 29 IGHGSFGAVY--------FA-TNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLK 79
Query: 86 HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFL 145
H N ++ G + LV E+ GS + L +P+ I +GL++L
Sbjct: 80 HPNTIEYKGCYLKEHTAWLVMEYC-LGSASD-LLEVHKKPLQEVEIAAITHGALQGLAYL 137
Query: 146 HGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYV 205
H N+I+RD+KA N+LL KL+DFG A ++ VGT + APE +
Sbjct: 138 H--SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPANS------FVGTPYWMAPEVI 189
Query: 206 AT---GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRI 262
G K DV+S G+ +EL + L A + + P L+
Sbjct: 190 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQ-------- 241
Query: 263 MDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL 301
S + + V CL P+ RP+ ++L
Sbjct: 242 ---------SNEWTDSFRGFVDYCLQKIPQERPASAELL 271
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 3e-15
Identities = 88/322 (27%), Positives = 135/322 (41%), Gaps = 44/322 (13%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKA--ESFQGHKEWLTEVIYLGQLR 85
++G+G +G V ID +T G VAIK++ E L E+ L LR
Sbjct: 7 VIGKGSYGVVCSA-IDTHT--------GEKVAIKKINDVFEHVSDATRILREIKLLRLLR 57
Query: 86 HENLVKLIGYCSESDNR-----LLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVAR 140
H ++V++ R +V+E M + H K ++ + R
Sbjct: 58 HPDIVEIKHIMLPPSRREFKDIYVVFELMES---DLHQVIKANDDLTPEHHQFFLYQLLR 114
Query: 141 GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR----DGPTGDNTHVSTRIVGT 196
L ++H ANV +RDLK N+L +++ K+ DFGLAR D PT T V T
Sbjct: 115 ALKYIHT--ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT---AIFWTDYVAT 169
Query: 197 RGYAAPEYVAT--GHLTPKSDVYSFGVVLLELLSGR---------RALDEDRGGLAEQTL 245
R Y APE + TP D++S G + E+L+G+ LD L +
Sbjct: 170 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSP 229
Query: 246 VEWADPFLRDSRRVLRIMDTRLGGQYSKK--EAQAVAAVVLQ-CLHMDPKNRPSMVDVLT 302
+ +RR L M + +S+K A +A +L+ L DPK+RP+ + L
Sbjct: 230 ETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA 289
Query: 303 S--LEQLHTSKDMPRTPPPAKL 322
+ L + P P KL
Sbjct: 290 DPYFKGLAKVEREPSAQPITKL 311
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 3e-15
Identities = 71/225 (31%), Positives = 102/225 (45%), Gaps = 21/225 (9%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKE---WLTEVIYLGQL 84
LLG+G FG V + +G A+K LK E E LTE L
Sbjct: 2 LLGKGTFGKVI---------LVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNT 52
Query: 85 RHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLS 143
RH L L Y ++ +RL V E+ G L HL R+ V S ++ L
Sbjct: 53 RHPFLTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERV--FSEDRARFYGAEIVSALG 109
Query: 144 FLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPE 203
+LH +V+YRDLK N++LD + + K++DFGL ++G + T GT Y APE
Sbjct: 110 YLH--SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCGTPEYLAPE 165
Query: 204 YVATGHLTPKSDVYSFGVVLLELLSGRRAL-DEDRGGLAEQTLVE 247
+ D + GVV+ E++ GR ++D L E L+E
Sbjct: 166 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME 210
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 4e-15
Identities = 48/148 (32%), Positives = 75/148 (50%), Gaps = 13/148 (8%)
Query: 95 YCS--ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI-AIDVARGLSFLHGLDAN 151
+C+ ++ V E++ G L H+ G + R + A ++ GL FLH
Sbjct: 62 FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEA---RARFYAAEIICGLQFLH--KKG 116
Query: 152 VIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLT 211
+IYRDLK NVLLD + + K++DFG+ ++ G+ ++ GT Y APE +
Sbjct: 117 IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGK--ASTFCGTPDYIAPEILKGQKYN 174
Query: 212 PKSDVYSFGVVLLELLSGRRAL---DED 236
D +SFGV+L E+L G+ DED
Sbjct: 175 ESVDWWSFGVLLYEMLIGQSPFHGEDED 202
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 4e-15
Identities = 68/213 (31%), Positives = 102/213 (47%), Gaps = 24/213 (11%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGH---KEWLTEVIYLGQLR 85
LG+G +G V A T VAIK++ F K L E+ L R
Sbjct: 8 LGQGAYGIVC-----SARNAETSEEET--VAIKKI-TNVFSKKILAKRALRELKLLRHFR 59
Query: 86 -HENLVKLIGY---CSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARG 141
H+N+ L + N L +YE + + L + + R G QP++ + G
Sbjct: 60 GHKNITCLYDMDIVFPGNFNELYLYEELMEADL-HQIIRSG-QPLTDAHFQSFIYQILCG 117
Query: 142 LSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR---DGPTGDNTHVSTRIVGTRG 198
L ++H ANV++RDLK N+L++++ K+ DFGLAR + P G+N T V TR
Sbjct: 118 LKYIH--SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENP-GENAGFMTEYVATRW 174
Query: 199 YAAPEYVATGHLTPKS-DVYSFGVVLLELLSGR 230
Y APE + + K+ DV+S G +L ELL +
Sbjct: 175 YRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 4e-15
Identities = 58/205 (28%), Positives = 100/205 (48%), Gaps = 24/205 (11%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHEN 88
+GEG G V T SG +VA+K++ Q + EV+ + +HEN
Sbjct: 28 IGEGSTGIVC---------IATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHEN 78
Query: 89 LVKLIGYCSESDNRLLVYEFMPKGSLENHLF--RKGVQPISWPTRVKIAIDVARGLSFLH 146
+V++ D +V EF+ G+L + + R + I+ + + V + LS LH
Sbjct: 79 VVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----AVCLAVLKALSVLH 133
Query: 147 GLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR--IVGTRGYAAPEY 204
VI+RD+K+ ++LL + KLSDFG + V R +VGT + APE
Sbjct: 134 A--QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQV----SKEVPRRKSLVGTPYWMAPEL 187
Query: 205 VATGHLTPKSDVYSFGVVLLELLSG 229
++ P+ D++S G++++E++ G
Sbjct: 188 ISRLPYGPEVDIWSLGIMVIEMVDG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 8e-15
Identities = 62/208 (29%), Positives = 103/208 (49%), Gaps = 29/208 (13%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHEN 88
LG+G FG V+K A K +G + A K ++ +S + ++++ E+ L H
Sbjct: 20 LGDGAFGKVYK--------AKNKE-TGALAAAKVIETKSEEELEDYMVEIEILATCNHPY 70
Query: 89 LVKLIGYCSESDNRLLVYEFMPKGSLENHLFR--KGVQPISWPTRVKIAIDVARGLSFLH 146
+VKL+G ++ EF P G+++ + +G+ P I + L +LH
Sbjct: 71 IVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTE---PQIQVICRQMLEALQYLH 127
Query: 147 GLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR---IVGTRGYAAPE 203
+ +I+RDLKA NVLL + + KL+DFG+ + N R +GT + APE
Sbjct: 128 SM--KIIHRDLKAGNVLLTLDGDIKLADFGV-----SAKNVKTLQRRDSFIGTPYWMAPE 180
Query: 204 YV--ATGHLTP---KSDVYSFGVVLLEL 226
V T TP K+D++S G+ L+E+
Sbjct: 181 VVMCETMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 8e-15
Identities = 64/256 (25%), Positives = 116/256 (45%), Gaps = 16/256 (6%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHEN 88
+GEG G V T+ +G VA+K++ Q + EV+ + HEN
Sbjct: 30 IGEGSTGIVC---------IATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHEN 80
Query: 89 LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL 148
+V + D +V EF+ G+L + + + T + + V R LS+LH
Sbjct: 81 VVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAT---VCLSVLRALSYLH-- 135
Query: 149 DANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG 208
+ VI+RD+K+ ++LL S+ KLSDFG +VGT + APE ++
Sbjct: 136 NQGVIHRDIKSDSILLTSDGRIKLSDFGFC--AQVSKEVPKRKSLVGTPYWMAPEVISRL 193
Query: 209 HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLG 268
+ D++S G++++E++ G + A + + + P ++DS +V ++ L
Sbjct: 194 PYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLD 253
Query: 269 GQYSKKEAQAVAAVVL 284
++ +Q A L
Sbjct: 254 LMLVREPSQRATAQEL 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 9e-15
Identities = 64/209 (30%), Positives = 96/209 (45%), Gaps = 23/209 (11%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQL--- 84
+LG+G FG VF A K G+ AIK LK + + ++ L
Sbjct: 2 MLGKGSFGKVF--------LAELK-GTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA 52
Query: 85 -RHENLVKLIGYCS--ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARG 141
H L L YC+ +N V E++ G L H+ + P A ++ G
Sbjct: 53 WEHPFLTHL--YCTFQTKENLFFVMEYLNGGDLMFHI--QSCHKFDLPRATFYAAEIICG 108
Query: 142 LSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAA 201
L FLH ++YRDLK N+LLD++ + K++DFG+ ++ GD + GT Y A
Sbjct: 109 LQFLH--SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK--TCTFCGTPDYIA 164
Query: 202 PEYVATGHLTPKSDVYSFGVVLLELLSGR 230
PE + D +SFGV+L E+L G+
Sbjct: 165 PEILLGQKYNTSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 1e-14
Identities = 56/204 (27%), Positives = 96/204 (47%), Gaps = 23/204 (11%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHEN 88
+G G +G V+K +G +VAIK +K E + E+ L + RH N
Sbjct: 11 IGSGTYGDVYKARDIA---------TGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPN 61
Query: 89 LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL 148
+V G D +V E+ GSL++ +++ P+S + + +GL++LH
Sbjct: 62 IVAYFGSYLRRDKLWIVMEYCGGGSLQD-IYQVTRGPLSELQIAYVCRETLKGLAYLHET 120
Query: 149 DANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR---IVGTRGYAAPEYV 205
I+RD+K +N+LL + + KL+DFG++ T + +GT + APE
Sbjct: 121 --GKIHRDIKGANILLTEDGDVKLADFGVS-----AQLTATIAKRKSFIGTPYWMAPEVA 173
Query: 206 A---TGHLTPKSDVYSFGVVLLEL 226
A G K D+++ G+ +EL
Sbjct: 174 AVERKGGYDGKCDIWALGITAIEL 197
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 1e-14
Identities = 55/201 (27%), Positives = 97/201 (48%), Gaps = 16/201 (7%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHEN 88
+G+G G VF +G VAIK++ + + + E++ + +L++ N
Sbjct: 27 IGQGASGTVFTA---------IDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPN 77
Query: 89 LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL 148
+V + D +V E++ GSL + + + + + + L FLH
Sbjct: 78 IVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAA---VCRECLQALEFLHA- 133
Query: 149 DANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG 208
VI+RD+K+ NVLL + + KL+DFG T + + ST +VGT + APE V
Sbjct: 134 -NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQ-ITPEQSKRST-MVGTPYWMAPEVVTRK 190
Query: 209 HLTPKSDVYSFGVVLLELLSG 229
PK D++S G++ +E++ G
Sbjct: 191 AYGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 1e-14
Identities = 73/225 (32%), Positives = 104/225 (46%), Gaps = 20/225 (8%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKE---WLTEVIYLGQL 84
LLG+G FG V + +G A+K LK E E LTE L
Sbjct: 2 LLGKGTFGKVI---------LVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS 52
Query: 85 RHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLS 143
RH L L Y ++ +RL V E+ G L HL R+ V S ++ L
Sbjct: 53 RHPFLTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERV--FSEDRARFYGAEIVSALD 109
Query: 144 FLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPE 203
+LH + NV+YRDLK N++LD + + K++DFGL ++G D + T GT Y APE
Sbjct: 110 YLHS-EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEG-IKDGATMKT-FCGTPEYLAPE 166
Query: 204 YVATGHLTPKSDVYSFGVVLLELLSGRRAL-DEDRGGLAEQTLVE 247
+ D + GVV+ E++ GR ++D L E L+E
Sbjct: 167 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME 211
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 1e-14
Identities = 64/218 (29%), Positives = 98/218 (44%), Gaps = 24/218 (11%)
Query: 22 NFCSDYLLGEGGFGCVF----KGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTE 77
NF +LG G +G VF G D K + K AE H TE
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAE----HT--RTE 54
Query: 78 VIYLGQLRHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 136
L +R + + Y ++D +L L+ +++ G L HL+++ S V++ I
Sbjct: 55 RQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTES---EVRVYI 111
Query: 137 -DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD--GPTGDNTHVSTRI 193
++ L LH L +IYRD+K N+LLDS + L+DFGL+++ + +
Sbjct: 112 AEIVLALDHLHQL--GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAY---SF 166
Query: 194 VGTRGYAAPEYVATGHLTPKS--DVYSFGVVLLELLSG 229
GT Y APE + G D +S GV+ ELL+G
Sbjct: 167 CGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 1e-14
Identities = 49/141 (34%), Positives = 76/141 (53%), Gaps = 9/141 (6%)
Query: 96 CSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIY 154
C ++++RL V EF+ G L H+ R+ P I +A L+FLH + +IY
Sbjct: 64 CFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLA--LNFLH--ERGIIY 119
Query: 155 RDLKASNVLLDSNFNAKLSDFGLARDG-PTGDNTHVSTRIVGTRGYAAPEYVATGHLTPK 213
RDLK NVLLD+ + KL+D+G+ ++G GD T + GT Y APE +
Sbjct: 120 RDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTT---STFCGTPNYIAPEILRGEDYGFS 176
Query: 214 SDVYSFGVVLLELLSGRRALD 234
D ++ GV++ E+++GR D
Sbjct: 177 VDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 1e-14
Identities = 79/284 (27%), Positives = 127/284 (44%), Gaps = 44/284 (15%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAE-SFQGHKEWLTEV-IYLGQLRH 86
LG G +G V D+ PT G ++A+KR++A + Q K L ++ I + +
Sbjct: 9 LGRGAYGVV-----DKMRHVPT----GTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDC 59
Query: 87 ENLVKLIGYCSESDNRLLVYEFMPKGSLEN---HLFRKGVQPISWPTRVKIAIDVARGLS 143
V G + + E M SL+ ++ KG I KIA+ + + L
Sbjct: 60 PYTVTFYGALFREGDVWICMEVM-DTSLDKFYKKVYDKG-LTIPEDILGKIAVSIVKALE 117
Query: 144 FLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGD--NTHVSTRIVGTRGYAA 201
+LH +VI+RD+K SNVL++ N KL DFG+ +G ++ T G + Y A
Sbjct: 118 YLHS-KLSVIHRDVKPSNVLINRNGQVKLCDFGI-----SGYLVDSVAKTIDAGCKPYMA 171
Query: 202 PEYV----ATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSR 257
PE + KSDV+S G+ ++EL +GR D W PF + +
Sbjct: 172 PERINPELNQKGYDVKSDVWSLGITMIELATGRFPYD------------SWKTPF-QQLK 218
Query: 258 RVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL 301
+V+ +L + E Q V +CL + K RP+ ++L
Sbjct: 219 QVVEEPSPQLPAEKFSPEFQ---DFVNKCLKKNYKERPNYPELL 259
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 2e-14
Identities = 72/291 (24%), Positives = 121/291 (41%), Gaps = 52/291 (17%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRL----------KAESFQGHKEWLTE 77
LG G FGCV+K K ++A+K + K E + + ++E
Sbjct: 7 HLGSGAFGCVYK--------VRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSE 58
Query: 78 V-IYLGQLRHENLVKLIGYCSESDNRLLVYEFM---PKGSLENHLFRKGVQPISWPTRVK 133
V I QLRH N+V+ E+D +V + + P G N L K Q +
Sbjct: 59 VTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKK-QRFTEERIWN 117
Query: 134 IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRI 193
I + + L +LH + +++RDL +N++L + ++DFGLA+ + + T +
Sbjct: 118 IFVQMVLALRYLHK-EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQ--KQPESKL-TSV 173
Query: 194 VGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 253
VGT Y+ PE V K+DV++FG +L + + PF
Sbjct: 174 VGTILYSCPEIVKNEPYGEKADVWAFGCILYQ-------------------MCTLQPPFY 214
Query: 254 RDSRRVLRIMDTRLGGQYSKKE----AQAVAAVVLQCLHMDPKNRPSMVDV 300
S +L + + Y ++ V V+ CL D + RP ++ V
Sbjct: 215 --STNMLSLATKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQV 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 2e-14
Identities = 86/319 (26%), Positives = 138/319 (43%), Gaps = 47/319 (14%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGH---KEWLTEVIYLGQLR 85
+G G +G V ID + G VAIK++ +F K L E+ L +
Sbjct: 13 IGSGAYGVVCSA-IDTRS--------GKKVAIKKI-PHAFDVPTLAKRTLRELKILRHFK 62
Query: 86 HENLVKL--IGYCSESDNR--LLVYEFMPKGSLENHLFR--KGVQPISWPTRVKIAIDVA 139
H+N++ + I +D + +V + M E+ L QP++ +
Sbjct: 63 HDNIIAIRDILRPPGADFKDVYVVMDLM-----ESDLHHIIHSDQPLTEEHIRYFLYQLL 117
Query: 140 RGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR--DGPTGDNTHVSTRIVGTR 197
RGL ++H ANVI+RDLK SN+L++ + ++ DFG+AR ++ + T V TR
Sbjct: 118 RGLKYIHS--ANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATR 175
Query: 198 GYAAPEYVATGH-LTPKSDVYSFGVVLLELLSGRRALDEDR-------------GGLAEQ 243
Y APE + + T D++S G + E+L GRR L + G +E+
Sbjct: 176 WYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQLFPGKNYVHQLKLILSVLGSPSEE 234
Query: 244 TLVEWADPFLRDSRRVL-RIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLT 302
L +R + L R + K +A+ ++ Q L DP+ R ++ L
Sbjct: 235 VLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEAL-DLLSQMLQFDPEERITVEQALQ 293
Query: 303 S--LEQLHTSKDMPRTPPP 319
L Q H D P PPP
Sbjct: 294 HPFLAQYHDPDDEPTCPPP 312
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 2e-14
Identities = 53/149 (35%), Positives = 77/149 (51%), Gaps = 18/149 (12%)
Query: 96 CSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIY 154
C ++ +RL V E++ G L + + V P V A ++A GL FLH +IY
Sbjct: 69 CFQTMDRLYFVMEYVNGGDLMYQI--QQVGRFKEPHAVFYAAEIAIGLFFLH--SKGIIY 124
Query: 155 RDLKASNVLLDSNFNAKLSDFGLAR----DGPTGDNTHVSTRIVGTRGYAAPEYVATGHL 210
RDLK NV+LDS + K++DFG+ + DG T + GT Y APE +A
Sbjct: 125 RDLKLDNVMLDSEGHIKIADFGMCKENMWDGVT------TKTFCGTPDYIAPEIIAYQPY 178
Query: 211 TPKSDVYSFGVVLLELLSGRRAL---DED 236
D ++FGV+L E+L+G+ DED
Sbjct: 179 GKSVDWWAFGVLLYEMLAGQAPFEGEDED 207
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 2e-14
Identities = 61/202 (30%), Positives = 102/202 (50%), Gaps = 24/202 (11%)
Query: 81 LGQLRHENLVKLIGYCSESDNRLL--VYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDV 138
L ++ H +++L + +E D R L + E++P G L ++L G S T + A ++
Sbjct: 55 LKEVSHPFIIRL--FWTEHDQRFLYMLMEYVPGGELFSYLRNSG--RFSNSTGLFYASEI 110
Query: 139 ARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRG 198
L +LH ++YRDLK N+LLD + KL+DFG A+ D T + GT
Sbjct: 111 VCALEYLHSK--EIVYRDLKPENILLDKEGHIKLTDFGFAKK--LRDRTWT---LCGTPE 163
Query: 199 YAAPEYVA-TGHLTPKSDVYSFGVVLLELLSGRRAL-DEDRGGLAEQTL---VEWA---D 250
Y APE + GH D ++ G+++ E+L G D++ G+ E+ L +E+ D
Sbjct: 164 YLAPEVIQSKGHNK-AVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLD 222
Query: 251 PFLRDSRRVLRIMD--TRLGGQ 270
+ +D + L ++D RLG
Sbjct: 223 LYAKDLIKKLLVVDRTRRLGNM 244
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 2e-14
Identities = 65/206 (31%), Positives = 94/206 (45%), Gaps = 21/206 (10%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKE----WLTEVIYLGQL 84
+G+G FG V A K G A+K L+ ++ KE + L +
Sbjct: 3 IGKGSFGKVL--------LAKHKA-DGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNV 53
Query: 85 RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI-AIDVARGLS 143
+H LV L +D V +++ G L HL R+ P R + A ++A L
Sbjct: 54 KHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEP---RARFYAAEIASALG 110
Query: 144 FLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPE 203
+LH L N+IYRDLK N+LLDS + L+DFGL ++G T ++ GT Y APE
Sbjct: 111 YLHSL--NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKT--TSTFCGTPEYLAPE 166
Query: 204 YVATGHLTPKSDVYSFGVVLLELLSG 229
+ D + G VL E+L G
Sbjct: 167 VLRKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 2e-14
Identities = 65/208 (31%), Positives = 106/208 (50%), Gaps = 23/208 (11%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIK--RLKAESFQGHKEWLTEVIYLGQLRH 86
+GEG +G V+K D+ T G +VA+K RL+ E + E+ L +L H
Sbjct: 7 IGEGTYGVVYKA-RDKLT--------GEIVALKKIRLETEDEGVPSTAIREISLLKELNH 57
Query: 87 ENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI-DVARGLSF 144
N+V+L+ S+N+L LV+EF+ L+ ++ + + P +K + + +G+++
Sbjct: 58 PNIVRLLDVV-HSENKLYLVFEFLDL-DLKKYMDSSPLTGLD-PPLIKSYLYQLLQGIAY 114
Query: 145 LHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEY 204
H V++RDLK N+L+D KL+DFGLAR G T V T Y APE
Sbjct: 115 CHS--HRVLHRDLKPQNLLIDREGALKLADFGLAR--AFGVPVRTYTHEVVTLWYRAPEI 170
Query: 205 VATGHL--TPKSDVYSFGVVLLELLSGR 230
+ TP D++S G + E+++ R
Sbjct: 171 LLGSRQYSTP-VDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 3e-14
Identities = 49/141 (34%), Positives = 77/141 (54%), Gaps = 9/141 (6%)
Query: 96 CSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIY 154
C ++ +RL LV E++ G L H+ R+ P I +A L+FLH + +IY
Sbjct: 64 CFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIA--LNFLH--ERGIIY 119
Query: 155 RDLKASNVLLDSNFNAKLSDFGLARDG-PTGDNTHVSTRIVGTRGYAAPEYVATGHLTPK 213
RDLK NVLLD++ + KL+D+G+ ++G GD T + GT Y APE +
Sbjct: 120 RDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTT---STFCGTPNYIAPEILRGEEYGFS 176
Query: 214 SDVYSFGVVLLELLSGRRALD 234
D ++ GV++ E+++GR D
Sbjct: 177 VDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 4e-14
Identities = 63/217 (29%), Positives = 98/217 (45%), Gaps = 38/217 (17%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEW-----LTEVIYLGQ 83
+G+G FG VFK + +VA+K++ E+ KE L E+ L
Sbjct: 20 IGQGTFGEVFKARHKKT---------KQIVALKKVLMEN---EKEGFPITALREIKILQL 67
Query: 84 LRHENLVKLIGYC---SESDNR-----LLVYEFMP---KGSLENHLFRKGVQPISWPTRV 132
L+HEN+V LI C + NR LV+EF G L N K V+ +
Sbjct: 68 LKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSN----KNVK-FTLSEIK 122
Query: 133 KIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR--DGPTGDNTHVS 190
K+ + GL ++H +++RD+KA+N+L+ + KL+DFGLAR +
Sbjct: 123 KVMKMLLNGLYYIH--RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRY 180
Query: 191 TRIVGTRGYAAPE-YVATGHLTPKSDVYSFGVVLLEL 226
T V T Y PE + P D++ G ++ E+
Sbjct: 181 TNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEM 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 4e-14
Identities = 79/260 (30%), Positives = 120/260 (46%), Gaps = 36/260 (13%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQL 84
++G GGFG V+ K +G + A+K L + QG L E I L +
Sbjct: 1 IIGRGGFGEVY---------GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLV 51
Query: 85 RHEN--LVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARG 141
+ + + Y + ++L + + M G L HL + GV S A ++ G
Sbjct: 52 STGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGV--FSEKEMRFYATEIILG 109
Query: 142 LSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAA 201
L +H + V+YRDLK +N+LLD + + ++SD GLA D + H S VGT GY A
Sbjct: 110 LEHMH--NRFVVYRDLKPANILLDEHGHVRISDLGLACDF-SKKKPHAS---VGTHGYMA 163
Query: 202 PEYVATGHLTPKS-DVYSFGVVLLELLSG----RRALDEDRGGLAEQTL---VEWADPFL 253
PE + G S D +S G +L +LL G R+ +D+ + TL VE D F
Sbjct: 164 PEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFS 223
Query: 254 RDSRRVL-----RIMDTRLG 268
+ + +L R + RLG
Sbjct: 224 PELKSLLEGLLQRDVSKRLG 243
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 4e-14
Identities = 67/206 (32%), Positives = 107/206 (51%), Gaps = 23/206 (11%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHE- 87
LG G G VFK KP SG+++A K + E + ++I Q+ HE
Sbjct: 13 LGAGNGGVVFK--------VSHKP-SGLIMARKLIHLEIKPAIR---NQIIRELQVLHEC 60
Query: 88 NLVKLIGYCSE--SDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSF 144
N ++G+ SD + + E M GSL+ L + G P +V IA V +GL++
Sbjct: 61 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTY 118
Query: 145 LHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEY 204
L +++RD+K SN+L++S KL DFG++ G D+ ++ VGTR Y +PE
Sbjct: 119 LRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFVGTRSYMSPER 173
Query: 205 VATGHLTPKSDVYSFGVVLLELLSGR 230
+ H + +SD++S G+ L+E+ GR
Sbjct: 174 LQGTHYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 5e-14
Identities = 51/151 (33%), Positives = 75/151 (49%), Gaps = 6/151 (3%)
Query: 79 IYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDV 138
+ L ++H LV L ++ V +F+ G L HL R+ P P A ++
Sbjct: 48 VLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFP--EPRARFYAAEI 105
Query: 139 ARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRG 198
A L +LH + N++YRDLK N+LLDS + L+DFGL ++G +T +T GT
Sbjct: 106 ASALGYLHSI--NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT--TTTFCGTPE 161
Query: 199 YAAPEYVATGHLTPKSDVYSFGVVLLELLSG 229
Y APE + D + G VL E+L G
Sbjct: 162 YLAPEVIRKQPYDNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 6e-14
Identities = 60/209 (28%), Positives = 102/209 (48%), Gaps = 17/209 (8%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKE---WLTEVIYLGQL 84
LLG+G FG V+ + D +T G + V + ES + KE E+ L L
Sbjct: 9 LLGQGAFGRVYLCY-DADT------GRELAVKQVQFDPESPETSKEVNALECEIQLLKNL 61
Query: 85 RHENLVKLIGYCSESDNRLL--VYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGL 142
HE +V+ G + R L E MP GS+++ L K ++ K + G+
Sbjct: 62 LHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL--KSYGALTENVTRKYTRQILEGV 119
Query: 143 SFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR-IVGTRGYAA 201
S+LH +++RD+K +N+L DS N KL DFG ++ T + + + GT + +
Sbjct: 120 SYLH--SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMS 177
Query: 202 PEYVATGHLTPKSDVYSFGVVLLELLSGR 230
PE ++ K+D++S G ++E+L+ +
Sbjct: 178 PEVISGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 6e-14
Identities = 48/141 (34%), Positives = 76/141 (53%), Gaps = 9/141 (6%)
Query: 96 CSESDNRLL-VYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIY 154
C ++++RL V E++ G L H+ R+ P I +A L++LH + +IY
Sbjct: 64 CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA--LNYLH--ERGIIY 119
Query: 155 RDLKASNVLLDSNFNAKLSDFGLARDG-PTGDNTHVSTRIVGTRGYAAPEYVATGHLTPK 213
RDLK NVLLDS + KL+D+G+ ++G GD T + GT Y APE +
Sbjct: 120 RDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---STFCGTPNYIAPEILRGEDYGFS 176
Query: 214 SDVYSFGVVLLELLSGRRALD 234
D ++ GV++ E+++GR D
Sbjct: 177 VDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 9e-14
Identities = 64/206 (31%), Positives = 95/206 (46%), Gaps = 19/206 (9%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKE----WLTEVIYLGQ 83
++G+G FG V A K G A+K L+ ++ KE + L
Sbjct: 2 VIGKGSFGKVL--------LAKRK-SDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKN 52
Query: 84 LRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLS 143
L+H LV L ++ V +++ G L HL R+ + P A +VA +
Sbjct: 53 LKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRE--RCFLEPRARFYAAEVASAIG 110
Query: 144 FLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPE 203
+LH L N+IYRDLK N+LLDS + L+DFGL ++G + T ++ GT Y APE
Sbjct: 111 YLHSL--NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET--TSTFCGTPEYLAPE 166
Query: 204 YVATGHLTPKSDVYSFGVVLLELLSG 229
+ D + G VL E+L G
Sbjct: 167 VLRKEPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 1e-13
Identities = 59/208 (28%), Positives = 93/208 (44%), Gaps = 20/208 (9%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLR 85
LG+GGFG V A +G + A K+L + +G++ + E L ++
Sbjct: 1 LGKGGFGEVS---------ACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV- 50
Query: 86 HENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQP--ISWPTRVKIAIDVARGL 142
H + + Y ++ L LV M G L H++ + P + GL
Sbjct: 51 HSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGL 110
Query: 143 SFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAP 202
LH +IYRDLK NVLLD++ N ++SD GLA + G + + GT G+ AP
Sbjct: 111 EHLH--QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TKGYAGTPGFMAP 166
Query: 203 EYVATGHLTPKSDVYSFGVVLLELLSGR 230
E + D ++ GV L E+++ R
Sbjct: 167 ELLQGEEYDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 69.2 bits (170), Expect = 2e-13
Identities = 58/206 (28%), Positives = 95/206 (46%), Gaps = 24/206 (11%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEW--LTEVIYLGQLR- 85
+GEG F V K Q+ +G AIK +K F+ ++ L E+ L +L
Sbjct: 7 IGEGTFSEVLKA---QSR------KTGKYYAIKCMKK-HFKSLEQVNNLREIQALRRLSP 56
Query: 86 HENLVKLIG--YCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLS 143
H N+++LI + ++ LV+E M E L + +P+ + + L
Sbjct: 57 HPNILRLIEVLFDRKTGRLALVFELMDMNLYE--LIKGRKRPLPEKRVKSYMYQLLKSLD 114
Query: 144 FLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPE 203
+H + +RD+K N+L+ + KL+DFG R + T + TR Y APE
Sbjct: 115 HMHR--NGIFHRDIKPENILIKDD-ILKLADFGSCR---GIYSKPPYTEYISTRWYRAPE 168
Query: 204 YVAT-GHLTPKSDVYSFGVVLLELLS 228
+ T G+ PK D+++ G V E+LS
Sbjct: 169 CLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 2e-13
Identities = 61/226 (26%), Positives = 108/226 (47%), Gaps = 34/226 (15%)
Query: 23 FCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLG 82
+ LG G G VF +D + VA+K++ Q K L E+ +
Sbjct: 7 YMDLRPLGCGSNGLVFSA-VDSD--------CDKRVAVKKIVLTDPQSVKHALREIKIIR 57
Query: 83 QLRHENLVKL--------------IGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISW 128
+L H+N+VK+ +G +E ++ +V E+M + L N L + P+S
Sbjct: 58 RLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYM-ETDLANVLEQ---GPLSE 113
Query: 129 PTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS-NFNAKLSDFGLAR--DGPTGD 185
+ RGL ++H ANV++RDLK +NV +++ + K+ DFGLAR D
Sbjct: 114 EHARLFMYQLLRGLKYIH--SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSH 171
Query: 186 NTHVSTRIVGTRGYAAPEYV-ATGHLTPKSDVYSFGVVLLELLSGR 230
++S +V T+ Y +P + + + T D+++ G + E+L+G+
Sbjct: 172 KGYLSEGLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 3e-13
Identities = 58/208 (27%), Positives = 103/208 (49%), Gaps = 19/208 (9%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKE---WLTEVIYLGQL 84
LLG G FG V+ + D +T G + V +S + KE E+ L L
Sbjct: 9 LLGRGAFGEVYLCY-DADT------GRELAVKQVPFDPDSQETSKEVNALECEIQLLKNL 61
Query: 85 RHENLVKLIGYCSESDNRLL--VYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGL 142
RH+ +V+ G + + + L E+MP GS+++ L K ++ + + +G+
Sbjct: 62 RHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQL--KAYGALTENVTRRYTRQILQGV 119
Query: 143 SFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPT--GDNTHVSTRIVGTRGYA 200
S+LH +++RD+K +N+L DS N KL DFG ++ T T + + + GT +
Sbjct: 120 SYLHS--NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKS-VTGTPYWM 176
Query: 201 APEYVATGHLTPKSDVYSFGVVLLELLS 228
+PE ++ K+DV+S ++E+L+
Sbjct: 177 SPEVISGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 3e-13
Identities = 68/216 (31%), Positives = 103/216 (47%), Gaps = 27/216 (12%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLT--EVIYLGQLR- 85
+GEG +G VFK +N G VA+KR++ ++ + T EV L L
Sbjct: 9 IGEGAYGKVFKARDLKN--------GGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 60
Query: 86 --HENLVKLIGYCSES----DNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVK-IAID 137
H N+V+L C+ S + +L LV+E + + L +L K +P +K +
Sbjct: 61 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYL-DKVPEPGVPTETIKDMMFQ 118
Query: 138 VARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR 197
+ RGL FLH V++RDLK N+L+ S+ KL+DFGLAR T +V T
Sbjct: 119 LLRGLDFLH--SHRVVHRDLKPQNILVTSSGQIKLADFGLAR---IYSFQMALTSVVVTL 173
Query: 198 GYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL 233
Y APE + D++S G + E+ R+ L
Sbjct: 174 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPL 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 3e-13
Identities = 62/191 (32%), Positives = 91/191 (47%), Gaps = 34/191 (17%)
Query: 53 GSGIVVAIKRLKAESFQGHKE---WLTEVIYLGQLRHENLVKLIGYCS-ESDNRL-LVYE 107
G+G AIK LK K+ E L +L H +V + CS + +NR+ + E
Sbjct: 41 GTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNM--MCSFQDENRVYFLLE 98
Query: 108 FMPKGSLENHLFRKGVQPISWPTRVKIAIDVAR--------GLSFLHGLDANVIYRDLKA 159
F+ G L HL + G + DVA+ +LH D +IYRDLK
Sbjct: 99 FVVGGELFTHLRKAG----------RFPNDVAKFYHAELVLAFEYLHSKD--IIYRDLKP 146
Query: 160 SNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYS 218
N+LLD+ + K++DFG A+ P D T + GT Y APE + + GH D ++
Sbjct: 147 ENLLLDNKGHVKVTDFGFAKKVP--DRTFT---LCGTPEYLAPEVIQSKGH-GKAVDWWT 200
Query: 219 FGVVLLELLSG 229
GV+L E ++G
Sbjct: 201 MGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 4e-13
Identities = 64/221 (28%), Positives = 110/221 (49%), Gaps = 39/221 (17%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEW-----LTEVIYLGQ 83
+GEG +G V+K D++T G +VA+K+++ ++ KE + E+ L Q
Sbjct: 15 IGEGTYGQVYKA-RDKDT--------GELVALKKVRLDN---EKEGFPITAIREIKILRQ 62
Query: 84 LRHENLVKLIGYCSESDNRL----------LVYEFMPK---GSLENHLFRKGVQPISWPT 130
L H N+V L ++ + L LV+E+M G LE+ L I +
Sbjct: 63 LNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIK--S 120
Query: 131 RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 190
+K ++ GL++ H N ++RD+K SN+LL++ KL+DFGLAR + ++ +
Sbjct: 121 FMKQLLE---GLNYCH--KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYT 175
Query: 191 TRIVGTRGYAAPE-YVATGHLTPKSDVYSFGVVLLELLSGR 230
+++ T Y PE + P DV+S G +L EL + +
Sbjct: 176 NKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 4e-13
Identities = 46/124 (37%), Positives = 72/124 (58%), Gaps = 7/124 (5%)
Query: 107 EFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS 166
E M GSL+ L K + I K++I V RGL++L +++RD+K SN+L++S
Sbjct: 83 EHMDGGSLDQVL--KEAKRIPEEILGKVSIAVLRGLAYLRE-KHQIMHRDVKPSNILVNS 139
Query: 167 NFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLEL 226
KL DFG++ G D+ ++ VGTR Y +PE + H + +SD++S G+ L+EL
Sbjct: 140 RGEIKLCDFGVS--GQLIDS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEL 195
Query: 227 LSGR 230
GR
Sbjct: 196 AIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 5e-13
Identities = 83/286 (29%), Positives = 129/286 (45%), Gaps = 45/286 (15%)
Query: 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF----QGHKEWLTE 77
NF +LG G +G VF + SG + A+K LK + + + TE
Sbjct: 1 NFELLKVLGTGAYGKVFL------VRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTE 54
Query: 78 VIYLGQLRHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTR-VKIA 135
L +R + + Y ++D +L L+ +++ G L HL Q + + V+I
Sbjct: 55 RQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHL----SQRERFKEQEVQIY 110
Query: 136 I-DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 194
++ L LH L +IYRD+K N+LLDSN + L+DFGL+++ D +
Sbjct: 111 SGEIVLALEHLHKL--GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHE-DEVERAYSFC 167
Query: 195 GTRGYAAPEYVA---TGHLTPKSDVYSFGVVLLELLSGRR--ALDEDRGGLAEQTLVEWA 249
GT Y AP+ V GH D +S GV++ ELL+G +D ++ AE
Sbjct: 168 GTIEYMAPDIVRGGDGGH-DKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEI------ 220
Query: 250 DPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHM-DPKNR 294
SRR+L+ +E A+A ++Q L M DPK R
Sbjct: 221 ------SRRILK------SEPPYPQEMSALAKDIIQRLLMKDPKKR 254
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 7e-13
Identities = 51/210 (24%), Positives = 102/210 (48%), Gaps = 15/210 (7%)
Query: 54 SGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGS 113
SG VA+K + Q + EV+ + +H+N+V++ + ++ EF+ G+
Sbjct: 45 SGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104
Query: 114 LENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLS 173
L + + + + T + V + L +LH VI+RD+K+ ++LL + KLS
Sbjct: 105 LTDIVSQTRLNEEQIAT---VCESVLQALCYLHS--QGVIHRDIKSDSILLTLDGRVKLS 159
Query: 174 DFG----LARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSG 229
DFG +++D P +VGT + APE ++ + D++S G++++E++ G
Sbjct: 160 DFGFCAQISKDVPK------RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDG 213
Query: 230 RRALDEDRGGLAEQTLVEWADPFLRDSRRV 259
D A + L + P L+++ ++
Sbjct: 214 EPPYFSDSPVQAMKRLRDSPPPKLKNAHKI 243
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 7e-13
Identities = 62/204 (30%), Positives = 93/204 (45%), Gaps = 25/204 (12%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEW---LTEVIYLGQLR 85
+G G FG V+ FA + VVAIK++ Q +++W + EV +L +LR
Sbjct: 23 IGHGSFGAVY--------FA-RDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 86 HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFL 145
H N ++ G LV E+ GS + L +P+ + +GL++L
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYC-LGSASD-LLEVHKKPLQEVEIAAVTHGALQGLAYL 131
Query: 146 HGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYV 205
H N+I+RD+KA N+LL KL DFG A + VGT + APE +
Sbjct: 132 H--SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX------FVGTPYWMAPEVI 183
Query: 206 AT---GHLTPKSDVYSFGVVLLEL 226
G K DV+S G+ +EL
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 7e-13
Identities = 65/212 (30%), Positives = 105/212 (49%), Gaps = 31/212 (14%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQG---HKEWLTEVIYLGQLR 85
+G G +G V + D T G+ VA+K+L + FQ K E+ L ++
Sbjct: 25 VGSGAYGSVCAAF-DTKT--------GLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMK 74
Query: 86 HENLVKLIGYCS------ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVA 139
HEN++ L+ + E ++ LV M G+ N++ + Q ++ + +
Sbjct: 75 HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVK--CQKLTDDHVQFLIYQIL 130
Query: 140 RGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGY 199
RGL ++H A++I+RDLK SN+ ++ + K+ DFGLAR T D T V TR Y
Sbjct: 131 RGLKYIH--SADIIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM---TGYVATRWY 183
Query: 200 AAPEYVATG-HLTPKSDVYSFGVVLLELLSGR 230
APE + H D++S G ++ ELL+GR
Sbjct: 184 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 7e-13
Identities = 65/209 (31%), Positives = 103/209 (49%), Gaps = 20/209 (9%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES-FQG-HKEWLTEVIYLGQLRH 86
+GEG +G VFK ++ T +VA+KR++ + +G L E+ L +L+H
Sbjct: 8 IGEGTYGTVFKA-KNRET--------HEIVALKRVRLDDDDEGVPSSALREICLLKELKH 58
Query: 87 ENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFL 145
+N+V+L SD +L LV+E+ + L+ + F I + +GL+F
Sbjct: 59 KNIVRLYDVL-HSDKKLTLVFEYCDQ-DLKKY-FDSCNGDIDPEIVKSFMFQLLKGLAFC 115
Query: 146 HGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYV 205
H NV++RDLK N+L++ N KL+DFGLAR G + V T Y P+ +
Sbjct: 116 H--SHNVLHRDLKPQNLLINKNGELKLADFGLAR--AFGIPVRCYSAEVVTLWYRPPDVL 171
Query: 206 ATGHLTPKS-DVYSFGVVLLELLSGRRAL 233
L S D++S G + EL + R L
Sbjct: 172 FGAKLYSTSIDMWSAGCIFAELANAGRPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 9e-13
Identities = 69/296 (23%), Positives = 121/296 (40%), Gaps = 41/296 (13%)
Query: 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEV 78
NF + +G G F V++ T G+ VA+K+++ + + + E+
Sbjct: 3 NFRIEKKIGRGQFSEVYRA---------TCLLDGVPVALKKVQIFDLMDAKARADCIKEI 53
Query: 79 IYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHL--FRKGVQPISWPTRVKIAI 136
L QL H N++K E + +V E G L + F+K + I T K +
Sbjct: 54 DLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFV 113
Query: 137 DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 196
+ L +H V++RD+K +NV + + KL D GL R + T + +VGT
Sbjct: 114 QLCSALEHMH--SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSLVGT 169
Query: 197 RGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDS 256
Y +PE + KSD++S G +L E+ + PF D
Sbjct: 170 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAA-------------------LQSPFYGDK 210
Query: 257 RRVLRIMDTRLGGQY----SKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLH 308
+ + Y S ++ + +V C++ DP+ RP + V +++H
Sbjct: 211 MNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 9e-13
Identities = 67/209 (32%), Positives = 107/209 (51%), Gaps = 22/209 (10%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRL-KAESFQGHKEWL---TEVIYLGQ 83
+LG+GG+G VF+ + + T A +G + A+K L KA + K+ E L
Sbjct: 3 VLGKGGYGKVFQ--VRKVTGA----DTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEA 56
Query: 84 LRHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGL 142
++H +V LI Y ++ +L L+ E++ G L HL R+G+ T +++ L
Sbjct: 57 VKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMHLEREGI--FMEDTACFYLSEISLAL 113
Query: 143 SFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDN-THVSTRIVGTRGYAA 201
LH +IYRDLK N+LLD+ + KL+DFGL ++ TH GT Y A
Sbjct: 114 EHLHQQ--GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT---FCGTIEYMA 168
Query: 202 PEYVA-TGHLTPKSDVYSFGVVLLELLSG 229
PE + +GH D +S G ++ ++L+G
Sbjct: 169 PEILMRSGH-GKAVDWWSLGALMYDMLTG 196
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.9 bits (164), Expect = 1e-12
Identities = 65/219 (29%), Positives = 96/219 (43%), Gaps = 34/219 (15%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQL-RH 86
++GEG +G V+K + T G +VAIK + +E E L + H
Sbjct: 13 VIGEGTYGKVYKA-RHKKT--------GQLVAIKIMDIIE-DEEEEIKEEYNILRKYSNH 62
Query: 87 ENLVKLIG------YCSESDNRLLVYEFMPKGS---LENHLFRKGVQPISWPTRVKIAID 137
N+ G D LV E GS L L +KG + + I +
Sbjct: 63 PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKG-KRLKEEWIAYILRE 121
Query: 138 VARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR--IVG 195
RGL++LH + VI+RD+K N+LL N KL DFG++ D+T + R +G
Sbjct: 122 TLRGLAYLH--ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQ---LDST-LGRRNTFIG 175
Query: 196 TRGYAAPEYVA-----TGHLTPKSDVYSFGVVLLELLSG 229
T + APE +A +SDV+S G+ +EL G
Sbjct: 176 TPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADG 214
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 1e-12
Identities = 56/174 (32%), Positives = 86/174 (49%), Gaps = 26/174 (14%)
Query: 138 VARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHV---STRIV 194
VARG+ FL I+RDL A N+LL N K+ DFGLARD D +V R+
Sbjct: 182 VARGMEFLA--SRKCIHRDLAARNILLSENNVVKICDFGLARD-IYKDPDYVRKGDARL- 237
Query: 195 GTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLR 254
+ APE + T +SDV+SFGV+L E+ S G + V+ + F R
Sbjct: 238 -PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS---------LGASPYPGVQIDEEFCR 287
Query: 255 DSRRVLRIMDTRLGG-QYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 307
+ TR+ +Y+ E + +++L C H +P++RP+ +++ L L
Sbjct: 288 RLKE-----GTRMRAPEYATPE---IYSIMLDCWHNNPEDRPTFSELVEILGDL 333
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 1e-12
Identities = 52/169 (30%), Positives = 75/169 (44%), Gaps = 37/169 (21%)
Query: 141 GLSFLHGLDA-------NVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRI 193
GL F+ L A ++I+RD+K++N+LL SN KL DFG ++ + V
Sbjct: 146 GLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTF 205
Query: 194 VGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 253
GT Y APE + K+D++S GV+L ELL+ +R PF
Sbjct: 206 CGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKR-------------------PF- 245
Query: 254 RDSRRVLRIMDTRLGGQYS------KKEAQAVAAVVLQCLHMDPKNRPS 296
D + +M L G+Y E Q + +L DPK RPS
Sbjct: 246 -DGENMEEVMHKTLAGRYDPLPPSISPEMQEIVTALLSS---DPKRRPS 290
|
Length = 496 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 2e-12
Identities = 44/122 (36%), Positives = 67/122 (54%), Gaps = 18/122 (14%)
Query: 118 LFRKGVQPISWPTRV--KIAIDVARGLSFL---HGLDANVIYRDLKASNVLLDSNFNAKL 172
L ++ PI P + K+ + + + L +L HG VI+RD+K SN+LLD++ N KL
Sbjct: 103 LLKRIQGPI--PEDILGKMTVAIVKALHYLKEKHG----VIHRDVKPSNILLDASGNVKL 156
Query: 173 SDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPK----SDVYSFGVVLLELLS 228
DFG++ G D + TR G Y APE + PK +DV+S G+ L+EL +
Sbjct: 157 CDFGIS--GRLVD-SKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELAT 213
Query: 229 GR 230
G+
Sbjct: 214 GQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 2e-12
Identities = 59/191 (30%), Positives = 89/191 (46%), Gaps = 33/191 (17%)
Query: 125 PISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTG 184
P++ + + VARG+ FL I+RDL A N+LL N K+ DFGLARD
Sbjct: 170 PLTMEDLICYSFQVARGMEFL--ASRKCIHRDLAARNILLSENNVVKICDFGLARD-IYK 226
Query: 185 DNTHV---STRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLA 241
D +V S R+ + APE + T +SDV+SFGV+L E+ S G +
Sbjct: 227 DPDYVRKGSARL--PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS---------LGAS 275
Query: 242 EQTLVEWADPF---LRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPS-- 296
V+ + F L+D R+ + + + ++L C DPK RP+
Sbjct: 276 PYPGVQINEEFCQRLKDGTRM----------RAPENATPEIYRIMLACWQGDPKERPTFS 325
Query: 297 -MVDVLTSLEQ 306
+V++L L Q
Sbjct: 326 ALVEILGDLLQ 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 2e-12
Identities = 65/213 (30%), Positives = 106/213 (49%), Gaps = 32/213 (15%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIK--RLKAESFQGHKEWLTEVIYLGQLRH 86
+GEG +G V+K D+ T +A+K RL+ E + E+ L +++H
Sbjct: 10 IGEGTYGVVYKAR-DRVT--------NETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
Query: 87 ENLVKLIGYCSESDNRL-LVYEFMPKGSLENHL-----FRKGVQPISWPTRVKIAI-DVA 139
N+V+L S+ RL LV+E++ L+ H+ F K P +K + +
Sbjct: 61 GNIVRLQDVV-HSEKRLYLVFEYLDL-DLKKHMDSSPDFAKN------PRLIKTYLYQIL 112
Query: 140 RGLSFLHGLDANVIYRDLKASNVLLDSNFNA-KLSDFGLARDGPTGDNTHVSTRIVGTRG 198
RG+++ H V++RDLK N+L+D NA KL+DFGLAR G T V T
Sbjct: 113 RGIAYCH--SHRVLHRDLKPQNLLIDRRTNALKLADFGLAR--AFGIPVRTFTHEVVTLW 168
Query: 199 YAAPE-YVATGHLTPKSDVYSFGVVLLELLSGR 230
Y APE + + H + D++S G + E+++ +
Sbjct: 169 YRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 2e-12
Identities = 62/206 (30%), Positives = 100/206 (48%), Gaps = 18/206 (8%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLK-AESFQGHKEW-LTEVIYLGQLR 85
++GEG +G V K + + +VAIK+ K +E + KE L E+ L L+
Sbjct: 8 VVGEGAYGVVLKCRHKE---------TKEIVAIKKFKDSEENEEVKETTLRELKMLRTLK 58
Query: 86 HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI-DVARGLSF 144
EN+V+L LV+E++ K LE + + P +V+ I + + + +
Sbjct: 59 QENIVELKEAFRRRGKLYLVFEYVEKNMLE---LLEEMPNGVPPEKVRSYIYQLIKAIHW 115
Query: 145 LHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEY 204
H D +++RD+K N+L+ N KL DFG AR+ G N + T V TR Y +PE
Sbjct: 116 CHKND--IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANY-TEYVATRWYRSPEL 172
Query: 205 VATGHLTPKSDVYSFGVVLLELLSGR 230
+ D++S G +L EL G+
Sbjct: 173 LLGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 66.3 bits (161), Expect = 3e-12
Identities = 73/282 (25%), Positives = 119/282 (42%), Gaps = 42/282 (14%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEW---LTEVIYLGQLR 85
+G G FG V+ FA + VVAIK++ Q +++W + EV +L +++
Sbjct: 33 IGHGSFGAVY--------FARDVRTNE-VVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIK 83
Query: 86 HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFL 145
H N ++ G LV E+ GS + L +P+ I +GL++L
Sbjct: 84 HPNSIEYKGCYLREHTAWLVMEYC-LGSASD-LLEVHKKPLQEVEIAAITHGALQGLAYL 141
Query: 146 HGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYV 205
H N+I+RD+KA N+LL KL+DFG A ++ VGT + APE +
Sbjct: 142 H--SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANS------FVGTPYWMAPEVI 193
Query: 206 AT---GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRI 262
G K DV+S G+ +EL + L A + + P L+
Sbjct: 194 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQ-------- 245
Query: 263 MDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL 304
S + + V CL P++RP+ ++L +
Sbjct: 246 ---------SNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHM 278
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.7 bits (161), Expect = 3e-12
Identities = 68/222 (30%), Positives = 108/222 (48%), Gaps = 38/222 (17%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKE-----WLTEVIYLG 82
+GEG +G V+K +G VA+K+++ +E L E+ L
Sbjct: 6 EIGEGAYGTVYKA---------RDLNTGRFVALKKVR---VPLSEEGIPLSTLREIALLK 53
Query: 83 QLR---HENLVKLIGYC--SESDNRL---LVYEFMPKGSLENHLFRKGVQPISWPTRVK- 133
QL H N+V+L+ C +D L LV+E + + L +L K +P P +K
Sbjct: 54 QLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYL-SKCPKPGLPPETIKD 111
Query: 134 IAIDVARGLSFLHGLDAN-VIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR 192
+ + RG+ FLH ++ +++RDLK N+L+ S+ K++DFGLAR T
Sbjct: 112 LMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLAR---IYSFEMALTS 165
Query: 193 IVGTRGYAAPE-YVATGHLTPKSDVYSFGVVLLELLSGRRAL 233
+V T Y APE + + + TP D++S G + EL RR L
Sbjct: 166 VVVTLWYRAPEVLLQSSYATP-VDMWSVGCIFAELFR-RRPL 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 4e-12
Identities = 49/151 (32%), Positives = 74/151 (49%), Gaps = 6/151 (3%)
Query: 79 IYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDV 138
+ L ++H LV L +D V +++ G L HL R+ + P A ++
Sbjct: 48 VLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRE--RCFLEPRARFYAAEI 105
Query: 139 ARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRG 198
A L +LH L N++YRDLK N+LLDS + L+DFGL ++ + T ++ GT
Sbjct: 106 ASALGYLHSL--NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGT--TSTFCGTPE 161
Query: 199 YAAPEYVATGHLTPKSDVYSFGVVLLELLSG 229
Y APE + D + G VL E+L G
Sbjct: 162 YLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 4e-12
Identities = 73/293 (24%), Positives = 126/293 (43%), Gaps = 35/293 (11%)
Query: 22 NFCSDYLLGEGGFGCVFKG--WIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVI 79
NF + +G G F V++ +D+ A K V + + A++ Q + + E+
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKK-----VQIFEMMDAKARQ---DCVKEID 54
Query: 80 YLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHL--FRKGVQPISWPTRVKIAID 137
L QL H N++K + E + +V E G L + F+K + I T K +
Sbjct: 55 LLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQ 114
Query: 138 VARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR 197
+ + +H V++RD+K +NV + + KL D GL R + T + +VGT
Sbjct: 115 LCSAVEHMH--SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSLVGTP 170
Query: 198 GYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAE--QTLVEWADPFLRD 255
Y +PE + KSD++S G +L E+ + + D+ L Q + + P L
Sbjct: 171 YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLP- 229
Query: 256 SRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLH 308
YS+K + V+ C++ DP RP + V +Q+H
Sbjct: 230 ------------TEHYSEKLRELVS----MCIYPDPDQRPDIGYVHQIAKQMH 266
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 5e-12
Identities = 55/201 (27%), Positives = 98/201 (48%), Gaps = 16/201 (7%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHEN 88
+G+G G V+ ID T G VAIK++ + + + E++ + + ++ N
Sbjct: 27 IGQGASGTVYTA-IDIAT--------GQEVAIKQMNLQQQPKKELIINEILVMRENKNPN 77
Query: 89 LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL 148
+V + D +V E++ GSL + + + + + + L FLH
Sbjct: 78 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDE---GQIAAVCRECLQALDFLH-- 132
Query: 149 DANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG 208
VI+RD+K+ N+LL + + KL+DFG T + + ST +VGT + APE V
Sbjct: 133 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQ-ITPEQSKRST-MVGTPYWMAPEVVTRK 190
Query: 209 HLTPKSDVYSFGVVLLELLSG 229
PK D++S G++ +E++ G
Sbjct: 191 AYGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 5e-12
Identities = 76/293 (25%), Positives = 118/293 (40%), Gaps = 54/293 (18%)
Query: 29 LGEGGFGCVFKG-WIDQNTFAPTKPGSGIVVAIKRLK-----AESFQGHKEWLTEVIYL- 81
LG+G F ++KG Q+ PG + V +K L + +F E L
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFF-------ETASLM 55
Query: 82 GQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQP-ISWPTRVKIAIDVAR 140
QL H++LVKL G C +N ++V E++ G L+ L R+ + W ++ +A +A
Sbjct: 56 SQLSHKHLVKLYGVCVRDEN-IMVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLAS 112
Query: 141 GLSFLHGLDANVIYRDLKASNVLL---DSNFN----AKLSDFGLARDGPTGDNTHVSTRI 193
L +L D +++ ++ N+L+ N KLSD G+ RI
Sbjct: 113 ALHYLE--DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI--TVLSREERVERI 168
Query: 194 VGTRGYAAPEYVATGH--LTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADP 251
+ APE + G LT +D +SFG LLE+ S G TL
Sbjct: 169 ----PWIAPECIRNGQASLTIAADKWSFGTTLLEICS--------NGEEPLSTL------ 210
Query: 252 FLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL 304
S R + + +A ++ QC DP RPS +L L
Sbjct: 211 ---SSSEKERFYQD--QHRLPMPDCAELANLINQCWTYDPTKRPSFRAILRDL 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 6e-12
Identities = 54/219 (24%), Positives = 91/219 (41%), Gaps = 36/219 (16%)
Query: 30 GEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLT---EVIYLGQLRH 86
G G +G V+K G AIK+ K + Q + E+ L +L+H
Sbjct: 9 GRGTYGRVYKAKRK-------NGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61
Query: 87 ENLVKLIGYCSESDNRL--LVYEFMPKGSLE--NHLFRKGVQPISWPTRVKIAIDVARGL 142
EN+V L+ E ++ L++++ + + I + + G+
Sbjct: 62 ENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGV 121
Query: 143 SFLHGLDAN-VIYRDLKASNVLLDSNFNA----KLSDFGLAR--DGP-----TGDNTHVS 190
+LH +N V++RDLK +N+L+ K+ D GLAR + P D
Sbjct: 122 HYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLD----- 173
Query: 191 TRIVGTRGYAAPEYV-ATGHLTPKSDVYSFGVVLLELLS 228
+V T Y APE + H T D+++ G + ELL+
Sbjct: 174 -PVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 7e-12
Identities = 52/167 (31%), Positives = 80/167 (47%), Gaps = 31/167 (18%)
Query: 77 EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 136
E+ L + H N+VK + ++ EFM GSLE
Sbjct: 122 EIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQF----------LA 171
Query: 137 DVAR----GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD-GPTGDNTHVST 191
DVAR G+++LH ++++RD+K SN+L++S N K++DFG++R T D + S
Sbjct: 172 DVARQILSGIAYLH--RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS- 228
Query: 192 RIVGTRGYAAPEYVAT--------GHLTPKSDVYSFGVVLLELLSGR 230
VGT Y +PE + T G+ D++S GV +LE GR
Sbjct: 229 --VGTIAYMSPERINTDLNHGAYDGY---AGDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 8e-12
Identities = 63/198 (31%), Positives = 96/198 (48%), Gaps = 14/198 (7%)
Query: 75 LTEVIYLGQLRHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVK 133
L E L Q+ +V L + +S +L LV F+ G L +HL R+G + +R +
Sbjct: 41 LAERTVLAQVNCPFIVPL-KFSFQSPEKLYLVLAFINGGELFHHLQREGRFDL---SRAR 96
Query: 134 IAI-DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR 192
++ L LH NVIYRDLK N+LLD + L DFGL + D+ +
Sbjct: 97 FYTAELLCALENLHKF--NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDK--TNT 152
Query: 193 IVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL-DEDRGGLAEQTLVE---W 248
GT Y APE + T D ++ GV+L E+L+G DE+ + + L E +
Sbjct: 153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRF 212
Query: 249 ADPFLRDSRRVLRIMDTR 266
D F RD++ +L + +R
Sbjct: 213 PDGFDRDAKDLLIGLLSR 230
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 1e-11
Identities = 63/207 (30%), Positives = 102/207 (49%), Gaps = 23/207 (11%)
Query: 29 LGEGGFGCVFKGW--IDQNTFAPTKPGSGIVVAIKRLKAESFQGHK-EWLTEVIYLGQLR 85
LGEG + VFKG + +N +VA+K ++ E +G + EV L L+
Sbjct: 14 LGEGTYATVFKGRSKLTEN-----------LVALKEIRLEHEEGAPCTAIREVSLLKDLK 62
Query: 86 HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI-DVARGLSF 144
H N+V L + LV+E++ K L+ ++ G I VKI + + RGL++
Sbjct: 63 HANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCG--NIMSMHNVKIFLYQILRGLAY 119
Query: 145 LHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPE- 203
H V++RDLK N+L++ KL+DFGLAR T+ S +V T Y P+
Sbjct: 120 CH--RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTY-SNEVV-TLWYRPPDV 175
Query: 204 YVATGHLTPKSDVYSFGVVLLELLSGR 230
+ + + + D++ G + E+ SGR
Sbjct: 176 LLGSSEYSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 1e-11
Identities = 43/158 (27%), Positives = 67/158 (42%), Gaps = 5/158 (3%)
Query: 76 TEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIA 135
E+ L + H ++ LI + V MPK + + P+ + I
Sbjct: 135 REIDILKTISHRAIINLIHAYR---WKSTVCMVMPKYKCDLFTYVDRSGPLPLEQAITIQ 191
Query: 136 IDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVG 195
+ L++LHG +I+RD+K N+ LD NA L DFG A +T G
Sbjct: 192 RRLLEALAYLHG--RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSG 249
Query: 196 TRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL 233
T +PE +A K+D++S G+VL E+ L
Sbjct: 250 TLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 1e-11
Identities = 63/215 (29%), Positives = 104/215 (48%), Gaps = 32/215 (14%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAE----SFQGHKEWLTEVIYLGQL 84
LG+G +G V+K +P +G+ +A+K ++ E F + E+ L +
Sbjct: 9 LGKGNYGSVYK--------VLHRP-TGVTMAMKEIRLELDESKFNQ---IIMELDILHKA 56
Query: 85 RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRV--KIAIDVARGL 142
+V G + E+M GSL+ L+ GV P V +I V +GL
Sbjct: 57 VSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGL 115
Query: 143 SFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGD-NTHVSTRIVGTRGYAA 201
FL + N+I+RD+K +NVL++ N KL DFG+ +G+ ++ +G + Y A
Sbjct: 116 KFLKE-EHNIIHRDVKPTNVLVNGNGQVKLCDFGV-----SGNLVASLAKTNIGCQSYMA 169
Query: 202 PEYVATGHL------TPKSDVYSFGVVLLELLSGR 230
PE + +G T +SDV+S G+ +LE+ GR
Sbjct: 170 PERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGR 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 1e-11
Identities = 64/206 (31%), Positives = 101/206 (49%), Gaps = 21/206 (10%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHK-EWLTEVIYLGQLRHE 87
LGEG + VFKG + +VA+K ++ E +G + EV L L+H
Sbjct: 13 LGEGTYATVFKG---------RSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHA 63
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI-DVARGLSFLH 146
N+V L LV+E++ L+ +L G + VKI + + RGLS+ H
Sbjct: 64 NIVTLHDIIHTERCLTLVFEYL-DSDLKQYLDNCG--NLMSMHNVKIFMFQLLRGLSYCH 120
Query: 147 GLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYV- 205
+++RDLK N+L++ KL+DFGLAR T+ S +V T Y P+ +
Sbjct: 121 --KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTY-SNEVV-TLWYRPPDVLL 176
Query: 206 -ATGHLTPKSDVYSFGVVLLELLSGR 230
+T + TP D++ G +L E+ +GR
Sbjct: 177 GSTEYSTP-IDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 1e-11
Identities = 53/212 (25%), Positives = 97/212 (45%), Gaps = 23/212 (10%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHEN 88
+GEG FG K + ++ + G V+ + S + +E EV L ++H N
Sbjct: 8 IGEGSFG---KAILVKSK----EDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPN 60
Query: 89 LVKLIGYCSESDNRLLVYEFMPKGSLENHL-FRKGV-----QPISWPTRVKIAIDVARGL 142
+V+ E+ N +V ++ G L + ++GV Q + W ++ +A+
Sbjct: 61 IVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALK----- 115
Query: 143 SFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAP 202
H D +++RD+K+ N+ L + KL DFG+AR ++ +GT Y +P
Sbjct: 116 ---HVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIAR--VLNSTVELARTCIGTPYYLSP 170
Query: 203 EYVATGHLTPKSDVYSFGVVLLELLSGRRALD 234
E KSD+++ G VL E+ + + A +
Sbjct: 171 EICENRPYNNKSDIWALGCVLYEMCTLKHAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 58/206 (28%), Positives = 98/206 (47%), Gaps = 26/206 (12%)
Query: 106 YEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLD 165
Y+ ++N L G + ++ + VARG+ FL N ++RDL A NVLL
Sbjct: 214 YKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFL--ASKNCVHRDLAARNVLLA 271
Query: 166 SNFNAKLSDFGLARDGPTGDNTHVS--TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVL 223
K+ DFGLARD D+ +VS + + + + APE + T SDV+S+G++L
Sbjct: 272 QGKIVKICDFGLARD-IMHDSNYVSKGSTFLPVK-WMAPESIFDNLYTTLSDVWSYGILL 329
Query: 224 LELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKE--AQAVAA 281
E+ S GG ++ DS +I + G + +K + Q V
Sbjct: 330 WEIFS--------LGGTPYPGMIV-------DSTFYNKI---KSGYRMAKPDHATQEVYD 371
Query: 282 VVLQCLHMDPKNRPSMVDVLTSLEQL 307
++++C + +P+ RPS + + +E L
Sbjct: 372 IMVKCWNSEPEKRPSFLHLSDIVESL 397
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 64.4 bits (156), Expect = 1e-11
Identities = 50/202 (24%), Positives = 95/202 (47%), Gaps = 18/202 (8%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHEN 88
+G+G G V+ +G VAI+++ + + + E++ + + ++ N
Sbjct: 28 IGQGASGTVYTA---------MDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 89 LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL 148
+V + D +V E++ GSL + + + + + + L FLH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDE---GQIAAVCRECLQALEFLH-- 133
Query: 149 DANVIYRDLKASNVLLDSNFNAKLSDFGL-ARDGPTGDNTHVSTRIVGTRGYAAPEYVAT 207
VI+RD+K+ N+LL + + KL+DFG A+ P + +VGT + APE V
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAPEVVTR 190
Query: 208 GHLTPKSDVYSFGVVLLELLSG 229
PK D++S G++ +E++ G
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 2e-11
Identities = 38/109 (34%), Positives = 56/109 (51%), Gaps = 2/109 (1%)
Query: 120 RKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR 179
+ P+ ++ + VA+G+ FL N I+RD+ A NVLL AK+ DFGLAR
Sbjct: 203 TEDSWPLDLDDLLRFSSQVAQGMDFLAS--KNCIHRDVAARNVLLTDGRVAKICDFGLAR 260
Query: 180 DGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 228
D N V + APE + T +SDV+S+G++L E+ S
Sbjct: 261 DIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 309
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 2e-11
Identities = 74/283 (26%), Positives = 124/283 (43%), Gaps = 51/283 (18%)
Query: 29 LGEGGFGCVFKG----WIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQL 84
LG+G F +FKG D T+ ++ R +ESF + QL
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESF------FEAASMMSQL 56
Query: 85 RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFR-KGVQPISWPTRVKIAIDVARGLS 143
H++LV G C D ++V E++ GSL+ +L + K + ISW ++++A +A L
Sbjct: 57 SHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALH 114
Query: 144 FLHGLDANVIYRDLKASNVLLDSNFNA--------KLSDFGLARDGPTGDNTHVSTRIVG 195
FL D + + ++ A NVLL + KLSD G++ T + I+
Sbjct: 115 FLE--DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI-------TVLPKEILL 165
Query: 196 TR-GYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 253
R + PE + +L+ +D +SFG L E+ SG ++ L
Sbjct: 166 ERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSG-----------GDKPLS------A 208
Query: 254 RDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPS 296
DS++ L+ + R Q + +A ++ QC+ +P RPS
Sbjct: 209 LDSQKKLQFYEDRH--QLPAPKWTELANLINQCMDYEPDFRPS 249
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 2e-11
Identities = 63/220 (28%), Positives = 101/220 (45%), Gaps = 32/220 (14%)
Query: 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGH---KEWLTE 77
+ + S +G G +G V ID+ T G VAIK+L + FQ K E
Sbjct: 15 ERYTSLKQVGSGAYGSVCSA-IDKRT--------GEKVAIKKL-SRPFQSEIFAKRAYRE 64
Query: 78 VIYLGQLRHENLVKLIG-YCSES--DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 134
+ L ++HEN++ L+ + S D Y MP ++ L + P+S +
Sbjct: 65 LTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMP--YMQTDLQKIMGHPLSEDKVQYL 122
Query: 135 AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 194
+ GL ++H A +I+RDLK N+ ++ + K+ DFGLAR H +
Sbjct: 123 VYQMLCGLKYIHS--AGIIHRDLKPGNLAVNEDCELKILDFGLAR--------HADAEMT 172
Query: 195 G---TRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGR 230
G TR Y APE + H D++S G ++ E+L+G+
Sbjct: 173 GYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 3e-11
Identities = 62/219 (28%), Positives = 99/219 (45%), Gaps = 45/219 (20%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGH---KEWLTEVIYLGQLR 85
+G G +G V +D+ T G VAIK+L FQ K E+ L ++
Sbjct: 23 VGSGAYGTVCSA-LDRRT--------GAKVAIKKLY-RPFQSELFAKRAYRELRLLKHMK 72
Query: 86 HENLVKLIGYCSESDNR------LLVYEFMPK--GSLENH--LFRKGVQPISWPTRVKIA 135
HEN++ L+ + + LV FM G L H L +Q + +
Sbjct: 73 HENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVY------- 125
Query: 136 IDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVG 195
+ +GL ++H A +I+RDLK N+ ++ + K+ DFGLAR + + G
Sbjct: 126 -QMLKGLKYIHA--AGIIHRDLKPGNLAVNEDCELKILDFGLAR--------QTDSEMTG 174
Query: 196 ---TRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGR 230
TR Y APE + H T D++S G ++ E+L+G+
Sbjct: 175 YVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 3e-11
Identities = 64/230 (27%), Positives = 99/230 (43%), Gaps = 43/230 (18%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQG--------------HKEW 74
LGEG +G V K D T G +VAIK++K H
Sbjct: 17 LGEGTYGKVEKA-YDTLT--------GKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTT 67
Query: 75 LTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVK- 133
L E+ + +++HEN++ L+ E D LV + M L+ + RK S +VK
Sbjct: 68 LRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDRKIRLTES---QVKC 123
Query: 134 IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR-------DGPTGDN 186
I + + GL+ LH ++RDL +N+ ++S K++DFGLAR +
Sbjct: 124 ILLQILNGLNVLH--KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKD 181
Query: 187 THVSTRI-----VGTRGYAAPEYV-ATGHLTPKSDVYSFGVVLLELLSGR 230
+ R V T Y APE + D++S G + ELL+G+
Sbjct: 182 ETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 4e-11
Identities = 37/91 (40%), Positives = 50/91 (54%), Gaps = 2/91 (2%)
Query: 138 VARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR 197
VA+G+SFL N I+RDL A N+LL K+ DFGLARD N V
Sbjct: 223 VAKGMSFL--ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPV 280
Query: 198 GYAAPEYVATGHLTPKSDVYSFGVVLLELLS 228
+ APE + T +SDV+S+G++L E+ S
Sbjct: 281 KWMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 5e-11
Identities = 57/212 (26%), Positives = 99/212 (46%), Gaps = 25/212 (11%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKA------ESFQGHKEWLTEVIYL 81
+LG G +G VF T +G + A+K L+ H TE L
Sbjct: 7 VLGTGAYGKVFL------VRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTR--TERNVL 58
Query: 82 GQLRHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI-DVA 139
+R + + Y +++ +L L+ +++ G + HL+++ S V+ ++
Sbjct: 59 EHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQR--DNFS-EDEVRFYSGEII 115
Query: 140 RGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGY 199
L LH L ++YRD+K N+LLDS + L+DFGL+++ + + + GT Y
Sbjct: 116 LALEHLHKL--GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYS-FCGTIEY 172
Query: 200 AAPEYV--ATGHLTPKSDVYSFGVVLLELLSG 229
APE + GH D +S G+++ ELL+G
Sbjct: 173 MAPEIIRGKGGH-GKAVDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 5e-11
Identities = 54/201 (26%), Positives = 91/201 (45%), Gaps = 18/201 (8%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHEN 88
+G G +G V+K +N +G + AIK +K E + E+I + +H N
Sbjct: 17 IGSGTYGDVYKA---RNV------NTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSN 67
Query: 89 LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL 148
+V G D + EF GSL++ G P+S ++ + +GL +LH
Sbjct: 68 IVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTG--PLSESQIAYVSRETLQGLYYLH-- 123
Query: 149 DANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT- 207
++RD+K +N+LL N + KL+DFG++ +GT + APE A
Sbjct: 124 SKGKMHRDIKGANILLTDNGHVKLADFGVS--AQITATIAKRKSFIGTPYWMAPEVAAVE 181
Query: 208 --GHLTPKSDVYSFGVVLLEL 226
G D+++ G+ +EL
Sbjct: 182 RKGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 6e-11
Identities = 55/176 (31%), Positives = 81/176 (46%), Gaps = 24/176 (13%)
Query: 135 AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 194
+ VA+G+ FL I+RDL A N+LL N K+ DFGLARD D +V R
Sbjct: 185 SFQVAKGMEFL--ASRKCIHRDLAARNILLSENNVVKICDFGLARD-IYKDPDYV--RKG 239
Query: 195 GTR---GYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADP 251
R + APE + T +SDV+SFGV+L E+ S G + V+ +
Sbjct: 240 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS---------LGASPYPGVKIDEE 290
Query: 252 FLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 307
F R + R+ Y+ E + +L C H +P RP+ +++ L L
Sbjct: 291 FCRRLKEGTRMR----APDYTTPE---MYQTMLDCWHGEPSQRPTFSELVEHLGNL 339
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 1e-10
Identities = 54/184 (29%), Positives = 87/184 (47%), Gaps = 20/184 (10%)
Query: 55 GIVVAIKRLKAESFQGH---KEWLTEVIYLGQLRHENLVKLIGYCS------ESDNRLLV 105
GI VA+K+L + FQ K E++ L + H+N++ L+ + E + LV
Sbjct: 46 GINVAVKKL-SRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLV 104
Query: 106 YEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLD 165
E M + + +S+ + + G+ LH A +I+RDLK SN+++
Sbjct: 105 MELMDANLCQVIHMELDHERMSY-----LLYQMLCGIKHLH--SAGIIHRDLKPSNIVVK 157
Query: 166 SNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLE 225
S+ K+ DFGLAR T + T V TR Y APE + D++S G ++ E
Sbjct: 158 SDCTLKILDFGLAR---TACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 214
Query: 226 LLSG 229
L+ G
Sbjct: 215 LVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 1e-10
Identities = 44/129 (34%), Positives = 66/129 (51%), Gaps = 11/129 (8%)
Query: 104 LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI-DVARGLSFLHGLDANVIYRDLKASNV 162
LV ++M G L HL ++G R K I ++ L LH +++YRDLK N+
Sbjct: 73 LVTDYMSGGELFWHLQKEGRFS---EDRAKFYIAELVLALEHLH--KYDIVYRDLKPENI 127
Query: 163 LLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYV--ATGHLTPKSDVYSFG 220
LLD+ + L DFGL++ T + T + GT Y APE + G+ T D +S G
Sbjct: 128 LLDATGHIALCDFGLSKANLTDNKT--TNTFCGTTEYLAPEVLLDEKGY-TKHVDFWSLG 184
Query: 221 VVLLELLSG 229
V++ E+ G
Sbjct: 185 VLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.5 bits (150), Expect = 1e-10
Identities = 55/194 (28%), Positives = 77/194 (39%), Gaps = 51/194 (26%)
Query: 75 LTEVIYLGQLRHENLVKLIGYCS--ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRV 132
LTE L L H L L Y S LV ++ P G L L ++ QP
Sbjct: 49 LTEQEILATLDHPFLPTL--YASFQTETYLCLVMDYCPGGEL-FRLLQR--QPGK----- 98
Query: 133 KIAIDVAR--------GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL------- 177
++ +VAR L +LH L ++YRDLK N+LL + + LSDF L
Sbjct: 99 CLSEEVARFYAAEVLLALEYLHLL--GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVE 156
Query: 178 -------ARDGPTGDNTHVSTR-------------IVGTRGYAAPEYVA-TGHLTPKSDV 216
R G + + VGT Y APE ++ GH D
Sbjct: 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH-GSAVDW 215
Query: 217 YSFGVVLLELLSGR 230
++ G++L E+L G
Sbjct: 216 WTLGILLYEMLYGT 229
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 1e-10
Identities = 57/214 (26%), Positives = 93/214 (43%), Gaps = 29/214 (13%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAE-SFQGHKEWLTEVIYLGQLRHE 87
+G G FG V I +T V +K LKA S + E+L + L+H
Sbjct: 3 IGNGWFGKVLLSEIYTDT-------GVARVVVKELKANASSKEQNEFLQQGDPYRILQHP 55
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTR-------VKIAIDVAR 140
N+++ +G C E+ LLV+E+ G L+++L ++ W R ++A ++A
Sbjct: 56 NILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQE-----QWHRRNSQLLLLQRMACEIAA 110
Query: 141 GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYA 200
G++ +H N ++ DL N L S+ K+ D+G+ D +
Sbjct: 111 GVTHMHKH--NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWL 168
Query: 201 APEYVATGH-------LTPKSDVYSFGVVLLELL 227
APE V H T S+V++ GV L EL
Sbjct: 169 APELVGEFHGGLITAEQTKPSNVWALGVTLWELF 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 1e-10
Identities = 55/227 (24%), Positives = 99/227 (43%), Gaps = 25/227 (11%)
Query: 77 EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHL--FRKGVQPISWPTRVKI 134
E L +L H +VK E D ++ E+ L+ L + + +S +
Sbjct: 52 EAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEW 111
Query: 135 AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 194
I + G+ ++H +++RDLKA N+ L +N K+ DFG++R + ++T
Sbjct: 112 FIQLLLGVHYMH--QRRILHRDLKAKNIFLKNNL-LKIGDFGVSR--LLMGSCDLATTFT 166
Query: 195 GTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLR 254
GT Y +PE + KSD++S G +L E+ A + +VE P L
Sbjct: 167 GTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLP 226
Query: 255 DSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL 301
++ YS++ + +++ L+ DP RPS ++L
Sbjct: 227 ET--------------YSRQ----LNSIMQSMLNKDPSLRPSAAEIL 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 2e-10
Identities = 61/217 (28%), Positives = 88/217 (40%), Gaps = 20/217 (9%)
Query: 16 SKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEW- 74
+K+ ++F LG G FG V F P VAIKR + K+
Sbjct: 25 NKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPP--------VAIKRFEKSKIIKQKQVD 76
Query: 75 --LTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRV 132
+E L + H V L G + LV EF+ G L R +P V
Sbjct: 77 HVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNK----RFPNDV 132
Query: 133 KIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR 192
L F + N++YRDLK N+LLD + K++DFG A+ T T
Sbjct: 133 GCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYT----- 187
Query: 193 IVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSG 229
+ GT Y APE + +D ++ G+ + E+L G
Sbjct: 188 LCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 2e-10
Identities = 61/248 (24%), Positives = 96/248 (38%), Gaps = 50/248 (20%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLK---AESFQGHKEWLTEVIYLGQL 84
L+G+GG G V+ + P VA+K+++ +E+ K +L E L
Sbjct: 9 LIGKGGMGEVYLAY---------DPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADL 59
Query: 85 RHENLVKLIGYCSESDNRLLVYEFMP--KGSLENHLFRKGVQPISWPTRVKIAIDVARGL 142
H +V + CS+ D VY MP +G L + Q S + V L
Sbjct: 60 IHPGIVPVYSICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFL 116
Query: 143 SFLHGLDANVIY--------RDLKASNVLLDSNFNAKLSDFGLA---------------- 178
S H + A + Y RDLK N+LL + D+G A
Sbjct: 117 SIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVD 176
Query: 179 RDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS---------G 229
+ + +IVGT Y APE + + +D+Y+ GV+L ++L+ G
Sbjct: 177 ERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKG 236
Query: 230 RRALDEDR 237
R+ D
Sbjct: 237 RKISYRDV 244
|
Length = 932 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 3e-10
Identities = 66/279 (23%), Positives = 121/279 (43%), Gaps = 38/279 (13%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLK-AESFQGHKEWLTEVIYLGQLRH 86
++GEG FG + + Q+ + K A+K ++ +S ++ E + L +++H
Sbjct: 7 VVGEGSFG---RALLVQHVNSDQK------YAMKEIRLPKSSSAVEDSRKEAVLLAKMKH 57
Query: 87 ENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFL 145
N+V E+D L +V E+ G L + + + T ++ + + G+ +
Sbjct: 58 PNIVAF-KESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHI 116
Query: 146 HGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR--DGPTGDNTHVSTRIVGTRGYAAPE 203
H + V++RD+K+ N+ L N KL DFG AR P + VGT Y PE
Sbjct: 117 H--EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA----YACTYVGTPYYVPPE 170
Query: 204 YVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIM 263
KSD++S G +L EL + + + W + L +V +
Sbjct: 171 IWENMPYNNKSDIWSLGCILYELCTLKHPFQAN----------SWKNLIL----KVCQGS 216
Query: 264 DTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLT 302
L YS + + +++ Q +P++RPS +L+
Sbjct: 217 YKPLPSHYSYE----LRSLIKQMFKRNPRSRPSATTILS 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 4e-10
Identities = 63/211 (29%), Positives = 99/211 (46%), Gaps = 29/211 (13%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLT--EVIYLGQLR- 85
+G G +G V+K P SG VA+K ++ ++ + T EV L +L
Sbjct: 8 IGVGAYGTVYKA---------RDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEA 58
Query: 86 --HENLVKLIGYC--SESDNRL---LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDV 138
H N+V+L+ C S +D LV+E + + L +L + + T +
Sbjct: 59 FDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQF 117
Query: 139 ARGLSFLHGLDAN-VIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS-TRIVGT 196
RGL FLH AN +++RDLK N+L+ S KL+DFGLAR + ++ T +V T
Sbjct: 118 LRGLDFLH---ANCIVHRDLKPENILVTSGGQVKLADFGLARIY----SCQMALTPVVVT 170
Query: 197 RGYAAPEYVATGHLTPKSDVYSFGVVLLELL 227
Y APE + D++S G + E+
Sbjct: 171 LWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 6e-10
Identities = 59/241 (24%), Positives = 105/241 (43%), Gaps = 25/241 (10%)
Query: 63 LKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRK 121
L+ S + K E L QL+H N+V D L +V F G L + L +
Sbjct: 35 LRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQ 94
Query: 122 GVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDG 181
+ + V+ + +A L +LH + ++++RDLK NV L K+ D G+AR
Sbjct: 95 KGKLLPENQVVEWFVQIAMALQYLH--EKHILHRDLKTQNVFLTRTNIIKVGDLGIAR-- 150
Query: 182 PTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALD-EDRGGL 240
+ +++ ++GT Y +PE + KSDV++ G + E+ + + A + +D L
Sbjct: 151 VLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSL 210
Query: 241 AEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDV 300
V RI++ +L K + + ++ L P+ RPS+ +
Sbjct: 211 ------------------VYRIIEGKL-PPMPKDYSPELGELIATMLSKRPEKRPSVKSI 251
Query: 301 L 301
L
Sbjct: 252 L 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 7e-10
Identities = 48/193 (24%), Positives = 84/193 (43%), Gaps = 19/193 (9%)
Query: 47 FAPTKPGSGIVVAIKRLKAESFQGHK-EWLTEVIYLGQLRHENLVKLIGYCSESDNRLLV 105
F TKPG V +K G K L E + L + H +++++ +V
Sbjct: 83 FVATKPGQPDPVVLK-------IGQKGTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMV 135
Query: 106 YEFMP--KGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVL 163
+P L +L ++ +P+ + I + GL +LH +I+RD+K N+
Sbjct: 136 ---LPHYSSDLYTYLTKR-SRPLPIDQALIIEKQILEGLRYLHAQ--RIIHRDVKTENIF 189
Query: 164 LDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVL 223
++ + D G A+ P + + GT APE +A K+D++S G+VL
Sbjct: 190 INDVDQVCIGDLGAAQ-FPVVAPAFLG--LAGTVETNAPEVLARDKYNSKADIWSAGIVL 246
Query: 224 LELLSGRRALDED 236
E+L+ + ED
Sbjct: 247 FEMLAYPSTIFED 259
|
Length = 357 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 8e-10
Identities = 54/182 (29%), Positives = 89/182 (48%), Gaps = 20/182 (10%)
Query: 58 VAIKRLKA--ESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSES------DNRLLVYEFM 109
VA+K+L +S + E+ L ++HEN++ L+ + + + LV M
Sbjct: 43 VAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLM 102
Query: 110 PKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFN 169
G+ N++ + Q +S + + RGL ++H A +I+RDLK SNV ++ +
Sbjct: 103 --GADLNNIVK--CQKLSDEHVQFLIYQLLRGLKYIH--SAGIIHRDLKPSNVAVNEDCE 156
Query: 170 AKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLS 228
++ DFGLAR D T V TR Y APE + H D++S G ++ ELL
Sbjct: 157 LRILDFGLARQ--ADDEM---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLK 211
Query: 229 GR 230
G+
Sbjct: 212 GK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 9e-10
Identities = 58/204 (28%), Positives = 97/204 (47%), Gaps = 17/204 (8%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHK-EWLTEVIYLGQLRHE 87
LGEG + V+KG + +VA+K ++ E +G + EV L L+H
Sbjct: 14 LGEGTYATVYKG---------RSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHA 64
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHG 147
N+V L + LV+E++ K L+ +L G I+ + RGL++ H
Sbjct: 65 NIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCG-NSINMHNVKLFLFQLLRGLNYCH- 121
Query: 148 LDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPE-YVA 206
V++RDLK N+L++ KL+DFGLAR T+ S +V T Y P+ +
Sbjct: 122 -RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY-SNEVV-TLWYRPPDILLG 178
Query: 207 TGHLTPKSDVYSFGVVLLELLSGR 230
+ + + D++ G + E+ +GR
Sbjct: 179 STDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 1e-09
Identities = 46/142 (32%), Positives = 70/142 (49%), Gaps = 14/142 (9%)
Query: 95 YCSESDNRLL--VYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANV 152
+ + D++ L V E+MP G L N + + P W R A +V L +H +
Sbjct: 109 HYAFQDDKYLYMVMEYMPGGDLVNLMSNYDI-PEKW-ARFYTA-EVVLALDAIHSM--GF 163
Query: 153 IYRDLKASNVLLDSNFNAKLSDFGLA-RDGPTGDNTHVSTRIVGTRGYAAPEYVAT---- 207
I+RD+K N+LLD + + KL+DFG + G T VGT Y +PE + +
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANG-MVRCDT-AVGTPDYISPEVLKSQGGD 221
Query: 208 GHLTPKSDVYSFGVVLLELLSG 229
G+ + D +S GV L E+L G
Sbjct: 222 GYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 2e-09
Identities = 33/90 (36%), Positives = 50/90 (55%), Gaps = 5/90 (5%)
Query: 141 GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYA 200
G+ LH A +I+RDLK SN+++ S+ K+ DFGLAR T + + T V TR Y
Sbjct: 130 GIKHLH--SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYR 184
Query: 201 APEYVATGHLTPKSDVYSFGVVLLELLSGR 230
APE + D++S G ++ E++ G
Sbjct: 185 APEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 2e-09
Identities = 45/141 (31%), Positives = 68/141 (48%), Gaps = 12/141 (8%)
Query: 95 YCSESDNRLL--VYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANV 152
+C+ D++ L V E+MP G L N + V P W +V L +H + +
Sbjct: 109 FCAFQDDKYLYMVMEYMPGGDLVNLMSNYDV-PEKWAKFY--TAEVVLALDAIHSM--GL 163
Query: 153 IYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT----G 208
I+RD+K N+LLD + + KL+DFG T VGT Y +PE + + G
Sbjct: 164 IHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDT-AVGTPDYISPEVLKSQGGDG 222
Query: 209 HLTPKSDVYSFGVVLLELLSG 229
+ + D +S GV L E+L G
Sbjct: 223 YYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 3e-09
Identities = 80/299 (26%), Positives = 132/299 (44%), Gaps = 51/299 (17%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHK-EWLTEVIYLGQLRHE 87
LGEG + V+KG N G +VA+K + ++ +G + E L L+H
Sbjct: 13 LGEGSYATVYKGISRIN---------GQLVALKVISMKTEEGVPFTAIREASLLKGLKHA 63
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRK--GVQPISWPTRVKIAIDVARGLSFL 145
N+V L + V+E+M L ++ + G+ P + R+ + RGL+++
Sbjct: 64 NIVLLHDIIHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYN--VRL-FMFQLLRGLAYI 119
Query: 146 HGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYV 205
HG ++++RDLK N+L+ KL+DFGLAR T+ S V T Y P+ +
Sbjct: 120 HG--QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSE--VVTLWYRPPDVL 175
Query: 206 --ATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWA-------------- 249
AT + + D++ G + +E+L G+ A + EQ W
Sbjct: 176 LGATDYSS-ALDIWGAGCIFIEMLQGQPAF-PGVSDVFEQLEKIWTVLGVPTEDTWPGVS 233
Query: 250 -------DPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL 301
+ FL + LR++ RL +A+ +A+ Q L M PK+R S D L
Sbjct: 234 KLPNYKPEWFLPCKPQQLRVVWKRLSRPP---KAEDLAS---QMLMMFPKDRISAQDAL 286
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 3e-09
Identities = 48/170 (28%), Positives = 74/170 (43%), Gaps = 24/170 (14%)
Query: 73 EWLTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRV 132
W+ ++ Y Q + DN LV E+ P G L + L R Q +
Sbjct: 61 PWIPQLQYAFQ--------------DKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQF 106
Query: 133 KIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR 192
+A ++ + +H + ++RD+K NVL+D + KL+DFG A T + S
Sbjct: 107 YLA-ELVLAIHSVHQM--GYVHRDIKPENVLIDRTGHIKLADFGSAA-RLTANKMVNSKL 162
Query: 193 IVGTRGYAAPEYVATGHLTPKS------DVYSFGVVLLELLSGRRALDED 236
VGT Y APE + T + K D +S GV+ E++ GR E
Sbjct: 163 PVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEG 212
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 4e-09
Identities = 56/216 (25%), Positives = 99/216 (45%), Gaps = 24/216 (11%)
Query: 29 LGEGGFG----CVFKGWIDQ-------NTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTE 77
L G FG C + ++ N+ KP ++A KR+KA S + + E
Sbjct: 156 LPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIA-KRVKAGS-RAAIQLENE 213
Query: 78 VIYLGQLRHENLVKLIGYCSESDNRLLV---YEFMPKGSLENHLFRKGVQPISWPTRVKI 134
++ LG+L HEN++K+ N ++ Y+F + + F +P+ TR I
Sbjct: 214 ILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTR-AI 272
Query: 135 AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRI- 193
+ + ++H D +I+RD+K N+ L+ + L DFG A + +
Sbjct: 273 MKQLLCAVEYIH--DKKLIHRDIKLENIFLNCDGKIVLGDFGTAM---PFEKEREAFDYG 327
Query: 194 -VGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 228
VGT +PE +A +D++S G++LL++LS
Sbjct: 328 WVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 4e-09
Identities = 58/211 (27%), Positives = 100/211 (47%), Gaps = 25/211 (11%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHK-EWLTEVIYLGQLRHE 87
LGEG + V+KG N G +VA+K ++ + +G + E L L+H
Sbjct: 13 LGEGSYATVYKGKSKVN---------GKLVALKVIRLQEEEGTPFTAIREASLLKGLKHA 63
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKG---SLENHLFRKGVQPISWPTRVKIAI-DVARGLS 143
N+V L + LV+E++ ++ H G+ P VK+ + + RGLS
Sbjct: 64 NIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKH--PGGLHP----ENVKLFLFQLLRGLS 117
Query: 144 FLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPE 203
++H +++RDLK N+L+ KL+DFGLAR +T+ S +V T Y P+
Sbjct: 118 YIH--QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTY-SNEVV-TLWYRPPD 173
Query: 204 -YVATGHLTPKSDVYSFGVVLLELLSGRRAL 233
+ + + D++ G + +E++ G A
Sbjct: 174 VLLGSTEYSTCLDMWGVGCIFVEMIQGVAAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 4e-09
Identities = 61/232 (26%), Positives = 94/232 (40%), Gaps = 77/232 (33%)
Query: 54 SGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHEN-------------LVKLIGYCSESD 100
+G + A+K+L+ +E++ Q+ H +VKL Y S D
Sbjct: 25 TGHIYAMKKLRK----------SEMLEKEQVAHVRAERDILAEADNPWVVKL--YYSFQD 72
Query: 101 NR--LLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLK 158
L+ E++P G + L +K TR IA + + +H L I+RD+K
Sbjct: 73 ENYLYLIMEYLPGGDMMTLLMKKDTFTEE-ETRFYIA-ETILAIDSIHKL--GYIHRDIK 128
Query: 159 ASNVLLDSNFNAKLSDFGLARDGPTG-DNTHVST--RI---------------------- 193
N+LLD+ + KLSDFGL TG +H + RI
Sbjct: 129 PDNLLLDAKGHIKLSDFGLC----TGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRK 184
Query: 194 ---------------VGTRGYAAPE-YVATGHLTPKSDVYSFGVVLLELLSG 229
VGT Y APE ++ TG+ + D +S GV++ E+L G
Sbjct: 185 AETWKRNRRALAYSTVGTPDYIAPEVFLQTGY-NKECDWWSLGVIMYEMLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 4e-09
Identities = 59/208 (28%), Positives = 100/208 (48%), Gaps = 25/208 (12%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHK-EWLTEVIYLGQLRHE 87
LGEG + V+KG G +VA+K ++ E +G + E L L+H
Sbjct: 13 LGEGSYATVYKGRSKLT---------GQLVALKEIRLEHEEGAPFTAIREASLLKDLKHA 63
Query: 88 NLVKL--IGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI-DVARGLSF 144
N+V L I + ++ LV+E++ L+ ++ G V++ + + RGL++
Sbjct: 64 NIVTLHDIIHTKKTLT--LVFEYLDT-DLKQYMDDCG--GGLSMHNVRLFLFQLLRGLAY 118
Query: 145 LHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEY 204
H V++RDLK N+L+ KL+DFGLAR T+ S +V T Y P+
Sbjct: 119 CH--QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTY-SNEVV-TLWYRPPDV 174
Query: 205 V--ATGHLTPKSDVYSFGVVLLELLSGR 230
+ +T + T D++ G + E+ +GR
Sbjct: 175 LLGSTEYSTS-LDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 5e-09
Identities = 55/216 (25%), Positives = 93/216 (43%), Gaps = 22/216 (10%)
Query: 18 IATKNFCSDYLL----GEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKE 73
I +N DY L G G +G V+K +G + A+K +K E
Sbjct: 2 ILRRNPQHDYELIQRVGSGTYGDVYKA---------RNLHTGELAAVKIIKLEPGDDFSL 52
Query: 74 WLTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVK 133
E+ + + +H N+V G + + E+ GSL++ G P+S
Sbjct: 53 IQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTG--PLSELQIAY 110
Query: 134 IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRI 193
+ + +GL++LH ++RD+K +N+LL N + KL+DFG+A
Sbjct: 111 VCRETLQGLAYLH--SKGKMHRDIKGANILLTDNGDVKLADFGVA--AKITATIAKRKSF 166
Query: 194 VGTRGYAAPEYVA---TGHLTPKSDVYSFGVVLLEL 226
+GT + APE A G D+++ G+ +EL
Sbjct: 167 IGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 5e-09
Identities = 47/144 (32%), Positives = 70/144 (48%), Gaps = 28/144 (19%)
Query: 100 DNRLL--VYEFMPKGSLENHLFRKGVQPISWP----TRVKIAIDVARGLSFLHGLDANVI 153
D+R L V E+MP G L N + V P W V +A+D + F+H
Sbjct: 114 DDRYLYMVMEYMPGGDLVNLMSNYDV-PEKWARFYTAEVVLALDAIHSMGFIH------- 165
Query: 154 YRDLKASNVLLDSNFNAKLSDFG----LARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-- 207
RD+K N+LLD + + KL+DFG + ++G +T VGT Y +PE + +
Sbjct: 166 -RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT-----AVGTPDYISPEVLKSQG 219
Query: 208 --GHLTPKSDVYSFGVVLLELLSG 229
G+ + D +S GV L E+L G
Sbjct: 220 GDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 6e-09
Identities = 60/217 (27%), Positives = 99/217 (45%), Gaps = 33/217 (15%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIK--RLKAESFQGHKEWLTEVIYLGQLRH 86
+GEG +G V+K D+NT G +VA+K RL+ + L E+ L L
Sbjct: 9 IGEGTYGKVYKA-RDKNT--------GKLVALKKTRLEMDEEGIPPTALREISLLQMLSE 59
Query: 87 EN-LVKLIGYCSESDNR-----LLVYEFMP---KGSLENHLFRKGVQPISWPTRVKIAID 137
+V+L+ + LV+E++ K ++++ R +P+ T
Sbjct: 60 SIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSN-GRGPGRPLPAKTIKSFMYQ 118
Query: 138 VARGLSFLHGLDANVIYRDLKASNVLLDSNFNA-KLSDFGLARDG--PTGDNTHVSTRIV 194
+ +G++ H V++RDLK N+L+D K++D GL R P TH IV
Sbjct: 119 LLKGVAHCHKH--GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTH---EIV 173
Query: 195 GTRGYAAPEYV--ATGHLTPKSDVYSFGVVLLELLSG 229
T Y APE + +T + TP D++S G + E+
Sbjct: 174 -TLWYRAPEVLLGSTHYSTP-VDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 8e-09
Identities = 48/185 (25%), Positives = 88/185 (47%), Gaps = 23/185 (12%)
Query: 58 VAIKRLKAESFQGHKEWL----TEVIYLGQLRHENLVKLIGYCSESDNRL----LVYEFM 109
V I+ K +GHK + E+ L ++ N++K+ G+ + + L L+ E+
Sbjct: 46 VIIRTFKKFH-KGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104
Query: 110 PKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFN 169
+G L L ++ + +S+ T++ +AID +GL L+ N Y++L + + L+ N+
Sbjct: 105 TRGYLREVLDKE--KDLSFKTKLDMAIDCCKGLYNLYKYT-NKPYKNLTSVSFLVTENYK 161
Query: 170 AKLSDFGLAR--DGPTGDNTHVSTRIVGTRGYAAPEYVAT--GHLTPKSDVYSFGVVLLE 225
K+ GL + P N V Y + + + T K D+YS GVVL E
Sbjct: 162 LKIICHGLEKILSSPPFKN-------VNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWE 214
Query: 226 LLSGR 230
+ +G+
Sbjct: 215 IFTGK 219
|
Length = 283 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 55.9 bits (134), Expect = 9e-09
Identities = 54/193 (27%), Positives = 89/193 (46%), Gaps = 26/193 (13%)
Query: 58 VAIKRLKAESFQGH---KEWLTEVIYLGQLRHENLVKLIGYCS------ESDNRLLVYEF 108
VAIK+L + FQ K E++ + + H+N++ L+ + E + LV E
Sbjct: 45 VAIKKL-SRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMEL 103
Query: 109 MPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNF 168
M + + +S+ + + G+ LH A +I+RDLK SN+++ S+
Sbjct: 104 MDANLCQVIQMELDHERMSY-----LLYQMLCGIKHLH--SAGIIHRDLKPSNIVVKSDC 156
Query: 169 NAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLE--- 225
K+ DFGLAR T + + T V TR Y APE + D++S G ++ E
Sbjct: 157 TLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVR 213
Query: 226 ---LLSGRRALDE 235
L GR +D+
Sbjct: 214 HKILFPGRDYIDQ 226
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 1e-08
Identities = 44/178 (24%), Positives = 74/178 (41%), Gaps = 19/178 (10%)
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQP----ISWPTRVKIAIDVARGLS 143
N+V L Y D+ LV + G L +H+ + P W + +A+D
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDA----- 100
Query: 144 FLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD-GPTGDNTHVSTRIVGTRGYAAP 202
LH ++ RDL +N+LLD + +L+ F + + D V Y AP
Sbjct: 101 -LH--REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVE------NMYCAP 151
Query: 203 EYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVL 260
E T D +S G +L ELL+G+ ++ G+ T + + ++R +L
Sbjct: 152 EVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGINTHTTLNIPEWVSEEARSLL 209
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 1e-08
Identities = 62/217 (28%), Positives = 92/217 (42%), Gaps = 32/217 (14%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQL-RH 86
L+G G +G V+KG +G + AIK + + +E E+ L + H
Sbjct: 13 LVGNGTYGQVYKG---------RHVKTGQLAAIKVMDVTGDE-EEEIKQEINMLKKYSHH 62
Query: 87 ENLVKLIGYCSES------DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVAR 140
N+ G + D LV EF GS+ + + + I ++ R
Sbjct: 63 RNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILR 122
Query: 141 GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR--DGPTGDNTHVSTRIVGTRG 198
GLS LH VI+RD+K NVLL N KL DFG++ D G +GT
Sbjct: 123 GLSHLH--QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRR----NTFIGTPY 176
Query: 199 YAAPEYVATGHLTP------KSDVYSFGVVLLELLSG 229
+ APE +A P KSD++S G+ +E+ G
Sbjct: 177 WMAPEVIACDE-NPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 60/245 (24%), Positives = 99/245 (40%), Gaps = 46/245 (18%)
Query: 76 TEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPT----- 130
+E+ L H +VK D LL+ E+ G L + ++ + + +
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGL 173
Query: 131 ---RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNT 187
++ +A+D +H RDLK++N+ L KL DFG ++ +
Sbjct: 174 LFYQIVLALDEVHSRKMMH--------RDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL 225
Query: 188 HVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVE 247
V++ GT Y APE + K+D++S GV+L ELL+ R
Sbjct: 226 DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHR---------------- 269
Query: 248 WADPFLRDSRRVLRIMDTRLGGQYSK---KEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL 304
PF S+R IM L G+Y + + A++ L +P RP T+
Sbjct: 270 ---PFKGPSQR--EIMQQVLYGKYDPFPCPVSSGMKALLDPLLSKNPALRP------TTQ 318
Query: 305 EQLHT 309
+ LHT
Sbjct: 319 QLLHT 323
|
Length = 478 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 1e-08
Identities = 53/189 (28%), Positives = 87/189 (46%), Gaps = 34/189 (17%)
Query: 58 VAIKRLKAESFQGH---KEWLTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSL 114
VAIK+L + FQ K E++ + + H+N++ L+ F P+ SL
Sbjct: 52 VAIKKL-SRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV------------FTPQKSL 98
Query: 115 ENHLFRKGVQPI---SWPTRVKIAIDVAR----------GLSFLHGLDANVIYRDLKASN 161
E V + + +++ +D R G+ LH A +I+RDLK SN
Sbjct: 99 EEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH--SAGIIHRDLKPSN 156
Query: 162 VLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGV 221
+++ S+ K+ DFGLAR T + + T V TR Y APE + D++S G
Sbjct: 157 IVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGC 213
Query: 222 VLLELLSGR 230
++ E++ G
Sbjct: 214 IMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 1e-08
Identities = 74/287 (25%), Positives = 113/287 (39%), Gaps = 79/287 (27%)
Query: 13 SMISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRL-KAESFQ-- 69
SM KI T +G G FG V + + K + + A+K L KA+
Sbjct: 1 SMFVKIKT--------IGIGAFGEV---CLVR------KVDTNALYAMKTLRKADVLMRN 43
Query: 70 --GHKEWLTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPIS 127
H + E L + +E +VKL + DN V +++P G + + L R G+
Sbjct: 44 QAAHVK--AERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEED 101
Query: 128 WPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDN- 186
R IA ++ + +H + I+RD+K N+L+D + + KL+DFGL TG
Sbjct: 102 L-ARFYIA-ELTCAIESVHKMG--FIHRDIKPDNILIDRDGHIKLTDFGLC----TGFRW 153
Query: 187 THVS---------------------------------------TRI-----VGTRGYAAP 202
TH S R VGT Y AP
Sbjct: 154 THDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAP 213
Query: 203 EYVA-TGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEW 248
E + TG+ T D +S GV+L E+L G+ D + ++ W
Sbjct: 214 EVLLRTGY-TQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINW 259
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 4e-08
Identities = 70/277 (25%), Positives = 109/277 (39%), Gaps = 34/277 (12%)
Query: 54 SGIVVAIKR--LKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSESDNRL-LVYEFMP 110
+ +VA+K+ L + S + K E+I QL+H N++ D+ L +V M
Sbjct: 24 TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILP-YVTSFIVDSELYVVSPLMA 82
Query: 111 KGSLENHLFRKGVQPISWPTRVKIAI---DVARGLSFLHGLDANVIYRDLKASNVLLDSN 167
GS E+ L K P P IA DV L ++H I+R +KAS++LL +
Sbjct: 83 YGSCEDLL--KTHFPEGLPELA-IAFILKDVLNALDYIHSKG--FIHRSVKASHILLSGD 137
Query: 168 FNAKLSDFGLARD----GPTGDNTHVSTR-IVGTRGYAAPEYVATGHL--TPKSDVYSFG 220
LS + G H + V + +PE + KSD+YS G
Sbjct: 138 GKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVG 197
Query: 221 VVLLELLSG---------RRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQ- 270
+ EL +G + L E G L + P DS R + +
Sbjct: 198 ITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRD 257
Query: 271 -----YSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLT 302
Y++ ++ V CL DP++RPS +L
Sbjct: 258 SVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 5e-08
Identities = 43/163 (26%), Positives = 77/163 (47%), Gaps = 6/163 (3%)
Query: 76 TEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIA 135
TE L + H ++++L G + + L+ +P+ + + + + I+ + I
Sbjct: 132 TEAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKRNIAICDILAIE 188
Query: 136 IDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVG 195
V R + +LH + +I+RD+KA N+ ++ + L DFG A P N + G
Sbjct: 189 RSVLRAIQYLH--ENRIIHRDIKAENIFINHPGDVCLGDFGAAC-FPVDINANKYYGWAG 245
Query: 196 TRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRG 238
T APE +A P D++S G+VL E+ + +L E G
Sbjct: 246 TIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDG 288
|
Length = 391 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 5e-08
Identities = 36/103 (34%), Positives = 51/103 (49%), Gaps = 2/103 (1%)
Query: 126 ISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGD 185
+S+ V + VA G+ FL N ++RDL A NVL+ K+ DFGLARD
Sbjct: 236 LSYMDLVGFSYQVANGMEFL--ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDS 293
Query: 186 NTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 228
N + APE + T SDV+SFG++L E+ +
Sbjct: 294 NYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 5e-08
Identities = 37/103 (35%), Positives = 50/103 (48%), Gaps = 18/103 (17%)
Query: 134 IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFG--LARDGPTGDNTHVST 191
+AID L ++H RD+K NVLLD N + +L+DFG L D T S
Sbjct: 113 LAIDSVHQLGYVH--------RDIKPDNVLLDKNGHIRLADFGSCLRLL---ADGTVQSN 161
Query: 192 RIVGTRGYAAPEYV-----ATGHLTPKSDVYSFGVVLLELLSG 229
VGT Y +PE + G P+ D +S GV + E+L G
Sbjct: 162 VAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 6e-08
Identities = 62/218 (28%), Positives = 96/218 (44%), Gaps = 34/218 (15%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQL-RH 86
++G G +G V+KG +G + AIK + + +E E+ L + H
Sbjct: 23 VVGNGTYGQVYKG---------RHVKTGQLAAIKVMDVTEDE-EEEIKLEINMLKKYSHH 72
Query: 87 ENLVKLIG-YCSES-----DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVAR 140
N+ G + +S D LV EF GS+ + + + I ++ R
Sbjct: 73 RNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILR 132
Query: 141 GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR--DGPTG-DNTHVSTRIVGTR 197
GL+ LH VI+RD+K NVLL N KL DFG++ D G NT +GT
Sbjct: 133 GLAHLHA--HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT-----FIGTP 185
Query: 198 GYAAPEYVATGHLTP------KSDVYSFGVVLLELLSG 229
+ APE +A P +SD++S G+ +E+ G
Sbjct: 186 YWMAPEVIACDE-NPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.6 bits (128), Expect = 8e-08
Identities = 56/200 (28%), Positives = 95/200 (47%), Gaps = 36/200 (18%)
Query: 64 KAESFQGHKE-----WLTEVIYLGQLRHENLVKLIG-YCSESDNRL-LVYEFMPKGSLEN 116
KA S++G KE + EV + +L+H+N+V+ I + ++++ +L ++ EF G L
Sbjct: 44 KAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSR 103
Query: 117 HLFR--KGVQPISWPTRVKIAIDVARGLSFLHGLD-----ANVIYRDLKASNVLLDS--- 166
++ + K I V I + L++ H L V++RDLK N+ L +
Sbjct: 104 NIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIR 163
Query: 167 ----------NFN----AKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYV--ATGHL 210
N N AK+ DFGL+++ H VGT Y +PE + T
Sbjct: 164 HIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAH---SCVGTPYYWSPELLLHETKSY 220
Query: 211 TPKSDVYSFGVVLLELLSGR 230
KSD+++ G ++ EL SG+
Sbjct: 221 DDKSDMWALGCIIYELCSGK 240
|
Length = 1021 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 2e-07
Identities = 64/234 (27%), Positives = 106/234 (45%), Gaps = 40/234 (17%)
Query: 81 LGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFR-KGVQPISWPTRVKIAIDVA 139
+ Q+ H +L + G C ++V EF+ G L+ L + KG P++W ++ +A +A
Sbjct: 70 MSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW--KITVAQQLA 127
Query: 140 RGLSFLHGLDANVIYRDLKASNVLL--------DSNFNAKLSDFGLARDGPTGDNTHVST 191
LS+L D N+++ ++ A N+LL S F KLSD G++ + +
Sbjct: 128 SALSYLE--DKNLVHGNVCAKNILLARLGLAEGTSPF-IKLSDPGVSFTALSREER---- 180
Query: 192 RIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD 250
V + APE V G L+ +D +SFG LLE+ D + L E+T E +
Sbjct: 181 --VERIPWIAPECVPGGNSLSTAADKWSFGTTLLEI-----CFDGE-VPLKERTPSE-KE 231
Query: 251 PFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL 304
F R+ + + +A ++ QCL +P RPS +L L
Sbjct: 232 RFYEKKHRL------------PEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 2e-07
Identities = 50/172 (29%), Positives = 76/172 (44%), Gaps = 37/172 (21%)
Query: 70 GHKEWLTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEF---MPKGSLENHLFRKGVQPI 126
G +W+T + Y Q NL ++ Y D L+ +F +P+ +L
Sbjct: 58 GDNQWITTLHYAFQ-DENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYL-------- 108
Query: 127 SWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFG----LARDGP 182
+ IAID L ++H RD+K N+L+D N + +L+DFG L DG
Sbjct: 109 ---AEMVIAIDSVHQLHYVH--------RDIKPDNILMDMNGHIRLADFGSCLKLMEDG- 156
Query: 183 TGDNTHVSTRIVGTRGYAAPEYV-----ATGHLTPKSDVYSFGVVLLELLSG 229
T S+ VGT Y +PE + G P+ D +S GV + E+L G
Sbjct: 157 ----TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 2e-07
Identities = 48/179 (26%), Positives = 71/179 (39%), Gaps = 47/179 (26%)
Query: 89 LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGV----QPISWPTRVKIAIDVARGLSF 144
+VK+ + N L+ EF+P G + L +K + +AID L F
Sbjct: 63 VVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGF 122
Query: 145 LHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA---------------RDGPTGD---- 185
+H RD+K N+LLD+ + KLSDFGL P D
Sbjct: 123 IH--------RDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQ 174
Query: 186 --------------NTHVSTRIVGTRGYAAPE-YVATGHLTPKSDVYSFGVVLLELLSG 229
++ VGT Y APE ++ TG+ D +S GV++ E+L G
Sbjct: 175 NMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGY-NKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 2e-07
Identities = 47/199 (23%), Positives = 78/199 (39%), Gaps = 57/199 (28%)
Query: 81 LGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPIS----WPTRVKIAI 136
L + +E +V+L + DN V +++P G + + L R G+ P + + A+
Sbjct: 55 LAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAV 114
Query: 137 DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL--------------ARDGP 182
+ + F+H RD+K N+L+D + + KL+DFGL + D
Sbjct: 115 ESVHKMGFIH--------RDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHV 166
Query: 183 TGDNTHVSTR-------------------------------IVGTRGYAAPEYVATGHLT 211
D+ S +VGT Y APE + T
Sbjct: 167 RQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT 226
Query: 212 PKSDVYSFGVVLLELLSGR 230
D +S GV+L E+L G+
Sbjct: 227 QLCDWWSVGVILYEMLVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 4e-07
Identities = 65/256 (25%), Positives = 96/256 (37%), Gaps = 71/256 (27%)
Query: 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIY 80
++F S ++G G FG V K +G V A+K L+ K + E
Sbjct: 1 EDFESLKVIGRGAFGEVR---------LVQKKDTGHVYAMKILR-------KADMLEKEQ 44
Query: 81 LGQLRHEN----------LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGV----QPI 126
+G +R E +VK+ + N L+ EF+P G + L +K +
Sbjct: 45 VGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQ 104
Query: 127 SWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA-------- 178
+ +AID L F+H RD+K N+LLDS + KLSDFGL
Sbjct: 105 FYIAETVLAIDSIHQLGFIH--------RDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHR 156
Query: 179 -----------------------RDGPT--GDNTHVSTRIVGTRGYAAPEYVATGHLTPK 213
R T + ++ VGT Y APE
Sbjct: 157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKL 216
Query: 214 SDVYSFGVVLLELLSG 229
D +S GV++ E+L G
Sbjct: 217 CDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 5e-07
Identities = 49/162 (30%), Positives = 70/162 (43%), Gaps = 28/162 (17%)
Query: 86 HENLVKLIGYCSESDNRL-----LVYEFMPKGS---LENHLFRKGVQPISWPTRVKIAID 137
H N+VK G ++D + LV E GS L L G Q + I
Sbjct: 78 HPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICG-QRLDEAMISYILYG 136
Query: 138 VARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRI---- 193
GL LH + +I+RD+K +N+LL + KL DFG++ STR+
Sbjct: 137 ALLGLQHLH--NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQ-------LTSTRLRRNT 187
Query: 194 -VGTRGYAAPEYVATGH-----LTPKSDVYSFGVVLLELLSG 229
VGT + APE +A + DV+S G+ +EL G
Sbjct: 188 SVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 6e-07
Identities = 32/86 (37%), Positives = 47/86 (54%), Gaps = 14/86 (16%)
Query: 153 IYRDLKASNVLLDSNFNAKLSDFG----LARDGPTGDNTHVSTRIVGTRGYAAPEYV--- 205
++RD+K NVLLD N + +L+DFG + +DG T S+ VGT Y +PE +
Sbjct: 124 VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG-----TVQSSVAVGTPDYISPEILQAM 178
Query: 206 --ATGHLTPKSDVYSFGVVLLELLSG 229
G P+ D +S GV + E+L G
Sbjct: 179 EDGMGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 60/242 (24%), Positives = 115/242 (47%), Gaps = 39/242 (16%)
Query: 13 SMISKIATKNFCSDYLLGEGGFGCVFKG-WIDQNTFAPTKPGSGIVVAIKRLKAESFQGH 71
+ I++ K++ ++G G FG V++ ID + VAIK++ Q
Sbjct: 58 NDINRSPNKSYKLGNIIGNGSFGVVYEAICIDTSE----------KVAIKKV----LQDP 103
Query: 72 KEWLTEVIYLGQLRHENLVKLIGY----CSESDNRLL----VYEFMPKGSLENHLFRKGV 123
+ E++ + L H N++ L Y C + + + + V EF+P+ ++ ++
Sbjct: 104 QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYAR 162
Query: 124 QPISWPT-RVKI-AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNA-KLSDFGLARD 180
+ P VK+ + + R L+++H + +RDLK N+L+D N + KL DFG A++
Sbjct: 163 NNHALPLFLVKLYSYQLCRALAYIH--SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKN 220
Query: 181 GPTGDNTHVSTRIVGTRGYAAPE-YVATGHLTPKSDVYSFGVVLLE------LLSGRRAL 233
G S + +R Y APE + + T D++S G ++ E + SG+ ++
Sbjct: 221 LLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSV 277
Query: 234 DE 235
D+
Sbjct: 278 DQ 279
|
Length = 440 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 4e-06
Identities = 46/162 (28%), Positives = 69/162 (42%), Gaps = 16/162 (9%)
Query: 86 HENLVKLIGYCSESDNR-----LLVYEFMPKGSLENHL--FRKGVQPISWPTRVKIAIDV 138
H N+VK G + D + LV E GS+ + + F K + + P I +
Sbjct: 74 HPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEA 133
Query: 139 ARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRG 198
GL LH I+RD+K +N+LL + KL DFG++ VGT
Sbjct: 134 LMGLQHLH--VNKTIHRDVKGNNILLTTEGGVKLVDFGVS--AQLTSTRLRRNTSVGTPF 189
Query: 199 YAAPEYVATGH-----LTPKSDVYSFGVVLLELLSGRRALDE 235
+ APE +A + DV+S G+ +EL G L +
Sbjct: 190 WMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLAD 231
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 5e-06
Identities = 55/223 (24%), Positives = 97/223 (43%), Gaps = 40/223 (17%)
Query: 83 QLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGL 142
Q+ H+++V L G C ++V EF+ G L+ + RK ++ P + K+A +A L
Sbjct: 60 QVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKS-DVLTTPWKFKVAKQLASAL 118
Query: 143 SFLHGLDANVIYRDLKASNVLL-----DSNFNA--KLSDFGLARDGPTGDNTHVSTR--I 193
S+L D ++++ ++ N+LL D KLSD G+ V +R
Sbjct: 119 SYLE--DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIP--------ITVLSRQEC 168
Query: 194 VGTRGYAAPEYVA-TGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPF 252
V + APE V + +L+ +D +SFG L E+ +D+ LAE+
Sbjct: 169 VERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDK-TLAEKE-------- 219
Query: 253 LRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRP 295
R + + + +A ++ C++ DP RP
Sbjct: 220 --------RFYEGQC--MLVTPSCKELADLMTHCMNYDPNQRP 252
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 5e-06
Identities = 31/103 (30%), Positives = 51/103 (49%), Gaps = 2/103 (1%)
Query: 123 VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGP 182
++P+ +A + + ++HG +I+RD+K NVL++ + L DFG A
Sbjct: 254 LRPLGLAQVTAVARQLLSAIDYIHG--EGIIHRDIKTENVLVNGPEDICLGDFGAACFAR 311
Query: 183 TGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLE 225
+T I GT APE +A TP D++S G+V+ E
Sbjct: 312 GSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 8e-06
Identities = 45/150 (30%), Positives = 69/150 (46%), Gaps = 19/150 (12%)
Query: 95 YCSESDNRLL--VYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANV 152
+CS R L V E++ G L G P+ R+ A V L +LH + +
Sbjct: 67 FCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDM-ARMYFAETVL-ALEYLH--NYGI 122
Query: 153 IYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHV-------STR------IVGTRGY 199
++RDLK N+L+ S + KL+DFGL++ G T++ TR + GT Y
Sbjct: 123 VHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEY 182
Query: 200 AAPEYVATGHLTPKSDVYSFGVVLLELLSG 229
APE + D ++ G++L E L G
Sbjct: 183 IAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 2e-05
Identities = 30/101 (29%), Positives = 51/101 (50%), Gaps = 12/101 (11%)
Query: 81 LGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPIS----WPTRVKIAI 136
L + +E +VKL + DN V +++P G + + L R V P + + +AI
Sbjct: 55 LAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAI 114
Query: 137 DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL 177
+ + F+H RD+K N+L+D + + KL+DFGL
Sbjct: 115 ESVHKMGFIH--------RDIKPDNILIDLDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 3e-05
Identities = 32/95 (33%), Positives = 50/95 (52%), Gaps = 6/95 (6%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWL-TEVIYLGQL-RH 86
LG G FG V ++ F K + + VA+K LKA + +E L +E+ L L +H
Sbjct: 46 LGAGAFGKV----VEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQH 101
Query: 87 ENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRK 121
+N+V L+G C+ L++ E+ G L N L +K
Sbjct: 102 KNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKK 136
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 3e-05
Identities = 31/105 (29%), Positives = 46/105 (43%), Gaps = 10/105 (9%)
Query: 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTE--- 77
LG G FG V ++ + K + + VA+K LK + +E L
Sbjct: 35 NRLSFGKTLGAGAFGKV----VEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELK 90
Query: 78 -VIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRK 121
+ YLG H N+V L+G C+ L++ E+ G L N L RK
Sbjct: 91 VLSYLGN--HINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRK 133
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 7e-05
Identities = 36/110 (32%), Positives = 54/110 (49%), Gaps = 13/110 (11%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQG-HKEWLTEV---IYLGQL 84
LG G FG V I + F K S VA+K LK + +K +TE+ I++G
Sbjct: 15 LGRGAFGKV----IQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGH- 69
Query: 85 RHENLVKLIGYCSESDNRLLV-YEFMPKGSLENHLFRKGVQPISWPTRVK 133
H N+V L+G C++ L+V E+ G+L N+L + + P R K
Sbjct: 70 -HLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYL--RSKRECFSPYRNK 116
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 1e-04
Identities = 27/79 (34%), Positives = 43/79 (54%), Gaps = 4/79 (5%)
Query: 101 NRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKAS 160
N LV E++ G +++ L G VK +VA L +LH +I+RDLK
Sbjct: 78 NVYLVMEYLIGGDVKSLLHIYGY--FDEEMAVKYISEVALALDYLH--RHGIIHRDLKPD 133
Query: 161 NVLLDSNFNAKLSDFGLAR 179
N+L+ + + KL+DFGL++
Sbjct: 134 NMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 2e-04
Identities = 34/99 (34%), Positives = 52/99 (52%), Gaps = 11/99 (11%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLK-AESFQGHKEWLTEV---IYLGQ 83
+LG G FG V ++ + F K S VA+K LK + HK ++E+ I++G
Sbjct: 14 VLGHGAFGKV----VEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGN 69
Query: 84 LRHENLVKLIGYCSESDNRLLV-YEFMPKGSLENHLFRK 121
H N+V L+G C++ + L+V EF G+L N L K
Sbjct: 70 --HLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAK 106
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 2e-04
Identities = 62/255 (24%), Positives = 112/255 (43%), Gaps = 42/255 (16%)
Query: 29 LGEGGFGCVFKG----WIDQNTFAPTK-PGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQ 83
+G G +G V+K D+ +A + G+GI ++ R E+ L +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACR--------------EIALLRE 54
Query: 84 LRHENLVKLIG-YCSESDNRL-LVYEFMPKGSLENHLFRKGVQ----PISWPTRVKIAID 137
L+H N++ L + S SD ++ L++++ F + + P+ P R +
Sbjct: 55 LKHPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLP-RSMVKSL 113
Query: 138 VARGLSFLHGLDAN-VIYRDLKASNVLL----DSNFNAKLSDFGLAR--DGPTGDNTHVS 190
+ + L +H L AN V++RDLK +N+L+ K++D G AR + P +
Sbjct: 114 LYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLD 173
Query: 191 TRIVGTRGYAAPE-YVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWA 249
+V T Y APE + H T D+++ G + ELL+ Q ++ +
Sbjct: 174 PVVV-TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH------CRQEDIKTS 226
Query: 250 DPFLRDS-RRVLRIM 263
+PF D R+ +M
Sbjct: 227 NPFHHDQLDRIFSVM 241
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 4e-04
Identities = 55/219 (25%), Positives = 99/219 (45%), Gaps = 35/219 (15%)
Query: 29 LGEGGFGCVFK-----GWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQ 83
+G G +G V+K G D++ G+GI ++ R E+ L +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACR--------------EIALLRE 54
Query: 84 LRHENLVKLIG-YCSESDNRL-LVYEFMPKGSLENHLFRKGVQ----PISWPTRVKIAID 137
L+H N++ L + S +D ++ L++++ F + + P+ P R +
Sbjct: 55 LKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLP-RGMVKSL 113
Query: 138 VARGLSFLHGLDAN-VIYRDLKASNVLL----DSNFNAKLSDFGLAR--DGPTGDNTHVS 190
+ + L +H L AN V++RDLK +N+L+ K++D G AR + P +
Sbjct: 114 LYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLD 173
Query: 191 TRIVGTRGYAAPE-YVATGHLTPKSDVYSFGVVLLELLS 228
+V T Y APE + H T D+++ G + ELL+
Sbjct: 174 PVVV-TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 5e-04
Identities = 44/181 (24%), Positives = 61/181 (33%), Gaps = 69/181 (38%)
Query: 104 LVYEFMPKGSLENHL-----FRKGVQPISWPTRVKIA-----IDVARGLSFLHGLDANVI 153
L+ EF+P G L L F + V TR +A I+ L F+H
Sbjct: 78 LIMEFLPGGDLMTMLIKYDTFSEDV------TRFYMAECVLAIEAVHKLGFIH------- 124
Query: 154 YRDLKASNVLLDSNFNAKLSDFGL---------------------ARDGPTGDNTHVSTR 192
RD+K N+L+D + KLSDFGL ++ N+
Sbjct: 125 -RDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDS 183
Query: 193 I------------------------VGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 228
I VGT Y APE + D +S G ++ E L
Sbjct: 184 INLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLI 243
Query: 229 G 229
G
Sbjct: 244 G 244
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.001
Identities = 34/100 (34%), Positives = 49/100 (49%), Gaps = 15/100 (15%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEW------LTEVIYLG 82
LG G FG V I+ + F K + VA+K LK + H E L +I++G
Sbjct: 15 LGRGAFGQV----IEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIG 68
Query: 83 QLRHENLVKLIGYCSESDNRLLV-YEFMPKGSLENHLFRK 121
H N+V L+G C++ L+V EF G+L N+L K
Sbjct: 69 H--HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSK 106
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 39.1 bits (92), Expect = 0.002
Identities = 44/157 (28%), Positives = 72/157 (45%), Gaps = 17/157 (10%)
Query: 86 HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFL 145
+ N +KL + +L+ +++ G L + L ++G +S KI + L+ L
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEG--KLSEAEVKKIIRQLVEALNDL 125
Query: 146 HGLDANVIYRDLKASNVLLD-SNFNAKLSDFGLARDGPTGDNTHVSTRIV--GTRGYAAP 202
H N+I+ D+K NVL D + L D+GL + + T GT Y +P
Sbjct: 126 HK--HNIIHNDIKLENVLYDRAKDRIYLCDYGLCK--------IIGTPSCYDGTLDYFSP 175
Query: 203 EYVATGHLTPKS-DVYSFGVVLLELLSGRRALDEDRG 238
E + GH S D ++ GV+ ELL+G+ ED
Sbjct: 176 EKIK-GHNYDVSFDWWAVGVLTYELLTGKHPFKEDED 211
|
Length = 267 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 350 | |||
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.96 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.96 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.96 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.94 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.94 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.91 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.91 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.91 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.9 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.9 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.9 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.89 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.89 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.87 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.86 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.85 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.83 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.81 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.8 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.8 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.79 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.77 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.75 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.74 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.72 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.72 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.69 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.65 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.65 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.64 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.62 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.61 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.55 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.47 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.44 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.4 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.37 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.37 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.34 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.33 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.32 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.21 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.18 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.16 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.13 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.13 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.04 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.02 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 99.01 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.93 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.91 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.73 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.72 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.69 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.64 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.52 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.39 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.32 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.28 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.24 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.2 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.16 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.07 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.91 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.9 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.85 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.8 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.75 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.62 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.62 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.6 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.57 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.56 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.39 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.38 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.3 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.25 | |
| PLN02236 | 344 | choline kinase | 97.15 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.15 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.05 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.03 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.02 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 97.02 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.93 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.87 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.68 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.53 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.36 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 96.28 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 96.25 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.88 | |
| PTZ00296 | 442 | choline kinase; Provisional | 95.8 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 95.73 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 95.54 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.18 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.12 | |
| PF02958 | 294 | EcKinase: Ecdysteroid kinase; InterPro: IPR004119 | 95.12 |
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-51 Score=356.13 Aligned_cols=270 Identities=25% Similarity=0.386 Sum_probs=224.9
Q ss_pred cccccCCCCchhhhhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhh-------HHHHH
Q 018785 3 LLIAMSDPSASMISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQG-------HKEWL 75 (350)
Q Consensus 3 ~~~~~~~~~~~~~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~-------~~~~~ 75 (350)
.+.+.+-.......+.....|.+.+.||+|+||.|-+| .+..+|+.||||+++...... .....
T Consensus 154 v~~~~s~d~~~~~pks~~d~yii~~~LGsGafg~Vkla---------~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~ 224 (475)
T KOG0615|consen 154 VFEDLSRDSSKVPPKSFNDYYIISKTLGSGAFGLVKLA---------YEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQ 224 (475)
T ss_pred eeecccchhccCccchhcceeEeeeeecCCceeEEEEE---------EEcccCcEEEeeeeehhhcccccccccchhhhH
Confidence 34444444445556667889999999999999999999 888899999999997654322 23357
Q ss_pred HHHHHHhccCCCcccceeeEEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeC
Q 018785 76 TEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYR 155 (350)
Q Consensus 76 ~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~ 155 (350)
+|+++|++|+||+|++++++|+..+..|+||||++||.|.+++..++ .+.+...+.++.||+.|+.||| ++||+||
T Consensus 225 ~EieILkkL~HP~IV~~~d~f~~~ds~YmVlE~v~GGeLfd~vv~nk--~l~ed~~K~~f~Qll~avkYLH--~~GI~HR 300 (475)
T KOG0615|consen 225 NEIEILKKLSHPNIVRIKDFFEVPDSSYMVLEYVEGGELFDKVVANK--YLREDLGKLLFKQLLTAVKYLH--SQGIIHR 300 (475)
T ss_pred HHHHHHHhcCCCCEEEEeeeeecCCceEEEEEEecCccHHHHHHhcc--ccccchhHHHHHHHHHHHHHHH--HcCcccc
Confidence 99999999999999999999999999999999999999999999886 7888899999999999999999 9999999
Q ss_pred CCCCCceEEcCC---CcEEEccccccccCCCCCCCcccccccCCCcccCccccccCCC---CCccchhhHHHHHHHHHhC
Q 018785 156 DLKASNVLLDSN---FNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHL---TPKSDVYSFGVVLLELLSG 229 (350)
Q Consensus 156 di~~~Nili~~~---~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~---~~~~DiwslG~ll~~ll~g 229 (350)
||||+|||+..+ ..+|++|||+|.... ........+||+.|.|||++.+... ..+.|+|||||++|-+|+|
T Consensus 301 DiKPeNILl~~~~e~~llKItDFGlAK~~g---~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG 377 (475)
T KOG0615|consen 301 DIKPENILLSNDAEDCLLKITDFGLAKVSG---EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSG 377 (475)
T ss_pred cCCcceEEeccCCcceEEEecccchhhccc---cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEecc
Confidence 999999999776 569999999998643 3445666899999999999977643 3477999999999999999
Q ss_pred CCCCcccccCc-chhhhhhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 230 RRALDEDRGGL-AEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 230 ~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
..||.+..... ..+++...... ........++++..+||.+||..||++|||+.++|+|
T Consensus 378 ~pPFS~~~~~~sl~eQI~~G~y~---------------f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 378 YPPFSEEYTDPSLKEQILKGRYA---------------FGPLQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred CCCcccccCCccHHHHHhcCccc---------------ccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 99998776544 33333332111 1112356789999999999999999999999999987
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-50 Score=363.37 Aligned_cols=255 Identities=27% Similarity=0.451 Sum_probs=220.5
Q ss_pred hhhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch---hhHHHHHHHHHHHhccCCCcccc
Q 018785 15 ISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLVK 91 (350)
Q Consensus 15 ~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~ 91 (350)
+.+....+|...+.||+|+|+.||.+ .+..+|+.||+|++.+... .+.+.+.+|+++.++|+||||++
T Consensus 12 i~D~~~~~Y~~g~~LGkGgFA~cYe~---------~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~ 82 (592)
T KOG0575|consen 12 IEDPRSKRYKRGRFLGKGGFARCYEA---------RDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQ 82 (592)
T ss_pred eecCCcceeeeeeeeccCcceEEEEE---------EEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEe
Confidence 44444478999999999999999999 7778899999999987432 34577899999999999999999
Q ss_pred eeeEEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEE
Q 018785 92 LIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAK 171 (350)
Q Consensus 92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~ 171 (350)
++++|++.++.|+|+|.|..++|.++++++. .+++.+++.++.||+.||.||| +.+|+|||||..|+|++.+.+||
T Consensus 83 f~~~FEDs~nVYivLELC~~~sL~el~Krrk--~ltEpEary~l~QIv~GlkYLH--~~~IiHRDLKLGNlfL~~~~~VK 158 (592)
T KOG0575|consen 83 FYHFFEDSNNVYIVLELCHRGSLMELLKRRK--PLTEPEARYFLRQIVEGLKYLH--SLGIIHRDLKLGNLFLNENMNVK 158 (592)
T ss_pred eeeEeecCCceEEEEEecCCccHHHHHHhcC--CCCcHHHHHHHHHHHHHHHHHH--hcCceecccchhheeecCcCcEE
Confidence 9999999999999999999999999998664 8999999999999999999999 99999999999999999999999
Q ss_pred EccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcch
Q 018785 172 LSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADP 251 (350)
Q Consensus 172 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~ 251 (350)
++|||+|...... .+.....+|||.|.|||++.....++.+||||+||+||.||.|++||+...-.+....+.
T Consensus 159 IgDFGLAt~le~~--~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik----- 231 (592)
T KOG0575|consen 159 IGDFGLATQLEYD--GERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIK----- 231 (592)
T ss_pred ecccceeeeecCc--ccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHH-----
Confidence 9999999875433 233445789999999999999999999999999999999999999998654322222221
Q ss_pred hhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 252 FLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
... -..|..++.++.+||.+||+.||.+|||+++++.|
T Consensus 232 ------------~~~--Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 232 ------------LNE--YSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred ------------hcC--cccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 111 13456889999999999999999999999999966
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-49 Score=339.46 Aligned_cols=255 Identities=30% Similarity=0.419 Sum_probs=217.5
Q ss_pred hhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch-hhHHHHHHHHHHHhccCCCcccceeeEEee
Q 018785 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (350)
Q Consensus 20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (350)
..+.+....||+|..|+||++ .+..++..+|+|++..... ...+++.+|+++++..+||+|+++|+.|..
T Consensus 78 ~~dle~~~~lG~G~gG~V~kv---------~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~ 148 (364)
T KOG0581|consen 78 LSDLERLGVLGSGNGGTVYKV---------RHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYS 148 (364)
T ss_pred HHHhhhhhhcccCCCcEEEEE---------EEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEe
Confidence 458889999999999999999 8889999999999955433 345789999999999999999999999999
Q ss_pred cCc-eEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccc
Q 018785 99 SDN-RLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL 177 (350)
Q Consensus 99 ~~~-~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~ 177 (350)
.+. ..++|||+++|+|.+++...+ .+++....+++.++++||.|||. +.+|+||||||.|||++..|.|||+|||.
T Consensus 149 ~~~~isI~mEYMDgGSLd~~~k~~g--~i~E~~L~~ia~~VL~GL~YLh~-~~~IIHRDIKPsNlLvNskGeVKicDFGV 225 (364)
T KOG0581|consen 149 NGEEISICMEYMDGGSLDDILKRVG--RIPEPVLGKIARAVLRGLSYLHE-ERKIIHRDIKPSNLLVNSKGEVKICDFGV 225 (364)
T ss_pred CCceEEeehhhcCCCCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhh-ccCeeeccCCHHHeeeccCCCEEeccccc
Confidence 884 999999999999999998764 79999999999999999999994 39999999999999999999999999999
Q ss_pred cccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhH
Q 018785 178 ARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSR 257 (350)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 257 (350)
+...... .-....||..|||||.+.+..|+.++||||||++++|+.+|+.||..... +...-.+
T Consensus 226 S~~lvnS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~------------~~~~~~~ 289 (364)
T KOG0581|consen 226 SGILVNS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNP------------PYLDIFE 289 (364)
T ss_pred cHHhhhh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCC------------CCCCHHH
Confidence 9754333 33457799999999999999999999999999999999999999976411 1122222
Q ss_pred HHHHhhhcccCCCCcHH-HHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 258 RVLRIMDTRLGGQYSKK-EAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 258 ~~~~~~~~~~~~~~~~~-~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
....++.... ..+|.+ +++++++|+..||+.||.+|||+.++++|
T Consensus 290 Ll~~Iv~~pp-P~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 290 LLCAIVDEPP-PRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred HHHHHhcCCC-CCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 3333333332 344554 89999999999999999999999999987
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-49 Score=328.90 Aligned_cols=261 Identities=24% Similarity=0.336 Sum_probs=212.5
Q ss_pred hhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch--hhHHHHHHHHHHHhccCCCcccceee
Q 018785 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLRHENLVKLIG 94 (350)
Q Consensus 17 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~ 94 (350)
.....+|+|.++||+|.||+||++ .+..+|..+|.|.+.-... ........|+.+|++|+||||+++++
T Consensus 15 ~~~l~~y~Il~~IG~GsFg~vykv---------~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~ 85 (375)
T KOG0591|consen 15 QKTLADYQILKKIGRGSFGEVYKV---------QCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYA 85 (375)
T ss_pred cccHHHHHHHHHHcCCcchheEEe---------eeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHH
Confidence 344678999999999999999999 7888899999998875433 33466889999999999999999998
Q ss_pred -EEeecCc-eEEEEEcCCCCChhhHHhh--cCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC--eeeCCCCCCceEEcCCC
Q 018785 95 -YCSESDN-RLLVYEFMPKGSLENHLFR--KGVQPISWPTRVKIAIDVARGLSFLHGLDAN--VIYRDLKASNVLLDSNF 168 (350)
Q Consensus 95 -~~~~~~~-~~lv~e~~~~~~L~~~l~~--~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~--i~H~di~~~Nili~~~~ 168 (350)
.|.+++. ++||||++..|+|...++. ...+.+++..+++++.|++.||.+||+.-.. |.||||||.||+++.+|
T Consensus 86 ~~f~~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~g 165 (375)
T KOG0591|consen 86 HSFIEDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANG 165 (375)
T ss_pred HhhhccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCC
Confidence 5555555 8999999999999999863 3456799999999999999999999931144 89999999999999999
Q ss_pred cEEEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhh
Q 018785 169 NAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEW 248 (350)
Q Consensus 169 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~ 248 (350)
.+||+|||+++.+.... .......|||.|++||.+.+..|+++||||||||++|||..-+.||.+.+-......+.+.
T Consensus 166 vvKLGDfGL~r~l~s~~--tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qg 243 (375)
T KOG0591|consen 166 VVKLGDFGLGRFLSSKT--TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQG 243 (375)
T ss_pred ceeeccchhHhHhcchh--HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcC
Confidence 99999999998754332 2334578999999999999999999999999999999999999999886432222222211
Q ss_pred cchhhhhhHHHHHhhhcccCCCCc-HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 018785 249 ADPFLRDSRRVLRIMDTRLGGQYS-KKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQ 306 (350)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 306 (350)
...++| .-+|.++..|+..|+.+||+.||+.-.++..+..
T Consensus 244 ------------------d~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 244 ------------------DYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred ------------------CCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 112234 5789999999999999999999996555544443
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-48 Score=335.31 Aligned_cols=252 Identities=27% Similarity=0.449 Sum_probs=212.0
Q ss_pred hhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEcccc--chhhHHHHHHHHHHHhccCCCcccceeeEEe
Q 018785 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAE--SFQGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (350)
Q Consensus 20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (350)
..+|.+.+.||+|.|++||+| .+..++..||||.+... .....+.+..|+.+|+.++||||+.+++++.
T Consensus 9 ~~~y~~~~~iG~GsfavVykg---------~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~ 79 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKG---------RHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIE 79 (429)
T ss_pred cccceehhhccCcceEEEEEe---------EeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEe
Confidence 468999999999999999999 77778899999999877 4455677889999999999999999999999
Q ss_pred ecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCC------CcEE
Q 018785 98 ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSN------FNAK 171 (350)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~------~~~~ 171 (350)
.++.+|+|||||+||+|.+|+..++ .+++..++.++.||+.||++|| +++|+||||||+|||++.+ -.+|
T Consensus 80 ~~~~i~lVMEyC~gGDLs~yi~~~~--~l~e~t~r~Fm~QLA~alq~L~--~~~IiHRDLKPQNiLLs~~~~~~~~~~LK 155 (429)
T KOG0595|consen 80 DDDFIYLVMEYCNGGDLSDYIRRRG--RLPEATARHFMQQLASALQFLH--ENNIIHRDLKPQNILLSTTARNDTSPVLK 155 (429)
T ss_pred cCCeEEEEEEeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCeeeccCCcceEEeccCCCCCCCceEE
Confidence 9999999999999999999999887 7999999999999999999999 9999999999999999775 4589
Q ss_pred EccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcch
Q 018785 172 LSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADP 251 (350)
Q Consensus 172 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~ 251 (350)
|+|||+++...... .....+|++.|||||++..+.|+.|+|+||+|+++|++++|+.||......+....+.+
T Consensus 156 IADFGfAR~L~~~~---~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k---- 228 (429)
T KOG0595|consen 156 IADFGFARFLQPGS---MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKK---- 228 (429)
T ss_pred ecccchhhhCCchh---HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhc----
Confidence 99999999765433 33457899999999999999999999999999999999999999986554333221111
Q ss_pred hhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 252 FLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
........+...+..+.+|+...++.+|.+|.+..+...+
T Consensus 229 ------------~~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~ 268 (429)
T KOG0595|consen 229 ------------GNEIVPVLPAELSNPLRELLISLLQRNPKDRISFEDFFDH 268 (429)
T ss_pred ------------cccccCchhhhccCchhhhhhHHHhcCccccCchHHhhhh
Confidence 1111122344566677788888888888888877766543
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-48 Score=323.49 Aligned_cols=268 Identities=26% Similarity=0.346 Sum_probs=217.2
Q ss_pred hcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch--hhHHHHHHHHHHHhccCCCcccceeeEEee
Q 018785 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (350)
Q Consensus 21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (350)
++|+...++|+|+||+||+| .++.+|+.||||.+..... .-.+..++|+++|++|+|||++.++.+|..
T Consensus 2 ekYE~LgkvGEGSYGvV~KC---------rnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrr 72 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKC---------RNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRR 72 (396)
T ss_pred cHHhhhhccccCcceEEEEe---------ccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHh
Confidence 57999999999999999999 8888999999999876543 223567899999999999999999999999
Q ss_pred cCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcccccc
Q 018785 99 SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 178 (350)
Q Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~ 178 (350)
...+++|+||++. ++.+.+...+. .++...+.+++.|++.|+.||| +++++||||||+||+|+.+|.+||+|||+|
T Consensus 73 krklhLVFE~~dh-TvL~eLe~~p~-G~~~~~vk~~l~Q~l~ai~~cH--k~n~IHRDIKPENILit~~gvvKLCDFGFA 148 (396)
T KOG0593|consen 73 KRKLHLVFEYCDH-TVLHELERYPN-GVPSELVKKYLYQLLKAIHFCH--KNNCIHRDIKPENILITQNGVVKLCDFGFA 148 (396)
T ss_pred cceeEEEeeecch-HHHHHHHhccC-CCCHHHHHHHHHHHHHHhhhhh--hcCeecccCChhheEEecCCcEEeccchhh
Confidence 9999999999955 67677777663 6899999999999999999999 999999999999999999999999999999
Q ss_pred ccCCCCCCCcccccccCCCcccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhH
Q 018785 179 RDGPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSR 257 (350)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 257 (350)
+.... .....+....|..|+|||++.| ..|+...||||+||++.||++|...|.+.++-.....+..-..+......
T Consensus 149 R~L~~--pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq 226 (396)
T KOG0593|consen 149 RTLSA--PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQ 226 (396)
T ss_pred HhhcC--CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHH
Confidence 87554 3333445677888999999988 58999999999999999999999999988876555555543333332221
Q ss_pred HHHHh------hhccc---CCCC---cHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 258 RVLRI------MDTRL---GGQY---SKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 258 ~~~~~------~~~~~---~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
..... +.-+. .+.+ ...++.-+.+|++.||..||.+|++.++++.|
T Consensus 227 ~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 227 SIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred HHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 11110 00000 0011 13456788999999999999999999999976
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-47 Score=343.93 Aligned_cols=266 Identities=33% Similarity=0.486 Sum_probs=230.2
Q ss_pred hhhhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCccccee
Q 018785 14 MISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLI 93 (350)
Q Consensus 14 ~~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 93 (350)
....+..+.+...+.||+|.||.||.|+|++. ..||+|.+.... ...+.+.+|+++|++|+|++|++++
T Consensus 199 d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~----------~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~ 267 (468)
T KOG0197|consen 199 DPWEIPREELKLIRELGSGQFGEVWLGKWNGS----------TKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLY 267 (468)
T ss_pred CCeeecHHHHHHHHHhcCCccceEEEEEEcCC----------CcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEE
Confidence 34455567788899999999999999999853 368999887764 3457788999999999999999999
Q ss_pred eEEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEc
Q 018785 94 GYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLS 173 (350)
Q Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~ 173 (350)
+++..++.++|||||++.|+|.+|+....+..+...+.+.++.||++|++||+ +++++||||-+.||||+.+..+|++
T Consensus 268 gV~~~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLe--s~~~IHRDLAARNiLV~~~~~vKIs 345 (468)
T KOG0197|consen 268 GVCTKQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLE--SKNYIHRDLAARNILVDEDLVVKIS 345 (468)
T ss_pred EEEecCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHH--hCCccchhhhhhheeeccCceEEEc
Confidence 99999989999999999999999999866678999999999999999999999 9999999999999999999999999
Q ss_pred cccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccccCcchhhhhhhcchh
Q 018785 174 DFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPF 252 (350)
Q Consensus 174 Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~ 252 (350)
|||+++.. ..+.........-...|+|||.+....++.+|||||||++||||+| |+.|+.++.+
T Consensus 346 DFGLAr~~-~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn-------------- 410 (468)
T KOG0197|consen 346 DFGLARLI-GDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSN-------------- 410 (468)
T ss_pred cccccccc-CCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCH--------------
Confidence 99999932 2222222222334556999999999999999999999999999998 7778877664
Q ss_pred hhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcCC
Q 018785 253 LRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSK 311 (350)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~ 311 (350)
....+.+....+.+.|..+|+++++++..||..+|++|||++.+...|+++....
T Consensus 411 ----~ev~~~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~ 465 (468)
T KOG0197|consen 411 ----EEVLELLERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTST 465 (468)
T ss_pred ----HHHHHHHhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhcc
Confidence 4556667777888889999999999999999999999999999999999998764
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-48 Score=338.31 Aligned_cols=269 Identities=27% Similarity=0.367 Sum_probs=220.1
Q ss_pred hhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh-hHHHHHHHHHHHhccC-CCcccceeeEE
Q 018785 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ-GHKEWLTEVIYLGQLR-HENLVKLIGYC 96 (350)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~-h~~i~~~~~~~ 96 (350)
.-++|.+.++||.|.||.||+| ....+|+.||||.++..... +...-.+|+..|++|+ ||||+++.+++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la---------~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi 78 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLA---------KSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVI 78 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEe---------eecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHh
Confidence 3579999999999999999999 77888999999998766432 2223467999999998 99999999999
Q ss_pred eecC-ceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccc
Q 018785 97 SESD-NRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDF 175 (350)
Q Consensus 97 ~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Df 175 (350)
.+.+ .+|+||||+ .++|+++++.+ .+.|++..+..|+.||++||+|+| .+|++|||+||+||||..+..+||+||
T Consensus 79 ~d~~~~L~fVfE~M-d~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiH--k~GfFHRDlKPENiLi~~~~~iKiaDF 154 (538)
T KOG0661|consen 79 RDNDRILYFVFEFM-DCNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIH--KHGFFHRDLKPENILISGNDVIKIADF 154 (538)
T ss_pred hccCceEeeeHHhh-hhhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHH--hcCcccccCChhheEecccceeEeccc
Confidence 9887 999999999 77999999888 579999999999999999999999 999999999999999998889999999
Q ss_pred cccccCCCCCCCcccccccCCCcccCccccc-cCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhh-cchhh
Q 018785 176 GLARDGPTGDNTHVSTRIVGTRGYAAPEYVA-TGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEW-ADPFL 253 (350)
Q Consensus 176 g~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~-~~~~~ 253 (350)
|+|+.... ....+....|..|+|||++. ...|+.+.|+||+||+++|+.+-+..|.|.++-.....+-+. +.|..
T Consensus 155 GLARev~S---kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~ 231 (538)
T KOG0661|consen 155 GLAREVRS---KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDK 231 (538)
T ss_pred cccccccc---CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCcc
Confidence 99985433 33345567888999999875 467899999999999999999999999988876555555443 33333
Q ss_pred hhh---HHHHHhhhcccCCC-------CcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 254 RDS---RRVLRIMDTRLGGQ-------YSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 254 ~~~---~~~~~~~~~~~~~~-------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
+.. ......++-..... +-...+.++.+||.+|+.+||.+|||+.++++|
T Consensus 232 ~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 232 DSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred ccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 222 22333333222221 112367899999999999999999999999987
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-47 Score=325.66 Aligned_cols=267 Identities=26% Similarity=0.382 Sum_probs=227.1
Q ss_pred hhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh---hHHHHHHHHHHHhccCCCccccee
Q 018785 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ---GHKEWLTEVIYLGQLRHENLVKLI 93 (350)
Q Consensus 17 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~ 93 (350)
....++|++.++||+|+||.||.+ .+..+++.+|+|++++.... ..+..+.|..+|..++||+|++++
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~V---------rk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ 91 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQV---------RKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLI 91 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEE---------EEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeE
Confidence 566889999999999999999999 66678999999999876543 346788999999999999999999
Q ss_pred eEEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEc
Q 018785 94 GYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLS 173 (350)
Q Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~ 173 (350)
..|.+.+.+|+|+||+.||.|...+++.+ .|++..++-++..|+.||.||| +.||+||||||+|||++.+|.++|+
T Consensus 92 ysFQt~~kLylVld~~~GGeLf~hL~~eg--~F~E~~arfYlaEi~lAL~~LH--~~gIiyRDlKPENILLd~~GHi~Lt 167 (357)
T KOG0598|consen 92 YSFQTEEKLYLVLDYLNGGELFYHLQREG--RFSEDRARFYLAEIVLALGYLH--SKGIIYRDLKPENILLDEQGHIKLT 167 (357)
T ss_pred EecccCCeEEEEEeccCCccHHHHHHhcC--CcchhHHHHHHHHHHHHHHHHH--hCCeeeccCCHHHeeecCCCcEEEe
Confidence 99999999999999999999999998776 7999999999999999999999 9999999999999999999999999
Q ss_pred cccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhh
Q 018785 174 DFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 253 (350)
Q Consensus 174 Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 253 (350)
|||++....... ......+||+.|+|||++.+..|+.++|.||||+++|+|++|..||...+.....+.+....
T Consensus 168 DFgL~k~~~~~~--~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k---- 241 (357)
T KOG0598|consen 168 DFGLCKEDLKDG--DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGK---- 241 (357)
T ss_pred ccccchhcccCC--CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCc----
Confidence 999998533322 23334789999999999999999999999999999999999999998876544444443321
Q ss_pred hhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCC----CHHHHHHH-------HHhhhcCCCCCCC
Q 018785 254 RDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRP----SMVDVLTS-------LEQLHTSKDMPRT 316 (350)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp----s~~~ll~~-------L~~~~~~~~~~~~ 316 (350)
....+.-.+.+.++++.++|..||.+|. ++.++.+| ++++...+-.|..
T Consensus 242 --------------~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~l~~k~l~PpF 301 (357)
T KOG0598|consen 242 --------------LPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEKLLAKKLSPPF 301 (357)
T ss_pred --------------CCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHHHHHhcCCCCCe
Confidence 1223445788999999999999999995 67777666 6666666555533
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-46 Score=335.88 Aligned_cols=255 Identities=25% Similarity=0.377 Sum_probs=219.8
Q ss_pred hhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhh---HHHHHHHHHHHhcc-CCCcccce
Q 018785 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQG---HKEWLTEVIYLGQL-RHENLVKL 92 (350)
Q Consensus 17 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~l-~h~~i~~~ 92 (350)
.....+|.+++.||.|.|++|++| .+..++..||||++.+...-. ...+..|-..|.+| .||+|+++
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A---------~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkL 139 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLA---------REKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKL 139 (604)
T ss_pred cCChhhcchhheeccccceeEEEe---------eecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEE
Confidence 344679999999999999999999 777899999999987664321 23456788888888 79999999
Q ss_pred eeEEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEE
Q 018785 93 IGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKL 172 (350)
Q Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l 172 (350)
+..|.++..+|+|+||+++|+|.+++.+.+ .|++..++.++.+|+.||+||| ++||+||||||+|||++.++.++|
T Consensus 140 y~TFQD~~sLYFvLe~A~nGdll~~i~K~G--sfde~caR~YAAeIldAleylH--~~GIIHRDlKPENILLd~dmhikI 215 (604)
T KOG0592|consen 140 YFTFQDEESLYFVLEYAPNGDLLDLIKKYG--SFDETCARFYAAEILDALEYLH--SNGIIHRDLKPENILLDKDGHIKI 215 (604)
T ss_pred EEEeecccceEEEEEecCCCcHHHHHHHhC--cchHHHHHHHHHHHHHHHHHHH--hcCceeccCChhheeEcCCCcEEE
Confidence 999999999999999999999999998886 7999999999999999999999 999999999999999999999999
Q ss_pred ccccccccCCCCCCC---------ccc--ccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcc
Q 018785 173 SDFGLARDGPTGDNT---------HVS--TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLA 241 (350)
Q Consensus 173 ~Dfg~~~~~~~~~~~---------~~~--~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~ 241 (350)
+|||.+..+...... ... ....||..|.+||++.....+.++|||+|||++|+|+.|+.||.+.++-..
T Consensus 216 TDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyli 295 (604)
T KOG0592|consen 216 TDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLI 295 (604)
T ss_pred eeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHH
Confidence 999999765443222 111 337899999999999999999999999999999999999999988776544
Q ss_pred hhhhhhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 242 EQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
.+.+.... -.++.+.++.+.+|++++|-.||.+|+|+++|.+|
T Consensus 296 FqkI~~l~-------------------y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 296 FQKIQALD-------------------YEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred HHHHHHhc-------------------ccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 44444322 23466778899999999999999999999999988
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-45 Score=328.55 Aligned_cols=267 Identities=32% Similarity=0.547 Sum_probs=223.3
Q ss_pred hhhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcE-EEEEEccccchhh--HHHHHHHHHHHhccCCCcccc
Q 018785 15 ISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIV-VAIKRLKAESFQG--HKEWLTEVIYLGQLRHENLVK 91 (350)
Q Consensus 15 ~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~-vaiK~~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~ 91 (350)
.......+..+.+.||+|+||+||+|.|.+ .. ||||.+....... .+.+.+|+.+|.+++||||++
T Consensus 35 ~~~i~~~~l~~~~~iG~G~~g~V~~~~~~g-----------~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~ 103 (362)
T KOG0192|consen 35 EEEIDPDELPIEEVLGSGSFGTVYKGKWRG-----------TDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQ 103 (362)
T ss_pred ceecChHHhhhhhhcccCCceeEEEEEeCC-----------ceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeee
Confidence 344456677778889999999999998874 44 9999998765433 458999999999999999999
Q ss_pred eeeEEeecC-ceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC-eeeCCCCCCceEEcCCC-
Q 018785 92 LIGYCSESD-NRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDAN-VIYRDLKASNVLLDSNF- 168 (350)
Q Consensus 92 ~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~-i~H~di~~~Nili~~~~- 168 (350)
+++++.+.. .+.+||||+++|+|.+++.......++...+..++.+|+.|+.||| +++ |+|+|||++|||++.++
T Consensus 104 f~G~~~~~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH--~~~~iIHrDLK~~NiLv~~~~~ 181 (362)
T KOG0192|consen 104 FYGACTSPPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLH--SEGPIIHRDLKSDNILVDLKGK 181 (362)
T ss_pred EEEEEcCCCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh--cCCCeeecccChhhEEEcCCCC
Confidence 999999887 7999999999999999998744458999999999999999999999 888 99999999999999997
Q ss_pred cEEEccccccccCCCCCCCcccccccCCCcccCccccc--cCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhh
Q 018785 169 NAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVA--TGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLV 246 (350)
Q Consensus 169 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~--~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~ 246 (350)
.+||+|||+++...... .......||..|+|||++. ...|+.++||||+|+++|||++|+.||.+......
T Consensus 182 ~~KI~DFGlsr~~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~----- 254 (362)
T KOG0192|consen 182 TLKIADFGLSREKVISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQV----- 254 (362)
T ss_pred EEEECCCccceeecccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHH-----
Confidence 99999999997643321 2233367899999999998 56999999999999999999999999987664211
Q ss_pred hhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcCCCC
Q 018785 247 EWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDM 313 (350)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~ 313 (350)
.........+...+..+++.+..|+.+||..||..||++.+++..|+.+......
T Consensus 255 ------------~~~v~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~ 309 (362)
T KOG0192|consen 255 ------------ASAVVVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS 309 (362)
T ss_pred ------------HHHHHhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence 1222233344455666889999999999999999999999999999998876443
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-46 Score=326.14 Aligned_cols=261 Identities=27% Similarity=0.465 Sum_probs=214.4
Q ss_pred hhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceeeEEeec
Q 018785 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (350)
Q Consensus 20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (350)
..+|...+.||+|+||+||++ .+..+|...|||.+........+.+.+|+.+|++++||||+++++.....
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~---------~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~ 86 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLA---------TNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSR 86 (313)
T ss_pred cchhhhhccccCccceEEEEE---------EecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccc
Confidence 467899999999999999999 66666999999998777544467789999999999999999999985554
Q ss_pred C--ceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcC-CCcEEEcccc
Q 018785 100 D--NRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS-NFNAKLSDFG 176 (350)
Q Consensus 100 ~--~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~-~~~~~l~Dfg 176 (350)
+ .+++.|||+.+|+|.+++...+. .+++..++.+..|+++||+||| ++|++|+||||+|||++. ++.+||+|||
T Consensus 87 ~~~~~~i~mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylH--s~g~vH~DiK~~NiLl~~~~~~~KlaDFG 163 (313)
T KOG0198|consen 87 ENDEYNIFMEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLH--SKGIVHCDIKPANILLDPSNGDVKLADFG 163 (313)
T ss_pred cCeeeEeeeeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHH--hCCEeccCcccceEEEeCCCCeEEeccCc
Confidence 4 58899999999999999998876 7999999999999999999999 999999999999999999 7999999999
Q ss_pred ccccCCC-CCCCcccccccCCCcccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhh
Q 018785 177 LARDGPT-GDNTHVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLR 254 (350)
Q Consensus 177 ~~~~~~~-~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~ 254 (350)
++..... ...........|++.|+|||++.++ ....++|||||||++.+|+||..||.... .
T Consensus 164 ~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~----------------~ 227 (313)
T KOG0198|consen 164 LAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFF----------------E 227 (313)
T ss_pred cccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhc----------------c
Confidence 9976543 1112223346799999999999853 34469999999999999999999997530 0
Q ss_pred hhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 018785 255 DSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLH 308 (350)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 308 (350)
.......+........++..++++..+++.+|+..||.+|||++++|+|---..
T Consensus 228 ~~~~~~~ig~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~ 281 (313)
T KOG0198|consen 228 EAEALLLIGREDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQ 281 (313)
T ss_pred hHHHHHHHhccCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhc
Confidence 011112222222223667789999999999999999999999999998854433
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=322.97 Aligned_cols=276 Identities=25% Similarity=0.313 Sum_probs=225.9
Q ss_pred CCCCchhhhhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhH-HHHHHHHHHHhccCC
Q 018785 8 SDPSASMISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGH-KEWLTEVIYLGQLRH 86 (350)
Q Consensus 8 ~~~~~~~~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~e~~~l~~l~h 86 (350)
+.......+....+.|++...||.|..++||+| ....+++.||||++..+..... ..++.|+..++.++|
T Consensus 13 ~~~~~~~~~p~n~~~YeL~e~IG~G~sa~V~~A---------~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~H 83 (516)
T KOG0582|consen 13 SASSSEKEFPLNAKDYELQEVIGVGASAVVYLA---------RCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDH 83 (516)
T ss_pred ccccccccCCCCccceeEEEEEeccceeEeeee---------eecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCC
Confidence 344445567777899999999999999999999 6677789999999988766544 778999999999999
Q ss_pred CcccceeeEEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcC
Q 018785 87 ENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS 166 (350)
Q Consensus 87 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~ 166 (350)
|||++++..|..+..+|+||.++.+|++.+.++..-...+++..+..+.++++.||.||| .+|.+|||||+.||||+.
T Consensus 84 PNIv~~~~sFvv~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH--~~G~IHRdvKAgnILi~~ 161 (516)
T KOG0582|consen 84 PNIVTYHCSFVVDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLH--QNGHIHRDVKAGNILIDS 161 (516)
T ss_pred CCcceEEEEEEecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHH--hcCceecccccccEEEcC
Confidence 999999999999999999999999999999998876678999999999999999999999 999999999999999999
Q ss_pred CCcEEEccccccccCCCCCCC--cccccccCCCcccCcccccc--CCCCCccchhhHHHHHHHHHhCCCCCcccccCcch
Q 018785 167 NFNAKLSDFGLARDGPTGDNT--HVSTRIVGTRGYAAPEYVAT--GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAE 242 (350)
Q Consensus 167 ~~~~~l~Dfg~~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~--~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~ 242 (350)
+|.|+|+|||.+........- .......|+++|+|||++.. ..|+.|+||||||++..||.+|..||....+-...
T Consensus 162 dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvL 241 (516)
T KOG0582|consen 162 DGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVL 241 (516)
T ss_pred CCcEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHH
Confidence 999999999987543332211 11145689999999999644 48999999999999999999999999877654333
Q ss_pred hhhhhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 243 QTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
..-.+...|... ....+.+.....+..+++++..||..||.+|||++++++|
T Consensus 242 l~tLqn~pp~~~---------t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 242 LLTLQNDPPTLL---------TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred HHHhcCCCCCcc---------cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 222222222111 0011112223456689999999999999999999999976
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=333.75 Aligned_cols=252 Identities=27% Similarity=0.392 Sum_probs=213.1
Q ss_pred hhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEcccc----ch-hhHHHHHHHHHHHhccC-CCcccc
Q 018785 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAE----SF-QGHKEWLTEVIYLGQLR-HENLVK 91 (350)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~----~~-~~~~~~~~e~~~l~~l~-h~~i~~ 91 (350)
...++|.+.+.||+|.||.|++| .+..++..||+|++... .. .....+.+|+.+++.+. ||||++
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a---------~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~ 84 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLA---------KHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIR 84 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEe---------eeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeE
Confidence 55789999999999999999999 77788899999987664 11 22345678999999998 999999
Q ss_pred eeeEEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCC-CcE
Q 018785 92 LIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSN-FNA 170 (350)
Q Consensus 92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~-~~~ 170 (350)
+++++.....+|+||||+.||.|.+++...+ .+.+.++..+++|++.|++||| +.||+||||||+||+++.+ +++
T Consensus 85 l~ev~~t~~~~~ivmEy~~gGdL~~~i~~~g--~l~E~~ar~~F~Qlisav~y~H--~~gi~HRDLK~ENilld~~~~~~ 160 (370)
T KOG0583|consen 85 LLEVFATPTKIYIVMEYCSGGDLFDYIVNKG--RLKEDEARKYFRQLISAVAYCH--SRGIVHRDLKPENILLDGNEGNL 160 (370)
T ss_pred EEEEEecCCeEEEEEEecCCccHHHHHHHcC--CCChHHHHHHHHHHHHHHHHHH--hCCEeeCCCCHHHEEecCCCCCE
Confidence 9999999999999999999999999998854 7999999999999999999999 9999999999999999999 999
Q ss_pred EEccccccccCCCCCCCcccccccCCCcccCccccccCC-CC-CccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhh
Q 018785 171 KLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGH-LT-PKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEW 248 (350)
Q Consensus 171 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~-~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~ 248 (350)
||+|||++.... .........+|++.|+|||++.+.. |+ .++||||+|++||.|++|..||...........
T Consensus 161 Kl~DFG~s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~k---- 234 (370)
T KOG0583|consen 161 KLSDFGLSAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRK---- 234 (370)
T ss_pred EEeccccccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHH----
Confidence 999999998753 2223344578999999999999877 86 789999999999999999999987442211111
Q ss_pred cchhhhhhHHHHHhhhcccCCCCcHHH-HHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 249 ADPFLRDSRRVLRIMDTRLGGQYSKKE-AQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
+... .-.++..+ ++++.+|+.+||..||.+|+|+.++++|
T Consensus 235 -------------i~~~--~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h 275 (370)
T KOG0583|consen 235 -------------IRKG--EFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEH 275 (370)
T ss_pred -------------HhcC--CccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhC
Confidence 1111 12334455 8999999999999999999999999954
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-46 Score=335.51 Aligned_cols=252 Identities=25% Similarity=0.399 Sum_probs=220.5
Q ss_pred hhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceeeEEeec
Q 018785 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (350)
Q Consensus 20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (350)
...|....+||+|..|.||.| .+..+++.||||.+........+-+.+|+.+|+..+|+||+.+++.|...
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A---------~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~ 342 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVA---------RKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVG 342 (550)
T ss_pred hhhhcchhhhccccccceeee---------eeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhccc
Confidence 468999999999999999999 78888999999999988777778899999999999999999999999999
Q ss_pred CceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccccc
Q 018785 100 DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR 179 (350)
Q Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~ 179 (350)
+.+|+||||++||+|.|.+... .+++.++..++..+++||+||| .+||+|+|||.+||+++.+|.+||+|||++.
T Consensus 343 deLWVVMEym~ggsLTDvVt~~---~~~E~qIA~Icre~l~aL~fLH--~~gIiHrDIKSDnILL~~~g~vKltDFGFca 417 (550)
T KOG0578|consen 343 DELWVVMEYMEGGSLTDVVTKT---RMTEGQIAAICREILQGLKFLH--ARGIIHRDIKSDNILLTMDGSVKLTDFGFCA 417 (550)
T ss_pred ceeEEEEeecCCCchhhhhhcc---cccHHHHHHHHHHHHHHHHHHH--hcceeeeccccceeEeccCCcEEEeeeeeee
Confidence 9999999999999999998776 5999999999999999999999 9999999999999999999999999999998
Q ss_pred cCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhHHH
Q 018785 180 DGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRV 259 (350)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (350)
....... ....-.|||+|+|||++....|+++.||||||++++||+.|+.||-..++-.....+.....|.
T Consensus 418 qi~~~~~--KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~------- 488 (550)
T KOG0578|consen 418 QISEEQS--KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPK------- 488 (550)
T ss_pred ccccccC--ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCC-------
Confidence 6544433 3344689999999999999999999999999999999999999997644332222222222222
Q ss_pred HHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 260 LRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
-..+..+++.+++|+.+||..|+++|+++.++|+|
T Consensus 489 ---------lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 489 ---------LKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred ---------cCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 23356789999999999999999999999999987
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=302.50 Aligned_cols=268 Identities=25% Similarity=0.337 Sum_probs=218.4
Q ss_pred hcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhh--HHHHHHHHHHHhccCCCcccceeeEEee
Q 018785 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQG--HKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (350)
Q Consensus 21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (350)
.+|...++||+|.||+||+| .+..+|+.||||.+......+ .....+|++.|+.++|+||+.++++|..
T Consensus 2 ~rY~~~~~lGEG~~gvVyka---------~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~ 72 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKA---------RDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPH 72 (318)
T ss_pred chhhhhhhhcCcceEEEEEE---------EecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccC
Confidence 58999999999999999999 788899999999998765432 3557889999999999999999999999
Q ss_pred cCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcccccc
Q 018785 99 SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 178 (350)
Q Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~ 178 (350)
.+.+.+|+||+ ..+|...++.+. ..++...++.++.+++.||+||| ++.|.||||||+|++++.+|.+|++|||++
T Consensus 73 ~~~l~lVfEfm-~tdLe~vIkd~~-i~l~pa~iK~y~~m~LkGl~y~H--~~~IlHRDlKPnNLLis~~g~lKiADFGLA 148 (318)
T KOG0659|consen 73 KSNLSLVFEFM-PTDLEVVIKDKN-IILSPADIKSYMLMTLKGLAYCH--SKWILHRDLKPNNLLISSDGQLKIADFGLA 148 (318)
T ss_pred CCceEEEEEec-cccHHHHhcccc-cccCHHHHHHHHHHHHHHHHHHH--hhhhhcccCCccceEEcCCCcEEeecccch
Confidence 99999999999 559999887654 47999999999999999999999 999999999999999999999999999999
Q ss_pred ccCCCCCCCcccccccCCCcccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhh-cc------
Q 018785 179 RDGPTGDNTHVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEW-AD------ 250 (350)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~-~~------ 250 (350)
+.+...... .+....|..|+|||++.|. .|+...|+||.||++.||+-|.+.|.+.++-+....+... +.
T Consensus 149 r~f~~p~~~--~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~W 226 (318)
T KOG0659|consen 149 RFFGSPNRI--QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQW 226 (318)
T ss_pred hccCCCCcc--cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccC
Confidence 986544433 2333678889999999886 7999999999999999999999999887765444444422 11
Q ss_pred hhhhhhHHHHH--hhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 251 PFLRDSRRVLR--IMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 251 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
|.+.......+ .........+...++.++.+|+.+||..||.+|+|+.++++|
T Consensus 227 P~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 227 PEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred ccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 22221111111 122222222445667888999999999999999999999976
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-45 Score=325.65 Aligned_cols=273 Identities=25% Similarity=0.320 Sum_probs=223.7
Q ss_pred hhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch--hhHHHHHHHHHHHhccCCCcccceee
Q 018785 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLRHENLVKLIG 94 (350)
Q Consensus 17 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~ 94 (350)
......|+..++||+|.||.||+| .+..+|+.||+|.+..... .......+|+.+|++|.||||+++.+
T Consensus 113 ~r~~~~feki~kIGeGTyg~VYkA---------r~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~e 183 (560)
T KOG0600|consen 113 PRRADSFEKIEKIGEGTYGQVYKA---------RDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEE 183 (560)
T ss_pred ccchHHHHHHHHhcCcchhheeEe---------eecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceee
Confidence 344578999999999999999999 7888999999999987763 33456789999999999999999999
Q ss_pred EEeec--CceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEE
Q 018785 95 YCSES--DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKL 172 (350)
Q Consensus 95 ~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l 172 (350)
+..+. ..+|+|+||++. +|.-++... .-.|++.+++-++.||++||+||| ++||.|||||..||||+.+|.+||
T Consensus 184 ivt~~~~~siYlVFeYMdh-DL~GLl~~p-~vkft~~qIKc~mkQLl~Gl~~cH--~~gvlHRDIK~SNiLidn~G~LKi 259 (560)
T KOG0600|consen 184 IVTSKLSGSIYLVFEYMDH-DLSGLLSSP-GVKFTEPQIKCYMKQLLEGLEYCH--SRGVLHRDIKGSNILIDNNGVLKI 259 (560)
T ss_pred EEEecCCceEEEEEecccc-hhhhhhcCC-CcccChHHHHHHHHHHHHHHHHHh--hcCeeeccccccceEEcCCCCEEe
Confidence 98776 689999999955 898877654 357999999999999999999999 999999999999999999999999
Q ss_pred ccccccccCCCCCCCcccccccCCCcccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcch
Q 018785 173 SDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADP 251 (350)
Q Consensus 173 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~ 251 (350)
+|||+++.+....... .+....|..|+|||++.|. .|+.+.|+||.||+|.||+.|+..|.+..+.+....|.++...
T Consensus 260 aDFGLAr~y~~~~~~~-~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGS 338 (560)
T KOG0600|consen 260 ADFGLARFYTPSGSAP-YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGS 338 (560)
T ss_pred ccccceeeccCCCCcc-cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCC
Confidence 9999999765544332 4456678899999999886 7999999999999999999999999999988888888876553
Q ss_pred hhhhhHHHHHhhhc---ccCC-------CCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 252 FLRDSRRVLRIMDT---RLGG-------QYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 252 ~~~~~~~~~~~~~~---~~~~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
...+.......... .... +.....+....+|+..||..||.+|.|+.++|++
T Consensus 339 P~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 339 PTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred CChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 33322211111100 0000 1123556788899999999999999999999854
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-45 Score=334.23 Aligned_cols=250 Identities=28% Similarity=0.411 Sum_probs=216.0
Q ss_pred hhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch---hhHHHHHHHHHHHhccCCCcccceeeEE
Q 018785 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLVKLIGYC 96 (350)
Q Consensus 20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (350)
-+-|++++-||.|+.|.|-+| ++..+|+.+|||++..... .....+.+|+-+|+.+.|||++.+|+++
T Consensus 11 iGpwkLgkTLG~Gstg~vrla---------kh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVw 81 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLA---------KHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVW 81 (786)
T ss_pred ccceeccccccCCCCceehhh---------hcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeee
Confidence 356889999999999999999 8999999999999987632 2235578999999999999999999999
Q ss_pred eecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcccc
Q 018785 97 SESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFG 176 (350)
Q Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg 176 (350)
++..++|+|.||++||-|.+++..++ ++++.++...++||+.|+.||| .-+|||+|+||+|++++..+++|++|||
T Consensus 82 e~~~~lylvlEyv~gGELFdylv~kG--~l~e~eaa~ff~QIi~gv~yCH--~~~icHRDLKpENlLLd~~~nIKIADFG 157 (786)
T KOG0588|consen 82 ENKQHLYLVLEYVPGGELFDYLVRKG--PLPEREAAHFFRQILDGVSYCH--AFNICHRDLKPENLLLDVKNNIKIADFG 157 (786)
T ss_pred ccCceEEEEEEecCCchhHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHh--hhcceeccCCchhhhhhcccCEeeeccc
Confidence 99999999999999999999999887 8999999999999999999999 8999999999999999999999999999
Q ss_pred ccccCCCCCCCcccccccCCCcccCccccccCCCC-CccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhh
Q 018785 177 LARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLT-PKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRD 255 (350)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~-~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 255 (350)
.|..-.++.. ...-+|.|.|.+||++.|..|+ .++||||.|++||.||+|..||++.+.......+..
T Consensus 158 MAsLe~~gkl---LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~-------- 226 (786)
T KOG0588|consen 158 MASLEVPGKL---LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQR-------- 226 (786)
T ss_pred eeecccCCcc---ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHc--------
Confidence 9986444333 3346799999999999999885 789999999999999999999985442111111111
Q ss_pred hHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018785 256 SRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL 304 (350)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 304 (350)
.. -++|..++.++++||.+||.+||++|.|+++|++|-
T Consensus 227 ---------G~--f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP 264 (786)
T KOG0588|consen 227 ---------GV--FEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHP 264 (786)
T ss_pred ---------Cc--ccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCc
Confidence 11 134678999999999999999999999999999983
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=318.39 Aligned_cols=252 Identities=23% Similarity=0.351 Sum_probs=217.5
Q ss_pred hhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhH---HHHHHHHHHHhccCCCcccceee
Q 018785 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGH---KEWLTEVIYLGQLRHENLVKLIG 94 (350)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~ 94 (350)
....+|++.+.||+|.||.|-+| .+...|+.||||.+.+....+. -.+++|++++..|+||||+.+|.
T Consensus 50 nlkHRyE~~etLGkGTYGKVk~A---------~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyE 120 (668)
T KOG0611|consen 50 NLKHRYEITETLGKGTYGKVKLA---------YEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYE 120 (668)
T ss_pred chhhHHHHHHHhcCCcccceeeh---------hhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhh
Confidence 34679999999999999999999 7888999999999987765544 45789999999999999999999
Q ss_pred EEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcc
Q 018785 95 YCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSD 174 (350)
Q Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~D 174 (350)
+|++.+.+.|||||..+|.|+||+.+.. .+++.+++.+++||++|+.||| .++++|+|||.+||++|.|+++|++|
T Consensus 121 VFENkdKIvivMEYaS~GeLYDYiSer~--~LsErEaRhfFRQIvSAVhYCH--knrVvHRDLKLENILLD~N~NiKIAD 196 (668)
T KOG0611|consen 121 VFENKDKIVIVMEYASGGELYDYISERG--SLSEREARHFFRQIVSAVHYCH--KNRVVHRDLKLENILLDQNNNIKIAD 196 (668)
T ss_pred hhcCCceEEEEEEecCCccHHHHHHHhc--cccHHHHHHHHHHHHHHHHHHh--hccceecccchhheeecCCCCeeeec
Confidence 9999999999999999999999998886 7999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCCCCCcccccccCCCcccCccccccCCC-CCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhh
Q 018785 175 FGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHL-TPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 253 (350)
Q Consensus 175 fg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 253 (350)
||++..+..... .+..+|++.|.+||++.|..| .+..|.||||++||.|+.|..||.+.+......++.
T Consensus 197 FGLSNly~~~kf---LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs------- 266 (668)
T KOG0611|consen 197 FGLSNLYADKKF---LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQIS------- 266 (668)
T ss_pred cchhhhhccccH---HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhh-------
Confidence 999987544433 445789999999999999988 478999999999999999999998866432222222
Q ss_pred hhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018785 254 RDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 305 (350)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~ 305 (350)
...+. ...-+.+..-||++||.+||++|.|+++|.+|.+
T Consensus 267 ----------~GaYr---EP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWW 305 (668)
T KOG0611|consen 267 ----------RGAYR---EPETPSDASGLIRWMLMVNPERRATIEDIASHWW 305 (668)
T ss_pred ----------ccccc---CCCCCchHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence 22111 1223456777999999999999999999999965
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-45 Score=297.95 Aligned_cols=265 Identities=24% Similarity=0.354 Sum_probs=216.6
Q ss_pred hhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceeeEEe
Q 018785 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (350)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (350)
+.++||+|.+.||.|||+-||++ ....++..+|+|.+...+.++.+..++|++..++++|||+++++++..
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV---------~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l 88 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLV---------KGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQL 88 (302)
T ss_pred EcCceEEEeeeecCCCceeeeee---------cccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHH
Confidence 45789999999999999999999 788899999999999998888899999999999999999999988764
Q ss_pred ecC-----ceEEEEEcCCCCChhhHHhhc--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCC--eeeCCCCCCceEEcCCC
Q 018785 98 ESD-----NRLLVYEFMPKGSLENHLFRK--GVQPISWPTRVKIAIDVARGLSFLHGLDAN--VIYRDLKASNVLLDSNF 168 (350)
Q Consensus 98 ~~~-----~~~lv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~i~~ql~~al~~lh~~~~~--i~H~di~~~Nili~~~~ 168 (350)
.+. ..|++++|+..|+|.+.+... ++..+++.+++.|+.++++||++|| ... ++|+||||.||+++..+
T Consensus 89 ~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH--~~~~~yAH~DiKP~NILls~~~ 166 (302)
T KOG2345|consen 89 REEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALH--EKEPPYAHRDIKPANILLSDSG 166 (302)
T ss_pred HhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHh--ccCCcccccCCCcceeEecCCC
Confidence 433 489999999999999999754 3447999999999999999999999 777 99999999999999999
Q ss_pred cEEEccccccccCCCCCCCcc-------cccccCCCcccCccccc---cCCCCCccchhhHHHHHHHHHhCCCCCccccc
Q 018785 169 NAKLSDFGLARDGPTGDNTHV-------STRIVGTRGYAAPEYVA---TGHLTPKSDVYSFGVVLLELLSGRRALDEDRG 238 (350)
Q Consensus 169 ~~~l~Dfg~~~~~~~~~~~~~-------~~~~~~~~~~~aPE~~~---~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~ 238 (350)
..+++|||+++.....-.... ......+..|+|||++. +...+.++|||||||+||.|+.|..||+....
T Consensus 167 ~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~ 246 (302)
T KOG2345|consen 167 LPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ 246 (302)
T ss_pred ceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh
Confidence 999999999986544322221 12245678899999884 45678999999999999999999999964332
Q ss_pred CcchhhhhhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 018785 239 GLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLH 308 (350)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 308 (350)
.-. .-.....+.....+....++..+.++++.||++||.+||++.+++++++.+.
T Consensus 247 ~Gg---------------SlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 247 QGG---------------SLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred cCC---------------eEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 100 0001111112222223348899999999999999999999999999998764
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-44 Score=325.14 Aligned_cols=270 Identities=29% Similarity=0.400 Sum_probs=211.5
Q ss_pred hhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch-hhHHHHHHHHHHHhcc-CCCcccceee
Q 018785 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQL-RHENLVKLIG 94 (350)
Q Consensus 17 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~ 94 (350)
.+..++|++.++||+|+||.||+|++... .+..++..||+|.+..... .....+..|+.+++.+ +||||+++++
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~ 78 (338)
T cd05102 3 EFPRDRLRLGKVLGHGAFGKVVEASAFGI----DKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLG 78 (338)
T ss_pred ccchhHceeeeEeccCCcceEEEEEEecc----CCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEe
Confidence 45678999999999999999999964321 2334567899999875432 2345688899999999 8999999999
Q ss_pred EEeec-CceEEEEEcCCCCChhhHHhhcC---------------------------------------------------
Q 018785 95 YCSES-DNRLLVYEFMPKGSLENHLFRKG--------------------------------------------------- 122 (350)
Q Consensus 95 ~~~~~-~~~~lv~e~~~~~~L~~~l~~~~--------------------------------------------------- 122 (350)
++... +..++||||+++|+|.+++....
T Consensus 79 ~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (338)
T cd05102 79 ACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTN 158 (338)
T ss_pred EecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccc
Confidence 87764 45789999999999999986532
Q ss_pred ---------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccccccCCCCCCCcccccc
Q 018785 123 ---------VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRI 193 (350)
Q Consensus 123 ---------~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~ 193 (350)
...++...+..++.|+++||+||| ++|++|+||||+||+++.++.++|+|||++...............
T Consensus 159 ~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH--~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~ 236 (338)
T cd05102 159 PPQETDDLWKSPLTMEDLICYSFQVARGMEFLA--SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSA 236 (338)
T ss_pred cchhccccccCCCCHHHHHHHHHHHHHHHHHHH--HCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCC
Confidence 124778888999999999999999 999999999999999999999999999999754322221112223
Q ss_pred cCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccccCcchhhhhhhcchhhhhhHHHHHhhhcccCCCCc
Q 018785 194 VGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYS 272 (350)
Q Consensus 194 ~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (350)
.++..|+|||.+.+..++.++||||||+++|+|++ |..||.+....... ...+........+
T Consensus 237 ~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~-----------------~~~~~~~~~~~~~ 299 (338)
T cd05102 237 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEF-----------------CQRLKDGTRMRAP 299 (338)
T ss_pred CCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHH-----------------HHHHhcCCCCCCC
Confidence 45677999999999999999999999999999997 99999764421111 0111111112234
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhc
Q 018785 273 KKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHT 309 (350)
Q Consensus 273 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 309 (350)
..+++.+.+++.+||+.||.+|||+.++++.|+.+..
T Consensus 300 ~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 300 ENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 4567889999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-45 Score=326.34 Aligned_cols=248 Identities=30% Similarity=0.399 Sum_probs=215.5
Q ss_pred hcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch--hhHHHHHHHHHHHhccCCCcccceeeEEee
Q 018785 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (350)
Q Consensus 21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (350)
++|.+.+.||+|.||+||+| ..+.+.+.||+|.+.+... .+.+.+.+|+++++.++||||+.+++.|+.
T Consensus 2 e~yhv~e~iG~Gsfg~VYKg---------rrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt 72 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKG---------RRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFET 72 (808)
T ss_pred cchhHHHHhcCCccceeeec---------ccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcc
Confidence 58999999999999999999 7888899999999987643 345678999999999999999999999999
Q ss_pred cCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcccccc
Q 018785 99 SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 178 (350)
Q Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~ 178 (350)
..++|+|+||+.| +|..++...+ .++++.+..++.+++.||.||| +.+|.|+|+||.||+++.+|.+||+|||++
T Consensus 73 ~~~~~vVte~a~g-~L~~il~~d~--~lpEe~v~~~a~~LVsaL~yLh--s~rilhrd~kPqniLl~~~~~~KlcdFg~A 147 (808)
T KOG0597|consen 73 SAHLWVVTEYAVG-DLFTILEQDG--KLPEEQVRAIAYDLVSALYYLH--SNRILHRDMKPQNILLEKGGTLKLCDFGLA 147 (808)
T ss_pred cceEEEEehhhhh-hHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHH--hcCcccccCCcceeeecCCCceeechhhhh
Confidence 9999999999966 9999998776 7999999999999999999999 999999999999999999999999999999
Q ss_pred ccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhHH
Q 018785 179 RDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRR 258 (350)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (350)
+.+.. .....+...|||.|+|||++.+..|+..+|+|||||++||++.|++||-...-.....
T Consensus 148 r~m~~--~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~--------------- 210 (808)
T KOG0597|consen 148 RAMST--NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVK--------------- 210 (808)
T ss_pred hhccc--CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHH---------------
Confidence 86433 4445566889999999999999999999999999999999999999995432111111
Q ss_pred HHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 259 VLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
.+... +...+...+..+..++..+|..||.+|.|-.+++.|
T Consensus 211 --~I~~d--~v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 211 --SILKD--PVKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred --HHhcC--CCCCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 11111 123455788999999999999999999999999876
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-44 Score=297.78 Aligned_cols=240 Identities=28% Similarity=0.411 Sum_probs=211.8
Q ss_pred hhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch---hhHHHHHHHHHHHhccCCCcccceee
Q 018785 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLVKLIG 94 (350)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~ 94 (350)
...++|++.+.||.|+||.|.++ ..+.+|..+|+|++..... .+.++..+|..+|+.+.||+++++++
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LV---------r~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~ 111 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLV---------REKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYG 111 (355)
T ss_pred cchhhhhheeeeccCccceEEEE---------EEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEE
Confidence 45679999999999999999999 6777799999999987754 45567889999999999999999999
Q ss_pred EEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcc
Q 018785 95 YCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSD 174 (350)
Q Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~D 174 (350)
.+.+.+.+|+||||+.||.|..++.+.. .|++..++.++.|++.||+||| +.++++||+||+|||+|.+|.+|++|
T Consensus 112 t~~d~~~lymvmeyv~GGElFS~Lrk~~--rF~e~~arFYAAeivlAleylH--~~~iiYRDLKPENiLlD~~G~iKitD 187 (355)
T KOG0616|consen 112 TFKDNSNLYMVMEYVPGGELFSYLRKSG--RFSEPHARFYAAEIVLALEYLH--SLDIIYRDLKPENLLLDQNGHIKITD 187 (355)
T ss_pred eeccCCeEEEEEeccCCccHHHHHHhcC--CCCchhHHHHHHHHHHHHHHHH--hcCeeeccCChHHeeeccCCcEEEEe
Confidence 9999999999999999999999998765 7999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhh
Q 018785 175 FGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLR 254 (350)
Q Consensus 175 fg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~ 254 (350)
||++...... .-..+|||.|+|||++....+..++|.||||+++|||+.|..||...+.....+.+..
T Consensus 188 FGFAK~v~~r-----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~------- 255 (355)
T KOG0616|consen 188 FGFAKRVSGR-----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILE------- 255 (355)
T ss_pred ccceEEecCc-----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHh-------
Confidence 9999864332 2347899999999999999999999999999999999999999987665333333322
Q ss_pred hhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCC
Q 018785 255 DSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNR 294 (350)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R 294 (350)
.. ...|.-.+.++.+|+..+|+.|-.+|
T Consensus 256 ----------~~--v~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 256 ----------GK--VKFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred ----------Cc--ccCCcccCHHHHHHHHHHHhhhhHhh
Confidence 22 24567788999999999999999999
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-44 Score=319.01 Aligned_cols=258 Identities=24% Similarity=0.338 Sum_probs=218.7
Q ss_pred hhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch---hhHHHHHHHHHHHhccCCCccccee
Q 018785 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLVKLI 93 (350)
Q Consensus 17 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~ 93 (350)
...-++|++.++||+|+||.||+| .+..+|..+|+|++++... .+..+++.|-.+|....+|.|++++
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLa---------rKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLy 207 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLA---------RKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLY 207 (550)
T ss_pred cCCcccchhheeeccccceeEEEE---------EEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEE
Confidence 446689999999999999999999 7888999999999987754 3456788899999999999999999
Q ss_pred eEEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEc
Q 018785 94 GYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLS 173 (350)
Q Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~ 173 (350)
..|.+.+.+||||||++||++..++.... .|++..++.++.+++.||..+| +.|++|+||||+|+|||..|.+||+
T Consensus 208 YsFQD~~~LYLiMEylPGGD~mTLL~~~~--~L~e~~arfYiaE~vlAI~~iH--~~gyIHRDIKPdNlLiD~~GHiKLS 283 (550)
T KOG0605|consen 208 YSFQDKEYLYLIMEYLPGGDMMTLLMRKD--TLTEDWARFYIAETVLAIESIH--QLGYIHRDIKPDNLLIDAKGHIKLS 283 (550)
T ss_pred EEecCCCeeEEEEEecCCccHHHHHHhcC--cCchHHHHHHHHHHHHHHHHHH--HcCcccccCChhheeecCCCCEeec
Confidence 99999999999999999999999998876 8999999999999999999999 9999999999999999999999999
Q ss_pred cccccccCCCC----------------------CCC----ccc-------------------ccccCCCcccCccccccC
Q 018785 174 DFGLARDGPTG----------------------DNT----HVS-------------------TRIVGTRGYAAPEYVATG 208 (350)
Q Consensus 174 Dfg~~~~~~~~----------------------~~~----~~~-------------------~~~~~~~~~~aPE~~~~~ 208 (350)
|||++...... ... ... ....|||.|+|||++.+.
T Consensus 284 DFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~k 363 (550)
T KOG0605|consen 284 DFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGK 363 (550)
T ss_pred cccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcC
Confidence 99998532110 000 000 114699999999999999
Q ss_pred CCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhc
Q 018785 209 HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLH 288 (350)
Q Consensus 209 ~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 288 (350)
.|+...|.|||||++||||.|.+||....+......+..|...+.. +....+++++.+||.+||.
T Consensus 364 gY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~f---------------P~~~~~s~eA~DLI~rll~ 428 (550)
T KOG0605|consen 364 GYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKF---------------PEEVDLSDEAKDLITRLLC 428 (550)
T ss_pred CCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccC---------------CCcCcccHHHHHHHHHHhc
Confidence 9999999999999999999999999988877666666655422211 1123456899999999999
Q ss_pred cCCCCCC---CHHHHHHH
Q 018785 289 MDPKNRP---SMVDVLTS 303 (350)
Q Consensus 289 ~dp~~Rp---s~~~ll~~ 303 (350)
||++|. .+++|.+|
T Consensus 429 -d~~~RLG~~G~~EIK~H 445 (550)
T KOG0605|consen 429 -DPENRLGSKGAEEIKKH 445 (550)
T ss_pred -CHHHhcCcccHHHHhcC
Confidence 999995 57777765
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-44 Score=290.35 Aligned_cols=259 Identities=24% Similarity=0.357 Sum_probs=225.2
Q ss_pred hhhhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh---hHHHHHHHHHHHhccCCCccc
Q 018785 14 MISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ---GHKEWLTEVIYLGQLRHENLV 90 (350)
Q Consensus 14 ~~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~ 90 (350)
....+.-++|++++.||+|.||.||+| ....++..||+|++.+.... ...++++|+++-..|+||||+
T Consensus 15 ~~~~~~l~dfeigr~LgkgkFG~vYla---------rekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnil 85 (281)
T KOG0580|consen 15 ATKTWTLDDFEIGRPLGKGKFGNVYLA---------REKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNIL 85 (281)
T ss_pred cccccchhhccccccccCCccccEeEe---------eeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHH
Confidence 345677889999999999999999999 67777899999998766432 246789999999999999999
Q ss_pred ceeeEEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcE
Q 018785 91 KLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNA 170 (350)
Q Consensus 91 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~ 170 (350)
++|++|.++...|+++||..+|.+...+.......+++.....++.|++.|+.||| .++|+||||||+|+|++..+.+
T Consensus 86 rlY~~fhd~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h--~k~VIhRdiKpenlLlg~~~~l 163 (281)
T KOG0580|consen 86 RLYGYFHDSKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCH--LKRVIHRDIKPENLLLGSAGEL 163 (281)
T ss_pred hhhhheeccceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhc--cCCcccCCCCHHHhccCCCCCe
Confidence 99999999999999999999999999999877788999999999999999999999 9999999999999999999999
Q ss_pred EEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcc
Q 018785 171 KLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD 250 (350)
Q Consensus 171 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~ 250 (350)
+++|||.+.... .......+||..|.+||.+.+...+...|+|++|++.|+++.|..||.....++....+...
T Consensus 164 kiAdfGwsV~~p----~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~-- 237 (281)
T KOG0580|consen 164 KIADFGWSVHAP----SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKV-- 237 (281)
T ss_pred eccCCCceeecC----CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHc--
Confidence 999999998643 22233467999999999999999999999999999999999999999865544333333321
Q ss_pred hhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 018785 251 PFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQ 306 (350)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 306 (350)
+-..+..++.++.++|.+|+..+|.+|.+..+++.|-.-
T Consensus 238 -----------------~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI 276 (281)
T KOG0580|consen 238 -----------------DLKFPSTISGGAADLISRLLVKNPIERLALTEVMDHPWI 276 (281)
T ss_pred -----------------cccCCcccChhHHHHHHHHhccCccccccHHHHhhhHHH
Confidence 123456788999999999999999999999999988654
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-44 Score=306.19 Aligned_cols=286 Identities=27% Similarity=0.371 Sum_probs=230.5
Q ss_pred hhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccc--cchhhHHHHHHHHHHHhccCCCcccceeeEEe
Q 018785 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKA--ESFQGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (350)
Q Consensus 20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (350)
..+|...+.||+|++|.|+.+ .+..+|+.||||.+.. ......+...+|+.+|+.++|+||+.+++++.
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA---------~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~ 91 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSA---------KDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFR 91 (359)
T ss_pred cceecccccccCcceeeEEEE---------EEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecc
Confidence 467777899999999999999 7788899999999973 34445577889999999999999999999986
Q ss_pred e-----cCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEE
Q 018785 98 E-----SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKL 172 (350)
Q Consensus 98 ~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l 172 (350)
. -+..|+|+|++ +.+|...++++. .++...+..++.|++.||.|+| +.+|+|||+||.|++++.+..+|+
T Consensus 92 p~~~~~f~DvYiV~elM-etDL~~iik~~~--~L~d~H~q~f~YQiLrgLKyiH--SAnViHRDLKPsNll~n~~c~lKI 166 (359)
T KOG0660|consen 92 PPSRDKFNDVYLVFELM-ETDLHQIIKSQQ--DLTDDHAQYFLYQILRGLKYIH--SANVIHRDLKPSNLLLNADCDLKI 166 (359)
T ss_pred cccccccceeEEehhHH-hhHHHHHHHcCc--cccHHHHHHHHHHHHHhcchhh--cccccccccchhheeeccCCCEEe
Confidence 5 35789999999 779999987764 5999999999999999999999 999999999999999999999999
Q ss_pred ccccccccCCCCCCCcccccccCCCcccCccccc-cCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcch
Q 018785 173 SDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVA-TGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADP 251 (350)
Q Consensus 173 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~ 251 (350)
+|||+++...........+....|..|+|||++. ...|+.+.||||+||++.||++|+..|.+.+.-.....+......
T Consensus 167 ~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGt 246 (359)
T KOG0660|consen 167 CDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGT 246 (359)
T ss_pred ccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCC
Confidence 9999999765442233345567788899999874 468999999999999999999999999998877666666655432
Q ss_pred hhhhhH------HHHHhhh---cccCCC---CcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHhhhcCCCCCCCC
Q 018785 252 FLRDSR------RVLRIMD---TRLGGQ---YSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS--LEQLHTSKDMPRTP 317 (350)
Q Consensus 252 ~~~~~~------~~~~~~~---~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~--L~~~~~~~~~~~~~ 317 (350)
.-.+.- .....+. ...... ..+..++...+|+.+||..||.+|+|+++.|+| |...+...+.|...
T Consensus 247 P~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP~~~ 326 (359)
T KOG0660|consen 247 PSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEPVCQ 326 (359)
T ss_pred CCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCCCCC
Confidence 211110 1111111 111111 123567899999999999999999999999998 89999888888554
Q ss_pred CC
Q 018785 318 PP 319 (350)
Q Consensus 318 ~~ 319 (350)
..
T Consensus 327 ~~ 328 (359)
T KOG0660|consen 327 PI 328 (359)
T ss_pred CC
Confidence 43
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=322.68 Aligned_cols=284 Identities=26% Similarity=0.383 Sum_probs=220.5
Q ss_pred ccccccCCCCchhhhhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch-hhHHHHHHHHHH
Q 018785 2 YLLIAMSDPSASMISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIY 80 (350)
Q Consensus 2 ~~~~~~~~~~~~~~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~ 80 (350)
|-+++-...+.........++|++.+.||+|+||.||+|++... .+..++..||+|.+..... .....+.+|+.+
T Consensus 19 ~~~~~~~~~~~~~~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~i 94 (374)
T cd05106 19 YTFIDPTQLPYNEKWEFPRDNLQFGKTLGAGAFGKVVEATAFGL----GKEDNVLRVAVKMLKASAHTDEREALMSELKI 94 (374)
T ss_pred ceeeCCccccccccccccHHHceehheecCCCcccEEEEEEecC----CcccccceeEEEeccCCCCHHHHHHHHHHHHH
Confidence 34555555555555567788999999999999999999865321 2334567899999976532 334567889999
Q ss_pred Hhcc-CCCcccceeeEEeecCceEEEEEcCCCCChhhHHhhcC-------------------------------------
Q 018785 81 LGQL-RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKG------------------------------------- 122 (350)
Q Consensus 81 l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------------------------------- 122 (350)
++.+ +|+||+++++.+...+..++||||+.+++|.+++....
T Consensus 95 l~~l~~h~nIv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (374)
T cd05106 95 LSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFS 174 (374)
T ss_pred HHhhccCCceeeEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhccccccccccc
Confidence 9999 89999999999999999999999999999999985431
Q ss_pred -------------------------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEE
Q 018785 123 -------------------------------VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAK 171 (350)
Q Consensus 123 -------------------------------~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~ 171 (350)
...++...+..++.|+++||.||| ++|++|+||||+||+++.++.++
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH--~~giiHrDLkp~Nil~~~~~~~k 252 (374)
T cd05106 175 SQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA--SKNCIHRDVAARNVLLTDGRVAK 252 (374)
T ss_pred ccccccccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHH--HCCEEeccCchheEEEeCCCeEE
Confidence 124778889999999999999999 99999999999999999999999
Q ss_pred EccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccccCcchhhhhhhcc
Q 018785 172 LSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWAD 250 (350)
Q Consensus 172 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~ 250 (350)
|+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||.........
T Consensus 253 L~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~-------- 324 (374)
T cd05106 253 ICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKF-------- 324 (374)
T ss_pred EeeceeeeeccCCcceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHH--------
Confidence 999999875433222212222334567999999988899999999999999999997 99999754321111
Q ss_pred hhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 018785 251 PFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLH 308 (350)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 308 (350)
............+..+++++.+++.+||+.||.+|||+.++++.|+++.
T Consensus 325 ---------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 325 ---------YKMVKRGYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred ---------HHHHHcccCccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 1111111112223345789999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=316.02 Aligned_cols=246 Identities=23% Similarity=0.313 Sum_probs=206.3
Q ss_pred hcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch---hhHHHHHHHHHHHhccCCCcccceeeEEe
Q 018785 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (350)
Q Consensus 21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (350)
++|++.+.||+|+||.||+| .+..+++.||+|.+..... .....+.+|+.+++.++||||+++++++.
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~---------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 71 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLV---------RDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEH 71 (291)
T ss_pred CCceeeeeeecCCCeEEEEE---------EEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhc
Confidence 47999999999999999999 5666789999999865432 23456788999999999999999999999
Q ss_pred ecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccc
Q 018785 98 ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL 177 (350)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~ 177 (350)
+.+..++||||+.+++|.+++.... .+++..+..++.|++.||+||| ++|++|+||+|+||+++.++.++|+|||+
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dlkp~NIli~~~~~~kl~Dfg~ 147 (291)
T cd05612 72 DQRFLYMLMEYVPGGELFSYLRNSG--RFSNSTGLFYASEIVCALEYLH--SKEIVYRDLKPENILLDKEGHIKLTDFGF 147 (291)
T ss_pred cCCeEEEEEeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCeeecCCCHHHeEECCCCCEEEEecCc
Confidence 9999999999999999999997664 6899999999999999999999 99999999999999999999999999999
Q ss_pred cccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhH
Q 018785 178 ARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSR 257 (350)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 257 (350)
+...... .....|++.|+|||.+.+..++.++|||||||++|+|++|..||.+.........+.
T Consensus 148 ~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~----------- 211 (291)
T cd05612 148 AKKLRDR-----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKIL----------- 211 (291)
T ss_pred chhccCC-----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-----------
Confidence 8754321 122458889999999998899999999999999999999999997654322111111
Q ss_pred HHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 018785 258 RVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPS-----MVDVLTS 303 (350)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-----~~~ll~~ 303 (350)
.. ....+..+++.+.+||++||+.||.+||+ ++++++|
T Consensus 212 ------~~--~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 212 ------AG--KLEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred ------hC--CcCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 11 11234456788999999999999999995 8998877
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=314.60 Aligned_cols=271 Identities=25% Similarity=0.309 Sum_probs=211.9
Q ss_pred hhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch-hhHHHHHHHHHHHhccCCCcccceeeEE
Q 018785 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLVKLIGYC 96 (350)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (350)
+..++|++.+.||+|+||.||++ .+..++..+|+|.+..... .....+.+|+.+++.++||||+++++++
T Consensus 2 l~~~~y~~~~~lg~G~~g~V~~~---------~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 72 (331)
T cd06649 2 LKDDDFERISELGAGNGGVVTKV---------QHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72 (331)
T ss_pred CCcccceEEEeecCCCCEEEEEE---------EECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEE
Confidence 34689999999999999999999 5666789999999876532 2345688999999999999999999999
Q ss_pred eecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCC-CeeeCCCCCCceEEcCCCcEEEccc
Q 018785 97 SESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDA-NVIYRDLKASNVLLDSNFNAKLSDF 175 (350)
Q Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~-~i~H~di~~~Nili~~~~~~~l~Df 175 (350)
..++..++||||+++++|.+++.... .+++..+..++.|++.||.||| +. +++|+||+|+||+++.++.++|+||
T Consensus 73 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH--~~~~ivH~dlkp~Nil~~~~~~~kl~Df 148 (331)
T cd06649 73 YSDGEISICMEHMDGGSLDQVLKEAK--RIPEEILGKVSIAVLRGLAYLR--EKHQIMHRDVKPSNILVNSRGEIKLCDF 148 (331)
T ss_pred EECCEEEEEeecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHh--hcCCEEcCCCChhhEEEcCCCcEEEccC
Confidence 99999999999999999999997654 6899999999999999999999 64 6999999999999999999999999
Q ss_pred cccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhc------
Q 018785 176 GLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWA------ 249 (350)
Q Consensus 176 g~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~------ 249 (350)
|++....... .....+++.|+|||.+.+..++.++|+|||||++|+|++|+.||...........+....
T Consensus 149 g~~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 224 (331)
T cd06649 149 GVSGQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEG 224 (331)
T ss_pred cccccccccc----cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccC
Confidence 9986542221 223458889999999999899999999999999999999999997544322111110000
Q ss_pred -----------------------chhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018785 250 -----------------------DPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 305 (350)
Q Consensus 250 -----------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~ 305 (350)
.+.......................+++++.+||.+||+.||++|||+.++++|-.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~ 303 (331)
T cd06649 225 EPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTF 303 (331)
T ss_pred CccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChH
Confidence 00000001111111111111122356789999999999999999999999998854
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-43 Score=309.59 Aligned_cols=269 Identities=24% Similarity=0.333 Sum_probs=204.5
Q ss_pred hcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch--hhHHHHHHHHHHHhccCCCcccceeeEEee
Q 018785 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (350)
Q Consensus 21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (350)
++|++.+.||+|++|+||+| .+..+++.||+|.+..... .....+.+|+.+++.++||||+++++++..
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~---------~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 71 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKC---------RHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRR 71 (287)
T ss_pred CCceEEEEecccCCEEEEEE---------EECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEec
Confidence 47999999999999999999 5566788999998875432 234567789999999999999999999999
Q ss_pred cCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcccccc
Q 018785 99 SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 178 (350)
Q Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~ 178 (350)
++..++||||+.++.+..+.... ..+++..++.++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||++
T Consensus 72 ~~~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH--~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~ 147 (287)
T cd07848 72 RGKLYLVFEYVEKNMLELLEEMP--NGVPPEKVRSYIYQLIKAIHWCH--KNDIVHRDIKPENLLISHNDVLKLCDFGFA 147 (287)
T ss_pred CCEEEEEEecCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEEcCCCcEEEeeccCc
Confidence 99999999999876665443332 36899999999999999999999 999999999999999999999999999999
Q ss_pred ccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhHH
Q 018785 179 RDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRR 258 (350)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (350)
........ .......+++.|+|||.+.+..++.++|+|||||++|+|++|+.||...........+.....+.......
T Consensus 148 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (287)
T cd07848 148 RNLSEGSN-ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMK 226 (287)
T ss_pred cccccccc-ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHH
Confidence 76432221 11223457889999999988899999999999999999999999998655432222222221111100000
Q ss_pred HH----Hh--hh-ccc------CCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 259 VL----RI--MD-TRL------GGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 259 ~~----~~--~~-~~~------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
.. .. .. ... .......++..+.+||.+||+.||++|||++++++|
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 227 LFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred hhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00 00 00 000 001122367789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=317.84 Aligned_cols=252 Identities=26% Similarity=0.363 Sum_probs=209.2
Q ss_pred hhhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch---hhHHHHHHHHHHHhccCCCcccc
Q 018785 15 ISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLVK 91 (350)
Q Consensus 15 ~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~ 91 (350)
...+.-.+|++.+.||+|+||.||+| .+..+++.||+|.+..... .....+.+|+.+++.++||||++
T Consensus 12 ~~~~~~~~y~~~~~lg~G~~g~V~~~---------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~ 82 (329)
T PTZ00263 12 TSSWKLSDFEMGETLGTGSFGRVRIA---------KHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVN 82 (329)
T ss_pred cCCCCchheEEEEEEEecCCeEEEEE---------EECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCc
Confidence 34445688999999999999999999 5566789999999875432 23456788999999999999999
Q ss_pred eeeEEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEE
Q 018785 92 LIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAK 171 (350)
Q Consensus 92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~ 171 (350)
+++++..++..++||||+.+++|.+++.... .+++..+..++.|++.||+||| +.|++|+||||+||+++.++.++
T Consensus 83 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH--~~~ivH~dlkp~NIll~~~~~~k 158 (329)
T PTZ00263 83 MMCSFQDENRVYFLLEFVVGGELFTHLRKAG--RFPNDVAKFYHAELVLAFEYLH--SKDIIYRDLKPENLLLDNKGHVK 158 (329)
T ss_pred EEEEEEcCCEEEEEEcCCCCChHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCeeecCCCHHHEEECCCCCEE
Confidence 9999999999999999999999999997764 6899999999999999999999 99999999999999999999999
Q ss_pred EccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcch
Q 018785 172 LSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADP 251 (350)
Q Consensus 172 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~ 251 (350)
|+|||++....... ....|++.|+|||.+.+..++.++|+|||||++|+|++|..||.+.........
T Consensus 159 l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~------- 226 (329)
T PTZ00263 159 VTDFGFAKKVPDRT-----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEK------- 226 (329)
T ss_pred EeeccCceEcCCCc-----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHH-------
Confidence 99999987542221 124688999999999999999999999999999999999999975432111111
Q ss_pred hhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 018785 252 FLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPS-----MVDVLTS 303 (350)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-----~~~ll~~ 303 (350)
+... ....+..++..+.+|+.+||+.||.+|++ ++++++|
T Consensus 227 ----------i~~~--~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 227 ----------ILAG--RLKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred ----------HhcC--CcCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 1111 11233446778999999999999999986 7888877
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-43 Score=309.35 Aligned_cols=253 Identities=26% Similarity=0.404 Sum_probs=206.8
Q ss_pred cccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh---hHHHHHHHHHHHhccCCCcccceeeEEee
Q 018785 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ---GHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (350)
Q Consensus 22 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (350)
.|++.+.||+|+||.||+| .+..+++.||+|.+...... ....+.+|+.+++.++|++|+++++.+.+
T Consensus 1 ~f~~~~~lg~G~~g~V~~~---------~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~ 71 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCAC---------QVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYET 71 (285)
T ss_pred CceEEEEEecCCCEEEEEE---------EEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEcc
Confidence 3788999999999999999 56667899999988754322 22356789999999999999999999999
Q ss_pred cCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcccccc
Q 018785 99 SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 178 (350)
Q Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~ 178 (350)
++..++||||+.+++|.+++.......+++..+..++.|++.||+||| +.|++|+||+|+||+++.++.++|+|||++
T Consensus 72 ~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH--~~~iiH~dikp~Nill~~~~~~kl~Dfg~~ 149 (285)
T cd05631 72 KDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ--RERIVYRDLKPENILLDDRGHIRISDLGLA 149 (285)
T ss_pred CCeEEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH--hCCEEeCCCCHHHEEECCCCCEEEeeCCCc
Confidence 999999999999999998886655457899999999999999999999 999999999999999999999999999998
Q ss_pred ccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhHH
Q 018785 179 RDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRR 258 (350)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (350)
....... ......|+..|+|||.+.+..++.++|||||||++|+|++|+.||...........+..
T Consensus 150 ~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~----------- 215 (285)
T cd05631 150 VQIPEGE---TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDR----------- 215 (285)
T ss_pred EEcCCCC---eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHH-----------
Confidence 7542221 12234688999999999999999999999999999999999999986543222111111
Q ss_pred HHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 018785 259 VLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPS-----MVDVLTS 303 (350)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-----~~~ll~~ 303 (350)
.+ .......+..+++++.+|+.+||+.||.+||+ ++++++|
T Consensus 216 ---~~-~~~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 216 ---RV-KEDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred ---Hh-hcccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 00 01112334567889999999999999999997 7888876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-43 Score=315.00 Aligned_cols=243 Identities=27% Similarity=0.390 Sum_probs=201.3
Q ss_pred ceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch---hhHHHHHHHHHHHhccCCCcccceeeEEeecCceE
Q 018785 27 YLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLVKLIGYCSESDNRL 103 (350)
Q Consensus 27 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 103 (350)
+.||+|+||.||+| .+..+|+.||+|++..... .....+..|+.+++.++||||+++++.+...+..+
T Consensus 1 ~~lG~G~~g~Vy~~---------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~ 71 (323)
T cd05571 1 KLLGKGTFGKVILV---------REKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLC 71 (323)
T ss_pred CeeeeCCCeEEEEE---------EECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEE
Confidence 46999999999999 5666789999999876432 22345678999999999999999999999999999
Q ss_pred EEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccccccCCC
Q 018785 104 LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPT 183 (350)
Q Consensus 104 lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~~~~~ 183 (350)
+||||+.+++|.+++.... .+++..+..++.||+.||+||| +.|++|+||||+||+++.++.++|+|||++.....
T Consensus 72 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~lH--~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~ 147 (323)
T cd05571 72 FVMEYANGGELFFHLSRER--VFSEDRARFYGAEIVSALGYLH--SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGIS 147 (323)
T ss_pred EEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--hCCeEeCCCCHHHEEECCCCCEEEeeCCCCccccc
Confidence 9999999999999987664 7899999999999999999999 99999999999999999999999999999864222
Q ss_pred CCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhHHHHHhh
Q 018785 184 GDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIM 263 (350)
Q Consensus 184 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (350)
. ........|++.|+|||++.+..++.++|||||||++|+|++|..||...........+ .
T Consensus 148 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~-----------------~ 208 (323)
T cd05571 148 D--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI-----------------L 208 (323)
T ss_pred C--CCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHH-----------------H
Confidence 1 11223356899999999999999999999999999999999999999654321111111 1
Q ss_pred hcccCCCCcHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 018785 264 DTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRP-----SMVDVLTS 303 (350)
Q Consensus 264 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~~ 303 (350)
.. ....+..+++++.+||.+||+.||++|| ++.++++|
T Consensus 209 ~~--~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 209 ME--EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred cC--CCCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 11 1233456788999999999999999999 89999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-43 Score=310.74 Aligned_cols=269 Identities=23% Similarity=0.297 Sum_probs=205.6
Q ss_pred hhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh-hHHHHHHHHHHHhccCCCcccceeeEEee
Q 018785 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ-GHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (350)
Q Consensus 20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (350)
.++|++.++||.|+||.||+| .+..++..||+|.+...... ....+.+|+.+++.++||||+++++++..
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 74 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKG---------RSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHT 74 (288)
T ss_pred cccceEeeEEecCCCEEEEEE---------EECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcC
Confidence 367999999999999999999 56667899999998754322 23456789999999999999999999999
Q ss_pred cCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcccccc
Q 018785 99 SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 178 (350)
Q Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~ 178 (350)
++..++||||+. ++|.+++.... ..++...+..++.|+++||+||| +.|++|+||||+||+++.++.++|+|||++
T Consensus 75 ~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH--~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~ 150 (288)
T cd07871 75 ERCLTLVFEYLD-SDLKQYLDNCG-NLMSMHNVKIFMFQLLRGLSYCH--KRKILHRDLKPQNLLINEKGELKLADFGLA 150 (288)
T ss_pred CCeEEEEEeCCC-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHHEEECCCCCEEECcCcce
Confidence 999999999996 49999886554 35788999999999999999999 999999999999999999999999999998
Q ss_pred ccCCCCCCCcccccccCCCcccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhh---
Q 018785 179 RDGPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLR--- 254 (350)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~--- 254 (350)
........ ......+++.|+|||.+.+ ..++.++|+||+||++|+|++|+.||.+.........+.........
T Consensus 151 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 228 (288)
T cd07871 151 RAKSVPTK--TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETW 228 (288)
T ss_pred eeccCCCc--cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHh
Confidence 65322211 1223457888999998865 56899999999999999999999999776543333333222111000
Q ss_pred ----hhHHHHHhhhcccC----CCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 255 ----DSRRVLRIMDTRLG----GQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 255 ----~~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
.............. ......++.++.+||.+||..||.+|||++++++|
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 229 PGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred hccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00111111100000 00112356789999999999999999999999865
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=314.43 Aligned_cols=254 Identities=25% Similarity=0.328 Sum_probs=219.7
Q ss_pred hhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh-hHHHHHHHHHHHhccCCCcccceeeE
Q 018785 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ-GHKEWLTEVIYLGQLRHENLVKLIGY 95 (350)
Q Consensus 17 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~ 95 (350)
......|+...+||+|.||.||+| .+..+++.||+|++..+... +.+++.+|+.+|.+++++||.++|+.
T Consensus 9 ~~~~~~~~~~~~IgrGsfG~Vyk~---------~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygs 79 (467)
T KOG0201|consen 9 IDPELLYTKLELIGRGSFGEVYKA---------IDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGS 79 (467)
T ss_pred CCcccccccchhccccccceeeee---------eeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhh
Confidence 344578899999999999999999 78888999999999877654 45788899999999999999999999
Q ss_pred EeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccc
Q 018785 96 CSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDF 175 (350)
Q Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Df 175 (350)
+..+..++++|||+.||++.+.+.... .+++..+.-++++++.|+.|+| ..+.+|+|||+.||++..+|.++|+||
T Consensus 80 yl~g~~LwiiMey~~gGsv~~lL~~~~--~~~E~~i~~ilre~l~~l~ylH--~~~kiHrDIKaanil~s~~g~vkl~Df 155 (467)
T KOG0201|consen 80 YLKGTKLWIIMEYCGGGSVLDLLKSGN--ILDEFEIAVILREVLKGLDYLH--SEKKIHRDIKAANILLSESGDVKLADF 155 (467)
T ss_pred eeecccHHHHHHHhcCcchhhhhccCC--CCccceeeeehHHHHHHhhhhh--hcceecccccccceeEeccCcEEEEec
Confidence 999999999999999999999997765 5588899999999999999999 999999999999999999999999999
Q ss_pred cccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhh
Q 018785 176 GLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRD 255 (350)
Q Consensus 176 g~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 255 (350)
|++........ ......||+.|||||++.+..|+.++||||||++.++|.+|.+|+....+......+.+
T Consensus 156 gVa~ql~~~~~--rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk-------- 225 (467)
T KOG0201|consen 156 GVAGQLTNTVK--RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPK-------- 225 (467)
T ss_pred ceeeeeechhh--ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccC--------
Confidence 99976433322 22557899999999999999999999999999999999999999987765333322222
Q ss_pred hHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 256 SRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
..+..+....++.+++|+..||..||+.|||+.++++|
T Consensus 226 ----------~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 226 ----------SAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred ----------CCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 22223344678899999999999999999999999987
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=318.14 Aligned_cols=269 Identities=28% Similarity=0.387 Sum_probs=210.7
Q ss_pred hhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch-hhHHHHHHHHHHHhcc-CCCccccee
Q 018785 16 SKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQL-RHENLVKLI 93 (350)
Q Consensus 16 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~ 93 (350)
.+...++|++.+.||+|+||.||+|++... .+..++..||+|++..... .....+.+|+.+++.+ +||||++++
T Consensus 30 ~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~----~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~ 105 (375)
T cd05104 30 WEFPRNRLSFGKTLGAGAFGKVVEATAYGL----FKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLL 105 (375)
T ss_pred cccchHHeehhheecCCccceEEEEEEecc----ccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeee
Confidence 344567899999999999999999965321 2345677899999875432 2345678899999999 899999999
Q ss_pred eEEeecCceEEEEEcCCCCChhhHHhhcC---------------------------------------------------
Q 018785 94 GYCSESDNRLLVYEFMPKGSLENHLFRKG--------------------------------------------------- 122 (350)
Q Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------------------------------------------------- 122 (350)
+++...+..++||||+++|+|.+++....
T Consensus 106 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 185 (375)
T cd05104 106 GACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADK 185 (375)
T ss_pred eeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccc
Confidence 99999999999999999999999986532
Q ss_pred ----------------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcccccccc
Q 018785 123 ----------------------VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD 180 (350)
Q Consensus 123 ----------------------~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~~ 180 (350)
...++...+..++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++..
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH--~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~ 263 (375)
T cd05104 186 RRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA--SKNCIHRDLAARNILLTHGRITKICDFGLARD 263 (375)
T ss_pred ccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH--HCCeeccCCchhhEEEECCCcEEEecCcccee
Confidence 124678889999999999999999 99999999999999999999999999999975
Q ss_pred CCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccccCcchhhhhhhcchhhhhhHHH
Q 018785 181 GPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRV 259 (350)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (350)
..............++..|+|||.+.+..++.++|+||||+++|+|++ |..||........ .
T Consensus 264 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~-----------------~ 326 (375)
T cd05104 264 IRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSK-----------------F 326 (375)
T ss_pred ccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHH-----------------H
Confidence 433222111222334567999999999999999999999999999998 8888865432111 1
Q ss_pred HHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 018785 260 LRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 307 (350)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~ 307 (350)
.+.+........+...+.++.+|+.+||+.||++|||+.++++.|++.
T Consensus 327 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 327 YKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred HHHHHhCccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 111111111222334567899999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=315.30 Aligned_cols=253 Identities=23% Similarity=0.353 Sum_probs=221.4
Q ss_pred hhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch--hhHHHHHHHHHHHhccCCCcccceeeEEe
Q 018785 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (350)
Q Consensus 20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (350)
..+|...+.+|+|+||.++++ .++..+..+++|.+..... ...+...+|+.+++++.||||+.+++.|.
T Consensus 3 m~~Ye~~~~iG~GafG~a~lv---------rhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~ 73 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLV---------RHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFE 73 (426)
T ss_pred cchhhhhhhcCccccchhhhh---------hhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchh
Confidence 468999999999999999999 7777888999998876543 34457889999999999999999999999
Q ss_pred ecCc-eEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcccc
Q 018785 98 ESDN-RLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFG 176 (350)
Q Consensus 98 ~~~~-~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg 176 (350)
+++. ++|||+|++||++.+.+.+..+..|+++.+..|+.|++.|+.||| +++|.|||||+.|||++.++.|+|+|||
T Consensus 74 ~~~~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH--~~~iLHRDlK~~Nifltk~~~VkLgDfG 151 (426)
T KOG0589|consen 74 EDGQLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLH--ENRVLHRDLKCANIFLTKDKKVKLGDFG 151 (426)
T ss_pred cCCceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH--hhhhhcccchhhhhhccccCceeecchh
Confidence 9998 999999999999999998887778999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhh
Q 018785 177 LARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDS 256 (350)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 256 (350)
++........ ......||+.|++||++.+.+|..++|||||||++|+|++-+.+|...+-......+..
T Consensus 152 laK~l~~~~~--~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~--------- 220 (426)
T KOG0589|consen 152 LAKILNPEDS--LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINR--------- 220 (426)
T ss_pred hhhhcCCchh--hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhh---------
Confidence 9987554431 23346799999999999999999999999999999999999999987654322222221
Q ss_pred HHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 257 RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
..-..++..++.++..++..|++.+|..||++.++|.+
T Consensus 221 ---------~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 221 ---------GLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred ---------ccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 12345677889999999999999999999999999987
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-43 Score=317.88 Aligned_cols=254 Identities=26% Similarity=0.360 Sum_probs=208.6
Q ss_pred hcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch---hhHHHHHHHHHHHhccCCCcccceeeEEe
Q 018785 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (350)
Q Consensus 21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (350)
++|++.+.||+|+||.||+| .+..+++.||+|++..... .....+..|+.+++.++||||+++++++.
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~ 71 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLA---------KKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQ 71 (333)
T ss_pred CCcEEEEEEeecCCeEEEEE---------EECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEE
Confidence 47999999999999999999 5566788999999876532 23456788999999999999999999999
Q ss_pred ecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccc
Q 018785 98 ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL 177 (350)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~ 177 (350)
..+..++||||+++++|.+++.... .+++..+..++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||+
T Consensus 72 ~~~~~~lv~e~~~g~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH--~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~ 147 (333)
T cd05600 72 DDEYLYLAMEYVPGGDFRTLLNNLG--VLSEDHARFYMAEMFEAVDALH--ELGYIHRDLKPENFLIDASGHIKLTDFGL 147 (333)
T ss_pred cCCEEEEEEeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCccccCCCHHHEEECCCCCEEEEeCcC
Confidence 9999999999999999999997654 6899999999999999999999 99999999999999999999999999999
Q ss_pred cccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhH
Q 018785 178 ARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSR 257 (350)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 257 (350)
+..... ......|++.|+|||.+.+..++.++|||||||++|+|++|..||...........+..+..
T Consensus 148 a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~------- 215 (333)
T cd05600 148 SKGIVT-----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKE------- 215 (333)
T ss_pred Cccccc-----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccc-------
Confidence 975433 22235688999999999999999999999999999999999999976543322222221110
Q ss_pred HHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 258 RVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
.............+++++.+++.+||..+|.+||++.++++|
T Consensus 216 ----~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 216 ----TLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred ----cccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 000000011112467899999999999999999999999987
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=326.81 Aligned_cols=266 Identities=24% Similarity=0.331 Sum_probs=220.1
Q ss_pred hhhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccC-CCccccee
Q 018785 15 ISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLR-HENLVKLI 93 (350)
Q Consensus 15 ~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~ 93 (350)
...+...+++|++.|.+|||+.||+| .+...|..||+|.+-.......+.+++|++++++|+ |+||+.++
T Consensus 31 ~~~Vg~~~v~V~~vLAEGGFa~VYla---------~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yi 101 (738)
T KOG1989|consen 31 TFTVGSHRVTVEKVLAEGGFAQVYLA---------QDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYI 101 (738)
T ss_pred EEEECCEEEEEEEEEccCCcEEEEEE---------EecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEe
Confidence 55677889999999999999999999 455556889999887777777788999999999996 99999999
Q ss_pred e-EEee--c----CceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcC
Q 018785 94 G-YCSE--S----DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS 166 (350)
Q Consensus 94 ~-~~~~--~----~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~ 166 (350)
+ .... . -..+|+||||.|+.|.||+..+-...|++.++++|+.++++|+++||.....++|||||-+||||..
T Consensus 102 dss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~ 181 (738)
T KOG1989|consen 102 DSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSA 181 (738)
T ss_pred ccccccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcC
Confidence 9 3321 1 2457999999999999999977666799999999999999999999965566999999999999999
Q ss_pred CCcEEEccccccccCCCCC-CCcc------cccccCCCcccCcccc---ccCCCCCccchhhHHHHHHHHHhCCCCCccc
Q 018785 167 NFNAKLSDFGLARDGPTGD-NTHV------STRIVGTRGYAAPEYV---ATGHLTPKSDVYSFGVVLLELLSGRRALDED 236 (350)
Q Consensus 167 ~~~~~l~Dfg~~~~~~~~~-~~~~------~~~~~~~~~~~aPE~~---~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~ 236 (350)
+|.+||||||.++--.... .... .-...-|+.|++||.+ .+..++.|+|||||||+||-|+....||++.
T Consensus 182 ~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~s 261 (738)
T KOG1989|consen 182 DGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEES 261 (738)
T ss_pred CCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcC
Confidence 9999999999997422221 1110 0113468889999976 5778999999999999999999999999865
Q ss_pred ccCcchhhhhhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcC
Q 018785 237 RGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 310 (350)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 310 (350)
.. ..+++..+.-+....++..+.+||..||++||.+||++-++++.+..+...
T Consensus 262 g~---------------------laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~ 314 (738)
T KOG1989|consen 262 GK---------------------LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK 314 (738)
T ss_pred cc---------------------eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence 32 334444444444568899999999999999999999999999999988877
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-42 Score=300.29 Aligned_cols=262 Identities=23% Similarity=0.413 Sum_probs=210.7
Q ss_pred hhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch-hhHHHHHHHHHHHhccCCCcccceeeEE
Q 018785 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLVKLIGYC 96 (350)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (350)
+..++|++.+.||+|+||.||+|+++ .....+..|++|.+..... .....+.+|+..++.++||||+++++++
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~------~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 75 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLK------LPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVI 75 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEe------cCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEE
Confidence 45678999999999999999999764 2234578999999876532 2335678899999999999999999999
Q ss_pred eecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcccc
Q 018785 97 SESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFG 176 (350)
Q Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg 176 (350)
..++..++||||+.+++|.+++.... ..+++..++.++.|++.||+||| +.|++|+||+|+||+++.++.++++|||
T Consensus 76 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~i~~al~~lH--~~~iiH~dikp~nili~~~~~~~l~dfg 152 (266)
T cd05064 76 TRGNTMMIVTEYMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLS--EMGYVHKGLAAHKVLVNSDLVCKISGFR 152 (266)
T ss_pred ecCCCcEEEEEeCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH--HCCEeeccccHhhEEEcCCCcEEECCCc
Confidence 99999999999999999999987653 36899999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccccCcchhhhhhhcchhhhh
Q 018785 177 LARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRD 255 (350)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 255 (350)
.+........ .......++..|+|||.+.+..++.++|||||||++|++++ |..||..........
T Consensus 153 ~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~------------ 219 (266)
T cd05064 153 RLQEDKSEAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIK------------ 219 (266)
T ss_pred ccccccccch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHH------------
Confidence 8764322111 11111234567999999999999999999999999999775 999997654321111
Q ss_pred hHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 018785 256 SRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 307 (350)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~ 307 (350)
.+........+..++..+.+++.+||+.+|.+||+++++++.|..+
T Consensus 220 ------~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 220 ------AVEDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred ------HHHCCCCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 1111122233556788999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-42 Score=303.05 Aligned_cols=264 Identities=29% Similarity=0.462 Sum_probs=213.4
Q ss_pred hhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch-hhHHHHHHHHHHHhccCCCcccceeeEEee
Q 018785 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (350)
Q Consensus 20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (350)
.++|++.+.||+|++|.||+|.+... ........|++|.+..... .....+.+|+..++.++||||+++++++..
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~----~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~ 79 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGP----NERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTK 79 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecC----CCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcC
Confidence 46899999999999999999965432 1234457899998875433 234568899999999999999999999999
Q ss_pred cCceEEEEEcCCCCChhhHHhhcCC--------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEE
Q 018785 99 SDNRLLVYEFMPKGSLENHLFRKGV--------------QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLL 164 (350)
Q Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~--------------~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili 164 (350)
.+..+++|||+++++|.+++..... ..++...+..++.|++.||.||| +.|++|+||+|+||++
T Consensus 80 ~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH--~~~i~H~dlkp~Nil~ 157 (283)
T cd05048 80 EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS--SHHFVHRDLAARNCLV 157 (283)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH--hCCeeccccccceEEE
Confidence 9999999999999999999976421 35788899999999999999999 9999999999999999
Q ss_pred cCCCcEEEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccccCcchh
Q 018785 165 DSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQ 243 (350)
Q Consensus 165 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~~~ 243 (350)
+.++.++|+|||++................+++.|+|||.+.+..++.++|+|||||++|+|++ |..||.+.......
T Consensus 158 ~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~- 236 (283)
T cd05048 158 GEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVI- 236 (283)
T ss_pred cCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH-
Confidence 9999999999999875433332222333455778999999988899999999999999999998 99998764432111
Q ss_pred hhhhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 018785 244 TLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 307 (350)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~ 307 (350)
..+........+..+++++.+|+.+||+.||.+||++.+++++|.++
T Consensus 237 -----------------~~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 237 -----------------EMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred -----------------HHHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 11112222234567889999999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=303.45 Aligned_cols=271 Identities=26% Similarity=0.446 Sum_probs=218.8
Q ss_pred hhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceeeEEe
Q 018785 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (350)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (350)
+..++|.+.+.||+|++|.||+|++... ....++..+++|.+..........+.+|+..++.++||||+++++++.
T Consensus 2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~----~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 77 (291)
T cd05094 2 IKRRDIVLKRELGEGAFGKVFLAECYNL----SPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCG 77 (291)
T ss_pred CchHHeEEeeeecccCCCeEEEeEeecc----CCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEc
Confidence 3467899999999999999999965432 233456779999988776666677889999999999999999999999
Q ss_pred ecCceEEEEEcCCCCChhhHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceE
Q 018785 98 ESDNRLLVYEFMPKGSLENHLFRKG--------------VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVL 163 (350)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~--------------~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nil 163 (350)
..+..++||||+++++|.+++..+. ...++...++.++.|++.||+||| ++|++|+||+|+||+
T Consensus 78 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH--~~~i~H~dlkp~Nil 155 (291)
T cd05094 78 DGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA--SQHFVHRDLATRNCL 155 (291)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH--hCCeeecccCcceEE
Confidence 9999999999999999999997643 134788999999999999999999 999999999999999
Q ss_pred EcCCCcEEEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccccCcch
Q 018785 164 LDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAE 242 (350)
Q Consensus 164 i~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~~ 242 (350)
++.++.++|+|||++................++..|+|||.+.+..++.++|+||||+++|+|++ |..||.........
T Consensus 156 ~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~ 235 (291)
T cd05094 156 VGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVI 235 (291)
T ss_pred EccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 99999999999999875433322222233445678999999988999999999999999999998 99998654432111
Q ss_pred hhhhhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcCCC
Q 018785 243 QTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKD 312 (350)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~ 312 (350)
.. .........+..++..+.+++.+||+.+|.+|||+.++++.|.++.....
T Consensus 236 ~~------------------~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~~~ 287 (291)
T cd05094 236 EC------------------ITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKATP 287 (291)
T ss_pred HH------------------HhCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhhcC
Confidence 11 11111112234467789999999999999999999999999999976543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-42 Score=306.50 Aligned_cols=276 Identities=28% Similarity=0.443 Sum_probs=209.5
Q ss_pred hhhhcccccceecccCceeEEeecccCCCcC-------CCCCCCCcEEEEEEccccch-hhHHHHHHHHHHHhccCCCcc
Q 018785 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFA-------PTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENL 89 (350)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~-------~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i 89 (350)
+..++|++.++||+|+||.||+|.+...... ......+..||+|.+..... .....+.+|+.++++++||||
T Consensus 2 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 81 (304)
T cd05096 2 FPRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNI 81 (304)
T ss_pred CchhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCe
Confidence 4568999999999999999999976532100 01234566899999876532 334568899999999999999
Q ss_pred cceeeEEeecCceEEEEEcCCCCChhhHHhhcC-----------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCe
Q 018785 90 VKLIGYCSESDNRLLVYEFMPKGSLENHLFRKG-----------------VQPISWPTRVKIAIDVARGLSFLHGLDANV 152 (350)
Q Consensus 90 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----------------~~~l~~~~~~~i~~ql~~al~~lh~~~~~i 152 (350)
+++++++.+.+..++||||+.+++|.+++.... ...++...+..++.|++.||.||| +.|+
T Consensus 82 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH--~~~i 159 (304)
T cd05096 82 IRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS--SLNF 159 (304)
T ss_pred eEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH--HCCc
Confidence 999999999999999999999999999986532 124677788999999999999999 9999
Q ss_pred eeCCCCCCceEEcCCCcEEEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh--CC
Q 018785 153 IYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS--GR 230 (350)
Q Consensus 153 ~H~di~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~--g~ 230 (350)
+|+||||+||+++.++.++|+|||++................++..|+|||.+.+..++.++|+||||+++|+|++ +.
T Consensus 160 vH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~ 239 (304)
T cd05096 160 VHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKE 239 (304)
T ss_pred cccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCC
Confidence 9999999999999999999999999975433322222223345678999999988899999999999999999987 55
Q ss_pred CCCcccccCcchhhhhhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 018785 231 RALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQ 306 (350)
Q Consensus 231 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 306 (350)
.||.............. .. ...........+..++..+.+|+.+||+.||.+|||+.++.+.|++
T Consensus 240 ~p~~~~~~~~~~~~~~~----~~-------~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 240 QPYGELTDEQVIENAGE----FF-------RDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCCCcCCHHHHHHHHHH----Hh-------hhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 67765443221111110 00 0000000011233567889999999999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=302.57 Aligned_cols=268 Identities=28% Similarity=0.436 Sum_probs=215.8
Q ss_pred hhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceeeEEee
Q 018785 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (350)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (350)
...+|.+.+.||+|+||.||++..... ....++..+++|.+..........+.+|+..+++++||+|+++++++..
T Consensus 3 ~~~~~~~~~~lg~G~~~~v~~~~~~~~----~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 78 (288)
T cd05093 3 KRHNIVLKRELGEGAFGKVFLAECYNL----CPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVE 78 (288)
T ss_pred chHHeeeccccCCcCCeeEEeeEeccC----CCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence 467899999999999999999964321 2334567799999877665556678899999999999999999999999
Q ss_pred cCceEEEEEcCCCCChhhHHhhcC-----------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCC
Q 018785 99 SDNRLLVYEFMPKGSLENHLFRKG-----------VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSN 167 (350)
Q Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~-----------~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~ 167 (350)
.+..++|+||+++++|.+++.... ...+++..+..++.|++.||+||| +.|++|+||+|+||+++.+
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH--~~~i~H~dlkp~Nili~~~ 156 (288)
T cd05093 79 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA--SQHFVHRDLATRNCLVGEN 156 (288)
T ss_pred CCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCeeecccCcceEEEccC
Confidence 999999999999999999986543 124899999999999999999999 9999999999999999999
Q ss_pred CcEEEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccccCcchhhhh
Q 018785 168 FNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLV 246 (350)
Q Consensus 168 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~~~~~~ 246 (350)
+.++|+|||++................++..|+|||.+.+..++.++|+||||+++|+|++ |..||...........+.
T Consensus 157 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~ 236 (288)
T cd05093 157 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT 236 (288)
T ss_pred CcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 9999999999875433222222222345667999999988899999999999999999998 888886544221111111
Q ss_pred hhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcC
Q 018785 247 EWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 310 (350)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 310 (350)
.......+..++.++.+++.+||+.||.+|||+.++++.|+++...
T Consensus 237 ------------------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 237 ------------------QGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred ------------------cCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 1111122334667899999999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=310.62 Aligned_cols=269 Identities=25% Similarity=0.340 Sum_probs=208.4
Q ss_pred hhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch-hhHHHHHHHHHHHhccCCCcccceeeEE
Q 018785 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLVKLIGYC 96 (350)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (350)
+..++|++.+.||.|+||.||++ .+..++..+++|.+..... .....+.+|+++++.++||||+++++++
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~---------~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 72 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKV---------SHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72 (333)
T ss_pred cchhhhheeccccCCCCEEEEEE---------EECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEE
Confidence 45689999999999999999999 5666788999998876532 2345688999999999999999999999
Q ss_pred eecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCC-CCeeeCCCCCCceEEcCCCcEEEccc
Q 018785 97 SESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLD-ANVIYRDLKASNVLLDSNFNAKLSDF 175 (350)
Q Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~-~~i~H~di~~~Nili~~~~~~~l~Df 175 (350)
..++..++||||+.+++|.+++.... .+++..+..++.|++.||.||| + .+++|+||+|+||+++.++.++|+||
T Consensus 73 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH--~~~~ivH~dlkp~Nili~~~~~~kL~Df 148 (333)
T cd06650 73 YSDGEISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDF 148 (333)
T ss_pred EECCEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--hcCCEEecCCChhhEEEcCCCCEEEeeC
Confidence 99999999999999999999997654 6889999999999999999999 6 47999999999999999999999999
Q ss_pred cccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhh-------
Q 018785 176 GLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEW------- 248 (350)
Q Consensus 176 g~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~------- 248 (350)
|++....... .....++..|+|||.+.+..++.++|+|||||++|+|++|+.||...........+...
T Consensus 149 g~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 224 (333)
T cd06650 149 GVSGQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAE 224 (333)
T ss_pred Ccchhhhhhc----cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccc
Confidence 9986532211 12245788999999999888999999999999999999999999754432111110000
Q ss_pred --------------------cchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 249 --------------------ADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 249 --------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
..+.......................++.++.+|+.+||+.||.+|||+.++++|
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h 299 (333)
T cd06650 225 SETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH 299 (333)
T ss_pred cccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence 0000000000111111111111112356789999999999999999999999976
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=306.42 Aligned_cols=282 Identities=54% Similarity=0.924 Sum_probs=226.7
Q ss_pred hhhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceee
Q 018785 15 ISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIG 94 (350)
Q Consensus 15 ~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 94 (350)
-...+.++|.-..+||+|+||.||+|.+.+ |..||||.+.........++..|+.++.+++|||++++++
T Consensus 69 el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~----------~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlG 138 (361)
T KOG1187|consen 69 ELRKATNNFSESNLIGEGGFGTVYKGVLSD----------GTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLG 138 (361)
T ss_pred HHHHHHhCCchhcceecCCCeEEEEEEECC----------CCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEE
Confidence 445567899999999999999999996643 4789999877665331455999999999999999999999
Q ss_pred EEeecC-ceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcC-CCCeeeCCCCCCceEEcCCCcEEE
Q 018785 95 YCSESD-NRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL-DANVIYRDLKASNVLLDSNFNAKL 172 (350)
Q Consensus 95 ~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~-~~~i~H~di~~~Nili~~~~~~~l 172 (350)
+|.+.+ ..+||+||+.+|+|.+.+.......++...+.+|+..++.||+|||.. ...|+|||||+.|||+|.+.+.||
T Consensus 139 yC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKl 218 (361)
T KOG1187|consen 139 YCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKL 218 (361)
T ss_pred EEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEc
Confidence 999998 499999999999999999766533789999999999999999999941 124999999999999999999999
Q ss_pred ccccccccCCCCCCCcccccc-cCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcch
Q 018785 173 SDFGLARDGPTGDNTHVSTRI-VGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADP 251 (350)
Q Consensus 173 ~Dfg~~~~~~~~~~~~~~~~~-~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~ 251 (350)
+|||++...... .. ..... .|+.+|++||.+..+..+.++||||+|+++.||++|+.+....... ....+..|..+
T Consensus 219 sDFGLa~~~~~~-~~-~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~-~~~~l~~w~~~ 295 (361)
T KOG1187|consen 219 SDFGLAKLGPEG-DT-SVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPR-GELSLVEWAKP 295 (361)
T ss_pred cCccCcccCCcc-cc-ceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCc-ccccHHHHHHH
Confidence 999999654331 11 11112 7899999999998899999999999999999999999888755421 22225565555
Q ss_pred hhhhhHHHHHhhhcccC-CCCcH-HHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcC
Q 018785 252 FLRDSRRVLRIMDTRLG-GQYSK-KEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 310 (350)
Q Consensus 252 ~~~~~~~~~~~~~~~~~-~~~~~-~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 310 (350)
.+.+. ....+++.... ...+. ..-..+..+..+|++.+|.+||++.++++.|..+...
T Consensus 296 ~~~~~-~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 296 LLEEG-KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred HHHCc-chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 55544 56666776655 44443 4566788999999999999999999999999665544
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=301.13 Aligned_cols=263 Identities=29% Similarity=0.461 Sum_probs=212.1
Q ss_pred hhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh-hHHHHHHHHHHHhccCCCcccceeeEEe
Q 018785 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ-GHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (350)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (350)
..++|.+.+.||+|++|.||+|++... ....++..|++|.+...... ....+.+|+.+++.+.||||+++++++.
T Consensus 3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~----~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 78 (280)
T cd05049 3 QRDTIVLKRELGEGAFGKVFLGECYHL----EPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCT 78 (280)
T ss_pred ChHHhhHHhhccccCCceEeeeeeccc----cCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEe
Confidence 467899999999999999999965432 22345788999998766544 3467889999999999999999999999
Q ss_pred ecCceEEEEEcCCCCChhhHHhhcC------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEc
Q 018785 98 ESDNRLLVYEFMPKGSLENHLFRKG------------VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLD 165 (350)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~------------~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~ 165 (350)
.....++||||+++++|.+++...+ ...++...+..++.|++.|+.+|| +.|++|+||+|+||+++
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH--~~~i~h~dlkp~nili~ 156 (280)
T cd05049 79 EGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA--SQHFVHRDLATRNCLVG 156 (280)
T ss_pred cCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh--hCCeeccccccceEEEc
Confidence 9999999999999999999997543 235788899999999999999999 99999999999999999
Q ss_pred CCCcEEEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccccCcchhh
Q 018785 166 SNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQT 244 (350)
Q Consensus 166 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~~~~ 244 (350)
.++.++|+|||.+................++..|+|||.+.+..++.++||||||+++|+|++ |..||...........
T Consensus 157 ~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~ 236 (280)
T cd05049 157 YDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIEC 236 (280)
T ss_pred CCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence 999999999999875333222222223345678999999999999999999999999999998 9999865443211111
Q ss_pred hhhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018785 245 LVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 305 (350)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~ 305 (350)
+........+..++..+.+++.+||+.||.+||++.++++.|.
T Consensus 237 ------------------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 237 ------------------ITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred ------------------HHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 1111112233457789999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-43 Score=318.85 Aligned_cols=275 Identities=24% Similarity=0.348 Sum_probs=218.5
Q ss_pred CchhhhhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccC-----
Q 018785 11 SASMISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLR----- 85 (350)
Q Consensus 11 ~~~~~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~----- 85 (350)
+.....++...+|.|.+.||+|+||.|-+| .+.++++.||||+++... .-..+...|+.+|..|+
T Consensus 176 Y~~v~~d~i~~rY~V~e~LGkGtFGQVvk~---------~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~ 245 (586)
T KOG0667|consen 176 YQLVVNDHIAYRYEVLEVLGKGSFGQVVKA---------YDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPD 245 (586)
T ss_pred eeEEecceeEEEEEEEEEecccccceeEEE---------EecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCC
Confidence 344566777889999999999999999999 788889999999997664 22355567888888885
Q ss_pred -CCcccceeeEEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEE
Q 018785 86 -HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLL 164 (350)
Q Consensus 86 -h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili 164 (350)
.-|+++++++|...+++|||+|.+ +.+|.++++.+....++...++.++.||+.||.+|| ..||+|+||||+|||+
T Consensus 246 ~~~n~Vrm~d~F~fr~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~--~l~IIHcDLKPENILL 322 (586)
T KOG0667|consen 246 DKYNIVRMLDYFYFRNHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLH--ELGIIHCDLKPENILL 322 (586)
T ss_pred CCeeEEEeeeccccccceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--hCCeeeccCChhheee
Confidence 468999999999999999999999 779999999998889999999999999999999999 9999999999999999
Q ss_pred cCC--CcEEEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcch
Q 018785 165 DSN--FNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAE 242 (350)
Q Consensus 165 ~~~--~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~ 242 (350)
..- ..+|++|||+++....... ..+.+..|+|||++.|..|+.+.|||||||+++||++|...|.+.+.....
T Consensus 323 ~~~~r~~vKVIDFGSSc~~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl 397 (586)
T KOG0667|consen 323 KDPKRSRIKVIDFGSSCFESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQL 397 (586)
T ss_pred ccCCcCceeEEecccccccCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHH
Confidence 653 3599999999986322221 355678899999999999999999999999999999999999988876665
Q ss_pred hhhhhhcc---hhhh-hhHHHHHhhhc-----------------------------ccCCC-----------CcHHHHHH
Q 018785 243 QTLVEWAD---PFLR-DSRRVLRIMDT-----------------------------RLGGQ-----------YSKKEAQA 278 (350)
Q Consensus 243 ~~~~~~~~---~~~~-~~~~~~~~~~~-----------------------------~~~~~-----------~~~~~~~~ 278 (350)
..+.+... +.+- ......+++.. ..... ........
T Consensus 398 ~~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~ 477 (586)
T KOG0667|consen 398 ARIIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKL 477 (586)
T ss_pred HHHHHHhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHH
Confidence 55554322 1110 00000011100 00000 11123357
Q ss_pred HHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 279 VAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 279 l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
+.++|++||.+||.+|+|..+.++|
T Consensus 478 F~dflk~~L~~dP~~R~tp~qal~H 502 (586)
T KOG0667|consen 478 FIDFLKRCLEWDPAERITPAQALNH 502 (586)
T ss_pred HHHHHHHHhccCchhcCCHHHHhcC
Confidence 8999999999999999999999988
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=305.08 Aligned_cols=262 Identities=28% Similarity=0.361 Sum_probs=212.7
Q ss_pred hhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh--------------hHHHHHHHHHHHhc
Q 018785 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ--------------GHKEWLTEVIYLGQ 83 (350)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--------------~~~~~~~e~~~l~~ 83 (350)
...++|++.+.||+|.||.|-+| .+..+++.||||++.+.... ..+..++|+.++++
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLa---------r~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKk 164 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLA---------RDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKK 164 (576)
T ss_pred eehhheehhhhhcCCccceEEEE---------eecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHh
Confidence 34579999999999999999999 77788999999998754211 12467899999999
Q ss_pred cCCCcccceeeEEee--cCceEEEEEcCCCCChhhHHhhcCCCC-CCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCC
Q 018785 84 LRHENLVKLIGYCSE--SDNRLLVYEFMPKGSLENHLFRKGVQP-ISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKAS 160 (350)
Q Consensus 84 l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~-l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~ 160 (350)
+.||||++++.+..+ .+.+|||+||+..|.+...- ..++ +++.+++++++.++.||+||| .+||+||||||.
T Consensus 165 l~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH--~QgiiHRDIKPs 239 (576)
T KOG0585|consen 165 LHHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLH--YQGIIHRDIKPS 239 (576)
T ss_pred cCCcCeeEEEEeecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHH--hcCeeccccchh
Confidence 999999999999875 46899999999777664432 2234 999999999999999999999 999999999999
Q ss_pred ceEEcCCCcEEEccccccccCCCCCC---CcccccccCCCcccCccccccCC----CCCccchhhHHHHHHHHHhCCCCC
Q 018785 161 NVLLDSNFNAKLSDFGLARDGPTGDN---THVSTRIVGTRGYAAPEYVATGH----LTPKSDVYSFGVVLLELLSGRRAL 233 (350)
Q Consensus 161 Nili~~~~~~~l~Dfg~~~~~~~~~~---~~~~~~~~~~~~~~aPE~~~~~~----~~~~~DiwslG~ll~~ll~g~~pf 233 (350)
|+|++.+|.+||+|||.+..+..... ........|||.|+|||+..++. .+.+.||||+|++||+|+.|+.||
T Consensus 240 NLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF 319 (576)
T KOG0585|consen 240 NLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPF 319 (576)
T ss_pred heEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCc
Confidence 99999999999999999986533311 11223478999999999887632 357899999999999999999999
Q ss_pred cccccCcchhhhhhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcC
Q 018785 234 DEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 310 (350)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 310 (350)
.+........ ++++....-+...++...+.+||.+||+.||++|.++.+|..|.+-...-
T Consensus 320 ~~~~~~~l~~-----------------KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g 379 (576)
T KOG0585|consen 320 FDDFELELFD-----------------KIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDG 379 (576)
T ss_pred ccchHHHHHH-----------------HHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccCC
Confidence 7765433333 33444433334446788999999999999999999999999998776663
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-44 Score=290.05 Aligned_cols=255 Identities=22% Similarity=0.327 Sum_probs=216.9
Q ss_pred hhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch--hhHHHHHHHHHHHhccCCCcccceeeE
Q 018785 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLRHENLVKLIGY 95 (350)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~ 95 (350)
...+.|.+.+.||+|.|+.|+++ .+..+|+.+++|+++.... .+.+.+.+|+.+.+.|+||||+++.+.
T Consensus 8 ~f~d~y~l~e~igkG~FSvVrRc---------~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~t 78 (355)
T KOG0033|consen 8 KFSDNYDVKEELGKGAFSVVRRC---------VHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 78 (355)
T ss_pred ccchhhhHHHHHccCchHHHHHH---------HhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhh
Confidence 44678999999999999999999 8888999999998865433 345788999999999999999999999
Q ss_pred EeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcC---CCcEEE
Q 018785 96 CSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS---NFNAKL 172 (350)
Q Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~---~~~~~l 172 (350)
+......|+|+|+++|+.|..-+.++. -+++..+...++||++||.||| .+||+|||++|+|+++.. ..-+||
T Consensus 79 i~~~~~~ylvFe~m~G~dl~~eIV~R~--~ySEa~aSH~~rQiLeal~yCH--~n~IvHRDvkP~nllLASK~~~A~vKL 154 (355)
T KOG0033|consen 79 IQEESFHYLVFDLVTGGELFEDIVARE--FYSEADASHCIQQILEALAYCH--SNGIVHRDLKPENLLLASKAKGAAVKL 154 (355)
T ss_pred hcccceeEEEEecccchHHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHH--hcCceeccCChhheeeeeccCCCceee
Confidence 999999999999999999988776653 5888899999999999999999 999999999999999954 345999
Q ss_pred ccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchh
Q 018785 173 SDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPF 252 (350)
Q Consensus 173 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 252 (350)
+|||++.... .........|+|.|++||++....|+..+|||+.|++||-|+.|..||.+.+.....+.+..
T Consensus 155 ~~FGvAi~l~---~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~----- 226 (355)
T KOG0033|consen 155 ADFGLAIEVN---DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKA----- 226 (355)
T ss_pred cccceEEEeC---CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhc-----
Confidence 9999998655 34445567899999999999999999999999999999999999999987553333332221
Q ss_pred hhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 253 LRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
..-..+......++++.++|+++||..||.+|+|+.+.|+|
T Consensus 227 ----------g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 227 ----------GAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred ----------cccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence 11122333456789999999999999999999999999877
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-42 Score=298.77 Aligned_cols=258 Identities=29% Similarity=0.466 Sum_probs=213.9
Q ss_pred hhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceeeEEe
Q 018785 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (350)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (350)
....+|++.++||.|++|.||+|. ... +..+++|.+..........+..|+..++.++||||+++++++.
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~---------~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 72 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGL---------WKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCS 72 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeE---------ecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEe
Confidence 456889999999999999999994 333 6789999998776656677889999999999999999999999
Q ss_pred ecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccc
Q 018785 98 ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL 177 (350)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~ 177 (350)
..+..++||||+++++|.+++.......++...+..++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||.
T Consensus 73 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH--~~~i~h~dl~~~nilv~~~~~~kl~d~g~ 150 (261)
T cd05148 73 VGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE--EQNSIHRDLAARNILVGEDLVCKVADFGL 150 (261)
T ss_pred cCCCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH--HCCeeccccCcceEEEcCCceEEEccccc
Confidence 9999999999999999999998766567899999999999999999999 99999999999999999999999999999
Q ss_pred cccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccccCcchhhhhhhcchhhhhh
Q 018785 178 ARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDS 256 (350)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 256 (350)
+........ ......++..|++||.+.+..++.++|+||||+++|+|++ |..||...........
T Consensus 151 ~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~------------ 216 (261)
T cd05148 151 ARLIKEDVY--LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQ------------ 216 (261)
T ss_pred hhhcCCccc--cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHH------------
Confidence 975422211 1112334567999999988889999999999999999998 8889865442111111
Q ss_pred HHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 018785 257 RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 307 (350)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~ 307 (350)
.........+..+++.+.+++.+||+.||.+|||+.++++.|+.+
T Consensus 217 ------~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 217 ------ITAGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred ------HHhCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 111122233456778899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=302.59 Aligned_cols=272 Identities=27% Similarity=0.387 Sum_probs=216.6
Q ss_pred hhhhhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch-hhHHHHHHHHHHHhcc-CCCccc
Q 018785 13 SMISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQL-RHENLV 90 (350)
Q Consensus 13 ~~~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~ 90 (350)
..-.++..++|++.+.||+|+||.||++.+... .....+..+|+|.+..... .....+.+|+.+++++ +||||+
T Consensus 27 ~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv 102 (302)
T cd05055 27 DLKWEFPRNNLSFGKTLGAGAFGKVVEATAYGL----SKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102 (302)
T ss_pred cccccccHHHeEEcceeeccCCeeEEEEEEecC----CCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcc
Confidence 345667788999999999999999999965321 2344577899998876532 3345688999999999 799999
Q ss_pred ceeeEEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcE
Q 018785 91 KLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNA 170 (350)
Q Consensus 91 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~ 170 (350)
++++.+...+..+++|||+.+++|.+++.......++..++..++.|++.||.||| +.+++|+||+|+||+++.++.+
T Consensus 103 ~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH--~~~ivH~dlkp~Nil~~~~~~~ 180 (302)
T cd05055 103 NLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA--SKNCIHRDLAARNVLLTHGKIV 180 (302)
T ss_pred eEEEEEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH--HCCeehhhhccceEEEcCCCeE
Confidence 99999999999999999999999999997655445899999999999999999999 9999999999999999999999
Q ss_pred EEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccccCcchhhhhhhc
Q 018785 171 KLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWA 249 (350)
Q Consensus 171 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~ 249 (350)
+|+|||.+................++..|+|||.+.+..++.++||||+|+++|+|++ |..||.........
T Consensus 181 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~------- 253 (302)
T cd05055 181 KICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKF------- 253 (302)
T ss_pred EECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHH-------
Confidence 9999999875433222111222345677999999988899999999999999999998 89998654321111
Q ss_pred chhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 018785 250 DPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 307 (350)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~ 307 (350)
............+...++.+.+++.+||..+|++|||+.++++.|.++
T Consensus 254 ----------~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 254 ----------YKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred ----------HHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 111111111222334577899999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-42 Score=305.24 Aligned_cols=269 Identities=23% Similarity=0.298 Sum_probs=201.2
Q ss_pred hhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh-hHHHHHHHHHHHhccCCCcccceeeEEee
Q 018785 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ-GHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (350)
Q Consensus 20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (350)
.++|++.+.||+|+||.||+| .+..+++.||+|++...... ....+.+|+.+++.++||||+++++++.+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~---------~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 74 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKG---------KSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHT 74 (303)
T ss_pred cccceEeeeEEecCCEEEEEE---------EECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEec
Confidence 478999999999999999999 56667899999998754322 23456789999999999999999999999
Q ss_pred cCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcccccc
Q 018785 99 SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 178 (350)
Q Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~ 178 (350)
.+..++||||+ +++|.+++.... ..++...+..++.|++.||+||| +.|++|+||||+||+++.++.++|+|||++
T Consensus 75 ~~~~~lv~e~~-~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH--~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 150 (303)
T cd07869 75 KETLTLVFEYV-HTDLCQYMDKHP-GGLHPENVKLFLFQLLRGLSYIH--QRYILHRDLKPQNLLISDTGELKLADFGLA 150 (303)
T ss_pred CCeEEEEEECC-CcCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEECCCCCEEECCCCcc
Confidence 99999999999 568888886653 36889999999999999999999 999999999999999999999999999998
Q ss_pred ccCCCCCCCcccccccCCCcccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCcccccCcc-hhhhhh-hcchhhhh
Q 018785 179 RDGPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLA-EQTLVE-WADPFLRD 255 (350)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~-~~~~~~-~~~~~~~~ 255 (350)
....... .......+++.|+|||++.+ ..++.++|+|||||++|+|++|..||.+..+... ...+.. ...+....
T Consensus 151 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 228 (303)
T cd07869 151 RAKSVPS--HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDT 228 (303)
T ss_pred eeccCCC--ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhh
Confidence 6432211 12233457889999998865 4578899999999999999999999976433111 111110 00000000
Q ss_pred hHHH---HHhhhcccCCCCc---------HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 256 SRRV---LRIMDTRLGGQYS---------KKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 256 ~~~~---~~~~~~~~~~~~~---------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
.... ............+ ...++.+.+|+.+||+.||.+|||+.++++|
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h 288 (303)
T cd07869 229 WPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH 288 (303)
T ss_pred ccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence 0000 0000000000000 1134678899999999999999999999975
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=308.23 Aligned_cols=270 Identities=29% Similarity=0.404 Sum_probs=211.9
Q ss_pred hhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch-hhHHHHHHHHHHHhcc-CCCcccceee
Q 018785 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQL-RHENLVKLIG 94 (350)
Q Consensus 17 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~ 94 (350)
.+..++|++.+.||.|+||.||+|+..+. .+..+++.||+|++..... .....+..|+..++++ +|+||+++++
T Consensus 3 ~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~----~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~ 78 (337)
T cd05054 3 EFPRDRLKLGKPLGRGAFGKVIQASAFGI----EKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLG 78 (337)
T ss_pred ccCHHHhhhhcccccCcCceEEecccccc----ccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheee
Confidence 45578999999999999999999965432 2445678999999875432 2335677899999999 7999999999
Q ss_pred EEee-cCceEEEEEcCCCCChhhHHhhcCC--------------------------------------------------
Q 018785 95 YCSE-SDNRLLVYEFMPKGSLENHLFRKGV-------------------------------------------------- 123 (350)
Q Consensus 95 ~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~-------------------------------------------------- 123 (350)
++.. +...++++||+.+++|.+++.....
T Consensus 79 ~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (337)
T cd05054 79 ACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEE 158 (337)
T ss_pred eEecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhccc
Confidence 8754 4578899999999999999864321
Q ss_pred ---------CCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccccccCCCCCCCccccccc
Q 018785 124 ---------QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 194 (350)
Q Consensus 124 ---------~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~ 194 (350)
..++...+..++.|++.||+||| +.|++|+||||.||+++.++.++|+|||++................
T Consensus 159 ~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH--~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~ 236 (337)
T cd05054 159 DEEGDELYKEPLTLEDLISYSFQVARGMEFLA--SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 236 (337)
T ss_pred chhhhHHhhcCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCC
Confidence 25788899999999999999999 9999999999999999999999999999997643332222222234
Q ss_pred CCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccccCcchhhhhhhcchhhhhhHHHHHhhhcccCCCCcH
Q 018785 195 GTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSK 273 (350)
Q Consensus 195 ~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (350)
++..|+|||.+.+..++.++|||||||++|+|++ |..||.+...... ....+........+.
T Consensus 237 ~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~-----------------~~~~~~~~~~~~~~~ 299 (337)
T cd05054 237 LPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE-----------------FCRRLKEGTRMRAPE 299 (337)
T ss_pred CCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH-----------------HHHHHhccCCCCCCc
Confidence 5667999999999999999999999999999998 9999875332111 001111111122234
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhc
Q 018785 274 KEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHT 309 (350)
Q Consensus 274 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 309 (350)
..++++.+++.+||+.+|++||++.+++++|..+..
T Consensus 300 ~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 300 YATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 567789999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=309.83 Aligned_cols=243 Identities=26% Similarity=0.383 Sum_probs=200.5
Q ss_pred ceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch---hhHHHHHHHHHHHhccCCCcccceeeEEeecCceE
Q 018785 27 YLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLVKLIGYCSESDNRL 103 (350)
Q Consensus 27 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 103 (350)
+.||+|+||.||++ .+..+|..||+|.+..... .....+..|+.+++.++||||+++++.+...+..+
T Consensus 1 ~~lG~G~~g~Vy~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~ 71 (323)
T cd05595 1 KLLGKGTFGKVILV---------REKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 71 (323)
T ss_pred CeeeeCCCEEEEEE---------EECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEE
Confidence 47999999999999 5666789999999876532 23345678999999999999999999999999999
Q ss_pred EEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccccccCCC
Q 018785 104 LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPT 183 (350)
Q Consensus 104 lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~~~~~ 183 (350)
+||||+++++|.+++.... .+++..++.++.||+.||.||| +.|++|+||||+||+++.++.++|+|||++.....
T Consensus 72 lv~E~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH--~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 147 (323)
T cd05595 72 FVMEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLH--SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 147 (323)
T ss_pred EEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCeEecCCCHHHEEEcCCCCEEecccHHhccccC
Confidence 9999999999998887654 6899999999999999999999 99999999999999999999999999999864222
Q ss_pred CCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhHHHHHhh
Q 018785 184 GDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIM 263 (350)
Q Consensus 184 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (350)
.. .......|++.|+|||.+.+..++.++|+|||||++|+|++|..||...........+ .
T Consensus 148 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~-----------------~ 208 (323)
T cd05595 148 DG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI-----------------L 208 (323)
T ss_pred CC--CccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH-----------------h
Confidence 11 1122356889999999999999999999999999999999999999754422111111 1
Q ss_pred hcccCCCCcHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 018785 264 DTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRP-----SMVDVLTS 303 (350)
Q Consensus 264 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~~ 303 (350)
.. ....+..+++++.++|.+||+.||.+|+ ++.++++|
T Consensus 209 ~~--~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 209 ME--EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred cC--CCCCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 11 1123456788999999999999999998 89999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=326.49 Aligned_cols=272 Identities=29% Similarity=0.446 Sum_probs=230.4
Q ss_pred hhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh-hHHHHHHHHHHHhccCCCcccceee
Q 018785 16 SKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ-GHKEWLTEVIYLGQLRHENLVKLIG 94 (350)
Q Consensus 16 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~ 94 (350)
-....++.+..+.||+|.||.||+|+..+- .-......||||.++..... ...+|++|++++..|+||||+++++
T Consensus 481 ~~i~r~~i~~~~eLGegaFGkVf~a~~~~l----~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlG 556 (774)
T KOG1026|consen 481 LEIPRSDIVFKEELGEGAFGKVFLAEAYGL----LPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLG 556 (774)
T ss_pred eEechhheeehhhhcCchhhhhhhhhccCC----CCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEE
Confidence 344456788889999999999999975421 22345678999999887665 6688999999999999999999999
Q ss_pred EEeecCceEEEEEcCCCCChhhHHhhcC--------CCC----CCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCce
Q 018785 95 YCSESDNRLLVYEFMPKGSLENHLFRKG--------VQP----ISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNV 162 (350)
Q Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------~~~----l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Ni 162 (350)
++.+++.+++|+||+..|+|.+|+..+. +.. ++..+.+.|+.||+.|+.||- ++.++||||-.+|+
T Consensus 557 VC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs--~~~FVHRDLATRNC 634 (774)
T KOG1026|consen 557 VCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS--SHHFVHRDLATRNC 634 (774)
T ss_pred EEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH--hCcccccchhhhhc
Confidence 9999999999999999999999997653 223 888999999999999999999 99999999999999
Q ss_pred EEcCCCcEEEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccccCcc
Q 018785 163 LLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLA 241 (350)
Q Consensus 163 li~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~ 241 (350)
+|.++..||++|||+++.....+.........-..+|||||.+..+.|+.+|||||+|++|||+++ |..||.+..+++.
T Consensus 635 LVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EV 714 (774)
T KOG1026|consen 635 LVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEV 714 (774)
T ss_pred eeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHH
Confidence 999999999999999987655554443333445678999999999999999999999999999998 7889887776444
Q ss_pred hhhhhhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcCC
Q 018785 242 EQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSK 311 (350)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~ 311 (350)
.+.+ ....-...|.++|.++++|+..||+.+|.+||++.+|-..|+......
T Consensus 715 Ie~i------------------~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s 766 (774)
T KOG1026|consen 715 IECI------------------RAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQAS 766 (774)
T ss_pred HHHH------------------HcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcC
Confidence 4333 333335667899999999999999999999999999999999887664
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=297.59 Aligned_cols=259 Identities=26% Similarity=0.417 Sum_probs=211.9
Q ss_pred hhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceeeEEe
Q 018785 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (350)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (350)
+...+|.+.+.||+|++|.||+| .....+..|++|.+.... .....+.+|+..++.++||+|+++++++.
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~---------~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 72 (263)
T cd05052 3 MERTDITMKHKLGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCT 72 (263)
T ss_pred CchHHeEEeeecCCcccceEEEE---------EEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEc
Confidence 45678999999999999999999 444567889999887543 33456788999999999999999999999
Q ss_pred ecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccc
Q 018785 98 ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL 177 (350)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~ 177 (350)
.++..+++|||+.+++|.+++.......++...+..++.|++++|++|| ++|++|+||+|+||+++.++.++|+|||.
T Consensus 73 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH--~~~i~H~dlkp~nil~~~~~~~kl~df~~ 150 (263)
T cd05052 73 REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVADFGL 150 (263)
T ss_pred CCCCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCEeecccCcceEEEcCCCcEEeCCCcc
Confidence 9999999999999999999997765557899999999999999999999 99999999999999999999999999999
Q ss_pred cccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccccCcchhhhhhhcchhhhhh
Q 018785 178 ARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDS 256 (350)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 256 (350)
+......... .......+..|+|||.+.+..++.++|+||||+++|+|++ |..||.+.......
T Consensus 151 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~-------------- 215 (263)
T cd05052 151 SRLMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY-------------- 215 (263)
T ss_pred ccccccceee-ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH--------------
Confidence 8764332211 1111223457999999988899999999999999999998 88888654321111
Q ss_pred HHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 018785 257 RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 307 (350)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~ 307 (350)
...........+..++.++.+++.+||+.+|++|||+.++++.|+.+
T Consensus 216 ----~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 216 ----ELLEKGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred ----HHHHCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 11111122234456778999999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-42 Score=322.92 Aligned_cols=255 Identities=22% Similarity=0.275 Sum_probs=207.9
Q ss_pred hhcccccceecccCceeEEeecccCCCcCCCCCCC-CcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceeeEEee
Q 018785 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGS-GIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (350)
Q Consensus 20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (350)
...|.+.+.||+|++|.||+| .+..+ +..|++|.+..........+..|+.+++.++||||+++++.+..
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a---------~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~ 136 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVA---------TRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKS 136 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEE---------EEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEE
Confidence 445999999999999999999 44444 67889998766555555667889999999999999999999999
Q ss_pred cCceEEEEEcCCCCChhhHHhhc--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcccc
Q 018785 99 SDNRLLVYEFMPKGSLENHLFRK--GVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFG 176 (350)
Q Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg 176 (350)
++..|+||||+++++|.+++... ....+++.++..++.|++.||.||| +.|++||||||+||+++.++.++|+|||
T Consensus 137 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH--~~~ivHrDlkp~NIll~~~~~~kL~DFg 214 (478)
T PTZ00267 137 DDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH--SRKMMHRDLKSANIFLMPTGIIKLGDFG 214 (478)
T ss_pred CCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH--hCCEEECCcCHHhEEECCCCcEEEEeCc
Confidence 99999999999999999988542 2346899999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhh
Q 018785 177 LARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDS 256 (350)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 256 (350)
++................|++.|+|||.+.+..++.++|||||||++|+|++|+.||..........
T Consensus 215 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~------------- 281 (478)
T PTZ00267 215 FSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQ------------- 281 (478)
T ss_pred CceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-------------
Confidence 9976543322222334568999999999988999999999999999999999999997543211111
Q ss_pred HHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 257 RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
.... ......+..+++++.++|.+||..||++||++.+++.+
T Consensus 282 ----~~~~-~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 282 ----QVLY-GKYDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred ----HHHh-CCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 1111 11112344577899999999999999999999998754
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=306.98 Aligned_cols=251 Identities=24% Similarity=0.367 Sum_probs=219.1
Q ss_pred hhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhh--HHHHHHHHHHHhccCCCcccceeeEE
Q 018785 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQG--HKEWLTEVIYLGQLRHENLVKLIGYC 96 (350)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (350)
..+-|.+++-||+|.|..|-+| .+.-+|+.||||++.+..... ..++.+|++.++.++||||+++|.+.
T Consensus 16 IAGLYDLekTlG~GHFAVVKLA---------rHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEVi 86 (864)
T KOG4717|consen 16 IAGLYDLEKTLGRGHFAVVKLA---------RHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVI 86 (864)
T ss_pred eeeeehhhhhhcCCceehhhhh---------hhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehh
Confidence 3577999999999999999999 888999999999998875543 46789999999999999999999999
Q ss_pred eecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEc-CCCcEEEccc
Q 018785 97 SESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLD-SNFNAKLSDF 175 (350)
Q Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~-~~~~~~l~Df 175 (350)
.....+|||+|.-++|+|.||+.++. ..+.+..+.+++.||+.|+.||| +..++|+||||+|+.+. .-|-|||+||
T Consensus 87 DTQTKlyLiLELGD~GDl~DyImKHe-~Gl~E~La~kYF~QI~~AI~YCH--qLHVVHRDLKPENVVFFEKlGlVKLTDF 163 (864)
T KOG4717|consen 87 DTQTKLYLILELGDGGDLFDYIMKHE-EGLNEDLAKKYFAQIVHAISYCH--QLHVVHRDLKPENVVFFEKLGLVKLTDF 163 (864)
T ss_pred cccceEEEEEEecCCchHHHHHHhhh-ccccHHHHHHHHHHHHHHHHHHh--hhhhhcccCCcceeEEeeecCceEeeec
Confidence 99999999999999999999998876 37999999999999999999999 99999999999999775 4588999999
Q ss_pred cccccCCCCCCCcccccccCCCcccCccccccCCCC-CccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhh
Q 018785 176 GLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLT-PKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLR 254 (350)
Q Consensus 176 g~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~-~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~ 254 (350)
|++..+..+... +..+|...|.|||++.|..|+ ++.||||||++||-|++|+.||+.-++.+.
T Consensus 164 GFSNkf~PG~kL---~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET------------- 227 (864)
T KOG4717|consen 164 GFSNKFQPGKKL---TTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET------------- 227 (864)
T ss_pred cccccCCCcchh---hcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh-------------
Confidence 999876665543 445799999999999999997 689999999999999999999987654333
Q ss_pred hhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 255 DSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
+..+++..+ ..|..++.++++||..||..||++|.|.++|..+
T Consensus 228 ----LTmImDCKY--tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 228 ----LTMIMDCKY--TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred ----hhhhhcccc--cCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 333333332 3577899999999999999999999999999866
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=299.87 Aligned_cols=265 Identities=25% Similarity=0.421 Sum_probs=208.7
Q ss_pred hhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccc-hhhHHHHHHHHHHHhccCCCcccceeeE
Q 018785 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES-FQGHKEWLTEVIYLGQLRHENLVKLIGY 95 (350)
Q Consensus 17 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 95 (350)
++..++|++.+.||+|++|.||+|++... ....++..||+|.+.... ......+.+|+..++.++||||++++++
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~----~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~ 77 (277)
T cd05062 2 EVAREKITMSRELGQGSFGMVYEGIAKGV----VKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGV 77 (277)
T ss_pred cccHHHceeeeeeccccCCeEEEEEeccC----CCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEE
Confidence 56789999999999999999999976532 233456789999886433 2334567889999999999999999999
Q ss_pred EeecCceEEEEEcCCCCChhhHHhhcC--------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCC
Q 018785 96 CSESDNRLLVYEFMPKGSLENHLFRKG--------VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSN 167 (350)
Q Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--------~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~ 167 (350)
+...+..++||||+.+++|.+++.... ...++...+..++.|++.||.||| +.|++|+||+|+||+++.+
T Consensus 78 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH--~~~~vH~dlkp~Nil~~~~ 155 (277)
T cd05062 78 VSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN--ANKFVHRDLAARNCMVAED 155 (277)
T ss_pred EcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCcchheEEEcCC
Confidence 999999999999999999999986532 123567788999999999999999 8999999999999999999
Q ss_pred CcEEEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccccCcchhhhh
Q 018785 168 FNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLV 246 (350)
Q Consensus 168 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~~~~~~ 246 (350)
+.++|+|||++................++..|+|||.+.+..++.++|+||||+++|+|++ |..||.+.........+.
T Consensus 156 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~ 235 (277)
T cd05062 156 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVM 235 (277)
T ss_pred CCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 9999999999875433222211222334667999999988899999999999999999998 688886544221111110
Q ss_pred hhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018785 247 EWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 305 (350)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~ 305 (350)
.......+..++..+.+++.+||+.||.+|||+.++++.|+
T Consensus 236 ------------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 236 ------------------EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred ------------------cCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 11111223456778999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-42 Score=308.63 Aligned_cols=243 Identities=27% Similarity=0.385 Sum_probs=200.7
Q ss_pred ceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch---hhHHHHHHHHHHHhccCCCcccceeeEEeecCceE
Q 018785 27 YLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLVKLIGYCSESDNRL 103 (350)
Q Consensus 27 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 103 (350)
+.||+|+||.||++ .+..++..||+|++..... .....+.+|+.+++.+.||||+++++.+...+..+
T Consensus 1 ~~lG~G~~g~Vy~~---------~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 71 (328)
T cd05593 1 KLLGKGTFGKVILV---------REKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLC 71 (328)
T ss_pred CeeeeCCCEEEEEE---------EECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEE
Confidence 46899999999999 6666789999999876432 23356778999999999999999999999999999
Q ss_pred EEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccccccCCC
Q 018785 104 LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPT 183 (350)
Q Consensus 104 lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~~~~~ 183 (350)
+||||+++++|.+++.... .+++..+..++.||+.||+||| +.|++|+||||+||+++.++.++|+|||++.....
T Consensus 72 lv~Ey~~~g~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH--~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~ 147 (328)
T cd05593 72 FVMEYVNGGELFFHLSRER--VFSEDRTRFYGAEIVSALDYLH--SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGIT 147 (328)
T ss_pred EEEeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--hCCeEecccCHHHeEECCCCcEEEecCcCCccCCC
Confidence 9999999999999887654 6899999999999999999999 99999999999999999999999999999864222
Q ss_pred CCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhHHHHHhh
Q 018785 184 GDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIM 263 (350)
Q Consensus 184 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (350)
. ........|++.|+|||.+.+..++.++|+|||||++|+|++|..||...........+ .
T Consensus 148 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~-----------------~ 208 (328)
T cd05593 148 D--AATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI-----------------L 208 (328)
T ss_pred c--ccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHh-----------------c
Confidence 1 11222356889999999999889999999999999999999999999754321111111 0
Q ss_pred hcccCCCCcHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 018785 264 DTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRP-----SMVDVLTS 303 (350)
Q Consensus 264 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~~ 303 (350)
. .....+..+++++.++|.+||+.||.+|+ ++.++++|
T Consensus 209 ~--~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 209 M--EDIKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred c--CCccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 0 11233456778999999999999999997 89999987
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=312.52 Aligned_cols=271 Identities=27% Similarity=0.385 Sum_probs=212.8
Q ss_pred hhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh-hHHHHHHHHHHHhccC-CCccccee
Q 018785 16 SKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ-GHKEWLTEVIYLGQLR-HENLVKLI 93 (350)
Q Consensus 16 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~-h~~i~~~~ 93 (350)
.....++|++.++||+|+||.||+|++... .....+..||||.+...... ....+..|+.+++++. ||||++++
T Consensus 32 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~----~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~ 107 (400)
T cd05105 32 WEFPRDGLVLGRILGSGAFGKVVEGTAYGL----SRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLL 107 (400)
T ss_pred eeccccceehhheecCCCCceEEEEEEccc----CCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEE
Confidence 344467899999999999999999965321 23344668999999765432 3456889999999996 99999999
Q ss_pred eEEeecCceEEEEEcCCCCChhhHHhhcC---------------------------------------------------
Q 018785 94 GYCSESDNRLLVYEFMPKGSLENHLFRKG--------------------------------------------------- 122 (350)
Q Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------------------------------------------------- 122 (350)
+++...+..++||||+++++|.+++..+.
T Consensus 108 ~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 187 (400)
T cd05105 108 GACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQ 187 (400)
T ss_pred EEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccc
Confidence 99999999999999999999999886431
Q ss_pred -------------------------------------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCC
Q 018785 123 -------------------------------------------VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKA 159 (350)
Q Consensus 123 -------------------------------------------~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~ 159 (350)
...++...+..++.|++.||.||| +.+++|+||+|
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH--~~~ivH~dikp 265 (400)
T cd05105 188 YVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA--SKNCVHRDLAA 265 (400)
T ss_pred cchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH--hCCeeCCCCCh
Confidence 124777888999999999999999 99999999999
Q ss_pred CceEEcCCCcEEEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCccccc
Q 018785 160 SNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRG 238 (350)
Q Consensus 160 ~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~ 238 (350)
+||+++.++.++|+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||.....
T Consensus 266 ~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~ 345 (400)
T cd05105 266 RNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIV 345 (400)
T ss_pred HhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccch
Confidence 999999999999999999875433222222222345677999999988899999999999999999997 8899865432
Q ss_pred CcchhhhhhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhc
Q 018785 239 GLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHT 309 (350)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 309 (350)
.... ...+........+..++..+.+++.+||+.||++|||+.++.+.|.++..
T Consensus 346 ~~~~-----------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 346 DSTF-----------------YNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred hHHH-----------------HHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 1110 01111111222344667899999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=295.08 Aligned_cols=261 Identities=29% Similarity=0.449 Sum_probs=210.2
Q ss_pred hhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh-hHHHHHHHHHHHhccCCCcccceeeEEee
Q 018785 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ-GHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (350)
Q Consensus 20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (350)
.++|++.+.||+|+||.||+|++.. ...+...|++|.+...... ....+..|+..++.++||||+++++++..
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~------~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 76 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKL------PGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTK 76 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEcc------CCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEec
Confidence 5789999999999999999997642 2234568999988765432 34567889999999999999999999999
Q ss_pred cCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcccccc
Q 018785 99 SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 178 (350)
Q Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~ 178 (350)
.+..+++||++.+++|.+++..... .++...+..++.|++.||.||| +++++|+||+|+||+++.++.++|+|||++
T Consensus 77 ~~~~~iv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~Lh--~~~i~H~di~p~nili~~~~~~~l~dfg~~ 153 (266)
T cd05033 77 SRPVMIITEYMENGSLDKFLRENDG-KFTVGQLVGMLRGIASGMKYLS--EMNYVHRDLAARNILVNSNLVCKVSDFGLS 153 (266)
T ss_pred CCceEEEEEcCCCCCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCcceEEEcCCCCEEECccchh
Confidence 9999999999999999999976543 6899999999999999999999 999999999999999999999999999999
Q ss_pred ccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccccCcchhhhhhhcchhhhhhH
Q 018785 179 RDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSR 257 (350)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 257 (350)
................++..|+|||.+.+..++.++|+||||+++|+|++ |..||...........+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~------------ 221 (266)
T cd05033 154 RRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAV------------ 221 (266)
T ss_pred hcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHH------------
Confidence 86542222211112234567999999988899999999999999999998 98898654322111111
Q ss_pred HHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 018785 258 RVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 307 (350)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~ 307 (350)
........+..++..+.+++.+||+.+|.+||++.+++++|.++
T Consensus 222 ------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 222 ------EDGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred ------HcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11111122345678899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-42 Score=308.12 Aligned_cols=241 Identities=26% Similarity=0.373 Sum_probs=198.1
Q ss_pred ecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccc---hhhHHHHHHHHHHHhccCCCcccceeeEEeecCceEEE
Q 018785 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES---FQGHKEWLTEVIYLGQLRHENLVKLIGYCSESDNRLLV 105 (350)
Q Consensus 29 lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 105 (350)
||+|+||.||+| .+..+++.||+|.+.... ......+..|+.++++++||||+++++.+...+..++|
T Consensus 1 lg~G~~g~Vy~~---------~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 71 (312)
T cd05585 1 IGKGSFGKVMQV---------RKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLV 71 (312)
T ss_pred CCcCCCeEEEEE---------EECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEE
Confidence 699999999999 566678899999987543 22335577899999999999999999999999999999
Q ss_pred EEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccccccCCCCC
Q 018785 106 YEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGD 185 (350)
Q Consensus 106 ~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~~~~~~~ 185 (350)
|||+.+++|.+++.... .+++..+..++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 72 ~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH--~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 147 (312)
T cd05585 72 LAFINGGELFHHLQREG--RFDLSRARFYTAELLCALENLH--KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD 147 (312)
T ss_pred EcCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--hCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC
Confidence 99999999999997654 6899999999999999999999 9999999999999999999999999999987532211
Q ss_pred CCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhHHHHHhhhc
Q 018785 186 NTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDT 265 (350)
Q Consensus 186 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (350)
.......|++.|+|||.+.+..++.++|||||||++|+|++|..||.......... .....
T Consensus 148 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~-----------------~~~~~ 208 (312)
T cd05585 148 --DKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYR-----------------KILQE 208 (312)
T ss_pred --CccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHH-----------------HHHcC
Confidence 12233568999999999999999999999999999999999999997543211111 11111
Q ss_pred ccCCCCcHHHHHHHHHHHHHhhccCCCCCCC---HHHHHHH
Q 018785 266 RLGGQYSKKEAQAVAAVVLQCLHMDPKNRPS---MVDVLTS 303 (350)
Q Consensus 266 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps---~~~ll~~ 303 (350)
....+..+++++.+++.+||..||.+||+ +.++++|
T Consensus 209 --~~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 209 --PLRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred --CCCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 12334567789999999999999999975 6777765
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=311.85 Aligned_cols=253 Identities=25% Similarity=0.299 Sum_probs=208.2
Q ss_pred hhhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch---hhHHHHHHHHHHHhccCCCcccc
Q 018785 15 ISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLVK 91 (350)
Q Consensus 15 ~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~ 91 (350)
......++|.+.+.||+|+||.||+|++.. ..+..||+|.+..... .....+.+|+.+++.++||||++
T Consensus 24 ~~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~ 95 (340)
T PTZ00426 24 KNKMKYEDFNFIRTLGTGSFGRVILATYKN--------EDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVN 95 (340)
T ss_pred CCCCChhhcEEEEEEeecCCeEEEEEEEEC--------CCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcc
Confidence 455567799999999999999999995432 1246899998865432 23356778999999999999999
Q ss_pred eeeEEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEE
Q 018785 92 LIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAK 171 (350)
Q Consensus 92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~ 171 (350)
+++++.+.+..++||||+.+++|.+++.... .+++..+..++.|++.||.||| +.|++|+||||+||+++.++.++
T Consensus 96 ~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~aL~~LH--~~~ivHrDLkp~NILl~~~~~ik 171 (340)
T PTZ00426 96 LYGSFKDESYLYLVLEFVIGGEFFTFLRRNK--RFPNDVGCFYAAQIVLIFEYLQ--SLNIVYRDLKPENLLLDKDGFIK 171 (340)
T ss_pred eEEEEEeCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCeEccCCCHHHEEECCCCCEE
Confidence 9999999999999999999999999997765 6899999999999999999999 99999999999999999999999
Q ss_pred EccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcch
Q 018785 172 LSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADP 251 (350)
Q Consensus 172 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~ 251 (350)
|+|||++...... .....|++.|+|||++.+..++.++|+|||||++|+|++|..||...........+.
T Consensus 172 L~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~----- 241 (340)
T PTZ00426 172 MTDFGFAKVVDTR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKIL----- 241 (340)
T ss_pred EecCCCCeecCCC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHh-----
Confidence 9999999754221 123468899999999998889999999999999999999999997644321111111
Q ss_pred hhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 018785 252 FLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRP-----SMVDVLTS 303 (350)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~~ 303 (350)
.. ....+..+++.+.+++++||+.||.+|+ +++++++|
T Consensus 242 ------------~~--~~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 242 ------------EG--IIYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred ------------cC--CCCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 11 1123445677899999999999999995 89999887
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=313.99 Aligned_cols=254 Identities=26% Similarity=0.357 Sum_probs=208.3
Q ss_pred hcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch---hhHHHHHHHHHHHhccCCCcccceeeEEe
Q 018785 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (350)
Q Consensus 21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (350)
++|++.+.||+|+||+||+| .+..+++.||+|++..... .....+..|..+++.++||+|+++++++.
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~---------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 71 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLV---------RDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQ 71 (350)
T ss_pred CCceEEEEEEeCCcEEEEEE---------EECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhhee
Confidence 47999999999999999999 5666789999999876432 23456788999999999999999999999
Q ss_pred ecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccc
Q 018785 98 ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL 177 (350)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~ 177 (350)
+++..++||||+.+++|.+++.... .+++..+..++.|++.||+||| +.|++|+||||+||+++.++.++|+|||+
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH--~~giiH~Dlkp~NIll~~~~~~kL~Dfg~ 147 (350)
T cd05573 72 DEEHLYLVMEYMPGGDLMNLLIRKD--VFPEETARFYIAELVLALDSVH--KLGFIHRDIKPDNILIDADGHIKLADFGL 147 (350)
T ss_pred cCCeEEEEEcCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCeeccCCCHHHeEECCCCCEEeecCCC
Confidence 9999999999999999999998763 7999999999999999999999 99999999999999999999999999999
Q ss_pred cccCCCCC---------------------------CCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCC
Q 018785 178 ARDGPTGD---------------------------NTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR 230 (350)
Q Consensus 178 ~~~~~~~~---------------------------~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~ 230 (350)
+....... .........|++.|+|||.+.+..++.++|||||||++|+|++|+
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~ 227 (350)
T cd05573 148 CKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGF 227 (350)
T ss_pred CccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCC
Confidence 87543322 001122356889999999999999999999999999999999999
Q ss_pred CCCcccccCcchhhhhhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCC-HHHHHHH
Q 018785 231 RALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPS-MVDVLTS 303 (350)
Q Consensus 231 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-~~~ll~~ 303 (350)
.||...........+..+. ..........+++++.+||.+||. ||.+||+ ++++++|
T Consensus 228 ~Pf~~~~~~~~~~~i~~~~---------------~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 228 PPFYSDTLQETYNKIINWK---------------ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred CCCCCCCHHHHHHHHhccC---------------CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 9997655322222221110 011111112368899999999998 9999999 9999987
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=298.18 Aligned_cols=253 Identities=21% Similarity=0.319 Sum_probs=204.3
Q ss_pred hhccccc--ceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhh---HHHHHHHHHHHhccCCCcccceee
Q 018785 20 TKNFCSD--YLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQG---HKEWLTEVIYLGQLRHENLVKLIG 94 (350)
Q Consensus 20 ~~~y~i~--~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~ 94 (350)
.+++... ..||+|+++.||+|.+ +|+.||||.+....... ...+.+|+.++++++||||+++++
T Consensus 17 ~~~i~~~~~~~i~~g~~~~v~~~~~-----------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g 85 (283)
T PHA02988 17 SDDIDKYTSVLIKENDQNSIYKGIF-----------NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYG 85 (283)
T ss_pred HHHcCCCCCeEEeeCCceEEEEEEE-----------CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEee
Confidence 3444444 6899999999999954 37789999987654332 356779999999999999999999
Q ss_pred EEee----cCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCC-CCeeeCCCCCCceEEcCCCc
Q 018785 95 YCSE----SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLD-ANVIYRDLKASNVLLDSNFN 169 (350)
Q Consensus 95 ~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~-~~i~H~di~~~Nili~~~~~ 169 (350)
++.+ ....++||||+++++|.+++.... .++......++.|++.||.+|| + .+++|+||+|+||+++.++.
T Consensus 86 ~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lH--~~~~~~Hrdlkp~nill~~~~~ 161 (283)
T PHA02988 86 FIIDIVDDLPRLSLILEYCTRGYLREVLDKEK--DLSFKTKLDMAIDCCKGLYNLY--KYTNKPYKNLTSVSFLVTENYK 161 (283)
T ss_pred eEEecccCCCceEEEEEeCCCCcHHHHHhhCC--CCChhHHHHHHHHHHHHHHHHH--hcCCCCCCcCChhhEEECCCCc
Confidence 9876 346789999999999999997654 6888999999999999999999 6 58999999999999999999
Q ss_pred EEEccccccccCCCCCCCcccccccCCCcccCcccccc--CCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhh
Q 018785 170 AKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT--GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVE 247 (350)
Q Consensus 170 ~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~ 247 (350)
++|+|||++....... ....++..|+|||.+.+ ..++.++||||||+++|+|++|..||.+.........
T Consensus 162 ~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~--- 233 (283)
T PHA02988 162 LKIICHGLEKILSSPP-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDL--- 233 (283)
T ss_pred EEEcccchHhhhcccc-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHH---
Confidence 9999999987532211 12457788999999876 6889999999999999999999999976542211111
Q ss_pred hcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhc
Q 018785 248 WADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHT 309 (350)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 309 (350)
..........+..+++.+.+++.+||+.||.+|||+.++++.|+++..
T Consensus 234 --------------i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 234 --------------IINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred --------------HHhcCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 111112223344678899999999999999999999999999998753
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=295.18 Aligned_cols=262 Identities=25% Similarity=0.325 Sum_probs=221.2
Q ss_pred hhhhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhH---HHHHHHHHHHhccCCCccc
Q 018785 14 MISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGH---KEWLTEVIYLGQLRHENLV 90 (350)
Q Consensus 14 ~~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~e~~~l~~l~h~~i~ 90 (350)
....+..+.|++.+.||+|.-|+||++ ...+++..+|+|++.+...... .....|-++|..+.||.+.
T Consensus 70 ~~~~l~l~~f~llk~LG~GdiG~VyL~---------~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlP 140 (459)
T KOG0610|consen 70 KDGSLGLRHFRLLKRLGCGDIGTVYLV---------ELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLP 140 (459)
T ss_pred CCCccCHHHHHHHHHcCCCCceeEEEE---------EecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccc
Confidence 445677889999999999999999999 4555678999999988765544 3456788999999999999
Q ss_pred ceeeEEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcE
Q 018785 91 KLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNA 170 (350)
Q Consensus 91 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~ 170 (350)
.+|..|+.+...+++||||.||+|..++++++.+.|++..++.++..++-||+||| -.||++|||||+||||.++|.+
T Consensus 141 TLYa~fet~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLH--mlGivYRDLKPENILvredGHI 218 (459)
T KOG0610|consen 141 TLYASFETDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLH--MLGIVYRDLKPENILVREDGHI 218 (459)
T ss_pred hhhheeeccceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHH--hhceeeccCCcceeEEecCCcE
Confidence 99999999999999999999999999999999999999999999999999999999 9999999999999999999999
Q ss_pred EEccccccccCCCC--------------------------------C-CC---------------------cccccccCC
Q 018785 171 KLSDFGLARDGPTG--------------------------------D-NT---------------------HVSTRIVGT 196 (350)
Q Consensus 171 ~l~Dfg~~~~~~~~--------------------------------~-~~---------------------~~~~~~~~~ 196 (350)
-|+||.++...... . .. .......||
T Consensus 219 MLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGT 298 (459)
T KOG0610|consen 219 MLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGT 298 (459)
T ss_pred EeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccc
Confidence 99999987532110 0 00 011125688
Q ss_pred CcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhHHHHHhhhcccCCCCcHHHH
Q 018785 197 RGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEA 276 (350)
Q Consensus 197 ~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (350)
-.|+|||++.|..-+.+.|.|+||+++||||.|..||.+.++.+....+.. ....-.-...++
T Consensus 299 hEYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~-----------------~~l~Fp~~~~vs 361 (459)
T KOG0610|consen 299 HEYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVG-----------------QPLKFPEEPEVS 361 (459)
T ss_pred cccccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhc-----------------CCCcCCCCCcch
Confidence 899999999999999999999999999999999999999887655544443 222122223677
Q ss_pred HHHHHHHHHhhccCCCCCCC----HHHHHHH
Q 018785 277 QAVAAVVLQCLHMDPKNRPS----MVDVLTS 303 (350)
Q Consensus 277 ~~l~~li~~~l~~dp~~Rps----~~~ll~~ 303 (350)
..+++||+++|-.||.+|.. +.+|.+|
T Consensus 362 ~~akDLIr~LLvKdP~kRlg~~rGA~eIK~H 392 (459)
T KOG0610|consen 362 SAAKDLIRKLLVKDPSKRLGSKRGAAEIKRH 392 (459)
T ss_pred hHHHHHHHHHhccChhhhhccccchHHhhcC
Confidence 89999999999999999988 8888776
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=308.40 Aligned_cols=274 Identities=25% Similarity=0.387 Sum_probs=204.6
Q ss_pred cccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccc--hhhHHHHHHHHHHHhccCCCcccceeeEEeec
Q 018785 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES--FQGHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (350)
Q Consensus 22 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (350)
+|++.+.||+|+||.||+| .+..++..||||.+.... ......+.+|+.+++.++||||+++++++...
T Consensus 1 ry~i~~~lg~G~~g~V~~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 71 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSA---------IDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPP 71 (338)
T ss_pred CeEEEEEEeecCCeEEEEE---------EECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEecc
Confidence 6899999999999999999 666778999999886432 22345678899999999999999999987543
Q ss_pred -----CceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcc
Q 018785 100 -----DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSD 174 (350)
Q Consensus 100 -----~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~D 174 (350)
...|+||||+ +++|.+++.... .+++..+..++.|+++||.||| +.|++|+||||+||+++.++.++|+|
T Consensus 72 ~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~dlkp~NIll~~~~~~kL~D 146 (338)
T cd07859 72 SRREFKDIYVVFELM-ESDLHQVIKAND--DLTPEHHQFFLYQLLRALKYIH--TANVFHRDLKPKNILANADCKLKICD 146 (338)
T ss_pred CCCCCceEEEEEecC-CCCHHHHHHhcc--cCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHeEECCCCcEEEcc
Confidence 2479999999 569999887654 6899999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCCCCC-cccccccCCCcccCcccccc--CCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcch
Q 018785 175 FGLARDGPTGDNT-HVSTRIVGTRGYAAPEYVAT--GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADP 251 (350)
Q Consensus 175 fg~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~--~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~ 251 (350)
||++......... .......+++.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+......
T Consensus 147 fg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~ 226 (338)
T cd07859 147 FGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGT 226 (338)
T ss_pred CccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCC
Confidence 9998753222211 12233568899999998865 67889999999999999999999999765432222222111110
Q ss_pred hhhh---------hHHHHHhhhcccCCCC---cHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHhhhc
Q 018785 252 FLRD---------SRRVLRIMDTRLGGQY---SKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS--LEQLHT 309 (350)
Q Consensus 252 ~~~~---------~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~--L~~~~~ 309 (350)
.... .......+........ ...+++.+.+++.+||+.||.+|||++++++| +..+..
T Consensus 227 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~ 298 (338)
T cd07859 227 PSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK 298 (338)
T ss_pred CCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence 0000 0000111111111111 11346788999999999999999999999987 444333
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=316.40 Aligned_cols=264 Identities=27% Similarity=0.426 Sum_probs=223.6
Q ss_pred hhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch---hhHHHHHHHHHHHhcc-CCCcccc
Q 018785 16 SKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQL-RHENLVK 91 (350)
Q Consensus 16 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l-~h~~i~~ 91 (350)
..+...+|++.++||+|.||.|+++ ..+.+++.+|||++++... ++.+..+.|..++... +||.+..
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~la---------e~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~ 433 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLA---------ELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVN 433 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEE---------EEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEee
Confidence 4667789999999999999999999 6667789999999988754 3456678888888887 4999999
Q ss_pred eeeEEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEE
Q 018785 92 LIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAK 171 (350)
Q Consensus 92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~ 171 (350)
++..|.+.+++|+||||+.||++...... ..|++..+..++..++.||.||| ++||++||||.+||++|..|.+|
T Consensus 434 L~~~fQT~~~l~fvmey~~Ggdm~~~~~~---~~F~e~rarfyaAev~l~L~fLH--~~~IIYRDlKLdNiLLD~eGh~k 508 (694)
T KOG0694|consen 434 LFSCFQTKEHLFFVMEYVAGGDLMHHIHT---DVFSEPRARFYAAEVVLGLQFLH--ENGIIYRDLKLDNLLLDTEGHVK 508 (694)
T ss_pred cccccccCCeEEEEEEecCCCcEEEEEec---ccccHHHHHHHHHHHHHHHHHHH--hcCceeeecchhheEEcccCcEE
Confidence 99999999999999999999995444433 36999999999999999999999 99999999999999999999999
Q ss_pred EccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcch
Q 018785 172 LSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADP 251 (350)
Q Consensus 172 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~ 251 (350)
|+|||++..... ........+|||-|+|||++.+..|+.+.|.||||++||+||.|+.||.+.+.++..+.|...
T Consensus 509 iADFGlcKe~m~--~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d--- 583 (694)
T KOG0694|consen 509 IADFGLCKEGMG--QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVND--- 583 (694)
T ss_pred ecccccccccCC--CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC---
Confidence 999999986432 233455689999999999999999999999999999999999999999988876655555431
Q ss_pred hhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH-------HHhhhcCCCCC
Q 018785 252 FLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPS-----MVDVLTS-------LEQLHTSKDMP 314 (350)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-----~~~ll~~-------L~~~~~~~~~~ 314 (350)
...+|..++.+...+++++|..+|++|.- +++|.+| .+.+..+.-.|
T Consensus 584 ----------------~~~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~r~i~P 642 (694)
T KOG0694|consen 584 ----------------EVRYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLLNRRIKP 642 (694)
T ss_pred ----------------CCCCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHHHhhccCCC
Confidence 13467788999999999999999999964 4666655 55565555555
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=312.53 Aligned_cols=267 Identities=27% Similarity=0.435 Sum_probs=217.8
Q ss_pred hhhhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch--hhHHHHHHHHHHHhccCCCcccc
Q 018785 14 MISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLRHENLVK 91 (350)
Q Consensus 14 ~~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~ 91 (350)
..+++..++..+...||+|.||+||+|+|+++ ||||+++.... ++.+.|+.|+.++++-+|.||+-
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whGd------------VAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlL 452 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHGD------------VAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILL 452 (678)
T ss_pred cccccCHHHhhccceeccccccceeecccccc------------eEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhhee
Confidence 46777788999999999999999999999864 89999876543 45678999999999999999999
Q ss_pred eeeEEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEE
Q 018785 92 LIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAK 171 (350)
Q Consensus 92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~ 171 (350)
+.+++..... .||+.||+|.+|+.++.-.. ..|+....++|+.|+++|+.||| .++|+|+|||.+|||+.++++|+
T Consensus 453 FMG~~~~p~~-AIiTqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLH--AK~IIHrDLKSnNIFl~~~~kVk 528 (678)
T KOG0193|consen 453 FMGACMNPPL-AIITQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLH--AKNIIHRDLKSNNIFLHEDLKVK 528 (678)
T ss_pred eehhhcCCce-eeeehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhh--hhhhhhhhccccceEEccCCcEE
Confidence 9999998776 99999999999999997554 47999999999999999999999 99999999999999999999999
Q ss_pred EccccccccCCCCCCCcccccccCCCcccCcccccc---CCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhh
Q 018785 172 LSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT---GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEW 248 (350)
Q Consensus 172 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~---~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~ 248 (350)
|+|||++..-..-..........|...|+|||++.. .+|++.+||||+|+++|||++|..||.....+.. +...
T Consensus 529 IgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqI---ifmV 605 (678)
T KOG0193|consen 529 IGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQI---IFMV 605 (678)
T ss_pred EecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhhe---EEEe
Confidence 999999975322222223334567788999999853 3789999999999999999999999983332221 1111
Q ss_pred cchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcC
Q 018785 249 ADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 310 (350)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 310 (350)
..-++. +.......+++.++.+|+..||..++++||.+.+|+..|+.+..+
T Consensus 606 GrG~l~-----------pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 606 GRGYLM-----------PDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred cccccC-----------ccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 111111 011122346788999999999999999999999999988888774
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-42 Score=313.28 Aligned_cols=254 Identities=23% Similarity=0.332 Sum_probs=204.6
Q ss_pred hcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch---hhHHHHHHHHHHHhccCCCcccceeeEEe
Q 018785 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (350)
Q Consensus 21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (350)
++|++.+.||+|+||+||+| .+..+++.||||++..... .....+.+|+.+++.++||||+++++.+.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~ 71 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLV---------QKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQ 71 (364)
T ss_pred CCceEEEEEEecCCEEEEEE---------EECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEE
Confidence 47999999999999999999 6666789999999975432 23355778999999999999999999999
Q ss_pred ecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccc
Q 018785 98 ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL 177 (350)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~ 177 (350)
+++..++||||+.+++|.+++.... .+++..+..++.|++.||+||| +.|++|+||||+||+++.++.++|+|||+
T Consensus 72 ~~~~~~lv~E~~~~g~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH--~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 147 (364)
T cd05599 72 DENYLYLIMEYLPGGDMMTLLMKKD--TFTEEETRFYIAETILAIDSIH--KLGYIHRDIKPDNLLLDAKGHIKLSDFGL 147 (364)
T ss_pred cCCeEEEEECCCCCcHHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCeEeccCCHHHeEECCCCCEEEeeccc
Confidence 9999999999999999999997765 6999999999999999999999 99999999999999999999999999999
Q ss_pred cccCCCCCCCc------------------------------------ccccccCCCcccCccccccCCCCCccchhhHHH
Q 018785 178 ARDGPTGDNTH------------------------------------VSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGV 221 (350)
Q Consensus 178 ~~~~~~~~~~~------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ 221 (350)
+.......... ......|++.|+|||++.+..++.++|||||||
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~ 227 (364)
T cd05599 148 CTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGV 227 (364)
T ss_pred ceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchh
Confidence 86432211100 001235899999999999999999999999999
Q ss_pred HHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCC---HH
Q 018785 222 VLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPS---MV 298 (350)
Q Consensus 222 ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps---~~ 298 (350)
++|+|++|..||...........+..+. ..........+++++.+||.+|+. +|.+|++ +.
T Consensus 228 il~el~~G~~Pf~~~~~~~~~~~i~~~~---------------~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~ 291 (364)
T cd05599 228 IMYEMLVGYPPFCSDNPQETYRKIINWK---------------ETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVN 291 (364)
T ss_pred HHHHhhcCCCCCCCCCHHHHHHHHHcCC---------------CccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHH
Confidence 9999999999997654322111111110 000001112457889999999997 9999997 99
Q ss_pred HHHHH
Q 018785 299 DVLTS 303 (350)
Q Consensus 299 ~ll~~ 303 (350)
++++|
T Consensus 292 ~ll~h 296 (364)
T cd05599 292 EIKSH 296 (364)
T ss_pred HHhcC
Confidence 99886
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=301.47 Aligned_cols=269 Identities=26% Similarity=0.358 Sum_probs=200.4
Q ss_pred hcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh--hHHHHHHHHHHHhcc---CCCcccceeeE
Q 018785 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ--GHKEWLTEVIYLGQL---RHENLVKLIGY 95 (350)
Q Consensus 21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l---~h~~i~~~~~~ 95 (350)
++|++.+.||+|+||.||+|+.. ..++..||+|.+...... ....+.+|+..++.+ .||||++++++
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~--------~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~ 72 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDL--------KNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDV 72 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEc--------CCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEE
Confidence 47999999999999999999431 234678999988654322 223445566666555 69999999998
Q ss_pred Ee-----ecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcE
Q 018785 96 CS-----ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNA 170 (350)
Q Consensus 96 ~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~ 170 (350)
+. .....++|||++. ++|.+++.......+++..+..++.|++.||.||| +.|++|+||||+||+++.++.+
T Consensus 73 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH--~~~iiH~dlkp~Nil~~~~~~~ 149 (290)
T cd07862 73 CTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH--SHRVVHRDLKPQNILVTSSGQI 149 (290)
T ss_pred EecccCCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH--HCCeeeCCCCHHHEEEcCCCCE
Confidence 75 3456899999995 69999998766557899999999999999999999 9999999999999999999999
Q ss_pred EEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcc
Q 018785 171 KLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD 250 (350)
Q Consensus 171 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~ 250 (350)
+|+|||++...... .......+++.|+|||.+.+..++.++|+|||||++|+|++|..||.+.........+.....
T Consensus 150 kl~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~ 226 (290)
T cd07862 150 KLADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIG 226 (290)
T ss_pred EEccccceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhC
Confidence 99999998754322 122334678899999999888999999999999999999999999987655433333332211
Q ss_pred hhh-hhhHHHH----HhhhcccCC---CCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 251 PFL-RDSRRVL----RIMDTRLGG---QYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 251 ~~~-~~~~~~~----~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
... .+..... ......... .....+++.+.+|+.+||+.||++|||+.++++|
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 227 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred CCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 000 0000000 000000000 1112456788999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=307.26 Aligned_cols=246 Identities=28% Similarity=0.416 Sum_probs=198.4
Q ss_pred ccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch---hhHHHHHHHHHH---HhccCCCcccceeeEE
Q 018785 23 FCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIY---LGQLRHENLVKLIGYC 96 (350)
Q Consensus 23 y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~---l~~l~h~~i~~~~~~~ 96 (350)
|++.+.||+|++|.||+| .+..+++.||||.+..... .....+..|... ++.++||||+++++++
T Consensus 1 y~i~~~lg~G~~g~Vy~~---------~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~ 71 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLA---------EYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACF 71 (324)
T ss_pred CeEEEEEeecCCEEEEEE---------EECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEE
Confidence 788999999999999999 5566789999999875432 223445555554 4566899999999999
Q ss_pred eecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcccc
Q 018785 97 SESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFG 176 (350)
Q Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg 176 (350)
...+..|+||||+++++|..++... .+++..+..++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||
T Consensus 72 ~~~~~~~lv~E~~~~~~L~~~~~~~---~l~~~~~~~~~~qi~~al~~lH--~~~ivHrdlkp~Nill~~~~~~kL~Dfg 146 (324)
T cd05589 72 QTEDHVCFVMEYAAGGDLMMHIHTD---VFSEPRAVFYAACVVLGLQYLH--ENKIVYRDLKLDNLLLDTEGFVKIADFG 146 (324)
T ss_pred EcCCEEEEEEcCCCCCcHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHH--hCCeEecCCCHHHeEECCCCcEEeCccc
Confidence 9999999999999999998887543 6899999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhh
Q 018785 177 LARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDS 256 (350)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 256 (350)
++....... .......|++.|+|||.+.+..++.++|+|||||++|+|++|+.||.+.........+
T Consensus 147 ~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i----------- 213 (324)
T cd05589 147 LCKEGMGFG--DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSI----------- 213 (324)
T ss_pred CCccCCCCC--CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHH-----------
Confidence 986422211 1223356889999999999999999999999999999999999999765432111111
Q ss_pred HHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 018785 257 RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRP-----SMVDVLTS 303 (350)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~~ 303 (350)
... ....+..+++.+.++|.+||..||.+|| ++.+++++
T Consensus 214 ------~~~--~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 214 ------VND--EVRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred ------HhC--CCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 111 1123445678899999999999999999 68888776
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=306.84 Aligned_cols=256 Identities=24% Similarity=0.347 Sum_probs=204.6
Q ss_pred cccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch----hhHHHHHHHHHHHhcc-CCCcccceeeEE
Q 018785 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF----QGHKEWLTEVIYLGQL-RHENLVKLIGYC 96 (350)
Q Consensus 22 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~e~~~l~~l-~h~~i~~~~~~~ 96 (350)
+|++.+.||+|+||.||+++.. .+..++..||+|++..... .....+..|..+++.+ .||+|+++++++
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~ 74 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKV------TGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAF 74 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEc------ccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEE
Confidence 5899999999999999998543 3345789999999865432 2234577899999999 599999999999
Q ss_pred eecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcccc
Q 018785 97 SESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFG 176 (350)
Q Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg 176 (350)
..++..++||||+.+++|.+++..+. .+++..+..++.|++.||.||| +.|++|+||||+||+++.++.++|+|||
T Consensus 75 ~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH--~~~ivHrDlkp~Nili~~~~~~kl~DfG 150 (332)
T cd05614 75 QTEAKLHLILDYVSGGEMFTHLYQRD--NFSEDEVRFYSGEIILALEHLH--KLGIVYRDIKLENILLDSEGHVVLTDFG 150 (332)
T ss_pred ecCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCcEecCCCHHHeEECCCCCEEEeeCc
Confidence 99999999999999999999997654 6899999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCCCCcccccccCCCcccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhh
Q 018785 177 LARDGPTGDNTHVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRD 255 (350)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 255 (350)
++......... ......|++.|+|||.+.+. .++.++|||||||++|+|++|..||...........+..
T Consensus 151 ~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~-------- 221 (332)
T cd05614 151 LSKEFLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSR-------- 221 (332)
T ss_pred CCccccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHH--------
Confidence 98754322221 12235689999999998765 478899999999999999999999975432211111110
Q ss_pred hHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 018785 256 SRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRP-----SMVDVLTS 303 (350)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~~ 303 (350)
... ......+..+++.+.+++.+||+.||++|| +++++++|
T Consensus 222 -----~~~--~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 222 -----RIL--KCDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred -----HHh--cCCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 001 111233456778899999999999999999 78888876
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=308.10 Aligned_cols=243 Identities=28% Similarity=0.381 Sum_probs=199.7
Q ss_pred ceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch---hhHHHHHHHHHHHhccCCCcccceeeEEeecCceE
Q 018785 27 YLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLVKLIGYCSESDNRL 103 (350)
Q Consensus 27 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 103 (350)
+.||+|+||.||++ .+..+|..||+|++..... .....+..|+.+++.++||||+++++.+...+..+
T Consensus 1 ~~lG~G~~g~V~~~---------~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~ 71 (325)
T cd05594 1 KLLGKGTFGKVILV---------KEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLC 71 (325)
T ss_pred CeeeeCCCEEEEEE---------EECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEE
Confidence 46999999999999 6666799999999876532 22345678899999999999999999999999999
Q ss_pred EEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCC-CCeeeCCCCCCceEEcCCCcEEEccccccccCC
Q 018785 104 LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLD-ANVIYRDLKASNVLLDSNFNAKLSDFGLARDGP 182 (350)
Q Consensus 104 lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~-~~i~H~di~~~Nili~~~~~~~l~Dfg~~~~~~ 182 (350)
+||||+.+++|.+++.... .+++..+..++.||+.||.||| + .|++|+||||+||+++.++.++|+|||++....
T Consensus 72 lv~E~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH--~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~ 147 (325)
T cd05594 72 FVMEYANGGELFFHLSRER--VFSEDRARFYGAEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGI 147 (325)
T ss_pred EEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--hcCCEEecCCCCCeEEECCCCCEEEecCCCCeecC
Confidence 9999999999999887654 6899999999999999999999 7 799999999999999999999999999986432
Q ss_pred CCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhHHHHHh
Q 018785 183 TGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRI 262 (350)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (350)
... .......|++.|+|||++.+..++.++|||||||++|+|++|..||.+.........+.
T Consensus 148 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~---------------- 209 (325)
T cd05594 148 KDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL---------------- 209 (325)
T ss_pred CCC--cccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHh----------------
Confidence 211 11223468899999999999999999999999999999999999997543211111110
Q ss_pred hhcccCCCCcHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 018785 263 MDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRP-----SMVDVLTS 303 (350)
Q Consensus 263 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~~ 303 (350)
. .....+..+++++.+++.+||+.||.+|+ ++.++++|
T Consensus 210 -~--~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 210 -M--EEIRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred -c--CCCCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 0 11123445678899999999999999997 89999977
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=307.26 Aligned_cols=248 Identities=29% Similarity=0.436 Sum_probs=201.8
Q ss_pred cccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch---hhHHHHHHHHHHHhccCC-CcccceeeEEe
Q 018785 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRH-ENLVKLIGYCS 97 (350)
Q Consensus 22 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~ 97 (350)
+|++.+.||+|+||.||+| .+..+++.||+|++..... .....+..|..++..+.| ++|+++++++.
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~---------~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~ 71 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLA---------ERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ 71 (324)
T ss_pred CceEEEEEeeccCeEEEEE---------EECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEE
Confidence 5899999999999999999 5566788999999876432 234556778888888875 55888999999
Q ss_pred ecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccc
Q 018785 98 ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL 177 (350)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~ 177 (350)
..+..|+||||+++++|.+++.... .+++..+..++.|++.||.||| +.|++|+||||+||+++.++.++|+|||+
T Consensus 72 ~~~~~~lv~E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH--~~~ivH~dlkp~Nill~~~~~~kL~Dfg~ 147 (324)
T cd05587 72 TMDRLYFVMEYVNGGDLMYHIQQVG--KFKEPHAVFYAAEIAIGLFFLH--SKGIIYRDLKLDNVMLDAEGHIKIADFGM 147 (324)
T ss_pred cCCEEEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCeEecCCCHHHeEEcCCCCEEEeecCc
Confidence 9999999999999999999987664 6899999999999999999999 99999999999999999999999999999
Q ss_pred cccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhH
Q 018785 178 ARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSR 257 (350)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 257 (350)
+........ ......|++.|+|||++.+..++.++|+||+||++|+|++|+.||.+.........+.
T Consensus 148 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~----------- 214 (324)
T cd05587 148 CKENIFGGK--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIM----------- 214 (324)
T ss_pred ceecCCCCC--ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH-----------
Confidence 864222111 1223568899999999999999999999999999999999999997654321111111
Q ss_pred HHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCH-----HHHHHH
Q 018785 258 RVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSM-----VDVLTS 303 (350)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-----~~ll~~ 303 (350)
. .....+..++.++.+++.+||..||.+|++. +++++|
T Consensus 215 ------~--~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 215 ------E--HNVSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred ------c--CCCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 1 1123345677889999999999999999976 677765
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=305.92 Aligned_cols=247 Identities=26% Similarity=0.388 Sum_probs=200.9
Q ss_pred cceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch----hhHHHHHHHHHHHhccCCCcccceeeEEeecCc
Q 018785 26 DYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF----QGHKEWLTEVIYLGQLRHENLVKLIGYCSESDN 101 (350)
Q Consensus 26 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 101 (350)
.+.||+|+||.||+++.. ....+++.||+|++..... .....+..|+.+++.++||||+++++.+..++.
T Consensus 1 ~~~lg~G~~g~V~~~~~~------~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~ 74 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKV------TGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGK 74 (323)
T ss_pred CceeeecCCeEEEEEEEc------ccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCe
Confidence 368999999999998543 2335688999999875432 223456789999999999999999999999999
Q ss_pred eEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccccccC
Q 018785 102 RLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDG 181 (350)
Q Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~~~ 181 (350)
.|+||||+.+++|.+++.... .+.+..+..++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++...
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 150 (323)
T cd05584 75 LYLILEYLSGGELFMHLEREG--IFMEDTACFYLSEISLALEHLH--QQGIIYRDLKPENILLDAQGHVKLTDFGLCKES 150 (323)
T ss_pred EEEEEeCCCCchHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHeEECCCCCEEEeeCcCCeec
Confidence 999999999999999997665 6888899999999999999999 999999999999999999999999999998643
Q ss_pred CCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhHHHHH
Q 018785 182 PTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLR 261 (350)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (350)
.... .......|++.|+|||.+.+..++.++||||||+++|+|++|..||.......... .
T Consensus 151 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~-----------------~ 211 (323)
T cd05584 151 IHEG--TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTID-----------------K 211 (323)
T ss_pred ccCC--CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHH-----------------H
Confidence 2221 11223468899999999988889999999999999999999999997644211111 1
Q ss_pred hhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 018785 262 IMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRP-----SMVDVLTS 303 (350)
Q Consensus 262 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~~ 303 (350)
.... ....+..+++.+.++|.+||+.||.+|| +++++++|
T Consensus 212 ~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 212 ILKG--KLNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred HHcC--CCCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 1111 1233455678899999999999999999 89999876
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=312.23 Aligned_cols=264 Identities=23% Similarity=0.267 Sum_probs=201.1
Q ss_pred hhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceeeEEee
Q 018785 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (350)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (350)
...+|.+.+.||+|+||.||+| .+..+++.||+|... ...+.+|+.++++++||||+++++++..
T Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~---------~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~ 154 (391)
T PHA03212 90 EKAGFSILETFTPGAEGFAFAC---------IDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTY 154 (391)
T ss_pred ccCCcEEEEEEcCCCCeEEEEE---------EECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEE
Confidence 3468999999999999999999 677789999999643 2345789999999999999999999999
Q ss_pred cCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcccccc
Q 018785 99 SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 178 (350)
Q Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~ 178 (350)
....++|+|++ +++|.+++.... .++...++.++.|++.||.||| +.||+|+||||+||+++.++.++|+|||++
T Consensus 155 ~~~~~lv~e~~-~~~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~ylH--~~~IvHrDiKP~NIll~~~~~vkL~DFG~a 229 (391)
T PHA03212 155 NKFTCLILPRY-KTDLYCYLAAKR--NIAICDILAIERSVLRAIQYLH--ENRIIHRDIKAENIFINHPGDVCLGDFGAA 229 (391)
T ss_pred CCeeEEEEecC-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCChHhEEEcCCCCEEEEeCCcc
Confidence 99999999999 568988887654 6899999999999999999999 899999999999999999999999999998
Q ss_pred ccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCc-------chhhhhhh-cc
Q 018785 179 RDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGL-------AEQTLVEW-AD 250 (350)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~-------~~~~~~~~-~~ 250 (350)
....... ........|++.|+|||++.+..++.++|||||||++|+|++|..||....... ....+... ..
T Consensus 230 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~ 308 (391)
T PHA03212 230 CFPVDIN-ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGT 308 (391)
T ss_pred ccccccc-ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcC
Confidence 6432211 112223568999999999999999999999999999999999998875432110 01111110 00
Q ss_pred -h--h-hhhhHHHHHhh----hcc--cCC-----CCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 251 -P--F-LRDSRRVLRIM----DTR--LGG-----QYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 251 -~--~-~~~~~~~~~~~----~~~--~~~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
+ + ........... ... ... .....++.++.+||.+||+.||.+|||++++++|
T Consensus 309 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 309 HPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred ChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 0 0 00000000000 000 000 0112457789999999999999999999999965
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=309.65 Aligned_cols=254 Identities=24% Similarity=0.329 Sum_probs=202.5
Q ss_pred hcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch---hhHHHHHHHHHHHhccCCCcccceeeEEe
Q 018785 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (350)
Q Consensus 21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (350)
++|++.+.||+|+||+||+| .+..+++.||+|++..... .....+..|..+++.++||+|+++++.+.
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~---------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~ 71 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLV---------QKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQ 71 (363)
T ss_pred CCceEeEEEEeCCCEEEEEE---------EECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence 47999999999999999999 6667789999999875432 22356778999999999999999999999
Q ss_pred ecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccc
Q 018785 98 ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL 177 (350)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~ 177 (350)
+....|+||||+++++|.+++.... .+++..+..++.|++.||.||| +.|++||||||+||+++.++.++|+|||+
T Consensus 72 ~~~~~~lv~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH--~~givHrDlKp~NILi~~~~~vkL~DFGl 147 (363)
T cd05628 72 DKLNLYLIMEFLPGGDMMTLLMKKD--TLTEEETQFYIAETVLAIDSIH--QLGFIHRDIKPDNLLLDSKGHVKLSDFGL 147 (363)
T ss_pred cCCeEEEEEcCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--hCCeEecCCCHHHeEECCCCCEEEeeccC
Confidence 9999999999999999999997764 7999999999999999999999 99999999999999999999999999999
Q ss_pred cccCCCCCCC---------------------------------cccccccCCCcccCccccccCCCCCccchhhHHHHHH
Q 018785 178 ARDGPTGDNT---------------------------------HVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLL 224 (350)
Q Consensus 178 ~~~~~~~~~~---------------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~ 224 (350)
+......... .......|++.|+|||++.+..++.++|+|||||++|
T Consensus 148 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ 227 (363)
T cd05628 148 CTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMY 227 (363)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHH
Confidence 8643221100 0011246899999999999999999999999999999
Q ss_pred HHHhCCCCCcccccCcchhhhhhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCC---CCCCHHHHH
Q 018785 225 ELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPK---NRPSMVDVL 301 (350)
Q Consensus 225 ~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~---~Rps~~~ll 301 (350)
+|++|..||.+.........+..+.. .........+++++.+++.+|+. +|. .||++++++
T Consensus 228 ell~G~~Pf~~~~~~~~~~~i~~~~~---------------~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~ 291 (363)
T cd05628 228 EMLIGYPPFCSETPQETYKKVMNWKE---------------TLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIK 291 (363)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHcCcC---------------cccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHh
Confidence 99999999976543222222211100 00001112356788999998765 444 468999999
Q ss_pred HH
Q 018785 302 TS 303 (350)
Q Consensus 302 ~~ 303 (350)
+|
T Consensus 292 ~h 293 (363)
T cd05628 292 TN 293 (363)
T ss_pred CC
Confidence 98
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-42 Score=289.61 Aligned_cols=268 Identities=25% Similarity=0.314 Sum_probs=215.6
Q ss_pred hcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhh--HHHHHHHHHHHhccCCCcccceeeEEee
Q 018785 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQG--HKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (350)
Q Consensus 21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (350)
++|+....|++|.||.||+| .++.+++.||+|.++.+.... .-...+|+.+|.+.+||||+.+..+..-
T Consensus 76 ~efe~lnrI~EGtyGiVYRa---------kdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG 146 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRA---------KDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVG 146 (419)
T ss_pred HHHHHHhhcccCcceeEEEe---------ccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEec
Confidence 68999999999999999999 888899999999997664221 1235789999999999999999988753
Q ss_pred --cCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcccc
Q 018785 99 --SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFG 176 (350)
Q Consensus 99 --~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg 176 (350)
-+..|+||||++. +|..++..-+ ++|...+++-++.|++.|++||| .+.|+|||||++|++++..|.+|++|||
T Consensus 147 ~~~d~iy~VMe~~Eh-DLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH--~~wilHRDLK~SNLLm~~~G~lKiaDFG 222 (419)
T KOG0663|consen 147 SNMDKIYIVMEYVEH-DLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLH--DNWILHRDLKTSNLLLSHKGILKIADFG 222 (419)
T ss_pred cccceeeeeHHHHHh-hHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHh--hceeEecccchhheeeccCCcEEecccc
Confidence 3579999999954 9999887665 58999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCCCCcccccccCCCcccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcc-----
Q 018785 177 LARDGPTGDNTHVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD----- 250 (350)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~----- 250 (350)
+|+.+... ....+....|..|+|||++.|. .|+.+.|+||+||++.+|+.+.+.|.+...-...+.+...-.
T Consensus 223 LAR~ygsp--~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~ 300 (419)
T KOG0663|consen 223 LAREYGSP--LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEA 300 (419)
T ss_pred hhhhhcCC--cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccc
Confidence 99875443 3345556778899999999886 689999999999999999999999999887766666665422
Q ss_pred --hhhhhhHHH-----HHhhhcccCCCCcHH-HHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 251 --PFLRDSRRV-----LRIMDTRLGGQYSKK-EAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 251 --~~~~~~~~~-----~~~~~~~~~~~~~~~-~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
|.+...... .+..-...+..++.. +++.-.+|+..+|..||.+|.|+++.|+|
T Consensus 301 iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 301 IWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred cCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 111111111 011111111122222 66889999999999999999999999987
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=297.08 Aligned_cols=256 Identities=36% Similarity=0.543 Sum_probs=202.5
Q ss_pred cccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch-hhHHHHHHHHHHHhccCCCcccceeeEEeecCce
Q 018785 24 CSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLVKLIGYCSESDNR 102 (350)
Q Consensus 24 ~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 102 (350)
.+.+.||.|.||.||+|.+.. .....+..|+||.+..... .....+.+|++.+++++||||+++++++...+..
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~-----~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~ 76 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQ-----KDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPL 76 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEES-----TTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSE
T ss_pred EEeeEEccCCCcEEEEEEEEc-----ccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccc
Confidence 356789999999999998864 3455688999999966433 3467889999999999999999999999988889
Q ss_pred EEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccccccCC
Q 018785 103 LLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGP 182 (350)
Q Consensus 103 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~~~~ 182 (350)
++|+||+.+++|.+++.......++...+..++.|++.||.||| +.+++|++|+++||+++.++.+||+|||++....
T Consensus 77 ~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh--~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~ 154 (259)
T PF07714_consen 77 FLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLH--SNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPIS 154 (259)
T ss_dssp EEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHH--HTTEEEST-SGGGEEEETTTEEEEESTTTGEETT
T ss_pred cccccccccccccccccccccccccccccccccccccccccccc--cccccccccccccccccccccccccccccccccc
Confidence 99999999999999999875557999999999999999999999 8999999999999999999999999999997653
Q ss_pred CCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccccCcchhhhhhhcchhhhhhHHHHH
Q 018785 183 TGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLR 261 (350)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (350)
................|+|||.+.+..++.++||||||+++|+|++ |+.||..........
T Consensus 155 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~------------------ 216 (259)
T PF07714_consen 155 EKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIE------------------ 216 (259)
T ss_dssp TSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHH------------------
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc------------------
Confidence 2222222233445667999999989999999999999999999999 678876543221111
Q ss_pred hhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018785 262 IMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL 304 (350)
Q Consensus 262 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 304 (350)
.+........+..++..+.+++.+||..||++|||+.++++.|
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 217 KLKQGQRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp HHHTTEETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred cccccccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 1122222334556788899999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=319.75 Aligned_cols=260 Identities=25% Similarity=0.326 Sum_probs=209.4
Q ss_pred hhhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch--hhHHHHHHHHHHHhccCCCcccce
Q 018785 15 ISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLRHENLVKL 92 (350)
Q Consensus 15 ~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~ 92 (350)
..+...++|++.+.||+|+||+||+| .+..+|+.||||.+..... .....+..|+..+..++|++++++
T Consensus 26 ~~~~~~~rY~i~~~LG~G~fG~Vy~a---------~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~ 96 (496)
T PTZ00283 26 TAKEQAKKYWISRVLGSGATGTVLCA---------KRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKC 96 (496)
T ss_pred cccccCCCEEEEEEEecCCCEEEEEE---------EEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEe
Confidence 33455689999999999999999999 5666789999999876532 334567789999999999999999
Q ss_pred eeEEeecC--------ceEEEEEcCCCCChhhHHhhcC--CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCce
Q 018785 93 IGYCSESD--------NRLLVYEFMPKGSLENHLFRKG--VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNV 162 (350)
Q Consensus 93 ~~~~~~~~--------~~~lv~e~~~~~~L~~~l~~~~--~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Ni 162 (350)
++.+...+ .+++||||+.+++|.+++.... ...+++..+..++.|++.||.||| +.|++|+||||+||
T Consensus 97 ~~~~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH--~~~IiHrDLKP~NI 174 (496)
T PTZ00283 97 HEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVH--SKHMIHRDIKSANI 174 (496)
T ss_pred ecceecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH--hCCEecCCCCHHHE
Confidence 88765432 3679999999999999986532 346899999999999999999999 99999999999999
Q ss_pred EEcCCCcEEEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcch
Q 018785 163 LLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAE 242 (350)
Q Consensus 163 li~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~ 242 (350)
+++.++.++|+|||++................|++.|+|||.+.+..++.++|||||||++|+|++|+.||.+.......
T Consensus 175 Ll~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~ 254 (496)
T PTZ00283 175 LLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVM 254 (496)
T ss_pred EEeCCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH
Confidence 99999999999999987643332222233456899999999999999999999999999999999999999754321111
Q ss_pred hhhhhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 243 QTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
. ... .......+..+++++.+++.+||..||.+||++.+++++
T Consensus 255 ~-----------------~~~-~~~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 255 H-----------------KTL-AGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred H-----------------HHh-cCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 0 111 111123455678899999999999999999999999875
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-42 Score=314.36 Aligned_cols=254 Identities=22% Similarity=0.310 Sum_probs=202.0
Q ss_pred hcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch---hhHHHHHHHHHHHhccCCCcccceeeEEe
Q 018785 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (350)
Q Consensus 21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (350)
++|++.+.||+|+||+||++ .+..+++.||+|.+..... .....+.+|+.+++.++||||+++++++.
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~---------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~ 71 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLV---------QKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQ 71 (377)
T ss_pred CCceEeEEEeecCCEEEEEE---------EECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEE
Confidence 47999999999999999999 5666789999998865432 22355778999999999999999999999
Q ss_pred ecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccc
Q 018785 98 ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL 177 (350)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~ 177 (350)
+.+..|+||||+++++|.+++.... .+++..++.++.|++.||+||| +.|++|+||||+||+++.++.++|+|||+
T Consensus 72 ~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~ql~~aL~~LH--~~givHrDlkp~NIll~~~~~~kl~DfGl 147 (377)
T cd05629 72 DAQYLYLIMEFLPGGDLMTMLIKYD--TFSEDVTRFYMAECVLAIEAVH--KLGFIHRDIKPDNILIDRGGHIKLSDFGL 147 (377)
T ss_pred cCCeeEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--hCCeeccCCCHHHEEECCCCCEEEeeccc
Confidence 9999999999999999999997654 6899999999999999999999 99999999999999999999999999999
Q ss_pred cccCCCCCCC-----------c----------------------------------ccccccCCCcccCccccccCCCCC
Q 018785 178 ARDGPTGDNT-----------H----------------------------------VSTRIVGTRGYAAPEYVATGHLTP 212 (350)
Q Consensus 178 ~~~~~~~~~~-----------~----------------------------------~~~~~~~~~~~~aPE~~~~~~~~~ 212 (350)
+......... . ......|++.|+|||++.+..++.
T Consensus 148 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 227 (377)
T cd05629 148 STGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQ 227 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCC
Confidence 8632111000 0 000135889999999999999999
Q ss_pred ccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCC
Q 018785 213 KSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPK 292 (350)
Q Consensus 213 ~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~ 292 (350)
++|+|||||++|+|++|..||...........+..+. ..........++.++.+||.+||. +|.
T Consensus 228 ~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~---------------~~~~~p~~~~~s~~~~dli~~lL~-~~~ 291 (377)
T cd05629 228 ECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWR---------------ETLYFPDDIHLSVEAEDLIRRLIT-NAE 291 (377)
T ss_pred ceeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccC---------------CccCCCCCCCCCHHHHHHHHHHhc-CHh
Confidence 9999999999999999999997644322211111110 000001112457789999999997 777
Q ss_pred CC---CCHHHHHHH
Q 018785 293 NR---PSMVDVLTS 303 (350)
Q Consensus 293 ~R---ps~~~ll~~ 303 (350)
+| +++.++++|
T Consensus 292 ~r~~r~~~~~~l~h 305 (377)
T cd05629 292 NRLGRGGAHEIKSH 305 (377)
T ss_pred hcCCCCCHHHHhcC
Confidence 65 599999987
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-41 Score=295.65 Aligned_cols=263 Identities=27% Similarity=0.446 Sum_probs=211.0
Q ss_pred hhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceeeEEee
Q 018785 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (350)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (350)
..++|++.++||+|+||.||++..... ....++..+++|.+..........+.+|+..++.++|+||+++++++..
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~----~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 78 (280)
T cd05092 3 KRRDIVLKWELGEGAFGKVFLAECHNL----LPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTE 78 (280)
T ss_pred ChHhceeccccCCccCCeEEEeEEecC----CCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEec
Confidence 457899999999999999999864321 2345677899998887666666788999999999999999999999999
Q ss_pred cCceEEEEEcCCCCChhhHHhhcCC-------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEc
Q 018785 99 SDNRLLVYEFMPKGSLENHLFRKGV-------------QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLD 165 (350)
Q Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~-------------~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~ 165 (350)
.+..+++|||+.+++|.+++..... ..++...+..++.|++.|++||| +.|++|+||+|+||+++
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH--~~~i~H~dlkp~nil~~ 156 (280)
T cd05092 79 GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA--SLHFVHRDLATRNCLVG 156 (280)
T ss_pred CCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH--HCCeecccccHhhEEEc
Confidence 9999999999999999999875431 25788999999999999999999 99999999999999999
Q ss_pred CCCcEEEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccccCcchhh
Q 018785 166 SNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQT 244 (350)
Q Consensus 166 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~~~~ 244 (350)
.++.++|+|||++................+++.|+|||.+.+..++.++|+|||||++|+|++ |..||...........
T Consensus 157 ~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 236 (280)
T cd05092 157 QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIEC 236 (280)
T ss_pred CCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHH
Confidence 999999999999865433221111222334567999999988999999999999999999998 8888864332111111
Q ss_pred hhhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018785 245 LVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 305 (350)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~ 305 (350)
.........+..+++.+.+++.+||+.||.+||++.++++.|+
T Consensus 237 ------------------~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 237 ------------------ITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred ------------------HHcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 1111112233456788999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-41 Score=297.50 Aligned_cols=269 Identities=27% Similarity=0.405 Sum_probs=213.0
Q ss_pred hhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch-hhHHHHHHHHHHHhcc-CCCccccee
Q 018785 16 SKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQL-RHENLVKLI 93 (350)
Q Consensus 16 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~ 93 (350)
.++..++|++.+.||+|++|.||++.+... ........+++|.+..... .....+.+|+.+++.+ +||||++++
T Consensus 7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~----~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~ 82 (293)
T cd05053 7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGL----DNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLL 82 (293)
T ss_pred cccCHhHeEEeeEecccccccEEEEEEecC----CCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEE
Confidence 345678999999999999999999965432 1124557899998875432 3345678899999999 799999999
Q ss_pred eEEeecCceEEEEEcCCCCChhhHHhhc--------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCC
Q 018785 94 GYCSESDNRLLVYEFMPKGSLENHLFRK--------------GVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKA 159 (350)
Q Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~--------------~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~ 159 (350)
+++..++..+++|||+.+++|.+++..+ ....++...+..++.|++.||+||| +.+++|+||+|
T Consensus 83 ~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH--~~~ivH~dlkp 160 (293)
T cd05053 83 GVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA--SKKCIHRDLAA 160 (293)
T ss_pred EEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH--HCCccccccce
Confidence 9999999999999999999999998652 2346889999999999999999999 99999999999
Q ss_pred CceEEcCCCcEEEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCccccc
Q 018785 160 SNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRG 238 (350)
Q Consensus 160 ~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~ 238 (350)
+||+++.++.++|+|||++................++..|+|||.+.+..++.++|+|||||++|+|++ |..||.....
T Consensus 161 ~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 240 (293)
T cd05053 161 RNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV 240 (293)
T ss_pred eeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCH
Confidence 999999999999999999976443322111122234567999999988899999999999999999997 8888865432
Q ss_pred CcchhhhhhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 018785 239 GLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLH 308 (350)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 308 (350)
.... ...........+..++..+.+|+.+||..||.+|||+.++++.|+.+-
T Consensus 241 ~~~~------------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 241 EELF------------------KLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HHHH------------------HHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 1111 111111122234456778999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=299.18 Aligned_cols=253 Identities=29% Similarity=0.425 Sum_probs=206.1
Q ss_pred cccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh---hHHHHHHHHHHHhccCCCcccceeeEEee
Q 018785 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ---GHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (350)
Q Consensus 22 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (350)
+|++.++||+|+||+||++ .+..++..||+|.+...... ....+.+|+.+++.++||+|+++++.+..
T Consensus 1 ~y~~~~~lg~G~~g~V~~~---------~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 71 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCAC---------QVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET 71 (285)
T ss_pred CceEEEEEecCCCeEEEEE---------EEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecC
Confidence 5889999999999999999 55566889999998654322 22346789999999999999999999999
Q ss_pred cCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcccccc
Q 018785 99 SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 178 (350)
Q Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~ 178 (350)
++..++||||+++++|.+++.......+++..+..++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||++
T Consensus 72 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~ 149 (285)
T cd05605 72 KDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH--RERIVYRDLKPENILLDDYGHIRISDLGLA 149 (285)
T ss_pred CCeEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH--HCCcEecCCCHHHEEECCCCCEEEeeCCCc
Confidence 999999999999999999887655457999999999999999999999 899999999999999999999999999998
Q ss_pred ccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhHH
Q 018785 179 RDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRR 258 (350)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (350)
....... ......++..|+|||.+.+..++.++|+||+|+++|+|++|+.||.+.........+.
T Consensus 150 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~------------ 214 (285)
T cd05605 150 VEIPEGE---TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVE------------ 214 (285)
T ss_pred eecCCCC---ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHH------------
Confidence 7543221 1123467889999999988899999999999999999999999997644321111111
Q ss_pred HHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 018785 259 VLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRP-----SMVDVLTS 303 (350)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~~ 303 (350)
..+. ......+..+++.+.+|+.+||..||.+|| +++++++|
T Consensus 215 --~~~~-~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 215 --RRVK-EDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred --HHhh-hcccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 1111 111223456788999999999999999999 88898876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=292.07 Aligned_cols=259 Identities=29% Similarity=0.426 Sum_probs=209.3
Q ss_pred hhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceeeEE
Q 018785 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYC 96 (350)
Q Consensus 17 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (350)
++..++|++.+.||+|++|.||+|.++ .+..|++|.+..... ....+.+|+..+++++||||+++++++
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~----------~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~ 70 (261)
T cd05068 2 EIDRTSIQLLRKLGAGQFGEVWEGLWN----------NTTPVAVKTLKPGTM-DPKDFLAEAQIMKKLRHPKLIQLYAVC 70 (261)
T ss_pred ccchhheeeEEEecccCCccEEEEEec----------CCeEEEEEeeCCCcc-cHHHHHHHHHHHHHCCCCCccceeEEE
Confidence 355688999999999999999998432 246799999876542 356688899999999999999999999
Q ss_pred eecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcccc
Q 018785 97 SESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFG 176 (350)
Q Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg 176 (350)
...+..+++||++.+++|.+++.......++...+..++.|++.||.+|| +.|++|+||+|+||+++.++.++|+|||
T Consensus 71 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dl~p~Nil~~~~~~~~l~dfg 148 (261)
T cd05068 71 TLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE--AQNYIHRDLAARNVLVGENNICKVADFG 148 (261)
T ss_pred ecCCCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH--hCCeeeccCCcceEEEcCCCCEEECCcc
Confidence 99999999999999999999997765557899999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccccCcchhhhhhhcchhhhh
Q 018785 177 LARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRD 255 (350)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 255 (350)
++......... .......+..|+|||...+..++.++|+||||+++|+|++ |+.||.+.........
T Consensus 149 ~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~----------- 216 (261)
T cd05068 149 LARVIKEDIYE-AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQ----------- 216 (261)
T ss_pred eEEEccCCccc-ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH-----------
Confidence 99765422111 1111222356999999988899999999999999999999 8989865432111111
Q ss_pred hHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 018785 256 SRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 307 (350)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~ 307 (350)
+........+..++..+.+++.+||+.+|.+||++.++++.|+.+
T Consensus 217 -------~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 217 -------VDQGYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred -------HHcCCCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 111111123345678899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=305.52 Aligned_cols=259 Identities=27% Similarity=0.334 Sum_probs=223.5
Q ss_pred hhhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh---hHHHHHHHHHHHhccC-CCccc
Q 018785 15 ISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ---GHKEWLTEVIYLGQLR-HENLV 90 (350)
Q Consensus 15 ~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~-h~~i~ 90 (350)
........|.+.+.||+|.||.||.+ .+..+|+.+|+|.+.+.... +...+.+|+.+|++++ ||||+
T Consensus 29 ~~~~~~~~Y~l~~~lG~G~Fg~v~~~---------~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv 99 (382)
T KOG0032|consen 29 FSEDIKEKYELGRELGRGQFGVVYLC---------REKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIV 99 (382)
T ss_pred ccccccccEEehhhhCCCCceEEEEE---------EecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEE
Confidence 34555678999999999999999999 77888999999999876543 3467899999999998 99999
Q ss_pred ceeeEEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCC---
Q 018785 91 KLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSN--- 167 (350)
Q Consensus 91 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~--- 167 (350)
.++++|++....++|||+++||.|.+.+... .+++..+..++.|+++++.||| +.|++|+||||+|+++...
T Consensus 100 ~l~~~~e~~~~~~lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH--~~gvvHrDlKpEN~L~~~~~~~ 174 (382)
T KOG0032|consen 100 QLKDAFEDPDSVYLVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLH--SLGVVHRDLKPENLLLASKDEG 174 (382)
T ss_pred EEEEEEEcCCeEEEEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHH--hCCceeccCCHHHeeeccccCC
Confidence 9999999999999999999999999999877 3999999999999999999999 9999999999999999543
Q ss_pred -CcEEEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhh
Q 018785 168 -FNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLV 246 (350)
Q Consensus 168 -~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~ 246 (350)
+.++++|||++..... .......+|++.|+|||++.+..|+...|+||+|+++|.|++|..||.+.........+.
T Consensus 175 ~~~ik~~DFGla~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~ 251 (382)
T KOG0032|consen 175 SGRIKLIDFGLAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAIL 251 (382)
T ss_pred CCcEEEeeCCCceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHH
Confidence 4799999999987544 445566889999999999998999999999999999999999999998877544443332
Q ss_pred hhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018785 247 EWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 305 (350)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~ 305 (350)
.... ....+....++..+.+++.+||..||.+|+|+.++|+|-+
T Consensus 252 ~~~~---------------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpW 295 (382)
T KOG0032|consen 252 RGDF---------------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPW 295 (382)
T ss_pred cCCC---------------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCcc
Confidence 2111 2334556788999999999999999999999999999733
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=310.87 Aligned_cols=255 Identities=24% Similarity=0.309 Sum_probs=202.8
Q ss_pred hcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch---hhHHHHHHHHHHHhccCCCcccceeeEEe
Q 018785 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (350)
Q Consensus 21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (350)
..|++.+.||+|+||+||+| .+..++..||+|++..... .....+..|+.+++.++||||+++++.+.
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~~---------~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~ 71 (381)
T cd05626 1 SMFVKIKTLGIGAFGEVCLA---------CKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQ 71 (381)
T ss_pred CCceEEEEEeecCCEEEEEE---------EECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEe
Confidence 36899999999999999999 5666789999999976432 23456788999999999999999999999
Q ss_pred ecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccc
Q 018785 98 ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL 177 (350)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~ 177 (350)
+.+..++||||+++++|.+++.... .+++..+..++.|++.||.||| +.||+|+||||+||+++.++.++|+|||+
T Consensus 72 ~~~~~~lv~E~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~~LH--~~givHrDlKp~Nili~~~~~~kL~DFGl 147 (381)
T cd05626 72 DKDNLYFVMDYIPGGDMMSLLIRME--VFPEVLARFYIAELTLAIESVH--KMGFIHRDIKPDNILIDLDGHIKLTDFGL 147 (381)
T ss_pred cCCEEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--hCCeeecCCcHHHEEECCCCCEEEeeCcC
Confidence 9999999999999999999997765 6899999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCCCC---------------------------------------------CcccccccCCCcccCccccccCCCCC
Q 018785 178 ARDGPTGDN---------------------------------------------THVSTRIVGTRGYAAPEYVATGHLTP 212 (350)
Q Consensus 178 ~~~~~~~~~---------------------------------------------~~~~~~~~~~~~~~aPE~~~~~~~~~ 212 (350)
+........ ........|++.|+|||.+.+..++.
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ 227 (381)
T cd05626 148 CTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQ 227 (381)
T ss_pred CcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCC
Confidence 753211000 00011246899999999998889999
Q ss_pred ccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhh--ccC
Q 018785 213 KSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCL--HMD 290 (350)
Q Consensus 213 ~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l--~~d 290 (350)
++|||||||++|+|++|..||...........+..+ ...........+++++.+||.+|+ ..+
T Consensus 228 ~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~---------------~~~~~~~~~~~~s~~~~dli~~ll~~~~~ 292 (381)
T cd05626 228 LCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINW---------------ENTLHIPPQVKLSPEAVDLITKLCCSAEE 292 (381)
T ss_pred ccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHcc---------------ccccCCCCCCCCCHHHHHHHHHHccCccc
Confidence 999999999999999999999764432211111110 001111112246788999999855 555
Q ss_pred CCCCCCHHHHHHH
Q 018785 291 PKNRPSMVDVLTS 303 (350)
Q Consensus 291 p~~Rps~~~ll~~ 303 (350)
|..|+++.++++|
T Consensus 293 ~~~R~~~~~~l~h 305 (381)
T cd05626 293 RLGRNGADDIKAH 305 (381)
T ss_pred ccCCCCHHHHhcC
Confidence 5669999999987
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-42 Score=292.56 Aligned_cols=277 Identities=27% Similarity=0.330 Sum_probs=217.2
Q ss_pred hhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh--hHHHHHHHHHHHhccCCCc-ccceeeEE
Q 018785 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ--GHKEWLTEVIYLGQLRHEN-LVKLIGYC 96 (350)
Q Consensus 20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~-i~~~~~~~ 96 (350)
-..|...++||+|+||+||+| ....+|+.||+|.+...... ......+|+.+++.++|+| |+.+++++
T Consensus 10 ~~~~~~~eklGeGtyg~Vyka---------r~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~ 80 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKA---------RSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVI 80 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEE---------EEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeee
Confidence 567888899999999999999 67777899999999877542 3455788999999999999 99999999
Q ss_pred eecC------ceEEEEEcCCCCChhhHHhhcCC--CCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCC
Q 018785 97 SESD------NRLLVYEFMPKGSLENHLFRKGV--QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNF 168 (350)
Q Consensus 97 ~~~~------~~~lv~e~~~~~~L~~~l~~~~~--~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~ 168 (350)
...+ .+++|+||. ..+|..++...+. ..++...++.++.||+.||+||| +++|+||||||.||+|+.+|
T Consensus 81 ~~~~~~~~~~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H--~~~IlHRDLKPQNlLi~~~G 157 (323)
T KOG0594|consen 81 HTSNNHRGIGKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLH--SHGILHRDLKPQNLLISSSG 157 (323)
T ss_pred eecccccccceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHH--hCCeecccCCcceEEECCCC
Confidence 8877 789999999 6699999987653 36777899999999999999999 99999999999999999999
Q ss_pred cEEEccccccccCCCCCCCcccccccCCCcccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhh
Q 018785 169 NAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVE 247 (350)
Q Consensus 169 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~ 247 (350)
.+||+|||+++-...... ..+...+|..|+|||++.|. .|+...||||+||+++||++++..|.+..+......+..
T Consensus 158 ~lKlaDFGlAra~~ip~~--~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~ 235 (323)
T KOG0594|consen 158 VLKLADFGLARAFSIPMR--TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFR 235 (323)
T ss_pred cEeeeccchHHHhcCCcc--cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHH
Confidence 999999999985433222 23446788889999999887 799999999999999999999999998887544444443
Q ss_pred hcc-hhhhhhHHHHHhhhcc---c----CCCCcH---HHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHhhhcC
Q 018785 248 WAD-PFLRDSRRVLRIMDTR---L----GGQYSK---KEAQAVAAVVLQCLHMDPKNRPSMVDVLTS--LEQLHTS 310 (350)
Q Consensus 248 ~~~-~~~~~~~~~~~~~~~~---~----~~~~~~---~~~~~l~~li~~~l~~dp~~Rps~~~ll~~--L~~~~~~ 310 (350)
... |............+-. . ...+.. ...++..+++.+||+.+|.+|.|+..+++| +..+...
T Consensus 236 ~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~~ 311 (323)
T KOG0594|consen 236 LLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPEK 311 (323)
T ss_pred HcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccccc
Confidence 321 2111111111111111 0 111111 122488999999999999999999999988 6555433
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=308.49 Aligned_cols=251 Identities=24% Similarity=0.344 Sum_probs=199.1
Q ss_pred hhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch-hhHHHHHHHHHHHhccCCCcccceeeEEe
Q 018785 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (350)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (350)
...+|++.+.||+|+||+||+| .+..+++.||||.+..... .....+.+|+.+++.++|+||+++++++.
T Consensus 72 ~~~~~~~~~~lg~G~~g~V~~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 142 (353)
T PLN00034 72 SLSELERVNRIGSGAGGTVYKV---------IHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFD 142 (353)
T ss_pred CHHHHhhhhhccCCCCeEEEEE---------EECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEec
Confidence 3578999999999999999999 5566788999999865432 23456889999999999999999999999
Q ss_pred ecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccc
Q 018785 98 ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL 177 (350)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~ 177 (350)
..+..++||||+++++|.+.. ..++..+..++.||+.||.||| +.|++|+||||+||+++.++.++|+|||+
T Consensus 143 ~~~~~~lv~e~~~~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH--~~~ivHrDlkp~NIll~~~~~~kL~DfG~ 214 (353)
T PLN00034 143 HNGEIQVLLEFMDGGSLEGTH------IADEQFLADVARQILSGIAYLH--RRHIVHRDIKPSNLLINSAKNVKIADFGV 214 (353)
T ss_pred cCCeEEEEEecCCCCcccccc------cCCHHHHHHHHHHHHHHHHHHH--HCCEeecCCCHHHEEEcCCCCEEEccccc
Confidence 999999999999999986532 4567788899999999999999 99999999999999999999999999999
Q ss_pred cccCCCCCCCcccccccCCCcccCcccccc-----CCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchh
Q 018785 178 ARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-----GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPF 252 (350)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 252 (350)
+........ ......|+..|+|||.+.. ...+.++|||||||++|+|++|+.||..........
T Consensus 215 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~--------- 283 (353)
T PLN00034 215 SRILAQTMD--PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWAS--------- 283 (353)
T ss_pred ceecccccc--cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHH---------
Confidence 875432211 1123468889999998743 234568999999999999999999997332211110
Q ss_pred hhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 253 LRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
.............+..++.++.+||.+||..||++|||+.++++|
T Consensus 284 ------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 284 ------LMCAICMSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred ------HHHHHhccCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 001111111223345677899999999999999999999999987
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-41 Score=292.87 Aligned_cols=259 Identities=26% Similarity=0.426 Sum_probs=209.4
Q ss_pred hhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceeeEE
Q 018785 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYC 96 (350)
Q Consensus 17 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (350)
++..++|++.++||+|++|.||+|... .+..|++|.+..... ....+.+|+.+++.++|+||+++++.+
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~----------~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~ 70 (261)
T cd05072 2 EIPRESIKLVKKLGAGQFGEVWMGYYN----------NSTKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVV 70 (261)
T ss_pred cCchHHeEEeeecCCcCCceEEEEEec----------CCceEEEEEccCCch-hHHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence 345789999999999999999999532 245789998765432 356788999999999999999999999
Q ss_pred eecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcccc
Q 018785 97 SESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFG 176 (350)
Q Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg 176 (350)
...+..++++|++.+++|.+++.......++...+..++.|++.||+||| +.+++|+||+|+||+++.++.++|+|||
T Consensus 71 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH--~~~i~H~dl~p~nili~~~~~~~l~dfg 148 (261)
T cd05072 71 TKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE--RKNYIHRDLRAANVLVSESLMCKIADFG 148 (261)
T ss_pred cCCCCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--HCCeeccccchhhEEecCCCcEEECCCc
Confidence 99999999999999999999997765557889999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccccCcchhhhhhhcchhhhh
Q 018785 177 LARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRD 255 (350)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 255 (350)
++......... ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||...........+
T Consensus 149 ~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~---------- 217 (261)
T cd05072 149 LARVIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSAL---------- 217 (261)
T ss_pred cceecCCCcee-ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHH----------
Confidence 99764332211 1122334567999999988889999999999999999998 89998654321111111
Q ss_pred hHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 018785 256 SRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 307 (350)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~ 307 (350)
...........++.++.+++.+||..+|++||+++++++.|+++
T Consensus 218 --------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 218 --------QRGYRMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred --------HcCCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 11111222335677899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=313.10 Aligned_cols=254 Identities=24% Similarity=0.337 Sum_probs=203.5
Q ss_pred hcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch---hhHHHHHHHHHHHhccCCCcccceeeEEe
Q 018785 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (350)
Q Consensus 21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (350)
++|++.+.||+|+||.||+| .+..+++.||+|++..... .....+.+|+.+++.++||+|+++++.+.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a---------~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~ 71 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLV---------RKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQ 71 (376)
T ss_pred CCceEEEEEEeCCCeEEEEE---------EECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEE
Confidence 47999999999999999999 5666789999999865432 23355778999999999999999999999
Q ss_pred ecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccc
Q 018785 98 ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL 177 (350)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~ 177 (350)
+++.+++||||+++++|.+++.... .+++..+..++.||+.||+||| +.|++|+||||+||+++.++.++|+|||+
T Consensus 72 ~~~~~~lv~E~~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH--~~~ivHrDlkp~Nill~~~~~ikL~DFG~ 147 (376)
T cd05598 72 DKDNLYFVMDYIPGGDMMSLLIRLG--IFEEDLARFYIAELTCAIESVH--KMGFIHRDIKPDNILIDRDGHIKLTDFGL 147 (376)
T ss_pred cCCEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--HCCeEeCCCCHHHEEECCCCCEEEEeCCC
Confidence 9999999999999999999997764 6889999999999999999999 99999999999999999999999999999
Q ss_pred cccCCCCCC-----------------------------------------CcccccccCCCcccCccccccCCCCCccch
Q 018785 178 ARDGPTGDN-----------------------------------------THVSTRIVGTRGYAAPEYVATGHLTPKSDV 216 (350)
Q Consensus 178 ~~~~~~~~~-----------------------------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di 216 (350)
+........ ........|++.|+|||++.+..++.++||
T Consensus 148 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 227 (376)
T cd05598 148 CTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDW 227 (376)
T ss_pred CccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceee
Confidence 753210000 000112468999999999999999999999
Q ss_pred hhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCC-
Q 018785 217 YSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRP- 295 (350)
Q Consensus 217 wslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp- 295 (350)
|||||++|+|++|+.||.+.........+..+. ..........+++++.++|.+|+ .+|.+|+
T Consensus 228 wSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~---------------~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~ 291 (376)
T cd05598 228 WSVGVILYEMLVGQPPFLADTPAETQLKVINWE---------------TTLHIPSQAKLSREASDLILRLC-CGAEDRLG 291 (376)
T ss_pred eeccceeeehhhCCCCCCCCCHHHHHHHHhccC---------------ccccCCCCCCCCHHHHHHHHHHh-cCHhhcCC
Confidence 999999999999999997654322211111110 00111112346778899999976 5999999
Q ss_pred --CHHHHHHH
Q 018785 296 --SMVDVLTS 303 (350)
Q Consensus 296 --s~~~ll~~ 303 (350)
++.++++|
T Consensus 292 ~~t~~ell~h 301 (376)
T cd05598 292 KNGADEIKAH 301 (376)
T ss_pred CCCHHHHhCC
Confidence 99999988
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-41 Score=294.88 Aligned_cols=265 Identities=25% Similarity=0.428 Sum_probs=210.9
Q ss_pred hhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccc-hhhHHHHHHHHHHHhccCCCcccceeeE
Q 018785 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES-FQGHKEWLTEVIYLGQLRHENLVKLIGY 95 (350)
Q Consensus 17 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 95 (350)
++..++|++.+.||+|+||.||+|.+... ....++..|++|.+.... ......+.+|+.+++.++||||++++++
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~----~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~ 77 (277)
T cd05032 2 ELPREKITLIRELGQGSFGMVYEGLAKGV----VKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGV 77 (277)
T ss_pred ccchHHeeEEeEecCCCCceEEEEEEecc----CCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEE
Confidence 34578999999999999999999966532 123456889999986543 2334567889999999999999999999
Q ss_pred EeecCceEEEEEcCCCCChhhHHhhcC--------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCC
Q 018785 96 CSESDNRLLVYEFMPKGSLENHLFRKG--------VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSN 167 (350)
Q Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--------~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~ 167 (350)
+......++||||+++++|.+++.... ...++...+..++.|++.||.||| +.+++|+||+|+||+++.+
T Consensus 78 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~di~p~nill~~~ 155 (277)
T cd05032 78 VSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA--AKKFVHRDLAARNCMVAED 155 (277)
T ss_pred EcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH--hCCccccccChheEEEcCC
Confidence 999999999999999999999986532 124677889999999999999999 9999999999999999999
Q ss_pred CcEEEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccccCcchhhhh
Q 018785 168 FNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLV 246 (350)
Q Consensus 168 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~~~~~~ 246 (350)
+.++|+|||++................++..|+|||.+.+..++.++|+||||+++|++++ |..||.........
T Consensus 156 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~---- 231 (277)
T cd05032 156 LTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVL---- 231 (277)
T ss_pred CCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHH----
Confidence 9999999999875433322222222345678999999988889999999999999999998 88888654322111
Q ss_pred hhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018785 247 EWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 305 (350)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~ 305 (350)
...........+..++..+.+++.+||+.+|++|||+.++++.|+
T Consensus 232 --------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 232 --------------KFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred --------------HHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 111111122334456789999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=311.24 Aligned_cols=254 Identities=24% Similarity=0.335 Sum_probs=202.7
Q ss_pred hcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch---hhHHHHHHHHHHHhccCCCcccceeeEEe
Q 018785 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (350)
Q Consensus 21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (350)
++|++.++||+|+||+||+| .+..+++.||+|.+..... .....+.+|+.+++.++||+|+++++.+.
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a---------~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~ 71 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLA---------RKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQ 71 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEE---------EECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEE
Confidence 36899999999999999999 6667789999999875432 23456788999999999999999999999
Q ss_pred ecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccc
Q 018785 98 ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL 177 (350)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~ 177 (350)
+++..++||||+++++|.+++.... .+++..+..++.||+.||.||| +.||+|+||||+||+++.++.++|+|||+
T Consensus 72 ~~~~~~lv~E~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~al~~lH--~~~ivHrDlKp~NILl~~~g~~kL~DFGl 147 (382)
T cd05625 72 DKDNLYFVMDYIPGGDMMSLLIRMG--IFPEDLARFYIAELTCAVESVH--KMGFIHRDIKPDNILIDRDGHIKLTDFGL 147 (382)
T ss_pred eCCEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEECCCCCEEEeECCC
Confidence 9999999999999999999997654 6899999999999999999999 99999999999999999999999999999
Q ss_pred cccCCCCCC---------------------------------------------CcccccccCCCcccCccccccCCCCC
Q 018785 178 ARDGPTGDN---------------------------------------------THVSTRIVGTRGYAAPEYVATGHLTP 212 (350)
Q Consensus 178 ~~~~~~~~~---------------------------------------------~~~~~~~~~~~~~~aPE~~~~~~~~~ 212 (350)
+........ ........|++.|+|||++.+..++.
T Consensus 148 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ 227 (382)
T cd05625 148 CTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQ 227 (382)
T ss_pred CccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCC
Confidence 753211000 00011235889999999999999999
Q ss_pred ccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCC
Q 018785 213 KSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPK 292 (350)
Q Consensus 213 ~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~ 292 (350)
++|+|||||++|+|++|..||...........+..+ ...........+++++.++|.+|+ .+|.
T Consensus 228 ~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~---------------~~~~~~p~~~~~s~~~~~li~~l~-~~p~ 291 (382)
T cd05625 228 LCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINW---------------QTSLHIPPQAKLSPEASDLIIKLC-RGPE 291 (382)
T ss_pred eeeEEechHHHHHHHhCCCCCCCCCHHHHHHHHHcc---------------CCCcCCCCcccCCHHHHHHHHHHc-cCHh
Confidence 999999999999999999999765432111111110 011111112356788999999976 5999
Q ss_pred CCCC---HHHHHHH
Q 018785 293 NRPS---MVDVLTS 303 (350)
Q Consensus 293 ~Rps---~~~ll~~ 303 (350)
+|++ ++++++|
T Consensus 292 ~R~~~~~~~ei~~h 305 (382)
T cd05625 292 DRLGKNGADEIKAH 305 (382)
T ss_pred HcCCCCCHHHHhcC
Confidence 9987 8888876
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=305.08 Aligned_cols=243 Identities=28% Similarity=0.414 Sum_probs=197.6
Q ss_pred ceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch---hhHHHHHHHHHHHhcc-CCCcccceeeEEeecCce
Q 018785 27 YLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQL-RHENLVKLIGYCSESDNR 102 (350)
Q Consensus 27 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 102 (350)
+.||+|+||+||+| .+..+++.||+|++..... .....+..|..++..+ +||||+++++++...+..
T Consensus 1 ~~lg~G~~g~V~~~---------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~ 71 (320)
T cd05590 1 RVLGKGSFGKVMLA---------RLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRL 71 (320)
T ss_pred CeeeeCCCeEEEEE---------EEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEE
Confidence 47999999999999 5566789999999875432 2334566777777766 799999999999999999
Q ss_pred EEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccccccCC
Q 018785 103 LLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGP 182 (350)
Q Consensus 103 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~~~~ 182 (350)
|+||||+++++|.+++.... .+++..+..++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++....
T Consensus 72 ~iv~Ey~~~g~L~~~i~~~~--~l~~~~~~~~~~ql~~~L~~lH--~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~ 147 (320)
T cd05590 72 FFVMEFVNGGDLMFHIQKSR--RFDEARARFYAAEITSALMFLH--DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGI 147 (320)
T ss_pred EEEEcCCCCchHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecC
Confidence 99999999999999887664 6899999999999999999999 9999999999999999999999999999986432
Q ss_pred CCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhHHHHHh
Q 018785 183 TGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRI 262 (350)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (350)
.. ........|++.|+|||.+.+..++.++|+|||||++|+|++|+.||...........+.
T Consensus 148 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~---------------- 209 (320)
T cd05590 148 FN--GKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAIL---------------- 209 (320)
T ss_pred cC--CCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHh----------------
Confidence 21 112233568999999999998899999999999999999999999997654322111111
Q ss_pred hhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCH------HHHHHH
Q 018785 263 MDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSM------VDVLTS 303 (350)
Q Consensus 263 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~------~~ll~~ 303 (350)
.. ....+..+++++.+++.+||+.||.+||++ +++++|
T Consensus 210 -~~--~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h 253 (320)
T cd05590 210 -ND--EVVYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH 253 (320)
T ss_pred -cC--CCCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence 11 112344567889999999999999999998 777765
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=294.98 Aligned_cols=262 Identities=26% Similarity=0.412 Sum_probs=208.2
Q ss_pred hhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch-hhHHHHHHHHHHHhccCCCcccceeeEEee
Q 018785 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (350)
Q Consensus 20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (350)
-.+|++.+.||+|+||.||+|++.. .+...+..+++|.+..... .....+.+|+.+++.+.||||+++++++..
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~-----~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 78 (283)
T cd05090 4 LSAVRFMEELGECAFGKIYKGHLYL-----PGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQ 78 (283)
T ss_pred hhhceeeeeccccCCcceEEEEEec-----CCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEec
Confidence 4689999999999999999996432 2344678899999875432 333567889999999999999999999999
Q ss_pred cCceEEEEEcCCCCChhhHHhhcC---------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceE
Q 018785 99 SDNRLLVYEFMPKGSLENHLFRKG---------------VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVL 163 (350)
Q Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~---------------~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nil 163 (350)
.+..+++|||+.+++|.+++.... ...++...+..++.|++.||.||| ++|++|+||+|+||+
T Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH--~~~i~H~dlkp~nil 156 (283)
T cd05090 79 EQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS--SHFFVHKDLAARNIL 156 (283)
T ss_pred CCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH--hcCeehhccccceEE
Confidence 999999999999999999985332 124788889999999999999999 999999999999999
Q ss_pred EcCCCcEEEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccccCcch
Q 018785 164 LDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAE 242 (350)
Q Consensus 164 i~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~~ 242 (350)
++.++.++|+|||++................++..|+|||.+.+..++.++|+||||+++|+|++ |..||.+.......
T Consensus 157 i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~ 236 (283)
T cd05090 157 IGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVI 236 (283)
T ss_pred EcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 99999999999999976433322222222344567999999988889999999999999999998 88888654321111
Q ss_pred hhhhhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 018785 243 QTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQ 306 (350)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 306 (350)
..+........+..+++.+.+++.+||+.||.+||++.+++++|..
T Consensus 237 ------------------~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 237 ------------------EMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred ------------------HHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 1111111122344567889999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-42 Score=309.40 Aligned_cols=254 Identities=24% Similarity=0.289 Sum_probs=204.8
Q ss_pred hcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch---hhHHHHHHHHHHHhccCCCcccceeeEEe
Q 018785 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (350)
Q Consensus 21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (350)
++|.+.+.||+|+||+||++ .+..+++.||+|.+..... .....+.+|..+++.++||+|+++++++.
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~---------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~ 71 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVV---------REKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQ 71 (330)
T ss_pred CCceEEEEEEeccCEEEEEE---------EECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEe
Confidence 47999999999999999999 5666789999999876533 23355788999999999999999999999
Q ss_pred ecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccc
Q 018785 98 ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL 177 (350)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~ 177 (350)
+.+..++||||+++++|.+++.... ..+++..+..++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||+
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~lH--~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~ 148 (330)
T cd05601 72 DKDNLYLVMEYQPGGDLLSLLNRYE-DQFDEDMAQFYLAELVLAIHSVH--QMGYVHRDIKPENVLIDRTGHIKLADFGS 148 (330)
T ss_pred cCCeEEEEECCCCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH--HCCeEcccCchHheEECCCCCEEeccCCC
Confidence 9999999999999999999997753 36899999999999999999999 99999999999999999999999999999
Q ss_pred cccCCCCCCCcccccccCCCcccCccccc------cCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcch
Q 018785 178 ARDGPTGDNTHVSTRIVGTRGYAAPEYVA------TGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADP 251 (350)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~------~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~ 251 (350)
+......... ......+++.|+|||++. +..++.++|||||||++|+|++|..||...........+...
T Consensus 149 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~--- 224 (330)
T cd05601 149 AARLTANKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNF--- 224 (330)
T ss_pred CeECCCCCce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcC---
Confidence 9754332221 222346889999999986 456788999999999999999999999764432111111110
Q ss_pred hhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 252 FLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
...........++.++.+|+.+||. +|.+|||++++++|
T Consensus 225 ------------~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 225 ------------QRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred ------------CCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 0000011122467889999999998 99999999999976
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=299.06 Aligned_cols=266 Identities=24% Similarity=0.382 Sum_probs=210.0
Q ss_pred hhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch-hhHHHHHHHHHHHhccCCCcccceeeEEe
Q 018785 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (350)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (350)
...+|++.+.||+|+||.||+|++... .......||+|.+..... .....+.+|+..++.++||||+++++++.
T Consensus 5 ~~~~f~~~~~lg~G~~g~Vy~~~~~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~ 79 (316)
T cd05108 5 KETEFKKIKVLGSGAFGTVYKGLWIPE-----GEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICL 79 (316)
T ss_pred chhhceeeeeeecCCCceEEEEEEecC-----CCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEc
Confidence 467899999999999999999965421 122244689999875432 33466888999999999999999999987
Q ss_pred ecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccc
Q 018785 98 ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL 177 (350)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~ 177 (350)
.. ..+++++++.+++|.+++..+. ..++...+..++.|++.||+||| +.|++|+||||+||+++.++.++|+|||+
T Consensus 80 ~~-~~~~v~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH--~~~iiH~dlkp~Nill~~~~~~kl~DfG~ 155 (316)
T cd05108 80 TS-TVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLE--ERRLVHRDLAARNVLVKTPQHVKITDFGL 155 (316)
T ss_pred CC-CceeeeecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHH--hcCeeccccchhheEecCCCcEEEccccc
Confidence 64 5789999999999999997654 35888899999999999999999 99999999999999999999999999999
Q ss_pred cccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccccCcchhhhhhhcchhhhhh
Q 018785 178 ARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDS 256 (350)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 256 (350)
+.................+..|++||.+.+..++.++||||||+++|+|++ |..||.+......
T Consensus 156 a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~--------------- 220 (316)
T cd05108 156 AKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI--------------- 220 (316)
T ss_pred cccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH---------------
Confidence 986543332222222234567999999999999999999999999999997 9999875432111
Q ss_pred HHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcCC
Q 018785 257 RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSK 311 (350)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~ 311 (350)
............+..++.++.+++.+||..+|.+||++.+++..|..+....
T Consensus 221 ---~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 221 ---SSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred ---HHHHhCCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 1111111122223445678999999999999999999999999999887553
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=292.01 Aligned_cols=253 Identities=25% Similarity=0.390 Sum_probs=207.2
Q ss_pred hcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch-----hhHHHHHHHHHHHhccCCCcccceeeE
Q 018785 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-----QGHKEWLTEVIYLGQLRHENLVKLIGY 95 (350)
Q Consensus 21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~ 95 (350)
++|.+.+.||+|++|.||.| .+..+++.+++|.+..... .....+.+|+.++++++||||++++++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~---------~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~ 72 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLC---------YDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGC 72 (263)
T ss_pred CcccccceecCCCceEEEEE---------EEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEE
Confidence 57999999999999999999 6666789999998865422 123467889999999999999999999
Q ss_pred EeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccc
Q 018785 96 CSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDF 175 (350)
Q Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Df 175 (350)
+..++..++|+|++++++|.+++.... .++...+..++.|++.||.+|| +.|++|+||+|+||+++.++.++|+||
T Consensus 73 ~~~~~~~~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lH--~~~i~H~dl~p~nilv~~~~~~~l~df 148 (263)
T cd06625 73 LRDDETLSIFMEYMPGGSVKDQLKAYG--ALTETVTRKYTRQILEGVEYLH--SNMIVHRDIKGANILRDSAGNVKLGDF 148 (263)
T ss_pred EccCCeEEEEEEECCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEEcCCCCEEEeec
Confidence 999999999999999999999987664 6889999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCCCCCcc-cccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhh
Q 018785 176 GLARDGPTGDNTHV-STRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLR 254 (350)
Q Consensus 176 g~~~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~ 254 (350)
|.+........... .....++..|+|||.+.+..++.++|+||||+++|+|++|+.||.......
T Consensus 149 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-------------- 214 (263)
T cd06625 149 GASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMA-------------- 214 (263)
T ss_pred ccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHH--------------
Confidence 99865432221111 122456778999999999889999999999999999999999986533211
Q ss_pred hhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 255 DSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
..............+..++..+.+++.+||..+|.+|||+.+++++
T Consensus 215 ---~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 215 ---AIFKIATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred ---HHHHHhccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 1111111222233455678899999999999999999999999976
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-41 Score=296.05 Aligned_cols=265 Identities=25% Similarity=0.373 Sum_probs=210.4
Q ss_pred hhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh-hHHHHHHHHHHHhccCCCcccceeeEE
Q 018785 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ-GHKEWLTEVIYLGQLRHENLVKLIGYC 96 (350)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (350)
+...+|++.+.||+|+||.||+|++... .....+..||+|.+...... ....+..|..++..++||||+++++++
T Consensus 2 i~~~~~~~~~~lg~G~~g~V~~~~~~~~----~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~ 77 (283)
T cd05091 2 INLSTVRFMEELGEDRFGKVYKGHLFGT----APGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVV 77 (283)
T ss_pred CCHHHHHHHHHhCCCCCCeEEEEEEecC----CCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEE
Confidence 3457899999999999999999966432 22345678999999755432 235678899999999999999999999
Q ss_pred eecCceEEEEEcCCCCChhhHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCce
Q 018785 97 SESDNRLLVYEFMPKGSLENHLFRKG--------------VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNV 162 (350)
Q Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~--------------~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Ni 162 (350)
...+..+++++|+.+++|.+++.... ...++...+..++.|++.||.|+| +.|++|+||||.||
T Consensus 78 ~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH--~~gi~H~dlkp~Ni 155 (283)
T cd05091 78 TKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS--SHHVVHKDLATRNV 155 (283)
T ss_pred cCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH--HcCccccccchhhe
Confidence 99999999999999999999985321 124788889999999999999999 99999999999999
Q ss_pred EEcCCCcEEEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccccCcc
Q 018785 163 LLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLA 241 (350)
Q Consensus 163 li~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~ 241 (350)
+++.++.++|+|||++................+++.|+|||.+.+..++.++|+|||||++|+|++ |..||.+......
T Consensus 156 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~ 235 (283)
T cd05091 156 LVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV 235 (283)
T ss_pred EecCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 999999999999999875433322222223345678999999988889999999999999999998 7778765432111
Q ss_pred hhhhhhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 018785 242 EQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQ 306 (350)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 306 (350)
...+........+.+++..+.+++.+||+.+|.+||++.++++.|+.
T Consensus 236 ------------------~~~i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 236 ------------------IEMIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred ------------------HHHHHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 11111222223455678889999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=303.30 Aligned_cols=243 Identities=26% Similarity=0.422 Sum_probs=194.7
Q ss_pred ceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch---hhHHHHHHHHHHHhc-cCCCcccceeeEEeecCce
Q 018785 27 YLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQ-LRHENLVKLIGYCSESDNR 102 (350)
Q Consensus 27 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~~~~~ 102 (350)
+.||+|+||.||+| .+..+++.||+|.+..... ........|..++.. .+||||+++++++...+..
T Consensus 1 ~~lG~G~~g~Vy~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~ 71 (316)
T cd05592 1 KVLGKGSFGKVMLA---------ELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHL 71 (316)
T ss_pred CeeeeCCCeEEEEE---------EECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEE
Confidence 46999999999999 5566788999999876432 122334455556654 4899999999999999999
Q ss_pred EEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccccccCC
Q 018785 103 LLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGP 182 (350)
Q Consensus 103 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~~~~ 182 (350)
++||||+++++|.+++.... .+++..+..++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||++....
T Consensus 72 ~lv~e~~~gg~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~LH--~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~ 147 (316)
T cd05592 72 FFVMEYLNGGDLMFHIQSSG--RFDEARARFYAAEIICGLQFLH--KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENM 147 (316)
T ss_pred EEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCEEeCCCCHHHeEECCCCCEEEccCcCCeECC
Confidence 99999999999999987654 6899999999999999999999 9999999999999999999999999999987532
Q ss_pred CCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhHHHHHh
Q 018785 183 TGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRI 262 (350)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (350)
... .......|++.|+|||.+.+..++.++|+|||||++|+|++|..||.+.........+.
T Consensus 148 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~---------------- 209 (316)
T cd05592 148 NGE--GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSIL---------------- 209 (316)
T ss_pred CCC--CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHH----------------
Confidence 222 22233568999999999999899999999999999999999999997654321111111
Q ss_pred hhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHH-HHHHH
Q 018785 263 MDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMV-DVLTS 303 (350)
Q Consensus 263 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~-~ll~~ 303 (350)
. .....+..++.++.+++.+||..||.+||++. ++++|
T Consensus 210 -~--~~~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h 248 (316)
T cd05592 210 -N--DRPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQH 248 (316)
T ss_pred -c--CCCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence 1 11223455678899999999999999999875 56553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=294.02 Aligned_cols=275 Identities=30% Similarity=0.440 Sum_probs=209.3
Q ss_pred hcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch-hhHHHHHHHHHHHhccCCCcccceeeEEeec
Q 018785 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (350)
Q Consensus 21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (350)
+.|.+.+.||+|+||+||++++.. ....++..||+|.+..... .....+.+|+..++.++||||+++++++...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~-----~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 78 (283)
T cd05080 4 RYLKKIRVLGEGHFGKVSLYCYDP-----ANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQ 78 (283)
T ss_pred hhceeceecccCCCcEEEEeeEcc-----ccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 344999999999999999875532 3445688999999876543 2345678899999999999999999987653
Q ss_pred --CceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccc
Q 018785 100 --DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL 177 (350)
Q Consensus 100 --~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~ 177 (350)
...+++|||+.+++|.+++... .+++..+..++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||+
T Consensus 79 ~~~~~~lv~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH--~~~i~H~dlkp~Nili~~~~~~~l~dfg~ 153 (283)
T cd05080 79 GGKGLQLIMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLH--SQHYIHRDLAARNVLLDNDRLVKIGDFGL 153 (283)
T ss_pred CCceEEEEecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHH--HCCeeccccChheEEEcCCCcEEEeeccc
Confidence 4578999999999999999764 5899999999999999999999 99999999999999999999999999999
Q ss_pred cccCCCCCCCcc-cccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhh
Q 018785 178 ARDGPTGDNTHV-STRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDS 256 (350)
Q Consensus 178 ~~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 256 (350)
+........... .....++..|+|||.+.+..++.++|+||||+++|+|++|..||........ ........ ....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~--~~~~~~~~-~~~~ 230 (283)
T cd05080 154 AKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE--EMIGPKQG-QMTV 230 (283)
T ss_pred ccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhh--hhhccccc-ccch
Confidence 876433222111 1112345569999999888899999999999999999999999865432111 00000000 0001
Q ss_pred HHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 018785 257 RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLH 308 (350)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 308 (350)
...............+..++.++.+++.+||+.+|++|||++++++.|+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 231 VRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 1111112222222334567789999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=301.61 Aligned_cols=268 Identities=22% Similarity=0.312 Sum_probs=204.4
Q ss_pred hcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh-hHHHHHHHHHHHhccCCCcccceeeEEeec
Q 018785 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ-GHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (350)
Q Consensus 21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (350)
++|++.+.||+|+||.||+| .+..++..||+|.+...... ....+.+|+.+++.++||||+++++++..+
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 76 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKG---------RSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTD 76 (309)
T ss_pred CceEEEEEecccCCEEEEEE---------EecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeC
Confidence 67999999999999999999 55667889999988754322 234567899999999999999999999999
Q ss_pred CceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccccc
Q 018785 100 DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR 179 (350)
Q Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~ 179 (350)
+..++||||+. ++|.+++.... ..++...+..++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||++.
T Consensus 77 ~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~lH--~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 152 (309)
T cd07872 77 KSLTLVFEYLD-KDLKQYMDDCG-NIMSMHNVKIFLYQILRGLAYCH--RRKVLHRDLKPQNLLINERGELKLADFGLAR 152 (309)
T ss_pred CeEEEEEeCCC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEECCCCCEEECccccce
Confidence 99999999995 48888876553 35888999999999999999999 9999999999999999999999999999986
Q ss_pred cCCCCCCCcccccccCCCcccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhh---
Q 018785 180 DGPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRD--- 255 (350)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~--- 255 (350)
....... ......+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||.+.........+.........+
T Consensus 153 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (309)
T cd07872 153 AKSVPTK--TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWP 230 (309)
T ss_pred ecCCCcc--ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Confidence 5322221 1222456788999998865 468899999999999999999999997765433333332221111000
Q ss_pred -hHHHHHhhhcccCC-------CCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 256 -SRRVLRIMDTRLGG-------QYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 256 -~~~~~~~~~~~~~~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
.............. .....+++++.+||.+||+.||.+|||+.++++|
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 231 GISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred hhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 00000000000000 0112467789999999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-41 Score=303.38 Aligned_cols=252 Identities=24% Similarity=0.356 Sum_probs=198.7
Q ss_pred ceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch---hhHHHHHHHHHHHhcc-CCCcccceeeEEeecCce
Q 018785 27 YLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQL-RHENLVKLIGYCSESDNR 102 (350)
Q Consensus 27 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 102 (350)
++||+|+||.||+| .+..+++.||+|++..... .....+..|..+++.+ +||||+++++++...+..
T Consensus 1 ~~lG~G~~g~V~~~---------~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~ 71 (329)
T cd05588 1 RVIGRGSYAKVLLV---------ELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRL 71 (329)
T ss_pred CeEeeCCCeEEEEE---------EECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEE
Confidence 47999999999999 5666789999999976432 2234577888888888 699999999999999999
Q ss_pred EEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccccccCC
Q 018785 103 LLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGP 182 (350)
Q Consensus 103 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~~~~ 182 (350)
|+||||+++++|.+++.... .+++..+..++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||++....
T Consensus 72 ~lv~e~~~~g~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~lH--~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~ 147 (329)
T cd05588 72 FFVIEFVSGGDLMFHMQRQR--KLPEEHARFYSAEISLALNFLH--ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGI 147 (329)
T ss_pred EEEEeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCeEecCCCHHHeEECCCCCEEECcCccccccc
Confidence 99999999999999887654 7999999999999999999999 9999999999999999999999999999986422
Q ss_pred CCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhHHHHHh
Q 018785 183 TGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRI 262 (350)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (350)
... .......|++.|+|||.+.+..++.++|+|||||++|+|++|..||.......... ........+.
T Consensus 148 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~---------~~~~~~~~~~ 216 (329)
T cd05588 148 RPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPD---------QNTEDYLFQV 216 (329)
T ss_pred cCC--CccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccccccccccc---------ccchHHHHHH
Confidence 111 12223568899999999999999999999999999999999999996432111000 0000000011
Q ss_pred hhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCC------HHHHHHH
Q 018785 263 MDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPS------MVDVLTS 303 (350)
Q Consensus 263 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps------~~~ll~~ 303 (350)
+.. .....+..++.++.++|.+||+.||.+|++ ++++++|
T Consensus 217 ~~~-~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 217 ILE-KQIRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred HHc-CCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 111 112234567788999999999999999987 6788766
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=294.55 Aligned_cols=265 Identities=28% Similarity=0.408 Sum_probs=210.1
Q ss_pred cccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch-hhHHHHHHHHHHHhccCCCcccceeeEEeecC
Q 018785 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLVKLIGYCSESD 100 (350)
Q Consensus 22 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 100 (350)
+|++.+.||+|+||.||+|+.... ........+++|.+..... .....+.+|+..++.++||||+++++.+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~----~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 76 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRL----KGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDG 76 (290)
T ss_pred CccccccccCcCCcceEEEEEecC----CCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCC
Confidence 588999999999999999965422 2223456788888875542 23456888999999999999999999999999
Q ss_pred ceEEEEEcCCCCChhhHHhhcC----------------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCC
Q 018785 101 NRLLVYEFMPKGSLENHLFRKG----------------------VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLK 158 (350)
Q Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~----------------------~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~ 158 (350)
..++++||+.+++|.+++.... ...++...++.++.|++.||.||| +.+++|+||+
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH--~~~ivH~dik 154 (290)
T cd05045 77 PLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA--EMKLVHRDLA 154 (290)
T ss_pred CcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH--HCCeehhhhh
Confidence 9999999999999999886421 135788899999999999999999 9999999999
Q ss_pred CCceEEcCCCcEEEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccc
Q 018785 159 ASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDR 237 (350)
Q Consensus 159 ~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~ 237 (350)
|+||+++.++.++|+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||.+..
T Consensus 155 p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 234 (290)
T cd05045 155 ARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA 234 (290)
T ss_pred hheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC
Confidence 9999999999999999999875433322212222334567999999988889999999999999999998 999986543
Q ss_pred cCcchhhhhhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcC
Q 018785 238 GGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 310 (350)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 310 (350)
.... ............+..++.++.+++.+||+.+|.+||++.++++.|+++..+
T Consensus 235 ~~~~------------------~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~ 289 (290)
T cd05045 235 PERL------------------FNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK 289 (290)
T ss_pred HHHH------------------HHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence 2111 111112122233455678999999999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=304.38 Aligned_cols=243 Identities=27% Similarity=0.409 Sum_probs=197.9
Q ss_pred ceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch---hhHHHHHHHHHHHhcc-CCCcccceeeEEeecCce
Q 018785 27 YLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQL-RHENLVKLIGYCSESDNR 102 (350)
Q Consensus 27 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 102 (350)
++||+|+||.||+| .+..+++.||+|++..... .....+..|..++..+ +||+|+++++++...+..
T Consensus 1 ~~lG~G~~g~Vy~~---------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~ 71 (321)
T cd05591 1 KVLGKGSFGKVMLA---------ELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRL 71 (321)
T ss_pred CccccCCCeEEEEE---------EECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeE
Confidence 46999999999999 5566788999999876432 2234466788888765 799999999999999999
Q ss_pred EEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccccccCC
Q 018785 103 LLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGP 182 (350)
Q Consensus 103 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~~~~ 182 (350)
++||||+++++|.+++.... .+++..+..++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++....
T Consensus 72 ~lv~E~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH--~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~ 147 (321)
T cd05591 72 FFVMEYVNGGDLMFQIQRSR--KFDEPRSRFYAAEVTLALMFLH--RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGI 147 (321)
T ss_pred EEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCeeccCCCHHHeEECCCCCEEEeecccceecc
Confidence 99999999999999887654 6899999999999999999999 9999999999999999999999999999986432
Q ss_pred CCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhHHHHHh
Q 018785 183 TGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRI 262 (350)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (350)
... .......|++.|+|||++.+..++.++|+|||||++|+|++|+.||...........+.
T Consensus 148 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~---------------- 209 (321)
T cd05591 148 LNG--VTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESIL---------------- 209 (321)
T ss_pred cCC--ccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHH----------------
Confidence 221 11223468899999999988899999999999999999999999997654322211111
Q ss_pred hhcccCCCCcHHHHHHHHHHHHHhhccCCCCCC-------CHHHHHHH
Q 018785 263 MDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRP-------SMVDVLTS 303 (350)
Q Consensus 263 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-------s~~~ll~~ 303 (350)
... ...+..++.++.+++.+||+.||++|+ +++++++|
T Consensus 210 -~~~--~~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 210 -HDD--VLYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred -cCC--CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 110 122334678899999999999999999 88888877
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=290.93 Aligned_cols=259 Identities=24% Similarity=0.340 Sum_probs=208.2
Q ss_pred hcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccc---hhhHHHHHHHHHHHhccCCCcccceeeEEe
Q 018785 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES---FQGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (350)
Q Consensus 21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (350)
++|++.+.||+|++|.||+| ....++..|+||.+.... ......+..|+..++.++||||+++++++.
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~---------~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 72 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRA---------TCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFI 72 (267)
T ss_pred cceeeeeeeccCCCeeEEEE---------EEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEE
Confidence 58999999999999999999 555568899999875432 233356788999999999999999999999
Q ss_pred ecCceEEEEEcCCCCChhhHHhhc--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccc
Q 018785 98 ESDNRLLVYEFMPKGSLENHLFRK--GVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDF 175 (350)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Df 175 (350)
..+..++++||+++++|.+++... ....+++..+..++.|++.||.||| +.|++|+||+|+||+++.++.++|+||
T Consensus 73 ~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH--~~~i~H~dl~~~nil~~~~~~~~l~d~ 150 (267)
T cd08228 73 EDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH--SRRVMHRDIKPANVFITATGVVKLGDL 150 (267)
T ss_pred ECCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHh--hCCeeCCCCCHHHEEEcCCCCEEECcc
Confidence 999999999999999999988542 2235888999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhh
Q 018785 176 GLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRD 255 (350)
Q Consensus 176 g~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 255 (350)
|.+....... .......++..|+|||.+.+..++.++|+||+|+++|+|++|+.||........
T Consensus 151 g~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~-------------- 214 (267)
T cd08228 151 GLGRFFSSKT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLF-------------- 214 (267)
T ss_pred ccceeccchh--HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHH--------------
Confidence 9887543221 111224577889999999888899999999999999999999999854321100
Q ss_pred hHHHHHhhhc-ccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 018785 256 SRRVLRIMDT-RLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLH 308 (350)
Q Consensus 256 ~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 308 (350)
.....+.. .........++..+.+++.+||..+|.+||++.++++.|++++
T Consensus 215 --~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 215 --SLCQKIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred --HHHHHHhcCCCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 00011111 1111223456788999999999999999999999999998874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=303.06 Aligned_cols=243 Identities=28% Similarity=0.423 Sum_probs=195.4
Q ss_pred ceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch---hhHHHHHHHHHHHhcc-CCCcccceeeEEeecCce
Q 018785 27 YLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQL-RHENLVKLIGYCSESDNR 102 (350)
Q Consensus 27 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 102 (350)
+.||+|+||.||+| .+..+|..||+|.+..... ........|..++... .||+|+++++++.+.+..
T Consensus 1 ~~lg~G~~g~V~~~---------~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~ 71 (316)
T cd05620 1 KVLGKGSFGKVLLA---------ELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHL 71 (316)
T ss_pred CeeeeCCCeEEEEE---------EECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEE
Confidence 47999999999999 5566789999999876432 2234456677777654 899999999999999999
Q ss_pred EEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccccccCC
Q 018785 103 LLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGP 182 (350)
Q Consensus 103 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~~~~ 182 (350)
|+||||+.+++|.+++.... .+++..+..++.|++.||+||| +.|++|+||||+||+++.++.++|+|||++....
T Consensus 72 ~lv~E~~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~~l~~lH--~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~ 147 (316)
T cd05620 72 FFVMEFLNGGDLMFHIQDKG--RFDLYRATFYAAEIVCGLQFLH--SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENV 147 (316)
T ss_pred EEEECCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCeEecCCCHHHeEECCCCCEEeCccCCCeecc
Confidence 99999999999999987654 6899999999999999999999 9999999999999999999999999999986422
Q ss_pred CCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhHHHHHh
Q 018785 183 TGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRI 262 (350)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (350)
... .......|++.|+|||.+.+..++.++|+|||||++|+|++|..||...........+.
T Consensus 148 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~---------------- 209 (316)
T cd05620 148 FGD--NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIR---------------- 209 (316)
T ss_pred cCC--CceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH----------------
Confidence 111 12233568899999999999999999999999999999999999997544221111110
Q ss_pred hhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHH-HHHHH
Q 018785 263 MDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMV-DVLTS 303 (350)
Q Consensus 263 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~-~ll~~ 303 (350)
. .....+..++.++.+++.+||+.||.+||++. ++++|
T Consensus 210 -~--~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h 248 (316)
T cd05620 210 -V--DTPHYPRWITKESKDILEKLFERDPTRRLGVVGNIRGH 248 (316)
T ss_pred -h--CCCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence 0 01123445678899999999999999999984 66644
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=289.09 Aligned_cols=249 Identities=27% Similarity=0.420 Sum_probs=198.6
Q ss_pred ceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch-hhHHHHHHHHHHHhccCCCcccceeeEEeecCceEEE
Q 018785 27 YLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLVKLIGYCSESDNRLLV 105 (350)
Q Consensus 27 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 105 (350)
+.||+|+||.||+| .+..++..+++|.+..... .....+.+|+.+++.++||||+++++++...+..++|
T Consensus 1 ~~lg~g~~g~vy~~---------~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 71 (252)
T cd05084 1 ERIGRGNFGEVFSG---------RLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV 71 (252)
T ss_pred CccCcccCccEEEE---------EEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEE
Confidence 46899999999999 5556688999998765432 3345688999999999999999999999999999999
Q ss_pred EEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccccccCCCCC
Q 018785 106 YEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGD 185 (350)
Q Consensus 106 ~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~~~~~~~ 185 (350)
|||+.+++|.+++.... ..+++..+..++.|+++||.||| +.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 72 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH--~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 148 (252)
T cd05084 72 MELVQGGDFLTFLRTEG-PRLKVKELIQMVENAAAGMEYLE--SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGV 148 (252)
T ss_pred EeeccCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH--hCCccccccchheEEEcCCCcEEECccccCccccccc
Confidence 99999999999986543 35889999999999999999999 9999999999999999999999999999987533221
Q ss_pred CCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccccCcchhhhhhhcchhhhhhHHHHHhhh
Q 018785 186 NTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMD 264 (350)
Q Consensus 186 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (350)
..........+..|+|||.+.+..++.++|+||||+++|+|++ |..||........ .....
T Consensus 149 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~------------------~~~~~ 210 (252)
T cd05084 149 YASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQT------------------REAIE 210 (252)
T ss_pred ccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHH------------------HHHHH
Confidence 1111111122446999999988889999999999999999997 8888864332111 11111
Q ss_pred cccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018785 265 TRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 305 (350)
Q Consensus 265 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~ 305 (350)
.......+..++..+.+++.+||+.+|.+|||+.++++.|.
T Consensus 211 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 211 QGVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred cCCCCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 11122334456788999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=306.34 Aligned_cols=276 Identities=25% Similarity=0.346 Sum_probs=216.4
Q ss_pred CCchhhhhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh-hHHHHHHHHHHHhccC-CC
Q 018785 10 PSASMISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ-GHKEWLTEVIYLGQLR-HE 87 (350)
Q Consensus 10 ~~~~~~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~-h~ 87 (350)
.+...-.+...++|.+.+.||+|+||.||+|++.+. .+..++..||+|++...... ....+..|+.++.++. ||
T Consensus 26 ~~~~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~----~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~ 101 (401)
T cd05107 26 LPYDSAWEMPRDNLVLGRTLGSGAFGRVVEATAHGL----SHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHL 101 (401)
T ss_pred CCCCCcceecHHHeehhhhccCCCceeEEEEEEcCC----CCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCC
Confidence 344445777788999999999999999999976532 23445778999999765332 2346788999999997 99
Q ss_pred cccceeeEEeecCceEEEEEcCCCCChhhHHhhcCC--------------------------------------------
Q 018785 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGV-------------------------------------------- 123 (350)
Q Consensus 88 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-------------------------------------------- 123 (350)
||+++++.+...+..++||||+.+++|.+++.....
T Consensus 102 niv~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (401)
T cd05107 102 NIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDM 181 (401)
T ss_pred CeEEEEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCcccccc
Confidence 999999999999999999999999999999965321
Q ss_pred ----------------------------------------------------CCCCHHHHHHHHHHHHHHHHHhhcCCCC
Q 018785 124 ----------------------------------------------------QPISWPTRVKIAIDVARGLSFLHGLDAN 151 (350)
Q Consensus 124 ----------------------------------------------------~~l~~~~~~~i~~ql~~al~~lh~~~~~ 151 (350)
..++...+..++.|++.||+||| +.+
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH--~~~ 259 (401)
T cd05107 182 SKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA--SKN 259 (401)
T ss_pred CCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh--cCC
Confidence 23566678889999999999999 999
Q ss_pred eeeCCCCCCceEEcCCCcEEEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CC
Q 018785 152 VIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GR 230 (350)
Q Consensus 152 i~H~di~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~ 230 (350)
++|+||+|.||+++.++.++|+|||++................++..|+|||.+.+..++.++|+||||+++|+|++ |+
T Consensus 260 ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~ 339 (401)
T cd05107 260 CVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGG 339 (401)
T ss_pred cCcccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCC
Confidence 99999999999999999999999999875432222111222345678999999988889999999999999999998 88
Q ss_pred CCCcccccCcchhhhhhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 018785 231 RALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLH 308 (350)
Q Consensus 231 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 308 (350)
.||......... ...+....+...+..++.++.+++.+||..+|.+||++.++++.|+.+.
T Consensus 340 ~P~~~~~~~~~~-----------------~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 340 TPYPELPMNEQF-----------------YNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred CCCCCCCchHHH-----------------HHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 888654321111 1111111112234456789999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=294.07 Aligned_cols=264 Identities=27% Similarity=0.414 Sum_probs=208.1
Q ss_pred hhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh-hHHHHHHHHHHHhccCCCcccceeeEE
Q 018785 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ-GHKEWLTEVIYLGQLRHENLVKLIGYC 96 (350)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (350)
+.+++|.+.+.||+|++|.||+|.+... ....++..|++|.+...... ....+..|+.+++.++|+||+++++++
T Consensus 3 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~----~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~ 78 (277)
T cd05036 3 VPRDSITLLRALGHGAFGEVYEGLYRGR----DGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVS 78 (277)
T ss_pred CCHHHcEeeeECCCCCCCcEEEEEEecC----CCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 4578899999999999999999966431 11236788999988754332 335678899999999999999999999
Q ss_pred eecCceEEEEEcCCCCChhhHHhhcCC-----CCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCC---
Q 018785 97 SESDNRLLVYEFMPKGSLENHLFRKGV-----QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNF--- 168 (350)
Q Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~-----~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~--- 168 (350)
.+.+..++||||+.+++|.+++..... ..+++..+..++.|++.||+||| +.+++|+||+|+||+++.++
T Consensus 79 ~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH--~~~ivH~dlkp~nil~~~~~~~~ 156 (277)
T cd05036 79 FERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE--ENHFIHRDIAARNCLLTCKGPGR 156 (277)
T ss_pred ccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH--HCCEeecccchheEEEeccCCCc
Confidence 998999999999999999999876531 25888999999999999999999 89999999999999998765
Q ss_pred cEEEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccccCcchhhhhh
Q 018785 169 NAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVE 247 (350)
Q Consensus 169 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~~~~~~~ 247 (350)
.++|+|||++.................+..|+|||.+.+..++.++|||||||++|+|++ |..||..........
T Consensus 157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~---- 232 (277)
T cd05036 157 VAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVME---- 232 (277)
T ss_pred ceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH----
Confidence 589999999976422221111112223457999999988899999999999999999997 889987644321111
Q ss_pred hcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018785 248 WADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 305 (350)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~ 305 (350)
.+........+..++..+.+++.+||+.+|++|||+.+++++|.
T Consensus 233 --------------~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 233 --------------FVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred --------------HHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 11111122334556788999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=293.61 Aligned_cols=272 Identities=24% Similarity=0.346 Sum_probs=210.0
Q ss_pred hhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceeeEEeec
Q 018785 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (350)
Q Consensus 20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (350)
.-.|+-.+++|+|.||.||.| .-..+++.||||.+-.... .-.+|+++|+.+.||||+++.-+|...
T Consensus 23 ~i~~~~~~liG~GsFg~Vyq~---------~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~ 89 (364)
T KOG0658|consen 23 EISYEAVRLIGSGSFGVVYQA---------KLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSS 89 (364)
T ss_pred EEEEEeeEEEeecccceEEEE---------EEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEec
Confidence 446888999999999999999 4445589999998755432 224789999999999999998887543
Q ss_pred C-----ceEEEEEcCCCCChhhHHhhc--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCC-CcEE
Q 018785 100 D-----NRLLVYEFMPKGSLENHLFRK--GVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSN-FNAK 171 (350)
Q Consensus 100 ~-----~~~lv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~-~~~~ 171 (350)
. .+.+||||+ ..+|.+++... ....++.-.++-+.+||+.||+||| +.|||||||||.|+|+|.+ |.+|
T Consensus 90 ~~~d~~~lnlVleym-P~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh--~~~IcHRDIKPqNlLvD~~tg~LK 166 (364)
T KOG0658|consen 90 TESDEVYLNLVLEYM-PETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLH--SHGICHRDIKPQNLLVDPDTGVLK 166 (364)
T ss_pred CCCchhHHHHHHHhc-hHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHH--hcCcccCCCChheEEEcCCCCeEE
Confidence 2 345899999 55999999742 2346888899999999999999999 8999999999999999976 8899
Q ss_pred EccccccccCCCCCCCcccccccCCCcccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcc
Q 018785 172 LSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD 250 (350)
Q Consensus 172 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~ 250 (350)
|+|||+|........+ .....+..|+|||++.|. .|+.+.||||.||++.||+-|+..|.+.+.......+.+...
T Consensus 167 icDFGSAK~L~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG 243 (364)
T KOG0658|consen 167 ICDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLG 243 (364)
T ss_pred eccCCcceeeccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhC
Confidence 9999999875444433 234568889999999886 899999999999999999999999999777666555554433
Q ss_pred -hhhhhhHHH---------HHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHhhhcC
Q 018785 251 -PFLRDSRRV---------LRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS--LEQLHTS 310 (350)
Q Consensus 251 -~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~--L~~~~~~ 310 (350)
|...+.... .++.............++++.+|+.++|..+|.+|.++.+++.| ++.++..
T Consensus 244 ~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~ 315 (364)
T KOG0658|consen 244 TPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP 315 (364)
T ss_pred CCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence 222221110 01111111112445678899999999999999999999999966 5555554
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=294.79 Aligned_cols=259 Identities=24% Similarity=0.326 Sum_probs=206.5
Q ss_pred hhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceeeEE
Q 018785 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYC 96 (350)
Q Consensus 17 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (350)
.....+|++.+.||+|+||.||+| .+..+++.|++|++..........+.+|+..++.++||||+++++.+
T Consensus 5 ~~~~~~y~~~~~lg~g~~g~vy~~---------~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~ 75 (267)
T cd06646 5 RNPQHDYELIQRVGSGTYGDVYKA---------RNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSY 75 (267)
T ss_pred cCchhhcchhheeecCCCeEEEEE---------EECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEE
Confidence 345678999999999999999999 55566889999998766544556678899999999999999999999
Q ss_pred eecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcccc
Q 018785 97 SESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFG 176 (350)
Q Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg 176 (350)
..++..++||||+.+++|.+++.... .+++..+..++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||
T Consensus 76 ~~~~~~~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dl~p~nill~~~~~~~l~dfg 151 (267)
T cd06646 76 LSREKLWICMEYCGGGSLQDIYHVTG--PLSELQIAYVCRETLQGLAYLH--SKGKMHRDIKGANILLTDNGDVKLADFG 151 (267)
T ss_pred EeCCEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--HCCccccCCCHHHEEECCCCCEEECcCc
Confidence 99999999999999999999887654 6899999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCCCCcccccccCCCcccCccccc---cCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhh
Q 018785 177 LARDGPTGDNTHVSTRIVGTRGYAAPEYVA---TGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 253 (350)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 253 (350)
++....... .......++..|+|||.+. ...++.++|+||+|+++|+|++|+.||...........+....
T Consensus 152 ~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~---- 225 (267)
T cd06646 152 VAAKITATI--AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSN---- 225 (267)
T ss_pred cceeecccc--cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCC----
Confidence 997542211 1112245778899999874 3457789999999999999999999986443211111000000
Q ss_pred hhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018785 254 RDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL 304 (350)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 304 (350)
.. .........++..+.+++.+||..+|++|||+++++++|
T Consensus 226 ---------~~-~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 226 ---------FQ-PPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred ---------CC-CCCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 00 000011224567899999999999999999999999865
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=303.80 Aligned_cols=248 Identities=28% Similarity=0.415 Sum_probs=201.0
Q ss_pred cccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh---hHHHHHHHHHHHhcc-CCCcccceeeEEe
Q 018785 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ---GHKEWLTEVIYLGQL-RHENLVKLIGYCS 97 (350)
Q Consensus 22 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l-~h~~i~~~~~~~~ 97 (350)
+|++.+.||+|+||.||+| .+..++..||+|.+...... .......|..++..+ .|++|+++++++.
T Consensus 1 df~~~~~lg~G~~g~Vy~~---------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~ 71 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLA---------ERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQ 71 (323)
T ss_pred CceEEEEEeeCCCeEEEEE---------EECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEe
Confidence 5889999999999999999 55667889999998764321 223456677777766 5899999999999
Q ss_pred ecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccc
Q 018785 98 ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL 177 (350)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~ 177 (350)
..+..++||||+++++|.+++.... .+++..+..++.|++.||.||| +.|++|+||||+||+++.++.++|+|||+
T Consensus 72 ~~~~~~lv~E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH--~~~ivHrDlkp~Nill~~~~~~kL~DfG~ 147 (323)
T cd05616 72 TMDRLYFVMEYVNGGDLMYQIQQVG--RFKEPHAVFYAAEIAIGLFFLH--SKGIIYRDLKLDNVMLDSEGHIKIADFGM 147 (323)
T ss_pred cCCEEEEEEcCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCEEecCCCHHHeEECCCCcEEEccCCC
Confidence 9999999999999999999987664 6899999999999999999999 99999999999999999999999999999
Q ss_pred cccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhH
Q 018785 178 ARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSR 257 (350)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 257 (350)
+....... .......|++.|+|||.+.+..++.++|+|||||++|+|++|+.||.+.........+.
T Consensus 148 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~----------- 214 (323)
T cd05616 148 CKENMWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM----------- 214 (323)
T ss_pred ceecCCCC--CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHH-----------
Confidence 86432211 11223568899999999999999999999999999999999999997654322211111
Q ss_pred HHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCH-----HHHHHH
Q 018785 258 RVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSM-----VDVLTS 303 (350)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-----~~ll~~ 303 (350)
.. ....+..++.++.+++.+||+.||.+|++. .++++|
T Consensus 215 ------~~--~~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05616 215 ------EH--NVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 257 (323)
T ss_pred ------hC--CCCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence 11 122345677899999999999999999984 667654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=296.92 Aligned_cols=274 Identities=26% Similarity=0.392 Sum_probs=213.7
Q ss_pred hhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccc-hhhHHHHHHHHHHHhcc-CCCcccceee
Q 018785 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES-FQGHKEWLTEVIYLGQL-RHENLVKLIG 94 (350)
Q Consensus 17 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~ 94 (350)
++..++|.+.+.||+|+||.||++++..... ....+...+|+|.+.... ......+..|+.+++.+ +||||+++++
T Consensus 14 ~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~--~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~ 91 (307)
T cd05098 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDK--EKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLG 91 (307)
T ss_pred eeehHHeEEeeeeccCCCeeEEEeEEeccCC--cccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence 4446899999999999999999996542110 112345679999987643 23345678899999999 7999999999
Q ss_pred EEeecCceEEEEEcCCCCChhhHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCC
Q 018785 95 YCSESDNRLLVYEFMPKGSLENHLFRKG--------------VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKAS 160 (350)
Q Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------------~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~ 160 (350)
++...+..++||||+.+++|.+++..+. ...++..+++.++.|++.||+||| +.|++|+||+|+
T Consensus 92 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH--~~gi~H~dlkp~ 169 (307)
T cd05098 92 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA--SKKCIHRDLAAR 169 (307)
T ss_pred EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH--HCCcccccccHH
Confidence 9999999999999999999999997642 124788899999999999999999 999999999999
Q ss_pred ceEEcCCCcEEEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccccC
Q 018785 161 NVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGG 239 (350)
Q Consensus 161 Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~ 239 (350)
||+++.++.++|+|||.+................++..|+|||.+.+..++.++|+||||+++|+|++ |..||......
T Consensus 170 Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~ 249 (307)
T cd05098 170 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 249 (307)
T ss_pred heEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH
Confidence 99999999999999999875432221111111223467999999988889999999999999999998 78888643321
Q ss_pred cchhhhhhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcCCC
Q 018785 240 LAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKD 312 (350)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~ 312 (350)
. ....+........+..++.++.+++.+||..+|.+|||+.++++.|..+.....
T Consensus 250 ~------------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~~ 304 (307)
T cd05098 250 E------------------LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALTS 304 (307)
T ss_pred H------------------HHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHhh
Confidence 1 111111122223344567899999999999999999999999999999887643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=289.73 Aligned_cols=251 Identities=22% Similarity=0.308 Sum_probs=206.5
Q ss_pred cccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccc-hhhHHHHHHHHHHHhccCCCcccceeeEEeecC
Q 018785 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES-FQGHKEWLTEVIYLGQLRHENLVKLIGYCSESD 100 (350)
Q Consensus 22 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 100 (350)
+|++.+.||.|++|.||++ .+..++..+++|.+.... ......+..|+..++.++|||++++++.+..++
T Consensus 1 ~y~~~~~lg~g~~g~v~~~---------~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 71 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLV---------QHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADG 71 (255)
T ss_pred CceEEEEeeccCCeEEEEE---------EEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECC
Confidence 5889999999999999999 566678999999886432 334466788999999999999999999999999
Q ss_pred ceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcccccccc
Q 018785 101 NRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD 180 (350)
Q Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~~ 180 (350)
..++++||+++++|.+++.......+++..+..++.|++.||.+|| +.|++|+||+|+||+++.++.++|+|||.+..
T Consensus 72 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH--~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~ 149 (255)
T cd08219 72 HLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH--EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARL 149 (255)
T ss_pred EEEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHh--hCCcccCCCCcceEEECCCCcEEEcccCccee
Confidence 9999999999999999987655557899999999999999999999 99999999999999999999999999999875
Q ss_pred CCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhHHHH
Q 018785 181 GPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVL 260 (350)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (350)
...... ......++..|+|||.+.+..++.++|+||+|+++|+|++|..||..........
T Consensus 150 ~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~----------------- 210 (255)
T cd08219 150 LTSPGA--YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLIL----------------- 210 (255)
T ss_pred eccccc--ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHH-----------------
Confidence 432221 1223457888999999988889999999999999999999999997543211110
Q ss_pred HhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 261 RIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
..........+..++..+.+++.+||+.||.+|||+.+++..
T Consensus 211 -~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 211 -KVCQGSYKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred -HHhcCCCCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 111111122344567789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=307.43 Aligned_cols=254 Identities=23% Similarity=0.266 Sum_probs=205.2
Q ss_pred hhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch---hhHHHHHHHHHHHhccCCCcccceee
Q 018785 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLVKLIG 94 (350)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~ 94 (350)
...++|++.+.||+|+||.||++ .+..++..||+|.+..... .....+.+|+.+++.++||||+++++
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~---------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~ 110 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLV---------RHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHY 110 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEE---------EECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEE
Confidence 34578999999999999999999 5666789999999865322 22345678999999999999999999
Q ss_pred EEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcc
Q 018785 95 YCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSD 174 (350)
Q Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~D 174 (350)
++.+++..++||||+++++|.+++... .+++..+..++.|++.||+||| +.|++|+||||+||+++.++.++|+|
T Consensus 111 ~~~~~~~~~lv~Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH--~~~ivHrDLkp~NILl~~~~~~kL~D 185 (370)
T cd05596 111 AFQDDKYLYMVMEYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIH--SMGFIHRDVKPDNMLLDKSGHLKLAD 185 (370)
T ss_pred EEecCCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHH--HCCeeccCCCHHHEEEcCCCCEEEEe
Confidence 999999999999999999999988654 5888999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCCCCCcccccccCCCcccCccccccC----CCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcc
Q 018785 175 FGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG----HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD 250 (350)
Q Consensus 175 fg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~----~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~ 250 (350)
||++........ .......|++.|+|||.+.+. .++.++|+|||||++|+|++|..||.........
T Consensus 186 fG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~-------- 256 (370)
T cd05596 186 FGTCMKMDANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTY-------- 256 (370)
T ss_pred ccceeeccCCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHH--------
Confidence 999875432211 112235689999999988653 4788999999999999999999999764421111
Q ss_pred hhhhhhHHHHHhhhcccCCCCc--HHHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 018785 251 PFLRDSRRVLRIMDTRLGGQYS--KKEAQAVAAVVLQCLHMDPKN--RPSMVDVLTS 303 (350)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~dp~~--Rps~~~ll~~ 303 (350)
..+.........+ ..++.++.+||.+||+.+|.+ |+|++++++|
T Consensus 257 ---------~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 257 ---------SKIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred ---------HHHHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 1111111111112 246789999999999999987 9999999987
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=288.57 Aligned_cols=251 Identities=27% Similarity=0.406 Sum_probs=207.2
Q ss_pred cccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccc--hhhHHHHHHHHHHHhccCCCcccceeeEEeec
Q 018785 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES--FQGHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (350)
Q Consensus 22 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (350)
+|.+.+.||+|++|.||+| ....++..|++|.+.... ......+.+|+.+++.++|||++++++.+...
T Consensus 1 ~~~~~~~l~~g~~~~v~~~---------~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 71 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKV---------VRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDK 71 (256)
T ss_pred CceEeEEecCCCCeEEEEE---------EEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccC
Confidence 5888999999999999999 555668899999886542 23456688899999999999999999999999
Q ss_pred CceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccccc
Q 018785 100 DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR 179 (350)
Q Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~ 179 (350)
+..++||||+++++|.+++.......++...+..++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||.+.
T Consensus 72 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH--~~~i~h~dl~~~nili~~~~~~~l~df~~~~ 149 (256)
T cd08529 72 GKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH--SKKILHRDIKSLNLFLDAYDNVKIGDLGVAK 149 (256)
T ss_pred CEEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCcceEEEeCCCCEEEcccccce
Confidence 99999999999999999998765557899999999999999999999 9999999999999999999999999999887
Q ss_pred cCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhHHH
Q 018785 180 DGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRV 259 (350)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (350)
....... ......+++.|+|||...+..++.++|+||||+++++|++|+.||..........
T Consensus 150 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~---------------- 211 (256)
T cd08529 150 LLSDNTN--FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALIL---------------- 211 (256)
T ss_pred eccCccc--hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHH----------------
Confidence 5433221 1223457788999999988889999999999999999999999997544211111
Q ss_pred HHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 260 LRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
.. ........+..++.++.+++.+||+.+|++||++.+++++
T Consensus 212 -~~-~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 212 -KI-IRGVFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred -HH-HcCCCCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 11 1111122344677899999999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=292.61 Aligned_cols=268 Identities=24% Similarity=0.392 Sum_probs=208.7
Q ss_pred hhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch-hhHHHHHHHHHHHhccCCCcccceeeE
Q 018785 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLVKLIGY 95 (350)
Q Consensus 17 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~ 95 (350)
++..++|++.++||+|+||.||+|..++. .....+..|++|.+..... .....+.+|+..++.++||||++++++
T Consensus 2 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~ 77 (288)
T cd05061 2 EVSREKITLLRELGQGSFGMVYEGNARDI----IKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGV 77 (288)
T ss_pred cccHHHceeeeeecCCCCcEEEEEEEecc----CCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEE
Confidence 45678999999999999999999865421 1223456899998865432 233457789999999999999999999
Q ss_pred EeecCceEEEEEcCCCCChhhHHhhcC--------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCC
Q 018785 96 CSESDNRLLVYEFMPKGSLENHLFRKG--------VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSN 167 (350)
Q Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--------~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~ 167 (350)
+...+..++||||+.+++|.+++.... ...++...+..++.|++.||.||| +++++|+||+|+||+++.+
T Consensus 78 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH--~~~i~H~dikp~nili~~~ 155 (288)
T cd05061 78 VSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN--AKKFVHRDLAARNCMVAHD 155 (288)
T ss_pred EcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCCcCCCCChheEEEcCC
Confidence 999999999999999999999996532 124566788899999999999999 9999999999999999999
Q ss_pred CcEEEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccccCcchhhhh
Q 018785 168 FNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLV 246 (350)
Q Consensus 168 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~~~~~~ 246 (350)
+.++|+|||++................++..|+|||.+.+..++.++|+|||||++|+|++ |..||.+........
T Consensus 156 ~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~--- 232 (288)
T cd05061 156 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK--- 232 (288)
T ss_pred CcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH---
Confidence 9999999999875433222211222334567999999988899999999999999999998 677886543211111
Q ss_pred hhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 018785 247 EWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLH 308 (350)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 308 (350)
.+........+..+++.+.+++.+||+.||++|||+.++++.|.+..
T Consensus 233 ---------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 233 ---------------FVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred ---------------HHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 11111111223345678999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=289.56 Aligned_cols=259 Identities=28% Similarity=0.456 Sum_probs=204.7
Q ss_pred ccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch--hhHHHHHHHHHHHhccCCCcccceeeEEeecC
Q 018785 23 FCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLRHENLVKLIGYCSESD 100 (350)
Q Consensus 23 y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 100 (350)
|++.+.||+|+||.||.|++.. +..++..||+|.+..... .....+..|+..++.++||||+++++++...+
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~------~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 74 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQ------DDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEAS 74 (273)
T ss_pred CccccccCcCCCceEEEEEEec------CCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCC
Confidence 6789999999999999996542 233468899999875432 23456888999999999999999999876654
Q ss_pred c------eEEEEEcCCCCChhhHHhhc----CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcE
Q 018785 101 N------RLLVYEFMPKGSLENHLFRK----GVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNA 170 (350)
Q Consensus 101 ~------~~lv~e~~~~~~L~~~l~~~----~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~ 170 (350)
. .++++||+++++|..++... ....++...+..++.|++.||.||| +.+++|+||+|+||+++.++.+
T Consensus 75 ~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH--~~~i~H~dlkp~Nil~~~~~~~ 152 (273)
T cd05035 75 SLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS--NRNFIHRDLAARNCMLREDMTV 152 (273)
T ss_pred ccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH--hCCeeccccchheEEECCCCeE
Confidence 4 78999999999999988543 2236889999999999999999999 9999999999999999999999
Q ss_pred EEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccccCcchhhhhhhc
Q 018785 171 KLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWA 249 (350)
Q Consensus 171 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~ 249 (350)
+|+|||++.................+..|++||.+.+..++.++|+|||||++|+|++ |..||.+..+....
T Consensus 153 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~------- 225 (273)
T cd05035 153 CVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIY------- 225 (273)
T ss_pred EECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHH-------
Confidence 9999999875433322211122234567999999988889999999999999999999 88888654321111
Q ss_pred chhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 018785 250 DPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 307 (350)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~ 307 (350)
..+........+..+++.+.+++.+||+.||.+|||+.+++++|.++
T Consensus 226 -----------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 226 -----------DYLRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred -----------HHHHcCCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11111122233456778999999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=301.90 Aligned_cols=243 Identities=29% Similarity=0.478 Sum_probs=198.3
Q ss_pred ceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch---hhHHHHHHHHHHHhcc-CCCcccceeeEEeecCce
Q 018785 27 YLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQL-RHENLVKLIGYCSESDNR 102 (350)
Q Consensus 27 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 102 (350)
+.||+|+||+||+| .+..++..||+|.+..... .....+..|..+++.+ .||||+++++++...+..
T Consensus 1 ~~lG~G~~g~V~~~---------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~ 71 (318)
T cd05570 1 KVLGKGSFGKVLLA---------ELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRL 71 (318)
T ss_pred CeeeeCCCeEEEEE---------EECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEE
Confidence 47999999999999 5566688999999876532 2334566788888877 699999999999999999
Q ss_pred EEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccccccCC
Q 018785 103 LLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGP 182 (350)
Q Consensus 103 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~~~~ 182 (350)
++||||+.+++|.+++.... .+++..+..++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||++....
T Consensus 72 ~lv~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH--~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 147 (318)
T cd05570 72 FFVMEYVNGGDLMFHIQRSG--RFDEPRARFYAAEIVLGLQFLH--ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGI 147 (318)
T ss_pred EEEEcCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--hCCeEccCCCHHHeEECCCCcEEecccCCCeecC
Confidence 99999999999999887664 6999999999999999999999 9999999999999999999999999999986422
Q ss_pred CCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhHHHHHh
Q 018785 183 TGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRI 262 (350)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (350)
.... ......+++.|+|||.+.+..++.++|+|||||++|+|++|..||...........+
T Consensus 148 ~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i----------------- 208 (318)
T cd05570 148 LGGV--TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSI----------------- 208 (318)
T ss_pred cCCC--cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHH-----------------
Confidence 2111 122345788999999999999999999999999999999999999754421111111
Q ss_pred hhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCH-----HHHHHH
Q 018785 263 MDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSM-----VDVLTS 303 (350)
Q Consensus 263 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-----~~ll~~ 303 (350)
... ....+..++..+.+||.+||..||.+|||+ .+++++
T Consensus 209 ~~~--~~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 209 LED--EVRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred HcC--CCCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 111 112344567899999999999999999999 888876
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=294.49 Aligned_cols=273 Identities=26% Similarity=0.381 Sum_probs=215.3
Q ss_pred hhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccc-hhhHHHHHHHHHHHhcc-CCCccccee
Q 018785 16 SKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES-FQGHKEWLTEVIYLGQL-RHENLVKLI 93 (350)
Q Consensus 16 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~ 93 (350)
.++...+|.+.+.||+|+||.||+|++..... .....+..|++|.+.... ......+.+|+..++.+ +||||++++
T Consensus 10 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~--~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~ 87 (304)
T cd05101 10 WEFSRDKLTLGKPLGEGCFGQVVMAEALGIDK--DKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLL 87 (304)
T ss_pred ccccHHHeeecceeeccCCceEEEEEEeccCC--CCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchhee
Confidence 46778999999999999999999996432100 123346689999887543 23446788999999999 799999999
Q ss_pred eEEeecCceEEEEEcCCCCChhhHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCC
Q 018785 94 GYCSESDNRLLVYEFMPKGSLENHLFRKG--------------VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKA 159 (350)
Q Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------------~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~ 159 (350)
+++......++||||+.+++|.+++.... ...++...+..++.|+++||.||| +.|++|+||+|
T Consensus 88 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH--~~givH~dlkp 165 (304)
T cd05101 88 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA--SQKCIHRDLAA 165 (304)
T ss_pred EEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH--HCCeeeccccc
Confidence 99999999999999999999999997642 135777889999999999999999 99999999999
Q ss_pred CceEEcCCCcEEEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCccccc
Q 018785 160 SNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRG 238 (350)
Q Consensus 160 ~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~ 238 (350)
+||+++.++.++|+|||.+................++..|+|||.+.+..++.++||||||+++|+|++ |..||.+...
T Consensus 166 ~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~ 245 (304)
T cd05101 166 RNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 245 (304)
T ss_pred ceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH
Confidence 999999999999999999976433322222222334567999999988889999999999999999998 7778765432
Q ss_pred CcchhhhhhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcC
Q 018785 239 GLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 310 (350)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 310 (350)
..... .+........+..++..+.+++.+||..+|.+|||+.++++.|.++..-
T Consensus 246 ~~~~~------------------~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 246 EELFK------------------LLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred HHHHH------------------HHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 11111 1111111223445678999999999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=304.27 Aligned_cols=267 Identities=25% Similarity=0.332 Sum_probs=201.4
Q ss_pred hhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccc--hhhHHHHHHHHHHHhccCCCcccceeeEE
Q 018785 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES--FQGHKEWLTEVIYLGQLRHENLVKLIGYC 96 (350)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (350)
..++|++.+.||+|+||.||++ .+..+|..||+|.+.... ......+.+|+.+++.++||||+++++++
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~---------~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 89 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAA---------FDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVF 89 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEE---------EEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeee
Confidence 4589999999999999999999 666778999999986542 23345677899999999999999999998
Q ss_pred eecC------ceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcE
Q 018785 97 SESD------NRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNA 170 (350)
Q Consensus 97 ~~~~------~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~ 170 (350)
...+ ..++||||+. ++|.+.+.. .++...+..++.|++.||.||| +.|++|+||||+||+++.++.+
T Consensus 90 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH--~~~ivHrDlkp~NIl~~~~~~~ 162 (359)
T cd07876 90 TPQKSLEEFQDVYLVMELMD-ANLCQVIHM----ELDHERMSYLLYQMLCGIKHLH--SAGIIHRDLKPSNIVVKSDCTL 162 (359)
T ss_pred ccCCCccccceeEEEEeCCC-cCHHHHHhc----cCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHHEEECCCCCE
Confidence 6543 4699999995 467666632 4788899999999999999999 9999999999999999999999
Q ss_pred EEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhh-c
Q 018785 171 KLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEW-A 249 (350)
Q Consensus 171 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~-~ 249 (350)
+|+|||++...... .......+++.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+... .
T Consensus 163 kl~Dfg~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~ 239 (359)
T cd07876 163 KILDFGLARTACTN---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLG 239 (359)
T ss_pred EEecCCCccccccC---ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 99999998653221 1122346788999999999999999999999999999999999999866432222111111 1
Q ss_pred chhhhhhHH----HHHhhhccc------------------CCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018785 250 DPFLRDSRR----VLRIMDTRL------------------GGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL 304 (350)
Q Consensus 250 ~~~~~~~~~----~~~~~~~~~------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 304 (350)
.+...-... ......... ........+..+.+||.+||..||++|||+.++++|-
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 316 (359)
T cd07876 240 TPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHP 316 (359)
T ss_pred CCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCc
Confidence 111100000 000000000 0011122456789999999999999999999999873
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=282.77 Aligned_cols=254 Identities=25% Similarity=0.385 Sum_probs=210.5
Q ss_pred hhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch----hh----HHHHHHHHHHHhcc-CCCcc
Q 018785 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF----QG----HKEWLTEVIYLGQL-RHENL 89 (350)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~----~~----~~~~~~e~~~l~~l-~h~~i 89 (350)
.-.+|.-.++||+|..++|-++ .+..+|..+++|++..... +. .+.-+.|+.+|+++ .||+|
T Consensus 15 fy~~y~pkeilgrgvss~vrRc---------i~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~I 85 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRC---------IHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYI 85 (411)
T ss_pred HHhhcChHHHhcccchhhhhhh---------hhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcE
Confidence 3468899999999999999998 7788899999998864321 11 23456799999998 69999
Q ss_pred cceeeEEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCc
Q 018785 90 VKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFN 169 (350)
Q Consensus 90 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~ 169 (350)
+++.++|+.+...|+|+|.+..|.|.|++.+.- .+++.+.+.|++|++++++|+| .++|+|+||||+||+++++-+
T Consensus 86 I~l~D~yes~sF~FlVFdl~prGELFDyLts~V--tlSEK~tR~iMrqlfegVeylH--a~~IVHRDLKpENILlddn~~ 161 (411)
T KOG0599|consen 86 IDLQDVYESDAFVFLVFDLMPRGELFDYLTSKV--TLSEKETRRIMRQLFEGVEYLH--ARNIVHRDLKPENILLDDNMN 161 (411)
T ss_pred EEeeeeccCcchhhhhhhhcccchHHHHhhhhe--eecHHHHHHHHHHHHHHHHHHH--HhhhhhcccChhheeeccccc
Confidence 999999999999999999999999999998876 7999999999999999999999 999999999999999999999
Q ss_pred EEEccccccccCCCCCCCcccccccCCCcccCcccccc------CCCCCccchhhHHHHHHHHHhCCCCCcccccCcchh
Q 018785 170 AKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT------GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQ 243 (350)
Q Consensus 170 ~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~------~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~ 243 (350)
++|+|||+++....+.. ....+|||+|+|||.+.. ..|+...|+|++|+++|.|+.|..||.....-....
T Consensus 162 i~isDFGFa~~l~~Gek---LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR 238 (411)
T KOG0599|consen 162 IKISDFGFACQLEPGEK---LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLR 238 (411)
T ss_pred eEEeccceeeccCCchh---HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHH
Confidence 99999999987655443 344689999999998843 368889999999999999999999996433211111
Q ss_pred hhhhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 244 TLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
.+.+ -.-....+...+++....+||.+||++||.+|.|++++|.|
T Consensus 239 ~Ime---------------GkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 239 MIME---------------GKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred HHHh---------------cccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 1111 01112233456889999999999999999999999999987
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=300.37 Aligned_cols=271 Identities=27% Similarity=0.376 Sum_probs=209.4
Q ss_pred hhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch-hhHHHHHHHHHHHhcc-CCCcccceee
Q 018785 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQL-RHENLVKLIG 94 (350)
Q Consensus 17 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~ 94 (350)
++..++|++.+.||+|+||.||+|++... .+..+++.||||.+..... .....+..|+.++.++ +||||+++++
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~ 78 (343)
T cd05103 3 EFPRDRLKLGKPLGRGAFGQVIEADAFGI----DKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 78 (343)
T ss_pred ccchhHhcccccccCCccceEEEEeeccC----CccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcc
Confidence 34567999999999999999999965422 2445688999999875432 2345678899999999 6899999999
Q ss_pred EEee-cCceEEEEEcCCCCChhhHHhhcC---------------------------------------------------
Q 018785 95 YCSE-SDNRLLVYEFMPKGSLENHLFRKG--------------------------------------------------- 122 (350)
Q Consensus 95 ~~~~-~~~~~lv~e~~~~~~L~~~l~~~~--------------------------------------------------- 122 (350)
++.. +...+++|||+++++|.+++....
T Consensus 79 ~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (343)
T cd05103 79 ACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSL 158 (343)
T ss_pred eeecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCcc
Confidence 8765 456789999999999999986532
Q ss_pred --------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccccccCCCCCCCc
Q 018785 123 --------------VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTH 188 (350)
Q Consensus 123 --------------~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~ 188 (350)
...++...+..++.|+++||+||| ++|++|+||+|.||+++.++.++|+|||++..........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH--~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 236 (343)
T cd05103 159 SDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLA--SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV 236 (343)
T ss_pred ccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchh
Confidence 123677788899999999999999 9999999999999999999999999999987543222212
Q ss_pred ccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccccCcchhhhhhhcchhhhhhHHHHHhhhccc
Q 018785 189 VSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRL 267 (350)
Q Consensus 189 ~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (350)
......++..|+|||.+.+..++.++|+||||+++|+|++ |..||......... ........
T Consensus 237 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~-----------------~~~~~~~~ 299 (343)
T cd05103 237 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF-----------------CRRLKEGT 299 (343)
T ss_pred hcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHH-----------------HHHHhccC
Confidence 2222334567999999988899999999999999999997 88888654321110 01111111
Q ss_pred CCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcC
Q 018785 268 GGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 310 (350)
Q Consensus 268 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 310 (350)
....+...++++.+++.+||+.||.+|||+.+++++|..+...
T Consensus 300 ~~~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 300 RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 1222334567899999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=288.64 Aligned_cols=258 Identities=31% Similarity=0.451 Sum_probs=205.8
Q ss_pred hhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceeeEEe
Q 018785 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (350)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (350)
+..++|++.++||+|++|.||+|++ ..+ ..|++|.+..... ....+.+|+.+++.++||||+++++.+.
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~---------~~~-~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~ 71 (262)
T cd05071 3 IPRESLRLEVKLGQGCFGEVWMGTW---------NGT-TRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS 71 (262)
T ss_pred CChHHeeEeeecCCCCCCcEEEEEe---------cCC-ceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC
Confidence 4467899999999999999999943 222 3589999876432 3456788999999999999999999875
Q ss_pred ecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccc
Q 018785 98 ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL 177 (350)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~ 177 (350)
. +..++||||+.+++|.+++.......++...+..++.|++.||+++| +.+++|+||+|+||+++.++.++|+|||.
T Consensus 72 ~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH--~~~i~H~dl~p~Nill~~~~~~~L~dfg~ 148 (262)
T cd05071 72 E-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE--RMNYVHRDLRAANILVGENLVCKVADFGL 148 (262)
T ss_pred C-CCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH--HCCccccccCcccEEEcCCCcEEeccCCc
Confidence 4 56899999999999999997654456889999999999999999999 99999999999999999999999999999
Q ss_pred cccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccccCcchhhhhhhcchhhhhh
Q 018785 178 ARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDS 256 (350)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 256 (350)
+......... ......++..|+|||...+..++.++|+||||+++|+|++ |..||...........
T Consensus 149 ~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~------------ 215 (262)
T cd05071 149 ARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ------------ 215 (262)
T ss_pred eeeccccccc-cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHH------------
Confidence 8754332211 1112335567999999988889999999999999999999 7878865432111111
Q ss_pred HHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 018785 257 RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLH 308 (350)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 308 (350)
.........+..++..+.+++.+|++.||.+||++.++++.|+...
T Consensus 216 ------~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 216 ------VERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred ------HhcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 1111112234467788999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=303.12 Aligned_cols=246 Identities=26% Similarity=0.369 Sum_probs=199.3
Q ss_pred ceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh--hHHHHHHHHHHHhccCCCcccceeeEEeecCceEE
Q 018785 27 YLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ--GHKEWLTEVIYLGQLRHENLVKLIGYCSESDNRLL 104 (350)
Q Consensus 27 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 104 (350)
+.||+|+||.||+++.. ....+|..+|+|++...... ....+..|+.++++++||||+++++++...+..|+
T Consensus 2 ~~lg~G~~g~Vy~~~~~------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 75 (318)
T cd05582 2 KVLGQGSFGKVFLVRKI------TGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYL 75 (318)
T ss_pred ceeeeCCCEEEEEEEEe------ccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEE
Confidence 67999999999998543 23457899999998765422 23456779999999999999999999999999999
Q ss_pred EEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccccccCCCC
Q 018785 105 VYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTG 184 (350)
Q Consensus 105 v~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~~~~~~ 184 (350)
||||+.+++|.+++.... .+++..++.++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||++......
T Consensus 76 v~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH--~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 151 (318)
T cd05582 76 ILDFLRGGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLH--SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH 151 (318)
T ss_pred EEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCC
Confidence 999999999999987654 6899999999999999999999 999999999999999999999999999998753222
Q ss_pred CCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhHHHHHhhh
Q 018785 185 DNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMD 264 (350)
Q Consensus 185 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (350)
. .......|++.|+|||.+.+..++.++|+|||||++|+|++|+.||........... +..
T Consensus 152 ~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~-----------------i~~ 212 (318)
T cd05582 152 E--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTM-----------------ILK 212 (318)
T ss_pred C--CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHH-----------------HHc
Confidence 1 112235688899999999888899999999999999999999999976442111111 111
Q ss_pred cccCCCCcHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 018785 265 TRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPS-----MVDVLTS 303 (350)
Q Consensus 265 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-----~~~ll~~ 303 (350)
. ....+..+++.+.+|+.+||+.||.+||+ +.+++++
T Consensus 213 ~--~~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~ 254 (318)
T cd05582 213 A--KLGMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRH 254 (318)
T ss_pred C--CCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCC
Confidence 1 11234457788999999999999999999 5666654
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=300.11 Aligned_cols=243 Identities=27% Similarity=0.431 Sum_probs=194.9
Q ss_pred ceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch---hhHHHHHHHHHHHhc-cCCCcccceeeEEeecCce
Q 018785 27 YLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQ-LRHENLVKLIGYCSESDNR 102 (350)
Q Consensus 27 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~~~~~ 102 (350)
+.||+|+||+||+| .+..+++.||+|.+..... ........|..++.. +.||||+++++++.+.+..
T Consensus 1 ~~lG~G~~g~Vy~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~ 71 (316)
T cd05619 1 KMLGKGSFGKVFLA---------ELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENL 71 (316)
T ss_pred CeeeeCCCEEEEEE---------EECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEE
Confidence 47999999999999 5566788999999876532 223345566677765 4899999999999999999
Q ss_pred EEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccccccCC
Q 018785 103 LLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGP 182 (350)
Q Consensus 103 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~~~~ 182 (350)
++||||+++++|.+++.... .+++..+..++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||++....
T Consensus 72 ~lv~ey~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~LH--~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~ 147 (316)
T cd05619 72 FFVMEYLNGGDLMFHIQSCH--KFDLPRATFYAAEIICGLQFLH--SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENM 147 (316)
T ss_pred EEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--hCCeEeCCCCHHHEEECCCCCEEEccCCcceECC
Confidence 99999999999999997654 6899999999999999999999 9999999999999999999999999999986432
Q ss_pred CCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhHHHHHh
Q 018785 183 TGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRI 262 (350)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (350)
.... ......|++.|+|||.+.+..++.++|+||+||++|+|++|..||...........+.
T Consensus 148 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~---------------- 209 (316)
T cd05619 148 LGDA--KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIR---------------- 209 (316)
T ss_pred CCCC--ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHH----------------
Confidence 2111 1223468899999999998899999999999999999999999997644221111110
Q ss_pred hhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHH-HHHHH
Q 018785 263 MDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMV-DVLTS 303 (350)
Q Consensus 263 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~-~ll~~ 303 (350)
. .....+..++.++.+++.+||+.||.+||++. ++++|
T Consensus 210 --~-~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h 248 (316)
T cd05619 210 --M-DNPCYPRWLTREAKDILVKLFVREPERRLGVKGDIRQH 248 (316)
T ss_pred --h-CCCCCCccCCHHHHHHHHHHhccCHhhcCCChHHHHcC
Confidence 0 01122345677899999999999999999997 66554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=297.62 Aligned_cols=248 Identities=27% Similarity=0.422 Sum_probs=200.6
Q ss_pred cccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch---hhHHHHHHHHHHHhccC-CCcccceeeEEe
Q 018785 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLR-HENLVKLIGYCS 97 (350)
Q Consensus 22 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~ 97 (350)
+|++.+.||+|+||+||+| .+..+|+.||+|++..... .....+..|..+++.+. |++|+++++++.
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~ 71 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLA---------ERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQ 71 (323)
T ss_pred CceEEEEEEecCCeEEEEE---------EECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEe
Confidence 4788999999999999999 6666789999999875432 22345667888888775 677888999999
Q ss_pred ecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccc
Q 018785 98 ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL 177 (350)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~ 177 (350)
..+..|+||||+++++|.+++.... .+++.++..++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||+
T Consensus 72 ~~~~~~lv~Ey~~~g~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH--~~~ivHrDikp~Nill~~~~~ikL~Dfg~ 147 (323)
T cd05615 72 TVDRLYFVMEYVNGGDLMYHIQQVG--KFKEPQAVFYAAEISVGLFFLH--RRGIIYRDLKLDNVMLDSEGHIKIADFGM 147 (323)
T ss_pred cCCEEEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCeeccCCCHHHeEECCCCCEEEecccc
Confidence 9999999999999999999987664 6999999999999999999999 99999999999999999999999999999
Q ss_pred cccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhH
Q 018785 178 ARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSR 257 (350)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 257 (350)
+....... .......|++.|+|||.+.+..++.++|+||+||++|+|++|..||.+.........+.
T Consensus 148 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~----------- 214 (323)
T cd05615 148 CKEHMVDG--VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIM----------- 214 (323)
T ss_pred ccccCCCC--ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH-----------
Confidence 86432211 11223458899999999998899999999999999999999999997654321111111
Q ss_pred HHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCH-----HHHHHH
Q 018785 258 RVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSM-----VDVLTS 303 (350)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-----~~ll~~ 303 (350)
.. ....+..++.++.+++.+||+.+|.+|++. +++++|
T Consensus 215 ------~~--~~~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05615 215 ------EH--NVSYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREH 257 (323)
T ss_pred ------hC--CCCCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcC
Confidence 11 122345567889999999999999999974 566655
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=301.15 Aligned_cols=252 Identities=24% Similarity=0.364 Sum_probs=197.8
Q ss_pred ceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch---hhHHHHHHHHHHHhcc-CCCcccceeeEEeecCce
Q 018785 27 YLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQL-RHENLVKLIGYCSESDNR 102 (350)
Q Consensus 27 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 102 (350)
+.||+|+||.||+| .+..+++.||+|++..... .....+..|..++.++ +||||+++++++...+..
T Consensus 1 ~~lG~G~~g~V~~~---------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~ 71 (329)
T cd05618 1 RVIGRGSYAKVLLV---------RLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL 71 (329)
T ss_pred CeeeeCCCeEEEEE---------EECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEE
Confidence 47999999999999 5666789999999876432 2334567788888776 799999999999999999
Q ss_pred EEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccccccCC
Q 018785 103 LLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGP 182 (350)
Q Consensus 103 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~~~~ 182 (350)
++||||+++++|.+++.... .+++..+..++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++....
T Consensus 72 ~lv~E~~~~~~L~~~~~~~~--~l~~~~~~~i~~qi~~~l~~lH--~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~ 147 (329)
T cd05618 72 FFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLH--ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 147 (329)
T ss_pred EEEEeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCeeeCCCCHHHEEECCCCCEEEeeCCcccccc
Confidence 99999999999998887654 6999999999999999999999 9999999999999999999999999999986432
Q ss_pred CCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhHHHHHh
Q 018785 183 TGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRI 262 (350)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (350)
... .......|++.|+|||.+.+..++.++|+|||||++|+|++|..||........... .........
T Consensus 148 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~---------~~~~~~~~~ 216 (329)
T cd05618 148 RPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ---------NTEDYLFQV 216 (329)
T ss_pred CCC--CccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCccc---------ccHHHHHHH
Confidence 211 112235688999999999999999999999999999999999999963221110000 000000010
Q ss_pred hhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCC------HHHHHHH
Q 018785 263 MDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPS------MVDVLTS 303 (350)
Q Consensus 263 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps------~~~ll~~ 303 (350)
+. ......+..++..+.++|.+||+.||.+||+ +.++++|
T Consensus 217 i~-~~~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 217 IL-EKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred Hh-cCCCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 11 1112345567888999999999999999998 4677766
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=293.09 Aligned_cols=254 Identities=31% Similarity=0.514 Sum_probs=203.6
Q ss_pred ccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHH--HHHHHHHHHhccCCCcccceeeEEeecC
Q 018785 23 FCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHK--EWLTEVIYLGQLRHENLVKLIGYCSESD 100 (350)
Q Consensus 23 y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~--~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 100 (350)
|++.+.||+|+||+||++ .+..+++.+|+|.+......... ....|+..+++++||||+++++++....
T Consensus 1 y~~~~~lg~G~~g~v~~~---------~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~ 71 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKA---------KNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDN 71 (260)
T ss_dssp EEEEEEEEEESSEEEEEE---------EETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESS
T ss_pred CEEeEEEEeCCCEEEEEE---------EECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccc
Confidence 789999999999999999 66777889999999877654332 3356999999999999999999999999
Q ss_pred ceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcccccccc
Q 018785 101 NRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD 180 (350)
Q Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~~ 180 (350)
..++|||++.+++|.+++.... .++...+..++.|+++||.+|| +.|++|+||+|+||+++.++.++|+|||.+..
T Consensus 72 ~~~~v~~~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~Lh--~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~ 147 (260)
T PF00069_consen 72 YLYIVMEYCPGGSLQDYLQKNK--PLSEEEILKIAYQILEALAYLH--SKGIVHRDIKPENILLDENGEVKLIDFGSSVK 147 (260)
T ss_dssp EEEEEEEEETTEBHHHHHHHHS--SBBHHHHHHHHHHHHHHHHHHH--HTTEEESSBSGGGEEESTTSEEEESSGTTTEE
T ss_pred cccccccccccccccccccccc--cccccccccccccccccccccc--cccccccccccccccccccccccccccccccc
Confidence 9999999998889999998443 6899999999999999999999 89999999999999999999999999999975
Q ss_pred CCCCCCCcccccccCCCcccCccccc-cCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhHHH
Q 018785 181 GPTGDNTHVSTRIVGTRGYAAPEYVA-TGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRV 259 (350)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (350)
. ...........++..|+|||.+. +..++.++|+||||+++|+|++|..||...........+..........
T Consensus 148 ~--~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~---- 221 (260)
T PF00069_consen 148 L--SENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPS---- 221 (260)
T ss_dssp S--TSTTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHH----
T ss_pred c--cccccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccc----
Confidence 3 12222333456788899999998 7889999999999999999999999998652111111111100000000
Q ss_pred HHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 260 LRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
. .......+..+.+++.+||+.||++|||+.+++++
T Consensus 222 -----~---~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 222 -----S---SQQSREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp -----H---TTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred -----c---ccccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 00011123789999999999999999999999864
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=302.35 Aligned_cols=243 Identities=26% Similarity=0.405 Sum_probs=193.9
Q ss_pred ceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh---hHHHHHHHH-HHHhccCCCcccceeeEEeecCce
Q 018785 27 YLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ---GHKEWLTEV-IYLGQLRHENLVKLIGYCSESDNR 102 (350)
Q Consensus 27 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~~~~~ 102 (350)
+.||+|+||+||+| .+..+|+.||+|.+...... ....+..|. .+++.++||||+++++.+...+..
T Consensus 1 ~~lg~G~~g~V~~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~ 71 (323)
T cd05575 1 KVIGKGSFGKVLLA---------KHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKL 71 (323)
T ss_pred CeeeeCCCeEEEEE---------EECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEE
Confidence 47999999999999 66667899999998754322 223334443 356778999999999999999999
Q ss_pred EEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccccccCC
Q 018785 103 LLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGP 182 (350)
Q Consensus 103 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~~~~ 182 (350)
++||||+.+++|.+++.... .+++..+..++.||+.||.||| +.|++|+||+|+||+++.++.++|+|||++....
T Consensus 72 ~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH--~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~ 147 (323)
T cd05575 72 YFVLDYVNGGELFFHLQRER--SFPEPRARFYAAEIASALGYLH--SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGI 147 (323)
T ss_pred EEEEcCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--HCCeEeCCCCHHHeEECCCCcEEEeccCCCcccc
Confidence 99999999999999887654 6899999999999999999999 9999999999999999999999999999986432
Q ss_pred CCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhHHHHHh
Q 018785 183 TGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRI 262 (350)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (350)
... .......|++.|+|||.+.+..++.++|+|||||++|+|++|..||...........+
T Consensus 148 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i----------------- 208 (323)
T cd05575 148 EHS--KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNI----------------- 208 (323)
T ss_pred cCC--CccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHH-----------------
Confidence 211 1223346889999999999999999999999999999999999999764422111111
Q ss_pred hhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCH----HHHHHH
Q 018785 263 MDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSM----VDVLTS 303 (350)
Q Consensus 263 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~----~~ll~~ 303 (350)
.... ...+..++..+.++|.+||+.||.+||++ .++++|
T Consensus 209 ~~~~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~ 251 (323)
T cd05575 209 LNKP--LRLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNH 251 (323)
T ss_pred HcCC--CCCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcC
Confidence 1111 12234567889999999999999999987 466554
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=287.05 Aligned_cols=253 Identities=32% Similarity=0.489 Sum_probs=209.5
Q ss_pred hhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceeeEEe
Q 018785 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (350)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (350)
+..++|++.+.||+|++|.||+|.. .|+.|++|.+..... ....+..|+.+++.++|+||+++++++.
T Consensus 3 ~~~~~~~~~~~ig~g~~g~v~~~~~-----------~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 70 (256)
T cd05039 3 INSKELKLGATIGKGEFGDVMLGDY-----------RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVL 70 (256)
T ss_pred cChhhccceeeeecCCCceEEEEEe-----------cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEc
Confidence 3578999999999999999999843 267899999977654 4567888999999999999999999999
Q ss_pred ecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccc
Q 018785 98 ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL 177 (350)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~ 177 (350)
..+..++|||++.+++|.+++.......+++..+..++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||.
T Consensus 71 ~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh--~~~i~H~di~p~Nili~~~~~~~l~d~g~ 148 (256)
T cd05039 71 QGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE--EKNFVHRDLAARNVLVSEDLVAKVSDFGL 148 (256)
T ss_pred CCCCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--hCCccchhcccceEEEeCCCCEEEccccc
Confidence 9999999999999999999998776557899999999999999999999 99999999999999999999999999999
Q ss_pred cccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccccCcchhhhhhhcchhhhhh
Q 018785 178 ARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDS 256 (350)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 256 (350)
+........ ....+..|+|||.+.+..++.++|+||||+++|++++ |..||........
T Consensus 149 ~~~~~~~~~-----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~--------------- 208 (256)
T cd05039 149 AKEASQGQD-----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV--------------- 208 (256)
T ss_pred ccccccccc-----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHH---------------
Confidence 976422211 1233456999999988889999999999999999997 9989864432111
Q ss_pred HHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 018785 257 RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 307 (350)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~ 307 (350)
...+........+..+++.+.+++.+||..+|.+|||+.++++.|.++
T Consensus 209 ---~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 209 ---VPHVEKGYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred ---HHHHhcCCCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 111111112233445678999999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=287.50 Aligned_cols=257 Identities=27% Similarity=0.417 Sum_probs=207.5
Q ss_pred hhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceeeEE
Q 018785 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYC 96 (350)
Q Consensus 17 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (350)
++..++|++.++||+|+||.||+|.. .++..|++|.+..... ....+.+|+.+++.++|||++++++++
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~----------~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~ 70 (260)
T cd05067 2 EVPRETLKLVKKLGAGQFGEVWMGYY----------NGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVV 70 (260)
T ss_pred ccchHHceeeeeeccCccceEEeeec----------CCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEE
Confidence 35578999999999999999999943 2367899998876543 346788899999999999999999987
Q ss_pred eecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcccc
Q 018785 97 SESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFG 176 (350)
Q Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg 176 (350)
. .+..+++||++.+++|.+++.......++...+..++.|++.||+||| +.|++|+||+|+||+++.++.++|+|||
T Consensus 71 ~-~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH--~~~i~H~dl~p~ni~i~~~~~~~l~dfg 147 (260)
T cd05067 71 T-QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE--RKNYIHRDLRAANILVSETLCCKIADFG 147 (260)
T ss_pred c-cCCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHh--cCCeecccccHHhEEEcCCCCEEEccCc
Confidence 4 467899999999999999987765567899999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccccCcchhhhhhhcchhhhh
Q 018785 177 LARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRD 255 (350)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 255 (350)
++........ .......++..|+|||.+.+..++.++|+||||+++|++++ |..||.+........
T Consensus 148 ~~~~~~~~~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~------------ 214 (260)
T cd05067 148 LARLIEDNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQ------------ 214 (260)
T ss_pred ceeecCCCCc-ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHH------------
Confidence 9875432211 11112334567999999988889999999999999999998 999997544211111
Q ss_pred hHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 018785 256 SRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQ 306 (350)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 306 (350)
.+........+...+.++.+++.+||+.+|++||+++++++.|+.
T Consensus 215 ------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 215 ------NLERGYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred ------HHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 111111223344567789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=288.62 Aligned_cols=258 Identities=31% Similarity=0.471 Sum_probs=209.6
Q ss_pred hhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceeeEE
Q 018785 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYC 96 (350)
Q Consensus 17 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (350)
++..++|++.+.||+|++|.||+|.++ .+..+++|.+..... ....+.+|+..++.++|++++++++++
T Consensus 2 ~~~~~~~~i~~~ig~g~~~~v~~~~~~----------~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~ 70 (261)
T cd05034 2 EIPRESLKLERKLGAGQFGEVWMGTWN----------GTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVC 70 (261)
T ss_pred ccchhheeeeeeeccCcceEEEEEEEc----------CCceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeee
Confidence 466789999999999999999998432 246789998876543 346788999999999999999999999
Q ss_pred eecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcccc
Q 018785 97 SESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFG 176 (350)
Q Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg 176 (350)
......++|||++++++|.+++.......++...+..++.|++.|+.||| ++|++|+||+|+||+++.++.++|+|||
T Consensus 71 ~~~~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh--~~~i~h~di~p~nili~~~~~~~l~d~g 148 (261)
T cd05034 71 SEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE--SRNYIHRDLAARNILVGENLVCKIADFG 148 (261)
T ss_pred ecCCceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCcchheEEEcCCCCEEECccc
Confidence 99899999999999999999998766567899999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccccCcchhhhhhhcchhhhh
Q 018785 177 LARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRD 255 (350)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 255 (350)
++........ ........+..|+|||.+.+..++.++|+||+|+++|+|++ |+.||.+.........+
T Consensus 149 ~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~---------- 217 (261)
T cd05034 149 LARLIEDDEY-TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQV---------- 217 (261)
T ss_pred cceeccchhh-hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH----------
Confidence 9875432111 11112224457999999988889999999999999999998 89998654322111111
Q ss_pred hHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 018785 256 SRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQ 306 (350)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 306 (350)
........+...+.++.+++.+||..+|.+||+++++++.|+.
T Consensus 218 --------~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 218 --------ERGYRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred --------HcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 1111122334457789999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=292.42 Aligned_cols=247 Identities=26% Similarity=0.418 Sum_probs=196.6
Q ss_pred ecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh---hHHHHHHHHHHHhccCCCcccceeeEEeecCceEEE
Q 018785 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ---GHKEWLTEVIYLGQLRHENLVKLIGYCSESDNRLLV 105 (350)
Q Consensus 29 lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 105 (350)
||+|+||.||++ ....+|+.+++|.+...... ....+..|+++++.++||||+++++.+..+...++|
T Consensus 1 lg~G~~g~Vy~~---------~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv 71 (277)
T cd05607 1 LGKGGFGEVCAV---------QVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLV 71 (277)
T ss_pred CCCCCceEEEEE---------EEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEE
Confidence 699999999999 55667899999988653321 223456799999999999999999999999999999
Q ss_pred EEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccccccCCCCC
Q 018785 106 YEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGD 185 (350)
Q Consensus 106 ~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~~~~~~~ 185 (350)
|||+.+++|.+++.......++...+..++.|++.||+||| +.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 72 ~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH--~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~ 149 (277)
T cd05607 72 MSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLH--SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK 149 (277)
T ss_pred EecCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH--HCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc
Confidence 99999999999887666557899999999999999999999 9999999999999999999999999999987543221
Q ss_pred CCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhHHHHHhhhc
Q 018785 186 NTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDT 265 (350)
Q Consensus 186 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (350)
......++..|+|||.+.+..++.++|+|||||++|+|++|..||...........+. ......
T Consensus 150 ---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~-------------~~~~~~ 213 (277)
T cd05607 150 ---TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELK-------------RRTLED 213 (277)
T ss_pred ---eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHH-------------HHhhcc
Confidence 1223457889999999988889999999999999999999999997543211111110 011111
Q ss_pred ccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 266 RLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 266 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
.. ......+++++.+|+.+||+.||.+||++.++++.
T Consensus 214 ~~-~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ 250 (277)
T cd05607 214 EV-KFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDD 250 (277)
T ss_pred cc-ccccccCCHHHHHHHHHHhccCHhhCCCCccchhh
Confidence 11 01123567889999999999999999999766543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=288.54 Aligned_cols=260 Identities=25% Similarity=0.378 Sum_probs=209.0
Q ss_pred hcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch---hhHHHHHHHHHHHhccCCCcccceeeEEe
Q 018785 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (350)
Q Consensus 21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (350)
++|++.+.||+|++|.||+| .+..++..+++|.+..... .....+.+|+.+++.++||||+++++++.
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~---------~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~ 72 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRA---------TCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFI 72 (267)
T ss_pred chhhhhhhhcccCCeEEEEE---------eecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeE
Confidence 57999999999999999999 5556688999998765322 23356788999999999999999999999
Q ss_pred ecCceEEEEEcCCCCChhhHHhhc--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccc
Q 018785 98 ESDNRLLVYEFMPKGSLENHLFRK--GVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDF 175 (350)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Df 175 (350)
.++..+++||++.+++|.+++... ....+++..+..++.|++.||.||| ++|++|+||+|+||+++.++.++|+||
T Consensus 73 ~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH--~~~i~H~dl~p~nili~~~~~~~l~df 150 (267)
T cd08229 73 EDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH--SRRVMHRDIKPANVFITATGVVKLGDL 150 (267)
T ss_pred eCCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEEcCCCCEEECcc
Confidence 999999999999999999988642 2246899999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhh
Q 018785 176 GLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRD 255 (350)
Q Consensus 176 g~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 255 (350)
|.+........ ......++..|+|||.+.+..++.++|+||||+++|+|++|..||.+...... ..
T Consensus 151 g~~~~~~~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~---------- 216 (267)
T cd08229 151 GLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY--SL---------- 216 (267)
T ss_pred hhhhccccCCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHH--HH----------
Confidence 98875432221 12224577889999999888899999999999999999999999865332100 00
Q ss_pred hHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 018785 256 SRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLH 308 (350)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 308 (350)
.............+..+++.+.+++.+||..||.+|||+.++++.+.++.
T Consensus 217 ---~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 217 ---CKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred ---hhhhhcCCCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 00000111111123357789999999999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=293.11 Aligned_cols=247 Identities=28% Similarity=0.410 Sum_probs=198.3
Q ss_pred ecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh---hHHHHHHHHHHHhccCCCcccceeeEEeecCceEEE
Q 018785 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ---GHKEWLTEVIYLGQLRHENLVKLIGYCSESDNRLLV 105 (350)
Q Consensus 29 lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 105 (350)
||+|+||+||++ .+..+++.||+|.+...... ....+..|+.+++.++||+|+++.+++...+..++|
T Consensus 1 lg~G~~g~Vy~~---------~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv 71 (280)
T cd05608 1 LGKGGFGEVSAC---------QMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLV 71 (280)
T ss_pred CCCCCceeEEEE---------EEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEE
Confidence 699999999999 66667899999998754332 224567899999999999999999999999999999
Q ss_pred EEcCCCCChhhHHhhc--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccccccCCC
Q 018785 106 YEFMPKGSLENHLFRK--GVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPT 183 (350)
Q Consensus 106 ~e~~~~~~L~~~l~~~--~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~~~~~ 183 (350)
|||+++++|.+++... ....+++..+..++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||.+.....
T Consensus 72 ~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH--~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 149 (280)
T cd05608 72 MTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH--QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKD 149 (280)
T ss_pred EeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEECCCCCEEEeeCccceecCC
Confidence 9999999998887432 2346899999999999999999999 99999999999999999999999999999875433
Q ss_pred CCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhHHHHHhh
Q 018785 184 GDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIM 263 (350)
Q Consensus 184 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (350)
... ......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...........+. ....
T Consensus 150 ~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~-------------~~~~ 214 (280)
T cd05608 150 GQS--KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK-------------QRIL 214 (280)
T ss_pred CCc--cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHH-------------Hhhc
Confidence 221 1223467889999999999999999999999999999999999997543221111111 0011
Q ss_pred hcccCCCCcHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 018785 264 DTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRP-----SMVDVLTS 303 (350)
Q Consensus 264 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~~ 303 (350)
. .....+..++..+.+++.+||+.||++|| +++++++|
T Consensus 215 ~--~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 215 N--DSVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred c--cCCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 1 11123445788999999999999999999 77888876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=295.69 Aligned_cols=252 Identities=23% Similarity=0.374 Sum_probs=207.4
Q ss_pred hhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceeeEEeec
Q 018785 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (350)
Q Consensus 20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (350)
..+|++.+.||+|++|.||+| .+..++..+++|.+..........+.+|+.+++.+.|||++++++.+..+
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~---------~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~ 89 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTA---------MDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG 89 (296)
T ss_pred ccceeeEEEecCCCCeEEEEE---------EECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeC
Confidence 369999999999999999999 55667889999998876655567788999999999999999999999999
Q ss_pred CceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccccc
Q 018785 100 DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR 179 (350)
Q Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~ 179 (350)
...++||||+.+++|.+++... .++..++..++.|++.||+||| +.|++|+||+|+||+++.++.++|+|||.+.
T Consensus 90 ~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~i~~ql~~aL~~LH--~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~ 164 (296)
T cd06654 90 DELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLH--SNQVIHRDIKSDNILLGMDGSVKLTDFGFCA 164 (296)
T ss_pred CEEEEeecccCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEEcCCCCEEECccccch
Confidence 9999999999999999998654 5788999999999999999999 9999999999999999999999999999887
Q ss_pred cCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhHHH
Q 018785 180 DGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRV 259 (350)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (350)
....... ......+++.|+|||.+.+..++.++|+||+||++|+|++|..||.............
T Consensus 165 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~------------- 229 (296)
T cd06654 165 QITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA------------- 229 (296)
T ss_pred hcccccc--ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHh-------------
Confidence 5322211 1122457788999999988889999999999999999999999996543211110000
Q ss_pred HHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 260 LRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
.........+..++..+.+++.+||..+|++||++.+++++
T Consensus 230 ---~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 230 ---TNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred ---cCCCCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 00111112234567889999999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=294.79 Aligned_cols=267 Identities=26% Similarity=0.354 Sum_probs=198.1
Q ss_pred cccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh--hHHHHHHHHHHHhcc---CCCcccceeeEE
Q 018785 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ--GHKEWLTEVIYLGQL---RHENLVKLIGYC 96 (350)
Q Consensus 22 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l---~h~~i~~~~~~~ 96 (350)
+|++.+.||+|++|+||+| .+..+++.||+|.+...... ......+|+..++.+ +||||+++++++
T Consensus 1 ~y~~~~~lg~g~~g~v~~~---------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~ 71 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKA---------RDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVC 71 (288)
T ss_pred CceEeeEEeecCCeEEEEE---------EECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeee
Confidence 5899999999999999999 66677999999988754321 123344566655554 799999999987
Q ss_pred ee-----cCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEE
Q 018785 97 SE-----SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAK 171 (350)
Q Consensus 97 ~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~ 171 (350)
.. ....++++|++. ++|.+++.......+++..+..++.|++.||.||| +.|++|+||+|+||+++.++.++
T Consensus 72 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH--~~~ivH~dikp~Nili~~~~~~k 148 (288)
T cd07863 72 ATSRTDRETKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH--ANCIVHRDLKPENILVTSGGQVK 148 (288)
T ss_pred ccccCCCCceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEECCCCCEE
Confidence 64 245789999995 58999887765556899999999999999999999 99999999999999999999999
Q ss_pred EccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcc-
Q 018785 172 LSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD- 250 (350)
Q Consensus 172 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~- 250 (350)
|+|||++........ .....++..|+|||.+.+..++.++|+||+||++|+|++|..||...........+.....
T Consensus 149 l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~ 225 (288)
T cd07863 149 LADFGLARIYSCQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGL 225 (288)
T ss_pred ECccCccccccCccc---CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCC
Confidence 999999875432211 1224578889999999888999999999999999999999999976543322222221110
Q ss_pred hhhhhhHHHHH----hhhcccC---CCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 251 PFLRDSRRVLR----IMDTRLG---GQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 251 ~~~~~~~~~~~----~~~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
+.......... ....... ......++..+.+++.+||+.||.+|||+.+++.|
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 226 PPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred CChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00000000000 0000000 01123456788999999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=305.37 Aligned_cols=270 Identities=23% Similarity=0.251 Sum_probs=206.0
Q ss_pred hhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceeeEE
Q 018785 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYC 96 (350)
Q Consensus 17 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (350)
.+...+|++.+.||.|++|.||++... +...+..|++|.+.... ...+|+.+++.++||||+++++++
T Consensus 88 ~~~~~~y~i~~~Lg~G~~g~Vy~~~~~-------~~~~~~~v~vK~~~~~~-----~~~~E~~il~~l~h~~iv~~~~~~ 155 (392)
T PHA03207 88 SVVRMQYNILSSLTPGSEGEVFVCTKH-------GDEQRKKVIVKAVTGGK-----TPGREIDILKTISHRAIINLIHAY 155 (392)
T ss_pred hhccCceEEEEeecCCCCeEEEEEEEc-------CCccceeEEEEeccccc-----cHHHHHHHHHhcCCCCccceeeeE
Confidence 344568999999999999999998542 33457889999876432 345799999999999999999999
Q ss_pred eecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcccc
Q 018785 97 SESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFG 176 (350)
Q Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg 176 (350)
......+++|+++ +++|.+++.... .+++..+..++.||+.||.||| +.|++|+||||+||+++.++.++|+|||
T Consensus 156 ~~~~~~~lv~e~~-~~~l~~~l~~~~--~l~~~~~~~i~~ql~~aL~~LH--~~givHrDlkp~Nill~~~~~~~l~DfG 230 (392)
T PHA03207 156 RWKSTVCMVMPKY-KCDLFTYVDRSG--PLPLEQAITIQRRLLEALAYLH--GRGIIHRDVKTENIFLDEPENAVLGDFG 230 (392)
T ss_pred eeCCEEEEEehhc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--HCCccccCCCHHHEEEcCCCCEEEccCc
Confidence 9999999999998 568989885443 7999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcc------
Q 018785 177 LARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD------ 250 (350)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~------ 250 (350)
++................|++.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+.....
T Consensus 231 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~ 310 (392)
T PHA03207 231 AACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHP 310 (392)
T ss_pred cccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCc
Confidence 99764443332223345689999999999999999999999999999999999999977654332222211100
Q ss_pred -hhhhh-hH---HHHHhhhcccCCC--Cc-----HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 251 -PFLRD-SR---RVLRIMDTRLGGQ--YS-----KKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 251 -~~~~~-~~---~~~~~~~~~~~~~--~~-----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
.+... .. ............. .+ ...+.++.++|.+||..||++|||+.+++.|
T Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 311 LEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred cccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000 00 0000001111110 11 1345688999999999999999999999987
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-40 Score=289.21 Aligned_cols=265 Identities=25% Similarity=0.379 Sum_probs=205.3
Q ss_pred hhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh-hHHHHHHHHHHHhccCCCcccceeeEEe
Q 018785 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ-GHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (350)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (350)
...+|++.+.||.|+||+||+|++..+ .......+++|.+...... ....+..|+..++.+.||||+++++++.
T Consensus 5 ~~~~~~~~~~lg~G~~~~vy~~~~~~~-----~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~ 79 (279)
T cd05111 5 KETELRKLKLLGSGVFGTVHKGIWIPE-----GDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP 79 (279)
T ss_pred CHhhceeccccCccCCcceEEEEEcCC-----CCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC
Confidence 357899999999999999999965421 1112235888887644322 2355677888899999999999999875
Q ss_pred ecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccc
Q 018785 98 ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL 177 (350)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~ 177 (350)
+...++++|++.+++|.+++.... ..+++..+..++.|++.||+||| +.|++|+||+|+||+++.++.++|+|||.
T Consensus 80 -~~~~~~i~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH--~~~iiH~dlkp~nili~~~~~~kl~Dfg~ 155 (279)
T cd05111 80 -GASLQLVTQLSPLGSLLDHVRQHR-DSLDPQRLLNWCVQIAKGMYYLE--EHRMVHRNLAARNILLKSDSIVQIADFGV 155 (279)
T ss_pred -CCccEEEEEeCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHH--HCCEeccccCcceEEEcCCCcEEEcCCcc
Confidence 456789999999999999997654 36899999999999999999999 99999999999999999999999999999
Q ss_pred cccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccccCcchhhhhhhcchhhhhh
Q 018785 178 ARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDS 256 (350)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 256 (350)
+................++..|++||.+.+..++.++|+||||+++|+|++ |..||.+........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~------------- 222 (279)
T cd05111 156 ADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPD------------- 222 (279)
T ss_pred ceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH-------------
Confidence 975433322222223345667999999988899999999999999999998 999987654221111
Q ss_pred HHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcC
Q 018785 257 RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 310 (350)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 310 (350)
.+........+..++..+.+++.+||..||.+|||+.++++.|..+...
T Consensus 223 -----~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~ 271 (279)
T cd05111 223 -----LLEKGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD 271 (279)
T ss_pred -----HHHCCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence 1111111122233566788999999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=304.71 Aligned_cols=267 Identities=26% Similarity=0.384 Sum_probs=204.7
Q ss_pred cccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccc--hhhHHHHHHHHHHHhccCCCcccceeeEEeec
Q 018785 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES--FQGHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (350)
Q Consensus 22 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (350)
+|++.+.||+|+||.||++ .+..+++.||+|.+.... ......+.+|+.+++.++||||+++++++...
T Consensus 1 ~~~~~~~lg~G~~g~V~~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 71 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSV---------TDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPP 71 (372)
T ss_pred CCcccceeeeCCCEEEEEE---------EECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCC
Confidence 5889999999999999999 566678999999886532 23345678899999999999999999999877
Q ss_pred C-----ceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcc
Q 018785 100 D-----NRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSD 174 (350)
Q Consensus 100 ~-----~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~D 174 (350)
+ ..++|+||+. ++|.+++.... .++...+..++.|++.||.||| +.|++|+||||+||+++.++.++|+|
T Consensus 72 ~~~~~~~~~lv~e~~~-~~l~~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH--~~~ivH~dlkp~Nili~~~~~~kL~D 146 (372)
T cd07853 72 HIDPFEEIYVVTELMQ-SDLHKIIVSPQ--PLSSDHVKVFLYQILRGLKYLH--SAGILHRDIKPGNLLVNSNCVLKICD 146 (372)
T ss_pred CccccceEEEEeeccc-cCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHH--hCCeeCCCCChHHEEECCCCCEEecc
Confidence 6 7899999994 68888876544 6899999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCCCCCcccccccCCCcccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcc-hh
Q 018785 175 FGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD-PF 252 (350)
Q Consensus 175 fg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~-~~ 252 (350)
||++........ .......+++.|+|||.+.+. .++.++||||+||++|+|++|+.||.+.........+..... +.
T Consensus 147 fg~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~ 225 (372)
T cd07853 147 FGLARVEEPDES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPS 225 (372)
T ss_pred ccceeecccCcc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence 999975432221 122234578889999998774 578999999999999999999999987665433333332211 11
Q ss_pred hhhhH----HHHHhh-hcccCC-------CCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 253 LRDSR----RVLRIM-DTRLGG-------QYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 253 ~~~~~----~~~~~~-~~~~~~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
..... .....+ ...... ......++++.+||.+||+.||.+|||+.++++|
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 226 LEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 11100 000000 000000 1123346789999999999999999999999987
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=286.45 Aligned_cols=259 Identities=25% Similarity=0.380 Sum_probs=209.4
Q ss_pred hcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccc---hhhHHHHHHHHHHHhccCCCcccceeeEEe
Q 018785 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES---FQGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (350)
Q Consensus 21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (350)
++|++.+.||.|++|.||+| ....+|..|++|.+.... ......+.+|+..+++++|++++++++.+.
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~---------~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~ 72 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKA---------ICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFI 72 (267)
T ss_pred CceeeeeeeccCCceEEEEE---------EEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeee
Confidence 58999999999999999999 555678899999886432 223456889999999999999999999999
Q ss_pred ecCceEEEEEcCCCCChhhHHhhc--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccc
Q 018785 98 ESDNRLLVYEFMPKGSLENHLFRK--GVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDF 175 (350)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Df 175 (350)
..+..++||||+++++|.+++... ....++...+..++.|++.||.+|| +.|++|+||+|+||+++.++.++|+||
T Consensus 73 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh--~~~i~h~dl~p~nil~~~~~~~~l~d~ 150 (267)
T cd08224 73 ENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH--SKRIMHRDIKPANVFITATGVVKLGDL 150 (267)
T ss_pred cCCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHH--hCCEecCCcChhhEEECCCCcEEEecc
Confidence 999999999999999999988643 2346899999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhh
Q 018785 176 GLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRD 255 (350)
Q Consensus 176 g~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 255 (350)
|.+........ ......++..|+|||.+.+..++.++|+||||+++|+|++|..||....... ..
T Consensus 151 ~~~~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~----------- 215 (267)
T cd08224 151 GLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL--YS----------- 215 (267)
T ss_pred ceeeeccCCCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccH--HH-----------
Confidence 99875432221 1122457788999999988889999999999999999999999986433110 00
Q ss_pred hHHHHHhhhcccCCCCcH-HHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 018785 256 SRRVLRIMDTRLGGQYSK-KEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLH 308 (350)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~-~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 308 (350)
.............+. .++..+.+++.+||..+|.+|||+.++++.|.+++
T Consensus 216 ---~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 216 ---LCKKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred ---HHhhhhcCCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 000011111112222 56778999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-40 Score=291.76 Aligned_cols=264 Identities=27% Similarity=0.403 Sum_probs=207.2
Q ss_pred hcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccc-hhhHHHHHHHHHHHhcc-CCCcccceeeEEee
Q 018785 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES-FQGHKEWLTEVIYLGQL-RHENLVKLIGYCSE 98 (350)
Q Consensus 21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~ 98 (350)
++|++.+.||+|+||.||+|++.. ......+++|.+.... ......+.+|+.+++++ +||||+++++++..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~-------~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 74 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKK-------DGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACEN 74 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecC-------CCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEcc
Confidence 589999999999999999995432 1123357888776432 23345688899999999 79999999999999
Q ss_pred cCceEEEEEcCCCCChhhHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEE
Q 018785 99 SDNRLLVYEFMPKGSLENHLFRKG--------------VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLL 164 (350)
Q Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~--------------~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili 164 (350)
.+..++++||+++++|.+++.... ...++...+..++.|++.||+||| +.|++|+||+|+||++
T Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH--~~~ivH~dlkp~Nill 152 (297)
T cd05089 75 RGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS--EKQFIHRDLAARNVLV 152 (297)
T ss_pred CCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH--HCCcccCcCCcceEEE
Confidence 999999999999999999996532 124788899999999999999999 9999999999999999
Q ss_pred cCCCcEEEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccccCcchh
Q 018785 165 DSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQ 243 (350)
Q Consensus 165 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~~~ 243 (350)
+.++.++|+|||++....... .......+..|+|||.+.+..++.++||||||+++|+|++ |..||..........
T Consensus 153 ~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~ 229 (297)
T cd05089 153 GENLASKIADFGLSRGEEVYV---KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYE 229 (297)
T ss_pred CCCCeEEECCcCCCcccccee---ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 999999999999986321111 1111122446999999988889999999999999999997 999996544211111
Q ss_pred hhhhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcCCCCC
Q 018785 244 TLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDMP 314 (350)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~~ 314 (350)
..........+..++..+.+|+.+||+.+|.+|||++++++.|..+.......
T Consensus 230 ------------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~~ 282 (297)
T cd05089 230 ------------------KLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKAY 282 (297)
T ss_pred ------------------HHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhccc
Confidence 11111122234457788999999999999999999999999999998775443
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-40 Score=289.37 Aligned_cols=269 Identities=28% Similarity=0.399 Sum_probs=212.1
Q ss_pred hhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccc-hhhHHHHHHHHHHHhccCCCcccceeeE
Q 018785 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES-FQGHKEWLTEVIYLGQLRHENLVKLIGY 95 (350)
Q Consensus 17 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 95 (350)
.+..++|++.+.||+|+||.||+|.+... ...++..|++|.+.... ......+.+|+..++.++||||++++++
T Consensus 2 ~~~~~~~~~~~~i~~g~~g~V~~~~~~~~-----~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~ 76 (280)
T cd05043 2 AISRDRVTLSDLLQEGTFGRIFYGILIDE-----KPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHV 76 (280)
T ss_pred ccchhheEEeeeecccCCceEEEEEEecC-----CCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 35678999999999999999999965431 12347889999886542 2335668889999999999999999998
Q ss_pred Eee-cCceEEEEEcCCCCChhhHHhhcCC------CCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCC
Q 018785 96 CSE-SDNRLLVYEFMPKGSLENHLFRKGV------QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNF 168 (350)
Q Consensus 96 ~~~-~~~~~lv~e~~~~~~L~~~l~~~~~------~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~ 168 (350)
+.. +...+++++++.+++|.+++..... ..++...+..++.|++.||+||| +.+++|+||+|+||+++.++
T Consensus 77 ~~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH--~~~i~H~di~p~nil~~~~~ 154 (280)
T cd05043 77 CIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH--KRGVIHKDIAARNCVIDEEL 154 (280)
T ss_pred EecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH--HCCEeecccCHhhEEEcCCC
Confidence 765 5678899999999999999876432 35899999999999999999999 99999999999999999999
Q ss_pred cEEEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccccCcchhhhhh
Q 018785 169 NAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVE 247 (350)
Q Consensus 169 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~~~~~~~ 247 (350)
.++|+|||++................++..|+|||.+.+..++.++||||||+++|++++ |..||.........
T Consensus 155 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~----- 229 (280)
T cd05043 155 QVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMA----- 229 (280)
T ss_pred cEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHH-----
Confidence 999999999975433322222222345567999999988889999999999999999998 99998654321111
Q ss_pred hcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcC
Q 018785 248 WADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 310 (350)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 310 (350)
...........+..+++++.+++.+||..||++|||+.++++.|.++...
T Consensus 230 -------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 230 -------------AYLKDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred -------------HHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 11111111122334677899999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=304.37 Aligned_cols=255 Identities=22% Similarity=0.262 Sum_probs=203.8
Q ss_pred hhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch---hhHHHHHHHHHHHhccCCCccccee
Q 018785 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLVKLI 93 (350)
Q Consensus 17 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~ 93 (350)
....++|++.+.||+|+||.||++ .+..+++.+|+|++..... .....+.+|..+++.++||||++++
T Consensus 39 ~~~~~~y~~~~~lG~G~fg~Vy~~---------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~ 109 (370)
T cd05621 39 QMKAEDYDVVKVIGRGAFGEVQLV---------RHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 109 (370)
T ss_pred CCCHHHCeEEEEEEecCCeEEEEE---------EECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEE
Confidence 344679999999999999999999 5666789999999865322 2234577899999999999999999
Q ss_pred eEEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEc
Q 018785 94 GYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLS 173 (350)
Q Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~ 173 (350)
+++.+++..++||||+++++|.+++... .+++..+..++.||+.||+||| +.|++||||||+||+++.++.++|+
T Consensus 110 ~~~~~~~~~~lv~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH--~~~IvHrDLKp~NILl~~~~~~kL~ 184 (370)
T cd05621 110 CAFQDDKYLYMVMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIH--SMGLIHRDVKPDNMLLDKHGHLKLA 184 (370)
T ss_pred EEEEcCCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHH--HCCeEecCCCHHHEEECCCCCEEEE
Confidence 9999999999999999999999998654 5889999999999999999999 9999999999999999999999999
Q ss_pred cccccccCCCCCCCcccccccCCCcccCccccccC----CCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhc
Q 018785 174 DFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG----HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWA 249 (350)
Q Consensus 174 Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~----~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~ 249 (350)
|||++........ .......|++.|+|||++.+. .++.++|+|||||++|+|++|..||.........
T Consensus 185 DFG~a~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~------- 256 (370)
T cd05621 185 DFGTCMKMDETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTY------- 256 (370)
T ss_pred ecccceecccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHH-------
Confidence 9999975432211 112335689999999998654 3788999999999999999999999764421111
Q ss_pred chhhhhhHHHHHhhhcccCCCC--cHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 018785 250 DPFLRDSRRVLRIMDTRLGGQY--SKKEAQAVAAVVLQCLHMDPKN--RPSMVDVLTS 303 (350)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~--Rps~~~ll~~ 303 (350)
..+......... ...++..+.+++.+||..++.+ |+++.++++|
T Consensus 257 ----------~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 257 ----------SKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred ----------HHHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 111111111111 2346788999999999855543 8999999988
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=289.95 Aligned_cols=278 Identities=24% Similarity=0.362 Sum_probs=210.1
Q ss_pred hhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceeeEEee-
Q 018785 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSE- 98 (350)
Q Consensus 20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~- 98 (350)
..+|++.+.||+|+||.||++++.. .+..++..|++|.+..........+.+|+.+++.++||||+++++++..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~-----~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 77 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDP-----LQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 77 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecC-----CcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccC
Confidence 3589999999999999999986432 3456788999999887766666778899999999999999999997643
Q ss_pred -cCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccc
Q 018785 99 -SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL 177 (350)
Q Consensus 99 -~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~ 177 (350)
....++|+||+++++|.+++.... ..++...+..++.|++.||+||| +.|++|+||+|+||+++.++.++|+|||+
T Consensus 78 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~aL~~LH--~~~i~H~dlkp~nili~~~~~~~l~dfg~ 154 (284)
T cd05081 78 GRRNLRLVMEYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYLG--SKRYVHRDLATRNILVESENRVKIGDFGL 154 (284)
T ss_pred CCCceEEEEEecCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHH--HCCceeccCCHhhEEECCCCeEEECCCcc
Confidence 356889999999999999986543 35889999999999999999999 99999999999999999999999999999
Q ss_pred cccCCCCCCCccc-ccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhh
Q 018785 178 ARDGPTGDNTHVS-TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDS 256 (350)
Q Consensus 178 ~~~~~~~~~~~~~-~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 256 (350)
+............ ....+...|+|||.+.+..++.++|+||||+++|+|++|..++........ ..+.... ......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~-~~~~~~~-~~~~~~ 232 (284)
T cd05081 155 TKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFM-RMMGNDK-QGQMIV 232 (284)
T ss_pred cccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhh-hhccccc-ccccch
Confidence 9864332221111 111233459999999888899999999999999999998877643321110 0000000 000000
Q ss_pred HHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 018785 257 RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 307 (350)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~ 307 (350)
...............+..++.++.+|+.+||..+|++|||+.++++.|+.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 233 YHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 111112222222233456778999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=286.32 Aligned_cols=252 Identities=28% Similarity=0.433 Sum_probs=202.0
Q ss_pred hhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceeeEEeec
Q 018785 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (350)
Q Consensus 20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (350)
.++|++.+.||+|+||.||+++++. +..+++|.+..... ....+..|+..++.++||||+++++++...
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~----------~~~~a~K~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 71 (256)
T cd05114 3 PSELTFMKELGSGQFGVVHLGKWRA----------QIKVAIKAINEGAM-SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQ 71 (256)
T ss_pred HHHcEEeeEecCCcCceEEEEEecc----------CceEEEEecccCCc-cHHHHHHHHHHHHHCCCCCceeEEEEEccC
Confidence 4679999999999999999995532 35789998764432 345678899999999999999999999999
Q ss_pred CceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccccc
Q 018785 100 DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR 179 (350)
Q Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~ 179 (350)
+..++||||+++++|.+++.... ..++...+..++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||.+.
T Consensus 72 ~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~ 148 (256)
T cd05114 72 KPLYIVTEFMENGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLE--RNSFIHRDLAARNCLVSSTGVVKVSDFGMTR 148 (256)
T ss_pred CCEEEEEEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHH--HCCccccccCcceEEEcCCCeEEECCCCCcc
Confidence 99999999999999999987543 25889999999999999999999 9999999999999999999999999999887
Q ss_pred cCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccccCcchhhhhhhcchhhhhhHH
Q 018785 180 DGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRR 258 (350)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (350)
........ ......++..|+|||.+.+..++.++|+||+|+++|+|++ |+.||...........+..
T Consensus 149 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~----------- 216 (256)
T cd05114 149 YVLDDEYT-SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISR----------- 216 (256)
T ss_pred ccCCCcee-ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC-----------
Confidence 54222211 1112234557999999988889999999999999999999 8889865443222111111
Q ss_pred HHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018785 259 VLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL 304 (350)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 304 (350)
......+...+..+.+++.+||+.+|.+|||+.++++.|
T Consensus 217 -------~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 217 -------GFRLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred -------CCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 111112333567899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=286.42 Aligned_cols=253 Identities=31% Similarity=0.506 Sum_probs=207.1
Q ss_pred ceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhh-HHHHHHHHHHHhccCCCcccceeeEEeecCceEEE
Q 018785 27 YLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQG-HKEWLTEVIYLGQLRHENLVKLIGYCSESDNRLLV 105 (350)
Q Consensus 27 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 105 (350)
+.||+|+||.||+|.+... ...+..+++|.+....... ...+.+|+..++.++|++++++++++......++|
T Consensus 1 ~~ig~g~~g~v~~~~~~~~------~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 74 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGK------DGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLV 74 (262)
T ss_pred CccccCCceEEEEEEEecC------CCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEE
Confidence 4789999999999965421 1347889999988765443 56788999999999999999999999999999999
Q ss_pred EEcCCCCChhhHHhhcC-------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcccccc
Q 018785 106 YEFMPKGSLENHLFRKG-------VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 178 (350)
Q Consensus 106 ~e~~~~~~L~~~l~~~~-------~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~ 178 (350)
|||+++++|.+++.... ...+++..+..++.|++.||++|| ++|++|+||+|+||+++.++.++|+|||.+
T Consensus 75 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH--~~~i~H~di~p~nili~~~~~~~l~dfg~~ 152 (262)
T cd00192 75 LEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA--SKKFVHRDLAARNCLVGEDLVVKISDFGLS 152 (262)
T ss_pred EEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH--cCCcccCccCcceEEECCCCcEEEcccccc
Confidence 99999999999997752 247999999999999999999999 999999999999999999999999999999
Q ss_pred ccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccccCcchhhhhhhcchhhhhhH
Q 018785 179 RDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSR 257 (350)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 257 (350)
................++..|+|||.+.+..++.++|+||||+++|+|++ |..||..........
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~-------------- 218 (262)
T cd00192 153 RDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLE-------------- 218 (262)
T ss_pred cccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHH--------------
Confidence 86544332222333456778999999988889999999999999999999 588987653211111
Q ss_pred HHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018785 258 RVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 305 (350)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~ 305 (350)
..........+..++.++.+++.+||+.+|.+|||+.+++++|+
T Consensus 219 ----~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 219 ----YLRKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ----HHHcCCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 11112223345566889999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=288.78 Aligned_cols=266 Identities=24% Similarity=0.380 Sum_probs=208.3
Q ss_pred hhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch-hhHHHHHHHHHHHhccCCCcccceeeEE
Q 018785 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLVKLIGYC 96 (350)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (350)
....+|++.++||.|+||+||+|++... ......+||+|.+..... .....+..|...++.++||||+++++++
T Consensus 4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~-----~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~ 78 (279)
T cd05109 4 LKETELKKVKVLGSGAFGTVYKGIWIPD-----GENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGIC 78 (279)
T ss_pred cchhheeeeeecCCCCCceEEEEEEecC-----CCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEE
Confidence 4568999999999999999999965432 111234689998865433 3345678899999999999999999988
Q ss_pred eecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcccc
Q 018785 97 SESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFG 176 (350)
Q Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg 176 (350)
.. ...+++++++++++|.+++..+. ..+++..+..++.|++.||+||| +++++|+||+|+||+++.++.++|+|||
T Consensus 79 ~~-~~~~l~~~~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~lH--~~~iiH~dlkp~Nil~~~~~~~kL~dfG 154 (279)
T cd05109 79 LT-STVQLVTQLMPYGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLE--EVRLVHRDLAARNVLVKSPNHVKITDFG 154 (279)
T ss_pred cC-CCcEEEEEcCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHH--HCCeeccccccceEEEcCCCcEEECCCC
Confidence 75 45789999999999999987643 36899999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccccCcchhhhhhhcchhhhh
Q 018785 177 LARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRD 255 (350)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 255 (350)
++................++..|+|||...+..++.++|||||||++|+|++ |..||........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~-------------- 220 (279)
T cd05109 155 LARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREI-------------- 220 (279)
T ss_pred ceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH--------------
Confidence 9976543222211222234567999999988899999999999999999998 8888865332111
Q ss_pred hHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcC
Q 018785 256 SRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 310 (350)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 310 (350)
...+........+..++.++.+++.+||+.||++||++.++++.|..+...
T Consensus 221 ----~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05109 221 ----PDLLEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD 271 (279)
T ss_pred ----HHHHHCCCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence 111111112223345678899999999999999999999999999887544
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=287.18 Aligned_cols=261 Identities=27% Similarity=0.440 Sum_probs=206.5
Q ss_pred hhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccc-hhhHHHHHHHHHHHhccCCCcccceeeEEee
Q 018785 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES-FQGHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (350)
Q Consensus 20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (350)
..+|++.+.||+|+||.||+|.+.. ....+..|++|.+.... ......+..|+..++.++||||+++++++.+
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~------~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~ 76 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKL------PGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK 76 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEec------CCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECC
Confidence 4579999999999999999996542 12234579999987653 3345678899999999999999999999999
Q ss_pred cCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcccccc
Q 018785 99 SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 178 (350)
Q Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~ 178 (350)
++..++||||+.+++|.+++.... ..++...+..++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||++
T Consensus 77 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~al~~lH--~~g~~H~dl~p~nili~~~~~~kl~dfg~~ 153 (269)
T cd05065 77 SRPVMIITEFMENGALDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLS--EMNYVHRDLAARNILVNSNLVCKVSDFGLS 153 (269)
T ss_pred CCceEEEEecCCCCcHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHH--HCCEeecccChheEEEcCCCcEEECCCccc
Confidence 999999999999999999987654 36899999999999999999999 999999999999999999999999999998
Q ss_pred ccCCCCCCCccccccc---CCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccccCcchhhhhhhcchhhh
Q 018785 179 RDGPTGDNTHVSTRIV---GTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLR 254 (350)
Q Consensus 179 ~~~~~~~~~~~~~~~~---~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~ 254 (350)
................ .+..|+|||.+.+..++.++|+||+|+++|++++ |..||...........+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i--------- 224 (269)
T cd05065 154 RFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAI--------- 224 (269)
T ss_pred cccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHH---------
Confidence 6543322211111111 1346999999988899999999999999999886 99998654321111111
Q ss_pred hhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 018785 255 DSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 307 (350)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~ 307 (350)
........+.+++..+.+++.+||+.+|.+||++.++++.|+++
T Consensus 225 ---------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 225 ---------EQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ---------HcCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11111222345677899999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=295.52 Aligned_cols=269 Identities=22% Similarity=0.290 Sum_probs=203.8
Q ss_pred hhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch-hhHHHHHHHHHHHhccCCCcccceeeEEee
Q 018785 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (350)
Q Consensus 20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (350)
.++|++.+.||.|++|.||+| .+..++..||+|.+..... .....+.+|+..++.++||||+++++++..
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~ 75 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKG---------RSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHT 75 (301)
T ss_pred ccceEEeeEeccCcCEEEEEE---------EEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEec
Confidence 468999999999999999999 5666788999998865432 223456789999999999999999999999
Q ss_pred cCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcccccc
Q 018785 99 SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 178 (350)
Q Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~ 178 (350)
.+..++||||+. ++|.+++.... ..+++..+..++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||++
T Consensus 76 ~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~lH--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 151 (301)
T cd07873 76 EKSLTLVFEYLD-KDLKQYLDDCG-NSINMHNVKLFLFQLLRGLNYCH--RRKVLHRDLKPQNLLINERGELKLADFGLA 151 (301)
T ss_pred CCeEEEEEeccc-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH--hCCeeCCCCCHHHEEECCCCcEEECcCcch
Confidence 999999999995 58988886643 36889999999999999999999 999999999999999999999999999998
Q ss_pred ccCCCCCCCcccccccCCCcccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhh----
Q 018785 179 RDGPTGDNTHVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL---- 253 (350)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~---- 253 (350)
........ ......+++.|+|||.+.+. .++.++|+||||+++|+|++|+.||...+.......+........
T Consensus 152 ~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 229 (301)
T cd07873 152 RAKSIPTK--TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETW 229 (301)
T ss_pred hccCCCCC--cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhc
Confidence 65322211 11223467889999988654 578899999999999999999999976554322222221111000
Q ss_pred hhhHHHHHhhhccc-------CCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 254 RDSRRVLRIMDTRL-------GGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 254 ~~~~~~~~~~~~~~-------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
.............. .......+++.+.+||.+||..||.+|||+.++++|
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 230 PGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred hhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 00000000000000 001123457789999999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=299.15 Aligned_cols=250 Identities=25% Similarity=0.357 Sum_probs=198.7
Q ss_pred ceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch---hhHHHHHHHHHHHhcc-CCCcccceeeEEeecCce
Q 018785 27 YLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQL-RHENLVKLIGYCSESDNR 102 (350)
Q Consensus 27 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 102 (350)
+.||+|+||.||+| ....+++.||+|++..... .....+..|..++.++ .||+|+++++++...+..
T Consensus 1 ~~lG~G~~g~V~~~---------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~ 71 (327)
T cd05617 1 RVIGRGSYAKVLLV---------RLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRL 71 (327)
T ss_pred CeeeeCCCeEEEEE---------EECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEE
Confidence 47999999999999 5566688999999976532 2334577888888888 699999999999999999
Q ss_pred EEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccccccCC
Q 018785 103 LLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGP 182 (350)
Q Consensus 103 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~~~~ 182 (350)
++||||+++++|.+++.... .+++..+..++.|++.||+||| +.|++|+||||+||+++.++.++|+|||++....
T Consensus 72 ~lv~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~qi~~al~~lH--~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~ 147 (327)
T cd05617 72 FLVIEYVNGGDLMFHMQRQR--KLPEEHARFYAAEICIALNFLH--ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGL 147 (327)
T ss_pred EEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCeeccCCCHHHEEEeCCCCEEEeccccceecc
Confidence 99999999999999887654 6999999999999999999999 9999999999999999999999999999986422
Q ss_pred CCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhHHHHHh
Q 018785 183 TGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRI 262 (350)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (350)
... .......|++.|+|||.+.+..++.++|+||||+++|+|++|..||........... .....+.
T Consensus 148 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~-----------~~~~~~~ 214 (327)
T cd05617 148 GPG--DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNT-----------EDYLFQV 214 (327)
T ss_pred CCC--CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCccccc-----------HHHHHHH
Confidence 211 112335688999999999999999999999999999999999999964332111100 0000111
Q ss_pred hhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCH------HHHHHH
Q 018785 263 MDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSM------VDVLTS 303 (350)
Q Consensus 263 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~------~~ll~~ 303 (350)
... .....+..++..+.+++.+||..||.+|+++ +++++|
T Consensus 215 ~~~-~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 215 ILE-KPIRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred HHh-CCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence 111 1123455677889999999999999999984 577766
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=292.68 Aligned_cols=253 Identities=25% Similarity=0.363 Sum_probs=205.3
Q ss_pred hhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceeeEEeec
Q 018785 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (350)
Q Consensus 20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (350)
++.|++.+.||.|++|.||+| .+..++..+++|.+..........+.+|+..++.++|||++++++.+..+
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~---------~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 81 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKA---------KNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWD 81 (292)
T ss_pred chhhhhhheecCCCCeEEEEE---------EECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeC
Confidence 467999999999999999999 56667889999999877666667788899999999999999999999999
Q ss_pred CceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccccc
Q 018785 100 DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR 179 (350)
Q Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~ 179 (350)
+..++||||+.+++|..++.+.. ..++...+..++.|++.+|.+|| +.|++|+||+|+||+++.++.++|+|||.+.
T Consensus 82 ~~~~lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH--~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~ 158 (292)
T cd06644 82 GKLWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLH--SMKIIHRDLKAGNVLLTLDGDIKLADFGVSA 158 (292)
T ss_pred CeEEEEEecCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHh--cCCeeecCCCcceEEEcCCCCEEEccCccce
Confidence 99999999999999988876543 36899999999999999999999 9999999999999999999999999999886
Q ss_pred cCCCCCCCcccccccCCCcccCccccc-----cCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhh
Q 018785 180 DGPTGDNTHVSTRIVGTRGYAAPEYVA-----TGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLR 254 (350)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~ 254 (350)
..... ........++..|+|||.+. ...++.++|+||||+++|+|++|..||..........
T Consensus 159 ~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~----------- 225 (292)
T cd06644 159 KNVKT--LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLL----------- 225 (292)
T ss_pred ecccc--ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHH-----------
Confidence 43221 11122345778899999874 3456789999999999999999999986543211110
Q ss_pred hhHHHHHhhhc-ccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 255 DSRRVLRIMDT-RLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 255 ~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
..... ......+..++.++.+++.+||..||++||++++++++
T Consensus 226 ------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 226 ------KIAKSEPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred ------HHhcCCCccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 11100 01112234567789999999999999999999999875
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=286.39 Aligned_cols=254 Identities=29% Similarity=0.424 Sum_probs=203.0
Q ss_pred hhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceeeEEee
Q 018785 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (350)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (350)
..++|++.+.||+|++|.||+|++.+ +..+++|.+..... ....+.+|+..++.++||||+++++++..
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~~----------~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 70 (256)
T cd05113 2 DPKDLTFLKELGTGQFGVVKYGKWRG----------QYDVAIKMIKEGSM-SEDEFIEEAKVMMKLSHEKLVQLYGVCTK 70 (256)
T ss_pred ChHHeEEeeEecCcccceEEEEEecC----------CCcEEEEEcCCCcc-cHHHHHHHHHHHhcCCCCCeeeEEEEEcc
Confidence 35789999999999999999995432 33599998875543 34568889999999999999999999999
Q ss_pred cCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcccccc
Q 018785 99 SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 178 (350)
Q Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~ 178 (350)
.+..+++|||+.+++|.+++..... .+++..++.++.|++.||.||| +.|++|+||+|.||+++.++.++|+|||.+
T Consensus 71 ~~~~~lv~e~~~~~~l~~~i~~~~~-~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dl~p~nili~~~~~~kl~d~g~~ 147 (256)
T cd05113 71 QRPIYIVTEYMSNGCLLNYLREHGK-RFQPSQLLEMCKDVCEGMAYLE--SKQFIHRDLAARNCLVDDQGCVKVSDFGLS 147 (256)
T ss_pred CCCcEEEEEcCCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH--hCCeeccccCcceEEEcCCCCEEECCCccc
Confidence 9999999999999999999876543 6899999999999999999999 999999999999999999999999999998
Q ss_pred ccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccccCcchhhhhhhcchhhhhhH
Q 018785 179 RDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSR 257 (350)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 257 (350)
........ .......++..|++||.+.+..++.++|+||||+++|+|++ |..||...........+.
T Consensus 148 ~~~~~~~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~----------- 215 (256)
T cd05113 148 RYVLDDEY-TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVS----------- 215 (256)
T ss_pred eecCCCce-eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHh-----------
Confidence 75432211 11112234567999999988889999999999999999998 888986544211111111
Q ss_pred HHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018785 258 RVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 305 (350)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~ 305 (350)
.......+...+..+.+++.+||..+|.+||++.++++.|+
T Consensus 216 -------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 216 -------QGLRLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred -------cCCCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 11111122335678999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=300.96 Aligned_cols=239 Identities=26% Similarity=0.381 Sum_probs=191.2
Q ss_pred ceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh---hHHHHHHH-HHHHhccCCCcccceeeEEeecCce
Q 018785 27 YLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ---GHKEWLTE-VIYLGQLRHENLVKLIGYCSESDNR 102 (350)
Q Consensus 27 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e-~~~l~~l~h~~i~~~~~~~~~~~~~ 102 (350)
+.||+|+||+||+| .+..+++.||+|++...... ....+..| ..+++.+.||||+++++.+...+..
T Consensus 1 ~~lg~G~fg~V~~~---------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~ 71 (325)
T cd05602 1 KVIGKGSFGKVLLA---------RHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKL 71 (325)
T ss_pred CeeeeCCCeEEEEE---------EECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeE
Confidence 47999999999999 55666889999998754321 12233333 3456788999999999999999999
Q ss_pred EEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccccccCC
Q 018785 103 LLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGP 182 (350)
Q Consensus 103 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~~~~ 182 (350)
++||||+.+++|.+++.... .+++..+..++.||++||.||| +.|++|+||||+||+++.++.++|+|||++....
T Consensus 72 ~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~L~~lH--~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~ 147 (325)
T cd05602 72 YFVLDYINGGELFYHLQRER--CFLEPRARFYAAEIASALGYLH--SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENI 147 (325)
T ss_pred EEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--HCCeEecCCCHHHeEECCCCCEEEccCCCCcccc
Confidence 99999999999999997654 6888999999999999999999 9999999999999999999999999999986432
Q ss_pred CCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhHHHHHh
Q 018785 183 TGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRI 262 (350)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (350)
... .......|++.|+|||++.+..++.++|||||||++|+|++|..||...........+.
T Consensus 148 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~---------------- 209 (325)
T cd05602 148 EHN--GTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL---------------- 209 (325)
T ss_pred cCC--CCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHH----------------
Confidence 211 12233568999999999999999999999999999999999999997544321111111
Q ss_pred hhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 018785 263 MDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVD 299 (350)
Q Consensus 263 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ 299 (350)
.. .......+++.+.+++.+||+.||.+|+++.+
T Consensus 210 -~~--~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~ 243 (325)
T cd05602 210 -NK--PLQLKPNITNSARHLLEGLLQKDRTKRLGAKD 243 (325)
T ss_pred -hC--CcCCCCCCCHHHHHHHHHHcccCHHHCCCCCC
Confidence 11 11223457788999999999999999998763
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=293.14 Aligned_cols=253 Identities=28% Similarity=0.427 Sum_probs=205.2
Q ss_pred cccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhh---HHHHHHHHHHHhccCCCcccceeeEEee
Q 018785 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQG---HKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (350)
Q Consensus 22 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (350)
.|++.+.||+|+||.||++ .+..+++.||+|.+....... ...+..|+.+++.++|++++++++.+.+
T Consensus 1 ~f~~~~~ig~G~~g~v~~~---------~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~ 71 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCAC---------QVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYET 71 (285)
T ss_pred CceeeEEeecCCCeEEEEE---------EEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEec
Confidence 4788899999999999999 666678999999886543222 2346789999999999999999999999
Q ss_pred cCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcccccc
Q 018785 99 SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 178 (350)
Q Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~ 178 (350)
.+..++||||+.+++|.+++.......+++..+..++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||++
T Consensus 72 ~~~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH--~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~ 149 (285)
T cd05630 72 KDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH--QERIVYRDLKPENILLDDHGHIRISDLGLA 149 (285)
T ss_pred CCEEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH--hCCEEeCCCCHHHEEECCCCCEEEeeccce
Confidence 999999999999999999987665557999999999999999999999 999999999999999999999999999998
Q ss_pred ccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhHH
Q 018785 179 RDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRR 258 (350)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (350)
........ .....|+..|+|||.+.+..++.++|+||+|+++|+|++|..||..............
T Consensus 150 ~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~----------- 215 (285)
T cd05630 150 VHVPEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVER----------- 215 (285)
T ss_pred eecCCCcc---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHh-----------
Confidence 65322211 1234688899999999988999999999999999999999999976432211111111
Q ss_pred HHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 018785 259 VLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPS-----MVDVLTS 303 (350)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-----~~~ll~~ 303 (350)
... ......+..+++++.+|+.+||+.||.+||| ++++++|
T Consensus 216 ---~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 216 ---LVK-EVQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred ---hhh-hhhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 000 0011233456788999999999999999999 8888875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=300.99 Aligned_cols=263 Identities=24% Similarity=0.309 Sum_probs=205.6
Q ss_pred CCchhhhhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEcccc--chhhHHHHHHHHHHHhcc-CC
Q 018785 10 PSASMISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAE--SFQGHKEWLTEVIYLGQL-RH 86 (350)
Q Consensus 10 ~~~~~~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l-~h 86 (350)
.....+..+.++.|++.++||+||.+.||++. ..+.+ .+|+|.+... .......+.+|+.+|.+| .|
T Consensus 350 ~~~~~~i~Vkg~~Yeilk~iG~GGSSkV~kV~---------~s~~~-iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~ 419 (677)
T KOG0596|consen 350 SSANEIIKVKGREYEILKQIGSGGSSKVFKVL---------NSDKQ-IYALKKVVLLEADNQTLDGYRNEIALLNKLKGH 419 (677)
T ss_pred CCcCeeEEECcchhhHHHhhcCCCcceeeeee---------cCCCc-chhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCC
Confidence 34457888999999999999999999999983 33333 4555544332 223456789999999999 59
Q ss_pred CcccceeeEEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcC
Q 018785 87 ENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS 166 (350)
Q Consensus 87 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~ 166 (350)
.+|++++++-..++.+|+|||+- ..+|...+.++... ...-.+..+..|++.|+.++| ..||+|.||||.|+++ -
T Consensus 420 ~~IIqL~DYEv~d~~lYmvmE~G-d~DL~kiL~k~~~~-~~~~~lk~ywkqML~aV~~IH--~~gIVHSDLKPANFLl-V 494 (677)
T KOG0596|consen 420 DKIIQLYDYEVTDGYLYMVMECG-DIDLNKILKKKKSI-DPDWFLKFYWKQMLLAVKTIH--QHGIVHSDLKPANFLL-V 494 (677)
T ss_pred ceEEEEeeeeccCceEEEEeecc-cccHHHHHHhccCC-CchHHHHHHHHHHHHHHHHHH--HhceeecCCCcccEEE-E
Confidence 99999999999999999999987 67999999877642 333378889999999999999 9999999999999999 6
Q ss_pred CCcEEEccccccccCCCCCCCcccccccCCCcccCccccccCC-----------CCCccchhhHHHHHHHHHhCCCCCcc
Q 018785 167 NFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGH-----------LTPKSDVYSFGVVLLELLSGRRALDE 235 (350)
Q Consensus 167 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-----------~~~~~DiwslG~ll~~ll~g~~pf~~ 235 (350)
.|.+||+|||++................||+.|++||.+.... .+.++|||||||+||+|+.|+.||..
T Consensus 495 kG~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~ 574 (677)
T KOG0596|consen 495 KGRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQ 574 (677)
T ss_pred eeeEEeeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHH
Confidence 7799999999998777776666667789999999999885432 55789999999999999999999975
Q ss_pred cccCcchhhhhhhcchhhhhhHHHHHhhhcccCCCCcHH-HHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 236 DRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKK-EAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
..+. ......+.+..-.-+++.- -..++.++++.||+.||++|||+.++|+|
T Consensus 575 ~~n~----------------~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 575 IINQ----------------IAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred HHHH----------------HHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 4321 1111222222111122211 11249999999999999999999999976
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=302.93 Aligned_cols=273 Identities=30% Similarity=0.427 Sum_probs=224.7
Q ss_pred hhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEcccc---chhhHHHHHHHHHHHhccCCCcccce
Q 018785 16 SKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAE---SFQGHKEWLTEVIYLGQLRHENLVKL 92 (350)
Q Consensus 16 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~ 92 (350)
+.+.-++..+.++||+|+||.||+|++... .......||||..... ...+..+++.|++++++++||||+++
T Consensus 152 Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~-----~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~ 226 (474)
T KOG0194|consen 152 WELSHSDIELGKKLGEGAFGEVFKGKLKLK-----NGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRF 226 (474)
T ss_pred cEEeccCccccceeecccccEEEEEEEEec-----CCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEE
Confidence 334445666778999999999999987632 1101223899988853 34567889999999999999999999
Q ss_pred eeEEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEE
Q 018785 93 IGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKL 172 (350)
Q Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l 172 (350)
||+......+++|||++.||+|.+++.+++. .++..+...++.+.+.||+||| +++++||||-.+|+|++.++.+|+
T Consensus 227 yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh--~k~~IHRDIAARNcL~~~~~~vKI 303 (474)
T KOG0194|consen 227 YGVAVLEEPLMLVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLH--SKNCIHRDIAARNCLYSKKGVVKI 303 (474)
T ss_pred EEEEcCCCccEEEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHH--HCCCcchhHhHHHheecCCCeEEe
Confidence 9999999999999999999999999988864 6999999999999999999999 999999999999999999999999
Q ss_pred ccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccccCcchhhhhhhcch
Q 018785 173 SDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADP 251 (350)
Q Consensus 173 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~ 251 (350)
+|||+++...... .......-...|+|||.+....|+.++||||+|+++||+++ |..||.+....
T Consensus 304 SDFGLs~~~~~~~--~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~------------ 369 (474)
T KOG0194|consen 304 SDFGLSRAGSQYV--MKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY------------ 369 (474)
T ss_pred CccccccCCccee--eccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH------------
Confidence 9999997543111 11111234567999999999999999999999999999999 78899876643
Q ss_pred hhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcCCCCCC
Q 018785 252 FLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDMPR 315 (350)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~~~ 315 (350)
.....+.....+...+...|..+..++.+|+..+|++|||+.++.+.|..+......+.
T Consensus 370 -----~v~~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~~~ 428 (474)
T KOG0194|consen 370 -----EVKAKIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEAFD 428 (474)
T ss_pred -----HHHHHHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccccc
Confidence 22233334555566677788899999999999999999999999999999998877653
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=284.32 Aligned_cols=251 Identities=28% Similarity=0.410 Sum_probs=199.7
Q ss_pred ceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch--hhHHHHHHHHHHHhccCCCcccceeeEEeecCceEE
Q 018785 27 YLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLRHENLVKLIGYCSESDNRLL 104 (350)
Q Consensus 27 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 104 (350)
+.||+|+||.||+|.+. ...++..+++|++..... .....+..|+.+++.+.||||+++++++. .+..++
T Consensus 1 ~~lg~G~~g~v~~~~~~-------~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~l 72 (257)
T cd05116 1 GELGSGNFGTVKKGMYK-------MKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWML 72 (257)
T ss_pred CcCCCcCCcceEEeEEe-------cCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEE
Confidence 36899999999999653 334578899998865432 23456888999999999999999999875 456789
Q ss_pred EEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccccccCCCC
Q 018785 105 VYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTG 184 (350)
Q Consensus 105 v~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~~~~~~ 184 (350)
|||++.+++|.+++.... .+++..+..++.|++.||.+|| ++|++|+||+|.||+++.++.++|+|||.+......
T Consensus 73 v~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH--~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~ 148 (257)
T cd05116 73 VMELAELGPLNKFLQKNK--HVTEKNITELVHQVSMGMKYLE--ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGAD 148 (257)
T ss_pred EEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--HCCEeecccchhhEEEcCCCeEEECCCccccccCCC
Confidence 999999999999997654 6899999999999999999999 999999999999999999999999999998754332
Q ss_pred CCCcc-cccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccccCcchhhhhhhcchhhhhhHHHHHh
Q 018785 185 DNTHV-STRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRI 262 (350)
Q Consensus 185 ~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (350)
..... .....++..|+|||.+.+..++.++|+||||+++|+|++ |..||......... ..
T Consensus 149 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~------------------~~ 210 (257)
T cd05116 149 ENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVT------------------QM 210 (257)
T ss_pred CCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH------------------HH
Confidence 22111 111223467999999988889999999999999999997 99999754321111 11
Q ss_pred hhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 018785 263 MDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 307 (350)
Q Consensus 263 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~ 307 (350)
+........+..+++++.++|.+||+.||.+||++.+|.+.|.+.
T Consensus 211 i~~~~~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 211 IESGERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred HHCCCCCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 111122234456788999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=292.76 Aligned_cols=274 Identities=24% Similarity=0.387 Sum_probs=213.0
Q ss_pred hhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccc-hhhHHHHHHHHHHHhcc-CCCcccceee
Q 018785 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES-FQGHKEWLTEVIYLGQL-RHENLVKLIG 94 (350)
Q Consensus 17 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~ 94 (350)
+....+|.+.+.||+|++|.||+|+...... ........+++|.+.... ......+..|+..++.+ .||||+++++
T Consensus 8 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~--~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 85 (314)
T cd05099 8 EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDK--SRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLG 85 (314)
T ss_pred cccHHHeeeeeeecCCCcccEEEeeecccCC--ccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEE
Confidence 3456799999999999999999996432110 122346678999887543 23345678899999999 6999999999
Q ss_pred EEeecCceEEEEEcCCCCChhhHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCC
Q 018785 95 YCSESDNRLLVYEFMPKGSLENHLFRKG--------------VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKAS 160 (350)
Q Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------------~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~ 160 (350)
++...+..+++|||+.+++|.+++.... ...++...+..++.|++.||.||| +.|++|+||+|+
T Consensus 86 ~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH--~~gi~H~dlkp~ 163 (314)
T cd05099 86 VCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE--SRRCIHRDLAAR 163 (314)
T ss_pred EEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH--HCCeeeccccce
Confidence 9999899999999999999999997642 135788899999999999999999 999999999999
Q ss_pred ceEEcCCCcEEEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccccC
Q 018785 161 NVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGG 239 (350)
Q Consensus 161 Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~ 239 (350)
||+++.++.++|+|||.+................++..|+|||.+.+..++.++|+||||+++|+|++ |..||......
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~ 243 (314)
T cd05099 164 NVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE 243 (314)
T ss_pred eEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999975433222111111223457999999988899999999999999999999 88888654321
Q ss_pred cchhhhhhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcCCC
Q 018785 240 LAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKD 312 (350)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~ 312 (350)
.... .+........+..++.++.+++.+||..+|++|||+.++++.|.++....+
T Consensus 244 ~~~~------------------~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~ 298 (314)
T cd05099 244 ELFK------------------LLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVS 298 (314)
T ss_pred HHHH------------------HHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHhc
Confidence 1111 111111122344567789999999999999999999999999999887543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=286.92 Aligned_cols=256 Identities=25% Similarity=0.353 Sum_probs=208.0
Q ss_pred hhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceeeEEeec
Q 018785 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (350)
Q Consensus 20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (350)
.++|++.+.||.|++|.||+| .+..++..+++|.+..........+..|+.+++.++||||+++++.+...
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~---------~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~ 72 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKA---------RDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRR 72 (262)
T ss_pred ccceEEEEEecCCCceEEEEe---------EecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeC
Confidence 368999999999999999999 55566788999999877656667889999999999999999999999999
Q ss_pred CceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccccc
Q 018785 100 DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR 179 (350)
Q Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~ 179 (350)
+..+++|||+.+++|.+++.... ..+++..+..++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||.+.
T Consensus 73 ~~~~l~~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh--~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~ 149 (262)
T cd06613 73 DKLWIVMEYCGGGSLQDIYQVTR-GPLSELQIAYVCRETLKGLAYLH--ETGKIHRDIKGANILLTEDGDVKLADFGVSA 149 (262)
T ss_pred CEEEEEEeCCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHH--hCCceecCCChhhEEECCCCCEEECccccch
Confidence 99999999999999999887652 36899999999999999999999 9999999999999999999999999999987
Q ss_pred cCCCCCCCcccccccCCCcccCccccccC---CCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhh
Q 018785 180 DGPTGDNTHVSTRIVGTRGYAAPEYVATG---HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDS 256 (350)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~---~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 256 (350)
...... .......++..|+|||.+.+. .++.++|+||+|+++|+|++|..||...........+...
T Consensus 150 ~~~~~~--~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~-------- 219 (262)
T cd06613 150 QLTATI--AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKS-------- 219 (262)
T ss_pred hhhhhh--hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc--------
Confidence 533221 112224567789999998776 7889999999999999999999999754422111111100
Q ss_pred HHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 257 RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
.. ..........++.++.+++.+||..+|.+|||+.+++.+
T Consensus 220 -----~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 220 -----NF-PPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred -----cC-CCccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00 000111234567889999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=288.87 Aligned_cols=277 Identities=28% Similarity=0.402 Sum_probs=210.0
Q ss_pred hhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccc-hhhHHHHHHHHHHHhccCCCcccceeeEEee
Q 018785 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES-FQGHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (350)
Q Consensus 20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (350)
+..|++.+.||+|+||.||++++.. ....++..|++|.+.... ......+.+|+.+++.+.|||++++++++..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~-----~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 77 (284)
T cd05079 3 KRFLKRIRDLGEGHFGKVELCRYDP-----EGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTE 77 (284)
T ss_pred hhhhhhceecCCCCceeEEEEEEcc-----CCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEec
Confidence 5678999999999999999996542 245668899999987553 2334568899999999999999999999877
Q ss_pred c--CceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcccc
Q 018785 99 S--DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFG 176 (350)
Q Consensus 99 ~--~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg 176 (350)
. ...++||||+++++|.+++.+.. ..++...+..++.|++.||+||| ++|++|+||+|+||+++.++.++|+|||
T Consensus 78 ~~~~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH--~~gi~H~dlkp~Nil~~~~~~~~l~dfg 154 (284)
T cd05079 78 DGGNGIKLIMEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLG--SRQYVHRDLAARNVLVESEHQVKIGDFG 154 (284)
T ss_pred CCCCceEEEEEccCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH--HCCeeecccchheEEEcCCCCEEECCCc
Confidence 5 56889999999999999986653 25899999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCCCCc-ccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhh
Q 018785 177 LARDGPTGDNTH-VSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRD 255 (350)
Q Consensus 177 ~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 255 (350)
++.......... ......++..|+|||.+.+..++.++|+||||+++|+|+++..|+........ .... .......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~--~~~~-~~~~~~~ 231 (284)
T cd05079 155 LTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFL--KMIG-PTHGQMT 231 (284)
T ss_pred cccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhh--hhcc-ccccccc
Confidence 997643322211 11224456679999999888899999999999999999998766432211000 0000 0000000
Q ss_pred hHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 018785 256 SRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 307 (350)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~ 307 (350)
................+..++..+.+|+.+||+.||.+|||+.++++.|+.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 232 VTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 0111111222222233456788999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-40 Score=291.74 Aligned_cols=275 Identities=25% Similarity=0.422 Sum_probs=207.0
Q ss_pred hhhhcccccceecccCceeEEeecccCCC-----cCCCCCCCCcEEEEEEccccch-hhHHHHHHHHHHHhccCCCcccc
Q 018785 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNT-----FAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLVK 91 (350)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~-----~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~ 91 (350)
...++|++.+.||+|+||.||+++..+.. ...........||+|.+..... .....+.+|++++++++|||+++
T Consensus 2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~ 81 (295)
T cd05097 2 FPRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIR 81 (295)
T ss_pred CchHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCe
Confidence 34679999999999999999998654321 0001223345689999876532 23456889999999999999999
Q ss_pred eeeEEeecCceEEEEEcCCCCChhhHHhhcC----------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCc
Q 018785 92 LIGYCSESDNRLLVYEFMPKGSLENHLFRKG----------VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASN 161 (350)
Q Consensus 92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~N 161 (350)
+++++...+..++||||+.+++|.+++.... ...++...+..++.|++.||+||| +.|++|+||+|+|
T Consensus 82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH--~~~i~H~dlkp~N 159 (295)
T cd05097 82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA--SLNFVHRDLATRN 159 (295)
T ss_pred EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH--hcCeeccccChhh
Confidence 9999999999999999999999999986542 123678889999999999999999 9999999999999
Q ss_pred eEEcCCCcEEEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh--CCCCCcccccC
Q 018785 162 VLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS--GRRALDEDRGG 239 (350)
Q Consensus 162 ili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~--g~~pf~~~~~~ 239 (350)
|+++.++.++|+|||++................++..|+|||.+.+..++.++|+||||+++|+|++ +..||......
T Consensus 160 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~ 239 (295)
T cd05097 160 CLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE 239 (295)
T ss_pred EEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH
Confidence 9999999999999999875433222222222344667999999988889999999999999999988 56677654332
Q ss_pred cchhhhhhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018785 240 LAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 305 (350)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~ 305 (350)
........ .............+..+++.+.+|+.+||+.||++|||+.++++.|.
T Consensus 240 ~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 240 QVIENTGE-----------FFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HHHHHHHH-----------hhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 21111111 00000011111123346789999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=311.41 Aligned_cols=271 Identities=22% Similarity=0.355 Sum_probs=200.0
Q ss_pred hhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceeeEEee
Q 018785 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (350)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (350)
..++|++.++||+|+||.||+| .+..+++.||||.+.... ....+|+.+++.++||||+++++++..
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~---------~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~ 130 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEA---------ICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYT 130 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEE---------EECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEee
Confidence 4568999999999999999999 556678899999875432 223468999999999999999887643
Q ss_pred c--------CceEEEEEcCCCCChhhHHhhc--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCC
Q 018785 99 S--------DNRLLVYEFMPKGSLENHLFRK--GVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNF 168 (350)
Q Consensus 99 ~--------~~~~lv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~ 168 (350)
. ..+++||||+. ++|.+++... ....+++..++.++.|++.||.||| +.|++||||||+||+++.++
T Consensus 131 ~~~~~~~~~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH--~~~IiHrDLKp~NILl~~~~ 207 (440)
T PTZ00036 131 ECFKKNEKNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH--SKFICHRDLKPQNLLIDPNT 207 (440)
T ss_pred cccccCCCceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH--HCCEecCCcCHHHEEEcCCC
Confidence 2 24678999995 5888777532 3347899999999999999999999 99999999999999998665
Q ss_pred -cEEEccccccccCCCCCCCcccccccCCCcccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhh
Q 018785 169 -NAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLV 246 (350)
Q Consensus 169 -~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~ 246 (350)
.++|+|||++........ .....+++.|+|||++.+. .++.++|||||||++|+|++|..||.+.........+.
T Consensus 208 ~~vkL~DFGla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~ 284 (440)
T PTZ00036 208 HTLKLCDFGSAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRII 284 (440)
T ss_pred CceeeeccccchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 699999999975433221 1224578899999988764 68999999999999999999999998765433322222
Q ss_pred hh-cchhhhhhHHHHH-hhh--------cccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHhhh
Q 018785 247 EW-ADPFLRDSRRVLR-IMD--------TRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS--LEQLH 308 (350)
Q Consensus 247 ~~-~~~~~~~~~~~~~-~~~--------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~--L~~~~ 308 (350)
.. ..+.......... ... .......+...++++.+||.+||..||.+|||+.++++| +..+.
T Consensus 285 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~ 358 (440)
T PTZ00036 285 QVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLR 358 (440)
T ss_pred HHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhh
Confidence 21 1111111000000 000 000011223456789999999999999999999999977 44443
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=292.81 Aligned_cols=254 Identities=26% Similarity=0.378 Sum_probs=206.7
Q ss_pred hhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceeeEEeec
Q 018785 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (350)
Q Consensus 20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (350)
.++|++.+.||.|++|.||+| ....++..+++|.+..........+..|+.++++++||||+++++.+..+
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~---------~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 74 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKA---------QHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYE 74 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEE---------EEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecC
Confidence 468999999999999999999 44556889999998776655667788999999999999999999999999
Q ss_pred CceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccccc
Q 018785 100 DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR 179 (350)
Q Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~ 179 (350)
...++||||+++++|.+++.... ..+++..+..++.|++.+|.||| +.|++|+||+|+||+++.++.++|+|||.+.
T Consensus 75 ~~~~lv~e~~~~~~L~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh--~~~i~h~dl~p~nili~~~~~~~l~d~g~~~ 151 (280)
T cd06611 75 NKLWILIEFCDGGALDSIMLELE-RGLTEPQIRYVCRQMLEALNFLH--SHKVIHRDLKAGNILLTLDGDVKLADFGVSA 151 (280)
T ss_pred CeEEEEeeccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCChhhEEECCCCCEEEccCccch
Confidence 99999999999999999887643 36999999999999999999999 9999999999999999999999999999886
Q ss_pred cCCCCCCCcccccccCCCcccCccccc-----cCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhh
Q 018785 180 DGPTGDNTHVSTRIVGTRGYAAPEYVA-----TGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLR 254 (350)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~ 254 (350)
...... .......++..|++||.+. +..++.++|+||||+++|+|++|..||...........+...
T Consensus 152 ~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~------ 223 (280)
T cd06611 152 KNKSTL--QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKS------ 223 (280)
T ss_pred hhcccc--cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcC------
Confidence 532221 1122345788899999874 345778999999999999999999999764322111111100
Q ss_pred hhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 255 DSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
.......+..++.++.+++.+||+.+|.+||++.+++++
T Consensus 224 ----------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 224 ----------EPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred ----------CCCCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 000111234567789999999999999999999999987
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-40 Score=285.37 Aligned_cols=251 Identities=24% Similarity=0.348 Sum_probs=204.0
Q ss_pred cccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch--hhHHHHHHHHHHHhccCCCcccceeeEEee-
Q 018785 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLRHENLVKLIGYCSE- 98 (350)
Q Consensus 22 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~- 98 (350)
+|++.+.||.|++|.||++ .+..+++.|++|.+..... .....+.+|+.+++.++|+|++++++.+..
T Consensus 1 ~y~~~~~lg~g~~~~v~~~---------~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLV---------RHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGE 71 (257)
T ss_pred CceEEEEecCCCCeEEEEE---------EEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCC
Confidence 5899999999999999999 5566688999999865432 334567889999999999999999988764
Q ss_pred cCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcccccc
Q 018785 99 SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 178 (350)
Q Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~ 178 (350)
+...++++|++++++|.+++.......+++.++..++.|++.++++|| +.|++|+||+|+||+++.++.++|+|||++
T Consensus 72 ~~~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH--~~~i~H~di~p~nil~~~~~~~~l~df~~~ 149 (257)
T cd08223 72 DGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH--EKHILHRDLKTQNVFLTRTNIIKVGDLGIA 149 (257)
T ss_pred CCEEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--hCCeeccCCCchhEEEecCCcEEEecccce
Confidence 446789999999999999998755557899999999999999999999 999999999999999999999999999998
Q ss_pred ccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhHH
Q 018785 179 RDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRR 258 (350)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (350)
....... .......+++.|+|||.+.+..++.++|+||+|+++++|++|+.||...+.....
T Consensus 150 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~---------------- 211 (257)
T cd08223 150 RVLENQC--DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLV---------------- 211 (257)
T ss_pred EEecccC--CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHH----------------
Confidence 7542221 1222345788899999999999999999999999999999999998653321110
Q ss_pred HHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 259 VLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
..... ......+..+++.+.+++.+||+.+|.+|||+.+++++
T Consensus 212 -~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 212 -YRIIE-GKLPPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred -HHHHh-cCCCCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 01111 11112345677899999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=284.06 Aligned_cols=251 Identities=31% Similarity=0.452 Sum_probs=203.5
Q ss_pred hhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceeeEE-e
Q 018785 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYC-S 97 (350)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~ 97 (350)
...+|++.+.||+|++|.||++... |..+++|.+.... ....+.+|+.+++.++|++++++++++ .
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~-----------~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 70 (256)
T cd05082 4 NMKELKLLQTIGKGEFGDVMLGDYR-----------GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVE 70 (256)
T ss_pred cHHhCeeeeeecccCCCeEEEEEEc-----------CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEc
Confidence 4568999999999999999998432 6678999886543 345688899999999999999999875 4
Q ss_pred ecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccc
Q 018785 98 ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL 177 (350)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~ 177 (350)
.++..++++||+++++|.+++.......+++..+..++.|++.||+||| ++|++|+||+|+||+++.++.++|+|||+
T Consensus 71 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dlkp~nil~~~~~~~kl~dfg~ 148 (256)
T cd05082 71 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE--ANNFVHRDLAARNVLVSEDNVAKVSDFGL 148 (256)
T ss_pred CCCceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--hCCEeccccchheEEEcCCCcEEecCCcc
Confidence 5567899999999999999998766556889999999999999999999 99999999999999999999999999999
Q ss_pred cccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccccCcchhhhhhhcchhhhhh
Q 018785 178 ARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDS 256 (350)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 256 (350)
+........ ....+..|+|||.+.+..++.++|+|||||++|+|++ |+.||.........
T Consensus 149 ~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~-------------- 209 (256)
T cd05082 149 TKEASSTQD-----TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV-------------- 209 (256)
T ss_pred ceeccccCC-----CCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHH--------------
Confidence 875322211 1223457999999988889999999999999999997 88888643321111
Q ss_pred HHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 018785 257 RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 307 (350)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~ 307 (350)
..+........+..+++.+.+++.+||+.+|++|||+.++++.|.++
T Consensus 210 ----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 210 ----PRVEKGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred ----HHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 11111112233456778999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=294.55 Aligned_cols=252 Identities=23% Similarity=0.372 Sum_probs=207.5
Q ss_pred hhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceeeEEeec
Q 018785 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (350)
Q Consensus 20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (350)
..+|++.+.||.|++|.||+| .+..+++.|++|.+..........+.+|+.+++.++|||++++++.+..+
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~ 88 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTA---------IDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG 88 (297)
T ss_pred hhhceeeeeeccCCCeEEEEE---------EECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 479999999999999999999 55667889999998766555556788899999999999999999999999
Q ss_pred CceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccccc
Q 018785 100 DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR 179 (350)
Q Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~ 179 (350)
+..++||||+++++|.+++... .++...+..++.|++.+|.+|| +.|++|+||+|+||+++.++.++|+|||.+.
T Consensus 89 ~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~l~~~L~~LH--~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~ 163 (297)
T cd06656 89 DELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALDFLH--SNQVIHRDIKSDNILLGMDGSVKLTDFGFCA 163 (297)
T ss_pred CEEEEeecccCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEECCCCCEEECcCccce
Confidence 9999999999999999998654 5788899999999999999999 8999999999999999999999999999986
Q ss_pred cCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhHHH
Q 018785 180 DGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRV 259 (350)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (350)
....... ......+++.|++||.+.+..++.++|+||+|+++|++++|..||..............
T Consensus 164 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~------------ 229 (297)
T cd06656 164 QITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT------------ 229 (297)
T ss_pred EccCCcc--CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeecc------------
Confidence 5322221 11224577889999999888899999999999999999999999965432111110000
Q ss_pred HHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 260 LRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
........+..++..+.+++.+||..||.+||++.+++++
T Consensus 230 ----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 230 ----NGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred ----CCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000111234567789999999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=293.83 Aligned_cols=252 Identities=25% Similarity=0.395 Sum_probs=207.8
Q ss_pred hhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceeeEEeec
Q 018785 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (350)
Q Consensus 20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (350)
..+|++.+.||.|++|.||+| .+..+++.|++|.+..........+.+|+..++.++|||++++++.+..+
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~---------~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 88 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTA---------IDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVG 88 (296)
T ss_pred cceEEEEEEEecCCCeEEEEE---------EEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecC
Confidence 357999999999999999999 66667899999998766555567788999999999999999999999999
Q ss_pred CceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccccc
Q 018785 100 DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR 179 (350)
Q Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~ 179 (350)
+..++|+||+.+++|.+++... .+++.++..++.|++.|+++|| +.|++|+||+|+||+++.++.++|+|||++.
T Consensus 89 ~~~~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH--~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~ 163 (296)
T cd06655 89 DELFVVMEYLAGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLH--ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCA 163 (296)
T ss_pred ceEEEEEEecCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEECCCCCEEEccCccch
Confidence 9999999999999999988654 5899999999999999999999 9999999999999999999999999999886
Q ss_pred cCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhHHH
Q 018785 180 DGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRV 259 (350)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (350)
....... ......++..|+|||.+.+..++.++|+||||+++|+|++|..||...........+..
T Consensus 164 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~------------ 229 (296)
T cd06655 164 QITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT------------ 229 (296)
T ss_pred hcccccc--cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh------------
Confidence 5332221 11224577889999999888899999999999999999999999976442111110000
Q ss_pred HHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 260 LRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
........+..+++.+.+++.+||..||.+||++.+++++
T Consensus 230 ----~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 230 ----NGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred ----cCCcccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 0011112234567889999999999999999999999965
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=302.43 Aligned_cols=266 Identities=23% Similarity=0.303 Sum_probs=201.7
Q ss_pred hhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccc--hhhHHHHHHHHHHHhccCCCcccceeeEE
Q 018785 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES--FQGHKEWLTEVIYLGQLRHENLVKLIGYC 96 (350)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (350)
..++|++.+.||+|+||.||++ .+..+++.||||.+.... ......+.+|+.+++.++||||+++++++
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~ 92 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAA---------YDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVF 92 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEE---------EECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceee
Confidence 3579999999999999999999 566678899999987543 23345677899999999999999999987
Q ss_pred eec------CceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcE
Q 018785 97 SES------DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNA 170 (350)
Q Consensus 97 ~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~ 170 (350)
... ...|+||||+. ++|.+++.. .++...+..++.|++.||.||| ++|++|+||||+||+++.++.+
T Consensus 93 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH--~~~ivH~Dlkp~NIll~~~~~~ 165 (364)
T cd07875 93 TPQKSLEEFQDVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLH--SAGIIHRDLKPSNIVVKSDCTL 165 (364)
T ss_pred cccccccccCeEEEEEeCCC-CCHHHHHHh----cCCHHHHHHHHHHHHHHHHHHh--hCCeecCCCCHHHEEECCCCcE
Confidence 543 35799999995 578777743 4788899999999999999999 9999999999999999999999
Q ss_pred EEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcc
Q 018785 171 KLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD 250 (350)
Q Consensus 171 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~ 250 (350)
+|+|||++...... .......++..|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+.....
T Consensus 166 kL~DfG~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 242 (364)
T cd07875 166 KILDFGLARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLG 242 (364)
T ss_pred EEEeCCCccccCCC---CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 99999999753221 112234678899999999999999999999999999999999999976654333322222111
Q ss_pred -hhh---hhhHHH-HHhhhcc------------------cCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 251 -PFL---RDSRRV-LRIMDTR------------------LGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 251 -~~~---~~~~~~-~~~~~~~------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
+.. ...... ....... .........+..+.+||.+||+.||.+|||+.++++|
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 243 TPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred CCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 100 000000 0000000 0001111234678999999999999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=292.12 Aligned_cols=269 Identities=26% Similarity=0.314 Sum_probs=207.1
Q ss_pred hcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh-hHHHHHHHHHHHhccCCCcccceeeEEeec
Q 018785 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ-GHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (350)
Q Consensus 21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (350)
++|++.+.||+|+||.||++ .+..++..+++|.+...... ....+.+|++++++++||||+++++++..+
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~---------~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 71 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKV---------LHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSD 71 (308)
T ss_pred CCceEEeeccCCCCeEEEEE---------EEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC
Confidence 47999999999999999999 56667889999988755322 335578899999999999999999999999
Q ss_pred CceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCC-CCeeeCCCCCCceEEcCCCcEEEcccccc
Q 018785 100 DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLD-ANVIYRDLKASNVLLDSNFNAKLSDFGLA 178 (350)
Q Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~-~~i~H~di~~~Nili~~~~~~~l~Dfg~~ 178 (350)
+..++||||+++++|.+++.... .+++..+..++.|+++||.||| + .+++|+||+|+||+++.++.++|+|||++
T Consensus 72 ~~~~lv~ey~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH--~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~ 147 (308)
T cd06615 72 GEISICMEHMDGGSLDQVLKKAG--RIPENILGKISIAVLRGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVS 147 (308)
T ss_pred CEEEEEeeccCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--hhCCEEECCCChHHEEEecCCcEEEccCCCc
Confidence 99999999999999999997664 6899999999999999999999 6 69999999999999999999999999988
Q ss_pred ccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchh------
Q 018785 179 RDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPF------ 252 (350)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~------ 252 (350)
....... .....++..|+|||.+.+..++.++|+||||+++|+|++|..||...........+.......
T Consensus 148 ~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (308)
T cd06615 148 GQLIDSM----ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESH 223 (308)
T ss_pred ccccccc----cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCc
Confidence 6432211 122457888999999988889999999999999999999999986544222111111000000
Q ss_pred -------------hhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 018785 253 -------------LRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQ 306 (350)
Q Consensus 253 -------------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 306 (350)
......................++.++.+++.+||..+|++|||+.+++++-.-
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~ 290 (308)
T cd06615 224 RPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFI 290 (308)
T ss_pred ccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhh
Confidence 000000111111111111112367789999999999999999999999988543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=283.35 Aligned_cols=253 Identities=32% Similarity=0.508 Sum_probs=201.7
Q ss_pred ceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh-hHHHHHHHHHHHhccCCCcccceeeEEeecCceEEE
Q 018785 27 YLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ-GHKEWLTEVIYLGQLRHENLVKLIGYCSESDNRLLV 105 (350)
Q Consensus 27 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 105 (350)
++||+|+||.||+|++.. ...++..+++|.+...... ....+..|+..++.+.|||++++++++. .+..++|
T Consensus 1 ~~ig~G~~g~v~~~~~~~------~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v 73 (257)
T cd05060 1 KELGHGNFGSVVKGVYLM------KSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLV 73 (257)
T ss_pred CccCccCceeEEEeEeec------cCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEE
Confidence 479999999999996542 2224578999998766542 3456888999999999999999999876 4568999
Q ss_pred EEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccccccCCCCC
Q 018785 106 YEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGD 185 (350)
Q Consensus 106 ~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~~~~~~~ 185 (350)
|||+.+++|.+++.... .+++..+..++.|++.||++|| ..+++|+||+|+||+++.++.++|+|||.+.......
T Consensus 74 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh--~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~ 149 (257)
T cd05060 74 MELAPLGPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLE--SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGS 149 (257)
T ss_pred EEeCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHh--hcCeeccCcccceEEEcCCCcEEeccccccceeecCC
Confidence 99999999999998765 6899999999999999999999 9999999999999999999999999999987653332
Q ss_pred CCcc-cccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccccCcchhhhhhhcchhhhhhHHHHHhh
Q 018785 186 NTHV-STRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIM 263 (350)
Q Consensus 186 ~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (350)
.... .....++..|+|||.+.+..++.++|+||||+++|+|++ |..||........... +
T Consensus 150 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~------------------~ 211 (257)
T cd05060 150 DYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAM------------------L 211 (257)
T ss_pred cccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHH------------------H
Confidence 2111 111223456999999988899999999999999999998 9999865443211111 1
Q ss_pred hcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 018785 264 DTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLH 308 (350)
Q Consensus 264 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 308 (350)
........+..++..+.+++.+||..+|.+||++.++++.|+.+.
T Consensus 212 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 212 ESGERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred HcCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 111112334456788999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=286.53 Aligned_cols=251 Identities=24% Similarity=0.448 Sum_probs=204.2
Q ss_pred cccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh---------hHHHHHHHHHHHhccCCCcccce
Q 018785 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ---------GHKEWLTEVIYLGQLRHENLVKL 92 (350)
Q Consensus 22 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---------~~~~~~~e~~~l~~l~h~~i~~~ 92 (350)
+|.+.+.||.|++|.||+| .+..++..+++|.+...... ....+.+|+.+++.++||||+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~a---------~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 71 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLG---------MNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQY 71 (267)
T ss_pred CccccceeecCCCeEEEEE---------EecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeE
Confidence 5889999999999999999 55566889999988654322 12457789999999999999999
Q ss_pred eeEEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEE
Q 018785 93 IGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKL 172 (350)
Q Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l 172 (350)
++++...+..++++||+++++|.+++.... .++...+..++.|++.||.+|| +.|++|+||+|+||+++.++.++|
T Consensus 72 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~l~~~l~~lH--~~~ivH~di~p~nil~~~~~~~~l 147 (267)
T cd06628 72 LGSSLDADHLNIFLEYVPGGSVAALLNNYG--AFEETLVRNFVRQILKGLNYLH--NRGIIHRDIKGANILVDNKGGIKI 147 (267)
T ss_pred EEEEEeCCccEEEEEecCCCCHHHHHHhcc--CccHHHHHHHHHHHHHHHHHHH--hcCcccccCCHHHEEEcCCCCEEe
Confidence 999999999999999999999999997664 6889999999999999999999 999999999999999999999999
Q ss_pred ccccccccCCCCCCC----cccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhh
Q 018785 173 SDFGLARDGPTGDNT----HVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEW 248 (350)
Q Consensus 173 ~Dfg~~~~~~~~~~~----~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~ 248 (350)
+|||.+......... .......++..|+|||.+.+..++.++|+||||+++|+|++|+.||..........
T Consensus 148 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~----- 222 (267)
T cd06628 148 SDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIF----- 222 (267)
T ss_pred cccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHH-----
Confidence 999998765322111 11112346788999999988889999999999999999999999997543211100
Q ss_pred cchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 249 ADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
. .........+..++..+.++|.+||+.||.+||++.+++++
T Consensus 223 ------------~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 223 ------------K-IGENASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred ------------H-HhccCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 0 01112223445677899999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=285.34 Aligned_cols=256 Identities=30% Similarity=0.455 Sum_probs=205.1
Q ss_pred hhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceeeEEe
Q 018785 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (350)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (350)
+..++|++.++||+|++|.||+|.+. .+..+++|.+..... ....+.+|+.+++.++|++++++++++.
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~----------~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~ 71 (260)
T cd05070 3 IPRESLQLIKKLGNGQFGEVWMGTWN----------GNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS 71 (260)
T ss_pred CchHHhhhhheeccccCceEEEEEec----------CCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC
Confidence 45678999999999999999999432 245689998876543 3456889999999999999999999875
Q ss_pred ecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccc
Q 018785 98 ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL 177 (350)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~ 177 (350)
.+..+++|||+.+++|.+++.......++...+..++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||.
T Consensus 72 -~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH--~~~i~H~di~p~Nili~~~~~~~l~dfg~ 148 (260)
T cd05070 72 -EEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE--RMNYIHRDLRSANILVGDGLVCKIADFGL 148 (260)
T ss_pred -CCCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCccceEEEeCCceEEeCCcee
Confidence 456899999999999999997665556899999999999999999999 89999999999999999999999999999
Q ss_pred cccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccccCcchhhhhhhcchhhhhh
Q 018785 178 ARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDS 256 (350)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 256 (350)
+......... ......++..|+|||...+..++.++|+||||+++|+|++ |..||.+.........
T Consensus 149 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~------------ 215 (260)
T cd05070 149 ARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQ------------ 215 (260)
T ss_pred eeeccCcccc-cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH------------
Confidence 9754322211 1111234456999999988889999999999999999999 8888865432111111
Q ss_pred HHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 018785 257 RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQ 306 (350)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 306 (350)
+........+...+..+.+++.+||..+|.+|||+.++++.|++
T Consensus 216 ------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 216 ------VERGYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred ------HHcCCCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 11111223345667889999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=288.80 Aligned_cols=257 Identities=25% Similarity=0.346 Sum_probs=205.3
Q ss_pred hhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceeeEEe
Q 018785 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (350)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (350)
...++|.+.+.||+|++|.||+| .+..++..|++|.+..........+.+|+..++.++||||+++++.+.
T Consensus 6 ~~~~~~~~~~~lg~g~~~~v~~~---------~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~ 76 (267)
T cd06645 6 NPQEDFELIQRIGSGTYGDVYKA---------RNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76 (267)
T ss_pred CcHHHHHHHHHhCCCCCeEEEEE---------EEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEE
Confidence 34579999999999999999999 566678899999987665455566788999999999999999999999
Q ss_pred ecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccc
Q 018785 98 ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL 177 (350)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~ 177 (350)
..+..++||||+++++|.+++.... .+++.++..++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||+
T Consensus 77 ~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dlkp~nili~~~~~~~l~dfg~ 152 (267)
T cd06645 77 RRDKLWICMEFCGGGSLQDIYHVTG--PLSESQIAYVSRETLQGLYYLH--SKGKMHRDIKGANILLTDNGHVKLADFGV 152 (267)
T ss_pred eCCEEEEEEeccCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEECCCCCEEECccee
Confidence 9999999999999999999987665 6899999999999999999999 89999999999999999999999999999
Q ss_pred cccCCCCCCCcccccccCCCcccCccccc---cCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhh
Q 018785 178 ARDGPTGDNTHVSTRIVGTRGYAAPEYVA---TGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLR 254 (350)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~ 254 (350)
+...... ........++..|+|||.+. ...++.++|+|||||++|+|++|..||...............
T Consensus 153 ~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~------ 224 (267)
T cd06645 153 SAQITAT--IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKS------ 224 (267)
T ss_pred eeEccCc--ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhcc------
Confidence 8654221 11122346788999999874 456888999999999999999999998644321111100000
Q ss_pred hhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 255 DSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
. ... ........++..+.+++.+||..+|++|||++++++|
T Consensus 225 ------~-~~~-~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 225 ------N-FQP-PKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred ------C-CCC-CcccccCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 0 000 0000011356789999999999999999999999865
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=303.95 Aligned_cols=254 Identities=24% Similarity=0.341 Sum_probs=202.5
Q ss_pred hcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch---hhHHHHHHHHHHHhccCCCcccceeeEEe
Q 018785 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (350)
Q Consensus 21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (350)
++|++.+.||+|+||.||++ .+..+++.||+|++..... .....+..|..++..++||+|+++++.+.
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~---------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~ 71 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLV---------QKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQ 71 (360)
T ss_pred CCceEEEEEeeCCCEEEEEE---------EECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 47899999999999999999 5666789999999875432 23456788999999999999999999999
Q ss_pred ecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccc
Q 018785 98 ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL 177 (350)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~ 177 (350)
+.+..++||||+++++|.+++.... .+++..+..++.|++.||.||| +.|++|+||||+||+++.++.++|+|||+
T Consensus 72 ~~~~~~lv~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~~L~~lH--~~givHrDLkp~NIli~~~~~vkL~DfG~ 147 (360)
T cd05627 72 DKRNLYLIMEFLPGGDMMTLLMKKD--TLSEEATQFYIAETVLAIDAIH--QLGFIHRDIKPDNLLLDAKGHVKLSDFGL 147 (360)
T ss_pred cCCEEEEEEeCCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--HCCeEccCCCHHHEEECCCCCEEEeeccC
Confidence 9999999999999999999997664 6899999999999999999999 99999999999999999999999999999
Q ss_pred cccCCCCCCC---------------------------------cccccccCCCcccCccccccCCCCCccchhhHHHHHH
Q 018785 178 ARDGPTGDNT---------------------------------HVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLL 224 (350)
Q Consensus 178 ~~~~~~~~~~---------------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~ 224 (350)
+......... .......|++.|+|||++.+..++.++|+|||||++|
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvily 227 (360)
T cd05627 148 CTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMY 227 (360)
T ss_pred CcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceee
Confidence 8643221100 0011246899999999999999999999999999999
Q ss_pred HHHhCCCCCcccccCcchhhhhhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCC---HHHHH
Q 018785 225 ELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPS---MVDVL 301 (350)
Q Consensus 225 ~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps---~~~ll 301 (350)
+|++|..||...........+..+. ..........+++++.+||.+|+. ||.+|++ +++++
T Consensus 228 el~tG~~Pf~~~~~~~~~~~i~~~~---------------~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~ 291 (360)
T cd05627 228 EMLIGYPPFCSETPQETYRKVMNWK---------------ETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIK 291 (360)
T ss_pred ecccCCCCCCCCCHHHHHHHHHcCC---------------CceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHh
Confidence 9999999997654322221111100 000001112357789999999774 9999984 78888
Q ss_pred HH
Q 018785 302 TS 303 (350)
Q Consensus 302 ~~ 303 (350)
+|
T Consensus 292 ~h 293 (360)
T cd05627 292 SH 293 (360)
T ss_pred cC
Confidence 77
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=300.97 Aligned_cols=266 Identities=24% Similarity=0.311 Sum_probs=200.9
Q ss_pred hhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch--hhHHHHHHHHHHHhccCCCcccceeeEE
Q 018785 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLRHENLVKLIGYC 96 (350)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (350)
..++|++.+.||+|+||.||++ .+..+++.||+|.+..... .....+.+|+.+++.++||||+++++++
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 85 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAA---------YDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVF 85 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEE---------EecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeee
Confidence 4579999999999999999999 6666789999999875432 2345677899999999999999999988
Q ss_pred eec------CceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcE
Q 018785 97 SES------DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNA 170 (350)
Q Consensus 97 ~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~ 170 (350)
... ...++||||++ +++.+.+.. .++...+..++.|++.||.||| +.|++|+||||+||+++.++.+
T Consensus 86 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH--~~givHrDikp~Nill~~~~~~ 158 (355)
T cd07874 86 TPQKSLEEFQDVYLVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLH--SAGIIHRDLKPSNIVVKSDCTL 158 (355)
T ss_pred eccccccccceeEEEhhhhc-ccHHHHHhh----cCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCChHHEEECCCCCE
Confidence 643 34689999995 477776643 4788899999999999999999 9999999999999999999999
Q ss_pred EEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhh-hc
Q 018785 171 KLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVE-WA 249 (350)
Q Consensus 171 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~-~~ 249 (350)
+|+|||++...... .......++..|+|||++.+..++.++|+|||||++|+|++|+.||.+.........+.. ..
T Consensus 159 kl~Dfg~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 235 (355)
T cd07874 159 KILDFGLARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLG 235 (355)
T ss_pred EEeeCcccccCCCc---cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 99999999753221 112234678899999999999999999999999999999999999976543222211111 11
Q ss_pred chhhh---hh-HHHHHhhhcc------------------cCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 250 DPFLR---DS-RRVLRIMDTR------------------LGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 250 ~~~~~---~~-~~~~~~~~~~------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
.+... .. .......... .........+..+.+||.+||+.||.+|||+.++++|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 236 TPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred CCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 11000 00 0000000000 0011122345678999999999999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=288.80 Aligned_cols=265 Identities=26% Similarity=0.375 Sum_probs=207.6
Q ss_pred hhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch-hhHHHHHHHHHHHhccCCCcccceeeEE
Q 018785 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLVKLIGYC 96 (350)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (350)
+..++|++.+.||+|+||.||+|+.... ....++..+++|.+..... .....+.+|+.+++.++||||+++++++
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~----~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~ 77 (288)
T cd05050 2 YPRNNIEYVRDIGQGAFGRVFQARAPGL----LPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVC 77 (288)
T ss_pred CChHhceecccccccccccEEEEEEccc----CCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEE
Confidence 3467899999999999999999965321 1234577899998876543 2345688899999999999999999999
Q ss_pred eecCceEEEEEcCCCCChhhHHhhcC--------------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCC
Q 018785 97 SESDNRLLVYEFMPKGSLENHLFRKG--------------------VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRD 156 (350)
Q Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~--------------------~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~d 156 (350)
..+...++++||+.+++|.+++.... ...++...++.++.|++.||++|| +++++|+|
T Consensus 78 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH--~~~i~H~d 155 (288)
T cd05050 78 AVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS--ERKFVHRD 155 (288)
T ss_pred cCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH--hCCeeccc
Confidence 99999999999999999999996432 124678889999999999999999 99999999
Q ss_pred CCCCceEEcCCCcEEEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcc
Q 018785 157 LKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDE 235 (350)
Q Consensus 157 i~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~ 235 (350)
|+|.||+++.++.++|+|||.+.................+..|+|||.+.+..++.++|+|||||++|+|++ |..||.+
T Consensus 156 l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~ 235 (288)
T cd05050 156 LATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYG 235 (288)
T ss_pred ccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999875433222111222234556999999988899999999999999999997 7778864
Q ss_pred cccCcchhhhhhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 018785 236 DRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQ 306 (350)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 306 (350)
....... ..+........+..++.++.+++.+||+.+|.+|||+.++++.|++
T Consensus 236 ~~~~~~~------------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 236 MAHEEVI------------------YYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred CCHHHHH------------------HHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 4321111 1111111112234567889999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=288.56 Aligned_cols=252 Identities=24% Similarity=0.348 Sum_probs=201.1
Q ss_pred hcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccc-hhhHHHHHHHHHHHhccCCCcccceeeEEeec
Q 018785 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES-FQGHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (350)
Q Consensus 21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (350)
++|++.++||+|++|.||+| .+..++..|++|.+.... ......+.+|+.++++++||||+++++.+...
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~---------~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 71 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKA---------YHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVE 71 (279)
T ss_pred CcchheeeeccCCCeEEEEE---------EEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEEC
Confidence 47899999999999999999 566678999999986543 23345688899999999999999999999999
Q ss_pred CceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccccc
Q 018785 100 DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR 179 (350)
Q Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~ 179 (350)
+..++||||+++++|..+. .+++..+..++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||++.
T Consensus 72 ~~~~lv~e~~~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~ 143 (279)
T cd06619 72 NRISICTEFMDGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLW--SLKILHRDVKPSNMLVNTRGQVKLCDFGVST 143 (279)
T ss_pred CEEEEEEecCCCCChHHhh------cCCHHHHHHHHHHHHHHHHHHH--HCCEeeCCCCHHHEEECCCCCEEEeeCCcce
Confidence 9999999999999986542 5788899999999999999999 9999999999999999999999999999987
Q ss_pred cCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhHHH
Q 018785 180 DGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRV 259 (350)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (350)
...... .....++..|+|||.+.+..++.++|+||||+++|+|++|..||............. ...
T Consensus 144 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~----------~~~ 209 (279)
T cd06619 144 QLVNSI----AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPL----------QLL 209 (279)
T ss_pred eccccc----ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchH----------HHH
Confidence 542221 222467889999999998899999999999999999999999996533211110000 000
Q ss_pred HHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 260 LRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
................++++.+++.+||+.+|.+||++++++++
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 210 QCIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred HHHhccCCCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 00011111111123466789999999999999999999999976
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=285.03 Aligned_cols=252 Identities=28% Similarity=0.420 Sum_probs=202.1
Q ss_pred hhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceeeEEeec
Q 018785 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (350)
Q Consensus 20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (350)
..+|++.+.||+|++|.||+|+++ .+..+++|.+..... ....+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~~~~~~lg~G~~~~v~~~~~~----------~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (256)
T cd05059 3 PSELTFLKELGSGQFGVVHLGKWR----------GKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQ 71 (256)
T ss_pred hHHcchhhhhccCCCceEEEeEec----------CCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCC
Confidence 467999999999999999999432 245789998865432 335677899999999999999999999999
Q ss_pred CceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccccc
Q 018785 100 DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR 179 (350)
Q Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~ 179 (350)
+..++|||++++++|.+++..+.. .+++..+..++.|++.||+||| +.|++|+||+|+||+++.++.++|+|||.+.
T Consensus 72 ~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH--~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~ 148 (256)
T cd05059 72 RPIFIVTEYMANGCLLNYLRERKG-KLGTEWLLDMCSDVCEAMEYLE--SNGFIHRDLAARNCLVGEDNVVKVSDFGLAR 148 (256)
T ss_pred CceEEEEecCCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHH--HCCcccccccHhhEEECCCCcEEECCcccce
Confidence 999999999999999999976543 6899999999999999999999 9999999999999999999999999999987
Q ss_pred cCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccccCcchhhhhhhcchhhhhhHH
Q 018785 180 DGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRR 258 (350)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (350)
........ ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||...........
T Consensus 149 ~~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~-------------- 213 (256)
T cd05059 149 YVLDDQYT-SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVES-------------- 213 (256)
T ss_pred eccccccc-ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHH--------------
Confidence 54321111 1111223346999999988899999999999999999998 7888865432211111
Q ss_pred HHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018785 259 VLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL 304 (350)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 304 (350)
+........+..++..+.+++.+||..+|++|||+.++++.|
T Consensus 214 ----~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 214 ----VSAGYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred ----HHcCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 111111223345788999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=286.18 Aligned_cols=258 Identities=28% Similarity=0.436 Sum_probs=198.7
Q ss_pred ccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccc--hhhHHHHHHHHHHHhccCCCcccceeeEEeec-
Q 018785 23 FCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES--FQGHKEWLTEVIYLGQLRHENLVKLIGYCSES- 99 (350)
Q Consensus 23 y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~- 99 (350)
|.+.+.||+|+||.||+|++... .....+|+|.+.... ......+..|+..++.++||||+++++++...
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~-------~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 73 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQD-------DSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTV 73 (272)
T ss_pred CccccccCcccCceEEEeEEccC-------CCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCC
Confidence 46789999999999999965321 122468999886542 33456788899999999999999999876432
Q ss_pred -----CceEEEEEcCCCCChhhHHhhc----CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcE
Q 018785 100 -----DNRLLVYEFMPKGSLENHLFRK----GVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNA 170 (350)
Q Consensus 100 -----~~~~lv~e~~~~~~L~~~l~~~----~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~ 170 (350)
...++++||+.+++|.+++... ....++...+..++.|++.||.||| +.+++|+||||+||+++.++.+
T Consensus 74 ~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dlkp~Nil~~~~~~~ 151 (272)
T cd05075 74 ESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS--SKSFIHRDLAARNCMLNENMNV 151 (272)
T ss_pred cccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHH--HCCeeccccchhheEEcCCCCE
Confidence 2468999999999999987432 2235889999999999999999999 9999999999999999999999
Q ss_pred EEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccccCcchhhhhhhc
Q 018785 171 KLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWA 249 (350)
Q Consensus 171 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~ 249 (350)
+|+|||++................+++.|++||.+.+..++.++|+||||+++|+|++ |..||...........+
T Consensus 152 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~---- 227 (272)
T cd05075 152 CVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYL---- 227 (272)
T ss_pred EECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH----
Confidence 9999999876433222111122234567999999988899999999999999999999 78888654321111111
Q ss_pred chhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 018785 250 DPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 307 (350)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~ 307 (350)
........+..++..+.+++.+||+.||++|||+.++++.|+++
T Consensus 228 --------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 228 --------------RQGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred --------------HcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11111122345677899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=284.62 Aligned_cols=263 Identities=29% Similarity=0.466 Sum_probs=208.0
Q ss_pred hhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccc-hhhHHHHHHHHHHHhccCCCcccceeeEE
Q 018785 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES-FQGHKEWLTEVIYLGQLRHENLVKLIGYC 96 (350)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (350)
+..++|+..+.||+|++|.||+|+... .......+++|.+.... ......+..|+.+++.++|||++++.+++
T Consensus 2 i~~~~~~~~~~lg~g~~g~vy~~~~~~------~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 75 (268)
T cd05063 2 IHPSHITKQKVIGAGEFGEVFRGILKM------PGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVV 75 (268)
T ss_pred CChHHceEeeEecCCCCccEEEEEEec------CCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEE
Confidence 346789999999999999999995531 11224579999887553 23346688899999999999999999999
Q ss_pred eecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcccc
Q 018785 97 SESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFG 176 (350)
Q Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg 176 (350)
...+..++||||+.+++|.+++.... ..++...+..++.|++.|+.||| +.|++|+||+|+||+++.++.++|+|||
T Consensus 76 ~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH--~~~i~H~dlkp~Nili~~~~~~kl~dfg 152 (268)
T cd05063 76 TKFKPAMIITEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLS--DMNYVHRDLAARNILVNSNLECKVSDFG 152 (268)
T ss_pred ccCCCcEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH--HCCeeccccchhhEEEcCCCcEEECCCc
Confidence 99999999999999999999987643 36899999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCCCCccc-ccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccccCcchhhhhhhcchhhh
Q 018785 177 LARDGPTGDNTHVS-TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLR 254 (350)
Q Consensus 177 ~~~~~~~~~~~~~~-~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~ 254 (350)
++............ .....+..|+|||.+.+..++.++|+||||+++|+|++ |..||.........
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~------------ 220 (268)
T cd05063 153 LSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVM------------ 220 (268)
T ss_pred cceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHH------------
Confidence 98754332221111 11122346999999988889999999999999999997 99998654321111
Q ss_pred hhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 018785 255 DSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 307 (350)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~ 307 (350)
..+........+..++..+.+++.+||+.+|.+||++.++++.|.++
T Consensus 221 ------~~i~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 221 ------KAINDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred ------HHHhcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11111112222345678899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-40 Score=294.04 Aligned_cols=255 Identities=27% Similarity=0.342 Sum_probs=207.7
Q ss_pred hcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh---hHHHHHHHHHHHhccCCCcccceeeEEe
Q 018785 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ---GHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (350)
Q Consensus 21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (350)
++|++.+.||+|++|+||+| .+..+++.+++|.+...... ....+..|+..++.++||+|+++++.+.
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~---------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 71 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLV---------RLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQ 71 (316)
T ss_pred CceEEeeeecCCccEEEEEE---------EEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeee
Confidence 47999999999999999999 55567899999998765433 3456788999999999999999999999
Q ss_pred ecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccc
Q 018785 98 ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL 177 (350)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~ 177 (350)
..+..++||||+.+++|.+++.......+++..+..++.|++.||+||| +.|++|+||+|+||+++.++.++|+|||+
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH--~~~i~H~dlkp~Nili~~~~~~~l~dfg~ 149 (316)
T cd05574 72 TETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH--LLGIVYRDLKPENILLHESGHIMLSDFDL 149 (316)
T ss_pred cCCEEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHH--HCCeeccCCChHHeEEcCCCCEEEeecch
Confidence 9999999999999999999998765567999999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCCCCCc---------------------------ccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCC
Q 018785 178 ARDGPTGDNTH---------------------------VSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR 230 (350)
Q Consensus 178 ~~~~~~~~~~~---------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~ 230 (350)
+.......... ......|+..|+|||.+.+..++.++||||||+++|+|++|.
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~ 229 (316)
T cd05574 150 SKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGT 229 (316)
T ss_pred hhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCC
Confidence 86532221110 011235678899999998888999999999999999999999
Q ss_pred CCCcccccCcchhhhhhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCC----HHHHHHH
Q 018785 231 RALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPS----MVDVLTS 303 (350)
Q Consensus 231 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps----~~~ll~~ 303 (350)
.||.+....... ...............+++.+.+++.+||..||++||| +++++.|
T Consensus 230 ~pf~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 230 TPFKGSNRDETF-----------------SNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred CCCCCCchHHHH-----------------HHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 999765432111 1111111111112236889999999999999999999 8888875
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=284.60 Aligned_cols=261 Identities=28% Similarity=0.430 Sum_probs=207.6
Q ss_pred hhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch-hhHHHHHHHHHHHhccCCCcccceeeEEee
Q 018785 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (350)
Q Consensus 20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (350)
.++|++.+.||+|+||.||+|++. .....+..+++|.+..... .....+..|+..++.++||||+++++++..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~------~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 76 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLK------LPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK 76 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEe------cCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence 578999999999999999999543 1122355799998875432 334578889999999999999999999999
Q ss_pred cCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcccccc
Q 018785 99 SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 178 (350)
Q Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~ 178 (350)
++..++||||+++++|.+++.... ..++..++..++.|++.||.+|| +.|++|+||+|+||+++.++.++|+|||++
T Consensus 77 ~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH--~~~i~h~dlkp~nili~~~~~~~l~dfg~~ 153 (267)
T cd05066 77 SKPVMIVTEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLS--DMGYVHRDLAARNILVNSNLVCKVSDFGLS 153 (267)
T ss_pred CCccEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH--HCCEeehhhchhcEEECCCCeEEeCCCCcc
Confidence 999999999999999999997654 36899999999999999999999 999999999999999999999999999998
Q ss_pred ccCCCCCCCcc-cccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccccCcchhhhhhhcchhhhhh
Q 018785 179 RDGPTGDNTHV-STRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDS 256 (350)
Q Consensus 179 ~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 256 (350)
........... .....++..|++||.+.+..++.++|+||||+++|++++ |..||...........+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~---------- 223 (267)
T cd05066 154 RVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIE---------- 223 (267)
T ss_pred cccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHh----------
Confidence 76433221111 111122457999999988889999999999999999886 999987544221111111
Q ss_pred HHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 018785 257 RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 307 (350)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~ 307 (350)
.......+..+++.+.+++.+|++.+|.+||++.++++.|.++
T Consensus 224 --------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 224 --------EGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred --------CCCcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 1111122345678899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=291.42 Aligned_cols=268 Identities=25% Similarity=0.308 Sum_probs=201.7
Q ss_pred cccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh--hHHHHHHHHHHHhccCCCcccceeeEEeec
Q 018785 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ--GHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (350)
Q Consensus 22 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (350)
+|++.+.||+|++|.||+| .+..++..|++|.+...... ....+.+|+.+++.++|||++++++++..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~---------~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 71 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKG---------RNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQE 71 (285)
T ss_pred CceEeeEecccCceEEEEE---------EECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeC
Confidence 5889999999999999999 55666889999988654322 235678899999999999999999999999
Q ss_pred CceEEEEEcCCCCChhhHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcccccc
Q 018785 100 DNRLLVYEFMPKGSLENHLFRKG-VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 178 (350)
Q Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~-~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~ 178 (350)
+..++||||+. ++|.+++.... ...++...+..++.|+++||.||| +.|++|+||+|+||+++.++.++|+|||++
T Consensus 72 ~~~~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~ 148 (285)
T cd07861 72 SRLYLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH--SRRVLHRDLKPQNLLIDNKGVIKLADFGLA 148 (285)
T ss_pred CeEEEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHH--hCCeeecCCCHHHEEEcCCCcEEECcccce
Confidence 99999999996 68988886543 246899999999999999999999 999999999999999999999999999998
Q ss_pred ccCCCCCCCcccccccCCCcccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhh-hcch---h-
Q 018785 179 RDGPTGDNTHVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVE-WADP---F- 252 (350)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~-~~~~---~- 252 (350)
....... .......+++.|+|||.+.+. .++.++|+||||+++|+|++|+.||.+............ +..+ .
T Consensus 149 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (285)
T cd07861 149 RAFGIPV--RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVW 226 (285)
T ss_pred eecCCCc--ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhh
Confidence 7532221 112223567889999987654 578899999999999999999999976543211111111 0000 0
Q ss_pred --hhhhHHHHHhhhc---ccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 253 --LRDSRRVLRIMDT---RLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 253 --~~~~~~~~~~~~~---~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
............. .........+++++.++|.+||..||.+|||+.+++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 227 PGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred hcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 0000000000000 00001123467889999999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-40 Score=292.38 Aligned_cols=263 Identities=29% Similarity=0.434 Sum_probs=205.7
Q ss_pred hhhhcccccceecccCceeEEeecccCCCcCCCCCCCC--cEEEEEEccccc-hhhHHHHHHHHHHHhcc-CCCccccee
Q 018785 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSG--IVVAIKRLKAES-FQGHKEWLTEVIYLGQL-RHENLVKLI 93 (350)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~--~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~ 93 (350)
+.-++|.+.+.||+|+||.||+|++. .++ ..+++|.+.... ......+.+|+..+.++ +||||++++
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~a~~~---------~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~ 74 (303)
T cd05088 4 LEWNDIKFQDVIGEGNFGQVLKARIK---------KDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74 (303)
T ss_pred cchhhceeeeeecCCCCceEEEEEEc---------cCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEE
Confidence 44578999999999999999999542 234 356777665432 23345678899999999 899999999
Q ss_pred eEEeecCceEEEEEcCCCCChhhHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCC
Q 018785 94 GYCSESDNRLLVYEFMPKGSLENHLFRKG--------------VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKA 159 (350)
Q Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------------~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~ 159 (350)
+++..++..++||||+++++|.+++.... ...++...++.++.|++.||+||| ++|++|+||+|
T Consensus 75 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH--~~gi~H~dlkp 152 (303)
T cd05088 75 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS--QKQFIHRDLAA 152 (303)
T ss_pred EEECCCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH--hCCccccccch
Confidence 99999999999999999999999996542 135789999999999999999999 99999999999
Q ss_pred CceEEcCCCcEEEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCccccc
Q 018785 160 SNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRG 238 (350)
Q Consensus 160 ~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~ 238 (350)
+||+++.++.++|+|||++...... ........+..|+|||.+.+..++.++||||||+++|+|++ |..||.....
T Consensus 153 ~Nili~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 229 (303)
T cd05088 153 RNILVGENYVAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC 229 (303)
T ss_pred heEEecCCCcEEeCccccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCCh
Confidence 9999999999999999998532111 11111223456999999988889999999999999999998 9999865432
Q ss_pred CcchhhhhhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcCCC
Q 018785 239 GLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKD 312 (350)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~ 312 (350)
...... .........+..+++++.+|+.+||+.+|++||+++++++.|..+.....
T Consensus 230 ~~~~~~------------------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~ 285 (303)
T cd05088 230 AELYEK------------------LPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 285 (303)
T ss_pred HHHHHH------------------HhcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence 211111 11111112233467789999999999999999999999999988766643
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=288.82 Aligned_cols=275 Identities=25% Similarity=0.409 Sum_probs=207.4
Q ss_pred hhhcccccceecccCceeEEeecccCCCc------CC-CCCCCCcEEEEEEccccch-hhHHHHHHHHHHHhccCCCccc
Q 018785 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTF------AP-TKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLV 90 (350)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~------~~-~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~ 90 (350)
..++|++.+.||+|+||.||++.+....- .. ....++..+++|.+..... .....+.+|+..++.++|+||+
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 82 (296)
T cd05095 3 PRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNII 82 (296)
T ss_pred ChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcc
Confidence 45789999999999999999986543110 00 1223456789999876532 3346788999999999999999
Q ss_pred ceeeEEeecCceEEEEEcCCCCChhhHHhhcCC---------CCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCc
Q 018785 91 KLIGYCSESDNRLLVYEFMPKGSLENHLFRKGV---------QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASN 161 (350)
Q Consensus 91 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~N 161 (350)
++++++..++..+++|||+.+++|.+++..... ..++...+..++.|++.||+||| +.|++|+||+|+|
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH--~~~i~H~dlkp~N 160 (296)
T cd05095 83 RLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS--SLNFVHRDLATRN 160 (296)
T ss_pred eEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH--HCCeecccCChhe
Confidence 999999999999999999999999999876431 24667789999999999999999 9999999999999
Q ss_pred eEEcCCCcEEEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh--CCCCCcccccC
Q 018785 162 VLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS--GRRALDEDRGG 239 (350)
Q Consensus 162 ili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~--g~~pf~~~~~~ 239 (350)
|+++.++.++|+|||++................++..|++||...+..++.++|+|||||++|+|++ |..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 9999999999999999875433222222222334567999998888889999999999999999998 67788654332
Q ss_pred cchhhhhhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 018785 240 LAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQ 306 (350)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 306 (350)
....... ..............+..+++.+.+|+.+||+.||.+||++.++++.|.+
T Consensus 241 ~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 241 QVIENTG-----------EFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred HHHHHHH-----------HHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 1111100 0000000011112233466889999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=301.24 Aligned_cols=257 Identities=22% Similarity=0.253 Sum_probs=204.3
Q ss_pred hhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch---hhHHHHHHHHHHHhccCCCcccce
Q 018785 16 SKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLVKL 92 (350)
Q Consensus 16 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~ 92 (350)
.....++|++.+.||+|+||.||+| .+..+++.+|+|++..... .....+.+|..+++.++||||+++
T Consensus 38 ~~~~~~~y~i~~~lG~G~fg~Vy~~---------~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~ 108 (371)
T cd05622 38 LRMKAEDYEVVKVIGRGAFGEVQLV---------RHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 108 (371)
T ss_pred cCcchhhcEEEEEEeecCCeEEEEE---------EECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeE
Confidence 3455689999999999999999999 6666789999999865322 223456789999999999999999
Q ss_pred eeEEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEE
Q 018785 93 IGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKL 172 (350)
Q Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l 172 (350)
++.+..++..++||||+++++|.+++... .+++..+..++.||+.||.||| ++|++|+||||+||+++.++.++|
T Consensus 109 ~~~~~~~~~~~lv~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH--~~~ivHrDLkp~NIll~~~~~ikL 183 (371)
T cd05622 109 FYAFQDDRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIH--SMGFIHRDVKPDNMLLDKSGHLKL 183 (371)
T ss_pred EEEEEcCCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHH--HCCEEeCCCCHHHEEECCCCCEEE
Confidence 99999999999999999999999998654 5889999999999999999999 999999999999999999999999
Q ss_pred ccccccccCCCCCCCcccccccCCCcccCccccccC----CCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhh
Q 018785 173 SDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG----HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEW 248 (350)
Q Consensus 173 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~----~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~ 248 (350)
+|||++........ .......|++.|+|||++.+. .++.++|+|||||++|+|++|..||..........
T Consensus 184 ~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~----- 257 (371)
T cd05622 184 ADFGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYS----- 257 (371)
T ss_pred EeCCceeEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHH-----
Confidence 99999975432211 112335689999999998654 37889999999999999999999997644211111
Q ss_pred cchhhhhhHHHHHhhhcc--cCCCCcHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHHH
Q 018785 249 ADPFLRDSRRVLRIMDTR--LGGQYSKKEAQAVAAVVLQCLHMDPKN--RPSMVDVLTSL 304 (350)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~dp~~--Rps~~~ll~~L 304 (350)
.+.... ........++..+.++|.+||..++.+ |++++++++|.
T Consensus 258 ------------~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 258 ------------KIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred ------------HHHcCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 111111 111122357889999999999844433 78999999875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=283.41 Aligned_cols=256 Identities=31% Similarity=0.456 Sum_probs=203.7
Q ss_pred hhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceeeEEe
Q 018785 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (350)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (350)
+..++|++.+.||+|++|.||+|.+. . +..+++|.+..... ....+.+|+.+++.++||+++++++++.
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~---------~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 71 (260)
T cd05069 3 IPRESLRLDVKLGQGCFGEVWMGTWN---------G-TTKVAIKTLKPGTM-MPEAFLQEAQIMKKLRHDKLVPLYAVVS 71 (260)
T ss_pred CChHHeeeeeeecCcCCCeEEEEEEc---------C-CceEEEEEcccCCc-cHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 44578999999999999999999443 2 23589998765432 3456788999999999999999998875
Q ss_pred ecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccc
Q 018785 98 ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL 177 (350)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~ 177 (350)
.+..+++|||+.+++|.+++.......++...+..++.|+++||.||| +.|++|+||+|+||+++.++.++|+|||.
T Consensus 72 -~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH--~~~i~H~dl~~~Nill~~~~~~~l~dfg~ 148 (260)
T cd05069 72 -EEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE--RMNYIHRDLRAANILVGDNLVCKIADFGL 148 (260)
T ss_pred -CCCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCEeecccCcceEEEcCCCeEEECCCcc
Confidence 456899999999999999997765556889999999999999999999 99999999999999999999999999999
Q ss_pred cccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccccCcchhhhhhhcchhhhhh
Q 018785 178 ARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDS 256 (350)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 256 (350)
+......... ......++..|+|||...+..++.++|+||||+++|+|++ |..||.+.........
T Consensus 149 ~~~~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~------------ 215 (260)
T cd05069 149 ARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQ------------ 215 (260)
T ss_pred ceEccCCccc-ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH------------
Confidence 9754322211 1112234567999999988889999999999999999999 8889875432111111
Q ss_pred HHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 018785 257 RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQ 306 (350)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 306 (350)
.........+...+..+.+++.+||..||.+||+++++++.|++
T Consensus 216 ------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 216 ------VERGYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred ------HHcCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 11111122344567899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=283.17 Aligned_cols=252 Identities=23% Similarity=0.345 Sum_probs=208.0
Q ss_pred cccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccc--hhhHHHHHHHHHHHhccCCCcccceeeEEeec
Q 018785 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES--FQGHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (350)
Q Consensus 22 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (350)
+|++.+.||.|++|.||.+ .+..++..+++|.+.... ......+.+|+.++++++|+||+++++++.+.
T Consensus 1 ~y~~~~~ig~g~~g~v~~~---------~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~ 71 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLY---------RRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDD 71 (256)
T ss_pred CceEeeEecccCCceEEEE---------EEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecC
Confidence 6899999999999999998 556678899999876543 23446678999999999999999999999999
Q ss_pred CceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccccc
Q 018785 100 DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR 179 (350)
Q Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~ 179 (350)
+..+++|||+++++|.+++.......++...+..++.|++.+|.||| +.|++|+||+|+||+++.++.++|+|||.+.
T Consensus 72 ~~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh--~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~ 149 (256)
T cd08221 72 NTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH--KAGILHRDIKTLNIFLTKAGLIKLGDFGISK 149 (256)
T ss_pred CeEEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH--hCCccccCCChHhEEEeCCCCEEECcCcceE
Confidence 99999999999999999998764457899999999999999999999 8999999999999999999999999999987
Q ss_pred cCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhHHH
Q 018785 180 DGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRV 259 (350)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (350)
....... ......+++.|.|||.+.+..++.++|+||||+++|+|++|..||..........
T Consensus 150 ~~~~~~~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~---------------- 211 (256)
T cd08221 150 ILGSEYS--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVV---------------- 211 (256)
T ss_pred Ecccccc--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHH----------------
Confidence 5433221 2233457889999999988889999999999999999999999986533211111
Q ss_pred HHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018785 260 LRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL 304 (350)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 304 (350)
..... .....+..++.++.+++.+||..+|.+||++.++++++
T Consensus 212 -~~~~~-~~~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 212 -KIVQG-NYTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred -HHHcC-CCCCCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 11111 11122345678899999999999999999999999763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=287.51 Aligned_cols=249 Identities=27% Similarity=0.361 Sum_probs=205.7
Q ss_pred hcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccc-hhhHHHHHHHHHHHhccCCCcccceeeEEeec
Q 018785 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES-FQGHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (350)
Q Consensus 21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (350)
++|++.+.||.|++|.||+| .+..+++.+++|.+.... ......+.+|+.+++.++|||++++++++.++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~---------~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 71 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKA---------IDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKG 71 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEE---------EECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEEC
Confidence 47999999999999999999 555678999999987654 23345678899999999999999999999999
Q ss_pred CceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccccc
Q 018785 100 DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR 179 (350)
Q Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~ 179 (350)
...++|+|++.+++|.+++... .+++..+..++.|++.|+.+|| +.+++|+||+|+||+++.++.++|+|||++.
T Consensus 72 ~~~~~v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh--~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~ 146 (274)
T cd06609 72 SKLWIIMEYCGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLH--EEGKIHRDIKAANILLSEEGDVKLADFGVSG 146 (274)
T ss_pred CeEEEEEEeeCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHHEEECCCCCEEEcccccce
Confidence 9999999999999999998765 6899999999999999999999 9999999999999999999999999999997
Q ss_pred cCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhHHH
Q 018785 180 DGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRV 259 (350)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (350)
...... .......++..|+|||.+.+..++.++|+||||+++|+|++|..||...........+.
T Consensus 147 ~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~------------- 211 (274)
T cd06609 147 QLTSTM--SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIP------------- 211 (274)
T ss_pred eecccc--cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhh-------------
Confidence 643322 12223457788999999988889999999999999999999999997544211111111
Q ss_pred HHhhhcccCCCCcHH-HHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 260 LRIMDTRLGGQYSKK-EAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 260 ~~~~~~~~~~~~~~~-~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
.......... ++.++.+++.+||..+|++|||+++++++
T Consensus 212 -----~~~~~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 212 -----KNNPPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred -----hcCCCCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 1111112222 67789999999999999999999999875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=317.39 Aligned_cols=276 Identities=30% Similarity=0.436 Sum_probs=226.8
Q ss_pred hhhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccc-hhhHHHHHHHHHHHhccCCCccccee
Q 018785 15 ISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES-FQGHKEWLTEVIYLGQLRHENLVKLI 93 (350)
Q Consensus 15 ~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~ 93 (350)
+..+.....+..+.||+|+||.||.|.+.+-. ....-..||+|.+.... .....+|..|..+++.++||||++++
T Consensus 686 lp~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~----~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~li 761 (1025)
T KOG1095|consen 686 LPEVPRKNVTLLRVLGKGAFGEVYEGTYSDVP----GSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLI 761 (1025)
T ss_pred cccCChhheEeeeeeccccccceEEEEEecCC----CCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEE
Confidence 34466778888999999999999999876432 11114568999887664 34567899999999999999999999
Q ss_pred eEEeecCceEEEEEcCCCCChhhHHhhcC-----CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCC
Q 018785 94 GYCSESDNRLLVYEFMPKGSLENHLFRKG-----VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNF 168 (350)
Q Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~ 168 (350)
+++-+....++++||++||+|..|+.+.. ...++..+.+.++.+++.|..||+ +++++||||..+|+|++...
T Consensus 762 Gv~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe--~~~fvHRDLAaRNCLL~~~r 839 (1025)
T KOG1095|consen 762 GVCLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE--SKHFVHRDLAARNCLLDERR 839 (1025)
T ss_pred EeecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH--hCCCcCcchhhhheeecccC
Confidence 99999999999999999999999997651 247899999999999999999999 99999999999999999999
Q ss_pred cEEEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccccCcchhhhhh
Q 018785 169 NAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVE 247 (350)
Q Consensus 169 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~~~~~~~ 247 (350)
.||++|||+|+...............-...|+|||.+....++.++||||||+++||+++ |..||...++.+.....
T Consensus 840 ~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~-- 917 (1025)
T KOG1095|consen 840 VVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDV-- 917 (1025)
T ss_pred cEEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHH--
Confidence 999999999985444443333333344567999999999999999999999999999999 78888776653332211
Q ss_pred hcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcCCCCC
Q 018785 248 WADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDMP 314 (350)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~~ 314 (350)
.... +...|..+++.++++|.+||+.+|++||++..|++.+.++.......
T Consensus 918 ---------------~~gg-RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~ 968 (1025)
T KOG1095|consen 918 ---------------LEGG-RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALGT 968 (1025)
T ss_pred ---------------HhCC-ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhccC
Confidence 1112 45567889999999999999999999999999999988887774433
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=283.99 Aligned_cols=265 Identities=24% Similarity=0.370 Sum_probs=210.3
Q ss_pred hhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccc-hhhHHHHHHHHHHHhccCCCcccceeeE
Q 018785 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES-FQGHKEWLTEVIYLGQLRHENLVKLIGY 95 (350)
Q Consensus 17 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 95 (350)
++...+|.+.+.||.|++|.||+|++... ......|++|...... ....+.+.+|+..++.+.||||++++++
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~------~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~ 75 (270)
T cd05056 2 EIQREDITLGRCIGEGQFGDVYQGVYMSP------ENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGV 75 (270)
T ss_pred eechhhceeeeeeCCccceeEEEEEEecC------CCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEE
Confidence 34567899999999999999999965421 1234578999887654 3445678899999999999999999998
Q ss_pred EeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccc
Q 018785 96 CSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDF 175 (350)
Q Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Df 175 (350)
+.+ +..++||||+++++|.+++.... ..++...+..++.|++.||.||| +.|++|+||+|+||+++.++.++|+||
T Consensus 76 ~~~-~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH--~~~~~H~dl~p~nili~~~~~~~l~d~ 151 (270)
T cd05056 76 ITE-NPVWIVMELAPLGELRSYLQVNK-YSLDLASLILYSYQLSTALAYLE--SKRFVHRDIAARNVLVSSPDCVKLGDF 151 (270)
T ss_pred EcC-CCcEEEEEcCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH--hCCeeccccChheEEEecCCCeEEccC
Confidence 875 56789999999999999997654 35899999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccccCcchhhhhhhcchhhh
Q 018785 176 GLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLR 254 (350)
Q Consensus 176 g~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~ 254 (350)
|++........ .......++..|+|||.+.+..++.++|+||||+++|++++ |..||...........+
T Consensus 152 g~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~--------- 221 (270)
T cd05056 152 GLSRYLEDESY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRI--------- 221 (270)
T ss_pred ceeeecccccc-eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH---------
Confidence 99875433221 11112233457999999888889999999999999999986 99999765432111111
Q ss_pred hhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcC
Q 018785 255 DSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 310 (350)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 310 (350)
........+..++..+.+++.+|+..+|.+|||+.++++.|.++...
T Consensus 222 ---------~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 222 ---------ENGERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred ---------HcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 11111223456678999999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=286.75 Aligned_cols=253 Identities=28% Similarity=0.406 Sum_probs=204.2
Q ss_pred cccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh---hHHHHHHHHHHHhccCCCcccceeeEEee
Q 018785 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ---GHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (350)
Q Consensus 22 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (350)
.|+..+.||.|+||+||+| .+..+++.+|+|.+...... ....+.+|+.+++.++|++++++.+.+..
T Consensus 1 ~~~~~~~lg~G~~g~vy~~---------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~ 71 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCAC---------QVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYET 71 (285)
T ss_pred CceEEEEEecCCCeEEEEE---------EECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEec
Confidence 4778899999999999999 55567889999998654322 22446789999999999999999999999
Q ss_pred cCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcccccc
Q 018785 99 SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 178 (350)
Q Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~ 178 (350)
++..+++|||+.+++|.+++.......++...+..++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||++
T Consensus 72 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH--~~~iiH~dikp~Nili~~~~~~kl~Dfg~~ 149 (285)
T cd05632 72 KDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH--RENTVYRDLKPENILLDDYGHIRISDLGLA 149 (285)
T ss_pred CCEEEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--hCCeeecCCCHHHEEECCCCCEEEecCCcc
Confidence 999999999999999999887655457999999999999999999999 999999999999999999999999999998
Q ss_pred ccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhHH
Q 018785 179 RDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRR 258 (350)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (350)
........ .....++..|+|||.+.+..++.++|+||+|+++|+|++|..||...........+..
T Consensus 150 ~~~~~~~~---~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~----------- 215 (285)
T cd05632 150 VKIPEGES---IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDR----------- 215 (285)
T ss_pred eecCCCCc---ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH-----------
Confidence 65332211 1224578899999999888999999999999999999999999975432211111110
Q ss_pred HHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 018785 259 VLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPS-----MVDVLTS 303 (350)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-----~~~ll~~ 303 (350)
.... .....+..++..+.+|+.+||+.||++||+ +.+++++
T Consensus 216 ---~~~~-~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 216 ---RVLE-TEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred ---hhhc-cccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 0000 011233456778999999999999999999 7788776
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=287.25 Aligned_cols=255 Identities=27% Similarity=0.362 Sum_probs=203.0
Q ss_pred hhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhcc-CCCcccceeeEE
Q 018785 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQL-RHENLVKLIGYC 96 (350)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~ 96 (350)
...+.|++.+.||+|+||.||+| ....+++.+++|.+.... .....+..|+..++.+ +|||++++++.+
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~---------~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~ 72 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKG---------RHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAF 72 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEE---------EEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEE
Confidence 35688999999999999999999 555668899999986554 3345678899999988 699999999998
Q ss_pred eec------CceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcE
Q 018785 97 SES------DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNA 170 (350)
Q Consensus 97 ~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~ 170 (350)
... ...+++|||+.+++|.+++.......+++..+..++.|++.||+||| +.+++|+||+|+||+++.++.+
T Consensus 73 ~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH--~~~ivh~dl~~~nili~~~~~~ 150 (272)
T cd06637 73 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH--QHKVIHRDIKGQNVLLTENAEV 150 (272)
T ss_pred eecCCCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH--HCCCccCCCCHHHEEECCCCCE
Confidence 653 45789999999999999998755557899999999999999999999 8999999999999999999999
Q ss_pred EEccccccccCCCCCCCcccccccCCCcccCccccc-----cCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhh
Q 018785 171 KLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVA-----TGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTL 245 (350)
Q Consensus 171 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~ 245 (350)
+|+|||++....... .......++..|+|||.+. +..++.++|+||+||++|+|++|+.||.........
T Consensus 151 ~l~Dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~--- 225 (272)
T cd06637 151 KLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL--- 225 (272)
T ss_pred EEccCCCceeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHH---
Confidence 999999987532211 1222355788899999885 335788999999999999999999999643321111
Q ss_pred hhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 246 VEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
...............++..+.+|+.+||..+|.+|||+.++++|
T Consensus 226 --------------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 226 --------------FLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred --------------HHHhcCCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 01111111112233567789999999999999999999999864
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=293.53 Aligned_cols=276 Identities=26% Similarity=0.383 Sum_probs=214.2
Q ss_pred hhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccc-hhhHHHHHHHHHHHhcc-CCCccccee
Q 018785 16 SKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES-FQGHKEWLTEVIYLGQL-RHENLVKLI 93 (350)
Q Consensus 16 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~ 93 (350)
.++...+|++.+.||+|+||.||+|++..... .....+..+++|.+.... ......+.+|+.+++++ +||||++++
T Consensus 7 ~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~--~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~ 84 (334)
T cd05100 7 WELSRTRLTLGKPLGEGCFGQVVMAEAIGIDK--DKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLL 84 (334)
T ss_pred cccCHhHeeecceeccccCCcEEEEEEeccCC--ccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeee
Confidence 34556789999999999999999996532110 112334578999887543 23346788899999999 799999999
Q ss_pred eEEeecCceEEEEEcCCCCChhhHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCC
Q 018785 94 GYCSESDNRLLVYEFMPKGSLENHLFRKG--------------VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKA 159 (350)
Q Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------------~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~ 159 (350)
+++..++..++++||+.+++|.+++.... ...++...+..++.|++.||+||| +.|++|+||+|
T Consensus 85 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH--~~givH~dlkp 162 (334)
T cd05100 85 GACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA--SQKCIHRDLAA 162 (334)
T ss_pred EEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH--HCCeecccccc
Confidence 99999999999999999999999997532 234777888999999999999999 99999999999
Q ss_pred CceEEcCCCcEEEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCccccc
Q 018785 160 SNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRG 238 (350)
Q Consensus 160 ~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~ 238 (350)
+||+++.++.++|+|||++................++..|+|||.+.+..++.++|+||||+++|+|++ |..||.+...
T Consensus 163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 242 (334)
T cd05100 163 RNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV 242 (334)
T ss_pred ceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH
Confidence 999999999999999999875433221111112233456999999999999999999999999999998 7888865432
Q ss_pred CcchhhhhhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcCCCC
Q 018785 239 GLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDM 313 (350)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~ 313 (350)
.... ..+........+..++.++.+++.+||+.+|.+|||+.+++++|.++......
T Consensus 243 ~~~~------------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~~ 299 (334)
T cd05100 243 EELF------------------KLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTST 299 (334)
T ss_pred HHHH------------------HHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcCC
Confidence 1111 11111112223445677899999999999999999999999999999866543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=284.14 Aligned_cols=265 Identities=25% Similarity=0.389 Sum_probs=210.2
Q ss_pred hhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch-hhHHHHHHHHHHHhccCCCcccceeeEE
Q 018785 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLVKLIGYC 96 (350)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (350)
+...+|++.+.||+|+||.||+|.+... .......+++|....... .....+.+|+..++.++|||++++++++
T Consensus 4 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~-----~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 78 (279)
T cd05057 4 LKETELEKIKVLGSGAFGTVYKGVWIPE-----GEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGIC 78 (279)
T ss_pred cCHHHcEEcceecCCCCccEEEEEEecC-----CCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence 4568999999999999999999965421 112234689998876543 3346688899999999999999999998
Q ss_pred eecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcccc
Q 018785 97 SESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFG 176 (350)
Q Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg 176 (350)
.. ...++|+||+.+++|.+++..... .+++..+..++.|++.||+||| +.|++|+||+|+||+++.++.++|+|||
T Consensus 79 ~~-~~~~~v~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~LH--~~~i~H~di~p~nil~~~~~~~kL~dfg 154 (279)
T cd05057 79 LS-SQVQLITQLMPLGCLLDYVRNHKD-NIGSQYLLNWCVQIAKGMSYLE--EKRLVHRDLAARNVLVKTPQHVKITDFG 154 (279)
T ss_pred ec-CceEEEEecCCCCcHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH--hCCEEecccCcceEEEcCCCeEEECCCc
Confidence 87 788999999999999999976542 5899999999999999999999 8999999999999999999999999999
Q ss_pred ccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccccCcchhhhhhhcchhhhh
Q 018785 177 LARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRD 255 (350)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 255 (350)
.+................++..|++||.+.+..++.++|+||||+++|++++ |..||..........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~------------ 222 (279)
T cd05057 155 LAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPD------------ 222 (279)
T ss_pred ccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHH------------
Confidence 9976543322222111223457999999988889999999999999999998 999987644211111
Q ss_pred hHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhc
Q 018785 256 SRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHT 309 (350)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 309 (350)
.+........+..++..+.+++.+||..+|.+||++.++++.|.++..
T Consensus 223 ------~~~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 223 ------LLEKGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred ------HHhCCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 111111122334456789999999999999999999999999999855
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=308.27 Aligned_cols=266 Identities=21% Similarity=0.286 Sum_probs=195.1
Q ss_pred hhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccC------CCcccc
Q 018785 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLR------HENLVK 91 (350)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~ 91 (350)
...++|++.++||+|+||+||+| .+..+++.||||++..... .......|+.+++.+. |+++++
T Consensus 126 ~~~~~y~i~~~lG~G~fg~V~~a---------~~~~~~~~vAvK~i~~~~~-~~~~~~~e~~~l~~l~~~~~~~~~~i~~ 195 (467)
T PTZ00284 126 VSTQRFKILSLLGEGTFGKVVEA---------WDRKRKEYCAVKIVRNVPK-YTRDAKIEIQFMEKVRQADPADRFPLMK 195 (467)
T ss_pred cCCCcEEEEEEEEeccCEEEEEE---------EEcCCCeEEEEEEEecchh-hHHHHHHHHHHHHHHhhcCcccCcceee
Confidence 44689999999999999999999 5666789999999864321 2233455666666654 456888
Q ss_pred eeeEEeec-CceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCC-CCeeeCCCCCCceEEcCCC-
Q 018785 92 LIGYCSES-DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLD-ANVIYRDLKASNVLLDSNF- 168 (350)
Q Consensus 92 ~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~-~~i~H~di~~~Nili~~~~- 168 (350)
+++++... ...++||+++ +++|.+++.... .+++..+..++.||+.||.||| + .||+|+||||+||+++.++
T Consensus 196 i~~~~~~~~~~~~iv~~~~-g~~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~yLH--~~~gIiHrDlKP~NILl~~~~~ 270 (467)
T PTZ00284 196 IQRYFQNETGHMCIVMPKY-GPCLLDWIMKHG--PFSHRHLAQIIFQTGVALDYFH--TELHLMHTDLKPENILMETSDT 270 (467)
T ss_pred eEEEEEcCCceEEEEEecc-CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--hcCCeecCCCCHHHEEEecCCc
Confidence 88888765 5688999988 889999887664 7999999999999999999999 7 5999999999999998765
Q ss_pred ---------------cEEEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCC
Q 018785 169 ---------------NAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL 233 (350)
Q Consensus 169 ---------------~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf 233 (350)
.++|+|||.+..... ......|++.|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus 271 ~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf 345 (467)
T PTZ00284 271 VVDPVTNRALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLY 345 (467)
T ss_pred ccccccccccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 499999998754211 122356899999999999999999999999999999999999999
Q ss_pred cccccCcchhhhhhhcchhhhhh---------HHHHHhhhcccCC-------------CC-cHHHHHHHHHHHHHhhccC
Q 018785 234 DEDRGGLAEQTLVEWADPFLRDS---------RRVLRIMDTRLGG-------------QY-SKKEAQAVAAVVLQCLHMD 290 (350)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~-------------~~-~~~~~~~l~~li~~~l~~d 290 (350)
.+.........+........... ............. .. .....+.+.+||.+||+.|
T Consensus 346 ~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~d 425 (467)
T PTZ00284 346 DTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYD 425 (467)
T ss_pred CCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcC
Confidence 87654333222222111100000 0000000000000 00 0112456889999999999
Q ss_pred CCCCCCHHHHHHH
Q 018785 291 PKNRPSMVDVLTS 303 (350)
Q Consensus 291 p~~Rps~~~ll~~ 303 (350)
|++|||++++++|
T Consensus 426 P~~R~ta~e~L~H 438 (467)
T PTZ00284 426 RQKRLNARQMTTH 438 (467)
T ss_pred hhhCCCHHHHhcC
Confidence 9999999999986
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=288.45 Aligned_cols=274 Identities=25% Similarity=0.394 Sum_probs=210.3
Q ss_pred hhhcccccceecccCceeEEeecccCCCcC-------CCCCCCCcEEEEEEccccch-hhHHHHHHHHHHHhccCCCccc
Q 018785 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFA-------PTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLV 90 (350)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~-------~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~ 90 (350)
..++|++.+.||+|+||.||+|+....... ..+...+..|++|.+..... .....+.+|+.++++++||||+
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~ 82 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIA 82 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEe
Confidence 457899999999999999999976532110 12334567899999876542 3456788899999999999999
Q ss_pred ceeeEEeecCceEEEEEcCCCCChhhHHhhcC---------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCc
Q 018785 91 KLIGYCSESDNRLLVYEFMPKGSLENHLFRKG---------VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASN 161 (350)
Q Consensus 91 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~N 161 (350)
++++++..++..++++|++.+++|.+++.... ...++...++.++.|++.||+||| +.|++|+||+|+|
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH--~~~i~H~dlkp~N 160 (296)
T cd05051 83 RLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE--SLNFVHRDLATRN 160 (296)
T ss_pred EEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH--HcCccccccchhc
Confidence 99999999999999999999999999987653 125889999999999999999999 9999999999999
Q ss_pred eEEcCCCcEEEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh--CCCCCcccccC
Q 018785 162 VLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS--GRRALDEDRGG 239 (350)
Q Consensus 162 ili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~--g~~pf~~~~~~ 239 (350)
|+++.++.++|+|||.+................++..|+|||.+.+..++.++||||||+++|+|++ +..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 9999999999999999875433322222233445678999999988889999999999999999998 66777544321
Q ss_pred cchhhhhhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018785 240 LAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 305 (350)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~ 305 (350)
........ .............+..++.++.+++.+||+.||.+|||+.++++.|.
T Consensus 241 ~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 241 QVIENAGH-----------FFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred HHHHHHHh-----------ccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 11111110 00000011111123345678999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=297.13 Aligned_cols=238 Identities=28% Similarity=0.419 Sum_probs=190.2
Q ss_pred ceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh---hHHHHHHHH-HHHhccCCCcccceeeEEeecCce
Q 018785 27 YLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ---GHKEWLTEV-IYLGQLRHENLVKLIGYCSESDNR 102 (350)
Q Consensus 27 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~~~~~ 102 (350)
++||+|+||.||+| .+..+++.||+|++...... ....+..|. .+++.++||||+++++.+.+.+..
T Consensus 1 ~~lg~G~~g~Vy~~---------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~ 71 (321)
T cd05603 1 KVIGKGSFGKVLLA---------KRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKL 71 (321)
T ss_pred CeeeeCCCEEEEEE---------EECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEE
Confidence 47999999999999 56667899999998754321 123344444 467888999999999999999999
Q ss_pred EEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccccccCC
Q 018785 103 LLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGP 182 (350)
Q Consensus 103 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~~~~ 182 (350)
++||||+++++|.+.+.... .+++..+..++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++....
T Consensus 72 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~lH--~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~ 147 (321)
T cd05603 72 YFVLDYVNGGELFFHLQRER--CFLEPRARFYAAEVASAIGYLH--SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGV 147 (321)
T ss_pred EEEEcCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCeEeccCCHHHeEECCCCCEEEccCCCCccCC
Confidence 99999999999998886654 6889999999999999999999 9999999999999999999999999999986422
Q ss_pred CCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhHHHHHh
Q 018785 183 TGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRI 262 (350)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (350)
... .......|++.|+|||.+.+..++.++|+|||||++|+|++|..||...+...... .+
T Consensus 148 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~-----------------~i 208 (321)
T cd05603 148 EPE--ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYD-----------------NI 208 (321)
T ss_pred CCC--CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHH-----------------HH
Confidence 211 12233468899999999988899999999999999999999999997643211111 11
Q ss_pred hhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHH
Q 018785 263 MDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMV 298 (350)
Q Consensus 263 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ 298 (350)
... ....+...+..+.+++.+||+.||.+|++..
T Consensus 209 ~~~--~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 209 LHK--PLQLPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred hcC--CCCCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 111 1223445677899999999999999998764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=286.71 Aligned_cols=277 Identities=27% Similarity=0.373 Sum_probs=213.6
Q ss_pred hhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh-hHHHHHHHHHHHhccCCCcccceeeEEee
Q 018785 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ-GHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (350)
Q Consensus 20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (350)
.++|++.+.||+|+||.||+|++.. .+..++..+|+|.+...... ....+..|+..++.+.||||+++++++..
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~-----~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~ 77 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDP-----LGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEK 77 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecC-----CCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeec
Confidence 5788999999999999999996643 23456889999998766543 45678999999999999999999999877
Q ss_pred --cCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcccc
Q 018785 99 --SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFG 176 (350)
Q Consensus 99 --~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg 176 (350)
....+++|||+++++|.+++..... .++...+..++.|++.||++|| +.|++|+||+|+||+++.++.++|+|||
T Consensus 78 ~~~~~~~lv~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~~~l~~aL~~lH--~~~i~H~dl~p~nil~~~~~~~~l~dfg 154 (284)
T cd05038 78 PGGRSLRLIMEYLPSGSLRDYLQRHRD-QINLKRLLLFSSQICKGMDYLG--SQRYIHRDLAARNILVESEDLVKISDFG 154 (284)
T ss_pred CCCCceEEEEecCCCCCHHHHHHhCcc-ccCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHhEEEcCCCCEEEcccc
Confidence 5678999999999999999976542 5899999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCCCCcc-cccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhh
Q 018785 177 LARDGPTGDNTHV-STRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRD 255 (350)
Q Consensus 177 ~~~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 255 (350)
.+........... .....++..|++||...+..++.++|+||||+++++|++|..|+.............. .....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~---~~~~~ 231 (284)
T cd05038 155 LAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIA---QGQMI 231 (284)
T ss_pred cccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccc---ccccc
Confidence 9986542222111 1112344569999999888899999999999999999999999865432211100000 00001
Q ss_pred hHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 018785 256 SRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 307 (350)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~ 307 (350)
.......+........+..++.++.+++.+||+.+|.+|||+.++++.|..+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 232 VTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 1111222222222233445678899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=288.73 Aligned_cols=254 Identities=23% Similarity=0.348 Sum_probs=204.1
Q ss_pred hcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceeeEEeecC
Q 018785 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSESD 100 (350)
Q Consensus 21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 100 (350)
+-|++.+.||.|++|.||+| .+..++..+++|.+..........+.+|+.+++.+.|||++++++.+..++
T Consensus 5 ~~~~i~~~lg~g~~g~v~~~---------~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~ 75 (282)
T cd06643 5 EFWEIIGELGDGAFGKVYKA---------QNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYEN 75 (282)
T ss_pred HHHHHHhhcccCCCeEEEEE---------EECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCC
Confidence 44789999999999999999 556668899999987666555677888999999999999999999999999
Q ss_pred ceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcccccccc
Q 018785 101 NRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD 180 (350)
Q Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~~ 180 (350)
..++|+||+.+++|.+++.... ..+++..+..++.|+++||.||| +.|++|+||+|+||+++.++.++|+|||++..
T Consensus 76 ~~~~v~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH--~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~ 152 (282)
T cd06643 76 NLWILIEFCAGGAVDAVMLELE-RPLTEPQIRVVCKQTLEALNYLH--ENKIIHRDLKAGNILFTLDGDIKLADFGVSAK 152 (282)
T ss_pred EEEEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH--HCCeeecCCCcccEEEccCCCEEEcccccccc
Confidence 9999999999999988876533 36899999999999999999999 99999999999999999999999999999865
Q ss_pred CCCCCCCcccccccCCCcccCccccc-----cCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhh
Q 018785 181 GPTGDNTHVSTRIVGTRGYAAPEYVA-----TGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRD 255 (350)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 255 (350)
..... .......++..|+|||.+. +..++.++|+||+||++|+|++|+.||...........+..
T Consensus 153 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~-------- 222 (282)
T cd06643 153 NTRTI--QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAK-------- 222 (282)
T ss_pred ccccc--cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhh--------
Confidence 32211 1122345788899999873 34678899999999999999999999865432111111100
Q ss_pred hHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018785 256 SRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL 304 (350)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 304 (350)
........+..++.++.+++.+||+.||.+||++.+++++-
T Consensus 223 --------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 263 (282)
T cd06643 223 --------SEPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHP 263 (282)
T ss_pred --------cCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCC
Confidence 00111122345678899999999999999999999998663
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=301.60 Aligned_cols=256 Identities=27% Similarity=0.427 Sum_probs=214.6
Q ss_pred hhhhhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccce
Q 018785 13 SMISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKL 92 (350)
Q Consensus 13 ~~~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 92 (350)
..++++..+...-.+-||+|+.|.||+|+++ ++.||||.++... ..+++.|++|+||||+.+
T Consensus 116 ~e~WeiPFe~IsELeWlGSGaQGAVF~Grl~-----------netVAVKKV~elk-------ETdIKHLRkLkH~NII~F 177 (904)
T KOG4721|consen 116 EELWEIPFEEISELEWLGSGAQGAVFLGRLH-----------NETVAVKKVRELK-------ETDIKHLRKLKHPNIITF 177 (904)
T ss_pred hhhccCCHHHhhhhhhhccCcccceeeeecc-----------CceehhHHHhhhh-------hhhHHHHHhccCcceeeE
Confidence 3456666667777888999999999999876 5679999875443 246778999999999999
Q ss_pred eeEEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEE
Q 018785 93 IGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKL 172 (350)
Q Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l 172 (350)
.+++.....++||||||..|-|...++... .++......|..+|+.++.||| ...|+|||||.-||||+.+..|||
T Consensus 178 kGVCtqsPcyCIiMEfCa~GqL~~VLka~~--~itp~llv~Wsk~IA~GM~YLH--~hKIIHRDLKSPNiLIs~~d~VKI 253 (904)
T KOG4721|consen 178 KGVCTQSPCYCIIMEFCAQGQLYEVLKAGR--PITPSLLVDWSKGIAGGMNYLH--LHKIIHRDLKSPNILISYDDVVKI 253 (904)
T ss_pred eeeecCCceeEEeeeccccccHHHHHhccC--ccCHHHHHHHHHHhhhhhHHHH--HhhHhhhccCCCceEeeccceEEe
Confidence 999999999999999999999999998765 7899999999999999999999 999999999999999999999999
Q ss_pred ccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchh
Q 018785 173 SDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPF 252 (350)
Q Consensus 173 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 252 (350)
+|||-+...... ...-...||..|+|||++.+...+.+.||||||++|||||||..||.+.+.......+-
T Consensus 254 sDFGTS~e~~~~---STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVG------ 324 (904)
T KOG4721|consen 254 SDFGTSKELSDK---STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVG------ 324 (904)
T ss_pred ccccchHhhhhh---hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEecc------
Confidence 999998753322 22333679999999999999999999999999999999999999997654322211111
Q ss_pred hhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcC
Q 018785 253 LRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 310 (350)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 310 (350)
...+....|..+|+.+.-|+++||+-.|..||++.+++.||+.+.+.
T Consensus 325 -----------sNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pe 371 (904)
T KOG4721|consen 325 -----------SNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPE 371 (904)
T ss_pred -----------CCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHH
Confidence 11122345678889999999999999999999999999999877654
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=295.09 Aligned_cols=268 Identities=20% Similarity=0.228 Sum_probs=199.6
Q ss_pred ccceeccc--CceeEEeecccCCCcCCCCCCCCcEEEEEEccccch--hhHHHHHHHHHHHhccCCCcccceeeEEeecC
Q 018785 25 SDYLLGEG--GFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLRHENLVKLIGYCSESD 100 (350)
Q Consensus 25 i~~~lg~G--~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 100 (350)
+.++||+| ++++||++ .+..+|+.||+|.+..... .....+.+|+.+++.++||||+++++++..++
T Consensus 2 ~~~~ig~G~~~~~~v~~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~ 72 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLA---------RYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN 72 (327)
T ss_pred hhhhccccccceEEEEEE---------eecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECC
Confidence 56789999 67899999 6777899999999876532 23356778999999999999999999999999
Q ss_pred ceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcccccccc
Q 018785 101 NRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD 180 (350)
Q Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~~ 180 (350)
..++||||+++++|.+++..+....+++..++.++.|++.||.||| +.|++|+||||+||+++.++.++++||+....
T Consensus 73 ~~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH--~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~ 150 (327)
T cd08227 73 ELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIH--HMGYVHRSVKASHILISVDGKVYLSGLRSNLS 150 (327)
T ss_pred EEEEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH--HCCEecCCCChhhEEEecCCcEEEcccchhhc
Confidence 9999999999999999997655456899999999999999999999 99999999999999999999999999986543
Q ss_pred CCCCCCCc-----ccccccCCCcccCcccccc--CCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhh
Q 018785 181 GPTGDNTH-----VSTRIVGTRGYAAPEYVAT--GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 253 (350)
Q Consensus 181 ~~~~~~~~-----~~~~~~~~~~~~aPE~~~~--~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 253 (350)
........ ......++..|+|||.+.+ ..++.++|+|||||++|+|++|..||.................+..
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 230 (327)
T cd08227 151 MINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCL 230 (327)
T ss_pred cccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCcccc
Confidence 21111100 1112345667999999876 4688999999999999999999999975443221111110000000
Q ss_pred hh-----hHHHH----------------------HhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 254 RD-----SRRVL----------------------RIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 254 ~~-----~~~~~----------------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
.+ .+... ..............+++.+.+|+.+||+.||++|||++++++|
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~ 307 (327)
T cd08227 231 LDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 307 (327)
T ss_pred ccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence 00 00000 0000000011233467789999999999999999999999976
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=304.57 Aligned_cols=267 Identities=24% Similarity=0.274 Sum_probs=199.9
Q ss_pred hhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceeeEEe
Q 018785 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (350)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (350)
+.+..|.+.+.||+|+||.||+| .+..+++.|+||.... ....+|+.++++++|+||+++++++.
T Consensus 166 ~~~~gy~i~~~Lg~G~~G~Vy~a---------~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~ 230 (461)
T PHA03211 166 VAGLGFAIHRALTPGSEGCVFES---------SHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRV 230 (461)
T ss_pred cccCCeEEEEEEccCCCeEEEEE---------EECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEE
Confidence 34668999999999999999999 6666788999996432 23457999999999999999999999
Q ss_pred ecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccc
Q 018785 98 ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL 177 (350)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~ 177 (350)
.++..++||+++ .++|.+++.... ..++...++.++.|++.||.||| +.||+|+||||+||+++.++.++|+|||+
T Consensus 231 ~~~~~~lv~e~~-~~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH--~~gIvHrDLKP~NILl~~~~~vkL~DFGl 306 (461)
T PHA03211 231 VGGLTCLVLPKY-RSDLYTYLGARL-RPLGLAQVTAVARQLLSAIDYIH--GEGIIHRDIKTENVLVNGPEDICLGDFGA 306 (461)
T ss_pred ECCEEEEEEEcc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH--HCCEEECcCCHHHEEECCCCCEEEcccCC
Confidence 999999999999 568988886543 36899999999999999999999 99999999999999999999999999999
Q ss_pred cccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccC--------cchhhhhhhc
Q 018785 178 ARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGG--------LAEQTLVEWA 249 (350)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~--------~~~~~~~~~~ 249 (350)
+................|+..|+|||++.+..++.++|||||||++|+|++|..++...... .....+....
T Consensus 307 a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~ 386 (461)
T PHA03211 307 ACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQ 386 (461)
T ss_pred ceecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhc
Confidence 97643332222223356899999999999999999999999999999999987655322111 0111111100
Q ss_pred c---hhh--hhhHHHHHhhh---cccC-------CCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 250 D---PFL--RDSRRVLRIMD---TRLG-------GQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 250 ~---~~~--~~~~~~~~~~~---~~~~-------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
. .+. ........... .... +......+.++.+||.+||+.||.+|||+.++|+|
T Consensus 387 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 387 VHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred cccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0 000 00000000000 0000 00011345689999999999999999999999986
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=284.75 Aligned_cols=262 Identities=26% Similarity=0.405 Sum_probs=208.4
Q ss_pred hhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh-hHHHHHHHHHHHhccCCCcccceeeEEee
Q 018785 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ-GHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (350)
Q Consensus 20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (350)
.++|++.+.||.|+||.||+|+.+.. ........+++|.+...... ....+.+|+.++++++|+||+++++++.+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~----~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 79 (275)
T cd05046 4 RSNLQEITTLGRGEFGEVFLAKAKGI----EEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCRE 79 (275)
T ss_pred hHhceeeeeecccceeEEEEEEeccC----CcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECC
Confidence 47899999999999999999976543 23445678999988665433 34668899999999999999999999999
Q ss_pred cCceEEEEEcCCCCChhhHHhhcCC-------CCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEE
Q 018785 99 SDNRLLVYEFMPKGSLENHLFRKGV-------QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAK 171 (350)
Q Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~-------~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~ 171 (350)
.+..++||||+++++|.+++..... ..++...+..++.|++.||.||| +.+++|+||+|+||+++.++.++
T Consensus 80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH--~~~i~H~dlkp~Nili~~~~~~~ 157 (275)
T cd05046 80 AEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS--NARFVHRDLAARNCLVSSQREVK 157 (275)
T ss_pred CCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh--hcCcccCcCccceEEEeCCCcEE
Confidence 9999999999999999999976542 15899999999999999999999 99999999999999999999999
Q ss_pred EccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccccCcchhhhhhhcc
Q 018785 172 LSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWAD 250 (350)
Q Consensus 172 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~ 250 (350)
++|||++....... ........++..|+|||.+.+..++.++|+||||+++|+|++ |..||..........
T Consensus 158 l~~~~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~------- 229 (275)
T cd05046 158 VSLLSLSKDVYNSE-YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLN------- 229 (275)
T ss_pred EcccccccccCccc-ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHH-------
Confidence 99999886432211 111222345667999999888888999999999999999998 777886433211111
Q ss_pred hhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018785 251 PFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 305 (350)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~ 305 (350)
...........+..++..+.+++.+||..+|.+|||+.++++.|+
T Consensus 230 ----------~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 230 ----------RLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred ----------HHHcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 111111112223456788999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=281.27 Aligned_cols=253 Identities=29% Similarity=0.452 Sum_probs=202.8
Q ss_pred ceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch-hhHHHHHHHHHHHhccCCCcccceeeEEeecCceEEE
Q 018785 27 YLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLVKLIGYCSESDNRLLV 105 (350)
Q Consensus 27 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 105 (350)
++||+|++|.||+|.+.. .......|++|.+..... .....+..|+..+++++||||+++++.+.. ...++|
T Consensus 1 ~~ig~g~~~~v~~~~~~~------~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v 73 (257)
T cd05040 1 KKLGDGSFGVVRRGEWST------SGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMV 73 (257)
T ss_pred CcCCccCcccEEeeeEec------CCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEE
Confidence 468999999999996642 123344799999988766 556778899999999999999999999988 889999
Q ss_pred EEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccccccCCCCC
Q 018785 106 YEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGD 185 (350)
Q Consensus 106 ~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~~~~~~~ 185 (350)
+|++++++|.+++.......++...+..++.|++.||.+|| +.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 74 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH--~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~ 151 (257)
T cd05040 74 TELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE--SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNE 151 (257)
T ss_pred EEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHH--hCCccccccCcccEEEecCCEEEeccccccccccccc
Confidence 99999999999997764346899999999999999999999 9999999999999999999999999999997653322
Q ss_pred CCc-ccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccccCcchhhhhhhcchhhhhhHHHHHhh
Q 018785 186 NTH-VSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIM 263 (350)
Q Consensus 186 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (350)
... ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||...........+.
T Consensus 152 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~----------------- 214 (257)
T cd05040 152 DHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKID----------------- 214 (257)
T ss_pred cceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-----------------
Confidence 211 1112345677999999988899999999999999999998 999986543211111110
Q ss_pred hcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018785 264 DTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 305 (350)
Q Consensus 264 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~ 305 (350)
........+..++..+.+++.+||+.+|.+|||+.++++.|.
T Consensus 215 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 215 KEGERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred hcCCcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 011112223456788999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=282.38 Aligned_cols=251 Identities=24% Similarity=0.352 Sum_probs=205.6
Q ss_pred cccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccc--hhhHHHHHHHHHHHhccCCCcccceeeEEeec
Q 018785 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES--FQGHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (350)
Q Consensus 22 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (350)
+|++.+.||+|++|.+|.+ .+..+|+.|++|.+.... ......+.+|+..++.++||||+++++++...
T Consensus 1 ~y~~~~~lg~g~~g~~~~~---------~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILV---------KSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEEN 71 (256)
T ss_pred CceEEEEeccCCceEEEEE---------EEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCC
Confidence 6899999999999999999 555668899999886542 23345788999999999999999999999999
Q ss_pred CceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccccc
Q 018785 100 DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR 179 (350)
Q Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~ 179 (350)
+..++|+||+.+++|.+++.......+++..+..++.|++.|+.+|| +.|++|+||+|+||+++.++.++++|||.+.
T Consensus 72 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh--~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~ 149 (256)
T cd08218 72 GNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH--DRKILHRDIKSQNIFLTKDGTIKLGDFGIAR 149 (256)
T ss_pred CeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH--hCCEecCCCCHHHEEEcCCCCEEEeecccee
Confidence 99999999999999999987655446889999999999999999999 9999999999999999999999999999987
Q ss_pred cCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhHHH
Q 018785 180 DGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRV 259 (350)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (350)
....... ......+++.|+|||.+.+..++.++|+||||+++++|++|..||........ .
T Consensus 150 ~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~-----------------~ 210 (256)
T cd08218 150 VLNSTVE--LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNL-----------------V 210 (256)
T ss_pred ecCcchh--hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHH-----------------H
Confidence 5433221 11223467889999999888899999999999999999999999864321110 1
Q ss_pred HHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 260 LRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
..... ......+...+.++.+++.+||+.+|.+||++.++++|
T Consensus 211 ~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 211 LKIIR-GSYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred HHHhc-CCCCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 11111 11122344567889999999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=298.12 Aligned_cols=264 Identities=23% Similarity=0.331 Sum_probs=199.6
Q ss_pred hhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch--hhHHHHHHHHHHHhccCCCcccceeeEEe
Q 018785 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (350)
Q Consensus 20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (350)
.++|++.+.||+|+||+||+| .+..++..||+|.+..... .....+.+|+.+++.++||||+++++++.
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~---------~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 84 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSA---------YDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFT 84 (343)
T ss_pred hhhhhhheecccCCCeEEEEE---------EECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhc
Confidence 579999999999999999999 5666788999999875432 23345678999999999999999999875
Q ss_pred ec------CceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEE
Q 018785 98 ES------DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAK 171 (350)
Q Consensus 98 ~~------~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~ 171 (350)
.. ...+++++++ +++|.+++... .+++..+..++.|++.||.||| +.|++|+||||+||+++.++.++
T Consensus 85 ~~~~~~~~~~~~~~~~~~-~~~l~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH--~~~ivHrdikp~Nil~~~~~~~k 158 (343)
T cd07878 85 PATSIENFNEVYLVTNLM-GADLNNIVKCQ---KLSDEHVQFLIYQLLRGLKYIH--SAGIIHRDLKPSNVAVNEDCELR 158 (343)
T ss_pred ccccccccCcEEEEeecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH--HCCeecccCChhhEEECCCCCEE
Confidence 43 3568999988 88998877543 6999999999999999999999 99999999999999999999999
Q ss_pred EccccccccCCCCCCCcccccccCCCcccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcc
Q 018785 172 LSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD 250 (350)
Q Consensus 172 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~ 250 (350)
|+|||++...... .....+++.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+.....
T Consensus 159 l~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 233 (343)
T cd07878 159 ILDFGLARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVG 233 (343)
T ss_pred EcCCccceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhC
Confidence 9999999754322 123457889999999877 5688999999999999999999999976543222222211110
Q ss_pred hhhhh------hHHHHHhhhcc---cCC---CCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 251 PFLRD------SRRVLRIMDTR---LGG---QYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 251 ~~~~~------~~~~~~~~~~~---~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
..... ........... ... ......++.+.+|+.+||..||.+|||+.++++|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 234 TPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred CCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000 00000000000 000 0011235678899999999999999999999987
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=283.16 Aligned_cols=251 Identities=27% Similarity=0.378 Sum_probs=205.8
Q ss_pred hcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceeeEEeecC
Q 018785 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSESD 100 (350)
Q Consensus 21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 100 (350)
++|++.+.||.|++|.||+| ....++..+++|.+..... ...+.+|+..++.++||||+++++.+....
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~---------~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~ 71 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKA---------IHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNT 71 (256)
T ss_pred ccchhhhhhcCCCCeEEEEE---------EEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCC
Confidence 68999999999999999999 4444578999999876543 567889999999999999999999999999
Q ss_pred ceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcccccccc
Q 018785 101 NRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD 180 (350)
Q Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~~ 180 (350)
..++++|++.+++|.+++.... ..+++..+..++.|++.|+.||| +.+++|+||+|+||+++.++.++|+|||++..
T Consensus 72 ~~~l~~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lh--~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~ 148 (256)
T cd06612 72 DLWIVMEYCGAGSVSDIMKITN-KTLTEEEIAAILYQTLKGLEYLH--SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQ 148 (256)
T ss_pred cEEEEEecCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCcceEEECCCCcEEEcccccchh
Confidence 9999999999999999986543 36899999999999999999999 99999999999999999999999999999875
Q ss_pred CCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhHHHH
Q 018785 181 GPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVL 260 (350)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (350)
...... ......++..|+|||.+.+..++.++|+||+|+++|+|++|..||...........+..
T Consensus 149 ~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~------------- 213 (256)
T cd06612 149 LTDTMA--KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPN------------- 213 (256)
T ss_pred cccCcc--ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhcc-------------
Confidence 433221 12234467889999999888999999999999999999999999975432211110000
Q ss_pred HhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 261 RIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
........+..++..+.+++.+||+.||++|||+.+++++
T Consensus 214 ---~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 214 ---KPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred ---CCCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 0011111234566789999999999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=284.68 Aligned_cols=256 Identities=24% Similarity=0.418 Sum_probs=202.5
Q ss_pred cccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh----------hHHHHHHHHHHHhccCCCcccc
Q 018785 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ----------GHKEWLTEVIYLGQLRHENLVK 91 (350)
Q Consensus 22 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~----------~~~~~~~e~~~l~~l~h~~i~~ 91 (350)
+|.+.+.||.|++|.||+| .+..+|+.+++|.+...... ..+.+..|+..++.++|||+++
T Consensus 2 ~~~~~~~lg~g~~~~vy~~---------~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 72 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLA---------LNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQ 72 (272)
T ss_pred ceeecceecccCceEEEEE---------eecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcce
Confidence 6889999999999999999 56667889999987543211 1245778999999999999999
Q ss_pred eeeEEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEE
Q 018785 92 LIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAK 171 (350)
Q Consensus 92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~ 171 (350)
+++++...+..++|+||+.+++|.+++.... .++...+..++.|++.||.+|| +.+++|+||+|+||+++.++.++
T Consensus 73 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH--~~~i~H~dl~~~nil~~~~~~~~ 148 (272)
T cd06629 73 YLGFETTEEYLSIFLEYVPGGSIGSCLRTYG--RFEEQLVRFFTEQVLEGLAYLH--SKGILHRDLKADNLLVDADGICK 148 (272)
T ss_pred EEEEeccCCceEEEEecCCCCcHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHh--hCCeeecCCChhhEEEcCCCeEE
Confidence 9999999999999999999999999997764 7899999999999999999999 89999999999999999999999
Q ss_pred EccccccccCCCCCCCcccccccCCCcccCccccccCC--CCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhc
Q 018785 172 LSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGH--LTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWA 249 (350)
Q Consensus 172 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~--~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~ 249 (350)
|+|||++................++..|+|||.+.+.. ++.++|+||||+++|++++|..||........ +...
T Consensus 149 l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~---~~~~- 224 (272)
T cd06629 149 ISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAA---MFKL- 224 (272)
T ss_pred EeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHH---HHHh-
Confidence 99999997543322222222345778899999887654 78999999999999999999999854322110 0000
Q ss_pred chhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 250 DPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
................++.++.+++.+||..+|.+|||+.++++|
T Consensus 225 ---------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 225 ---------GNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred ---------hccccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 000001111112234567899999999999999999999999876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=279.79 Aligned_cols=251 Identities=28% Similarity=0.428 Sum_probs=198.8
Q ss_pred eecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh-hHHHHHHHHHHHhccCCCcccceeeEEeecCceEEEE
Q 018785 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ-GHKEWLTEVIYLGQLRHENLVKLIGYCSESDNRLLVY 106 (350)
Q Consensus 28 ~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 106 (350)
.||+|+||.||+|++. ....+..|++|.+...... ....+.+|+.+++.++||||+++++++.. ...++||
T Consensus 2 ~ig~G~~g~v~~~~~~-------~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~ 73 (257)
T cd05115 2 ELGSGNFGCVKKGVYK-------MRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVM 73 (257)
T ss_pred ccCCCCcccEEEEEEe-------cCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEE
Confidence 3899999999998653 2234667999988765432 23568899999999999999999998764 5789999
Q ss_pred EcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccccccCCCCCC
Q 018785 107 EFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDN 186 (350)
Q Consensus 107 e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~~~~~~~~ 186 (350)
||+++++|.+++.... ..+++..++.++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||++........
T Consensus 74 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~ 150 (257)
T cd05115 74 EMASGGPLNKFLSGKK-DEITVSNVVELMHQVSMGMKYLE--GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDS 150 (257)
T ss_pred EeCCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH--hcCeeecccchheEEEcCCCcEEeccCCccccccCCcc
Confidence 9999999999986543 36899999999999999999999 99999999999999999999999999999875433222
Q ss_pred Ccc-cccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccccCcchhhhhhhcchhhhhhHHHHHhhh
Q 018785 187 THV-STRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMD 264 (350)
Q Consensus 187 ~~~-~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (350)
... .....++..|+|||.+.+..++.++|+||||+++|++++ |..||........ ...+.
T Consensus 151 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~------------------~~~~~ 212 (257)
T cd05115 151 YYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEV------------------MSFIE 212 (257)
T ss_pred ceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHH------------------HHHHH
Confidence 111 111223467999999988889999999999999999996 9999975442111 11111
Q ss_pred cccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 018785 265 TRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 307 (350)
Q Consensus 265 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~ 307 (350)
.......+..+++++.+++.+||..+|++||++.++.+.|..+
T Consensus 213 ~~~~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 213 QGKRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 2222234456688999999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=297.38 Aligned_cols=238 Identities=26% Similarity=0.392 Sum_probs=190.3
Q ss_pred ceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch---hhHHHHHHHH-HHHhccCCCcccceeeEEeecCce
Q 018785 27 YLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEV-IYLGQLRHENLVKLIGYCSESDNR 102 (350)
Q Consensus 27 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~~~~~ 102 (350)
+.||+|+||.||+| .+..+|+.+|+|++..... .....+..|. .+++.++||||+++++.+...+..
T Consensus 1 ~~lG~G~~g~V~~~---------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~ 71 (325)
T cd05604 1 KVIGKGSFGKVLLA---------KRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKL 71 (325)
T ss_pred CceeeCCCeEEEEE---------EECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEE
Confidence 46999999999999 5666789999999875432 1223344444 456778999999999999999999
Q ss_pred EEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccccccCC
Q 018785 103 LLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGP 182 (350)
Q Consensus 103 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~~~~ 182 (350)
++||||+.+++|.+++.... .+++..+..++.||+.||.||| +.|++|+||||+||+++.++.++|+|||++....
T Consensus 72 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH--~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~ 147 (325)
T cd05604 72 YFVLDFVNGGELFFHLQRER--SFPEPRARFYAAEIASALGYLH--SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGI 147 (325)
T ss_pred EEEEcCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCeeecCCCHHHeEECCCCCEEEeecCCcccCC
Confidence 99999999999998887654 7899999999999999999999 9999999999999999999999999999986432
Q ss_pred CCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhHHHHHh
Q 018785 183 TGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRI 262 (350)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (350)
... .......|++.|+|||.+.+..++.++|+|||||++|+|++|..||...........+
T Consensus 148 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~----------------- 208 (325)
T cd05604 148 AQS--DTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNI----------------- 208 (325)
T ss_pred CCC--CCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHH-----------------
Confidence 211 1223356889999999999999999999999999999999999999754422111111
Q ss_pred hhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHH
Q 018785 263 MDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMV 298 (350)
Q Consensus 263 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ 298 (350)
.... .......+..+.+++.+||+.+|.+||++.
T Consensus 209 ~~~~--~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~ 242 (325)
T cd05604 209 LHKP--LVLRPGASLTAWSILEELLEKDRQRRLGAK 242 (325)
T ss_pred HcCC--ccCCCCCCHHHHHHHHHHhccCHHhcCCCC
Confidence 1111 112334677899999999999999999875
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=293.75 Aligned_cols=256 Identities=20% Similarity=0.228 Sum_probs=199.8
Q ss_pred hcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch---hhHHHHHHHHHHHhccCCCcccceeeEEe
Q 018785 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (350)
Q Consensus 21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (350)
++|++.+.||+|+||.||++ .+..+++.||+|++..... .....+.+|..+++.++|++|+++++++.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~---------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 71 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVV---------KMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQ 71 (331)
T ss_pred CCceEEEEEEecCCeEEEEE---------EECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEe
Confidence 47999999999999999999 5566788999999875322 22345778999999999999999999999
Q ss_pred ecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccc
Q 018785 98 ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL 177 (350)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~ 177 (350)
+++..++||||+.+++|.+++.... ..+++..+..++.|++.||+||| ++|++|+||||+||+++.++.++|+|||+
T Consensus 72 ~~~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 148 (331)
T cd05597 72 DENNLYLVMDYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVLAIDSVH--QLGYVHRDIKPDNVLLDKNGHIRLADFGS 148 (331)
T ss_pred cCCeEEEEEecCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH--hCCeEECCCCHHHEEECCCCCEEEEECCc
Confidence 9999999999999999999997643 36899999999999999999999 99999999999999999999999999999
Q ss_pred cccCCCCCCCcccccccCCCcccCcccccc-----CCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchh
Q 018785 178 ARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-----GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPF 252 (350)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 252 (350)
+........ .......|++.|+|||++.+ ..++.++|+||+||++|+|++|+.||...........+...
T Consensus 149 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~---- 223 (331)
T cd05597 149 CLRLLADGT-VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH---- 223 (331)
T ss_pred eeecCCCCC-ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcC----
Confidence 865332221 11222458899999999863 45778999999999999999999999754321111111100
Q ss_pred hhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 018785 253 LRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKN--RPSMVDVLTS 303 (350)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~--Rps~~~ll~~ 303 (350)
............+++.+.+++.+||..++.+ |++++++++|
T Consensus 224 ----------~~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 224 ----------KEHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred ----------CCcccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 0000000112236788999999988654443 7899999988
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=283.65 Aligned_cols=256 Identities=29% Similarity=0.432 Sum_probs=200.7
Q ss_pred ceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch-hhHHHHHHHHHHHhccCCCcccceeeEEeecCceEEE
Q 018785 27 YLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLVKLIGYCSESDNRLLV 105 (350)
Q Consensus 27 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 105 (350)
+.||+|++|.||+|++.+.. .....+..+++|.+..... .....+.+|+..++.++||||+++++++...+..++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~---~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 77 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDIL---GPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYII 77 (269)
T ss_pred CccccccceeEEeeeecccc---cCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEE
Confidence 46899999999999765321 1223456899998765432 3356688899999999999999999999999999999
Q ss_pred EEcCCCCChhhHHhhcC-----CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCC-----cEEEccc
Q 018785 106 YEFMPKGSLENHLFRKG-----VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNF-----NAKLSDF 175 (350)
Q Consensus 106 ~e~~~~~~L~~~l~~~~-----~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~-----~~~l~Df 175 (350)
||++++++|.+++.... ...++...+..++.|++.||.||| +.+++|+||+|+||+++.++ .++|+||
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH--~~~i~H~dl~p~nil~~~~~~~~~~~~~l~df 155 (269)
T cd05044 78 MELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE--QMHFIHRDLAARNCLVSEKGYDADRVVKIGDF 155 (269)
T ss_pred EeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH--hCCcccCCCChheEEEecCCCCCCcceEECCc
Confidence 99999999999996532 234788899999999999999999 89999999999999999877 8999999
Q ss_pred cccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccccCcchhhhhhhcchhhh
Q 018785 176 GLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLR 254 (350)
Q Consensus 176 g~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~ 254 (350)
|++................++..|+|||.+.+..++.++|+||||+++|+|++ |..||..........
T Consensus 156 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~----------- 224 (269)
T cd05044 156 GLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQ----------- 224 (269)
T ss_pred ccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHH-----------
Confidence 99875433222222222345677999999998899999999999999999998 999986543211111
Q ss_pred hhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018785 255 DSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 305 (350)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~ 305 (350)
.+........+..++..+.+++.+||..+|.+||++.++++.|.
T Consensus 225 -------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 225 -------HVTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred -------HHhcCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 11111112234567789999999999999999999999999886
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=280.95 Aligned_cols=258 Identities=27% Similarity=0.443 Sum_probs=206.3
Q ss_pred hhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceeeEE
Q 018785 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYC 96 (350)
Q Consensus 17 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (350)
++..++|++.++||+|++|.||++.+. .+..+++|.+.... .....+.+|+.+++.++|+||+++++++
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~vy~~~~~----------~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~ 70 (260)
T cd05073 2 EIPRESLKLEKKLGAGQFGEVWMATYN----------KHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVV 70 (260)
T ss_pred cccccceeEEeEecCccceEEEEEEec----------CCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEE
Confidence 355789999999999999999999432 24568999887543 2345678899999999999999999998
Q ss_pred eecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcccc
Q 018785 97 SESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFG 176 (350)
Q Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg 176 (350)
.. ...+++|||+.+++|.+++.......++...+..++.|++.||.+|| +.|++|+||+|+||+++.++.++|+|||
T Consensus 71 ~~-~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH--~~~i~H~dl~p~ni~i~~~~~~~l~d~~ 147 (260)
T cd05073 71 TK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE--QRNYIHRDLRAANILVSASLVCKIADFG 147 (260)
T ss_pred cC-CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHH--hCCccccccCcceEEEcCCCcEEECCCc
Confidence 87 78899999999999999998765556888899999999999999999 8999999999999999999999999999
Q ss_pred ccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccccCcchhhhhhhcchhhhh
Q 018785 177 LARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRD 255 (350)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 255 (350)
.+......... ......++..|+|||.+.+..++.++|+||||+++|++++ |..||...........
T Consensus 148 ~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~----------- 215 (260)
T cd05073 148 LARVIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRA----------- 215 (260)
T ss_pred ceeeccCCCcc-cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHH-----------
Confidence 98754322211 1112334567999999988889999999999999999998 8889875432111111
Q ss_pred hHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 018785 256 SRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 307 (350)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~ 307 (350)
+........+...+.++.+++.+||+.+|.+||++.++++.|..+
T Consensus 216 -------~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~~ 260 (260)
T cd05073 216 -------LERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 260 (260)
T ss_pred -------HhCCCCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence 111111222345677899999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=283.59 Aligned_cols=251 Identities=25% Similarity=0.362 Sum_probs=207.3
Q ss_pred hhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccc-hhhHHHHHHHHHHHhccCCCcccceeeEEee
Q 018785 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES-FQGHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (350)
Q Consensus 20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (350)
...|+..+.||.|++|.||.| .+..++..|++|.+.... ......+..|+.+++.+.||+|+++++++.+
T Consensus 3 ~~~y~~~~~lg~g~~~~vy~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 73 (277)
T cd06640 3 EELFTKLERIGKGSFGEVFKG---------IDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK 73 (277)
T ss_pred HHhhhhhhhcccCCCeEEEEE---------EEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE
Confidence 357889999999999999999 555668899999887543 2344668889999999999999999999999
Q ss_pred cCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcccccc
Q 018785 99 SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 178 (350)
Q Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~ 178 (350)
+...++||||+.+++|.+++... .++...+..++.|++.||.+|| +.+++|+||+|+||+++.++.++++|||.+
T Consensus 74 ~~~~~lv~e~~~~~~L~~~i~~~---~l~~~~~~~~~~~l~~~l~~lh--~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~ 148 (277)
T cd06640 74 GTKLWIIMEYLGGGSALDLLRAG---PFDEFQIATMLKEILKGLDYLH--SEKKIHRDIKAANVLLSEQGDVKLADFGVA 148 (277)
T ss_pred CCEEEEEEecCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH--hCCccCcCCChhhEEEcCCCCEEEcccccc
Confidence 99999999999999999988653 5888999999999999999999 999999999999999999999999999998
Q ss_pred ccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhHH
Q 018785 179 RDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRR 258 (350)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (350)
........ ......++..|+|||.+.+..++.++|+||||+++|+|++|..||..........
T Consensus 149 ~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~--------------- 211 (277)
T cd06640 149 GQLTDTQI--KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLF--------------- 211 (277)
T ss_pred eeccCCcc--ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhh---------------
Confidence 65432221 1222356778999999988889999999999999999999999987544221111
Q ss_pred HHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018785 259 VLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL 304 (350)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 304 (350)
.............++..+.+++.+||+.+|.+||++.+++++-
T Consensus 212 ---~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 254 (277)
T cd06640 212 ---LIPKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHK 254 (277)
T ss_pred ---hhhcCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhCh
Confidence 1111112234556788999999999999999999999999873
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=296.45 Aligned_cols=265 Identities=23% Similarity=0.312 Sum_probs=196.6
Q ss_pred hhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceeeEE
Q 018785 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYC 96 (350)
Q Consensus 17 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (350)
.....+|++.+.||+|+||.||+| .+..++..||+|+..... ...|+.+++.++||||+++++++
T Consensus 62 ~~~~~~y~~~~~lg~G~~g~Vy~~---------~~~~~~~~valK~~~~~~------~~~E~~~l~~l~h~~iv~~~~~~ 126 (357)
T PHA03209 62 VVASLGYTVIKTLTPGSEGRVFVA---------TKPGQPDPVVLKIGQKGT------TLIEAMLLQNVNHPSVIRMKDTL 126 (357)
T ss_pred hhhhcCcEEEEEecCCCCeEEEEE---------EECCCCceEEEEeCCccc------cHHHHHHHHhCCCCCCcChhheE
Confidence 344568999999999999999999 555668899999754332 24588999999999999999999
Q ss_pred eecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcccc
Q 018785 97 SESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFG 176 (350)
Q Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg 176 (350)
...+..++|++++ .++|.+++.... ..+++..+..++.|++.||.||| +.|++|+||||+||+++.++.++|+|||
T Consensus 127 ~~~~~~~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH--~~~ivHrDlkp~Nill~~~~~~kl~DfG 202 (357)
T PHA03209 127 VSGAITCMVLPHY-SSDLYTYLTKRS-RPLPIDQALIIEKQILEGLRYLH--AQRIIHRDVKTENIFINDVDQVCIGDLG 202 (357)
T ss_pred EeCCeeEEEEEcc-CCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEECCCCCEEEecCc
Confidence 9999999999999 568888886543 36899999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhh-------hhhhc
Q 018785 177 LARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQT-------LVEWA 249 (350)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~-------~~~~~ 249 (350)
++....... ......|+..|+|||.+.+..++.++|+|||||++|+|+++..++........... +....
T Consensus 203 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~ 279 (357)
T PHA03209 203 AAQFPVVAP---AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKII 279 (357)
T ss_pred cccccccCc---ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHH
Confidence 986422211 12234588899999999999999999999999999999987665533222111110 00000
Q ss_pred -------chhh--hhhHHHHHhhhcc--cCCC-------CcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 250 -------DPFL--RDSRRVLRIMDTR--LGGQ-------YSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 250 -------~~~~--~~~~~~~~~~~~~--~~~~-------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
..+. ........+.... .... ....++.++.+||.+||+.||.+|||+.++++|
T Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h 351 (357)
T PHA03209 280 STLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY 351 (357)
T ss_pred HHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence 0000 0000000000000 0000 011345677889999999999999999999976
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=283.58 Aligned_cols=259 Identities=26% Similarity=0.354 Sum_probs=207.2
Q ss_pred hcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch-hhHHHHHHHHHHHhccCCCcccceeeEEeec
Q 018785 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (350)
Q Consensus 21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (350)
++|++.+.||.|++|+||+| ....++..+++|.+..... .....+.+|+..++.++|+|++++++.+..+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~---------~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAA---------ICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVG 71 (267)
T ss_pred CcceeeeeecCCCCeEEEEE---------EEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeC
Confidence 47999999999999999999 4444688999999875432 2456788999999999999999999999999
Q ss_pred CceEEEEEcCCCCChhhHHhhcCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcccccc
Q 018785 100 DNRLLVYEFMPKGSLENHLFRKGV-QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 178 (350)
Q Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~-~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~ 178 (350)
+..++++|++++++|.+++..... ..+++..+..++.|++.||++|| +.|++|+||+|+||+++.++.++|+|||++
T Consensus 72 ~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh--~~~i~h~~l~p~ni~~~~~~~~~l~df~~~ 149 (267)
T cd06610 72 DELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH--SNGQIHRDIKAGNILLGEDGSVKIADFGVS 149 (267)
T ss_pred CEEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHhEEEcCCCCEEEcccchH
Confidence 999999999999999999976432 46899999999999999999999 999999999999999999999999999998
Q ss_pred ccCCCCCCCc--ccccccCCCcccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhh
Q 018785 179 RDGPTGDNTH--VSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRD 255 (350)
Q Consensus 179 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 255 (350)
.......... ......++..|++||.+... .++.++|+||||+++|+|++|+.||.................+.
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--- 226 (267)
T cd06610 150 ASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPS--- 226 (267)
T ss_pred HHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCC---
Confidence 7544433221 22334578889999988766 78899999999999999999999997654322221111110000
Q ss_pred hHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 256 SRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
.........+++.+.+++.+||..||++|||+.++++|
T Consensus 227 ----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 227 ----------LETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred ----------cCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 00000123567889999999999999999999999875
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=288.19 Aligned_cols=246 Identities=28% Similarity=0.418 Sum_probs=204.5
Q ss_pred hcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch---hhHHHHHHHHHHHhccCCCcccceeeEEe
Q 018785 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (350)
Q Consensus 21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (350)
++|++.+.||+|++|.||++ .+..+++.+++|.+..... .....+.+|+++++++.||||+++++++.
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~---------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 71 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLV---------RHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQ 71 (290)
T ss_pred CceEEEEEeecCCCeEEEEE---------EEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEE
Confidence 47999999999999999999 4555688999999865432 23456788999999999999999999999
Q ss_pred ecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccc
Q 018785 98 ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL 177 (350)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~ 177 (350)
.++..++||||+++++|.+++.... .++...+..++.|+++||.+|| +.|++|+||+|.||+++.++.++|+|||+
T Consensus 72 ~~~~~~~v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~qil~~l~~lH--~~~i~H~dl~p~nili~~~~~~kl~dfg~ 147 (290)
T cd05580 72 DDSNLYLVMEYVPGGELFSHLRKSG--RFPEPVARFYAAQVVLALEYLH--SLDIVYRDLKPENLLLDSDGYIKITDFGF 147 (290)
T ss_pred cCCeEEEEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCEecCCCCHHHEEECCCCCEEEeeCCC
Confidence 9999999999999999999997764 7899999999999999999999 99999999999999999999999999999
Q ss_pred cccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhH
Q 018785 178 ARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSR 257 (350)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 257 (350)
+...... .....+++.|+|||.+.+..++.++|+||||+++|+|++|..||...........
T Consensus 148 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~------------- 209 (290)
T cd05580 148 AKRVKGR-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEK------------- 209 (290)
T ss_pred ccccCCC-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-------------
Confidence 8764332 2224578889999999888889999999999999999999999965442111111
Q ss_pred HHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 018785 258 RVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRP-----SMVDVLTS 303 (350)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~~ 303 (350)
... .....+...+..+.+++.+||..||.+|+ +++++++|
T Consensus 210 ----~~~--~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 210 ----ILE--GKVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred ----Hhc--CCccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 111 11123445678999999999999999998 78888765
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=278.84 Aligned_cols=248 Identities=31% Similarity=0.486 Sum_probs=199.5
Q ss_pred ceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh-hHHHHHHHHHHHhccCCCcccceeeEEeecCceEEE
Q 018785 27 YLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ-GHKEWLTEVIYLGQLRHENLVKLIGYCSESDNRLLV 105 (350)
Q Consensus 27 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 105 (350)
++||.|++|.||++ .+.. ++.|++|.+...... ....+..|+.+++++.||+|+++++++...+..++|
T Consensus 1 ~~lg~g~~g~v~~~---------~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 70 (251)
T cd05041 1 EKIGKGNFGDVYKG---------VLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIV 70 (251)
T ss_pred CccccCCCceEEEE---------EEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEE
Confidence 47999999999999 4444 788999988765443 456788999999999999999999999999999999
Q ss_pred EEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccccccCCCCC
Q 018785 106 YEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGD 185 (350)
Q Consensus 106 ~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~~~~~~~ 185 (350)
+|++.+++|.+++.... ..++...+..++.+++.+|.+|| +++++|+||+|+||+++.++.++|+|||.+.......
T Consensus 71 ~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~~~~~l~~lH--~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~ 147 (251)
T cd05041 71 MELVPGGSLLTFLRKKK-NRLTVKKLLQMSLDAAAGMEYLE--SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGI 147 (251)
T ss_pred EEcCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH--hCCEehhhcCcceEEEcCCCcEEEeeccccccccCCc
Confidence 99999999999986643 26788899999999999999999 9999999999999999999999999999987543211
Q ss_pred CCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccccCcchhhhhhhcchhhhhhHHHHHhhh
Q 018785 186 NTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMD 264 (350)
Q Consensus 186 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (350)
..........+..|+|||.+.+..++.++|+||||+++|+|++ |..||........... +.
T Consensus 148 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~------------------~~ 209 (251)
T cd05041 148 YTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRER------------------IE 209 (251)
T ss_pred ceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHH------------------Hh
Confidence 1111111223456999999988889999999999999999998 7888865442211111 11
Q ss_pred cccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018785 265 TRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 305 (350)
Q Consensus 265 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~ 305 (350)
.......+...+..+.+++.+||..+|.+|||+.++++.|.
T Consensus 210 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 210 SGYRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred cCCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 11112234456789999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=281.91 Aligned_cols=255 Identities=22% Similarity=0.434 Sum_probs=205.7
Q ss_pred cccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch------hhHHHHHHHHHHHhccCCCcccceeeE
Q 018785 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF------QGHKEWLTEVIYLGQLRHENLVKLIGY 95 (350)
Q Consensus 22 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~ 95 (350)
+|+..+.||+|++|.||+| .+..+++.+++|.+..... .....+..|+..++.++|+||++++++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~---------~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 71 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQA---------RDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGA 71 (268)
T ss_pred CccccceecCcCceEEEEE---------EEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhce
Confidence 5889999999999999999 5666789999998865431 123568899999999999999999999
Q ss_pred EeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCC-cEEEcc
Q 018785 96 CSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNF-NAKLSD 174 (350)
Q Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~-~~~l~D 174 (350)
+.+.+..++|+||+.+++|.+++.... .+++..+..++.|++.||.+|| +.|++|+||+|.||+++.++ .++|+|
T Consensus 72 ~~~~~~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~ql~~al~~LH--~~~i~H~~i~~~nil~~~~~~~~~l~d 147 (268)
T cd06630 72 TCEDSHFNLFVEWMAGGSVSHLLSKYG--AFKEAVIINYTEQLLRGLSYLH--ENQIIHRDVKGANLLIDSTGQRLRIAD 147 (268)
T ss_pred eccCCeEEEEEeccCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEEcCCCCEEEEcc
Confidence 999999999999999999999997654 6899999999999999999999 99999999999999998776 599999
Q ss_pred ccccccCCCCCCC--cccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchh
Q 018785 175 FGLARDGPTGDNT--HVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPF 252 (350)
Q Consensus 175 fg~~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 252 (350)
||.+......... .......++..|+|||.+.+..++.++|+||||+++++|++|..||...........+
T Consensus 148 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~------- 220 (268)
T cd06630 148 FGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALI------- 220 (268)
T ss_pred cccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHH-------
Confidence 9998754332111 1112245678899999998888999999999999999999999999643321111111
Q ss_pred hhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 253 LRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
............+..+++++.+++.+||..+|.+||++.+++++
T Consensus 221 -------~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 221 -------FKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred -------HHHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 11111122234456678899999999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=280.16 Aligned_cols=250 Identities=24% Similarity=0.391 Sum_probs=204.8
Q ss_pred cccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch--hhHHHHHHHHHHHhccCCCcccceeeEEeec
Q 018785 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (350)
Q Consensus 22 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (350)
+|++.+.||+|++|.||++ .+..+++.+++|.+..... .....+.+|+..++.++|||++++++.+..+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~---------~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 71 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLC---------RRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLED 71 (256)
T ss_pred CceEEEEecccCceEEEEE---------EEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecC
Confidence 6899999999999999999 4555688999999876532 3346788999999999999999999999999
Q ss_pred CceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCC-cEEEcccccc
Q 018785 100 DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNF-NAKLSDFGLA 178 (350)
Q Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~-~~~l~Dfg~~ 178 (350)
+..++|+|++++++|.+++.......+++..+..++.|++.++.+|| ++|++|+||+|+||+++.++ .++|+|||.+
T Consensus 72 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh--~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~ 149 (256)
T cd08220 72 KALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH--TKLILHRDLKTQNILLDKHKMVVKIGDFGIS 149 (256)
T ss_pred CEEEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEEcCCCCEEEEccCCCc
Confidence 99999999999999999998765556899999999999999999999 99999999999999998654 5799999999
Q ss_pred ccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhHH
Q 018785 179 RDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRR 258 (350)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (350)
........ .....++..|+|||.+.+..++.++|+||+|+++|+|++|..||...........+
T Consensus 150 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~------------- 213 (256)
T cd08220 150 KILSSKSK---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKI------------- 213 (256)
T ss_pred eecCCCcc---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHH-------------
Confidence 75433221 12245778899999998888899999999999999999999999654422111111
Q ss_pred HHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 259 VLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
. .......+..++.++.+++.+||..+|.+|||+.+++++
T Consensus 214 ----~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 214 ----M-SGTFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred ----H-hcCCCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 1 111112334567889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=279.21 Aligned_cols=256 Identities=31% Similarity=0.492 Sum_probs=205.0
Q ss_pred ccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh-hHHHHHHHHHHHhccCCCcccceeeEEeecCc
Q 018785 23 FCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ-GHKEWLTEVIYLGQLRHENLVKLIGYCSESDN 101 (350)
Q Consensus 23 y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 101 (350)
+++.+.||.|+||.||++++... ...++..|++|.+...... ....+..|+..++.++|++|+++++++.+.+.
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 75 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGL-----SGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEP 75 (258)
T ss_pred CcccceeccCCCcceEEEEecCC-----CCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCe
Confidence 46789999999999999965431 1134589999999766543 45678899999999999999999999999999
Q ss_pred eEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccccccC
Q 018785 102 RLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDG 181 (350)
Q Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~~~ 181 (350)
.+++||++.+++|.+++.......+++..+..++.|++.||++|| +.|++|+||+|+||+++.++.++|+|||.+...
T Consensus 76 ~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh--~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~ 153 (258)
T smart00219 76 LMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE--SKNFIHRDLAARNCLVGENLVVKISDFGLSRDL 153 (258)
T ss_pred eEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHh--cCCeeecccccceEEEccCCeEEEcccCCceec
Confidence 999999999999999997765333899999999999999999999 999999999999999999999999999999765
Q ss_pred CCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccccCcchhhhhhhcchhhhhhHHHH
Q 018785 182 PTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVL 260 (350)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (350)
......... ...++..|++||.+.+..++.++|+||||+++++|++ |..||...........
T Consensus 154 ~~~~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~---------------- 216 (258)
T smart00219 154 YDDDYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEY---------------- 216 (258)
T ss_pred ccccccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH----------------
Confidence 443221111 1235678999999988889999999999999999998 7778765332111111
Q ss_pred HhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018785 261 RIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL 304 (350)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 304 (350)
.........+..++.++.+++.+||..||.+|||+.++++.|
T Consensus 217 --~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 217 --LKKGYRLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred --HhcCCCCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 111111223344778899999999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=281.00 Aligned_cols=252 Identities=25% Similarity=0.408 Sum_probs=200.9
Q ss_pred hcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccc-----hhhHHHHHHHHHHHhccCCCcccceeeE
Q 018785 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES-----FQGHKEWLTEVIYLGQLRHENLVKLIGY 95 (350)
Q Consensus 21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 95 (350)
.+|++.+.||+|++|.||+| .+..++..|++|.+.... ......+.+|+.+++.++||||++++++
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~---------~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 72 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLC---------YDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGC 72 (266)
T ss_pred CCccccceecCCCCEEEEEE---------EEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEE
Confidence 47999999999999999999 666778899999876432 1233567889999999999999999998
Q ss_pred Eeec--CceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEc
Q 018785 96 CSES--DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLS 173 (350)
Q Consensus 96 ~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~ 173 (350)
+.+. ...++++||+++++|.+++.... .++...++.++.|++.||++|| +.+++|+||+|+||+++.++.++|+
T Consensus 73 ~~~~~~~~~~l~~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~LH--~~~i~H~~l~p~nil~~~~~~~~l~ 148 (266)
T cd06651 73 LRDRAEKTLTIFMEYMPGGSVKDQLKAYG--ALTESVTRKYTRQILEGMSYLH--SNMIVHRDIKGANILRDSAGNVKLG 148 (266)
T ss_pred EEcCCCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--hCCeeeCCCCHHHEEECCCCCEEEc
Confidence 8753 56789999999999999997654 5889999999999999999999 9999999999999999999999999
Q ss_pred cccccccCCCCCC-CcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchh
Q 018785 174 DFGLARDGPTGDN-THVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPF 252 (350)
Q Consensus 174 Dfg~~~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 252 (350)
|||++........ ........++..|+|||.+.+..++.++|+||+||++|+|++|+.||.......
T Consensus 149 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~------------ 216 (266)
T cd06651 149 DFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMA------------ 216 (266)
T ss_pred cCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHH------------
Confidence 9999875432211 111122446788999999988889999999999999999999999997532211
Q ss_pred hhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 253 LRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
..............+..+++.+.+++ +||..+|++||+++++++|
T Consensus 217 -----~~~~~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 217 -----AIFKIATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred -----HHHHHhcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 11111111122334556677888888 6777899999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=286.26 Aligned_cols=268 Identities=26% Similarity=0.338 Sum_probs=202.5
Q ss_pred hcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch--hhHHHHHHHHHHHhccCCCcccceeeEEee
Q 018785 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (350)
Q Consensus 21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (350)
++|++.+.||+|++|.||+| .+..+++.|++|.+..... .....+.+|+.+++.++|||++++++++..
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~---------~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~ 71 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKC---------RNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRR 71 (286)
T ss_pred CceeeeeeecccCCeEEEEE---------EECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEee
Confidence 47999999999999999999 5556689999998865432 223457789999999999999999999999
Q ss_pred cCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcccccc
Q 018785 99 SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 178 (350)
Q Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~ 178 (350)
....++||||+++++|..+..... .+++..+..++.|++.+|+||| +.|++|+||+|+||+++.++.++|+|||++
T Consensus 72 ~~~~~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~ql~~~l~~LH--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~ 147 (286)
T cd07847 72 KRKLHLVFEYCDHTVLNELEKNPR--GVPEHLIKKIIWQTLQAVNFCH--KHNCIHRDVKPENILITKQGQIKLCDFGFA 147 (286)
T ss_pred CCEEEEEEeccCccHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHH--HCCceecCCChhhEEEcCCCcEEECccccc
Confidence 999999999998887777665443 6899999999999999999999 899999999999999999999999999999
Q ss_pred ccCCCCCCCcccccccCCCcccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhH
Q 018785 179 RDGPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSR 257 (350)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 257 (350)
........ ......++..|+|||.+.+ ..++.++|+||+|+++|+|++|+.||.+.........+............
T Consensus 148 ~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (286)
T cd07847 148 RILTGPGD--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQ 225 (286)
T ss_pred eecCCCcc--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHh
Confidence 76433321 1122346778999998876 46788999999999999999999999865543222222211111111000
Q ss_pred HHH-------HhhhcccCC-----CCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 258 RVL-------RIMDTRLGG-----QYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 258 ~~~-------~~~~~~~~~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
... ......... .....++..+.+|+.+||+.+|++||++.+++.|
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 226 QIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred hhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 000 000000000 0012356789999999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=280.52 Aligned_cols=252 Identities=24% Similarity=0.364 Sum_probs=202.1
Q ss_pred hcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccc-----hhhHHHHHHHHHHHhccCCCcccceeeE
Q 018785 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES-----FQGHKEWLTEVIYLGQLRHENLVKLIGY 95 (350)
Q Consensus 21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 95 (350)
.+|++.+.||+|++|.||.| .+..++..|++|.+.... ......+.+|+..++.+.||||++++++
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~---------~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 72 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLC---------YDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGC 72 (265)
T ss_pred CcceEeeEEecCCceEEEEE---------EEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeE
Confidence 57999999999999999999 566678999999875322 1234567889999999999999999998
Q ss_pred Eeec--CceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEc
Q 018785 96 CSES--DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLS 173 (350)
Q Consensus 96 ~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~ 173 (350)
+.+. ..++++|||+++++|.+++.... .+++..+..++.|++.||.+|| +.+++|+||+|+||+++.++.++|+
T Consensus 73 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH--~~~i~H~dl~p~nil~~~~~~~~l~ 148 (265)
T cd06652 73 LRDPMERTLSIFMEHMPGGSIKDQLKSYG--ALTENVTRKYTRQILEGVSYLH--SNMIVHRDIKGANILRDSVGNVKLG 148 (265)
T ss_pred eccCCCceEEEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--hCCEecCCCCHHHEEecCCCCEEEC
Confidence 8764 46789999999999999987654 5888999999999999999999 9999999999999999999999999
Q ss_pred cccccccCCCCCCC-cccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchh
Q 018785 174 DFGLARDGPTGDNT-HVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPF 252 (350)
Q Consensus 174 Dfg~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 252 (350)
|||.+......... .......++..|+|||.+.+..++.++|+||||+++|+|++|+.||.......
T Consensus 149 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~------------ 216 (265)
T cd06652 149 DFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA------------ 216 (265)
T ss_pred cCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHH------------
Confidence 99998754322111 11222457788999999988889999999999999999999999996432111
Q ss_pred hhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 253 LRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
..............+..++..+.+++.+|+. +|.+||++++++++
T Consensus 217 -----~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 217 -----AIFKIATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred -----HHHHHhcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 1111111222233456677889999999995 99999999999865
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=289.60 Aligned_cols=266 Identities=19% Similarity=0.263 Sum_probs=190.0
Q ss_pred cceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceeeEEee--cCceE
Q 018785 26 DYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSE--SDNRL 103 (350)
Q Consensus 26 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~ 103 (350)
.++||+|+||+||+|+.. +..++..+|+|.+..... ...+.+|+.+++.++||||+++++++.. +...+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~-------~~~~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 76 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRK-------DGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVW 76 (317)
T ss_pred ccccccCCCeEEEEEEEc-------cCCCCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEE
Confidence 468999999999999542 234578899998865432 2456789999999999999999998854 45678
Q ss_pred EEEEcCCCCChhhHHhhcC-------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEE----cCCCcEEE
Q 018785 104 LVYEFMPKGSLENHLFRKG-------VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLL----DSNFNAKL 172 (350)
Q Consensus 104 lv~e~~~~~~L~~~l~~~~-------~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili----~~~~~~~l 172 (350)
+++||+ +++|.+++.... ...+++..+..++.|++.||.||| +.|++|+||||+||++ +.++.++|
T Consensus 77 lv~e~~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH--~~~ivHrDlkp~Nil~~~~~~~~~~~kl 153 (317)
T cd07868 77 LLFDYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH--ANWVLHRDLKPANILVMGEGPERGRVKI 153 (317)
T ss_pred EEEecc-CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH--hCCEEcCCCCHHHEEEecCCCCcCcEEE
Confidence 999998 568888875331 225889999999999999999999 9999999999999999 45678999
Q ss_pred ccccccccCCCCCC-CcccccccCCCcccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCcccccCcch--------
Q 018785 173 SDFGLARDGPTGDN-THVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAE-------- 242 (350)
Q Consensus 173 ~Dfg~~~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~-------- 242 (350)
+|||++........ ........+++.|+|||.+.+. .++.++|+||+||++|+|++|+.||.........
T Consensus 154 ~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~ 233 (317)
T cd07868 154 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ 233 (317)
T ss_pred eecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHH
Confidence 99999976432221 1122335678899999998774 5889999999999999999999999754432110
Q ss_pred -hhhhh-hcchhhhhhHHHHH---------hhhcccC--C-------CCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018785 243 -QTLVE-WADPFLRDSRRVLR---------IMDTRLG--G-------QYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLT 302 (350)
Q Consensus 243 -~~~~~-~~~~~~~~~~~~~~---------~~~~~~~--~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 302 (350)
..+.. ...+...+...... ....... . ......+..+.+||.+||+.||.+|||++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~ 313 (317)
T cd07868 234 LDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 313 (317)
T ss_pred HHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00100 00011000000000 0000000 0 000112356889999999999999999999987
Q ss_pred H
Q 018785 303 S 303 (350)
Q Consensus 303 ~ 303 (350)
|
T Consensus 314 h 314 (317)
T cd07868 314 D 314 (317)
T ss_pred C
Confidence 5
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=284.87 Aligned_cols=251 Identities=25% Similarity=0.359 Sum_probs=204.9
Q ss_pred hhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccc-hhhHHHHHHHHHHHhccCCCcccceeeEEee
Q 018785 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES-FQGHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (350)
Q Consensus 20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (350)
...|++.+.||+|++|.||+| .+..++..||+|.+.... ......+.+|+..++.++||||+++++.+..
T Consensus 3 ~~~y~~~~~l~~g~~~~vy~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 73 (277)
T cd06642 3 EELFTKLERIGKGSFGEVYKG---------IDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLK 73 (277)
T ss_pred HHHHHHHHHhcCCCCeeEEEE---------EEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhccccc
Confidence 357888999999999999999 555568899999887543 2334568899999999999999999999999
Q ss_pred cCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcccccc
Q 018785 99 SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 178 (350)
Q Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~ 178 (350)
++..++|+||+.+++|.+++... .+++..+..++.|++.|+.||| +.|++|+||+|+||+++.++.++|+|||++
T Consensus 74 ~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH--~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~ 148 (277)
T cd06642 74 GTKLWIIMEYLGGGSALDLLKPG---PLEETYIATILREILKGLDYLH--SERKIHRDIKAANVLLSEQGDVKLADFGVA 148 (277)
T ss_pred CCceEEEEEccCCCcHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHh--cCCeeccCCChheEEEeCCCCEEEcccccc
Confidence 99999999999999999988643 5889999999999999999999 999999999999999999999999999998
Q ss_pred ccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhHH
Q 018785 179 RDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRR 258 (350)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (350)
....... .......++..|+|||.+.+..++.++|+||||+++|+|++|..||...........
T Consensus 149 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~-------------- 212 (277)
T cd06642 149 GQLTDTQ--IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFL-------------- 212 (277)
T ss_pred ccccCcc--hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhh--------------
Confidence 6543221 112224567889999999888899999999999999999999999865432211111
Q ss_pred HHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018785 259 VLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL 304 (350)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 304 (350)
............++.++.+++.+||+.+|.+||++.+++++-
T Consensus 213 ----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 254 (277)
T cd06642 213 ----IPKNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHK 254 (277)
T ss_pred ----hhcCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhH
Confidence 111111122345677899999999999999999999999863
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=280.15 Aligned_cols=249 Identities=29% Similarity=0.472 Sum_probs=203.4
Q ss_pred cccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch-----hhHHHHHHHHHHHhccCCCcccceeeEE
Q 018785 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-----QGHKEWLTEVIYLGQLRHENLVKLIGYC 96 (350)
Q Consensus 22 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (350)
+|+..+.||+|++|.||+| ....++..|++|.+..... .....+.+|+.+++.++|+||+++++++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~---------~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~ 71 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEG---------LNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTE 71 (258)
T ss_pred CccccceeeecCCceEEEE---------EEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeE
Confidence 5888999999999999999 4555688999998865432 2346688999999999999999999999
Q ss_pred eecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcccc
Q 018785 97 SESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFG 176 (350)
Q Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg 176 (350)
..+...++++||+++++|.+++.... .++...+..++.|++.||++|| +.|++|+||+|+||+++.++.++|+|||
T Consensus 72 ~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dl~~~ni~~~~~~~~kl~d~~ 147 (258)
T cd06632 72 REEDNLYIFLELVPGGSLAKLLKKYG--SFPEPVIRLYTRQILLGLEYLH--DRNTVHRDIKGANILVDTNGVVKLADFG 147 (258)
T ss_pred ecCCeEEEEEEecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEECCCCCEEEccCc
Confidence 99999999999999999999997664 6889999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCCCCcccccccCCCcccCccccccCC-CCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhh
Q 018785 177 LARDGPTGDNTHVSTRIVGTRGYAAPEYVATGH-LTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRD 255 (350)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 255 (350)
.+....... ......++..|++||.+.... ++.++|+||||+++|+|++|+.||.........
T Consensus 148 ~~~~~~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~------------- 211 (258)
T cd06632 148 MAKQVVEFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAV------------- 211 (258)
T ss_pred cceeccccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHH-------------
Confidence 987543322 122345788899999987766 899999999999999999999999654311100
Q ss_pred hHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 256 SRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
............+..+++.+.+++.+||+.+|.+||++.+++.+
T Consensus 212 ----~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 212 ----FKIGRSKELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred ----HHHHhcccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 01111011122344567889999999999999999999999864
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=314.00 Aligned_cols=263 Identities=22% Similarity=0.327 Sum_probs=206.9
Q ss_pred hcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch---hhHHHHHHHHHHHhccCCCcccceeeEEe
Q 018785 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (350)
Q Consensus 21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (350)
++|++.++||+|+||.||+| .+..+|+.||+|.+..... .....+.+|+.+++.++||||+++++++.
T Consensus 2 grYeIi~~LGkGgfG~VYlA---------~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~ 72 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLA---------YDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICS 72 (932)
T ss_pred CCeEEEEEEecCCCEEEEEE---------EECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEe
Confidence 58999999999999999999 5666789999999875432 22356788999999999999999999999
Q ss_pred ecCceEEEEEcCCCCChhhHHhhcC---------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCC
Q 018785 98 ESDNRLLVYEFMPKGSLENHLFRKG---------VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNF 168 (350)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~---------~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~ 168 (350)
+++..+++|||++|++|.+++.... ...++...+..++.|++.||+||| +.|++||||||+||+++.++
T Consensus 73 d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH--s~GIIHRDLKPeNILLd~dg 150 (932)
T PRK13184 73 DGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH--SKGVLHRDLKPDNILLGLFG 150 (932)
T ss_pred eCCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH--HCCccccCCchheEEEcCCC
Confidence 9999999999999999999886421 123556678899999999999999 89999999999999999999
Q ss_pred cEEEccccccccCCCCCC----------------CcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCC
Q 018785 169 NAKLSDFGLARDGPTGDN----------------THVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRA 232 (350)
Q Consensus 169 ~~~l~Dfg~~~~~~~~~~----------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~p 232 (350)
.++|+|||++........ ........|++.|+|||.+.+..++.++|+|||||++|+|++|..|
T Consensus 151 ~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~P 230 (932)
T PRK13184 151 EVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230 (932)
T ss_pred CEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCC
Confidence 999999999975421110 0111224689999999999999999999999999999999999999
Q ss_pred CcccccCcchhhhhhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCC-CHHHHHHHHHhhhcC
Q 018785 233 LDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRP-SMVDVLTSLEQLHTS 310 (350)
Q Consensus 233 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-s~~~ll~~L~~~~~~ 310 (350)
|........... ..............+++.+.+++.+||+.||++|+ +++++++.|+.....
T Consensus 231 F~~~~~~ki~~~----------------~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 231 YRRKKGRKISYR----------------DVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG 293 (932)
T ss_pred CCCcchhhhhhh----------------hhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 976332111000 00000000111235678899999999999999995 677777888877554
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=278.16 Aligned_cols=248 Identities=31% Similarity=0.499 Sum_probs=201.7
Q ss_pred hhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceeeEEeec
Q 018785 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (350)
Q Consensus 20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (350)
.++|++.+.||+|+||.||++.. ++..+++|.+.... ....+.+|+..++.++|||++++++++..
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~-----------~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~- 70 (254)
T cd05083 5 LQKLTLGEIIGEGEFGAVLQGEY-----------TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILH- 70 (254)
T ss_pred HHHceeeeeeccCCCCceEeccc-----------CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcC-
Confidence 47899999999999999999832 46779999886543 33567889999999999999999999865
Q ss_pred CceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccccc
Q 018785 100 DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR 179 (350)
Q Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~ 179 (350)
+..+++|||+.+++|.+++.......++...+..++.|++.||.+|| +.|++|+||+|+||+++.++.++|+|||++.
T Consensus 71 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH--~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~ 148 (254)
T cd05083 71 NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE--SKKLVHRDLAARNILVSEDGVAKVSDFGLAR 148 (254)
T ss_pred CCcEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH--hCCeeccccCcceEEEcCCCcEEECCCccce
Confidence 45799999999999999998766556899999999999999999999 9999999999999999999999999999987
Q ss_pred cCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccccCcchhhhhhhcchhhhhhHH
Q 018785 180 DGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRR 258 (350)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (350)
...... .....+..|+|||.+.+..++.++|+||||+++|+|++ |..||..........
T Consensus 149 ~~~~~~-----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~--------------- 208 (254)
T cd05083 149 VGSMGV-----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKE--------------- 208 (254)
T ss_pred eccccC-----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHH---------------
Confidence 532211 11223457999999988899999999999999999997 888986544211111
Q ss_pred HHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 018785 259 VLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQ 306 (350)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 306 (350)
..........+..++..+.+++.+||+.+|.+||++.++++.|..
T Consensus 209 ---~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 209 ---CVEKGYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred ---HHhCCCCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 111111222344567889999999999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=284.61 Aligned_cols=267 Identities=27% Similarity=0.328 Sum_probs=208.6
Q ss_pred hhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch-hhHHHHHHHHHHHhccCCCcccceeeEE
Q 018785 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLVKLIGYC 96 (350)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (350)
+..++|++.+.||+|++|+||++ .+..++..|++|++..... .....+.+|+++++.++||||+++++.+
T Consensus 2 l~~~~~~~~~~ig~g~~g~v~~~---------~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 72 (284)
T cd06620 2 LRNEDLETISDLGAGNGGSVSKV---------KHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72 (284)
T ss_pred ccHHHHHHHHHcCCCCCeEEEEE---------EEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeE
Confidence 45689999999999999999999 5556688999998765432 3346788999999999999999999999
Q ss_pred eecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcccc
Q 018785 97 SESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFG 176 (350)
Q Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg 176 (350)
...+..++|+||+++++|.+++...+ .++...+..++.+++.+|.|||+ ..+++|+||+|+||+++.++.++|+|||
T Consensus 73 ~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~-~~~i~H~dl~p~nil~~~~~~~~l~d~g 149 (284)
T cd06620 73 LNENNICMCMEFMDCGSLDRIYKKGG--PIPVEILGKIAVAVVEGLTYLYN-VHRIMHRDIKPSNILVNSRGQIKLCDFG 149 (284)
T ss_pred ecCCEEEEEEecCCCCCHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHH-hcCeeccCCCHHHEEECCCCcEEEccCC
Confidence 99999999999999999999887654 68999999999999999999993 2689999999999999999999999999
Q ss_pred ccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhh
Q 018785 177 LARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDS 256 (350)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 256 (350)
++....... .....++..|+|||.+.+..++.++|+||+||++|+|++|..||.............. .-.
T Consensus 150 l~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~------~~~ 219 (284)
T cd06620 150 VSGELINSI----ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPM------GIL 219 (284)
T ss_pred cccchhhhc----cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhh------HHH
Confidence 886432211 1234578889999999888999999999999999999999999975443211000000 000
Q ss_pred HHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 018785 257 RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQ 306 (350)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 306 (350)
..................++.++.+|+.+||+.||.+|||+.+++++..-
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~ 269 (284)
T cd06620 220 DLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPF 269 (284)
T ss_pred HHHHHHhhccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccc
Confidence 01111111111111122367789999999999999999999999987433
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=295.22 Aligned_cols=242 Identities=24% Similarity=0.335 Sum_probs=189.3
Q ss_pred ecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhh---HHHHHHHHHHHhcc---CCCcccceeeEEeecCce
Q 018785 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQG---HKEWLTEVIYLGQL---RHENLVKLIGYCSESDNR 102 (350)
Q Consensus 29 lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~~~~ 102 (350)
||+|+||+||+| .+..++..||+|++....... ......|..++... .||+|+++++.+...+..
T Consensus 1 lG~G~~g~Vy~~---------~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~ 71 (330)
T cd05586 1 IGKGTFGQVYQV---------RKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDL 71 (330)
T ss_pred CCCCCceEEEEE---------EECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeE
Confidence 799999999999 666678999999986543221 22334455555544 699999999999999999
Q ss_pred EEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccccccCC
Q 018785 103 LLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGP 182 (350)
Q Consensus 103 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~~~~ 182 (350)
++||||+.+++|.+++.... .+++..+..++.||+.||+||| +.|++|+||||+||+++.++.++|+|||++....
T Consensus 72 ~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qil~al~~LH--~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~ 147 (330)
T cd05586 72 YLVTDYMSGGELFWHLQKEG--RFSEDRAKFYIAELVLALEHLH--KYDIVYRDLKPENILLDATGHIALCDFGLSKANL 147 (330)
T ss_pred EEEEcCCCCChHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--HCCeEeccCCHHHeEECCCCCEEEecCCcCcCCC
Confidence 99999999999999887654 6899999999999999999999 9999999999999999999999999999986432
Q ss_pred CCCCCcccccccCCCcccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhHHHHH
Q 018785 183 TGDNTHVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLR 261 (350)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (350)
... .......|++.|+|||.+.+. .++.++|||||||++|+|++|..||...........+.
T Consensus 148 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~--------------- 210 (330)
T cd05586 148 TDN--KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIA--------------- 210 (330)
T ss_pred CCC--CCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHH---------------
Confidence 221 112235688999999988764 57899999999999999999999997643211111111
Q ss_pred hhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCC----CHHHHHHH
Q 018785 262 IMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRP----SMVDVLTS 303 (350)
Q Consensus 262 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp----s~~~ll~~ 303 (350)
.... ......+++++.+++.+||..||.+|| ++.++++|
T Consensus 211 --~~~~-~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h 253 (330)
T cd05586 211 --FGKV-RFPKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEH 253 (330)
T ss_pred --cCCC-CCCCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence 0000 001123577899999999999999998 67777765
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=279.65 Aligned_cols=253 Identities=26% Similarity=0.395 Sum_probs=209.3
Q ss_pred hcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch-hhHHHHHHHHHHHhccCCCcccceeeEEeec
Q 018785 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (350)
Q Consensus 21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (350)
++|++.+.||.|++|.||+| .+..+++.|++|.+..... .....+..|+..+..++|+|++++++++...
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~---------~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKV---------RHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKE 71 (264)
T ss_pred CcceeeeeeeecCCeEEEEE---------EEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccC
Confidence 47899999999999999999 5666789999999877654 3456788999999999999999999999999
Q ss_pred CceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCC-CCeeeCCCCCCceEEcCCCcEEEcccccc
Q 018785 100 DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLD-ANVIYRDLKASNVLLDSNFNAKLSDFGLA 178 (350)
Q Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~-~~i~H~di~~~Nili~~~~~~~l~Dfg~~ 178 (350)
+..++|+||+++++|.+++.... .+++..++.++.|++.++.+|| + .|++|+||+|+||+++.++.++|+|||.+
T Consensus 72 ~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~l~~~l~~lh--~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~ 147 (264)
T cd06623 72 GEISIVLEYMDGGSLADLLKKVG--KIPEPVLAYIARQILKGLDYLH--TKRHIIHRDIKPSNLLINSKGEVKIADFGIS 147 (264)
T ss_pred CeEEEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHh--ccCCCccCCCCHHHEEECCCCCEEEccCccc
Confidence 99999999999999999997763 7899999999999999999999 8 99999999999999999999999999998
Q ss_pred ccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhHH
Q 018785 179 RDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRR 258 (350)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (350)
......... .....++..|+|||.+.+..++.++|+||||+++|+|++|..||......... .
T Consensus 148 ~~~~~~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~---------------~ 210 (264)
T cd06623 148 KVLENTLDQ--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFF---------------E 210 (264)
T ss_pred eecccCCCc--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHH---------------H
Confidence 764332222 12345678899999998889999999999999999999999999765421110 1
Q ss_pred HHHhhhcccCCCCcHH-HHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 259 VLRIMDTRLGGQYSKK-EAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 259 ~~~~~~~~~~~~~~~~-~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
....+........+.. ++..+.+++.+||..+|++|||+.+++++
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 211 LMQAICDGPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred HHHHHhcCCCCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 1111111122223344 78899999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=283.23 Aligned_cols=254 Identities=26% Similarity=0.350 Sum_probs=201.6
Q ss_pred hhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhcc-CCCcccceeeEEe
Q 018785 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQL-RHENLVKLIGYCS 97 (350)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~ 97 (350)
..++|++.+.||+|++|.||+| .+..+++.+++|.+...... ...+.+|+.+++++ .|+||+++++++.
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~---------~~~~~~~~~~~k~~~~~~~~-~~~~~~e~~~l~~~~~h~~i~~~~~~~~ 73 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKA---------RHKKTGQLVAIKIMDIIEDE-EEEIKEEYNILRKYSNHPNIATFYGAFI 73 (275)
T ss_pred chhheeheeeecCCCCeEEEEE---------EECCCCcEEEEEEEecCchh-HHHHHHHHHHHHHhcCCCChheEEEEEE
Confidence 4589999999999999999999 55556889999998766533 45688999999999 6999999999997
Q ss_pred ecC------ceEEEEEcCCCCChhhHHhhcC--CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCc
Q 018785 98 ESD------NRLLVYEFMPKGSLENHLFRKG--VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFN 169 (350)
Q Consensus 98 ~~~------~~~lv~e~~~~~~L~~~l~~~~--~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~ 169 (350)
... ..++||||+++++|.+++.... ...+++..+..++.|++.||.||| +.|++|+||+|+||+++.++.
T Consensus 74 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH--~~~i~H~~l~p~ni~~~~~~~ 151 (275)
T cd06608 74 KKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH--ENKVIHRDIKGQNILLTKNAE 151 (275)
T ss_pred ecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHh--cCCcccCCCCHHHEEEccCCe
Confidence 644 4899999999999999886533 347899999999999999999999 999999999999999999999
Q ss_pred EEEccccccccCCCCCCCcccccccCCCcccCcccccc-----CCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhh
Q 018785 170 AKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-----GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQT 244 (350)
Q Consensus 170 ~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~ 244 (350)
++|+|||.+....... .......++..|+|||.+.. ..++.++|+||||+++|+|++|..||..........
T Consensus 152 ~~l~d~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~- 228 (275)
T cd06608 152 VKLVDFGVSAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALF- 228 (275)
T ss_pred EEECCCccceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHH-
Confidence 9999999986532221 11223457888999998753 346788999999999999999999996433211111
Q ss_pred hhhhcchhhhhhHHHHHhhhccc-CCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 245 LVEWADPFLRDSRRVLRIMDTRL-GGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
+...... ....+..+++.+.+++.+||..||.+|||+.+++++
T Consensus 229 ----------------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 229 ----------------KIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred ----------------HhhccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 1111111 111223467789999999999999999999999864
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=286.69 Aligned_cols=267 Identities=24% Similarity=0.300 Sum_probs=199.3
Q ss_pred cccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh--hHHHHHHHHHHHhccCCCcccceeeEEeec
Q 018785 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ--GHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (350)
Q Consensus 22 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (350)
+|++.+.||+|++|.||+| .+..+|..+++|.+...... ....+.+|+.++++++||||+++++++.+.
T Consensus 1 ~y~~~~~l~~g~~~~vy~~---------~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~ 71 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKA---------KNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSD 71 (284)
T ss_pred CceeEEEecccCCeEEEEE---------EECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccC
Confidence 5899999999999999999 56667889999988654322 224567899999999999999999999999
Q ss_pred CceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccccc
Q 018785 100 DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR 179 (350)
Q Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~ 179 (350)
+..++|+||+. ++|.+++.... ..+++..+..++.|+++||.||| +.|++|+||+|+||+++.++.++|+|||++.
T Consensus 72 ~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH--~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~ 147 (284)
T cd07839 72 KKLTLVFEYCD-QDLKKYFDSCN-GDIDPEIVKSFMFQLLKGLAFCH--SHNVLHRDLKPQNLLINKNGELKLADFGLAR 147 (284)
T ss_pred CceEEEEecCC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH--HCCEecCCCCHHHEEEcCCCcEEECccchhh
Confidence 99999999995 58888876543 36899999999999999999999 9999999999999999999999999999987
Q ss_pred cCCCCCCCcccccccCCCcccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCccccc-Ccchhhhhhhcc-hhhhhh
Q 018785 180 DGPTGDNTHVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRALDEDRG-GLAEQTLVEWAD-PFLRDS 256 (350)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~ll~~ll~g~~pf~~~~~-~~~~~~~~~~~~-~~~~~~ 256 (350)
....... ......++..|+|||.+.+. .++.++|+||||+++|+|++|..||..... ......+..... +.....
T Consensus 148 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (284)
T cd07839 148 AFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESW 225 (284)
T ss_pred ccCCCCC--CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHh
Confidence 5432221 11224567889999988765 478999999999999999999988643322 111111111100 000000
Q ss_pred HHHHHhhhcccC---------CCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 257 RRVLRIMDTRLG---------GQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 257 ~~~~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
............ ......+++++.+++.+||+.||.+|||++++++|
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 226 PGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred HHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 000000000000 01122457889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=284.53 Aligned_cols=268 Identities=23% Similarity=0.317 Sum_probs=204.2
Q ss_pred cccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch--hhHHHHHHHHHHHhccCCCcccceeeEEeec
Q 018785 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (350)
Q Consensus 22 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (350)
+|++.+.||.|++|.||+| .+..+|..|++|.+..... .....+..|+.+++.++|||++++++++..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~---------~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 71 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKA---------KDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHG 71 (286)
T ss_pred CceEEeecccCCCcEEEEE---------EECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecC
Confidence 5899999999999999999 5555688999999876542 2345688899999999999999999999999
Q ss_pred CceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccccc
Q 018785 100 DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR 179 (350)
Q Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~ 179 (350)
...++|+||+ +++|.+++.... ..+++..++.++.|++.||+||| +.|++|+||+|+||+++.++.++|+|||.+.
T Consensus 72 ~~~~~v~e~~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~ 147 (286)
T cd07832 72 SGFVLVMEYM-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMH--ANGIMHRDLKPANLLISADGVLKIADFGLAR 147 (286)
T ss_pred CeeEEEeccc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCcCHHHEEEcCCCcEEEeeeeecc
Confidence 9999999999 999999986544 46999999999999999999999 9999999999999999999999999999987
Q ss_pred cCCCCCCCcccccccCCCcccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcc-hhhhhh-
Q 018785 180 DGPTGDNTHVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD-PFLRDS- 256 (350)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~- 256 (350)
....... .......++..|+|||.+.+. .++.++|+||+|+++++|++|..||....+......+..... +.....
T Consensus 148 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (286)
T cd07832 148 LFSEEEP-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWP 226 (286)
T ss_pred cccCCCC-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHh
Confidence 6533321 112234578889999988654 468999999999999999999888865443222211111100 000000
Q ss_pred -----HHHHHhhhccc-C---CCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 257 -----RRVLRIMDTRL-G---GQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 257 -----~~~~~~~~~~~-~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
........... . .......+..+.+++.+||..+|.+|||++++++|
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 227 GLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred hccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000000000 0 00112456899999999999999999999999876
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=279.00 Aligned_cols=252 Identities=30% Similarity=0.447 Sum_probs=196.2
Q ss_pred ceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccc-hhhHHHHHHHHHHHhcc-CCCcccceeeEEeecCceEE
Q 018785 27 YLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES-FQGHKEWLTEVIYLGQL-RHENLVKLIGYCSESDNRLL 104 (350)
Q Consensus 27 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l 104 (350)
+.||+|+||.||+|++.+ ......+++|.+.... ......+.+|+..+.++ .||||+++++++...+..++
T Consensus 1 ~~lg~g~~g~v~~~~~~~-------~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 73 (270)
T cd05047 1 DVIGEGNFGQVLKARIKK-------DGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 73 (270)
T ss_pred CcCCCCCCceEEEEEEcC-------CCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceE
Confidence 468999999999995432 1122357888877533 23345788899999999 79999999999999999999
Q ss_pred EEEcCCCCChhhHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcE
Q 018785 105 VYEFMPKGSLENHLFRKG--------------VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNA 170 (350)
Q Consensus 105 v~e~~~~~~L~~~l~~~~--------------~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~ 170 (350)
+|||+++++|.+++..+. ...++...+..++.|++.||+||| +.|++|+||+|+||+++.++.+
T Consensus 74 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH--~~~i~H~dikp~nili~~~~~~ 151 (270)
T cd05047 74 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS--QKQFIHRDLAARNILVGENYVA 151 (270)
T ss_pred EEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH--HCCEeecccccceEEEcCCCeE
Confidence 999999999999986542 124788899999999999999999 9999999999999999999999
Q ss_pred EEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccccCcchhhhhhhc
Q 018785 171 KLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWA 249 (350)
Q Consensus 171 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~ 249 (350)
+|+|||++....... .......+..|+|||.+.+..++.++|+||||+++|+|++ |..||.+.........
T Consensus 152 kl~dfgl~~~~~~~~---~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~----- 223 (270)
T cd05047 152 KIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK----- 223 (270)
T ss_pred EECCCCCccccchhh---hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHH-----
Confidence 999999985321111 1111223456999999988889999999999999999997 9999965432111111
Q ss_pred chhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 018785 250 DPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLH 308 (350)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 308 (350)
+........+..++.++.+++.+||..+|.+|||+.++++.|..+.
T Consensus 224 -------------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 224 -------------LPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred -------------HhCCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 1111112223346678999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=282.36 Aligned_cols=254 Identities=28% Similarity=0.378 Sum_probs=205.4
Q ss_pred hcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch-hhHHHHHHHHHHHhccCCCcccceeeEEeec
Q 018785 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (350)
Q Consensus 21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (350)
++|++.+.||.|++|.||++ .+..+++.+++|.+..... .....+.+|+..++.+.||||+++++.+..+
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~---------~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 71 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKV---------LHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNN 71 (265)
T ss_pred CcchHHHHhcCCCCeEEEEE---------EEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecC
Confidence 47889999999999999999 5666789999998876643 3345678899999999999999999999999
Q ss_pred CceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCC-CCeeeCCCCCCceEEcCCCcEEEcccccc
Q 018785 100 DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLD-ANVIYRDLKASNVLLDSNFNAKLSDFGLA 178 (350)
Q Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~-~~i~H~di~~~Nili~~~~~~~l~Dfg~~ 178 (350)
+..++++|++.+++|.+++.... ..+++..+..++.|+++|++++| + .|++|+||+|+||+++.++.++|+|||.+
T Consensus 72 ~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH--~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~ 148 (265)
T cd06605 72 GDISICMEYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLH--EKHKIIHRDVKPSNILVNSRGQIKLCDFGVS 148 (265)
T ss_pred CEEEEEEEecCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHc--CCCCeecCCCCHHHEEECCCCCEEEeecccc
Confidence 99999999999899999997653 47899999999999999999999 7 99999999999999999999999999988
Q ss_pred ccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhHH
Q 018785 179 RDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRR 258 (350)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (350)
........ ....++..|+|||.+.+..++.++|+||||+++|+|++|..||........ .. ...
T Consensus 149 ~~~~~~~~----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~--~~----------~~~ 212 (265)
T cd06605 149 GQLVNSLA----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPD--GI----------FEL 212 (265)
T ss_pred hhhHHHHh----hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccc--cH----------HHH
Confidence 64322111 114577889999999888999999999999999999999999965432100 00 000
Q ss_pred HHHhhhcccCCCCcHH-HHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 259 VLRIMDTRLGGQYSKK-EAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 259 ~~~~~~~~~~~~~~~~-~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
....... .....+.. ++.++.++|.+||..||++|||+.+++.+
T Consensus 213 ~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 213 LQYIVNE-PPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred HHHHhcC-CCCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 1111111 11122333 78889999999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=284.65 Aligned_cols=255 Identities=27% Similarity=0.337 Sum_probs=202.1
Q ss_pred hhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhcc-CCCcccceeeEE
Q 018785 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQL-RHENLVKLIGYC 96 (350)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~ 96 (350)
...++|++.+.||.|+||.||+| .+..+++.+++|.+..... ....+..|+..++.+ +|||++++++++
T Consensus 13 ~~~~~~~~~~~lg~g~~~~v~~~---------~~~~~~~~~a~K~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~ 82 (282)
T cd06636 13 DPAGIFELVEVVGNGTYGQVYKG---------RHVKTGQLAAIKVMDVTED-EEEEIKLEINMLKKYSHHRNIATYYGAF 82 (282)
T ss_pred ChhhhhhhheeeccCCCeEEEEE---------EEcCCCcEEEEEEEecChH-HHHHHHHHHHHHHHhcCCCcEEEEeeeh
Confidence 45689999999999999999999 5556688999998866542 335677888888888 699999999998
Q ss_pred ee------cCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcE
Q 018785 97 SE------SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNA 170 (350)
Q Consensus 97 ~~------~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~ 170 (350)
.. .+..+++|||+.+++|.+++.......+++..+..++.|++.|+.||| +.|++|+||+|+||+++.++.+
T Consensus 83 ~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH--~~~ivH~dl~~~nili~~~~~~ 160 (282)
T cd06636 83 IKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLH--AHKVIHRDIKGQNVLLTENAEV 160 (282)
T ss_pred hcccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEECCCCCE
Confidence 53 457899999999999999998765556888899999999999999999 9999999999999999999999
Q ss_pred EEccccccccCCCCCCCcccccccCCCcccCccccc-----cCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhh
Q 018785 171 KLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVA-----TGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTL 245 (350)
Q Consensus 171 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~ 245 (350)
+|+|||++........ ......++..|+|||.+. +..++.++|+||||+++|+|++|..||..........
T Consensus 161 ~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~-- 236 (282)
T cd06636 161 KLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF-- 236 (282)
T ss_pred EEeeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh--
Confidence 9999999875322111 122345788899999875 3467889999999999999999999996543211110
Q ss_pred hhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 246 VEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
..............++.++.++|.+||..||.+|||+.+++++
T Consensus 237 ---------------~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 237 ---------------LIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred ---------------hHhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 1111111112233567899999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=283.28 Aligned_cols=254 Identities=25% Similarity=0.373 Sum_probs=202.4
Q ss_pred hcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccc-hhhHHHHHHHHHHHhccCCCcccceeeEEeec
Q 018785 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES-FQGHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (350)
Q Consensus 21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (350)
++|++.+.||+|++|.||++ .+..++..|++|.+.... ......+.+|+..+++++||||+++++.+...
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~---------~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 71 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKV---------LHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIE 71 (286)
T ss_pred ChhhhhhhhcccCCeEEEEE---------EEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecC
Confidence 47999999999999999999 555568899999886542 22345678899999999999999999999999
Q ss_pred CceEEEEEcCCCCChhhHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcccccc
Q 018785 100 DNRLLVYEFMPKGSLENHLFRKG-VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 178 (350)
Q Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~-~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~ 178 (350)
+..++||||+++++|.+++.... ...+++..+..++.|++.||.|||+ +.+++|+||+|+||+++.++.++|+|||.+
T Consensus 72 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~~i~H~dl~p~nil~~~~~~~~l~dfg~~ 150 (286)
T cd06622 72 GAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE-EHNIIHRDVKPTNVLVNGNGQVKLCDFGVS 150 (286)
T ss_pred CeEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh-cCCEeeCCCCHHHEEECCCCCEEEeecCCc
Confidence 99999999999999999886531 2368999999999999999999993 259999999999999999999999999998
Q ss_pred ccCCCCCCCcccccccCCCcccCccccccC------CCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchh
Q 018785 179 RDGPTGDNTHVSTRIVGTRGYAAPEYVATG------HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPF 252 (350)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~------~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 252 (350)
....... .....++..|+|||.+.+. .++.++|+|||||++|+|++|..||..........
T Consensus 151 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~--------- 217 (286)
T cd06622 151 GNLVASL----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFA--------- 217 (286)
T ss_pred ccccCCc----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHH---------
Confidence 6532211 1223467789999988544 34789999999999999999999996432211111
Q ss_pred hhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 253 LRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
...... .......+..++.++.+++.+||+.+|.+||++.+++.+
T Consensus 218 -----~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 218 -----QLSAIV-DGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred -----HHHHHh-hcCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 111111 111223445688899999999999999999999999976
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=276.34 Aligned_cols=256 Identities=28% Similarity=0.461 Sum_probs=195.4
Q ss_pred ceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEcccc-chhhHHHHHHHHHHHhccCCCcccceeeEEe-ecCceEE
Q 018785 27 YLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAE-SFQGHKEWLTEVIYLGQLRHENLVKLIGYCS-ESDNRLL 104 (350)
Q Consensus 27 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~l 104 (350)
+.||+|+||.||+|++.. ....+..+++|.+... .......+.+|..+++.++|||++++++++. .++..++
T Consensus 1 ~~lg~g~~g~v~~~~~~~------~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~l 74 (262)
T cd05058 1 RVIGKGHFGCVYHGTLID------SDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLV 74 (262)
T ss_pred CcccccCCceEEEEEEec------CCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEE
Confidence 468999999999996542 2234568999987543 2234567788999999999999999999765 4556889
Q ss_pred EEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccccccCCCC
Q 018785 105 VYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTG 184 (350)
Q Consensus 105 v~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~~~~~~ 184 (350)
++||+.+++|.+++.... ..++...+..++.|+++||.||| +.+++|+||+|+||+++.++.++|+|||++......
T Consensus 75 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~ 151 (262)
T cd05058 75 VLPYMKHGDLRNFIRSET-HNPTVKDLIGFGLQVAKGMEYLA--SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDK 151 (262)
T ss_pred EEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH--hCCccccccCcceEEEcCCCcEEECCccccccccCC
Confidence 999999999999997654 24677788899999999999999 999999999999999999999999999998753322
Q ss_pred CCC--cccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCC-CCCcccccCcchhhhhhhcchhhhhhHHHHH
Q 018785 185 DNT--HVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR-RALDEDRGGLAEQTLVEWADPFLRDSRRVLR 261 (350)
Q Consensus 185 ~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (350)
... .......++..|+|||.+.+..++.++||||||+++|+|++|+ .||........ ..
T Consensus 152 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~------------------~~ 213 (262)
T cd05058 152 EYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDI------------------TV 213 (262)
T ss_pred cceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH------------------HH
Confidence 111 1111223456799999998889999999999999999999964 45543321110 01
Q ss_pred hhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhc
Q 018785 262 IMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHT 309 (350)
Q Consensus 262 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 309 (350)
.+........+..+++.+.+++.+||..+|++||++.++++.|+++..
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 214 YLLQGRRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred HHhcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 111111112233457789999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=282.11 Aligned_cols=249 Identities=26% Similarity=0.345 Sum_probs=205.7
Q ss_pred cccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch---hhHHHHHHHHHHHhccCCCcccceeeEEee
Q 018785 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (350)
Q Consensus 22 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (350)
+|++.+.||.|++|.||+| .+..++..|++|.+..... .....+.+|+..+++++||||+++++.+..
T Consensus 1 ~y~~~~~i~~g~~~~v~~~---------~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 71 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIV---------QKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQD 71 (258)
T ss_pred CceEEEEeccCCCceEEEE---------EEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcC
Confidence 5899999999999999999 5556788999999876532 234678889999999999999999999999
Q ss_pred cCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcccccc
Q 018785 99 SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 178 (350)
Q Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~ 178 (350)
++..++|+||+.+++|.+++.... .+++..+..++.|+++||.||| +.|++|+||+|+||+++.++.++|+|||.+
T Consensus 72 ~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lh--~~~i~h~dl~~~nil~~~~~~~~l~d~~~~ 147 (258)
T cd05578 72 EENMYLVVDLLLGGDLRYHLSQKV--KFSEEQVKFWICEIVLALEYLH--SKGIIHRDIKPDNILLDEQGHVHITDFNIA 147 (258)
T ss_pred CCeEEEEEeCCCCCCHHHHHHhcC--CcCHHHHHHHHHHHHHHHHHHH--hCCeeccCCCHHHeEEcCCCCEEEeecccc
Confidence 999999999999999999997763 7899999999999999999999 999999999999999999999999999998
Q ss_pred ccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhHH
Q 018785 179 RDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRR 258 (350)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (350)
....... ......++..|+|||.+.+..++.++|+||||+++|+|++|..||...........
T Consensus 148 ~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~-------------- 210 (258)
T cd05578 148 TKVTPDT---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQI-------------- 210 (258)
T ss_pred cccCCCc---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHH--------------
Confidence 7643332 12234577889999999888899999999999999999999999976553211110
Q ss_pred HHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCH--HHHHH
Q 018785 259 VLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSM--VDVLT 302 (350)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~--~~ll~ 302 (350)
...... .....+...+..+.++|.+||+.||.+||++ +++++
T Consensus 211 -~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 211 -RAKQET-ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred -HHHhcc-ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence 011110 2233445567899999999999999999999 66654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=286.51 Aligned_cols=253 Identities=19% Similarity=0.230 Sum_probs=199.8
Q ss_pred hcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch---hhHHHHHHHHHHHhccCCCcccceeeEEe
Q 018785 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (350)
Q Consensus 21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (350)
++|++.++||+|+||.||++ ....+++.+|+|++..... .....+.+|..++..+.|++|+++++.+.
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~---------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 71 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVV---------KLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQ 71 (332)
T ss_pred CCceEEEEEEeCCCeEEEEE---------EECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEe
Confidence 47999999999999999999 5555688999999865322 22344778899999999999999999999
Q ss_pred ecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccc
Q 018785 98 ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL 177 (350)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~ 177 (350)
+.+..++||||+.+++|.+++.... ..+++..+..++.|++.||.||| +.|++|+||||+||+++.++.++|+|||+
T Consensus 72 ~~~~~~lv~ey~~~g~L~~~l~~~~-~~l~~~~~~~~~~qi~~al~~lH--~~~iiHrDlkp~Nili~~~~~~kL~DfG~ 148 (332)
T cd05623 72 DENNLYLVMDYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVIAIDSVH--QLHYVHRDIKPDNILMDMNGHIRLADFGS 148 (332)
T ss_pred cCCEEEEEEeccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH--HCCeEecCCCHHHEEECCCCCEEEeecch
Confidence 9999999999999999999997643 26899999999999999999999 99999999999999999999999999999
Q ss_pred cccCCCCCCCcccccccCCCcccCccccc-----cCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchh
Q 018785 178 ARDGPTGDNTHVSTRIVGTRGYAAPEYVA-----TGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPF 252 (350)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 252 (350)
+........ .......|++.|+|||++. ...++.++|+|||||++|+|++|+.||...........+
T Consensus 149 a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i------- 220 (332)
T cd05623 149 CLKLMEDGT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI------- 220 (332)
T ss_pred heecccCCc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHH-------
Confidence 864322211 1122346899999999886 346788999999999999999999999754422211111
Q ss_pred hhhhHHHHHhhhcccCC---CCcHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 018785 253 LRDSRRVLRIMDTRLGG---QYSKKEAQAVAAVVLQCLHMDPKN--RPSMVDVLTS 303 (350)
Q Consensus 253 ~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~--Rps~~~ll~~ 303 (350)
....... .....+++++.+|+.+||..++.+ |++++++++|
T Consensus 221 ----------~~~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 221 ----------MNHKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred ----------hCCCccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 1111111 112356789999999999665544 6899999988
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=285.50 Aligned_cols=252 Identities=24% Similarity=0.380 Sum_probs=206.5
Q ss_pred hhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceeeEEeec
Q 018785 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (350)
Q Consensus 20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (350)
..+|.+.+.||+|++|.||++ .+..++..|++|.+..........+.+|+.+++.++|||++++++.+...
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~---------~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~ 88 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTA---------IDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVG 88 (293)
T ss_pred hhhceeeeEecCCCCeEEEEE---------EEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeC
Confidence 479999999999999999999 55556788999998765545556788899999999999999999999999
Q ss_pred CceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccccc
Q 018785 100 DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR 179 (350)
Q Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~ 179 (350)
+..++|+||+++++|.+++.+. .++...+..++.|++.||.+|| +.|++|+||+|+||+++.++.++|+|||++.
T Consensus 89 ~~~~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH--~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~ 163 (293)
T cd06647 89 DELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLH--SNQVIHRDIKSDNILLGMDGSVKLTDFGFCA 163 (293)
T ss_pred CcEEEEEecCCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHH--hCCEeeccCCHHHEEEcCCCCEEEccCccee
Confidence 9999999999999999998754 5788899999999999999999 9999999999999999999999999999886
Q ss_pred cCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhHHH
Q 018785 180 DGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRV 259 (350)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (350)
....... ......+++.|++||.+.+..++.++|+||+|+++|++++|..||...........+..
T Consensus 164 ~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~------------ 229 (293)
T cd06647 164 QITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT------------ 229 (293)
T ss_pred ccccccc--ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhc------------
Confidence 5332221 11223577889999999888899999999999999999999999975443211111110
Q ss_pred HHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 260 LRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
........+..++..+.+++.+||..+|.+||++.+++.|
T Consensus 230 ----~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 230 ----NGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred ----CCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0001111233467789999999999999999999999977
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=287.46 Aligned_cols=252 Identities=25% Similarity=0.363 Sum_probs=203.8
Q ss_pred hhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceeeEEeec
Q 018785 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (350)
Q Consensus 20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (350)
.+.|.....||.|++|.||++ .+..++..|+||.+..........+.+|+..++.++|||++++++.+..+
T Consensus 21 ~~~~~~~~~lg~g~~g~v~~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~ 91 (292)
T cd06658 21 REYLDSFIKIGEGSTGIVCIA---------TEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVG 91 (292)
T ss_pred HHHHhhhhcccCCCCeEEEEE---------EECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecC
Confidence 356666788999999999999 56667889999998766555566788999999999999999999999999
Q ss_pred CceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccccc
Q 018785 100 DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR 179 (350)
Q Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~ 179 (350)
+..++||||+++++|.+++... .+++..+..++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||++.
T Consensus 92 ~~~~lv~e~~~~~~L~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH--~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~ 166 (292)
T cd06658 92 DELWVVMEFLEGGALTDIVTHT---RMNEEQIATVCLSVLRALSYLH--NQGVIHRDIKSDSILLTSDGRIKLSDFGFCA 166 (292)
T ss_pred CeEEEEEeCCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH--HCCEeecCCCHHHEEEcCCCCEEEccCcchh
Confidence 9999999999999999987543 5889999999999999999999 8999999999999999999999999999986
Q ss_pred cCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhHHH
Q 018785 180 DGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRV 259 (350)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (350)
...... .......++..|+|||.+.+..++.++|+||+|+++|+|++|..||...........+
T Consensus 167 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~-------------- 230 (292)
T cd06658 167 QVSKEV--PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRI-------------- 230 (292)
T ss_pred hccccc--ccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--------------
Confidence 532221 1122345788899999998888999999999999999999999999754321110000
Q ss_pred HHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 260 LRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
...... .......++..+.+++.+||..||.+|||+++++++
T Consensus 231 ~~~~~~--~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 231 RDNLPP--RVKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred HhcCCC--ccccccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 000000 011122456789999999999999999999999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=284.44 Aligned_cols=265 Identities=25% Similarity=0.392 Sum_probs=205.4
Q ss_pred hhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh-hHHHHHHHHHHHhccCCCcccceeeEEe
Q 018785 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ-GHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (350)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (350)
..++|++.+.||+|++|.||+|.+... .......+++|.+...... ....+..|+.+++.++||||+++++++.
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~ 79 (303)
T cd05110 5 KETELKRVKVLGSGAFGTVYKGIWVPE-----GETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCL 79 (303)
T ss_pred chhhceeccccccCCCccEEEEEEecC-----CCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEc
Confidence 467899999999999999999965321 1111236788988755432 2345788999999999999999999886
Q ss_pred ecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccc
Q 018785 98 ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL 177 (350)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~ 177 (350)
.. ..+++++++.+++|.+++.... ..++...+..++.|++.||.||| ++|++|+||+|+||+++.++.++|+|||+
T Consensus 80 ~~-~~~~v~e~~~~g~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH--~~~ivH~dikp~Nill~~~~~~kL~Dfg~ 155 (303)
T cd05110 80 SP-TIQLVTQLMPHGCLLDYVHEHK-DNIGSQLLLNWCVQIAKGMMYLE--ERRLVHRDLAARNVLVKSPNHVKITDFGL 155 (303)
T ss_pred CC-CceeeehhcCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHh--hcCeeccccccceeeecCCCceEEccccc
Confidence 54 5679999999999999987654 35888999999999999999999 99999999999999999999999999999
Q ss_pred cccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccccCcchhhhhhhcchhhhhh
Q 018785 178 ARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDS 256 (350)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 256 (350)
+................++..|++||.+.+..++.++||||||+++|+|++ |+.||.+.......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~-------------- 221 (303)
T cd05110 156 ARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIP-------------- 221 (303)
T ss_pred cccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH--------------
Confidence 976433222212222334567999999988999999999999999999997 88998654321111
Q ss_pred HHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcC
Q 018785 257 RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 310 (350)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 310 (350)
...........+..++..+.+++.+||..+|.+||++.++++.|..+...
T Consensus 222 ----~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 222 ----DLLEKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred ----HHHHCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 11111111122334567899999999999999999999999999988655
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=278.63 Aligned_cols=259 Identities=29% Similarity=0.426 Sum_probs=200.7
Q ss_pred ccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccc--hhhHHHHHHHHHHHhccCCCcccceeeEEeecC
Q 018785 23 FCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES--FQGHKEWLTEVIYLGQLRHENLVKLIGYCSESD 100 (350)
Q Consensus 23 y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 100 (350)
|++.+.||+|++|.||+|.+. ....++..|++|.+.... ......+.+|+..++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 74 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLK------SEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSR 74 (273)
T ss_pred CcchhcccCCCCCCEEeeEee------ccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence 678899999999999999654 234568899999887543 233456788999999999999999999876532
Q ss_pred ------ceEEEEEcCCCCChhhHHhhcC----CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcE
Q 018785 101 ------NRLLVYEFMPKGSLENHLFRKG----VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNA 170 (350)
Q Consensus 101 ------~~~lv~e~~~~~~L~~~l~~~~----~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~ 170 (350)
..+++++|+.+++|.+++.... ...++...+..++.|++.||+||| +.|++|+||+|+||+++.++.+
T Consensus 75 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH--~~~i~H~dikp~nili~~~~~~ 152 (273)
T cd05074 75 AKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS--SKNFIHRDLAARNCMLNENMTV 152 (273)
T ss_pred CCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCEeecccchhhEEEcCCCCE
Confidence 2368899999999998875321 124788899999999999999999 9999999999999999999999
Q ss_pred EEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccccCcchhhhhhhc
Q 018785 171 KLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWA 249 (350)
Q Consensus 171 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~ 249 (350)
+|+|||++................+++.|++||.+.+..++.++|+||||+++|+|++ |..||...........+.
T Consensus 153 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~--- 229 (273)
T cd05074 153 CVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLI--- 229 (273)
T ss_pred EECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHH---
Confidence 9999999876433222111122234567999999988889999999999999999999 788886543211111110
Q ss_pred chhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 018785 250 DPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 307 (350)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~ 307 (350)
.......+...+..+.+++.+||+.+|++|||+.++++.|+++
T Consensus 230 ---------------~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 230 ---------------KGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred ---------------cCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1111122335667899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=279.34 Aligned_cols=252 Identities=28% Similarity=0.447 Sum_probs=201.8
Q ss_pred cccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch------hhHHHHHHHHHHHhccCCCcccceeeE
Q 018785 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF------QGHKEWLTEVIYLGQLRHENLVKLIGY 95 (350)
Q Consensus 22 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~ 95 (350)
+|++.+.||.|+||.||+|. . .+++.+++|.+..... .....+.+|+..++.++|+||++++++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~---------~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~ 70 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGL---------T-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGT 70 (265)
T ss_pred CccccceEeccCCeEEEEEE---------E-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeE
Confidence 58999999999999999983 2 2477899998764421 223457889999999999999999999
Q ss_pred EeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccc
Q 018785 96 CSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDF 175 (350)
Q Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Df 175 (350)
+.+.+..++++||+++++|.+++.+.. .+++..+..++.|++.||++|| +.+++|+||+|+||+++.++.++|+||
T Consensus 71 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dl~p~nil~~~~~~~~l~df 146 (265)
T cd06631 71 CLDDNTISIFMEFVPGGSISSILNRFG--PLPEPVFCKYTKQILDGVAYLH--NNCVVHRDIKGNNVMLMPNGIIKLIDF 146 (265)
T ss_pred eecCCeEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--hCCcccCCcCHHhEEECCCCeEEeccc
Confidence 999999999999999999999997654 6889999999999999999999 899999999999999999999999999
Q ss_pred cccccCCCCCC----CcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcch
Q 018785 176 GLARDGPTGDN----THVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADP 251 (350)
Q Consensus 176 g~~~~~~~~~~----~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~ 251 (350)
|.+........ ........++..|+|||.+.+..++.++|+||||+++|+|++|..||...........+.
T Consensus 147 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~----- 221 (265)
T cd06631 147 GCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIG----- 221 (265)
T ss_pred hhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhh-----
Confidence 98875322111 111122457888999999988889999999999999999999999996543211110000
Q ss_pred hhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 252 FLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
.........+..++.++.+++.+||..+|.+||++.+++++
T Consensus 222 -----------~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 262 (265)
T cd06631 222 -----------AHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRH 262 (265)
T ss_pred -----------hccCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 00011122344577889999999999999999999999864
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=290.97 Aligned_cols=253 Identities=19% Similarity=0.223 Sum_probs=200.1
Q ss_pred hcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch---hhHHHHHHHHHHHhccCCCcccceeeEEe
Q 018785 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (350)
Q Consensus 21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (350)
++|++.+.||+|+||.||++ .+..+++.||+|.+..... .....+.+|..++..++|++|+++++++.
T Consensus 1 d~y~i~~~lG~G~fg~V~~~---------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~ 71 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVV---------KMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQ 71 (331)
T ss_pred CCceEEEEEeeCCCeEEEEE---------EECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 47999999999999999999 5556788999999865321 22345778899999999999999999999
Q ss_pred ecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccc
Q 018785 98 ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL 177 (350)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~ 177 (350)
..+..|+||||+.+++|.+++.... ..+++..+..++.|++.||.||| +.|++|+||||+||+++.++.++|+|||+
T Consensus 72 ~~~~~~lv~Ey~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~lH--~~~iiHrDlkp~Nill~~~~~~kl~DfG~ 148 (331)
T cd05624 72 DENYLYLVMDYYVGGDLLTLLSKFE-DRLPEDMARFYIAEMVLAIHSIH--QLHYVHRDIKPDNVLLDMNGHIRLADFGS 148 (331)
T ss_pred cCCEEEEEEeCCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH--HCCeeeccCchHHEEEcCCCCEEEEeccc
Confidence 9999999999999999999997643 36899999999999999999999 99999999999999999999999999999
Q ss_pred cccCCCCCCCcccccccCCCcccCcccccc-----CCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchh
Q 018785 178 ARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-----GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPF 252 (350)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 252 (350)
+........ .......|++.|+|||.+.+ ..++.++|+||+|+++|+|++|+.||...........+
T Consensus 149 a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i------- 220 (331)
T cd05624 149 CLKMNQDGT-VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI------- 220 (331)
T ss_pred eeeccCCCc-eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHH-------
Confidence 865432221 11223468999999998865 46788999999999999999999999754322111111
Q ss_pred hhhhHHHHHhhhcccCC---CCcHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 018785 253 LRDSRRVLRIMDTRLGG---QYSKKEAQAVAAVVLQCLHMDPKN--RPSMVDVLTS 303 (350)
Q Consensus 253 ~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~--Rps~~~ll~~ 303 (350)
....... .....+++++.+++.+||..++.+ |++++++++|
T Consensus 221 ----------~~~~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 221 ----------MNHEERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred ----------HcCCCcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 1111001 111246789999999999876554 4689999877
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=284.63 Aligned_cols=268 Identities=25% Similarity=0.333 Sum_probs=202.4
Q ss_pred cccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch--hhHHHHHHHHHHHhccCCCcccceeeEEeec
Q 018785 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (350)
Q Consensus 22 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (350)
+|++.+.||.|++|.||+| .+..++..|+||.+..... .....+..|++.+++++||||+++++++..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~---------~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 71 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKA---------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTE 71 (284)
T ss_pred CceeeeeecCCCceEEEEE---------EECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccC
Confidence 5889999999999999999 5566788999998875432 2235678899999999999999999999999
Q ss_pred CceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccccc
Q 018785 100 DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR 179 (350)
Q Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~ 179 (350)
+..++||||+. ++|.+++.......++...+..++.|++.||+||| +.+++|+||+|+||+++.++.++|+|||++.
T Consensus 72 ~~~~~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh--~~~i~H~~l~p~nill~~~~~~~l~dfg~~~ 148 (284)
T cd07860 72 NKLYLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 148 (284)
T ss_pred CcEEEEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEECCCCCEEEeeccchh
Confidence 99999999995 68999887665567899999999999999999999 9999999999999999999999999999986
Q ss_pred cCCCCCCCcccccccCCCcccCccccccCC-CCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchh------
Q 018785 180 DGPTGDNTHVSTRIVGTRGYAAPEYVATGH-LTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPF------ 252 (350)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~------ 252 (350)
....... ......++..|+|||.+.+.. ++.++|+||||+++|+|++|+.||...........+.......
T Consensus 149 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (284)
T cd07860 149 AFGVPVR--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP 226 (284)
T ss_pred hcccCcc--ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhh
Confidence 5322211 112234577899999886654 5889999999999999999999997654322221111111000
Q ss_pred -hhhhHHHHHhhhcccC---CCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 253 -LRDSRRVLRIMDTRLG---GQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 253 -~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
................ ......++.++.++|.+||+.||.+|||++++++|
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 227 GVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred hhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 0000000000000000 01112356788999999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=277.48 Aligned_cols=256 Identities=27% Similarity=0.355 Sum_probs=192.0
Q ss_pred ceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch-hhHHHHHHHHHHHhccCCCcccceeeEEeecCceEEE
Q 018785 27 YLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLVKLIGYCSESDNRLLV 105 (350)
Q Consensus 27 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 105 (350)
+.||+|+||.||+|++. +..++..+++|.+..... .....+.+|+..++.++||||+++++.+.+....++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~-------~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 73 (269)
T cd05087 1 KEIGNGWFGKVILGEVN-------SGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLV 73 (269)
T ss_pred CcccccCCceEEEEEEc-------CCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEE
Confidence 46899999999999653 233467799998876543 2234678899999999999999999999999999999
Q ss_pred EEcCCCCChhhHHhhcC---CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccccccCC
Q 018785 106 YEFMPKGSLENHLFRKG---VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGP 182 (350)
Q Consensus 106 ~e~~~~~~L~~~l~~~~---~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~~~~ 182 (350)
|||+++++|.+++.... ....+...+..++.|++.|+.||| +.+++|+||+|+||+++.++.++|+|||.+....
T Consensus 74 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH--~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~ 151 (269)
T cd05087 74 MEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH--KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKY 151 (269)
T ss_pred EECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH--HCCEeccccCcceEEEcCCCcEEECCcccccccc
Confidence 99999999999996532 124566778889999999999999 9999999999999999999999999999986432
Q ss_pred CCCCCcccccccCCCcccCccccccC-------CCCCccchhhHHHHHHHHHh-CCCCCcccccCcchhhhhhhcchhhh
Q 018785 183 TGDNTHVSTRIVGTRGYAAPEYVATG-------HLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLR 254 (350)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~aPE~~~~~-------~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~ 254 (350)
............++..|+|||.+.+. .++.++|+||||+++|+|++ |..||..............
T Consensus 152 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~------- 224 (269)
T cd05087 152 KEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVR------- 224 (269)
T ss_pred CcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhh-------
Confidence 22211112224456779999987542 35789999999999999996 9999965432211110000
Q ss_pred hhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018785 255 DSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 305 (350)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~ 305 (350)
...............++.+.+++.+|+ .+|++|||+++++..|+
T Consensus 225 ------~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 225 ------EQQLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred ------cccCCCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 000001111122245677899999998 68999999999998775
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=313.51 Aligned_cols=257 Identities=22% Similarity=0.349 Sum_probs=201.0
Q ss_pred hhhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch--hhHHHHHHHHHHHhccCCCcccce
Q 018785 15 ISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLRHENLVKL 92 (350)
Q Consensus 15 ~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~ 92 (350)
..+...++|++.+.||.|+||+||+| .+..++..+++|.+..... .....+..|+.+++.++||||+++
T Consensus 7 ~ge~~l~~YeIl~kLG~GgFGtVYLA---------kdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl 77 (1021)
T PTZ00266 7 DGESRLNEYEVIKKIGNGRFGEVFLV---------KHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRY 77 (1021)
T ss_pred CCccccCCEEEEEEEecCCCeEEEEE---------EECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeE
Confidence 35566789999999999999999999 5666788999998875432 234568889999999999999999
Q ss_pred eeEEee--cCceEEEEEcCCCCChhhHHhhc--CCCCCCHHHHHHHHHHHHHHHHHhhcCC-------CCeeeCCCCCCc
Q 018785 93 IGYCSE--SDNRLLVYEFMPKGSLENHLFRK--GVQPISWPTRVKIAIDVARGLSFLHGLD-------ANVIYRDLKASN 161 (350)
Q Consensus 93 ~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~i~~ql~~al~~lh~~~-------~~i~H~di~~~N 161 (350)
+++|.. ...+|+||||+.+++|.+++... ....+++..++.|+.||+.||.||| + .+|+|+||||+|
T Consensus 78 ~d~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLH--s~g~~~~~k~IVHRDLKPeN 155 (1021)
T PTZ00266 78 IDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCH--NLKDGPNGERVLHRDLKPQN 155 (1021)
T ss_pred EEEEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH--hcccccccCCceeccCcHHH
Confidence 998854 35689999999999999998653 1236999999999999999999999 6 459999999999
Q ss_pred eEEcCC-----------------CcEEEccccccccCCCCCCCcccccccCCCcccCcccccc--CCCCCccchhhHHHH
Q 018785 162 VLLDSN-----------------FNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT--GHLTPKSDVYSFGVV 222 (350)
Q Consensus 162 ili~~~-----------------~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~DiwslG~l 222 (350)
||++.+ +.++|+|||++....... ......+++.|+|||++.+ ..++.++|||||||+
T Consensus 156 ILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~I 232 (1021)
T PTZ00266 156 IFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCI 232 (1021)
T ss_pred eEeecCccccccccccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHH
Confidence 999642 348999999997542221 1223468999999999854 458899999999999
Q ss_pred HHHHHhCCCCCcccccCcchhhhhhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018785 223 LLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLT 302 (350)
Q Consensus 223 l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 302 (350)
||+|++|..||....... .....+.... .......+.++.+||.+||..+|.+||++.++|.
T Consensus 233 LYELLTGk~PF~~~~~~~-----------------qli~~lk~~p-~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 233 IYELCSGKTPFHKANNFS-----------------QLISELKRGP-DLPIKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred HHHHHHCCCCCCcCCcHH-----------------HHHHHHhcCC-CCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 999999999996433211 0111111111 1111245778999999999999999999999996
Q ss_pred H
Q 018785 303 S 303 (350)
Q Consensus 303 ~ 303 (350)
+
T Consensus 295 h 295 (1021)
T PTZ00266 295 Y 295 (1021)
T ss_pred c
Confidence 4
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=285.71 Aligned_cols=268 Identities=28% Similarity=0.409 Sum_probs=202.0
Q ss_pred hcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh--hHHHHHHHHHHHhccCCCcccceeeEEee
Q 018785 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ--GHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (350)
Q Consensus 21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (350)
++|++.+.||+|++|.||+| .+..+++.|++|.+...... ....+.+|+.+++.++||||+++++++..
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~---------~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 71 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKC---------KHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRR 71 (286)
T ss_pred CceeEeeeeccCCCeEEEEE---------EECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhccc
Confidence 47999999999999999999 55556889999987654322 23567889999999999999999999999
Q ss_pred cCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcccccc
Q 018785 99 SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 178 (350)
Q Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~ 178 (350)
++..++|+||+++++|.++..... .++...+..++.|++.||+||| +.|++|+||+|+||+++.++.++|+|||++
T Consensus 72 ~~~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH--~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~ 147 (286)
T cd07846 72 KKRLYLVFEFVDHTVLDDLEKYPN--GLDESRVRKYLFQILRGIEFCH--SHNIIHRDIKPENILVSQSGVVKLCDFGFA 147 (286)
T ss_pred CCeEEEEEecCCccHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHH--HCCccccCCCHHHEEECCCCcEEEEeeeee
Confidence 999999999999888887665443 5899999999999999999999 899999999999999999999999999998
Q ss_pred ccCCCCCCCcccccccCCCcccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhH
Q 018785 179 RDGPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSR 257 (350)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 257 (350)
........ ......++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||...........+............
T Consensus 148 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (286)
T cd07846 148 RTLAAPGE--VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQ 225 (286)
T ss_pred eeccCCcc--ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhH
Confidence 75433221 1222456778999998865 35678999999999999999999998754432222222211111100000
Q ss_pred HHH---Hhh----hccc-----CCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 258 RVL---RIM----DTRL-----GGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 258 ~~~---~~~----~~~~-----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
... ... .... .......++..+.+++.+||..+|++||++.+++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 226 EIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred HHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 000 000 0000 000123467889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=284.61 Aligned_cols=267 Identities=27% Similarity=0.339 Sum_probs=202.7
Q ss_pred cccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh-----hHHHHHHHHHHHhccCCCcccceeeEE
Q 018785 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ-----GHKEWLTEVIYLGQLRHENLVKLIGYC 96 (350)
Q Consensus 22 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (350)
+|.+.+.||.|++|.||+| .+..+++.|++|.+...... ....+..|+..++.++|+||+++++++
T Consensus 1 ~y~~~~~lg~g~~~~vy~~---------~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~ 71 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKA---------RDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVF 71 (298)
T ss_pred CceeeeeeeeccccEEEEE---------EECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhhee
Confidence 5889999999999999999 56666889999998765433 234567899999999999999999999
Q ss_pred eecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcccc
Q 018785 97 SESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFG 176 (350)
Q Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg 176 (350)
.+.+..++||||+ +++|.+++.... ..+++..+..++.|+++||.||| +.|++|+||+|+||+++.++.++|+|||
T Consensus 72 ~~~~~~~lv~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH--~~~i~H~dl~p~nill~~~~~~~l~dfg 147 (298)
T cd07841 72 GHKSNINLVFEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLH--SNWILHRDLKPNNLLIASDGVLKLADFG 147 (298)
T ss_pred ecCCEEEEEEccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHH--hCCeeecCCChhhEEEcCCCCEEEccce
Confidence 9999999999999 889999987654 36899999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCCCCcccccccCCCcccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhc-chhhh
Q 018785 177 LARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWA-DPFLR 254 (350)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~-~~~~~ 254 (350)
++........ ......++..|+|||.+.+ ..++.++|+|||||++|+|++|..||...........+.... .+...
T Consensus 148 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (298)
T cd07841 148 LARSFGSPNR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEE 225 (298)
T ss_pred eeeeccCCCc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchh
Confidence 9976433221 1122345677999998855 467889999999999999999987776554322222221110 00000
Q ss_pred hhH---HHHHhhhccc-----CCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 255 DSR---RVLRIMDTRL-----GGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 255 ~~~---~~~~~~~~~~-----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
... .......... ........+..+.+++.+||+.||++|||+.+++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 226 NWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred hhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 000 0000000000 001123456789999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=286.03 Aligned_cols=256 Identities=19% Similarity=0.285 Sum_probs=202.2
Q ss_pred hcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch---hhHHHHHHHHHHHhccCCCcccceeeEEe
Q 018785 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (350)
Q Consensus 21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (350)
++|++.+.||+|++|.||++ .+..+++.|++|.+..... .....+.+|+.+++.++||||+++++.+.
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~---------~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 71 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLV---------RHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFE 71 (305)
T ss_pred CCceEeeEeecCCCeeEEEE---------EECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEe
Confidence 47999999999999999999 6666788999998876542 23356778999999999999999999999
Q ss_pred ecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccc
Q 018785 98 ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL 177 (350)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~ 177 (350)
.++..++||||++|++|.+++.... .+++..+..++.|++.||.||| +.|++|+||+|.||+++.++.++|+|||.
T Consensus 72 ~~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dl~p~NIll~~~~~~~l~dfg~ 147 (305)
T cd05609 72 TKRHLCMVMEYVEGGDCATLLKNIG--ALPVDMARMYFAETVLALEYLH--NYGIVHRDLKPDNLLITSMGHIKLTDFGL 147 (305)
T ss_pred cCCEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCccccCCchHHEEECCCCCEEEeeCCC
Confidence 9999999999999999999997664 6899999999999999999999 89999999999999999999999999998
Q ss_pred cccCCCCCCC-------------cccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhh
Q 018785 178 ARDGPTGDNT-------------HVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQT 244 (350)
Q Consensus 178 ~~~~~~~~~~-------------~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~ 244 (350)
+......... .......++..|+|||.+.+..++.++|+||||+++|+|++|..||.+.........
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~ 227 (305)
T cd05609 148 SKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQ 227 (305)
T ss_pred ccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 8632111000 001123467789999999888899999999999999999999999975432211111
Q ss_pred hhhhcchhhhhhHHHHHhhhcccC-CCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 018785 245 LVEWADPFLRDSRRVLRIMDTRLG-GQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQ 306 (350)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 306 (350)
.. ..... ......++.++.+++.+||+.||++||+...+++.|..
T Consensus 228 ~~-----------------~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 228 VI-----------------SDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred HH-----------------hcccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 11 00000 01112467889999999999999999996555554444
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=272.69 Aligned_cols=247 Identities=32% Similarity=0.478 Sum_probs=196.7
Q ss_pred ceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh-hHHHHHHHHHHHhccCCCcccceeeEEeecCceEEE
Q 018785 27 YLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ-GHKEWLTEVIYLGQLRHENLVKLIGYCSESDNRLLV 105 (350)
Q Consensus 27 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 105 (350)
++||+|++|.||+|.. ..+..+++|.+...... ....+.+|+..++.+.||||+++++++...+..++|
T Consensus 1 ~~ig~g~~g~vy~~~~----------~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 70 (250)
T cd05085 1 ELLGKGNFGEVFKGTL----------KDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIV 70 (250)
T ss_pred CccCCCCCceEEEEEe----------cCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEE
Confidence 4789999999999932 24678999988765432 234678899999999999999999999999999999
Q ss_pred EEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccccccCCCCC
Q 018785 106 YEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGD 185 (350)
Q Consensus 106 ~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~~~~~~~ 185 (350)
|||+++++|.+++.... ..++...+..++.|++.+|.++| +.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 71 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH--~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 147 (250)
T cd05085 71 MELVPGGDFLSFLRKKK-DELKTKQLVKFALDAAAGMAYLE--SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGI 147 (250)
T ss_pred EECCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH--hCCeeecccChheEEEcCCCeEEECCCccceeccccc
Confidence 99999999999886544 35789999999999999999999 9999999999999999999999999999986432211
Q ss_pred CCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccccCcchhhhhhhcchhhhhhHHHHHhhh
Q 018785 186 NTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMD 264 (350)
Q Consensus 186 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (350)
. .......++..|+|||.+.+..++.++|+||||+++|++++ |..||........... +.
T Consensus 148 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~------------------~~ 208 (250)
T cd05085 148 Y-SSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQ------------------VE 208 (250)
T ss_pred c-ccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH------------------HH
Confidence 1 11111233456999999988889999999999999999998 8889865432111111 11
Q ss_pred cccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018785 265 TRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 305 (350)
Q Consensus 265 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~ 305 (350)
.......+..++..+.+++.+|+..+|.+||++.++++.|.
T Consensus 209 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 209 KGYRMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 11112234456789999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=282.11 Aligned_cols=257 Identities=26% Similarity=0.309 Sum_probs=199.9
Q ss_pred hhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhcc-CCCcccceeeEE
Q 018785 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQL-RHENLVKLIGYC 96 (350)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~ 96 (350)
...++|++.+.||+|++|.||+| .+..++..+++|.+..... ....+..|+.+++.+ +||||+++++++
T Consensus 15 ~~~~~~~~~~~lg~g~~~~vy~~---------~~~~~~~~~~ik~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 84 (286)
T cd06638 15 DPSDTWEIIETIGKGTYGKVFKV---------LNKKNGSKAAVKILDPIHD-IDEEIEAEYNILKALSDHPNVVKFYGMY 84 (286)
T ss_pred CcccceeeeeeeccCCCcEEEEE---------EECCCCceeEEEeeccccc-hHHHHHHHHHHHHHHhcCCCeeeeeeee
Confidence 35689999999999999999999 5566688999998765432 235577889999998 699999999987
Q ss_pred e-----ecCceEEEEEcCCCCChhhHHhhc--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCc
Q 018785 97 S-----ESDNRLLVYEFMPKGSLENHLFRK--GVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFN 169 (350)
Q Consensus 97 ~-----~~~~~~lv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~ 169 (350)
. .++..++||||+++++|.+++... ....+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dlkp~nili~~~~~ 162 (286)
T cd06638 85 YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH--VNKTIHRDVKGNNILLTTEGG 162 (286)
T ss_pred eecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHH--hCCccccCCCHHhEEECCCCC
Confidence 3 345689999999999999987532 2346888999999999999999999 899999999999999999999
Q ss_pred EEEccccccccCCCCCCCcccccccCCCcccCcccccc-----CCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhh
Q 018785 170 AKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-----GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQT 244 (350)
Q Consensus 170 ~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~ 244 (350)
++|+|||++....... .......++..|+|||.+.+ ..++.++|+||+||++|+|++|+.||...........
T Consensus 163 ~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~ 240 (286)
T cd06638 163 VKLVDFGVSAQLTSTR--LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFK 240 (286)
T ss_pred EEEccCCceeecccCC--CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhh
Confidence 9999999987543221 11223457888999998743 4578899999999999999999999865432111100
Q ss_pred hhhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018785 245 LVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL 304 (350)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 304 (350)
... ........+..++..+.+++.+||+.||++|||+.+++++.
T Consensus 241 ~~~----------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 241 IPR----------------NPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred ccc----------------cCCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 000 00000111223466899999999999999999999999874
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=285.61 Aligned_cols=251 Identities=22% Similarity=0.337 Sum_probs=202.7
Q ss_pred hcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceeeEEeecC
Q 018785 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSESD 100 (350)
Q Consensus 21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 100 (350)
..|.....||.|+||.||+| .+..++..|++|.+..........+.+|+..++.+.|||++++++++..++
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~---------~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~ 91 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIA---------REKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGE 91 (297)
T ss_pred hhHHhhhhcCCCCceeEEEE---------EEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCC
Confidence 45556678999999999999 555678899999987655445567888999999999999999999999999
Q ss_pred ceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcccccccc
Q 018785 101 NRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD 180 (350)
Q Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~~ 180 (350)
..++|+||+++++|.+++... .+++..+..++.|++.||.+|| +.|++|+||+|+||+++.++.++|+|||++..
T Consensus 92 ~~~iv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH--~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~ 166 (297)
T cd06659 92 ELWVLMEFLQGGALTDIVSQT---RLNEEQIATVCESVLQALCYLH--SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQ 166 (297)
T ss_pred eEEEEEecCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHeEEccCCcEEEeechhHhh
Confidence 999999999999999977553 5899999999999999999999 99999999999999999999999999998864
Q ss_pred CCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhHHHH
Q 018785 181 GPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVL 260 (350)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (350)
..... .......++..|+|||.+.+..++.++|+||||+++|+|++|..||...........+...
T Consensus 167 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~------------ 232 (297)
T cd06659 167 ISKDV--PKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS------------ 232 (297)
T ss_pred ccccc--ccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc------------
Confidence 32221 1122345788899999998888999999999999999999999999754321111111000
Q ss_pred HhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 261 RIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
..........++..+.+++.+||+.+|.+||++.+++++
T Consensus 233 ----~~~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 233 ----PPPKLKNAHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred ----CCCCccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 000011123456789999999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=276.61 Aligned_cols=254 Identities=25% Similarity=0.399 Sum_probs=202.0
Q ss_pred hhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceeeEEeec
Q 018785 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (350)
Q Consensus 20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (350)
...+.....||+|+||.||+| .+..++..|++|.+..........+.+|+.+++.++|+||+++++++..+
T Consensus 7 ~~~~~~~~~lg~g~~g~v~~~---------~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 77 (268)
T cd06624 7 YDENGERVVLGKGTYGIVYAA---------RDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSEN 77 (268)
T ss_pred cccCCceEEEecCCceEEEEe---------EecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccC
Confidence 344555668999999999999 55566889999998877666667889999999999999999999999999
Q ss_pred CceEEEEEcCCCCChhhHHhhcCCCCC--CHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcC-CCcEEEcccc
Q 018785 100 DNRLLVYEFMPKGSLENHLFRKGVQPI--SWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS-NFNAKLSDFG 176 (350)
Q Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~l--~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~-~~~~~l~Dfg 176 (350)
+..++|+||+.+++|.+++.... ..+ +...+..++.|++.||+||| +.|++|+||+|.||+++. ++.++|+|||
T Consensus 78 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH--~~~i~h~dl~p~nil~~~~~~~~~l~dfg 154 (268)
T cd06624 78 GFFKIFMEQVPGGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLH--DNQIVHRDIKGDNVLVNTYSGVVKISDFG 154 (268)
T ss_pred CEEEEEEecCCCCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHH--HCCEeecCCCHHHEEEcCCCCeEEEecch
Confidence 99999999999999999997642 134 77888899999999999999 999999999999999976 6789999999
Q ss_pred ccccCCCCCCCcccccccCCCcccCccccccC--CCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhh
Q 018785 177 LARDGPTGDNTHVSTRIVGTRGYAAPEYVATG--HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLR 254 (350)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~ 254 (350)
.+........ ......++..|+|||.+.+. .++.++|+||+|+++|+|++|..||..........
T Consensus 155 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~----------- 221 (268)
T cd06624 155 TSKRLAGINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAM----------- 221 (268)
T ss_pred hheecccCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhH-----------
Confidence 9865432221 12223578889999988654 37889999999999999999999986432211000
Q ss_pred hhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 255 DSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
............+..+++++.+++.+||+.+|.+|||+.+++.|
T Consensus 222 -----~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 222 -----FKVGMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred -----hhhhhhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 00000011123445677889999999999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=275.87 Aligned_cols=252 Identities=26% Similarity=0.415 Sum_probs=204.0
Q ss_pred cccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh--hHHHHHHHHHHHhccCCCcccceeeEEeec
Q 018785 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ--GHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (350)
Q Consensus 22 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (350)
+|.+.+.||+|++|.||+| ....++..|++|.+...... ....+..|+.+++.++|++|+++++++...
T Consensus 1 ~y~~~~~lg~G~~~~v~~~---------~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~ 71 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTA---------VNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHR 71 (264)
T ss_pred CceeeeEeecCCCcEEEEE---------EECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecC
Confidence 6899999999999999999 55556889999998766543 557789999999999999999999999999
Q ss_pred CceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccccc
Q 018785 100 DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR 179 (350)
Q Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~ 179 (350)
+..++|+||+++++|.+++.... .+++..+..++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||++.
T Consensus 72 ~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lh--~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~ 147 (264)
T cd06626 72 EKVYIFMEYCSGGTLEELLEHGR--ILDEHVIRVYTLQLLEGLAYLH--SHGIVHRDIKPANIFLDHNGVIKLGDFGCAV 147 (264)
T ss_pred CEEEEEEecCCCCcHHHHHhhcC--CCChHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEECCCCCEEEccccccc
Confidence 99999999999999999987654 5888899999999999999999 9999999999999999999999999999987
Q ss_pred cCCCCCCCcc--cccccCCCcccCccccccCC---CCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhh
Q 018785 180 DGPTGDNTHV--STRIVGTRGYAAPEYVATGH---LTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLR 254 (350)
Q Consensus 180 ~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~---~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~ 254 (350)
.......... .....++..|+|||.+.+.. .+.++|+||+|+++|++++|+.||..........
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~----------- 216 (264)
T cd06626 148 KLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIM----------- 216 (264)
T ss_pred ccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHH-----------
Confidence 6443322211 11245678899999987765 7899999999999999999999996543111000
Q ss_pred hhHHHHHhhhcccCCCCc--HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 255 DSRRVLRIMDTRLGGQYS--KKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
.. .........+ ..+++.+.+++.+||+.+|.+|||+.+++.+
T Consensus 217 -----~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~ 261 (264)
T cd06626 217 -----FH-VGAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQH 261 (264)
T ss_pred -----HH-HhcCCCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00 0001111122 2347889999999999999999999998754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=274.82 Aligned_cols=251 Identities=24% Similarity=0.378 Sum_probs=208.1
Q ss_pred cccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch--hhHHHHHHHHHHHhccCCCcccceeeEEeec
Q 018785 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (350)
Q Consensus 22 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (350)
+|++.+.||.|++|.||++ .+..++..+++|.+..... .....+.+|++.++.++|||++++.+.+..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~---------~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~ 71 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLV---------RRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEK 71 (258)
T ss_pred CceEEeeeccCCCeEEEEE---------EEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecC
Confidence 5899999999999999999 5555688999999876543 4456788999999999999999999999999
Q ss_pred CceEEEEEcCCCCChhhHHhhcC--CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccc
Q 018785 100 DNRLLVYEFMPKGSLENHLFRKG--VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL 177 (350)
Q Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~--~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~ 177 (350)
+..++|+|++++++|.+++.... ...++...+..++.+++.||.+|| +.|++|+||+|+||+++.++.++|+|||.
T Consensus 72 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh--~~~~~H~dl~~~nil~~~~~~~~l~d~~~ 149 (258)
T cd08215 72 GKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH--SRKILHRDIKPQNIFLTSNGLVKLGDFGI 149 (258)
T ss_pred CEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHH--hCCEecccCChHHeEEcCCCcEEECCccc
Confidence 99999999999999999997653 347999999999999999999999 89999999999999999999999999999
Q ss_pred cccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhH
Q 018785 178 ARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSR 257 (350)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 257 (350)
+....... .......+++.|+|||...+..++.++|+||+|+++++|++|..||...........
T Consensus 150 ~~~~~~~~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~------------- 214 (258)
T cd08215 150 SKVLSSTV--DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALK------------- 214 (258)
T ss_pred eeecccCc--ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHH-------------
Confidence 87643332 122334678889999999888899999999999999999999999865432111111
Q ss_pred HHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 258 RVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
.........+..++..+.+++.+||..+|.+|||+.+++++
T Consensus 215 -----~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 215 -----ILKGQYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred -----HhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 11111223344667899999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=274.98 Aligned_cols=253 Identities=24% Similarity=0.330 Sum_probs=204.7
Q ss_pred cccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccc--hhhHHHHHHHHHHHhccCCCcccceeeEEee-
Q 018785 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES--FQGHKEWLTEVIYLGQLRHENLVKLIGYCSE- 98 (350)
Q Consensus 22 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~- 98 (350)
+|++.+.||.|++|.||++ .+..++..+++|.+.... ......+..|+..++.++||||+++++.+..
T Consensus 1 ~y~~~~~lg~g~~~~v~~~---------~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKV---------RRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDR 71 (265)
T ss_pred CceeeeeeccCCCeEEEEe---------eecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecC
Confidence 5889999999999999999 666678999999886543 2334567889999999999999999997754
Q ss_pred -cCceEEEEEcCCCCChhhHHhhc--CCCCCCHHHHHHHHHHHHHHHHHhhcC---CCCeeeCCCCCCceEEcCCCcEEE
Q 018785 99 -SDNRLLVYEFMPKGSLENHLFRK--GVQPISWPTRVKIAIDVARGLSFLHGL---DANVIYRDLKASNVLLDSNFNAKL 172 (350)
Q Consensus 99 -~~~~~lv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~i~~ql~~al~~lh~~---~~~i~H~di~~~Nili~~~~~~~l 172 (350)
....+++|||+++++|.+++... ....+++..+..++.|++.||.+||.. +.+++|+||+|+||+++.++.++|
T Consensus 72 ~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl 151 (265)
T cd08217 72 SNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKL 151 (265)
T ss_pred CCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEE
Confidence 45678999999999999998653 234789999999999999999999943 568999999999999999999999
Q ss_pred ccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchh
Q 018785 173 SDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPF 252 (350)
Q Consensus 173 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 252 (350)
+|||++........ ......+++.|+|||.+.+..++.++|+||||+++++|++|..||.........
T Consensus 152 ~d~g~~~~~~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~---------- 219 (265)
T cd08217 152 GDFGLAKILGHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLA---------- 219 (265)
T ss_pred ecccccccccCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHH----------
Confidence 99999976433322 122345788899999998888999999999999999999999999764421111
Q ss_pred hhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 253 LRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
..+........+...+..+.+++.+||+.+|.+||++.+++++
T Consensus 220 --------~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 220 --------SKIKEGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred --------HHHhcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 1111122223455677899999999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=274.19 Aligned_cols=253 Identities=25% Similarity=0.418 Sum_probs=209.3
Q ss_pred cccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch--hhHHHHHHHHHHHhccCCCcccceeeEEeec
Q 018785 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (350)
Q Consensus 22 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (350)
+|++.+.||+|++|.||+| .+..++..|++|.+..... .....+.+|+..+++++||||+++++.+...
T Consensus 1 ~~~~~~~i~~g~~~~v~~~---------~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLA---------LDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDE 71 (260)
T ss_pred CceeeeEeeecCceEEEEE---------EECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecC
Confidence 5888999999999999999 5556788999999876653 3456788999999999999999999999988
Q ss_pred --CceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccc
Q 018785 100 --DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL 177 (350)
Q Consensus 100 --~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~ 177 (350)
+..++++|++.+++|.+++.... .++...+..++.|++.+|+||| +.|++|+||+|+||+++.++.++|+|||.
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh--~~~~~h~dl~p~ni~i~~~~~~~l~d~~~ 147 (260)
T cd06606 72 EKNTLNIFLEYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLH--SNGIVHRDIKGANILVDSDGVVKLADFGC 147 (260)
T ss_pred CCCeEEEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCccccCCCHHHEEEcCCCCEEEccccc
Confidence 88999999999999999998765 7999999999999999999999 89999999999999999999999999999
Q ss_pred cccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhH
Q 018785 178 ARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSR 257 (350)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 257 (350)
+................++..|++||.+.+...+.++|+||||+++++|++|..||...... . .
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~--------------~ 211 (260)
T cd06606 148 AKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNP--M--------------A 211 (260)
T ss_pred EEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch--H--------------H
Confidence 97654443211122345778899999998888999999999999999999999999765410 0 0
Q ss_pred HHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 258 RVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
..............+...+..+.+++.+|++.||.+||++.+++.+
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 212 ALYKIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred HHHhccccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 0111111122233455668899999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=280.40 Aligned_cols=269 Identities=22% Similarity=0.322 Sum_probs=198.3
Q ss_pred hhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh-hHHHHHHHHHHHhccCCCcccceeeEEee
Q 018785 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ-GHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (350)
Q Consensus 20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (350)
.++|++.+.||+|++|.||+| .+..+++.|++|.+...... ....+.+|+.+++.++||||+++++++.+
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~---------~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 74 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKG---------RSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHT 74 (291)
T ss_pred ccceeEEEEEeecCCeEEEEE---------EEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEec
Confidence 368999999999999999999 55566889999998654322 22446689999999999999999999999
Q ss_pred cCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcccccc
Q 018785 99 SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 178 (350)
Q Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~ 178 (350)
++..++||||+. ++|.+++..... .++...+..++.|+++||.||| +.|++|+||+|+||+++.++.++|+|||++
T Consensus 75 ~~~~~lv~e~~~-~~L~~~~~~~~~-~~~~~~~~~~~~ql~~al~~lH--~~~i~H~dl~p~nil~~~~~~~kl~dfg~~ 150 (291)
T cd07844 75 KKTLTLVFEYLD-TDLKQYMDDCGG-GLSMHNVRLFLFQLLRGLAYCH--QRRVLHRDLKPQNLLISERGELKLADFGLA 150 (291)
T ss_pred CCeEEEEEecCC-CCHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHH--hCCeecccCCHHHEEEcCCCCEEECccccc
Confidence 999999999996 499998876543 6899999999999999999999 999999999999999999999999999998
Q ss_pred ccCCCCCCCcccccccCCCcccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCcccccC-cchhhhhhh-cchhhh-
Q 018785 179 RDGPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRALDEDRGG-LAEQTLVEW-ADPFLR- 254 (350)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~-~~~~~~~~~-~~~~~~- 254 (350)
........ ......++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||...... .....+... ..+...
T Consensus 151 ~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (291)
T cd07844 151 RAKSVPSK--TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEET 228 (291)
T ss_pred cccCCCCc--cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhh
Confidence 64322111 1122345778999998865 45789999999999999999999999654421 111111100 000000
Q ss_pred --hhHHHHHhhhcccC----C---CCcHHHH--HHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 255 --DSRRVLRIMDTRLG----G---QYSKKEA--QAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 255 --~~~~~~~~~~~~~~----~---~~~~~~~--~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
.............. . .....++ .++.+++.+||+.+|.+|||+.+++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 229 WPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred hhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 00000000000000 0 0001122 678899999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=282.51 Aligned_cols=269 Identities=27% Similarity=0.382 Sum_probs=202.8
Q ss_pred hcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch--hhHHHHHHHHHHHhccCCCcccceeeEEee
Q 018785 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (350)
Q Consensus 21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (350)
++|++.+.||+|++|.||+| .+..+++.|++|.+..... .....+.+|+++++.++|+||+++++++..
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~---------~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 71 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKC---------RNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR 71 (288)
T ss_pred CceeEEEEecccCCeeEEEE---------EeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE
Confidence 47999999999999999999 5666688999998865432 234668899999999999999999999999
Q ss_pred cCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcccccc
Q 018785 99 SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 178 (350)
Q Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~ 178 (350)
++..++++||+.++.+..+.... ..++...+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||.+
T Consensus 72 ~~~~~iv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH--~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~ 147 (288)
T cd07833 72 KGRLYLVFEYVERTLLELLEASP--GGLPPDAVRSYIWQLLQAIAYCH--SHNIIHRDIKPENILVSESGVLKLCDFGFA 147 (288)
T ss_pred CCEEEEEEecCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHeEECCCCCEEEEeeecc
Confidence 99999999999876665544433 35899999999999999999999 999999999999999999999999999998
Q ss_pred ccCCCCCCCcccccccCCCcccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhH
Q 018785 179 RDGPTGDNTHVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSR 257 (350)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 257 (350)
......... ......++..|+|||.+.+. .++.++|+||||+++|+|++|..||.+.........+............
T Consensus 148 ~~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (288)
T cd07833 148 RALRARPAS-PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQ 226 (288)
T ss_pred cccCCCccc-cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHh
Confidence 765443321 12224567789999999887 8899999999999999999999999755432221111111100000000
Q ss_pred HHH---------Hhhhcc----cCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 258 RVL---------RIMDTR----LGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 258 ~~~---------~~~~~~----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
... ...... .....+..++.++.+++.+||..+|++|||+++++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 227 ELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred hhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 000 000000 0001222347889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=277.46 Aligned_cols=256 Identities=29% Similarity=0.354 Sum_probs=190.4
Q ss_pred ceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh-hHHHHHHHHHHHhccCCCcccceeeEEeecCceEEE
Q 018785 27 YLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ-GHKEWLTEVIYLGQLRHENLVKLIGYCSESDNRLLV 105 (350)
Q Consensus 27 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 105 (350)
+.||+|+||.||+|.... ......+++|.+...... ....+.+|+..++.++||||+++++.+......++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~-------~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv 73 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHR-------GMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLV 73 (269)
T ss_pred CcCCccCCceEEEEEEec-------CCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEE
Confidence 468999999999996432 123567889987654332 235578899999999999999999999999999999
Q ss_pred EEcCCCCChhhHHhhcCC---CCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccccccCC
Q 018785 106 YEFMPKGSLENHLFRKGV---QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGP 182 (350)
Q Consensus 106 ~e~~~~~~L~~~l~~~~~---~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~~~~ 182 (350)
|||+.+++|.+++..... ...+...+..++.|++.||+||| +.|++|+||||+||+++.++.++|+|||++....
T Consensus 74 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~ 151 (269)
T cd05042 74 LEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH--QADFIHSDLALRNCQLTADLSVKIGDYGLALEQY 151 (269)
T ss_pred EEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH--hcCEecccccHhheEecCCCcEEEeccccccccc
Confidence 999999999999976532 23467788899999999999999 9999999999999999999999999999986432
Q ss_pred CCCCCcccccccCCCcccCcccccc-------CCCCCccchhhHHHHHHHHHh-CCCCCcccccCcchhhhhhhcchhhh
Q 018785 183 TGDNTHVSTRIVGTRGYAAPEYVAT-------GHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLR 254 (350)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~aPE~~~~-------~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~ 254 (350)
............++..|+|||.+.. ..++.++|+|||||++|+|++ |..||....+...........
T Consensus 152 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~----- 226 (269)
T cd05042 152 PEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQ----- 226 (269)
T ss_pred cchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhcc-----
Confidence 2211111122334567999998642 356789999999999999999 777886543211111111000
Q ss_pred hhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018785 255 DSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 305 (350)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~ 305 (350)
............+++.+.+++..|+ .||++|||++++++.|.
T Consensus 227 --------~~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 227 --------DIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred --------CccCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 0000111223456778888999998 59999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=280.24 Aligned_cols=251 Identities=24% Similarity=0.352 Sum_probs=202.9
Q ss_pred hcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceeeEEeecC
Q 018785 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSESD 100 (350)
Q Consensus 21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 100 (350)
.+|...+.||.|++|.||++ .+..++..+++|.+..........+.+|+.+++.++|||++++++++...+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~---------~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~ 89 (285)
T cd06648 19 SYLDNFVKIGEGSTGIVCIA---------TDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGD 89 (285)
T ss_pred HhhhcceEeccCCCeEEEEE---------EECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCC
Confidence 46666789999999999999 555568899999887655455566888999999999999999999999999
Q ss_pred ceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcccccccc
Q 018785 101 NRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD 180 (350)
Q Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~~ 180 (350)
..++++||+.+++|.+++... .++...+..++.|++.||++|| +.|++|+||+|+||+++.++.++|+|||.+..
T Consensus 90 ~~~~v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH--~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~ 164 (285)
T cd06648 90 ELWVVMEFLEGGALTDIVTHT---RMNEEQIATVCLAVLKALSFLH--AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQ 164 (285)
T ss_pred eEEEEEeccCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCChhhEEEcCCCcEEEcccccchh
Confidence 999999999999999998763 5899999999999999999999 99999999999999999999999999998764
Q ss_pred CCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhHHHH
Q 018785 181 GPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVL 260 (350)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (350)
...... ......++..|+|||.+.+..++.++|+||+|+++|+|++|+.||...........+...
T Consensus 165 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~------------ 230 (285)
T cd06648 165 VSKEVP--RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN------------ 230 (285)
T ss_pred hccCCc--ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhc------------
Confidence 322111 112245788899999998888999999999999999999999998653321111111100
Q ss_pred HhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 261 RIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
.......+..++..+.+++.+||..+|++|||+.+++++
T Consensus 231 ----~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 231 ----LPPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred ----CCCCCcccccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 000011122367789999999999999999999999965
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=284.79 Aligned_cols=269 Identities=27% Similarity=0.322 Sum_probs=201.7
Q ss_pred hhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhh--HHHHHHHHHHHhccCCCcccceeeEEe
Q 018785 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQG--HKEWLTEVIYLGQLRHENLVKLIGYCS 97 (350)
Q Consensus 20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (350)
.++|++.+.||.|++|.||+| .+..+|+.||+|.+....... .....+|+.++++++|+|++++++++.
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 76 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRA---------RDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVV 76 (309)
T ss_pred ccceeEeeeeeecCCEEEEEE---------EECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEe
Confidence 468999999999999999999 566678999999986543221 234567999999999999999999987
Q ss_pred ec--CceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccc
Q 018785 98 ES--DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDF 175 (350)
Q Consensus 98 ~~--~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Df 175 (350)
.. +..++||||+. ++|.+++.... ..+++..+..++.|++.||.||| +.|++|+||+|+||+++.++.++|+||
T Consensus 77 ~~~~~~~~lv~e~~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH--~~~i~H~dl~p~nil~~~~~~~kL~df 152 (309)
T cd07845 77 GKHLDSIFLVMEYCE-QDLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLH--ENFIIHRDLKVSNLLLTDKGCLKIADF 152 (309)
T ss_pred cCCCCeEEEEEecCC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEECCCCCEEECcc
Confidence 55 56899999995 58988886543 46899999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCCCCCcccccccCCCcccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhh
Q 018785 176 GLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLR 254 (350)
Q Consensus 176 g~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~ 254 (350)
|.+......... .....++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||...........+.........
T Consensus 153 g~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~ 230 (309)
T cd07845 153 GLARTYGLPAKP--MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNE 230 (309)
T ss_pred ceeeecCCccCC--CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 999764332211 122335677999998865 45789999999999999999999999866554433333322110000
Q ss_pred hh----HHHH---HhhhcccCCC----CcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 255 DS----RRVL---RIMDTRLGGQ----YSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 255 ~~----~~~~---~~~~~~~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
.. .... .......... .....++++.++|.+||+.||++|||+++++.|
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 231 SIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred hhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00 0000 0000000000 011247788999999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=290.88 Aligned_cols=269 Identities=25% Similarity=0.413 Sum_probs=232.4
Q ss_pred hhhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceee
Q 018785 15 ISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIG 94 (350)
Q Consensus 15 ~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 94 (350)
-++....+.....+||-|.||.||.|+|+.. .-.||||.++....+ .++|+.|+.+++.++|||++++++
T Consensus 261 kWEmeRtdItMkhKLGGGQYGeVYeGvWKky---------slTvAVKtLKEDtMe-veEFLkEAAvMKeikHpNLVqLLG 330 (1157)
T KOG4278|consen 261 KWEMERTDITMKHKLGGGQYGEVYEGVWKKY---------SLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 330 (1157)
T ss_pred hhhccchheeeeeccCCCcccceeeeeeecc---------ceeeehhhhhhcchh-HHHHHHHHHHHHhhcCccHHHHhh
Confidence 3445556677788999999999999998865 356899999877644 678999999999999999999999
Q ss_pred EEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcc
Q 018785 95 YCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSD 174 (350)
Q Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~D 174 (350)
+|..+..+|||+||+.+|+|.+|+.+.....++....+.++.||..|++||. .++++||||-..|+|+.++..||++|
T Consensus 331 VCT~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLE--kknFIHRDLAARNCLVgEnhiVKvAD 408 (1157)
T KOG4278|consen 331 VCTHEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLE--KKNFIHRDLAARNCLVGENHIVKVAD 408 (1157)
T ss_pred hhccCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHH--HhhhhhhhhhhhhccccccceEEeec
Confidence 9999999999999999999999999887777888889999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccccCcchhhhhhhcchhh
Q 018785 175 FGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFL 253 (350)
Q Consensus 175 fg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~ 253 (350)
||+++.+...... ..........|+|||.+....++.++|||+||++||++.| |-.||.+.+
T Consensus 409 FGLsRlMtgDTYT-AHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid---------------- 471 (1157)
T KOG4278|consen 409 FGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID---------------- 471 (1157)
T ss_pred cchhhhhcCCcee-cccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc----------------
Confidence 9999986554332 2222334556999999999999999999999999999998 566877654
Q ss_pred hhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcCCCCC
Q 018785 254 RDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDMP 314 (350)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~~ 314 (350)
..++...+...++.+-+..|++.+++|++.||+++|.+||++.++-+.++.++...++.
T Consensus 472 --lSqVY~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~sSis 530 (1157)
T KOG4278|consen 472 --LSQVYGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSSSIS 530 (1157)
T ss_pred --HHHHHHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcccccc
Confidence 24455666777788889999999999999999999999999999999999998876654
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=289.19 Aligned_cols=280 Identities=26% Similarity=0.372 Sum_probs=210.7
Q ss_pred hhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccc--hhhHHHHHHHHHHHhccCCCcccceeeEEe
Q 018785 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES--FQGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (350)
Q Consensus 20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (350)
.++|.+.+.||.|++|+||+| .+..++..|+||.+.... ......+.+|+.+++.++||||+++++++.
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~ 74 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSA---------KNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMP 74 (337)
T ss_pred ccceeEEEEeccCCCeEEEEE---------EecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHhee
Confidence 568999999999999999999 666779999999886532 223445678999999999999999999876
Q ss_pred ec-----CceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEE
Q 018785 98 ES-----DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKL 172 (350)
Q Consensus 98 ~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l 172 (350)
.. ...++++||+ +++|.+++.... .+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|
T Consensus 75 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH--~~~i~H~dlkp~Nil~~~~~~~kL 149 (337)
T cd07858 75 PPHREAFNDVYIVYELM-DTDLHQIIRSSQ--TLSDDHCQYFLYQLLRGLKYIH--SANVLHRDLKPSNLLLNANCDLKI 149 (337)
T ss_pred cccccccCcEEEEEeCC-CCCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHH--hCCEecCCCCHHHEEEcCCCCEEE
Confidence 44 3579999999 568998887654 6999999999999999999999 999999999999999999999999
Q ss_pred ccccccccCCCCCCCcccccccCCCcccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcch
Q 018785 173 SDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADP 251 (350)
Q Consensus 173 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~ 251 (350)
+|||++....... .......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||.+.........+......
T Consensus 150 ~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 227 (337)
T cd07858 150 CDFGLARTTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGS 227 (337)
T ss_pred CcCccccccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCC
Confidence 9999997643322 11223456778999998765 46889999999999999999999999765432222222111110
Q ss_pred hhhh------hHHHHHhhh---cccC---CCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHhhhcCCCCCC
Q 018785 252 FLRD------SRRVLRIMD---TRLG---GQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS--LEQLHTSKDMPR 315 (350)
Q Consensus 252 ~~~~------~~~~~~~~~---~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~--L~~~~~~~~~~~ 315 (350)
.... ......... .... ......+++++.+++.+||+.+|.+|||++++++| +..+......|.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~~~~~ 305 (337)
T cd07858 228 PSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSDEPV 305 (337)
T ss_pred CChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCcccCcc
Confidence 0000 000000010 0000 01123567889999999999999999999999999 877766655443
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=273.44 Aligned_cols=251 Identities=29% Similarity=0.443 Sum_probs=206.1
Q ss_pred cccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceeeEEeecCc
Q 018785 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSESDN 101 (350)
Q Consensus 22 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 101 (350)
+|++.+.||+|++|.||++ .+..++..+++|.+..........+.+|+..++.++||+++++++++..++.
T Consensus 1 ~y~~~~~l~~g~~~~v~~~---------~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 71 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKA---------RHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDE 71 (253)
T ss_pred CceeeeeeccCCceEEEEE---------EECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCe
Confidence 5889999999999999999 5555688999999987765556778899999999999999999999999999
Q ss_pred eEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccccccC
Q 018785 102 RLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDG 181 (350)
Q Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~~~ 181 (350)
.++++||+.+++|.+++.... ..++...+..++.|++++|.+|| +.|++|+||+|+||+++.++.++|+|||.+...
T Consensus 72 ~~l~~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh--~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~ 148 (253)
T cd05122 72 LWIVMEFCSGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLH--SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQL 148 (253)
T ss_pred EEEEEecCCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhh--cCCEecCCCCHHHEEEccCCeEEEeeccccccc
Confidence 999999999999999987653 36899999999999999999999 899999999999999999999999999998764
Q ss_pred CCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhHHHHH
Q 018785 182 PTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLR 261 (350)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (350)
..... .....++..|+|||.+.+..++.++|+||||+++++|++|+.||............. .
T Consensus 149 ~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~--------------~ 211 (253)
T cd05122 149 SDTKA---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIA--------------T 211 (253)
T ss_pred ccccc---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHH--------------h
Confidence 33321 223457788999999988888999999999999999999999987543211110000 0
Q ss_pred hhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 262 IMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 262 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
...........++..+.+++.+||+.||.+|||+.++++|
T Consensus 212 --~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 212 --NGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred --cCCCCcCcccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0000011112236789999999999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=287.93 Aligned_cols=266 Identities=25% Similarity=0.331 Sum_probs=201.5
Q ss_pred hhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccc--hhhHHHHHHHHHHHhccCCCcccceeeEE
Q 018785 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES--FQGHKEWLTEVIYLGQLRHENLVKLIGYC 96 (350)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (350)
..++|++.+.||+|++|.||+| .+..++..||+|.+.... ......+.+|+.+++.++||||+++++++
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 84 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAA---------YDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVF 84 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEE---------EECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeee
Confidence 4689999999999999999999 666678999999986532 23345677899999999999999999988
Q ss_pred eec------CceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcE
Q 018785 97 SES------DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNA 170 (350)
Q Consensus 97 ~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~ 170 (350)
... ...++||||+ .++|.+.+... ++...+..++.|++.||+||| +.|++|+||+|+||+++.++.+
T Consensus 85 ~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH--~~gi~H~dlkp~Nil~~~~~~~ 157 (353)
T cd07850 85 TPQKSLEEFQDVYLVMELM-DANLCQVIQMD----LDHERMSYLLYQMLCGIKHLH--SAGIIHRDLKPSNIVVKSDCTL 157 (353)
T ss_pred ccCCCccccCcEEEEEecc-CCCHHHHHhhc----CCHHHHHHHHHHHHHHHHHHH--hCCeeeCCCCHHHEEECCCCCE
Confidence 643 3579999999 45888877542 888899999999999999999 8999999999999999999999
Q ss_pred EEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhh-c
Q 018785 171 KLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEW-A 249 (350)
Q Consensus 171 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~-~ 249 (350)
+|+|||++....... ......++..|+|||.+.+..++.++|+|||||++|+|++|+.||...+.......+... .
T Consensus 158 kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~ 234 (353)
T cd07850 158 KILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLG 234 (353)
T ss_pred EEccCccceeCCCCC---CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcC
Confidence 999999997543221 122245678899999999999999999999999999999999999765432222222111 1
Q ss_pred chhh---hhhH-HHHHhhhccc-------------------CCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 250 DPFL---RDSR-RVLRIMDTRL-------------------GGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 250 ~~~~---~~~~-~~~~~~~~~~-------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
.+.. .... .......... ....+...+..+.++|.+||+.||.+|||+.++++|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 235 TPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred CCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1100 0000 0000000000 000122356788999999999999999999999977
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=276.78 Aligned_cols=249 Identities=25% Similarity=0.391 Sum_probs=191.9
Q ss_pred eecccCceeEEeecccCCCc---------------CCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccce
Q 018785 28 LLGEGGFGCVFKGWIDQNTF---------------APTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKL 92 (350)
Q Consensus 28 ~lg~G~~g~V~~~~~~~~~~---------------~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 92 (350)
.||+|+||.||+|++..... ...+......|++|.+..........+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999997642110 001233456789998876655555678889999999999999999
Q ss_pred eeEEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCC----
Q 018785 93 IGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNF---- 168 (350)
Q Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~---- 168 (350)
++++......++||||+++++|..++.... ..++...+..++.|++.||+||| ++|++|+||+|+||+++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH--~~~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEK-GRVPVAWKITVAQQLASALSYLE--DKNLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH--cCCccCCCCCcccEEEeccCcccC
Confidence 999999999999999999999998886533 36889999999999999999999 99999999999999997643
Q ss_pred ---cEEEccccccccCCCCCCCcccccccCCCcccCcccccc-CCCCCccchhhHHHHHHHHH-hCCCCCcccccCcchh
Q 018785 169 ---NAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELL-SGRRALDEDRGGLAEQ 243 (350)
Q Consensus 169 ---~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~ll~~ll-~g~~pf~~~~~~~~~~ 243 (350)
.++++|||.+...... ....++..|+|||.+.+ ..++.++|+||||+++|+|+ +|..||..........
T Consensus 159 ~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~ 232 (274)
T cd05076 159 TSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER 232 (274)
T ss_pred ccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH
Confidence 3799999987542211 11245677999998865 56889999999999999984 6888886543221111
Q ss_pred hhhhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018785 244 TLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 305 (350)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~ 305 (350)
. .... ...+...++.+.+++.+||+.+|++|||+.++++.|+
T Consensus 233 ~------------------~~~~--~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 233 F------------------YEKK--HRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred H------------------HHhc--cCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 0 0000 1112223467899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=278.49 Aligned_cols=246 Identities=28% Similarity=0.423 Sum_probs=198.2
Q ss_pred ecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch---hhHHHHHHHHHHHhccCCCcccceeeEEeecCceEEE
Q 018785 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLVKLIGYCSESDNRLLV 105 (350)
Q Consensus 29 lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 105 (350)
||+|+||+||+| .+..+|+.|++|.+..... .....+..|+.+++.++||+++++++.+...+..++|
T Consensus 1 lg~g~~g~vy~~---------~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 71 (277)
T cd05577 1 LGKGGFGEVCAC---------QVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLV 71 (277)
T ss_pred CCCCCceeEEEE---------EEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEE
Confidence 689999999999 5556688999998865432 2234457899999999999999999999999999999
Q ss_pred EEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccccccCCCCC
Q 018785 106 YEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGD 185 (350)
Q Consensus 106 ~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~~~~~~~ 185 (350)
|||+++++|.+++.......+++..+..++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||.+......
T Consensus 72 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH--~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~- 148 (277)
T cd05577 72 MTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLH--QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG- 148 (277)
T ss_pred EecCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHHEEECCCCCEEEccCcchhhhccC-
Confidence 99999999999997766557999999999999999999999 999999999999999999999999999988754321
Q ss_pred CCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhHHHHHhhhc
Q 018785 186 NTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDT 265 (350)
Q Consensus 186 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (350)
.......++..|+|||.+.+..++.++|+||||+++|+|++|+.||...........+... . .
T Consensus 149 --~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--------------~-~ 211 (277)
T cd05577 149 --KKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRR--------------T-L 211 (277)
T ss_pred --CccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhc--------------c-c
Confidence 1112234677899999998888999999999999999999999999765432211111110 0 0
Q ss_pred ccCCCCcHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 018785 266 RLGGQYSKKEAQAVAAVVLQCLHMDPKNRP-----SMVDVLTS 303 (350)
Q Consensus 266 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~~ 303 (350)
......+..+++.+.++|.+||+.||.+|| ++.++++|
T Consensus 212 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h 254 (277)
T cd05577 212 EMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREH 254 (277)
T ss_pred cccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhC
Confidence 111223445688999999999999999999 77778764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=275.08 Aligned_cols=251 Identities=24% Similarity=0.390 Sum_probs=203.8
Q ss_pred cccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch--hhHHHHHHHHHHHhccCCCcccceeeEEeec
Q 018785 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (350)
Q Consensus 22 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (350)
+|.+.+.||+|++|.||+| ....+|..+++|.+..... .....+.+|+.+++.++|+|++++++.+...
T Consensus 1 ~~~~~~~l~~g~~~~v~~~---------~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~ 71 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLA---------KAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQEN 71 (257)
T ss_pred CceEEEEecCCCcceEEEE---------EEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccC
Confidence 5889999999999999999 5566688899999866432 2345678899999999999999999999999
Q ss_pred CceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCc-EEEcccccc
Q 018785 100 DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFN-AKLSDFGLA 178 (350)
Q Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~-~~l~Dfg~~ 178 (350)
+..++|+||+.+++|.+++.......+++..+..++.|+++||.||| +.+++|+||+|+||+++.++. ++|+|||.+
T Consensus 72 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh--~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~ 149 (257)
T cd08225 72 GRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH--DRKILHRDIKSQNIFLSKNGMVAKLGDFGIA 149 (257)
T ss_pred CeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH--HCCcccccCCHHHEEEcCCCCeEEecccccc
Confidence 99999999999999999997765556899999999999999999999 999999999999999988864 699999988
Q ss_pred ccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhHH
Q 018785 179 RDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRR 258 (350)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (350)
........ ......++..|+|||.+.+..++.++|+||||+++++|++|..||..........
T Consensus 150 ~~~~~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~--------------- 212 (257)
T cd08225 150 RQLNDSME--LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVL--------------- 212 (257)
T ss_pred hhccCCcc--cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHH---------------
Confidence 75432221 1222457888999999888889999999999999999999999986543211111
Q ss_pred HHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 259 VLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
..... ........++.++.+++.+||..+|++|||+.+++++
T Consensus 213 --~~~~~-~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 213 --KICQG-YFAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred --HHhcc-cCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 11111 1112233566789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=280.96 Aligned_cols=267 Identities=24% Similarity=0.296 Sum_probs=201.7
Q ss_pred ccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh--hHHHHHHHHHHHhccCCCcccceeeEEeecC
Q 018785 23 FCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ--GHKEWLTEVIYLGQLRHENLVKLIGYCSESD 100 (350)
Q Consensus 23 y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 100 (350)
|++.+.||.|++|.||+| .+..+|..|++|.+...... ....+.+|+..++.++||+++++++++.+++
T Consensus 1 y~~~~~l~~g~~~~vy~~---------~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~ 71 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKA---------RDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSEN 71 (283)
T ss_pred CchheEecCCCCeEEEEE---------EEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCC
Confidence 678999999999999999 55557899999988755322 2356778999999999999999999999999
Q ss_pred ceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcccccccc
Q 018785 101 NRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD 180 (350)
Q Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~~ 180 (350)
..++++||+ +++|.+++.......+++..+..++.|++.||+||| +.+++|+||+|+||+++.++.++|+|||++..
T Consensus 72 ~~~iv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH--~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~ 148 (283)
T cd07835 72 KLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH--SHRVLHRDLKPQNLLIDREGALKLADFGLARA 148 (283)
T ss_pred eEEEEEecc-CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH--HCCeeCCCCCHHHEEEcCCCcEEEeecccccc
Confidence 999999999 569999987765456899999999999999999999 89999999999999999999999999999875
Q ss_pred CCCCCCCcccccccCCCcccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhh----h
Q 018785 181 GPTGDNTHVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLR----D 255 (350)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~----~ 255 (350)
....... .....++..|+|||.+.+. .++.++|+||||+++|+|++|..||...........+......... .
T Consensus 149 ~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (283)
T cd07835 149 FGVPVRT--YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPG 226 (283)
T ss_pred cCCCccc--cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhh
Confidence 4322111 1223457789999987654 5788999999999999999999999765432221111111000000 0
Q ss_pred hHHHHHhhhcc------cCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 256 SRRVLRIMDTR------LGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 256 ~~~~~~~~~~~------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
........... ........++..+.+++.+||+.||.+|||+++++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 227 VTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00000000000 0001123456789999999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=276.44 Aligned_cols=249 Identities=27% Similarity=0.374 Sum_probs=203.5
Q ss_pred hcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch-hhHHHHHHHHHHHhccCCCcccceeeEEeec
Q 018785 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (350)
Q Consensus 21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (350)
+-|++.+.||+|+||.||+| .+..++..+|+|.+..... .....+.+|+..++.++||||+++++.+..+
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~---------~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 74 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKG---------IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKD 74 (277)
T ss_pred HhhhhheeEeecCCeEEEEE---------EECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeC
Confidence 45888999999999999999 5555688999998765432 3345678899999999999999999999999
Q ss_pred CceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccccc
Q 018785 100 DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR 179 (350)
Q Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~ 179 (350)
+..++||||+.+++|.+++... .++...+..++.|++.++.+|| +.|++|+||+|+||+++.++.++|+|||++.
T Consensus 75 ~~~~lv~e~~~~~~l~~~i~~~---~~~~~~~~~~~~~l~~~l~~lh--~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~ 149 (277)
T cd06641 75 TKLWIIMEYLGGGSALDLLEPG---PLDETQIATILREILKGLDYLH--SEKKIHRDIKAANVLLSEHGEVKLADFGVAG 149 (277)
T ss_pred CeEEEEEEeCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHc--cCCeecCCCCHHhEEECCCCCEEEeecccce
Confidence 9999999999999999988643 5889999999999999999999 9999999999999999999999999999886
Q ss_pred cCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhHHH
Q 018785 180 DGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRV 259 (350)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (350)
...... .......++..|+|||.+.+..++.++|+||+|+++|+|++|..||...........
T Consensus 150 ~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~--------------- 212 (277)
T cd06641 150 QLTDTQ--IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFL--------------- 212 (277)
T ss_pred ecccch--hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHH---------------
Confidence 533221 112224567789999999888889999999999999999999999865332111111
Q ss_pred HHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 260 LRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
+...........++.++.+++.+||+.+|.+||++.++++|
T Consensus 213 ---~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 213 ---IPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred ---HhcCCCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 11111122344567889999999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=278.79 Aligned_cols=252 Identities=27% Similarity=0.359 Sum_probs=195.0
Q ss_pred hcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch-hhHHHHHHHHH-HHhccCCCcccceeeEEee
Q 018785 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVI-YLGQLRHENLVKLIGYCSE 98 (350)
Q Consensus 21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~ 98 (350)
++|++.+.||+|+||.||+| .+..+|..||+|.+..... .....+..|.. .++.++|||++++++++..
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~ 71 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKM---------RHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFR 71 (283)
T ss_pred CCceEEEEecccCCeEEEEE---------EEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEec
Confidence 47999999999999999999 6667799999998876532 22233444555 4666789999999999999
Q ss_pred cCceEEEEEcCCCCChhhHHhhc--CCCCCCHHHHHHHHHHHHHHHHHhhcCCC-CeeeCCCCCCceEEcCCCcEEEccc
Q 018785 99 SDNRLLVYEFMPKGSLENHLFRK--GVQPISWPTRVKIAIDVARGLSFLHGLDA-NVIYRDLKASNVLLDSNFNAKLSDF 175 (350)
Q Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~i~~ql~~al~~lh~~~~-~i~H~di~~~Nili~~~~~~~l~Df 175 (350)
++..+++|||++ ++|.+++... ....+++..++.++.|++.||.||| ++ +++|+||+|+||+++.++.++|+||
T Consensus 72 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH--~~~~i~h~dlkp~nil~~~~~~~kl~df 148 (283)
T cd06617 72 EGDVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH--SKLSVIHRDVKPSNVLINRNGQVKLCDF 148 (283)
T ss_pred CCcEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh--hcCCeecCCCCHHHEEECCCCCEEEeec
Confidence 999999999995 6888887542 2346899999999999999999999 76 9999999999999999999999999
Q ss_pred cccccCCCCCCCcccccccCCCcccCcccccc----CCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcch
Q 018785 176 GLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT----GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADP 251 (350)
Q Consensus 176 g~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~----~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~ 251 (350)
|.+....... ......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||...... ..
T Consensus 149 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~-------- 215 (283)
T cd06617 149 GISGYLVDSV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP--FQ-------- 215 (283)
T ss_pred cccccccccc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC--HH--------
Confidence 9987542211 1122456778999998865 45688999999999999999999998643211 00
Q ss_pred hhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 252 FLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
.................++.++.+++.+||..+|.+||++.+++++
T Consensus 216 ------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 216 ------QLKQVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred ------HHHHHHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0011111111111123467889999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=273.00 Aligned_cols=252 Identities=29% Similarity=0.465 Sum_probs=201.1
Q ss_pred hhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceeeEEeec
Q 018785 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (350)
Q Consensus 20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (350)
..+|++.+.||.|++|.||++.+. .+..+++|.+..... ....+.+|+..++.++||+++++++++...
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~----------~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWL----------EKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTER 71 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEe----------CCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccC
Confidence 468999999999999999998542 255789998875443 245678899999999999999999999999
Q ss_pred CceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccccc
Q 018785 100 DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR 179 (350)
Q Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~ 179 (350)
...++|+||+++++|.+++.... ..++...+..++.|++.++++|| +.+++|+||+|.||+++.++.++|+|||.+.
T Consensus 72 ~~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH--~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~ 148 (256)
T cd05112 72 SPICLVFEFMEHGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLE--SSNVIHRDLAARNCLVGENQVVKVSDFGMTR 148 (256)
T ss_pred CceEEEEEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHH--HCCccccccccceEEEcCCCeEEECCCccee
Confidence 99999999999999999987644 25788999999999999999999 9999999999999999999999999999886
Q ss_pred cCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccccCcchhhhhhhcchhhhhhHH
Q 018785 180 DGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRR 258 (350)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (350)
....... .......++..|+|||.+.+..++.++|+||||+++|+|++ |..||...........+
T Consensus 149 ~~~~~~~-~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~------------- 214 (256)
T cd05112 149 FVLDDQY-TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETI------------- 214 (256)
T ss_pred ecccCcc-cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHH-------------
Confidence 5322211 11112234567999999988889999999999999999998 88898654422111111
Q ss_pred HHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018785 259 VLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL 304 (350)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 304 (350)
........+...+..+.+|+.+||+.+|++|||+.++++.|
T Consensus 215 -----~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 215 -----NAGFRLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred -----hCCCCCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 11111111233567899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=273.04 Aligned_cols=252 Identities=24% Similarity=0.369 Sum_probs=204.1
Q ss_pred hcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEcccc-----chhhHHHHHHHHHHHhccCCCcccceeeE
Q 018785 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAE-----SFQGHKEWLTEVIYLGQLRHENLVKLIGY 95 (350)
Q Consensus 21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 95 (350)
.+|++.+.||+|++|.||+| .+..++..|++|.+... .......+.+|+.++++++||||+++++.
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~---------~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~ 72 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLC---------YDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGC 72 (264)
T ss_pred CceeeeeeEccCCCeEEEEE---------EEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEE
Confidence 57999999999999999999 56667899999987532 12334568889999999999999999999
Q ss_pred Eeec--CceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEc
Q 018785 96 CSES--DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLS 173 (350)
Q Consensus 96 ~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~ 173 (350)
+.+. ...++++|++.+++|.+++.... .+++..+..++.|++.||.+|| +.|++|+||+|+||+++.++.++|+
T Consensus 73 ~~~~~~~~~~~v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~al~~LH--~~~i~H~dl~p~ni~i~~~~~~~l~ 148 (264)
T cd06653 73 LRDPEEKKLSIFVEYMPGGSIKDQLKAYG--ALTENVTRRYTRQILQGVSYLH--SNMIVHRDIKGANILRDSAGNVKLG 148 (264)
T ss_pred EEcCCCCEEEEEEEeCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--hCCEecCCCCHHHEEEcCCCCEEEC
Confidence 8764 45789999999999999987654 5889999999999999999999 9999999999999999999999999
Q ss_pred cccccccCCCCCCC-cccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchh
Q 018785 174 DFGLARDGPTGDNT-HVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPF 252 (350)
Q Consensus 174 Dfg~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 252 (350)
|||++......... .......++..|+|||.+.+..++.++|+||||+++|+|++|+.||......
T Consensus 149 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------------- 215 (264)
T cd06653 149 DFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM------------- 215 (264)
T ss_pred ccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH-------------
Confidence 99999754321111 1112245788899999998888999999999999999999999999653211
Q ss_pred hhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 253 LRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
....+..........+..+++.+.+++.+||. +|..||++.+++.|
T Consensus 216 ----~~~~~~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 216 ----AAIFKIATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred ----HHHHHHHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 11122222223344567788999999999999 57999999998865
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=280.17 Aligned_cols=268 Identities=25% Similarity=0.311 Sum_probs=202.3
Q ss_pred hcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhh--HHHHHHHHHHHhccCCCcccceeeEEee
Q 018785 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQG--HKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (350)
Q Consensus 21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (350)
++|++.+.||.|++|.||+| .+..++..+++|.+....... ...+.+|+..+++++||||+++++++..
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~---------~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~ 75 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRA---------RDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVG 75 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEE---------EECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEe
Confidence 58999999999999999999 555668899999987554322 2345689999999999999999999887
Q ss_pred c--CceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcccc
Q 018785 99 S--DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFG 176 (350)
Q Consensus 99 ~--~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg 176 (350)
. +..++|+||+. ++|.+++.... ..+++..+..++.|++.||+||| +.|++|+||+|+||+++.++.++|+|||
T Consensus 76 ~~~~~~~lv~e~~~-~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH--~~~i~H~dl~p~nili~~~~~~~l~d~g 151 (293)
T cd07843 76 SNLDKIYMVMEYVE-HDLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLH--DNWILHRDLKTSNLLLNNRGILKICDFG 151 (293)
T ss_pred cCCCcEEEEehhcC-cCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH--HCCeeeccCCHHHEEECCCCcEEEeecC
Confidence 7 89999999995 59999887654 26899999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCCCCcccccccCCCcccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcc-hhhh
Q 018785 177 LARDGPTGDNTHVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD-PFLR 254 (350)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~-~~~~ 254 (350)
++........ ......+++.|+|||.+.+. .++.++|+||||+++|+|++|..||...........+..... +...
T Consensus 152 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~ 229 (293)
T cd07843 152 LAREYGSPLK--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEK 229 (293)
T ss_pred ceeeccCCcc--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchH
Confidence 9876433221 12224467789999988664 468899999999999999999999976554322222221111 0000
Q ss_pred hhHHH---HH--------hhhcccCCCCcHH-HHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 255 DSRRV---LR--------IMDTRLGGQYSKK-EAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 255 ~~~~~---~~--------~~~~~~~~~~~~~-~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
..... .. ..........+.. +++.+.++|.+||+.+|++|||+.+++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 230 IWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred HHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 00000 00 0000001112222 47889999999999999999999999865
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=278.75 Aligned_cols=255 Identities=27% Similarity=0.402 Sum_probs=207.8
Q ss_pred hhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceeeEEe
Q 018785 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (350)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (350)
.....|.+.+.||.|++|.||+| .+..++..+++|.+..... ....+..|++.++.++|+|++++++.+.
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~---------~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 85 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKA---------TDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYL 85 (286)
T ss_pred CccccchHhHhccCCCCeEEEEE---------EEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEE
Confidence 45678999999999999999999 4555688999999876654 4566788999999999999999999999
Q ss_pred ecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccc
Q 018785 98 ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL 177 (350)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~ 177 (350)
..+..++++||+++++|.+++.... ..++...+..++.|++.+|.+|| +.|++|+||+|+||+++.++.++|+|||.
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH--~~gi~H~dl~p~ni~i~~~~~~~l~d~~~ 162 (286)
T cd06614 86 VGDELWVVMEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLH--SQNVIHRDIKSDNILLSKDGSVKLADFGF 162 (286)
T ss_pred ECCEEEEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHH--hCCeeeCCCChhhEEEcCCCCEEECccch
Confidence 9999999999999999999998764 36899999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhH
Q 018785 178 ARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSR 257 (350)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 257 (350)
+........ ......++..|++||.+.+..++.++|+||||+++|+|++|..||...........
T Consensus 163 ~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~------------- 227 (286)
T cd06614 163 AAQLTKEKS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFL------------- 227 (286)
T ss_pred hhhhccchh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHH-------------
Confidence 864322211 11223467789999999888899999999999999999999999865432111111
Q ss_pred HHHHhhhccc-CCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018785 258 RVLRIMDTRL-GGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL 304 (350)
Q Consensus 258 ~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 304 (350)
...... .......++..+.+++.+||+.+|.+|||+.+++++-
T Consensus 228 ----~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~ 271 (286)
T cd06614 228 ----ITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHP 271 (286)
T ss_pred ----HHhcCCCCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhCh
Confidence 111111 1111233678899999999999999999999998753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=288.61 Aligned_cols=260 Identities=26% Similarity=0.418 Sum_probs=217.7
Q ss_pred cccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccc-hhhHHHHHHHHHHHhccCCCcccceeeEEeecC
Q 018785 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES-FQGHKEWLTEVIYLGQLRHENLVKLIGYCSESD 100 (350)
Q Consensus 22 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 100 (350)
.....++||.|.||.||.|.+.. ..++..-.||||..+... .+..+.|++|+.+++.+.||||+++++++.+ .
T Consensus 390 ~Itl~r~iG~GqFGdVy~gvYt~-----~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~ 463 (974)
T KOG4257|consen 390 LITLKRLIGEGQFGDVYKGVYTD-----PEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-Q 463 (974)
T ss_pred hccHHHhhcCCcccceeeeEecc-----cccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-c
Confidence 34455689999999999998864 224456679999888743 3456789999999999999999999999987 4
Q ss_pred ceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcccccccc
Q 018785 101 NRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD 180 (350)
Q Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~~ 180 (350)
..|+|||.+..|.|..|+..++ ..++......++.||+.||+||| +..++||||-.+||++.....|||+|||+++.
T Consensus 464 P~WivmEL~~~GELr~yLq~nk-~sL~l~tL~ly~~Qi~talaYLe--SkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~ 540 (974)
T KOG4257|consen 464 PMWIVMELAPLGELREYLQQNK-DSLPLRTLTLYCYQICTALAYLE--SKRFVHRDIAARNILVSSPQCVKLADFGLSRY 540 (974)
T ss_pred ceeEEEecccchhHHHHHHhcc-ccchHHHHHHHHHHHHHHHHHHH--hhchhhhhhhhhheeecCcceeeecccchhhh
Confidence 7899999999999999998776 36888899999999999999999 99999999999999999999999999999987
Q ss_pred CCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccccCcchhhhhhhcchhhhhhHHH
Q 018785 181 GPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRV 259 (350)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (350)
.......... .-.-..-|+|||.+.-..++.++|||.||+++||++. |..||.+-.+......+
T Consensus 541 ~ed~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~i-------------- 605 (974)
T KOG4257|consen 541 LEDDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHI-------------- 605 (974)
T ss_pred ccccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEe--------------
Confidence 5444332222 2223446999999999999999999999999999876 88999887664443333
Q ss_pred HHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhc
Q 018785 260 LRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHT 309 (350)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 309 (350)
....+.+.|..+|+.++.|+.+||+.+|.+||.+.++...|+.+..
T Consensus 606 ----EnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 606 ----ENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred ----cCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 3334456678999999999999999999999999999999988876
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=295.23 Aligned_cols=254 Identities=24% Similarity=0.386 Sum_probs=212.4
Q ss_pred hhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceeeEEeec
Q 018785 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (350)
Q Consensus 20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (350)
..-|.|+..||.|+||.||+| ....++-..|.|++...+.+..++++-|+++|....||+|+++++.|..+
T Consensus 31 ~d~WeIiGELGDGAFGKVyKA---------~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~e 101 (1187)
T KOG0579|consen 31 RDHWEIIGELGDGAFGKVYKA---------VNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFE 101 (1187)
T ss_pred HHHHHHHhhhcCccchhhhhh---------hcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhcc
Confidence 346889999999999999999 55666777888999888878888999999999999999999999999999
Q ss_pred CceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccccc
Q 018785 100 DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR 179 (350)
Q Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~ 179 (350)
+.++++.|||.||-....+..-+ ..+++.++..++.|++.||.||| ++.|+|+|||..|||++.+|.++|+|||.+.
T Consensus 102 nkLwiliEFC~GGAVDaimlEL~-r~LtE~QIqvvc~q~ldALn~LH--s~~iIHRDLKAGNiL~TldGdirLADFGVSA 178 (1187)
T KOG0579|consen 102 NKLWILIEFCGGGAVDAIMLELG-RVLTEDQIQVVCYQVLDALNWLH--SQNIIHRDLKAGNILLTLDGDIRLADFGVSA 178 (1187)
T ss_pred CceEEEEeecCCchHhHHHHHhc-cccchHHHHHHHHHHHHHHHHHh--hcchhhhhccccceEEEecCcEeeecccccc
Confidence 99999999999988888776655 47999999999999999999999 9999999999999999999999999999986
Q ss_pred cCCCCCCCcccccccCCCcccCccccc-----cCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhh
Q 018785 180 DGPTGDNTHVSTRIVGTRGYAAPEYVA-----TGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLR 254 (350)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~ 254 (350)
.. ...-......+|||+|+|||++. ..+|+.++||||||++|.+|..+.+|-...++-...-.+..-..|.+
T Consensus 179 Kn--~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTL- 255 (1187)
T KOG0579|consen 179 KN--KSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTL- 255 (1187)
T ss_pred cc--hhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcc-
Confidence 42 22222334578999999999874 45899999999999999999999998766554322222222111111
Q ss_pred hhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 255 DSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
..|..-+..+.+++.+||..||..||++.++++|
T Consensus 256 ---------------lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 256 ---------------LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred ---------------cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 1244567789999999999999999999999987
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=273.89 Aligned_cols=244 Identities=28% Similarity=0.366 Sum_probs=198.9
Q ss_pred ecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch---hhHHHHHHHHHHHhccCCCcccceeeEEeecCceEEE
Q 018785 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLVKLIGYCSESDNRLLV 105 (350)
Q Consensus 29 lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 105 (350)
||.|++|.||+| .+..++..+++|.+..... .....+..|+.+++.++||||+++++.+.+++..+++
T Consensus 1 lg~g~~~~v~~~---------~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 71 (262)
T cd05572 1 LGVGGFGRVELV---------KVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYML 71 (262)
T ss_pred CCCCCceEEEEE---------EECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEE
Confidence 689999999999 5555688999999875432 2345688999999999999999999999999999999
Q ss_pred EEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccccccCCCCC
Q 018785 106 YEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGD 185 (350)
Q Consensus 106 ~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~~~~~~~ 185 (350)
+||+++++|.+++.... .++...+..++.|+++||.||| +.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 72 ~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lH--~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~ 147 (262)
T cd05572 72 MEYCLGGELWTILRDRG--LFDEYTARFYIACVVLAFEYLH--NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ 147 (262)
T ss_pred EecCCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHh--hCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc
Confidence 99999999999997654 5899999999999999999999 9999999999999999999999999999997643332
Q ss_pred CCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhHHHHHhhhc
Q 018785 186 NTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDT 265 (350)
Q Consensus 186 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (350)
......++..|++||.+.+..++.++|+||+|+++|+|++|..||....... ..........
T Consensus 148 ---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---------------~~~~~~~~~~ 209 (262)
T cd05572 148 ---KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP---------------MEIYNDILKG 209 (262)
T ss_pred ---ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH---------------HHHHHHHhcc
Confidence 1222457788999999888889999999999999999999999997654210 0011111111
Q ss_pred ccCCCCcHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 018785 266 RLGGQYSKKEAQAVAAVVLQCLHMDPKNRPS-----MVDVLTS 303 (350)
Q Consensus 266 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-----~~~ll~~ 303 (350)
......+...++++.+++.+||+.+|.+||+ +.++++|
T Consensus 210 ~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~ 252 (262)
T cd05572 210 NGKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKH 252 (262)
T ss_pred CCCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcC
Confidence 1222334445789999999999999999999 8888764
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=276.20 Aligned_cols=247 Identities=26% Similarity=0.360 Sum_probs=191.5
Q ss_pred ceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceeeEEeecCceEEEE
Q 018785 27 YLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSESDNRLLVY 106 (350)
Q Consensus 27 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 106 (350)
+.||+|+||.||+|......- ........+++|.+..........+.+|..+++.+.|||++++++++..+...++||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~--~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 78 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGD--YGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ 78 (258)
T ss_pred CCCCcccchhheeeeeccccc--ccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence 468999999999996532100 012234568888886655455567888999999999999999999999999999999
Q ss_pred EcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCc--------EEEcccccc
Q 018785 107 EFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFN--------AKLSDFGLA 178 (350)
Q Consensus 107 e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~--------~~l~Dfg~~ 178 (350)
||+.+++|.+++..+.. .++...+..++.|++.||+||| +.|++|+||+|+||+++.++. ++++|||.+
T Consensus 79 e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~lH--~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 79 EYVKFGSLDTYLKKNKN-LINISWKLEVAKQLAWALHFLE--DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred ecCCCCcHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCccceEEEecccccccCCCceEEecccccc
Confidence 99999999999876542 6889999999999999999999 999999999999999987765 699999988
Q ss_pred ccCCCCCCCcccccccCCCcccCccccccC-CCCCccchhhHHHHHHHHHhCC-CCCcccccCcchhhhhhhcchhhhhh
Q 018785 179 RDGPTGDNTHVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGR-RALDEDRGGLAEQTLVEWADPFLRDS 256 (350)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~ll~~ll~g~-~pf~~~~~~~~~~~~~~~~~~~~~~~ 256 (350)
...... ....++..|+|||.+.+. .++.++|+||||+++|+|++|. .||........
T Consensus 156 ~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~--------------- 214 (258)
T cd05078 156 ITVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK--------------- 214 (258)
T ss_pred cccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH---------------
Confidence 643221 123467789999998764 5789999999999999999995 45543221100
Q ss_pred HHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018785 257 RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL 304 (350)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 304 (350)
...... ....+...+.++.+++.+||+.||++|||++++++.|
T Consensus 215 ---~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 215 ---LQFYED--RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred ---HHHHHc--cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 000011 1223334557899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=273.11 Aligned_cols=249 Identities=23% Similarity=0.366 Sum_probs=191.9
Q ss_pred ceecccCceeEEeecccCCCcC---CCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceeeEEeecCceE
Q 018785 27 YLLGEGGFGCVFKGWIDQNTFA---PTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSESDNRL 103 (350)
Q Consensus 27 ~~lg~G~~g~V~~~~~~~~~~~---~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 103 (350)
+.||+|++|.||+|++...... .........+++|.+..........+.+|+..++.++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 4689999999999976432100 0112345578999887665555567888999999999999999999999999999
Q ss_pred EEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCc-------EEEcccc
Q 018785 104 LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFN-------AKLSDFG 176 (350)
Q Consensus 104 lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~-------~~l~Dfg 176 (350)
+||||+++++|..++.... ..++...++.++.|+++||+||| +++++|+||+|+||+++.++. ++++|||
T Consensus 81 lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH--~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKS-DVLTTPWKFKVAKQLASALSYLE--DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred EEEecccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhh--hCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 9999999999988876543 36899999999999999999999 999999999999999987654 8999999
Q ss_pred ccccCCCCCCCcccccccCCCcccCccccc-cCCCCCccchhhHHHHHHHHH-hCCCCCcccccCcchhhhhhhcchhhh
Q 018785 177 LARDGPTGDNTHVSTRIVGTRGYAAPEYVA-TGHLTPKSDVYSFGVVLLELL-SGRRALDEDRGGLAEQTLVEWADPFLR 254 (350)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~~DiwslG~ll~~ll-~g~~pf~~~~~~~~~~~~~~~~~~~~~ 254 (350)
++...... ....++..|+|||.+. +..++.++||||||+++|+|+ +|..||........
T Consensus 158 ~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~------------- 218 (262)
T cd05077 158 IPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK------------- 218 (262)
T ss_pred CCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH-------------
Confidence 88643221 1234667799999886 467889999999999999998 57777754321110
Q ss_pred hhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018785 255 DSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL 304 (350)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 304 (350)
..+..... ......++++.+|+.+||+.||.+||++.++++++
T Consensus 219 -----~~~~~~~~--~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 219 -----ERFYEGQC--MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred -----HHHHhcCc--cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 00001100 11122356889999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=269.40 Aligned_cols=259 Identities=23% Similarity=0.294 Sum_probs=208.3
Q ss_pred hhcccccc-eecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhcc-CCCcccceeeEEe
Q 018785 20 TKNFCSDY-LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQL-RHENLVKLIGYCS 97 (350)
Q Consensus 20 ~~~y~i~~-~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~ 97 (350)
.++|.+.. +||-|-.|.|-.+ .++.+|+.+|+|++... ...++|+++--.. .||||+.++++|+
T Consensus 60 tedY~is~qvLG~GinGkV~~C---------~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVye 125 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQC---------VHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYE 125 (400)
T ss_pred hhhheehhhhhccccCCceEEE---------EeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhh
Confidence 56777764 8999999999999 88889999999987543 3345677665444 6999999999987
Q ss_pred e----cCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcC---CCcE
Q 018785 98 E----SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS---NFNA 170 (350)
Q Consensus 98 ~----~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~---~~~~ 170 (350)
+ ..++.+|||.++||.|...+..++...|++.++..|+.||+.|+.||| +.+|.||||||+|+|... |..+
T Consensus 126 Ns~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH--~~nIAHRDlKpENLLyt~t~~na~l 203 (400)
T KOG0604|consen 126 NSYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLH--SMNIAHRDLKPENLLYTTTSPNAPL 203 (400)
T ss_pred hhccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHH--hcchhhccCChhheeeecCCCCcce
Confidence 5 357889999999999999999999889999999999999999999999 999999999999999965 4569
Q ss_pred EEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcc
Q 018785 171 KLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD 250 (350)
Q Consensus 171 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~ 250 (350)
||+|||++..... .......+.||.|.|||++-...|+...|+||+|+++|-|++|..||-.........
T Consensus 204 KLtDfGFAK~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aisp------- 273 (400)
T KOG0604|consen 204 KLTDFGFAKETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP------- 273 (400)
T ss_pred EecccccccccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCCh-------
Confidence 9999999986433 223344678999999999988899999999999999999999999996544321111
Q ss_pred hhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 018785 251 PFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLH 308 (350)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 308 (350)
.....+..-.-..+.+-...+|+...++|+.+|..+|.+|.|+.++++|=+--.
T Consensus 274 ----gMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~ 327 (400)
T KOG0604|consen 274 ----GMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQ 327 (400)
T ss_pred ----hHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcc
Confidence 111112222222333445689999999999999999999999999998855433
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=278.68 Aligned_cols=255 Identities=27% Similarity=0.301 Sum_probs=198.9
Q ss_pred hhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhcc-CCCcccceeeEEe
Q 018785 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQL-RHENLVKLIGYCS 97 (350)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~ 97 (350)
..++|.+.+.||+|++|.||++ .+..+++.+++|.+..... ....+..|+.+++++ +|||++++++++.
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~---------~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~~h~ni~~~~~~~~ 89 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKV---------TNKKDGSLAAVKILDPISD-VDEEIEAEYNILQSLPNHPNVVKFYGMFY 89 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEE---------EECCCCCEEEEEEeccccc-HHHHHHHHHHHHHHhcCCCCeEEEEEEEE
Confidence 4688999999999999999999 5566788999998865432 234567788889888 7999999999986
Q ss_pred ec-----CceEEEEEcCCCCChhhHHhhc--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcE
Q 018785 98 ES-----DNRLLVYEFMPKGSLENHLFRK--GVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNA 170 (350)
Q Consensus 98 ~~-----~~~~lv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~ 170 (350)
.. +..++|+||+.+++|.+++... ....+++..+..++.|++.||.+|| +.|++|+||+|+||+++.++.+
T Consensus 90 ~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH--~~~ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 90 KADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH--NNRIIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred eccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH--hCCeeccCCCHHHEEEcCCCCE
Confidence 54 3579999999999999988632 2346899999999999999999999 9999999999999999999999
Q ss_pred EEccccccccCCCCCCCcccccccCCCcccCccccccC-----CCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhh
Q 018785 171 KLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG-----HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTL 245 (350)
Q Consensus 171 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-----~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~ 245 (350)
+|+|||++........ ......++..|+|||.+... .++.++|+||||+++|+|++|+.||...........+
T Consensus 168 kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~ 245 (291)
T cd06639 168 KLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKI 245 (291)
T ss_pred EEeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHH
Confidence 9999999875432221 11224577889999987543 3678999999999999999999999754321111111
Q ss_pred hhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 246 VEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
.... ......+...+..+.+++.+||+.+|++||++.++++|
T Consensus 246 ~~~~----------------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 246 PRNP----------------PPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred hcCC----------------CCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 0000 00011123455689999999999999999999999876
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=276.85 Aligned_cols=268 Identities=25% Similarity=0.365 Sum_probs=202.6
Q ss_pred cccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh-hHHHHHHHHHHHhccCCCcccceeeEEeecC
Q 018785 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ-GHKEWLTEVIYLGQLRHENLVKLIGYCSESD 100 (350)
Q Consensus 22 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 100 (350)
+|++.+.||.|++|.||+| .+..+|..|++|.+...... ....+.+|+.++++++||||+++++.+...+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~---------~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 71 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKG---------RNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTEN 71 (284)
T ss_pred CceEeeeeccCCceEEEEE---------EECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCC
Confidence 5899999999999999999 56667899999998765432 2355678999999999999999999999999
Q ss_pred ceEEEEEcCCCCChhhHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccccc
Q 018785 101 NRLLVYEFMPKGSLENHLFRKG-VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR 179 (350)
Q Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~-~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~ 179 (350)
..++||||+.+ +|.+++.... ...+++..+..++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||++.
T Consensus 72 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH--~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~ 148 (284)
T cd07836 72 KLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH--ENRVLHRDLKPQNLLINKRGELKLADFGLAR 148 (284)
T ss_pred cEEEEEecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHH--HCCeeeCCCCHHHEEECCCCcEEEeecchhh
Confidence 99999999964 8888886543 236899999999999999999999 8999999999999999999999999999986
Q ss_pred cCCCCCCCcccccccCCCcccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhh-cchhhhhhH
Q 018785 180 DGPTGDNTHVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEW-ADPFLRDSR 257 (350)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~ 257 (350)
....... ......++..|++||.+.+. .++.++|+||||+++|+|++|..||.+.........+... ..+......
T Consensus 149 ~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (284)
T cd07836 149 AFGIPVN--TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWP 226 (284)
T ss_pred hhcCCcc--ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHH
Confidence 5322211 11223467789999988664 5688999999999999999999999876543322222211 111110000
Q ss_pred HHHH--hhhcccC-------CCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 258 RVLR--IMDTRLG-------GQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 258 ~~~~--~~~~~~~-------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
.... ....... ......++..+.+++.+||+.||.+||++.+++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 227 GISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred HHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0000 0000000 00112456789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=276.25 Aligned_cols=248 Identities=27% Similarity=0.396 Sum_probs=200.2
Q ss_pred cccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch-hhHHHHHHHHHHHhccC---CCcccceeeEEe
Q 018785 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLR---HENLVKLIGYCS 97 (350)
Q Consensus 22 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~ 97 (350)
.|++.+.||.|++|.||+| .+..++..+++|.+..... .....+.+|+.+++.+. |||++++++++.
T Consensus 2 ~y~~~~~l~~g~~g~v~~~---------~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~ 72 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRG---------KHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYL 72 (277)
T ss_pred hhhhhhheeccCCceEEEE---------EEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeee
Confidence 5888999999999999999 5556788999998875432 33456778888888886 999999999999
Q ss_pred ecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccc
Q 018785 98 ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL 177 (350)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~ 177 (350)
.+...++||||+++++|.+++... .+++..+..++.|++.+|.+|| +.|++|+||+|+||+++.++.++|+|||+
T Consensus 73 ~~~~~~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh--~~~i~H~dl~p~ni~i~~~~~~~l~dfg~ 147 (277)
T cd06917 73 KGPRLWIIMEYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIH--KVGVIHRDIKAANILVTNTGNVKLCDFGV 147 (277)
T ss_pred eCCEEEEEEecCCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHH--hCCcccCCcCHHHEEEcCCCCEEEccCCc
Confidence 999999999999999999988654 6899999999999999999999 99999999999999999999999999999
Q ss_pred cccCCCCCCCcccccccCCCcccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhh
Q 018785 178 ARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDS 256 (350)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 256 (350)
+........ ......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...........+.
T Consensus 148 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~---------- 215 (277)
T cd06917 148 AALLNQNSS--KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIP---------- 215 (277)
T ss_pred eeecCCCcc--ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccc----------
Confidence 876443321 1223457888999998765 457899999999999999999999997543211111000
Q ss_pred HHHHHhhhcccCCCCcH-HHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 257 RRVLRIMDTRLGGQYSK-KEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 257 ~~~~~~~~~~~~~~~~~-~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
.......+. .++.++.+++.+||+.||++||++.+++++
T Consensus 216 --------~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 216 --------KSKPPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred --------cCCCCCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 000111111 266789999999999999999999999875
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=286.17 Aligned_cols=282 Identities=26% Similarity=0.379 Sum_probs=207.0
Q ss_pred hhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch-hhHHHHHHHHHHHhccCCCcccceeeEEee
Q 018785 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (350)
Q Consensus 20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (350)
+++|++.++||+|++|.||+| .+..+|..||+|.+..... .....+.+|+.+++.++||||+++++++..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 74 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSA---------THKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRP 74 (336)
T ss_pred ccceEEEEEEEecCCeEEEEE---------EEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeec
Confidence 578999999999999999999 5666789999999864322 233557789999999999999999998764
Q ss_pred c-----CceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEc
Q 018785 99 S-----DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLS 173 (350)
Q Consensus 99 ~-----~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~ 173 (350)
. ...++++|++. ++|.+.+... .+++..+..++.|++.||.+|| +.|++|+||+|+||+++.++.++|+
T Consensus 75 ~~~~~~~~~~lv~e~~~-~~l~~~~~~~---~l~~~~~~~i~~ql~~aL~~LH--~~~ivH~dlkp~Nill~~~~~~kl~ 148 (336)
T cd07849 75 PSFESFNDVYIVQELME-TDLYKLIKTQ---HLSNDHIQYFLYQILRGLKYIH--SANVLHRDLKPSNLLLNTNCDLKIC 148 (336)
T ss_pred ccccccceEEEEehhcc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH--hCCeeccCCCHHHEEECCCCCEEEC
Confidence 4 35799999995 5888877543 6899999999999999999999 9999999999999999999999999
Q ss_pred cccccccCCCCCCCc-ccccccCCCcccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcc-
Q 018785 174 DFGLARDGPTGDNTH-VSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD- 250 (350)
Q Consensus 174 Dfg~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~- 250 (350)
|||++.......... ......++..|+|||.+.+ ..++.++|+||+|+++|+|++|+.||.+.........+.....
T Consensus 149 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~ 228 (336)
T cd07849 149 DFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGT 228 (336)
T ss_pred cccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCC
Confidence 999987543322111 1123457888999998654 4688999999999999999999999976443221111111110
Q ss_pred hhhhhhH--------HHHHhhhcccCCC---CcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHhhhcCCCCCCC
Q 018785 251 PFLRDSR--------RVLRIMDTRLGGQ---YSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS--LEQLHTSKDMPRT 316 (350)
Q Consensus 251 ~~~~~~~--------~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~--L~~~~~~~~~~~~ 316 (350)
+...+.. ............. ....++.++.+++.+||+.+|.+|||+.++++| +.......+.|..
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~~~~~~~ 307 (336)
T cd07849 229 PSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDPSDEPVA 307 (336)
T ss_pred CCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCCCCcccC
Confidence 0000000 0000000000000 012346789999999999999999999999998 7777665454433
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=289.25 Aligned_cols=248 Identities=30% Similarity=0.394 Sum_probs=208.6
Q ss_pred hhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEcccc---chhhHHHHHHHHHHHhccCCCcccceeeEE
Q 018785 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAE---SFQGHKEWLTEVIYLGQLRHENLVKLIGYC 96 (350)
Q Consensus 20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (350)
-..|.-.+.||.|.||.||.| .+..+.+.||||.+.-. +.+.+.++..|+..|+++.|||++.+.++|
T Consensus 25 Eklf~dLrEIGHGSFGAVYfA---------rd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCy 95 (948)
T KOG0577|consen 25 EKLFSDLREIGHGSFGAVYFA---------RDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCY 95 (948)
T ss_pred HHHHHHHHHhcCCccceeEEe---------eccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCccccccee
Confidence 456777889999999999999 67778999999998654 345567899999999999999999999999
Q ss_pred eecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcccc
Q 018785 97 SESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFG 176 (350)
Q Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg 176 (350)
-.+...|+||||| -|+-.|++.-.. +++.+.++..|+.+.+.||+||| +.+.+|+|||..||+++..|.|||+|||
T Consensus 96 Lre~TaWLVMEYC-lGSAsDlleVhk-KplqEvEIAAi~~gaL~gLaYLH--S~~~IHRDiKAGNILLse~g~VKLaDFG 171 (948)
T KOG0577|consen 96 LREHTAWLVMEYC-LGSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLH--SHNRIHRDIKAGNILLSEPGLVKLADFG 171 (948)
T ss_pred eccchHHHHHHHH-hccHHHHHHHHh-ccchHHHHHHHHHHHHHHHHHHH--HhhHHhhhccccceEecCCCeeeecccc
Confidence 9999999999999 568888886554 47999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCCCCcccccccCCCcccCccccc---cCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhh
Q 018785 177 LARDGPTGDNTHVSTRIVGTRGYAAPEYVA---TGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 253 (350)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 253 (350)
.+....+ ....+|||+|+|||++. .+.|+-+.||||||++..+|...++|+..++.-.....|.+
T Consensus 172 SAsi~~P------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQ------ 239 (948)
T KOG0577|consen 172 SASIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ------ 239 (948)
T ss_pred chhhcCc------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHh------
Confidence 9975333 33467999999999884 46899999999999999999999999866553222222222
Q ss_pred hhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 254 RDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
...+......-++.++.|+..||+.-|.+|||.++++.|
T Consensus 240 -----------NesPtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 240 -----------NESPTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred -----------cCCCCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 112222245678899999999999999999999999877
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=298.75 Aligned_cols=268 Identities=28% Similarity=0.455 Sum_probs=230.7
Q ss_pred hhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch-hhHHHHHHHHHHHhccCCCcccceee
Q 018785 16 SKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLVKLIG 94 (350)
Q Consensus 16 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~ 94 (350)
.++..+...|+++||.|.||.|++|+++ ..-+....||||.++.... .++.+|+.|+.++-++.||||+++.+
T Consensus 624 kEId~s~i~Ie~VIGaGEFGEVc~GrLk------~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEG 697 (996)
T KOG0196|consen 624 KEIDPSCVKIEKVIGAGEFGEVCSGRLK------LPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEG 697 (996)
T ss_pred hhcChhheEEEEEEecccccceeccccc------CCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEE
Confidence 3455678889999999999999999886 3334578999999988754 45688999999999999999999999
Q ss_pred EEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcc
Q 018785 95 YCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSD 174 (350)
Q Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~D 174 (350)
+........||+||+++|+|..|+..+.+ .|+.-++..+++.|+.|+.||- +.+++||||..+|||++.+...|+.|
T Consensus 698 VVTks~PvMIiTEyMENGsLDsFLR~~DG-qftviQLVgMLrGIAsGMkYLs--dm~YVHRDLAARNILVNsnLvCKVsD 774 (996)
T KOG0196|consen 698 VVTKSKPVMIITEYMENGSLDSFLRQNDG-QFTVIQLVGMLRGIASGMKYLS--DMNYVHRDLAARNILVNSNLVCKVSD 774 (996)
T ss_pred EEecCceeEEEhhhhhCCcHHHHHhhcCC-ceEeehHHHHHHHHHHHhHHHh--hcCchhhhhhhhheeeccceEEEecc
Confidence 99999999999999999999999998875 5898899999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCCCCCccccc-ccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccccCcchhhhhhhcchh
Q 018785 175 FGLARDGPTGDNTHVSTR-IVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPF 252 (350)
Q Consensus 175 fg~~~~~~~~~~~~~~~~-~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~ 252 (350)
||+++...........+. -.-..+|+|||.+....++.++|+||+|++|||.++ |..||.++.+
T Consensus 775 FGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN-------------- 840 (996)
T KOG0196|consen 775 FGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-------------- 840 (996)
T ss_pred ccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch--------------
Confidence 999996544432221111 112457999999999999999999999999999886 8889877665
Q ss_pred hhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcC
Q 018785 253 LRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 310 (350)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 310 (350)
..+.+-+...++-+.|.++|..+.+|+..||+.|-.+||.+.+|+..|+++..+
T Consensus 841 ----QdVIkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 841 ----QDVIKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN 894 (996)
T ss_pred ----HHHHHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence 344555556666778899999999999999999999999999999999998765
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=273.08 Aligned_cols=254 Identities=24% Similarity=0.391 Sum_probs=200.0
Q ss_pred cccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccc----------hhhHHHHHHHHHHHhc-cCCCccc
Q 018785 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES----------FQGHKEWLTEVIYLGQ-LRHENLV 90 (350)
Q Consensus 22 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~----------~~~~~~~~~e~~~l~~-l~h~~i~ 90 (350)
.|++.+.||+|++|.||+|.+.. .++..+++|.+.... ......+.+|+.++.+ ++||||+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~--------~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~ 72 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKN--------NGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIV 72 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcC--------CCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCee
Confidence 48899999999999999995432 157889999875332 1223456678887765 6999999
Q ss_pred ceeeEEeecCceEEEEEcCCCCChhhHHhhc--CCCCCCHHHHHHHHHHHHHHHHHhhcCC-CCeeeCCCCCCceEEcCC
Q 018785 91 KLIGYCSESDNRLLVYEFMPKGSLENHLFRK--GVQPISWPTRVKIAIDVARGLSFLHGLD-ANVIYRDLKASNVLLDSN 167 (350)
Q Consensus 91 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~i~~ql~~al~~lh~~~-~~i~H~di~~~Nili~~~ 167 (350)
++++++..++..+++|||+++++|.+++... ....++...++.++.|++.+|.+|| + .+++|+||+|+||+++.+
T Consensus 73 ~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh--~~~~i~H~dl~~~nil~~~~ 150 (269)
T cd08528 73 RYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLH--KEKRIVHRDLTPNNIMLGED 150 (269)
T ss_pred eEEeeEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhc--cCCceeecCCCHHHEEECCC
Confidence 9999999999999999999999999987532 2346899999999999999999999 5 689999999999999999
Q ss_pred CcEEEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhh
Q 018785 168 FNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVE 247 (350)
Q Consensus 168 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~ 247 (350)
+.++|+|||.+....... ......++..|++||.+.+..++.++|+||||+++|+|++|..||...........
T Consensus 151 ~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~--- 224 (269)
T cd08528 151 DKVTITDFGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATK--- 224 (269)
T ss_pred CcEEEecccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHH---
Confidence 999999999997643322 22335578889999999888899999999999999999999999864332111111
Q ss_pred hcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018785 248 WADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 305 (350)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~ 305 (350)
.............+++.+.+++.+||+.||++||++.++.+++.
T Consensus 225 --------------~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 225 --------------IVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred --------------HhhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 11111111112245678999999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=276.74 Aligned_cols=269 Identities=23% Similarity=0.317 Sum_probs=198.1
Q ss_pred hhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhh-HHHHHHHHHHHhccCCCcccceeeEEee
Q 018785 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQG-HKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (350)
Q Consensus 20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (350)
..+|++.+.||+|++|.||+| .+..++..|++|.+....... ...+.+|+..++.++|+||+++++++..
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~---------~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~ 74 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKG---------ISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHT 74 (291)
T ss_pred cceeEEEEEEEecCCEEEEEE---------EEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEec
Confidence 478999999999999999999 566668899999986553322 2356789999999999999999999999
Q ss_pred cCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcccccc
Q 018785 99 SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 178 (350)
Q Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~ 178 (350)
++..++|+||+ ++++.+++.... ..++...+..++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||++
T Consensus 75 ~~~~~lv~e~~-~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH--~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~ 150 (291)
T cd07870 75 KETLTFVFEYM-HTDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIH--GQHILHRDLKPQNLLISYLGELKLADFGLA 150 (291)
T ss_pred CCeEEEEEecc-cCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCChHHEEEcCCCcEEEeccccc
Confidence 99999999999 468887776543 35788889999999999999999 899999999999999999999999999988
Q ss_pred ccCCCCCCCcccccccCCCcccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCcccccCcc-hhhhhh-hcchhhhh
Q 018785 179 RDGPTGDNTHVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLA-EQTLVE-WADPFLRD 255 (350)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~-~~~~~~-~~~~~~~~ 255 (350)
........ ......++..|+|||.+.+. .++.++|+||||+++|+|++|..||........ ...... ...+....
T Consensus 151 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 228 (291)
T cd07870 151 RAKSIPSQ--TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDT 228 (291)
T ss_pred cccCCCCC--CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhh
Confidence 65322211 12223467889999988764 578899999999999999999999975443100 000000 00000000
Q ss_pred hHHHHH-------hhhcccCCCC-----cHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 256 SRRVLR-------IMDTRLGGQY-----SKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 256 ~~~~~~-------~~~~~~~~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
...... .......... ....+..+.+++.+|+..||.+|||+.+++.|
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 229 WPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred hhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 000000 0000000000 01125688999999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=280.42 Aligned_cols=266 Identities=20% Similarity=0.272 Sum_probs=188.8
Q ss_pred cceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceeeEEee--cCceE
Q 018785 26 DYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSE--SDNRL 103 (350)
Q Consensus 26 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~ 103 (350)
..+||+|+||+||+|+.. +..++..||+|.+.... ....+.+|+.+++.++||||+++++++.. +...+
T Consensus 6 g~~lG~G~~g~Vy~~~~~-------~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 76 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRK-------DGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVW 76 (317)
T ss_pred ceEeccCCCeeEEEEEec-------CCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEE
Confidence 358999999999999542 23456889999886543 23456789999999999999999998853 46778
Q ss_pred EEEEcCCCCChhhHHhhc-------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEE----cCCCcEEE
Q 018785 104 LVYEFMPKGSLENHLFRK-------GVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLL----DSNFNAKL 172 (350)
Q Consensus 104 lv~e~~~~~~L~~~l~~~-------~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili----~~~~~~~l 172 (350)
+|+||+ +++|.+++... ....+++..+..++.|++.||.||| +.|++|+||||+||++ +.++.++|
T Consensus 77 lv~e~~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH--~~~ivH~Dlkp~Nil~~~~~~~~~~~kl 153 (317)
T cd07867 77 LLFDYA-EHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH--ANWVLHRDLKPANILVMGEGPERGRVKI 153 (317)
T ss_pred EEEeee-CCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH--hCCEEcCCCCHHHEEEccCCCCCCcEEE
Confidence 999998 45888877532 1225788899999999999999999 9999999999999999 45678999
Q ss_pred ccccccccCCCCCCC-cccccccCCCcccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCcccccCcchh------h
Q 018785 173 SDFGLARDGPTGDNT-HVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQ------T 244 (350)
Q Consensus 173 ~Dfg~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~------~ 244 (350)
+|||++......... .......+++.|+|||.+.+. .++.++|||||||++|+|++|..||.......... .
T Consensus 154 ~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~ 233 (317)
T cd07867 154 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQ 233 (317)
T ss_pred eeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHH
Confidence 999999754332211 112234678889999998764 57899999999999999999999997544321100 0
Q ss_pred h---hh-hcchhhhhhHHH---------HHhhhcc-c--------CCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018785 245 L---VE-WADPFLRDSRRV---------LRIMDTR-L--------GGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLT 302 (350)
Q Consensus 245 ~---~~-~~~~~~~~~~~~---------~~~~~~~-~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 302 (350)
+ .. ...+...+.... ....... . ........+..+.+|+.+||..||.+|||+.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~ 313 (317)
T cd07867 234 LDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQ 313 (317)
T ss_pred HHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhc
Confidence 0 00 000000000000 0000000 0 00001123456889999999999999999999986
Q ss_pred H
Q 018785 303 S 303 (350)
Q Consensus 303 ~ 303 (350)
|
T Consensus 314 h 314 (317)
T cd07867 314 D 314 (317)
T ss_pred C
Confidence 5
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=281.04 Aligned_cols=272 Identities=23% Similarity=0.292 Sum_probs=198.7
Q ss_pred cccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccc---hhhHHHHHHHHHHHhccCCCcccceeeEEee
Q 018785 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES---FQGHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (350)
Q Consensus 22 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (350)
+|++.+.||+|++|.||+|+... ..++..||+|.+.... ......+.+|+.+++.++||||+++++++..
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~-------~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 73 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKN-------GKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLE 73 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecC-------CCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeC
Confidence 58899999999999999994321 1268999999987743 2334567789999999999999999999988
Q ss_pred c--CceEEEEEcCCCCChhhHHhhcC---CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcC----CCc
Q 018785 99 S--DNRLLVYEFMPKGSLENHLFRKG---VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS----NFN 169 (350)
Q Consensus 99 ~--~~~~lv~e~~~~~~L~~~l~~~~---~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~----~~~ 169 (350)
. ...++|||++. +++.+++.... ...+++..++.++.|++.||.||| +.+++|+||+|+||+++. ++.
T Consensus 74 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH--~~~i~h~dlkp~Nil~~~~~~~~~~ 150 (316)
T cd07842 74 HADKSVYLLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH--SNWVLHRDLKPANILVMGEGPERGV 150 (316)
T ss_pred CCCceEEEEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH--hCCEeeCCCCHHHEEEcCCCCccce
Confidence 8 78999999995 57877775332 236889999999999999999999 999999999999999999 899
Q ss_pred EEEccccccccCCCCCC-CcccccccCCCcccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCcccccCcch-----
Q 018785 170 AKLSDFGLARDGPTGDN-THVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAE----- 242 (350)
Q Consensus 170 ~~l~Dfg~~~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~----- 242 (350)
++|+|||++........ ........++..|+|||.+.+. .++.++|+||||+++++|++|..||.+.......
T Consensus 151 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~ 230 (316)
T cd07842 151 VKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQ 230 (316)
T ss_pred EEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhH
Confidence 99999999876433222 1112234567889999988664 5789999999999999999999999866543310
Q ss_pred -hhhhhh----cchhhh------hhHHHHHhhhcccCCCCc-----------HHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 018785 243 -QTLVEW----ADPFLR------DSRRVLRIMDTRLGGQYS-----------KKEAQAVAAVVLQCLHMDPKNRPSMVDV 300 (350)
Q Consensus 243 -~~~~~~----~~~~~~------~~~~~~~~~~~~~~~~~~-----------~~~~~~l~~li~~~l~~dp~~Rps~~~l 300 (350)
..+... ..+... .................+ ...+..+.+++.+||+.||++|||+.++
T Consensus 231 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~ei 310 (316)
T cd07842 231 RDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEA 310 (316)
T ss_pred HHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHH
Confidence 000000 000000 000000000000000001 1345679999999999999999999999
Q ss_pred HHH
Q 018785 301 LTS 303 (350)
Q Consensus 301 l~~ 303 (350)
++|
T Consensus 311 l~~ 313 (316)
T cd07842 311 LEH 313 (316)
T ss_pred hcC
Confidence 865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=279.54 Aligned_cols=269 Identities=22% Similarity=0.283 Sum_probs=200.1
Q ss_pred hcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch--hhHHHHHHHHHHHhccCCCcccceeeEEee
Q 018785 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (350)
Q Consensus 21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (350)
++|++.+.||.|++|+||+| .+..+|+.|++|.+..... .....+.+|+..++.++||||+++++++..
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~---------~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 72 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKA---------RDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHS 72 (294)
T ss_pred CceEEEEEecCCCCEEEEEE---------EecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEec
Confidence 57999999999999999999 5566788999998865432 223567789999999999999999999999
Q ss_pred cCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcC-CCcEEEccccc
Q 018785 99 SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS-NFNAKLSDFGL 177 (350)
Q Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~-~~~~~l~Dfg~ 177 (350)
++..++||||+. ++|.+++.......+++..+..++.|++.||+||| +++++|+||+|+||+++. ++.++|+|||+
T Consensus 73 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH--~~~i~H~dl~p~nill~~~~~~~kl~dfg~ 149 (294)
T PLN00009 73 EKRLYLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH--SHRVLHRDLKPQNLLIDRRTNALKLADFGL 149 (294)
T ss_pred CCeEEEEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHH--hCCeeCCCCCcceEEEECCCCEEEEccccc
Confidence 999999999994 58888887665445788889999999999999999 899999999999999985 55799999999
Q ss_pred cccCCCCCCCcccccccCCCcccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhh-cchhh--
Q 018785 178 ARDGPTGDNTHVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEW-ADPFL-- 253 (350)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~-~~~~~-- 253 (350)
+........ ......+++.|+|||.+.+. .++.++|+||+|+++|+|++|..||...........+... ..+..
T Consensus 150 ~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 227 (294)
T PLN00009 150 ARAFGIPVR--TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEET 227 (294)
T ss_pred ccccCCCcc--ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence 965322211 11223467789999988664 5788999999999999999999999764432211111110 00000
Q ss_pred -hhhHHHHHhhhccc--CC----CCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 254 -RDSRRVLRIMDTRL--GG----QYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 254 -~~~~~~~~~~~~~~--~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
.............. .. .....+++.+.+++.+||+.+|++||++.+++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 228 WPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred ccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000000000000 00 0123456789999999999999999999999975
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=271.34 Aligned_cols=249 Identities=24% Similarity=0.350 Sum_probs=205.5
Q ss_pred cccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch--hhHHHHHHHHHHHhccCCCcccceeeEEeec
Q 018785 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (350)
Q Consensus 22 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (350)
+|++.+.||.|++|.||++ .+..+++.+++|.+..... .....+.+|+..++.++|+||+++++++...
T Consensus 1 ~y~~~~~i~~g~~~~v~~~---------~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKV---------KRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDG 71 (256)
T ss_pred CceEeeeecCCCceeEEEE---------EECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccC
Confidence 5899999999999999999 5566788999999875432 3345677899999999999999999999999
Q ss_pred CceEEEEEcCCCCChhhHHhhcC--CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccc
Q 018785 100 DNRLLVYEFMPKGSLENHLFRKG--VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL 177 (350)
Q Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~--~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~ 177 (350)
...++|+|++++++|.+++.... ...++...+..++.|++.||++|| +.|++|+||+|+||+++.++.++|+|||+
T Consensus 72 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh--~~~i~h~~l~~~ni~~~~~~~~kl~d~g~ 149 (256)
T cd08530 72 NKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH--EQKILHRDLKSANILLVANDLVKIGDLGI 149 (256)
T ss_pred CEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh--hCCcccCCCCcceEEEecCCcEEEeeccc
Confidence 99999999999999999986621 246889999999999999999999 99999999999999999999999999999
Q ss_pred cccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhH
Q 018785 178 ARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSR 257 (350)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 257 (350)
+...... ......++..|++||.+.+..++.++|+||||+++|+|++|..||.........
T Consensus 150 ~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~--------------- 210 (256)
T cd08530 150 SKVLKKN----MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLR--------------- 210 (256)
T ss_pred hhhhccC----CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---------------
Confidence 8765433 112244678899999998888999999999999999999999999754421111
Q ss_pred HHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 258 RVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
...........+..++.++.+++.+||..+|.+||++.+++++
T Consensus 211 ---~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 211 ---YKVQRGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred ---HHHhcCCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 1111112223344677889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=279.96 Aligned_cols=270 Identities=24% Similarity=0.321 Sum_probs=197.6
Q ss_pred hcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh--hHHHHHHHHHHHhccCCCcccceeeEEee
Q 018785 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ--GHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (350)
Q Consensus 21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (350)
++|++.+.||+|++|.||+| .+..+++.||+|.+...... ....+.+|+.++++++||+|+++++++..
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~---------~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 82 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKA---------RHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRT 82 (310)
T ss_pred hheEEEEEeecCCCEEEEEE---------EECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEec
Confidence 57999999999999999999 56667899999988654322 22345679999999999999999998866
Q ss_pred cC--------ceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcE
Q 018785 99 SD--------NRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNA 170 (350)
Q Consensus 99 ~~--------~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~ 170 (350)
.+ ..++||||+. ++|.+++.... ..+++.+++.++.|+++||.||| +.|++|+||+|+||+++.++.+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH--~~~i~H~dl~p~nil~~~~~~~ 158 (310)
T cd07865 83 KATPYNRYKGSFYLVFEFCE-HDLAGLLSNKN-VKFTLSEIKKVMKMLLNGLYYIH--RNKILHRDMKAANILITKDGIL 158 (310)
T ss_pred ccccccCCCceEEEEEcCCC-cCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHH--HCCeeccCCCHHHEEECCCCcE
Confidence 54 3499999994 58888776543 36899999999999999999999 8999999999999999999999
Q ss_pred EEccccccccCCCCCCC--cccccccCCCcccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhh
Q 018785 171 KLSDFGLARDGPTGDNT--HVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVE 247 (350)
Q Consensus 171 ~l~Dfg~~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~ 247 (350)
+|+|||++......... .......++..|+|||.+.+. .++.++|+||+|+++|+|++|..||.+.........+..
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~ 238 (310)
T cd07865 159 KLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQ 238 (310)
T ss_pred EECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 99999999754332221 112234567789999988665 468899999999999999999999976554322222222
Q ss_pred hcchhh----hhhHHHHHhhhcccCCC---------CcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 248 WADPFL----RDSRRVLRIMDTRLGGQ---------YSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 248 ~~~~~~----~~~~~~~~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
...... ................. .....+..+.++|.+||..||.+|||++++++|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 239 LCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred HhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 111000 00000000000000000 011124577899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=273.52 Aligned_cols=257 Identities=26% Similarity=0.404 Sum_probs=221.7
Q ss_pred hhhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceee
Q 018785 15 ISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIG 94 (350)
Q Consensus 15 ~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 94 (350)
+.+...+-|.++.+||+|.||.||+| .+..+|+.+|||.+..++ +..++..|+.++.+...|+++++|+
T Consensus 27 L~K~PEEVFDi~~KLGEGSYGSV~KA---------IH~EsG~v~AIK~VPV~s--DLQEIIKEISIMQQC~S~yVVKYYG 95 (502)
T KOG0574|consen 27 LNKPPEEVFDIVGKLGEGSYGSVHKA---------IHRESGHVLAIKKVPVDT--DLQEIIKEISIMQQCKSKYVVKYYG 95 (502)
T ss_pred hcCChHHHHHHHHHhcCCcchHHHHH---------HHhccCcEEEEEecCccc--hHHHHHHHHHHHHHcCCchhhhhhh
Confidence 33444567889999999999999999 899999999999998775 5677889999999999999999999
Q ss_pred EEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcc
Q 018785 95 YCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSD 174 (350)
Q Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~D 174 (350)
.|-....+|+|||||--|++.|.+..+. +++++.++..+++.-+.+|+||| ...-+|||||..||+++.+|..+|+|
T Consensus 96 SYFK~sDLWIVMEYCGAGSiSDI~R~R~-K~L~E~EIs~iL~~TLKGL~YLH--~~~KIHRDIKAGNILLNT~G~AKLAD 172 (502)
T KOG0574|consen 96 SYFKHSDLWIVMEYCGAGSISDIMRARR-KPLSEQEISAVLRDTLKGLQYLH--DLKKIHRDIKAGNILLNTDGIAKLAD 172 (502)
T ss_pred hhccCCceEeehhhcCCCcHHHHHHHhc-CCccHHHHHHHHHHHHhHHHHHH--HHHHHHhhcccccEEEcccchhhhhh
Confidence 9999999999999998899999887654 58999999999999999999999 88899999999999999999999999
Q ss_pred ccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhh
Q 018785 175 FGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLR 254 (350)
Q Consensus 175 fg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~ 254 (350)
||.+... .+.-...+..+|||.|+|||++..-.|+.++||||||++..+|..|+.||....+-...-.+...+.|.++
T Consensus 173 FGVAGQL--TDTMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~ 250 (502)
T KOG0574|consen 173 FGVAGQL--TDTMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFK 250 (502)
T ss_pred ccccchh--hhhHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCC
Confidence 9999642 22222334578999999999999999999999999999999999999999887765555444444444443
Q ss_pred hhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 255 DSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
. |..-+.++.++++.||-.+|++|.|+.++++|
T Consensus 251 K----------------PE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 251 K----------------PEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred C----------------hHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 3 34557799999999999999999999999887
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=276.69 Aligned_cols=250 Identities=29% Similarity=0.377 Sum_probs=200.0
Q ss_pred hhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch---hhHHHHHHHHHHHhccCCCcccceeeEE
Q 018785 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLVKLIGYC 96 (350)
Q Consensus 20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (350)
..+|.+.+.||+|++|+||+| .+..+++.|++|.+..... .....+..|+.+++.++|||++++.+++
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~---------~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~ 84 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFA---------RDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCY 84 (307)
T ss_pred chhhhhheeecCCCCeEEEEE---------EEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 467999999999999999999 5555688999998864322 2335678899999999999999999999
Q ss_pred eecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcccc
Q 018785 97 SESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFG 176 (350)
Q Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg 176 (350)
..++..++|+||+. +++.+++.... ..+++..+..++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||
T Consensus 85 ~~~~~~~lv~e~~~-g~l~~~~~~~~-~~l~~~~~~~~~~ql~~~L~~LH--~~~i~H~dl~p~nIl~~~~~~~kL~dfg 160 (307)
T cd06607 85 LREHTAWLVMEYCL-GSASDILEVHK-KPLQEVEIAAICHGALQGLAYLH--SHERIHRDIKAGNILLTEPGTVKLADFG 160 (307)
T ss_pred EeCCeEEEEHHhhC-CCHHHHHHHcc-cCCCHHHHHHHHHHHHHHHHHHH--HCCceecCCCcccEEECCCCCEEEeecC
Confidence 99999999999995 58878776443 36899999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCCCCcccccccCCCcccCccccc---cCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhh
Q 018785 177 LARDGPTGDNTHVSTRIVGTRGYAAPEYVA---TGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 253 (350)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 253 (350)
++...... ....++..|+|||.+. ...++.++|+||+|+++|+|++|..||...........
T Consensus 161 ~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~--------- 225 (307)
T cd06607 161 SASLVSPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH--------- 225 (307)
T ss_pred cceecCCC------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHH---------
Confidence 88653222 1234677899999874 35688899999999999999999999865432111100
Q ss_pred hhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018785 254 RDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 305 (350)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~ 305 (350)
.............++..+.+++.+||..+|++||++.+++.+..
T Consensus 226 --------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 269 (307)
T cd06607 226 --------IAQNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRF 269 (307)
T ss_pred --------HhcCCCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChh
Confidence 00111111123346778999999999999999999999998643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=275.74 Aligned_cols=259 Identities=27% Similarity=0.362 Sum_probs=200.6
Q ss_pred hcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch-hhHHHHHHHHHHHhccCCCcccceeeEEeec
Q 018785 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (350)
Q Consensus 21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (350)
++|+..+.||.|.+|.||+| .+..++..+++|.+..... .....+.+|++.++.++||||+++++++...
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~---------~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 71 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKC---------RLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDE 71 (287)
T ss_pred CceEEEEEeccCCceEEEEE---------EECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcc
Confidence 46889999999999999999 5555789999998875533 2345688899999999999999999988543
Q ss_pred --CceEEEEEcCCCCChhhHHhhc--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccc
Q 018785 100 --DNRLLVYEFMPKGSLENHLFRK--GVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDF 175 (350)
Q Consensus 100 --~~~~lv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Df 175 (350)
+..++||||+++++|.+++... ....++...+..++.|++.||.||| +.|++|+||+|+||+++.++.++|+||
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH--~~~i~H~dl~~~nil~~~~~~~~l~df 149 (287)
T cd06621 72 SSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH--SRKIIHRDIKPSNILLTRKGQVKLCDF 149 (287)
T ss_pred CCCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEEecCCeEEEeec
Confidence 4689999999999999987532 2346888999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCc-chhhhhhhcchhhh
Q 018785 176 GLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGL-AEQTLVEWADPFLR 254 (350)
Q Consensus 176 g~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~-~~~~~~~~~~~~~~ 254 (350)
|++........ ....++..|++||.+.+..++.++|+||||+++|+|++|..||....... ........ .
T Consensus 150 g~~~~~~~~~~----~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~----~- 220 (287)
T cd06621 150 GVSGELVNSLA----GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSY----I- 220 (287)
T ss_pred ccccccccccc----ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHH----H-
Confidence 99865322211 12346778999999988899999999999999999999999997553210 00000000 0
Q ss_pred hhHHHHHhhhcccCC--CCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018785 255 DSRRVLRIMDTRLGG--QYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL 304 (350)
Q Consensus 255 ~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 304 (350)
.......... ......++.+.+++.+||..+|.+|||+.+++++-
T Consensus 221 -----~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~ 267 (287)
T cd06621 221 -----VNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHP 267 (287)
T ss_pred -----hcCCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCc
Confidence 0000000000 01123567899999999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=269.63 Aligned_cols=256 Identities=23% Similarity=0.323 Sum_probs=188.8
Q ss_pred ceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccc-hhhHHHHHHHHHHHhccCCCcccceeeEEeecCceEEE
Q 018785 27 YLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES-FQGHKEWLTEVIYLGQLRHENLVKLIGYCSESDNRLLV 105 (350)
Q Consensus 27 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 105 (350)
+.||+|+||.||+|++.. ......+++|.+.... ......+.+|...++.++||||+++++.+......++|
T Consensus 1 ~~lg~G~~g~v~~~~~~~-------~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv 73 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYT-------DTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLV 73 (268)
T ss_pred CcCCCCcCceEEEEEEEc-------CCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEE
Confidence 369999999999985432 2234556777766543 23346788899999999999999999999999999999
Q ss_pred EEcCCCCChhhHHhhcC--CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccccccCCC
Q 018785 106 YEFMPKGSLENHLFRKG--VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPT 183 (350)
Q Consensus 106 ~e~~~~~~L~~~l~~~~--~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~~~~~ 183 (350)
|||+++++|.+++.... ...++...+..++.|++.||+||| +.+++|+||+|+||+++.++.++|+|||++.....
T Consensus 74 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH--~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~ 151 (268)
T cd05086 74 FEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH--KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYK 151 (268)
T ss_pred EecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH--HCCeeccCCccceEEEcCCccEEecccccccccCc
Confidence 99999999999997642 234667778899999999999999 89999999999999999999999999998753222
Q ss_pred CCCCcccccccCCCcccCcccccc-------CCCCCccchhhHHHHHHHHHhC-CCCCcccccCcchhhhhhhcchhhhh
Q 018785 184 GDNTHVSTRIVGTRGYAAPEYVAT-------GHLTPKSDVYSFGVVLLELLSG-RRALDEDRGGLAEQTLVEWADPFLRD 255 (350)
Q Consensus 184 ~~~~~~~~~~~~~~~~~aPE~~~~-------~~~~~~~DiwslG~ll~~ll~g-~~pf~~~~~~~~~~~~~~~~~~~~~~ 255 (350)
...........++..|+|||.+.+ ..++.++|+||||+++|+|+++ ..||...........+..
T Consensus 152 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~-------- 223 (268)
T cd05086 152 EDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIK-------- 223 (268)
T ss_pred chhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh--------
Confidence 111111223456778999998743 2457789999999999999974 567754332111111100
Q ss_pred hHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018785 256 SRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 305 (350)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~ 305 (350)
..............+++.+.+++..|| .+|++||+++++++.|.
T Consensus 224 -----~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 224 -----DQQVKLFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred -----hcccccCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 000001112223346778899999999 68999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=268.98 Aligned_cols=249 Identities=31% Similarity=0.488 Sum_probs=206.5
Q ss_pred cccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch--hhHHHHHHHHHHHhccCCCcccceeeEEeec
Q 018785 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (350)
Q Consensus 22 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (350)
+|++.+.||+|++|.||++ .+..+++.|++|.+..... .....+.+|+++++++.||+++++++++..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~---------~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKG---------LNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETS 71 (254)
T ss_pred CceeeeEEcccCCeEEEEE---------EEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeC
Confidence 5889999999999999999 5556688999999877654 3456788999999999999999999999999
Q ss_pred CceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccccc
Q 018785 100 DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR 179 (350)
Q Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~ 179 (350)
+..++++|++.+++|.+++.... .+++..+..++.|++.+|.+|| +.|++|+||+|+||+++.++.++|+|||.+.
T Consensus 72 ~~~~~v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~~l~~lH--~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~ 147 (254)
T cd06627 72 DSLYIILEYAENGSLRQIIKKFG--PFPESLVAVYVYQVLQGLAYLH--EQGVIHRDIKAANILTTKDGVVKLADFGVAT 147 (254)
T ss_pred CEEEEEEecCCCCcHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHh--hCCcccCCCCHHHEEECCCCCEEEeccccce
Confidence 99999999999999999997664 7899999999999999999999 9999999999999999999999999999997
Q ss_pred cCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhHHH
Q 018785 180 DGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRV 259 (350)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (350)
........ .....++..|++||...+..++.++|+|++|+++|+|++|..||.........
T Consensus 148 ~~~~~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~----------------- 208 (254)
T cd06627 148 KLNDVSKD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAAL----------------- 208 (254)
T ss_pred ecCCCccc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHH-----------------
Confidence 64433221 22345778899999988888899999999999999999999998653321110
Q ss_pred HHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 260 LRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
.... .......+..++..+.+++.+||..+|++|||+.+++++
T Consensus 209 ~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 251 (254)
T cd06627 209 FRIV-QDDHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKH 251 (254)
T ss_pred HHHh-ccCCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence 0111 111123344567899999999999999999999999854
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=277.60 Aligned_cols=251 Identities=24% Similarity=0.392 Sum_probs=206.5
Q ss_pred hcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch---hhHHHHHHHHHHHhccC-CCcccceeeEE
Q 018785 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLR-HENLVKLIGYC 96 (350)
Q Consensus 21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~-h~~i~~~~~~~ 96 (350)
++|.+.+.||+|++|.||+| ....++..|++|++..... .....+..|..+++++. ||||+++++++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~---------~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~ 71 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLA---------KEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTF 71 (280)
T ss_pred CCceEeeeecCCCceEEEEE---------EEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHh
Confidence 47999999999999999999 5556789999999876422 22356778999999998 99999999999
Q ss_pred eecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcccc
Q 018785 97 SESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFG 176 (350)
Q Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg 176 (350)
..++..++|||++.+++|.+++.... .++...+..++.|++.||.+|| +.|++|+||+|+||+++.++.++|+|||
T Consensus 72 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~Lh--~~~~~H~dl~~~ni~i~~~~~~~l~df~ 147 (280)
T cd05581 72 QDEENLYFVLEYAPNGELLQYIRKYG--SLDEKCTRFYAAEILLALEYLH--SKGIIHRDLKPENILLDKDMHIKITDFG 147 (280)
T ss_pred cCCceEEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCeeecCCCHHHeEECCCCCEEecCCc
Confidence 99999999999999999999998765 7999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCCCC------------------cccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCccccc
Q 018785 177 LARDGPTGDNT------------------HVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRG 238 (350)
Q Consensus 177 ~~~~~~~~~~~------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~ 238 (350)
.+......... .......++..|+|||...+..++.++|+||||++++++++|..||.....
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~ 227 (280)
T cd05581 148 TAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE 227 (280)
T ss_pred cccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH
Confidence 98754333221 112234567889999998888899999999999999999999999976542
Q ss_pred CcchhhhhhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCH----HHHHHH
Q 018785 239 GLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSM----VDVLTS 303 (350)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~----~~ll~~ 303 (350)
...... .. ......+..+++.+.+++.+||+.+|.+||++ +++++|
T Consensus 228 ~~~~~~-----------------~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 228 YLTFQK-----------------IL--KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred HHHHHH-----------------HH--hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 111110 00 11223445568889999999999999999999 888765
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=277.47 Aligned_cols=249 Identities=24% Similarity=0.371 Sum_probs=199.6
Q ss_pred ccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceeeEEeecCce
Q 018785 23 FCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSESDNR 102 (350)
Q Consensus 23 y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 102 (350)
|....+||+|++|.||++ ....++..|++|.+..........+.+|+..++.++|+|++++++.+..++..
T Consensus 22 ~~~~~~lg~g~~g~v~~~---------~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 92 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIA---------TVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDEL 92 (292)
T ss_pred hhhHHHcCCCCCeEEEEE---------EEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEE
Confidence 333468999999999999 55567899999988655544556688899999999999999999999999999
Q ss_pred EEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccccccCC
Q 018785 103 LLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGP 182 (350)
Q Consensus 103 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~~~~ 182 (350)
++||||+++++|.+++... .+++..+..++.|++.+++||| +.|++|+||+|.||+++.++.++|+|||.+....
T Consensus 93 ~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH--~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~ 167 (292)
T cd06657 93 WVVMEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLKALSVLH--AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS 167 (292)
T ss_pred EEEEecCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEECCCCCEEEcccccceecc
Confidence 9999999999999977543 5889999999999999999999 8999999999999999999999999999886533
Q ss_pred CCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhHHHHHh
Q 018785 183 TGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRI 262 (350)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (350)
... .......++..|++||.+.+..++.++|+||+|+++|+|++|..||...........+.. .
T Consensus 168 ~~~--~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~--------------~ 231 (292)
T cd06657 168 KEV--PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD--------------N 231 (292)
T ss_pred ccc--ccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--------------h
Confidence 221 112224577889999998888889999999999999999999999875432111111100 0
Q ss_pred hhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 263 MDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 263 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
... .......+++.+.+++.+||+.+|.+||++.+++++
T Consensus 232 ~~~--~~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 232 LPP--KLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred CCc--ccCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 000 001123457789999999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=277.68 Aligned_cols=256 Identities=26% Similarity=0.339 Sum_probs=196.7
Q ss_pred hcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch-hhHHHHHHHHHHHhccC-CCcccceeeEEee
Q 018785 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLR-HENLVKLIGYCSE 98 (350)
Q Consensus 21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~ 98 (350)
.+|...+.||+|+||.||++ .+..++..+++|.+..... .....+..|+..+.++. ||||+++++++..
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~---------~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~ 74 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKM---------LHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFR 74 (288)
T ss_pred HHhHHHHHhCCCCceEEEEE---------EECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEec
Confidence 57788899999999999999 5666789999998875432 23456788999999985 9999999999999
Q ss_pred cCceEEEEEcCCCCChhhHHh---hcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccc
Q 018785 99 SDNRLLVYEFMPKGSLENHLF---RKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDF 175 (350)
Q Consensus 99 ~~~~~lv~e~~~~~~L~~~l~---~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Df 175 (350)
++..+++||++ ++++.++.. ......+++..+..++.|++.||+|||+ +.+++|+||+|+||+++.++.++|+||
T Consensus 75 ~~~~~~~~e~~-~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~-~~~i~H~dlkp~Nil~~~~~~~kl~df 152 (288)
T cd06616 75 EGDCWICMELM-DISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE-ELKIIHRDVKPSNILLDRNGNIKLCDF 152 (288)
T ss_pred CCcEEEEEecc-cCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh-cCCeeccCCCHHHEEEccCCcEEEeec
Confidence 99999999998 456665442 2233479999999999999999999992 359999999999999999999999999
Q ss_pred cccccCCCCCCCcccccccCCCcccCccccccC---CCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchh
Q 018785 176 GLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG---HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPF 252 (350)
Q Consensus 176 g~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~---~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 252 (350)
|++........ .....++..|+|||.+.+. .++.++|+||+|+++|+|++|+.||..... ....+....
T Consensus 153 g~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~--- 224 (288)
T cd06616 153 GISGQLVDSIA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS--VFDQLTQVV--- 224 (288)
T ss_pred chhHHhccCCc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch--HHHHHhhhc---
Confidence 99865322211 1223467889999998766 688999999999999999999999965431 001110000
Q ss_pred hhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 253 LRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
...........+..++.++.+|+.+||+.+|++|||+++++++
T Consensus 225 --------~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 225 --------KGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred --------CCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000001111223477899999999999999999999999976
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=272.84 Aligned_cols=263 Identities=23% Similarity=0.284 Sum_probs=196.5
Q ss_pred ccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh-hHHHHHHHHHHHhccC-CCcccceeeEEeec-
Q 018785 23 FCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ-GHKEWLTEVIYLGQLR-HENLVKLIGYCSES- 99 (350)
Q Consensus 23 y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~- 99 (350)
|++.+.||+|++|.||+| .+..++..|++|.+...... .......|+..++++. |+|++++++++.+.
T Consensus 1 y~~~~~lg~g~~~~v~~~---------~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 71 (282)
T cd07831 1 YKILGKIGEGTFSEVLKA---------QSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRK 71 (282)
T ss_pred CceEeeccccccceEEEE---------EEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCC
Confidence 788999999999999999 55667889999988754221 2223456888888885 99999999999887
Q ss_pred -CceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcccccc
Q 018785 100 -DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 178 (350)
Q Consensus 100 -~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~ 178 (350)
+..++|+||+. ++|.+++.... ..+++..+..++.|++.||.||| +.|++|+||+|+||+++. +.++|+|||++
T Consensus 72 ~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH--~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~ 146 (282)
T cd07831 72 TGRLALVFELMD-MNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMH--RNGIFHRDIKPENILIKD-DILKLADFGSC 146 (282)
T ss_pred CCcEEEEEecCC-ccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH--HCCceecccCHHHEEEcC-CCeEEEecccc
Confidence 88999999995 58888886543 36899999999999999999999 999999999999999999 99999999999
Q ss_pred ccCCCCCCCcccccccCCCcccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhH
Q 018785 179 RDGPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSR 257 (350)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 257 (350)
......... ....++..|+|||.+.+ ..++.++|+||+||++|+|++|..||.+.+.......+............
T Consensus 147 ~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (282)
T cd07831 147 RGIYSKPPY---TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVL 223 (282)
T ss_pred cccccCCCc---CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHH
Confidence 754332221 22346788999997644 55788999999999999999999999775543322222221111000000
Q ss_pred HHHHhhhcccCC-----------CCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 258 RVLRIMDTRLGG-----------QYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 258 ~~~~~~~~~~~~-----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
.... ....... .....++..+.++|.+||..+|.+||++++++++
T Consensus 224 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 224 KKFR-KSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred Hhhc-ccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 0000 0000000 0112467899999999999999999999999875
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=275.17 Aligned_cols=266 Identities=26% Similarity=0.346 Sum_probs=203.6
Q ss_pred ccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh--hHHHHHHHHHHHhccCCCcccceeeEEeecC
Q 018785 23 FCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ--GHKEWLTEVIYLGQLRHENLVKLIGYCSESD 100 (350)
Q Consensus 23 y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 100 (350)
|++.+.||.|++|.||+| .+..+++.+++|.+...... ....+..|+..++.++|++|+++++++..++
T Consensus 1 y~~~~~i~~g~~~~v~~~---------~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 71 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKA---------RDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKG 71 (283)
T ss_pred CccceeeecCCCceEEEE---------EcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCC
Confidence 678899999999999999 66667899999988765433 3456778999999999999999999999999
Q ss_pred ceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcccccccc
Q 018785 101 NRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD 180 (350)
Q Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~~ 180 (350)
..++|+||+.+ +|.+++.... ..++...+..++.|+++||.+|| +.+++|+||+|+||+++.++.++|+|||.+..
T Consensus 72 ~~~~v~e~~~~-~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH--~~~i~H~dl~p~nili~~~~~~~l~df~~~~~ 147 (283)
T cd05118 72 DLYLVFEFMDT-DLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCH--SHGILHRDLKPENLLINTEGVLKLADFGLARS 147 (283)
T ss_pred CEEEEEeccCC-CHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHH--HCCeeecCcCHHHEEECCCCcEEEeeeeeeEe
Confidence 99999999954 8888887654 47899999999999999999999 99999999999999999999999999999876
Q ss_pred CCCCCCCcccccccCCCcccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhh-hcchhhhhhHH
Q 018785 181 GPTGDNTHVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVE-WADPFLRDSRR 258 (350)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~ 258 (350)
...... ......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...........+.. ...+.......
T Consensus 148 ~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (283)
T cd05118 148 FGSPVR--PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPK 225 (283)
T ss_pred cCCCcc--cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhccc
Confidence 543321 11223467789999998776 788999999999999999999999976554222211111 11110000000
Q ss_pred HHH-------hhhcccC---CCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 259 VLR-------IMDTRLG---GQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 259 ~~~-------~~~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
... ....... ......++.++.++|.+||+.||.+||++.+++.+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 226 FTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred chhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 000 0000000 11223567899999999999999999999999864
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=273.28 Aligned_cols=243 Identities=26% Similarity=0.389 Sum_probs=190.3
Q ss_pred eecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh---hHHHHHHHHHH---HhccCCCcccceeeEEeecCc
Q 018785 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ---GHKEWLTEVIY---LGQLRHENLVKLIGYCSESDN 101 (350)
Q Consensus 28 ~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~---l~~l~h~~i~~~~~~~~~~~~ 101 (350)
+||+|+||.||++ .+..++..+|+|.+...... ......+|..+ +....||+++.+++.+..++.
T Consensus 1 ~lg~G~~g~Vy~~---------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 71 (279)
T cd05633 1 IIGRGGFGEVYGC---------RKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDK 71 (279)
T ss_pred CcccCCCeEEEEE---------EECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCe
Confidence 4899999999999 55567899999988654321 11223334333 333479999999999999999
Q ss_pred eEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccccccC
Q 018785 102 RLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDG 181 (350)
Q Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~~~ 181 (350)
.++||||+.+++|.+++..+. .+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++...
T Consensus 72 ~~lv~e~~~~~~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH--~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~ 147 (279)
T cd05633 72 LCFILDLMNGGDLHYHLSQHG--VFSEKEMRFYATEIILGLEHMH--NRFVVYRDLKPANILLDEHGHVRISDLGLACDF 147 (279)
T ss_pred EEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--HCCcCCCCCCHHHEEECCCCCEEEccCCcceec
Confidence 999999999999999887664 6999999999999999999999 999999999999999999999999999998643
Q ss_pred CCCCCCcccccccCCCcccCccccc-cCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhHHHH
Q 018785 182 PTGDNTHVSTRIVGTRGYAAPEYVA-TGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVL 260 (350)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (350)
.... .....++..|+|||.+. +..++.++|+||+||++|+|++|..||......... .+.
T Consensus 148 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~~~-------------- 208 (279)
T cd05633 148 SKKK----PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EID-------------- 208 (279)
T ss_pred cccC----ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH-HHH--------------
Confidence 2221 12245788999999886 456889999999999999999999999754321110 000
Q ss_pred HhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 018785 261 RIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRP-----SMVDVLTS 303 (350)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~~ 303 (350)
..........+..+++++.+++.+||..||.+|| |++++++|
T Consensus 209 -~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 209 -RMTLTVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred -HHhhcCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 0011122334556788999999999999999999 69998876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=274.71 Aligned_cols=269 Identities=16% Similarity=0.164 Sum_probs=192.4
Q ss_pred hhhhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhH-----------HHHHHHHHHHh
Q 018785 14 MISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGH-----------KEWLTEVIYLG 82 (350)
Q Consensus 14 ~~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~-----------~~~~~e~~~l~ 82 (350)
.+.++.+++|++.++||+|+||+||+|++..+ ...+..+++|+......... .....++..+.
T Consensus 5 ~~~~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~------~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~ 78 (294)
T PHA02882 5 PLIDITGKEWKIDKLIGCGGFGCVYETQCASD------HCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIH 78 (294)
T ss_pred eeeccCCCceEEeeEEecCCCceEEEEEEcCC------cccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhc
Confidence 45667789999999999999999999954321 11255677776443321110 11223344556
Q ss_pred ccCCCcccceeeEEeecC----ceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCC
Q 018785 83 QLRHENLVKLIGYCSESD----NRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLK 158 (350)
Q Consensus 83 ~l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~ 158 (350)
.+.|++++++++...... ..+++++++ ..++.+.+.... ..++..+..++.|++.||+||| +.+++|||||
T Consensus 79 ~~~h~~i~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH--~~~iiHrDiK 153 (294)
T PHA02882 79 NIDHLGIPKYYGCGSFKRCRMYYRFILLEKL-VENTKEIFKRIK--CKNKKLIKNIMKDMLTTLEYIH--EHGISHGDIK 153 (294)
T ss_pred cCCCCCCCcEEEeeeEecCCceEEEEEEehh-ccCHHHHHHhhc--cCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCC
Confidence 678999999998766543 336788877 457777765543 4678889999999999999999 9999999999
Q ss_pred CCceEEcCCCcEEEccccccccCCCCCCC-----cccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCC
Q 018785 159 ASNVLLDSNFNAKLSDFGLARDGPTGDNT-----HVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL 233 (350)
Q Consensus 159 ~~Nili~~~~~~~l~Dfg~~~~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf 233 (350)
|+||+++.++.++|+|||++......... .......|++.|+|||.+.+..++.++|||||||++|+|++|+.||
T Consensus 154 p~Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~ 233 (294)
T PHA02882 154 PENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPW 233 (294)
T ss_pred HHHEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 99999999999999999999754322111 1112246899999999999999999999999999999999999999
Q ss_pred cccccCcchhhhhhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018785 234 DEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL 304 (350)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 304 (350)
.+............ ......+... .......++.+.+++..|+..+|++||+++++++.|
T Consensus 234 ~~~~~~~~~~~~~~---------~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 234 KGFGHNGNLIHAAK---------CDFIKRLHEG--KIKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred CccccchHHHHHhH---------HHHHHHhhhh--hhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 86532111110000 0000000000 011224468899999999999999999999999876
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=283.44 Aligned_cols=275 Identities=28% Similarity=0.390 Sum_probs=209.9
Q ss_pred cccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccc--hhhHHHHHHHHHHHhccCCCcccceeeEEeec
Q 018785 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES--FQGHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (350)
Q Consensus 22 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (350)
+|++.+.||.|++|.||+| .+..++..|++|.+.... ......+.+|+..++.++||||+++++++...
T Consensus 1 ~y~i~~~ig~g~~~~v~~~---------~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSA---------VDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPP 71 (330)
T ss_pred CceeeeeecCCCCeEEEEE---------EeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhccc
Confidence 6899999999999999999 555668999999887654 23446788899999999999999999998776
Q ss_pred C-----ceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcc
Q 018785 100 D-----NRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSD 174 (350)
Q Consensus 100 ~-----~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~D 174 (350)
. ..|++|+|+. ++|.+++.... .+++..+..++.|++.||++|| +.|++|+||+|.||+++.++.++|+|
T Consensus 72 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH--~~gi~H~dlkp~nili~~~~~~~L~d 146 (330)
T cd07834 72 SPEDFNDVYIVTELME-TDLHKVIKSPQ--PLTDDHIQYFLYQILRGLKYLH--SANVIHRDLKPSNILVNSNCDLKICD 146 (330)
T ss_pred CcccccceEEEecchh-hhHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEEcCCCCEEEcc
Confidence 5 7899999995 58988886654 7999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCCCCC-cccccccCCCcccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchh
Q 018785 175 FGLARDGPTGDNT-HVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPF 252 (350)
Q Consensus 175 fg~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 252 (350)
||.+......... .......++..|+|||.+.+. .++.++|+||||+++|+|++|..||...........+.......
T Consensus 147 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~ 226 (330)
T cd07834 147 FGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTP 226 (330)
T ss_pred cCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCC
Confidence 9999864443210 112234567889999999887 88999999999999999999999997766433322222211111
Q ss_pred hhh------hHHHHHhhhc---ccC---CCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHhhhcC
Q 018785 253 LRD------SRRVLRIMDT---RLG---GQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS--LEQLHTS 310 (350)
Q Consensus 253 ~~~------~~~~~~~~~~---~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~--L~~~~~~ 310 (350)
..+ .......... ... ......++..+.+++.+||+.+|.+||++++++.+ +..+...
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~ 298 (330)
T cd07834 227 SEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDP 298 (330)
T ss_pred ChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhccc
Confidence 000 0000011110 000 01122357889999999999999999999999987 6555544
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=283.37 Aligned_cols=271 Identities=24% Similarity=0.351 Sum_probs=203.5
Q ss_pred hhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch--hhHHHHHHHHHHHhccCCCcccceeeEEe
Q 018785 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (350)
Q Consensus 20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (350)
+++|++.+.||.|++|.||+| .+..+|..|++|.+..... .....+.+|+.+++.++||||+++++++.
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~---------~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 74 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSA---------IDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILR 74 (334)
T ss_pred hhceeeeeeeecCCCeEEEEE---------EEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhcc
Confidence 489999999999999999999 6667789999998875432 23456778999999999999999999876
Q ss_pred e----cCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEc
Q 018785 98 E----SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLS 173 (350)
Q Consensus 98 ~----~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~ 173 (350)
. ....++|+||+ +++|.+++.... .+++..+..++.|++.||.||| +.|++|+||+|+||+++.++.++|+
T Consensus 75 ~~~~~~~~~~lv~e~~-~~~l~~~~~~~~--~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~dlkp~Nil~~~~~~~kl~ 149 (334)
T cd07855 75 PPGADFKDVYVVMDLM-ESDLHHIIHSDQ--PLTEEHIRYFLYQLLRGLKYIH--SANVIHRDLKPSNLLVNEDCELRIG 149 (334)
T ss_pred ccCCCCceEEEEEehh-hhhHHHHhccCC--CCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEEcCCCcEEec
Confidence 3 35679999999 468999886554 5899999999999999999999 9999999999999999999999999
Q ss_pred cccccccCCCCCCC--cccccccCCCcccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhh-c
Q 018785 174 DFGLARDGPTGDNT--HVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEW-A 249 (350)
Q Consensus 174 Dfg~~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~-~ 249 (350)
|||.+......... .......++..|+|||.+.+ ..++.++|+||+|+++|+|++|+.||...........+... .
T Consensus 150 dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g 229 (334)
T cd07855 150 DFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLG 229 (334)
T ss_pred ccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhC
Confidence 99998654322211 11223467888999998765 46889999999999999999999999765433222211111 0
Q ss_pred chhhhh--------hHHHHHhhhcccCC---CCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018785 250 DPFLRD--------SRRVLRIMDTRLGG---QYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL 304 (350)
Q Consensus 250 ~~~~~~--------~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 304 (350)
.+...- .............. ......+.++.++|.+||+.+|.+|||+.+++.+-
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~ 295 (334)
T cd07855 230 SPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHP 295 (334)
T ss_pred CChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhCh
Confidence 010000 00000000000000 01134578899999999999999999999999873
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=279.90 Aligned_cols=269 Identities=22% Similarity=0.276 Sum_probs=198.3
Q ss_pred cceeccc--CceeEEeecccCCCcCCCCCCCCcEEEEEEccccch--hhHHHHHHHHHHHhccCCCcccceeeEEeecCc
Q 018785 26 DYLLGEG--GFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLRHENLVKLIGYCSESDN 101 (350)
Q Consensus 26 ~~~lg~G--~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 101 (350)
...||+| ++|+||++ .+..+|+.||+|++..... ...+.+.+|+.+++.++||||+++++++..++.
T Consensus 3 ~~~ig~g~~~~~~v~~a---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~ 73 (328)
T cd08226 3 QVEIGRGFCNLTSVYLA---------RHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSW 73 (328)
T ss_pred HHHhCCcccCceeEEEE---------EEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCc
Confidence 3456766 88999999 6777899999999875432 234667889999999999999999999999999
Q ss_pred eEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccccccC
Q 018785 102 RLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDG 181 (350)
Q Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~~~ 181 (350)
.++|+||+.+++|.+++.......+++..+..++.|++.||+||| +.|++|+||||+||+++.++.++++||+.+...
T Consensus 74 ~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH--~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~ 151 (328)
T cd08226 74 LWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLH--QNGYIHRNIKASHILISGDGLVSLSGLSHLYSL 151 (328)
T ss_pred eEEEEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEEeCCCcEEEechHHHhhh
Confidence 999999999999999998765456899999999999999999999 999999999999999999999999999765432
Q ss_pred CCCCCCcc-----cccccCCCcccCccccccC--CCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcc--hh
Q 018785 182 PTGDNTHV-----STRIVGTRGYAAPEYVATG--HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD--PF 252 (350)
Q Consensus 182 ~~~~~~~~-----~~~~~~~~~~~aPE~~~~~--~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~--~~ 252 (350)
........ .....++..|++||.+.+. .++.++|+||+||++|+|++|..||................. +.
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 231 (328)
T cd08226 152 VRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPL 231 (328)
T ss_pred hccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCc
Confidence 11111100 1112244569999998764 478899999999999999999999976543222111111000 00
Q ss_pred ----hhhhHHHH----------------------HhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018785 253 ----LRDSRRVL----------------------RIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 305 (350)
Q Consensus 253 ----~~~~~~~~----------------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~ 305 (350)
........ ..............+++.+.+|+.+||+.||++|||+.++++|-.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~ 310 (328)
T cd08226 232 DITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAF 310 (328)
T ss_pred cccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHH
Confidence 00000000 000011112223457789999999999999999999999998743
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=269.34 Aligned_cols=247 Identities=28% Similarity=0.437 Sum_probs=189.7
Q ss_pred ceecccCceeEEeecccCCCc-CCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceeeEEeecCceEEE
Q 018785 27 YLLGEGGFGCVFKGWIDQNTF-APTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSESDNRLLV 105 (350)
Q Consensus 27 ~~lg~G~~g~V~~~~~~~~~~-~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 105 (350)
+.||+|+||.||+|.+..... ..........+++|.+...... ...+.+|+.+++.++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 468999999999997653210 0001222346788877655433 5678889999999999999999999888 778999
Q ss_pred EEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCC-------cEEEcccccc
Q 018785 106 YEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNF-------NAKLSDFGLA 178 (350)
Q Consensus 106 ~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~-------~~~l~Dfg~~ 178 (350)
|||+.+++|.+++..... .++...+..++.|++.||.||| ++|++|+||+|+||+++.++ .++|+|||++
T Consensus 79 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~LH--~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 79 EEYVKFGPLDVFLHREKN-NVSLHWKLDVAKQLASALHYLE--DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEcCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHh--hCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 999999999999976543 6899999999999999999999 99999999999999999887 7999999998
Q ss_pred ccCCCCCCCcccccccCCCcccCccccccC--CCCCccchhhHHHHHHHHHh-CCCCCcccccCcchhhhhhhcchhhhh
Q 018785 179 RDGPTGDNTHVSTRIVGTRGYAAPEYVATG--HLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRD 255 (350)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 255 (350)
..... .....+...|+|||.+.+. .++.++|+||||+++|+|++ |..||.............
T Consensus 156 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~--------- 220 (259)
T cd05037 156 ITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ--------- 220 (259)
T ss_pred ccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh---------
Confidence 75432 1123355679999998776 78899999999999999999 466775543211110000
Q ss_pred hHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018785 256 SRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL 304 (350)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 304 (350)
.. ...+......+.+++.+||..+|.+|||+.++++.|
T Consensus 221 ---------~~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 221 ---------DQ--HRLPMPDCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred ---------cC--CCCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 00 011111227889999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=271.52 Aligned_cols=244 Identities=28% Similarity=0.398 Sum_probs=195.1
Q ss_pred ecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch---hhHHHHHHHHHHHhccCCCcccceeeEEeecCceEEE
Q 018785 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLVKLIGYCSESDNRLLV 105 (350)
Q Consensus 29 lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 105 (350)
||.|++|.||++ .+..+|+.+++|.+..... .....+.+|+..++.++||||+++++.+..+...+++
T Consensus 1 lg~g~~~~vy~~---------~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 71 (265)
T cd05579 1 ISKGAYGRVFLA---------KKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLV 71 (265)
T ss_pred CCCCCceEEEEE---------EECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEE
Confidence 689999999999 5556689999999876543 3345688899999999999999999999999999999
Q ss_pred EEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccccccCCCCC
Q 018785 106 YEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGD 185 (350)
Q Consensus 106 ~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~~~~~~~ 185 (350)
+|++.+++|.+++.... .+++..+..++.|+++||++|| +.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 72 ~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH--~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~ 147 (265)
T cd05579 72 MEYLPGGDLASLLENVG--SLDEDVARIYIAEIVLALEYLH--SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRR 147 (265)
T ss_pred EecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCc
Confidence 99999999999997755 6899999999999999999999 9999999999999999999999999999987543322
Q ss_pred C------CcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhHHH
Q 018785 186 N------THVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRV 259 (350)
Q Consensus 186 ~------~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (350)
. ........++..|++||...+...+.++|+||||+++|+|++|..||...........+.
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~------------- 214 (265)
T cd05579 148 QINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNIL------------- 214 (265)
T ss_pred ccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh-------------
Confidence 1 112223456778999999988889999999999999999999999996544221111111
Q ss_pred HHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018785 260 LRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLT 302 (350)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 302 (350)
...........++..+.+++.+||+.+|.+|||+..+.+
T Consensus 215 ----~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~ 253 (265)
T cd05579 215 ----NGKIEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEE 253 (265)
T ss_pred ----cCCcCCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHH
Confidence 001111111124788999999999999999999944433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=275.45 Aligned_cols=269 Identities=22% Similarity=0.279 Sum_probs=197.9
Q ss_pred hcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh--hHHHHHHHHHHHhccC-CCcccceeeEEe
Q 018785 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ--GHKEWLTEVIYLGQLR-HENLVKLIGYCS 97 (350)
Q Consensus 21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~-h~~i~~~~~~~~ 97 (350)
++|++.+.||+|++|.||+| .+..+++.|++|.+...... ....+.+|+.+++.+. ||||+++++++.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~---------~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~ 71 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKA---------RDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEH 71 (295)
T ss_pred CCceEeeEecccCCeEEEEE---------EECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEe
Confidence 47999999999999999999 55667889999987654322 2356778999999995 699999999988
Q ss_pred ecCc-----eEEEEEcCCCCChhhHHhhcC---CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcC-CC
Q 018785 98 ESDN-----RLLVYEFMPKGSLENHLFRKG---VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS-NF 168 (350)
Q Consensus 98 ~~~~-----~~lv~e~~~~~~L~~~l~~~~---~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~-~~ 168 (350)
..+. .|+||||+.+ +|.+++.... ...+++..++.++.|+++||.||| +.|++|+||+|+||+++. ++
T Consensus 72 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH--~~~i~H~dl~~~nil~~~~~~ 148 (295)
T cd07837 72 VEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH--KHGVMHRDLKPQNLLVDKQKG 148 (295)
T ss_pred ecCCCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH--HCCeeecCCChHHEEEecCCC
Confidence 7665 8999999965 8988886542 236899999999999999999999 999999999999999998 88
Q ss_pred cEEEccccccccCCCCCCCcccccccCCCcccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhh
Q 018785 169 NAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVE 247 (350)
Q Consensus 169 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~ 247 (350)
.++|+|||.+......... .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.........+..
T Consensus 149 ~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~ 226 (295)
T cd07837 149 LLKIADLGLGRAFSIPVKS--YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFK 226 (295)
T ss_pred eEEEeecccceecCCCccc--cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence 9999999998754222111 112345778999998765 4578999999999999999999999976543222111111
Q ss_pred hc-chhhhh---hHHHHHhhhcc-----cCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 248 WA-DPFLRD---SRRVLRIMDTR-----LGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 248 ~~-~~~~~~---~~~~~~~~~~~-----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
.. .+.... ........... ........++.++.++|.+||..||.+||++.+++.|
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 227 LLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred HhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 10 000000 00000000000 0000112467889999999999999999999999865
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=282.81 Aligned_cols=272 Identities=26% Similarity=0.422 Sum_probs=226.1
Q ss_pred hhhhhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhH-HHHHHHHHHHhccCCCcccc
Q 018785 13 SMISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGH-KEWLTEVIYLGQLRHENLVK 91 (350)
Q Consensus 13 ~~~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~e~~~l~~l~h~~i~~ 91 (350)
.-+.+..-+...++++||+|.||.|.++.... +..||+|+++....... ++|..|++.|.+++||||+.
T Consensus 530 ~al~EfPRs~L~~~ekiGeGqFGEVhLCeveg----------~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIve 599 (807)
T KOG1094|consen 530 PALVEFPRSRLRFKEKIGEGQFGEVHLCEVEG----------PLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVE 599 (807)
T ss_pred cchhhcchhheehhhhhcCcccceeEEEEecC----------ceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeE
Confidence 33556667788999999999999999985432 68999999998866554 78999999999999999999
Q ss_pred eeeEEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEE
Q 018785 92 LIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAK 171 (350)
Q Consensus 92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~ 171 (350)
+++++..++.+++|+||++.|+|.+|+.++.-..+.-.....++.||+.|++||. +.+++||||.++|+|++.++++|
T Consensus 600 LvGVC~~DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLe--s~nfVHrd~a~rNcLv~~e~~iK 677 (807)
T KOG1094|consen 600 LLGVCVQDDPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLE--SLNFVHRDLATRNCLVDGEFTIK 677 (807)
T ss_pred EEeeeecCCchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHH--hhchhhccccccceeecCcccEE
Confidence 9999999999999999999999999999885434455667789999999999999 99999999999999999999999
Q ss_pred EccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHH--hCCCCCcccccCcchhhhhhhc
Q 018785 172 LSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELL--SGRRALDEDRGGLAEQTLVEWA 249 (350)
Q Consensus 172 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll--~g~~pf~~~~~~~~~~~~~~~~ 249 (350)
++|||.++-....+......+..-..+|+|||.+.-+.++.++|+|++|+++||++ +.+.||....++...+....
T Consensus 678 iadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~-- 755 (807)
T KOG1094|consen 678 IADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGE-- 755 (807)
T ss_pred ecCcccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhh--
Confidence 99999999776767666666677778899999999999999999999999999985 57889876654333222221
Q ss_pred chhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 018785 250 DPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 307 (350)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~ 307 (350)
.............|.-++..+.+++.+||..+.++|||++++..+|.+.
T Consensus 756 ---------~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 756 ---------FFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred ---------hcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 1111111122234667889999999999999999999999999888764
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=273.71 Aligned_cols=255 Identities=28% Similarity=0.389 Sum_probs=203.4
Q ss_pred hhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch---hhHHHHHHHHHHHhccCCCcccceeeEE
Q 018785 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLVKLIGYC 96 (350)
Q Consensus 20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (350)
.+.|...+.||+|+||.||++ .+..++..+++|.+..... .....+..|+..++.++|||++++++++
T Consensus 24 ~~~f~~~~~lg~G~~~~v~~~---------~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 94 (317)
T cd06635 24 EKLFTDLREIGHGSFGAVYFA---------RDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCY 94 (317)
T ss_pred hhhhhhhheeccCCCeEEEEE---------EEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 356889999999999999999 5555688999998864422 2335678899999999999999999999
Q ss_pred eecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcccc
Q 018785 97 SESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFG 176 (350)
Q Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg 176 (350)
..++..++||||+. +++.+.+.... ..++...+..++.|++.|+.||| +.|++|+||+|+||+++.++.++|+|||
T Consensus 95 ~~~~~~~lv~e~~~-g~l~~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lH--~~~i~H~dL~p~Nil~~~~~~~kl~dfg 170 (317)
T cd06635 95 LREHTAWLVMEYCL-GSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLH--SHNMIHRDIKAGNILLTEPGQVKLADFG 170 (317)
T ss_pred eeCCeEEEEEeCCC-CCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCcccEEECCCCCEEEecCC
Confidence 99999999999995 58888775543 36899999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCCCCcccccccCCCcccCccccc---cCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhh
Q 018785 177 LARDGPTGDNTHVSTRIVGTRGYAAPEYVA---TGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 253 (350)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 253 (350)
++...... ....++..|+|||.+. +..++.++|+||+|+++|+|++|..||...........
T Consensus 171 ~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~--------- 235 (317)
T cd06635 171 SASIASPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH--------- 235 (317)
T ss_pred CccccCCc------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHH---------
Confidence 88643221 2235778899999873 45688899999999999999999999865332111111
Q ss_pred hhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcC
Q 018785 254 RDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 310 (350)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 310 (350)
.............+++.+.+++.+||+.+|.+||++.++++++..+...
T Consensus 236 --------~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 284 (317)
T cd06635 236 --------IAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRER 284 (317)
T ss_pred --------HHhccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccC
Confidence 1111111122335677899999999999999999999999987766554
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=293.54 Aligned_cols=282 Identities=22% Similarity=0.277 Sum_probs=191.9
Q ss_pred hhhhhcccccceecccCceeEEeecccCCCcC------CCCCCCCcE----EEEEEccccchhhHHHHHHHHHHHhccCC
Q 018785 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFA------PTKPGSGIV----VAIKRLKAESFQGHKEWLTEVIYLGQLRH 86 (350)
Q Consensus 17 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~------~~~~~~~~~----vaiK~~~~~~~~~~~~~~~e~~~l~~l~h 86 (350)
+...++|++.+.||+|+||+||+|.+...... ......+.. ++.|.+... ......+.+|+.+++.++|
T Consensus 144 ~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~Ei~il~~l~H 222 (501)
T PHA03210 144 DEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAG-SRAAIQLENEILALGRLNH 222 (501)
T ss_pred hhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcc-hHHHHHHHHHHHHHHhCCC
Confidence 33457899999999999999999865321100 000001111 111222111 1233567889999999999
Q ss_pred CcccceeeEEeecCceEEEEEcCCCCChhhHHhhcC---CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceE
Q 018785 87 ENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKG---VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVL 163 (350)
Q Consensus 87 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nil 163 (350)
|||+++++++...+..|+|++++ +++|.+++.... ........+..++.|++.||.||| +.||+|+||||+|||
T Consensus 223 pnIv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH--~~gIiHrDLKP~NIL 299 (501)
T PHA03210 223 ENILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH--DKKLIHRDIKLENIF 299 (501)
T ss_pred CCcCcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEE
Confidence 99999999999999999999998 568888775432 122345678889999999999999 999999999999999
Q ss_pred EcCCCcEEEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchh
Q 018785 164 LDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQ 243 (350)
Q Consensus 164 i~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~ 243 (350)
++.++.++|+|||++........ .......|+..|+|||++.+..++.++|||||||++|+|++|..++..........
T Consensus 300 l~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~ 378 (501)
T PHA03210 300 LNCDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGK 378 (501)
T ss_pred ECCCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHH
Confidence 99999999999999975433221 11223568999999999999999999999999999999999876543222211111
Q ss_pred hhhhhcc-------hhhhhhHHHHHhhhcccCC----CC-----cHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 244 TLVEWAD-------PFLRDSRRVLRIMDTRLGG----QY-----SKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 244 ~~~~~~~-------~~~~~~~~~~~~~~~~~~~----~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
.+..... .+..........+...... .. ...++.++.++|.+||+.||.+|||+.++++|
T Consensus 379 ~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 379 QLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 1111000 0000000111111110000 00 01234577889999999999999999999976
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=284.39 Aligned_cols=254 Identities=24% Similarity=0.325 Sum_probs=217.0
Q ss_pred hhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhh--HHHHHHHHHHHhccCCCcccceee
Q 018785 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQG--HKEWLTEVIYLGQLRHENLVKLIG 94 (350)
Q Consensus 17 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~ 94 (350)
...-..|.+.+.||+|.|+.|.+| .+..++..||||.+.+..... ...+.+|+++++.++||||++++.
T Consensus 52 ~~~vg~y~i~~tig~g~f~~V~La---------~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~ 122 (596)
T KOG0586|consen 52 SNSVGLYVIIKTIGKGNFAKVKLA---------RHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFS 122 (596)
T ss_pred cccccceeeeeeeccceeEEEEee---------EecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeee
Confidence 344578999999999999999999 788889999999998775433 345889999999999999999999
Q ss_pred EEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcc
Q 018785 95 YCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSD 174 (350)
Q Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~D 174 (350)
+.+....+|+||||+.++.+.+++..++ ...+..+..++.|++.|++||| +++++|+|||++|++++.+-+++|+|
T Consensus 123 v~~t~~~lylV~eya~~ge~~~yl~~~g--r~~e~~ar~~F~q~vsaveYcH--~k~ivHrdLk~eNilL~~~mnikIaD 198 (596)
T KOG0586|consen 123 VIETEATLYLVMEYASGGELFDYLVKHG--RMKEKEARAKFRQIVSAVEYCH--SKNIVHRDLKAENILLDENMNIKIAD 198 (596)
T ss_pred eeeecceeEEEEEeccCchhHHHHHhcc--cchhhhhhhhhHHHHHHHHHHh--hcceeccccchhhcccccccceeeec
Confidence 9999999999999999999999999887 5666899999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCCCCCcccccccCCCcccCccccccCCC-CCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhh
Q 018785 175 FGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHL-TPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 253 (350)
Q Consensus 175 fg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 253 (350)
||++..+.. .......+|++-|.|||++.+..| .+..|+|++|+++|.|++|..||++..-.........
T Consensus 199 fgfS~~~~~---~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~------ 269 (596)
T KOG0586|consen 199 FGFSTFFDY---GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLR------ 269 (596)
T ss_pred cccceeecc---cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchhee------
Confidence 999987653 333455779999999999999876 4889999999999999999999987664433322221
Q ss_pred hhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018785 254 RDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 305 (350)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~ 305 (350)
.. -.++.-++-++.++|+++|-.+|.+|++++++.++-+
T Consensus 270 -----------gk--~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W 308 (596)
T KOG0586|consen 270 -----------GK--YRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRW 308 (596)
T ss_pred -----------ee--ecccceeechhHHHHHHhhccCccccCCHHHhhhhcc
Confidence 11 1223455678999999999999999999999998743
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=286.60 Aligned_cols=260 Identities=26% Similarity=0.425 Sum_probs=219.6
Q ss_pred hhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh-hHHHHHHHHHHHhccCCCcccceeeEE
Q 018785 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ-GHKEWLTEVIYLGQLRHENLVKLIGYC 96 (350)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (350)
+..++.+..++||+|+||.|++|.|. .-.++-..||||++...... .-.+|++|+..+.+|.||+++++|++.
T Consensus 107 Ipee~i~l~e~LG~GsFgvV~rg~Wt------~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvV 180 (1039)
T KOG0199|consen 107 IPEEQIKLYELLGEGSFGVVKRGTWT------QPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVV 180 (1039)
T ss_pred ccHHHHHHHHHhcCcceeeEeecccc------CCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeee
Confidence 34567788899999999999999886 33445678999999877654 457899999999999999999999999
Q ss_pred eecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcccc
Q 018785 97 SESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFG 176 (350)
Q Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg 176 (350)
.+ ..+.+|+|.++.|+|.+.+.+.....|-......++.||+.|+.||. +++++||||-..|+++.....|||+|||
T Consensus 181 l~-qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLe--skrlvHRDLAARNlllasprtVKI~DFG 257 (1039)
T KOG0199|consen 181 LD-QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLE--SKRLVHRDLAARNLLLASPRTVKICDFG 257 (1039)
T ss_pred cc-chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHh--hhhhhhhhhhhhhheecccceeeeeccc
Confidence 87 67789999999999999998866667889999999999999999999 9999999999999999998899999999
Q ss_pred ccccCCCCCCCccccc-ccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccccCcchhhhhhhcchhhh
Q 018785 177 LARDGPTGDNTHVSTR-IVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLR 254 (350)
Q Consensus 177 ~~~~~~~~~~~~~~~~-~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~ 254 (350)
+.+-.......+.+.. ..-...|+|||.+....++.++|+|++|+++|||++ |+.||.+...
T Consensus 258 LmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g---------------- 321 (1039)
T KOG0199|consen 258 LMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG---------------- 321 (1039)
T ss_pred ceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH----------------
Confidence 9987666555544433 233456999999999999999999999999999998 6779877653
Q ss_pred hhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018785 255 DSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL 304 (350)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 304 (350)
....+.++...+-.-++.+++++++++++||..+|.+|||+.+|.+.+
T Consensus 322 --~qIL~~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 322 --IQILKNIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred --HHHHHhccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 233344444555566789999999999999999999999999997443
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=269.00 Aligned_cols=245 Identities=24% Similarity=0.296 Sum_probs=193.5
Q ss_pred hhccccccee--cccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhcc-CCCcccceeeEE
Q 018785 20 TKNFCSDYLL--GEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQL-RHENLVKLIGYC 96 (350)
Q Consensus 20 ~~~y~i~~~l--g~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~ 96 (350)
.++|.+.+.+ |.|+||.||++ .+..++..+++|.+........ |......+ +|||++++++.+
T Consensus 13 ~~~~~~~~~~~lg~g~~g~v~~~---------~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~ 78 (267)
T PHA03390 13 LKNCEIVKKLKLIDGKFGKVSVL---------KHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSV 78 (267)
T ss_pred HHhhccccceeecCCCceEEEEE---------EEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEE
Confidence 3677777776 99999999999 6666789999999875532221 22222222 799999999999
Q ss_pred eecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCC-cEEEccc
Q 018785 97 SESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNF-NAKLSDF 175 (350)
Q Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~-~~~l~Df 175 (350)
...+..++||||+++++|.+++.... .+++.++..++.|++.||.+|| +.|++|+||+|+||+++.++ .++|+||
T Consensus 79 ~~~~~~~iv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH--~~~i~H~dl~p~nil~~~~~~~~~l~df 154 (267)
T PHA03390 79 TTLKGHVLIMDYIKDGDLFDLLKKEG--KLSEAEVKKIIRQLVEALNDLH--KHNIIHNDIKLENVLYDRAKDRIYLCDY 154 (267)
T ss_pred ecCCeeEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--hCCeeeCCCCHHHEEEeCCCCeEEEecC
Confidence 99999999999999999999997764 7999999999999999999999 89999999999999999988 9999999
Q ss_pred cccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhh
Q 018785 176 GLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRD 255 (350)
Q Consensus 176 g~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 255 (350)
|.+...... ....++..|+|||.+.+..++.++|+||+|+++|+|++|..||..........
T Consensus 155 g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~------------ 216 (267)
T PHA03390 155 GLCKIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDL------------ 216 (267)
T ss_pred ccceecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhH------------
Confidence 988653221 12347788999999988899999999999999999999999997543321100
Q ss_pred hHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCC-HHHHHHH
Q 018785 256 SRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPS-MVDVLTS 303 (350)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-~~~ll~~ 303 (350)
....... .........+++.+.++|.+||+.+|.+||+ ++++++|
T Consensus 217 -~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 217 -ESLLKRQ--QKKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred -HHHHHhh--cccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence 0001111 1111233467889999999999999999995 6998864
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=279.19 Aligned_cols=281 Identities=27% Similarity=0.403 Sum_probs=207.4
Q ss_pred hhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEcccc--chhhHHHHHHHHHHHhcc-CCCcccceee
Q 018785 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAE--SFQGHKEWLTEVIYLGQL-RHENLVKLIG 94 (350)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~ 94 (350)
...++|++.+.||+|++|.||+| .+..++..+++|.+... .......+..|+.+++++ +||||+++++
T Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~---------~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~ 74 (337)
T cd07852 4 HILRKYEILQKLGKGAYGIVWKA---------IDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLN 74 (337)
T ss_pred hhhhHHHHhHhhcCCCCeeEEEE---------EEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceee
Confidence 45689999999999999999999 55556889999987543 222334567899999999 9999999999
Q ss_pred EEeec--CceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEE
Q 018785 95 YCSES--DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKL 172 (350)
Q Consensus 95 ~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l 172 (350)
++... ...++|||++. ++|.+++... .++...+..++.|++.||.||| +.|++|+||+|+||+++.++.++|
T Consensus 75 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH--~~~i~H~dl~p~nill~~~~~~kl 148 (337)
T cd07852 75 VIKAENDKDIYLVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIH--SGNVIHRDLKPSNILLNSDCRVKL 148 (337)
T ss_pred eeccCCCceEEEEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEEcCCCcEEE
Confidence 88653 36799999995 5998888654 5788889999999999999999 999999999999999999999999
Q ss_pred ccccccccCCCCCCC---cccccccCCCcccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhh
Q 018785 173 SDFGLARDGPTGDNT---HVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEW 248 (350)
Q Consensus 173 ~Dfg~~~~~~~~~~~---~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~ 248 (350)
+|||.+......... .......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||.+.........+...
T Consensus 149 ~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~ 228 (337)
T cd07852 149 ADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEV 228 (337)
T ss_pred eeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence 999999765433221 12223457888999998755 46788999999999999999999999765443322222221
Q ss_pred cchhh-hhhHH-----HHHhhh---cccC---CCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHhhhcCCCC
Q 018785 249 ADPFL-RDSRR-----VLRIMD---TRLG---GQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS--LEQLHTSKDM 313 (350)
Q Consensus 249 ~~~~~-~~~~~-----~~~~~~---~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~--L~~~~~~~~~ 313 (350)
..... ..... ...... .... ......++.++.+++.+||+.||.+|||+.+++++ +.++......
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~~~~~ 307 (337)
T cd07852 229 IGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNPSDE 307 (337)
T ss_pred hCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhccCCCC
Confidence 11100 00000 000010 0000 01112357889999999999999999999999987 6665444333
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=282.57 Aligned_cols=269 Identities=24% Similarity=0.326 Sum_probs=199.7
Q ss_pred hhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceeeEEeec
Q 018785 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (350)
Q Consensus 20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (350)
+.+|++.+.||.|++|.||+| .+..++..|++|.+........+.+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~---------~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~ 74 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSA---------VDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPS 74 (342)
T ss_pred CcceEEEEEecCCCCEEEEEE---------EECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccc
Confidence 589999999999999999999 66677899999998776655567788999999999999999999876543
Q ss_pred --------------CceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEc
Q 018785 100 --------------DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLD 165 (350)
Q Consensus 100 --------------~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~ 165 (350)
...++|+||+. ++|.+++... .+++..+..++.|+++||.||| +.|++|+||+|+||+++
T Consensus 75 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH--~~givH~dikp~Nili~ 148 (342)
T cd07854 75 GSDLTEDVGSLTELNSVYIVQEYME-TDLANVLEQG---PLSEEHARLFMYQLLRGLKYIH--SANVLHRDLKPANVFIN 148 (342)
T ss_pred ccccccccccccccceEEEEeeccc-ccHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHHEEEc
Confidence 35789999995 5898888643 5899999999999999999999 99999999999999997
Q ss_pred C-CCcEEEccccccccCCCCCCCc-ccccccCCCcccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCcccccCcch
Q 018785 166 S-NFNAKLSDFGLARDGPTGDNTH-VSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAE 242 (350)
Q Consensus 166 ~-~~~~~l~Dfg~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~ 242 (350)
. ++.++|+|||.+.......... ......++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||.........
T Consensus 149 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~ 228 (342)
T cd07854 149 TEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQM 228 (342)
T ss_pred CCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 4 5578999999987543221111 1122346778999997654 56788999999999999999999999765432222
Q ss_pred hhhhhh-cchhhhhhHHHH----Hhhh---cccCC---CCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 243 QTLVEW-ADPFLRDSRRVL----RIMD---TRLGG---QYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 243 ~~~~~~-~~~~~~~~~~~~----~~~~---~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
..+... +........... .... ..... .....++.++.+|+.+||+.||.+|||+.++++|
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 229 QLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred HHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 111110 000000000000 0000 00000 0112356789999999999999999999999976
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=267.13 Aligned_cols=243 Identities=25% Similarity=0.329 Sum_probs=189.8
Q ss_pred ceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhh---HHHHHHHHHH-HhccCCCcccceeeEEeecCce
Q 018785 27 YLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQG---HKEWLTEVIY-LGQLRHENLVKLIGYCSESDNR 102 (350)
Q Consensus 27 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~e~~~-l~~l~h~~i~~~~~~~~~~~~~ 102 (350)
+.||.|++|.||+| .+..+++.||+|.+....... ...+..|... .....|+|++++++++..++..
T Consensus 2 ~~l~~g~~~~v~~a---------~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~ 72 (260)
T cd05611 2 KPISKGAFGSVYLA---------KKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYL 72 (260)
T ss_pred ccCCcCCCeeEEEE---------EecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeE
Confidence 57899999999999 666678899999987543221 2223344433 4455899999999999999999
Q ss_pred EEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccccccCC
Q 018785 103 LLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGP 182 (350)
Q Consensus 103 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~~~~ 182 (350)
++|+||+.+++|.+++.... .+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++....
T Consensus 73 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 148 (260)
T cd05611 73 YLVMEYLNGGDCASLIKTLG--GLPEDWAKQYIAEVVLGVEDLH--QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGL 148 (260)
T ss_pred EEEEeccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHeEECCCCcEEEeecccceecc
Confidence 99999999999999997654 6899999999999999999999 8999999999999999999999999999886532
Q ss_pred CCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhHHHHHh
Q 018785 183 TGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRI 262 (350)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (350)
. .....++..|++||.+.+..++.++|+||||+++|+|++|..||...........+..
T Consensus 149 ~------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--------------- 207 (260)
T cd05611 149 E------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILS--------------- 207 (260)
T ss_pred c------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHh---------------
Confidence 2 1223467889999999888889999999999999999999999975443211111100
Q ss_pred hhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCH---HHHHHH
Q 018785 263 MDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSM---VDVLTS 303 (350)
Q Consensus 263 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~---~~ll~~ 303 (350)
............+++.+.+++.+||..+|++||++ +++++|
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~ 251 (260)
T cd05611 208 RRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSH 251 (260)
T ss_pred cccCCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcC
Confidence 00011112233567899999999999999999966 455544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=281.50 Aligned_cols=270 Identities=25% Similarity=0.319 Sum_probs=199.9
Q ss_pred hhccc-ccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhh--------------HHHHHHHHHHHhcc
Q 018785 20 TKNFC-SDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQG--------------HKEWLTEVIYLGQL 84 (350)
Q Consensus 20 ~~~y~-i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~--------------~~~~~~e~~~l~~l 84 (350)
.++|. +.+.||.|++|+||+| .+..+++.||+|.+....... ...+.+|+.+++.+
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 77 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKA---------YDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEI 77 (335)
T ss_pred ccchhhhhhcccCCCceeEEEE---------EECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhC
Confidence 35665 5678999999999999 555678899999886543221 12467899999999
Q ss_pred CCCcccceeeEEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEE
Q 018785 85 RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLL 164 (350)
Q Consensus 85 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili 164 (350)
+||||+++++++..++..++|||++. ++|.+++.... .+++..+..++.|++.||.+|| +.|++|+||+|+||++
T Consensus 78 ~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~~~ql~~aL~~LH--~~~i~H~dl~~~nill 152 (335)
T PTZ00024 78 KHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKI--RLTESQVKCILLQILNGLNVLH--KWYFMHRDLSPANIFI 152 (335)
T ss_pred CCcceeeeeEEEecCCcEEEEEeccc-cCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--hCCeecccccHHHeEE
Confidence 99999999999999999999999995 69999887654 6899999999999999999999 9999999999999999
Q ss_pred cCCCcEEEccccccccCCCCCC------------CcccccccCCCcccCccccccC-CCCCccchhhHHHHHHHHHhCCC
Q 018785 165 DSNFNAKLSDFGLARDGPTGDN------------THVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRR 231 (350)
Q Consensus 165 ~~~~~~~l~Dfg~~~~~~~~~~------------~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~ll~~ll~g~~ 231 (350)
+.++.++|+|||.+........ ........++..|+|||.+.+. .++.++|+||||+++|+|++|..
T Consensus 153 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~ 232 (335)
T PTZ00024 153 NSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKP 232 (335)
T ss_pred CCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 9999999999999875431110 0111123457789999988764 46889999999999999999999
Q ss_pred CCcccccCcchhhhhhhcc-hhhhhhHHHHH---h--hhcccC---CCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018785 232 ALDEDRGGLAEQTLVEWAD-PFLRDSRRVLR---I--MDTRLG---GQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLT 302 (350)
Q Consensus 232 pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~---~--~~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 302 (350)
||...........+..... +.......... . ...... .......++++.+++.+||+.+|++|||+++++.
T Consensus 233 p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 233 LFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred CCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 9976654332222221111 00000000000 0 000000 0011234678999999999999999999999997
Q ss_pred H
Q 018785 303 S 303 (350)
Q Consensus 303 ~ 303 (350)
+
T Consensus 313 ~ 313 (335)
T PTZ00024 313 H 313 (335)
T ss_pred C
Confidence 5
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=271.65 Aligned_cols=271 Identities=23% Similarity=0.297 Sum_probs=209.0
Q ss_pred hhhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccC-C-C----c
Q 018785 15 ISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLR-H-E----N 88 (350)
Q Consensus 15 ~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h-~----~ 88 (350)
.+++..++|.+...+|+|.||.|-.+ .+..++..||||+++.-. .-.+..+-|+++|.++. + | -
T Consensus 83 ~gD~l~~Ry~i~~~lGeGtFGkV~ec---------~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~r 152 (415)
T KOG0671|consen 83 VGDILTNRYEIVDLLGEGTFGKVVEC---------WDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFR 152 (415)
T ss_pred eccccccceehhhhhcCCcccceEEE---------eecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceE
Confidence 46777899999999999999999999 555568999999886543 22345667899999983 2 2 2
Q ss_pred ccceeeEEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcC--
Q 018785 89 LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS-- 166 (350)
Q Consensus 89 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~-- 166 (350)
++++.++|+-.++.+||+|.+ |-++.+|+..++..+++...++.+++||++++++|| +.+++|.||||+||++-.
T Consensus 153 cv~m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh--~~kl~HTDLKPENILfvss~ 229 (415)
T KOG0671|consen 153 CVQMRDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLH--DLKLTHTDLKPENILFVSSE 229 (415)
T ss_pred EEeeehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHH--hcceeecCCChheEEEeccc
Confidence 566677799999999999998 789999999998889999999999999999999999 999999999999999831
Q ss_pred ------------------CCcEEEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh
Q 018785 167 ------------------NFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 228 (350)
Q Consensus 167 ------------------~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~ 228 (350)
+..++++|||.++.-.... .....|..|+|||++.+-.|+..+||||+||+|+|+.+
T Consensus 230 ~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~Elyt 304 (415)
T KOG0671|consen 230 YFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYT 304 (415)
T ss_pred eEEEeccCCccceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeec
Confidence 3458999999998633333 34567889999999999999999999999999999999
Q ss_pred CCCCCcccccCcchhhhhhhcchhhhhhHH---HHHhhh-cccCC-----------------------CCcHHHHHHHHH
Q 018785 229 GRRALDEDRGGLAEQTLVEWADPFLRDSRR---VLRIMD-TRLGG-----------------------QYSKKEAQAVAA 281 (350)
Q Consensus 229 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~-~~~~~-----------------------~~~~~~~~~l~~ 281 (350)
|...|....+.+-...+.....|.-..... ..++.. ...++ ........++.+
T Consensus 305 G~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfD 384 (415)
T KOG0671|consen 305 GETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFD 384 (415)
T ss_pred cceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHH
Confidence 999998777554333333322222111100 111111 11110 001223357999
Q ss_pred HHHHhhccCCCCCCCHHHHHHH
Q 018785 282 VVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 282 li~~~l~~dp~~Rps~~~ll~~ 303 (350)
||++||..||.+|+|+.|++.|
T Consensus 385 Ll~~mL~fDP~~RiTl~EAL~H 406 (415)
T KOG0671|consen 385 LLRRMLEFDPARRITLREALSH 406 (415)
T ss_pred HHHHHHccCccccccHHHHhcC
Confidence 9999999999999999999875
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=273.85 Aligned_cols=267 Identities=24% Similarity=0.331 Sum_probs=200.9
Q ss_pred ccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccc--hhhHHHHHHHHHHHhccCCCcccceeeEEeec-
Q 018785 23 FCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES--FQGHKEWLTEVIYLGQLRHENLVKLIGYCSES- 99 (350)
Q Consensus 23 y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~- 99 (350)
|++.+.||.|++|.||+| ....+++.+++|.+.... ......+.+|+.+++.++|||++++++++...
T Consensus 1 y~~~~~l~~g~~~~vy~~---------~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 71 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKA---------RNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKG 71 (287)
T ss_pred CeeeEEeccCCCeEEEEE---------EECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCC
Confidence 678999999999999999 555568899999998763 23345678899999999999999999999888
Q ss_pred -CceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcccccc
Q 018785 100 -DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 178 (350)
Q Consensus 100 -~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~ 178 (350)
+..++|+||+. ++|.+++.... ..+++..++.++.|+++||++|| +.|++|+||+|+||+++.++.++|+|||.+
T Consensus 72 ~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH--~~~~~h~dl~p~nil~~~~~~~~l~d~g~~ 147 (287)
T cd07840 72 KGSIYMVFEYMD-HDLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLH--SNGILHRDIKGSNILINNDGVLKLADFGLA 147 (287)
T ss_pred CCcEEEEecccc-ccHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHH--HCCceeccCcHHHeEEcCCCCEEEccccce
Confidence 88999999995 58988886653 36899999999999999999999 899999999999999999999999999999
Q ss_pred ccCCCCCCCcccccccCCCcccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchh-hh--
Q 018785 179 RDGPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPF-LR-- 254 (350)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~-~~-- 254 (350)
......... ......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...........+....... ..
T Consensus 148 ~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (287)
T cd07840 148 RPYTKRNSA-DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENW 226 (287)
T ss_pred eeccCCCcc-cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhc
Confidence 765443211 1222345778999998765 467899999999999999999999997655432222222111000 00
Q ss_pred -hhHHHHHhhhcccCC--------CCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 255 -DSRRVLRIMDTRLGG--------QYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 255 -~~~~~~~~~~~~~~~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
............... .....++..+.+++.+||..+|.+||++.+++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 227 PGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred cccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 000000000000000 0011137789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=270.51 Aligned_cols=266 Identities=24% Similarity=0.328 Sum_probs=198.0
Q ss_pred ccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh--hHHHHHHHHHHHhcc---CCCcccceeeEEe
Q 018785 23 FCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ--GHKEWLTEVIYLGQL---RHENLVKLIGYCS 97 (350)
Q Consensus 23 y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l---~h~~i~~~~~~~~ 97 (350)
|++.+.||+|++|.||+| .+..++..+++|.+...... ....+.+|+.+++.+ .|||++++++++.
T Consensus 1 y~~~~~l~~g~~~~v~~~---------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~ 71 (287)
T cd07838 1 YEELAEIGEGAYGTVYKA---------RDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCH 71 (287)
T ss_pred CeEEEEecccCceEEEEE---------EECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEe
Confidence 678999999999999999 44456889999998754322 123455676666555 6999999999998
Q ss_pred ecCc-----eEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEE
Q 018785 98 ESDN-----RLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKL 172 (350)
Q Consensus 98 ~~~~-----~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l 172 (350)
..+. .+++||++. ++|.+++.......+++..+..++.|++.||.+|| +.+++|+||+|+||+++.++.++|
T Consensus 72 ~~~~~~~~~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH--~~~i~h~~l~~~nili~~~~~~~l 148 (287)
T cd07838 72 GPRTDRELKLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLH--SHRIVHRDLKPQNILVTSDGQVKI 148 (287)
T ss_pred eccCCCCceeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH--HCCeeeccCChhhEEEccCCCEEE
Confidence 8776 899999995 58999887765446899999999999999999999 899999999999999999999999
Q ss_pred ccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcch-
Q 018785 173 SDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADP- 251 (350)
Q Consensus 173 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~- 251 (350)
+|||.+........ .....++..|+|||.+.+..++.++|+||+|+++|+|++|..||...........+......
T Consensus 149 ~dfg~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (287)
T cd07838 149 ADFGLARIYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLP 225 (287)
T ss_pred eccCcceeccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCC
Confidence 99999876433221 12234677899999999889999999999999999999999998765543322222211000
Q ss_pred hhhhhHHH----HHhhhcccC---CCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 252 FLRDSRRV----LRIMDTRLG---GQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 252 ~~~~~~~~----~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
........ ......... ......+++.+.+++.+||+.||.+||++.+++.|
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 226 SEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred ChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 00000000 000000000 11123456888999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=275.11 Aligned_cols=251 Identities=22% Similarity=0.261 Sum_probs=188.0
Q ss_pred CCCCCcEEEEEEcccc--chhhHHHHHHHHHHHhccCCCcccceeeEEeecCceEEEEEcCCCCChhhHHhhcCCCCCCH
Q 018785 51 KPGSGIVVAIKRLKAE--SFQGHKEWLTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISW 128 (350)
Q Consensus 51 ~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~ 128 (350)
+..++..||+|.+... .......+..|+..++.++||||+++++++.+.+..+++|||+.+++|.+++.......+++
T Consensus 21 ~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~ 100 (314)
T cd08216 21 HKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPE 100 (314)
T ss_pred ecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHHHhcccCCCH
Confidence 3447899999998765 23445678899999999999999999999999999999999999999999998765457899
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccccccCCCCCCC-----cccccccCCCcccCcc
Q 018785 129 PTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNT-----HVSTRIVGTRGYAAPE 203 (350)
Q Consensus 129 ~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~-----~~~~~~~~~~~~~aPE 203 (350)
..+..++.|++.||+||| +.+++|+||+|+||+++.++.++++||+.+......... .......++..|+|||
T Consensus 101 ~~~~~~~~~l~~~L~~LH--~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE 178 (314)
T cd08216 101 LAIAFILKDVLNALDYIH--SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPE 178 (314)
T ss_pred HHHHHHHHHHHHHHHHHH--HCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccccccccCHH
Confidence 999999999999999999 999999999999999999999999999988643322111 1112234567799999
Q ss_pred cccc--CCCCCccchhhHHHHHHHHHhCCCCCcccccCcchh-hhhhhcchhhhhh------H--------HHHHhhhcc
Q 018785 204 YVAT--GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQ-TLVEWADPFLRDS------R--------RVLRIMDTR 266 (350)
Q Consensus 204 ~~~~--~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~------~--------~~~~~~~~~ 266 (350)
.+.+ ..++.++|+||+|+++|+|++|..||.......... .+.......+... . .........
T Consensus 179 ~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (314)
T cd08216 179 VLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDS 258 (314)
T ss_pred HhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcccccccccchhhh
Confidence 8865 358889999999999999999999997644321110 0000000000000 0 000000111
Q ss_pred cCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 267 LGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 267 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
........++.++.+++.+||+.||++|||++++++|
T Consensus 259 ~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 259 VDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred hhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 1122345667889999999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=270.42 Aligned_cols=266 Identities=26% Similarity=0.379 Sum_probs=200.2
Q ss_pred ccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh-hHHHHHHHHHHHhccC-CCcccceeeEEeecC
Q 018785 23 FCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ-GHKEWLTEVIYLGQLR-HENLVKLIGYCSESD 100 (350)
Q Consensus 23 y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~ 100 (350)
|++.+.||.|++|+||+| ....+++.|+||.+...... ......+|+..++++. |||++++++++..++
T Consensus 1 y~~~~~ig~g~~g~v~~~---------~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 71 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLA---------RNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFREND 71 (283)
T ss_pred CeeheeeccCCceEEEEE---------EECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCC
Confidence 788999999999999999 55556889999988655322 2223456888999998 999999999999999
Q ss_pred ceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcccccccc
Q 018785 101 NRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD 180 (350)
Q Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~~ 180 (350)
..++||||+ +++|.+++.......++...+..++.|++.+|.||| +.|++|+||+|+||+++.++.++|+|||.+..
T Consensus 72 ~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh--~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~ 148 (283)
T cd07830 72 ELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH--KHGFFHRDLKPENLLVSGPEVVKIADFGLARE 148 (283)
T ss_pred cEEEEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCChhhEEEcCCCCEEEeeccccee
Confidence 999999999 789999887765457899999999999999999999 99999999999999999999999999999875
Q ss_pred CCCCCCCcccccccCCCcccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhh----
Q 018785 181 GPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRD---- 255 (350)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~---- 255 (350)
...... .....++..|+|||.+.+ ..++.++|+||||+++++|++|+.||...........+..........
T Consensus 149 ~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (283)
T cd07830 149 IRSRPP---YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPE 225 (283)
T ss_pred ccCCCC---cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhh
Confidence 433221 122456778999998744 467899999999999999999999997665433322222211111100
Q ss_pred hHHHHHhhhcccC-------CCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 256 SRRVLRIMDTRLG-------GQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 256 ~~~~~~~~~~~~~-------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
............. .......+..+.+++.+||+.+|.+|||+++++.+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 226 GYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred HhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 0000000000000 00011225789999999999999999999999865
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=286.11 Aligned_cols=245 Identities=27% Similarity=0.437 Sum_probs=206.6
Q ss_pred eecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceeeEEeecCceEEEEE
Q 018785 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSESDNRLLVYE 107 (350)
Q Consensus 28 ~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 107 (350)
+||+|.||+||.| .+..+...+|||-+..........+.+|+.+-+.|.|.||+++++.+.+++.+-|.||
T Consensus 582 VLGKGTYG~VYA~---------RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFME 652 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAA---------RDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFME 652 (1226)
T ss_pred EeecCceeEEEee---------ccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEee
Confidence 8999999999999 6777789999999988776667789999999999999999999999999999999999
Q ss_pred cCCCCChhhHHhhcCCCCC--CHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcC-CCcEEEccccccccCCCC
Q 018785 108 FMPKGSLENHLFRKGVQPI--SWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS-NFNAKLSDFGLARDGPTG 184 (350)
Q Consensus 108 ~~~~~~L~~~l~~~~~~~l--~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~-~~~~~l~Dfg~~~~~~~~ 184 (350)
.++||+|.+++...=+ ++ .+..+..+..||++||.||| .+.|+|||||-+|++|+. .|.+|+.|||-+.+....
T Consensus 653 qVPGGSLSsLLrskWG-PlKDNEstm~fYtkQILeGLkYLH--en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi 729 (1226)
T KOG4279|consen 653 QVPGGSLSSLLRSKWG-PLKDNESTMNFYTKQILEGLKYLH--ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI 729 (1226)
T ss_pred cCCCCcHHHHHHhccC-CCccchhHHHHHHHHHHHHhhhhh--hcceeeccccCCcEEEeeccceEEecccccchhhccC
Confidence 9999999999976522 45 77888899999999999999 999999999999999954 688999999999875443
Q ss_pred CCCcccccccCCCcccCccccccC--CCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhHHHHHh
Q 018785 185 DNTHVSTRIVGTRGYAAPEYVATG--HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRI 262 (350)
Q Consensus 185 ~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (350)
.. ......||.-|+|||++..+ .|+.++|||||||++.||.||++||-...........+.
T Consensus 730 nP--~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVG--------------- 792 (1226)
T KOG4279|consen 730 NP--CTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVG--------------- 792 (1226)
T ss_pred Cc--cccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhc---------------
Confidence 32 23346799999999999765 688999999999999999999999976554322221111
Q ss_pred hhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018785 263 MDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLT 302 (350)
Q Consensus 263 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 302 (350)
.-+.-.+.|..++.+++.+|.+|+.+||.+||++.++|.
T Consensus 793 -myKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 793 -MYKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred -ceecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 111223567889999999999999999999999999985
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=274.19 Aligned_cols=272 Identities=25% Similarity=0.316 Sum_probs=201.5
Q ss_pred hhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch--hhHHHHHHHHHHHhccCCCcccceee
Q 018785 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLRHENLVKLIG 94 (350)
Q Consensus 17 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~ 94 (350)
+...++|++.+.||.|++|.||+| .+..+++.|++|.+..... .....+.+|+.+++.++|||++++++
T Consensus 3 ~~~~~~~~~~~~lg~g~~g~v~~~---------~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~ 73 (302)
T cd07864 3 KRCVDKFDIIGQIGEGTYGQVYKA---------RDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKE 73 (302)
T ss_pred hhhhhhhheeeeecccCCEEEEEE---------EECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeh
Confidence 456789999999999999999999 5555688999999875432 22345678999999999999999999
Q ss_pred EEeecC----------ceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEE
Q 018785 95 YCSESD----------NRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLL 164 (350)
Q Consensus 95 ~~~~~~----------~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili 164 (350)
++.+.. ..++|+||+.+ ++.+++.... ..++...+..++.|++.||+||| +.|++|+||+|+||++
T Consensus 74 ~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH--~~~i~H~dl~p~nili 149 (302)
T cd07864 74 IVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGL-VHFSEDHIKSFMKQLLEGLNYCH--KKNFLHRDIKCSNILL 149 (302)
T ss_pred eecCcchhhhccccCCcEEEEEcccCc-cHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEE
Confidence 887654 78999999965 7878776542 36899999999999999999999 9999999999999999
Q ss_pred cCCCcEEEccccccccCCCCCCCcccccccCCCcccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCcccccCcchh
Q 018785 165 DSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQ 243 (350)
Q Consensus 165 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~ 243 (350)
+.++.++|+|||.+........ .......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||..........
T Consensus 150 ~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~ 228 (302)
T cd07864 150 NNKGQIKLADFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLE 228 (302)
T ss_pred CCCCcEEeCcccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 9999999999999876433321 111122346679999987653 57889999999999999999999997544322222
Q ss_pred hhhhhcchhhh----hhHHHHHh--------hhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 244 TLVEWADPFLR----DSRRVLRI--------MDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 244 ~~~~~~~~~~~----~~~~~~~~--------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
.+......... +....... ..... ......++..+.+++.+||+.||.+||++.+++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 229 LISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRL-REEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred HHHHHhCCCChhhcccccccccccccccccccccch-hhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 22221100000 00000000 00000 00112357889999999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=266.34 Aligned_cols=254 Identities=27% Similarity=0.371 Sum_probs=215.0
Q ss_pred hhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhH---HHHHHHHHHHhccCCCcccce
Q 018785 16 SKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGH---KEWLTEVIYLGQLRHENLVKL 92 (350)
Q Consensus 16 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~ 92 (350)
.++--++|...++||+|.||.|.++ ..+.+++.+|+|+++++..-.. .+-..|-++|+...||.+..+
T Consensus 163 ~kvTm~dFdfLKvLGkGTFGKVIL~---------rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~L 233 (516)
T KOG0690|consen 163 NKVTMEDFDFLKVLGKGTFGKVILC---------REKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSL 233 (516)
T ss_pred ceeccchhhHHHHhcCCccceEEEE---------eecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHh
Confidence 3445678999999999999999999 7888999999999988755333 345678899999999999999
Q ss_pred eeEEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEE
Q 018785 93 IGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKL 172 (350)
Q Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l 172 (350)
.-.|...+.+++||||..||.|.-.+.... .+++...+.+...|+.||.||| +++|++||+|.+|.++|.+|.+|+
T Consensus 234 KYsFQt~drlCFVMeyanGGeLf~HLsrer--~FsE~RtRFYGaEIvsAL~YLH--s~~ivYRDlKLENLlLDkDGHIKi 309 (516)
T KOG0690|consen 234 KYSFQTQDRLCFVMEYANGGELFFHLSRER--VFSEDRTRFYGAEIVSALGYLH--SRNIVYRDLKLENLLLDKDGHIKI 309 (516)
T ss_pred hhhhccCceEEEEEEEccCceEeeehhhhh--cccchhhhhhhHHHHHHhhhhh--hCCeeeeechhhhheeccCCceEe
Confidence 999999999999999999999988886654 7999999999999999999999 999999999999999999999999
Q ss_pred ccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchh
Q 018785 173 SDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPF 252 (350)
Q Consensus 173 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 252 (350)
+|||++... ..........+|||.|+|||++....|+.+.|.|.+|+++|+|++|+.||...+.......+...
T Consensus 310 tDFGLCKE~--I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~e---- 383 (516)
T KOG0690|consen 310 TDFGLCKEE--IKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILME---- 383 (516)
T ss_pred eecccchhc--ccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhh----
Confidence 999999752 23333445578999999999999999999999999999999999999999876654443333321
Q ss_pred hhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 018785 253 LRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRP-----SMVDVLTS 303 (350)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~~ 303 (350)
....|..++++...|+..+|..||.+|. .+.+|.+|
T Consensus 384 ---------------d~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h 424 (516)
T KOG0690|consen 384 ---------------DLKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRH 424 (516)
T ss_pred ---------------hccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence 1245778899999999999999999994 34555544
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=274.88 Aligned_cols=271 Identities=25% Similarity=0.317 Sum_probs=197.4
Q ss_pred hhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhh--HHHHHHHHHHHhccCCCcccceeeEEe
Q 018785 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQG--HKEWLTEVIYLGQLRHENLVKLIGYCS 97 (350)
Q Consensus 20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (350)
.++|++.+.||.|++|.||+| .+..+++.+++|.+......+ .....+|+++++.++||||+++++++.
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~---------~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 77 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKA---------RQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAV 77 (311)
T ss_pred cccEEEEEEeccCCCEEEEEE---------EECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhhee
Confidence 579999999999999999999 556668899999886543222 235678999999999999999999875
Q ss_pred ecC--------ceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCc
Q 018785 98 ESD--------NRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFN 169 (350)
Q Consensus 98 ~~~--------~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~ 169 (350)
... .+++|++|+. +++...+.... ..+++..+..++.|+++||.||| +.|++|+||+|+||+++.++.
T Consensus 78 ~~~~~~~~~~~~~~lv~~~~~-~~l~~~~~~~~-~~~~~~~~~~i~~~l~~al~~lH--~~~i~H~dl~p~nil~~~~~~ 153 (311)
T cd07866 78 ERPDKSKRKRGSVYMVTPYMD-HDLSGLLENPS-VKLTESQIKCYMLQLLEGINYLH--ENHILHRDIKAANILIDNQGI 153 (311)
T ss_pred cccccccccCceEEEEEecCC-cCHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEECCCCC
Confidence 433 4699999984 47777775433 36999999999999999999999 999999999999999999999
Q ss_pred EEEccccccccCCCCCCCcc---------cccccCCCcccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCcccccC
Q 018785 170 AKLSDFGLARDGPTGDNTHV---------STRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRALDEDRGG 239 (350)
Q Consensus 170 ~~l~Dfg~~~~~~~~~~~~~---------~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~ 239 (350)
++|+|||++........... .....+++.|+|||.+.+. .++.++|+||||+++|+|++|..||.+....
T Consensus 154 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~ 233 (311)
T cd07866 154 LKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDI 233 (311)
T ss_pred EEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHH
Confidence 99999999975433221111 1223457789999987654 5788999999999999999999999765543
Q ss_pred cchhhhhhhcchhhhh----hHHHHHhh----hcccCCC---CcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 240 LAEQTLVEWADPFLRD----SRRVLRIM----DTRLGGQ---YSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 240 ~~~~~~~~~~~~~~~~----~~~~~~~~----~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
.....+.......... ........ ....... .....++.+.+++.+||+.||.+|||+.+++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 234 DQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred HHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 2222222111100000 00000000 0000000 011234678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=271.51 Aligned_cols=256 Identities=28% Similarity=0.364 Sum_probs=201.8
Q ss_pred hhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccc---hhhHHHHHHHHHHHhccCCCccccee
Q 018785 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES---FQGHKEWLTEVIYLGQLRHENLVKLI 93 (350)
Q Consensus 17 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~ 93 (350)
+.....|...+.||+|++|.||+| .+..++..+++|.+.... ......+.+|+.+++.++|+|+++++
T Consensus 11 ~~~~~~~~~~~~lg~g~~g~v~~~---------~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 81 (308)
T cd06634 11 DDPEKLFSDLREIGHGSFGAVYFA---------RDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81 (308)
T ss_pred CCcHHHHHHHHheeeCCCEEEEEE---------EEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEE
Confidence 334567889999999999999999 555568899999886432 22345677899999999999999999
Q ss_pred eEEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEc
Q 018785 94 GYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLS 173 (350)
Q Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~ 173 (350)
+++......++|+||+. +++.+++.... ..++...+..++.|++.|+.||| +.+++|+||+|+||+++.++.++|+
T Consensus 82 ~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~l~~~~~~~~~~~l~~~l~~LH--~~~i~H~dl~p~nil~~~~~~~kl~ 157 (308)
T cd06634 82 GCYLREHTAWLVMEYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLH--SHNMIHRDVKAGNILLSEPGLVKLG 157 (308)
T ss_pred EEEEcCCeeEEEEEccC-CCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHhEEECCCCcEEEC
Confidence 99999999999999995 58888775443 36899999999999999999999 9999999999999999999999999
Q ss_pred cccccccCCCCCCCcccccccCCCcccCccccc---cCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcc
Q 018785 174 DFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVA---TGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD 250 (350)
Q Consensus 174 Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~ 250 (350)
|||++...... ....++..|+|||.+. ...++.++||||||+++|+|++|..||..........
T Consensus 158 dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~------- 224 (308)
T cd06634 158 DFGSASIMAPA------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY------- 224 (308)
T ss_pred CcccceeecCc------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHH-------
Confidence 99988653221 2235678899999874 3467889999999999999999999986533211111
Q ss_pred hhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 018785 251 PFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLH 308 (350)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 308 (350)
..............++..+.++|.+||..+|.+||++++++++-....
T Consensus 225 ----------~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~ 272 (308)
T cd06634 225 ----------HIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (308)
T ss_pred ----------HHhhcCCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccc
Confidence 011111111123356788999999999999999999999998854443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=270.60 Aligned_cols=248 Identities=28% Similarity=0.412 Sum_probs=198.0
Q ss_pred hhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch---hhHHHHHHHHHHHhccCCCcccceeeEE
Q 018785 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLVKLIGYC 96 (350)
Q Consensus 20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (350)
.+.|...+.||+|++|+||+| .+..++..|++|.+..... .....+..|+..++.++|||++++++++
T Consensus 20 ~~~~~~~~~lg~g~~g~v~~~---------~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 90 (313)
T cd06633 20 EEIFVGLHEIGHGSFGAVYFA---------TNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCY 90 (313)
T ss_pred HHHhhcceeeccCCCeEEEEE---------EECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEE
Confidence 445777889999999999999 5566789999999865432 2335678899999999999999999999
Q ss_pred eecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcccc
Q 018785 97 SESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFG 176 (350)
Q Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg 176 (350)
.+....++||||+. +++.+++.... ..++...+..++.|++.+|.||| +.|++|+||+|+||+++.++.++|+|||
T Consensus 91 ~~~~~~~lv~e~~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~al~~LH--~~gi~H~dl~p~nili~~~~~~kL~dfg 166 (313)
T cd06633 91 LKEHTAWLVMEYCL-GSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLH--SHNMIHRDIKAGNILLTEPGQVKLADFG 166 (313)
T ss_pred EeCCEEEEEEecCC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCChhhEEECCCCCEEEeecC
Confidence 99999999999994 58888776543 36899999999999999999999 8999999999999999999999999999
Q ss_pred ccccCCCCCCCcccccccCCCcccCccccc---cCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhh
Q 018785 177 LARDGPTGDNTHVSTRIVGTRGYAAPEYVA---TGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 253 (350)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 253 (350)
++..... .....++..|+|||.+. +..++.++|+||||+++|+|++|..||...........+
T Consensus 167 ~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~-------- 232 (313)
T cd06633 167 SASKSSP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI-------- 232 (313)
T ss_pred CCcccCC------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH--------
Confidence 8864221 12345778899999874 456888999999999999999999998654321111111
Q ss_pred hhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 254 RDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
............++..+.+++.+||+.+|.+||++.+++.+
T Consensus 233 ---------~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 233 ---------AQNDSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred ---------HhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11111111223456789999999999999999999999976
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=267.43 Aligned_cols=243 Identities=26% Similarity=0.393 Sum_probs=190.0
Q ss_pred eecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhh---HHHHHHH---HHHHhccCCCcccceeeEEeecCc
Q 018785 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQG---HKEWLTE---VIYLGQLRHENLVKLIGYCSESDN 101 (350)
Q Consensus 28 ~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~e---~~~l~~l~h~~i~~~~~~~~~~~~ 101 (350)
.||+|+||.||+| .+..+++.||+|.+....... ......| +..++...||+|+++++.+...+.
T Consensus 1 ~ig~g~~g~Vy~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 71 (278)
T cd05606 1 IIGRGGFGEVYGC---------RKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 71 (278)
T ss_pred CcccCCCeEEEEE---------EEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCE
Confidence 4899999999999 556678999999887543221 1122233 334445579999999999999999
Q ss_pred eEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccccccC
Q 018785 102 RLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDG 181 (350)
Q Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~~~ 181 (350)
.++||||+.|++|.+++.... .+++..+..++.|++.|+.||| +.+++|+||+|+||+++.++.++|+|||.+...
T Consensus 72 ~~~v~e~~~g~~L~~~l~~~~--~l~~~~~~~~~~ql~~~l~~lH--~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~ 147 (278)
T cd05606 72 LSFILDLMNGGDLHYHLSQHG--VFSEAEMRFYAAEIILGLEHMH--NRFVVYRDLKPANILLDEHGHVRISDLGLACDF 147 (278)
T ss_pred EEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--HCCEEcCCCCHHHEEECCCCCEEEccCcCcccc
Confidence 999999999999999887654 6999999999999999999999 899999999999999999999999999998653
Q ss_pred CCCCCCcccccccCCCcccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhHHHH
Q 018785 182 PTGDNTHVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVL 260 (350)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (350)
.... .....++..|+|||.+.+. .++.++|+||+|+++|+|++|..||.......... ..
T Consensus 148 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~---------------~~ 208 (278)
T cd05606 148 SKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE---------------ID 208 (278)
T ss_pred CccC----CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHH---------------HH
Confidence 2221 1224578899999998754 68899999999999999999999997643211100 00
Q ss_pred HhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 018785 261 RIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRP-----SMVDVLTS 303 (350)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~~ 303 (350)
... .......+..++.++.+++.+||..+|.+|| ++.+++++
T Consensus 209 ~~~-~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 209 RMT-LTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred HHh-hccCCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 000 0111233445678999999999999999999 99999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=270.31 Aligned_cols=266 Identities=24% Similarity=0.331 Sum_probs=202.0
Q ss_pred ccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccc--hhhHHHHHHHHHHHhccCCCcccceeeEEeecC
Q 018785 23 FCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES--FQGHKEWLTEVIYLGQLRHENLVKLIGYCSESD 100 (350)
Q Consensus 23 y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 100 (350)
|++.+.||+|++|.||+| ....+++.+++|.+.... ......+..|+..++.++|++++++++++...+
T Consensus 1 y~~~~~ig~g~~~~vy~~---------~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 71 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKA---------RDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTER 71 (282)
T ss_pred CeeehcccccCcceEEEe---------eecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCC
Confidence 677889999999999999 666678999999988753 223356778999999999999999999999999
Q ss_pred ceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcccccccc
Q 018785 101 NRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD 180 (350)
Q Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~~ 180 (350)
..++|+|++. ++|.+++.... ..+++..+..++.|++.||.+|| +.|++|+||+|+||+++.++.++|+|||.+..
T Consensus 72 ~~~~v~e~~~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH--~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~ 147 (282)
T cd07829 72 KLYLVFEYCD-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCH--SHRILHRDLKPQNILINRDGVLKLADFGLARA 147 (282)
T ss_pred ceEEEecCcC-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCChheEEEcCCCCEEEecCCcccc
Confidence 9999999996 59999997763 36899999999999999999999 89999999999999999999999999999876
Q ss_pred CCCCCCCcccccccCCCcccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhh-h--
Q 018785 181 GPTGDNTHVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRD-S-- 256 (350)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~-- 256 (350)
...... ......++..|+|||.+.+. .++.++|+||||+++|+|++|..||...........+.......... .
T Consensus 148 ~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (282)
T cd07829 148 FGIPLR--TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPG 225 (282)
T ss_pred cCCCcc--ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHh
Confidence 433221 11223456679999988766 78899999999999999999999997655332222222111000000 0
Q ss_pred -HHH---HHhhhccc---CCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 257 -RRV---LRIMDTRL---GGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 257 -~~~---~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
... ........ ........+..+.+++.+||..||++||++++++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 226 VTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred hcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 000 00000000 001112346789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=265.23 Aligned_cols=250 Identities=24% Similarity=0.303 Sum_probs=194.9
Q ss_pred cccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEcccc---c--hhhHHHHHHHHHHHhccCCCcccceeeEE
Q 018785 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAE---S--FQGHKEWLTEVIYLGQLRHENLVKLIGYC 96 (350)
Q Consensus 22 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~---~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (350)
+|.+.+.||+|++|.||++++ ...+..+++|++... . ......+..|+.+++.++||||+++++.+
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 71 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKD---------KKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASF 71 (260)
T ss_pred CceeeeeecCCCCceEEEEEe---------cCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHH
Confidence 689999999999999999944 333444555544321 1 12234566788999999999999999999
Q ss_pred eecCceEEEEEcCCCCChhhHHhhc--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcc
Q 018785 97 SESDNRLLVYEFMPKGSLENHLFRK--GVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSD 174 (350)
Q Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~D 174 (350)
.+.+..++|+||+++++|.+++... ....+++..+..++.|+++||.||| +.|++|+||+|+||+++. +.++|+|
T Consensus 72 ~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH--~~~i~h~~l~~~nili~~-~~~~l~d 148 (260)
T cd08222 72 LERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH--QRRILHRDLKAKNIFLKN-NLLKIGD 148 (260)
T ss_pred hcCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH--HcCccccCCChhheEeec-CCEeecc
Confidence 9999999999999999999988642 2346899999999999999999999 999999999999999975 5699999
Q ss_pred ccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhh
Q 018785 175 FGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLR 254 (350)
Q Consensus 175 fg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~ 254 (350)
||.+........ ......++..|+|||.+.+..++.++|+||+|+++|+|++|..||.........
T Consensus 149 ~g~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~------------ 214 (260)
T cd08222 149 FGVSRLLMGSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVV------------ 214 (260)
T ss_pred cCceeecCCCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHH------------
Confidence 999875433221 122345678899999988888899999999999999999999998643211100
Q ss_pred hhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 255 DSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
... ........+..++.++.+++.+||..+|++||++.+++++
T Consensus 215 -----~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 215 -----LRI-VEGPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred -----HHH-HcCCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 011 1111223345678899999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=282.35 Aligned_cols=250 Identities=25% Similarity=0.388 Sum_probs=201.9
Q ss_pred hcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEcccc----chhhHHHHHHHHHHHhccCCCcccceeeEE
Q 018785 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAE----SFQGHKEWLTEVIYLGQLRHENLVKLIGYC 96 (350)
Q Consensus 21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (350)
+-.+...+||+|.|-+||+| .+..+|..||---+... .....+.+..|+.+|+.|+||||+++|+.|
T Consensus 40 Ry~k~~evLGrGafKtVYka---------~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW 110 (632)
T KOG0584|consen 40 RYLKFDEVLGRGAFKTVYKA---------FDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSW 110 (632)
T ss_pred ceeehhhhcccccceeeeec---------cccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeehe
Confidence 34466779999999999999 78888888875544332 123346789999999999999999999999
Q ss_pred eecCc--eEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCC-CcEEEc
Q 018785 97 SESDN--RLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSN-FNAKLS 173 (350)
Q Consensus 97 ~~~~~--~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~-~~~~l~ 173 (350)
.+... +.+|+|.+..|+|..|+++.. ..+...+..|++||+.||.|||+....|+|||||-+||||+.+ |.|||+
T Consensus 111 ~d~~n~~in~iTEL~TSGtLr~Y~kk~~--~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIG 188 (632)
T KOG0584|consen 111 VDTDNKTINFITELFTSGTLREYRKKHR--RVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIG 188 (632)
T ss_pred ecCCCceeeeeeecccCCcHHHHHHHhc--cCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeec
Confidence 87655 789999999999999999886 7888999999999999999999888889999999999999764 889999
Q ss_pred cccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhh
Q 018785 174 DFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 253 (350)
Q Consensus 174 Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 253 (350)
|+|+|......... ..+|||-|||||.+. ..|+...||||||+++.||.|+..||....+.-...
T Consensus 189 DLGLAtl~r~s~ak----svIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIY---------- 253 (632)
T KOG0584|consen 189 DLGLATLLRKSHAK----SVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIY---------- 253 (632)
T ss_pred chhHHHHhhccccc----eeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHH----------
Confidence 99999874433322 257999999999875 899999999999999999999999998766422111
Q ss_pred hhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 254 RDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
.+.+....+..+..--.++++++|.+||.. ..+|+|+.++|++
T Consensus 254 ------KKV~SGiKP~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 254 ------KKVTSGIKPAALSKVKDPEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred ------HHHHcCCCHHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 111111111112222247899999999999 9999999999864
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=267.78 Aligned_cols=256 Identities=27% Similarity=0.365 Sum_probs=199.9
Q ss_pred cccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch----hhHHHHHHHHHHHhcc-CCCcccceeeEE
Q 018785 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF----QGHKEWLTEVIYLGQL-RHENLVKLIGYC 96 (350)
Q Consensus 22 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~e~~~l~~l-~h~~i~~~~~~~ 96 (350)
+|++.+.||.|++|.||.++.. ....+|..|++|.+..... .....+..|+.+++.+ +|++|+++++.+
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~------~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~ 74 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKV------SGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF 74 (290)
T ss_pred CceeeeeeccCCcceEEEEEec------cCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEe
Confidence 4889999999999999998543 2234688999999875432 2235677899999999 599999999999
Q ss_pred eecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcccc
Q 018785 97 SESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFG 176 (350)
Q Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg 176 (350)
..+...++|+||+++++|.+++.... .++...+..++.|++.||.+|| +.|++|+||+|+||+++.++.++|+|||
T Consensus 75 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH--~~~i~H~dl~p~nil~~~~~~~kl~dfg 150 (290)
T cd05613 75 QTDTKLHLILDYINGGELFTHLSQRE--RFKEQEVQIYSGEIVLALEHLH--KLGIIYRDIKLENILLDSNGHVVLTDFG 150 (290)
T ss_pred ecCCeEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--hCCeeccCCCHHHeEECCCCCEEEeeCc
Confidence 99999999999999999999997664 6889999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCCCCcccccccCCCcccCccccccC--CCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhh
Q 018785 177 LARDGPTGDNTHVSTRIVGTRGYAAPEYVATG--HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLR 254 (350)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~ 254 (350)
++........ .......++..|++||.+.+. .++.++|+||||+++|+|++|..||...........+..
T Consensus 151 ~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~------- 222 (290)
T cd05613 151 LSKEFHEDEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISR------- 222 (290)
T ss_pred cceecccccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHH-------
Confidence 9875432211 111224577889999988653 467899999999999999999999864322111111110
Q ss_pred hhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 018785 255 DSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRP-----SMVDVLTS 303 (350)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~~ 303 (350)
.... .....+..+++.+.+++.+||+.||.+|| ++++++++
T Consensus 223 ------~~~~--~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 223 ------RILK--SEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred ------Hhhc--cCCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 0000 11223445678899999999999999997 77777765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=260.74 Aligned_cols=262 Identities=24% Similarity=0.331 Sum_probs=205.7
Q ss_pred cceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhcc-CCCcccceeeEEeecCceEE
Q 018785 26 DYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQL-RHENLVKLIGYCSESDNRLL 104 (350)
Q Consensus 26 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l 104 (350)
.++||+|+++.|--+ ....+|..+|||++.+...-.+....+|++++.+. .|+||++++++|++++..||
T Consensus 83 ~e~LGeGAyasVqtc---------v~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYL 153 (463)
T KOG0607|consen 83 SELLGEGAYASVQTC---------VSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYL 153 (463)
T ss_pred HHHhcCccceeeeee---------eeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEE
Confidence 358999999999998 78888999999999888655667788999999998 59999999999999999999
Q ss_pred EEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCc---EEEccccccccC
Q 018785 105 VYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFN---AKLSDFGLARDG 181 (350)
Q Consensus 105 v~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~---~~l~Dfg~~~~~ 181 (350)
|||-+.||+|...+.++. .|++.++..++..|+.||.+|| .+||.|||+||+||+...... |||+||.+....
T Consensus 154 VfEKm~GGplLshI~~~~--~F~E~EAs~vvkdia~aLdFlH--~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~ 229 (463)
T KOG0607|consen 154 VFEKMRGGPLLSHIQKRK--HFNEREASRVVKDIASALDFLH--TKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGI 229 (463)
T ss_pred EEecccCchHHHHHHHhh--hccHHHHHHHHHHHHHHHHHHh--hcCcccccCCccceeecCCCCcCceeeecccccccc
Confidence 999999999999998876 7999999999999999999999 999999999999999976544 899999987643
Q ss_pred CCCCCCc-----ccccccCCCcccCccccc-----cCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcch
Q 018785 182 PTGDNTH-----VSTRIVGTRGYAAPEYVA-----TGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADP 251 (350)
Q Consensus 182 ~~~~~~~-----~~~~~~~~~~~~aPE~~~-----~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~ 251 (350)
.....-. ......|+..|||||++. ...|+.+.|+||||+++|-||+|..||.+.-...--+.--+....
T Consensus 230 k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~ 309 (463)
T KOG0607|consen 230 KLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRV 309 (463)
T ss_pred ccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHH
Confidence 2222211 122367888899999872 246899999999999999999999999765432111111000000
Q ss_pred hhhhhHHHHHhhhcc---cCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 252 FLRDSRRVLRIMDTR---LGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 252 ~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
. .+.+...+.+. .+..-...++.+..+++..+|-.|+.+|.++..++.|
T Consensus 310 C---Q~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnh 361 (463)
T KOG0607|consen 310 C---QNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNH 361 (463)
T ss_pred H---HHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCC
Confidence 0 11111122221 1223356789999999999999999999999999874
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=263.46 Aligned_cols=277 Identities=22% Similarity=0.263 Sum_probs=203.8
Q ss_pred hhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh--hHHHHHHHHHHHhccCCCcccceeeEEe
Q 018785 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ--GHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (350)
Q Consensus 20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (350)
...|++.+.||+|.+|.||+|+-+. ....-...+|||.++.+... -.....+|+.+++.++|||++.+..+|-
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~-----~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl 97 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKN-----TNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFL 97 (438)
T ss_pred HHHhhccceecccccceeeEeeecc-----CCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHh
Confidence 4789999999999999999994322 11112447899998766321 1245678999999999999999999987
Q ss_pred e-cCceEEEEEcCCCCChhhHHhhc---CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCC----Cc
Q 018785 98 E-SDNRLLVYEFMPKGSLENHLFRK---GVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSN----FN 169 (350)
Q Consensus 98 ~-~~~~~lv~e~~~~~~L~~~l~~~---~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~----~~ 169 (350)
. +...++++||.+. +|++.+.-+ ..+.++...++.|++||+.++.||| ++=|.||||||.||++..+ |.
T Consensus 98 ~~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH--~NWvlHRDLKPaNIlvmgdgperG~ 174 (438)
T KOG0666|consen 98 SHDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLH--SNWVLHRDLKPANILVMGDGPERGR 174 (438)
T ss_pred ccCceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHh--hhheeeccCCcceEEEeccCCccCe
Confidence 7 7889999999955 999988533 2357888999999999999999999 9999999999999999887 89
Q ss_pred EEEccccccccCCCCCCCc-ccccccCCCcccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCcccccCcchh----
Q 018785 170 AKLSDFGLARDGPTGDNTH-VSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQ---- 243 (350)
Q Consensus 170 ~~l~Dfg~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~---- 243 (350)
||++|||+++.+...-... .......|..|+|||++.|. .|+.+.|+|++||++.||++-++.|.+........
T Consensus 175 VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq 254 (438)
T KOG0666|consen 175 VKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQ 254 (438)
T ss_pred eEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCch
Confidence 9999999999765543332 23335567789999999886 79999999999999999999999887644322211
Q ss_pred -----hhhhh-------cchhhhhhHHH---HHhhhcccCCCC--c------HHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 018785 244 -----TLVEW-------ADPFLRDSRRV---LRIMDTRLGGQY--S------KKEAQAVAAVVLQCLHMDPKNRPSMVDV 300 (350)
Q Consensus 244 -----~~~~~-------~~~~~~~~~~~---~~~~~~~~~~~~--~------~~~~~~l~~li~~~l~~dp~~Rps~~~l 300 (350)
.+... .+|.+...... ...+........ . ..-++...+|+.+||..||.+|.|+++.
T Consensus 255 ~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qA 334 (438)
T KOG0666|consen 255 HDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQA 334 (438)
T ss_pred HHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHH
Confidence 11111 11222111111 111111111110 0 1123458899999999999999999999
Q ss_pred HHHH
Q 018785 301 LTSL 304 (350)
Q Consensus 301 l~~L 304 (350)
+++.
T Consensus 335 leh~ 338 (438)
T KOG0666|consen 335 LEHP 338 (438)
T ss_pred hccc
Confidence 9873
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=268.32 Aligned_cols=259 Identities=26% Similarity=0.350 Sum_probs=202.1
Q ss_pred cccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch----hhHHHHHHHHHHHhcc-CCCcccceeeEE
Q 018785 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF----QGHKEWLTEVIYLGQL-RHENLVKLIGYC 96 (350)
Q Consensus 22 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~e~~~l~~l-~h~~i~~~~~~~ 96 (350)
+|++.+.||+|++|.||+++.. ....++..|++|.+..... .....+..|+.++..+ +||+|+++++.+
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~------~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ 74 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKV------GGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAF 74 (288)
T ss_pred CceEEEEeccCCCceEEEEEEe------ccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheee
Confidence 4889999999999999998543 2334678899998875432 2234577899999999 599999999999
Q ss_pred eecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcccc
Q 018785 97 SESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFG 176 (350)
Q Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg 176 (350)
..+...++||||+.+++|.+++.... .+++..+..++.|++++|.+|| +.|++|+||+|+||+++.++.++|+|||
T Consensus 75 ~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH--~~~~~H~dl~p~nil~~~~~~~~l~dfg 150 (288)
T cd05583 75 QTDTKLHLILDYVNGGELFTHLYQRE--HFTESEVRVYIAEIVLALDHLH--QLGIIYRDIKLENILLDSEGHVVLTDFG 150 (288)
T ss_pred ecCCEEEEEEecCCCCcHHHHHhhcC--CcCHHHHHHHHHHHHHHHHHHH--HCCeeccCCCHHHeEECCCCCEEEEECc
Confidence 99999999999999999999987653 6899999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCCCCcccccccCCCcccCccccccCC--CCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhh
Q 018785 177 LARDGPTGDNTHVSTRIVGTRGYAAPEYVATGH--LTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLR 254 (350)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~--~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~ 254 (350)
++......... ......++..|++||.+.+.. .+.++|+||||+++|+|++|..||...........+.
T Consensus 151 ~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~-------- 221 (288)
T cd05583 151 LSKEFLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEIS-------- 221 (288)
T ss_pred ccccccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHH--------
Confidence 98754332211 112245778899999987654 7889999999999999999999996432211111110
Q ss_pred hhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 018785 255 DSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQ 306 (350)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 306 (350)
..... .....+..++..+.+++.+||+.||++|||+.++.+.|..
T Consensus 222 -----~~~~~--~~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 222 -----RRILK--SKPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred -----HHHHc--cCCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 00111 1123344567889999999999999999998777665554
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=280.02 Aligned_cols=265 Identities=24% Similarity=0.342 Sum_probs=200.7
Q ss_pred hhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccc--hhhHHHHHHHHHHHhccCCCcccceeeEE
Q 018785 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES--FQGHKEWLTEVIYLGQLRHENLVKLIGYC 96 (350)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (350)
..++|++.+.||+|++|.||+| .+..++..|++|.+.... ......+.+|+.+++.+.|||++++.+++
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~---------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 83 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSA---------FDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVF 83 (343)
T ss_pred ccCceEEEEEeccCCceEEEEE---------EECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHh
Confidence 3678999999999999999999 555678899999886542 22335567899999999999999999988
Q ss_pred eecCc------eEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcE
Q 018785 97 SESDN------RLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNA 170 (350)
Q Consensus 97 ~~~~~------~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~ 170 (350)
...+. .++|+|++ +++|.+++... .+++..+..++.|+++||.+|| +.|++|+||+|+||+++.++.+
T Consensus 84 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~---~l~~~~~~~~~~ql~~aL~~LH--~~gi~H~dlkp~Nill~~~~~~ 157 (343)
T cd07851 84 TPASSLEDFQDVYLVTHLM-GADLNNIVKCQ---KLSDDHIQFLVYQILRGLKYIH--SAGIIHRDLKPSNIAVNEDCEL 157 (343)
T ss_pred hccccccccccEEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHeEECCCCCE
Confidence 76554 89999998 77999988653 6899999999999999999999 8999999999999999999999
Q ss_pred EEccccccccCCCCCCCcccccccCCCcccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhc
Q 018785 171 KLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWA 249 (350)
Q Consensus 171 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~ 249 (350)
+|+|||++...... .....++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||...........+....
T Consensus 158 kL~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~ 232 (343)
T cd07851 158 KILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLV 232 (343)
T ss_pred EEcccccccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Confidence 99999999754322 122346778999998765 367889999999999999999999997654432222222111
Q ss_pred chhh----hh-----hHHHHHhhhcccCCC---CcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 250 DPFL----RD-----SRRVLRIMDTRLGGQ---YSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 250 ~~~~----~~-----~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
.... .. ............... ....+++.+.+++.+||..||.+|||+.++++|
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 233 GTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred CCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 1000 00 000000000000001 112347889999999999999999999999876
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=273.34 Aligned_cols=254 Identities=26% Similarity=0.390 Sum_probs=214.9
Q ss_pred hhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhh---HHHHHHHHHHHhccCCCcccce
Q 018785 16 SKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQG---HKEWLTEVIYLGQLRHENLVKL 92 (350)
Q Consensus 16 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~ 92 (350)
..+..+.|+.-++||+|+||.||.+ ....+|+-+|.|.+.+..... ....+.|-.+|.+++.+.|+.+
T Consensus 180 qpvt~n~F~~~RvlGkGGFGEV~ac---------qvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVsl 250 (591)
T KOG0986|consen 180 QPVTKNTFRVYRVLGKGGFGEVCAC---------QVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSL 250 (591)
T ss_pred hhccccceeeeEEEecccccceeEE---------EEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEE
Confidence 4556778999999999999999999 667789999999886654332 2346788999999999999999
Q ss_pred eeEEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEE
Q 018785 93 IGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKL 172 (350)
Q Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l 172 (350)
--.|++.+.+++|+..+.||+|.-.+...+...|+++.+..++.+|+-+|++|| +.+|++||+||+|||+|+.|+++|
T Consensus 251 aYAfeTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH--~~~iVYRDLKPeNILLDd~GhvRI 328 (591)
T KOG0986|consen 251 AYAFETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLH--RRRIVYRDLKPENILLDDHGHVRI 328 (591)
T ss_pred eeeecCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHH--hcceeeccCChhheeeccCCCeEe
Confidence 989999999999999999999999998887788999999999999999999999 999999999999999999999999
Q ss_pred ccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchh
Q 018785 173 SDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPF 252 (350)
Q Consensus 173 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 252 (350)
+|+|++........ .....||.+|||||++.+..|+...|.|+|||++|+|+.|+.||.........+.+..
T Consensus 329 SDLGLAvei~~g~~---~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdr----- 400 (591)
T KOG0986|consen 329 SDLGLAVEIPEGKP---IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDR----- 400 (591)
T ss_pred eccceEEecCCCCc---cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHH-----
Confidence 99999986544433 3335799999999999999999999999999999999999999976554333322221
Q ss_pred hhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHH
Q 018785 253 LRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMV 298 (350)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ 298 (350)
. ......+++...++++.+|++.+|..||.+|.-..
T Consensus 401 ---------r-~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 401 ---------R-TLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred ---------H-HhcchhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence 1 11123456778899999999999999999997554
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=276.49 Aligned_cols=271 Identities=23% Similarity=0.340 Sum_probs=202.6
Q ss_pred hhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch--hhHHHHHHHHHHHhccCCCcccceeeEE
Q 018785 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLRHENLVKLIGYC 96 (350)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (350)
.+++|++.+.||+|++|.||+| .+..++..||+|.+..... .....+..|+.+++.++||||+++++++
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~---------~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 83 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSA---------LDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVF 83 (343)
T ss_pred cccceEEEEEeeecCCeEEEEE---------EECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeee
Confidence 4678999999999999999999 5666789999998864322 2234577899999999999999999998
Q ss_pred eecC------ceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcE
Q 018785 97 SESD------NRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNA 170 (350)
Q Consensus 97 ~~~~------~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~ 170 (350)
..+. ..++||+++ +++|.+++... .+++..+..++.|++.||.||| +.|++|+||+|+||+++.++.+
T Consensus 84 ~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~---~l~~~~~~~i~~qi~~al~~LH--~~gi~H~dlkp~Nill~~~~~~ 157 (343)
T cd07880 84 TPDLSLDRFHDFYLVMPFM-GTDLGKLMKHE---KLSEDRIQFLVYQMLKGLKYIH--AAGIIHRDLKPGNLAVNEDCEL 157 (343)
T ss_pred cCCccccccceEEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEEcCCCCE
Confidence 7654 348999998 77998887643 6899999999999999999999 9999999999999999999999
Q ss_pred EEccccccccCCCCCCCcccccccCCCcccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhc
Q 018785 171 KLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWA 249 (350)
Q Consensus 171 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~ 249 (350)
+|+|||.+...... .....+++.|++||.+.+ ..++.++|+||||+++|+|++|..||...........+....
T Consensus 158 kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~ 232 (343)
T cd07880 158 KILDFGLARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVT 232 (343)
T ss_pred EEeecccccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 99999998753221 122346778999998866 457889999999999999999999997654322222222111
Q ss_pred chhhhh---------hHHHHHhhhcccCC---CCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHhhhc
Q 018785 250 DPFLRD---------SRRVLRIMDTRLGG---QYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS--LEQLHT 309 (350)
Q Consensus 250 ~~~~~~---------~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~--L~~~~~ 309 (350)
...... .............. .....+++.+.++|.+||+.||.+|||+.+++.+ +.....
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~ 306 (343)
T cd07880 233 GTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHD 306 (343)
T ss_pred CCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcC
Confidence 110000 00000000000000 1123456789999999999999999999999965 444433
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=307.03 Aligned_cols=253 Identities=26% Similarity=0.348 Sum_probs=211.7
Q ss_pred hcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh--hHHHHHHHHHHHhccCCCcccceeeEEee
Q 018785 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ--GHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (350)
Q Consensus 21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (350)
-++.-...||.|.||.||-| .+..+|+-.|+|-+...... ....+.+|+.++..++|||+++++++-..
T Consensus 1235 ~rWqrg~~Ig~G~fG~VYta---------vN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvH 1305 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTA---------VNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVH 1305 (1509)
T ss_pred eeeccccccCCcceeeeEEe---------ecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeec
Confidence 47888889999999999999 78888999999977655433 23457889999999999999999999999
Q ss_pred cCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcccccc
Q 018785 99 SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 178 (350)
Q Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~ 178 (350)
.+..+|.||||++|+|.+.+.... ..++.....+..|+++|++||| +.||+||||||.||+++.+|.+|++|||.+
T Consensus 1306 Rekv~IFMEyC~~GsLa~ll~~gr--i~dE~vt~vyt~qll~gla~LH--~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa 1381 (1509)
T KOG4645|consen 1306 REKVYIFMEYCEGGSLASLLEHGR--IEDEMVTRVYTKQLLEGLAYLH--EHGIVHRDIKPANILLDFNGLIKYGDFGSA 1381 (1509)
T ss_pred HHHHHHHHHHhccCcHHHHHHhcc--hhhhhHHHHHHHHHHHHHHHHH--hcCceecCCCccceeeecCCcEEeecccce
Confidence 999999999999999999887654 5677777788899999999999 999999999999999999999999999999
Q ss_pred ccCCCCCCCc--ccccccCCCcccCccccccC---CCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhh
Q 018785 179 RDGPTGDNTH--VSTRIVGTRGYAAPEYVATG---HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 253 (350)
Q Consensus 179 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~---~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 253 (350)
.......... ......||+.|+|||++.+. .-..++|||||||++.||+||+.||...++.-..+..+....
T Consensus 1382 ~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh--- 1458 (1509)
T KOG4645|consen 1382 VKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGH--- 1458 (1509)
T ss_pred eEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccC---
Confidence 8755442111 12346899999999999765 345789999999999999999999988776555444443222
Q ss_pred hhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 254 RDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
...+|..++.+-+++|.+||..||++|+++.+++++
T Consensus 1459 --------------~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1459 --------------KPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred --------------CCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 223456689999999999999999999999988875
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=255.20 Aligned_cols=252 Identities=25% Similarity=0.366 Sum_probs=197.7
Q ss_pred hcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh-hHHHHHHHHHHHhcc-CCCcccceeeEEee
Q 018785 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ-GHKEWLTEVIYLGQL-RHENLVKLIGYCSE 98 (350)
Q Consensus 21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~ 98 (350)
++.++...||.|..|.||++ ....+|...|||.+...... .-+.+...+.++..- .+|+|++++++|..
T Consensus 92 ndl~~l~dlGsGtcG~V~k~---------~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~ 162 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKM---------RFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFIT 162 (391)
T ss_pred HHhhhHHhhcCCCccceEEE---------EEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEee
Confidence 45567789999999999999 66677999999998776533 334455566655444 59999999999999
Q ss_pred cCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcccccc
Q 018785 99 SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 178 (350)
Q Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~ 178 (350)
+...++.||.+ ..-+..++ .....++++.-+-++...++.||.||.. ..||+|||+||.|||+|..|++||+|||++
T Consensus 163 n~dV~IcMelM-s~C~ekLl-krik~piPE~ilGk~tva~v~AL~YLKe-KH~viHRDvKPSNILlDe~GniKlCDFGIs 239 (391)
T KOG0983|consen 163 NTDVFICMELM-STCAEKLL-KRIKGPIPERILGKMTVAIVKALYYLKE-KHGVIHRDVKPSNILLDERGNIKLCDFGIS 239 (391)
T ss_pred CchHHHHHHHH-HHHHHHHH-HHhcCCchHHhhhhhHHHHHHHHHHHHH-hcceeecccCccceEEccCCCEEeeccccc
Confidence 99999999987 43444444 4444579999899999999999999986 789999999999999999999999999999
Q ss_pred ccCCCCCCCcccccccCCCcccCcccccc---CCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhh
Q 018785 179 RDGPTGDNTHVSTRIVGTRGYAAPEYVAT---GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRD 255 (350)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~---~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 255 (350)
.+.-..... ++..|.+.|+|||.+.- ..|+.++||||||++++||.||+.||.+... +
T Consensus 240 GrlvdSkAh---trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~t----------------d 300 (391)
T KOG0983|consen 240 GRLVDSKAH---TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKT----------------D 300 (391)
T ss_pred ceeeccccc---ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCc----------------c
Confidence 765443333 33458889999998853 4789999999999999999999999987542 1
Q ss_pred hHHHHHhhhcccCC-CCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 256 SRRVLRIMDTRLGG-QYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 256 ~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
.+.+.++++...+. ......++.+++++..||+.|+.+||...++++|
T Consensus 301 Fe~ltkvln~ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 301 FEVLTKVLNEEPPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred HHHHHHHHhcCCCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 22222333322111 1223478999999999999999999999999976
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=273.11 Aligned_cols=274 Identities=24% Similarity=0.305 Sum_probs=197.6
Q ss_pred cccccceecccCceeEEeecccCCCcCCCCCCC--CcEEEEEEccccchh--hHHHHHHHHHHHhcc-CCCcccceeeEE
Q 018785 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGS--GIVVAIKRLKAESFQ--GHKEWLTEVIYLGQL-RHENLVKLIGYC 96 (350)
Q Consensus 22 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~--~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l-~h~~i~~~~~~~ 96 (350)
+|++.+.||+|+||.||+++ +... +..||+|.+...... ....+..|+..++++ +||||+++++..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~---------~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 71 (332)
T cd07857 1 RYELIKELGQGAYGIVCSAR---------NAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMD 71 (332)
T ss_pred CceEEEEccccCCeEEEEEE---------eCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeee
Confidence 58899999999999999994 3344 788999988653222 235577899999999 599999999875
Q ss_pred ee----cCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEE
Q 018785 97 SE----SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKL 172 (350)
Q Consensus 97 ~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l 172 (350)
.. ....+++++++ +++|.+++.... .+++..+..++.|++.||.||| +.|++|+||+|+||+++.++.++|
T Consensus 72 ~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH--~~givH~dlkp~Nili~~~~~~kl 146 (332)
T cd07857 72 IVFPGNFNELYLYEELM-EADLHQIIRSGQ--PLTDAHFQSFIYQILCGLKYIH--SANVLHRDLKPGNLLVNADCELKI 146 (332)
T ss_pred eeccccCCcEEEEEecc-cCCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHHeEEcCCCCEEe
Confidence 33 24578899988 568999886554 6899999999999999999999 999999999999999999999999
Q ss_pred ccccccccCCCCCCC--cccccccCCCcccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhc
Q 018785 173 SDFGLARDGPTGDNT--HVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWA 249 (350)
Q Consensus 173 ~Dfg~~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~ 249 (350)
+|||.+......... .......++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||...........+....
T Consensus 147 ~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 226 (332)
T cd07857 147 CDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVL 226 (332)
T ss_pred CcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHh
Confidence 999999754322211 11223467888999998765 468899999999999999999999997654322222111111
Q ss_pred c-hhhhhh-----HH---HHHhhhcccCC---CCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHhhhc
Q 018785 250 D-PFLRDS-----RR---VLRIMDTRLGG---QYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS--LEQLHT 309 (350)
Q Consensus 250 ~-~~~~~~-----~~---~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~--L~~~~~ 309 (350)
. +..... .. ........... .....++..+.+++.+||+.||.+|||+.+++++ |.+.+.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~ 300 (332)
T cd07857 227 GTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHD 300 (332)
T ss_pred CCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcC
Confidence 0 000000 00 00000000000 0112246789999999999999999999999866 444433
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=274.71 Aligned_cols=265 Identities=24% Similarity=0.347 Sum_probs=198.8
Q ss_pred hhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch--hhHHHHHHHHHHHhccCCCcccceeeEE
Q 018785 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLRHENLVKLIGYC 96 (350)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (350)
..++|.+.+.||+|+||.||+| .+..++..||+|.+..... .....+.+|+.++++++||||+++++++
T Consensus 15 ~~~~y~~~~~lg~G~~g~v~~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~ 85 (345)
T cd07877 15 VPERYQNLSPVGSGAYGSVCAA---------FDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVF 85 (345)
T ss_pred ccCceEEEEEeeecCCeEEEEE---------EEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeee
Confidence 4589999999999999999999 5556789999998875432 2345677899999999999999999988
Q ss_pred eec------CceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcE
Q 018785 97 SES------DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNA 170 (350)
Q Consensus 97 ~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~ 170 (350)
... ...+++++++ +++|.+++... .+++..+..++.|++.||.||| +.|++|+||+|+||+++.++.+
T Consensus 86 ~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH--~~~ivH~dlkp~NIll~~~~~~ 159 (345)
T cd07877 86 TPARSLEEFNDVYLVTHLM-GADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIH--SADIIHRDLKPSNLAVNEDCEL 159 (345)
T ss_pred eecccccccccEEEEehhc-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH--HCCeeecCCChHHEEEcCCCCE
Confidence 643 3467888877 88998877643 5899999999999999999999 9999999999999999999999
Q ss_pred EEccccccccCCCCCCCcccccccCCCcccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhc
Q 018785 171 KLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWA 249 (350)
Q Consensus 171 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~ 249 (350)
+|+|||++...... .....++..|+|||.+.+ ..++.++|+||+||++|+|++|+.||...........+....
T Consensus 160 kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 234 (345)
T cd07877 160 KILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 234 (345)
T ss_pred EEeccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 99999998753221 122456788999998866 468889999999999999999999997544322222221111
Q ss_pred c---hhhh----h--hHHHHHhhhcccCC---CCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 250 D---PFLR----D--SRRVLRIMDTRLGG---QYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 250 ~---~~~~----~--~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
. +... . .............. ......++++.++|.+||+.||.+||++.+++.|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 235 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred CCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 0 0000 0 00000100100000 0011246789999999999999999999999977
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=272.71 Aligned_cols=276 Identities=28% Similarity=0.373 Sum_probs=205.1
Q ss_pred hhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch--hhHHHHHHHHHHHhccCCCcccceeeEE
Q 018785 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLRHENLVKLIGYC 96 (350)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (350)
.+++|++.+.||.|++|.||+| .+..++..|++|.+..... .....+..|+.+++.++||||+++.+++
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 78 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSA---------RDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIF 78 (328)
T ss_pred cccceEEEEeecccCCeEEEEE---------EECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeE
Confidence 5788999999999999999999 6666789999998764322 2345677899999999999999999998
Q ss_pred ee-cCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccc
Q 018785 97 SE-SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDF 175 (350)
Q Consensus 97 ~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Df 175 (350)
.. .+..++++|++ +++|.+++... .++...+..++.|+++||.||| +.|++|+||+|.||+++.++.++|+||
T Consensus 79 ~~~~~~~~lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~~ql~~aL~~LH--~~~iiH~dl~p~Nili~~~~~~~l~df 152 (328)
T cd07856 79 ISPLEDIYFVTELL-GTDLHRLLTSR---PLEKQFIQYFLYQILRGLKYVH--SAGVVHRDLKPSNILINENCDLKICDF 152 (328)
T ss_pred ecCCCcEEEEeehh-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHHEeECCCCCEEeCcc
Confidence 65 56789999998 67898887643 5788889999999999999999 999999999999999999999999999
Q ss_pred cccccCCCCCCCcccccccCCCcccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhh
Q 018785 176 GLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLR 254 (350)
Q Consensus 176 g~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~ 254 (350)
|.+....... ....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...........+.........
T Consensus 153 g~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~ 227 (328)
T cd07856 153 GLARIQDPQM-----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPD 227 (328)
T ss_pred ccccccCCCc-----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 9987432211 12346778999998765 57899999999999999999999999765432221111111000000
Q ss_pred h------hHHHHHhhhcc-cCCCC-----cHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHhhhcCCCCC
Q 018785 255 D------SRRVLRIMDTR-LGGQY-----SKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS--LEQLHTSKDMP 314 (350)
Q Consensus 255 ~------~~~~~~~~~~~-~~~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~--L~~~~~~~~~~ 314 (350)
+ ........... ..... ...+++.+.++|.+||+.+|++||++++++.+ +.........|
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~~~~~ 301 (328)
T cd07856 228 DVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPTDEP 301 (328)
T ss_pred HHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCCcccc
Confidence 0 00001111110 00111 12356889999999999999999999999977 55444443333
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=261.64 Aligned_cols=241 Identities=29% Similarity=0.421 Sum_probs=197.2
Q ss_pred ecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh---hHHHHHHHHHHHhccCCCcccceeeEEeecCceEEE
Q 018785 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ---GHKEWLTEVIYLGQLRHENLVKLIGYCSESDNRLLV 105 (350)
Q Consensus 29 lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 105 (350)
||.|++|.||++ .+..+++.+++|.+...... ....+..|+.+++.++|||++++++.+..++..++|
T Consensus 1 lg~G~~~~v~~~---------~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 71 (250)
T cd05123 1 LGKGSFGKVLLV---------RKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLV 71 (250)
T ss_pred CCCCCceEEEEE---------EECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEE
Confidence 689999999999 55556889999998765432 345678899999999999999999999999999999
Q ss_pred EEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccccccCCCCC
Q 018785 106 YEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGD 185 (350)
Q Consensus 106 ~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~~~~~~~ 185 (350)
||++.+++|.+++.... .+++..+..++.|+++||.++| +.+++|+||+|+||+++.++.++|+|||.+.......
T Consensus 72 ~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lh--~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~ 147 (250)
T cd05123 72 LEYAPGGELFSHLSKEG--RFSEERARFYAAEIVLALEYLH--SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG 147 (250)
T ss_pred EecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--HCCceecCCCcceEEEcCCCcEEEeecCcceecccCC
Confidence 99999999999997764 6899999999999999999999 9999999999999999999999999999987643322
Q ss_pred CCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhHHHHHhhhc
Q 018785 186 NTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDT 265 (350)
Q Consensus 186 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (350)
.......++..|++||.+.+..++.++|+||||+++|++++|..||.......... ....
T Consensus 148 --~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~-----------------~~~~- 207 (250)
T cd05123 148 --SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYE-----------------KILK- 207 (250)
T ss_pred --CcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHH-----------------HHhc-
Confidence 11223456778999999988888999999999999999999999996543211110 1111
Q ss_pred ccCCCCcHHHHHHHHHHHHHhhccCCCCCCCH---HHHHHH
Q 018785 266 RLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSM---VDVLTS 303 (350)
Q Consensus 266 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~---~~ll~~ 303 (350)
.....+...+..+.+++.+||..||++||++ +++++|
T Consensus 208 -~~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~ 247 (250)
T cd05123 208 -DPLRFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAH 247 (250)
T ss_pred -CCCCCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhC
Confidence 1123444557889999999999999999999 666543
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=266.75 Aligned_cols=256 Identities=25% Similarity=0.368 Sum_probs=196.6
Q ss_pred hhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh-hHHHHHHHHHHHhcc-CCCcccceee
Q 018785 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ-GHKEWLTEVIYLGQL-RHENLVKLIG 94 (350)
Q Consensus 17 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l-~h~~i~~~~~ 94 (350)
....++|++.+.||+|++|.||+| .+..++..|+||.+...... ....+..|+..+... .||||+++++
T Consensus 11 ~~~~~~~~~~~~lg~g~~~~v~~~---------~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~ 81 (296)
T cd06618 11 PADLNDLENLGEIGSGTCGQVYKM---------RFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYG 81 (296)
T ss_pred cCCcchheeeeEeeccCCeEEEEE---------EECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhhe
Confidence 445688999999999999999999 55556889999998754322 234455566666565 5999999999
Q ss_pred EEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCC-CCeeeCCCCCCceEEcCCCcEEEc
Q 018785 95 YCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLD-ANVIYRDLKASNVLLDSNFNAKLS 173 (350)
Q Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~-~~i~H~di~~~Nili~~~~~~~l~ 173 (350)
++..+...+++||++ ++++.+++.... ..+++..+..++.|++.|++||| + .|++|+||+|+||+++.++.++|+
T Consensus 82 ~~~~~~~~~~v~e~~-~~~l~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH--~~~~i~H~dl~p~nill~~~~~~kL~ 157 (296)
T cd06618 82 YFITDSDVFICMELM-STCLDKLLKRIQ-GPIPEDILGKMTVAIVKALHYLK--EKHGVIHRDVKPSNILLDASGNVKLC 157 (296)
T ss_pred eeecCCeEEEEeecc-CcCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH--hhCCEecCCCcHHHEEEcCCCCEEEC
Confidence 999999999999998 557887776543 37899999999999999999999 6 599999999999999999999999
Q ss_pred cccccccCCCCCCCcccccccCCCcccCccccccCC----CCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhc
Q 018785 174 DFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGH----LTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWA 249 (350)
Q Consensus 174 Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~----~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~ 249 (350)
|||.+........ .....++..|+|||.+.+.. ++.++|+||||+++|+|++|+.||...... .+.
T Consensus 158 dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~----- 227 (296)
T cd06618 158 DFGISGRLVDSKA---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE--FEV----- 227 (296)
T ss_pred ccccchhccCCCc---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH--HHH-----
Confidence 9999865422211 12234677899999986553 788999999999999999999999643211 000
Q ss_pred chhhhhhHHHHHhhhcc-cCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018785 250 DPFLRDSRRVLRIMDTR-LGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL 304 (350)
Q Consensus 250 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 304 (350)
........ ........++.++.+|+.+||..||.+||++++++++-
T Consensus 228 ---------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~ 274 (296)
T cd06618 228 ---------LTKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHP 274 (296)
T ss_pred ---------HHHHhcCCCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence 00111111 01111124677899999999999999999999999774
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=273.79 Aligned_cols=270 Identities=23% Similarity=0.364 Sum_probs=199.5
Q ss_pred hhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch--hhHHHHHHHHHHHhccCCCcccceeeEEe
Q 018785 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (350)
Q Consensus 20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (350)
..+|.+.+.||+|++|.||+| .+..+|+.||+|.+..... .....+.+|+.+++.+.||||+++++++.
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~ 84 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSA---------IDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFT 84 (342)
T ss_pred ccceEEEEEeeecCCeEEEEE---------EeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheec
Confidence 468999999999999999999 5556789999998865322 22345778999999999999999999987
Q ss_pred ecC------ceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEE
Q 018785 98 ESD------NRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAK 171 (350)
Q Consensus 98 ~~~------~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~ 171 (350)
... ..++|++++. .+|.++.. ..++...+..++.|++.||+||| +.|++|+||+|+||+++.++.++
T Consensus 85 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH--~~~i~H~dlkp~NIll~~~~~~k 157 (342)
T cd07879 85 SAVSGDEFQDFYLVMPYMQ-TDLQKIMG----HPLSEDKVQYLVYQMLCGLKYIH--SAGIIHRDLKPGNLAVNEDCELK 157 (342)
T ss_pred ccccCCCCceEEEEecccc-cCHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEECCCCCEE
Confidence 543 4589999984 47766542 25899999999999999999999 89999999999999999999999
Q ss_pred EccccccccCCCCCCCcccccccCCCcccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcc
Q 018785 172 LSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD 250 (350)
Q Consensus 172 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~ 250 (350)
|+|||++...... .....++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||.+.........+.....
T Consensus 158 L~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~ 232 (342)
T cd07879 158 ILDFGLARHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTG 232 (342)
T ss_pred EeeCCCCcCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 9999998753221 112346778999998866 4688999999999999999999999976543222111111100
Q ss_pred ---hhhhhh------HHHHHhhhcccCCCC---cHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHhhhcC
Q 018785 251 ---PFLRDS------RRVLRIMDTRLGGQY---SKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS--LEQLHTS 310 (350)
Q Consensus 251 ---~~~~~~------~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~--L~~~~~~ 310 (350)
+.+.+. ............... ....+..+.+|+.+||+.||.+||++.+++.| ++.+...
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~ 306 (342)
T cd07879 233 VPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDA 306 (342)
T ss_pred CCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccc
Confidence 000000 000000000000000 12356788999999999999999999999977 7777654
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=271.69 Aligned_cols=246 Identities=25% Similarity=0.348 Sum_probs=206.7
Q ss_pred cceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh--hHHHHHHHHHHHhccCCCcccceeeEEeecCceE
Q 018785 26 DYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ--GHKEWLTEVIYLGQLRHENLVKLIGYCSESDNRL 103 (350)
Q Consensus 26 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 103 (350)
.+.||+|.||+||-| .+..+|+.||||++.+..+. +...++.|+.+|.++.||+|+.+...|++.+..|
T Consensus 569 devLGSGQFG~VYgg---------~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervF 639 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGG---------KHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVF 639 (888)
T ss_pred HhhccCCcceeeecc---------eecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEE
Confidence 569999999999999 89999999999999876553 3467999999999999999999999999999999
Q ss_pred EEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCC---CcEEEcccccccc
Q 018785 104 LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSN---FNAKLSDFGLARD 180 (350)
Q Consensus 104 lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~---~~~~l~Dfg~~~~ 180 (350)
+|||-+ .|++.+.+.+.....+++.....++.||+.||.||| -++|+|+||||+||++... -.+||+|||+++.
T Consensus 640 VVMEKl-~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH--~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARi 716 (888)
T KOG4236|consen 640 VVMEKL-HGDMLEMILSSEKGRLPERITKFLVTQILVALRYLH--FKNIVHCDLKPENVLLASASPFPQVKLCDFGFARI 716 (888)
T ss_pred EEehhh-cchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhh--hcceeeccCCchheeeccCCCCCceeeccccceee
Confidence 999999 557778777666668999999999999999999999 9999999999999999765 3499999999986
Q ss_pred CCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhHHHH
Q 018785 181 GPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVL 260 (350)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (350)
..+. .......|||.|+|||++.++.|...-|+||+|+++|.-++|..||....+ ..+++
T Consensus 717 IgEk---sFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd--IndQI--------------- 776 (888)
T KOG4236|consen 717 IGEK---SFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED--INDQI--------------- 776 (888)
T ss_pred cchh---hhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc--hhHHh---------------
Confidence 3332 223346799999999999999999999999999999999999999975331 11111
Q ss_pred HhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 261 RIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
+...--++.....+++....+||..+|++.-.+|.|.+..++|
T Consensus 777 QNAaFMyPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh 819 (888)
T KOG4236|consen 777 QNAAFMYPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSH 819 (888)
T ss_pred hccccccCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccc
Confidence 1111112234456889999999999999999999999988776
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=290.68 Aligned_cols=249 Identities=31% Similarity=0.438 Sum_probs=190.6
Q ss_pred hhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccc-hhhHHHHHHHHHHHhccCCCcccceeeEEee
Q 018785 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES-FQGHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (350)
Q Consensus 20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (350)
..+|+..++||+|+||.||++ .++-+|..||||.+.... ......+.+|+..|.+|+||||++++..+.+
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkV---------RNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVE 548 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKV---------RNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVE 548 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEE---------eecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhc
Confidence 368899999999999999999 666779999999997764 2334668899999999999999999876510
Q ss_pred --------------------------------------------------------------------------------
Q 018785 99 -------------------------------------------------------------------------------- 98 (350)
Q Consensus 99 -------------------------------------------------------------------------------- 98 (350)
T Consensus 549 s~~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~ 628 (1351)
T KOG1035|consen 549 STAELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGR 628 (1351)
T ss_pred cCCccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccc
Confidence
Q ss_pred -------------------------------c--------CceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHH
Q 018785 99 -------------------------------S--------DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVA 139 (350)
Q Consensus 99 -------------------------------~--------~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~ 139 (350)
+ -.+||-||||+..++.+++..+.... .....++++++|+
T Consensus 629 ~~S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~-~~d~~wrLFreIl 707 (1351)
T KOG1035|consen 629 NLSNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS-QRDEAWRLFREIL 707 (1351)
T ss_pred ccccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch-hhHHHHHHHHHHH
Confidence 0 12578899998877777776664111 4678999999999
Q ss_pred HHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccccccCCC----------------CCCCcccccccCCCcccCcc
Q 018785 140 RGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPT----------------GDNTHVSTRIVGTRGYAAPE 203 (350)
Q Consensus 140 ~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~~~~~----------------~~~~~~~~~~~~~~~~~aPE 203 (350)
+||+|+| ++|++||||||.|||++.++.|||+|||++..... .......+...||..|+|||
T Consensus 708 EGLaYIH--~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPE 785 (1351)
T KOG1035|consen 708 EGLAYIH--DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPE 785 (1351)
T ss_pred HHHHHHH--hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHH
Confidence 9999999 99999999999999999999999999999985110 01111335578999999999
Q ss_pred ccccC---CCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhHHHHHhhhcccCCCCc------HH
Q 018785 204 YVATG---HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYS------KK 274 (350)
Q Consensus 204 ~~~~~---~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~ 274 (350)
++.+. .|+.|+|+||||++|+||+. ||... ......+.......+| ..
T Consensus 786 ll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~Ts--------------------MERa~iL~~LR~g~iP~~~~f~~~ 842 (1351)
T KOG1035|consen 786 LLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTS--------------------MERASILTNLRKGSIPEPADFFDP 842 (1351)
T ss_pred HhcccccccccchhhhHHHHHHHHHHhc---cCCch--------------------HHHHHHHHhcccCCCCCCcccccc
Confidence 98665 49999999999999999997 34321 1111111111122221 22
Q ss_pred HHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 275 EAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 275 ~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
.-+.-..+|++|++.||.+|||+.++|++
T Consensus 843 ~~~~e~slI~~Ll~hdP~kRPtA~eLL~s 871 (1351)
T KOG1035|consen 843 EHPEEASLIRWLLSHDPSKRPTATELLNS 871 (1351)
T ss_pred cchHHHHHHHHHhcCCCccCCCHHHHhhc
Confidence 33456789999999999999999999864
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=275.01 Aligned_cols=245 Identities=24% Similarity=0.284 Sum_probs=202.2
Q ss_pred hhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhcc-CCCcccceeeEEe
Q 018785 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQL-RHENLVKLIGYCS 97 (350)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~ 97 (350)
....|.+...+|.|+|+.|-.+ .+..+++..++|++...... ..+|...+... +||||+++.+++.
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~---------~~~~t~~~~~vkii~~~~~~----~~~e~~~~~~~~~h~niv~~~~v~~ 386 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYC---------ESSPTDQEPAVKIISKRADD----NQDEIPISLLVRDHPNIVKSHDVYE 386 (612)
T ss_pred cchhhccccccCCCCccceeee---------eccccccchhheeccccccc----cccccchhhhhcCCCcceeecceec
Confidence 4678999999999999999998 78888999999999776222 12355444444 7999999999999
Q ss_pred ecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEE-cCCCcEEEcccc
Q 018785 98 ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLL-DSNFNAKLSDFG 176 (350)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili-~~~~~~~l~Dfg 176 (350)
++.+.|+|||.+.|+-+.+.+...+ ....++..|+.+|+.|+.||| .+|++||||||+|||+ +..++++|+|||
T Consensus 387 ~~~~~~~v~e~l~g~ell~ri~~~~---~~~~e~~~w~~~lv~Av~~LH--~~gvvhRDLkp~NIL~~~~~g~lrltyFG 461 (612)
T KOG0603|consen 387 DGKEIYLVMELLDGGELLRRIRSKP---EFCSEASQWAAELVSAVDYLH--EQGVVHRDLKPGNILLDGSAGHLRLTYFG 461 (612)
T ss_pred CCceeeeeehhccccHHHHHHHhcc---hhHHHHHHHHHHHHHHHHHHH--hcCeeecCCChhheeecCCCCcEEEEEec
Confidence 9999999999999999988887764 333788899999999999999 9999999999999999 588999999999
Q ss_pred ccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhh
Q 018785 177 LARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDS 256 (350)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 256 (350)
.+...... ....+.|..|.|||++....|++++|+||||++||+||+|+.||.....+
T Consensus 462 ~a~~~~~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~----------------- 519 (612)
T KOG0603|consen 462 FWSELERS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG----------------- 519 (612)
T ss_pred hhhhCchh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-----------------
Confidence 99864443 22235677899999999999999999999999999999999999865543
Q ss_pred HHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 018785 257 RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQ 306 (350)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 306 (350)
..+............+|+.+++|+.+||++||.+|+++.+++.|=..
T Consensus 520 ---~ei~~~i~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 520 ---IEIHTRIQMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred ---HHHHHhhcCCccccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 11111222223346789999999999999999999999999988555
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=276.09 Aligned_cols=282 Identities=25% Similarity=0.345 Sum_probs=211.2
Q ss_pred hhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch-hhHHHHHHHHHHHhccCCCcccceeeEEe
Q 018785 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (350)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (350)
.+..|...+.||+|+||.||+| .+..+|+.||||.++.... ...+....|++++++++||||+++.++-+
T Consensus 11 ~~y~W~~~e~LG~Ga~g~V~rg---------rnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee 81 (732)
T KOG4250|consen 11 ENYLWEMDERLGKGAFGNVYRG---------RNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEE 81 (732)
T ss_pred CCcceeehhhhcCCccceeeee---------cccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCC
Confidence 3467888999999999999999 7888999999999987543 34466788999999999999999999866
Q ss_pred ecC------ceEEEEEcCCCCChhhHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCC--C
Q 018785 98 ESD------NRLLVYEFMPKGSLENHLFRKG-VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSN--F 168 (350)
Q Consensus 98 ~~~------~~~lv~e~~~~~~L~~~l~~~~-~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~--~ 168 (350)
+.. ...++||||.||+|...+.+.. ...+++.+++.++..+..|+.||| .+||+||||||.||++... |
T Consensus 82 ~~~~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~Lr--En~IvHRDlKP~NIvl~~Gedg 159 (732)
T KOG4250|consen 82 TKFLGLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLR--ENGIVHRDLKPGNIVLQIGEDG 159 (732)
T ss_pred ccccCcccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHH--HcCceeccCCCCcEEEeecCCC
Confidence 543 5679999999999999997542 347999999999999999999999 9999999999999998433 3
Q ss_pred c--EEEccccccccCCCCCCCcccccccCCCcccCccccc-cCCCCCccchhhHHHHHHHHHhCCCCCcccccCcc----
Q 018785 169 N--AKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVA-TGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLA---- 241 (350)
Q Consensus 169 ~--~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~---- 241 (350)
. .||+|||.|+..... .......||+.|++||++. .+.|+...|.||+||++|++.||..||..-.....
T Consensus 160 q~IyKLtDfG~Arel~d~---s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~ 236 (732)
T KOG4250|consen 160 QSIYKLTDFGAARELDDN---SLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEI 236 (732)
T ss_pred ceEEeeecccccccCCCC---CeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchh
Confidence 3 799999999864333 3556688999999999998 48899999999999999999999999964333211
Q ss_pred -hhhhhhhcchhh-----hhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCC--CHHHHHHHHHhhhcCCCC
Q 018785 242 -EQTLVEWADPFL-----RDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRP--SMVDVLTSLEQLHTSKDM 313 (350)
Q Consensus 242 -~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp--s~~~ll~~L~~~~~~~~~ 313 (350)
...+.+.+.... ........-..-+....+.......+...+..+|..+|.+|. ...+....+..+-...-+
T Consensus 237 ~~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~~vv 316 (732)
T KOG4250|consen 237 MWHIITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNLKVV 316 (732)
T ss_pred hhhhhccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhhhee
Confidence 111111111000 000000000001111223344445667788899999999998 777777777666655443
Q ss_pred C
Q 018785 314 P 314 (350)
Q Consensus 314 ~ 314 (350)
.
T Consensus 317 h 317 (732)
T KOG4250|consen 317 H 317 (732)
T ss_pred E
Confidence 3
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=290.59 Aligned_cols=254 Identities=24% Similarity=0.272 Sum_probs=210.7
Q ss_pred hhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch---hhHHHHHHHHHHHhccCCCcccceee
Q 018785 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLVKLIG 94 (350)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~ 94 (350)
...++|.|.++||+|+||.|.++ .++.+++.||.|++++... ....-|.+|-.+|-.-+.+=|+.++-
T Consensus 72 l~~~DfeilKvIGrGaFGEV~lV---------r~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~Lhy 142 (1317)
T KOG0612|consen 72 LKAEDFEILKVIGRGAFGEVALV---------RHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHY 142 (1317)
T ss_pred CCHHhhHHHHHhcccccceeEEE---------EeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHH
Confidence 44679999999999999999999 7888899999999987432 23345777888888778999999999
Q ss_pred EEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcc
Q 018785 95 YCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSD 174 (350)
Q Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~D 174 (350)
.|.++.++|+||||+.||+|..++.+.. .+++..++.++..|+.||.-+| +.|++||||||+|||+|..|.++|+|
T Consensus 143 AFQD~~~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH--~mgyVHRDiKPDNvLld~~GHikLAD 218 (1317)
T KOG0612|consen 143 AFQDERYLYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLH--SMGYVHRDIKPDNVLLDKSGHIKLAD 218 (1317)
T ss_pred HhcCccceEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHH--hccceeccCCcceeEecccCcEeecc
Confidence 9999999999999999999999998886 7999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCCCCCcccccccCCCcccCccccc----c-CCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhc
Q 018785 175 FGLARDGPTGDNTHVSTRIVGTRGYAAPEYVA----T-GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWA 249 (350)
Q Consensus 175 fg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~----~-~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~ 249 (350)
||.+-.+...+ ........|||.|.+||++. + +.|+...|.||+|+++|+|+.|..||....-...+..
T Consensus 219 FGsClkm~~dG-~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~K----- 292 (1317)
T KOG0612|consen 219 FGSCLKMDADG-TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGK----- 292 (1317)
T ss_pred chhHHhcCCCC-cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHH-----
Confidence 99998754433 33344578999999999984 3 5688999999999999999999999965443222222
Q ss_pred chhhhhhHHHHHhhhcccCCCCc--HHHHHHHHHHHHHhhccCCCCCCC---HHHHHHH
Q 018785 250 DPFLRDSRRVLRIMDTRLGGQYS--KKEAQAVAAVVLQCLHMDPKNRPS---MVDVLTS 303 (350)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~dp~~Rps---~~~ll~~ 303 (350)
+++-...-.+| .++|.++.+||.+++. +|+.|.. ++++..|
T Consensus 293 ------------Im~hk~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~H 338 (1317)
T KOG0612|consen 293 ------------IMNHKESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNH 338 (1317)
T ss_pred ------------HhchhhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhC
Confidence 22221111223 4589999999999885 7888887 9999887
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=268.21 Aligned_cols=276 Identities=22% Similarity=0.266 Sum_probs=216.6
Q ss_pred CchhhhhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccC-----
Q 018785 11 SASMISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLR----- 85 (350)
Q Consensus 11 ~~~~~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~----- 85 (350)
+...++++...+|.+....|+|-|++|.+| .+...|..||||+|....... ..=+.|+++|++|+
T Consensus 422 Yrv~igE~LD~RY~V~~~~GkGvFs~Vvra---------~D~~r~~~vAiKIIRnNE~M~-KtGl~EleiLkKL~~AD~E 491 (752)
T KOG0670|consen 422 YRVRIGELLDSRYEVQGYTGKGVFSTVVRA---------RDQARGQEVAIKIIRNNEVMH-KTGLKELEILKKLNDADPE 491 (752)
T ss_pred EEEehhhhhcceeEEEeccccceeeeeeec---------cccCCCCeeEEEEeecchHHh-hhhhHHHHHHHHhhccCch
Confidence 345689999999999999999999999999 777778899999997664332 33356899999995
Q ss_pred -CCcccceeeEEeecCceEEEEEcCCCCChhhHHhhcCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceE
Q 018785 86 -HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGV-QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVL 163 (350)
Q Consensus 86 -h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nil 163 (350)
-.+.+.++..|...+++|||+|.+ ..+|.+.++..+. -.+....+..++.||+-||..|. ..||+|.||||+|||
T Consensus 492 dk~Hclrl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK--~c~vlHaDIKPDNiL 568 (752)
T KOG0670|consen 492 DKFHCLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLK--KCGVLHADIKPDNIL 568 (752)
T ss_pred hhhHHHHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHH--hcCeeecccCccceE
Confidence 467889999999999999999998 7799999987652 35788899999999999999999 999999999999999
Q ss_pred EcCC-CcEEEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcch
Q 018785 164 LDSN-FNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAE 242 (350)
Q Consensus 164 i~~~-~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~ 242 (350)
|.+. ..++|||||.|....... .+....+..|+|||++.|-.|+...|+||+||+||+|.||+..|.+..+....
T Consensus 569 VNE~k~iLKLCDfGSA~~~~ene----itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~ML 644 (752)
T KOG0670|consen 569 VNESKNILKLCDFGSASFASENE----ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQML 644 (752)
T ss_pred eccCcceeeeccCcccccccccc----ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHH
Confidence 9876 458999999997533222 22233455699999999999999999999999999999999999998887666
Q ss_pred hhhhhhcchhhhhhHHHHHhhhcccC--------------------------------------CCCc---HHHHHHHHH
Q 018785 243 QTLVEWADPFLRDSRRVLRIMDTRLG--------------------------------------GQYS---KKEAQAVAA 281 (350)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~--------------------------------------~~~~---~~~~~~l~~ 281 (350)
....++-.++-...-...++.+.... +.++ ..+-..+.+
T Consensus 645 rl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rd 724 (752)
T KOG0670|consen 645 RLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRD 724 (752)
T ss_pred HHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHH
Confidence 55554433322111111111111000 0122 234468999
Q ss_pred HHHHhhccCCCCCCCHHHHHHH
Q 018785 282 VVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 282 li~~~l~~dp~~Rps~~~ll~~ 303 (350)
|+..||..||.+|.|+.+.|+|
T Consensus 725 LLdkml~LdP~KRit~nqAL~H 746 (752)
T KOG0670|consen 725 LLDKMLILDPEKRITVNQALKH 746 (752)
T ss_pred HHHHHhccChhhcCCHHHHhcC
Confidence 9999999999999999999876
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=231.85 Aligned_cols=267 Identities=25% Similarity=0.321 Sum_probs=205.6
Q ss_pred cccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh--hHHHHHHHHHHHhccCCCcccceeeEEeec
Q 018785 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ--GHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (350)
Q Consensus 22 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (350)
+|...++||+|.+|+||+| .+..+++.||+|.+...... -.....+|+.+++.++|.||++++++...+
T Consensus 3 ~ydkmekigegtygtvfka---------rn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsd 73 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKA---------RNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSD 73 (292)
T ss_pred chHHHHhhcCCcceeeEec---------ccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccC
Confidence 5777889999999999999 77788999999988765432 246678999999999999999999999999
Q ss_pred CceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccccc
Q 018785 100 DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR 179 (350)
Q Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~ 179 (350)
..+.+|+||| ..+|..+..+-.+ .++.+.++.++.|++.+|.+|| +.++.|+|+||.|.+|+.+|.++|+|||+++
T Consensus 74 kkltlvfe~c-dqdlkkyfdslng-~~d~~~~rsfmlqllrgl~fch--shnvlhrdlkpqnllin~ngelkladfglar 149 (292)
T KOG0662|consen 74 KKLTLVFEFC-DQDLKKYFDSLNG-DLDPEIVRSFMLQLLRGLGFCH--SHNVLHRDLKPQNLLINRNGELKLADFGLAR 149 (292)
T ss_pred ceeEEeHHHh-hHHHHHHHHhcCC-cCCHHHHHHHHHHHHhhhhhhh--hhhhhhccCCcceEEeccCCcEEecccchhh
Confidence 9999999999 5689888876553 7899999999999999999999 9999999999999999999999999999998
Q ss_pred cCCCCCCCcccccccCCCcccCccccccC-CCCCccchhhHHHHHHHHHh-CCCCCcccccCcchhhhhhhcc-hhhhhh
Q 018785 180 DGPTGDNTHVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWAD-PFLRDS 256 (350)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~-~~~~~~ 256 (350)
-+...- ........|..|++|.++.|. -|+...|+||-||++.|+.. |++.|.+.+-......+..... +.....
T Consensus 150 afgipv--rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~w 227 (292)
T KOG0662|consen 150 AFGIPV--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQW 227 (292)
T ss_pred hcCCce--EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccC
Confidence 543322 122334567889999999886 58899999999999999987 5566776665444444443211 111111
Q ss_pred HHHHHhhhcccCCCCc---------HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 257 RRVLRIMDTRLGGQYS---------KKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 257 ~~~~~~~~~~~~~~~~---------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
....+..+-.....++ +.+...-++|++++|.-+|.+|+++++.++|
T Consensus 228 ps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 228 PSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred CccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 1111111111111111 2233456789999999999999999998865
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=254.18 Aligned_cols=220 Identities=22% Similarity=0.267 Sum_probs=178.1
Q ss_pred cCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceeeEEeecCceEEEEEcCCC
Q 018785 32 GGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPK 111 (350)
Q Consensus 32 G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 111 (350)
|.+|.||++ .+..+++.+|+|.+..... ...|...+....||||+++++++...+..+++|||+.+
T Consensus 4 g~~~~v~~~---------~~~~~~~~~~~K~i~~~~~-----~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 69 (237)
T cd05576 4 GVIDKVLLV---------MDTRTQQTFILKGLRKSSE-----YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEG 69 (237)
T ss_pred cccceEEEE---------EEccCCcEEEEEeecchhh-----hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCC
Confidence 889999999 6777899999999876542 22344455556799999999999999999999999999
Q ss_pred CChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccccccCCCCCCCcccc
Q 018785 112 GSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVST 191 (350)
Q Consensus 112 ~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~ 191 (350)
++|.+++.... .+++..+..++.|+++||.||| +.|++|+||+|+||+++.++.++++|||.+....... .
T Consensus 70 ~~L~~~l~~~~--~l~~~~~~~~~~ql~~~l~~lH--~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~ 140 (237)
T cd05576 70 GKLWSHISKFL--NIPEECVKRWAAEMVVALDALH--REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----D 140 (237)
T ss_pred CCHHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH--hCCeeccCCCHHHEEEcCCCCEEEecccchhcccccc-----c
Confidence 99999987654 5899999999999999999999 9999999999999999999999999999875432211 1
Q ss_pred cccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhHHHHHhhhcccCCCC
Q 018785 192 RIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQY 271 (350)
Q Consensus 192 ~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (350)
...++..|+|||...+..++.++|+||+|+++|+|++|..|+....... ........
T Consensus 141 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-----------------------~~~~~~~~ 197 (237)
T cd05576 141 GEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI-----------------------NTHTTLNI 197 (237)
T ss_pred cCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-----------------------ccccccCC
Confidence 2334667999999888888999999999999999999998764322100 00001123
Q ss_pred cHHHHHHHHHHHHHhhccCCCCCCCH
Q 018785 272 SKKEAQAVAAVVLQCLHMDPKNRPSM 297 (350)
Q Consensus 272 ~~~~~~~l~~li~~~l~~dp~~Rps~ 297 (350)
+..+++.+.+++.+||+.||.+||++
T Consensus 198 ~~~~~~~~~~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 198 PEWVSEEARSLLQQLLQFNPTERLGA 223 (237)
T ss_pred cccCCHHHHHHHHHHccCCHHHhcCC
Confidence 44567889999999999999999986
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=285.76 Aligned_cols=147 Identities=28% Similarity=0.377 Sum_probs=131.5
Q ss_pred hhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch---hhHHHHHHHHHHHhccCCCcccceeeEE
Q 018785 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLVKLIGYC 96 (350)
Q Consensus 20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (350)
-++|++.++||+|+||+||+| .+..+++.||||++..... .....+..|+..++.++||+|+++++++
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a---------~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~ 73 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLG---------RKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSL 73 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEE---------EECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEE
Confidence 368999999999999999999 5556789999999875432 2235678899999999999999999999
Q ss_pred eecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcccc
Q 018785 97 SESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFG 176 (350)
Q Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg 176 (350)
...+..|+||||+.+++|.+++.... .+++..++.++.||+.||.||| ..+|+|+||||+|||++.++.++|+|||
T Consensus 74 ~~~~~~~lVmEy~~g~~L~~li~~~~--~l~~~~~~~i~~qil~aL~yLH--~~gIiHrDLKP~NILl~~~g~vkL~DFG 149 (669)
T cd05610 74 QSANNVYLVMEYLIGGDVKSLLHIYG--YFDEEMAVKYISEVALALDYLH--RHGIIHRDLKPDNMLISNEGHIKLTDFG 149 (669)
T ss_pred EECCEEEEEEeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--hCCEEeCCccHHHEEEcCCCCEEEEeCC
Confidence 99999999999999999999997654 6889999999999999999999 8999999999999999999999999999
Q ss_pred ccc
Q 018785 177 LAR 179 (350)
Q Consensus 177 ~~~ 179 (350)
++.
T Consensus 150 ls~ 152 (669)
T cd05610 150 LSK 152 (669)
T ss_pred CCc
Confidence 875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=248.84 Aligned_cols=271 Identities=25% Similarity=0.339 Sum_probs=209.5
Q ss_pred hhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh--hHHHHHHHHHHHhccCCCcccceeeEEe
Q 018785 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ--GHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (350)
Q Consensus 20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (350)
.+.|....++|+|.||.||+| ....+|+.|++|++-.++.. -.....+|+.+|..|+|+|++.++.++.
T Consensus 16 ~~~yek~~kigqGtfgeVFkA---------r~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~ 86 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKA---------RSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICR 86 (376)
T ss_pred chHHHHHHhcCCchHHHHHHH---------hhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHh
Confidence 568899999999999999999 66777888999876543321 1245678999999999999999988864
Q ss_pred e--------cCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCc
Q 018785 98 E--------SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFN 169 (350)
Q Consensus 98 ~--------~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~ 169 (350)
. ...+|+|+++|+. +|.-++.... ..++..++.+++.+++++|.|+| ...|+|||+|+.|++|+.+|.
T Consensus 87 tk~Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~~-vr~sls~Ikk~Mk~Lm~GL~~iH--r~kilHRDmKaaNvLIt~dgi 162 (376)
T KOG0669|consen 87 TKATPTNRDRATFYLVFDFCEH-DLAGLLSNRK-VRFSLSEIKKVMKGLMNGLYYIH--RNKILHRDMKAANVLITKDGI 162 (376)
T ss_pred hccCCcccccceeeeeHHHhhh-hHHHHhcCcc-ccccHHHHHHHHHHHHHHHHHHH--HhhHHhhcccHhhEEEcCCce
Confidence 3 2347999999954 8888775543 47999999999999999999999 999999999999999999999
Q ss_pred EEEccccccccCCCCCCCcc--cccccCCCcccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhh
Q 018785 170 AKLSDFGLARDGPTGDNTHV--STRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLV 246 (350)
Q Consensus 170 ~~l~Dfg~~~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~ 246 (350)
++|+|||+++.+........ .+....|..|++||.+.|. .|+++.|+|+-||++.+|+++.+.+.+..+......+.
T Consensus 163 lklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is 242 (376)
T KOG0669|consen 163 LKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLIS 242 (376)
T ss_pred EEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHH
Confidence 99999999976554443322 2334568889999999876 79999999999999999999999999988877766666
Q ss_pred hhcc-------hhhhhhHHHHHhhhcccCCCC---------cHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 247 EWAD-------PFLRDSRRVLRIMDTRLGGQY---------SKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 247 ~~~~-------~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
.+.. |...+..-...+-.++..... +-.-.++..+|+.+||..||.+|+++++++.|
T Consensus 243 ~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 243 QLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred HHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 5533 222222211111111111111 11113578899999999999999999999877
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=265.05 Aligned_cols=258 Identities=22% Similarity=0.299 Sum_probs=218.8
Q ss_pred hhhhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch---hhHHHHHHHHHHHhccCCCccc
Q 018785 14 MISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLV 90 (350)
Q Consensus 14 ~~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~ 90 (350)
...++..+++.+..-||.|+||.|=+++.+. ....+|+|++++... .+.+++..|-.++.....|.|+
T Consensus 413 e~a~v~l~dl~~iaTLGvGgFGRVELV~~~~---------~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIv 483 (732)
T KOG0614|consen 413 EFAQVKLSDLKRIATLGVGGFGRVELVKVNS---------QKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIV 483 (732)
T ss_pred hhcccchhhhhhhhhcccCccceEEEEEecc---------cchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHH
Confidence 4556777889999999999999999985542 223578888876543 3456778899999999999999
Q ss_pred ceeeEEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcE
Q 018785 91 KLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNA 170 (350)
Q Consensus 91 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~ 170 (350)
++|..|.++...|++||.|-||.|+..+..++ .|+...++.++..+++|++||| ++||++|||||+|.+++.+|-+
T Consensus 484 rLYrTfrd~kyvYmLmEaClGGElWTiLrdRg--~Fdd~tarF~~acv~EAfeYLH--~k~iIYRDLKPENllLd~~Gy~ 559 (732)
T KOG0614|consen 484 RLYRTFRDSKYVYMLMEACLGGELWTILRDRG--SFDDYTARFYVACVLEAFEYLH--RKGIIYRDLKPENLLLDNRGYL 559 (732)
T ss_pred HHHHHhccchhhhhhHHhhcCchhhhhhhhcC--CcccchhhhhHHHHHHHHHHHH--hcCceeccCChhheeeccCCce
Confidence 99999999999999999999999999998876 7999999999999999999999 9999999999999999999999
Q ss_pred EEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcc
Q 018785 171 KLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD 250 (350)
Q Consensus 171 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~ 250 (350)
||.|||++....... ..-..+|||.|.|||++.+...+.+.|.||||+++|||++|.+||.+.++-.....+..
T Consensus 560 KLVDFGFAKki~~g~---KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILk--- 633 (732)
T KOG0614|consen 560 KLVDFGFAKKIGSGR---KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILK--- 633 (732)
T ss_pred EEeehhhHHHhccCC---ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHh---
Confidence 999999998643332 33347899999999999999999999999999999999999999998776444443332
Q ss_pred hhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHHH
Q 018785 251 PFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPS-----MVDVLTSL 304 (350)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-----~~~ll~~L 304 (350)
.......|..++....+|++++...+|.+|.- +.+|.+|-
T Consensus 634 --------------Gid~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~ 678 (732)
T KOG0614|consen 634 --------------GIDKIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHR 678 (732)
T ss_pred --------------hhhhhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhh
Confidence 22224557788889999999999999999975 78888884
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=255.50 Aligned_cols=246 Identities=30% Similarity=0.444 Sum_probs=209.2
Q ss_pred hhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhH---HHHHHHHHHHhcc-CCCcccce
Q 018785 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGH---KEWLTEVIYLGQL-RHENLVKL 92 (350)
Q Consensus 17 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~e~~~l~~l-~h~~i~~~ 92 (350)
.+...+|....+||+|+||.|.+| ...++.+.+|||++++...-+. +--+.|-++|... +-|.++++
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLa---------erkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~ql 415 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLA---------ERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQL 415 (683)
T ss_pred ceeecccceEEEeccCccceeeee---------cccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHH
Confidence 344678999999999999999999 7888899999999987654332 2234566666655 57889999
Q ss_pred eeEEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEE
Q 018785 93 IGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKL 172 (350)
Q Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l 172 (350)
+..|.+-+.+|+||||+.||+|--.+++.+ .+.+..+..++..|+-||-+|| ++||++||||.+|||++.+|.++|
T Consensus 416 HScFQTmDRLyFVMEyvnGGDLMyhiQQ~G--kFKEp~AvFYAaEiaigLFFLh--~kgIiYRDLKLDNvmLd~eGHiKi 491 (683)
T KOG0696|consen 416 HSCFQTMDRLYFVMEYVNGGDLMYHIQQVG--KFKEPVAVFYAAEIAIGLFFLH--SKGIIYRDLKLDNVMLDSEGHIKI 491 (683)
T ss_pred HHHhhhhhheeeEEEEecCchhhhHHHHhc--ccCCchhhhhhHHHHHHhhhhh--cCCeeeeeccccceEeccCCceEe
Confidence 999999999999999999999998888876 7899999999999999999999 999999999999999999999999
Q ss_pred ccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchh
Q 018785 173 SDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPF 252 (350)
Q Consensus 173 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 252 (350)
+|||.+...-.... .....+|||.|+|||++..++|+.+.|.||+|++||||+.|+.||++.+.++..+.+.+.
T Consensus 492 ~DFGmcKEni~~~~--TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~eh---- 565 (683)
T KOG0696|consen 492 ADFGMCKENIFDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEH---- 565 (683)
T ss_pred eecccccccccCCc--ceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHc----
Confidence 99999975333222 233478999999999999999999999999999999999999999998876555555431
Q ss_pred hhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCC
Q 018785 253 LRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPS 296 (350)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps 296 (350)
+..+|..+|.+..++++..|..+|.+|..
T Consensus 566 ---------------nvsyPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 566 ---------------NVSYPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred ---------------cCcCcccccHHHHHHHHHHhhcCCccccC
Confidence 23567889999999999999999999953
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=290.39 Aligned_cols=262 Identities=30% Similarity=0.507 Sum_probs=197.4
Q ss_pred hcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceeeEEeecC
Q 018785 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSESD 100 (350)
Q Consensus 21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 100 (350)
..|....+||+|+||.||+| ....++..||+|.+....... ..|+..+++++||||+++++++.+++
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~---------~~~~~~~~vavK~~~~~~~~~----~~~~~~l~~l~HpnIv~~~~~~~~~~ 756 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKG---------KSIKNGMQFVVKEINDVNSIP----SSEIADMGKLQHPNIVKLIGLCRSEK 756 (968)
T ss_pred hhCCcccEEccCCCeeEEEE---------EECCCCcEEEEEEccCCcccc----HHHHHHHhhCCCCCcceEEEEEEcCC
Confidence 46778889999999999999 455568899999886543221 24578899999999999999999999
Q ss_pred ceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcC-CCCeeeCCCCCCceEEcCCCcEEEccccccc
Q 018785 101 NRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL-DANVIYRDLKASNVLLDSNFNAKLSDFGLAR 179 (350)
Q Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~-~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~ 179 (350)
..++||||+++++|.+++. .++...+..++.|++.|++|||.. +.+++|+||||+||+++.++..++. |+...
T Consensus 757 ~~~lv~Ey~~~g~L~~~l~-----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~ 830 (968)
T PLN00113 757 GAYLIHEYIEGKNLSEVLR-----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPG 830 (968)
T ss_pred CCEEEEeCCCCCcHHHHHh-----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccc
Confidence 9999999999999999984 378889999999999999999932 4599999999999999988877664 54443
Q ss_pred cCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhHHH
Q 018785 180 DGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRV 259 (350)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (350)
.... .....+++.|+|||.+.+..++.++||||+|+++|||++|+.||...... ...+..+......+ ...
T Consensus 831 ~~~~------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~-~~~ 901 (968)
T PLN00113 831 LLCT------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGV--HGSIVEWARYCYSD-CHL 901 (968)
T ss_pred cccc------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCC--CCcHHHHHHHhcCc-cch
Confidence 2111 11235678899999999999999999999999999999999998543221 11122221111111 001
Q ss_pred HHhhhcccC--CCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcC
Q 018785 260 LRIMDTRLG--GQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 310 (350)
Q Consensus 260 ~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 310 (350)
....+.... .........++.+++.+||+.||++|||+.++++.|+++...
T Consensus 902 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~ 954 (968)
T PLN00113 902 DMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS 954 (968)
T ss_pred hheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence 111111111 122345566788999999999999999999999999998664
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=250.16 Aligned_cols=266 Identities=26% Similarity=0.435 Sum_probs=201.1
Q ss_pred hhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhc--cCCCcccceee
Q 018785 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQ--LRHENLVKLIG 94 (350)
Q Consensus 17 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~--l~h~~i~~~~~ 94 (350)
....++.++.+.||+|.||.||+|+|. |+.||||++.... .....+|.++... |+|+||+.+++
T Consensus 207 RTiarqI~L~e~IGkGRyGEVwrG~wr-----------Ge~VAVKiF~srd---E~SWfrEtEIYqTvmLRHENILgFIa 272 (513)
T KOG2052|consen 207 RTIARQIVLQEIIGKGRFGEVWRGRWR-----------GEDVAVKIFSSRD---ERSWFRETEIYQTVMLRHENILGFIA 272 (513)
T ss_pred HhhhheeEEEEEecCccccceeecccc-----------CCceEEEEecccc---hhhhhhHHHHHHHHHhccchhhhhhh
Confidence 345678999999999999999999987 7789999997554 3445566666554 58999999998
Q ss_pred EEeecC----ceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhc------CCCCeeeCCCCCCceEE
Q 018785 95 YCSESD----NRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHG------LDANVIYRDLKASNVLL 164 (350)
Q Consensus 95 ~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~------~~~~i~H~di~~~Nili 164 (350)
.-..++ .+|||++|.+.|+|.||+.++ .++....++++..++.||+|||. -+..|.|||||.+||+|
T Consensus 273 aD~~~~gs~TQLwLvTdYHe~GSL~DyL~r~---tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILV 349 (513)
T KOG2052|consen 273 ADNKDNGSWTQLWLVTDYHEHGSLYDYLNRN---TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV 349 (513)
T ss_pred ccccCCCceEEEEEeeecccCCcHHHHHhhc---cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEE
Confidence 865443 678999999999999999886 69999999999999999999992 14568999999999999
Q ss_pred cCCCcEEEccccccccCCCCCCC--cccccccCCCcccCccccccCC----CC--CccchhhHHHHHHHHHhC-------
Q 018785 165 DSNFNAKLSDFGLARDGPTGDNT--HVSTRIVGTRGYAAPEYVATGH----LT--PKSDVYSFGVVLLELLSG------- 229 (350)
Q Consensus 165 ~~~~~~~l~Dfg~~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~----~~--~~~DiwslG~ll~~ll~g------- 229 (350)
..++...++|+|++......... ...+...||.+|+|||++.... +. ..+||||||.++||+...
T Consensus 350 Kkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~ 429 (513)
T KOG2052|consen 350 KKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIV 429 (513)
T ss_pred ccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEe
Confidence 99999999999999875554322 2345578999999999986542 21 368999999999999752
Q ss_pred ---CCCCcccccCcchhhhhhhcchhhhhhHHHHHhhhcccCCCC-----cHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 018785 230 ---RRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQY-----SKKEAQAVAAVVLQCLHMDPKNRPSMVDVL 301 (350)
Q Consensus 230 ---~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll 301 (350)
+.||.+.-+.. |.+.+... -....+.+... ....-..+.++++.||..||.-|.|+-.+.
T Consensus 430 eey~~Pyyd~Vp~D----------Ps~eeMrk--VVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriK 497 (513)
T KOG2052|consen 430 EEYQLPYYDVVPSD----------PSFEEMRK--VVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIK 497 (513)
T ss_pred hhhcCCcccCCCCC----------CCHHHHhc--ceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHH
Confidence 34554322211 11111111 11111111111 223446788999999999999999999999
Q ss_pred HHHHhhhcCC
Q 018785 302 TSLEQLHTSK 311 (350)
Q Consensus 302 ~~L~~~~~~~ 311 (350)
+.|.++....
T Consensus 498 Ktl~~l~~~~ 507 (513)
T KOG2052|consen 498 KTLAKLSNSD 507 (513)
T ss_pred HHHHHHhcCh
Confidence 9999998653
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=250.45 Aligned_cols=274 Identities=28% Similarity=0.402 Sum_probs=205.6
Q ss_pred hhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhc--cCCCcccceeeEEe
Q 018785 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQ--LRHENLVKLIGYCS 97 (350)
Q Consensus 20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~--l~h~~i~~~~~~~~ 97 (350)
.......+++|+|.||.||+|.++ ++.||||+++..... .+..|-.+.+. +.|+||+++++.-+
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL~-----------~~~VAVKifp~~~kq---s~~~Ek~Iy~lp~m~h~nIl~Fi~~ek 274 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQLD-----------NRLVAVKIFPEQEKQ---SFQNEKNIYSLPGMKHENILQFIGAEK 274 (534)
T ss_pred CCchhhHHHhhcCccceeehhhcc-----------CceeEEEecCHHHHH---HHHhHHHHHhccCccchhHHHhhchhc
Confidence 556778899999999999999765 578999999876543 44455555444 58999999999876
Q ss_pred ecC----ceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcC-------CCCeeeCCCCCCceEEcC
Q 018785 98 ESD----NRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL-------DANVIYRDLKASNVLLDS 166 (350)
Q Consensus 98 ~~~----~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~-------~~~i~H~di~~~Nili~~ 166 (350)
... .++||++|.+.|+|.+|+..+ .++.....+++..++.||+|||.- +..|+|||||.+||||..
T Consensus 275 r~t~~~~eywLVt~fh~kGsL~dyL~~n---tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~ 351 (534)
T KOG3653|consen 275 RGTADRMEYWLVTEFHPKGSLCDYLKAN---TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKN 351 (534)
T ss_pred cCCccccceeEEeeeccCCcHHHHHHhc---cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEcc
Confidence 655 889999999999999999988 599999999999999999999932 456999999999999999
Q ss_pred CCcEEEccccccccCCCCCCCcccccccCCCcccCccccccCC-CC-----CccchhhHHHHHHHHHhCCCCCcc-cccC
Q 018785 167 NFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGH-LT-----PKSDVYSFGVVLLELLSGRRALDE-DRGG 239 (350)
Q Consensus 167 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~-----~~~DiwslG~ll~~ll~g~~pf~~-~~~~ 239 (350)
|++..|+|||++..+.............||.+|||||++.|.. +. .+.||||+|.++|||++....+.. ..+.
T Consensus 352 DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~ 431 (534)
T KOG3653|consen 352 DLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPE 431 (534)
T ss_pred CCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCc
Confidence 9999999999998877665554445578999999999997753 22 368999999999999997665531 1111
Q ss_pred cchhhhh--hhcchhhhhhHHHHHhhhcccCCCCcH-----HHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcCCC
Q 018785 240 LAEQTLV--EWADPFLRDSRRVLRIMDTRLGGQYSK-----KEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKD 312 (350)
Q Consensus 240 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~ 312 (350)
...... -...|.+.+. ....+..+.+..++. .....+++.+..||..|++-|.|+.=+.+.+.++....+
T Consensus 432 -Yqlpfe~evG~hPt~e~m--q~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~ 508 (534)
T KOG3653|consen 432 -YQLPFEAEVGNHPTLEEM--QELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE 508 (534)
T ss_pred -ccCchhHHhcCCCCHHHH--HHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence 000000 0111222221 122222222222222 234678999999999999999999999998888877654
Q ss_pred C
Q 018785 313 M 313 (350)
Q Consensus 313 ~ 313 (350)
.
T Consensus 509 ~ 509 (534)
T KOG3653|consen 509 D 509 (534)
T ss_pred c
Confidence 3
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=267.75 Aligned_cols=256 Identities=27% Similarity=0.366 Sum_probs=212.6
Q ss_pred hhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhcc-CCCcccceeeEE
Q 018785 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQL-RHENLVKLIGYC 96 (350)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~ 96 (350)
.....|+|...||.|.+|.||++ .+..+++..|+|+....... .+++..|+.+|+.+ .|||+..++++|
T Consensus 16 dp~d~~ei~evig~Gtygkv~k~---------k~~~~~~~aa~kI~~~~~d~-deEiE~eynil~~~~~hpnv~~fyg~~ 85 (953)
T KOG0587|consen 16 DPADIFEIIEVIGNGTYGKVYKG---------RHVKTGQLAAIKIMDPTEDE-EEEIELEYNMLKKYSHHPNVATFYGAF 85 (953)
T ss_pred CCCCccEEEEEEeeccceeEEEE---------eeeecCceeeeEeecCCccc-cHHHHHHHHHHHhccCCCCcceEEEEE
Confidence 34678999999999999999999 77788889999988776533 35677889999988 599999999998
Q ss_pred e-----ecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEE
Q 018785 97 S-----ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAK 171 (350)
Q Consensus 97 ~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~ 171 (350)
. .++.+|||||||.||+..|+++...+..+.+..+..|++.++.|+.+|| ...++|+||+-.||+++.++.||
T Consensus 86 ~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH--~nkviHRDikG~NiLLT~e~~VK 163 (953)
T KOG0587|consen 86 IKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLH--NNKVIHRDIKGQNVLLTENAEVK 163 (953)
T ss_pred EEecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHh--hcceeeecccCceEEEeccCcEE
Confidence 5 3578999999999999999998777778999999999999999999999 99999999999999999999999
Q ss_pred EccccccccCCCCCCCcccccccCCCcccCccccccC-----CCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhh
Q 018785 172 LSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG-----HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLV 246 (350)
Q Consensus 172 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-----~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~ 246 (350)
|+|||++...... ........||+.|+|||++... .|+.++|+||||++..||--|.+|+-++.+....-.+.
T Consensus 164 LvDFGvSaQldsT--~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~Ip 241 (953)
T KOG0587|consen 164 LVDFGVSAQLDST--VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP 241 (953)
T ss_pred Eeeeeeeeeeecc--cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCC
Confidence 9999999753222 2223446799999999998543 57789999999999999999999987766543333333
Q ss_pred hhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 247 EWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
..+.|.+.. +..-+.++.++|..||..|.++||+..++++|
T Consensus 242 RNPPPkLkr----------------p~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 242 RNPPPKLKR----------------PKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred CCCCccccc----------------hhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 333332222 44557799999999999999999999998865
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=271.04 Aligned_cols=273 Identities=27% Similarity=0.408 Sum_probs=220.8
Q ss_pred hhhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch-hhHHHHHHHHHHHhcc-CCCcccce
Q 018785 15 ISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQL-RHENLVKL 92 (350)
Q Consensus 15 ~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~ 92 (350)
..++..++..+.+.||+|.||.|++|..+..... .......||||..+.... .+...+..|+.+++.+ .||||+.+
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~--~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~l 367 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKA--LLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNL 367 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccc--cccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhh
Confidence 4556666677888999999999999976542210 022367899999876543 3457789999999999 59999999
Q ss_pred eeEEeecCceEEEEEcCCCCChhhHHhhcC------C--------CCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCC
Q 018785 93 IGYCSESDNRLLVYEFMPKGSLENHLFRKG------V--------QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLK 158 (350)
Q Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------~--------~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~ 158 (350)
++.+...+.+++|+||+..|+|.+|+..+. . ..++..+.+.++.||+.|++||+ +..++||||-
T Consensus 368 lG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~--~~~~vHRDLA 445 (609)
T KOG0200|consen 368 LGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA--SVPCVHRDLA 445 (609)
T ss_pred eeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh--hCCccchhhh
Confidence 999999999999999999999999997664 0 13888999999999999999999 9999999999
Q ss_pred CCceEEcCCCcEEEccccccccCCCCCCCccc-ccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCccc
Q 018785 159 ASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS-TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDED 236 (350)
Q Consensus 159 ~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~-~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~ 236 (350)
.+||++..+..+|++|||+++........... ....-...|+|||.+....|+.++||||+|++|||+++ |..|+.+.
T Consensus 446 aRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~ 525 (609)
T KOG0200|consen 446 ARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGI 525 (609)
T ss_pred hhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCC
Confidence 99999999999999999999864333332211 11012345999999999999999999999999999998 67787652
Q ss_pred ccCcchhhhhhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 018785 237 RGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLH 308 (350)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 308 (350)
. ......+.+....+...|..++++++++++.||+.+|++||++.++.+.+....
T Consensus 526 ~-----------------~~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l 580 (609)
T KOG0200|consen 526 P-----------------PTEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL 580 (609)
T ss_pred C-----------------cHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence 2 112223456666667778888999999999999999999999999999999853
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=241.60 Aligned_cols=237 Identities=32% Similarity=0.464 Sum_probs=193.1
Q ss_pred CceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhh-HHHHHHHHHHHhccCCCcccceeeEEeecCceEEEEEcCCC
Q 018785 33 GFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQG-HKEWLTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPK 111 (350)
Q Consensus 33 ~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 111 (350)
++|.||+| ....+++.+++|.+....... ...+.+|+..+++++|++++++++.+......++++|++.+
T Consensus 1 ~~g~v~~~---------~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~ 71 (244)
T smart00220 1 SFGKVYLA---------RDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDG 71 (244)
T ss_pred CceEEEEE---------EECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCC
Confidence 57899999 455568899999998766544 67889999999999999999999999999999999999988
Q ss_pred CChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccccccCCCCCCCcccc
Q 018785 112 GSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVST 191 (350)
Q Consensus 112 ~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~ 191 (350)
++|.+++.... .++...+..++.+++.++.+|| +.+++|+||+|.||+++.++.++|+|||.+....... ...
T Consensus 72 ~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh--~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~ 144 (244)
T smart00220 72 GDLFDLLKKRG--RLSEDEARFYARQILSALEYLH--SNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLT 144 (244)
T ss_pred CCHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHH--HcCeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccc
Confidence 89999987654 3889999999999999999999 8999999999999999999999999999998654432 222
Q ss_pred cccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhHHHHHhhhcccCCCC
Q 018785 192 RIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQY 271 (350)
Q Consensus 192 ~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (350)
...++..|++||...+..++.++|+|++|++++++++|..||....... ..............
T Consensus 145 ~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~-----------------~~~~~~~~~~~~~~ 207 (244)
T smart00220 145 TFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLL-----------------ELFKKIGKPKPPFP 207 (244)
T ss_pred cccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH-----------------HHHHHHhccCCCCc
Confidence 3456778999999988888999999999999999999999986532111 11111111111111
Q ss_pred cH--HHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018785 272 SK--KEAQAVAAVVLQCLHMDPKNRPSMVDVLT 302 (350)
Q Consensus 272 ~~--~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 302 (350)
.. .++.++.+++.+||..+|++||++.++++
T Consensus 208 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 208 PPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred cccccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 11 16778999999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=246.40 Aligned_cols=271 Identities=24% Similarity=0.318 Sum_probs=226.7
Q ss_pred hhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccc-hhhHHHHHHHHHHHhccCCCcccceee
Q 018785 16 SKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES-FQGHKEWLTEVIYLGQLRHENLVKLIG 94 (350)
Q Consensus 16 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~ 94 (350)
..+...|++...++-+|.||.||.|.|.+. ..-.+.+.|.+|.++... .-+...+..|..++..+.|||++++.+
T Consensus 279 l~v~r~Rv~l~~llqEGtFGri~~gI~~eE----dt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~ 354 (563)
T KOG1024|consen 279 LTVQRCRVRLSCLLQEGTFGRIYRGIWREE----DTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLG 354 (563)
T ss_pred hhhhhhheechhhhhcCchhheeeeeeccc----CCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeE
Confidence 345566888899999999999999977643 233445667788776543 234466889999999999999999999
Q ss_pred EEe-ecCceEEEEEcCCCCChhhHHhhc------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCC
Q 018785 95 YCS-ESDNRLLVYEFMPKGSLENHLFRK------GVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSN 167 (350)
Q Consensus 95 ~~~-~~~~~~lv~e~~~~~~L~~~l~~~------~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~ 167 (350)
+.. +.+..+.++.+..-++|..|+... .-+.++..+...++.|++.|++||| +.|++|.||-.+|.+|++.
T Consensus 355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh--~~~ViHkDiAaRNCvIdd~ 432 (563)
T KOG1024|consen 355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH--NHGVIHKDIAARNCVIDDQ 432 (563)
T ss_pred EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH--hcCcccchhhhhcceehhh
Confidence 864 456788999998889999999732 2245777788899999999999999 9999999999999999999
Q ss_pred CcEEEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccccCcchhhhh
Q 018785 168 FNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLV 246 (350)
Q Consensus 168 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~~~~~~ 246 (350)
..|||+|=.+++..-..+..+..........|++||.+.+..|+.++|+||||+++|||++ |+.|+...++.+.
T Consensus 433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm----- 507 (563)
T KOG1024|consen 433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEM----- 507 (563)
T ss_pred eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHH-----
Confidence 9999999999998878887777777778888999999999999999999999999999998 7888877664333
Q ss_pred hhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcC
Q 018785 247 EWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 310 (350)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 310 (350)
...+....+-..|.++|+++..++.-||+..|++||+++++...|++++..
T Consensus 508 -------------~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~q 558 (563)
T KOG1024|consen 508 -------------EHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQ 558 (563)
T ss_pred -------------HHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHH
Confidence 334444555566789999999999999999999999999999999998765
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=249.23 Aligned_cols=141 Identities=24% Similarity=0.338 Sum_probs=122.2
Q ss_pred chhhhhhhh-hcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccC-----
Q 018785 12 ASMISKIAT-KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLR----- 85 (350)
Q Consensus 12 ~~~~~~~~~-~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~----- 85 (350)
+..++++.. .+|.+.++||-|.|++||+| .+....++||+|+.+....- .+....|+++|+++.
T Consensus 68 pV~IGD~F~~gRY~v~rKLGWGHFSTVWLa---------wDtq~~r~VAlKVvKSAqhY-tEaAlDEIklL~~v~~~Dp~ 137 (590)
T KOG1290|consen 68 PVRIGDVFNGGRYHVQRKLGWGHFSTVWLA---------WDTQNKRYVALKVVKSAQHY-TEAALDEIKLLQQVREGDPN 137 (590)
T ss_pred eeeccccccCceEEEEEeccccccceeEEE---------eeccCCeEEEEEEEehhhHH-HHHHHHHHHHHHHHHhcCCC
Confidence 345777776 99999999999999999999 66667899999998754322 345678999999883
Q ss_pred ---CCcccceeeEEee----cCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCC
Q 018785 86 ---HENLVKLIGYCSE----SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLK 158 (350)
Q Consensus 86 ---h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~ 158 (350)
...|+++++.|.. +.+.++|+|++ |.+|..++.....+.++...++.|+.|++.||.|||+ ..||+|.|||
T Consensus 138 ~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~-ecgIIHTDlK 215 (590)
T KOG1290|consen 138 DPGKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHR-ECGIIHTDLK 215 (590)
T ss_pred CCCCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHH-hcCccccCCC
Confidence 3569999999864 56889999999 9999999999888899999999999999999999998 8999999999
Q ss_pred CCceEE
Q 018785 159 ASNVLL 164 (350)
Q Consensus 159 ~~Nili 164 (350)
|+|||+
T Consensus 216 PENvLl 221 (590)
T KOG1290|consen 216 PENVLL 221 (590)
T ss_pred cceeee
Confidence 999998
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=266.26 Aligned_cols=262 Identities=27% Similarity=0.399 Sum_probs=217.5
Q ss_pred hcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch-hhHHHHHHHHHHHhccCCCcccceeeEEeec
Q 018785 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (350)
Q Consensus 21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (350)
...+.+++||+|+||+||+|.|-+. ...-.-+||||++..... ....++.+|+..+.++.|||++++++++..+
T Consensus 696 telkk~kvLGsgAfGtV~kGiw~Pe-----ge~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s 770 (1177)
T KOG1025|consen 696 TELKKDKVLGSGAFGTVYKGIWIPE-----GENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLS 770 (1177)
T ss_pred hhhhhhceeccccceeEEeeeEecC-----CceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccc
Confidence 4566778999999999999987642 222345899998765543 3457799999999999999999999999876
Q ss_pred CceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccccc
Q 018785 100 DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR 179 (350)
Q Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~ 179 (350)
. +-||++|+++|+|.|++..+. ..+..+..+.|+.||++|+.||| .++++||||-.+|+||..-..+++.|||++.
T Consensus 771 ~-~qlvtq~mP~G~LlDyvr~hr-~~igsq~lLnw~~QIAkgM~YLe--~qrlVHrdLaaRNVLVksP~hvkitdfgla~ 846 (1177)
T KOG1025|consen 771 T-LQLVTQLMPLGCLLDYVREHR-DNIGSQDLLNWCYQIAKGMKYLE--EQRLVHRDLAARNVLVKSPNHVKITDFGLAK 846 (1177)
T ss_pred h-HHHHHHhcccchHHHHHHHhh-ccccHHHHHHHHHHHHHHHHHHH--hcchhhhhhhhhheeecCCCeEEEEecchhh
Confidence 5 779999999999999998765 47889999999999999999999 9999999999999999999999999999998
Q ss_pred cCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccccCcchhhhhhhcchhhhhhHH
Q 018785 180 DGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRR 258 (350)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (350)
..................-|+|-|.+....|+.++||||+|+++||++| |..|+.+....+
T Consensus 847 ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e------------------ 908 (1177)
T KOG1025|consen 847 LLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE------------------ 908 (1177)
T ss_pred ccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH------------------
Confidence 7666555444333344556999999999999999999999999999998 899998766422
Q ss_pred HHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhc
Q 018785 259 VLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHT 309 (350)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 309 (350)
....+....+-..|..++.+++.++.+||..|+..||+++++.+.++....
T Consensus 909 I~dlle~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar 959 (1177)
T KOG1025|consen 909 IPDLLEKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR 959 (1177)
T ss_pred hhHHHhccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence 223333444455677889999999999999999999999999988877643
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=249.65 Aligned_cols=260 Identities=24% Similarity=0.316 Sum_probs=204.2
Q ss_pred hhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhh-------HHHHHHHHHHHhccCCCccc
Q 018785 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQG-------HKEWLTEVIYLGQLRHENLV 90 (350)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~-------~~~~~~e~~~l~~l~h~~i~ 90 (350)
....+|-+..+||+|+|+.||+| .+....++||+|+-.....+. .+...+|..+-+.|.||.|+
T Consensus 460 tLn~RYLlLhLLGrGGFSEVyKA---------FDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIV 530 (775)
T KOG1151|consen 460 TLNDRYLLLHLLGRGGFSEVYKA---------FDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIV 530 (775)
T ss_pred chHHHHHHHHHhccccHHHHHHh---------cccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceee
Confidence 45689999999999999999999 788889999999764432221 24467899999999999999
Q ss_pred ceeeEEeec-CceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcC---
Q 018785 91 KLIGYCSES-DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS--- 166 (350)
Q Consensus 91 ~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~--- 166 (350)
++|++|.-+ +.++-|+|||+|.+|.-|++.+. .+++.+++.|+.||+.||.||...+..|+|-||||.|||+-.
T Consensus 531 KlYDyfslDtdsFCTVLEYceGNDLDFYLKQhk--lmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~Gta 608 (775)
T KOG1151|consen 531 KLYDYFSLDTDSFCTVLEYCEGNDLDFYLKQHK--LMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTA 608 (775)
T ss_pred eeeeeeeeccccceeeeeecCCCchhHHHHhhh--hhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcc
Confidence 999999765 56678999999999998888776 799999999999999999999966788999999999999943
Q ss_pred CCcEEEccccccccCCCCCCCccc-----ccccCCCcccCcccccc----CCCCCccchhhHHHHHHHHHhCCCCCcccc
Q 018785 167 NFNAKLSDFGLARDGPTGDNTHVS-----TRIVGTRGYAAPEYVAT----GHLTPKSDVYSFGVVLLELLSGRRALDEDR 237 (350)
Q Consensus 167 ~~~~~l~Dfg~~~~~~~~~~~~~~-----~~~~~~~~~~aPE~~~~----~~~~~~~DiwslG~ll~~ll~g~~pf~~~~ 237 (350)
-|.++++|||++..+......... ....||..|+|||++.- ...+.+.||||+|+++|+++.|+.||....
T Consensus 609 cGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnq 688 (775)
T KOG1151|consen 609 CGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQ 688 (775)
T ss_pred cceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCch
Confidence 467999999999877665444322 23568888999998743 356789999999999999999999997654
Q ss_pred cCcchhhhhhhcchhhhhhHHHHHhhhcccCC-CCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018785 238 GGLAEQTLVEWADPFLRDSRRVLRIMDTRLGG-QYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLT 302 (350)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 302 (350)
.... +.+ ...++....-. +.-+.++.+..++|++||+.-.++|.+..++..
T Consensus 689 sQQd---ILq-----------eNTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 689 SQQD---ILQ-----------ENTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred hHHH---HHh-----------hhchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 3211 111 11111111101 112357789999999999999999999888753
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=227.67 Aligned_cols=262 Identities=18% Similarity=0.256 Sum_probs=198.5
Q ss_pred hhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccC-CCcccceeeEEee
Q 018785 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLR-HENLVKLIGYCSE 98 (350)
Q Consensus 20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~ 98 (350)
.++|++.+++|+|.++.||.| .+..+++.++||++++-. ...+.+|+.+|..|. +|||++++++..+
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg---------~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~D 104 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEG---------INITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKD 104 (338)
T ss_pred cchHHHHHHHcCccHhhHhcc---------cccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcC
Confidence 569999999999999999999 777788999999987653 456789999999995 9999999999876
Q ss_pred c--CceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCC-CcEEEccc
Q 018785 99 S--DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSN-FNAKLSDF 175 (350)
Q Consensus 99 ~--~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~-~~~~l~Df 175 (350)
. ....+|+|++++.+...+.. .++...+...+.+++.||.||| +.||.|||+||.|++|+.. ..++|+||
T Consensus 105 p~SktpaLiFE~v~n~Dfk~ly~-----tl~d~dIryY~~elLkALdyCH--S~GImHRDVKPhNvmIdh~~rkLrlIDW 177 (338)
T KOG0668|consen 105 PESKTPSLIFEYVNNTDFKQLYP-----TLTDYDIRYYIYELLKALDYCH--SMGIMHRDVKPHNVMIDHELRKLRLIDW 177 (338)
T ss_pred ccccCchhHhhhhccccHHHHhh-----hhchhhHHHHHHHHHHHHhHHH--hcCcccccCCcceeeechhhceeeeeec
Confidence 4 46679999997766655442 5888899999999999999999 9999999999999999875 55999999
Q ss_pred cccccCCCCCCCcccccccCCCcccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCc-ccccCcchhhhhhhcc-hh
Q 018785 176 GLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRALD-EDRGGLAEQTLVEWAD-PF 252 (350)
Q Consensus 176 g~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~ll~~ll~g~~pf~-~~~~~~~~~~~~~~~~-~~ 252 (350)
|++..+........ ...+..|--||++.. ..|+.+-|+|||||++..|+..+.||. +.++....-.+..... ..
T Consensus 178 GLAEFYHp~~eYnV---RVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~e 254 (338)
T KOG0668|consen 178 GLAEFYHPGKEYNV---RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDE 254 (338)
T ss_pred chHhhcCCCceeee---eeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHH
Confidence 99987655544322 345566889998754 578999999999999999999999885 4333322222222111 00
Q ss_pred ---------hhhhHHHHHhhhcccCC--------CCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 253 ---------LRDSRRVLRIMDTRLGG--------QYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 253 ---------~~~~~~~~~~~~~~~~~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
+.-......++....+. +..-.+++++.+|+.++|.-|..+|+|+.+.+.|
T Consensus 255 l~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 255 LYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred HHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 00011111111111111 1122346899999999999999999999999876
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=239.15 Aligned_cols=258 Identities=24% Similarity=0.305 Sum_probs=198.2
Q ss_pred hhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch-hhHHHHHHHHHHHhc-cCCCccccee
Q 018785 16 SKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQ-LRHENLVKLI 93 (350)
Q Consensus 16 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~-l~h~~i~~~~ 93 (350)
.+....+.+-...||.|.||+|++- .++.+|+..|||.+..... .+...++.|.+...+ -++|+|+++|
T Consensus 59 ~~F~~~~Lqdlg~iG~G~fG~V~KM---------~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfy 129 (361)
T KOG1006|consen 59 HTFTSDNLQDLGEIGNGAFGTVNKM---------LHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFY 129 (361)
T ss_pred cccccchHHHHHHhcCCcchhhhhh---------hcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHh
Confidence 3344455666778999999999998 8888999999999987765 333556777775554 4799999999
Q ss_pred eEEeecCceEEEEEcCCCCChhhHHhh---cCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcE
Q 018785 94 GYCSESDNRLLVYEFMPKGSLENHLFR---KGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNA 170 (350)
Q Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~ 170 (350)
+..-.++..|+.||.+ ..+|..+... .....+++.-+-.|....+.||.||.. ...++|||+||+|||++..|.+
T Consensus 130 Ga~F~EGdcWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~-~lkiIHRDvKPSNILldr~G~v 207 (361)
T KOG1006|consen 130 GALFSEGDCWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE-ELKIIHRDVKPSNILLDRHGDV 207 (361)
T ss_pred hhhhcCCceeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH-HhhhhhccCChhheEEecCCCE
Confidence 9988888999999998 6677665532 122368888888888889999999976 7889999999999999999999
Q ss_pred EEccccccccCCCCCCCcccccccCCCcccCcccccc--CCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhh
Q 018785 171 KLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT--GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEW 248 (350)
Q Consensus 171 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~ 248 (350)
||+|||++...... ...+...|...|+|||.+.. ..|+.+||+||||++|||+.||..|+.+.+.. .
T Consensus 208 KLCDFGIcGqLv~S---iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~sv--f------ 276 (361)
T KOG1006|consen 208 KLCDFGICGQLVDS---IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSV--F------ 276 (361)
T ss_pred eeecccchHhHHHH---HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHH--H------
Confidence 99999999653222 22333457777999998854 46999999999999999999999999876541 1
Q ss_pred cchhhhhhHHHHHhhhcccCCC----CcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 249 ADPFLRDSRRVLRIMDTRLGGQ----YSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
++..+......+.- -...++..+..+|..||..|-..||...+++++
T Consensus 277 --------eql~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 277 --------EQLCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred --------HHHHHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 11111111111111 113478899999999999999999999999864
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=260.90 Aligned_cols=269 Identities=19% Similarity=0.236 Sum_probs=169.8
Q ss_pred hhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceeeE--
Q 018785 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGY-- 95 (350)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~-- 95 (350)
...++|.+.++||+|+||.||+|++..+ ....+..||+|.+...... +.... ..++...+.++..+...
T Consensus 129 ~~~~~y~l~~~LG~G~FG~VYka~~~~~-----~~~~~~~vAvK~~~~~~~~--e~~~~--e~l~~~~~~~~~~~~~~~~ 199 (566)
T PLN03225 129 FKKDDFVLGKKLGEGAFGVVYKASLVNK-----QSKKEGKYVLKKATEYGAV--EIWMN--ERVRRACPNSCADFVYGFL 199 (566)
T ss_pred CccCCeEEeEEEeeCCCeEEEEEEEcCC-----ccccCcEEEEEEecccchh--HHHHH--HHHHhhchhhHHHHHHhhh
Confidence 3567999999999999999999954321 1122789999987643211 11111 11222222222222211
Q ss_pred ----EeecCceEEEEEcCCCCChhhHHhhcCCC------------------CCCHHHHHHHHHHHHHHHHHhhcCCCCee
Q 018785 96 ----CSESDNRLLVYEFMPKGSLENHLFRKGVQ------------------PISWPTRVKIAIDVARGLSFLHGLDANVI 153 (350)
Q Consensus 96 ----~~~~~~~~lv~e~~~~~~L~~~l~~~~~~------------------~l~~~~~~~i~~ql~~al~~lh~~~~~i~ 153 (350)
...+...++|+||+.+++|.+++...... ......+..++.|++.||.||| +.+|+
T Consensus 200 ~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH--~~gIi 277 (566)
T PLN03225 200 EPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH--STGIV 277 (566)
T ss_pred cccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH--HCCEE
Confidence 24556789999999999999998654310 1123346679999999999999 99999
Q ss_pred eCCCCCCceEEcC-CCcEEEccccccccCCCCCCCcccccccCCCcccCccccccC----------------------CC
Q 018785 154 YRDLKASNVLLDS-NFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG----------------------HL 210 (350)
Q Consensus 154 H~di~~~Nili~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~----------------------~~ 210 (350)
|+||||+|||++. ++.++|+|||++........ .......+++.|+|||.+... .+
T Consensus 278 HRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~ 356 (566)
T PLN03225 278 HRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNL 356 (566)
T ss_pred eCcCCHHHEEEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccC
Confidence 9999999999986 57899999999975433221 222335678899999965322 23
Q ss_pred CCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhHHHHHhhhcccCCC------CcHHHHHHHHHHHH
Q 018785 211 TPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQ------YSKKEAQAVAAVVL 284 (350)
Q Consensus 211 ~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~ 284 (350)
+.++||||+||++|+|+++..++..... .....+.... . +............... ..........+||.
T Consensus 357 ~~k~DVwSlGviL~el~~~~~~~~~~~~-~~~~~l~~~~-~---~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~ 431 (566)
T PLN03225 357 PDRFDIYSAGLIFLQMAFPNLRSDSNLI-QFNRQLKRND-Y---DLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLK 431 (566)
T ss_pred CCCcccHHHHHHHHHHHhCcCCCchHHH-HHHHHHHhcC-C---cHHHHHHhhccccchhhhhhhhhccccchHHHHHHH
Confidence 4567999999999999997765432110 0000000000 0 0000111111110000 00111234568999
Q ss_pred HhhccCCCCCCCHHHHHHH
Q 018785 285 QCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 285 ~~l~~dp~~Rps~~~ll~~ 303 (350)
+||+.||.+|||+.++++|
T Consensus 432 ~mL~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 432 SMMRFKGRQRISAKAALAH 450 (566)
T ss_pred HHccCCcccCCCHHHHhCC
Confidence 9999999999999999987
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=235.79 Aligned_cols=253 Identities=25% Similarity=0.361 Sum_probs=204.4
Q ss_pred hhhhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhh---HHHHHHHHHHHhcc-CCCcc
Q 018785 14 MISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQG---HKEWLTEVIYLGQL-RHENL 89 (350)
Q Consensus 14 ~~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~l-~h~~i 89 (350)
....+..++|.+.++||+|.|..|.++ ...++.+.+|+|+++++-..+ ......|-.+..+- +||.+
T Consensus 243 ~~~~l~l~df~ll~vigrgsyakvl~~---------~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pfl 313 (593)
T KOG0695|consen 243 ISQGLGLQDFDLLRVIGRGSYAKVLLV---------RLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFL 313 (593)
T ss_pred cccccccccceeeeeecCcchhhhhhe---------ehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeE
Confidence 345667789999999999999999999 667788999999998765433 23345566666665 69999
Q ss_pred cceeeEEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCc
Q 018785 90 VKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFN 169 (350)
Q Consensus 90 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~ 169 (350)
+-++.+|.++..+++|.||++||+|--.+.++. +++++.++.+...|+.||.||| ++||+++|||.+|++++..|.
T Consensus 314 vglhscfqtesrlffvieyv~ggdlmfhmqrqr--klpeeharfys~ei~lal~flh--~rgiiyrdlkldnvlldaegh 389 (593)
T KOG0695|consen 314 VGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEICLALNFLH--ERGIIYRDLKLDNVLLDAEGH 389 (593)
T ss_pred EehhhhhcccceEEEEEEEecCcceeeehhhhh--cCcHHHhhhhhHHHHHHHHHHh--hcCeeeeeccccceEEccCCc
Confidence 999999999999999999999999977676654 7999999999999999999999 999999999999999999999
Q ss_pred EEEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcc--cccCc--chhhh
Q 018785 170 AKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDE--DRGGL--AEQTL 245 (350)
Q Consensus 170 ~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~--~~~~~--~~~~~ 245 (350)
+||+|+|.+....... ......+|||.|.|||++.|..|.+..|.|+||+++++|+.|+.||.- +++.. ..+.+
T Consensus 390 ikltdygmcke~l~~g--d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedyl 467 (593)
T KOG0695|consen 390 IKLTDYGMCKEGLGPG--DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYL 467 (593)
T ss_pred eeecccchhhcCCCCC--cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHH
Confidence 9999999997643333 234457899999999999999999999999999999999999999963 22211 11111
Q ss_pred hhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCC
Q 018785 246 VEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPS 296 (350)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps 296 (350)
.+ -++.. ....|...+-....+++.-|..||.+|..
T Consensus 468 fq-------------vilek--qiriprslsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 468 FQ-------------VILEK--QIRIPRSLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred HH-------------HHhhh--cccccceeehhhHHHHHHhhcCCcHHhcC
Confidence 11 11111 12345667777888999999999999953
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-31 Score=250.13 Aligned_cols=278 Identities=21% Similarity=0.240 Sum_probs=186.3
Q ss_pred hhhhhcccccceecccCceeEEeecccCCCc-------CCCCCCCCcEEEEEEccccchhhHHH--------------HH
Q 018785 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTF-------APTKPGSGIVVAIKRLKAESFQGHKE--------------WL 75 (350)
Q Consensus 17 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~-------~~~~~~~~~~vaiK~~~~~~~~~~~~--------------~~ 75 (350)
.+..++|.+.++||+|+||+||+|.+..... .......++.||||.+.......... ..
T Consensus 141 r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~ 220 (507)
T PLN03224 141 RWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGM 220 (507)
T ss_pred CccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhH
Confidence 4567899999999999999999996532110 01233456789999986543222222 23
Q ss_pred HHHHHHhccCCCcc-----cceeeEEee--------cCceEEEEEcCCCCChhhHHhhcC--------------------
Q 018785 76 TEVIYLGQLRHENL-----VKLIGYCSE--------SDNRLLVYEFMPKGSLENHLFRKG-------------------- 122 (350)
Q Consensus 76 ~e~~~l~~l~h~~i-----~~~~~~~~~--------~~~~~lv~e~~~~~~L~~~l~~~~-------------------- 122 (350)
.|+..+.+++|.++ +++++++.. .+..++|+||+.+++|.+++....
T Consensus 221 vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~ 300 (507)
T PLN03224 221 VEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDN 300 (507)
T ss_pred HHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhh
Confidence 45666666655543 556666542 356899999999999999886421
Q ss_pred --CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccccccCCCCCCCcccccccCCCccc
Q 018785 123 --VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYA 200 (350)
Q Consensus 123 --~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~ 200 (350)
...++...++.++.|++.+|.|+| +.+++|+||||+||+++.++.++|+|||++......... ......+++.|+
T Consensus 301 ~~~~~~~~~~~~~i~~ql~~aL~~lH--~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~ 377 (507)
T PLN03224 301 MPQDKRDINVIKGVMRQVLTGLRKLH--RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYS 377 (507)
T ss_pred cccccCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCccee
Confidence 113456678899999999999999 899999999999999999999999999998653322111 111123478899
Q ss_pred CccccccCC--------------------CC--CccchhhHHHHHHHHHhCCC-CCcccccCcchhhhhhhcchhhhhhH
Q 018785 201 APEYVATGH--------------------LT--PKSDVYSFGVVLLELLSGRR-ALDEDRGGLAEQTLVEWADPFLRDSR 257 (350)
Q Consensus 201 aPE~~~~~~--------------------~~--~~~DiwslG~ll~~ll~g~~-pf~~~~~~~~~~~~~~~~~~~~~~~~ 257 (350)
+||.+.... +. .+.|+||+||++++|++|.. ||......... .... ..+..
T Consensus 378 aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~--~~~~----~~~~~ 451 (507)
T PLN03224 378 PPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTE--LRQY----DNDLN 451 (507)
T ss_pred ChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhH--Hhhc----cchHH
Confidence 999875322 11 24699999999999999876 66432211110 0000 00001
Q ss_pred HHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCC---CCCCCHHHHHHH
Q 018785 258 RVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDP---KNRPSMVDVLTS 303 (350)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp---~~Rps~~~ll~~ 303 (350)
..................++...+|+.+||..+| .+|+|++++|+|
T Consensus 452 ~~r~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 452 RWRMYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred HHHhhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 1111111122222334567899999999999766 689999999987
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=249.60 Aligned_cols=248 Identities=25% Similarity=0.366 Sum_probs=201.5
Q ss_pred hhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch---hhHHHHHHHHHHHhccCCCcccceeeE
Q 018785 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLVKLIGY 95 (350)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~ 95 (350)
.++-|..++-||-|+||.|.++ .+..+...+|.|.+.+... .+..+.+.|-.+|..-.++-|+++|-.
T Consensus 627 dKSmFvkik~iGvGAFGeV~Lv---------~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyyS 697 (1034)
T KOG0608|consen 627 DKSMFVKIKTIGVGAFGEVCLV---------RKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYS 697 (1034)
T ss_pred cccceEEEeeecccccceeEEE---------eecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEE
Confidence 3667889999999999999999 5666778899998876543 234557788899999999999999999
Q ss_pred EeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccc
Q 018785 96 CSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDF 175 (350)
Q Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Df 175 (350)
|.+.+.+|+||+|+.||++-.++.+.+ -|.+..++.++..+.-|+++.| ..|++||||||+|||||.+|.+||+||
T Consensus 698 FQDkdnLYFVMdYIPGGDmMSLLIrmg--IFeE~LARFYIAEltcAiesVH--kmGFIHRDiKPDNILIDrdGHIKLTDF 773 (1034)
T KOG0608|consen 698 FQDKDNLYFVMDYIPGGDMMSLLIRMG--IFEEDLARFYIAELTCAIESVH--KMGFIHRDIKPDNILIDRDGHIKLTDF 773 (1034)
T ss_pred eccCCceEEEEeccCCccHHHHHHHhc--cCHHHHHHHHHHHHHHHHHHHH--hccceecccCccceEEccCCceeeeec
Confidence 999999999999999999999998876 7999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCC---------CCCCc-------------------------------ccccccCCCcccCccccccCCCCCccc
Q 018785 176 GLARDGPT---------GDNTH-------------------------------VSTRIVGTRGYAAPEYVATGHLTPKSD 215 (350)
Q Consensus 176 g~~~~~~~---------~~~~~-------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~D 215 (350)
|++..+.- ++... ......||+.|+|||++....++...|
T Consensus 774 GLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cd 853 (1034)
T KOG0608|consen 774 GLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCD 853 (1034)
T ss_pred cccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccch
Confidence 99973211 11000 001146999999999999999999999
Q ss_pred hhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCC
Q 018785 216 VYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRP 295 (350)
Q Consensus 216 iwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 295 (350)
.|+.|++||+|+.|+.||....+......+..|.. ++ .-.+...++.++.+||.+++. +++.|.
T Consensus 854 wws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~-----------~l----~~~~~~~ls~e~~~li~kLc~-sad~RL 917 (1034)
T KOG0608|consen 854 WWSVGVILYEMLVGQPPFLADTPGETQYKVINWRN-----------FL----HIPYQGNLSKEALDLIQKLCC-SADSRL 917 (1034)
T ss_pred hhHhhHHHHHHhhCCCCccCCCCCcceeeeeehhh-----------cc----ccccccccCHHHHHHHHHHhc-Chhhhh
Confidence 99999999999999999988777666665555432 11 112334567778888877543 555663
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-32 Score=257.73 Aligned_cols=245 Identities=28% Similarity=0.416 Sum_probs=188.1
Q ss_pred ccccceecccCce-eEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhcc-CCCcccceeeEEeecC
Q 018785 23 FCSDYLLGEGGFG-CVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQL-RHENLVKLIGYCSESD 100 (350)
Q Consensus 23 y~i~~~lg~G~~g-~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~ 100 (350)
|.-.+++|.|+.| .||+|.+. |+.||||.+-.+.. .-..+|+..|+.- .||||+++++.-.+..
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye-----------~R~VAVKrll~e~~---~~A~rEi~lL~eSD~H~NviRyyc~E~d~q 576 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE-----------GREVAVKRLLEEFF---DFAQREIQLLQESDEHPNVIRYYCSEQDRQ 576 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC-----------CceehHHHHhhHhH---HHHHHHHHHHHhccCCCceEEEEeeccCCc
Confidence 4445678899888 56999775 67899998866543 2356899999888 6999999999999999
Q ss_pred ceEEEEEcCCCCChhhHHhhc--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcC---C--CcEEEc
Q 018785 101 NRLLVYEFMPKGSLENHLFRK--GVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS---N--FNAKLS 173 (350)
Q Consensus 101 ~~~lv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~---~--~~~~l~ 173 (350)
..||..|.| .++|.+++... ..........+.+..|+++||++|| +.+|+||||||.||||+. + ..++|.
T Consensus 577 F~YIalELC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLH--sl~iVHRDLkPQNILI~~~~~~~~~ra~iS 653 (903)
T KOG1027|consen 577 FLYIALELC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLH--SLKIVHRDLKPQNILISVPSADGTLRAKIS 653 (903)
T ss_pred eEEEEehHh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHH--hcccccccCCCceEEEEccCCCcceeEEec
Confidence 999999999 77999999874 1111121356788899999999999 899999999999999976 3 458999
Q ss_pred cccccccCCCCCCCc-ccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhC-CCCCcccccCcchhhhhhhcch
Q 018785 174 DFGLARDGPTGDNTH-VSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSG-RRALDEDRGGLAEQTLVEWADP 251 (350)
Q Consensus 174 Dfg~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g-~~pf~~~~~~~~~~~~~~~~~~ 251 (350)
|||++.......... ......|+.+|+|||++.......+.|||||||++|+.++| .+||......+.
T Consensus 654 DfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~---------- 723 (903)
T KOG1027|consen 654 DFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA---------- 723 (903)
T ss_pred ccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh----------
Confidence 999998876655432 23456799999999999999888899999999999999886 889975432110
Q ss_pred hhhhhHHHHHhhhcccC-CCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 252 FLRDSRRVLRIMDTRLG-GQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 252 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
.++..... ..+......+..+||.+|+.++|..||++.+++.|
T Consensus 724 ---------NIl~~~~~L~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 724 ---------NILTGNYTLVHLEPLPDCEAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred ---------hhhcCccceeeeccCchHHHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 01110000 00111111188999999999999999999999876
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-33 Score=230.93 Aligned_cols=271 Identities=25% Similarity=0.390 Sum_probs=209.0
Q ss_pred hhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccc--hhhHHHHHHHHHHHhccCCCcccceeeEEe
Q 018785 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES--FQGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (350)
Q Consensus 20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (350)
..+.+-.+.||-|+||.||.+ .+..+|+.|++|.+..-. ......+.+|+.+|..++|.|++..+++..
T Consensus 52 q~Di~PDRPIGYGAFGVVWsV---------TDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQ 122 (449)
T KOG0664|consen 52 QQDIQPDRPIGYGAFGVVWSV---------TDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQ 122 (449)
T ss_pred cccCCCCCcccccceeEEEec---------cCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcC
Confidence 346778899999999999999 888899999999886432 234567889999999999999999998865
Q ss_pred ec-----CceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEE
Q 018785 98 ES-----DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKL 172 (350)
Q Consensus 98 ~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l 172 (350)
-. ..+|+++|.+ ..+|...+.+- +.++...++-++.||+.+|.||| +.+|.||||||.|.+++.|..+|+
T Consensus 123 Pph~dfFqEiYV~TELm-QSDLHKIIVSP--Q~Ls~DHvKVFlYQILRGLKYLH--sA~ILHRDIKPGNLLVNSNCvLKI 197 (449)
T KOG0664|consen 123 PANPSFFQELYVLTELM-QSDLHKIIVSP--QALTPDHVKVFVYQILRGLKYLH--TANILHRDIKPGNLLVNSNCILKI 197 (449)
T ss_pred CCCchHHHHHHHHHHHH-HhhhhheeccC--CCCCcchhhhhHHHHHhhhHHHh--hcchhhccCCCccEEeccCceEEe
Confidence 43 3567888888 55787777554 37888899999999999999999 999999999999999999999999
Q ss_pred ccccccccCCCCCCCcccccccCCCcccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcc-
Q 018785 173 SDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD- 250 (350)
Q Consensus 173 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~- 250 (350)
+|||+++.... +.....+....|.+|+|||++.|. .|+.+.||||+||++.||+..+..|..-.+-+..+.+.++..
T Consensus 198 CDFGLARvee~-d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGT 276 (449)
T KOG0664|consen 198 CDFGLARTWDQ-RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGT 276 (449)
T ss_pred cccccccccch-hhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCC
Confidence 99999986433 333344556678899999999886 799999999999999999999999987776666666655433
Q ss_pred hhhhhhHHH-----HHhhhcccCCC---------CcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018785 251 PFLRDSRRV-----LRIMDTRLGGQ---------YSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 305 (350)
Q Consensus 251 ~~~~~~~~~-----~~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~ 305 (350)
|.+.+.... ..++......+ .+..-.-+..+++.+++..||++|.+..+.+.++.
T Consensus 277 Ps~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 277 PSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred CcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 333322111 11111111111 11123346778899999999999999999887754
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-32 Score=244.66 Aligned_cols=197 Identities=28% Similarity=0.376 Sum_probs=170.6
Q ss_pred hcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhH--------HHHHHHHHHHhccC---CCcc
Q 018785 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGH--------KEWLTEVIYLGQLR---HENL 89 (350)
Q Consensus 21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~--------~~~~~e~~~l~~l~---h~~i 89 (350)
.+|...+.||.|+||.|++| .++.+...|+||.+.++..-.. -..-.|+++|..++ |+||
T Consensus 561 s~yttlq~lG~GAyGkV~la---------i~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NI 631 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLA---------IHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENI 631 (772)
T ss_pred ccceeeeeccccccceEEEe---------eecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccch
Confidence 46999999999999999999 6667788999999977643211 11345888888886 9999
Q ss_pred cceeeEEeecCceEEEEEc-CCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCC
Q 018785 90 VKLIGYCSESDNRLLVYEF-MPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNF 168 (350)
Q Consensus 90 ~~~~~~~~~~~~~~lv~e~-~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~ 168 (350)
++++++|++++..||+||. -+|-+|.+++..++ .+++.++..|+.|++.|+++|| +.||+|||||-+|+.++.+|
T Consensus 632 lKlLdfFEddd~yyl~te~hg~gIDLFd~IE~kp--~m~E~eAk~IFkQV~agi~hlh--~~~ivhrdikdenvivd~~g 707 (772)
T KOG1152|consen 632 LKLLDFFEDDDYYYLETEVHGEGIDLFDFIEFKP--RMDEPEAKLIFKQVVAGIKHLH--DQGIVHRDIKDENVIVDSNG 707 (772)
T ss_pred hhhhheeecCCeeEEEecCCCCCcchhhhhhccC--ccchHHHHHHHHHHHhcccccc--ccCceecccccccEEEecCC
Confidence 9999999999999999997 46679999998887 7999999999999999999999 99999999999999999999
Q ss_pred cEEEccccccccCCCCCCCcccccccCCCcccCccccccCCC-CCccchhhHHHHHHHHHhCCCCCc
Q 018785 169 NAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHL-TPKSDVYSFGVVLLELLSGRRALD 234 (350)
Q Consensus 169 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~DiwslG~ll~~ll~g~~pf~ 234 (350)
-++|+|||.+.....+. .....||..|.|||++.|..| ...-|||+||++||.++....||-
T Consensus 708 ~~klidfgsaa~~ksgp----fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 708 FVKLIDFGSAAYTKSGP----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred eEEEeeccchhhhcCCC----cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 99999999997643332 344679999999999988877 467899999999999999998874
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-30 Score=215.88 Aligned_cols=212 Identities=38% Similarity=0.592 Sum_probs=182.5
Q ss_pred ecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh-hHHHHHHHHHHHhccCCCcccceeeEEeecCceEEEEE
Q 018785 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ-GHKEWLTEVIYLGQLRHENLVKLIGYCSESDNRLLVYE 107 (350)
Q Consensus 29 lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 107 (350)
||.|.+|.||++ ....+++.+++|.+...... ....+.+|+..++.+.|++++++++++......++++|
T Consensus 1 l~~g~~~~v~~~---------~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e 71 (215)
T cd00180 1 LGEGGFGTVYLA---------RDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVME 71 (215)
T ss_pred CCcCCceEEEEE---------EecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEe
Confidence 689999999999 55556889999998876543 34668899999999999999999999999999999999
Q ss_pred cCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcC-CCcEEEccccccccCCCCCC
Q 018785 108 FMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS-NFNAKLSDFGLARDGPTGDN 186 (350)
Q Consensus 108 ~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~-~~~~~l~Dfg~~~~~~~~~~ 186 (350)
++.+++|.+++.... ..++...+..++.+++.++.+|| +.|++|+||+|.||+++. ++.++|+|||.+........
T Consensus 72 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh--~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~ 148 (215)
T cd00180 72 YCEGGSLKDLLKENE-GKLSEDEILRILLQILEGLEYLH--SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS 148 (215)
T ss_pred cCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH--hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc
Confidence 998899999987653 35889999999999999999999 899999999999999999 89999999999976433321
Q ss_pred CcccccccCCCcccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhHHHHHhhhc
Q 018785 187 THVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDT 265 (350)
Q Consensus 187 ~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (350)
......+...|.+||..... ..+.++|+|++|+++++|
T Consensus 149 --~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------------- 187 (215)
T cd00180 149 --LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------------- 187 (215)
T ss_pred --hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------------
Confidence 12224467789999988776 888999999999999999
Q ss_pred ccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018785 266 RLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL 304 (350)
Q Consensus 266 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 304 (350)
..+.+++.+|++.||.+||++.++++++
T Consensus 188 -----------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 -----------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred -----------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 3677899999999999999999998753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=224.37 Aligned_cols=265 Identities=26% Similarity=0.330 Sum_probs=201.6
Q ss_pred hhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccc--hhhHHHHHHHHHHHhccCCCcccceeeEE
Q 018785 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES--FQGHKEWLTEVIYLGQLRHENLVKLIGYC 96 (350)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (350)
...||.-.+.+|.|.- .|..+ .+.-.+++|++|.+..+. ....+...+|+.++..++|+||++++.+|
T Consensus 15 v~~Ry~nL~p~~~g~~-~v~~a---------~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~f 84 (369)
T KOG0665|consen 15 VPKRYVNLKPIGSGAQ-IVVAA---------FDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVF 84 (369)
T ss_pred eeeeeeeecccCCCCc-eEEec---------chhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeecc
Confidence 3568889999999998 67777 778889999999876552 23346677899999999999999999998
Q ss_pred eec------CceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcE
Q 018785 97 SES------DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNA 170 (350)
Q Consensus 97 ~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~ 170 (350)
.-. ...|+|||++ ..+|...+.. .++-..+..++.|++.|+.|+| +.||+||||||+||++..++.+
T Consensus 85 tP~~~l~~~~e~y~v~e~m-~~nl~~vi~~----elDH~tis~i~yq~~~~ik~lh--s~~IihRdLkPsnivv~~~~~l 157 (369)
T KOG0665|consen 85 TPQKTLEEFQEVYLVMELM-DANLCQVILM----ELDHETISYILYQMLCGIKHLH--SAGIIHRDLKPSNIVVNSDCTL 157 (369)
T ss_pred CccccHHHHHhHHHHHHhh-hhHHHHHHHH----hcchHHHHHHHHHHHHHHHHHH--hcceeecccCcccceecchhhe
Confidence 543 3568999999 6699998873 4788899999999999999999 9999999999999999999999
Q ss_pred EEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhh-c
Q 018785 171 KLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEW-A 249 (350)
Q Consensus 171 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~-~ 249 (350)
|+.|||++...... -..+....+..|+|||++.+..+....||||+||++.+|++|+..|.+.+.-.....+.+. +
T Consensus 158 Ki~dfg~ar~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lg 234 (369)
T KOG0665|consen 158 KILDFGLARTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLG 234 (369)
T ss_pred eeccchhhcccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhc
Confidence 99999999853332 3445567788899999999999999999999999999999999999865532222222211 1
Q ss_pred c---hhhhhhHHHHHhhh------------cc-cCC------CCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 250 D---PFLRDSRRVLRIMD------------TR-LGG------QYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 250 ~---~~~~~~~~~~~~~~------------~~-~~~------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
. .+..+...-....- .. .+. +.+..-+..+++++.+||-.||++|.|++++|.|
T Consensus 235 tpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 235 TPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred CCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 1 11111000000000 00 000 1112234578899999999999999999999987
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=207.41 Aligned_cols=208 Identities=26% Similarity=0.343 Sum_probs=168.9
Q ss_pred hhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhh-HHHHHHHHHHHhcc-CCCccccee
Q 018785 16 SKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQG-HKEWLTEVIYLGQL-RHENLVKLI 93 (350)
Q Consensus 16 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~e~~~l~~l-~h~~i~~~~ 93 (350)
.++...+......||+|++|.|=+- .+..+|...|+|.+......+ ...+.+|+.+..+- .+|.++.+|
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekm---------rh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~Fy 111 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKM---------RHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFY 111 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhhe---------eeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEee
Confidence 4566667777889999999988776 677889999999987764432 24466677766554 699999999
Q ss_pred eEEeecCceEEEEEcCCCCChhhHHhhc--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEE
Q 018785 94 GYCSESDNRLLVYEFMPKGSLENHLFRK--GVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAK 171 (350)
Q Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~ 171 (350)
+.+......++.||.+ ..+|..|..+- .+..+++..+-+|+..+++||.|||+ +..++|||+||.|||++.+|.||
T Consensus 112 Ga~~regdvwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~-kL~vIHRDvKPsNiLIn~~GqVK 189 (282)
T KOG0984|consen 112 GALFREGDVWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS-KLSVIHRDVKPSNILINYDGQVK 189 (282)
T ss_pred hhhhccccEEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH-HhhhhhccCCcceEEEccCCcEE
Confidence 9998889999999998 56887776432 33578999999999999999999997 78999999999999999999999
Q ss_pred EccccccccCCCCCCCcccccccCCCcccCcccccc----CCCCCccchhhHHHHHHHHHhCCCCCcccc
Q 018785 172 LSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT----GHLTPKSDVYSFGVVLLELLSGRRALDEDR 237 (350)
Q Consensus 172 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~----~~~~~~~DiwslG~ll~~ll~g~~pf~~~~ 237 (350)
++|||++......-. .+...|..-|+|||.+.. ..|+.++||||||+++.||.+++.||....
T Consensus 190 iCDFGIsG~L~dSiA---kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~ 256 (282)
T KOG0984|consen 190 ICDFGISGYLVDSIA---KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG 256 (282)
T ss_pred EcccccceeehhhhH---HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence 999999975433221 222346667999998743 478999999999999999999999997543
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-28 Score=208.00 Aligned_cols=275 Identities=18% Similarity=0.218 Sum_probs=225.3
Q ss_pred hhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhcc-CCCcccceeeEE
Q 018785 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQL-RHENLVKLIGYC 96 (350)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~ 96 (350)
+.+-.|++.++||+|.||.++.| .+.-++++||||..+..+ ....++.|+...+.| ..++|...|-+.
T Consensus 25 ~VG~hyrVGkKIGeGsFG~lf~G---------~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFG 93 (449)
T KOG1165|consen 25 MVGPHYRVGKKIGEGSFGVLFLG---------KNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFG 93 (449)
T ss_pred EecccceeccccccCcceeeecc---------cccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeec
Confidence 56789999999999999999999 788889999999877665 456788999999998 589999999888
Q ss_pred eecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCC-----cEE
Q 018785 97 SESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNF-----NAK 171 (350)
Q Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~-----~~~ 171 (350)
.++-+-.||+|.+ |.+|.|++...+ ..|+...+..++.|++.-++++| .+.++.|||||+|+||...+ .+.
T Consensus 94 qeG~~NiLVidLL-GPSLEDLFD~Cg-R~FSvKTV~miA~Qmi~rie~vH--~k~LIYRDIKPdNFLIGrp~~k~~n~Ih 169 (449)
T KOG1165|consen 94 QEGKYNILVIDLL-GPSLEDLFDLCG-RRFSVKTVAMIAKQMITRIEYVH--EKDLIYRDIKPDNFLIGRPGTKDANVIH 169 (449)
T ss_pred cccchhhhhhhhh-CcCHHHHHHHhc-CcccHHhHHHHHHHHHHHHHHHH--hcceeecccCccceeecCCCCCCCceEE
Confidence 8888889999999 999999887655 58999999999999999999999 99999999999999996533 489
Q ss_pred EccccccccCCCCCCCccc-----ccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhh
Q 018785 172 LSDFGLARDGPTGDNTHVS-----TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLV 246 (350)
Q Consensus 172 l~Dfg~~~~~~~~~~~~~~-----~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~ 246 (350)
++|||++..+......... ....||.+||+...+.|...+.+.|+-|||-+++++|-|..||.+.......+...
T Consensus 170 iiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYe 249 (449)
T KOG1165|consen 170 IIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYE 249 (449)
T ss_pred EEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHH
Confidence 9999999876555443222 23679999999999999999999999999999999999999999876544443333
Q ss_pred hhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcCCCCCCCCC
Q 018785 247 EWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDMPRTPP 318 (350)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~~~~~~ 318 (350)
+..+...... ...+...+|.++..-+.-.-..+-.+-|+.+.+...+.++.......-...
T Consensus 250 KIGe~Kr~T~-----------i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~t~Dg~ 310 (449)
T KOG1165|consen 250 KIGETKRSTP-----------IEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGETDDGE 310 (449)
T ss_pred HhccccccCC-----------HHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCCccccc
Confidence 3222111100 011234578899999999999999999999999999999998876664433
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=209.17 Aligned_cols=200 Identities=34% Similarity=0.481 Sum_probs=172.1
Q ss_pred ccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh-hHHHHHHHHHHHhccCCCcccceeeEEeecCc
Q 018785 23 FCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ-GHKEWLTEVIYLGQLRHENLVKLIGYCSESDN 101 (350)
Q Consensus 23 y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 101 (350)
|.+.+.||.|++|.||++ ....+++.+++|.+...... ....+..|+..++.++|++++++++.+.....
T Consensus 1 ~~~~~~i~~g~~~~v~~~---------~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~ 71 (225)
T smart00221 1 YELGKKLGEGAFGKVYLA---------RDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEP 71 (225)
T ss_pred CceeeEeecCCCeEEEEE---------EEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCc
Confidence 678899999999999999 55556789999999877654 56778899999999999999999999999999
Q ss_pred eEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccccccC
Q 018785 102 RLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDG 181 (350)
Q Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~~~ 181 (350)
.++++|++.+++|.+++..... .++...+..++.+++.++.+|| +.+++|+||+|.||+++.++.++|+|||.+...
T Consensus 72 ~~~v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh--~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~ 148 (225)
T smart00221 72 LYLVMEYCEGGDLFDYLRKKGG-KLSEEEARFYLRQILEALEYLH--SLGIVHRDLKPENILLGMDGLVKLADFGLARFI 148 (225)
T ss_pred eEEEEeccCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEEcCCCCEEEeeCceeeEe
Confidence 9999999988899999977642 1788999999999999999999 889999999999999999999999999998765
Q ss_pred CCCCCCcccccccCCCcccCcccc-ccCCCCCccchhhHHHHHHHHHhCCCCCcc
Q 018785 182 PTGDNTHVSTRIVGTRGYAAPEYV-ATGHLTPKSDVYSFGVVLLELLSGRRALDE 235 (350)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~~DiwslG~ll~~ll~g~~pf~~ 235 (350)
...... ......+...|++||.+ ....++.++|+|+||+++++|++|+.||..
T Consensus 149 ~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 149 HRDLAA-LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cCcccc-cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 443211 11223466779999988 666778899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=208.33 Aligned_cols=254 Identities=22% Similarity=0.329 Sum_probs=190.4
Q ss_pred hhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccC-CCcccceeeE-Ee
Q 018785 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLR-HENLVKLIGY-CS 97 (350)
Q Consensus 20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~-~~ 97 (350)
.+.|.|.+.||.|.||.+-++ .+..+...+++|.++.+... ..++.+|...--.|+ |.||+.-|++ |.
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~---------eHr~s~t~ivlKavp~p~tt-~~dF~rEfhY~~~Ls~H~hIi~tY~vaFq 92 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLA---------EHRQSKTRIVLKAVPRPQTT-QADFVREFHYSFFLSPHQHIIDTYEVAFQ 92 (378)
T ss_pred hhhhhHHHHhcccceeeEEee---------eccCCceEEEeeccCcchhh-HHHHHHHhccceeeccchhhhHHHHHHhh
Confidence 468999999999999999999 88899999999999887643 567888888777774 9999998886 66
Q ss_pred ecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcC--CCcEEEccc
Q 018785 98 ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS--NFNAKLSDF 175 (350)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~--~~~~~l~Df 175 (350)
..+..++++||++.|+|.+-+... .+.+.....++.|+++||.|+| +++++|||||.+||||-. ...+||+||
T Consensus 93 t~d~YvF~qE~aP~gdL~snv~~~---GigE~~~K~v~~ql~SAi~fMH--sknlVHRdlK~eNiLif~~df~rvKlcDF 167 (378)
T KOG1345|consen 93 TSDAYVFVQEFAPRGDLRSNVEAA---GIGEANTKKVFAQLLSAIEFMH--SKNLVHRDLKAENILIFDADFYRVKLCDF 167 (378)
T ss_pred cCceEEEeeccCccchhhhhcCcc---cccHHHHHHHHHHHHHHHHHhh--ccchhhcccccceEEEecCCccEEEeeec
Confidence 777888999999999999888765 5889999999999999999999 999999999999999943 347999999
Q ss_pred cccccCCCCCCCcccccccCCCcccCccccccC-----CCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcc
Q 018785 176 GLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG-----HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD 250 (350)
Q Consensus 176 g~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-----~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~ 250 (350)
|..+.... ...+......|.+||..... ...+.+|+|+||+++|.+++|..||+......
T Consensus 168 G~t~k~g~-----tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d---------- 232 (378)
T KOG1345|consen 168 GLTRKVGT-----TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMD---------- 232 (378)
T ss_pred ccccccCc-----eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccC----------
Confidence 99975211 11122234458888865332 34678999999999999999999997322110
Q ss_pred hhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCC---CCHHHHHHHH
Q 018785 251 PFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNR---PSMVDVLTSL 304 (350)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R---ps~~~ll~~L 304 (350)
+...+.....+......+ ......++.+.++.++-|.+++++| .+.......+
T Consensus 233 ~~Y~~~~~w~~rk~~~~P-~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~ 288 (378)
T KOG1345|consen 233 KPYWEWEQWLKRKNPALP-KKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCL 288 (378)
T ss_pred chHHHHHHHhcccCccCc-hhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHH
Confidence 111111222222222111 1223467788999999999999999 4444444443
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-30 Score=235.44 Aligned_cols=255 Identities=25% Similarity=0.362 Sum_probs=207.5
Q ss_pred hhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceeeEEe
Q 018785 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (350)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (350)
-...+|.....+|+|.+|.||++ .++.+++..|+|+++..-..+..-+.+|+-+++..+||||+.+++.+.
T Consensus 12 nP~ddyellqrvgsgTygdvyKa---------Rd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsyl 82 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKA---------RDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYL 82 (829)
T ss_pred CCccchhheeeecCCcccchhhh---------cccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhh
Confidence 45689999999999999999999 777889999999999887777777889999999999999999999999
Q ss_pred ecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccc
Q 018785 98 ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL 177 (350)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~ 177 (350)
..+.++++||||.||+|.+...-.+ .+++.++..+++.-+.+++||| +.|=+|||||-.||+++..|.++|.|||.
T Consensus 83 r~dklwicMEycgggslQdiy~~Tg--plselqiayvcRetl~gl~ylh--s~gk~hRdiKGanilltd~gDvklaDfgv 158 (829)
T KOG0576|consen 83 RRDKLWICMEYCGGGSLQDIYHVTG--PLSELQIAYVCRETLQGLKYLH--SQGKIHRDIKGANILLTDEGDVKLADFGV 158 (829)
T ss_pred hhcCcEEEEEecCCCcccceeeecc--cchhHHHHHHHhhhhccchhhh--cCCcccccccccceeecccCceeecccCc
Confidence 9999999999999999999775554 8999999999999999999999 89999999999999999999999999999
Q ss_pred cccCCCCCCCcccccccCCCcccCcccc---ccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhh--hhcchh
Q 018785 178 ARDGPTGDNTHVSTRIVGTRGYAAPEYV---ATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLV--EWADPF 252 (350)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~---~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~--~~~~~~ 252 (350)
+-.. ...-.+....+|++.|+|||+- ....|...+|+|++|+...++-.-+.|.....+........ .+..+.
T Consensus 159 saqi--tati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~ 236 (829)
T KOG0576|consen 159 SAQI--TATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPT 236 (829)
T ss_pred hhhh--hhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCc
Confidence 8542 2222233347899999999976 45678999999999999999988777654333211111111 011111
Q ss_pred hhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 253 LRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
+.+ ...-++.+.+|++.+|..+|++||+++.+|.|
T Consensus 237 lkD----------------k~kws~~fh~fvK~altknpKkRptaeklL~h 271 (829)
T KOG0576|consen 237 LKD----------------KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQH 271 (829)
T ss_pred ccC----------------CccchHHHHHHHHHHhcCCCccCCChhhheec
Confidence 111 12335678899999999999999999987764
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-29 Score=217.75 Aligned_cols=272 Identities=22% Similarity=0.308 Sum_probs=200.9
Q ss_pred hhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhcc-CCCcccceeeE
Q 018785 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQL-RHENLVKLIGY 95 (350)
Q Consensus 17 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~ 95 (350)
....+.|.++.+||.|.|++||++.+.. ....++.||+|.+...+. ...+..|+++|..+ .+.||+++.+.
T Consensus 32 p~~~~~~~~v~kigeGsFssv~~a~~~~------~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~ 103 (418)
T KOG1167|consen 32 PFISNAYKVVNKIGEGSFSSVYKATDIE------QDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGC 103 (418)
T ss_pred hhhhhhhhhhccccccchhhhhhhhHhh------hccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhh
Confidence 3445789999999999999999995431 123688999999987763 34578899999999 59999999999
Q ss_pred EeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcC-CCcEEEcc
Q 018785 96 CSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS-NFNAKLSD 174 (350)
Q Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~-~~~~~l~D 174 (350)
+..++...+|+||++.....++.. .++..++..+++.++.||.++| .+||+||||||.|++.+. .+.-.|+|
T Consensus 104 ~rnnd~v~ivlp~~~H~~f~~l~~-----~l~~~~i~~Yl~~ll~Al~~~h--~~GIvHRDiKpsNFL~n~~t~rg~LvD 176 (418)
T KOG1167|consen 104 FRNNDQVAIVLPYFEHDRFRDLYR-----SLSLAEIRWYLRNLLKALAHLH--KNGIVHRDIKPSNFLYNRRTQRGVLVD 176 (418)
T ss_pred hccCCeeEEEecccCccCHHHHHh-----cCCHHHHHHHHHHHHHHhhhhh--ccCccccCCCccccccccccCCceEEe
Confidence 999999999999999999988885 4678899999999999999999 999999999999999975 56789999
Q ss_pred ccccccCCCCC--------------C-------------------Cc---------ccccccCCCcccCccccccC-CCC
Q 018785 175 FGLARDGPTGD--------------N-------------------TH---------VSTRIVGTRGYAAPEYVATG-HLT 211 (350)
Q Consensus 175 fg~~~~~~~~~--------------~-------------------~~---------~~~~~~~~~~~~aPE~~~~~-~~~ 211 (350)
||++....... . .. ......||++|+|||++... ..+
T Consensus 177 FgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qt 256 (418)
T KOG1167|consen 177 FGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQT 256 (418)
T ss_pred chhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcC
Confidence 99987210000 0 00 00114699999999998664 567
Q ss_pred CccchhhHHHHHHHHHhCCCCCcccccCcc-hhhhh-hhcchhh-------------h------------hhHHH-HHhh
Q 018785 212 PKSDVYSFGVVLLELLSGRRALDEDRGGLA-EQTLV-EWADPFL-------------R------------DSRRV-LRIM 263 (350)
Q Consensus 212 ~~~DiwslG~ll~~ll~g~~pf~~~~~~~~-~~~~~-~~~~~~~-------------~------------~~~~~-~~~~ 263 (350)
.++||||.|+++..++++..||.....+.. ...+. -+.+..+ . ....+ ...+
T Consensus 257 taiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~ 336 (418)
T KOG1167|consen 257 TAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESI 336 (418)
T ss_pred CccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhc
Confidence 899999999999999999999965443321 11111 1111000 0 01111 0000
Q ss_pred hc-cc---CCC-CcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 264 DT-RL---GGQ-YSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 264 ~~-~~---~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
.. .. ... .....+..+.+|+.+||..||.+|.|+++.|+|
T Consensus 337 ~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 337 YKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred ccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 00 00 011 112334589999999999999999999999976
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.4e-28 Score=196.14 Aligned_cols=274 Identities=20% Similarity=0.229 Sum_probs=218.1
Q ss_pred hhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccC-CCcccceeeEE
Q 018785 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLR-HENLVKLIGYC 96 (350)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~ 96 (350)
+.+++|+++++||+|+||.+|+| ....+|+.||||+..... ....+.-|..+.+.|+ ..+|..+..++
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~---------~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~ 80 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLG---------ISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYG 80 (341)
T ss_pred eeccceEEEEeecCCchhheeee---------eeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhc
Confidence 45789999999999999999999 888899999999876543 2345677888888885 68888888899
Q ss_pred eecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCC---CcEEEc
Q 018785 97 SESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSN---FNAKLS 173 (350)
Q Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~---~~~~l~ 173 (350)
.+...-.+||+.+ |.+|.+++.-.. ..++..+++-++.|++.-++|+| .++++|+||||+|++..-+ ..+.|+
T Consensus 81 ~e~~ynvlVMdLL-GPsLEdLfnfC~-R~ftmkTvLMLaDQml~RiEyvH--~r~fiHRDIKPdNFLMGlgrh~~kl~LI 156 (341)
T KOG1163|consen 81 TEKDYNVLVMDLL-GPSLEDLFNFCS-RRFTMKTVLMLADQMLSRIEYVH--LRNFIHRDIKPDNFLMGLGRHCNKLYLI 156 (341)
T ss_pred cccccceeeeecc-CccHHHHHHHHh-hhhhHHhHHHHHHHHHHHHHHHH--hhccccccCCccceeeccccccceEEEE
Confidence 9999999999999 999999886544 47999999999999999999999 9999999999999999654 459999
Q ss_pred cccccccCCCCCCCcc-----cccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhh
Q 018785 174 DFGLARDGPTGDNTHV-----STRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEW 248 (350)
Q Consensus 174 Dfg~~~~~~~~~~~~~-----~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~ 248 (350)
|||++..+........ .....||.+|.+-..+.+...+.+.|+-|+|.++.++.-|..||++.......+.....
T Consensus 157 DFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI 236 (341)
T KOG1163|consen 157 DFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKI 236 (341)
T ss_pred eccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHH
Confidence 9999987655433222 22357899999999888889999999999999999999999999987754443333322
Q ss_pred cchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcCCCCCCCC
Q 018785 249 ADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDMPRTP 317 (350)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~~~~~ 317 (350)
.+..+ ......+....|.++.-.+.-|-..--++-|+...+.+.+..++...+-....
T Consensus 237 ~EkK~-----------s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~~~d~ 294 (341)
T KOG1163|consen 237 SEKKM-----------STPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNHQYDY 294 (341)
T ss_pred HHhhc-----------CCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhccccCCe
Confidence 11111 11111123456778888888899888999999999999888888876655443
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.3e-27 Score=211.11 Aligned_cols=265 Identities=23% Similarity=0.226 Sum_probs=205.7
Q ss_pred cccccceecccCceeEEeecccCCCcCCCCCCC-CcEEEEEEccccchhhHHHHHHHHHHHhccC----CCcccceeeEE
Q 018785 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGS-GIVVAIKRLKAESFQGHKEWLTEVIYLGQLR----HENLVKLIGYC 96 (350)
Q Consensus 22 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~----h~~i~~~~~~~ 96 (350)
+|.+.++||+|+||.||.+.. ... ...+|+|............+..|..++..+. .+++..+++.+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~---------~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G 89 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSD---------KSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHG 89 (322)
T ss_pred ceEEeeeccccCCceEEEEEe---------cCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEec
Confidence 899999999999999999943 333 4678888877654333336677888888886 36889999998
Q ss_pred -eecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCC-----CcE
Q 018785 97 -SESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSN-----FNA 170 (350)
Q Consensus 97 -~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~-----~~~ 170 (350)
......|+||+.+ |.+|.++....+...++..++..++.|++.+|.++| +.|++||||||.|+++... ..+
T Consensus 90 ~~~~~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH--~~G~iHRDiKp~N~~~g~~~~~~~~~~ 166 (322)
T KOG1164|consen 90 RSTEDFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLH--SKGFIHRDIKPENFVVGQSSRSEVRTL 166 (322)
T ss_pred cCCCceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHH--hcCcccCCcCHHHeeecCCCCcccceE
Confidence 4777889999988 999999887776678999999999999999999999 9999999999999999765 359
Q ss_pred EEccccccc--cCCCCCCC--cc----cccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcch
Q 018785 171 KLSDFGLAR--DGPTGDNT--HV----STRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAE 242 (350)
Q Consensus 171 ~l~Dfg~~~--~~~~~~~~--~~----~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~ 242 (350)
.|+|||+++ ........ .. .....||..|+++.++.+...+.+.|+||+++++.+++.|..||.........
T Consensus 167 ~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~ 246 (322)
T KOG1164|consen 167 YLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLK 246 (322)
T ss_pred EEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchH
Confidence 999999998 32222211 11 12345999999999999999999999999999999999999999665543222
Q ss_pred hhhhhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcCCC
Q 018785 243 QTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKD 312 (350)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~ 312 (350)
..+......... .......+.++.++...+-..+..++|....+...|.+......
T Consensus 247 ~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~~ 302 (322)
T KOG1164|consen 247 SKFEKDPRKLLT--------------DRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSEG 302 (322)
T ss_pred HHHHHHhhhhcc--------------ccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhcC
Confidence 222211110000 00223345677788888888999999999999999998888763
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=4e-26 Score=187.76 Aligned_cols=166 Identities=23% Similarity=0.241 Sum_probs=127.2
Q ss_pred CChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccccccCCCCCCCcccc
Q 018785 112 GSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVST 191 (350)
Q Consensus 112 ~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~ 191 (350)
|+|.+++..++ ..+++..++.++.|++.||.||| +.+ ||+||+++.++.+++ ||.+.......
T Consensus 1 GsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH--~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~------ 63 (176)
T smart00750 1 VSLADILEVRG-RPLNEEEIWAVCLQCLRALRELH--RQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ------ 63 (176)
T ss_pred CcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHH--hcC------CcccEeEcCccceee--ccceEeecccc------
Confidence 58999997643 36999999999999999999999 777 999999999999998 99887532211
Q ss_pred cccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcc-hhhhhhhcchhhhhhHHHHHhhhccc--C
Q 018785 192 RIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLA-EQTLVEWADPFLRDSRRVLRIMDTRL--G 268 (350)
Q Consensus 192 ~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~--~ 268 (350)
..+++.|+|||++.+..++.++|||||||++|+|++|+.||........ ...+. ....... .
T Consensus 64 -~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~--------------~~~~~~~~~~ 128 (176)
T smart00750 64 -SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILL--------------NGMPADDPRD 128 (176)
T ss_pred -CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHH--------------HHhccCCccc
Confidence 2478899999999999999999999999999999999999965432110 01110 0000000 0
Q ss_pred CCCcHHHHH--HHHHHHHHhhccCCCCCCCHHHHHHHHHhhhc
Q 018785 269 GQYSKKEAQ--AVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHT 309 (350)
Q Consensus 269 ~~~~~~~~~--~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 309 (350)
......++. .+.+++.+||..+|.+||++.++++++..+..
T Consensus 129 ~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 129 RSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred cccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence 011233444 69999999999999999999999999887654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-26 Score=231.64 Aligned_cols=197 Identities=21% Similarity=0.245 Sum_probs=137.4
Q ss_pred ccCC-CcccceeeEE-------eecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeee
Q 018785 83 QLRH-ENLVKLIGYC-------SESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIY 154 (350)
Q Consensus 83 ~l~h-~~i~~~~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H 154 (350)
.++| +||..+++.+ ..+..+++++|++ +++|.+++.... ..++..+++.++.||++||.||| ++||+|
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH--~~gIvH 103 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD-RSVDAFECFHVFRQIVEIVNAAH--SQGIVV 103 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc-ccccHHHHHHHHHHHHHHHHHHH--hCCeee
Confidence 3445 5777777766 2334677889987 779999996542 46999999999999999999999 999999
Q ss_pred CCCCCCceEEcCCCcEE-------------------EccccccccCCCCCC--------------CcccccccCCCcccC
Q 018785 155 RDLKASNVLLDSNFNAK-------------------LSDFGLARDGPTGDN--------------THVSTRIVGTRGYAA 201 (350)
Q Consensus 155 ~di~~~Nili~~~~~~~-------------------l~Dfg~~~~~~~~~~--------------~~~~~~~~~~~~~~a 201 (350)
|||||+|||++..+.++ ++|||+++....... ........+++.|+|
T Consensus 104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 183 (793)
T PLN00181 104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS 183 (793)
T ss_pred ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence 99999999996655444 555555432110000 000011347888999
Q ss_pred ccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHH
Q 018785 202 PEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAA 281 (350)
Q Consensus 202 PE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 281 (350)
||++.+..++.++|||||||++|||++|..|+..... .+.... ... ... ......+...+
T Consensus 184 PE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~-----~~~~~~----------~~~----~~~-~~~~~~~~~~~ 243 (793)
T PLN00181 184 PEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR-----TMSSLR----------HRV----LPP-QILLNWPKEAS 243 (793)
T ss_pred hhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH-----HHHHHH----------Hhh----cCh-hhhhcCHHHHH
Confidence 9999999999999999999999999998887643210 000000 000 000 00111345668
Q ss_pred HHHHhhccCCCCCCCHHHHHHH
Q 018785 282 VVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 282 li~~~l~~dp~~Rps~~~ll~~ 303 (350)
++.+||+++|.+||++.++++|
T Consensus 244 ~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 244 FCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHHHhCCCChhhCcChHHHhhc
Confidence 8999999999999999999976
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.2e-24 Score=192.15 Aligned_cols=172 Identities=19% Similarity=0.133 Sum_probs=130.0
Q ss_pred hhhhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccc-----hhhHHHHHHHHHHHhccCCCc
Q 018785 14 MISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES-----FQGHKEWLTEVIYLGQLRHEN 88 (350)
Q Consensus 14 ~~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~ 88 (350)
.-......+|.+.+.||+|+||+||+|+.. ..+++.+|||.+.... ......+.+|+.++++++|++
T Consensus 11 ~~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~--------~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~ 82 (365)
T PRK09188 11 DQIPALSARFVETAVLKRDVFSTVERGYFA--------GDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIG 82 (365)
T ss_pred cccccccCCceEccEEeecCcEEEEEEEEc--------CCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCC
Confidence 334566789999999999999999999432 1247778999865331 123456889999999999999
Q ss_pred ccceeeEEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCC-CCCceEEcCC
Q 018785 89 LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDL-KASNVLLDSN 167 (350)
Q Consensus 89 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di-~~~Nili~~~ 167 (350)
+++.+.. .+..|+||||++|++|.. .. . .. ...++.|++++|.||| +.|++|||| ||+||+++.+
T Consensus 83 iv~~l~~---~~~~~LVmE~~~G~~L~~-~~--~---~~---~~~~~~~i~~aL~~lH--~~gIiHrDL~KP~NILv~~~ 148 (365)
T PRK09188 83 VVPQLLA---TGKDGLVRGWTEGVPLHL-AR--P---HG---DPAWFRSAHRALRDLH--RAGITHNDLAKPQNWLMGPD 148 (365)
T ss_pred CCcEEEE---cCCcEEEEEccCCCCHHH-hC--c---cc---hHHHHHHHHHHHHHHH--HCCCeeCCCCCcceEEEcCC
Confidence 9853322 246799999999999963 21 1 11 1467889999999999 999999999 9999999999
Q ss_pred CcEEEccccccccCCCCCCCcc------cccccCCCcccCcccccc
Q 018785 168 FNAKLSDFGLARDGPTGDNTHV------STRIVGTRGYAAPEYVAT 207 (350)
Q Consensus 168 ~~~~l~Dfg~~~~~~~~~~~~~------~~~~~~~~~~~aPE~~~~ 207 (350)
+.++|+|||++........... .....++..|.+||.+..
T Consensus 149 ~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 149 GEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred CCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 9999999999986544332222 124567788999998754
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.4e-25 Score=183.44 Aligned_cols=250 Identities=22% Similarity=0.356 Sum_probs=198.7
Q ss_pred cccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch--hhHHHHHHHHHHHhccCCCcccceeeEEeec
Q 018785 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (350)
Q Consensus 22 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (350)
...+..+|.....|..|+|+|.+++ ++.|++..... ...++|.+|...|+-++||||+.+++.+...
T Consensus 191 ~lnl~tkl~e~hsgelwrgrwqgnd-----------ivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsp 259 (448)
T KOG0195|consen 191 SLNLITKLAESHSGELWRGRWQGND-----------IVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSP 259 (448)
T ss_pred hhhhhhhhccCCCcccccccccCcc-----------hhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCC
Confidence 3445668889999999999998543 66787765433 2346788999999999999999999999999
Q ss_pred CceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEc--cccc
Q 018785 100 DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLS--DFGL 177 (350)
Q Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~--Dfg~ 177 (350)
.++.++..|++.++|+..+.....--.+..++.+++..++.+++|||+...-+.---++...++||++.+.++. |--+
T Consensus 260 pnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kf 339 (448)
T KOG0195|consen 260 PNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKF 339 (448)
T ss_pred CCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheeccccee
Confidence 99999999999999999998776556777899999999999999999766666677789999999988665543 3222
Q ss_pred cccCCCCCCCcccccccCCCcccCccccccCCCC---CccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhh
Q 018785 178 ARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLT---PKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLR 254 (350)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~---~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~ 254 (350)
+.. .......|.|++||.+...+-+ .++|+||+++++|||.|...||....+-+.-
T Consensus 340 sfq---------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg------------ 398 (448)
T KOG0195|consen 340 SFQ---------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG------------ 398 (448)
T ss_pred eee---------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh------------
Confidence 211 1223467889999998765433 5799999999999999999999876543222
Q ss_pred hhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 018785 255 DSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLH 308 (350)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 308 (350)
-++.-+..+...|+.++..+..|+.-|+..||.+||.+..++-.|++..
T Consensus 399 -----mkialeglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 399 -----MKIALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred -----hhhhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 2333345566778899999999999999999999999999998887653
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-25 Score=214.39 Aligned_cols=255 Identities=22% Similarity=0.257 Sum_probs=187.7
Q ss_pred cccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEcc-----ccchhhH-HHHHHHHHHHhccCCCcccceeeEEe
Q 018785 24 CSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLK-----AESFQGH-KEWLTEVIYLGQLRHENLVKLIGYCS 97 (350)
Q Consensus 24 ~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~-----~~~~~~~-~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (350)
.-..++|.|.+|.|+.+.. ......+..|.+. ....... ..+-.|+.+-..++|||++.....+.
T Consensus 321 ~~~~~~g~ga~g~~~~~~~---------~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~ 391 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKR---------RSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQ 391 (601)
T ss_pred CccceeeecccCceEEEEe---------cCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHh
Confidence 4667899999996666522 1122222333221 1111111 11455666777789999988888777
Q ss_pred ecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccc
Q 018785 98 ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL 177 (350)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~ 177 (350)
+.....-.|||+++ +|..++.... .++..++.-++.|++.|+.|+| +.|+.|+|+|++|++++.+|.++++|||.
T Consensus 392 ~~~~~~~~mE~~~~-Dlf~~~~~~~--~~~~~e~~c~fKqL~~Gv~y~h--~~GiahrdlK~enll~~~~g~lki~Dfg~ 466 (601)
T KOG0590|consen 392 EIDGILQSMEYCPY-DLFSLVMSNG--KLTPLEADCFFKQLLRGVKYLH--SMGLAHRDLKLENLLVTENGILKIIDFGA 466 (601)
T ss_pred hcccchhhhhcccH-HHHHHHhccc--ccchhhhhHHHHHHHHHHHHHH--hcCceeccCccccEEEecCCceEEeecCc
Confidence 76666666999988 9999998764 6888899999999999999999 99999999999999999999999999999
Q ss_pred cccCCCCCCC--cccccccCCCcccCccccccCCCCC-ccchhhHHHHHHHHHhCCCCCcccccCcchh-hhhhhcchhh
Q 018785 178 ARDGPTGDNT--HVSTRIVGTRGYAAPEYVATGHLTP-KSDVYSFGVVLLELLSGRRALDEDRGGLAEQ-TLVEWADPFL 253 (350)
Q Consensus 178 ~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~-~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~-~~~~~~~~~~ 253 (350)
+..+...... .......|...|.|||.+.+..|++ ..||||.|+++..|.+|+.||.......... .....
T Consensus 467 ~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~----- 541 (601)
T KOG0590|consen 467 ASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYS----- 541 (601)
T ss_pred ceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccc-----
Confidence 9877666555 4556678899999999999999986 5899999999999999999997544322211 00000
Q ss_pred hhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 254 RDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
.......-...+...++...+.+|.+||++||.+|.|+++|++.
T Consensus 542 ------~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 542 ------DQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred ------cccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 00000000112334677889999999999999999999999864
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.3e-24 Score=206.92 Aligned_cols=266 Identities=18% Similarity=0.182 Sum_probs=199.8
Q ss_pred cCCCCchhhhhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCC
Q 018785 7 MSDPSASMISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRH 86 (350)
Q Consensus 7 ~~~~~~~~~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h 86 (350)
+......-.+++.+..|.|.+.||+|+||.||.| .+.. |+.||+|+-++.+.+....-.+-...|+.---
T Consensus 684 ~~~l~~~~~~~~~~~~~~I~~e~G~g~y~~vy~a---------~~~~-~~~~alK~e~P~~~WEfYI~~q~~~RLk~~~~ 753 (974)
T KOG1166|consen 684 VPKLNPNTEFEVGGEKFCISKEIGEGSYGSVYVA---------THSN-GKLVALKVEKPPNPWEFYICLQVMERLKPQML 753 (974)
T ss_pred ccccCccceeeecceeEEEEeeeccccceEEEEe---------ecCC-CcEEEEEeecCCCceeeeehHHHHHhhchhhh
Confidence 3344455578889999999999999999999999 4444 99999999998887754332222233331124
Q ss_pred CcccceeeEEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcC
Q 018785 87 ENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS 166 (350)
Q Consensus 87 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~ 166 (350)
+.|..+...+.-.+.-++|++|.+.|+|.++++.. +.+++..+..++.|++..+++|| ..+|+||||||+|+++..
T Consensus 754 ~~~~~~~~a~~~~~~S~lv~ey~~~Gtlld~~N~~--~~m~e~lv~~~~~qml~ive~lH--~~~IIHgDiKPDNfll~~ 829 (974)
T KOG1166|consen 754 PSIMHISSAHVFQNASVLVSEYSPYGTLLDLINTN--KVMDEYLVMFFSCQMLRIVEHLH--AMGIIHGDIKPDNFLLRR 829 (974)
T ss_pred cchHHHHHHHccCCcceeeeeccccccHHHhhccC--CCCCchhhhHHHHHHHHHHHHHH--hcceecccCCcceeEeec
Confidence 56666777777778889999999999999999843 47899999999999999999999 999999999999999942
Q ss_pred -------CCcEEEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccC
Q 018785 167 -------NFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGG 239 (350)
Q Consensus 167 -------~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~ 239 (350)
+-.++|+|||.+..+..............+..|-.+|...|..|+..+|.|.|+.+++.||.|+..= .
T Consensus 830 ~~~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q-~---- 904 (974)
T KOG1166|consen 830 EICADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME-V---- 904 (974)
T ss_pred ccCCCCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH-h----
Confidence 3449999999998766666666666778899999999999999999999999999999999997631 0
Q ss_pred cchhhhhhhcchhhhhhHHHHHhhhcccCCCCcHHH-HHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcCC
Q 018785 240 LAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKE-AQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSK 311 (350)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~ 311 (350)
+.+..+. ....++.-. -+-..+++..+|..|-..=|.+.++...|+.....+
T Consensus 905 --------~~g~~~~------------~~~~~~Ry~~~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~~ 957 (974)
T KOG1166|consen 905 --------KNGSSWM------------VKTNFPRYWKRDMWNKFFDLLLNPDCDTLPNLQELRTELEEVLAEH 957 (974)
T ss_pred --------cCCccee------------ccccchhhhhHHHHHHHHHHHhCcCcccchhHHHHHHHHHHHHHHH
Confidence 0000000 000001111 123456777788866666688888888888776554
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.7e-24 Score=177.17 Aligned_cols=179 Identities=13% Similarity=0.117 Sum_probs=138.3
Q ss_pred chhhhhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHH---------HHHHHHHHh
Q 018785 12 ASMISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKE---------WLTEVIYLG 82 (350)
Q Consensus 12 ~~~~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~---------~~~e~~~l~ 82 (350)
.....+...++|++.++||.|+||.||++ .. ++..+|||.+.......... +.+|+..+.
T Consensus 22 ~~~~~~~l~~~y~~~~~l~~~~f~~v~l~---------~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~ 90 (232)
T PRK10359 22 KEIFDDFLSYNIKTIKVFRNIDDTKVSLI---------DT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTD 90 (232)
T ss_pred HHHHHHHhhCceEEEEEecCCCceEEEEE---------ec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHH
Confidence 35567788999999999999999999996 23 25579999997654333222 578999999
Q ss_pred ccCCCcccceeeEEeec--------CceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeee
Q 018785 83 QLRHENLVKLIGYCSES--------DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIY 154 (350)
Q Consensus 83 ~l~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H 154 (350)
++.||+|..+.+++... +..+++|||++|.+|.++. .+++ ....+++.++..+| ..|++|
T Consensus 91 rL~~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~------~~~~----~~~~~i~~~l~~lH--~~gi~H 158 (232)
T PRK10359 91 RVRSEGLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMP------EISE----DVKAKIKASIESLH--QHGMVS 158 (232)
T ss_pred HHHHCCCCcceEeeeecccccccccCCeEEEEEEECCccHHHhh------hccH----HHHHHHHHHHHHHH--HcCCcc
Confidence 99999999999886643 3578999999999998873 2333 24558999999999 999999
Q ss_pred CCCCCCceEEcCCCcEEEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh
Q 018785 155 RDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 228 (350)
Q Consensus 155 ~di~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~ 228 (350)
+|++|.||+++.+| ++|+|||.......... ....+....++.++|+|+||+++..+..
T Consensus 159 ~Dikp~Nili~~~g-i~liDfg~~~~~~e~~a--------------~d~~vler~y~~~~di~~lg~~~~~~~~ 217 (232)
T PRK10359 159 GDPHKGNFIVSKNG-LRIIDLSGKRCTAQRKA--------------KDRIDLERHYGIKNEIKDLGYYLLIYKK 217 (232)
T ss_pred CCCChHHEEEeCCC-EEEEECCCcccccchhh--------------HHHHHHHhHhcccccccceeEeehHHHH
Confidence 99999999999988 99999998864321111 0113344556789999999999876544
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.1e-22 Score=177.78 Aligned_cols=253 Identities=32% Similarity=0.482 Sum_probs=196.2
Q ss_pred ccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh---hHHHHHHHHHHHhccCCC-cccceeeEEee
Q 018785 23 FCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ---GHKEWLTEVIYLGQLRHE-NLVKLIGYCSE 98 (350)
Q Consensus 23 y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~-~i~~~~~~~~~ 98 (350)
|.+.+.||.|.|+.||.+.. . ..+++|.+...... ....+.+|...++.+.|+ +++++.+.+..
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~---------~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~ 69 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARD---------R---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQD 69 (384)
T ss_pred ceeEEeecCCCCeEEEEEEe---------c---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEec
Confidence 78899999999999999943 2 67888988766543 356788899999999988 79999999977
Q ss_pred cCceEEEEEcCCCCChhhHHhhcCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCC-cEEEcccc
Q 018785 99 SDNRLLVYEFMPKGSLENHLFRKGV-QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNF-NAKLSDFG 176 (350)
Q Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~-~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~-~~~l~Dfg 176 (350)
....+++++++.++++.+++..... ..++......++.|++.++.++| ..+++|+|++|+||+++..+ .++++|||
T Consensus 70 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H--~~~~~hrd~kp~nil~~~~~~~~~l~dfg 147 (384)
T COG0515 70 EGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH--SKGIIHRDIKPENILLDRDGRVVKLIDFG 147 (384)
T ss_pred CCEEEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHH--hCCeeccCCCHHHeeecCCCCeEEEeccC
Confidence 7778999999999999977765432 26889999999999999999999 99999999999999999988 69999999
Q ss_pred ccccCCCCCCCc----ccccccCCCcccCcccccc---CCCCCccchhhHHHHHHHHHhCCCCCcccccC----cchhhh
Q 018785 177 LARDGPTGDNTH----VSTRIVGTRGYAAPEYVAT---GHLTPKSDVYSFGVVLLELLSGRRALDEDRGG----LAEQTL 245 (350)
Q Consensus 177 ~~~~~~~~~~~~----~~~~~~~~~~~~aPE~~~~---~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~----~~~~~~ 245 (350)
.+.......... ......++..|++||.+.+ ...+...|+|++|+++++++.|..||...... .....+
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~ 227 (384)
T COG0515 148 LAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKII 227 (384)
T ss_pred cceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHH
Confidence 987543333221 2345678999999999987 57889999999999999999999997655431 111111
Q ss_pred hhhcchhhhhhHHHHHhhhcccCCCCc----HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 246 VEWADPFLRDSRRVLRIMDTRLGGQYS----KKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
.....+ ....... ......+.+++..++..+|..|.+.......
T Consensus 228 ~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 228 LELPTP--------------SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred HhcCCc--------------ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 111100 0000111 1223578899999999999999998887765
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.2e-23 Score=176.70 Aligned_cols=235 Identities=19% Similarity=0.289 Sum_probs=151.8
Q ss_pred hhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch---hhHHHHHHHHHHHhccC----------C
Q 018785 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLR----------H 86 (350)
Q Consensus 20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~----------h 86 (350)
...+...+.||.|+++.||.+ .+..+++.+++|++..... ...+.+++|......+. |
T Consensus 11 ~r~l~~~~~i~~g~~~~v~~v---------~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~ 81 (288)
T PF14531_consen 11 PRTLVRGRIIGKGGFSIVFEV---------TDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRH 81 (288)
T ss_dssp EEEEEEEEEEEEETTEEEEEE---------EETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHH
T ss_pred ceEEEEccccccCCceEEEEE---------EEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHh
Confidence 346677889999999999999 8888999999998765442 23455666665555432 2
Q ss_pred CcccceeeEEee---------cC--------ceEEEEEcCCCCChhhHHhh---cCCC--CCCHHHHHHHHHHHHHHHHH
Q 018785 87 ENLVKLIGYCSE---------SD--------NRLLVYEFMPKGSLENHLFR---KGVQ--PISWPTRVKIAIDVARGLSF 144 (350)
Q Consensus 87 ~~i~~~~~~~~~---------~~--------~~~lv~e~~~~~~L~~~l~~---~~~~--~l~~~~~~~i~~ql~~al~~ 144 (350)
-.++..++.... .. ..+++|+-+ .++|.+++.. .... .+.......+..|++..+++
T Consensus 82 ~r~l~P~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~ 160 (288)
T PF14531_consen 82 LRFLVPLDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVAN 160 (288)
T ss_dssp H-B---SEEEEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHH
T ss_pred ceEEeeeEEEEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHH
Confidence 334444444321 11 336788877 6688887642 2211 22333445667899999999
Q ss_pred hhcCCCCeeeCCCCCCceEEcCCCcEEEccccccccCCCCCCCcccccccCCCcccCcccccc--------CCCCCccch
Q 018785 145 LHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT--------GHLTPKSDV 216 (350)
Q Consensus 145 lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--------~~~~~~~Di 216 (350)
|| ..|++|+||+|+|++++.+|.+.|+||+........ ... ...+..|.|||.... ..++.+.|.
T Consensus 161 Lh--~~GlVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~----~~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~Da 233 (288)
T PF14531_consen 161 LH--SYGLVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTR----YRC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDA 233 (288)
T ss_dssp HH--HTTEEEST-SGGGEEE-TTS-EEE--GGGEEETTEE----EEG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHH
T ss_pred Hh--hcceEecccceeeEEEcCCCCEEEcChHHHeecCce----eec-cCCCcccCChhhhhhhcccCcccceeeeccCH
Confidence 99 999999999999999999999999999887642111 111 234567999997633 246788999
Q ss_pred hhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCC
Q 018785 217 YSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNR 294 (350)
Q Consensus 217 wslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R 294 (350)
|+||+++|.|+|+..||........... .-.... ++|+.++.||..+|+.||.+|
T Consensus 234 W~LG~~ly~lWC~~lPf~~~~~~~~~~~----------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 234 WQLGITLYSLWCGRLPFGLSSPEADPEW----------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHHHHHHHHSS-STCCCGGGSTSGG----------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHHHHHHHHHHHccCCCCCCCccccccc----------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 9999999999999999986543222111 001223 788999999999999999987
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.1e-24 Score=203.36 Aligned_cols=248 Identities=22% Similarity=0.261 Sum_probs=178.7
Q ss_pred cccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch-hhHHHHHHHHHH--HhccCCCcccceeeEEee
Q 018785 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIY--LGQLRHENLVKLIGYCSE 98 (350)
Q Consensus 22 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~--l~~l~h~~i~~~~~~~~~ 98 (350)
+|..++.||++.|-.|.+|+.. .|. |+||++-.... -..+.+.+++.- .+..++||.+++.-+.+.
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~----------eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t 92 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDR----------EGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVT 92 (1431)
T ss_pred ceeeecccCchhhhhhhhccCC----------Cce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHh
Confidence 8999999999999999998332 344 88998865542 222333333333 444589999999988888
Q ss_pred cCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcccccc
Q 018785 99 SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 178 (350)
Q Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~ 178 (350)
+...|+|-+|+ ..+|.|.+..++ -+...+.+-|+.||+.||..|| ..||+|||||.+||||+.-+=+.|+||...
T Consensus 93 ~kAAylvRqyv-khnLyDRlSTRP--FL~~iEKkWiaFQLL~al~qcH--~~gVcHGDIKsENILiTSWNW~~LtDFAsF 167 (1431)
T KOG1240|consen 93 DKAAYLVRQYV-KHNLYDRLSTRP--FLVLIEKKWIAFQLLKALSQCH--KLGVCHGDIKSENILITSWNWLYLTDFASF 167 (1431)
T ss_pred hHHHHHHHHHH-hhhhhhhhccch--HHHHHHHHHHHHHHHHHHHHHH--HcCccccccccceEEEeeechhhhhccccc
Confidence 88899999998 559999998876 6888889999999999999999 999999999999999998877899999876
Q ss_pred ccCCCC-CCC----cccccccCCCcccCccccccC-----------CCCCccchhhHHHHHHHHHh-CCCCCcccccCcc
Q 018785 179 RDGPTG-DNT----HVSTRIVGTRGYAAPEYVATG-----------HLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLA 241 (350)
Q Consensus 179 ~~~~~~-~~~----~~~~~~~~~~~~~aPE~~~~~-----------~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~ 241 (350)
....-. ++. ........-.+|.|||.+... ..+++.||||+||+++||++ |++||.-..
T Consensus 168 KPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ---- 243 (1431)
T KOG1240|consen 168 KPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ---- 243 (1431)
T ss_pred CCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH----
Confidence 432211 111 112222334569999987431 15678999999999999988 577775322
Q ss_pred hhhhhhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 242 EQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
+..+......+.+...+.+ .+..++.|+..|++.||.+|.|+++.|+.
T Consensus 244 ---L~aYr~~~~~~~e~~Le~I-----------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 244 ---LLAYRSGNADDPEQLLEKI-----------EDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred ---HHhHhccCccCHHHHHHhC-----------cCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 1111000011111111111 12378899999999999999999999987
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.9e-22 Score=164.15 Aligned_cols=139 Identities=18% Similarity=0.186 Sum_probs=107.9
Q ss_pred ccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh--h------------------------HHHHHHHH
Q 018785 25 SDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ--G------------------------HKEWLTEV 78 (350)
Q Consensus 25 i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~------------------------~~~~~~e~ 78 (350)
+...||+|++|.||+| .+. +|++||||++...... . ......|+
T Consensus 1 ~~~~ig~G~~~~Vy~a---------~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~ 70 (190)
T cd05147 1 INGCISTGKEANVYHA---------TTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEM 70 (190)
T ss_pred CCCccccccceEEEEE---------ECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHH
Confidence 3578999999999999 554 7999999998754211 0 01223588
Q ss_pred HHHhccCCCcccceeeEEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHh-hcCCCCeeeCCC
Q 018785 79 IYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFL-HGLDANVIYRDL 157 (350)
Q Consensus 79 ~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~l-h~~~~~i~H~di 157 (350)
..+..+.++++.....+.. ...++||||+.|+++....... ..++...+..++.|++.+|.++ | +.|++|+||
T Consensus 71 ~~l~~l~~~~v~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~--~~~~~~~~~~i~~qi~~~L~~l~H--~~giiHrDl 144 (190)
T cd05147 71 RNLKRLVTAGIPCPEPILL--KSHVLVMEFIGDDGWAAPRLKD--APLSESKARELYLQVIQIMRILYQ--DCRLVHADL 144 (190)
T ss_pred HHHHHHHHCCCCCCcEEEe--cCCEEEEEEeCCCCCcchhhhc--CCCCHHHHHHHHHHHHHHHHHHHH--hCCcccCCC
Confidence 9999998877754443322 2238999999887766554333 2689999999999999999999 8 889999999
Q ss_pred CCCceEEcCCCcEEEcccccccc
Q 018785 158 KASNVLLDSNFNAKLSDFGLARD 180 (350)
Q Consensus 158 ~~~Nili~~~~~~~l~Dfg~~~~ 180 (350)
||+||+++ ++.++|+|||++..
T Consensus 145 kP~NIli~-~~~v~LiDFG~a~~ 166 (190)
T cd05147 145 SEYNLLYH-DGKLYIIDVSQSVE 166 (190)
T ss_pred CHHHEEEE-CCcEEEEEcccccc
Confidence 99999998 57899999999974
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2e-21 Score=169.07 Aligned_cols=196 Identities=20% Similarity=0.261 Sum_probs=143.0
Q ss_pred CCCcccceeeEEee---------------------------cCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHH
Q 018785 85 RHENLVKLIGYCSE---------------------------SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAID 137 (350)
Q Consensus 85 ~h~~i~~~~~~~~~---------------------------~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~q 137 (350)
.||||+.+...|.+ ...+|+||..+ ..+|.+++-.+ ..+.....-++.|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~---~~s~r~~~~~laQ 349 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTR---HRSYRTGRVILAQ 349 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcC---CCchHHHHHHHHH
Confidence 59999999887632 34679999998 66999999776 4677788889999
Q ss_pred HHHHHHHhhcCCCCeeeCCCCCCceEEcC--CC--cEEEccccccccCCCC----CCCcccccccCCCcccCccccccCC
Q 018785 138 VARGLSFLHGLDANVIYRDLKASNVLLDS--NF--NAKLSDFGLARDGPTG----DNTHVSTRIVGTRGYAAPEYVATGH 209 (350)
Q Consensus 138 l~~al~~lh~~~~~i~H~di~~~Nili~~--~~--~~~l~Dfg~~~~~~~~----~~~~~~~~~~~~~~~~aPE~~~~~~ 209 (350)
+++|+.||| ..||.|+|+|.+||++.- ++ .+++.|||++---... ......-..-|+...+|||+...-+
T Consensus 350 lLEav~hL~--~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P 427 (598)
T KOG4158|consen 350 LLEAVTHLH--KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP 427 (598)
T ss_pred HHHHHHHHH--HccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence 999999999 999999999999999943 33 3899999987531111 1111122345778899999875432
Q ss_pred ------CCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHH
Q 018785 210 ------LTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVV 283 (350)
Q Consensus 210 ------~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 283 (350)
.-.++|.|+.|.+.||+++...||-....... +.. ...+..-..++..+++.+++++
T Consensus 428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L-------------~~r----~Yqe~qLPalp~~vpp~~rqlV 490 (598)
T KOG4158|consen 428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLL-------------DTR----TYQESQLPALPSRVPPVARQLV 490 (598)
T ss_pred CCceeeccchhhhhhhhhhHHHHhccCCcccccchhee-------------chh----hhhhhhCCCCcccCChHHHHHH
Confidence 12479999999999999999999965221100 000 0112222345678899999999
Q ss_pred HHhhccCCCCCCCHHHHHHH
Q 018785 284 LQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 284 ~~~l~~dp~~Rps~~~ll~~ 303 (350)
..+|+.||.+|++..-....
T Consensus 491 ~~lL~r~pskRvsp~iAANv 510 (598)
T KOG4158|consen 491 FDLLKRDPSKRVSPNIAANV 510 (598)
T ss_pred HHHhcCCccccCCccHHHhH
Confidence 99999999999886554443
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=8.8e-21 Score=157.65 Aligned_cols=140 Identities=16% Similarity=0.141 Sum_probs=109.9
Q ss_pred ccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh---------------------h-----HHHHHHHH
Q 018785 25 SDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ---------------------G-----HKEWLTEV 78 (350)
Q Consensus 25 i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---------------------~-----~~~~~~e~ 78 (350)
+.+.||+|++|.||+| .+. +|+.||||++...... . ......|.
T Consensus 1 ~~~~ig~G~~~~Vy~a---------~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~ 70 (190)
T cd05145 1 INGCISTGKEANVYHA---------RTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEF 70 (190)
T ss_pred CCceeecCCCcEEEEE---------EcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHH
Confidence 4678999999999999 444 6899999998764211 0 11235788
Q ss_pred HHHhccCCCcccceeeEEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCC-CCeeeCCC
Q 018785 79 IYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLD-ANVIYRDL 157 (350)
Q Consensus 79 ~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~-~~i~H~di 157 (350)
..+.++.++++.....+... ..++||||+.|+++........ .++...+..++.|++.++.++| . .|++|+||
T Consensus 71 ~~l~~l~~~~i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~~--~~~~~~~~~i~~~l~~~l~~lH--~~~givHrDl 144 (190)
T cd05145 71 RNLKRLYEAGVPVPEPILLK--KNVLVMEFIGDDGSPAPRLKDV--PLEEEEAEELYEQVVEQMRRLY--QEAGLVHGDL 144 (190)
T ss_pred HHHHHHHhCCCCCceEEEec--CCEEEEEEecCCCchhhhhhhc--cCCHHHHHHHHHHHHHHHHHHH--HhCCEecCCC
Confidence 99999999887655554433 3489999998875544322222 5788899999999999999999 7 99999999
Q ss_pred CCCceEEcCCCcEEEccccccccC
Q 018785 158 KASNVLLDSNFNAKLSDFGLARDG 181 (350)
Q Consensus 158 ~~~Nili~~~~~~~l~Dfg~~~~~ 181 (350)
||+||+++ ++.++|+|||++...
T Consensus 145 kP~NIll~-~~~~~liDFG~a~~~ 167 (190)
T cd05145 145 SEYNILYH-DGKPYIIDVSQAVEL 167 (190)
T ss_pred ChhhEEEE-CCCEEEEEcccceec
Confidence 99999998 889999999999753
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=9e-20 Score=149.84 Aligned_cols=189 Identities=18% Similarity=0.124 Sum_probs=138.4
Q ss_pred ccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhH----HHHHHHHHHHhccC-CCcccceeeEEe
Q 018785 23 FCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGH----KEWLTEVIYLGQLR-HENLVKLIGYCS 97 (350)
Q Consensus 23 y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~e~~~l~~l~-h~~i~~~~~~~~ 97 (350)
..+...|++|+||+||.+ .. .+.+++.+.+........ ..+.+|+++|++|. ++++.+++++
T Consensus 4 ~~~~~~l~~~~f~~v~~~---------~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~-- 70 (218)
T PRK12274 4 PAVNEPLKSDTFGRILLV---------RG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW-- 70 (218)
T ss_pred cccceeecCCCcceEEEe---------ec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE--
Confidence 346789999999999986 22 477788777665543222 24788999999995 5888888875
Q ss_pred ecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCC-CCCceEEcCCCcEEEcccc
Q 018785 98 ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDL-KASNVLLDSNFNAKLSDFG 176 (350)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di-~~~Nili~~~~~~~l~Dfg 176 (350)
+..+++|+|+.|.+|...... ....++.|++.+|.++| +.|++|+|| +|.||+++.++.++|+|||
T Consensus 71 --~~~~lvmeyI~G~~L~~~~~~---------~~~~~~~qi~~~L~~lH--~~GIvHrDL~kp~NILv~~~g~i~LIDFG 137 (218)
T PRK12274 71 --DGRHLDRSYLAGAAMYQRPPR---------GDLAYFRAARRLLQQLH--RCGVAHNDLAKEANWLVQEDGSPAVIDFQ 137 (218)
T ss_pred --cCEEEEEeeecCccHHhhhhh---------hhHHHHHHHHHHHHHHH--HCcCccCCCCCcceEEEcCCCCEEEEECC
Confidence 456899999999888654311 11357789999999999 999999999 7999999999999999999
Q ss_pred ccccCCCCCCC----cc-------cccccCCCcccCccccccC-CCC-CccchhhHHHHHHHHHhCCCCCcccc
Q 018785 177 LARDGPTGDNT----HV-------STRIVGTRGYAAPEYVATG-HLT-PKSDVYSFGVVLLELLSGRRALDEDR 237 (350)
Q Consensus 177 ~~~~~~~~~~~----~~-------~~~~~~~~~~~aPE~~~~~-~~~-~~~DiwslG~ll~~ll~g~~pf~~~~ 237 (350)
++......... .. .....+++.++.|+...-- ..+ .+.+.++.|+-+|.++|++.+.-+..
T Consensus 138 ~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 138 LAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred CceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 99854433221 00 0112356667777643221 223 57789999999999999998865433
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.1e-20 Score=173.51 Aligned_cols=229 Identities=27% Similarity=0.363 Sum_probs=181.5
Q ss_pred eecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhh--HHHHHHHHHHHhccC-CCcccceeeEEeecCceEE
Q 018785 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQG--HKEWLTEVIYLGQLR-HENLVKLIGYCSESDNRLL 104 (350)
Q Consensus 28 ~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l 104 (350)
.+|.|.+|.|++++-- .....|..++.|+........ ......|-.++...+ ||.++++.-.+..+..+++
T Consensus 1 vlg~g~~gkvfLvrk~------~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l 74 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKA------GGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYL 74 (612)
T ss_pred CCCcCCCcchHHHHHh------ccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhH
Confidence 3789999999987532 334456777888766543321 124456777777775 9999999999999999999
Q ss_pred EEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccccccCCCC
Q 018785 105 VYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTG 184 (350)
Q Consensus 105 v~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~~~~~~ 184 (350)
++++..|+.|...+.... .+++.........++-+++++| +.+++|+|+|++||+++.+|.+++.|||++...-..
T Consensus 75 ~ld~~rgg~lft~l~~~~--~f~~~~~~~~~aelaLald~lh--~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~ 150 (612)
T KOG0603|consen 75 ILDFLRGGDLFTRLSKEV--MFDELDVAFYLAELALALDHLH--KLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKE 150 (612)
T ss_pred hhhhcccchhhhccccCC--chHHHHHHHHHHHHHHHHhhcc--hhHHHHhcccccceeecccCccccCCchhhhHhHhh
Confidence 999999999987776554 6888888888899999999999 999999999999999999999999999999753222
Q ss_pred CCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhHHHHHhhh
Q 018785 185 DNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMD 264 (350)
Q Consensus 185 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (350)
.. .+|+..|+|||++. ....++|.|++|+++++|++|..||.. +....+..
T Consensus 151 ~~------~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~---------------------~~~~~Il~ 201 (612)
T KOG0603|consen 151 KI------ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG---------------------DTMKRILK 201 (612)
T ss_pred hh------cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch---------------------HHHHHHhh
Confidence 22 26888999999987 567789999999999999999999975 00111111
Q ss_pred cccCCCCcHHHHHHHHHHHHHhhccCCCCCCCH
Q 018785 265 TRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSM 297 (350)
Q Consensus 265 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~ 297 (350)
. ....|...+..+++++.+++..+|.+|.-.
T Consensus 202 ~--~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 202 A--ELEMPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred h--ccCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 1 124577888999999999999999999644
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=7.2e-19 Score=147.08 Aligned_cols=136 Identities=18% Similarity=0.175 Sum_probs=105.2
Q ss_pred cccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhcc-----CCCcccceeeEEee
Q 018785 24 CSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQL-----RHENLVKLIGYCSE 98 (350)
Q Consensus 24 ~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~ 98 (350)
.-.++||+|++|.||.- . .++.. +||++........+.+.+|+..++.+ .||||+++++++++
T Consensus 5 ~~~~~LG~G~~~~Vy~h---------p--~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et 72 (210)
T PRK10345 5 SEQSPLGTGRHRKCYAH---------P--EDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVET 72 (210)
T ss_pred CCcceecCCCceEEEEC---------C--CCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEe
Confidence 44678999999999952 1 22444 58988765444556789999999999 57999999999998
Q ss_pred cC---ceE-EEEEc--CCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHH-HHhhcCCCCeeeCCCCCCceEEcCC----
Q 018785 99 SD---NRL-LVYEF--MPKGSLENHLFRKGVQPISWPTRVKIAIDVARGL-SFLHGLDANVIYRDLKASNVLLDSN---- 167 (350)
Q Consensus 99 ~~---~~~-lv~e~--~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al-~~lh~~~~~i~H~di~~~Nili~~~---- 167 (350)
+. ..+ +|+|| ..+++|.+++.+. .+++. ..++.|++.++ +||| +.+|+|+||||+||+++.+
T Consensus 73 ~~g~g~v~~~I~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh--~~~IvhrDlKp~NILl~~~~~~~ 145 (210)
T PRK10345 73 DCGTGYVYDVIADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLL--DNRIVTMELKPQNILCQRISESE 145 (210)
T ss_pred CCCCeEEEEEEecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHH--HCCEeecCCCHHHEEEeccCCCC
Confidence 74 333 78999 4568999999653 35555 35677888777 9999 9999999999999999743
Q ss_pred CcEEEcccccc
Q 018785 168 FNAKLSDFGLA 178 (350)
Q Consensus 168 ~~~~l~Dfg~~ 178 (350)
+.++|+|++-+
T Consensus 146 ~~~~LiDg~G~ 156 (210)
T PRK10345 146 VIPVVCDNIGE 156 (210)
T ss_pred CcEEEEECCCC
Confidence 37999995433
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.3e-19 Score=151.99 Aligned_cols=145 Identities=16% Similarity=0.108 Sum_probs=111.1
Q ss_pred hhcccccceecccCceeEEeecccCCCcCCC-CCCCCcEEEEEEccccchh------------------------hHHHH
Q 018785 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPT-KPGSGIVVAIKRLKAESFQ------------------------GHKEW 74 (350)
Q Consensus 20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~-~~~~~~~vaiK~~~~~~~~------------------------~~~~~ 74 (350)
+.-|.+.+.||+|++|.||+| . +..+|+.||+|.+...... ....+
T Consensus 27 ~~~~~i~~~Lg~G~~g~Vy~a---------~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 97 (237)
T smart00090 27 GILSAIGGCISTGKEANVYHA---------LDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWA 97 (237)
T ss_pred CchHHhCCeeccCcceeEEEE---------EecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHH
Confidence 346999999999999999999 4 4557899999998754210 01235
Q ss_pred HHHHHHHhccCCCcccceeeEEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC-ee
Q 018785 75 LTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDAN-VI 153 (350)
Q Consensus 75 ~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~-i~ 153 (350)
..|+..++++.+.+ +.+..++.. ...++|||++.|.+|........ .+....+..++.|+++++.+|| +.| ++
T Consensus 98 ~~E~~~L~~L~~~~-i~~p~~~~~-~~~~lV~E~~~g~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~LH--~~g~ii 171 (237)
T smart00090 98 EKEFRNLQRLYEAG-VPVPKPIAW-RRNVLVMEFIGGDGLPAPRLKDV--EPEEEEEFELYDDILEEMRKLY--KEGELV 171 (237)
T ss_pred HHHHHHHHHHHhcC-CCCCeeeEe-cCceEEEEEecCCcccccccccC--CcchHHHHHHHHHHHHHHHHHH--hcCCEE
Confidence 67999999996532 222222222 23589999998888876553332 4666677899999999999999 899 99
Q ss_pred eCCCCCCceEEcCCCcEEEcccccccc
Q 018785 154 YRDLKASNVLLDSNFNAKLSDFGLARD 180 (350)
Q Consensus 154 H~di~~~Nili~~~~~~~l~Dfg~~~~ 180 (350)
|+||+|+||+++ ++.++|+|||.+..
T Consensus 172 H~Dikp~NIli~-~~~i~LiDFg~a~~ 197 (237)
T smart00090 172 HGDLSEYNILVH-DGKVVIIDVSQSVE 197 (237)
T ss_pred eCCCChhhEEEE-CCCEEEEEChhhhc
Confidence 999999999999 88899999998864
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=7.8e-19 Score=161.17 Aligned_cols=219 Identities=25% Similarity=0.374 Sum_probs=163.9
Q ss_pred HhccCCCcccceeeEEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCC
Q 018785 81 LGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKAS 160 (350)
Q Consensus 81 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~ 160 (350)
|+.+.|.|+.++++...++...+.|.+++..|+|.|.+.... ..++..-...+++.++.+++|+|+ +...+|+.++..
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~-~~~d~~F~~s~~rdi~~Gl~ylh~-s~i~~hg~l~s~ 78 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED-IKLDYFFILSFIRDISKGLAYLHN-SPIGYHGALKSS 78 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc-cCccHHHHHHHHHHHHHHHHHHhc-Ccceeeeeeccc
Confidence 467889999999999999999999999999999999997643 467888888999999999999996 333499999999
Q ss_pred ceEEcCCCcEEEccccccccCCCCCCCcccccccCCCcccCccccccC-------CCCCccchhhHHHHHHHHHhCCCCC
Q 018785 161 NVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG-------HLTPKSDVYSFGVVLLELLSGRRAL 233 (350)
Q Consensus 161 Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-------~~~~~~DiwslG~ll~~ll~g~~pf 233 (350)
|.+++....+|++|||+.....................|.|||.+.+. ..+.+.|+||+|++++++++.+.||
T Consensus 79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~ 158 (484)
T KOG1023|consen 79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF 158 (484)
T ss_pred cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence 999999999999999999765321111111112234459999988663 1466799999999999999999999
Q ss_pred cccccCcchhhhhhhcchhhhhhHHHHHhhhcccCCCCc--HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcCC
Q 018785 234 DEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYS--KKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSK 311 (350)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~ 311 (350)
...........+.... ........+.... ...++++..++.+||..+|.+||+++.+-..+..+....
T Consensus 159 ~~~~~~~~~~eii~~~----------~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~~ 228 (484)
T KOG1023|consen 159 DLRNLVEDPDEIILRV----------KKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKGG 228 (484)
T ss_pred ccccccCChHHHHHHH----------HhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcccc
Confidence 8655433322222210 0001111111111 144557999999999999999999999999998887753
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.9e-19 Score=172.37 Aligned_cols=210 Identities=22% Similarity=0.320 Sum_probs=151.8
Q ss_pred hhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceeeEEeec
Q 018785 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (350)
Q Consensus 20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (350)
-.+|..++.+..|++|.||++ .+..+.+++|.| +++++.-. ++ ++....+|.++
T Consensus 82 e~df~~IklisngAygavylv---------rh~~trqrfa~k-iNkq~lil----Rn---ilt~a~npfvv--------- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLV---------RHKETRQRFAMK-INKQNLIL----RN---ILTFAGNPFVV--------- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeee---------eccccccchhhc-ccccchhh----hc---cccccCCccee---------
Confidence 468999999999999999999 788888999984 44433111 11 22222334332
Q ss_pred CceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccccc
Q 018785 100 DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR 179 (350)
Q Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~ 179 (350)
|+-...++.-+ +++... +.+++|+| +.||+|+|+||+|.+|+.-|.+|++|||++.
T Consensus 136 ------------gDc~tllk~~g--~lPvdm--------vla~Eylh--~ygivhrdlkpdnllIT~mGhiKlTDfgLsk 191 (1205)
T KOG0606|consen 136 ------------GDCATLLKNIG--PLPVDM--------VLAVEYLH--SYGIVHRDLKPDNLLITSMGHIKLTDFGLSK 191 (1205)
T ss_pred ------------chhhhhcccCC--CCcchh--------hHHhHhhc--cCCeecCCCCCCcceeeecccccccchhhhh
Confidence 34445554333 333322 78899999 9999999999999999999999999999986
Q ss_pred cCCCCCCCcc-------------cccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhh
Q 018785 180 DGPTGDNTHV-------------STRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLV 246 (350)
Q Consensus 180 ~~~~~~~~~~-------------~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~ 246 (350)
.......... ....+||+.|.|||++.-..|....|.|++|+++|+++-|..||.+..+++....+.
T Consensus 192 ~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~vi 271 (1205)
T KOG0606|consen 192 KGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVI 271 (1205)
T ss_pred hhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhh
Confidence 4332221111 112479999999999999999999999999999999999999999887655544433
Q ss_pred hhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCC
Q 018785 247 EWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRP 295 (350)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 295 (350)
...-.+.. -....++++++++.++|+.+|..|.
T Consensus 272 sd~i~wpE----------------~dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 272 SDDIEWPE----------------EDEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred hhhccccc----------------cCcCCCHHHHHHHHHHHHhChHhhc
Confidence 21111111 1124567899999999999999994
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.3e-17 Score=141.16 Aligned_cols=134 Identities=23% Similarity=0.338 Sum_probs=111.4
Q ss_pred ceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh--------hHHHHHHHHHHHhccCCCcccceeeEEee
Q 018785 27 YLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ--------GHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (350)
Q Consensus 27 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (350)
+.||+|++|.||+|++ .|..+++|........ ....+.+|+..+..+.|+++.....++..
T Consensus 2 ~~l~~G~~~~vy~~~~-----------~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~ 70 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-----------LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVD 70 (211)
T ss_pred cccccCceEEEEEEee-----------CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEe
Confidence 6799999999999943 3667889976543211 12346788999999999998888777777
Q ss_pred cCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcccccc
Q 018785 99 SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 178 (350)
Q Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~ 178 (350)
.+..+++|||++|++|.+++.... . ....++.+++.+|.++| +.|++|+|++|.||+++ ++.++|+|||.+
T Consensus 71 ~~~~~lv~e~~~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH--~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a 141 (211)
T PRK14879 71 PENFIIVMEYIEGEPLKDLINSNG-----M-EELELSREIGRLVGKLH--SAGIIHGDLTTSNMILS-GGKIYLIDFGLA 141 (211)
T ss_pred CCCCEEEEEEeCCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHH--hCCcccCCCCcccEEEE-CCCEEEEECCcc
Confidence 788899999999999999886532 1 78889999999999999 99999999999999998 788999999988
Q ss_pred cc
Q 018785 179 RD 180 (350)
Q Consensus 179 ~~ 180 (350)
..
T Consensus 142 ~~ 143 (211)
T PRK14879 142 EF 143 (211)
T ss_pred cC
Confidence 64
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.6e-17 Score=138.06 Aligned_cols=130 Identities=22% Similarity=0.362 Sum_probs=105.0
Q ss_pred eecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch--------hhHHHHHHHHHHHhccCCCcccceeeEEeec
Q 018785 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--------QGHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (350)
Q Consensus 28 ~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (350)
.||+|++|.||+|.+ .+..+++|....... .....+.+|+..++.+.++++....-++...
T Consensus 1 ~ig~G~~~~vy~~~~-----------~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~ 69 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-----------LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDP 69 (199)
T ss_pred CCCCCceEEEEEeec-----------CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEC
Confidence 489999999999943 356789998543221 1124567899999999888776666666666
Q ss_pred CceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccccc
Q 018785 100 DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR 179 (350)
Q Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~ 179 (350)
+..++||||++|++|.+++.... . .++.+++.+|.++| +.|++|+|++|.||+++ ++.++++|||.+.
T Consensus 70 ~~~~lv~e~~~g~~l~~~~~~~~--~-------~~~~~i~~~l~~lH--~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~ 137 (199)
T TIGR03724 70 DNKTIVMEYIEGKPLKDVIEEGN--D-------ELLREIGRLVGKLH--KAGIVHGDLTTSNIIVR-DDKLYLIDFGLGK 137 (199)
T ss_pred CCCEEEEEEECCccHHHHHhhcH--H-------HHHHHHHHHHHHHH--HCCeecCCCCcceEEEE-CCcEEEEECCCCc
Confidence 77899999999999999875432 1 78899999999999 99999999999999998 7899999999886
Q ss_pred c
Q 018785 180 D 180 (350)
Q Consensus 180 ~ 180 (350)
.
T Consensus 138 ~ 138 (199)
T TIGR03724 138 Y 138 (199)
T ss_pred C
Confidence 4
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.72 E-value=7e-18 Score=152.41 Aligned_cols=169 Identities=25% Similarity=0.382 Sum_probs=128.5
Q ss_pred CceEEEEEcCCCCChhhHHhhc-CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcccccc
Q 018785 100 DNRLLVYEFMPKGSLENHLFRK-GVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 178 (350)
Q Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~ 178 (350)
..+|+.|+++...+|.+++..+ .....+....+.++.|++.++.| ++.+|+|++|.||+...+..+++.|||+.
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y-----k~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY-----KGLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh-----ccchhhhccccccccccchhhhhhhhhhe
Confidence 3578999999999999999733 34467777899999999999988 69999999999999999999999999999
Q ss_pred ccCCCCC----CCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhC-CCCCcccccCcchhhhhhhcchhh
Q 018785 179 RDGPTGD----NTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSG-RRALDEDRGGLAEQTLVEWADPFL 253 (350)
Q Consensus 179 ~~~~~~~----~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g-~~pf~~~~~~~~~~~~~~~~~~~~ 253 (350)
....... .....+...|+..|++||.+.+..|+.++|||+||++|++++.. ...|..
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er------------------ 465 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER------------------ 465 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH------------------
Confidence 8655444 12234557799999999999999999999999999999999982 222211
Q ss_pred hhhHHHHHhhhcccCCCCcHH---HHHHHHHHHHHhhccCCCCCCCH
Q 018785 254 RDSRRVLRIMDTRLGGQYSKK---EAQAVAAVVLQCLHMDPKNRPSM 297 (350)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~---~~~~l~~li~~~l~~dp~~Rps~ 297 (350)
...........+++. --+.-..|+.+|+.+.|.+||++
T Consensus 466 ------~~t~~d~r~g~ip~~~~~d~p~e~~ll~~lls~~p~~RP~~ 506 (516)
T KOG1033|consen 466 ------IATLTDIRDGIIPPEFLQDYPEEYTLLQQLLSPSPEERPSA 506 (516)
T ss_pred ------HHhhhhhhcCCCChHHhhcCcHHHHHHHHhcCCCcccCchH
Confidence 111111111122211 11345679999999999999943
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.72 E-value=6.9e-17 Score=135.29 Aligned_cols=137 Identities=18% Similarity=0.128 Sum_probs=106.1
Q ss_pred hcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh----------------------hHHHHHHHH
Q 018785 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ----------------------GHKEWLTEV 78 (350)
Q Consensus 21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~----------------------~~~~~~~e~ 78 (350)
..|.+.+.||+|++|.||++. .. +|+.|+||++...... .......|+
T Consensus 15 ~~~~~~~~i~~G~~g~Vy~~~---------~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~ 84 (198)
T cd05144 15 VVESLGNQIGVGKESDVYLAL---------DP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEF 84 (198)
T ss_pred chhhcCCccccCcceEEEEEE---------cC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHH
Confidence 349999999999999999983 32 5889999987643210 012356788
Q ss_pred HHHhccCCCc--ccceeeEEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCC
Q 018785 79 IYLGQLRHEN--LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRD 156 (350)
Q Consensus 79 ~~l~~l~h~~--i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~d 156 (350)
..+..+.+++ +...++ ....++||||++|++|.+.... .....++.+++.++.++| ..|++|+|
T Consensus 85 ~~l~~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh--~~gi~H~D 150 (198)
T cd05144 85 AALKALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAY--KHGIIHGD 150 (198)
T ss_pred HHHHHHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHH--HCCCCcCC
Confidence 8888887763 444433 2456899999999888765421 245678899999999999 89999999
Q ss_pred CCCCceEEcCCCcEEEccccccccC
Q 018785 157 LKASNVLLDSNFNAKLSDFGLARDG 181 (350)
Q Consensus 157 i~~~Nili~~~~~~~l~Dfg~~~~~ 181 (350)
|+|.||+++.++.++|+|||.+...
T Consensus 151 l~p~Nill~~~~~~~liDfg~~~~~ 175 (198)
T cd05144 151 LSEFNILVDDDEKIYIIDWPQMVST 175 (198)
T ss_pred CCcccEEEcCCCcEEEEECCccccC
Confidence 9999999999999999999999643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.69 E-value=2.5e-16 Score=151.25 Aligned_cols=136 Identities=21% Similarity=0.250 Sum_probs=108.4
Q ss_pred hcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccc--------hhhHHHHHHHHHHHhccCCCcccce
Q 018785 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES--------FQGHKEWLTEVIYLGQLRHENLVKL 92 (350)
Q Consensus 21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~ 92 (350)
..|...++||+|+||+||+|.+.. ..+++|...... ......+.+|+..++.+.|+++...
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~-----------~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p 401 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLG-----------RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTP 401 (535)
T ss_pred cccCccceeccCCcEEEEEEeecC-----------ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCee
Confidence 345678899999999999985532 123333321110 0112457889999999999999888
Q ss_pred eeEEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEE
Q 018785 93 IGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKL 172 (350)
Q Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l 172 (350)
..+.......++||||++|++|.+++. ....++.+++.+|.+|| +.|++|+||||+||++ .++.++|
T Consensus 402 ~~~~~~~~~~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH--~~giiHrDlkp~NILl-~~~~~~l 468 (535)
T PRK09605 402 VIYDVDPEEKTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLH--KAGIVHGDLTTSNFIV-RDDRLYL 468 (535)
T ss_pred EEEEEeCCCCEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHH--hCCCccCCCChHHEEE-ECCcEEE
Confidence 777777778899999999999999885 34678899999999999 9999999999999999 6778999
Q ss_pred cccccccc
Q 018785 173 SDFGLARD 180 (350)
Q Consensus 173 ~Dfg~~~~ 180 (350)
+|||++..
T Consensus 469 iDFGla~~ 476 (535)
T PRK09605 469 IDFGLGKY 476 (535)
T ss_pred EeCccccc
Confidence 99999964
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.9e-17 Score=158.79 Aligned_cols=260 Identities=23% Similarity=0.262 Sum_probs=199.2
Q ss_pred hhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccc--hhhHHHHHHHHHHHhccC-CCcccceeeE
Q 018785 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES--FQGHKEWLTEVIYLGQLR-HENLVKLIGY 95 (350)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~-h~~i~~~~~~ 95 (350)
....|.+.+-||+|.++.|-+.... ......++.|.+.... .........|...-+.++ |.|++.+++.
T Consensus 18 ~~~~~~~~~~ig~gs~~~~~~~~~~--------~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~ 89 (601)
T KOG0590|consen 18 PNSQYKLSRSIGKGSFSSSALASNS--------RDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEP 89 (601)
T ss_pred ccccccccccccccccchhhhhhhc--------CCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCc
Confidence 3678999999999999999876322 2335556666665443 222344455677777776 9999999999
Q ss_pred EeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCC-cEEEcc
Q 018785 96 CSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNF-NAKLSD 174 (350)
Q Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~-~~~l~D 174 (350)
....+..++++++..|+++.+.+........+...+...+.|+..++.|+|. ..++.|+|++|+|.+++.++ .+++.|
T Consensus 90 ~~~~~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~-~~~~~h~~ikP~n~~l~~s~~~l~~~d 168 (601)
T KOG0590|consen 90 SSSPRSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHP-ENGVTHRDIKPSNSLLDESGSALKIAD 168 (601)
T ss_pred cCCCcccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCc-ccccccCCCCCccchhccCCCcccCCC
Confidence 9999999999999999999988853333356777888999999999999996 68999999999999999999 999999
Q ss_pred ccccccCCC-CCCCcccccccC-CCcccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcch
Q 018785 175 FGLARDGPT-GDNTHVSTRIVG-TRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADP 251 (350)
Q Consensus 175 fg~~~~~~~-~~~~~~~~~~~~-~~~~~aPE~~~~~-~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~ 251 (350)
||++..+.. ...........| ++.|.|||...+. ......|+||.|+++..+++|..||..........
T Consensus 169 f~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~-------- 240 (601)
T KOG0590|consen 169 FGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRY-------- 240 (601)
T ss_pred chhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccc--------
Confidence 999987666 444444455677 8999999998885 44678999999999999999999997655432110
Q ss_pred hhhhhHHHHHhhh--cccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 252 FLRDSRRVLRIMD--TRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 252 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
..... ..........++....+++.+++..+|..|.+.+++-..
T Consensus 241 --------~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d 286 (601)
T KOG0590|consen 241 --------SSWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLD 286 (601)
T ss_pred --------eeecccccccccCccccCChhhhhcccccccCCchhcccccccccc
Confidence 00011 111133455677888999999999999999999988644
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.65 E-value=1e-15 Score=126.94 Aligned_cols=137 Identities=19% Similarity=0.171 Sum_probs=95.7
Q ss_pred ccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh--hHHH----------------------HHHHHHH
Q 018785 25 SDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ--GHKE----------------------WLTEVIY 80 (350)
Q Consensus 25 i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~----------------------~~~e~~~ 80 (350)
+.+.||+|++|+||+| .+. +++.||||++...... .... ...|...
T Consensus 1 ~~~~lg~G~~g~Vy~a---------~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~ 70 (187)
T cd05119 1 VGGPIGTGKEADVYLA---------LDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRN 70 (187)
T ss_pred CCcccccccceeEEEE---------ECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHH
Confidence 3578999999999999 333 5889999988754221 1111 1345555
Q ss_pred HhccCCC--cccceeeEEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCC-CCeeeCCC
Q 018785 81 LGQLRHE--NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLD-ANVIYRDL 157 (350)
Q Consensus 81 l~~l~h~--~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~-~~i~H~di 157 (350)
+..+.+. .+.++++. ...++||||+.++++........ ... ..+..++.+++.++.++| . .|++|+||
T Consensus 71 l~~l~~~~~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~--~~~-~~~~~~~~~~~~~l~~lh--~~~~ivH~Dl 141 (187)
T cd05119 71 LKRLYEAGVPVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDV--RLL-EDPEELYDQILELMRKLY--REAGLVHGDL 141 (187)
T ss_pred HHHHHHcCCCCCceEec----CCCEEEEEEeCCCCccChhhhhh--hhc-ccHHHHHHHHHHHHHHHh--hccCcCcCCC
Confidence 5555333 24444433 24589999998854332111111 011 567889999999999999 7 99999999
Q ss_pred CCCceEEcCCCcEEEccccccccC
Q 018785 158 KASNVLLDSNFNAKLSDFGLARDG 181 (350)
Q Consensus 158 ~~~Nili~~~~~~~l~Dfg~~~~~ 181 (350)
+|+||+++ ++.++|+|||.+...
T Consensus 142 ~p~Nili~-~~~~~liDfg~a~~~ 164 (187)
T cd05119 142 SEYNILVD-DGKVYIIDVPQAVEI 164 (187)
T ss_pred ChhhEEEE-CCcEEEEECcccccc
Confidence 99999999 889999999999753
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.64 E-value=6.4e-15 Score=137.10 Aligned_cols=169 Identities=20% Similarity=0.226 Sum_probs=133.7
Q ss_pred CCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceeeEEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHH
Q 018785 50 TKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWP 129 (350)
Q Consensus 50 ~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~ 129 (350)
..+.++.+|.|..++...........+.++.|+.++||+|+++++.++.++.+|+|+|.+ ..|..++.+. +..
T Consensus 32 t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~l-----~~~ 104 (690)
T KOG1243|consen 32 TRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKEL-----GKE 104 (690)
T ss_pred ceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHHh-----HHH
Confidence 566778899999887776544456778899999999999999999999999999999997 4677777654 366
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccccccCCCCCCCcccccccCCCcccCccccccCC
Q 018785 130 TRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGH 209 (350)
Q Consensus 130 ~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~ 209 (350)
.+...++||+.||.+||. +.+++|++|+...|+|+..|.++|++|.++.......... ........|..|+.+....
T Consensus 105 ~v~~Gl~qIl~AL~FL~~-d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~--~~~~~~~s~~~P~~~~~s~ 181 (690)
T KOG1243|consen 105 EVCLGLFQILAALSFLND-DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPA--KSLYLIESFDDPEEIDPSE 181 (690)
T ss_pred HHHHHHHHHHHHHHHHhc-cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCccc--ccchhhhcccChhhcCccc
Confidence 778889999999999976 8999999999999999999999999999987543333211 1111223466776543332
Q ss_pred CCCccchhhHHHHHHHHHhCC
Q 018785 210 LTPKSDVYSFGVVLLELLSGR 230 (350)
Q Consensus 210 ~~~~~DiwslG~ll~~ll~g~ 230 (350)
-..|.|.|||++++++.|.
T Consensus 182 --~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 182 --WSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred --cchhhhhHHHHHHHHhCcc
Confidence 4579999999999999993
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.62 E-value=4.2e-15 Score=118.51 Aligned_cols=134 Identities=22% Similarity=0.137 Sum_probs=109.1
Q ss_pred ccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCC--CcccceeeEEeecCce
Q 018785 25 SDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRH--ENLVKLIGYCSESDNR 102 (350)
Q Consensus 25 i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~ 102 (350)
+.+.||+|.++.||++... +..+++|....... ...+..|...++.+.+ .++.+++......+..
T Consensus 2 ~~~~i~~g~~~~v~~~~~~-----------~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~ 68 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK-----------DEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWS 68 (155)
T ss_pred cceecccccccceEEEEec-----------CCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCcc
Confidence 5678999999999999432 25789998866543 4567788999999865 5888888888888889
Q ss_pred EEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCC-CCeeeCCCCCCceEEcCCCcEEEcccccccc
Q 018785 103 LLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLD-ANVIYRDLKASNVLLDSNFNAKLSDFGLARD 180 (350)
Q Consensus 103 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~-~~i~H~di~~~Nili~~~~~~~l~Dfg~~~~ 180 (350)
++++||+.+..+..+ +......++.+++++++.+|... .+++|+|++|+||+++..+.++++|||.+..
T Consensus 69 ~~v~e~~~g~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 69 YLLMEWIEGETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred EEEEEecCCeecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 999999988777654 34466778899999999999311 4799999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.61 E-value=1e-14 Score=125.27 Aligned_cols=135 Identities=21% Similarity=0.211 Sum_probs=100.4
Q ss_pred cceec-ccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch-------------hhHHHHHHHHHHHhccCCCcc--
Q 018785 26 DYLLG-EGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-------------QGHKEWLTEVIYLGQLRHENL-- 89 (350)
Q Consensus 26 ~~~lg-~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-------------~~~~~~~~e~~~l~~l~h~~i-- 89 (350)
...|| .|+.|+||.+... +..++||.+..... .....+.+|+.++..+.|+++
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-----------~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~v 104 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-----------GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPV 104 (239)
T ss_pred CceeecCCCCccEEEEEeC-----------CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCC
Confidence 34676 7888888887322 56788887753211 122456789999999988775
Q ss_pred cceeeEEeecCc----eEEEEEcCCC-CChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEE
Q 018785 90 VKLIGYCSESDN----RLLVYEFMPK-GSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLL 164 (350)
Q Consensus 90 ~~~~~~~~~~~~----~~lv~e~~~~-~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili 164 (350)
+..+++...... .++|||+++| .+|.+++... .++.. .+.+++.+|.+|| +.|++|+||+|.||++
T Consensus 105 P~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~~---~l~~~----~~~~i~~~l~~lH--~~GI~HrDlkp~NILv 175 (239)
T PRK01723 105 PRPIAARVVRHGLFYRADILIERIEGARDLVALLQEA---PLSEE----QWQAIGQLIARFH--DAGVYHADLNAHNILL 175 (239)
T ss_pred ceeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhcC---CCCHH----HHHHHHHHHHHHH--HCCCCCCCCCchhEEE
Confidence 566665443222 2599999987 6898887543 34443 3568999999999 9999999999999999
Q ss_pred cCCCcEEEcccccccc
Q 018785 165 DSNFNAKLSDFGLARD 180 (350)
Q Consensus 165 ~~~~~~~l~Dfg~~~~ 180 (350)
+.++.++|+|||.+..
T Consensus 176 ~~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 176 DPDGKFWLIDFDRGEL 191 (239)
T ss_pred cCCCCEEEEECCCccc
Confidence 9988999999998875
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.55 E-value=7.7e-15 Score=135.17 Aligned_cols=256 Identities=26% Similarity=0.269 Sum_probs=186.9
Q ss_pred hhhhhcccccceecc--cCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch--hhHHHHHHHHHHHhcc-CCCcccc
Q 018785 17 KIATKNFCSDYLLGE--GGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQL-RHENLVK 91 (350)
Q Consensus 17 ~~~~~~y~i~~~lg~--G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l-~h~~i~~ 91 (350)
.+....+.+...+|. |.+|.+|.++. ....++..+++|.-+.... .....-.+|+...+.+ .|++.++
T Consensus 110 s~~~~~~~~~~~~g~~~g~~~s~~~~~~-------~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~ 182 (524)
T KOG0601|consen 110 SFFDQRFPISSRTGSLPGSKGSVFKSRC-------TNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVR 182 (524)
T ss_pred chhhhhcccccccccCCCCCceeecccC-------CcccCCcccccccccCCCCCccccccccchhhcccccCccccccc
Confidence 344567888999999 99999999843 1266788899887433222 2233345566666666 5999999
Q ss_pred eeeEEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHH----HHHHhhcCCCCeeeCCCCCCceEEcCC
Q 018785 92 LIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVAR----GLSFLHGLDANVIYRDLKASNVLLDSN 167 (350)
Q Consensus 92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~----al~~lh~~~~~i~H~di~~~Nili~~~ 167 (350)
.+..++..+.+|+-+|.+ +.+|..+..... ..++...++..+.+..+ ||.++| +.+++|.|++|.||+...+
T Consensus 183 ~~~~~e~~~~lfiqtE~~-~~sl~~~~~~~~-~~~p~~~l~~~~~~~~~~~~~al~~~h--s~~~~~~~~kp~~i~~~~~ 258 (524)
T KOG0601|consen 183 DSPAWEGSGILFIQTELC-GESLQSYCHTPC-NFLPDNLLWNSLRDWLSRDVTALSHLH--SNNIVHDDLKPANIFTTSD 258 (524)
T ss_pred cCcccccCCcceeeeccc-cchhHHhhhccc-ccCCchhhhhHHhhhhhcccccccccC--CCcccccccchhheecccc
Confidence 999999999999999998 678888886544 35788899999999999 999999 9999999999999999999
Q ss_pred -CcEEEccccccccCCCCCCCccc---ccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchh
Q 018785 168 -FNAKLSDFGLARDGPTGDNTHVS---TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQ 243 (350)
Q Consensus 168 -~~~~l~Dfg~~~~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~ 243 (350)
...+++|||+............. .+..+...|++||.. ...++...|+|++|.++.+-.++..++....+.
T Consensus 259 ~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~---- 333 (524)
T KOG0601|consen 259 WTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKNS---- 333 (524)
T ss_pred cceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCCC----
Confidence 88999999998765444422221 223577889999965 667788999999999999998887765432110
Q ss_pred hhhhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018785 244 TLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLT 302 (350)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 302 (350)
.+..++... ...++-..-+.++...+.+|++.+|..|++.+.+..
T Consensus 334 -----~W~~~r~~~---------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 334 -----SWSQLRQGY---------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred -----Ccccccccc---------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 000000000 001111223455666999999999999999877764
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.47 E-value=9.3e-14 Score=118.89 Aligned_cols=204 Identities=24% Similarity=0.315 Sum_probs=141.0
Q ss_pred HHHHHhccCCCcccceeeEEeec-----CceEEEEEcCCCCChhhHHhhc--CCCCCCHHHHHHHHHHHHHHHHHhhcCC
Q 018785 77 EVIYLGQLRHENLVKLIGYCSES-----DNRLLVYEFMPKGSLENHLFRK--GVQPISWPTRVKIAIDVARGLSFLHGLD 149 (350)
Q Consensus 77 e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~i~~ql~~al~~lh~~~ 149 (350)
-..-|-++-|.|+++++.++.+. ....+++||+..+++..|+++. ....+....-.+|+.||+.||.|||+++
T Consensus 117 vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~ 196 (458)
T KOG1266|consen 117 VFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC
Confidence 34555666799999999998654 3568999999999999999754 3346778888899999999999999999
Q ss_pred CCeeeCCCCCCceEEcCCCcEEEccccccccCCCCCCC---cccccccCCCcccCccccccCCCCCccchhhHHHHHHHH
Q 018785 150 ANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNT---HVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLEL 226 (350)
Q Consensus 150 ~~i~H~di~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~l 226 (350)
.-++|+++..+.|++..+|-+++.- +.-......... .......+.++|.+||.=...+..-++|||++|+...+|
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~-~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlem 275 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGS-VAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEM 275 (458)
T ss_pred CccccCCcchhheeecCCceEEecc-cCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHH
Confidence 9999999999999999998777632 111111011000 111224567889999976666777899999999999999
Q ss_pred HhCCCCCccccc-CcchhhhhhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 227 LSGRRALDEDRG-GLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 227 l~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
.-+..--..... ......+.. .... ...+--+.++..|++..|..||++..++-|
T Consensus 276 ailEiq~tnseS~~~~ee~ia~-----------~i~~-----------len~lqr~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 276 AILEIQSTNSESKVEVEENIAN-----------VIIG-----------LENGLQRGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred HHheeccCCCcceeehhhhhhh-----------heee-----------ccCccccCcCcccccCCCCCCcchhhhhcC
Confidence 877643211111 011111100 0000 001122458899999999999999998866
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.44 E-value=7.5e-13 Score=123.38 Aligned_cols=139 Identities=17% Similarity=0.183 Sum_probs=96.0
Q ss_pred cceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhH----------------------------------
Q 018785 26 DYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGH---------------------------------- 71 (350)
Q Consensus 26 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~---------------------------------- 71 (350)
.+.||+|++|.||+|+.. +|+.||||+..+......
T Consensus 122 ~~plasaSigQVh~A~l~----------~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~ 191 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLV----------DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFE 191 (437)
T ss_pred CcceeeeehhheEEEEec----------CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHH
Confidence 468999999999999653 478999999865421110
Q ss_pred ------HHHHHHHHHHhcc----C-CCcccceeeEE-eecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHH
Q 018785 72 ------KEWLTEVIYLGQL----R-HENLVKLIGYC-SESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVA 139 (350)
Q Consensus 72 ------~~~~~e~~~l~~l----~-h~~i~~~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~ 139 (350)
-++..|+..+.++ . ++++ .+-.++ ...+..++||||++|.+|.++...... .. ....++.+++
T Consensus 192 ~~l~~Eldf~~Ea~n~~~~~~~~~~~~~v-~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~-~~---~~~~ia~~~~ 266 (437)
T TIGR01982 192 KTLRRELDLRREAANASELGENFKNDPGV-YVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA-GL---DRKALAENLA 266 (437)
T ss_pred HHHHHHHCHHHHHHHHHHHHHhcCCCCCE-EeCCEehhhcCCceEEEEeECCcccccHHHHHhc-CC---CHHHHHHHHH
Confidence 0133455544444 2 3333 222222 334557899999999999987753221 12 2345666666
Q ss_pred H-HHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccccccC
Q 018785 140 R-GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDG 181 (350)
Q Consensus 140 ~-al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~~~ 181 (350)
. .+..+| ..|++|+|++|.||+++.++.++++|||++...
T Consensus 267 ~~~l~ql~--~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l 307 (437)
T TIGR01982 267 RSFLNQVL--RDGFFHADLHPGNIFVLKDGKIIALDFGIVGRL 307 (437)
T ss_pred HHHHHHHH--hCCceeCCCCcccEEECCCCcEEEEeCCCeeEC
Confidence 5 467889 899999999999999999999999999998753
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.40 E-value=7.1e-12 Score=103.12 Aligned_cols=143 Identities=16% Similarity=0.112 Sum_probs=97.9
Q ss_pred cceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch---------------------hh-HHH----HHHHHH
Q 018785 26 DYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---------------------QG-HKE----WLTEVI 79 (350)
Q Consensus 26 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---------------------~~-~~~----~~~e~~ 79 (350)
...||.|.-+.||.|...+.. .....+..+|||++..... .. ... ...|+.
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~---~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r 78 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNE---TEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMH 78 (197)
T ss_pred CCccccCcceEEEEEecCccc---ccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHH
Confidence 467899999999999422110 0112467899998753110 01 112 237888
Q ss_pred HHhccCC--CcccceeeEEeecCceEEEEEcCCCCChhh-HHhhcCCCCCCHHHHHHHHHHHHHHHHHh-hcCCCCeeeC
Q 018785 80 YLGQLRH--ENLVKLIGYCSESDNRLLVYEFMPKGSLEN-HLFRKGVQPISWPTRVKIAIDVARGLSFL-HGLDANVIYR 155 (350)
Q Consensus 80 ~l~~l~h--~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~-~l~~~~~~~l~~~~~~~i~~ql~~al~~l-h~~~~~i~H~ 155 (350)
.|+++.. -++.+++++ ..-++|||++.+..+.. .+... .++..+...+..+++.++..+ | ..|++|+
T Consensus 79 ~L~rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~---~~~~~~~~~i~~~i~~~l~~l~H--~~glVHG 149 (197)
T cd05146 79 NLKRMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA---KLNDEEMKNAYYQVLSMMKQLYK--ECNLVHA 149 (197)
T ss_pred HHHHHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc---ccCHHHHHHHHHHHHHHHHHHHH--hCCeecC
Confidence 8888843 445555554 45679999996543322 22221 355566778889999999988 9 8999999
Q ss_pred CCCCCceEEcCCCcEEEccccccccC
Q 018785 156 DLKASNVLLDSNFNAKLSDFGLARDG 181 (350)
Q Consensus 156 di~~~Nili~~~~~~~l~Dfg~~~~~ 181 (350)
||++.||++. ++.+.|+|||.+...
T Consensus 150 DLs~~NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 150 DLSEYNMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred CCCHHHEEEE-CCcEEEEECCCceeC
Confidence 9999999996 468999999998753
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.37 E-value=2.8e-12 Score=104.48 Aligned_cols=128 Identities=17% Similarity=0.078 Sum_probs=93.1
Q ss_pred cceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcc-cceeeEEeecCceEE
Q 018785 26 DYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENL-VKLIGYCSESDNRLL 104 (350)
Q Consensus 26 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~l 104 (350)
.+.|+.|.++.||+++. .+..+++|....... ....+..|+..++.+...++ .+++... .+..++
T Consensus 3 ~~~l~~G~~~~vy~~~~-----------~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~l 68 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV-----------ANKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVL 68 (170)
T ss_pred eeecCCcccCceEEEEE-----------CCeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeE
Confidence 46789999999999842 266899998765532 12345678888888754443 3444443 234589
Q ss_pred EEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC-----eeeCCCCCCceEEcCCCcEEEccccccc
Q 018785 105 VYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDAN-----VIYRDLKASNVLLDSNFNAKLSDFGLAR 179 (350)
Q Consensus 105 v~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~-----i~H~di~~~Nili~~~~~~~l~Dfg~~~ 179 (350)
||||++|.++.+. . . ....++.+++++|+.|| ..+ ++|+|++|.||+++ ++.++++||+.+.
T Consensus 69 v~e~i~G~~l~~~----~---~---~~~~~~~~l~~~l~~LH--~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 69 ITEFIEGSELLTE----D---F---SDPENLEKIAKLLKKLH--SSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred EEEecCCCccccc----c---c---cCHHHHHHHHHHHHHHh--CCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 9999999887653 0 1 11345678999999999 666 49999999999998 6689999999886
Q ss_pred c
Q 018785 180 D 180 (350)
Q Consensus 180 ~ 180 (350)
.
T Consensus 136 ~ 136 (170)
T cd05151 136 M 136 (170)
T ss_pred C
Confidence 3
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.37 E-value=1.5e-11 Score=97.48 Aligned_cols=143 Identities=22% Similarity=0.234 Sum_probs=108.8
Q ss_pred ccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch-----h---hHHHHHHHHHHHhccCCCcccceeeEE
Q 018785 25 SDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-----Q---GHKEWLTEVIYLGQLRHENLVKLIGYC 96 (350)
Q Consensus 25 i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-----~---~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (350)
...++.+|+-+.|+++.+. |+.++||.-..... + ......+|++.|.++.--+|.-..-++
T Consensus 11 ~l~likQGAEArv~~~~~~-----------Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~ 79 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-----------GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIF 79 (229)
T ss_pred cceeeeccceeeEeeeccC-----------CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEE
Confidence 6778899999999998654 67777884322211 1 224567899998888655666555567
Q ss_pred eecCceEEEEEcCCC-CChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCc---EEE
Q 018785 97 SESDNRLLVYEFMPK-GSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFN---AKL 172 (350)
Q Consensus 97 ~~~~~~~lv~e~~~~-~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~---~~l 172 (350)
.+...-.|+|||++| .++.+++...............++.++-+.+.-|| .++++||||..+||++..++. +.|
T Consensus 80 ~D~~~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH--~ndiiHGDLTTSNill~~~~~~~~~~l 157 (229)
T KOG3087|consen 80 IDTYGGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLH--DNDIIHGDLTTSNILLRSDGNQITPIL 157 (229)
T ss_pred EecCCCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhh--hCCeecccccccceEEecCCCcCceEE
Confidence 777777899999966 48888887765444444455789999999999999 999999999999999966543 589
Q ss_pred cccccccc
Q 018785 173 SDFGLARD 180 (350)
Q Consensus 173 ~Dfg~~~~ 180 (350)
+|||++..
T Consensus 158 Idfgls~~ 165 (229)
T KOG3087|consen 158 IDFGLSSV 165 (229)
T ss_pred Eeecchhc
Confidence 99999975
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.34 E-value=1.5e-12 Score=122.86 Aligned_cols=142 Identities=14% Similarity=0.141 Sum_probs=90.4
Q ss_pred hcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhh------------------------------
Q 018785 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQG------------------------------ 70 (350)
Q Consensus 21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~------------------------------ 70 (350)
..|.. +.||+|++|.||+|+. ..+|+.||||+..+.....
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l---------~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~ 189 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARL---------KDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREV 189 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEE---------CCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHH
Confidence 45676 7999999999999954 3458999999987542110
Q ss_pred ----HHH------HHHHHHHHhcc----CCCcccceeeEEee-cCceEEEEEcCCCCChhhHH--hhcCC--CCCCHHHH
Q 018785 71 ----HKE------WLTEVIYLGQL----RHENLVKLIGYCSE-SDNRLLVYEFMPKGSLENHL--FRKGV--QPISWPTR 131 (350)
Q Consensus 71 ----~~~------~~~e~~~l~~l----~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l--~~~~~--~~l~~~~~ 131 (350)
.+. +..|+..+.++ .+...+.+-.++.+ .+..++||||++|+++.++. ...+. ..+.+..+
T Consensus 190 v~e~~~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v 269 (537)
T PRK04750 190 VAEFEKTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGV 269 (537)
T ss_pred HHHHHHHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHH
Confidence 111 23333333333 23333333333322 45567999999999998753 22210 01222222
Q ss_pred HHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCC----cEEEccccccccC
Q 018785 132 VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNF----NAKLSDFGLARDG 181 (350)
Q Consensus 132 ~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~----~~~l~Dfg~~~~~ 181 (350)
..++. .+. ..|++|+|++|.||+++.++ .++++|||.+...
T Consensus 270 ~~~~~-------Qif--~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l 314 (537)
T PRK04750 270 EVFFT-------QVF--RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL 314 (537)
T ss_pred HHHHH-------HHH--hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence 23333 334 57999999999999999888 8999999998754
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.33 E-value=6e-11 Score=105.38 Aligned_cols=273 Identities=15% Similarity=0.128 Sum_probs=170.1
Q ss_pred hhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhcc-CCCcccceeeE--
Q 018785 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQL-RHENLVKLIGY-- 95 (350)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~-- 95 (350)
-++-....+.||+|+-+.+|-.- . -+. .+-|++.............| |... .||-+-.-+.+
T Consensus 9 ~ge~i~~gr~LgqGgea~ly~l~---------e--~~d-~VAKIYh~Pppa~~aqk~a~---la~~p~~p~~~~rvaWPq 73 (637)
T COG4248 9 YGEPIPPGRPLGQGGEADLYTLG---------E--VRD-QVAKIYHAPPPAAQAQKVAE---LAATPDAPLLNYRVAWPQ 73 (637)
T ss_pred cCcccCCCccccCCccceeeecc---------h--hhc-hhheeecCCCchHHHHHHHH---hccCCCCcchhhhhcccH
Confidence 34455677899999999999641 1 122 34588877654433322222 2222 34433220110
Q ss_pred ----E-eecCceEEEEEcCCCCC-hhhHHh----hcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEc
Q 018785 96 ----C-SESDNRLLVYEFMPKGS-LENHLF----RKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLD 165 (350)
Q Consensus 96 ----~-~~~~~~~lv~e~~~~~~-L~~~l~----~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~ 165 (350)
. ..+....++|..+.|.. +.+++. ++..........+++++.|+.+.+.|| ..|.+-||++++|+|++
T Consensus 74 a~L~G~~~~~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH--~~Gh~vGDVn~~~~lVs 151 (637)
T COG4248 74 ATLHGGRRGKVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLH--EHGHVVGDVNQNSFLVS 151 (637)
T ss_pred HHhhCCCccceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHH--hcCCcccccCccceeee
Confidence 1 12223668888876652 233332 223345777889999999999999999 99999999999999999
Q ss_pred CCCcEEEccccccccCCCCCCCcccccccCCCcccCccccc-----cCCCCCccchhhHHHHHHHHHhC-CCCCcccccC
Q 018785 166 SNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVA-----TGHLTPKSDVYSFGVVLLELLSG-RRALDEDRGG 239 (350)
Q Consensus 166 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~DiwslG~ll~~ll~g-~~pf~~~~~~ 239 (350)
.++.|+|+|=+..... ..........|.+.|++||.-. +..-+..+|.|.||+++++++.| ++||.+....
T Consensus 152 d~~~V~LVdsDsfqi~---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~ 228 (637)
T COG4248 152 DDSKVVLVDSDSFQIN---ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLI 228 (637)
T ss_pred cCceEEEEcccceeec---cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCccccc
Confidence 9999999986654432 3333344467888999999753 33556789999999999999876 9999875532
Q ss_pred cchhhhhh--hcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccC--CCCCCCHHHHHHHHHhhhcCC
Q 018785 240 LAEQTLVE--WADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMD--PKNRPSMVDVLTSLEQLHTSK 311 (350)
Q Consensus 240 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d--p~~Rps~~~ll~~L~~~~~~~ 311 (350)
.....-.+ ...-.+....................-+++++..|..+|+... +.-|||++.++..|..+....
T Consensus 229 ~~ap~p~E~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L 304 (637)
T COG4248 229 SDAPNPLETDIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQL 304 (637)
T ss_pred CCCCCcchhhhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhh
Confidence 11110000 0000000001101111111111122356788999999999654 568999999999998887764
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.32 E-value=3.1e-11 Score=96.15 Aligned_cols=131 Identities=24% Similarity=0.332 Sum_probs=99.4
Q ss_pred ceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch-----hh---HHHHHHHHHHHhccCCCcccceeeEEee
Q 018785 27 YLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-----QG---HKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (350)
Q Consensus 27 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-----~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (350)
..+++|+-+.+|.+.|. |..+++|.=.+... +. .....+|+.++.++.--+|....=++.+
T Consensus 2 ~~i~~GAEa~i~~~~~~-----------g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD 70 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-----------GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVD 70 (204)
T ss_pred chhhCCcceeEEeeecc-----------CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEc
Confidence 45788999999998553 44466774322211 11 1345678999988876666666666677
Q ss_pred cCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcccccc
Q 018785 99 SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 178 (350)
Q Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~ 178 (350)
.....|+|||++|..|.+++... ...++..+-..+.-|| .+|++|+||+++||++... .+.++|||++
T Consensus 71 ~~~~~I~me~I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH--~~givHGDLTtsNiIl~~~-~i~~IDfGLg 138 (204)
T COG3642 71 PDNGLIVMEYIEGELLKDALEEA---------RPDLLREVGRLVGKLH--KAGIVHGDLTTSNIILSGG-RIYFIDFGLG 138 (204)
T ss_pred CCCCEEEEEEeCChhHHHHHHhc---------chHHHHHHHHHHHHHH--hcCeecCCCccceEEEeCC-cEEEEECCcc
Confidence 77888999999999999888765 2456777888888999 9999999999999999666 4999999999
Q ss_pred cc
Q 018785 179 RD 180 (350)
Q Consensus 179 ~~ 180 (350)
..
T Consensus 139 ~~ 140 (204)
T COG3642 139 EF 140 (204)
T ss_pred cc
Confidence 64
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.21 E-value=3.2e-10 Score=103.18 Aligned_cols=214 Identities=17% Similarity=0.224 Sum_probs=147.2
Q ss_pred ceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceeeEEee----cCceEEEEEcC
Q 018785 34 FGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSE----SDNRLLVYEFM 109 (350)
Q Consensus 34 ~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~ 109 (350)
..+.|++ ...-+|..|++|.++............-.+.++++.|+|++++.++|.. +..+++|++|+
T Consensus 289 ~~Ttyk~---------~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYy 359 (655)
T KOG3741|consen 289 SITTYKA---------TSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYY 359 (655)
T ss_pred cceeEee---------eeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecC
Confidence 3467787 6667799999999854433333233345778899999999999998863 45678999997
Q ss_pred CC-CChhhHHhhcC-------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccc
Q 018785 110 PK-GSLENHLFRKG-------------VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDF 175 (350)
Q Consensus 110 ~~-~~L~~~l~~~~-------------~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Df 175 (350)
++ ++|.++..... ....++..+|.++.||..||.++| +.|+.-+-|.+.+|+++.+-++++..-
T Consensus 360 P~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIH--ssGLAck~L~~~kIlv~G~~RIriS~C 437 (655)
T KOG3741|consen 360 PSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIH--SSGLACKTLDLKKILVTGKMRIRISGC 437 (655)
T ss_pred CCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHH--hcCceeecccHhHeEeeCcceEEEecc
Confidence 65 37777664332 235778899999999999999999 899999999999999999888998877
Q ss_pred cccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCC-CcccccCcchhhhhhhcchhhh
Q 018785 176 GLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRA-LDEDRGGLAEQTLVEWADPFLR 254 (350)
Q Consensus 176 g~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~p-f~~~~~~~~~~~~~~~~~~~~~ 254 (350)
|......... .+| +. -..+-|.-.||.++..|.+|..- +... .......
T Consensus 438 ~i~Dvl~~d~--------------~~~--le---~~Qq~D~~~lG~ll~aLAt~~~ns~~~d---~~~~s~~-------- 487 (655)
T KOG3741|consen 438 GIMDVLQEDP--------------TEP--LE---SQQQNDLRDLGLLLLALATGTENSNRTD---STQSSHL-------- 487 (655)
T ss_pred cceeeecCCC--------------Ccc--hh---HHhhhhHHHHHHHHHHHhhccccccccc---chHHHHH--------
Confidence 7665433322 111 11 12356888999999999999541 1100 0000000
Q ss_pred hhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 255 DSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
......++.++++++.-+...++.+ -++.+++.+
T Consensus 488 --------------~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 488 --------------TRITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred --------------HHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence 1122356667777777777777766 566666654
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.18 E-value=3e-11 Score=111.70 Aligned_cols=252 Identities=21% Similarity=0.215 Sum_probs=175.3
Q ss_pred hhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHH--HHHHHHHHhcc-CCCcccceeeE
Q 018785 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKE--WLTEVIYLGQL-RHENLVKLIGY 95 (350)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~--~~~e~~~l~~l-~h~~i~~~~~~ 95 (350)
...+|..+..||.|.|+.|+... .+..++..+++|-..........+ -..|..+...+ .|.+++.++..
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~--------~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~ 334 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVS--------KRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSS 334 (524)
T ss_pred ecCCcceeEEccCCccccceeee--------ecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCC
Confidence 35688899999999999999873 222456678888665443222221 23455555555 58888888888
Q ss_pred EeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCC-CcEEEcc
Q 018785 96 CSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSN-FNAKLSD 174 (350)
Q Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~-~~~~l~D 174 (350)
+......|+-.||++++++...+... ..+++...+.+..|++.++.++| +..++|.|++|.||++..+ +..++.|
T Consensus 335 W~~~r~~~ip~e~~~~~s~~l~~~~~--~~~d~~~~~~~~~q~~~~l~~i~--s~~~~~~d~~psni~i~~~~~~~~~~~ 410 (524)
T KOG0601|consen 335 WSQLRQGYIPLEFCEGGSSSLRSVTS--QMLDEDPRLRLTAQILTALNVIH--SKLFVHLDVKPSNILISNDGFFSKLGD 410 (524)
T ss_pred ccccccccCchhhhcCcchhhhhHHH--HhcCcchhhhhHHHHHhcccccc--chhhhcccccccceeeccchhhhhccc
Confidence 88888888999999999887776332 36888899999999999999999 9999999999999999886 6678999
Q ss_pred ccccccCCCCCCCcccccccCCCcc-cCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhh
Q 018785 175 FGLARDGPTGDNTHVSTRIVGTRGY-AAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 253 (350)
Q Consensus 175 fg~~~~~~~~~~~~~~~~~~~~~~~-~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 253 (350)
|+....+....... ...+..| .++.......+..+.|+++||..+.+.+++...-.....
T Consensus 411 ~~~~t~~~~~~~~~----~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~--------------- 471 (524)
T KOG0601|consen 411 FGCWTRLAFSSGVF----HHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ--------------- 471 (524)
T ss_pred cccccccceecccc----cccccccccchhhccccccccccccccccccccccccCcccCccccc---------------
Confidence 99886422211111 1122223 345555566778899999999999999998653221110
Q ss_pred hhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 018785 254 RDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLH 308 (350)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 308 (350)
...+.... .........++..+.+.++.+++..||++.++..+..-..
T Consensus 472 ------~~~i~~~~-~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~ 519 (524)
T KOG0601|consen 472 ------SLTIRSGD-TPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYR 519 (524)
T ss_pred ------ceeeeccc-ccCCCchHHhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence 00001110 1112233478888999999999999999988876654433
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.16 E-value=3.4e-10 Score=96.31 Aligned_cols=141 Identities=20% Similarity=0.241 Sum_probs=103.6
Q ss_pred ceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch-hhHHHHHHHHHHHhccCC--CcccceeeEEeec---C
Q 018785 27 YLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRH--ENLVKLIGYCSES---D 100 (350)
Q Consensus 27 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~---~ 100 (350)
+.|+.|..+.+|++... +|..+++|....... .....+..|+..++.+.+ .++.+++.+.... +
T Consensus 4 ~~l~~G~~n~~~~v~~~----------~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~ 73 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG----------GGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLG 73 (223)
T ss_pred eecCCCccceEEEEEec----------CCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccC
Confidence 56899999999998421 257899998765432 134567889999998865 4456677766553 3
Q ss_pred ceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcC--------------------------------
Q 018785 101 NRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL-------------------------------- 148 (350)
Q Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~-------------------------------- 148 (350)
..++|||+++|.++.+.+.. ..++......++.+++.+|..||+.
T Consensus 74 ~~~~v~e~i~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 150 (223)
T cd05154 74 TPFYVMERVDGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASR 150 (223)
T ss_pred CceEEEEEeCCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhc
Confidence 66899999999888776532 1466667777777777777777732
Q ss_pred ----------------------CCCeeeCCCCCCceEEcC--CCcEEEcccccccc
Q 018785 149 ----------------------DANVIYRDLKASNVLLDS--NFNAKLSDFGLARD 180 (350)
Q Consensus 149 ----------------------~~~i~H~di~~~Nili~~--~~~~~l~Dfg~~~~ 180 (350)
...++|+|+++.||+++. ++.+.++||+.+..
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 151 TDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred ccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 234689999999999988 56689999998864
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.13 E-value=2.2e-11 Score=118.77 Aligned_cols=251 Identities=20% Similarity=0.219 Sum_probs=175.4
Q ss_pred hhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccc---hhhHHHHHHHHHHHhccCCCcccceeeE
Q 018785 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES---FQGHKEWLTEVIYLGQLRHENLVKLIGY 95 (350)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 95 (350)
....+.+.+-+-+|.++.++.+ ....+|....+|+..... ..+.+..+.+-..+-...+|.++.....
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~---------~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s 872 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPA---------SPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPS 872 (1205)
T ss_pred CCccceecccccCCCCcccccC---------CccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCC
Confidence 3456777778889999999987 555666555555443221 1111222222222222234666655555
Q ss_pred EeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccc
Q 018785 96 CSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDF 175 (350)
Q Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Df 175 (350)
+......+++++++.+++|...+...+ ..+.+-.......+..++++|| ...+.|+|++|.|.++..++...+.||
T Consensus 873 ~~~rsP~~L~~~~~~~~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~--s~~r~h~~~~p~~~l~~~~gh~~l~~~ 948 (1205)
T KOG0606|consen 873 FPCRSPLPLVGHYLNGGDLPSKLHNSG--CLSAEPARSPILERVQSLESLH--SSLRKHRDLKPDSLLIAYDGHRPLTDF 948 (1205)
T ss_pred CCCCCCcchhhHHhccCCchhhhhcCC--CcccccccchhHHHHhhhhccc--cchhhcccccccchhhcccCCcccCcc
Confidence 566678899999999999988887665 5666677777788899999999 777999999999999999999999999
Q ss_pred cccccCCCC-----------------------------CCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHH
Q 018785 176 GLARDGPTG-----------------------------DNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLEL 226 (350)
Q Consensus 176 g~~~~~~~~-----------------------------~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~l 226 (350)
+........ +.........+++.|.+||...+..-...+|.|+.|+++++.
T Consensus 949 ~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~ 1028 (1205)
T KOG0606|consen 949 GTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEV 1028 (1205)
T ss_pred ccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhh
Confidence 832210000 000111235688999999999999999999999999999999
Q ss_pred HhCCCCCcccccCcchhhhhhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHH
Q 018785 227 LSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMV 298 (350)
Q Consensus 227 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ 298 (350)
++|..||.....+...+.+.....++. .-+...+...++++.+.+..+|.+|..+.
T Consensus 1029 l~g~pp~na~tpq~~f~ni~~~~~~~p----------------~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1029 LTGIPPFNAETPQQIFENILNRDIPWP----------------EGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred hcCCCCCCCcchhhhhhccccCCCCCC----------------CCccccChhhhhhhhhhhccCchhccCcc
Confidence 999999987766544433333222111 12345677899999999999999997765
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.13 E-value=1.3e-09 Score=94.74 Aligned_cols=123 Identities=15% Similarity=0.125 Sum_probs=89.2
Q ss_pred CcEEEEEEccccchhh-----------HHHHHHHHHHHhccCCCcc--cceeeEEee-----cCceEEEEEcCCCC-Chh
Q 018785 55 GIVVAIKRLKAESFQG-----------HKEWLTEVIYLGQLRHENL--VKLIGYCSE-----SDNRLLVYEFMPKG-SLE 115 (350)
Q Consensus 55 ~~~vaiK~~~~~~~~~-----------~~~~~~e~~~l~~l~h~~i--~~~~~~~~~-----~~~~~lv~e~~~~~-~L~ 115 (350)
|+.+.||......... .....+|+..+..+..-+| +.++.+++. ....++|||++++. +|.
T Consensus 45 g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~ 124 (268)
T PRK15123 45 GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLE 124 (268)
T ss_pred CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHH
Confidence 5678899664433111 1136688888877743232 334445543 23468999999876 899
Q ss_pred hHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcC-------CCcEEEccccccc
Q 018785 116 NHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS-------NFNAKLSDFGLAR 179 (350)
Q Consensus 116 ~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~-------~~~~~l~Dfg~~~ 179 (350)
+++........+......++.+++..+..|| ..|++|+|+++.||+++. +..+.|+||+.+.
T Consensus 125 ~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH--~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 125 DYCADWATNPPDPRLKRMLIKRVATMVRDMH--AAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred HHHHhhcccCCCHHHHHHHHHHHHHHHHHHH--HCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 9886432235667778899999999999999 999999999999999975 4679999999885
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.04 E-value=9.7e-11 Score=110.02 Aligned_cols=150 Identities=25% Similarity=0.392 Sum_probs=106.5
Q ss_pred HHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccccccCCCCCCCccc-------ccccCCCcccCccccccCC
Q 018785 137 DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS-------TRIVGTRGYAAPEYVATGH 209 (350)
Q Consensus 137 ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~-------~~~~~~~~~~aPE~~~~~~ 209 (350)
+.+.|+.++|+ +.+++|++|.|++|.++.++.+||++|+++............ .-......|.+||.+.+..
T Consensus 107 ~v~dgl~flh~-sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~ 185 (700)
T KOG2137|consen 107 NVADGLAFLHR-SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTT 185 (700)
T ss_pred cccchhhhhcc-CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcccc
Confidence 34489999998 899999999999999999999999999988754442221111 1123456699999999988
Q ss_pred CCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhcc
Q 018785 210 LTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHM 289 (350)
Q Consensus 210 ~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 289 (350)
.+.++|+||+|+++|.+..|+.+...-........ ............++..++.++++=+.+++..
T Consensus 186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~--------------~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~ 251 (700)
T KOG2137|consen 186 NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYS--------------FSRNLLNAGAFGYSNNLPSELRESLKKLLNG 251 (700)
T ss_pred ccccccceeeeeEEEEEecCCcchhhccCCcchhh--------------hhhcccccccccccccCcHHHHHHHHHHhcC
Confidence 89999999999999999965554322221111111 1111111112233467889999999999999
Q ss_pred CCCCCCCHHHHH
Q 018785 290 DPKNRPSMVDVL 301 (350)
Q Consensus 290 dp~~Rps~~~ll 301 (350)
++.-||++..++
T Consensus 252 ~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 252 DSAVRPTLDLLL 263 (700)
T ss_pred CcccCcchhhhh
Confidence 999999766654
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.02 E-value=2.6e-09 Score=87.61 Aligned_cols=97 Identities=23% Similarity=0.264 Sum_probs=65.7
Q ss_pred HHHHHHHHHhccCCC--cccceeeEEeecCceEEEEEcCC--CCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHH-hhc
Q 018785 73 EWLTEVIYLGQLRHE--NLVKLIGYCSESDNRLLVYEFMP--KGSLENHLFRKGVQPISWPTRVKIAIDVARGLSF-LHG 147 (350)
Q Consensus 73 ~~~~e~~~l~~l~h~--~i~~~~~~~~~~~~~~lv~e~~~--~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~-lh~ 147 (350)
....|+..|.++..- ++.+++++. .-++||||+. |..+..+. ... ++......++.+++..+.. +|
T Consensus 54 ~~~~E~~~L~~l~~~Gv~vP~p~~~~----~~~ivME~I~~~G~~~~~l~-~~~---~~~~~~~~~~~~il~~~~~~~~- 124 (188)
T PF01163_consen 54 WAKKEFRNLKRLYEAGVPVPKPYDYN----RNVIVMEYIGEDGVPLPRLK-DVD---LSPEEPKELLEEILEEIIKMLH- 124 (188)
T ss_dssp HHHHHHHHHHHCCCTT-SS--EEEEE----TTEEEEE--EETTEEGGCHH-HCG---GGGSTHHHHHHHHHHHHHHHHH-
T ss_pred HHHHHHHHHHHHHHCCccCCcEEEEe----CCEEEEEecCCCccchhhHH-hcc---ccchhHHHHHHHHHHHHHHHHH-
Confidence 357899999999755 455565443 3469999997 55554433 321 2244667788888885544 68
Q ss_pred CCCCeeeCCCCCCceEEcCCCcEEEcccccccc
Q 018785 148 LDANVIYRDLKASNVLLDSNFNAKLSDFGLARD 180 (350)
Q Consensus 148 ~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~~ 180 (350)
..|++|||+++.||+++.+ .+.++|||.+..
T Consensus 125 -~~givHGDLs~~NIlv~~~-~~~iIDf~qav~ 155 (188)
T PF01163_consen 125 -KAGIVHGDLSEYNILVDDG-KVYIIDFGQAVD 155 (188)
T ss_dssp -CTTEEESS-STTSEEEETT-CEEE--GTTEEE
T ss_pred -hcCceecCCChhhEEeecc-eEEEEecCccee
Confidence 8999999999999999887 899999999875
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.01 E-value=2.7e-09 Score=90.26 Aligned_cols=136 Identities=18% Similarity=0.141 Sum_probs=101.1
Q ss_pred cccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccc----------------------hhhHHHHHHHHH
Q 018785 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES----------------------FQGHKEWLTEVI 79 (350)
Q Consensus 22 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~----------------------~~~~~~~~~e~~ 79 (350)
=+.+...||-|.-+.||.|. +. +|.+++||.=.... ..+.....+|.+
T Consensus 92 ve~iG~~IGvGKEsdVY~~~---------~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~ 161 (304)
T COG0478 92 VEAIGTKIGVGKESDVYVAI---------DP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFE 161 (304)
T ss_pred HHhhccccccCccceEEEEE---------CC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHH
Confidence 36678899999999999983 32 57889999643211 011234578999
Q ss_pred HHhccCCC--cccceeeEEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCC
Q 018785 80 YLGQLRHE--NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDL 157 (350)
Q Consensus 80 ~l~~l~h~--~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di 157 (350)
.|..|... .+.+.++.- .-.+|||+++|..|...- ++......++..|++.+..+- ..|++|||+
T Consensus 162 ~L~~L~~~G~~VP~P~~~n----RHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~--~~GiVHGDl 228 (304)
T COG0478 162 ALQRLYPEGVKVPKPIAWN----RHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAY--RRGIVHGDL 228 (304)
T ss_pred HHHHhhhcCCCCCCccccc----cceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHH--HcCccccCC
Confidence 99998654 666666543 346999999886665533 234456667778888888777 789999999
Q ss_pred CCCceEEcCCCcEEEcccccccc
Q 018785 158 KASNVLLDSNFNAKLSDFGLARD 180 (350)
Q Consensus 158 ~~~Nili~~~~~~~l~Dfg~~~~ 180 (350)
++-||+++.+|.++++||-.+..
T Consensus 229 SefNIlV~~dg~~~vIDwPQ~v~ 251 (304)
T COG0478 229 SEFNILVTEDGDIVVIDWPQAVP 251 (304)
T ss_pred chheEEEecCCCEEEEeCccccc
Confidence 99999999999999999987753
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.93 E-value=1.5e-08 Score=83.71 Aligned_cols=139 Identities=19% Similarity=0.150 Sum_probs=99.5
Q ss_pred eecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccc------hhhHHHHHHHHHHHhccCC--CcccceeeEEe-e
Q 018785 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES------FQGHKEWLTEVIYLGQLRH--ENLVKLIGYCS-E 98 (350)
Q Consensus 28 ~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~-~ 98 (350)
--|+||.+.|+..... |..+-+|.-.... ......+.+|+..|..+.. -.+.++. ++. .
T Consensus 25 N~~rgG~SgV~r~~~~-----------g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~ 92 (216)
T PRK09902 25 NYRRNGMSGVQCVERN-----------GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAV 92 (216)
T ss_pred CcCCCCcceEEEEEeC-----------CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeee
Confidence 3467888889887433 2356677543111 1134568889998888842 2244444 322 1
Q ss_pred ----cCceEEEEEcCCC-CChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCc--EE
Q 018785 99 ----SDNRLLVYEFMPK-GSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFN--AK 171 (350)
Q Consensus 99 ----~~~~~lv~e~~~~-~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~--~~ 171 (350)
.-..+||+|-+.| .+|.+++......+.+......+..+++.++..|| +.|+.|+|+.+.||+++.++. +.
T Consensus 93 k~~~~~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH--~~Gv~Hgdly~khIll~~~g~~~v~ 170 (216)
T PRK09902 93 KIEGEWRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMH--SVNRQHGCCYVRHIYVKTEGKAEAG 170 (216)
T ss_pred ccCCceEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHH--HCCCcCCCCCHhheeecCCCCeeEE
Confidence 1235799997743 58888887665446677788899999999999999 999999999999999986677 99
Q ss_pred Ecccccccc
Q 018785 172 LSDFGLARD 180 (350)
Q Consensus 172 l~Dfg~~~~ 180 (350)
|+||.-++.
T Consensus 171 lIDlEk~r~ 179 (216)
T PRK09902 171 FLDLEKSRR 179 (216)
T ss_pred EEEhhccch
Confidence 999987764
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.91 E-value=2.6e-08 Score=83.72 Aligned_cols=105 Identities=25% Similarity=0.253 Sum_probs=81.4
Q ss_pred HHHHHHHHHHhccC--CCcccceeeEEeecC----ceEEEEEcCCCC-ChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHH
Q 018785 72 KEWLTEVIYLGQLR--HENLVKLIGYCSESD----NRLLVYEFMPKG-SLENHLFRKGVQPISWPTRVKIAIDVARGLSF 144 (350)
Q Consensus 72 ~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~----~~~lv~e~~~~~-~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~ 144 (350)
....+|+..+..+. .-.+.+++++.+... ..++|+|++++. +|.+++.... ..+......++.+++..++-
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~--~~~~~~~~~ll~~l~~~i~~ 133 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE--QLDPSQRRELLRALARLIAK 133 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc--ccchhhHHHHHHHHHHHHHH
Confidence 34667777776663 223445556655432 347999999874 7999887644 25666788999999999999
Q ss_pred hhcCCCCeeeCCCCCCceEEcCCC---cEEEcccccccc
Q 018785 145 LHGLDANVIYRDLKASNVLLDSNF---NAKLSDFGLARD 180 (350)
Q Consensus 145 lh~~~~~i~H~di~~~Nili~~~~---~~~l~Dfg~~~~ 180 (350)
|| ..|++|+|+++.|||++.++ .+.|+||+.+..
T Consensus 134 lH--~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 134 LH--DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HH--HCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 99 99999999999999999887 799999998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.73 E-value=7.3e-08 Score=90.81 Aligned_cols=140 Identities=16% Similarity=0.159 Sum_probs=91.6
Q ss_pred ceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhH----------------------------------H
Q 018785 27 YLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGH----------------------------------K 72 (350)
Q Consensus 27 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~----------------------------------~ 72 (350)
..|+.++-|.||+|+++ +|+.||||+..+.-.... +
T Consensus 131 ~PiAsASIaQVH~A~L~----------sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~ 200 (517)
T COG0661 131 EPIASASIAQVHRAVLK----------SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEK 200 (517)
T ss_pred CchhhhhHhhheeEEec----------CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHH
Confidence 68899999999999765 289999999764211100 1
Q ss_pred ------HHHHHHHHHhcc-----CCCcccceeeEEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHH
Q 018785 73 ------EWLTEVIYLGQL-----RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARG 141 (350)
Q Consensus 73 ------~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~a 141 (350)
++..|...+.++ ..+.+.-..=+++-.+.-.++|||++|..+.+...-.. ..++...+.....++.-
T Consensus 201 ~l~~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f~- 278 (517)
T COG0661 201 RLREELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAFL- 278 (517)
T ss_pred HHHHHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHHH-
Confidence 133444444443 23443333323344567789999999999999853322 24554443333222221
Q ss_pred HHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccccccC
Q 018785 142 LSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDG 181 (350)
Q Consensus 142 l~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~~~ 181 (350)
..+- ..|++|+|.+|.||+++.+|.+.+.|||.....
T Consensus 279 -~q~~--~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l 315 (517)
T COG0661 279 -RQLL--RDGFFHADPHPGNILVRSDGRIVLLDFGIVGRL 315 (517)
T ss_pred -HHHH--hcCccccCCCccceEEecCCcEEEEcCcceecC
Confidence 2222 459999999999999999999999999998754
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.72 E-value=3.2e-07 Score=78.16 Aligned_cols=137 Identities=11% Similarity=0.044 Sum_probs=84.8
Q ss_pred ceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCC--cccceeeEEeecCceEE
Q 018785 27 YLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHE--NLVKLIGYCSESDNRLL 104 (350)
Q Consensus 27 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~--~i~~~~~~~~~~~~~~l 104 (350)
..||+|..+.||+. . +..+++|...... ......+|.+.++.+..- .+.+++++.+..+...+
T Consensus 7 ~~i~~G~t~~~y~~---------~----~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~gl 71 (226)
T TIGR02172 7 TQTGEGGNGESYTH---------K----TGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGL 71 (226)
T ss_pred eeecCCCCcceeEe---------c----CCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeee
Confidence 57899999999984 1 3457789887543 334568899999888533 35677888877777889
Q ss_pred EEEcCCCCC-hhhHH--------------hh-----cC--CCCCCHHHHHH-H--------------HHHHHHHHHHhhc
Q 018785 105 VYEFMPKGS-LENHL--------------FR-----KG--VQPISWPTRVK-I--------------AIDVARGLSFLHG 147 (350)
Q Consensus 105 v~e~~~~~~-L~~~l--------------~~-----~~--~~~l~~~~~~~-i--------------~~ql~~al~~lh~ 147 (350)
||++++|.+ +...+ .+ +. ........... + ...+...+.- +.
T Consensus 72 v~e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~-~~ 150 (226)
T TIGR02172 72 IYELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKE-VP 150 (226)
T ss_pred eeeecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHh-CC
Confidence 999998864 21111 00 00 00111111110 0 0011111111 11
Q ss_pred CCCCeeeCCCCCCceEEcCCCcEEEcccccccc
Q 018785 148 LDANVIYRDLKASNVLLDSNFNAKLSDFGLARD 180 (350)
Q Consensus 148 ~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~~ 180 (350)
....++|+|++|.||+++.++ +.++||+.+..
T Consensus 151 ~~~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 151 DTSTCLHGDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCCceEecCCCCCcEEEcCCC-cEEEechhcCc
Confidence 144578999999999999887 99999998853
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.69 E-value=3.2e-07 Score=76.25 Aligned_cols=143 Identities=15% Similarity=0.121 Sum_probs=95.2
Q ss_pred hhhhhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHH---------HHHHHHHHhc
Q 018785 13 SMISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKE---------WLTEVIYLGQ 83 (350)
Q Consensus 13 ~~~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~---------~~~e~~~l~~ 83 (350)
....++...+|.+.+++......-|.+...+ |..+++|..........+. ..+.+..+..
T Consensus 23 ~l~~~i~~~~~~~~kv~k~~~r~~ValIei~-----------~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~ 91 (229)
T PF06176_consen 23 ELGEKILDNNYKIIKVFKNTKRNYVALIEID-----------GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDK 91 (229)
T ss_pred HHHHHHHhCCceEEEeecCCCccEEEEEEEC-----------CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHH
Confidence 3456777889999999998877777665332 6778899876654322221 2233333333
Q ss_pred c---CCCcccceeeEEe-----ecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeC
Q 018785 84 L---RHENLVKLIGYCS-----ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYR 155 (350)
Q Consensus 84 l---~h~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~ 155 (350)
+ .--....++.+.+ .....+++|||++|..|.+... +++ .+...+.+++..+| ..|++||
T Consensus 92 i~~~g~~~~~~~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH--~~G~~HG 159 (229)
T PF06176_consen 92 IRNEGFTEPADPYLAAEKKIFRYTSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLH--KHGFYHG 159 (229)
T ss_pred HHHcCccccccceeeeeeeeccceeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHH--HcCCccC
Confidence 3 2233333333322 2344568999999998887652 332 24456778899999 9999999
Q ss_pred CCCCCceEEcCCCcEEEccccccc
Q 018785 156 DLKASNVLLDSNFNAKLSDFGLAR 179 (350)
Q Consensus 156 di~~~Nili~~~~~~~l~Dfg~~~ 179 (350)
|.+|.|++++.+ .++++||+...
T Consensus 160 D~hpgNFlv~~~-~i~iID~~~k~ 182 (229)
T PF06176_consen 160 DPHPGNFLVSNN-GIRIIDTQGKR 182 (229)
T ss_pred CCCcCcEEEECC-cEEEEECcccc
Confidence 999999999855 59999997654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.64 E-value=4.4e-07 Score=76.27 Aligned_cols=143 Identities=20% Similarity=0.173 Sum_probs=94.1
Q ss_pred hhhcccccceec---ccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhh-------------------HH----
Q 018785 19 ATKNFCSDYLLG---EGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQG-------------------HK---- 72 (350)
Q Consensus 19 ~~~~y~i~~~lg---~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~-------------------~~---- 72 (350)
..++..+....| .|.-+.||+|. ...+..+|+|++......- .+
T Consensus 43 L~~rg~i~~~~g~istGKEA~Vy~a~----------~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~ 112 (268)
T COG1718 43 LLSRGVITELVGCISTGKEANVYLAE----------TGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVF 112 (268)
T ss_pred HhcCCceeeeEeeecCCcceEEEeec----------cCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHH
Confidence 345555555555 56667899972 2457899999986532211 11
Q ss_pred -HHHHHHHHHhccC--CCcccceeeEEeecCceEEEEEcCCCC-ChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcC
Q 018785 73 -EWLTEVIYLGQLR--HENLVKLIGYCSESDNRLLVYEFMPKG-SLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL 148 (350)
Q Consensus 73 -~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~~~-~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~ 148 (350)
..+.|+..|+++. +=.+.+.+.+... .||||++... .-.-.+..- .+...+...+..++++.+.-|-.
T Consensus 113 ~W~~kEf~NL~R~~eAGVrvP~Pi~~~~n----VLvMEfIg~~g~pAP~LkDv---~~e~~e~~~~~~~~v~~~~~l~~- 184 (268)
T COG1718 113 AWARKEFRNLKRAYEAGVRVPEPIAFRNN----VLVMEFIGDDGLPAPRLKDV---PLELEEAEGLYEDVVEYMRRLYK- 184 (268)
T ss_pred HHHHHHHHHHHHHHHcCCCCCCceeecCC----eEEEEeccCCCCCCCCcccC---CcCchhHHHHHHHHHHHHHHHHH-
Confidence 1355777777773 4445555655543 5999998332 111122211 23333677788888888888762
Q ss_pred CCCeeeCCCCCCceEEcCCCcEEEcccccccc
Q 018785 149 DANVIYRDLKASNVLLDSNFNAKLSDFGLARD 180 (350)
Q Consensus 149 ~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~~ 180 (350)
..+++|+||+.-|||+. ++.+.++||+.+..
T Consensus 185 ~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~ 215 (268)
T COG1718 185 EAGLVHGDLSEYNILVH-DGEPYIIDVSQAVT 215 (268)
T ss_pred hcCcccccchhhheEEE-CCeEEEEECccccc
Confidence 49999999999999998 77899999999975
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.52 E-value=2e-06 Score=74.37 Aligned_cols=137 Identities=18% Similarity=0.103 Sum_probs=81.6
Q ss_pred ecccCc-eeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccC-CCcccceeeEEeecCceEEEE
Q 018785 29 LGEGGF-GCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLR-HENLVKLIGYCSESDNRLLVY 106 (350)
Q Consensus 29 lg~G~~-g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~ 106 (350)
|..|.+ ..||+. ... +..+++|...... ...+..|+.+++.+. +-.+.+++++...++..++||
T Consensus 6 ~~~g~~~~~v~~~---------~~~--~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~ 71 (244)
T cd05150 6 VTEGQSGATVYRL---------DGK--NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLT 71 (244)
T ss_pred cCCCCCcCeEEEE---------cCC--CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEE
Confidence 344444 688987 322 3568888876543 234567888888873 455667777777767789999
Q ss_pred EcCCCCChhhHHh-------------------hcC--CCCCCHH--HHHHH-----------------------HHHHHH
Q 018785 107 EFMPKGSLENHLF-------------------RKG--VQPISWP--TRVKI-----------------------AIDVAR 140 (350)
Q Consensus 107 e~~~~~~L~~~l~-------------------~~~--~~~l~~~--~~~~i-----------------------~~ql~~ 140 (350)
++++|.++..... .-+ ...+... ..... ...+..
T Consensus 72 e~i~G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 151 (244)
T cd05150 72 SAVPGVPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYA 151 (244)
T ss_pred EeeCCccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHH
Confidence 9999887764321 000 0011100 00000 111111
Q ss_pred HHHHhh--cCCCCeeeCCCCCCceEEcCCCcEEEccccccc
Q 018785 141 GLSFLH--GLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR 179 (350)
Q Consensus 141 al~~lh--~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~ 179 (350)
.|.... .....++|+|+.|.||++++++.+.|+||+.+.
T Consensus 152 ~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 152 ELEATRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred HHHhhCCCcCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 111110 013458999999999999998778899998775
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.39 E-value=3.3e-06 Score=67.26 Aligned_cols=132 Identities=18% Similarity=0.153 Sum_probs=94.1
Q ss_pred hcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccc-eeeEEeec
Q 018785 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVK-LIGYCSES 99 (350)
Q Consensus 21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~-~~~~~~~~ 99 (350)
..-+..+.|++|..|.||+|.|. |..+++|+-..++ ....+.-|+++|..+.-.++-+ ++.+.++
T Consensus 22 ~~~~v~~~L~KG~~s~Vyl~~~~-----------~~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~yg~~- 87 (201)
T COG2112 22 YELRVEKELAKGTTSVVYLGEWR-----------GGEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFYGED- 87 (201)
T ss_pred hhhhhhhhhhcccccEEEEeecc-----------CceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEechh-
Confidence 34456789999999999999775 4578999876664 4467888999999887555544 3333332
Q ss_pred CceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCC-CCceEEcCCCcEEEcccccc
Q 018785 100 DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLK-ASNVLLDSNFNAKLSDFGLA 178 (350)
Q Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~-~~Nili~~~~~~~l~Dfg~~ 178 (350)
++.|||+.|-.|.+..... +. +-...++++---|- ..||-|+.|+ |...++..++.+.|+||..+
T Consensus 88 ---~i~me~i~G~~L~~~~~~~-----~r----k~l~~vlE~a~~LD--~~GI~H~El~~~~k~vlv~~~~~~iIDFd~A 153 (201)
T COG2112 88 ---FIRMEYIDGRPLGKLEIGG-----DR----KHLLRVLEKAYKLD--RLGIEHGELSRPWKNVLVNDRDVYIIDFDSA 153 (201)
T ss_pred ---hhhhhhhcCcchhhhhhcc-----cH----HHHHHHHHHHHHHH--HhccchhhhcCCceeEEecCCcEEEEEccch
Confidence 3669999888888766421 22 22334556655566 7899999997 66666667779999999998
Q ss_pred cc
Q 018785 179 RD 180 (350)
Q Consensus 179 ~~ 180 (350)
+.
T Consensus 154 t~ 155 (201)
T COG2112 154 TF 155 (201)
T ss_pred hh
Confidence 73
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.32 E-value=1.4e-05 Score=66.16 Aligned_cols=128 Identities=20% Similarity=0.277 Sum_probs=87.8
Q ss_pred cceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccc----------------hhhHHHHHHHHHHHhccC----
Q 018785 26 DYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES----------------FQGHKEWLTEVIYLGQLR---- 85 (350)
Q Consensus 26 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~----------------~~~~~~~~~e~~~l~~l~---- 85 (350)
...||+|+.-.||.- .. .....||+..... .....+..+|+.....+.
T Consensus 6 ~~~i~~G~~R~cy~H-----------P~-dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~ 73 (199)
T PF10707_consen 6 SDLIAQGGERDCYQH-----------PD-DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRG 73 (199)
T ss_pred CcccccCCCceEEEC-----------CC-CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccC
Confidence 467999999999974 11 2335688887665 112334455555444443
Q ss_pred --CCcccceeeEEeecCceEEEEEcCC------CCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCC
Q 018785 86 --HENLVKLIGYCSESDNRLLVYEFMP------KGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDL 157 (350)
Q Consensus 86 --h~~i~~~~~~~~~~~~~~lv~e~~~------~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di 157 (350)
+.+|.+++++.+++-.+.+|+|.+. ..||.+++... .++. ..... +-+-..+|- +.+|+.+|+
T Consensus 74 ~~~~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~---~~~~-~~~~~---L~~f~~~l~--~~~Iv~~dl 144 (199)
T PF10707_consen 74 VDWSHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG---GLTE-ELRQA---LDEFKRYLL--DHHIVIRDL 144 (199)
T ss_pred CcccccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC---CccH-HHHHH---HHHHHHHHH--HcCCeecCC
Confidence 8999999999999999999999753 23788888554 3554 33333 334445666 788999999
Q ss_pred CCCceEEcCCC----cEEEcc
Q 018785 158 KASNVLLDSNF----NAKLSD 174 (350)
Q Consensus 158 ~~~Nili~~~~----~~~l~D 174 (350)
+|.||++..++ .++|+|
T Consensus 145 ~~~NIv~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 145 NPHNIVVQRRDSGEFRLVLID 165 (199)
T ss_pred CcccEEEEecCCCceEEEEEe
Confidence 99999996542 467776
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.28 E-value=1.1e-05 Score=69.42 Aligned_cols=73 Identities=15% Similarity=0.155 Sum_probs=45.8
Q ss_pred ceecccCce-eEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCC---cccceeeEEeec---
Q 018785 27 YLLGEGGFG-CVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHE---NLVKLIGYCSES--- 99 (350)
Q Consensus 27 ~~lg~G~~g-~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~---~i~~~~~~~~~~--- 99 (350)
+.|+.|+.. .||+. +..+++|...... ....+..|...++.+... .+.++++.....
T Consensus 3 ~~~~~gG~~n~vy~~--------------~~~~VlR~~~~~~--~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~ 66 (235)
T cd05155 3 EPVDSGGTDNATFRL--------------GDDMSVRLPSAAG--YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGY 66 (235)
T ss_pred eeccCCCcccceEEc--------------CCceEEEcCCccc--hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCC
Confidence 567777666 58886 2347788755432 344678899988887521 344444443332
Q ss_pred CceEEEEEcCCCCChh
Q 018785 100 DNRLLVYEFMPKGSLE 115 (350)
Q Consensus 100 ~~~~lv~e~~~~~~L~ 115 (350)
...+++|++++|.++.
T Consensus 67 ~~~~~l~~~i~G~~l~ 82 (235)
T cd05155 67 PWPWSVYRWLEGETAT 82 (235)
T ss_pred CcceEEEEeecCCCCC
Confidence 2348899999887764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.24 E-value=1.1e-05 Score=69.05 Aligned_cols=141 Identities=19% Similarity=0.188 Sum_probs=78.7
Q ss_pred cceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCC--CcccceeeEE---eecC
Q 018785 26 DYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRH--ENLVKLIGYC---SESD 100 (350)
Q Consensus 26 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~---~~~~ 100 (350)
.+.|+.|..+.||++. ... ..+++|..... .....+..|..+++.+.. ..+.+++... ....
T Consensus 2 i~~l~~G~~n~~~~v~---------~~~--~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~ 68 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVT---------TDD--GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNG 68 (239)
T ss_dssp EEEEEESSSSEEEEEE---------ETT--SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETS
T ss_pred CccCCCCCeeeEEEEE---------ECC--cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccc
Confidence 4678999999999983 222 37889987665 345567778888877742 2355666533 2233
Q ss_pred ceEEEEEcCCCCChhh----------------HHh---hc--CCCCCCHHH-------------------------HHHH
Q 018785 101 NRLLVYEFMPKGSLEN----------------HLF---RK--GVQPISWPT-------------------------RVKI 134 (350)
Q Consensus 101 ~~~lv~e~~~~~~L~~----------------~l~---~~--~~~~l~~~~-------------------------~~~i 134 (350)
..+++|++++|.++.. .+. .. ....+.... ...+
T Consensus 69 ~~~~~~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (239)
T PF01636_consen 69 FPYLLMEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEEL 148 (239)
T ss_dssp EEEEEEEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHH
T ss_pred cceEEEEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHH
Confidence 4689999998887777 111 11 000111000 0001
Q ss_pred HHHHHHHHH-Hhh-cCCCCeeeCCCCCCceEEc-CCCcEEEccccccc
Q 018785 135 AIDVARGLS-FLH-GLDANVIYRDLKASNVLLD-SNFNAKLSDFGLAR 179 (350)
Q Consensus 135 ~~ql~~al~-~lh-~~~~~i~H~di~~~Nili~-~~~~~~l~Dfg~~~ 179 (350)
..+++..+. .++ .....++|+|++|.||+++ .++.+-|+||+.+.
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 149 EERLLQELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHHHHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred HHHHHHHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 111222222 111 1256799999999999999 56666799998775
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.20 E-value=7.7e-05 Score=61.51 Aligned_cols=99 Identities=26% Similarity=0.288 Sum_probs=76.2
Q ss_pred HHHHHHhccCC-CcccceeeEEeecCceEEEEEcCCCCChhhH---HhhcCCCCCCHHHHHHHHHHHHHHHHHhhcC-CC
Q 018785 76 TEVIYLGQLRH-ENLVKLIGYCSESDNRLLVYEFMPKGSLENH---LFRKGVQPISWPTRVKIAIDVARGLSFLHGL-DA 150 (350)
Q Consensus 76 ~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~---l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~-~~ 150 (350)
.|.-+++.+.+ +++++++|++.. ++++|+...+++... +... ...+...+.+++.++++.+.+++.. ..
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~--~~~~w~~R~~iA~~lL~~l~~l~~~~~~ 81 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQF--LQSPWEQRAKIALQLLELLEELDHGPLG 81 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccc--cccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 47777888864 699999999854 589999865555421 1111 1467889999999999999999821 24
Q ss_pred CeeeCCCCCCceEEcCCCcEEEcccccccc
Q 018785 151 NVIYRDLKASNVLLDSNFNAKLSDFGLARD 180 (350)
Q Consensus 151 ~i~H~di~~~Nili~~~~~~~l~Dfg~~~~ 180 (350)
.+.-.|++++|+-++.+++++++|.+....
T Consensus 82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred cEEEeecchHHeEEeCCCcEEEEechhcch
Confidence 588899999999999999999999987753
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.16 E-value=2.4e-05 Score=73.92 Aligned_cols=138 Identities=16% Similarity=0.133 Sum_probs=85.7
Q ss_pred cceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhh-------------------------------HHH-
Q 018785 26 DYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQG-------------------------------HKE- 73 (350)
Q Consensus 26 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~-------------------------------~~~- 73 (350)
.+.||....|.||+|+.++ |+.||||+-++.-... .+.
T Consensus 166 ~~piaaASlaQVhrA~L~~----------G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L 235 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKN----------GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSL 235 (538)
T ss_pred cchhhhcchhheEEEEecC----------CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhh
Confidence 4688999999999996542 8899999865421110 011
Q ss_pred -----HHHHHHHHhc----cCCCc------ccceeeEEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHH
Q 018785 74 -----WLTEVIYLGQ----LRHEN------LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDV 138 (350)
Q Consensus 74 -----~~~e~~~l~~----l~h~~------i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql 138 (350)
+..|++...+ +.|-+ |.+++. .-...-.|+|||++|..+.|.-.-.. ..++...+..-+.+.
T Consensus 236 ~~ELDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~--~~st~RVLtME~~~G~~i~Dl~~i~~-~gi~~~~i~~~l~~~ 312 (538)
T KOG1235|consen 236 PQELDFTKEAKNAERFRENFKDFSLLTYVLVPKVYW--DLSTKRVLTMEYVDGIKINDLDAIDK-RGISPHDILNKLVEA 312 (538)
T ss_pred HhhcchHHHHHhHHHHHHHHHhcccccceeCCeehh--hcCcceEEEEEecCCccCCCHHHHHH-cCCCHHHHHHHHHHH
Confidence 2223332222 23444 333332 22346689999999998877543221 146655544443333
Q ss_pred HHHHHHhhcCCCCeeeCCCCCCceEEcC----CCcEEEcccccccc
Q 018785 139 ARGLSFLHGLDANVIYRDLKASNVLLDS----NFNAKLSDFGLARD 180 (350)
Q Consensus 139 ~~al~~lh~~~~~i~H~di~~~Nili~~----~~~~~l~Dfg~~~~ 180 (350)
..-.-+ ..|++|+|-+|.||++.. ++.+++.|||+...
T Consensus 313 ~~~qIf----~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~ 354 (538)
T KOG1235|consen 313 YLEQIF----KTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAV 354 (538)
T ss_pred HHHHHH----hcCCccCCCCCCcEEEecCCCCCccEEEEccccccc
Confidence 332222 358999999999999984 56799999999864
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.07 E-value=4.9e-05 Score=77.14 Aligned_cols=82 Identities=16% Similarity=0.223 Sum_probs=54.7
Q ss_pred cceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch-hhHHHHHHHHHHHhccC-CCcc--cceeeEEeec--
Q 018785 26 DYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLR-HENL--VKLIGYCSES-- 99 (350)
Q Consensus 26 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~-h~~i--~~~~~~~~~~-- 99 (350)
.+.++.|.+..+|+..+... .....+++|....... .....+.+|+.+++.+. |.++ .+++.++.+.
T Consensus 43 v~~l~gG~sn~ty~l~~~~~-------~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v 115 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNG-------GSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASV 115 (822)
T ss_pred EEEeCCCCcCceEEEEECCC-------CcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCc
Confidence 56778899999998743211 1123577787654321 23456789999999985 5554 6667766554
Q ss_pred -CceEEEEEcCCCCCh
Q 018785 100 -DNRLLVYEFMPKGSL 114 (350)
Q Consensus 100 -~~~~lv~e~~~~~~L 114 (350)
+..|+|||+++|..+
T Consensus 116 ~G~~flVME~v~G~~~ 131 (822)
T PLN02876 116 IGTAFYIMEYLEGRIF 131 (822)
T ss_pred CCCceEEEEecCCccc
Confidence 467899999987653
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.91 E-value=7.9e-05 Score=64.88 Aligned_cols=137 Identities=18% Similarity=0.109 Sum_probs=75.8
Q ss_pred eecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcc-cceeeEEeecCceEEEE
Q 018785 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENL-VKLIGYCSESDNRLLVY 106 (350)
Q Consensus 28 ~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~ 106 (350)
.+..|-...+|+.. .++..+++|........-.-....|...++.+...++ .+++.... .++|+
T Consensus 3 ~~~~G~tn~~y~~~-----------~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~ 67 (256)
T TIGR02721 3 TLSGGLTNRSWRIE-----------HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLV 67 (256)
T ss_pred cCCCcCcCCeEEEE-----------eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEE
Confidence 35667788899872 2356788887654322111134578888888853322 33443332 36999
Q ss_pred EcCCCCChhhH--------------Hhh-c----CCCCCCHHH-HHHHHHHH---------HHHHHHhhc------CCCC
Q 018785 107 EFMPKGSLENH--------------LFR-K----GVQPISWPT-RVKIAIDV---------ARGLSFLHG------LDAN 151 (350)
Q Consensus 107 e~~~~~~L~~~--------------l~~-~----~~~~l~~~~-~~~i~~ql---------~~al~~lh~------~~~~ 151 (350)
+|++|.++... +.+ + ...+++... +..+..++ ...+..+.. ....
T Consensus 68 e~i~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 147 (256)
T TIGR02721 68 EWLEGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLA 147 (256)
T ss_pred EeccCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCe
Confidence 99988765421 110 0 011222211 11111111 111222210 0235
Q ss_pred eeeCCCCCCceEEcCCCcEEEcccccccc
Q 018785 152 VIYRDLKASNVLLDSNFNAKLSDFGLARD 180 (350)
Q Consensus 152 i~H~di~~~Nili~~~~~~~l~Dfg~~~~ 180 (350)
++|+|+.|.||+++.++ +.|+||+.+..
T Consensus 148 l~H~Dl~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 148 PLHMDVHAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred eecCCCCcCcEEEeCCC-CEEEeccccCc
Confidence 89999999999998876 78999998864
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.90 E-value=4.9e-05 Score=76.45 Aligned_cols=200 Identities=21% Similarity=0.231 Sum_probs=131.1
Q ss_pred HHHHHHHHHhccCCCcccceeeEEeecCce----EEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcC
Q 018785 73 EWLTEVIYLGQLRHENLVKLIGYCSESDNR----LLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL 148 (350)
Q Consensus 73 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~----~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~ 148 (350)
...-|+..+..+.|+|+..++.+..+.... .+..+++.+.++...+..-. ..+....+.+..++.++|.++|
T Consensus 228 ~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~--~i~~~~~r~~~~~~~~GL~~~h-- 303 (1351)
T KOG1035|consen 228 TTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG--SIPLETLRILHQKLLEGLAYLH-- 303 (1351)
T ss_pred HHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc--ccCHHHHHHHHHHHhhhHHHHH--
Confidence 345577788888999999998876544322 24456777778888776665 6888899999999999999999
Q ss_pred CCCeeeCCCCCC---ceEEcCCCcEEEc--cccccccCCCCCCCcccccccCCCcccCccccccCCCCC--ccchhhHHH
Q 018785 149 DANVIYRDLKAS---NVLLDSNFNAKLS--DFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTP--KSDVYSFGV 221 (350)
Q Consensus 149 ~~~i~H~di~~~---Nili~~~~~~~l~--Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~--~~DiwslG~ 221 (350)
+....|.-+... +.-++..+.+... ||+.+......... ........+.++|......+.. ..|+|++|.
T Consensus 304 ~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~---~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgl 380 (1351)
T KOG1035|consen 304 SLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS---FSDLLAEIRNADEDLKENTAKKSRLTDLWCLGL 380 (1351)
T ss_pred HhccceeEEecccccccccCccceeecchhhhcccccCCCcccc---hhhcCccccccccccccccchhhhhhHHHHHHH
Confidence 555544444433 3333445556655 88777654332221 1122344466777665555443 479999999
Q ss_pred HHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 018785 222 VLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL 301 (350)
Q Consensus 222 ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll 301 (350)
++..+..|..+-..... ...+ ++........+.+.+|+..++++|+++.+++
T Consensus 381 l~~~~~~~~~i~~~~~~--------------------~~~~--------l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll 432 (1351)
T KOG1035|consen 381 LLLQLSQGEDISEKSAV--------------------PVSL--------LDVLSTSELLDALPKCLDEDSEERLSALELL 432 (1351)
T ss_pred HHhhhhhcCcccccccc--------------------hhhh--------hccccchhhhhhhhhhcchhhhhccchhhhh
Confidence 99999988764221100 0000 0111112677889999999999999999999
Q ss_pred HHHHhh
Q 018785 302 TSLEQL 307 (350)
Q Consensus 302 ~~L~~~ 307 (350)
.+.-.-
T Consensus 433 ~~~f~~ 438 (1351)
T KOG1035|consen 433 THPFLR 438 (1351)
T ss_pred hchhcc
Confidence 775433
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.85 E-value=3.2e-06 Score=79.57 Aligned_cols=189 Identities=16% Similarity=0.095 Sum_probs=129.6
Q ss_pred hhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCc-ccceeeEEee
Q 018785 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHEN-LVKLIGYCSE 98 (350)
Q Consensus 20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~ 98 (350)
..-|....-+++++++.+++.+ ..++.. ...+.+... ....-++++|.+++||| .+..++-++.
T Consensus 241 ~kws~~fh~fvK~altknpKkR---------ptaekl-L~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~ 305 (829)
T KOG0576|consen 241 TKWSEFFHNFVKGALTKNPKKR---------PTAEKL-LQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDG 305 (829)
T ss_pred ccchHHHHHHHHHHhcCCCccC---------CChhhh-eeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCc
Confidence 3455666677888888888862 222222 224443322 44567889999999999 6666666777
Q ss_pred cCceEEEEEcCCCC-ChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccc
Q 018785 99 SDNRLLVYEFMPKG-SLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL 177 (350)
Q Consensus 99 ~~~~~lv~e~~~~~-~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~ 177 (350)
+...+++++++.++ +......... -.+.+.+...+.+.-..+++++| +--=+|+| ||+..+ +..++.+|+.
T Consensus 306 E~~~~i~~~i~s~~rs~~~~~~~se-~~~~~~~~~~~~r~et~~l~~l~--~~~~~~~d----~~l~s~-~~~~~~~~~v 377 (829)
T KOG0576|consen 306 EDYLWIPMRICSTGRSSALEMTVSE-IALEQYQFAYPLRKETRPLAELH--SSYKVHRD----NILGSE-EEVKLLDFAV 377 (829)
T ss_pred ccccchhhhhhcCCccccccCChhh-Hhhhhhhhhhhhhhhcccccccc--cccccCcc----cccccc-cccccccccC
Confidence 78888999998666 2222221111 13555566667777788999999 44446676 666644 6789999998
Q ss_pred cccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCc
Q 018785 178 ARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALD 234 (350)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~ 234 (350)
........ ......+++.+++||......+....|.|++|.-..++-.|-.|-.
T Consensus 378 ~~~L~~~~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 378 PPQLTRTM---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred CcccCccc---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 86543332 3344678899999999999999999999999987777777766643
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.80 E-value=0.00058 Score=60.80 Aligned_cols=87 Identities=11% Similarity=0.086 Sum_probs=59.3
Q ss_pred hhhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCC---Ccccc
Q 018785 15 ISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRH---ENLVK 91 (350)
Q Consensus 15 ~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h---~~i~~ 91 (350)
+....+..-.-.+.||.|..+.||.... .++ .+++|..+.. .....+..|+..|+.+.- -.+.+
T Consensus 8 ~~~~~~~~~~~~~~i~~G~~~~vy~~~~----------~~~-~~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~ 74 (297)
T PRK10593 8 LSHLLGEKLSRVECISEQPYAALWALYD----------SQG-NPMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPT 74 (297)
T ss_pred HHHHhchhhheeeecCCccceeEEEEEc----------CCC-CEEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCc
Confidence 3444455666677899999999999621 123 4667774331 123567889998888842 46778
Q ss_pred eeeEEee---cCceEEEEEcCCCCCh
Q 018785 92 LIGYCSE---SDNRLLVYEFMPKGSL 114 (350)
Q Consensus 92 ~~~~~~~---~~~~~lv~e~~~~~~L 114 (350)
+++++.. .+..++|||+++|.++
T Consensus 75 V~~~~~~~~~~g~~~LVmE~i~G~~~ 100 (297)
T PRK10593 75 VYGVMTHEQSPGPDVLLLERLRGVSV 100 (297)
T ss_pred EEEEeccCCcCCCeEEEEeccCCEec
Confidence 8877654 3668999999988765
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.75 E-value=0.00042 Score=59.43 Aligned_cols=77 Identities=18% Similarity=0.103 Sum_probs=45.8
Q ss_pred cceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCc-ccceeeEEeecCceEE
Q 018785 26 DYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHEN-LVKLIGYCSESDNRLL 104 (350)
Q Consensus 26 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~l 104 (350)
.+.|..|-...+|++.... ..+..|++|+....... .....+|+..++.+...+ ..+++.... + .+
T Consensus 3 i~~l~gG~tN~~~~v~~~~--------~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~ 69 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKE--------DNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ--N--GL 69 (235)
T ss_pred EEEcCCcccceEEEEEcCC--------CCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cE
Confidence 3567788888999873210 03467888977643221 122346787888774333 333443332 2 48
Q ss_pred EEEcCCCCChh
Q 018785 105 VYEFMPKGSLE 115 (350)
Q Consensus 105 v~e~~~~~~L~ 115 (350)
+|||++|.++.
T Consensus 70 l~e~i~G~~l~ 80 (235)
T cd05157 70 IYEFIPGRTLE 80 (235)
T ss_pred EEEeeCCCcCC
Confidence 99999887663
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.62 E-value=0.0011 Score=54.65 Aligned_cols=126 Identities=31% Similarity=0.435 Sum_probs=84.4
Q ss_pred hhcccccceecccCc-eeEEeecccCCCcCCCCCCCCcEEEEEEccc---cc-------hh-----------hHHHHHHH
Q 018785 20 TKNFCSDYLLGEGGF-GCVFKGWIDQNTFAPTKPGSGIVVAIKRLKA---ES-------FQ-----------GHKEWLTE 77 (350)
Q Consensus 20 ~~~y~i~~~lg~G~~-g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~---~~-------~~-----------~~~~~~~e 77 (350)
+.+++..+.||.|.- |.||++++. |..+|+|++.. .. .. ....+.+|
T Consensus 36 ~~~I~flefLg~g~~~~~V~kv~I~-----------g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~E 104 (207)
T PF13095_consen 36 GDDIEFLEFLGHGSHDGYVFKVEID-----------GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCE 104 (207)
T ss_pred CCcEeeeeecCCCCceeEEEEEEEC-----------CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHH
Confidence 478999999999999 999999765 66899999321 10 00 01235566
Q ss_pred HHHHhcc---CCCcc--cceeeEEeecC------------------ceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHH
Q 018785 78 VIYLGQL---RHENL--VKLIGYCSESD------------------NRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 134 (350)
Q Consensus 78 ~~~l~~l---~h~~i--~~~~~~~~~~~------------------~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i 134 (350)
.+..-+| .+.++ ++++++..-.. ...||.||..... .++. .-
T Consensus 105 CRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~~----~~ 169 (207)
T PF13095_consen 105 CRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQI----RD 169 (207)
T ss_pred HHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccch----hH
Confidence 6655554 56666 88888863220 1246677654433 1222 23
Q ss_pred HHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcccccc
Q 018785 135 AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 178 (350)
Q Consensus 135 ~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~ 178 (350)
+.+|.+-+..+| ..||+-+|+++.|.. +| +|+|||.+
T Consensus 170 ~~~~~~dl~~~~--k~gI~~~Dv~~~ny~---~G--~lvDfs~~ 206 (207)
T PF13095_consen 170 IPQMLRDLKILH--KLGIVPRDVKPRNYR---GG--KLVDFSSS 206 (207)
T ss_pred HHHHHHHHHHHH--HCCeeeccCcccccc---CC--EEEecccC
Confidence 456777788899 999999999999985 33 78899864
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.62 E-value=0.00081 Score=60.07 Aligned_cols=82 Identities=17% Similarity=0.176 Sum_probs=49.0
Q ss_pred ceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCc-ccceeeEEeecCceEEE
Q 018785 27 YLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHEN-LVKLIGYCSESDNRLLV 105 (350)
Q Consensus 27 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~lv 105 (350)
+.|..|-...+|+....... .....+..+++|+..... ........|...++.+...+ ..+++.++.. .+|
T Consensus 4 ~~l~gGltN~~y~v~~~~~~---~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v 75 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDED---ALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRI 75 (302)
T ss_pred EEecCcccceeEEEEcCCcc---cccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cch
Confidence 45667777789987433211 123346789999876543 22234567777777774322 3445555432 368
Q ss_pred EEcCCCCChhh
Q 018785 106 YEFMPKGSLEN 116 (350)
Q Consensus 106 ~e~~~~~~L~~ 116 (350)
++|++|.++..
T Consensus 76 ~e~i~G~~l~~ 86 (302)
T cd05156 76 EEFIPSRTLTT 86 (302)
T ss_pred hheeCCCcCCH
Confidence 99988876643
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.60 E-value=0.0018 Score=58.25 Aligned_cols=32 Identities=31% Similarity=0.351 Sum_probs=27.1
Q ss_pred CCCeeeCCCCCCceEEcCCCcEEEcccccccc
Q 018785 149 DANVIYRDLKASNVLLDSNFNAKLSDFGLARD 180 (350)
Q Consensus 149 ~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~~ 180 (350)
..+++|+|+++.||+++.+...-++||+.+..
T Consensus 186 p~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 186 PRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred CcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 46899999999999998665568999998863
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.57 E-value=0.0027 Score=58.46 Aligned_cols=77 Identities=18% Similarity=0.117 Sum_probs=49.7
Q ss_pred cceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEcccc------c-hhhHHHHHHHHHHHhccC---CCcccceeeE
Q 018785 26 DYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAE------S-FQGHKEWLTEVIYLGQLR---HENLVKLIGY 95 (350)
Q Consensus 26 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~------~-~~~~~~~~~e~~~l~~l~---h~~i~~~~~~ 95 (350)
.+.||.|.+..||++. ....++.++||.-.+. . .........|.+.|+.+. ...+++++.+
T Consensus 31 ~~elggGn~N~VyrV~---------~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~ 101 (401)
T PRK09550 31 AREIGDGNLNLVFRVS---------DTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY 101 (401)
T ss_pred eeEcCCCceEEEEEEE---------eCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE
Confidence 4578999999999984 3222357899975421 1 113345566777777762 3456666666
Q ss_pred EeecCceEEEEEcCCCCC
Q 018785 96 CSESDNRLLVYEFMPKGS 113 (350)
Q Consensus 96 ~~~~~~~~lv~e~~~~~~ 113 (350)
. .+..++|||++++..
T Consensus 102 D--~~~~~lVME~L~~~~ 117 (401)
T PRK09550 102 D--EELAVTVMEDLSDHK 117 (401)
T ss_pred C--CCCCEEEEecCCCcc
Confidence 3 356789999987643
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.56 E-value=0.0016 Score=57.98 Aligned_cols=141 Identities=16% Similarity=0.058 Sum_probs=79.2
Q ss_pred cceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCC--cccceee------EEe
Q 018785 26 DYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHE--NLVKLIG------YCS 97 (350)
Q Consensus 26 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~--~i~~~~~------~~~ 97 (350)
.+.|..|....+|+... .+..+++|..... ....+..|+.++..+..- .+.+++. +..
T Consensus 19 i~~i~~G~~n~~y~v~~-----------~~~~~vLr~~~~~---~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~ 84 (296)
T cd05153 19 FEGISAGIENTNYFVTT-----------DSGRYVLTLFEKV---SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSE 84 (296)
T ss_pred eecccCccccceEEEEe-----------CCCcEEEEEcCCC---ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeee
Confidence 45677787789998621 1235888987652 234455677777666322 2334333 123
Q ss_pred ecCceEEEEEcCCCCChhh----HHhh------------cC--CC--C-CCHHHHH------------HHHHHHHHHHHH
Q 018785 98 ESDNRLLVYEFMPKGSLEN----HLFR------------KG--VQ--P-ISWPTRV------------KIAIDVARGLSF 144 (350)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~----~l~~------------~~--~~--~-l~~~~~~------------~i~~ql~~al~~ 144 (350)
..+..++|+++++|..+.. .... .. .. . ....... .....+..++.+
T Consensus 85 ~~~~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 164 (296)
T cd05153 85 LAGKPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELAR 164 (296)
T ss_pred eCCceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHH
Confidence 3456789999998876532 0000 00 00 0 0000000 001112223333
Q ss_pred hh-----cCCCCeeeCCCCCCceEEcCCCcEEEcccccccc
Q 018785 145 LH-----GLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD 180 (350)
Q Consensus 145 lh-----~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~~ 180 (350)
+. ....+++|+|++|.|++++.++.+.++||+.+..
T Consensus 165 l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 165 QDAFDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred HHhhhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 33 1136799999999999999877778999998853
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.39 E-value=0.0018 Score=57.96 Aligned_cols=138 Identities=18% Similarity=0.129 Sum_probs=91.4
Q ss_pred ccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccc--hhh--------------------H----HHHHHHH
Q 018785 25 SDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES--FQG--------------------H----KEWLTEV 78 (350)
Q Consensus 25 i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~--------------------~----~~~~~e~ 78 (350)
|-..|..|.-+.||.|. ..+|..+|||+++-.- +.+ + .....|+
T Consensus 148 inGCiSTGKEANVYHat----------~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~ 217 (520)
T KOG2270|consen 148 INGCISTGKEANVYHAT----------EEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEM 217 (520)
T ss_pred cccccccCccceeEeee----------cCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHH
Confidence 44466678888999973 3346679999875210 000 0 1235678
Q ss_pred HHHhccCCCcccceeeEEeecCceEEEEEcCCCCChhh--HHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCC
Q 018785 79 IYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLEN--HLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRD 156 (350)
Q Consensus 79 ~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~--~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~d 156 (350)
+.|+++...+|.-.--+... .-.|||+++ |.+=+- .+.. ..++...+..+-.|++.-+.-|-+ ..+++|.|
T Consensus 218 RNLkRl~~aGIP~PePIlLk--~hVLVM~Fl-Grdgw~aPkLKd---~~ls~~ka~~~Y~~~v~~MR~lY~-~c~LVHAD 290 (520)
T KOG2270|consen 218 RNLKRLNNAGIPCPEPILLK--NHVLVMEFL-GRDGWAAPKLKD---ASLSTSKARELYQQCVRIMRRLYQ-KCRLVHAD 290 (520)
T ss_pred HHHHHHHhcCCCCCCceeee--cceEeeeec-cCCCCcCccccc---ccCChHHHHHHHHHHHHHHHHHHH-Hhceeccc
Confidence 88888876664433333322 236999998 332221 1221 246666788888888888877754 78999999
Q ss_pred CCCCceEEcCCCcEEEcccccccc
Q 018785 157 LKASNVLLDSNFNAKLSDFGLARD 180 (350)
Q Consensus 157 i~~~Nili~~~~~~~l~Dfg~~~~ 180 (350)
|+--|+|+ .+|.+.++|-+.+..
T Consensus 291 LSEfN~Ly-hdG~lyiIDVSQSVE 313 (520)
T KOG2270|consen 291 LSEFNLLY-HDGKLYIIDVSQSVE 313 (520)
T ss_pred hhhhhheE-ECCEEEEEEcccccc
Confidence 99999999 567899999988864
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.38 E-value=0.00022 Score=62.62 Aligned_cols=135 Identities=15% Similarity=0.077 Sum_probs=91.8
Q ss_pred cccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEcccc--ch-----------------h---hHHHHHHHHH
Q 018785 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAE--SF-----------------Q---GHKEWLTEVI 79 (350)
Q Consensus 22 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~-----------------~---~~~~~~~e~~ 79 (350)
=+.++..||-|.-+-||.+-+. .|.+.++|.-... ++ + ++-....|..
T Consensus 93 v~svGnqIGVGKESDIY~v~d~----------~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfa 162 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADE----------EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFA 162 (465)
T ss_pred hhhhccccccccccceEEEecC----------CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHH
Confidence 4678889999999999998332 3566777743211 11 0 1112345777
Q ss_pred HHhccC--CCcccceeeEEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCC
Q 018785 80 YLGQLR--HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDL 157 (350)
Q Consensus 80 ~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di 157 (350)
.++.|. --.+.+.+++. .-++||+++.|..|...-.- . ....+...+...+.-|- ..|++|+|+
T Consensus 163 fmkaL~e~gfpVPkpiD~~----RH~Vvmelv~g~Pl~~v~~v-----~---d~~~ly~~lm~~Iv~la--~~GlIHgDF 228 (465)
T KOG2268|consen 163 FMKALYERGFPVPKPIDHN----RHCVVMELVDGYPLRQVRHV-----E---DPPTLYDDLMGLIVRLA--NHGLIHGDF 228 (465)
T ss_pred HHHHHHHcCCCCCCccccc----ceeeHHHhhcccceeeeeec-----C---ChHHHHHHHHHHHHHHH--HcCceeccc
Confidence 777773 24455555543 34689999988777664321 1 23445556666777777 889999999
Q ss_pred CCCceEEcCCCcEEEcccccccc
Q 018785 158 KASNVLLDSNFNAKLSDFGLARD 180 (350)
Q Consensus 158 ~~~Nili~~~~~~~l~Dfg~~~~ 180 (350)
+--||+++.++.++++||-.+..
T Consensus 229 NEFNimv~dd~~i~vIDFPQmvS 251 (465)
T KOG2268|consen 229 NEFNIMVKDDDKIVVIDFPQMVS 251 (465)
T ss_pred chheeEEecCCCEEEeechHhhc
Confidence 99999999999999999987654
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.30 E-value=0.0038 Score=55.59 Aligned_cols=142 Identities=16% Similarity=0.197 Sum_probs=82.9
Q ss_pred ccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccc--cchhhHHHHHHHHHHHhccCC--CcccceeeEEee
Q 018785 23 FCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKA--ESFQGHKEWLTEVIYLGQLRH--ENLVKLIGYCSE 98 (350)
Q Consensus 23 y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~--~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~ 98 (350)
..+.+.+..|..-.+|.. ... ++++++. .+. ..........+|+.+++.+.- -.+...++++.+
T Consensus 27 ~~~v~~~~~G~sn~t~~~---------~~~--~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~ 94 (321)
T COG3173 27 LLIVEEISGGWSNDTFRL---------GDT--GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGE 94 (321)
T ss_pred CceeeeccCCcccceEEE---------ecC--CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCccccccccc
Confidence 334445544544455554 222 7788888 442 333455677889999988853 233444555555
Q ss_pred cC--ceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHH-HHHHHHHHHhhcC---------------------------
Q 018785 99 SD--NRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIA-IDVARGLSFLHGL--------------------------- 148 (350)
Q Consensus 99 ~~--~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~-~ql~~al~~lh~~--------------------------- 148 (350)
+. ..|.||+|++|..+.+...... .. ...+ ..++..|+.||+.
T Consensus 95 ~~~g~pf~v~~~veGe~~~~~~~~~~---~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~ 167 (321)
T COG3173 95 GYLGTPFYVMEWVEGEVVWSALPPES---LG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYR 167 (321)
T ss_pred CCCCCceEEEEEecceeccCcCCccc---ch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHH
Confidence 44 6699999998853332221110 00 0011 1222233333310
Q ss_pred -----------------------------CCCeeeCCCCCCceEEcCCCcEEEccccccccCCC
Q 018785 149 -----------------------------DANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPT 183 (350)
Q Consensus 149 -----------------------------~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~~~~~ 183 (350)
...++|||+.+.|++++..+.+-++||+.+.....
T Consensus 168 ~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP 231 (321)
T COG3173 168 RAKKELGGRIPLADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDP 231 (321)
T ss_pred HHHHhccCCCchHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCCc
Confidence 23469999999999999998899999999986433
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.25 E-value=0.0067 Score=54.33 Aligned_cols=32 Identities=34% Similarity=0.353 Sum_probs=28.2
Q ss_pred CCCeeeCCCCCCceEEcCCCcEEEcccccccc
Q 018785 149 DANVIYRDLKASNVLLDSNFNAKLSDFGLARD 180 (350)
Q Consensus 149 ~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~~ 180 (350)
..+++|+|+++.|++++.++.+.++||+.+..
T Consensus 186 ~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 186 PRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred CCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 57899999999999999887678999998853
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.15 E-value=0.005 Score=56.06 Aligned_cols=144 Identities=15% Similarity=0.081 Sum_probs=79.3
Q ss_pred ceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCc-ccceeeEEeecCceEEE
Q 018785 27 YLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHEN-LVKLIGYCSESDNRLLV 105 (350)
Q Consensus 27 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~lv 105 (350)
..|..|-.-.+|++.+... ....+..|++|+...... ..-....|..+++.+..-+ -.++++.+..+ .|
T Consensus 42 ~~l~gGlTN~~y~v~~~~~-----~~~~~~~~v~Ri~g~~t~-~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v 111 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTK-----EGNLGRKVLVRIYGEGVE-LFFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RV 111 (344)
T ss_pred EEcCCcccceeEEEEeCCC-----CCCCCCeEEEEEccCCCC-eeechHHHHHHHHHHHHcCCCCceEEEECCc----eE
Confidence 3555577889999754321 122357899998866532 2222356788888775333 33455555432 58
Q ss_pred EEcCCCCChhhHH--------------h---hcC--CCC-CC-HHHHHHHHHHH--------------------HHHHHH
Q 018785 106 YEFMPKGSLENHL--------------F---RKG--VQP-IS-WPTRVKIAIDV--------------------ARGLSF 144 (350)
Q Consensus 106 ~e~~~~~~L~~~l--------------~---~~~--~~~-l~-~~~~~~i~~ql--------------------~~al~~ 144 (350)
.+|+++.++...- . ... ... .+ ...+..+..++ +..|..
T Consensus 112 ~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~ 191 (344)
T PLN02236 112 EEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEK 191 (344)
T ss_pred EEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHH
Confidence 9998776664210 0 000 000 11 11222222111 111111
Q ss_pred -hh--cCCCCeeeCCCCCCceEEcC-CCcEEEcccccccc
Q 018785 145 -LH--GLDANVIYRDLKASNVLLDS-NFNAKLSDFGLARD 180 (350)
Q Consensus 145 -lh--~~~~~i~H~di~~~Nili~~-~~~~~l~Dfg~~~~ 180 (350)
+. .....++|+|+++.||+++. ++.+.++||..+..
T Consensus 192 ~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 192 ELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred HhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 11 11346899999999999976 46799999998853
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.15 E-value=0.0054 Score=53.98 Aligned_cols=32 Identities=22% Similarity=0.366 Sum_probs=26.1
Q ss_pred CCCeeeCCCCCCceEEcCCCc-EEEcccccccc
Q 018785 149 DANVIYRDLKASNVLLDSNFN-AKLSDFGLARD 180 (350)
Q Consensus 149 ~~~i~H~di~~~Nili~~~~~-~~l~Dfg~~~~ 180 (350)
...++|+|+++.||+++.++. .-++||+.+..
T Consensus 184 ~~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 184 HTVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CCeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 345899999999999987555 46999998864
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.05 E-value=0.0053 Score=54.14 Aligned_cols=85 Identities=21% Similarity=0.209 Sum_probs=49.8
Q ss_pred hhhhhhhhccc--ccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhcc---CCCc
Q 018785 14 MISKIATKNFC--SDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQL---RHEN 88 (350)
Q Consensus 14 ~~~~~~~~~y~--i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l---~h~~ 88 (350)
.+.+..+..+. -.+.++.|....+|+.. .++..+.||+-... ....+..|+.-|+.| ..-.
T Consensus 8 ~~~~~~~~~~~i~~~~~v~GG~i~~a~~~~-----------~~~~~~FvK~~~~~---~~~~f~~Ea~gL~~L~~~~~~~ 73 (288)
T PF03881_consen 8 QISEQLGADFKITSIEPVSGGDINEAYRLD-----------TDGGSYFVKVNSES---GRDMFEGEAEGLKALAEANPIR 73 (288)
T ss_dssp HHHHHHTS-----EEEEE--SSSSEEEEEE-----------TTS-EEEEEEEEGG---GCCHHHHHHHHHHHHCHTTTSB
T ss_pred HHHHHhCCCCceeeeEecCCCChhheEEEE-----------CCCccEEEEecChh---hHHHHHHHHHHHHHHHhcCCCC
Confidence 34555555544 44578889999999872 34678889977632 223456677777666 4566
Q ss_pred ccceeeEEeecCceEEEEEcCCCC
Q 018785 89 LVKLIGYCSESDNRLLVYEFMPKG 112 (350)
Q Consensus 89 i~~~~~~~~~~~~~~lv~e~~~~~ 112 (350)
+.+++.+...++..||||||++.+
T Consensus 74 vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 74 VPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp S--EEEEEE-SSCCEEEEE-----
T ss_pred CCeEEEEEeecCCceEEEEeecCC
Confidence 788888888888889999998665
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.03 E-value=0.0014 Score=60.97 Aligned_cols=166 Identities=23% Similarity=0.385 Sum_probs=97.3
Q ss_pred HHHHHHHHHHHhccCCCcccceeeEEeec-CceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCC
Q 018785 71 HKEWLTEVIYLGQLRHENLVKLIGYCSES-DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLD 149 (350)
Q Consensus 71 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~ 149 (350)
...+....++++.+.|++...++++.+.. ....+|+|++ +.+|.+.+..+..... ... .|
T Consensus 26 s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~l~~~---s~~------------~~--- 86 (725)
T KOG1093|consen 26 SIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGNLKDE---SLL------------AH--- 86 (725)
T ss_pred HHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcccchh---hhc------------cc---
Confidence 35567788999999999999999987654 4567899999 7799998876641111 100 22
Q ss_pred CCeeeCCCCCCceEEcCCCcEEEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhC
Q 018785 150 ANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSG 229 (350)
Q Consensus 150 ~~i~H~di~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g 229 (350)
++.|- |++. .+| ..... | | ....+++|||++|.++.++.-|
T Consensus 87 -~~~~~-----~~~~-------~td-~~~t~------------------~--~-----~~~~pKsdVwsl~~i~~el~L~ 127 (725)
T KOG1093|consen 87 -GVLHL-----NIIY-------ITD-HFLTK------------------Y--P-----SPIGPKSDVWSLGFIILELYLG 127 (725)
T ss_pred -cccee-----hhhh-------ccc-ccccc------------------C--C-----CCCCcchhhhhHHHHHHHHHHh
Confidence 22221 1211 122 00100 0 1 0011499999999999999999
Q ss_pred CCCCcccccCcchhhhhhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 018785 230 RRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL 301 (350)
Q Consensus 230 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll 301 (350)
...+......+....+..+.-. + .......... .....++..+.++...|+...|..||...++.
T Consensus 128 ~~l~~~~~~s~~l~~i~k~~~~---d-~~~~~~a~e~---~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~ 192 (725)
T KOG1093|consen 128 ISLEAELTESEYLEILLKYYTD---D-QELLSTAMEH---LIQLLADKKRLPLLKKCLWLEPIIRPLPMELS 192 (725)
T ss_pred hHHHHHHHHHHHHHHHHHhccC---c-hhHHHHHHHH---HHHHhhhHhHHHHhccCCccccccccchhHHh
Confidence 8877655544333333332111 1 1111110000 12234567788899999999999888655443
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.02 E-value=0.013 Score=52.96 Aligned_cols=31 Identities=16% Similarity=0.274 Sum_probs=26.2
Q ss_pred CCCeeeCCCCCCceEEcCCCcEEEcccccccc
Q 018785 149 DANVIYRDLKASNVLLDSNFNAKLSDFGLARD 180 (350)
Q Consensus 149 ~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~~ 180 (350)
...++|||+++.||+++.+ .++++|+..+..
T Consensus 191 ~~~llHGDl~~gNi~~~~~-~~~~iD~e~~~~ 221 (370)
T TIGR01767 191 AETLLHGDLHSGSIFVSEH-ETKVIDPEFAFY 221 (370)
T ss_pred cceeeeccCCcccEEEcCC-CCEEEcCccccc
Confidence 5678999999999999776 477999988764
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=97.02 E-value=0.0029 Score=53.29 Aligned_cols=30 Identities=30% Similarity=0.397 Sum_probs=21.5
Q ss_pred CCeeeCCCCCCceEE-cCCCcEEEccccccc
Q 018785 150 ANVIYRDLKASNVLL-DSNFNAKLSDFGLAR 179 (350)
Q Consensus 150 ~~i~H~di~~~Nili-~~~~~~~l~Dfg~~~ 179 (350)
..++|+|+.+.||++ +.++.++|+||..+.
T Consensus 143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp EEEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred ceEeeccCccccEEeccCCCeEEEecHHHHh
Confidence 457899999999999 888999999999885
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.93 E-value=0.011 Score=53.57 Aligned_cols=30 Identities=20% Similarity=0.223 Sum_probs=25.9
Q ss_pred CeeeCCCCCCceEEcC-CCcEEEcccccccc
Q 018785 151 NVIYRDLKASNVLLDS-NFNAKLSDFGLARD 180 (350)
Q Consensus 151 ~i~H~di~~~Nili~~-~~~~~l~Dfg~~~~ 180 (350)
-++|+|+.+.||++++ ++.++|+||+.+..
T Consensus 183 v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 183 VFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred EEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 3799999999999975 46899999998864
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.87 E-value=0.0056 Score=54.82 Aligned_cols=105 Identities=15% Similarity=0.122 Sum_probs=71.6
Q ss_pred cCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcccccc
Q 018785 99 SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 178 (350)
Q Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~ 178 (350)
....|++|++- |+++.- +. .-..+++..++++.+..+.-+.. .-..-|+|+...||+|+ +|+|-|+||-++
T Consensus 298 ~~y~yl~~kdh-gt~is~-ik-----~~~~~e~lsff~s~~sil~~lek-kf~fehrnlt~~niLId-~GnvtLIDfkls 368 (488)
T COG5072 298 TLYLYLHFKDH-GTPISI-IK-----ADRSEEELSFFWSCISILDILEK-KFPFEHRNLTLDNILID-EGNVTLIDFKLS 368 (488)
T ss_pred ceEEEEEEecC-Cceeee-ee-----cccHHHHHHHHHHHHHHHhhhhh-cCCcccccccccceeee-cCceEEEEeeee
Confidence 34556778865 555533 32 24556889999999998888874 66788999999999999 999999999999
Q ss_pred ccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHH
Q 018785 179 RDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFG 220 (350)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG 220 (350)
+.....+. .....+-.|-.+.|.. +..-+||.+-
T Consensus 369 Rl~~~q~~-------isy~rldhp~lF~G~d-d~QFeIYrlM 402 (488)
T COG5072 369 RLSYSQGI-------ISYNRLDHPDLFNGVD-DYQFEIYRLM 402 (488)
T ss_pred ecccCCce-------eeccccCchhhhcCcc-ceeeeHHHHH
Confidence 84222211 1222344565555433 6777787653
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.68 E-value=0.031 Score=50.09 Aligned_cols=32 Identities=19% Similarity=0.168 Sum_probs=28.9
Q ss_pred CCCeeeCCCCCCceEEcCCCcEEEcccccccc
Q 018785 149 DANVIYRDLKASNVLLDSNFNAKLSDFGLARD 180 (350)
Q Consensus 149 ~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~~ 180 (350)
..++||+|+.++|++++.++.+.++||..+..
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 45899999999999999998999999998864
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.53 E-value=0.062 Score=49.60 Aligned_cols=74 Identities=11% Similarity=0.083 Sum_probs=46.2
Q ss_pred ccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch-------hhHHHHHHHHHHHhccC---CCcccceee
Q 018785 25 SDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-------QGHKEWLTEVIYLGQLR---HENLVKLIG 94 (350)
Q Consensus 25 i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~e~~~l~~l~---h~~i~~~~~ 94 (350)
..+.||.|....||+. .+. +..++||.-..... -.......|+..|+.+. ...+.+++.
T Consensus 36 ~~~eiggGn~N~VyrV---------~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~ 104 (418)
T PLN02756 36 KIKEVGDGNLNFVYIV---------VSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYH 104 (418)
T ss_pred eEEEcCCCceeeEEEE---------EcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEE
Confidence 3567899999999997 331 34588886542111 01222334466665553 346777777
Q ss_pred EEeecCceEEEEEcCCC
Q 018785 95 YCSESDNRLLVYEFMPK 111 (350)
Q Consensus 95 ~~~~~~~~~lv~e~~~~ 111 (350)
+.. +..+++||++++
T Consensus 105 ~de--d~~vlvME~L~~ 119 (418)
T PLN02756 105 FDR--TMALIGMRYLEP 119 (418)
T ss_pred ECC--CCCEEEEeecCC
Confidence 776 456789999966
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.36 E-value=0.032 Score=51.23 Aligned_cols=31 Identities=23% Similarity=0.292 Sum_probs=26.8
Q ss_pred CCCeeeCCCCCCceEEcCCCcEEEcccccccc
Q 018785 149 DANVIYRDLKASNVLLDSNFNAKLSDFGLARD 180 (350)
Q Consensus 149 ~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~~ 180 (350)
...++|||++|.|||++.+ .++++|..++..
T Consensus 226 ~~aLlHGDlHtGSI~v~~~-~~kvIDpEFAfy 256 (409)
T PRK12396 226 AQALIHGDLHTGSVFVKND-STKVIDPEFAFY 256 (409)
T ss_pred chhhccCcCCCCCEEecCC-ceEEEccccccc
Confidence 5567999999999999876 589999988875
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.28 E-value=0.015 Score=52.92 Aligned_cols=62 Identities=21% Similarity=0.065 Sum_probs=45.1
Q ss_pred ceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcC
Q 018785 101 NRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS 166 (350)
Q Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~ 166 (350)
...++-+|..|.++..++...+ .++....+++.-...|+-.+-- -.+++|.|++|.||++.-
T Consensus 319 ~~vl~E~~~~Gl~v~~~v~~~~---~pe~l~kkva~lg~~AllkMl~-vDNFvHaDlHPGNVlirf 380 (565)
T KOG1236|consen 319 DLVLVETYERGLSVLRFVKWKS---QPEALVKKVAKLGVNALLKMLI-VDNFVHADLHPGNVLIRF 380 (565)
T ss_pred cceeeeeccccccHHhhhhccc---ChHHHHHHHHHHHHHHHHHHHH-hhcceecccCCCcEEEEe
Confidence 3456667788889999987664 4555666777766777654432 568999999999999943
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=96.25 E-value=0.11 Score=43.87 Aligned_cols=78 Identities=19% Similarity=0.183 Sum_probs=51.1
Q ss_pred cccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhcc---CCCcccceeeEEeecC
Q 018785 24 CSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQL---RHENLVKLIGYCSESD 100 (350)
Q Consensus 24 ~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~~ 100 (350)
+..+.+.-|.--..|...+. ..++.+|+=..+ ....+..|+.-|+.+ +.-.+.+++.+....+
T Consensus 19 ~er~~v~gG~inea~~v~dg-----------~~~~FvK~n~~~---~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~ 84 (286)
T COG3001 19 KEREEVSGGDINEAWRLRDG-----------TDPFFVKCNQRE---QLSMFTAEADGLELLARSNTITVPKVIAVGASRD 84 (286)
T ss_pred hcccccCCccccceeEeecC-----------CcceEEEecchh---hHHHHHHHHHHHHHHHhcCCccccceEEecCCCC
Confidence 33445555665566665322 456788864332 234456666655555 5577888899999999
Q ss_pred ceEEEEEcCCCCChh
Q 018785 101 NRLLVYEFMPKGSLE 115 (350)
Q Consensus 101 ~~~lv~e~~~~~~L~ 115 (350)
+.|+|++|++-+.+.
T Consensus 85 ~sylVle~L~~~~~d 99 (286)
T COG3001 85 HSYLVLEYLPTGPLD 99 (286)
T ss_pred eeEEEEeeccCCCCC
Confidence 999999998776554
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.88 E-value=0.082 Score=48.76 Aligned_cols=30 Identities=23% Similarity=0.090 Sum_probs=25.1
Q ss_pred CCeeeCCCCCCceEEcCCCcEEEcccccccc
Q 018785 150 ANVIYRDLKASNVLLDSNFNAKLSDFGLARD 180 (350)
Q Consensus 150 ~~i~H~di~~~Nili~~~~~~~l~Dfg~~~~ 180 (350)
..+||+|+.+.||+.+. +.+.++||..+..
T Consensus 227 ~VfCHNDL~~gNIL~~~-~~l~lID~EYA~~ 256 (383)
T PTZ00384 227 VLFCHNDLFFTNILDFN-QGIYFIDFDFAGF 256 (383)
T ss_pred eeeeeccCCcccEEecC-CCEEEEEeccccC
Confidence 56799999999998754 4699999998853
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.80 E-value=0.09 Score=49.47 Aligned_cols=84 Identities=13% Similarity=0.048 Sum_probs=46.7
Q ss_pred ccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCccc-ceeeEEeecCceE
Q 018785 25 SDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLV-KLIGYCSESDNRL 103 (350)
Q Consensus 25 i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~-~~~~~~~~~~~~~ 103 (350)
-.+.|..|-.-.+|++...+.. .......++.|++++.......- -.-..|..+++.+..-++- ++++.+. -+
T Consensus 109 ~i~~l~gGlTN~~f~v~~~~~~-~~~~~~~~~~~lvRiyG~~te~l-IdR~~E~~v~~~ls~~gi~P~l~~~f~----gg 182 (442)
T PTZ00296 109 RVNQILSGLTNQLFEVSLKEET-ANNYPSIRRRVLFRIYGKDVDEL-YNPISEFEVYKTMSKYRIAPQLLNTFS----GG 182 (442)
T ss_pred EEEEecCcccCceEEEEecCCC-CccccCcCceEEEEecCCCccce-eCHHHHHHHHHHHHHCCCCCceEEEeC----CC
Confidence 4556667777788988544221 00111235689999886654221 1234566666666433332 3445443 24
Q ss_pred EEEEcCCCCCh
Q 018785 104 LVYEFMPKGSL 114 (350)
Q Consensus 104 lv~e~~~~~~L 114 (350)
.|.+|++|.+|
T Consensus 183 ~I~efi~g~~l 193 (442)
T PTZ00296 183 RIEEWLYGDPL 193 (442)
T ss_pred EEEEeeCCccC
Confidence 68899987644
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=95.73 E-value=0.0018 Score=67.58 Aligned_cols=157 Identities=14% Similarity=0.034 Sum_probs=108.7
Q ss_pred HHHHHHHhccCCCcccceeeEEee--cCceEEEEEcCCCCChhhHHhhcC--CCCCCHHHHHHHHHHHHHHHHHhhcCC-
Q 018785 75 LTEVIYLGQLRHENLVKLIGYCSE--SDNRLLVYEFMPKGSLENHLFRKG--VQPISWPTRVKIAIDVARGLSFLHGLD- 149 (350)
Q Consensus 75 ~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~--~~~l~~~~~~~i~~ql~~al~~lh~~~- 149 (350)
..|...++...|+++...+.-... ....+..++++.+|.+.+.+.+.. ...++..-+.....+.+.+..-+|+..
T Consensus 1277 l~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tn 1356 (2724)
T KOG1826|consen 1277 LSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTN 1356 (2724)
T ss_pred hhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhccc
Confidence 334445555678887776655433 345678999999999999886543 223444444444444466666666421
Q ss_pred --CCeeeCCCCCCceEEcCCCcEEEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHH
Q 018785 150 --ANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELL 227 (350)
Q Consensus 150 --~~i~H~di~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll 227 (350)
.-.+|.++++-|.+|..+-++++.++|+.+.. ...........+++.|+.|++...-.++.++|+|..|+.+|..-
T Consensus 1357 lg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIk--np~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1357 LGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIK--NPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRS 1434 (2724)
T ss_pred CCccchhhhhhhhccceecCCccccccccccccc--CchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHh
Confidence 22579999999999999999999999999721 11112223355677788888877778888899999999999998
Q ss_pred hCCCCC
Q 018785 228 SGRRAL 233 (350)
Q Consensus 228 ~g~~pf 233 (350)
.|..+|
T Consensus 1435 ~~n~~f 1440 (2724)
T KOG1826|consen 1435 DGNAYF 1440 (2724)
T ss_pred cccHHH
Confidence 887765
|
|
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=95.54 E-value=0.028 Score=49.17 Aligned_cols=51 Identities=24% Similarity=0.111 Sum_probs=38.7
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcccccccc
Q 018785 130 TRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD 180 (350)
Q Consensus 130 ~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~~ 180 (350)
.....+..+-.++.-.+.-..-+||+|+.|+|++.+..+.+.|+||..|..
T Consensus 133 ~~~~~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~ 183 (269)
T COG0510 133 LLRKKLKELRRALEEVPKDDLVPCHNDLNPGNLLLTDKGGLFLIDWEYAGL 183 (269)
T ss_pred HHHHHHHHHHHHhhhcCCCceeeecCCCCccceEEcCCCcEEEEecccCCC
Confidence 344455566666666662013689999999999999989999999999864
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.18 E-value=0.47 Score=49.66 Aligned_cols=32 Identities=38% Similarity=0.450 Sum_probs=27.1
Q ss_pred CCCeeeCCCCCCceEEcCCC--cEE-Ecccccccc
Q 018785 149 DANVIYRDLKASNVLLDSNF--NAK-LSDFGLARD 180 (350)
Q Consensus 149 ~~~i~H~di~~~Nili~~~~--~~~-l~Dfg~~~~ 180 (350)
..+++|+|+++.||+++.++ .+. |+|||-+..
T Consensus 202 p~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 202 PAQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred CcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 57899999999999998875 454 999998864
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.12 E-value=0.69 Score=41.78 Aligned_cols=30 Identities=20% Similarity=0.212 Sum_probs=25.2
Q ss_pred CCCeeeCCCCCCceEEcCCCcEEEcccccccc
Q 018785 149 DANVIYRDLKASNVLLDSNFNAKLSDFGLARD 180 (350)
Q Consensus 149 ~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~~ 180 (350)
..+++|+|+.+.||+++ + .+.++||+-+..
T Consensus 195 ~~~liHgD~h~~NvL~~-d-~~~iIDFDd~~~ 224 (325)
T PRK11768 195 RLLRLHGDCHPGNILWR-D-GPHFVDLDDARM 224 (325)
T ss_pred CccceecCCCchhcccc-C-CcEEEeCCCCCC
Confidence 56789999999999995 4 578999998853
|
|
| >PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function | Back alignment and domain information |
|---|
Probab=95.12 E-value=0.13 Score=45.69 Aligned_cols=79 Identities=10% Similarity=0.148 Sum_probs=45.2
Q ss_pred cccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch-----hhHHHHHHHHHHHhcc-------C------CCcccc
Q 018785 30 GEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-----QGHKEWLTEVIYLGQL-------R------HENLVK 91 (350)
Q Consensus 30 g~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~e~~~l~~l-------~------h~~i~~ 91 (350)
|.|..|.+|++++.... ..........++||....... .....+.+|+...+.+ . ...+.+
T Consensus 2 Gd~y~s~~~rv~v~~~~-~~~~~~~~~s~ivK~~p~~~~~~~~~~~~~~f~~E~~fY~~~~p~l~~~~~~~~~~~~~~P~ 80 (294)
T PF02958_consen 2 GDNYLSDMYRVTVTYEL-KGDGKNEPLSLIVKSPPTNPSRREFLREMGSFRREIFFYRELLPELEELQKEAGDPFKFFPK 80 (294)
T ss_pred CCcceeEEEEEEEEEEE-ccCCCceEEEEEEEeCCCchhhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHhccccceeece
Confidence 67888999998775310 002344466788898762211 1123456666555543 1 123456
Q ss_pred eeeEEeecCceEEEEEcC
Q 018785 92 LIGYCSESDNRLLVYEFM 109 (350)
Q Consensus 92 ~~~~~~~~~~~~lv~e~~ 109 (350)
++....+.+..+||||.+
T Consensus 81 ~~~~~~~~~~~~lvlEDL 98 (294)
T PF02958_consen 81 CYYADEDPGDEVLVLEDL 98 (294)
T ss_pred EEEeccCCCceeeehhhh
Confidence 666655555678999865
|
All known members of this group are proteins from drosophila and Caenorhabditis elegans. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 350 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-49 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-48 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 6e-47 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-46 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-46 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 4e-46 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-45 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 4e-43 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-24 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-24 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 7e-23 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-22 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 3e-22 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-22 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-22 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-22 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 6e-22 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 7e-22 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 9e-22 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-21 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-21 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-21 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-21 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-21 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-21 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-21 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-21 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-21 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-21 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-21 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-21 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-21 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-21 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 3e-21 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 3e-21 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-21 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-21 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-21 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 3e-21 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 5e-21 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 5e-21 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 6e-21 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 6e-21 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 6e-21 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 7e-21 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 7e-21 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 7e-21 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-20 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-20 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-20 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-20 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-20 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-20 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-20 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-20 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-20 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-20 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-20 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-20 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-20 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-20 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-20 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-20 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-20 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 3e-20 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-20 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-20 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-20 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-20 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-20 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-20 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-20 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 4e-20 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 4e-20 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 4e-20 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 4e-20 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 4e-20 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 4e-20 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 4e-20 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 4e-20 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-20 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 4e-20 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 4e-20 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 4e-20 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 5e-20 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-20 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-20 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 6e-20 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-20 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 6e-20 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 7e-20 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-20 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 9e-20 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-19 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-19 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-19 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-19 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-19 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-19 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-19 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-19 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-19 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-19 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-19 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-19 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-19 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-19 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-19 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-19 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-19 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-19 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-19 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-19 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-19 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-19 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-19 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-19 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-19 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-19 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-19 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-19 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-19 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-19 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-19 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 3e-19 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 3e-19 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-19 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 3e-19 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-19 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-19 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-19 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-19 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 4e-19 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 5e-19 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 5e-19 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-19 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 5e-19 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 6e-19 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 6e-19 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 7e-19 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 8e-19 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 8e-19 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-19 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 8e-19 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 8e-19 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 9e-19 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-18 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-18 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-18 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-18 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-18 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-18 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-18 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-18 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-18 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-18 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-18 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-18 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-18 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-18 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-18 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-18 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-18 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-18 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-18 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-18 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-18 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-18 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-18 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-18 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-18 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-18 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-18 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-18 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-18 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-18 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-18 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 3e-18 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-18 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 4e-18 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 4e-18 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 4e-18 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 4e-18 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 4e-18 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 4e-18 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 4e-18 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 4e-18 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 4e-18 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 5e-18 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 5e-18 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 6e-18 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 6e-18 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 6e-18 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 6e-18 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 7e-18 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-18 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 7e-18 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 7e-18 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 7e-18 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 7e-18 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 8e-18 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 8e-18 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 8e-18 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 8e-18 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 8e-18 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 8e-18 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 8e-18 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 8e-18 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 8e-18 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 8e-18 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 8e-18 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 8e-18 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 9e-18 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 9e-18 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-17 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-17 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-17 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-17 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-17 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-17 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-17 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-17 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-17 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-17 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-17 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-17 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-17 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-17 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-17 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-17 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-17 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-17 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-17 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-17 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-17 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-17 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-17 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-17 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-17 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-17 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-17 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-17 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-17 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-17 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-17 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-17 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-17 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-17 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-17 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-17 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 3e-17 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-17 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-17 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 3e-17 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-17 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 3e-17 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-17 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-17 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-17 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 4e-17 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 4e-17 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 4e-17 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 4e-17 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 4e-17 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-17 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-17 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 4e-17 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-17 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-17 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-17 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 4e-17 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 4e-17 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 4e-17 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 5e-17 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 5e-17 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 5e-17 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 6e-17 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 6e-17 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-17 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 7e-17 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 8e-17 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 8e-17 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-16 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-16 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-16 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-16 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-16 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-16 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-16 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-16 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-16 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-16 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-16 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-16 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-16 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-16 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-16 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-16 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-16 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-16 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-16 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-16 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-16 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-16 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-16 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-16 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-16 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-16 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-16 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-16 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 3e-16 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-16 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-16 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-16 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-16 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 4e-16 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-16 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 4e-16 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 4e-16 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 4e-16 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 4e-16 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 5e-16 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 6e-16 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 6e-16 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 6e-16 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 7e-16 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 7e-16 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 7e-16 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 7e-16 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 8e-16 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 8e-16 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 8e-16 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 9e-16 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 9e-16 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-15 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-15 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-15 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-15 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-15 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-15 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-15 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-15 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-15 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-15 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-15 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-15 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-15 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-15 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-15 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-15 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-15 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-15 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-15 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-15 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-15 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-15 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-15 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-15 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-15 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-15 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-15 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-15 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-15 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-15 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-15 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 3e-15 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-15 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-15 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 4e-15 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-15 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 4e-15 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 4e-15 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-15 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 4e-15 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 4e-15 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 5e-15 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 5e-15 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 5e-15 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 5e-15 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 5e-15 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-15 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-15 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 5e-15 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 5e-15 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 5e-15 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 5e-15 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-15 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 6e-15 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 6e-15 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 6e-15 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 6e-15 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-15 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 6e-15 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 6e-15 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 6e-15 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-15 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 6e-15 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 6e-15 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 6e-15 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 6e-15 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-15 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-15 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 6e-15 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 7e-15 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 7e-15 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 7e-15 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 9e-15 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 9e-15 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-14 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-14 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-14 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-14 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-14 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-14 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-14 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-14 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-14 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-14 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-14 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-14 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-14 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-14 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-14 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-14 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-14 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-14 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-14 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-14 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-14 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-14 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-14 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-14 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 3e-14 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-14 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-14 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-14 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-14 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-14 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-14 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-14 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-14 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-14 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-14 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 3e-14 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-14 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-14 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 4e-14 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 4e-14 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 4e-14 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 4e-14 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 5e-14 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 5e-14 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 5e-14 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 5e-14 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 5e-14 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 5e-14 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-14 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 6e-14 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 6e-14 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 6e-14 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 6e-14 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-14 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 6e-14 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-14 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 7e-14 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 7e-14 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 7e-14 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 7e-14 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 7e-14 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 7e-14 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 7e-14 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 8e-14 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 8e-14 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 8e-14 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 8e-14 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 9e-14 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 9e-14 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-14 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 9e-14 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-13 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-13 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-13 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-13 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-13 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-13 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-13 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-13 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-13 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-13 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-13 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-13 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-13 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-13 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-13 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-13 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-13 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-13 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-13 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-13 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-13 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-13 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-13 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-13 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-13 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-13 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-13 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-13 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-13 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-13 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-13 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-13 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-13 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-13 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-13 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-13 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-13 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-13 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-13 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-13 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-13 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-13 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-13 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-13 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-13 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-13 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-13 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-13 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-13 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-13 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-13 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-13 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-13 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-13 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 3e-13 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-13 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-13 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-13 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-13 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-13 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-13 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-13 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-13 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-13 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-13 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-13 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-13 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-13 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-13 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-13 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 4e-13 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 4e-13 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 4e-13 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 4e-13 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-13 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-13 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-13 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 4e-13 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 4e-13 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 4e-13 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 4e-13 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-13 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 4e-13 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 4e-13 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 4e-13 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 4e-13 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 4e-13 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 4e-13 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-13 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 4e-13 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 4e-13 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 4e-13 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 4e-13 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 4e-13 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-13 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 5e-13 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 5e-13 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 5e-13 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 5e-13 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 5e-13 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 5e-13 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 5e-13 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 5e-13 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-13 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 5e-13 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 5e-13 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 5e-13 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 5e-13 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 5e-13 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-13 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-13 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-13 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 5e-13 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 6e-13 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 6e-13 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-13 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 6e-13 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 6e-13 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 6e-13 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 6e-13 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 6e-13 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-13 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 7e-13 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-13 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 8e-13 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-13 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 8e-13 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 9e-13 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-12 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-12 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-12 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-12 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-12 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-12 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-12 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-12 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-12 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-12 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-12 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-12 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-12 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-12 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-12 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-12 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-12 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-12 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-12 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-12 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-12 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-12 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-12 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-12 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-12 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-12 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-12 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-12 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-12 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-12 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-12 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-12 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-12 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-12 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 4e-12 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 4e-12 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-12 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 4e-12 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 4e-12 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-12 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 5e-12 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-12 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 6e-12 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-12 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-12 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 6e-12 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 6e-12 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 6e-12 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 9e-12 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 9e-12 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 9e-12 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 9e-12 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 9e-12 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 9e-12 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-11 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-11 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-11 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-11 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-11 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-11 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-11 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-11 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-11 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-11 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-11 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-11 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-11 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-11 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-11 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-11 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-11 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 3e-11 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-11 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 3e-11 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 3e-11 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-11 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 3e-11 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 4e-11 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 4e-11 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 4e-11 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 4e-11 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-11 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 4e-11 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 4e-11 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 4e-11 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-11 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 5e-11 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 5e-11 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 5e-11 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-11 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 5e-11 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 5e-11 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-11 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 5e-11 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-11 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 5e-11 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 5e-11 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 5e-11 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 6e-11 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 7e-11 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 7e-11 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 7e-11 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-11 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 8e-11 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 9e-11 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 9e-11 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-10 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-10 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-10 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-10 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-10 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-10 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-10 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-10 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-10 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-10 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-10 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-10 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-10 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-10 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-10 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-10 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-10 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-10 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-10 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-10 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-10 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-10 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-10 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-10 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-10 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-10 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 3e-10 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-10 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-10 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-10 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-10 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 4e-10 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 4e-10 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 4e-10 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 4e-10 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 4e-10 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 4e-10 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 4e-10 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 4e-10 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 4e-10 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 4e-10 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 4e-10 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 4e-10 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 4e-10 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-10 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 4e-10 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 4e-10 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-10 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-10 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 5e-10 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 5e-10 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-10 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 5e-10 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 5e-10 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 5e-10 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 5e-10 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-10 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 5e-10 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 6e-10 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 6e-10 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 6e-10 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 7e-10 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 7e-10 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 8e-10 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 8e-10 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 9e-10 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 9e-10 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-09 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-09 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-09 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-09 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-09 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-09 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-09 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-09 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-09 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-09 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-09 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-09 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 1e-09 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-09 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-09 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-09 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-09 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-09 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-09 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-09 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-09 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-09 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-09 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-09 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-09 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-09 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-09 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-09 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-09 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-09 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-09 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-09 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-09 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-09 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-09 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-09 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-09 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-09 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-09 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-09 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-09 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-09 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-09 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-09 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-09 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-09 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-09 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-09 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-09 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-09 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-09 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-09 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-09 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-09 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-09 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-09 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-09 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-09 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-09 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-09 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-09 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-09 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-09 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-09 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-09 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-09 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-09 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-09 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-09 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-09 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-09 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-09 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-09 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-09 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-09 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-09 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-09 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-09 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-09 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 4e-09 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 4e-09 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 4e-09 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 4e-09 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 4e-09 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 4e-09 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 4e-09 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 4e-09 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 4e-09 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 4e-09 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 4e-09 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-09 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 4e-09 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 4e-09 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 4e-09 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 4e-09 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 4e-09 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 4e-09 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 4e-09 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 5e-09 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 5e-09 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 5e-09 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 5e-09 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 5e-09 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 5e-09 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 6e-09 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 6e-09 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 7e-09 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 7e-09 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 8e-09 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-08 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-08 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-08 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 1e-08 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-08 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-08 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-08 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-08 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-08 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-08 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-08 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-08 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-08 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-08 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-08 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-08 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-08 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-08 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-08 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-08 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-08 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-08 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-08 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-08 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 3e-08 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 3e-08 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-08 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-08 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 3e-08 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 4e-08 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 4e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 4e-08 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 5e-08 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 5e-08 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 5e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 5e-08 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-08 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 7e-08 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 8e-08 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 8e-08 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 8e-08 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-07 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-07 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-07 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 1e-07 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 1e-07 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-07 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-07 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-07 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-07 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-07 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-07 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-07 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-07 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-07 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-07 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-07 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-07 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 2e-07 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-07 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-07 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-07 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-07 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-07 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-07 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-07 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 3e-07 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-07 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 3e-07 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-07 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-07 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 4e-07 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 4e-07 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 4e-07 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 4e-07 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 8e-07 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 9e-07 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 9e-07 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 9e-07 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-06 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-06 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-06 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-06 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-06 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-06 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-06 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-06 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-06 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-06 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-06 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-06 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 1e-06 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-06 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-06 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-06 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-06 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-06 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-06 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-06 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-06 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-06 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-06 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-06 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-06 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 2e-06 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 2e-06 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-06 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 4e-06 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 4e-06 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 4e-06 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 477 bits (1231), Expect = e-171
Identities = 112/305 (36%), Positives = 172/305 (56%), Gaps = 29/305 (9%)
Query: 17 KIATKNF------CSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKA----E 66
K T NF +GEGGFG V+KG+++ VA+K+L A
Sbjct: 21 KNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-----------NTTVAVKKLAAMVDIT 69
Query: 67 SFQGHKEWLTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLF-RKGVQP 125
+ + +++ E+ + + +HENLV+L+G+ S+ D+ LVY +MP GSL + L G P
Sbjct: 70 TEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPP 129
Query: 126 ISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGD 185
+SW R KIA A G++FLH + + I+RD+K++N+LLD F AK+SDFGLAR
Sbjct: 130 LSWHMRCKIAQGAANGINFLH--ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFA 187
Query: 186 NTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTL 245
T +++RIVGT Y APE + G +TPKSD+YSFGVVLLE+++G A+DE R Q L
Sbjct: 188 QTVMTSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDEHRE---PQLL 243
Query: 246 VEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 305
++ + + + + +D ++ +A+ +V QCLH RP + V L+
Sbjct: 244 LDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQ 302
Query: 306 QLHTS 310
++ S
Sbjct: 303 EMTAS 307
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 445 bits (1146), Expect = e-158
Identities = 115/291 (39%), Positives = 166/291 (57%), Gaps = 16/291 (5%)
Query: 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLT 76
+ AT NF +L+G G FG V+KG + G VA+KR ES QG +E+ T
Sbjct: 35 EEATNNFDHKFLIGHGVFGKVYKGVLR----------DGAKVALKRRTPESSQGIEEFET 84
Query: 77 EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKG--VQPISWPTRVKI 134
E+ L RH +LV LIG+C E + +L+Y++M G+L+ HL+ +SW R++I
Sbjct: 85 EIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEI 144
Query: 135 AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 194
I ARGL +LH +I+RD+K+ N+LLD NF K++DFG+++ G D TH+ST +
Sbjct: 145 CIGAARGLHYLH--TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVK 202
Query: 195 GTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLR 254
GT GY PEY G LT KSDVYSFGVVL E+L R A+ + L EWA
Sbjct: 203 GTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPR-EMVNLAEWAVESHN 261
Query: 255 DSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 305
+ ++ +I+D L + + + ++CL + ++RPSM DVL LE
Sbjct: 262 -NGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 396 bits (1020), Expect = e-139
Identities = 115/294 (39%), Positives = 175/294 (59%), Gaps = 17/294 (5%)
Query: 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHK-EWL 75
++A+ NF + +LG GGFG V+KG + G +VA+KRLK E QG + ++
Sbjct: 26 QVASDNFSNKNILGRGGFGKVYKGRLA----------DGTLVAVKRLKEERTQGGELQFQ 75
Query: 76 TEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLF--RKGVQPISWPTRVK 133
TEV + H NL++L G+C RLLVY +M GS+ + L + P+ WP R +
Sbjct: 76 TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQR 135
Query: 134 IAIDVARGLSFLH-GLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR 192
IA+ ARGL++LH D +I+RD+KA+N+LLD F A + DFGLA+ D THV+T
Sbjct: 136 IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD-THVTTA 194
Query: 193 IVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDR-GGLAEQTLVEWADP 251
+ GT G+ APEY++TG + K+DV+ +GV+LLEL++G+RA D R + L++W
Sbjct: 195 VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 254
Query: 252 FLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 305
L++ +++ ++D L G Y +E + + V L C P RP M +V+ LE
Sbjct: 255 LLKE-KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 257 bits (658), Expect = 2e-84
Identities = 83/320 (25%), Positives = 128/320 (40%), Gaps = 42/320 (13%)
Query: 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWL-- 75
+ + G FGCV+K + VA+K + Q W
Sbjct: 21 FQSMPLQLLEVKARGRFGCVWKAQLL-----------NEYVAVKIFPIQDKQ---SWQNE 66
Query: 76 TEVIYLGQLRHENLVKLIGYCSESDN----RLLVYEFMPKGSLENHLFRKGVQPISWPTR 131
EV L ++HEN+++ IG + L+ F KGSL + L +SW
Sbjct: 67 YEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA---NVVSWNEL 123
Query: 132 VKIAIDVARGLSFLH--------GLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPT 183
IA +ARGL++LH G + +RD+K+ NVLL +N A ++DFGLA
Sbjct: 124 CHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEA 183
Query: 184 GDNTHVSTRIVGTRGYAAPEYVATGHL-----TPKSDVYSFGVVLLELLSGRRALDEDRG 238
G + + VGTR Y APE + + D+Y+ G+VL EL S A D
Sbjct: 184 GKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVD 243
Query: 239 G--LAEQTLVEWADPFLRDSRR--VLRIMDTRLGGQYSKKEA-QAVAAVVLQCLHMDPKN 293
L + + P L D + V + L + K + + +C D +
Sbjct: 244 EYMLPFEEEI-GQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEA 302
Query: 294 RPSMVDVLTSLEQLHTSKDM 313
R S V + Q+ ++
Sbjct: 303 RLSAGCVGERITQMQRLTNI 322
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 236 bits (603), Expect = 6e-76
Identities = 77/345 (22%), Positives = 132/345 (38%), Gaps = 53/345 (15%)
Query: 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTE 77
+ N L+G G +G V+KG +D VA+K + Q ++ E
Sbjct: 10 LDLDNLKLLELIGRGRYGAVYKGSLD-----------ERPVAVKVFSFANRQ---NFINE 55
Query: 78 V-IY-LGQLRHENLVKLIGYCSE-----SDNRLLVYEFMPKGSLENHLFRKGVQPISWPT 130
IY + + H+N+ + I LLV E+ P GSL +L W +
Sbjct: 56 KNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL---HTSDWVS 112
Query: 131 RVKIAIDVARGLSFLH-------GLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR---- 179
++A V RGL++LH + +RDL + NVL+ ++ +SDFGL+
Sbjct: 113 SCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTG 172
Query: 180 --DGPTGDNTHVSTRIVGTRGYAAPEY-------VATGHLTPKSDVYSFGVVLLELLSGR 230
G+ + + VGT Y APE + D+Y+ G++ E+
Sbjct: 173 NRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC 232
Query: 231 RALDEDRGG----LAEQTLVEWADPFLRDSRRVLRIMDTRL----GGQYSKKEAQAVAAV 282
L +A QT V P D + ++ R + + +++
Sbjct: 233 TDLFPGESVPEYQMAFQTEV-GNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKET 291
Query: 283 VLQCLHMDPKNRPSMVDVLTSLEQLHTSKDMPRTPPPAKLHHHHH 327
+ C D + R + + +L + ++ P HHHHH
Sbjct: 292 IEDCWDQDAEARLTAQXAEERMAELMMIWERNKSVSPTAHHHHHH 336
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 216 bits (553), Expect = 1e-68
Identities = 80/311 (25%), Positives = 127/311 (40%), Gaps = 42/311 (13%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHEN 88
LG+G FG K T +G V+ +K L + + +L EV + L H N
Sbjct: 18 LGKGCFGQAIKV---------THRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPN 68
Query: 89 LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL 148
++K IG + + E++ G+L + Q W RV A D+A G+++LH +
Sbjct: 69 VLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQ-YPWSQRVSFAKDIASGMAYLHSM 127
Query: 149 DANVIYRDLKASNVLLDSNFNAKLSDFGLAR------------DGPTGDNTHVSTRIVGT 196
N+I+RDL + N L+ N N ++DFGLAR + +VG
Sbjct: 128 --NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGN 185
Query: 197 RGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDS 256
+ APE + K DV+SFG+VL E++ A D L +R
Sbjct: 186 PYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNA---DPDYLPRTMDFGLN---VRGF 239
Query: 257 RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL--HTSKDMP 314
+ + + ++C +DP+ RPS V + LE L H + +P
Sbjct: 240 LDRYCPPNC----------PPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLP 289
Query: 315 RTPPPAKLHHH 325
P +L
Sbjct: 290 LGPQLEQLDRG 300
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 208 bits (532), Expect = 1e-65
Identities = 80/310 (25%), Positives = 132/310 (42%), Gaps = 49/310 (15%)
Query: 29 LGEGGFGCVFKG-WIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHE 87
+G G FG V K W VAIK++++ES + K ++ E+ L ++ H
Sbjct: 16 VGRGAFGVVCKAKW------------RAKDVAIKQIESESER--KAFIVELRQLSRVNHP 61
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQP-ISWPTRVKIAIDVARGLSFLH 146
N+VKL G C + LV E+ GSL N L P + + + ++G+++LH
Sbjct: 62 NIVKLYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLH 119
Query: 147 GLDAN-VIYRDLKASNVLLDSNFN-AKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEY 204
+ +I+RDLK N+LL + K+ DFG A D T G+ + APE
Sbjct: 120 SMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD-----IQTHMTNNKGSAAWMAPEV 174
Query: 205 VATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMD 264
+ + K DV+S+G++L E+++ R+ PF RIM
Sbjct: 175 FEGSNYSEKCDVFSWGIILWEVITRRK-------------------PFDEIGGPAFRIMW 215
Query: 265 TRLGGQ---YSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDMPRTPPPAK 321
G K + + +++ +C DP RPSM +++ + L + P P +
Sbjct: 216 AVHNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHL--MRYFPGADEPLQ 273
Query: 322 LHHHHHHHNH 331
H
Sbjct: 274 YPCQHSLPPG 283
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 208 bits (532), Expect = 2e-65
Identities = 86/296 (29%), Positives = 137/296 (46%), Gaps = 41/296 (13%)
Query: 29 LGEGGFGCVFKG-WIDQNTFAPTKPGSGIVVAIKRLKAESFQGH--KEWLTEVIYLGQLR 85
+G G FG V + W G VA+K L + F E+L EV + +LR
Sbjct: 45 IGAGSFGTVHRAEW------------HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLR 92
Query: 86 HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGV-QPISWPTRVKIAIDVARGLSF 144
H N+V +G ++ N +V E++ +GSL L + G + + R+ +A DVA+G+++
Sbjct: 93 HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNY 152
Query: 145 LHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEY 204
LH + +++R+LK+ N+L+D + K+ DFGL+R + + S GT + APE
Sbjct: 153 LHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS--SKSAAGTPEWMAPEV 210
Query: 205 VATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD-PFLRDSRRVLRIM 263
+ KSDVYSFGV+L EL + + W + + V
Sbjct: 211 LRDEPSNEKSDVYSFGVILWELATLQ---------------QPWGNLNPAQVVAAVGF-K 254
Query: 264 DTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDMPRTPPP 319
RL + + VAA++ C +P RPS ++ L L S PPP
Sbjct: 255 CKRL--EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA----VPPP 304
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 202 bits (515), Expect = 3e-63
Identities = 77/314 (24%), Positives = 128/314 (40%), Gaps = 88/314 (28%)
Query: 29 LGEGGFGCVFKG-WIDQNTFAPTKPGSGIVVAIKRLKAESFQGH-------KEWLTEVIY 80
+G+GGFG V KG + + VVAIK L +G +E+ EV
Sbjct: 27 IGKGGFGLVHKGRLVKDKS----------VVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 81 LGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVAR 140
+ L H N+VKL G +V EF+P G L + L K PI W ++++ +D+A
Sbjct: 77 MSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKA-HPIKWSVKLRLMLDIAL 133
Query: 141 GLSFLHGLDANVIYRDLKASNVLLDS-----NFNAKLSDFGLARDGPTGDNTHVSTRIVG 195
G+ ++ + +++RDL++ N+ L S AK++DFGL++ + H + ++G
Sbjct: 134 GIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLG 188
Query: 196 TRGYAAPEYVATGHL--TPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 253
+ APE + T K+D YSF ++L +L+G PF
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEG-------------------PF- 228
Query: 254 RDSRRVLRIMDTRLGGQYSKKEAQAVAAVVL--------------------QCLHMDPKN 293
+YS + + + + C DPK
Sbjct: 229 ---------------DEYSYGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKK 273
Query: 294 RPSMVDVLTSLEQL 307
RP ++ L +L
Sbjct: 274 RPHFSYIVKELSEL 287
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 2e-61
Identities = 71/285 (24%), Positives = 124/285 (43%), Gaps = 36/285 (12%)
Query: 29 LGEGGFGCVFKG-WIDQNTFAPTKPGSGIVVAIKRLKAESFQGH--KEWLTEVIYLGQLR 85
+G G FG V+KG W VA+K L + + + EV L + R
Sbjct: 32 IGSGSFGTVYKGKWHGD-------------VAVKMLNVTAPTPQQLQAFKNEVGVLRKTR 78
Query: 86 HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFL 145
H N++ +GY + +V ++ SL +HL + + IA ARG+ +L
Sbjct: 79 HVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHASETK-FEMKKLIDIARQTARGMDYL 136
Query: 146 HGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPE-- 203
H ++I+RDLK++N+ L + K+ DFGLA + +H ++ G+ + APE
Sbjct: 137 HAK--SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 194
Query: 204 -YVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRI 262
+ + +SDVY+FG+VL EL++G+ + + + R S
Sbjct: 195 RMQDSNPYSFQSDVYAFGIVLYELMTGQLPYS----NINNRDQIIEM--VGRGSLSPDLS 248
Query: 263 MDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 307
+ + + ++ +CL RPS +L +E+L
Sbjct: 249 -------KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEEL 286
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 198 bits (505), Expect = 4e-61
Identities = 71/311 (22%), Positives = 125/311 (40%), Gaps = 44/311 (14%)
Query: 28 LLGEGGFGCVFKG-WIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEV-IY-LGQL 84
+G+G +G V+ G W + VA+K W E IY +
Sbjct: 44 QIGKGRYGEVWMGKWRGEK------------VAVKVFFTTEEA---SWFRETEIYQTVLM 88
Query: 85 RHENLVKLIGYCSESDNR----LLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVAR 140
RHEN++ I + L+ ++ GSL ++L + + +K+A
Sbjct: 89 RHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVS 145
Query: 141 GLSFLHGLDA------NVIYRDLKASNVLLDSNFNAKLSDFGLAR--DGPTGDNTHVSTR 192
GL LH + +RDLK+ N+L+ N ++D GLA T +
Sbjct: 146 GLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNT 205
Query: 193 IVGTRGYAAPEYVATGHLTP-------KSDVYSFGVVLLELLSGRRALDEDRGGLAEQTL 245
VGT+ Y PE V L +D+YSFG++L E+ +
Sbjct: 206 RVGTKRYMPPE-VLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHD 264
Query: 246 VEWADPFLRDSRRVLRIMDTR--LGGQYSKKEA-QAVAAVVLQCLHMDPKNRPSMVDVLT 302
+ +DP D R ++ I R ++S E + + ++ +C +P +R + + V
Sbjct: 265 LVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKK 324
Query: 303 SLEQLHTSKDM 313
+L ++ S+D+
Sbjct: 325 TLAKMSESQDI 335
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 6e-61
Identities = 63/287 (21%), Positives = 117/287 (40%), Gaps = 44/287 (15%)
Query: 29 LGEGGFGCVFKG-WIDQNTFAPTKPGSGIVVAIKRLKAESFQGH--KEWLTEVIYLGQLR 85
L E G ++KG W G + +K LK + +++ E L
Sbjct: 18 LNENHSGELWKGRW------------QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFS 65
Query: 86 HENLVKLIGYCSE--SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLS 143
H N++ ++G C + + L+ +MP GSL N L + VK A+D+ARG++
Sbjct: 66 HPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMA 125
Query: 144 FLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPE 203
FLH L+ + L + +V++D + A++S + + S + + APE
Sbjct: 126 FLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKF-------SFQSPGRMYAPAWVAPE 178
Query: 204 ---YVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVL 260
+D++SF V+L EL++ A+ + +E + R
Sbjct: 179 ALQKKPEDTNRRSADMWSFAVLLWELVTREVP-------FADLSNMEIGMKVALEGLR-P 230
Query: 261 RIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 307
I + V+ ++ C++ DP RP ++ LE++
Sbjct: 231 TI---------PPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKM 268
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 8e-60
Identities = 81/294 (27%), Positives = 124/294 (42%), Gaps = 52/294 (17%)
Query: 29 LGEGGFGCVFKG-WIDQNTFAPTKPGSGIVVAIKRLKAESFQGH----KEWLTEVIYLGQ 83
+G GGFG V++ WI VA+K + + + + E
Sbjct: 15 IGIGGFGKVYRAFWIGDE------------VAVKAARHDPDEDISQTIENVRQEAKLFAM 62
Query: 84 LRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLS 143
L+H N++ L G C + N LV EF G L L K I V A+ +ARG++
Sbjct: 63 LKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK---RIPPDILVNWAVQIARGMN 119
Query: 144 FLHGLD-ANVIYRDLKASNVLLD--------SNFNAKLSDFGLARDGPTGDNTHVSTRIV 194
+LH +I+RDLK+SN+L+ SN K++DFGLAR+ T +
Sbjct: 120 YLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE---WHRTTKMSA-A 175
Query: 195 GTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD-PFL 253
G + APE + + SDV+S+GV+L ELL+G V + L
Sbjct: 176 GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGE---------------VPFRGIDGL 220
Query: 254 RDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 307
+ V L + A ++ C + DP +RPS ++L L +
Sbjct: 221 AVAYGVAM-NKLAL--PIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 2e-59
Identities = 59/294 (20%), Positives = 111/294 (37%), Gaps = 49/294 (16%)
Query: 29 LGEGGFGCVFKG-WIDQNTFAPTKPGSGIVVAIKRLKAESFQGH--KEWLTEVIYLGQLR 85
+G+G FG V+ G W + VAI+ + E K + EV+ Q R
Sbjct: 41 IGKGRFGQVYHGRWHGE-------------VAIRLIDIERDNEDQLKAFKREVMAYRQTR 87
Query: 86 HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFL 145
HEN+V +G C + ++ +L + + R + +IA ++ +G+ +L
Sbjct: 88 HENVVLFMGACMSPPHLAIITSLCKGRTLYSVV-RDAKIVLDVNKTRQIAQEIVKGMGYL 146
Query: 146 HGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR---DGPTGDNTHVSTRIVGTRGYAAP 202
H ++++DLK+ NV D N ++DFGL G G + AP
Sbjct: 147 HAK--GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAP 203
Query: 203 E---------YVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 253
E + SDV++ G + EL + + ++
Sbjct: 204 EIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFK----TQPAEAIIWQMG--- 256
Query: 254 RDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 307
+ L + + ++ ++L C + + RP+ ++ LE+L
Sbjct: 257 TGMKPNLSQIGM----------GKEISDILLFCWAFEQEERPTFTKLMDMLEKL 300
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 191 bits (486), Expect = 9e-59
Identities = 71/309 (22%), Positives = 129/309 (41%), Gaps = 52/309 (16%)
Query: 28 LLGEGGFGCVFKG-WIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEV-IY-LGQL 84
+G+G +G V++G W +N VA+K + + W E +Y L
Sbjct: 15 CVGKGRYGEVWRGSWQGEN------------VAVKIFSSRDEK---SWFRETELYNTVML 59
Query: 85 RHENLVKLIGYCSESDNR----LLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVAR 140
RHEN++ I S + L+ + GSL ++L + + ++I + +A
Sbjct: 60 RHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL---TTLDTVSCLRIVLSIAS 116
Query: 141 GLSFLHGLDA------NVIYRDLKASNVLLDSNFNAKLSDFGLAR--DGPTGDNTHVSTR 192
GL+ LH + +RDLK+ N+L+ N ++D GLA T +
Sbjct: 117 GLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNP 176
Query: 193 IVGTRGYAAPE------YVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLV 246
VGT+ Y APE V + D+++FG+VL E+ G+ E
Sbjct: 177 RVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR-----MVSNGIVEDYKP 231
Query: 247 EWAD-----PFLRDSRRVLRIMDTRL---GGQYSKKEAQAVAAVVLQCLHMDPKNRPSMV 298
+ D P D R+V+ + R +S ++A ++ +C + +P R + +
Sbjct: 232 PFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTAL 291
Query: 299 DVLTSLEQL 307
+ +L ++
Sbjct: 292 RIKKTLTKI 300
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 7e-58
Identities = 72/310 (23%), Positives = 130/310 (41%), Gaps = 42/310 (13%)
Query: 28 LLGEGGFGCVFKG-WIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEV-IY-LGQL 84
+G+G FG V++G W + VA+K + + W E IY L
Sbjct: 49 SIGKGRFGEVWRGKWRGEE------------VAVKIFSSREER---SWFREAEIYQTVML 93
Query: 85 RHENLVKLIGYCSESDNR----LLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVAR 140
RHEN++ I ++ + LV ++ GSL ++L R ++ +K+A+ A
Sbjct: 94 RHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTAS 150
Query: 141 GLSFLHGLDA------NVIYRDLKASNVLLDSNFNAKLSDFGLAR--DGPTGDNTHVSTR 192
GL+ LH + +RDLK+ N+L+ N ++D GLA D T
Sbjct: 151 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNH 210
Query: 193 IVGTRGYAAPE----YVATGHL--TPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLV 246
VGT+ Y APE + H ++D+Y+ G+V E+ +
Sbjct: 211 RVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL 270
Query: 247 EWADPFLRDSRRVLRIMDTRL---GGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303
+DP + + R+V+ R S + + +A ++ +C + + R + + + +
Sbjct: 271 VPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330
Query: 304 LEQLHTSKDM 313
L QL + +
Sbjct: 331 LSQLSQQEGI 340
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 3e-51
Identities = 71/295 (24%), Positives = 133/295 (45%), Gaps = 33/295 (11%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHEN 88
LG+G FG V + P + +G VVA+K+L+ + + +++ E+ L L+H+N
Sbjct: 18 LGKGNFGSVEMC-----RYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 72
Query: 89 LVKLIGYCSESDNR--LLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLH 146
+VK G C + R L+ E++P GSL ++L +K + I ++ + +G+ +L
Sbjct: 73 IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYLG 131
Query: 147 GLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRG---YAAPE 203
I+RDL N+L+++ K+ DFGL + P + APE
Sbjct: 132 --TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKE--PGESPIFWYAPE 187
Query: 204 YVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLR-DSRRVLRI 262
+ + SDV+SFGVVL EL + ++ + AE + D + ++ +
Sbjct: 188 SLTESKFSVASDVWSFGVVLYELFTYI---EKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 244
Query: 263 MDT--RLGGQYSKKEA-----QAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 310
+ RL + ++ +C + + RPS D+ ++Q+ +
Sbjct: 245 LKNNGRL-------PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 4e-51
Identities = 76/318 (23%), Positives = 129/318 (40%), Gaps = 62/318 (19%)
Query: 29 LGEGGFGCVFKG-WIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHE 87
LG+G F +FKG + + V +K L + + + +L H+
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHE---TEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHG 147
+LV G C D +LV EF+ GSL+ +L +K I+ ++++A +A + FL
Sbjct: 73 HLVLNYGVCVCGDENILVQEFVKFGSLDTYL-KKNKNCINILWKLEVAKQLAAAMHFLE- 130
Query: 148 LDANVIYRDLKASNVLLDSNFN--------AKLSDFGLARDGPTGDNTHVSTRIVGTRGY 199
+ +I+ ++ A N+LL + KLSD G++ ++
Sbjct: 131 -ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT------------VLPKDIL 177
Query: 200 ------AAPEYVATG-HLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADP 251
PE + +L +D +SFG L E+ S G + P
Sbjct: 178 QERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDK-------------------P 218
Query: 252 FL-RDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 310
DS+R L+ + Q +A +A ++ C+ +P +RPS ++ L L T
Sbjct: 219 LSALDSQRKLQFYED--RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP 276
Query: 311 KDMPRTPPPAKLHHHHHH 328
+PR HHHHHH
Sbjct: 277 DLVPR-----GSHHHHHH 289
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 6e-51
Identities = 82/290 (28%), Positives = 121/290 (41%), Gaps = 29/290 (10%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGH-KEWLTEVIYLGQLRHE 87
LGEG FG V + P +G VA+K LK ES H + E+ L L HE
Sbjct: 29 LGEGHFGKVELC-----RYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHE 83
Query: 88 NLVKLIGYCSESDNR--LLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFL 145
N+VK G C+E L+ EF+P GSL+ +L K I+ ++K A+ + +G+ +L
Sbjct: 84 NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL-PKNKNKINLKQQLKYAVQICKGMDYL 142
Query: 146 HGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR---GYAAP 202
++RDL A NVL++S K+ DFGL + T + + AP
Sbjct: 143 G--SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKD--DRDSPVFWYAP 198
Query: 203 EYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLR 261
E + SDV+SFGV L ELL+ L R++
Sbjct: 199 ECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMT----VTRLVN 254
Query: 262 IMDT--RLGGQYSKKEA--QAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 307
+ RL V ++ +C P NR S +++ E L
Sbjct: 255 TLKEGKRL----PCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 7e-51
Identities = 75/309 (24%), Positives = 136/309 (44%), Gaps = 28/309 (9%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHEN 88
LG+G FG V D P +G +VA+K+L+ +++ E+ L L +
Sbjct: 31 LGKGNFGSVELCRYD-----PLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDF 85
Query: 89 LVKLIGYCSESDNR--LLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLH 146
+VK G + LV E++P G L + L ++ + + + + +G+ +L
Sbjct: 86 IVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL-QRHRARLDASRLLLYSSQICKGMEYLG 144
Query: 147 GLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRG---YAAPE 203
++RDL A N+L++S + K++DFGLA+ P + +V + + APE
Sbjct: 145 --SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVRE--PGQSPIFWYAPE 200
Query: 204 YVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRI 262
++ + +SDV+SFGVVL EL + ++ AE + + + R+L +
Sbjct: 201 SLSDNIFSRQSDVWSFGVVLYELFTYCDKS----CSPSAEFLRMMGCERDVPALSRLLEL 256
Query: 263 MDTRLGGQYSKKEA--QAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDMPRTP--- 317
++ G + A V ++ C P++RPS + L+ L + T
Sbjct: 257 LEE--GQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETHAFT 314
Query: 318 -PPAKLHHH 325
P HH
Sbjct: 315 AHPEGKHHS 323
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 7e-51
Identities = 77/290 (26%), Positives = 119/290 (41%), Gaps = 48/290 (16%)
Query: 29 LGEGGFGCVFKG-WIDQNTFAPTKPGSGIVVAIKRLKAE-SFQGHKEWLTEVIYLGQLRH 86
+G G FG VF G NT +VA+K + ++L E L Q H
Sbjct: 122 IGRGNFGEVFSGRLRADNT----------LVAVKSCRETLPPDLKAKFLQEARILKQYSH 171
Query: 87 ENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLH 146
N+V+LIG C++ +V E + G L R + T +++ D A G+ +L
Sbjct: 172 PNIVRLIGVCTQKQPIYIVMELVQGGDFLTFL-RTEGARLRVKTLLQMVGDAAAGMEYLE 230
Query: 147 GLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGY----AAP 202
I+RDL A N L+ K+SDFG++R+ G G R AP
Sbjct: 231 --SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGV----YAASGGLRQVPVKWTAP 284
Query: 203 EYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDS-RRVL 260
E + G + +SDV+SFG++L E S G P+ S ++
Sbjct: 285 EALNYGRYSSESDVWSFGILLWETFSLGAS-------------------PYPNLSNQQTR 325
Query: 261 RIMDTRLGGQYSKKEA--QAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLH 308
++ GG+ E AV ++ QC +P RPS + L+ +
Sbjct: 326 EFVEK--GGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 2e-50
Identities = 72/294 (24%), Positives = 136/294 (46%), Gaps = 31/294 (10%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHEN 88
LG+G FG V + P + +G VVA+K+L+ + + +++ E+ L L+H+N
Sbjct: 49 LGKGNFGSVEMC-----RYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 103
Query: 89 LVKLIGYCSESDNR--LLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLH 146
+VK G C + R L+ E++P GSL ++L +K + I ++ + +G+ +L
Sbjct: 104 IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYLG 162
Query: 147 GLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRG-----YAA 201
I+RDL N+L+++ K+ DFGL + P + G + A
Sbjct: 163 --TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVK----EPGESPIFWYA 216
Query: 202 PEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLR-DSRRVL 260
PE + + SDV+SFGVVL EL + ++ + AE + D + ++
Sbjct: 217 PESLTESKFSVASDVWSFGVVLYELFTYI---EKSKSPPAEFMRMIGNDKQGQMIVFHLI 273
Query: 261 RIMDT--RLGGQYSKKEA--QAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 310
++ RL + + + ++ +C + + RPS D+ ++Q+
Sbjct: 274 ELLKNNGRL----PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 4e-50
Identities = 84/292 (28%), Positives = 131/292 (44%), Gaps = 29/292 (9%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAE-SFQGHKEWLTEVIYLGQLRHE 87
LGEG FG V D PT G+G +VA+K LKA+ Q W E+ L L HE
Sbjct: 39 LGEGHFGKVSLYCYD-----PTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHE 93
Query: 88 NLVKLIGYCSESDNR--LLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFL 145
+++K G C ++ LV E++P GSL ++L + I + A + G+++L
Sbjct: 94 HIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL-PR--HSIGLAQLLLFAQQICEGMAYL 150
Query: 146 HGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRG-----YA 200
H + I+RDL A NVLLD++ K+ DFGLA+ P G + V G +
Sbjct: 151 HAQ--HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR----VREDGDSPVFWY 204
Query: 201 APEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVL 260
APE + SDV+SFGV L ELL+ + E + + +L
Sbjct: 205 APECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELL 264
Query: 261 RIMDTRLGGQYSKKEA--QAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 310
G + + + V ++ C + RP+ +++ L+ +H
Sbjct: 265 ER-----GERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEK 311
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 9e-49
Identities = 79/310 (25%), Positives = 131/310 (42%), Gaps = 49/310 (15%)
Query: 29 LGEGGFGCVFKG-WIDQNTFAPTKPGSGIVVAIKRLKAESFQGHK-EWLTEVIYLGQLRH 86
LG G FG V +G + I VAIK LK + + E + E + QL +
Sbjct: 18 LGCGNFGSVRQGVY--------RMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDN 69
Query: 87 ENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLH 146
+V+LIG C + +LV E G L L + I ++ V+ G+ +L
Sbjct: 70 PYIVRLIGVCQA-EALMLVMEMAGGGPLHKFL-VGKREEIPVSNVAELLHQVSMGMKYLE 127
Query: 147 GLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR---GYAAPE 203
+ N ++RDL A NVLL + AK+SDFGL++ D+ + + + + APE
Sbjct: 128 --EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR--SAGKWPLKWYAPE 183
Query: 204 YVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLR-DSRRVLR 261
+ + +SDV+S+GV + E LS G++ P+ + V+
Sbjct: 184 CINFRKFSSRSDVWSYGVTMWEALSYGQK-------------------PYKKMKGPEVMA 224
Query: 262 IMDTRLGGQYSKKEA--QAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDMPRTPPP 319
++ G + + A++ C ++RP + V + + S
Sbjct: 225 FIEQ--GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS-----LASK 277
Query: 320 AKLHHHHHHH 329
+ HHHHHHH
Sbjct: 278 VEGHHHHHHH 287
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 1e-48
Identities = 69/312 (22%), Positives = 137/312 (43%), Gaps = 45/312 (14%)
Query: 9 DPSASMISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF 68
P+ +++ + F +LG G FG V+KG + P I VAIK L+ +
Sbjct: 3 APNQALLRILKETEFKKIKVLGSGAFGTVYKG-----LWIPEGEKVKIPVAIKELREATS 57
Query: 69 QGHK-EWLTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPIS 127
E L E + + + ++ +L+G C L+ + MP G L +++ R+ I
Sbjct: 58 PKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYV-REHKDNIG 115
Query: 128 WPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNT 187
+ + +A+G+++L D +++RDL A NVL+ + + K++DFGLA+ +
Sbjct: 116 SQYLLNWCVQIAKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 173
Query: 188 HVSTRIVGTR---GYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQ 243
+ + G + + A E + T +SDV+S+GV + EL++ G +
Sbjct: 174 YHAE---GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK------------ 218
Query: 244 TLVEWADPFL-RDSRRVLRIMDT--RLGGQYSKKEA--QAVAAVVLQCLHMDPKNRPSMV 298
P+ + + I++ RL + V ++ +C +D +RP
Sbjct: 219 -------PYDGIPASEISSILEKGERL----PQPPICTIDVYMIMRKCWMIDADSRPKFR 267
Query: 299 DVLTSLEQLHTS 310
+++ ++
Sbjct: 268 ELIIEFSKMARD 279
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 7e-48
Identities = 78/295 (26%), Positives = 126/295 (42%), Gaps = 48/295 (16%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAE-SFQGHKEWLTEVIYLGQLRHE 87
+G G FGCV+ G G I A+K L ++LTE I + H
Sbjct: 33 IGRGHFGCVYHG------TLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHP 86
Query: 88 NLVKLIGYCSESDN-RLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLH 146
N++ L+G C S+ L+V +M G L N + R + + + VA+G+ +L
Sbjct: 87 NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQVAKGMKYLA 145
Query: 147 GLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYA------ 200
++RDL A N +LD F K++DFGLARD + + G
Sbjct: 146 --SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE----YYSVHNKTGAKLPVKWM 199
Query: 201 APEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRG-----GLAEQTLVEWADPFLRD 255
A E + T T KSDV+SFGV+L EL++ RG + + +L
Sbjct: 200 ALESLQTQKFTTKSDVWSFGVLLWELMT--------RGAPPYPDVNTFDITV----YLLQ 247
Query: 256 SRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 310
RR+L+ + V+L+C H + RPS ++++ + + ++
Sbjct: 248 GRRLLQPEYCP----------DPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 292
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 6e-47
Identities = 79/309 (25%), Positives = 133/309 (43%), Gaps = 51/309 (16%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLRH 86
LG G FG V KG+ VA+K LK E+ E L E + QL +
Sbjct: 25 LGSGNFGTVKKGYY-------QMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDN 77
Query: 87 ENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLH 146
+V++IG C ++ +LV E G L +L ++ + + +++ V+ G+ +L
Sbjct: 78 PYIVRMIGICEA-ESWMLVMEMAELGPLNKYL-QQN-RHVKDKNIIELVHQVSMGMKYLE 134
Query: 147 GLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR---GYAAPE 203
++N ++RDL A NVLL + AK+SDFGL++ +N + + + + APE
Sbjct: 135 --ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT--HGKWPVKWYAPE 190
Query: 204 YVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLR-DSRRVLR 261
+ + KSDV+SFGV++ E S G++ P+ V
Sbjct: 191 CINYYKFSSKSDVWSFGVLMWEAFSYGQK-------------------PYRGMKGSEVTA 231
Query: 262 IMDTRLGGQYSKKEA--QAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDMPRTPPP 319
+++ G + + + ++ C D +NRP V L +
Sbjct: 232 MLEK--GERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD-------VV 282
Query: 320 AKLHHHHHH 328
+ HHHHHH
Sbjct: 283 NEGHHHHHH 291
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 158 bits (403), Expect = 8e-47
Identities = 82/290 (28%), Positives = 135/290 (46%), Gaps = 48/290 (16%)
Query: 29 LGEGGFGCVFKG-WIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHE 87
+G G FG V G W++++ VAIK ++ E ++++ E + +L H
Sbjct: 16 IGSGQFGLVHLGYWLNKDK-----------VAIKTIR-EGAMSEEDFIEEAEVMMKLSHP 63
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHG 147
LV+L G C E LV EFM G L ++L R + T + + +DV G+++L
Sbjct: 64 KLVQLYGVCLEQAPICLVTEFMEHGCLSDYL-RTQRGLFAAETLLGMCLDVCEGMAYLE- 121
Query: 148 LDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR---GYAAPEY 204
+A VI+RDL A N L+ N K+SDFG+ R D+ + T GT+ +A+PE
Sbjct: 122 -EACVIHRDLAARNCLVGENQVIKVSDFGMTRF--VLDDQY--TSSTGTKFPVKWASPEV 176
Query: 205 VATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLR-DSRRVLRI 262
+ + KSDV+SFGV++ E+ S G+ P+ + V+
Sbjct: 177 FSFSRYSSKSDVWSFGVLMWEVFSEGKI-------------------PYENRSNSEVVED 217
Query: 263 MDTRLGGQYSKKEA--QAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 310
+ T G + K V ++ C P++RP+ +L L ++ S
Sbjct: 218 IST--GFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 1e-46
Identities = 80/299 (26%), Positives = 142/299 (47%), Gaps = 39/299 (13%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAE-SFQGHKEWLTEVIYLGQLRHE 87
+G G FG V+KG + + VAIK LKA + + ++L E +GQ H
Sbjct: 52 IGAGEFGEVYKG-----MLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHH 106
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHG 147
N+++L G S+ +++ E+M G+L+ L R+ S V + +A G+ +L
Sbjct: 107 NIIRLEGVISKYKPMMIITEYMENGALDKFL-REKDGEFSVLQLVGMLRGIAAGMKYLA- 164
Query: 148 LDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR---GYAAPEY 204
+ N ++RDL A N+L++SN K+SDFGL+R D+ + G + + APE
Sbjct: 165 -NMNYVHRDLAARNILVNSNLVCKVSDFGLSRV--LEDDPEATYTTSGGKIPIRWTAPEA 221
Query: 205 VATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDS-RRVLRI 262
++ T SDV+SFG+V+ E+++ G R P+ S V++
Sbjct: 222 ISYRKFTSASDVWSFGIVMWEVMTYGER-------------------PYWELSNHEVMKA 262
Query: 263 MDTRLGGQYSKKEA--QAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDMPRTPPP 319
++ G + A+ +++QC + RP D+++ L++L + D +T
Sbjct: 263 IND--GFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKTLAD 319
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 1e-46
Identities = 82/328 (25%), Positives = 134/328 (40%), Gaps = 63/328 (19%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLK--AESFQGHKEWLTEVIYLGQLRH 86
LG+G FG V + + GS + VA+K LK + +E+L E + + H
Sbjct: 31 LGKGEFGSVREA------QLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDH 84
Query: 87 ENLVKLIGYCSESDNR------LLVYEFMPKGSLENHL----FRKGVQPISWPTRVKIAI 136
++ KL+G S + +++ FM G L L + + T V+ +
Sbjct: 85 PHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMV 144
Query: 137 DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 196
D+A G+ +L N I+RDL A N +L + ++DFGL+R +GD G
Sbjct: 145 DIACGMEYLS--SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYR-----QGC 197
Query: 197 RG-----YAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRG-----GLAEQTLV 246
+ A E +A T SDV++FGV + E+++ RG G+ +
Sbjct: 198 ASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMT--------RGQTPYAGIENAEIY 249
Query: 247 EWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQ 306
+L R+ + + + V ++ QC DPK RPS + LE
Sbjct: 250 N----YLIGGNRLKQPPECM----------EEVYDLMYQCWSADPKQRPSFTCLRMELEN 295
Query: 307 LHTSKDMPRTPPPA------KLHHHHHH 328
+ + T + HHHHHH
Sbjct: 296 ILGHLSVLSTSQDPLYINIERAHHHHHH 323
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 2e-46
Identities = 83/300 (27%), Positives = 133/300 (44%), Gaps = 40/300 (13%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAE-SFQGHKEWLTEVIYLGQLRHE 87
+G G G V G + VAIK LKA + + +++L+E +GQ H
Sbjct: 57 IGSGDSGEVCYGR------LRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHP 110
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHG 147
N+++L G + ++V E+M GSL+ L R + V + V G+ +L
Sbjct: 111 NIIRLEGVVTRGRLAMIVTEYMENGSLDTFL-RTHDGQFTIMQLVGMLRGVGAGMRYLS- 168
Query: 148 LDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR---GYAAPEY 204
D ++RDL A NVL+DSN K+SDFGL+R + +T G + + APE
Sbjct: 169 -DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTT--GGKIPIRWTAPEA 225
Query: 205 VATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLR-DSRRVLRI 262
+A + SDV+SFGVV+ E+L+ G R P+ +R V+
Sbjct: 226 IAFRTFSSASDVWSFGVVMWEVLAYGER-------------------PYWNMTNRDVISS 266
Query: 263 MDTRLGGQYSKKEA--QAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDMPRTPPPA 320
++ G + A+ ++L C H D RP +++ L+ L S + R
Sbjct: 267 VEE--GYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPESLRATATV 324
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 2e-46
Identities = 80/293 (27%), Positives = 131/293 (44%), Gaps = 44/293 (15%)
Query: 29 LGEGGFGCVFKG-WIDQNTFAPTKPGSGIVVAIKRLKAESFQGHK---EWLTEVIYLGQL 84
LG+G FG V +G W + G + VA+K LK + + +++ EV + L
Sbjct: 26 LGDGSFGVVRRGEWDAPS-------GKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 78
Query: 85 RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSF 144
H NL++L G +V E P GSL + L RK T + A+ VA G+ +
Sbjct: 79 DHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRL-RKHQGHFLLGTLSRYAVQVAEGMGY 136
Query: 145 LHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR---GYAA 201
L I+RDL A N+LL + K+ DFGL R P D+ +V + + A
Sbjct: 137 LE--SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE--HRKVPFAWCA 192
Query: 202 PEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLR-DSRRV 259
PE + T + SD + FGV L E+ + G+ P++ + ++
Sbjct: 193 PESLKTRTFSHASDTWMFGVTLWEMFTYGQE-------------------PWIGLNGSQI 233
Query: 260 LRIMDTRLGGQYSKKEA--QAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 310
L +D + G + + E Q + V++QC P++RP+ V + L + +
Sbjct: 234 LHKID-KEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT 285
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 4e-46
Identities = 68/312 (21%), Positives = 138/312 (44%), Gaps = 41/312 (13%)
Query: 9 DPSASMISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF 68
P+ +++ + F +LG G FG V+KG + P I VAIK L+ +
Sbjct: 3 APNQALLRILKETEFKKIKVLGSGAFGTVYKG-----LWIPEGEKVKIPVAIKELREATS 57
Query: 69 QGHK-EWLTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPIS 127
E L E + + + ++ +L+G C L+ + MP G L +++ R+ I
Sbjct: 58 PKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYV-REHKDNIG 115
Query: 128 WPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNT 187
+ + +A+G+++L D +++RDL A NVL+ + + K++DFGLA+ +
Sbjct: 116 SQYLLNWCVQIAKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 173
Query: 188 HVSTRIVGTR---GYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQ 243
+ + G + + A E + T +SDV+S+GV + EL++ G +
Sbjct: 174 YHAE---GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK------------ 218
Query: 244 TLVEWADPFL-RDSRRVLRIMDTRLGGQYSKKEA--QAVAAVVLQCLHMDPKNRPSMVDV 300
P+ + + I++ G + + V ++++C +D +RP ++
Sbjct: 219 -------PYDGIPASEISSILEK--GERLPQPPICTIDVYMIMVKCWMIDADSRPKFREL 269
Query: 301 LTSLEQLHTSKD 312
+ ++
Sbjct: 270 IIEFSKMARDPQ 281
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 4e-46
Identities = 79/295 (26%), Positives = 126/295 (42%), Gaps = 48/295 (16%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAE-SFQGHKEWLTEVIYLGQLRHE 87
+G G FGCV+ G G I A+K L ++LTE I + H
Sbjct: 97 IGRGHFGCVYHG------TLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHP 150
Query: 88 NLVKLIGYCSESDN-RLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLH 146
N++ L+G C S+ L+V +M G L N + R + + + VA+G+ FL
Sbjct: 151 NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQVAKGMKFLA 209
Query: 147 GLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVG------TRGYA 200
++RDL A N +LD F K++DFGLARD + V +
Sbjct: 210 --SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM---- 263
Query: 201 APEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRG-----GLAEQTLVEWADPFLRD 255
A E + T T KSDV+SFGV+L EL++ RG + + +L
Sbjct: 264 ALESLQTQKFTTKSDVWSFGVLLWELMT--------RGAPPYPDVNTFDITV----YLLQ 311
Query: 256 SRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 310
RR+L+ + V+L+C H + RPS ++++ + + ++
Sbjct: 312 GRRLLQPEYCP----------DPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 356
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 5e-46
Identities = 82/297 (27%), Positives = 139/297 (46%), Gaps = 34/297 (11%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAE-SFQGHKEWLTEVIYLGQLRHE 87
+G G FG V G I VAIK LK + + +++L E +GQ H
Sbjct: 53 VGAGEFGEVCSGR------LKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 106
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHG 147
N+++L G ++S ++V E+M GSL++ L RK + V + +A G+ +L
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-RKHDAQFTVIQLVGMLRGIASGMKYLS- 164
Query: 148 LDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR---GYAAPEY 204
D ++RDL A N+L++SN K+SDFGL R D+ + G + + +PE
Sbjct: 165 -DMGYVHRDLAARNILINSNLVCKVSDFGLGRV--LEDDPEAAYTTRGGKIPIRWTSPEA 221
Query: 205 VATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIM 263
+A T SDV+S+G+VL E++S G R ++ Q +++ + + R+ M
Sbjct: 222 IAYRKFTSASDVWSYGIVLWEVMSYGERPY----WEMSNQDVIK----AVDEGYRLPPPM 273
Query: 264 DTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDMPRTPPPA 320
D A+ ++L C D NRP +++ L++L + + A
Sbjct: 274 DC----------PAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSA 320
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 156 bits (398), Expect = 6e-46
Identities = 71/291 (24%), Positives = 135/291 (46%), Gaps = 45/291 (15%)
Query: 29 LGEGGFGCVFKG-WIDQNTFAPTKPGSGIVVAIKRLKAE-SFQGHKEWLTEVIYLGQLRH 86
LGEG FG V++G + + G I VA+K K + + +++++E + + L H
Sbjct: 20 LGEGFFGEVYEGVYTNHK-------GEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDH 72
Query: 87 ENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLH 146
++VKLIG E + ++ E P G L ++L + + T V ++ + + +++L
Sbjct: 73 PHIVKLIGIIEE-EPTWIIMELYPYGELGHYL-ERNKNSLKVLTLVLYSLQICKAMAYLE 130
Query: 147 GLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR---GYAAPE 203
N ++RD+ N+L+ S KL DFGL+R D + TR + +PE
Sbjct: 131 --SINCVHRDIAVRNILVASPECVKLGDFGLSRY--IEDEDYYKAS--VTRLPIKWMSPE 184
Query: 204 YVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFL-RDSRRVLR 261
+ T SDV+ F V + E+LS G++ PF +++ V+
Sbjct: 185 SINFRRFTTASDVWMFAVCMWEILSFGKQ-------------------PFFWLENKDVIG 225
Query: 262 IMDTRLGGQYSKKEA--QAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 310
+++ G + K + + ++ +C DP +RP +++ SL ++
Sbjct: 226 VLEK--GDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 9e-46
Identities = 77/303 (25%), Positives = 135/303 (44%), Gaps = 56/303 (18%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAE--SFQGHKEWLTEVIYLGQLRH 86
LGEG FG V +G + G+ + VA+K +K + S + +E+L+E + H
Sbjct: 42 LGEGEFGSVMEG------NLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSH 95
Query: 87 ENLVKLIGYCSESDNR-----LLVYEFMPKGSLENHL----FRKGVQPISWPTRVKIAID 137
N+++L+G C E ++ +++ FM G L +L G + I T +K +D
Sbjct: 96 PNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVD 155
Query: 138 VARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR 197
+A G+ +L + N ++RDL A N +L + ++DFGL++ +GD G
Sbjct: 156 IALGMEYLS--NRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYR-----QGRI 208
Query: 198 G-----YAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRG-----GLAEQTLVE 247
+ A E +A T KSDV++FGV + E+ + RG G+ + +
Sbjct: 209 AKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT--------RGMTPYPGVQNHEMYD 260
Query: 248 WADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 307
+L R+ + D + ++ C DP +RP+ + LE+L
Sbjct: 261 ----YLLHGHRLKQPEDCL----------DELYEIMYSCWRTDPLDRPTFSVLRLQLEKL 306
Query: 308 HTS 310
S
Sbjct: 307 LES 309
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 1e-45
Identities = 71/287 (24%), Positives = 130/287 (45%), Gaps = 35/287 (12%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES-FQGHKEWLTEVIYLGQLRHE 87
LG G FG V KG + P I V IK ++ +S Q + ++ +G L H
Sbjct: 21 LGSGVFGTVHKG-----VWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHA 75
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHG 147
++V+L+G C S + LV +++P GSL +H+ R+ + + + +A+G+ +L
Sbjct: 76 HIVRLLGLCPGS-SLQLVTQYLPLGSLLDHV-RQHRGALGPQLLLNWGVQIAKGMYYLE- 132
Query: 148 LDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR---GYAAPEY 204
+ +++R+L A NVLL S +++DFG+A P D + + + + A E
Sbjct: 133 -EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYS---EAKTPIKWMALES 188
Query: 205 VATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIM 263
+ G T +SDV+S+GV + EL++ G GL + + L R+ +
Sbjct: 189 IHFGKYTHQSDVWSYGVTVWELMTFGAEPYA----GLRLAEVPD----LLEKGERLAQPQ 240
Query: 264 DTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 310
V V+++C +D RP+ ++ ++
Sbjct: 241 ICT----------IDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 2e-45
Identities = 74/293 (25%), Positives = 137/293 (46%), Gaps = 46/293 (15%)
Query: 29 LGEGGFGCVFKG-WIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHE 87
LG G +G V++G W + VA+K LK ++ + +E+L E + +++H
Sbjct: 21 LGGGQYGEVYEGVWKKYSL----------TVAVKTLKEDTME-VEEFLKEAAVMKEIKHP 69
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHG 147
NLV+L+G C+ ++ EFM G+L ++L Q +S + +A ++ + +L
Sbjct: 70 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE- 128
Query: 148 LDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR---GYAAPEY 204
N I+RDL A N L+ N K++DFGL+R +T+ + G + + APE
Sbjct: 129 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRL--MTGDTYTAHA--GAKFPIKWTAPES 183
Query: 205 VATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLR-DSRRVLRI 262
+A + KSDV++FGV+L E+ + G P+ D +V +
Sbjct: 184 LAYNKFSIKSDVWAFGVLLWEIATYGMS-------------------PYPGIDLSQVYEL 224
Query: 263 MDTRLGGQYSKKEA--QAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDM 313
++ + + E + V ++ C +P +RPS ++ + E + +
Sbjct: 225 LEK--DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSI 275
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 161 bits (408), Expect = 2e-45
Identities = 74/290 (25%), Positives = 134/290 (46%), Gaps = 40/290 (13%)
Query: 29 LGEGGFGCVFKG-WIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHE 87
LG G +G V++G W + VA+K LK ++ + +E+L E + +++H
Sbjct: 228 LGGGQYGEVYEGVW----------KKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHP 276
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHG 147
NLV+L+G C+ ++ EFM G+L ++L Q +S + +A ++ + +L
Sbjct: 277 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE- 335
Query: 148 LDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT 207
N I+R+L A N L+ N K++DFGL+R TGD + APE +A
Sbjct: 336 -KKNFIHRNLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPESLAY 393
Query: 208 GHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLR-DSRRVLRIMDT 265
+ KSDV++FGV+L E+ + G P+ D +V +++
Sbjct: 394 NKFSIKSDVWAFGVLLWEIATYGMS-------------------PYPGIDLSQVYELLEK 434
Query: 266 RLGGQYSKKEA--QAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDM 313
+ + E + V ++ C +P +RPS ++ + E + +
Sbjct: 435 --DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSI 482
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 2e-45
Identities = 83/291 (28%), Positives = 135/291 (46%), Gaps = 54/291 (18%)
Query: 29 LGEGGFGCVFKG-WIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHE 87
+G+G FG V G + G VA+K +K ++ + +L E + QLRH
Sbjct: 201 IGKGEFGDVMLGDY------------RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHS 246
Query: 88 NLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLH 146
NLV+L+G E L +V E+M KGSL ++L +G + +K ++DV + +L
Sbjct: 247 NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 306
Query: 147 GLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR---GYAAPE 203
N ++RDL A NVL+ + AK+SDFGL ++ S+ + + APE
Sbjct: 307 --GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKE--------ASSTQDTGKLPVKWTAPE 356
Query: 204 YVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLR-DSRRVLR 261
+ + KSDV+SFG++L E+ S GR P+ R + V+
Sbjct: 357 ALREKKFSTKSDVWSFGILLWEIYSFGRV-------------------PYPRIPLKDVVP 397
Query: 262 IMDTRLGGQYSKKEA--QAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 310
++ G + + AV V+ C H+D RP+ + + LE + T
Sbjct: 398 RVEK--GYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 2e-45
Identities = 79/295 (26%), Positives = 125/295 (42%), Gaps = 48/295 (16%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAE-SFQGHKEWLTEVIYLGQLRHE 87
+G+G FG V+ G + + I AIK L Q + +L E + + L H
Sbjct: 29 IGKGHFGVVYHG------EYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHP 82
Query: 88 NLVKLIGYCSESDNRLL-VYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLH 146
N++ LIG + + +M G L + R + + + + VARG+ +L
Sbjct: 83 NVLALIGIMLPPEGLPHVLLPYMCHGDLLQFI-RSPQRNPTVKDLISFGLQVARGMEYLA 141
Query: 147 GLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVG------TRGYA 200
+ ++RDL A N +LD +F K++DFGLARD + V T
Sbjct: 142 --EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWT---- 195
Query: 201 APEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRG-----GLAEQTLVEWADPFLRD 255
A E + T T KSDV+SFGV+L ELL+ RG + L FL
Sbjct: 196 ALESLQTYRFTTKSDVWSFGVLLWELLT--------RGAPPYRHIDPFDLTH----FLAQ 243
Query: 256 SRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 310
RR+ + ++ V+ QC DP RP+ ++ +EQ+ ++
Sbjct: 244 GRRLPQPEYCP----------DSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSA 288
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 3e-45
Identities = 86/295 (29%), Positives = 136/295 (46%), Gaps = 42/295 (14%)
Query: 29 LGEGGFGCVFKG-WIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHE 87
LG+G FG V+ G W VAIK LK + +L E + +LRHE
Sbjct: 192 LGQGCFGEVWMGTWNGT-----------TRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHE 239
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHG 147
LV+L SE + +V E+M KGSL + L + + + P V +A +A G++++
Sbjct: 240 KLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE- 297
Query: 148 LDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT 207
N ++RDL+A+N+L+ N K++DFGLAR + T + + APE
Sbjct: 298 -RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-WTAPEAALY 355
Query: 208 GHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLR-DSRRVLRIMDT 265
G T KSDV+SFG++L EL + GR P+ +R VL ++
Sbjct: 356 GRFTIKSDVWSFGILLTELTTKGRV-------------------PYPGMVNREVLDQVER 396
Query: 266 RLGGQYSKKEA--QAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDMPRTPP 318
G + +++ ++ QC +P+ RP+ + LE TS + P
Sbjct: 397 --GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 449
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 3e-45
Identities = 84/291 (28%), Positives = 135/291 (46%), Gaps = 54/291 (18%)
Query: 29 LGEGGFGCVFKG-WIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHE 87
+G+G FG V G + G VA+K +K ++ + +L E + QLRH
Sbjct: 29 IGKGEFGDVMLGDY------------RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHS 74
Query: 88 NLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLH 146
NLV+L+G E L +V E+M KGSL ++L +G + +K ++DV + +L
Sbjct: 75 NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 134
Query: 147 GLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR---GYAAPE 203
N ++RDL A NVL+ + AK+SDFGL ++ S+ + + APE
Sbjct: 135 --GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKE--------ASSTQDTGKLPVKWTAPE 184
Query: 204 YVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLR-DSRRVLR 261
+ + KSDV+SFG++L E+ S GR P+ R + V+
Sbjct: 185 ALREKKFSTKSDVWSFGILLWEIYSFGRV-------------------PYPRIPLKDVVP 225
Query: 262 IMDTRLGGQYSKKEA--QAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 310
++ G + + AV V+ C H+D RPS + + LE + T
Sbjct: 226 RVEK--GYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 5e-45
Identities = 77/304 (25%), Positives = 126/304 (41%), Gaps = 50/304 (16%)
Query: 29 LGEGGFGCVFKG-WIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHE 87
LGEG FG VF + ++VA+K LK S +++ E L L+H+
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDK-----MLVAVKALKEASESARQDFQREAELLTMLQHQ 103
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHL-------------FRKGVQPISWPTRVKI 134
++V+ G C+E L+V+E+M G L L P+ + +
Sbjct: 104 HIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 163
Query: 135 AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 194
A VA G+ +L + ++RDL N L+ K+ DFG++RD + D V
Sbjct: 164 ASQVAAGMVYLA--GLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYR-----V 216
Query: 195 GTRG-----YAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEW 248
G R + PE + T +SDV+SFGVVL E+ + G++ L+ ++
Sbjct: 217 GGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPW----YQLSNTEAID- 271
Query: 249 ADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLH 308
+ R + R V A++ C +P+ R S+ DV L+ L
Sbjct: 272 ---CITQGRELERPRACP----------PEVYAIMRGCWQREPQQRHSIKDVHARLQALA 318
Query: 309 TSKD 312
+
Sbjct: 319 QAPP 322
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 5e-45
Identities = 79/288 (27%), Positives = 129/288 (44%), Gaps = 48/288 (16%)
Query: 29 LGEGGFGCVFKG-WIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHE 87
LG G FG V G W Q VA+K +K E E+ E + +L H
Sbjct: 16 LGSGQFGVVKLGKWKGQ-----------YDVAVKMIK-EGSMSEDEFFQEAQTMMKLSHP 63
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHG 147
LVK G CS+ +V E++ G L N+L R + + +++ DV G++FL
Sbjct: 64 KLVKFYGVCSKEYPIYIVTEYISNGCLLNYL-RSHGKGLEPSQLLEMCYDVCEGMAFLE- 121
Query: 148 LDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR---GYAAPEY 204
I+RDL A N L+D + K+SDFG+ R D+ +VS+ GT+ ++APE
Sbjct: 122 -SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRY--VLDDQYVSSV--GTKFPVKWSAPEV 176
Query: 205 VATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDS-RRVLRI 262
+ KSDV++FG+++ E+ S G+ P+ + V+
Sbjct: 177 FHYFKYSSKSDVWAFGILMWEVFSLGKM-------------------PYDLYTNSEVVLK 217
Query: 263 MDTRLGGQYSKKEA--QAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLH 308
+ G + + + ++ C H P+ RP+ +L+S+E L
Sbjct: 218 VSQ--GHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLR 263
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 1e-44
Identities = 71/299 (23%), Positives = 134/299 (44%), Gaps = 54/299 (18%)
Query: 29 LGEGGFGCVFKG-WIDQNTFAPTKPGSGIVVAIKRLKAE-SFQGHKEWLTEVIYLGQLRH 86
LG+G FG V++G K VAIK + S + E+L E + +
Sbjct: 33 LGQGSFGMVYEGVAKG-----VVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNC 87
Query: 87 ENLVKLIGYCSESDNRLLVYEFMPKGSLENHL--------FRKGVQPISWPTRVKIAIDV 138
++V+L+G S+ L++ E M +G L+++L + P S +++A ++
Sbjct: 88 HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEI 147
Query: 139 ARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRG 198
A G+++L+ ++RDL A N ++ +F K+ DFG+ RD D G +G
Sbjct: 148 ADGMAYLNAN--KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR-----KGGKG 200
Query: 199 Y-----AAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRG-----GLAEQTLVEW 248
+PE + G T SDV+SFGVVL E+ + GL+ + ++
Sbjct: 201 LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT--------LAEQPYQGLSNEQVLR- 251
Query: 249 ADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 307
F+ + + + + + ++ C +PK RPS +++++S+++
Sbjct: 252 ---FVMEGGLLDKPDNCP----------DMLFELMRMCWQYNPKMRPSFLEIISSIKEE 297
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 2e-44
Identities = 72/287 (25%), Positives = 124/287 (43%), Gaps = 48/287 (16%)
Query: 29 LGEGGFGCVFKG-WIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHE 87
LG G FG V G W Q VAIK +K E E++ E + L HE
Sbjct: 32 LGTGQFGVVKYGKWRGQ-----------YDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHE 79
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHG 147
LV+L G C++ ++ E+M G L N+L R+ +++ DV + +L
Sbjct: 80 KLVQLYGVCTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLE- 137
Query: 148 LDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR---GYAAPEY 204
++RDL A N L++ K+SDFGL+R D+ + T VG++ ++ PE
Sbjct: 138 -SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRY--VLDDEY--TSSVGSKFPVRWSPPEV 192
Query: 205 VATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDS-RRVLRI 262
+ + KSD+++FGV++ E+ S G+ P+ R +
Sbjct: 193 LMYSKFSSKSDIWAFGVLMWEIYSLGKM-------------------PYERFTNSETAEH 233
Query: 263 MDTRLGGQYSKKEA--QAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 307
+ G + + + V ++ C H RP+ +L+++ +
Sbjct: 234 IAQ--GLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 278
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 2e-44
Identities = 78/316 (24%), Positives = 126/316 (39%), Gaps = 54/316 (17%)
Query: 29 LGEGGFGCVFKG-WIDQNTFAPTKPGSGIVVAIKRLKAE-SFQGHKEWLTEVIYLGQLRH 86
LG G FG V++G S + VA+K L S Q ++L E + + + H
Sbjct: 38 LGHGAFGEVYEGQVSGMP-----NDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNH 92
Query: 87 ENLVKLIGYCSESDNRLLVYEFMPKGSLENHL-----FRKGVQPISWPTRVKIAIDVARG 141
+N+V+ IG +S R ++ E M G L++ L ++ + +A D+A G
Sbjct: 93 QNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 152
Query: 142 LSFLHGLDANVIYRDLKASNVLLD---SNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRG 198
+L + + I+RD+ A N LL AK+ DFG+ARD G
Sbjct: 153 CQYLE--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS-----YYRKGGCA 205
Query: 199 Y-----AAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRG-----GLAEQTLVEW 248
PE G T K+D +SFGV+L E+ S G + Q ++E
Sbjct: 206 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS--------LGYMPYPSKSNQEVLE- 256
Query: 249 ADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLH 308
F+ R+ + V ++ QC P++RP+ +L +E
Sbjct: 257 ---FVTSGGRMDPPKNCP----------GPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303
Query: 309 TSKDMPRTPPPAKLHH 324
D+ T P +
Sbjct: 304 QDPDVINTALPIEYGP 319
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 6e-44
Identities = 86/295 (29%), Positives = 136/295 (46%), Gaps = 42/295 (14%)
Query: 29 LGEGGFGCVFKG-WIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHE 87
LG+G FG V+ G W VAIK LK + +L E + +LRHE
Sbjct: 275 LGQGCFGEVWMGTWNGTTR-----------VAIKTLK-PGTMSPEAFLQEAQVMKKLRHE 322
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHG 147
LV+L SE + +V E+M KGSL + L + + + P V +A +A G++++
Sbjct: 323 KLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE- 380
Query: 148 LDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT 207
N ++RDL+A+N+L+ N K++DFGLAR + T + + APE
Sbjct: 381 -RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-WTAPEAALY 438
Query: 208 GHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLR-DSRRVLRIMDT 265
G T KSDV+SFG++L EL + GR P+ +R VL ++
Sbjct: 439 GRFTIKSDVWSFGILLTELTTKGRV-------------------PYPGMVNREVLDQVER 479
Query: 266 RLGGQYSKKEA--QAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDMPRTPP 318
G + +++ ++ QC +P+ RP+ + LE TS + P
Sbjct: 480 --GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 532
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 6e-44
Identities = 70/290 (24%), Positives = 120/290 (41%), Gaps = 43/290 (14%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAE-SFQGHKEWLTEVIYLGQLRHE 87
+GEG FG V +G + + VAIK K S +++L E + + Q H
Sbjct: 23 IGEGQFGDVHQG------IYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 76
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHG 147
++VKLIG +E+ ++ E G L + L + + + + A ++ L++L
Sbjct: 77 HIVKLIGVITEN-PVWIIMELCTLGELRSFL-QVRKYSLDLASLILYAYQLSTALAYLE- 133
Query: 148 LDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR---GYAAPEY 204
++RD+ A NVL+ SN KL DFGL+R D+T+ + + APE
Sbjct: 134 -SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKAS--KGKLPIKWMAPES 188
Query: 205 VATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDS-RRVLRI 262
+ T SDV+ FGV + E+L G + PF V+
Sbjct: 189 INFRRFTSASDVWMFGVCMWEILMHGVK-------------------PFQGVKNNDVIGR 229
Query: 263 MDTRLGGQYSKKEA--QAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 310
++ G + + +++ +C DP RP ++ L +
Sbjct: 230 IEN--GERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 8e-44
Identities = 75/305 (24%), Positives = 128/305 (41%), Gaps = 55/305 (18%)
Query: 29 LGEGGFGCVFKG-WIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHE 87
LGEG FG VF + + ++VA+K LK + K++ E L L+HE
Sbjct: 23 LGEGAFGKVFLAECYN-----LSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHE 77
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHL--------------FRKGVQPISWPTRVK 133
++VK G C + D ++V+E+M G L L R+ + +
Sbjct: 78 HIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 137
Query: 134 IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRI 193
IA +A G+ +L + ++RDL N L+ +N K+ DFG++RD + D
Sbjct: 138 IASQIASGMVYLA--SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYR----- 190
Query: 194 VGTRG-----YAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEW 248
VG + PE + T +SDV+SFGV+L E+ + +Q
Sbjct: 191 VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT-----------YGKQ----- 234
Query: 249 ADPF-LRDSRRVLRIMDTRLGGQYSKKEA--QAVAAVVLQCLHMDPKNRPSMVDVLTSLE 305
P+ + V+ + G + + V V+L C +P+ R ++ ++ L
Sbjct: 235 --PWFQLSNTEVIECITQ--GRVLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYKILH 290
Query: 306 QLHTS 310
L +
Sbjct: 291 ALGKA 295
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 3e-43
Identities = 77/299 (25%), Positives = 141/299 (47%), Gaps = 53/299 (17%)
Query: 29 LGEGGFGCVFKG-WIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHE 87
LG G FG V+ + VA+K +K + +L E + L+H+
Sbjct: 196 LGAGQFGEVWMATYNKHTK-----------VAVKTMK-PGSMSVEAFLAEANVMKTLQHD 243
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHG 147
LVKL ++ + ++ EFM KGSL + L P + + +A G++F+
Sbjct: 244 KLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE- 301
Query: 148 LDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRG---YAAPEY 204
N I+RDL+A+N+L+ ++ K++DFGLAR DN + T G + + APE
Sbjct: 302 -QRNYIHRDLRAANILVSASLVCKIADFGLARV--IEDNEY--TAREGAKFPIKWTAPEA 356
Query: 205 VATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLR-DSRRVLRI 262
+ G T KSDV+SFG++L+E+++ GR P+ + V+R
Sbjct: 357 INFGSFTIKSDVWSFGILLMEIVTYGRI-------------------PYPGMSNPEVIRA 397
Query: 263 MDTRLGGQYSKKEA--QAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS-----KDMP 314
++ G + + E + + ++++C P+ RP+ + + L+ +T+ +++P
Sbjct: 398 LER--GYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATESQYEEIP 454
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 3e-43
Identities = 78/299 (26%), Positives = 140/299 (46%), Gaps = 48/299 (16%)
Query: 29 LGEGGFGCVFKG-WIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHE 87
LG G FG V+ G + VA+K LK S +L E + QL+H+
Sbjct: 21 LGAGQFGEVWMGYYNGHTK-----------VAVKSLKQGSMS-PDAFLAEANLMKQLQHQ 68
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHG 147
LV+L ++ + ++ E+M GSL + L ++ + +A +A G++F+
Sbjct: 69 RLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE- 126
Query: 148 LDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR---GYAAPEY 204
+ N I+RDL+A+N+L+ + K++DFGLAR DN + T G + + APE
Sbjct: 127 -ERNYIHRDLRAANILVSDTLSCKIADFGLARL--IEDNEY--TAREGAKFPIKWTAPEA 181
Query: 205 VATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLR-DSRRVLRI 262
+ G T KSDV+SFG++L E+++ GR P+ + V++
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVTHGRI-------------------PYPGMTNPEVIQN 222
Query: 263 MDTRLGGQYSKKEA--QAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDMPRTPPP 319
++ G + + + + + ++ C P++RP+ + + LE T+ + P P
Sbjct: 223 LER--GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQYQPQP 279
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 4e-43
Identities = 78/307 (25%), Positives = 125/307 (40%), Gaps = 46/307 (14%)
Query: 29 LGEGGFGCVFKG-WIDQNTFAPTKPGSGIVVAIKRLKAE-SFQGHKEWLTEVIYLGQLRH 86
LG G FG V++G S + VA+K L S Q ++L E + + + H
Sbjct: 79 LGHGAFGEVYEGQVSGMP-----NDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNH 133
Query: 87 ENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGV-----QPISWPTRVKIAIDVARG 141
+N+V+ IG +S R ++ E M G L++ L ++ + +A D+A G
Sbjct: 134 QNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 193
Query: 142 LSFLHGLDANVIYRDLKASNVLLD---SNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRG 198
+L + + I+RD+ A N LL AK+ DFG+ARD G
Sbjct: 194 CQYLE--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYR-----KGGCA 246
Query: 199 Y-----AAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPF 252
PE G T K+D +SFGV+L E+ S G + Q ++E F
Sbjct: 247 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY----PSKSNQEVLE----F 298
Query: 253 LRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKD 312
+ R+ + V ++ QC P++RP+ +L +E D
Sbjct: 299 VTSGGRMDPPKNCP----------GPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD 348
Query: 313 MPRTPPP 319
+ T P
Sbjct: 349 VINTALP 355
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 155 bits (392), Expect = 2e-42
Identities = 68/286 (23%), Positives = 116/286 (40%), Gaps = 35/286 (12%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAE-SFQGHKEWLTEVIYLGQLRHE 87
+GEG FG V +G + + VAIK K S +++L E + + Q H
Sbjct: 398 IGEGQFGDVHQG------IYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 451
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHG 147
++VKLIG +E + ++ E G L + L + + + + A ++ L++L
Sbjct: 452 HIVKLIGVITE-NPVWIIMELCTLGELRSFL-QVRKFSLDLASLILYAYQLSTALAYLE- 508
Query: 148 LDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT 207
++RD+ A NVL+ SN KL DFGL+R S + + APE +
Sbjct: 509 -SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM-APESINF 566
Query: 208 GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDS-RRVLRIMDTR 266
T SDV+ FGV + E+L + PF V+ ++
Sbjct: 567 RRFTSASDVWMFGVCMWEILM-----------HGVK-------PFQGVKNNDVIGRIEN- 607
Query: 267 LGGQYSKKEA--QAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 310
G + + +++ +C DP RP ++ L +
Sbjct: 608 -GERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 3e-42
Identities = 66/280 (23%), Positives = 102/280 (36%), Gaps = 46/280 (16%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKE---WLTEVIYLGQL 84
LG G +G VFK G + A+KR + F+G K+ L EV ++
Sbjct: 64 RLGHGSYGEVFKV---------RSKEDGRLYAVKRSMSP-FRGPKDRARKLAEVGSHEKV 113
Query: 85 -RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLS 143
+H V+L E L E SL+ H G + D L+
Sbjct: 114 GQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALA 171
Query: 144 FLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPE 203
LH +++ D+K +N+ L KL DFGL + T V G Y APE
Sbjct: 172 HLH--SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV---QEGDPRYMAPE 226
Query: 204 YVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLR-- 261
+ + +DV+S G+ +LE+ P + + LR
Sbjct: 227 LLQGSY-GTAADVFSLGLTILEVACNMEL------------------PHGGEGWQQLRQG 267
Query: 262 IMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL 301
+ S E + +V++ L DPK R + +L
Sbjct: 268 YLPPEFTAGLS-SELR---SVLVMMLEPDPKLRATAEALL 303
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 3e-42
Identities = 72/291 (24%), Positives = 123/291 (42%), Gaps = 44/291 (15%)
Query: 29 LGEGGFGCVFKG-WIDQNTFAPTKPGSGIVVAIKRLKAE-SFQGHKEWLTEVIYLGQLRH 86
LG G FG V +G + I VAIK LK +E + E + QL +
Sbjct: 344 LGCGNFGSVRQGVY--------RMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDN 395
Query: 87 ENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLH 146
+V+LIG C + +LV E G L L K + I ++ V+ G+ +L
Sbjct: 396 PYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQVSMGMKYLE 453
Query: 147 GLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR---GYAAPE 203
+ N ++R+L A NVLL + AK+SDFGL++ D+ + + + + APE
Sbjct: 454 --EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR--SAGKWPLKWYAPE 509
Query: 204 YVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLR-DSRRVLR 261
+ + +SDV+S+GV + E LS G++ P+ + V+
Sbjct: 510 CINFRKFSSRSDVWSYGVTMWEALSYGQK-------------------PYKKMKGPEVMA 550
Query: 262 IMDTRLGGQYSKKEA--QAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 310
++ G + + A++ C ++RP + V + + S
Sbjct: 551 FIEQ--GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 599
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 4e-42
Identities = 72/306 (23%), Positives = 122/306 (39%), Gaps = 61/306 (19%)
Query: 16 SKIATKNFCSDY----LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGH 71
+ K F D+ L+G GGFG VFK + G IKR+K +
Sbjct: 2 AHTVDKRFGMDFKEIELIGSGGFGQVFKA-KHRID--------GKTYVIKRVKYNN---- 48
Query: 72 KEWLTEVIYLGQLRHENLVKLIGYCSESDNRL----------------LVYEFMPKGSLE 115
++ EV L +L H N+V G D + EF KG+LE
Sbjct: 49 EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLE 108
Query: 116 NHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDF 175
+ ++ + + +++ + +G+ ++H +I RDLK SN+ L K+ DF
Sbjct: 109 QWIEKRRGEKLDKVLALELFEQITKGVDYIH--SKKLINRDLKPSNIFLVDTKQVKIGDF 166
Query: 176 GLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDE 235
GL + N TR GT Y +PE +++ + D+Y+ G++L ELL
Sbjct: 167 GLVT---SLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD---- 219
Query: 236 DRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRP 295
S+ + D + + KKE ++ + L P++RP
Sbjct: 220 ---------------TAFETSKFFTDLRDGIISDIFDKKEKT----LLQKLLSKKPEDRP 260
Query: 296 SMVDVL 301
+ ++L
Sbjct: 261 NTSEIL 266
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 4e-42
Identities = 85/311 (27%), Positives = 130/311 (41%), Gaps = 65/311 (20%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAE-SFQGHKEWLTEVIYLGQL-R 85
++GEG FG V K I K G + AIKR+K S H+++ E+ L +L
Sbjct: 32 VIGEGNFGQVLKARIK-------KDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 84
Query: 86 HENLVKLIGYCSESDNRLLVYEFMPKGSLENHL--------------FRKGVQPISWPTR 131
H N++ L+G C L E+ P G+L + L +S
Sbjct: 85 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 132 VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVST 191
+ A DVARG+ +L I+RDL A N+L+ N+ AK++DFGL+R +V
Sbjct: 145 LHFAADVARGMDYLS--QKQFIHRDLAARNILVGENYVAKIADFGLSRG----QEVYVKK 198
Query: 192 RIVGTRG-----YAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRG-----GLA 241
T G + A E + T SDV+S+GV+L E++S G G+
Sbjct: 199 ----TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS--------LGGTPYCGMT 246
Query: 242 EQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL 301
L E L R+ + ++ V ++ QC P RPS +L
Sbjct: 247 CAELYE----KLPQGYRLEKPLNCD----------DEVYDLMRQCWREKPYERPSFAQIL 292
Query: 302 TSLEQLHTSKD 312
SL ++ +
Sbjct: 293 VSLNRMLEERK 303
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 3e-41
Identities = 75/301 (24%), Positives = 124/301 (41%), Gaps = 50/301 (16%)
Query: 29 LGEGGFGCVFKG-WIDQNTFAPTKPGSGIVVAIKRLKAE-SFQGHKEWLTEVIYLGQLRH 86
LGE FG V+KG T+ VAIK LK + +E+ E + +L+H
Sbjct: 17 LGEDRFGKVYKGHLFGPAPGEQTQA-----VAIKTLKDKAEGPLREEFRHEAMLRARLQH 71
Query: 87 ENLVKLIGYCSESDNRLLVYEFMPKGSLENHL--------------FRKGVQPISWPTRV 132
N+V L+G ++ +++ + G L L R + P V
Sbjct: 72 PNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV 131
Query: 133 KIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR 192
+ +A G+ +L +V+++DL NVL+ N K+SD GL R+ D +
Sbjct: 132 HLVAQIAAGMEYLS--SHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGN 189
Query: 193 ----IVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVE 247
I APE + G + SD++S+GVVL E+ S G + G + Q +VE
Sbjct: 190 SLLPIRWM----APEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPY----CGYSNQDVVE 241
Query: 248 WADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 307
+R+ + + D V A++++C + P RP D+ + L
Sbjct: 242 ----MIRNRQVLPCPDDCP----------AWVYALMIECWNEFPSRRPRFKDIHSRLRAW 287
Query: 308 H 308
Sbjct: 288 G 288
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 3e-41
Identities = 76/335 (22%), Positives = 129/335 (38%), Gaps = 52/335 (15%)
Query: 8 SDPSASMISKIATKNFCSDY----LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRL 63
+ N +++ +G G F V++ G+ VA+K++
Sbjct: 15 QFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRA---------ACLLDGVPVALKKV 65
Query: 64 KAESFQGHKE---WLTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHL-- 118
+ K + E+ L QL H N++K E + +V E G L +
Sbjct: 66 QIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKH 125
Query: 119 FRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 178
F+K + I T K + + L +H V++RD+K +NV + + KL D GL
Sbjct: 126 FKKQKRLIPERTVWKYFVQLCSALEHMH--SRRVMHRDIKPANVFITATGVVKLGDLGLG 183
Query: 179 RDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRG 238
R T + +VGT Y +PE + KSD++S G +L E+ + + D+
Sbjct: 184 RF--FSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM 241
Query: 239 GLAEQTLVEWADPFLRDSRRVLRIMDTR----LGGQYSKKEAQAVAAVVLQCLHMDPKNR 294
L L +I YS + + +V C++ DP+ R
Sbjct: 242 NL----------YSL-----CKKIEQCDYPPLPSDHYS----EELRQLVNMCINPDPEKR 282
Query: 295 PSMVDVLTSLEQLHTSKDMPRTPPPAKLHHHHHHH 329
P + V +++H + L HHHHHH
Sbjct: 283 PDVTYVYDVAKRMHACTA-------SSLEHHHHHH 310
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 9e-41
Identities = 76/318 (23%), Positives = 131/318 (41%), Gaps = 77/318 (24%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAE-SFQGHKEWLTEVIYLGQL-RH 86
LGEG FG V KP + VA+K LK + + + + ++E+ + + +H
Sbjct: 43 LGEGAFGQVVMAEA--VGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 87 ENLVKLIGYCSESDNRLLVYEFMPKGSLENHL--------------FRKGVQPISWPTRV 132
+N++ L+G C++ ++ E+ KG+L +L R + +++ V
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 133 KIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR 192
+ARG+ +L I+RDL A NVL+ N K++DFGLARD D
Sbjct: 161 SCTYQLARGMEYLA--SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDY-----Y 213
Query: 193 IVGTRG-----YAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRG-----GLAE 242
T G + APE + T +SDV+SFGV++ E+ + G G+
Sbjct: 214 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT--------LGGSPYPGIPV 265
Query: 243 QTLVEWADPFLRDSRR----------VLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPK 292
+ L + L++ R + +M C H P
Sbjct: 266 EELFK----LLKEGHRMDKPANCTNELYMMM--------------------RDCWHAVPS 301
Query: 293 NRPSMVDVLTSLEQLHTS 310
RP+ ++ L+++ T
Sbjct: 302 QRPTFKQLVEDLDRILTL 319
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 1e-40
Identities = 78/311 (25%), Positives = 135/311 (43%), Gaps = 63/311 (20%)
Query: 29 LGEGGFGCVFKG-WIDQNTFAPTKPGSGIVVAIKRLKAE-SFQGHKEWLTEVIYLGQL-R 85
LGEG FG V + KP + VA+K LK + + + + ++E+ + + +
Sbjct: 89 LGEGCFGQVVMAEAVG---IDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 145
Query: 86 HENLVKLIGYCSESDNRLLVYEFMPKGSLENHL--------------FRKGVQPISWPTR 131
H+N++ L+G C++ ++ E+ KG+L +L R + +++
Sbjct: 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205
Query: 132 VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVST 191
V +ARG+ +L I+RDL A NVL+ N K++DFGLARD D
Sbjct: 206 VSCTYQLARGMEYLASQ--KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDY----- 258
Query: 192 RIVGTRG-----YAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRG-----GLA 241
T G + APE + T +SDV+SFGV++ E+ + G G+
Sbjct: 259 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT--------LGGSPYPGIP 310
Query: 242 EQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEA--QAVAAVVLQCLHMDPKNRPSMVD 299
+ L + L++ R MD K + ++ C H P RP+
Sbjct: 311 VEELFK----LLKEGHR----MD--------KPANCTNELYMMMRDCWHAVPSQRPTFKQ 354
Query: 300 VLTSLEQLHTS 310
++ L+++ T
Sbjct: 355 LVEDLDRILTL 365
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 2e-40
Identities = 70/330 (21%), Positives = 119/330 (36%), Gaps = 73/330 (22%)
Query: 23 FCSDY----LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLK-AESFQGHKEWLTE 77
+ +D+ LG GGFG VF+ AIKR++ ++ + E
Sbjct: 3 YLTDFEPIQCLGRGGFGVVFEA---------KNKVDDCNYAIKRIRLPNRELAREKVMRE 53
Query: 78 VIYLGQLRHENLVKLIGYCSESDN---------RLLVY---EFMPKGSLENHL-FRKGVQ 124
V L +L H +V+ E + ++ +Y + K +L++ + R ++
Sbjct: 54 VKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIE 113
Query: 125 PISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR----- 179
+ I + +A + FLH +++RDLK SN+ + K+ DFGL
Sbjct: 114 ERERSVCLHIFLQIAEAVEFLH--SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQD 171
Query: 180 -----DGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALD 234
T VGT+ Y +PE + + K D++S G++L ELL
Sbjct: 172 EEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY------ 225
Query: 235 EDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLG------GQYSKKEAQAVAAVVLQCLH 288
PF RV + D R Q E +V L
Sbjct: 226 ----------------PFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYV----MVQDMLS 265
Query: 289 MDPKNRPSMVDVLTSLEQLHTSKDMPRTPP 318
P RP ++++ + + D P
Sbjct: 266 PSPMERPEAINIIEN--AVFEDLDFPGKTV 293
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 3e-40
Identities = 73/313 (23%), Positives = 125/313 (39%), Gaps = 68/313 (21%)
Query: 29 LGEGGFGCVFKG-WIDQNTFAPTKPGSGIVVAIKRLKAE-SFQGHKEWLTEVIYLGQLRH 86
+GEG FG VF+ + P +VA+K LK E S ++ E + + +
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPF-----TMVAVKMLKEEASADMQADFQREAALMAEFDN 109
Query: 87 ENLVKLIGYCSESDNRLLVYEFMPKGSLENHL----------------------FRKGVQ 124
N+VKL+G C+ L++E+M G L L G
Sbjct: 110 PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPP 169
Query: 125 PISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTG 184
P+S ++ IA VA G+++L ++RDL N L+ N K++DFGL+R+ +
Sbjct: 170 PLSCAEQLCIARQVAAGMAYLSER--KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 227
Query: 185 DNTHVSTRIVGTRGY-----AAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRG- 238
D PE + T +SDV+++GVVL E+ S G
Sbjct: 228 D-----YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS--------YGL 274
Query: 239 ----GLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNR 294
G+A + ++ ++RD + + + ++ C P +R
Sbjct: 275 QPYYGMAHEEVIY----YVRDGNILACPENCP----------LELYNLMRLCWSKLPADR 320
Query: 295 PSMVDVLTSLEQL 307
PS + L+++
Sbjct: 321 PSFCSIHRILQRM 333
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 6e-40
Identities = 58/276 (21%), Positives = 103/276 (37%), Gaps = 39/276 (14%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIK--RLKAESFQGHKEWLTEVIYLGQLR 85
+G G F V+KG +D T + VA + + + + + E L L+
Sbjct: 33 EIGRGSFKTVYKG-LDTET--------TVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQ 83
Query: 86 HENLVKLIGYC---SESDNRLLVY-EFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARG 141
H N+V+ + +++ E M G+L+ +L R + + +G
Sbjct: 84 HPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKG 141
Query: 142 LSFLHGLDANVIYRDLKASNVLLDS-NFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYA 200
L FLH +I+RDLK N+ + + K+ D GLA T + ++GT +
Sbjct: 142 LQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA----TLKRASFAKAVIGTPEFM 197
Query: 201 APEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVL 260
APE + DVY+FG+ +LE+ + E +
Sbjct: 198 APEMYEEKY-DESVDVYAFGMCMLEMATSEYPYSECQNAAQ----------------IYR 240
Query: 261 RIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPS 296
R+ + K V ++ C+ + R S
Sbjct: 241 RVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYS 276
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 1e-39
Identities = 79/323 (24%), Positives = 128/323 (39%), Gaps = 88/323 (27%)
Query: 29 LGEGGFGCVFKG-WIDQNTFAPTKPGSGIVVAIKRLKAE-SFQGHKEWLTEVIYLGQLRH 86
LGEG FG V K A VA+K LK S ++ L+E L Q+ H
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTT-----VAVKMLKENASPSELRDLLSEFNVLKQVNH 85
Query: 87 ENLVKLIGYCSESDNRLLVYEFMPKGSLENHL----------------------FRKGVQ 124
+++KL G CS+ LL+ E+ GSL L +
Sbjct: 86 PHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDER 145
Query: 125 PISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTG 184
++ + A +++G+ +L + +++RDL A N+L+ K+SDFGL+RD
Sbjct: 146 ALTMGDLISFAWQISQGMQYLA--EMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEE 203
Query: 185 DNTHVSTRIVGTRG-----YAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRG- 238
D+ + ++G + A E + T +SDV+SFGV+L E+++ G
Sbjct: 204 DSY-----VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT--------LGG 250
Query: 239 ----GLAEQTLVEWADPFLRDSRR----------VLRIMDTRLGGQYSKKEAQAVAAVVL 284
G+ + L L+ R + R+M L
Sbjct: 251 NPYPGIPPERLFN----LLKTGHRMERPDNCSEEMYRLM--------------------L 286
Query: 285 QCLHMDPKNRPSMVDVLTSLEQL 307
QC +P RP D+ LE++
Sbjct: 287 QCWKQEPDKRPVFADISKDLEKM 309
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 2e-39
Identities = 68/311 (21%), Positives = 118/311 (37%), Gaps = 60/311 (19%)
Query: 23 FCSDY----LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEV 78
+ SD+ +LG+G FG V K AIK+++ + L+EV
Sbjct: 4 YASDFEEIAVLGQGAFGQVVKA---------RNALDSRYYAIKKIRHTEEK-LSTILSEV 53
Query: 79 IYLGQLRHENLVKLIGYCSESDNRL-------------LVYEFMPKGSLENHLFRKGVQP 125
+ L L H+ +V+ E N + + E+ G+L + + + +
Sbjct: 54 MLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENL-N 112
Query: 126 ISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR------ 179
++ + LS++H +I+RDLK N+ +D + N K+ DFGLA+
Sbjct: 113 QQRDEYWRLFRQILEALSYIH--SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSL 170
Query: 180 ------DGPTGDNTHVSTRIVGTRGYAAPEYVA-TGHLTPKSDVYSFGVVLLELLSGRRA 232
++ T +GT Y A E + TGH K D+YS G++ E++
Sbjct: 171 DILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFST 230
Query: 233 LDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPK 292
+R + L+ R V K E + ++ + DP
Sbjct: 231 -GMERVNI------------LKKLRSVSIEFPPDFDDNKMKVEKK----IIRLLIDHDPN 273
Query: 293 NRPSMVDVLTS 303
RP +L S
Sbjct: 274 KRPGARTLLNS 284
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 3e-39
Identities = 73/309 (23%), Positives = 124/309 (40%), Gaps = 59/309 (19%)
Query: 29 LGEGGFGCVFKG-WIDQNTFAPTKPGSGIVVAIKRLKAE-SFQGHKEWLTEVIYLGQL-R 85
LG G FG V + + A + VA+K LK + H+ ++E+ L +
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRT-----VAVKMLKEGATHSEHRALMSELKILIHIGH 89
Query: 86 HENLVKLIGYCSESDN-RLLVYEFMPKGSLENHL--------------FRKGVQPISWPT 130
H N+V L+G C++ +++ EF G+L +L ++
Sbjct: 90 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 149
Query: 131 RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 190
+ + VA+G+ FL I+RDL A N+LL K+ DFGLARD +
Sbjct: 150 LICYSFQVAKGMEFLA--SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD---- 203
Query: 191 TRIVGTRG-----YAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTL 245
+ + APE + T +SDV+SFGV+L E+ S L
Sbjct: 204 -YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-----------LGAS-- 249
Query: 246 VEWADPF--LRDSRRVLRIMDTRLGGQYSKKEA--QAVAAVVLQCLHMDPKNRPSMVDVL 301
P+ ++ R + + G + + + +L C H +P RP+ +++
Sbjct: 250 -----PYPGVKIDEEFCRRL--KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELV 302
Query: 302 TSLEQLHTS 310
L L +
Sbjct: 303 EHLGNLLQA 311
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 4e-39
Identities = 65/307 (21%), Positives = 108/307 (35%), Gaps = 43/307 (14%)
Query: 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLT 76
I K++ LGEGGF V G A+KR+ Q +E
Sbjct: 25 IIDNKHYLFIQKLGEGGFSYVDLV---------EGLHDGHFYALKRILCHEQQDREEAQR 75
Query: 77 EVIYLGQLRHENLVKLIGYCSESDNR----LLVYEFMPKGSLENHL--FRKGVQPISWPT 130
E H N+++L+ YC L+ F +G+L N + + ++
Sbjct: 76 EADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQ 135
Query: 131 RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 190
+ + + + RGL +H +RDLK +N+LL L D G
Sbjct: 136 ILWLLLGICRGLEAIH--AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQ 193
Query: 191 TRIV-------GTRGYAAPEYVAT---GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGL 240
+ T Y APE + + ++DV+S G VL ++ G D
Sbjct: 194 ALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG 253
Query: 241 AEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDV 300
L V + ++S A+ ++ + +DP RP + +
Sbjct: 254 DSVALA------------VQNQLSIPQSPRHS----SALWQLLNSMMTVDPHQRPHIPLL 297
Query: 301 LTSLEQL 307
L+ LE L
Sbjct: 298 LSQLEAL 304
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 4e-39
Identities = 63/322 (19%), Positives = 116/322 (36%), Gaps = 36/322 (11%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEW---LTEVIYLGQL 84
+GEG FG G IK + KE EV L +
Sbjct: 31 KIGEGSFGKAILV---------KSTEDGRQYVIKEINISR-MSSKEREESRREVAVLANM 80
Query: 85 RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSF 144
+H N+V+ E+ + +V ++ G L + + + + + L
Sbjct: 81 KHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKH 140
Query: 145 LHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEY 204
+H D +++RD+K+ N+ L + +L DFG+AR ++ +GT Y +PE
Sbjct: 141 VH--DRKILHRDIKSQNIFLTKDGTVQLGDFGIARV--LNSTVELARACIGTPYYLSPEI 196
Query: 205 VATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMD 264
KSD+++ G VL EL + + A + + + LV +++
Sbjct: 197 CENKPYNNKSDIWALGCVLYELCTLKHAFE----AGSMKNLV----------LKIISGSF 242
Query: 265 TRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS-LEQLHTSKDMPRTPPPAKLH 323
+ YS + ++V Q +P++RPS+ +L K + +
Sbjct: 243 PPVSLHYS----YDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKRIEKFLSPQLIAEEFC 298
Query: 324 HHHHHHNHHQGIKHTNPPRKTS 345
Q I P +
Sbjct: 299 LKTFSKFGSQPIPAKRPASGQN 320
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 1e-38
Identities = 77/320 (24%), Positives = 130/320 (40%), Gaps = 77/320 (24%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAE-SFQGHKEWLTEVIYLGQL-RH 86
LGEG FG V + KP VA+K LK++ + + + ++E+ + + +H
Sbjct: 77 LGEGAFGQVVLA--EAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 134
Query: 87 ENLVKLIGYCSESDNRLLVYEFMPKGSLENHL--------------FRKGVQPISWPTRV 132
+N++ L+G C++ ++ E+ KG+L +L + +S V
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194
Query: 133 KIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR 192
A VARG+ +L I+RDL A NVL+ + K++DFGLARD D
Sbjct: 195 SCAYQVARGMEYLA--SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY----- 247
Query: 193 IVGTRG-----YAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRG-----GLAE 242
T G + APE + T +SDV+SFGV+L E+ + G G+
Sbjct: 248 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT--------LGGSPYPGVPV 299
Query: 243 QTLVEWADPFLRDSRR----------VLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPK 292
+ L + L++ R + +M C H P
Sbjct: 300 EELFK----LLKEGHRMDKPSNCTNELYMMM--------------------RDCWHAVPS 335
Query: 293 NRPSMVDVLTSLEQLHTSKD 312
RP+ ++ L+++
Sbjct: 336 QRPTFKQLVEDLDRIVALTS 355
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 1e-38
Identities = 77/302 (25%), Positives = 133/302 (44%), Gaps = 54/302 (17%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAE-SFQGHKEWLTEVIYLGQL-RH 86
LG G FG V + F K + + VA+K LK+ + ++E+ + L +H
Sbjct: 54 LGAGAFGKVVEA----TAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQH 109
Query: 87 ENLVKLIGYCSESDNRLLVYEFMPKGSLENHL------------FRKGVQPISWPTRVKI 134
EN+V L+G C+ L++ E+ G L N L F S +
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHF 169
Query: 135 AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 194
+ VA+G++FL N I+RD+ A NVLL + AK+ DFGLARD N IV
Sbjct: 170 SSQVAQGMAFLA--SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNY-----IV 222
Query: 195 GTRG-----YAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWA 249
+ APE + T +SDV+S+G++L E+ S L
Sbjct: 223 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS-----------LGLN------ 265
Query: 250 DPF--LRDSRRVLRIMDTRLGGQYSKKEA--QAVAAVVLQCLHMDPKNRPSMVDVLTSLE 305
P+ + + + +++ G Q ++ + + +++ C ++P +RP+ + + L+
Sbjct: 266 -PYPGILVNSKFYKLVKD--GYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQ 322
Query: 306 QL 307
+
Sbjct: 323 EQ 324
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-38
Identities = 75/314 (23%), Positives = 115/314 (36%), Gaps = 74/314 (23%)
Query: 29 LGEGGFGCVFKG-WIDQNTFAPTKPGSGIVVAIKRLKAE-SFQGHKEWLTEVIYLGQL-R 85
LG G FG V + K + + VA+K LK + ++E+ L L
Sbjct: 31 LGAGAFGKVVEATAYGLI-----KSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 85
Query: 86 HENLVKLIGYCSESDNRLLVYEFMPKGSLENHL----------------FRKGVQPISWP 129
H N+V L+G C+ L++ E+ G L N L +
Sbjct: 86 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 145
Query: 130 TRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHV 189
+ + VA+G++FL N I+RDL A N+LL K+ DFGLARD N V
Sbjct: 146 DLLSFSYQVAKGMAFLA--SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 203
Query: 190 STR----IVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTL 245
+ APE + T +SDV+S+G+ L EL S G +
Sbjct: 204 KGNARLPVKWM----APESIFNCVYTFESDVWSYGIFLWELFS--------LGSSPYPGM 251
Query: 246 VEWAD--PFLRDSRRVLR----------IMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKN 293
+ +++ R+L IM C DP
Sbjct: 252 PVDSKFYKMIKEGFRMLSPEHAPAEMYDIM--------------------KTCWDADPLK 291
Query: 294 RPSMVDVLTSLEQL 307
RP+ ++ +E+
Sbjct: 292 RPTFKQIVQLIEKQ 305
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 4e-38
Identities = 73/330 (22%), Positives = 131/330 (39%), Gaps = 60/330 (18%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLR-H 86
+L EGGF V++ GSG A+KRL + + ++ + EV ++ +L H
Sbjct: 35 VLAEGGFAFVYEA---------QDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGH 85
Query: 87 ENLVKLIGYCSESDNR-------LLVYEFMPKGSLENHLFRKGVQ-PISWPTRVKIAIDV 138
N+V+ S L+ + KG L L + + P+S T +KI
Sbjct: 86 PNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQT 145
Query: 139 ARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA---RDGPTGDNTHVSTRIV- 194
R + +H +I+RDLK N+LL + KL DFG A P + +V
Sbjct: 146 CRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVE 205
Query: 195 ------GTRGYAAPEYVAT---GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTL 245
T Y PE + + K D+++ G +L L +
Sbjct: 206 EEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ--------------- 250
Query: 246 VEWADPFLRDSRRVLRIMDTRLGGQYS----KKEAQAVAAVVLQCLHMDPKNRPSMVDVL 301
PF + LRI + G+YS + +++ L ++P+ R S+ +V+
Sbjct: 251 ----HPF--EDGAKLRI----VNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVV 300
Query: 302 TSLEQLHTSKDMPRTPPPAKLHHHHHHHNH 331
L+++ ++++ P +L + +
Sbjct: 301 HQLQEIAAARNVNPKSPITELLEQNGGYGS 330
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 1e-36
Identities = 65/283 (22%), Positives = 117/283 (41%), Gaps = 38/283 (13%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAE--SFQGHKEWLTEVIYLGQLR 85
+G G +G K + G ++ K L + + ++EV L +L+
Sbjct: 13 TIGTGSYGRCQKI---------RRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK 63
Query: 86 HENLVKLIG-YCSESDNRL-LVYEFMPKGSLENHL--FRKGVQPISWPTRVKIAIDVARG 141
H N+V+ ++ L +V E+ G L + + K Q + +++ +
Sbjct: 64 HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 123
Query: 142 LSFLH---GLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRG 198
L H V++RDLK +NV LD N KL DFGLAR +T + VGT
Sbjct: 124 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHDTSFAKTFVGTPY 181
Query: 199 YAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRR 258
Y +PE + KSD++S G +L EL + +++ L +
Sbjct: 182 YMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFT----AFSQKELA----------GK 227
Query: 259 VLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL 301
+ R+ +YS + ++ + L++ +RPS+ ++L
Sbjct: 228 IREGKFRRIPYRYS----DELNEIITRMLNLKDYHRPSVEEIL 266
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 1e-36
Identities = 78/319 (24%), Positives = 128/319 (40%), Gaps = 79/319 (24%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAE-SFQGHKEWLTEVIYLGQL-RH 86
LG G FG V + +K G I VA+K LK + + ++E+ + QL H
Sbjct: 53 LGSGAFGKVMNATA----YGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSH 108
Query: 87 ENLVKLIGYCSESDNRLLVYEFMPKGSLENHL---------------------FRKGVQP 125
EN+V L+G C+ S L++E+ G L N+L + +
Sbjct: 109 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 168
Query: 126 ISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGD 185
+++ + A VA+G+ FL + ++RDL A NVL+ K+ DFGLARD +
Sbjct: 169 LTFEDLLCFAYQVAKGMEFLE--FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDS 226
Query: 186 NTHVSTRIVGTRG-----YAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGL 240
N +V + APE + G T KSDV+S+G++L E+ S G
Sbjct: 227 N-----YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS--------LGVN 273
Query: 241 AEQTLVEWAD--PFLRDSRRVLR----------IMDTRLGGQYSKKEAQAVAAVVLQCLH 288
+ A+ +++ ++ + IM C
Sbjct: 274 PYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIM--------------------QSCWA 313
Query: 289 MDPKNRPSMVDVLTSLEQL 307
D + RPS ++ + L
Sbjct: 314 FDSRKRPSFPNLTSFLGCQ 332
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 4e-35
Identities = 68/285 (23%), Positives = 109/285 (38%), Gaps = 30/285 (10%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKE-WLTEVIYLGQLRHE 87
LG GGFG V + WI Q+T G VAIK+ + E ++E W E+ + +L H
Sbjct: 22 LGTGGFGYVLR-WIHQDT--------GEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHP 72
Query: 88 NLVKLI------GYCSESDNRLLVYEFMPKGSLENHLFRKG-VQPISWPTRVKIAIDVAR 140
N+V + +D LL E+ G L +L + + + D++
Sbjct: 73 NVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISS 132
Query: 141 GLSFLHGLDANVIYRDLKASNVLLDSNFNA---KLSDFGLARDGPTGDNTHVSTRIVGTR 197
L +LH + +I+RDLK N++L K+ D G A++ + VGT
Sbjct: 133 ALRYLH--ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE--LDQGELCTEF-VGTL 187
Query: 198 GYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD----PFL 253
Y APE + T D +SFG + E ++G R + + V
Sbjct: 188 QYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVY 247
Query: 254 RDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQC-LHMDPKNRPSM 297
D ++ + LQC L + R +
Sbjct: 248 DDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTD 292
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 6e-35
Identities = 60/311 (19%), Positives = 112/311 (36%), Gaps = 40/311 (12%)
Query: 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKE-WL 75
+ + +LG+G VF+ + T G + AIK SF + +
Sbjct: 5 STSNHLWLLSDILGQGATANVFR-GRHKKT--------GDLFAIKVFNNISFLRPVDVQM 55
Query: 76 TEVIYLGQLRHENLVKLIGY--CSESDNRLLVYEFMPKGSLENHLFRKG-VQPISWPTRV 132
E L +L H+N+VKL + + +++L+ EF P GSL L + +
Sbjct: 56 REFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFL 115
Query: 133 KIAIDVARGLSFLHGLDANVIYRDLKASNVLL----DSNFNAKLSDFGLARDGPTGDNTH 188
+ DV G++ L + +++R++K N++ D KL+DFG AR+ D+
Sbjct: 116 IVLRDVVGGMNHLR--ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--LEDDEQ 171
Query: 189 VSTRIVGTRGYAAPEYVATGHL--------TPKSDVYSFGVVLLELLSGRRALDEDRGGL 240
+ + GT Y P+ L D++S GV +G G
Sbjct: 172 FVS-LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR 230
Query: 241 AEQTLVE----------WADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMD 290
+ ++ + ++ + D + S+ + V+ L D
Sbjct: 231 RNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEAD 290
Query: 291 PKNRPSMVDVL 301
+
Sbjct: 291 QEKCWGFDQFF 301
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 1e-34
Identities = 61/289 (21%), Positives = 111/289 (38%), Gaps = 47/289 (16%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGH--KEWLTEVIYLGQLR 85
+G GG VF+ +++ + AIK + E + E+ YL +L+
Sbjct: 16 QIGSGGSSKVFQV-LNEK---------KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQ 65
Query: 86 H--ENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLS 143
+ +++L Y +V E L + L +K I R ++ +
Sbjct: 66 QHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVH 122
Query: 144 FLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPE 203
+H +++ DLK +N L+ KL DFG+A + V VGT Y PE
Sbjct: 123 TIH--QHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 179
Query: 204 -----------YVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPF 252
+ ++PKSDV+S G +L + G+ + ++
Sbjct: 180 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS----------- 228
Query: 253 LRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL 301
++ I+D ++ + + V+ CL DPK R S+ ++L
Sbjct: 229 -----KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 272
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-34
Identities = 61/289 (21%), Positives = 110/289 (38%), Gaps = 47/289 (16%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGH--KEWLTEVIYLGQLR 85
+G GG VF+ +++ + AIK + E + E+ YL +L+
Sbjct: 35 QIGSGGSSKVFQV-LNEK---------KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQ 84
Query: 86 HENL--VKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLS 143
+ ++L Y +V E L + L +K I R ++ +
Sbjct: 85 QHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKK--SIDPWERKSYWKNMLEAVH 141
Query: 144 FLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPE 203
+H +++ DLK +N L+ KL DFG+A + V VGT Y PE
Sbjct: 142 TIH--QHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 198
Query: 204 -----------YVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPF 252
+ ++PKSDV+S G +L + G+ + ++
Sbjct: 199 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS----------- 247
Query: 253 LRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL 301
++ I+D ++ + + V+ CL DPK R S+ ++L
Sbjct: 248 -----KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 291
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-34
Identities = 62/321 (19%), Positives = 111/321 (34%), Gaps = 40/321 (12%)
Query: 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKE-WL 75
+ + +LG+G VF+ + T G + AIK SF + +
Sbjct: 5 STSNHLWLLSDILGQGATANVFR-GRHKKT--------GDLFAIKVFNNISFLRPVDVQM 55
Query: 76 TEVIYLGQLRHENLVKLIGYCSESDNRL--LVYEFMPKGSLENHLFRKG-VQPISWPTRV 132
E L +L H+N+VKL E+ R L+ EF P GSL L + +
Sbjct: 56 REFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFL 115
Query: 133 KIAIDVARGLSFLHGLDANVIYRDLKASNVLL----DSNFNAKLSDFGLARDGPTGDNTH 188
+ DV G++ L + +++R++K N++ D KL+DFG AR+ D+
Sbjct: 116 IVLRDVVGGMNHLR--ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--LEDDEQ 171
Query: 189 VSTRIVGTRGYAAPEYVATGHL--------TPKSDVYSFGVVLLELLSGRRALDEDRGGL 240
+ + GT Y P+ L D++S GV +G G
Sbjct: 172 FVS-LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR 230
Query: 241 AEQTLVE----------WADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMD 290
+ ++ + ++ + D + S+ + V+ L D
Sbjct: 231 RNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEAD 290
Query: 291 PKNRPSMVDVLTSLEQLHTSK 311
+ +
Sbjct: 291 QEKCWGFDQFFAETSDILHRM 311
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-34
Identities = 39/228 (17%), Positives = 74/228 (32%), Gaps = 20/228 (8%)
Query: 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLT 76
++ +K +LLGEG F V++ A +K K +
Sbjct: 61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKN----KQKFVLKVQKPANPWEFYIGTQ 116
Query: 77 EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGV---QPISWPTRVK 133
+ L +K + +LV E G+L N + + + +
Sbjct: 117 LMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVIS 176
Query: 134 IAIDVARGLSFLHGLDANVIYRDLKASNVLL-----------DSNFNAKLSDFGLARDGP 182
A+ + + +H D +I+ D+K N +L D + L D G + D
Sbjct: 177 FAMRMLYMIEQVH--DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMK 234
Query: 183 TGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR 230
+ T T G+ E ++ + D + + +L G
Sbjct: 235 LFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 3e-34
Identities = 70/310 (22%), Positives = 118/310 (38%), Gaps = 59/310 (19%)
Query: 9 DPSASMISKIATKNFCSDYLLGEGGFGC-VFKGWIDQNTFAPTKPGSGIVVAIKRLKAES 67
+ S ++ KI +FC +LG G G V++G D VA+KR+ E
Sbjct: 15 ETSVVIVGKI---SFCPKDVLGHGAEGTIVYRGMFD-----------NRDVAVKRILPEC 60
Query: 68 FQGHKEWLTEVIYLGQL-RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPI 126
F EV L + H N+++ + + + E +L+ ++ +K +
Sbjct: 61 FSFADR---EVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHL 116
Query: 127 SWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLL-----DSNFNAKLSDFGLAR-- 179
+ GL+ LH L N+++RDLK N+L+ A +SDFGL +
Sbjct: 117 GLEPI-TLLQQTTSGLAHLHSL--NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL 173
Query: 180 DGPTGDNTHVSTRIVGTRGYAAPEYV---ATGHLTPKSDVYSFGVVLLELLSGRRALDED 236
+ S + GT G+ APE + + T D++S G V ++S
Sbjct: 174 AVGRHSFSRRSG-VPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH---- 228
Query: 237 RGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAV-----VLQCLHMDP 291
PF + +R I+ + V + + + MDP
Sbjct: 229 --------------PFGKSLQRQANIL--LGACSLDCLHPEKHEDVIARELIEKMIAMDP 272
Query: 292 KNRPSMVDVL 301
+ RPS VL
Sbjct: 273 QKRPSAKHVL 282
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 5e-34
Identities = 61/289 (21%), Positives = 110/289 (38%), Gaps = 47/289 (16%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKR--LKAESFQGHKEWLTEVIYLGQLR 85
+G GG VF+ +++ + AIK L+ Q + E+ YL +L+
Sbjct: 63 QIGSGGSSKVFQV-LNEK---------KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQ 112
Query: 86 HENL--VKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLS 143
+ ++L Y +V E L + L +K I R ++ +
Sbjct: 113 QHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVH 169
Query: 144 FLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPE 203
+H +++ DLK +N L+ KL DFG+A + V VG Y PE
Sbjct: 170 TIH--QHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPE 226
Query: 204 -----------YVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPF 252
+ ++PKSDV+S G +L + G+ + ++
Sbjct: 227 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS----------- 275
Query: 253 LRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL 301
++ I+D ++ + + V+ CL DPK R S+ ++L
Sbjct: 276 -----KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 319
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 1e-33
Identities = 64/304 (21%), Positives = 105/304 (34%), Gaps = 50/304 (16%)
Query: 3 LLIAMSDPSASMISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKR 62
+L+ + +G G FG V + D+ T G A+K+
Sbjct: 40 VLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRM-KDKQT--------GFQCAVKK 90
Query: 63 LKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKG 122
++ E F+ E++ L +V L G E + E + GSL + + G
Sbjct: 91 VRLEVFRVE-----ELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMG 145
Query: 123 VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSN-FNAKLSDFGLAR-- 179
+ + GL +LH +++ D+KA NVLL S+ A L DFG A
Sbjct: 146 --CLPEDRALYYLGQALEGLEYLH--TRRILHGDVKADNVLLSSDGSRAALCDFGHALCL 201
Query: 180 -DGPTGDNTHVSTRIVGTRGYAAPEYV-ATGHLTPKSDVYSFGVVLLELLSGRRALDEDR 237
G + I GT + APE V K D++S ++L +L+G
Sbjct: 202 QPDGLGKSLLTGDYIPGTETHMAPEVVMGKPC-DAKVDIWSSCCMMLHMLNGCHP----- 255
Query: 238 GGLAEQTLVEWADPFLRDSRRVLRIMDTR-----LGGQYSKKEAQAVAAVVLQCLHMDPK 292
W L+I + + A + + L +P
Sbjct: 256 ----------WTQ--YFRGPLCLKIASEPPPIREIPPSCAP----LTAQAIQEGLRKEPV 299
Query: 293 NRPS 296
+R S
Sbjct: 300 HRAS 303
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-33
Identities = 54/302 (17%), Positives = 102/302 (33%), Gaps = 58/302 (19%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKA---ESFQGHKEWLTEVIYLGQL 84
+ GG G ++ +D+N +G V +K L Q + E +L ++
Sbjct: 87 CIAHGGLGWIYLA-LDRNV-------NGRPVVLKGLVHSGDAEAQ--AMAMAERQFLAEV 136
Query: 85 RHENLVKLIGYCSESDNRL-----LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVA 139
H ++V++ + +D +V E++ SL+ + + + +++
Sbjct: 137 VHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEIL 192
Query: 140 RGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGY 199
LS+LH ++Y DLK N++L KL D G + GT G+
Sbjct: 193 PALSYLH--SIGLVYNDLKPENIMLTEE-QLKLIDLGAVS-RINSFGY-----LYGTPGF 243
Query: 200 AAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRV 259
APE + T +D+Y+ G L L
Sbjct: 244 QAPE-IVRTGPTVATDIYTVGRTLAALTLDLP-------------------TRNGRYVDG 283
Query: 260 LRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRP-SMVDVLTSLEQLHTSKDMPRTPP 318
L D L + ++ + + DP+ R + ++ L + T
Sbjct: 284 LPEDDPVLK------TYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLREVVAQDTGV 337
Query: 319 PA 320
P
Sbjct: 338 PR 339
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 3e-33
Identities = 62/275 (22%), Positives = 120/275 (43%), Gaps = 37/275 (13%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHE 87
+LG+G +G V+ G D + + +AIK + + + E+ L+H+
Sbjct: 29 VLGKGTYGIVYAG-RDLSN--------QVRIAIKEIPERDSRYSQPLHEEIALHKHLKHK 79
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRK-GVQPISWPTRVKIAIDVARGLSFLH 146
N+V+ +G SE+ + E +P GSL L K G + T + GL +LH
Sbjct: 80 NIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH 139
Query: 147 GLDANVIYRDLKASNVLLDS-NFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYV 205
D +++RD+K NVL+++ + K+SDFG ++ + GT Y APE +
Sbjct: 140 --DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKR--LAGINPCTETFTGTLQYMAPEII 195
Query: 206 ---ATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVL-R 261
G+ +D++S G ++E+ +G+ + + L + + + +
Sbjct: 196 DKGPRGY-GKAADIWSLGCTIIEMATGKPP---------------FYE--LGEPQAAMFK 237
Query: 262 IMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPS 296
+ ++ + + + A +L+C DP R
Sbjct: 238 VGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRAC 272
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 3e-33
Identities = 73/298 (24%), Positives = 123/298 (41%), Gaps = 37/298 (12%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLT----EVIYLGQ 83
LG GG V+ D I VAIK + + +E L EV Q
Sbjct: 18 KLGGGGMSTVYLAE-DTIL--------NIKVAIKAIFIP-PREKEETLKRFEREVHNSSQ 67
Query: 84 LRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLS 143
L H+N+V +I E D LV E++ +L ++ G P+S T + + G+
Sbjct: 68 LSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHG--PLSVDTAINFTNQILDGIK 125
Query: 144 FLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPE 203
H D +++RD+K N+L+DSN K+ DFG+A+ T + ++GT Y +PE
Sbjct: 126 HAH--DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNH-VLGTVQYFSPE 182
Query: 204 YVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRG-GLAEQTLVEWADPFLRDSRRVLRI 262
+D+YS G+VL E+L G + + +A + + + D R+ +
Sbjct: 183 QAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDI-- 240
Query: 263 MDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDMPRTPPPA 320
Q+++ V+L+ D NR + + + L + R
Sbjct: 241 -------------PQSLSNVILRATEKDKANRYKTIQEM--KDDLSSVLHENRANEDV 283
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 9e-33
Identities = 69/300 (23%), Positives = 119/300 (39%), Gaps = 38/300 (12%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLT----EVIYLGQ 83
L+G GG G V++ D +VA+K + + T E G+
Sbjct: 41 LVGRGGMGDVYEAE-DTVR--------ERIVALKLMSET-LSSDPVFRTRMQREARTAGR 90
Query: 84 LRHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGL 142
L+ ++V + + E D +L + + L L R+G P++ P V I + L
Sbjct: 91 LQEPHVVPIHDF-GEIDGQLYVDMRLINGVDLAAMLRRQG--PLAPPRAVAIVRQIGSAL 147
Query: 143 SFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAP 202
H A +RD+K N+L+ ++ A L DFG+A T + VGT Y AP
Sbjct: 148 DAAH--AAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGN-TVGTLYYMAP 204
Query: 203 EYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRI 262
E + H T ++D+Y+ VL E L+G D+ + + + A P R +
Sbjct: 205 ERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQ-AIPRPSTVRPGI-- 261
Query: 263 MDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNR-PSMVDVLTSLEQLHTSKDMPRTPPPAK 321
A AV+ + + +P++R + D+ + + D R +
Sbjct: 262 -------------PVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATADQDRATDILR 308
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 123 bits (309), Expect = 1e-32
Identities = 67/360 (18%), Positives = 111/360 (30%), Gaps = 116/360 (32%)
Query: 23 FCSDY----LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLK-AESFQGHKEWLTE 77
+ +D+ +G GGFG VF+ AIKR++ ++ + E
Sbjct: 4 YLTDFEPIQCMGRGGFGVVFEA---------KNKVDDCNYAIKRIRLPNRELAREKVMRE 54
Query: 78 VIYLGQLRHENLVKLIGYC----------------------------------------- 96
V L +L H +V+
Sbjct: 55 VKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRR 114
Query: 97 SESDNRLLVYEFMPKGSLENHLF-----------------RKGVQPISWPTRVKIAIDVA 139
+ + + S + +L+ R ++ + I I +A
Sbjct: 115 MDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIA 174
Query: 140 RGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD----------GPTGDNTHV 189
+ FLH +++RDLK SN+ + K+ DFGL
Sbjct: 175 EAVEFLH--SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYAT 232
Query: 190 STRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWA 249
T VGT+ Y +PE + + + K D++S G++L ELL
Sbjct: 233 HTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLY--------------------- 271
Query: 250 DPFLRDSRRVLRIMDTRLG------GQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303
F RV I D R Q +E +V L P RP D++ +
Sbjct: 272 -SFSTQMERVRIITDVRNLKFPLLFTQKYPQEHM----MVQDMLSPSPTERPEATDIIEN 326
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-32
Identities = 63/320 (19%), Positives = 116/320 (36%), Gaps = 72/320 (22%)
Query: 11 SASMISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAE--SF 68
+ M S+ T+ F +G G FG VFK + + G + AIKR K
Sbjct: 2 AMGMKSRYTTE-FHELEKIGSGEFGSVFKC-VKRLD--------GCIYAIKRSKKPLAGS 51
Query: 69 QGHKEWLTEVIYLGQL-RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHL--FRKGVQP 125
+ L EV L +H ++V+ +E D+ L+ E+ GSL + + + +
Sbjct: 52 VDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSY 111
Query: 126 ISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSN------------------ 167
+ + V RGL ++H ++++ D+K SN+ +
Sbjct: 112 FKEAELKDLLLQVGRGLRYIH--SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASN 169
Query: 168 -FNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVA--TGHLTPKSDVYSFGVVLL 224
K+ D G + V G + A E + HL PK+D+++ + ++
Sbjct: 170 KVMFKIGDLGHVT---RISSPQV---EEGDSRFLANEVLQENYTHL-PKADIFALALTVV 222
Query: 225 ELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDT---RLGGQYSKKEAQAVAA 281
P R+ + I R+ S +E
Sbjct: 223 CAAGAE--------------------PLPRNGDQWHEIRQGRLPRIPQVLS-QEFT---E 258
Query: 282 VVLQCLHMDPKNRPSMVDVL 301
++ +H DP+ RPS + ++
Sbjct: 259 LLKVMIHPDPERRPSAMALV 278
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 5e-31
Identities = 79/312 (25%), Positives = 128/312 (41%), Gaps = 53/312 (16%)
Query: 7 MSDPSASMISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAE 66
MS+ S+++ I ++ ++G G V VAIKR+ E
Sbjct: 1 MSEDSSALPWSINRDDYELQEVIGSGATAVVQAA-YCAPK--------KEKVAIKRINLE 51
Query: 67 SFQGHKEWL-TEVIYLGQLRHENLVKLIGYCS-ESDNRL-LVYEFMPKGSLEN---HLFR 120
Q + L E+ + Q H N+V Y S + L LV + + GS+ + H+
Sbjct: 52 KCQTSMDELLKEIQAMSQCHHPNIVSY--YTSFVVKDELWLVMKLLSGGSVLDIIKHIVA 109
Query: 121 KGVQPISWPTRVKIAI---DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL 177
KG IA +V GL +LH I+RD+KA N+LL + + +++DFG+
Sbjct: 110 KGEHKSGVLDESTIATILREVLEGLEYLHKN--GQIHRDVKAGNILLGEDGSVQIADFGV 167
Query: 178 -ARDGPTGDNTHVSTR--IVGTRGYAAPEYVATGHL-TPKSDVYSFGVVLLELLSGR--- 230
A GD T R VGT + APE + K+D++SFG+ +EL +G
Sbjct: 168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPY 227
Query: 231 ------RALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVL 284
+ L ++ P L + D + +Y K + ++
Sbjct: 228 HKYPPMKVL---------MLTLQNDPPSLETGVQ-----DKEMLKKYGKSFRKMIS---- 269
Query: 285 QCLHMDPKNRPS 296
CL DP+ RP+
Sbjct: 270 LCLQKDPEKRPT 281
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 7e-31
Identities = 67/319 (21%), Positives = 115/319 (36%), Gaps = 77/319 (24%)
Query: 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIY 80
S+ +LG G G V Q +F G VA+KR+ + E+
Sbjct: 15 NLVVSEKILGYGSSGTVVF----QGSF------QGRPVAVKRMLIDFCDIALM---EIKL 61
Query: 81 LGQL-RHENLVKLIGYCSESDNRLLVYEFMPKGSL-----ENHLFRKGVQPISWPTRVKI 134
L + H N+++ + + E +L ++ + ++ + +
Sbjct: 62 LTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISL 120
Query: 135 AIDVARGLSFLHGLDANVIYRDLKASNVLLDS-------------NFNAKLSDFGLAR-- 179
+A G++ LH L +I+RDLK N+L+ + N +SDFGL +
Sbjct: 121 LRQIASGVAHLHSL--KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKL 178
Query: 180 -DGPTGDNTHVSTRIVGTRGYAAPE-------YVATGHLTPKSDVYSFGVVLLELLSGRR 231
G + T+++ GT G+ APE LT D++S G V +LS +
Sbjct: 179 DSGQSSFRTNLNN-PSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGK 237
Query: 232 ALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAV--------- 282
PF R I+ G +S E + +
Sbjct: 238 ------------------HPFGDKYSRESNIIR----GIFSLDEMKCLHDRSLIAEATDL 275
Query: 283 VLQCLHMDPKNRPSMVDVL 301
+ Q + DP RP+ + VL
Sbjct: 276 ISQMIDHDPLKRPTAMKVL 294
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 9e-31
Identities = 78/308 (25%), Positives = 125/308 (40%), Gaps = 54/308 (17%)
Query: 10 PSASMISKIATKNFCSDY----LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRL-- 63
+ M + +T F Y +LG+G FG V +G A+K +
Sbjct: 11 ATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILC---------KDKITGQECAVKVISK 61
Query: 64 -KAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKG 122
+ + + L EV L QL H N++KL + + LV E G L + + +
Sbjct: 62 RQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK 121
Query: 123 VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS---NFNAKLSDFGLAR 179
S +I V G++++H +++RDLK N+LL+S + N ++ DFGL+
Sbjct: 122 --RFSEVDAARIIRQVLSGITYMH--KNKIVHRDLKPENLLLESKSKDANIRIIDFGLST 177
Query: 180 DGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGG 239
+ + +GT Y APE V G K DV+S GV+L LLSG
Sbjct: 178 ---HFEASKKMKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCP-------- 225
Query: 240 LAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYS------KKEAQAVAAVVLQCLHMDPKN 293
PF + I+ G+Y+ KK +++ ++ + L P
Sbjct: 226 -----------PFNGANEY--DILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSM 272
Query: 294 RPSMVDVL 301
R S D L
Sbjct: 273 RISARDAL 280
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 9e-31
Identities = 71/324 (21%), Positives = 122/324 (37%), Gaps = 40/324 (12%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLT----EVIYLGQ 83
+LG GG V D VA+K L+A+ + E
Sbjct: 19 ILGFGGMSEVHLAR-DLRD--------HRDVAVKVLRAD-LARDPSFYLRFRREAQNAAA 68
Query: 84 LRHENLVKLIGYCSESDNRL----LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVA 139
L H +V + +V E++ +L + + +G P++ +++ D
Sbjct: 69 LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADAC 126
Query: 140 RGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVST-RIVGTRG 198
+ L+F H +I+RD+K +N+++ + K+ DFG+AR N+ T ++GT
Sbjct: 127 QALNFSH--QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 184
Query: 199 YAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRR 258
Y +PE + +SDVYS G VL E+L+G D + V A +R+
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD-------SPVSVAYQHVREDPI 237
Query: 259 VLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDMPRTPP 318
L + + AVVL+ L +P+NR + L +
Sbjct: 238 PPSARHEGL--------SADLDAVVLKALAKNPENRYQTAAEM--RADLVRVHNGEPPEA 287
Query: 319 PAKLHHHHHHHNHHQGIKHTNPPR 342
P L + + PR
Sbjct: 288 PKVLTDAERTSLLSSAAGNLSGPR 311
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-30
Identities = 34/310 (10%), Positives = 65/310 (20%), Gaps = 63/310 (20%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEW---LTEVIYLGQL 84
L G VF D A+K + E +L
Sbjct: 69 PLRVGDRSVVFLV-RDVER--------LEDFALKVFTMGAENSRSELERLHEATFAAARL 119
Query: 85 RHENLVKLIGYC--------------------------SESDNRLLVYEFMPKGSLEN-- 116
E+ + N LL+ LE
Sbjct: 120 LGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAA-SVDLELLF 178
Query: 117 ---HLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLS 173
+ + R + L +++ N+ + + L
Sbjct: 179 STLDFVYVFRGDEGILALHILTAQLIRLAANLQ--SKGLVHGHFTPDNLFIMPDGRLMLG 236
Query: 174 DFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHL--TPKSDVYSFGVVLLELLSGRR 231
D T YA E++ T + + G+ + +
Sbjct: 237 DVSALWKVGTRGPA-----SSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL 291
Query: 232 ALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDP 291
G+ DS L V ++ + L+ D
Sbjct: 292 PFGLVTPGIKGSWKRPSLRVPGTDS----------LAFGSCTPLPDFVKTLIGRFLNFDR 341
Query: 292 KNRPSMVDVL 301
+ R ++ +
Sbjct: 342 RRRLLPLEAM 351
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-30
Identities = 57/206 (27%), Positives = 89/206 (43%), Gaps = 20/206 (9%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHK---EWLTEVIYLGQL 84
LG+G FG V+ A K S ++A+K L + + EV L
Sbjct: 16 PLGKGKFGNVY--------LAREKQ-SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 85 RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSF 144
RH N+++L GY ++ L+ E+ P G++ L + ++A LS+
Sbjct: 67 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSY 124
Query: 145 LHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEY 204
H VI+RD+K N+LL S K++DFG + P + GT Y PE
Sbjct: 125 CHSK--RVIHRDIKPENLLLGSAGELKIADFGWSVHAP--SSRRTDL--CGTLDYLPPEM 178
Query: 205 VATGHLTPKSDVYSFGVVLLELLSGR 230
+ K D++S GV+ E L G+
Sbjct: 179 IEGRMHDEKVDLWSLGVLCYEFLVGK 204
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 4e-30
Identities = 54/229 (23%), Positives = 93/229 (40%), Gaps = 24/229 (10%)
Query: 8 SDPSASMISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIK-----R 62
+ ++ + + + LG+GGF F+ + + V A K
Sbjct: 28 KEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEI---------SDADTKEVFAGKIVPKSL 78
Query: 63 LKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKG 122
L + E+ L H+++V G+ ++D +V E + SL R+
Sbjct: 79 LLKPHQREKMS--MEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRK 136
Query: 123 VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGP 182
++ P + G +LH VI+RDLK N+ L+ + K+ DFGLA
Sbjct: 137 --ALTEPEARYYLRQIVLGCQYLHRN--RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 192
Query: 183 TGDNTHVSTRIVGTRGYAAPEYVA-TGHLTPKSDVYSFGVVLLELLSGR 230
+ GT Y APE ++ GH + + DV+S G ++ LL G+
Sbjct: 193 YDGERK-KV-LCGTPNYIAPEVLSKKGH-SFEVDVWSIGCIMYTLLVGK 238
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 4e-30
Identities = 43/227 (18%), Positives = 82/227 (36%), Gaps = 41/227 (18%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLT------------ 76
L +G F + + A+K+ + + +++
Sbjct: 39 LNQGKFNKIILC---EKD--------NKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKY 87
Query: 77 -----EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGV------QP 125
E+ + +++E + G + D ++YE+M S+ V
Sbjct: 88 DDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCF 147
Query: 126 ISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGD 185
I I V S++H + N+ +RD+K SN+L+D N KLSDFG +
Sbjct: 148 IPIQVIKCIIKSVLNSFSYIHN-EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK- 205
Query: 186 NTHVSTRIVGTRGYAAPEYVAT--GHLTPKSDVYSFGVVLLELLSGR 230
+ GT + PE+ + + K D++S G+ L +
Sbjct: 206 --KIKG-SRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNV 249
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 5e-30
Identities = 68/317 (21%), Positives = 109/317 (34%), Gaps = 64/317 (20%)
Query: 11 SASMISKIATKNFCSDY----LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLK-- 64
+ M + Y LG G +G V + AIK +K
Sbjct: 22 NPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLC---------KEKNGHSEKAIKVIKKS 72
Query: 65 ----------AESFQGHKEWL-TEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGS 113
++ + E + E+ L L H N++KL + LV EF G
Sbjct: 73 QFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGE 132
Query: 114 LENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS---NFNA 170
L + + I + G+ +LH N+++RD+K N+LL++ N
Sbjct: 133 LFEQIINRH--KFDECDAANIMKQILSGICYLH--KHNIVHRDIKPENILLENKNSLLNI 188
Query: 171 KLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR 230
K+ DFGL+ + +GT Y APE V K DV+S GV++ LL G
Sbjct: 189 KIVDFGLSS---FFSKDYKLRDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGY 244
Query: 231 RALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYS------KKEAQAVAAVVL 284
PF + + I+ G+Y K + ++
Sbjct: 245 P-------------------PFGGQNDQ--DIIKKVEKGKYYFDFNDWKNISDEAKELIK 283
Query: 285 QCLHMDPKNRPSMVDVL 301
L D R + + L
Sbjct: 284 LMLTYDYNKRCTAEEAL 300
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 6e-30
Identities = 75/307 (24%), Positives = 118/307 (38%), Gaps = 53/307 (17%)
Query: 10 PSASMISKIATKNFCSDY----LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKA 65
+ M + Y LG G +G V + + AIK ++
Sbjct: 22 ATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLC---------RDKVTHVERAIKIIRK 72
Query: 66 ESFQG--HKEWLTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGV 123
S + + L EV L L H N++KL + + N LV E G L + + +
Sbjct: 73 TSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRM- 131
Query: 124 QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS---NFNAKLSDFGLARD 180
+ I V G+++LH N+++RDLK N+LL+S + K+ DFGL+
Sbjct: 132 -KFNEVDAAVIIKQVLSGVTYLH--KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSA- 187
Query: 181 GPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGL 240
+N +GT Y APE V K DV+S GV+L LL+G
Sbjct: 188 --VFENQKKMKERLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGYP--------- 235
Query: 241 AEQTLVEWADPFLRDSRRVLRIMDTRLGGQYS------KKEAQAVAAVVLQCLHMDPKNR 294
PF + + I+ G+Y+ K ++ ++ Q L D + R
Sbjct: 236 ----------PFGGQTDQ--EILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRR 283
Query: 295 PSMVDVL 301
S L
Sbjct: 284 ISAQQAL 290
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 114 bits (289), Expect = 7e-30
Identities = 72/331 (21%), Positives = 122/331 (36%), Gaps = 65/331 (19%)
Query: 9 DPSASMISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIK-----RL 63
+ ++ + + + LG+GGF F+ + + V A K L
Sbjct: 3 EIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEI---------SDADTKEVFAGKIVPKSLL 53
Query: 64 KAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGV 123
+ E+ L H+++V G+ ++D +V E + SL R+
Sbjct: 54 LKPHQREKMS--MEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRK- 110
Query: 124 QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPT 183
++ P + G +LH VI+RDLK N+ L+ + K+ DFGLA
Sbjct: 111 -ALTEPEARYYLRQIVLGCQYLHRN--RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 167
Query: 184 GDNTHVSTRIVGTRGYAAPEYVA-TGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAE 242
+ GT Y APE ++ GH + + DV+S G ++ LL G+
Sbjct: 168 DGERK-KV-LCGTPNYIAPEVLSKKGH-SFEVDVWSIGCIMYTLLVGKP----------- 213
Query: 243 QTLVEWADPFLRDSRRVL--RIMDTRLGGQYS-----KKEAQAVAAVVLQCLHMDPKNRP 295
PF + RI +YS A +++ + L DP RP
Sbjct: 214 --------PFETSCLKETYLRIKK----NEYSIPKHINPVAA---SLIQKMLQTDPTARP 258
Query: 296 SMVDVLTSLEQLH---TSKDMPRTPPPAKLH 323
++ ++L TS +P P L
Sbjct: 259 TINELLN-----DEFFTSGYIPARLPITCLT 284
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 66/207 (31%), Positives = 98/207 (47%), Gaps = 19/207 (9%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEW---LTEVIYLGQL 84
+LG+GGFG V A +G + A K+L+ + + K L E L ++
Sbjct: 191 VLGKGGFGEVC---------ACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV 241
Query: 85 RHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLS 143
+V L Y E+ + L LV M G L+ H++ G V A ++ GL
Sbjct: 242 NSRFVVSLA-YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLE 300
Query: 144 FLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPE 203
LH ++YRDLK N+LLD + + ++SD GLA P G R VGT GY APE
Sbjct: 301 DLHRE--RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK--GR-VGTVGYMAPE 355
Query: 204 YVATGHLTPKSDVYSFGVVLLELLSGR 230
V T D ++ G +L E+++G+
Sbjct: 356 VVKNERYTFSPDWWALGCLLYEMIAGQ 382
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-29
Identities = 66/303 (21%), Positives = 117/303 (38%), Gaps = 50/303 (16%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES-FQGHKEWLTEVIYLGQLRHE 87
LG G G VFK + + G+V+A K + E + + E+ L +
Sbjct: 41 LGAGNGGVVFKV-SHKPS--------GLVMARKLIHLEIKPAIRNQIIRELQVLHECNSP 91
Query: 88 NLVKLIG-YCSESDNRLLVY---EFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLS 143
+V G + S+ + + E M GSL+ K I K++I V +GL+
Sbjct: 92 YIVGFYGAFYSDGE----ISICMEHMDGGSLDQ--VLKKAGRIPEQILGKVSIAVIKGLT 145
Query: 144 FLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPE 203
+L +++RD+K SN+L++S KL DFG++ ++ ++ VGTR Y +PE
Sbjct: 146 YLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ---LIDSMANS-FVGTRSYMSPE 200
Query: 204 YVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIM 263
+ H + +SD++S G+ L+E+ GR + E + ++ R
Sbjct: 201 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 260
Query: 264 DTRLGGQYSKKEAQAVAAVVLQ-------------------------CLHMDPKNRPSMV 298
L +L CL +P R +
Sbjct: 261 GRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLK 320
Query: 299 DVL 301
++
Sbjct: 321 QLM 323
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-29
Identities = 61/207 (29%), Positives = 95/207 (45%), Gaps = 19/207 (9%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHK---EWLTEVIYLGQL 84
LLG+G F V++ +G+ VAIK + ++ EV QL
Sbjct: 18 LLGKGSFAGVYRA---------ESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQL 68
Query: 85 RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSF 144
+H ++++L Y +S+ LV E G + +L + +P S + G+ +
Sbjct: 69 KHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRV-KPFSENEARHFMHQIITGMLY 127
Query: 145 LHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEY 204
LH +++RDL SN+LL N N K++DFGLA H T + GT Y +PE
Sbjct: 128 LHSH--GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKH-YT-LCGTPNYISPEI 183
Query: 205 VA-TGHLTPKSDVYSFGVVLLELLSGR 230
+ H +SDV+S G + LL GR
Sbjct: 184 ATRSAH-GLESDVWSLGCMFYTLLIGR 209
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-29
Identities = 75/328 (22%), Positives = 130/328 (39%), Gaps = 58/328 (17%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEV-IYLGQLRH 86
+G G +G V K + + + G ++A+KR+++ + K+ L ++ + +
Sbjct: 30 IGRGAYGSVNKM-VHKPS--------GQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDC 80
Query: 87 ENLVKLIGYCSESDNRLLVYEFMPKGSLEN---HLFRKGVQPISWPTRVKIAIDVARGLS 143
+V+ G + + E M S + +++ I KI + + L+
Sbjct: 81 PYIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALN 139
Query: 144 FLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTG--DNTHVSTRIVGTRGYAA 201
L + +I+RD+K SN+LLD + N KL DFG++ G ++ TR G R Y A
Sbjct: 140 HLKE-NLKIIHRDIKPSNILLDRSGNIKLCDFGIS-----GQLVDSIAKTRDAGCRPYMA 193
Query: 202 PEYVATGHLTP----KSDVYSFGVVLLELLSGRRALDEDRGGLAE-QTLVEWADPFLRDS 256
PE + +SDV+S G+ L EL +GR + + +V+ P L +S
Sbjct: 194 PERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNS 253
Query: 257 RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPS----------------MVDV 300
++S V CL D RP V+V
Sbjct: 254 E----------EREFSPSFINFVN----LCLTKDESKRPKYKELLKHPFILMYEERAVEV 299
Query: 301 LTSLEQLHTSKDMPRTPPPAKLHHHHHH 328
+ ++ + P HHHHHH
Sbjct: 300 ACYVCKILDQMPATPSSPMYVDHHHHHH 327
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 3e-29
Identities = 81/283 (28%), Positives = 121/283 (42%), Gaps = 53/283 (18%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLT-EVIYLGQLRHE 87
+G+G FG VFKG ID T VVAIK + E + E + E+ L Q
Sbjct: 30 IGKGSFGEVFKG-IDNRT--------QKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 88 NLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLH 146
+ K G D +L ++ E++ GS L G P+ I ++ +GL +LH
Sbjct: 81 YVTKYYG-SYLKDTKLWIIMEYLGGGSA-LDLLEPG--PLDETQIATILREILKGLDYLH 136
Query: 147 GLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR---IVGTRGYAAPE 203
I+RD+KA+NVLL + KL+DFG+A G T + VGT + APE
Sbjct: 137 --SEKKIHRDIKAANVLLSEHGEVKLADFGVA-----GQLTDTQIKRNTFVGTPFWMAPE 189
Query: 204 YVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLR-DSRRVLRI 262
+ K+D++S G+ +EL G P +VL +
Sbjct: 190 VIKQSAYDSKADIWSLGITAIELARGE-------------------PPHSELHPMKVLFL 230
Query: 263 MDT----RLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL 301
+ L G YSK + V CL+ +P RP+ ++L
Sbjct: 231 IPKNNPPTLEGNYSKPLKEFVE----ACLNKEPSFRPTAKELL 269
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 4e-29
Identities = 53/329 (16%), Positives = 98/329 (29%), Gaps = 68/329 (20%)
Query: 28 LLGEGGFGCVFKGWIDQNT---FA---PTKPGSGIVVAIKRLKAES-----FQGHKEWLT 76
+LG+ + DQ T F P AIK++K E +G K
Sbjct: 85 VLGQEDPYAYLEAT-DQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143
Query: 77 EVIYLGQLRHENLVKLIGYCSESD-----------NRLLVYEFMPK--GSLENHLFRKGV 123
++L + +LVK +R +Y M + L
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203
Query: 124 Q--PISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDG 181
+ R+++ + V R L+ LH +++ L+ +++LD L+ F
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLH--HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV-- 259
Query: 182 PTGDNTHVSTRIVGTRGYAAPEYVA----------TGHLTPKSDVYSFGVVLLELLSGRR 231
G + RG+A PE A +T D ++ G+ + +
Sbjct: 260 RDGASAVSPI----GRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADL 315
Query: 232 ALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDP 291
P D+ R Q V A++ L
Sbjct: 316 -------------------PNTDDAALGGSEWIFRSCKNIP----QPVRALLEGFLRYPK 352
Query: 292 KNRPSMVDVLTSLEQLHTSKDMPRTPPPA 320
++R + + + E ++ P
Sbjct: 353 EDRLLPLQAMETPEYEQLRTELSAALPLY 381
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 5e-29
Identities = 73/297 (24%), Positives = 117/297 (39%), Gaps = 53/297 (17%)
Query: 20 TKNFCSDY----LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRL-KAESFQGHKEW 74
F Y +LG+G FG V K + A+K + KA +
Sbjct: 17 QGTFAERYNIVCMLGKGSFGEVLKC---------KDRITQQEYAVKVINKASAKNKDTST 67
Query: 75 L-TEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVK 133
+ EV L +L H N++KL +S + +V E G L + + ++ S +
Sbjct: 68 ILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK--RFSEHDAAR 125
Query: 134 IAIDVARGLSFLHGLDANVIYRDLKASNVLLDS---NFNAKLSDFGLARDGPTGDNTHVS 190
I V G++++H N+++RDLK N+LL+S + + K+ DFGL+
Sbjct: 126 IIKQVFSGITYMH--KHNIVHRDLKPENILLESKEKDCDIKIIDFGLST---CFQQNTKM 180
Query: 191 TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD 250
+GT Y APE V G K DV+S GV+L LLSG
Sbjct: 181 KDRIGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGTP------------------- 220
Query: 251 PFLRDSRRVLRIMDTRLGGQYS------KKEAQAVAAVVLQCLHMDPKNRPSMVDVL 301
PF + I+ G+Y+ + + ++ + L P R + L
Sbjct: 221 PFYGKNEY--DILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCL 275
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 6e-29
Identities = 46/311 (14%), Positives = 94/311 (30%), Gaps = 69/311 (22%)
Query: 28 LLGEGGFGCVFKGWIDQNT---FA---PTKPGSGIVVAIKRLKAESF------------- 68
+LG+ + DQ T F P AIK++K E
Sbjct: 80 VLGQEDPYAYLEA-TDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 138
Query: 69 -QGHKEWLTEVIYLGQLRHENLVKLIGYCS--ESDNRLLVYEFM--PKGSLENHLFRKGV 123
+ H ++ + + + ++++ +R +Y M + L
Sbjct: 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198
Query: 124 Q--PISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDG 181
+ R+++ + V R L+ LH +++ L+ +++LD L+ F
Sbjct: 199 THKSLVHHARLQLTLQVIRLLASLH--HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV-- 254
Query: 182 PTGDNTHVSTRIVGTRGYAAPEYVAT-----------GHLTPKSDVYSFGVVLLELLSGR 230
G +RG+ PE A +T D ++ G+V+ +
Sbjct: 255 RDGARVVS----SVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
Query: 231 RALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMD 290
P +D+ R Q V A++ L
Sbjct: 311 L-------------------PITKDAALGGSEWIFRSCKNIP----QPVRALLEGFLRYP 347
Query: 291 PKNRPSMVDVL 301
++R + +
Sbjct: 348 KEDRLLPLQAM 358
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 7e-29
Identities = 53/206 (25%), Positives = 85/206 (41%), Gaps = 20/206 (9%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHK---EWLTEVIYLGQL 84
LG+G FG V+ A K + ++A+K L + + E+ L
Sbjct: 21 PLGKGKFGNVY--------LAREK-QNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHL 71
Query: 85 RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSF 144
RH N++++ Y + L+ EF P+G L L + G ++A L +
Sbjct: 72 RHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHG--RFDEQRSATFMEELADALHY 129
Query: 145 LHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEY 204
H VI+RD+K N+L+ K++DFG + P T + GT Y PE
Sbjct: 130 CHER--KVIHRDIKPENLLMGYKGELKIADFGWSVHAP-SLRRR--T-MCGTLDYLPPEM 183
Query: 205 VATGHLTPKSDVYSFGVVLLELLSGR 230
+ K D++ GV+ E L G
Sbjct: 184 IEGKTHDEKVDLWCAGVLCYEFLVGM 209
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-28
Identities = 70/281 (24%), Positives = 112/281 (39%), Gaps = 48/281 (17%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES-FQGHKEWLTEV-IYLGQLRH 86
LG G +G V K + G ++A+KR++A Q K L ++ I + +
Sbjct: 15 LGRGAYGVVEKM-RHVPS--------GQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDC 65
Query: 87 ENLVKLIG-YCSESDNRLLVY---EFMPKGSLENHL--FRKGVQPISWPTRVKIAIDVAR 140
V G E D V+ E M SL+ Q I KIA+ + +
Sbjct: 66 PFTVTFYGALFREGD----VWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVK 120
Query: 141 GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYA 200
L LH +VI+RD+K SNVL+++ K+ DFG++ + G + Y
Sbjct: 121 ALEHLHS-KLSVIHRDVKPSNVLINALGQVKMCDFGISGY---LVDDVAKDIDAGCKPYM 176
Query: 201 APEYVATGHLTP----KSDVYSFGVVLLELLSGRRALDEDRGGLAE-QTLVEWADPFLRD 255
APE + KSD++S G+ ++EL R D + + +VE P L
Sbjct: 177 APERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPA 236
Query: 256 SRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPS 296
++S + + QCL + K RP+
Sbjct: 237 -------------DKFSAEFVDFTS----QCLKKNSKERPT 260
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-28
Identities = 79/329 (24%), Positives = 125/329 (37%), Gaps = 58/329 (17%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEW-----LTEVIYLGQ 83
+GEG +G VFK +++T G +VAIK+ L E+ L Q
Sbjct: 11 IGEGSYGVVFKC-RNRDT--------GQIVAIKKFLESED---DPVIKKIALREIRMLKQ 58
Query: 84 LRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLS 143
L+H NLV L+ LV+E+ ++ + L R + + I + ++
Sbjct: 59 LKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQ-RGVPEHLVKSITWQTLQAVN 116
Query: 144 FLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD--GPTGDNTHVSTRIVGTRGYAA 201
F H N I+RD+K N+L+ + KL DFG AR GP+ V TR Y +
Sbjct: 117 FCH--KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDE----VATRWYRS 170
Query: 202 PEY-VATGHLTPKSDVYSFGVVLLELLSGR----------------RALDEDRGGLAEQT 244
PE V P DV++ G V ELLSG + L G L +
Sbjct: 171 PELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTL----GDLIPRH 226
Query: 245 LVEWAD----PFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDV 300
+ + L ++ A+ ++ CLHMDP R + +
Sbjct: 227 ---QQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPAL-GLLKGCLHMDPTERLTCEQL 282
Query: 301 LTS--LEQLHTSKDMPRTPPPAKLHHHHH 327
L E + +D+ + + +
Sbjct: 283 LHHPYFENIREIEDLAKEHDKPAENLYFQ 311
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 5e-28
Identities = 62/209 (29%), Positives = 91/209 (43%), Gaps = 20/209 (9%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEW---LTEVIYLGQL 84
+LG GGFG VF A +G + A K+L + + K + + E L ++
Sbjct: 192 VLGRGGFGEVF---------ACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV 242
Query: 85 RHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWP-TRVKI-AIDVARG 141
+V L Y E+ L LV M G + H++ + R + G
Sbjct: 243 HSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG 301
Query: 142 LSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAA 201
L LH N+IYRDLK NVLLD + N ++SD GLA + G GT G+ A
Sbjct: 302 LEHLHQR--NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGY-AGTPGFMA 357
Query: 202 PEYVATGHLTPKSDVYSFGVVLLELLSGR 230
PE + D ++ GV L E+++ R
Sbjct: 358 PELLLGEEYDFSVDYFALGVTLYEMIAAR 386
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 109 bits (276), Expect = 8e-28
Identities = 77/337 (22%), Positives = 134/337 (39%), Gaps = 69/337 (20%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKE-----WLTEVIYLGQ 83
LG G + V+KG +++ T G+ VA+K +K + +E + E+ + +
Sbjct: 13 LGNGTYATVYKG-LNKTT--------GVYVALKEVKLD----SEEGTPSTAIREISLMKE 59
Query: 84 LRHENLVKLIGYCSESDNRLLVYEFMP---KGSLENHLFRKGVQPISWPTRVKIAIDVAR 140
L+HEN+V+L + LV+EFM K +++ + + + +
Sbjct: 60 LKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQ 119
Query: 141 GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD--GPTGDNTHVSTRIVGTRG 198
GL+F H + +++RDLK N+L++ KL DFGLAR P + +V T
Sbjct: 120 GLAFCH--ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSS---EVV-TLW 173
Query: 199 YAAPEYVATG--HLTPKSDVYSFGVVLLELLSGR----------------RALDEDRGGL 240
Y AP+ V G + D++S G +L E+++G+ + G
Sbjct: 174 YRAPD-VLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIM----GTP 228
Query: 241 AEQT------LVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNR 294
E L ++ + R LR L + + + L ++P R
Sbjct: 229 NESLWPSVTKLPKYNPNIQQRPPRDLR---QVLQPHTKEPLDGNLMDFLHGLLQLNPDMR 285
Query: 295 PSMVDVLTSLEQLH---TSKDMPRTPPPAKLHHHHHH 328
S L H + ++ HHHHHH
Sbjct: 286 LSAKQALH-----HPWFAEYYHHASMGGSRSHHHHHH 317
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-27
Identities = 69/307 (22%), Positives = 110/307 (35%), Gaps = 51/307 (16%)
Query: 10 PSASMISKIATKNFCSDY----LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKA 65
S+ + + LG G FG V + SG+ IK +
Sbjct: 7 HSSGRENLYFQGTIDDLFIFKRKLGSGAFGDVHLV---------EERSSGLERVIKTINK 57
Query: 66 ESFQGHKEWL-TEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQ 124
+ Q E + E+ L L H N++K+ + N +V E G L + +
Sbjct: 58 DRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQAR 117
Query: 125 PISWPTR--VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS---NFNAKLSDFGLAR 179
+ ++ + L++ H +V+++DLK N+L + K+ DFGLA
Sbjct: 118 GKALSEGYVAELMKQMMNALAYFHSQ--HVVHKDLKPENILFQDTSPHSPIKIIDFGLAE 175
Query: 180 DGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGG 239
+ ST GT Y APE V +T K D++S GVV+ LL+G
Sbjct: 176 ---LFKSDEHSTNAAGTALYMAPE-VFKRDVTFKCDIWSAGVVMYFLLTGCL-------- 223
Query: 240 LAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEA-----QAVAAVVLQCLHMDPKNR 294
PF S + + + ++ Q L DP+ R
Sbjct: 224 -----------PFTGTSLE--EVQQKATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERR 270
Query: 295 PSMVDVL 301
PS VL
Sbjct: 271 PSAAQVL 277
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-27
Identities = 62/278 (22%), Positives = 109/278 (39%), Gaps = 43/278 (15%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES-FQGHKEWLTEV-IYLGQLRH 86
+G G G V+K + T G V+A+K+++ + +K L ++ + L
Sbjct: 33 MGSGTCGQVWKM-RFRKT--------GHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDC 83
Query: 87 ENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLH 146
+V+ G + + + E M + + L ++ PI K+ + + + L +L
Sbjct: 84 PYIVQCFGTFITNTDVFIAMELMGTCAEK--LKKRMQGPIPERILGKMTVAIVKALYYLK 141
Query: 147 GLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTG--DNTHVSTRIVGTRGYAAPEY 204
VI+RD+K SN+LLD KL DFG++ G + R G Y APE
Sbjct: 142 E-KHGVIHRDVKPSNILLDERGQIKLCDFGIS-----GRLVDDKAKDRSAGCAAYMAPER 195
Query: 205 VATGHL-----TPKSDVYSFGVVLLELLSGRRALDEDRGGLAE-QTLVEWADPFLRDSRR 258
+ ++DV+S G+ L+EL +G+ + +++ P L
Sbjct: 196 IDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMG 255
Query: 259 VLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPS 296
+S V CL D + RP
Sbjct: 256 ------------FSGDFQSFVK----DCLTKDHRKRPK 277
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-27
Identities = 65/283 (22%), Positives = 122/283 (43%), Gaps = 52/283 (18%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHEN 88
+G+G G V+ +D T G VAI+++ + + + E++ + + ++ N
Sbjct: 28 IGQGASGTVYTA-MDVAT--------GQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 89 LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL 148
+V + D +V E++ GSL + + + + + + + L FLH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTET--CMDEGQIAAVCRECLQALEFLHSN 135
Query: 149 DANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR---IVGTRGYAAPEYV 205
VI+RD+K+ N+LL + + KL+DFG T ++ +VGT + APE V
Sbjct: 136 --QVIHRDIKSDNILLGMDGSVKLTDFGFC-----AQITPEQSKRSTMVGTPYWMAPEVV 188
Query: 206 ATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDS-RRVLRIMD 264
PK D++S G++ +E++ G P+L ++ R L ++
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGE-------------------PPYLNENPLRALYLIA 229
Query: 265 T----RLGG--QYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL 301
T L + S + +CL MD + R S ++L
Sbjct: 230 TNGTPELQNPEKLSAIFRDFLN----RCLEMDVEKRGSAKELL 268
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-27
Identities = 66/293 (22%), Positives = 122/293 (41%), Gaps = 65/293 (22%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHEN 88
LG+G FG V+K ++ T G + A K ++ +S + ++++ E+ L H
Sbjct: 27 LGDGAFGKVYKA-KNKET--------GALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77
Query: 89 LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI---DVARGLSFL 145
+VKL+G ++ EF P G+++ + + + + T +I + + L+FL
Sbjct: 78 IVKLLGAYYHDGKLWIMIEFCPGGAVDA-IMLELDRGL---TEPQIQVVCRQMLEALNFL 133
Query: 146 HGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR---IVGTRGYAAP 202
H +I+RDLKA NVL+ + +L+DFG++ N + +GT + AP
Sbjct: 134 HSK--RIIHRDLKAGNVLMTLEGDIRLADFGVS-----AKNLKTLQKRDSFIGTPYWMAP 186
Query: 203 EYVATGHLT-----PKSDVYSFGVVLLELLSGR---------RALDEDRGGLAEQTLVEW 248
E V + K+D++S G+ L+E+ R L + +
Sbjct: 187 EVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL---------LKIAKS 237
Query: 249 ADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL 301
P L ++S + + L +P+ RPS +L
Sbjct: 238 DPPTLLT------------PSKWSVEFRDFLK----IALDKNPETRPSAAQLL 274
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 3e-27
Identities = 65/292 (22%), Positives = 110/292 (37%), Gaps = 57/292 (19%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIK-----RLKAESFQGHKEWLTEVIYLGQ 83
+G+G F V + +G A+K + + ++ E
Sbjct: 32 IGKGPFSVVRRC---------INRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82
Query: 84 LRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRV--KIAIDVARG 141
L+H ++V+L+ S +V+EFM L + ++ + V +
Sbjct: 83 LKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEA 142
Query: 142 LSFLHGLDANVIYRDLKASNVLLDS---NFNAKLSDFGLARDGPTGDNTHVSTRIVGTRG 198
L + H N+I+RD+K VLL S + KL FG+A G++ V+ VGT
Sbjct: 143 LRYCHDN--NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ--LGESGLVAGGRVGTPH 198
Query: 199 YAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRR 258
+ APE V DV+ GV+L LLSG PF
Sbjct: 199 FMAPEVVKREPYGKPVDVWGCGVILFILLSGCL-------------------PFYGTKE- 238
Query: 259 VLRIMDTRLGGQYS---------KKEAQAVAAVVLQCLHMDPKNRPSMVDVL 301
R+ + + G+Y + A+ +V + L +DP R ++ + L
Sbjct: 239 --RLFEGIIKGKYKMNPRQWSHISESAK---DLVRRMLMLDPAERITVYEAL 285
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 4e-27
Identities = 63/212 (29%), Positives = 99/212 (46%), Gaps = 28/212 (13%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEW---LTEVIYLGQL 84
++G GGFG V+ K +G + A+K L + + + L E I L +
Sbjct: 196 IIGRGGFGEVY---------GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLV 246
Query: 85 RHEN---LVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKI-AIDVA 139
+ +V + Y + ++L + + M G L HL + GV + ++ A ++
Sbjct: 247 STGDCPFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA---DMRFYAAEII 302
Query: 140 RGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGY 199
GL +H V+YRDLK +N+LLD + + ++SD GLA D H VGT GY
Sbjct: 303 LGLEHMHNR--FVVYRDLKPANILLDEHGHVRISDLGLACDFS-KKKPH--AS-VGTHGY 356
Query: 200 AAPEYVATGHLTPKS-DVYSFGVVLLELLSGR 230
APE + G S D +S G +L +LL G
Sbjct: 357 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 4e-27
Identities = 76/309 (24%), Positives = 114/309 (36%), Gaps = 73/309 (23%)
Query: 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVI 79
F L+G G +G V+KG T G + AIK + +E E+
Sbjct: 23 AGIFELVELVGNGTYGQVYKG-RHVKT--------GQLAAIKVMDVTG-DEEEEIKQEIN 72
Query: 80 YLGQL-RHENLVKLIG-----YCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRV 132
L + H N+ G D++L LV EF GS+ + + +
Sbjct: 73 MLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTL---KEE 129
Query: 133 KIAI---DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHV 189
IA ++ RGLS LH VI+RD+K NVLL N KL DFG++
Sbjct: 130 WIAYICREILRGLSHLH--QHKVIHRDIKGQNVLLTENAEVKLVDFGVS-----AQLDRT 182
Query: 190 STR---IVGTRGYAAPEYVATGHLT-----PKSDVYSFGVVLLELLSGR---------RA 232
R +GT + APE +A KSD++S G+ +E+ G RA
Sbjct: 183 VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA 242
Query: 233 LDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPK 292
L + P L+ ++SKK + CL +
Sbjct: 243 L---------FLIPRNPAPRLKSK-------------KWSKKFQSFIE----SCLVKNHS 276
Query: 293 NRPSMVDVL 301
RP+ ++
Sbjct: 277 QRPATEQLM 285
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 7e-27
Identities = 61/210 (29%), Positives = 93/210 (44%), Gaps = 28/210 (13%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEW-----LTEVIYLGQ 83
+GEG +G V K +++T G +VAIK+ + + E+ L Q
Sbjct: 33 VGEGSYGMVMKC-RNKDT--------GRIVAIKKFLESDD---DKMVKKIAMREIKLLKQ 80
Query: 84 LRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLS 143
LRHENLV L+ C + LV+EF+ ++ + L + + K + G+
Sbjct: 81 LRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFP-NGLDYQVVQKYLFQIINGIG 138
Query: 144 FLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD--GPTGDNTHVSTRIVGTRGYAA 201
F H N+I+RD+K N+L+ + KL DFG AR P V TR Y A
Sbjct: 139 FCH--SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDD----EVATRWYRA 192
Query: 202 PEY-VATGHLTPKSDVYSFGVVLLELLSGR 230
PE V DV++ G ++ E+ G
Sbjct: 193 PELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 7e-27
Identities = 61/289 (21%), Positives = 119/289 (41%), Gaps = 64/289 (22%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHEN 88
+GEG G V ++++ G VA+K + Q + EV+ + +H N
Sbjct: 53 IGEGSTGIVCLA-REKHS--------GRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103
Query: 89 LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVK---IAI---DVARGL 142
+V++ + ++ EF+ G+L + I R+ IA V + L
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALTD---------IVSQVRLNEEQIATVCEAVLQAL 154
Query: 143 SFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR---IVGTRGY 199
++LH VI+RD+K+ ++LL + KLSDFG + + +VGT +
Sbjct: 155 AYLHAQ--GVIHRDIKSDSILLTLDGRVKLSDFGFC-----AQISKDVPKRKSLVGTPYW 207
Query: 200 AAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDS-RR 258
APE ++ + D++S G++++E++ G P+ DS +
Sbjct: 208 MAPEVISRSLYATEVDIWSLGIMVIEMVDGE-------------------PPYFSDSPVQ 248
Query: 259 VLRIMDT----RLGG--QYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL 301
++ + +L + S + + L DP+ R + ++L
Sbjct: 249 AMKRLRDSPPPKLKNSHKVSPVLRDFLE----RMLVRDPQERATAQELL 293
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 7e-27
Identities = 65/295 (22%), Positives = 107/295 (36%), Gaps = 51/295 (17%)
Query: 20 TKNFCSDY----LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWL 75
+ Y +G G +G V + G+ I A K++ + +
Sbjct: 4 KGDINQYYTLENTIGRGSWGEVKIA---------VQKGTRIRRAAKKIPKYFVEDVDRFK 54
Query: 76 TEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIA 135
E+ + L H N+++L ++ + LV E G L + K +I
Sbjct: 55 QEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKR--VFRESDAARIM 112
Query: 136 IDVARGLSFLHGLDANVIYRDLKASNVLLDS---NFNAKLSDFGLARDGPTGDNTHVSTR 192
DV +++ H L NV +RDLK N L + + KL DFGLA +
Sbjct: 113 KDVLSAVAYCHKL--NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAA---RFKPGKMMRT 167
Query: 193 IVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPF 252
VGT Y +P+ V G P+ D +S GV++ LL G PF
Sbjct: 168 KVGTPYYVSPQ-VLEGLYGPECDEWSAGVMMYVLLCGYP-------------------PF 207
Query: 253 LRDSRRVLRIMDTRLGGQYSKKEA------QAVAAVVLQCLHMDPKNRPSMVDVL 301
+ +M G ++ E +++ + L PK R + + L
Sbjct: 208 SAPTDS--EVMLKIREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQAL 260
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 9e-27
Identities = 61/341 (17%), Positives = 105/341 (30%), Gaps = 91/341 (26%)
Query: 20 TKNFCSDY----LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIK-----RLKAESFQG 70
Y +G+G +G V + + + AIK +++ + +
Sbjct: 21 LLELQKKYHLKGAIGQGSYGVVRVA---------IENQTRAIRAIKIMNKNKIRQINPKD 71
Query: 71 HKEWLTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPT 130
+ TEV + +L H N+ +L + LV E G L + L
Sbjct: 72 VERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCA 131
Query: 131 RV--------------------------------------KIAIDVARGLSFLHGLDANV 152
I + L +LH +
Sbjct: 132 MDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ--GI 189
Query: 153 IYRDLKASNVLLDSNFNA--KLSDFGLARDGPTGDNTHVS--TRIVGTRGYAAPEYVATG 208
+RD+K N L +N + KL DFGL+++ +N T GT + APE + T
Sbjct: 190 CHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTT 249
Query: 209 HL--TPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTR 266
+ PK D +S GV+L LL G PF + +
Sbjct: 250 NESYGPKCDAWSAGVLLHLLLMGAV-------------------PFPGVNDA--DTISQV 288
Query: 267 LGGQYS--KKEAQAVAA----VVLQCLHMDPKNRPSMVDVL 301
L + ++ ++ L+ + R + L
Sbjct: 289 LNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRAL 329
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-26
Identities = 59/215 (27%), Positives = 102/215 (47%), Gaps = 35/215 (16%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHEN 88
+G G FG V++ ++ G +VAIK++ Q + E+ + +L H N
Sbjct: 62 IGNGSFGVVYQA-KLCDS--------GELVAIKKV----LQDKRFKNRELQIMRKLDHCN 108
Query: 89 LVKLIGY-CSESDNRL-----LVYEFMPKGSLENHL--FRKGVQPISWPTRVKIAI-DVA 139
+V+L + S + + LV +++P+ ++ + + Q + VK+ + +
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLP-VIYVKLYMYQLF 166
Query: 140 RGLSFLHGLDANVIYRDLKASNVLLDSNFNA-KLSDFGLARD-GPTGDNTHVSTRIVGTR 197
R L+++H + +RD+K N+LLD + KL DFG A+ N + +R
Sbjct: 167 RSLAYIHS--FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY----ICSR 220
Query: 198 GYAAPEYV--ATGHLTPKSDVYSFGVVLLELLSGR 230
Y APE + AT T DV+S G VL ELL G+
Sbjct: 221 YYRAPELIFGAT-DYTSSIDVWSAGCVLAELLLGQ 254
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-26
Identities = 74/300 (24%), Positives = 118/300 (39%), Gaps = 59/300 (19%)
Query: 20 TKNFCSDY----LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRL-KAESFQGHKEW 74
F Y +LG+G FG V K + A+K + KA +
Sbjct: 17 QGTFAERYNIVCMLGKGSFGEVLKC---------KDRITQQEYAVKVINKASAKNKDTST 67
Query: 75 L-TEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVK 133
+ EV L +L H N++KL +S + +V E G L + + ++ S +
Sbjct: 68 ILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR--FSEHDAAR 125
Query: 134 IAIDVARGLSFLHGLDANVIYRDLKASNVLLDS---NFNAKLSDFGLARDGPTGDNTHVS 190
I V G++++H N+++RDLK N+LL+S + + K+ DFGL+
Sbjct: 126 IIKQVFSGITYMHKH--NIVHRDLKPENILLESKEKDCDIKIIDFGLST---CFQQNTKM 180
Query: 191 TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD 250
+GT Y APE V G K DV+S GV+L LLSG
Sbjct: 181 KDRIGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGTP------------------- 220
Query: 251 PFLRDSRRVLRIMDTRLGGQYS---------KKEAQAVAAVVLQCLHMDPKNRPSMVDVL 301
PF + I+ G+Y+ +A+ ++ + L P R + L
Sbjct: 221 PFYGKNEY--DILKRVETGKYAFDLPQWRTISDDAK---DLIRKMLTFHPSLRITATQCL 275
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-26
Identities = 49/216 (22%), Positives = 85/216 (39%), Gaps = 36/216 (16%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEW---LTEVIYLGQL 84
+LGEG F V + + AIK L+ + E + +L
Sbjct: 37 ILGEGSFSTVVLA---------RELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL 87
Query: 85 RHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVAR--- 140
H VKL + + D +L + G L ++ + G R
Sbjct: 88 DHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIG----------SFDETCTRFYT 136
Query: 141 -----GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVG 195
L +LHG +I+RDLK N+LL+ + + +++DFG A+ + VG
Sbjct: 137 AEIVSALEYLHGK--GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVG 194
Query: 196 TRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGR 230
T Y +PE + SD+++ G ++ +L++G
Sbjct: 195 TAQYVSPELLTEKSA-CKSSDLWALGCIIYQLVAGL 229
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 3e-26
Identities = 71/331 (21%), Positives = 122/331 (36%), Gaps = 66/331 (19%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGH---KEWLTEVIYLGQLR 85
+G G G V D VAIK+L + FQ K E++ + +
Sbjct: 70 IGSGAQGIVCAA-YDAVL--------DRNVAIKKL-SRPFQNQTHAKRAYRELVLMKCVN 119
Query: 86 HENLVKLI-----GYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVA 139
H+N++ L+ E + LV E M + +L + + + +
Sbjct: 120 HKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLCQVIQMELDHERMSYLLYQML 174
Query: 140 RGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGY 199
G+ LH A +I+RDLK SN+++ S+ K+ DFGLAR T + + T V TR Y
Sbjct: 175 CGIKHLH--SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYY 229
Query: 200 AAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL---------------------DEDRG 238
APE + D++S G ++ E++ + L E
Sbjct: 230 RAPEVILGMGYKENVDIWSVGCIMGEMV-RHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 288
Query: 239 GLAEQTLVEWADPFLRDSRRVLRI------MDTRLGGQYSKKEAQAVAAVVL--QCLHMD 290
L ++ + + + D+ + +A A L + L +D
Sbjct: 289 KLQPT-----VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVID 343
Query: 291 PKNRPSMVDVLTS--LEQLHTSKDMPRTPPP 319
P R S+ D L + + ++ PP
Sbjct: 344 PAKRISVDDALQHPYINVWYDPAEVEAPPPQ 374
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 5e-26
Identities = 52/220 (23%), Positives = 90/220 (40%), Gaps = 38/220 (17%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLT----EVIYLGQ 83
LLGEG +G V + D T A+K LK + + E+ L +
Sbjct: 12 LLGEGSYGKVKEVL-DSET--------LCRRAVKILKKKKLRRIPNGEANVKKEIQLLRR 62
Query: 84 LRHENLVKLIG-YCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVAR- 140
LRH+N+++L+ +E ++ +V E+ G E + + + + A
Sbjct: 63 LRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPEK-------RFPVCQAHG 113
Query: 141 -------GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRI 193
GL +LH ++++D+K N+LL + K+S G+A
Sbjct: 114 YFCQLIDGLEYLHSQ--GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTS 171
Query: 194 VGTRGYAAPEYVATGHLT---PKSDVYSFGVVLLELLSGR 230
G+ + PE +A G T K D++S GV L + +G
Sbjct: 172 QGSPAFQPPE-IANGLDTFSGFKVDIWSAGVTLYNITTGL 210
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 6e-26
Identities = 63/218 (28%), Positives = 99/218 (45%), Gaps = 38/218 (17%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKE-----WLTEVIYLGQ 83
+GEG +G VFK ++ T +VA+KR++ + E L E+ L +
Sbjct: 10 IGEGTYGTVFKA-KNRET--------HEIVALKRVRLDDD---DEGVPSSALREICLLKE 57
Query: 84 LRHENLVKLIGYCSESDNRLLVYEFMP---KGSLENHLFRKGVQPISWPTRVK-IAIDVA 139
L+H+N+V+L LV+EF K ++ + P VK +
Sbjct: 58 LKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN-----GDLD-PEIVKSFLFQLL 111
Query: 140 RGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD--GPTGDNTHVSTRIVGTR 197
+GL F H NV++RDLK N+L++ N KL++FGLAR P + +V T
Sbjct: 112 KGLGFCH--SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA---EVV-TL 165
Query: 198 GYAAPEYVATG--HLTPKSDVYSFGVVLLELLSGRRAL 233
Y P+ V G + D++S G + EL + R L
Sbjct: 166 WYRPPD-VLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 7e-26
Identities = 64/300 (21%), Positives = 112/300 (37%), Gaps = 61/300 (20%)
Query: 20 TKNFCSDY----LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWL 75
T N + +LG G F VF + +G + A+K +K
Sbjct: 4 TTNIRKTFIFMEVLGSGAFSEVFLV---------KQRLTGKLFALKCIKKSPAFRDSSLE 54
Query: 76 TEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTR--VK 133
E+ L +++HEN+V L + + LV + + G L + + +G + +
Sbjct: 55 NEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERG----VYTEKDASL 110
Query: 134 IAIDVARGLSFLHGLDANVIYRDLKASNVLLDS---NFNAKLSDFGLARDGPTGDNTHVS 190
+ V + +LH +++RDLK N+L + N ++DFGL++ G +
Sbjct: 111 VIQQVLSAVKYLHEN--GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG----IM 164
Query: 191 TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD 250
+ GT GY APE +A + D +S GV+ LL G
Sbjct: 165 STACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYP------------------- 205
Query: 251 PFLRDSRRVLRIMDTRLGGQYS---------KKEAQAVAAVVLQCLHMDPKNRPSMVDVL 301
PF ++ ++ + G Y + A+ + L DP R + L
Sbjct: 206 PFYEETES--KLFEKIKEGYYEFESPFWDDISESAK---DFICHLLEKDPNERYTCEKAL 260
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 8e-26
Identities = 67/335 (20%), Positives = 117/335 (34%), Gaps = 66/335 (19%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGH---KEWLTEVIYLGQLR 85
+G G G V D VAIK+L + FQ K E++ + +
Sbjct: 33 IGSGAQGIVCAA-YDAIL--------ERNVAIKKL-SRPFQNQTHAKRAYRELVLMKCVN 82
Query: 86 HENLVKLIG-YCSESDNRL-----LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVA 139
H+N++ L+ + + +V E M + +L + + + +
Sbjct: 83 HKNIIGLLNVFTPQKSLEEFQDVYIVMELM-----DANLCQVIQMELDHERMSYLLYQML 137
Query: 140 RGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGY 199
G+ LH A +I+RDLK SN+++ S+ K+ DFGLAR T + + T V TR Y
Sbjct: 138 CGIKHLH--SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYY 192
Query: 200 AAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL---------------------DEDRG 238
APE + D++S G ++ E++ L E
Sbjct: 193 RAPEVILGMGYKENVDIWSVGCIMGEMI-KGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK 251
Query: 239 GLAEQTLVEWADPFLRDSRRVLRI------MDTRLGGQYSKKEAQAVAAVVL--QCLHMD 290
L ++ + + D + +A A L + L +D
Sbjct: 252 KLQPT-----VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVID 306
Query: 291 PKNRPSMVDVLTS--LEQLHTSKDMPRTPPPAKLH 323
R S+ + L + + + PP
Sbjct: 307 ASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDK 341
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 8e-26
Identities = 58/213 (27%), Positives = 93/213 (43%), Gaps = 31/213 (14%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLT-EVIYLGQLRH 86
LGEG +G V +++ T VA+K + + E + E+ L H
Sbjct: 14 TLGEGAYGEVQLA-VNRVT--------EEAVAVKIVDMKRAVDCPENIKKEICINKMLNH 64
Query: 87 ENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVAR------ 140
EN+VK G+ E + + L E+ G L + + + A+
Sbjct: 65 ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI----------GMPEPDAQRFFHQL 114
Query: 141 --GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRG 198
G+ +LHG+ + +RD+K N+LLD N K+SDFGLA + + ++ GT
Sbjct: 115 MAGVVYLHGI--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 172
Query: 199 YAAPEYVA-TGHLTPKSDVYSFGVVLLELLSGR 230
Y APE + DV+S G+VL +L+G
Sbjct: 173 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 8e-26
Identities = 67/215 (31%), Positives = 106/215 (49%), Gaps = 35/215 (16%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKE-----WLTEVIYLGQ 83
LGEG F V+K D+NT +VAIK++K K+ L E+ L +
Sbjct: 18 LGEGQFATVYKA-RDKNT--------NQIVAIKKIKLGHRSEAKDGINRTALREIKLLQE 68
Query: 84 LRHENLVKLIGYCSESDNRLLVYEFMP---KGSLENHLFRKGVQPISWPTRVK-IAIDVA 139
L H N++ L+ N LV++FM + ++++ ++ P+ +K +
Sbjct: 69 LSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDN-----SLVLT-PSHIKAYMLMTL 122
Query: 140 RGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR--DGPTGDNTHVSTRIVGTR 197
+GL +LH +++RDLK +N+LLD N KL+DFGLA+ P TH ++V TR
Sbjct: 123 QGLEYLH--QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTH---QVV-TR 176
Query: 198 GYAAPE--YVATGHLTPKSDVYSFGVVLLELLSGR 230
Y APE + A D+++ G +L ELL
Sbjct: 177 WYRAPELLFGAR-MYGVGVDMWAVGCILAELLLRV 210
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 8e-26
Identities = 73/297 (24%), Positives = 126/297 (42%), Gaps = 62/297 (20%)
Query: 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVI 79
+ F LGEG +G V+K I + T G +VAIK++ E +E + E+
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKA-IHKET--------GQIVAIKQVPVE--SDLQEIIKEIS 76
Query: 80 YLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI--- 136
+ Q ++VK G ++ + +V E+ GS+ + + R + + T +IA
Sbjct: 77 IMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSD-IIRLRNKTL---TEDEIATILQ 132
Query: 137 DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR---I 193
+GL +LH + I+RD+KA N+LL++ +AKL+DFG+A G T + +
Sbjct: 133 STLKGLEYLHFM--RKIHRDIKAGNILLNTEGHAKLADFGVA-----GQLTDTMAKRNTV 185
Query: 194 VGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR---------RALDEDRGGLAEQT 244
+GT + APE + +D++S G+ +E+ G+ RA+
Sbjct: 186 IGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAI---------FM 236
Query: 245 LVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL 301
+ P R +S V QCL P+ R + +L
Sbjct: 237 IPTNPPPTFRKPEL------------WSDNFTDFVK----QCLVKSPEQRATATQLL 277
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 9e-26
Identities = 56/308 (18%), Positives = 99/308 (32%), Gaps = 57/308 (18%)
Query: 30 GEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ--GHKEWLTEVIYLGQLRHE 87
G V + T G V ++R+ E+ E+ H
Sbjct: 36 GFEDLMTVNLA-RYKPT--------GEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHP 86
Query: 88 NLVKLIGYCS-ESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI---DVARGL 142
N+V + +DN L +V FM GS ++ + + ++ IA V + L
Sbjct: 87 NIVPY--RATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELA---IAYILQGVLKAL 141
Query: 143 SFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFG----LARDGPTGDNTHVSTRI-VGTR 197
++H ++R +KAS++L+ + LS + G H + V
Sbjct: 142 DYIH--HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVL 199
Query: 198 GYAAPEYVATGHL--TPKSDVYSFGVVLLELLSGR---------RAL------------- 233
+ +PE + KSD+YS G+ EL +G + L
Sbjct: 200 PWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLD 259
Query: 234 -----DEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLH 288
E+ +++ + Y + + V QCL
Sbjct: 260 TSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQ 319
Query: 289 MDPKNRPS 296
+P RPS
Sbjct: 320 RNPDARPS 327
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 65/312 (20%), Positives = 109/312 (34%), Gaps = 60/312 (19%)
Query: 8 SDPSASMISKIATKNFCSDY----LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRL 63
+I + Y LG G FG V + T+ +G A K +
Sbjct: 140 WKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRV---------TERATGNNFAAKFV 190
Query: 64 KAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGV 123
+ E+ + LRH LV L + + +++YEFM G E LF K
Sbjct: 191 MTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGG--E--LFEKVA 246
Query: 124 QPISWPTRVKIAI---DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNA--KLSDFGLA 178
+ + + V +GL +H N ++ DLK N++ + + KL DFGL
Sbjct: 247 DEHNKMSEDEAVEYMRQVCKGLCHMHEN--NYVHLDLKPENIMFTTKRSNELKLIDFGLT 304
Query: 179 RDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRG 238
+ V GT +AAPE + +D++S GV+ LLSG
Sbjct: 305 AHLDPKQSVKV---TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLS------- 354
Query: 239 GLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYS---------KKEAQAVAAVVLQCLHM 289
PF ++ + ++ ++ + + + L
Sbjct: 355 ------------PFGGENDD--ETLRNVKSCDWNMDDSAFSGISEDGK---DFIRKLLLA 397
Query: 290 DPKNRPSMVDVL 301
DP R ++ L
Sbjct: 398 DPNTRMTIHQAL 409
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-25
Identities = 60/220 (27%), Positives = 98/220 (44%), Gaps = 39/220 (17%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEW----LTEVIYLGQL 84
G+G FG V G +++T G+ VAIK++ Q + L + L L
Sbjct: 31 AGQGTFGTVQLG-KEKST--------GMSVAIKKV----IQ-DPRFRNRELQIMQDLAVL 76
Query: 85 RHENLVKLI------GYCSESDNRL-LVYEFMPKGSLENHL--FRKGVQPISWPTRVKIA 135
H N+V+L G D L +V E++P +L + + P +K+
Sbjct: 77 HHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPP-PILIKVF 134
Query: 136 I-DVARGLSFLHGLDANVIYRDLKASNVLLD-SNFNAKLSDFGLARD-GPTGDNTHVSTR 192
+ + R + LH NV +RD+K NVL++ ++ KL DFG A+ P+ N
Sbjct: 135 LFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAY--- 191
Query: 193 IVGTRGYAAPEYV--ATGHLTPKSDVYSFGVVLLELLSGR 230
+ +R Y APE + H T D++S G + E++ G
Sbjct: 192 -ICSRYYRAPELIFGNQ-HYTTAVDIWSVGCIFAEMMLGE 229
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 5e-25
Identities = 58/213 (27%), Positives = 93/213 (43%), Gaps = 31/213 (14%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLT-EVIYLGQLRH 86
LGEG +G V +++ T VA+K + + E + E+ L H
Sbjct: 14 TLGEGAYGEVQLA-VNRVT--------EEAVAVKIVDMKRAVDCPENIKKEICINKMLNH 64
Query: 87 ENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVAR------ 140
EN+VK G+ E + + L E+ G L + + + A+
Sbjct: 65 ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI----------GMPEPDAQRFFHQL 114
Query: 141 --GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRG 198
G+ +LHG+ + +RD+K N+LLD N K+SDFGLA + + ++ GT
Sbjct: 115 MAGVVYLHGI--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 172
Query: 199 YAAPEYVA-TGHLTPKSDVYSFGVVLLELLSGR 230
Y APE + DV+S G+VL +L+G
Sbjct: 173 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 6e-25
Identities = 66/303 (21%), Positives = 113/303 (37%), Gaps = 64/303 (21%)
Query: 20 TKNFCSDY----LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIK-----RLKAESFQG 70
+ F +Y LG+G F V + +G+ A K +L A FQ
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRC---------VHKTTGLEFAAKIINTKKLSARDFQK 51
Query: 71 HKEWLTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPT 130
+ E +L+H N+V+L E LV++ + G L + + S
Sbjct: 52 LE---REARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF--YSEAD 106
Query: 131 RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS---NFNAKLSDFGLARDGPTGDNT 187
+ +++ H +++R+LK N+LL S KL+DFGLA +++
Sbjct: 107 ASHCIQQILESIAYCHSN--GIVHRNLKPENLLLASKAKGAAVKLADFGLAI---EVNDS 161
Query: 188 HVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVE 247
GT GY +PE + + D+++ GV+L LL G
Sbjct: 162 EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYP---------------- 205
Query: 248 WADPFLRDSRRVLRIMDTRLGGQYS---------KKEAQAVAAVVLQCLHMDPKNRPSMV 298
PF + + R+ G Y EA+ +++ L ++PK R +
Sbjct: 206 ---PFWDEDQH--RLYAQIKAGAYDYPSPEWDTVTPEAK---SLIDSMLTVNPKKRITAD 257
Query: 299 DVL 301
L
Sbjct: 258 QAL 260
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 6e-25
Identities = 79/316 (25%), Positives = 124/316 (39%), Gaps = 68/316 (21%)
Query: 6 AMSDPSASMISKIA--TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRL 63
++ DP + + K F +G G FG V+ D VVAIK++
Sbjct: 37 SLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFA-RDVRN--------SEVVAIKKM 87
Query: 64 KAESFQGHKEW---LTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFR 120
Q +++W + EV +L +LRH N ++ G LV E+ + +
Sbjct: 88 SYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVH 147
Query: 121 KGVQPISWPTRVKIAI---DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL 177
K P+ V+IA +GL++LH N+I+RD+KA N+LL KL DFG
Sbjct: 148 KK--PL---QEVEIAAVTHGALQGLAYLHSH--NMIHRDVKAGNILLSEPGLVKLGDFGS 200
Query: 178 ARDGPTGDNTHVSTR--IVGTRGYAAPEYVAT---GHLTPKSDVYSFGVVLLELLSGRRA 232
A + ++ VGT + APE + G K DV+S G+ +EL
Sbjct: 201 A--------SIMAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER--- 249
Query: 233 LDEDRGGLAEQTLVEWADPFLRD--SRRVLRIMDT----RL-GGQYSKKEAQAVAAVVLQ 285
P L + + L + L G +S+ V
Sbjct: 250 -----------------KPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVD----S 288
Query: 286 CLHMDPKNRPSMVDVL 301
CL P++RP+ +L
Sbjct: 289 CLQKIPQDRPTSEVLL 304
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 6e-25
Identities = 74/316 (23%), Positives = 122/316 (38%), Gaps = 63/316 (19%)
Query: 12 ASMISKIATKNFCSDY----LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIK------ 61
A++ +T F +Y +LG G V + I + T A+K
Sbjct: 4 AALPGSHSTHGFYENYEPKEILGRGVSSVVRRC-IHKPT--------CKEYAVKIIDVTG 54
Query: 62 --RLKAESFQGHKEWL-TEVIYLGQL-RHENLVKLIGYCSESDNRLLVYEFMPKGSLENH 117
AE Q +E EV L ++ H N+++L + LV++ M KG L ++
Sbjct: 55 GGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDY 114
Query: 118 LFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL 177
L K +S KI + + LH N+++RDLK N+LLD + N KL+DFG
Sbjct: 115 LTEKVT--LSEKETRKIMRALLEVICALH--KLNIVHRDLKPENILLDDDMNIKLTDFGF 170
Query: 178 ARDGPTGDNTHVSTRIVGTRGYAAPE------YVATGHLTPKSDVYSFGVVLLELLSGRR 231
+ G+ + GT Y APE + D++S GV++ LL+G
Sbjct: 171 SCQLDPGEKL---REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP 227
Query: 232 ALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYS------KKEAQAVAAVVLQ 285
PF + ++ + G Y + V +V +
Sbjct: 228 -------------------PFWHRKQM--LMLRMIMSGNYQFGSPEWDDYSDTVKDLVSR 266
Query: 286 CLHMDPKNRPSMVDVL 301
L + P+ R + + L
Sbjct: 267 FLVVQPQKRYTAEEAL 282
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 6e-25
Identities = 66/302 (21%), Positives = 110/302 (36%), Gaps = 57/302 (18%)
Query: 18 IATKNFCSDY----LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRL--KAESFQGH 71
I F +Y LG+G F V + K +G A + K S + H
Sbjct: 4 ITCTRFTEEYQLFEELGKGAFSVVRRC---------VKVLAGQEYAAMIINTKKLSARDH 54
Query: 72 KEWLTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTR 131
++ E L+H N+V+L SE + L+++ + G L + + S
Sbjct: 55 QKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREY--YSEADA 112
Query: 132 VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS---NFNAKLSDFGLARDGPTGDNTH 188
+ + H + V++R+LK N+LL S KL+DFGLA +
Sbjct: 113 SHCIQQILEAVLHCHQM--GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE--GEQQ 168
Query: 189 VSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEW 248
GT GY +PE + D+++ GV+L LL G
Sbjct: 169 AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYP----------------- 211
Query: 249 ADPFLRDSRRVLRIMDTRLGGQYS---------KKEAQAVAAVVLQCLHMDPKNRPSMVD 299
PF + + R+ G Y EA+ ++ + L ++P R + +
Sbjct: 212 --PFWDEDQH--RLYQQIKAGAYDFPSPEWDTVTPEAK---DLINKMLTINPSKRITAAE 264
Query: 300 VL 301
L
Sbjct: 265 AL 266
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 8e-25
Identities = 76/320 (23%), Positives = 120/320 (37%), Gaps = 66/320 (20%)
Query: 9 DPSASMISKIATKNFCSDY----LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIK--- 61
P + A K F Y ++G G V + +G A+K
Sbjct: 78 GPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRC---------VHRATGHEFAVKIME 128
Query: 62 ----RLKAESFQGHKEWL-TEVIYLGQLR-HENLVKLIGYCSESDNRLLVYEFMPKGSLE 115
RL E + +E E L Q+ H +++ LI S LV++ M KG L
Sbjct: 129 VTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELF 188
Query: 116 NHLFRKGVQPISWPTR--VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLS 173
++L K + + I + +SFLH N+++RDLK N+LLD N +LS
Sbjct: 189 DYLTEKV----ALSEKETRSIMRSLLEAVSFLHAN--NIVHRDLKPENILLDDNMQIRLS 242
Query: 174 DFGLARDGPTGDNTHVSTRIVGTRGYAAPE------YVATGHLTPKSDVYSFGVVLLELL 227
DFG + G+ + GT GY APE + D+++ GV+L LL
Sbjct: 243 DFGFSCHLEPGEKL---RELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLL 299
Query: 228 SGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEA------QAVAA 281
+G PF + ++ + GQY V
Sbjct: 300 AGSP-------------------PFWHRRQI--LMLRMIMEGQYQFSSPEWDDRSSTVKD 338
Query: 282 VVLQCLHMDPKNRPSMVDVL 301
++ + L +DP+ R + L
Sbjct: 339 LISRLLQVDPEARLTAEQAL 358
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 8e-25
Identities = 56/300 (18%), Positives = 106/300 (35%), Gaps = 54/300 (18%)
Query: 17 KIATKNFCSDY----LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHK 72
++ + Y LG G FG V + + +G V K +
Sbjct: 43 EVKQGSVYDYYDILEELGSGAFGVVHRC---------VEKATGRVFVAKFINTPYPLDKY 93
Query: 73 EWLTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRV 132
E+ + QL H L+ L + +L+ EF+ G L + + + + +S +
Sbjct: 94 TVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK-MSEAEVI 152
Query: 133 KIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNA--KLSDFGLARDGPTGDNTHVS 190
GL +H ++++ D+K N++ ++ + K+ DFGLA + +
Sbjct: 153 NYMRQACEGLKHMHEH--SIVHLDIKPENIMCETKKASSVKIIDFGLAT---KLNPDEIV 207
Query: 191 TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD 250
T +AAPE V + +D+++ GV+ LLSG
Sbjct: 208 KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLS------------------- 248
Query: 251 PFLRDSRRVLRIMDTRLGGQYS---------KKEAQAVAAVVLQCLHMDPKNRPSMVDVL 301
PF + + + EA+ + L +P+ R ++ D L
Sbjct: 249 PFAGEDDL--ETLQNVKRCDWEFDEDAFSSVSPEAK---DFIKNLLQKEPRKRLTVHDAL 303
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-24
Identities = 48/218 (22%), Positives = 92/218 (42%), Gaps = 29/218 (13%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHEN 88
+G G +G V+K A+K+++ E+ L +L+H N
Sbjct: 29 VGRGTYGHVYKAK-------RKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPN 79
Query: 89 LVKLIG-YCSESDNRL-LVYEFMP---KGSLENHLFRKGVQ---PISWPTRVKIAIDVAR 140
++ L + S +D ++ L++++ ++ H K + + + +
Sbjct: 80 VISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILD 139
Query: 141 GLSFLHGLDANVIYRDLKASNVLLDSNFNA----KLSDFGLAR--DGPTGDNTHVSTRIV 194
G+ +LH V++RDLK +N+L+ K++D G AR + P + +V
Sbjct: 140 GIHYLH--ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 197
Query: 195 GTRGYAAPEYVATG--HLTPKSDVYSFGVVLLELLSGR 230
T Y APE + G H T D+++ G + ELL+
Sbjct: 198 -TFWYRAPE-LLLGARHYTKAIDIWAIGCIFAELLTSE 233
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-24
Identities = 71/236 (30%), Positives = 111/236 (47%), Gaps = 30/236 (12%)
Query: 5 IAMSDPSASMISKIATKNFCSDYL--LGEGGFGCVF---KGWIDQNTFAPTKPGSGIVVA 59
IA++ K F + L LG+G FG VF K + + + A
Sbjct: 8 IAITHHVKEGHEKADPSQF--ELLKVLGQGSFGKVFLVKK---------ISGSDARQLYA 56
Query: 60 IKRLKAESFQGHKEW--LTEVIYLGQLRHENLVKLIGYCSESDNRL-LVYEFMPKGSLEN 116
+K LK + + E L ++ H +VKL Y +++ +L L+ +F+ G L
Sbjct: 57 MKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFT 115
Query: 117 HLFRKGVQPISWPTRVKI-AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDF 175
L ++ + VK ++A L LH L +IYRDLK N+LLD + KL+DF
Sbjct: 116 RLSKEVMFTEE---DVKFYLAELALALDHLHSL--GIIYRDLKPENILLDEEGHIKLTDF 170
Query: 176 GLARDGPTGDNTHVSTRIVGTRGYAAPEYVA-TGHLTPKSDVYSFGVVLLELLSGR 230
GL+++ + + GT Y APE V GH T +D +SFGV++ E+L+G
Sbjct: 171 GLSKESIDHEKK--AYSFCGTVEYMAPEVVNRRGH-TQSADWWSFGVLMFEMLTGT 223
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-24
Identities = 68/345 (19%), Positives = 121/345 (35%), Gaps = 77/345 (22%)
Query: 6 AMSDPSASMISKIATKNFCSDY----LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIK 61
+ + + S Y LLG GGFG V+ G + + VAIK
Sbjct: 24 CNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSG---------IRVSDNLPVAIK 74
Query: 62 -----RLKAESFQGHKEWLT-EVIYLGQLRHE--NLVKLIGYCSESDNRLLVYEF-MPKG 112
R+ + + EV+ L ++ +++L+ + D+ +L+ E P
Sbjct: 75 HVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQ 134
Query: 113 SLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSN-FNAK 171
L + + +G + V + H V++RD+K N+L+D N K
Sbjct: 135 DLFDFITERG--ALQEELARSFFWQVLEAVRHCHNC--GVLHRDIKDENILIDLNRGELK 190
Query: 172 LSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHL--TPKSDVYSFGVVLLELLSG 229
L DFG GTR Y+ PE++ H + V+S G++L +++ G
Sbjct: 191 LIDFGSG-ALLKDTVYTDF---DGTRVYSPPEWIR-YHRYHGRSAAVWSLGILLYDMVCG 245
Query: 230 RRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSK-----KEAQAVAAVVL 284
PF ++R GQ E Q ++
Sbjct: 246 DI-------------------PF-EHDEEIIR-------GQVFFRQRVSSECQ---HLIR 275
Query: 285 QCLHMDPKNRPSMVDVLT--------SLEQLHTSKDMPRTPPPAK 321
CL + P +RP+ ++ ++ +P P+K
Sbjct: 276 WCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPGPSK 320
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-24
Identities = 62/241 (25%), Positives = 109/241 (45%), Gaps = 39/241 (16%)
Query: 5 IAMSDPSASMISKIATKNFCSDYL----LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAI 60
+ +S + + Y +GEG +G V+K +++ G +VA+
Sbjct: 1 MHHHHHHSSGRENLYFQGLMEKYQKLEKVGEGTYGVVYKA---KDS-------QGRIVAL 50
Query: 61 KRLKAESFQGHKE-----WLTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMP---KG 112
KR++ ++ E + E+ L +L H N+V LI LV+EFM K
Sbjct: 51 KRIRLDAE---DEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKK 107
Query: 113 SLENHLFRKGVQPISWPTRVK-IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAK 171
L+ + + +++K + RG++ H +++RDLK N+L++S+ K
Sbjct: 108 VLDENK-----TGLQ-DSQIKIYLYQLLRGVAHCH--QHRILHRDLKPQNLLINSDGALK 159
Query: 172 LSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG--HLTPKSDVYSFGVVLLELLSG 229
L+DFGLAR G T V T Y AP+ V G + D++S G + E+++G
Sbjct: 160 LADFGLAR--AFGIPVRSYTHEVVTLWYRAPD-VLMGSKKYSTSVDIWSIGCIFAEMITG 216
Query: 230 R 230
+
Sbjct: 217 K 217
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-24
Identities = 83/319 (26%), Positives = 135/319 (42%), Gaps = 49/319 (15%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGH---KEWLTEVIYLGQLR 85
+GEG +G V D + VAIK++ F+ + L E+ L + R
Sbjct: 35 IGEGAYGMVCSA-YDNLN--------KVRVAIKKISP--FEHQTYCQRTLREIKILLRFR 83
Query: 86 HENLVKLIG----YCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVK-IAIDVA 139
HEN++ + E + +V + M + L + Q +S + +
Sbjct: 84 HENIIGINDIIRAPTIEQMKDVYIVQDLM--ETDLYKLLKT--QHLS-NDHICYFLYQIL 138
Query: 140 RGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR-DGPTGDNTHVSTRIVGTRG 198
RGL ++H ANV++RDLK SN+LL++ + K+ DFGLAR P D+T T V TR
Sbjct: 139 RGLKYIHS--ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 196
Query: 199 YAAPEYV-ATGHLTPKSDVYSFGVVLLELLSGR------------RALDEDRGGLAEQTL 245
Y APE + + T D++S G +L E+LS R + G +++ L
Sbjct: 197 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 256
Query: 246 VEWADPFLRDSRRVLRIMDTRLGGQYSKK--EAQAVAAVVLQ-CLHMDPKNRPSMVDVLT 302
+ +R L + + +++ A + A +L L +P R + L
Sbjct: 257 NCIINL---KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313
Query: 303 S--LEQLHTSKDMPRTPPP 319
LEQ + D P P
Sbjct: 314 HPYLEQYYDPSDEPIAEAP 332
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 3e-24
Identities = 70/306 (22%), Positives = 121/306 (39%), Gaps = 61/306 (19%)
Query: 20 TKNFCSDY----LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIK-----RLKAESFQG 70
K +Y LG G G V ++ T VAI+ + S +
Sbjct: 130 PKALRDEYIMSKTLGSGACGEVKLA-FERKT--------CKKVAIRIISKRKFAIGSARE 180
Query: 71 HKEWL---TEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPIS 127
L TE+ L +L H ++K+ + ++++ +V E M G L + + +
Sbjct: 181 ADPALNVETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNK--RLK 237
Query: 128 WPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS---NFNAKLSDFGLARDGPTG 184
T + + +LH + +I+RDLK NVLL S + K++DFG ++ G
Sbjct: 238 EATCKLYFYQMLLAVQYLH--ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LG 293
Query: 185 DNTHVSTRIVGTRGYAAPEYVATGHL---TPKSDVYSFGVVLLELLSGRRALDEDRGGLA 241
+ + + T + GT Y APE + + D +S GV+L LSG
Sbjct: 294 ETSLMRT-LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGY----------- 341
Query: 242 EQTLVEWADPFLRDSRRVLRIMDTRLGGQYS------KKEAQAVAAVVLQCLHMDPKNRP 295
PF +V + D G+Y+ + ++ +V + L +DPK R
Sbjct: 342 --------PPFSEHRTQV-SLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARF 392
Query: 296 SMVDVL 301
+ + L
Sbjct: 393 TTEEAL 398
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-24
Identities = 64/307 (20%), Positives = 113/307 (36%), Gaps = 58/307 (18%)
Query: 13 SMISKIATKNFCSDY----LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF 68
S A+ F +Y LG+G F V + +G+ A K + +
Sbjct: 17 SEFMMNASTKFSDNYDVKEELGKGAFSVVRRC---------VHKTTGLEFAAKIINTKKL 67
Query: 69 QG--HKEWLTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPI 126
++ E +L+H N+V+L E LV++ + G L + +
Sbjct: 68 SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF--Y 125
Query: 127 SWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS---NFNAKLSDFGLARDGPT 183
S + +++ H +++R+LK N+LL S KL+DFGLA
Sbjct: 126 SEADASHCIQQILESIAYCHSN--GIVHRNLKPENLLLASKAKGAAVKLADFGLAI---E 180
Query: 184 GDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQ 243
+++ GT GY +PE + + D+++ GV+L LL G
Sbjct: 181 VNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYP------------ 228
Query: 244 TLVEWADPFLRDSRRVLRIMDTRLGGQYS---------KKEAQAVAAVVLQCLHMDPKNR 294
PF + + R+ G Y EA+ +++ L ++PK R
Sbjct: 229 -------PFWDEDQH--RLYAQIKAGAYDYPSPEWDTVTPEAK---SLIDSMLTVNPKKR 276
Query: 295 PSMVDVL 301
+ L
Sbjct: 277 ITADQAL 283
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-24
Identities = 61/307 (19%), Positives = 109/307 (35%), Gaps = 62/307 (20%)
Query: 17 KIATKNFCSDY-----LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRL-KAESFQG 70
+ DY +LG G G V + +G A+K L + +
Sbjct: 20 EPKKYAVTDDYQLSKQVLGLGVNGKVLEC---------FHRRTGQKCALKLLYDSPKAR- 69
Query: 71 HKEWLTEVIYLGQL-RHENLVKLIGYCSESDNR----LLVYEFMPKGSLENHLFRKGVQP 125
EV + Q ++V ++ + L++ E M G L + + +G Q
Sbjct: 70 -----QEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQA 124
Query: 126 ISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLL---DSNFNAKLSDFGLARDGP 182
+ +I D+ + FLH N+ +RD+K N+L + + KL+DFG A++
Sbjct: 125 FTEREAAEIMRDIGTAIQFLH--SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT 182
Query: 183 TGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAE 242
+ T T Y APE + D++S GV++ LL G
Sbjct: 183 QNA---LQT-PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFP----------- 227
Query: 243 QTLVEWADPFLRDSRRVL--RIMDTRLGGQYSKKEA------QAVAAVVLQCLHMDPKNR 294
PF ++ + + + GQY + ++ L DP R
Sbjct: 228 --------PFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTER 279
Query: 295 PSMVDVL 301
++ +
Sbjct: 280 LTITQFM 286
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 4e-24
Identities = 78/332 (23%), Positives = 118/332 (35%), Gaps = 67/332 (20%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEW-----------LTE 77
+ G +G V G +D GI VAIKR+ G L E
Sbjct: 30 ISSGSYGAVCAG-VDS---------EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLRE 79
Query: 78 VIYLGQLRHENLVKL----IGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRV 132
+ L H N++ L + + + ++L LV E M L + IS P +
Sbjct: 80 IRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DL-AQVIHDQRIVIS-PQHI 136
Query: 133 K-IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVST 191
+ + GL LH +A V++RDL N+LL N + + DF LAR T
Sbjct: 137 QYFMYHILLGLHVLH--EAGVVHRDLHPGNILLADNNDITICDFNLAR---EDTADANKT 191
Query: 192 RIVGTRGYAAPEYV-ATGHLTPKSDVYSFGVVLLELLSGRRAL----------------- 233
V R Y APE V T D++S G V+ E+ R+AL
Sbjct: 192 HYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMF-NRKALFRGSTFYNQLNKIVEVV 250
Query: 234 ----DEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHM 289
ED + + A +LR+S + + A+ ++ + L
Sbjct: 251 GTPKIEDVVMFSSPS----ARDYLRNSLSNVPARA--WTAVVPTADPVAL-DLIAKMLEF 303
Query: 290 DPKNRPSMVDVLTS--LEQLHTSKDMPRTPPP 319
+P+ R S L E L D+
Sbjct: 304 NPQRRISTEQALRHPYFESLFDPLDLTEGLSE 335
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 5e-24
Identities = 57/228 (25%), Positives = 98/228 (42%), Gaps = 23/228 (10%)
Query: 10 PSASMISKIATKNFCSDY------LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRL 63
P I S Y +LG G FG V K + +G+ +A K +
Sbjct: 72 PFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKC---------EETATGLKLAAKII 122
Query: 64 KAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGV 123
K + +E E+ + QL H NL++L ++ +LV E++ G L + + +
Sbjct: 123 KTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESY 182
Query: 124 QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNA--KLSDFGLARDG 181
++ + + G+ +H + +++ DLK N+L + K+ DFGLAR
Sbjct: 183 N-LTELDTILFMKQICEGIRHMHQM--YILHLDLKPENILCVNRDAKQIKIIDFGLARRY 239
Query: 182 PTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSG 229
+ V GT + APE V ++ +D++S GV+ LLSG
Sbjct: 240 KPREKLKV---NFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSG 284
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 5e-24
Identities = 60/215 (27%), Positives = 97/215 (45%), Gaps = 39/215 (18%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKE-----WLTEVIYLGQ 83
LGEG + V+KG +VA+K ++ E H+E + EV L
Sbjct: 10 LGEGTYATVYKGKSKLT---------DNLVALKEIRLE----HEEGAPCTAIREVSLLKD 56
Query: 84 LRHENLVKLIGYCSESDNRLLVYEFMP---KGSLENHLFRKGVQPISWPTRVK-IAIDVA 139
L+H N+V L + LV+E++ K L++ I+ VK +
Sbjct: 57 LKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCG-----NIIN-MHNVKLFLFQLL 110
Query: 140 RGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD--GPTGDNTHVSTRIVGTR 197
RGL++ H V++RDLK N+L++ KL+DFGLAR PT + +V T
Sbjct: 111 RGLAYCH--RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDN---EVV-TL 164
Query: 198 GYAAPEYVATG--HLTPKSDVYSFGVVLLELLSGR 230
Y P+ + G + + D++ G + E+ +GR
Sbjct: 165 WYRPPD-ILLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 5e-24
Identities = 62/227 (27%), Positives = 96/227 (42%), Gaps = 50/227 (22%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKE-----WLTEVIYLGQ 83
+G+G FG VFK + T G VA+K++ E+ KE L E+ L
Sbjct: 25 IGQGTFGEVFKA-RHRKT--------GQKVALKKVLMENE---KEGFPITALREIKILQL 72
Query: 84 LRHENLVKLIGYCSESDNRL--------LVYEFMP---KGSLENHLFRKGVQPISWPTRV 132
L+HEN+V LI C + LV++F G L N L +
Sbjct: 73 LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL-----VKFTLSEIK 127
Query: 133 KIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR--DGPTGDNTHVS 190
++ + GL ++H +++RD+KA+NVL+ + KL+DFGLAR +
Sbjct: 128 RVMQMLLNGLYYIH--RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 185
Query: 191 TRIVGTRGYAAPE-------YVATGHLTPKSDVYSFGVVLLELLSGR 230
T V T Y PE Y P D++ G ++ E+ +
Sbjct: 186 TNRVVTLWYRPPELLLGERDY------GPPIDLWGAGCIMAEMWTRS 226
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 7e-24
Identities = 72/309 (23%), Positives = 112/309 (36%), Gaps = 48/309 (15%)
Query: 20 TKNFCSDY-----LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEW 74
+ F Y +LGEG V + A+K ++ +
Sbjct: 7 SGRFEDVYQLQEDVLGEGAHARVQTC---------INLITSQEYAVKIIEKQPGHIRSRV 57
Query: 75 LTEVIYLGQLR-HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTR-- 131
EV L Q + H N+++LI + E D LV+E M GS+ +H+ ++ +
Sbjct: 58 FREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRR----HFNELEA 113
Query: 132 VKIAIDVARGLSFLHGLDANVIYRDLKASNVLL---DSNFNAKLSDFGLAR-----DGPT 183
+ DVA L FLH + +RDLK N+L + K+ DF L +
Sbjct: 114 SVVVQDVASALDFLHNK--GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCS 171
Query: 184 GDNTHVSTRIVGTRGYAAPEYVATGHLTPKS-----DVYSFGVVLLELLSGRRALDEDRG 238
+T G+ Y APE V D++S GV+L LLSG
Sbjct: 172 PISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFV---- 227
Query: 239 GLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYS--KKEAQAV--AA--VVLQCLHMDPK 292
D + ++ G+Y K+ + AA ++ + L D K
Sbjct: 228 --GRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAK 285
Query: 293 NRPSMVDVL 301
R S VL
Sbjct: 286 QRLSAAQVL 294
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 98.0 bits (245), Expect = 7e-24
Identities = 63/219 (28%), Positives = 101/219 (46%), Gaps = 44/219 (20%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIK-----RLKAESFQGHKEWLTEVIYLG 82
LG G FG V G Q T G VA+K ++++ G + E+ L
Sbjct: 18 TLGVGTFGKVKIG-EHQLT--------GHKVAVKILNRQKIRSLDVVGKIK--REIQNLK 66
Query: 83 QLRHENLVKLIGY-CSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVAR 140
RH +++KL Y + +V E++ G L +++ + G ++ AR
Sbjct: 67 LFRHPHIIKL--YQVISTPTDFFMVMEYVSGGELFDYICKHG----------RVEEMEAR 114
Query: 141 --------GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR 192
+ + H V++RDLK NVLLD++ NAK++DFGL+ G+ S
Sbjct: 115 RLFQQILSAVDYCHRH--MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS-- 170
Query: 193 IVGTRGYAAPEYVA-TGHLTPKSDVYSFGVVLLELLSGR 230
G+ YAAPE ++ + P+ D++S GV+L LL G
Sbjct: 171 -CGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGT 208
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 8e-24
Identities = 58/215 (26%), Positives = 96/215 (44%), Gaps = 39/215 (18%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKE-----WLTEVIYLGQ 83
+GEG +G V+K + G A+K+++ E E + E+ L +
Sbjct: 10 IGEGTYGVVYKA----------QNNYGETFALKKIRLEKE---DEGIPSTTIREISILKE 56
Query: 84 LRHENLVKLIGYCSESDNRLLVYEFMP---KGSLENHLFRKGVQPISWPTRVK-IAIDVA 139
L+H N+VKL +LV+E + K L+ + K + +
Sbjct: 57 LKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCE-----GGLE-SVTAKSFLLQLL 110
Query: 140 RGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD--GPTGDNTHVSTRIVGTR 197
G+++ H D V++RDLK N+L++ K++DFGLAR P TH IV T
Sbjct: 111 NGIAYCH--DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH---EIV-TL 164
Query: 198 GYAAPEYVATG--HLTPKSDVYSFGVVLLELLSGR 230
Y AP+ V G + D++S G + E+++G
Sbjct: 165 WYRAPD-VLMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 9e-24
Identities = 59/263 (22%), Positives = 102/263 (38%), Gaps = 40/263 (15%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEW---LTEVIYLGQL 84
+G+G FG V K + + A+K + + E E+ + L
Sbjct: 22 AIGKGSFGKVCIV---------QKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGL 72
Query: 85 RHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKI-AIDVARGL 142
H LV L Y + + + +V + + G L HL + VK+ ++ L
Sbjct: 73 EHPFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEE---TVKLFICELVMAL 128
Query: 143 SFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAP 202
+L +I+RD+K N+LLD + + ++DF +A P T + GT+ Y AP
Sbjct: 129 DYLQNQ--RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI---TTMAGTKPYMAP 183
Query: 203 EYVA----TGHLTPKSDVYSFGVVLLELLSGRR----ALDEDRGGLAEQTL---VEWADP 251
E + G+ + D +S GV ELL GRR + V +
Sbjct: 184 EMFSSRKGAGY-SFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSA 242
Query: 252 FLRDSRRVLRIM-----DTRLGG 269
+ ++ +L+ + D R
Sbjct: 243 WSQEMVSLLKKLLEPNPDQRFSQ 265
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 9e-24
Identities = 57/229 (24%), Positives = 93/229 (40%), Gaps = 30/229 (13%)
Query: 15 ISKIATKNFCSDY----LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIK-----RLKA 65
+ + Y LG G F V K + +G+ A K + +A
Sbjct: 2 METFKQQKVEDFYDIGEELGSGQFAIVKKC---------REKSTGLEYAAKFIKKRQSRA 52
Query: 66 ESFQGHKEWL-TEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQ 124
+E + EV L Q+ H N++ L + +L+ E + G L + L +K
Sbjct: 53 SRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKES- 111
Query: 125 PISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS----NFNAKLSDFGLARD 180
+S + G+++LH + + DLK N++L + KL DFGLA
Sbjct: 112 -LSEEEATSFIKQILDGVNYLHTK--KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH- 167
Query: 181 GPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSG 229
++ I GT + APE V L ++D++S GV+ LLSG
Sbjct: 168 --EIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 1e-23
Identities = 54/215 (25%), Positives = 98/215 (45%), Gaps = 36/215 (16%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHEN 88
+G G FG VF+ + V AIK++ + + E+ + ++H N
Sbjct: 48 IGNGSFGVVFQA-KLVES--------DEV-AIKKVLQDK----RFKNRELQIMRIVKHPN 93
Query: 89 LVKLIGYCSESDNRL------LVYEFMPKGSLENHL--FRKGVQPISWPTRVKIAI-DVA 139
+V L + + ++ LV E++P+ ++ + K Q + +K+ + +
Sbjct: 94 VVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMP-MLLIKLYMYQLL 151
Query: 140 RGLSFLHGLDANVIYRDLKASNVLLDSNFNA-KLSDFGLARD-GPTGDNTHVSTRIVGTR 197
R L+++H + +RD+K N+LLD KL DFG A+ N + +R
Sbjct: 152 RSLAYIHS--IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSY----ICSR 205
Query: 198 GYAAPEYV--ATGHLTPKSDVYSFGVVLLELLSGR 230
Y APE + AT + T D++S G V+ EL+ G+
Sbjct: 206 YYRAPELIFGAT-NYTTNIDIWSTGCVMAELMQGQ 239
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 67/208 (32%), Positives = 95/208 (45%), Gaps = 21/208 (10%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEW---LTEVIYLGQL 84
LLG+G FG V + +G A+K LK E E LTE L
Sbjct: 155 LLGKGTFGKVILV---------KEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS 205
Query: 85 RHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKI-AIDVARGL 142
RH L L Y ++ +RL V E+ G L HL R+ V R + ++ L
Sbjct: 206 RHPFLTALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSED---RARFYGAEIVSAL 261
Query: 143 SFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAP 202
+LH + NV+YRDLK N++LD + + K++DFGL ++G T GT Y AP
Sbjct: 262 DYLHS-EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKTFCGTPEYLAP 318
Query: 203 EYVATGHLTPKSDVYSFGVVLLELLSGR 230
E + D + GVV+ E++ GR
Sbjct: 319 EVLEDNDYGRAVDWWGLGVVMYEMMCGR 346
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 1e-23
Identities = 59/296 (19%), Positives = 111/296 (37%), Gaps = 55/296 (18%)
Query: 21 KNFCSDY----LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLT 76
K Y LG G FG V + + S K +K +
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRC---------VETSSKKTYMAKFVKVKG-TDQVLVKK 50
Query: 77 EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 136
E+ L RH N++ L + ++++EF+ + + + ++ V
Sbjct: 51 EISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFE-LNEREIVSYVH 109
Query: 137 DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNA--KLSDFGLARDGPTGDNTHVSTRIV 194
V L FLH N+ + D++ N++ + ++ K+ +FG AR GDN + +
Sbjct: 110 QVCEALQFLHSH--NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LF 164
Query: 195 GTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLR 254
Y APE ++ +D++S G ++ LLSG PFL
Sbjct: 165 TAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGIN-------------------PFLA 205
Query: 255 DSRRVLRIMDTRLGGQYS---------KKEAQAVAAVVLQCLHMDPKNRPSMVDVL 301
++ + +I++ + +Y+ EA V + L + K+R + + L
Sbjct: 206 ETNQ--QIIENIMNAEYTFDEEAFKEISIEAM---DFVDRLLVKERKSRMTASEAL 256
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 2e-23
Identities = 71/318 (22%), Positives = 127/318 (39%), Gaps = 52/318 (16%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGH---KEWLTEVIYLGQLR 85
+G G +G V ID+ + G VAIK+L + FQ K E++ L ++
Sbjct: 32 VGSGAYGSVCSA-IDKRS--------GEKVAIKKL-SRPFQSEIFAKRAYRELLLLKHMQ 81
Query: 86 HENLVKLI-----GYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVA 139
HEN++ L+ + LV FM + L + S + +
Sbjct: 82 HENVIGLLDVFTPASSLRNFYDFYLVMPFM-----QTDLQKIMGLKFSEEKIQYLVYQML 136
Query: 140 RGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGY 199
+GL ++H A V++RDLK N+ ++ + K+ DFGLAR T V TR Y
Sbjct: 137 KGLKYIHS--AGVVHRDLKPGNLAVNEDCELKILDFGLAR-----HADAEMTGYVVTRWY 189
Query: 200 AAPEYV-ATGHLTPKSDVYSFGVVLLELLSGR------------RALDEDRGGLAEQTLV 246
APE + + H D++S G ++ E+L+G+ + + G + +
Sbjct: 190 RAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQ 249
Query: 247 EWADPFLRDSRRVLRIMDTRLGGQYSKKEAQA-VAAVVL--QCLHMDPKNRPSMVDVLTS 303
+ D ++ ++ + +++ +A A L + L +D R + LT
Sbjct: 250 KLNDKA---AKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306
Query: 304 --LEQLHTSKDMPRTPPP 319
E ++ P
Sbjct: 307 PFFEPFRDPEEETEAQQP 324
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 2e-23
Identities = 64/209 (30%), Positives = 98/209 (46%), Gaps = 24/209 (11%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEW---LTEVIYLGQL 84
LLG+G FG V + +G A+K L+ E E +TE L
Sbjct: 12 LLGKGTFGKVILV---------REKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 62
Query: 85 RHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKI-AIDVARGL 142
RH L L Y ++ +RL V E+ G L HL R+ V R + ++ L
Sbjct: 63 RHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEE---RARFYGAEIVSAL 118
Query: 143 SFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAP 202
+LH +V+YRD+K N++LD + + K++DFGL ++G + T + T GT Y AP
Sbjct: 119 EYLHSR--DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-MKT-FCGTPEYLAP 174
Query: 203 EYVA-TGHLTPKSDVYSFGVVLLELLSGR 230
E + + D + GVV+ E++ GR
Sbjct: 175 EVLEDNDY-GRAVDWWGLGVVMYEMMCGR 202
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 2e-23
Identities = 58/226 (25%), Positives = 92/226 (40%), Gaps = 30/226 (13%)
Query: 18 IATKNFCSDY----LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIK-----RLKAESF 68
+ Y LG G F V K + +G+ A K + +A
Sbjct: 5 FKQQKVEDFYDIGEELGSGQFAIVKKC---------REKSTGLEYAAKFIKKRQSRASRR 55
Query: 69 QGHKEWL-TEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPIS 127
+E + EV L Q+ H N++ L + +L+ E + G L + L +K +S
Sbjct: 56 GVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES--LS 113
Query: 128 WPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS----NFNAKLSDFGLARDGPT 183
+ G+++LH + + DLK N++L + KL DFGLA +
Sbjct: 114 EEEATSFIKQILDGVNYLHTK--KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED 171
Query: 184 GDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSG 229
G I GT + APE V L ++D++S GV+ LLSG
Sbjct: 172 GVEFKN---IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 99.5 bits (248), Expect = 3e-23
Identities = 65/220 (29%), Positives = 104/220 (47%), Gaps = 46/220 (20%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIK-----RLKAESFQGHKEWLTEVIYLG 82
LG G FG V G + T G VA+K ++++ G E+ L
Sbjct: 23 TLGVGTFGKVKVG-KHELT--------GHKVAVKILNRQKIRSLDVVGKIR--REIQNLK 71
Query: 83 QLRHENLVKLIGY-CSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVAR 140
RH +++KL Y + + + +V E++ G L +++ + G ++ +R
Sbjct: 72 LFRHPHIIKL--YQVISTPSDIFMVMEYVSGGELFDYICKNG----------RLDEKESR 119
Query: 141 --------GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR 192
G+ + H V++RDLK NVLLD++ NAK++DFGL+ G+ S
Sbjct: 120 RLFQQILSGVDYCHRH--MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS-- 175
Query: 193 IVGTRGYAAPEYVATGHL--TPKSDVYSFGVVLLELLSGR 230
G+ YAAPE V +G L P+ D++S GV+L LL G
Sbjct: 176 -CGSPNYAAPE-VISGRLYAGPEVDIWSSGVILYALLCGT 213
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 97.2 bits (243), Expect = 4e-23
Identities = 60/210 (28%), Positives = 100/210 (47%), Gaps = 22/210 (10%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRL-KAESFQGHKEW---LTEVIYLGQ 83
+LG+GG+G VF Q +G + A+K L KA + K+ E L +
Sbjct: 24 VLGKGGYGKVF-----QVRKVTGA-NTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEE 77
Query: 84 LRHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKI-AIDVARG 141
++H +V LI Y ++ +L L+ E++ G L L R+G+ +++
Sbjct: 78 VKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMED---TACFYLAEISMA 133
Query: 142 LSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAA 201
L LH +IYRDLK N++L+ + KL+DFGL ++ + GT Y A
Sbjct: 134 LGHLHQK--GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTV--THTFCGTIEYMA 189
Query: 202 PEYVA-TGHLTPKSDVYSFGVVLLELLSGR 230
PE + +GH D +S G ++ ++L+G
Sbjct: 190 PEILMRSGH-NRAVDWWSLGALMYDMLTGA 218
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 4e-23
Identities = 55/223 (24%), Positives = 103/223 (46%), Gaps = 40/223 (17%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGH---KEWLTEVIYLGQLR 85
LG GG G VF +D + VAIK++ K L E+ + +L
Sbjct: 19 LGCGGNGLVFSA-VDNDC--------DKRVAIKKI---VLTDPQSVKHALREIKIIRRLD 66
Query: 86 HENLVKLI--------------GYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTR 131
H+N+VK+ G +E ++ +V E+M + ++ + P+
Sbjct: 67 HDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM--ETDLANVLEQ--GPLL-EEH 121
Query: 132 VK-IAIDVARGLSFLHGLDANVIYRDLKASNVLLDS-NFNAKLSDFGLAR-DGPTGDNTH 188
+ + RGL ++H ANV++RDLK +N+ +++ + K+ DFGLAR P +
Sbjct: 122 ARLFMYQLLRGLKYIHS--ANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKG 179
Query: 189 VSTRIVGTRGYAAPE-YVATGHLTPKSDVYSFGVVLLELLSGR 230
+ + T+ Y +P ++ + T D+++ G + E+L+G+
Sbjct: 180 HLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 5e-23
Identities = 63/216 (29%), Positives = 100/216 (46%), Gaps = 30/216 (13%)
Query: 28 LLGEGGFGCVF---KGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEW----LTEVIY 80
+LG G +G VF K + +G + A+K LK + + TE
Sbjct: 61 VLGTGAYGKVFLVRK---------ISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQV 111
Query: 81 LGQLRHEN-LVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKI-AID 137
L +R LV L Y +++ +L L+ +++ G L HL ++ V+I +
Sbjct: 112 LEHIRQSPFLVTLH-YAFQTETKLHLILDYINGGELFTHLSQRERFTEH---EVQIYVGE 167
Query: 138 VARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR 197
+ L LH L +IYRD+K N+LLDSN + L+DFGL+++ + GT
Sbjct: 168 IVLALEHLHKL--GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD-FCGTI 224
Query: 198 GYAAPE---YVATGHLTPKSDVYSFGVVLLELLSGR 230
Y AP+ +GH D +S GV++ ELL+G
Sbjct: 225 EYMAPDIVRGGDSGH-DKAVDWWSLGVLMYELLTGA 259
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 6e-23
Identities = 67/303 (22%), Positives = 104/303 (34%), Gaps = 53/303 (17%)
Query: 18 IATKNFCSDY-------LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQG 70
+ F Y LGEG F K S A+K +
Sbjct: 1 MKDSPFYQHYDLDLKDKPLGEGSFSICRKC---------VHKKSNQAFAVKIISKRMEAN 51
Query: 71 HKEWLTEVIYLGQLR-HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWP 129
++ E+ L H N+VKL + + LV E + G L + +K +
Sbjct: 52 TQK---EITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKK----HFS 104
Query: 130 TR--VKIAIDVARGLSFLHGLDANVIYRDLKASNVLL---DSNFNAKLSDFGLARDGPTG 184
I + +S +H D V++RDLK N+L + N K+ DFG AR
Sbjct: 105 ETEASYIMRKLVSAVSHMH--DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARL--KP 160
Query: 185 DNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQT 244
+ T YAAPE + D++S GV+L +LSG+
Sbjct: 161 PDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPF----------- 209
Query: 245 LVEWADPFLRDSRRVLRIMDTRLGGQYS--KKEAQAV--AA--VVLQCLHMDPKNRPSMV 298
+ + IM G +S + + V A ++ L +DP R M
Sbjct: 210 ---QSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMS 266
Query: 299 DVL 301
+
Sbjct: 267 GLR 269
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 8e-23
Identities = 63/220 (28%), Positives = 98/220 (44%), Gaps = 36/220 (16%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGH---KEWLTEVIYLGQLR 85
LGEG +G V + T G +VAIK+++ F L E+ L +
Sbjct: 19 LGEGAYGVVCSA-THKPT--------GEIVAIKKIEP--FDKPLFALRTLREIKILKHFK 67
Query: 86 HENLVKLI----GYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVK-IAIDVA 139
HEN++ + E+ N + ++ E M + + + Q +S ++
Sbjct: 68 HENIITIFNIQRPDSFENFNEVYIIQELM--QTDLHRVIST--QMLS-DDHIQYFIYQTL 122
Query: 140 RGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR--------DGPTGDNTHVST 191
R + LHG +NVI+RDLK SN+L++SN + K+ DFGLAR +
Sbjct: 123 RAVKVLHG--SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMV 180
Query: 192 RIVGTRGYAAPEYV-ATGHLTPKSDVYSFGVVLLELLSGR 230
V TR Y APE + + + DV+S G +L EL R
Sbjct: 181 EFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 95.3 bits (238), Expect = 8e-23
Identities = 58/211 (27%), Positives = 90/211 (42%), Gaps = 26/211 (12%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIK-----RLKAESFQGHKEWL-TEVIYLG 82
LG G F V K + G+G A K RL + +E + EV L
Sbjct: 13 LGSGQFAIVRKC---------RQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 83 QLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGL 142
++RH N++ L + +L+ E + G L + L K ++ + + G+
Sbjct: 64 EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKES--LTEDEATQFLKQILDGV 121
Query: 143 SFLHGLDANVIYRDLKASNVLLDS----NFNAKLSDFGLARDGPTGDNTHVSTRIVGTRG 198
+LH + + DLK N++L N KL DFG+A G+ I GT
Sbjct: 122 HYLHSK--RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN---IFGTPE 176
Query: 199 YAAPEYVATGHLTPKSDVYSFGVVLLELLSG 229
+ APE V L ++D++S GV+ LLSG
Sbjct: 177 FVAPEIVNYEPLGLEADMWSIGVITYILLSG 207
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 8e-23
Identities = 65/232 (28%), Positives = 102/232 (43%), Gaps = 27/232 (11%)
Query: 7 MSDPSASMISKIATKNFCSDYL--LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLK 64
++ S+ K+ ++F LG+G FG VF A K + AIK LK
Sbjct: 3 LNKERPSLQIKLKIEDF--ILHKMLGKGSFGKVF--------LAEFK-KTNQFFAIKALK 51
Query: 65 AESFQGHKEW---LTE-VIYLGQLRHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLF 119
+ + + E + H L + ++ L V E++ G L H+
Sbjct: 52 KDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQ 110
Query: 120 RKGVQPISWPTRVKI-AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 178
+S R A ++ GL FLH ++YRDLK N+LLD + + K++DFG+
Sbjct: 111 SCHKFDLS---RATFYAAEIILGLQFLHSK--GIVYRDLKLDNILLDKDGHIKIADFGMC 165
Query: 179 RDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR 230
++ GD +T GT Y APE + D +SFGV+L E+L G+
Sbjct: 166 KENMLGDAK-TNT-FCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 215
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 9e-23
Identities = 50/230 (21%), Positives = 94/230 (40%), Gaps = 25/230 (10%)
Query: 11 SASMISKIATKNFCSDY-----LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKA 65
+ + +NF + Y LG G F V + +G A K LK
Sbjct: 14 GTENLYFQSMENFNNFYILTSKELGRGKFAVVRQC---------ISKSTGQEYAAKFLKK 64
Query: 66 ESFQG--HKEWLTEVIYLGQLRH-ENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKG 122
E L E+ L + ++ L + +L+ E+ G + + +
Sbjct: 65 RRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPEL 124
Query: 123 VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLL---DSNFNAKLSDFGLAR 179
+ +S +++ + G+ +LH N+++ DLK N+LL + K+ DFG++R
Sbjct: 125 AEMVSENDVIRLIKQILEGVYYLHQN--NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSR 182
Query: 180 DGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSG 229
G + I+GT Y APE + +T +D+++ G++ LL+
Sbjct: 183 K--IGHACELRE-IMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTH 229
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 9e-23
Identities = 58/218 (26%), Positives = 94/218 (43%), Gaps = 40/218 (18%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKE-----WLTEVIYLGQ 83
LGEG +G V+K ID T VAIKR++ E +E + EV L +
Sbjct: 42 LGEGTYGEVYKA-IDTVT--------NETVAIKRIRLEHE---EEGVPGTAIREVSLLKE 89
Query: 84 LRHENLVKLIGYCSESDNRLLVYEFMP---KGSLENHLFRKGVQPISWPTRVK-IAIDVA 139
L+H N+++L + L++E+ K ++ + +S +K +
Sbjct: 90 LQHRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKN------PDVS-MRVIKSFLYQLI 142
Query: 140 RGLSFLHGLDANVIYRDLKASNVLLDSNFNA-----KLSDFGLARDGPTGDNTHVSTRIV 194
G++F H ++RDLK N+LL + + K+ DFGLAR G T +
Sbjct: 143 NGVNFCH--SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR--AFGIPIRQFTHEI 198
Query: 195 GTRGYAAPEYVATG--HLTPKSDVYSFGVVLLELLSGR 230
T Y PE + G H + D++S + E+L
Sbjct: 199 ITLWYRPPE-ILLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 1e-22
Identities = 62/218 (28%), Positives = 94/218 (43%), Gaps = 45/218 (20%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIK-----RLKAESFQGHKEWLTEVIYLGQ 83
+G+G F V T G VAIK +L S Q EV +
Sbjct: 23 IGKGNFAKVKLA-RHILT--------GREVAIKIIDKTQLNPTSLQKLF---REVRIMKI 70
Query: 84 LRHENLVKLIGY-CSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVAR- 140
L H N+VKL + E++ L L+ E+ G + ++L G ++ AR
Sbjct: 71 LNHPNIVKL--FEVIETEKTLYLIMEYASGGEVFDYLVAHG----------RMKEKEARS 118
Query: 141 -------GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRI 193
+ + H +++RDLKA N+LLD++ N K++DFG + + G
Sbjct: 119 KFRQIVSAVQYCHQK--RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAF--- 173
Query: 194 VGTRGYAAPEYVA-TGHLTPKSDVYSFGVVLLELLSGR 230
G YAAPE + P+ DV+S GV+L L+SG
Sbjct: 174 CGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGS 211
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 1e-22
Identities = 61/300 (20%), Positives = 107/300 (35%), Gaps = 58/300 (19%)
Query: 20 TKNFCSDY----LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWL 75
+ F Y +G G + + I + T + A+K + +E
Sbjct: 17 SIQFTDGYEVKEDIGVGSYSVCKRC-IHKAT--------NMEFAVKIIDKSKRDPTEE-- 65
Query: 76 TEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIA 135
I L +H N++ L + +V E M G L + + R+ S +
Sbjct: 66 -IEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQK--FFSEREASAVL 122
Query: 136 IDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNA----KLSDFGLARDGPTGDNTHVST 191
+ + + +LH V++RDLK SN+L ++ DFG A+ +N + T
Sbjct: 123 FTITKTVEYLH--AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL-RAENGLLMT 179
Query: 192 RIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSG----RRALDEDRGGLAEQTLVE 247
T + APE + D++S GV+L +L+G D+ +
Sbjct: 180 -PCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILA----- 233
Query: 248 WADPFLRDSRRVLRIMDTRLGGQYS------KKEAQAVAAVVLQCLHMDPKNRPSMVDVL 301
RI G++S + +V + LH+DP R + VL
Sbjct: 234 -------------RIGS----GKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVL 276
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 1e-22
Identities = 58/224 (25%), Positives = 93/224 (41%), Gaps = 30/224 (13%)
Query: 20 TKNFCSDY----LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIK-----RLKAESFQG 70
+N Y LG G F V K + +G+ A K R K+
Sbjct: 6 QENVDDYYDTGEELGSGQFAVVKKC---------REKSTGLQYAAKFIKKRRTKSSRRGV 56
Query: 71 HKEWL-TEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWP 129
+E + EV L +++H N++ L + +L+ E + G L + L K ++
Sbjct: 57 SREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEE 114
Query: 130 TRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS----NFNAKLSDFGLARDGPTGD 185
+ + G+ +LH L + + DLK N++L K+ DFGLA D
Sbjct: 115 EATEFLKQILNGVYYLHSL--QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KID 169
Query: 186 NTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSG 229
+ I GT + APE V L ++D++S GV+ LLSG
Sbjct: 170 FGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 2e-22
Identities = 60/317 (18%), Positives = 111/317 (35%), Gaps = 61/317 (19%)
Query: 7 MSDPSASMISKIATKNFCSDY-----LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIK 61
+I DY +LG G G V + + A+K
Sbjct: 43 FPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQI---------FNKRTQEKFALK 93
Query: 62 RL-KAESFQGHKEWLTEV-IYLGQLRHENLVKLIGYC----SESDNRLLVYEFMPKGSLE 115
L + EV ++ + ++V+++ + L+V E + G L
Sbjct: 94 MLQDCPKAR------REVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELF 147
Query: 116 NHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS---NFNAKL 172
+ + +G Q + +I + + +LH + N+ +RD+K N+L S N KL
Sbjct: 148 SRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI--NIAHRDVKPENLLYTSKRPNAILKL 205
Query: 173 SDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRA 232
+DFG A++ + + T T Y APE + D++S GV++ LL G
Sbjct: 206 TDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYP- 261
Query: 233 LDEDRGGLAEQTLVEWADPFLRDSRRVL--RIMDTRLGGQYSKKEA------QAVAAVVL 284
PF + + + GQY + V ++
Sbjct: 262 ------------------PFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIR 303
Query: 285 QCLHMDPKNRPSMVDVL 301
L +P R ++ + +
Sbjct: 304 NLLKTEPTQRMTITEFM 320
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 2e-22
Identities = 46/211 (21%), Positives = 84/211 (39%), Gaps = 29/211 (13%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLR-HE 87
LG G + VF+ + V +K LK K+ E+ L LR
Sbjct: 44 LGRGKYSEVFEAI-NITN--------NEKVVVKILKPVK---KKKIKREIKILENLRGGP 91
Query: 88 NLVKL--IGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI-DVARGLSF 144
N++ L I S LV+E + N F++ Q ++ ++ + ++ + L +
Sbjct: 92 NIITLADIVKDPVSRTPALVFEH-----VNNTDFKQLYQTLT-DYDIRFYMYEILKALDY 145
Query: 145 LHGLDANVIYRDLKASNVLLDS-NFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPE 203
H +++RD+K NV++D + +L D+GLA V +R + PE
Sbjct: 146 CHS--MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE---FYHPGQEYNVRVASRYFKGPE 200
Query: 204 -YVATGHLTPKSDVYSFGVVLLELLSGRRAL 233
V D++S G +L ++ +
Sbjct: 201 LLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 2e-22
Identities = 72/305 (23%), Positives = 119/305 (39%), Gaps = 61/305 (20%)
Query: 21 KNFCSDY----LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEW-- 74
K +Y LG G G V ++ T VAIK + F
Sbjct: 6 KALRDEYIMSKTLGSGACGEVKLA-FERKT--------CKKVAIKIISKRKFAIGSAREA 56
Query: 75 ------LTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISW 128
TE+ L +L H ++K+ + ++++ +V E M G L + + +
Sbjct: 57 DPALNVETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNK--RLKE 113
Query: 129 PTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS---NFNAKLSDFGLARDGPTGD 185
T + + +LH + +I+RDLK NVLL S + K++DFG ++ G+
Sbjct: 114 ATCKLYFYQMLLAVQYLH--ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK--ILGE 169
Query: 186 NTHVSTRIVGTRGYAAPE---YVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAE 242
+ + T + GT Y APE V T D +S GV+L LSG
Sbjct: 170 TSLMRT-LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGY------------ 216
Query: 243 QTLVEWADPFLRDSRRVLRIMDTRLGGQYS------KKEAQAVAAVVLQCLHMDPKNRPS 296
PF +V + D G+Y+ + ++ +V + L +DPK R +
Sbjct: 217 -------PPFSEHRTQV-SLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFT 268
Query: 297 MVDVL 301
+ L
Sbjct: 269 TEEAL 273
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 2e-22
Identities = 79/355 (22%), Positives = 149/355 (41%), Gaps = 76/355 (21%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGH---KEWLTEVIYLGQLR 85
LG+G +G V+K ID+ T G VVA+K++ ++FQ + E++ L +L
Sbjct: 17 LGKGAYGIVWKS-IDRRT--------GEVVAVKKI-FDAFQNSTDAQRTFREIMILTELS 66
Query: 86 -HENLVKLIG-YCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVK-IAIDVARG 141
HEN+V L+ +++D + LV+++M + + + R + P + + + +
Sbjct: 67 GHENIVNLLNVLRADNDRDVYLVFDYM--ETDLHAVIRA--NILE-PVHKQYVVYQLIKV 121
Query: 142 LSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR-------------------DGP 182
+ +LH +++RD+K SN+LL++ + K++DFGL+R
Sbjct: 122 IKYLHS--GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTEN 179
Query: 183 TGDNTHVSTRIVGTRGYAAPEY-VATGHLTPKSDVYSFGVVLLELLSGRRAL-------- 233
D+ + T V TR Y APE + + T D++S G +L E+L + +
Sbjct: 180 FDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEIL-CGKPIFPGSSTMN 238
Query: 234 -------------DEDRGGLAE---QTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQ 277
+ED + +T++E + + R + T+ K +
Sbjct: 239 QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPK 298
Query: 278 AVA---AVVL--QCLHMDPKNRPSMVDVLTS--LEQLHTSKDMPRTPPPAKLHHH 325
A A+ L + L +P R S D L + H + P + +
Sbjct: 299 ADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPNEEPNCDHIITIPIN 353
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 3e-22
Identities = 67/303 (22%), Positives = 114/303 (37%), Gaps = 87/303 (28%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIK-----RLKAESFQGHKEWLT-EVIYL 81
LLG+GGFG VF G + + VAIK R+ S EV L
Sbjct: 38 LLGKGGFGTVFAG---------HRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALL 88
Query: 82 GQLR----HENLVKLIGYCSESDNRLLVYEF-MPKGSLENHLFRKGVQPISWPTRVKIAI 136
++ H +++L+ + + +LV E +P L +++ KG +
Sbjct: 89 WKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKG----------PLGE 138
Query: 137 DVAR--------GLSFLHGLDANVIYRDLKASNVLLDS-NFNAKLSDFGLA---RDGPTG 184
+R + H V++RD+K N+L+D AKL DFG D P
Sbjct: 139 GPSRCFFGQVVAAIQHCH--SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPY- 195
Query: 185 DNTHVSTRIVGTRGYAAPEYVATGHLT-PKSDVYSFGVVLLELLSGRRALDEDRGGLAEQ 243
GTR Y+ PE+++ + V+S G++L +++ G
Sbjct: 196 ---TDF---DGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDI------------ 237
Query: 244 TLVEWADPFLRDSRRVLRIMDTRLGGQYSK-----KEAQAVAAVVLQCLHMDPKNRPSMV 298
PF + +L + + A+ + +CL P +RPS+
Sbjct: 238 -------PF-ERDQEILE-------AELHFPAHVSPDCCAL---IRRCLAPKPSSRPSLE 279
Query: 299 DVL 301
++L
Sbjct: 280 EIL 282
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 4e-22
Identities = 58/217 (26%), Positives = 97/217 (44%), Gaps = 32/217 (14%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEW-----LTEVIYLGQ 83
+G G +G V+K D ++ G VA+K ++ + G + EV L +
Sbjct: 17 IGVGAYGTVYKA-RDPHS--------GHFVALKSVRVPNGGGGGGGLPISTVREVALLRR 67
Query: 84 LR---HENLVKLI----GYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVK-I 134
L H N+V+L+ ++ + ++ LV+E + + L +L + + +K +
Sbjct: 68 LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLP-AETIKDL 125
Query: 135 AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD-GPTGDNTHVSTRI 193
RGL FLH +++RDLK N+L+ S KL+DFGLAR T V
Sbjct: 126 MRQFLRGLDFLH--ANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPV---- 179
Query: 194 VGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR 230
V T Y APE + D++S G + E+ +
Sbjct: 180 VVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 4e-22
Identities = 66/298 (22%), Positives = 110/298 (36%), Gaps = 57/298 (19%)
Query: 20 TKNFCSDY----LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWL 75
+ LG G V++ + G+ A+K LK K
Sbjct: 48 RDALSDFFEVESELGRGATSIVYRC---------KQKGTQKPYALKVLKKT--VDKKIVR 96
Query: 76 TEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIA 135
TE+ L +L H N++KL LV E + G L + + KG S
Sbjct: 97 TEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGY--YSERDAADAV 154
Query: 136 IDVARGLSFLHGLDANVIYRDLKASNVLL---DSNFNAKLSDFGLARDGPTGDNTHVSTR 192
+ +++LH +++RDLK N+L + K++DFGL++ ++ +
Sbjct: 155 KQILEAVAYLHEN--GIVHRDLKPENLLYATPAPDAPLKIADFGLSK---IVEHQVLMKT 209
Query: 193 IVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPF 252
+ GT GY APE + P+ D++S G++ LL G PF
Sbjct: 210 VCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFE-------------------PF 250
Query: 253 LRDSRRVLRIMDTRLGGQYS---------KKEAQAVAAVVLQCLHMDPKNRPSMVDVL 301
D R + L +Y A+ +V + + +DPK R + L
Sbjct: 251 -YDERGDQFMFRRILNCEYYFISPWWDEVSLNAK---DLVRKLIVLDPKKRLTTFQAL 304
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 5e-22
Identities = 60/210 (28%), Positives = 101/210 (48%), Gaps = 25/210 (11%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEW---LTE-VIYLGQ 83
++G+G FG V + A+K L+ ++ KE ++E + L
Sbjct: 45 VIGKGSFGKVLLA---------RHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKN 95
Query: 84 LRHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKI-AIDVARG 141
++H LV L + ++ ++L V +++ G L HL R+ R + A ++A
Sbjct: 96 VKHPFLVGLH-FSFQTADKLYFVLDYINGGELFYHLQRERCFLEP---RARFYAAEIASA 151
Query: 142 LSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAA 201
L +LH L N++YRDLK N+LLDS + L+DFGL ++ ++T ++ GT Y A
Sbjct: 152 LGYLHSL--NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST--TSTFCGTPEYLA 207
Query: 202 PEYVA-TGHLTPKSDVYSFGVVLLELLSGR 230
PE + + D + G VL E+L G
Sbjct: 208 PEVLHKQPY-DRTVDWWCLGAVLYEMLYGL 236
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 5e-22
Identities = 57/207 (27%), Positives = 88/207 (42%), Gaps = 23/207 (11%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEW---LTEVIYLGQL 84
LG G FG V SG A+K L + K+ L E L +
Sbjct: 48 TLGTGSFGRVMLV---------KHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 85 RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSF 144
LVKL ++ N +V E++ G + +HL R G R A + +
Sbjct: 99 NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH-ARFYAA-QIVLTFEY 156
Query: 145 LHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEY 204
LH L ++IYRDLK N+L+D +++DFG A+ T + GT APE
Sbjct: 157 LHSL--DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-----LCGTPEALAPEI 209
Query: 205 VAT-GHLTPKSDVYSFGVVLLELLSGR 230
+ + G+ D ++ GV++ E+ +G
Sbjct: 210 ILSKGY-NKAVDWWALGVLIYEMAAGY 235
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 6e-22
Identities = 49/219 (22%), Positives = 85/219 (38%), Gaps = 26/219 (11%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIK-----RLKAESFQGHKEWLT---EVIY 80
LG G FG V W + + V +K ++ + + + E+
Sbjct: 32 LGSGAFGFV---WTAVDKEKNKE------VVVKFIKKEKVLEDCWIEDPKLGKVTLEIAI 82
Query: 81 LGQLRHENLVKLIGYCSESDNRLLVYEFMPKGS-LENHLFRKGVQPISWPTRVKIAIDVA 139
L ++ H N++K++ LV E G L + R + P I +
Sbjct: 83 LSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHP--RLDEPLASYIFRQLV 140
Query: 140 RGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGY 199
+ +L ++I+RD+K N+++ +F KL DFG A G + GT Y
Sbjct: 141 SAVGYLRLK--DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTF---CGTIEY 195
Query: 200 AAPEYVA-TGHLTPKSDVYSFGVVLLELLSGRRALDEDR 237
APE + + P+ +++S GV L L+ E
Sbjct: 196 CAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELE 234
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 7e-22
Identities = 45/167 (26%), Positives = 82/167 (49%), Gaps = 28/167 (16%)
Query: 77 EVIYLGQLRHENLVKLIG-YCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKI 134
E+ L +L H N+VKL+ +++ L +V+E + +G + PT +
Sbjct: 86 EIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV----MEV-------PTLKPL 134
Query: 135 AIDVAR--------GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDN 186
+ D AR G+ +LH +I+RD+K SN+L+ + + K++DFG++ + G +
Sbjct: 135 SEDQARFYFQDLIKGIEYLHYQ--KIIHRDIKPSNLLVGEDGHIKIADFGVSNE-FKGSD 191
Query: 187 THVSTRIVGTRGYAAPEYVATGHLT---PKSDVYSFGVVLLELLSGR 230
+S VGT + APE ++ DV++ GV L + G+
Sbjct: 192 ALLSNT-VGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 8e-22
Identities = 63/220 (28%), Positives = 98/220 (44%), Gaps = 40/220 (18%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKE-----WLTEVIYLGQ 83
+GEG +G VFK +N G VA+KR++ ++ +E + EV L
Sbjct: 19 IGEGAYGKVFKARDLKNG--------GRFVALKRVRVQTG---EEGMPLSTIREVAVLRH 67
Query: 84 LR---HENLVKLI----GYCSESDNRL-LVYEFMP---KGSLENHLFRKGVQPISWPTRV 132
L H N+V+L ++ + +L LV+E + L+ +P +
Sbjct: 68 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVP-----EPGVPTETI 122
Query: 133 K-IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD-GPTGDNTHVS 190
K + + RGL FLH V++RDLK N+L+ S+ KL+DFGLAR T V
Sbjct: 123 KDMMFQLLRGLDFLH--SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSV- 179
Query: 191 TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR 230
V T Y APE + D++S G + E+ +
Sbjct: 180 ---VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 1e-21
Identities = 64/219 (29%), Positives = 95/219 (43%), Gaps = 45/219 (20%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIK-----RLKAESFQGHKEWLTEVIYLG 82
LGEG FG V T VA+K LK E E+ YL
Sbjct: 16 TLGEGSFGKVKLA-THYKT--------QQKVALKFISRQLLKKSDMHMRVE--REISYLK 64
Query: 83 QLRHENLVKLIGY-CSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVAR 140
LRH +++KL Y + + +V E+ G L +++ K ++ D R
Sbjct: 65 LLRHPHIIKL--YDVITTPTDIVMVIEYA-GGELFDYIVEKK----------RMTEDEGR 111
Query: 141 --------GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR 192
+ + H +++RDLK N+LLD N N K++DFGL+ G+ S
Sbjct: 112 RFFQQIICAIEYCHRH--KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS-- 167
Query: 193 IVGTRGYAAPEYVA-TGHLTPKSDVYSFGVVLLELLSGR 230
G+ YAAPE + + P+ DV+S G+VL +L GR
Sbjct: 168 -CGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGR 205
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 1e-21
Identities = 49/222 (22%), Positives = 80/222 (36%), Gaps = 41/222 (18%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKE---WLTEVIYLGQL 84
++G G F V +G V A+K + E + E L
Sbjct: 68 VIGRGAFSEVAVV---------KMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNG 118
Query: 85 RHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVAR--- 140
+ +L + + +N L LV E+ G L L + G +I ++AR
Sbjct: 119 DRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGE---------RIPAEMARFYL 168
Query: 141 -----GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVG 195
+ +H L ++RD+K N+LLD + +L+DFG VG
Sbjct: 169 AEIVMAIDSVHRL--GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLV-AVG 225
Query: 196 TRGYAAPEYVATGHLTPKSDVY-------SFGVVLLELLSGR 230
T Y +PE + P + Y + GV E+ G+
Sbjct: 226 TPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 2e-21
Identities = 75/317 (23%), Positives = 133/317 (41%), Gaps = 51/317 (16%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGH---KEWLTEVIYLGQLR 85
+G G +G V +D T G VAIK+L FQ K E+ L +R
Sbjct: 33 VGSGAYGAVCSA-VDGRT--------GAKVAIKKL-YRPFQSELFAKRAYRELRLLKHMR 82
Query: 86 HENLVKL--IGYCSESDNRL----LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVA 139
HEN++ L + E+ + LV FM G+ L + + + + +
Sbjct: 83 HENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKH--EKLGEDRIQFLVYQML 138
Query: 140 RGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGY 199
+GL ++H A +I+RDLK N+ ++ + K+ DFGLAR D+ T V TR Y
Sbjct: 139 KGLRYIHA--AGIIHRDLKPGNLAVNEDCELKILDFGLAR---QADSEM--TGYVVTRWY 191
Query: 200 AAPEYV-ATGHLTPKSDVYSFGVVLLELLSGR------------RALDEDRGGLAEQTLV 246
APE + T D++S G ++ E+++G+ + + + G + +
Sbjct: 192 RAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ 251
Query: 247 EWADPFLRDSRRVLRIMDTRLGGQYSKKEAQA-VAAVVL--QCLHMDPKNRPSMVDVLTS 303
+++ ++ + ++ A AV L + L +D + R + + L
Sbjct: 252 RLQSD---EAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308
Query: 304 --LEQLHTSKDMPRTPP 318
E LH ++D P+
Sbjct: 309 PYFESLHDTEDEPQVQK 325
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 2e-21
Identities = 60/210 (28%), Positives = 98/210 (46%), Gaps = 25/210 (11%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEW---LTE-VIYLGQ 83
+LG+G FG V + G+ + A+K LK + + + E +
Sbjct: 27 VLGKGSFGKVMLS---------ERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALP 77
Query: 84 LRHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKI-AIDVARG 141
+ L +L C ++ +RL V E++ G L H+ + G A ++A G
Sbjct: 78 GKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP---HAVFYAAEIAIG 133
Query: 142 LSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAA 201
L FL +IYRDLK NV+LDS + K++DFG+ ++ T + GT Y A
Sbjct: 134 LFFLQSK--GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT--TKTFCGTPDYIA 189
Query: 202 PEYVA-TGHLTPKSDVYSFGVVLLELLSGR 230
PE +A + D ++FGV+L E+L+G+
Sbjct: 190 PEIIAYQPY-GKSVDWWAFGVLLYEMLAGQ 218
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 2e-21
Identities = 81/318 (25%), Positives = 133/318 (41%), Gaps = 53/318 (16%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGH---KEWLTEVIYLGQLR 85
+G G +G V + D T G+ VA+K+L + FQ K E+ L ++
Sbjct: 37 VGSGAYGSVCAAF-DTKT--------GLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMK 86
Query: 86 HENLVKLI-----GYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVK-IAIDV 138
HEN++ L+ E N + LV M L N++ + Q ++ V+ + +
Sbjct: 87 HENVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DL-NNIVKC--QKLT-DDHVQFLIYQI 141
Query: 139 ARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRG 198
RGL ++H A++I+RDLK SN+ ++ + K+ DFGLAR T V TR
Sbjct: 142 LRGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTADEMTGYVATRW 194
Query: 199 YAAPEYV-ATGHLTPKSDVYSFGVVLLELLSGR------------RALDEDRGGLAEQTL 245
Y APE + H D++S G ++ ELL+GR + + G + L
Sbjct: 195 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 254
Query: 246 VEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQA-VAAVVL--QCLHMDPKNRPSMVDVLT 302
+ + +R ++ + ++ A AV L + L +D R + L
Sbjct: 255 KKISSE---SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311
Query: 303 S--LEQLHTSKDMPRTPP 318
Q H D P P
Sbjct: 312 HAYFAQYHDPDDEPVADP 329
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 3e-21
Identities = 66/232 (28%), Positives = 105/232 (45%), Gaps = 29/232 (12%)
Query: 8 SDPSASMISKIATKNFCSDYL--LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKA 65
+ + +++ NF +++ LG+G FG V +G + A+K LK
Sbjct: 10 NGIGVNSSNRLGIDNF--EFIRVLGKGSFGKVMLA---------RVKETGDLYAVKVLKK 58
Query: 66 ESFQGHKEW---LTE-VIYLGQLRHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFR 120
+ + +TE I H L +L C ++ +RL V EF+ G L H+ +
Sbjct: 59 DVILQDDDVECTMTEKRILSLARNHPFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQK 117
Query: 121 KGVQPISWPTRVKI-AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR 179
+ R + A ++ L FLH +IYRDLK NVLLD + KL+DFG+ +
Sbjct: 118 SRRFDEA---RARFYAAEIISALMFLHDK--GIIYRDLKLDNVLLDHEGHCKLADFGMCK 172
Query: 180 DGPTGDNTHVSTRIVGTRGYAAPEYVA-TGHLTPKSDVYSFGVVLLELLSGR 230
+G T + GT Y APE + + P D ++ GV+L E+L G
Sbjct: 173 EGICNGVT--TATFCGTPDYIAPEILQEMLY-GPAVDWWAMGVLLYEMLCGH 221
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 93.9 bits (233), Expect = 3e-21
Identities = 60/209 (28%), Positives = 97/209 (46%), Gaps = 23/209 (11%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEW---LTE-VIYLGQ 83
+LG+G FG V + G+ + A+K LK + + + E +
Sbjct: 348 VLGKGSFGKVMLS---------ERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALP 398
Query: 84 LRHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKI-AIDVARG 141
+ L +L C ++ +RL V E++ G L H+ + G A ++A G
Sbjct: 399 GKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP---HAVFYAAEIAIG 454
Query: 142 LSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAA 201
L FL +IYRDLK NV+LDS + K++DFG+ ++ T + GT Y A
Sbjct: 455 LFFLQSK--GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT--TKTFCGTPDYIA 510
Query: 202 PEYVATGHLTPKSDVYSFGVVLLELLSGR 230
PE +A D ++FGV+L E+L+G+
Sbjct: 511 PEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 4e-21
Identities = 55/217 (25%), Positives = 87/217 (40%), Gaps = 42/217 (19%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRL-KAESFQGHKEWLTEVIYLGQLRH 86
+G G FG D+ T +VA+K + + + + + E+I LRH
Sbjct: 27 DIGSGNFGVARLM-RDKLT--------KELVAVKYIERGAAIDENVQ--REIINHRSLRH 75
Query: 87 ENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVAR----- 140
N+V+ + L ++ E+ G L + G + + D AR
Sbjct: 76 PNIVRFKEVI-LTPTHLAIIMEYASGGELYERICNAG----------RFSEDEARFFFQQ 124
Query: 141 ---GLSFLHGLDANVIYRDLKASNVLLDSNF--NAKLSDFGLARDGPTGDNTHVSTRIVG 195
G+S+ H + + +RDLK N LLD + K+ DFG ++ + VG
Sbjct: 125 LLSGVSYCHSM--QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST---VG 179
Query: 196 TRGYAAPEYVATGHL--TPKSDVYSFGVVLLELLSGR 230
T Y APE V +DV+S GV L +L G
Sbjct: 180 TPAYIAPE-VLLRQEYDGKIADVWSCGVTLYVMLVGA 215
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 4e-21
Identities = 58/215 (26%), Positives = 95/215 (44%), Gaps = 39/215 (18%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEW---LTEVIYLGQL 84
LG G FG V +G A+K LK E K+ E + L +
Sbjct: 13 TLGTGSFGRVHLI---------RSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV 63
Query: 85 RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVAR---- 140
H ++++ G ++ ++ +++ G L + L + + VA+
Sbjct: 64 THPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQ----------RFPNPVAKFYAA 113
Query: 141 ----GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 196
L +LH ++IYRDLK N+LLD N + K++DFG A+ P T + GT
Sbjct: 114 EVCLALEYLHSK--DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT-----LCGT 166
Query: 197 RGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGR 230
Y APE V+T + D +SFG+++ E+L+G
Sbjct: 167 PDYIAPEVVSTKPY-NKSIDWWSFGILIYEMLAGY 200
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 4e-21
Identities = 69/364 (18%), Positives = 126/364 (34%), Gaps = 90/364 (24%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGH---KEWLTEVIYLGQLR 85
+G G +G V+ D+NT VAIK++ F+ K L E+ L +L+
Sbjct: 34 IGRGSYGYVYLA-YDKNT--------EKNVAIKKV-NRMFEDLIDCKRILREITILNRLK 83
Query: 86 HENLVKL----IGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVK-IAIDVA 139
+ +++L I + L +V E S LF+ ++ +K I ++
Sbjct: 84 SDYIIRLYDLIIPDDLLKFDELYIVLEIA--DSDLKKLFKTP-IFLT-EEHIKTILYNLL 139
Query: 140 RGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGY 199
G +F+H + +I+RDLK +N LL+ + + K+ DFGLAR + +T++ +
Sbjct: 140 LGENFIHE--SGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEP 197
Query: 200 AAP---------EYVAT------------GHLTPKSDVYSFGVVLLELLSGRRALDEDRG 238
+V T + T D++S G + ELL+ ++ D
Sbjct: 198 GPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPT 257
Query: 239 G----------LAEQTLVEWADPFLRDSRRVL-RIMDTRLG-------GQYSKKEAQAV- 279
+ +R L I + +G +K E
Sbjct: 258 NRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNI-IGTPTEDDLKNINKPEVIKYI 316
Query: 280 --------------------AAVVL--QCLHMDPKNRPSMVDVLTS--LEQLHTSKDMPR 315
+ L L +P R ++ L L+ + K
Sbjct: 317 KLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKKLENF 376
Query: 316 TPPP 319
+
Sbjct: 377 STKK 380
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 5e-21
Identities = 54/221 (24%), Positives = 87/221 (39%), Gaps = 41/221 (18%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKE---WLTEVIYLGQL 84
++G G FG V + V A+K L E + E L
Sbjct: 81 VIGRGAFGEVAVV---------KLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNG 131
Query: 85 RHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVAR--- 140
+ + L Y + DN L LV ++ G L L + ++ ++AR
Sbjct: 132 DSKWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLLSK---------FEDRLPEEMARFYL 181
Query: 141 -----GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVG 195
+ +H L + ++RD+K N+L+D N + +L+DFG D T S+ VG
Sbjct: 182 AEMVIAIDSVHQL--HYVHRDIKPDNILMDMNGHIRLADFGSCLKLME-DGTVQSSVAVG 238
Query: 196 TRGYAAPE------YVATGHLTPKSDVYSFGVVLLELLSGR 230
T Y +PE + P+ D +S GV + E+L G
Sbjct: 239 TPDYISPEILQAMEGGKGRY-GPECDWWSLGVCMYEMLYGE 278
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 5e-21
Identities = 58/210 (27%), Positives = 101/210 (48%), Gaps = 25/210 (11%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEW---LTE-VIYLGQ 83
++G G + V + + A+K +K E ++ TE ++
Sbjct: 16 VIGRGSYAKVLLV---------RLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQA 66
Query: 84 LRHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKI-AIDVARG 141
H LV L C ++++RL V E++ G L H+ R+ P + + +++
Sbjct: 67 SNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE---HARFYSAEISLA 122
Query: 142 LSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAA 201
L++LH +IYRDLK NVLLDS + KL+D+G+ ++G +T ST GT Y A
Sbjct: 123 LNYLHER--GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT-TST-FCGTPNYIA 178
Query: 202 PEYVA-TGHLTPKSDVYSFGVVLLELLSGR 230
PE + + D ++ GV++ E+++GR
Sbjct: 179 PEILRGEDY-GFSVDWWALGVLMFEMMAGR 207
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 8e-21
Identities = 58/246 (23%), Positives = 97/246 (39%), Gaps = 65/246 (26%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHEN 88
LG G FG V + D + G A+K++ Q + E+ + L H N
Sbjct: 15 LGTGSFGIVCEV-FDIES--------GKRFALKKV----LQDPRYKNRELDIMKVLDHVN 61
Query: 89 LVKLIGY-------------------------------------CSESDNRL-LVYEFMP 110
++KL+ Y + L ++ E++P
Sbjct: 62 IIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP 121
Query: 111 KGSLENHL--FRKGVQPISWPTRVKIAI-DVARGLSFLHGLDANVIYRDLKASNVLLDSN 167
+L L F + + I + I I + R + F+H + +RD+K N+L++S
Sbjct: 122 D-TLHKVLKSFIRSGRSIP-MNLISIYIYQLFRAVGFIHS--LGICHRDIKPQNLLVNSK 177
Query: 168 FNA-KLSDFGLARD-GPTGDNTHVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLL 224
N KL DFG A+ P+ + + +R Y APE + TP D++S G V
Sbjct: 178 DNTLKLCDFGSAKKLIPSEPSVAY----ICSRFYRAPELMLGATEYTPSIDLWSIGCVFG 233
Query: 225 ELLSGR 230
EL+ G+
Sbjct: 234 ELILGK 239
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 1e-20
Identities = 57/210 (27%), Positives = 101/210 (48%), Gaps = 25/210 (11%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEW---LTE-VIYLGQ 83
++G G + V + + A++ +K E ++ TE ++
Sbjct: 59 VIGRGSYAKVLLV---------RLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQA 109
Query: 84 LRHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKI-AIDVARG 141
H LV L C ++++RL V E++ G L H+ R+ P + + +++
Sbjct: 110 SNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE---HARFYSAEISLA 165
Query: 142 LSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAA 201
L++LH +IYRDLK NVLLDS + KL+D+G+ ++G +T ST GT Y A
Sbjct: 166 LNYLHER--GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT-TST-FCGTPNYIA 221
Query: 202 PEYVA-TGHLTPKSDVYSFGVVLLELLSGR 230
PE + + D ++ GV++ E+++GR
Sbjct: 222 PEILRGEDY-GFSVDWWALGVLMFEMMAGR 250
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 88.3 bits (219), Expect = 3e-20
Identities = 40/296 (13%), Positives = 79/296 (26%), Gaps = 60/296 (20%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQL 84
G ++ D VA+ + + +E L+ + L ++
Sbjct: 38 FHGGVPPLQFWQAL-DTAL--------DRQVALTFVDPQGVLPDDVLQETLSRTLRLSRI 88
Query: 85 RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSF 144
+ +++ L+V E++ GSL+ + P ++ +A
Sbjct: 89 DKPGVARVLDVVHTRAGGLVVAEWIRGGSLQ-EVADTSPSP---VGAIRAMQSLAAAADA 144
Query: 145 LHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEY 204
H A V S V + + + L+ D
Sbjct: 145 AH--RAGVALSIDHPSRVRVSIDGDVVLAYPATMPDA----------------------- 179
Query: 205 VATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMD 264
P+ D+ G L LL R L E + + R +
Sbjct: 180 ------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDI- 232
Query: 265 TRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDMPRTPPPA 320
++AV + + D R + +L ++Q D P
Sbjct: 233 -----------PFQISAVAARSVQGDGGIRSAS-TLLNLMQQATAVADRTEVLGPI 276
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 8e-20
Identities = 55/219 (25%), Positives = 83/219 (37%), Gaps = 40/219 (18%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKE---WLTEVIYLGQL 84
++G G FG V + V A+K L + + E +
Sbjct: 76 VIGRGAFGEVQLV---------RHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA 126
Query: 85 RHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVAR--- 140
+V+L Y + D L +V E+MP G L N + + AR
Sbjct: 127 NSPWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLM-SNY----------DVPEKWARFYT 174
Query: 141 -----GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVG 195
L +H + I+RD+K N+LLD + + KL+DFG T VG
Sbjct: 175 AEVVLALDAIHSM--GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT-AVG 231
Query: 196 TRGYAAPEYV----ATGHLTPKSDVYSFGVVLLELLSGR 230
T Y +PE + G+ + D +S GV L E+L G
Sbjct: 232 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 270
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 88.3 bits (219), Expect = 2e-19
Identities = 70/372 (18%), Positives = 132/372 (35%), Gaps = 98/372 (26%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGH---KEWLTEVIYLGQLR 85
+G G +G V + D+ VVAIK++ F+ K L E+ L +L
Sbjct: 61 IGTGSYGHVCEA-YDKLE--------KRVVAIKKI-LRVFEDLIDCKRILREIAILNRLN 110
Query: 86 HENLVKL----IGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVK-IAIDVA 139
H+++VK+ I E + L +V E S LFR ++ +K + ++
Sbjct: 111 HDHVVKVLDIVIPKDVEKFDELYVVLEIA--DSDFKKLFRTP-VYLT-ELHIKTLLYNLL 166
Query: 140 RGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGY 199
G+ ++H A +++RDLK +N L++ + + K+ DFGLAR +N + I
Sbjct: 167 VGVKYVH--SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDD 224
Query: 200 AAP--------------EYVAT------------GHLTPKSDVYSFGVVLLELLS----- 228
+V T + T DV+S G + ELL+
Sbjct: 225 MNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKEN 284
Query: 229 -----GRRAL----DEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLG-------GQYS 272
R L ++ ++ + ++ I + LG
Sbjct: 285 VAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNI-LGTPSEEDIEALE 343
Query: 273 KKEAQAV---------------------AAVVL--QCLHMDPKNRPSMVDVLTS--LEQL 307
K++A+ A+ L + L +P R ++ + L +++
Sbjct: 344 KEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEV 403
Query: 308 HTSKDMPRTPPP 319
++
Sbjct: 404 RIAEVETNATEK 415
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 85.0 bits (210), Expect = 1e-18
Identities = 50/200 (25%), Positives = 78/200 (39%), Gaps = 32/200 (16%)
Query: 115 ENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSD 174
E ++ + + VA+G+ FL I+RDL A N+LL K+ D
Sbjct: 179 EEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA--SRKCIHRDLAARNILLSEKNVVKICD 236
Query: 175 FGLARDGPTGDNTHVSTRIVGTRGYA-----APEYVATGHLTPKSDVYSFGVVLLELLSG 229
FGLARD + + APE + T +SDV+SFGV+L E+ S
Sbjct: 237 FGLARDIYKDPDY-----VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS- 290
Query: 230 RRALDEDRGGLAEQTLVEWAD--PFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCL 287
G + + L++ R M Y+ E + +L C
Sbjct: 291 -------LGASPYPGVKIDEEFCRRLKEGTR----MRAP---DYTTPE---MYQTMLDCW 333
Query: 288 HMDPKNRPSMVDVLTSLEQL 307
H +P RP+ +++ L L
Sbjct: 334 HGEPSQRPTFSELVEHLGNL 353
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 63.0 bits (153), Expect = 3e-11
Identities = 40/157 (25%), Positives = 64/157 (40%), Gaps = 19/157 (12%)
Query: 29 LGEGGFGCVFKG-WIDQNTFAPTKPGSGIVVAIKRLKAE-SFQGHKEWLTEVIYLGQL-R 85
LG G FG V + + K + VA+K LK + H+ ++E+ L +
Sbjct: 30 LGRGAFGQVIEADAFGID-----KTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 84
Query: 86 HENLVKLIGYCSESDNRLLV-YEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSF 144
H N+V L+G C++ L+V EF G+L +L R + +G F
Sbjct: 85 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL---------RSKRNEFVPYKTKGARF 135
Query: 145 LHGLD-ANVIYRDLKASNVLLDSNFNAKLSDFGLARD 180
G D I DLK + S+ ++ S F +
Sbjct: 136 RQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKS 172
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 7e-17
Identities = 56/317 (17%), Positives = 104/317 (32%), Gaps = 88/317 (27%)
Query: 10 PSASMISKIATKNFCSDY-----LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRL- 63
P +I DY +LG G G V + + A+K L
Sbjct: 2 PHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQI---------FNKRTQEKFALKMLQ 52
Query: 64 KAESFQGHKEWLTEV-IYLGQLRHENLVKLIGYC----SESDNRLLVYEFMPKGSLENHL 118
+ EV ++ + ++V+++ + L+V E + G L + +
Sbjct: 53 DCPKAR------REVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI 106
Query: 119 FRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS---NFNAKLSDF 175
+G Q + +I + + +LH + N+ +RD+K N+L S N KL+DF
Sbjct: 107 QDRGDQAFTEREASEIMKSIGEAIQYLHSI--NIAHRDVKPENLLYTSKRPNAILKLTDF 164
Query: 176 GLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDE 235
G A + Y D++S GV++ LL G
Sbjct: 165 GFA-------------KETTGEKY-----------DKSCDMWSLGVIMYILLCGYP---- 196
Query: 236 DRGGLAEQTLVEWADPFLRDSRRVL--RIMDTRLGGQYS---------KKEAQAVAAVVL 284
PF + + + GQY +E + ++
Sbjct: 197 ---------------PFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVK---MLIR 238
Query: 285 QCLHMDPKNRPSMVDVL 301
L +P R ++ + +
Sbjct: 239 NLLKTEPTQRMTITEFM 255
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 4e-15
Identities = 56/217 (25%), Positives = 89/217 (41%), Gaps = 36/217 (16%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRH-E 87
+G G FG ++ G D G VAIK ++ H + E ++
Sbjct: 17 IGSGSFGDIYLG-TDIAA--------GEEVAIKLECVKT--KHPQLHIESKIYKMMQGGV 65
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHG 147
+ + +E D ++V E + SLE LF + S T + +A + + ++H
Sbjct: 66 GIPTIRWCGAEGDYNVMVMELLGP-SLE-DLFNFCSRKFSLKTVLLLADQMISRIEYIH- 122
Query: 148 LDANVIYRDLKASNVLLDSNFNAK---LSDFGLA---RDGPTGDNTHVSTR----IVGTR 197
N I+RD+K N L+ + DFGLA RD T H+ R + GT
Sbjct: 123 -SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH--QHIPYRENKNLTGTA 179
Query: 198 GYAAPEYVATGHL----TPKSDVYSFGVVLLELLSGR 230
YA+ + T HL + + D+ S G VL+ G
Sbjct: 180 RYAS---INT-HLGIEQSRRDDLESLGYVLMYFNLGS 212
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 3e-14
Identities = 55/220 (25%), Positives = 91/220 (41%), Gaps = 42/220 (19%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKA-ESFQGHKEWLTEVIYLGQLRH 86
L+G+G FG V K + D+ VAIK +K ++F + EV L +
Sbjct: 61 LIGKGSFGQVVKAY-DRVE--------QEWVAIKIIKNKKAF--LNQAQIEVRLLELMNK 109
Query: 87 E------NLVKLIGY-------CSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVK 133
+V L + C LV+E + +L + L + +S K
Sbjct: 110 HDTEMKYYIVHLKRHFMFRNHLC-------LVFEMLSY-NLYDLLRNTNFRGVSLNLTRK 161
Query: 134 IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNA--KLSDFGLARDGPTGDNTHVST 191
A + L FL + ++I+ DLK N+LL + + K+ DFG + +
Sbjct: 162 FAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS----CQLGQRIYQ 217
Query: 192 RIVGTRGYAAPEYVATGHL-TPKSDVYSFGVVLLELLSGR 230
I +R Y +PE V G D++S G +L+E+ +G
Sbjct: 218 YIQ-SRFYRSPE-VLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 5e-14
Identities = 58/236 (24%), Positives = 93/236 (39%), Gaps = 40/236 (16%)
Query: 13 SMISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIK--RLKAESFQG 70
SM + NF +G G FG + G + T VAIK +K+ + Q
Sbjct: 1 SMGVLMVGPNFRVGKKIGCGNFGELRLG-KNLYT--------NEYVAIKLEPMKSRAPQL 51
Query: 71 HKEWLTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPT 130
H E+ + + ++ + +V E + SLE LF + S T
Sbjct: 52 HLEYRFYKQLGSG---DGIPQVYYFGPCGKYNAMVLELLGP-SLE-DLFDLCDRTFSLKT 106
Query: 131 RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAK-----LSDFGLA---RDGP 182
+ IAI + + ++H N+IYRD+K N L+ N + DF LA D
Sbjct: 107 VLMIAIQLISRMEYVH--SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPE 164
Query: 183 TGDNTHVSTR----IVGTRGYAAPEYVATGHL----TPKSDVYSFGVVLLELLSGR 230
T H+ R + GT Y + + T HL + + D+ + G + + L G
Sbjct: 165 TK--KHIPYREHKSLTGTARYMS---INT-HLGKEQSRRDDLEALGHMFMYFLRGS 214
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 8e-14
Identities = 50/220 (22%), Positives = 88/220 (40%), Gaps = 40/220 (18%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIK--RLKAESFQGHKEWLTEVIYLGQLRH 86
+GEG FG +F+G + VAIK ++++ Q E+ Y
Sbjct: 18 IGEGSFGVIFEG-TNLLN--------NQQVAIKFEPRRSDAPQLRDEYR---TYKLLAGC 65
Query: 87 ENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLH 146
+ + + E + +LV + + SLE L + S T A + + +H
Sbjct: 66 TGIPNVYYFGQEGLHNVLVIDLLGP-SLE-DLLDLCGRKFSVKTVAMAAKQMLARVQSIH 123
Query: 147 GLDANVIYRDLKASNVLLDSNFNAK-----LSDFGLA---RDGPTGDNTHVSTR----IV 194
+ +++YRD+K N L+ + + DFG+ RD T H+ R +
Sbjct: 124 --EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTK--QHIPYREKKNLS 179
Query: 195 GTRGYAAPEYVATGHL----TPKSDVYSFGVVLLELLSGR 230
GT Y + + T HL + + D+ + G V + L G
Sbjct: 180 GTARYMS---INT-HLGREQSRRDDLEALGHVFMYFLRGS 215
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 70.4 bits (172), Expect = 2e-13
Identities = 59/217 (27%), Positives = 93/217 (42%), Gaps = 36/217 (16%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLR-HE 87
+G G FG ++ G + T VAIK ++ H + L E L+
Sbjct: 15 IGSGSFGEIYLG-TNIQT--------NEEVAIKLENVKT--KHPQLLYESKIYRILQGGT 63
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHG 147
+ + + E D +LV + + SLE LF + +S T + +A + + F+H
Sbjct: 64 GIPNVRWFGVEGDYNVLVMDLLGP-SLE-DLFNFCSRKLSLKTVLMLADQMINRVEFVH- 120
Query: 148 LDANVIYRDLKASNVLLDSNFNAK---LSDFGLA---RDGPTGDNTHVSTR----IVGTR 197
+ ++RD+K N L+ A + DFGLA RD T H+ R + GT
Sbjct: 121 -SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH--QHIPYRENKNLTGTA 177
Query: 198 GYAAPEYVATGHL----TPKSDVYSFGVVLLELLSGR 230
YA+ V T HL + + D+ S G VL+ L G
Sbjct: 178 RYAS---VNT-HLGIEQSRRDDLESLGYVLMYFLRGS 210
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 2e-13
Identities = 43/224 (19%), Positives = 90/224 (40%), Gaps = 38/224 (16%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLR-- 85
LG G F V+ D VA+K ++ + + E+ L ++
Sbjct: 26 KLGWGHFSTVWLAK-DMVN--------NTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDA 75
Query: 86 ---------HENLVKLIG---YCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRV 132
+++KL+ + + + +V+E + +L + + + I
Sbjct: 76 DNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVK 134
Query: 133 KIAIDVARGLSFLHGLDANVIYRDLKASNVLLD------SNFNAKLSDFGLARDGPTGDN 186
+I+ + GL ++H +I+ D+K NVL++ + K++D G A +
Sbjct: 135 QISKQLLLGLDYMHR-RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW----YD 189
Query: 187 THVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR 230
H + I TR Y +PE + +D++S ++ EL++G
Sbjct: 190 EHYTNSIQ-TREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 4e-13
Identities = 57/220 (25%), Positives = 94/220 (42%), Gaps = 44/220 (20%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKA-ESFQGHKEWLTEVIYLGQLRH 86
++G+G FG V K + D VA+K ++ + F H++ E+ L LR
Sbjct: 104 VIGKGSFGQVVKAY-DHKV--------HQHVALKMVRNEKRF--HRQAAEEIRILEHLRK 152
Query: 87 E------NLVKLIGY-------CSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVK 133
+ N++ ++ C + +E + +L + + Q S P K
Sbjct: 153 QDKDNTMNVIHMLENFTFRNHIC-------MTFELLSM-NLYELIKKNKFQGFSLPLVRK 204
Query: 134 IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNA--KLSDFGLARDGPTGDNTHVST 191
A + + L LH +I+ DLK N+LL + K+ DFG + ++ V T
Sbjct: 205 FAHSILQCLDALH--KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS----CYEHQRVYT 258
Query: 192 RIVGTRGYAAPEYVATGHL-TPKSDVYSFGVVLLELLSGR 230
I +R Y APE V G D++S G +L ELL+G
Sbjct: 259 YIQ-SRFYRAPE-VILGARYGMPIDMWSLGCILAELLTGY 296
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 67.5 bits (165), Expect = 9e-13
Identities = 38/247 (15%), Positives = 88/247 (35%), Gaps = 38/247 (15%)
Query: 10 PSASMISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIK------RL 63
P+ ++++ + + + G +++ +T ++K RL
Sbjct: 31 PTGTVLTDKSGRQWKLKSFQTRDNQGILYEA-APTSTLTCDSGPQKQKFSLKLDAKDGRL 89
Query: 64 KAESFQGHKEWLTEVIY----LGQLRHENLVKLIGY-CSESDNRLLVYEFMPKGSLENHL 118
E + + L + +G+ + R LV + + SL++ L
Sbjct: 90 FNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGR-SLQSAL 148
Query: 119 FRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAK--LSDFG 176
+S + +++A + L FLH + ++ ++ A N+ +D ++ L+ +G
Sbjct: 149 DVSPKHVLSERSVLQVACRLLDALEFLH--ENEYVHGNVTAENIFVDPEDQSQVTLAGYG 206
Query: 177 LA---RDGPTGDNTHVSTR------IVGTRGYAAPEYVATGHL----TPKSDVYSFGVVL 223
A HV+ G + + + H + +SD+ S G +
Sbjct: 207 FAFRYCP----SGKHVAYVEGSRSPHEGDLEFIS---MDL-HKGCGPSRRSDLQSLGYCM 258
Query: 224 LELLSGR 230
L+ L G
Sbjct: 259 LKWLYGF 265
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 2e-12
Identities = 39/249 (15%), Positives = 97/249 (38%), Gaps = 42/249 (16%)
Query: 10 PSASMISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ 69
+I+ +A + +G+GGFGC++ ++ + + +K +++
Sbjct: 24 AVGEIITDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSD----APCVVKVEPSDNGP 79
Query: 70 -----------GHKEWLTEVIYLGQLRHENLVKLIGY----CSESDNRLLVYEFMPKGSL 114
E + + I +L++ + K G + R ++ + L
Sbjct: 80 LFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS-DL 138
Query: 115 ENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAK--L 172
+ ++ + S T +++++ + L ++H + ++ D+KASN+LL+ + L
Sbjct: 139 Q-KIYEANAKRFSRKTVLQLSLRILDILEYIH--EHEYVHGDIKASNLLLNYKNPDQVYL 195
Query: 173 SDFGLA---RDGPTGDNTHVSTR----IVGTRGYAAPEYVATGHL----TPKSDVYSFGV 221
D+GLA + + GT + + + H + + D+ G
Sbjct: 196 VDYGLAYRYCPEGV--HKAYAADPKRCHDGTIEFTS---IDA-HNGVAPSRRGDLEILGY 249
Query: 222 VLLELLSGR 230
+++ L+G
Sbjct: 250 CMIQWLTGH 258
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 9e-11
Identities = 54/236 (22%), Positives = 86/236 (36%), Gaps = 60/236 (25%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKA-ESFQGHKEWLTEVIYLGQLRH 86
LGEG FG V + D VA+K ++ + + E+ L +++
Sbjct: 26 NLGEGTFGKVVECL-DHAR-------GKSQVALKIIRNVGKY--REAARLEINVLKKIKE 75
Query: 87 E------NLVKLIGY-------CSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVK 133
+ V + + C + +E + K + L QP P
Sbjct: 76 KDKENKFLCVLMSDWFNFHGHMC-------IAFELLGK-NTFEFLKENNFQPYPLPHVRH 127
Query: 134 IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNA-------------------KLSD 174
+A + L FLH + + + DLK N+L ++ +++D
Sbjct: 128 MAYQLCHALRFLH--ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVAD 185
Query: 175 FGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHL-TPKSDVYSFGVVLLELLSG 229
FG A T D+ H +T IV TR Y PE V DV+S G +L E G
Sbjct: 186 FGSA----TFDHEHHTT-IVATRHYRPPE-VILELGWAQPCDVWSIGCILFEYYRG 235
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 2e-10
Identities = 54/241 (22%), Positives = 90/241 (37%), Gaps = 66/241 (27%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKA-ESFQGHKEWLTEVIYLGQLRH 86
+G+G FG V + A+K ++ + + + E L ++++
Sbjct: 42 KMGDGTFGRVLLCQ-HIDN--------KKYYAVKVVRNIKKY--TRSAKIEADILKKIQN 90
Query: 87 E-----NLVKLIGY-------CSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 134
+ N+VK G C L++E + SL + R
Sbjct: 91 DDINNNNIVKYHGKFMYYDHMC-------LIFEPLGP-SLYEIITRNNYNGFHIEDIKLY 142
Query: 135 AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNA------------------------ 170
I++ + L++L ++ + DLK N+LLD +
Sbjct: 143 CIEILKALNYLR--KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTG 200
Query: 171 -KLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHL-TPKSDVYSFGVVLLELLS 228
KL DFG A T + + + I+ TR Y APE V SD++SFG VL EL +
Sbjct: 201 IKLIDFGCA----TFKSDYHGS-IINTRQYRAPE-VILNLGWDVSSDMWSFGCVLAELYT 254
Query: 229 G 229
G
Sbjct: 255 G 255
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 3e-10
Identities = 57/241 (23%), Positives = 91/241 (37%), Gaps = 70/241 (29%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKA-ESFQGHKEWLTEVIYLGQLRH 86
LGEG FG V + D G VA+K +K + + + +E+ L L
Sbjct: 21 TLGEGAFGKVVECI-DHKA-------GGRHVAVKIVKNVDRY--CEAARSEIQVLEHLNT 70
Query: 87 E------NLVKLIGY-------CSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVK 133
V+++ + C +V+E + S + + G P K
Sbjct: 71 TDPNSTFRCVQMLEWFEHHGHIC-------IVFELLGL-STYDFIKENGFLPFRLDHIRK 122
Query: 134 IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNA-------------------KLSD 174
+A + + ++FLH + + DLK N+L + K+ D
Sbjct: 123 MAYQICKSVNFLH--SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVD 180
Query: 175 FGLARDGPTGDNTHVSTRIVGTRGYAAPE------YVATGHLTPKSDVYSFGVVLLELLS 228
FG A T D+ H ST +V TR Y APE + + DV+S G +L+E
Sbjct: 181 FGSA----TYDDEHHST-LVSTRHYRAPEVILALGW------SQPCDVWSIGCILIEYYL 229
Query: 229 G 229
G
Sbjct: 230 G 230
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 57.6 bits (139), Expect = 2e-09
Identities = 43/279 (15%), Positives = 81/279 (29%), Gaps = 91/279 (32%)
Query: 104 LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVL 163
+V+E + L + + Q + P KI V +GL +LH +I+ D+K N+L
Sbjct: 122 MVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHT-KCRIIHTDIKPENIL 179
Query: 164 L-------------------------------------------------DSNFNAKLSD 174
L K++D
Sbjct: 180 LSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIAD 239
Query: 175 FGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRR--- 231
G A T + TR Y + E + +D++S + EL +G
Sbjct: 240 LGNACWV---HKHF--TEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFE 294
Query: 232 -----ALDEDRGGLAEQTLV------EWAD------------------PFLRDSRRVLRI 262
D +A + + L+ +
Sbjct: 295 PHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVL 354
Query: 263 MDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL 301
++ ++S++EA +L L + P+ R + + L
Sbjct: 355 VEKY---EWSQEEAAGFTDFLLPMLELIPEKRATAAECL 390
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 7e-09
Identities = 45/255 (17%), Positives = 93/255 (36%), Gaps = 49/255 (19%)
Query: 6 AMSDPSASMISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKA 65
+M P ++ + + +G GGFG ++ N A +K
Sbjct: 22 SMPFPEGKVLDDMEGNQWVLGKKIGSGGFGLIYLA-FPTNK--------PEKDARHVVKV 72
Query: 66 ESFQGHKEWLTEVIYLGQLRHENLV---------------KLIGY----CSESDNRLLVY 106
E Q + +E+ + ++ ++ + G R +V
Sbjct: 73 EY-QENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVM 131
Query: 107 EFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS 166
E + L+ + + T +++ I + L ++H + ++ D+KA+N+LL
Sbjct: 132 ERLGI-DLQ-KISGQN-GTFKKSTVLQLGIRMLDVLEYIH--ENEYVHGDIKAANLLLGY 186
Query: 167 NFNAK--LSDFGLA-RDGPTGDNTHVSTR----IVGTRGYAAPEYVATGHL----TPKSD 215
+ L+D+GL+ R P G++ GT + + + H + +SD
Sbjct: 187 KNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTS---LDA-HKGVALSRRSD 242
Query: 216 VYSFGVVLLELLSGR 230
V G +L L G+
Sbjct: 243 VEILGYCMLRWLCGK 257
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 53.7 bits (128), Expect = 3e-08
Identities = 48/250 (19%), Positives = 67/250 (26%), Gaps = 74/250 (29%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRL--------KAESFQGHKEWLTEVIY 80
+GEG FG VF+ D VAIK + + +E L E+I
Sbjct: 28 IGEGVFGEVFQTIADHTP-----------VAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 81 LGQL---------RHENLVKLIG----------------------YCSESDNRL------ 103
+L R E + L S +D
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 104 --LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASN 161
+V EF G + K S T I + L+ +RDL N
Sbjct: 137 LFIVLEFEFGGIDLEQMRTK---LSSLATAKSILHQLTASLAVAEAS-LRFEHRDLHWGN 192
Query: 162 VLLDSNFNAKLSDFGLARDG---------PTGDNTHVSTRIVGTRGYA---APEYVATGH 209
VLL KL + D T G + E + TG
Sbjct: 193 VLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTGD 252
Query: 210 LTPKSDVYSF 219
+ D+Y
Sbjct: 253 GDYQFDIYRL 262
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 49.1 bits (116), Expect = 2e-06
Identities = 45/350 (12%), Positives = 97/350 (27%), Gaps = 108/350 (30%)
Query: 52 PGSG-IVVAIKRLKAESFQGHKE----WLTEVIYLGQLRHENLVKLIGYCSESDNRL--- 103
GSG VA+ + Q + WL + C+ + L
Sbjct: 159 LGSGKTWVALDVCLSYKVQCKMDFKIFWLN----------------LKNCNSPETVLEML 202
Query: 104 --LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGL----SFLHGLDANVIYRDL 157
L+Y+ P + + + R+ R L + + L ++ ++
Sbjct: 203 QKLLYQIDPNWTSRSD------HSSNIKLRIHSIQAELRRLLKSKPYENCL---LVLLNV 253
Query: 158 KASNVLLDSNFNAKL----SDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPK 213
+ + N + K+ + TH+S ++ + LTP
Sbjct: 254 QNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISL-----------DHHSMT-LTPD 301
Query: 214 SDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDS-RRVLRIMDTRLGGQYS 272
+ LL + LD L + L +P +R +
Sbjct: 302 E--------VKSLLL--KYLDCRPQDLPREVLT--TNPRRLSIIAESIRDGLATWD-NWK 348
Query: 273 KKEAQAVAAVVLQCL-HMDPK----------------NRPSMV-----------DVLTSL 304
+ ++ L ++P + P+++ DV+ +
Sbjct: 349 HVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVV 408
Query: 305 EQLHTSKDMPRTPPPAKLHHHHHH-----HN------HHQGIKHTNPPRK 343
+LH + + P + + + H + H N P+
Sbjct: 409 NKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKT 458
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 350 | |||
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.92 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.9 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.79 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.69 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.43 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.21 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.14 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.1 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.82 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.75 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.64 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.51 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.43 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.28 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 98.15 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.13 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.01 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.87 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.82 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.73 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.57 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.49 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.35 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.3 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.29 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.25 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.96 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.96 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.84 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.73 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.02 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.41 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 90.99 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 89.57 |
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-57 Score=407.58 Aligned_cols=252 Identities=22% Similarity=0.335 Sum_probs=209.8
Q ss_pred hcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch--hhHHHHHHHHHHHhccCCCcccceeeEEee
Q 018785 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (350)
Q Consensus 21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (350)
++|++.+.||+|+||+||+| .+..+|+.||||++..... ...+.+.+|+.++++++||||+++++++.+
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a---------~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~ 94 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILV---------KSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEE 94 (350)
T ss_dssp CCEEEEEEC------CEEEE---------EETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEE---------EECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEE
Confidence 68999999999999999999 6677899999999976532 345678999999999999999999999999
Q ss_pred cCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcccccc
Q 018785 99 SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 178 (350)
Q Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~ 178 (350)
++.+||||||++||+|.+++.......+++.+++.++.||+.||.||| ++||+||||||+|||++.+|.+||+|||++
T Consensus 95 ~~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH--~~~IiHRDlKp~NILl~~~g~vKl~DFGla 172 (350)
T 4b9d_A 95 NGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH--DRKILHRDIKSQNIFLTKDGTVQLGDFGIA 172 (350)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH--HTTCEETTCCGGGEEECTTCCEEECSTTEE
T ss_pred CCEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHH--HCCeeeccCCHHHEEECCCCCEEEcccccc
Confidence 999999999999999999998776667899999999999999999999 999999999999999999999999999999
Q ss_pred ccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhHH
Q 018785 179 RDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRR 258 (350)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (350)
...... ........||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+.......+.
T Consensus 173 ~~~~~~--~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~------------ 238 (350)
T 4b9d_A 173 RVLNST--VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKII------------ 238 (350)
T ss_dssp SCCCHH--HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH------------
T ss_pred eeecCC--cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHH------------
Confidence 753221 112234679999999999999999999999999999999999999998654322222211
Q ss_pred HHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 259 VLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
... ....+..+++++.+||.+||+.||.+|||++++++|
T Consensus 239 -----~~~-~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 239 -----SGS-FPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp -----HTC-CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -----cCC-CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111 123455678899999999999999999999999986
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-57 Score=400.05 Aligned_cols=269 Identities=29% Similarity=0.441 Sum_probs=223.4
Q ss_pred hhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceeeEEe
Q 018785 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (350)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (350)
+..++|.+.+.||+|+||+||+|++... ....++..||||.++.......+.+.+|+.++++++||||+++++++.
T Consensus 10 I~r~~~~l~~~lG~G~fG~Vy~a~~~~~----~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~ 85 (299)
T 4asz_A 10 IKRHNIVLKRELGEGAFGKVFLAECYNL----CPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCV 85 (299)
T ss_dssp CCGGGEEEEEEEEC--CCCEEEEEECSC----C----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred cCHHHeEEeeEEeeCCCcEEEEEEECCc----ccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEe
Confidence 3457899999999999999999976532 344568899999998777666788999999999999999999999999
Q ss_pred ecCceEEEEEcCCCCChhhHHhhcC-----------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcC
Q 018785 98 ESDNRLLVYEFMPKGSLENHLFRKG-----------VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS 166 (350)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~-----------~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~ 166 (350)
+++..++||||+++|+|.+++.... ...+++.+++.++.|++.||+||| +++|+||||||+|||++.
T Consensus 86 ~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH--~~~iiHRDlKp~NILl~~ 163 (299)
T 4asz_A 86 EGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA--SQHFVHRDLATRNCLVGE 163 (299)
T ss_dssp SSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEECG
T ss_pred eCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCcccCccCHhhEEECC
Confidence 9999999999999999999997642 347999999999999999999999 899999999999999999
Q ss_pred CCcEEEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccccCcchhhh
Q 018785 167 NFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTL 245 (350)
Q Consensus 167 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~~~~~ 245 (350)
++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||+| |+.||.+.........
T Consensus 164 ~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~- 242 (299)
T 4asz_A 164 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIEC- 242 (299)
T ss_dssp GGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH-
T ss_pred CCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-
Confidence 99999999999975433333223333568999999999999999999999999999999998 8999987553222111
Q ss_pred hhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcC
Q 018785 246 VEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 310 (350)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 310 (350)
+........+..+|+++.+|+.+||+.||++|||++++.+.|+++...
T Consensus 243 -----------------i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 243 -----------------ITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp -----------------HHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -----------------HHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 112222345667889999999999999999999999999999998765
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-56 Score=399.72 Aligned_cols=269 Identities=28% Similarity=0.457 Sum_probs=218.7
Q ss_pred hhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceeeEEe
Q 018785 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (350)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (350)
+..++|.+.++||+|+||+||+|++... .+..++..||||.++.......+.+.+|+.++++++||||+++++++.
T Consensus 38 i~~~d~~l~~~LG~G~fG~Vy~a~~~~~----~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~ 113 (329)
T 4aoj_A 38 IKRRDIVLKWELGEGAFGKVFLAECHNL----LPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCT 113 (329)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEESSS----CC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred cCHHHeEEEEEEccCCCcEEEEEEECCc----ccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 3457899999999999999999987542 345678999999998777666788999999999999999999999999
Q ss_pred ecCceEEEEEcCCCCChhhHHhhcC-------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEE
Q 018785 98 ESDNRLLVYEFMPKGSLENHLFRKG-------------VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLL 164 (350)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~-------------~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili 164 (350)
+.+.++|||||+++|+|.+++.... ..++++.+++.++.|++.||+||| +.+|+||||||+|||+
T Consensus 114 ~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH--~~~iiHRDLKp~NILl 191 (329)
T 4aoj_A 114 EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA--GLHFVHRDLATRNCLV 191 (329)
T ss_dssp SSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEE
T ss_pred ECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh--cCCeecccccHhhEEE
Confidence 9999999999999999999997642 235899999999999999999999 8999999999999999
Q ss_pred cCCCcEEEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccccCcchh
Q 018785 165 DSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQ 243 (350)
Q Consensus 165 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~~~ 243 (350)
+.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||+| |+.||.+........
T Consensus 192 ~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~ 271 (329)
T 4aoj_A 192 GQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAID 271 (329)
T ss_dssp ETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHH
T ss_pred CCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 9999999999999986544443334445678999999999999999999999999999999998 899997655322211
Q ss_pred hhhhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcC
Q 018785 244 TLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 310 (350)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 310 (350)
. +....+...+..+++++.+|+.+||+.||++|||+.+++++|+.+...
T Consensus 272 ~------------------i~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 272 C------------------ITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp H------------------HHHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred H------------------HHcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 1 112223345667889999999999999999999999999999998765
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-57 Score=400.95 Aligned_cols=252 Identities=21% Similarity=0.323 Sum_probs=217.6
Q ss_pred hhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch---hhHHHHHHHHHHHhccCCCcccceeeEE
Q 018785 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLVKLIGYC 96 (350)
Q Consensus 20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (350)
.++|++.+.||+|+||+||+| .+..+|+.||||++..... .....+.+|+.++++++||||+++++++
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a---------~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~ 101 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLA---------RELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTF 101 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEE---------EETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred ccccEEEEEEecccCeEEEEE---------EECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 468999999999999999999 6777899999999976432 3356789999999999999999999999
Q ss_pred eecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcccc
Q 018785 97 SESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFG 176 (350)
Q Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg 176 (350)
++++.+|+||||++||+|.+++.+.+ .+++.+++.++.||+.||+||| ++||+||||||+|||++.++.+||+|||
T Consensus 102 ~~~~~~yivmEy~~gG~L~~~i~~~~--~l~e~~~~~~~~qi~~al~ylH--~~~IiHRDlKPeNILl~~~g~vKl~DFG 177 (311)
T 4aw0_A 102 QDDEKLYFGLSYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLH--GKGIIHRDLKPENILLNEDMHIQITDFG 177 (311)
T ss_dssp ECSSEEEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECTTSCEEECCCT
T ss_pred EeCCEEEEEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCCccCCCCHHHeEEcCCCCEEEEEcC
Confidence 99999999999999999999998765 7999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhh
Q 018785 177 LARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDS 256 (350)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 256 (350)
++...............+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+.......+.
T Consensus 178 la~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~---------- 247 (311)
T 4aw0_A 178 TAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKII---------- 247 (311)
T ss_dssp TCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH----------
T ss_pred CceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH----------
Confidence 9987654444444455789999999999999999999999999999999999999997654322222221
Q ss_pred HHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 257 RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
... ...+..+++++.+||.+||..||.+|||+++++.+
T Consensus 248 -------~~~--~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~ 285 (311)
T 4aw0_A 248 -------KLE--YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 285 (311)
T ss_dssp -------HTC--CCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCH
T ss_pred -------cCC--CCCCcccCHHHHHHHHHHccCCHhHCcChHHHcCC
Confidence 111 23455678899999999999999999999987654
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-57 Score=405.14 Aligned_cols=251 Identities=24% Similarity=0.355 Sum_probs=215.1
Q ss_pred hcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceeeEEeecC
Q 018785 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSESD 100 (350)
Q Consensus 21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 100 (350)
++|++.++||+|+||+||+| .+..+|+.||||++........+.+.+|+.+++.++||||+++++++.+++
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a---------~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~ 144 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIA---------TVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD 144 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEE---------EETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred HhcEEeEEeecCcCeEEEEE---------EECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 56999999999999999999 667789999999997766555667889999999999999999999999999
Q ss_pred ceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcccccccc
Q 018785 101 NRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD 180 (350)
Q Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~~ 180 (350)
.+||||||++||+|.+++... .+++.+++.++.||+.||+||| ++||+||||||+|||++.+|.+||+|||++..
T Consensus 145 ~~~ivmEy~~gg~L~~~l~~~---~l~e~~~~~~~~qi~~aL~ylH--~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~ 219 (346)
T 4fih_A 145 ELWVVMEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLH--AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQ 219 (346)
T ss_dssp EEEEEECCCTTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH--HCCcccccCCHHHEEECCCCCEEEecCcCcee
Confidence 999999999999999999764 5999999999999999999999 99999999999999999999999999999986
Q ss_pred CCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhHHHH
Q 018785 181 GPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVL 260 (350)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (350)
..... .......||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.........+...
T Consensus 220 ~~~~~--~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~------------ 285 (346)
T 4fih_A 220 VSKEV--PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN------------ 285 (346)
T ss_dssp CCSSS--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS------------
T ss_pred cCCCC--CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcC------------
Confidence 43322 2234467999999999999999999999999999999999999999765432222222111
Q ss_pred HhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 261 RIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
.......+..+++++.+||.+||+.||++|||++++++|
T Consensus 286 ----~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 286 ----LPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp ----SCCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ----CCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 011122345678999999999999999999999999986
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-56 Score=395.13 Aligned_cols=257 Identities=23% Similarity=0.291 Sum_probs=216.3
Q ss_pred hhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceeeEEeec
Q 018785 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (350)
Q Consensus 20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (350)
.+.|++.++||+|+||+||+| .+..+|+.||||+++..... .+|+.+++.++||||+++++++.++
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a---------~~~~~g~~vAiK~i~~~~~~-----~~E~~il~~l~HpnIV~l~~~~~~~ 122 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRM---------KDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGAVREG 122 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEE---------EETTTCCEEEEEEEETTTCC-----THHHHTTTTCCCTTBCCEEEEEEET
T ss_pred hhheEeCcEeccCCCeEEEEE---------EECCCCCEEEEEEECHHHhH-----HHHHHHHHhCCCCCCCcEEEEEEEC
Confidence 357888999999999999999 66778999999999765432 3689999999999999999999999
Q ss_pred CceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCC-cEEEcccccc
Q 018785 100 DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNF-NAKLSDFGLA 178 (350)
Q Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~-~~~l~Dfg~~ 178 (350)
+.+||||||++||+|.+++...+ .+++..++.++.|++.||+||| ++||+||||||+|||++.+| .+||+|||++
T Consensus 123 ~~~~ivmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH--~~~IiHRDlKp~NILl~~~g~~vKl~DFGla 198 (336)
T 4g3f_A 123 PWVNIFMELLEGGSLGQLIKQMG--CLPEDRALYYLGQALEGLEYLH--TRRILHGDVKADNVLLSSDGSRAALCDFGHA 198 (336)
T ss_dssp TEEEEEECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH--TTTEECSCCCGGGEEECTTSCCEEECCCTTC
T ss_pred CEEEEEEeccCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCceecccCHHHEEEeCCCCEEEEeeCCCC
Confidence 99999999999999999998765 7999999999999999999999 99999999999999999987 5999999999
Q ss_pred ccCCCCCCCc---ccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhh
Q 018785 179 RDGPTGDNTH---VSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRD 255 (350)
Q Consensus 179 ~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 255 (350)
.......... ......||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.........+.....+
T Consensus 199 ~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~---- 274 (336)
T 4g3f_A 199 LCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPP---- 274 (336)
T ss_dssp EEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCG----
T ss_pred eEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCC----
Confidence 8654332211 123357999999999999999999999999999999999999999876655444433322111
Q ss_pred hHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcC
Q 018785 256 SRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 310 (350)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 310 (350)
....+..+++.+.+||.+||+.||.+|||+.+++++|......
T Consensus 275 ------------~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~ 317 (336)
T 4g3f_A 275 ------------IREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQE 317 (336)
T ss_dssp ------------GGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ------------chhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhh
Confidence 1123557789999999999999999999999999999887654
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-56 Score=393.63 Aligned_cols=269 Identities=25% Similarity=0.382 Sum_probs=221.2
Q ss_pred hhhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch-hhHHHHHHHHHHHhccCCCccccee
Q 018785 15 ISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLVKLI 93 (350)
Q Consensus 15 ~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~ 93 (350)
+.++...++++.++||+|+||+||+|++.+. .+..+++.||||.+..... ...+.+.+|+.++++++||||++++
T Consensus 20 ~~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~----~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~ 95 (308)
T 4gt4_A 20 LKEISLSAVRFMEELGEDRFGKVYKGHLFGP----APGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLL 95 (308)
T ss_dssp CCBCCGGGEEEEEEEEECSSCEEEEEEEC-----------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccCCHHHCeEeeEeccCCCcEEEEEEEcCC----ccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcc
Confidence 4456677899999999999999999987532 3455688999999975532 3356799999999999999999999
Q ss_pred eEEeecCceEEEEEcCCCCChhhHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCC
Q 018785 94 GYCSESDNRLLVYEFMPKGSLENHLFRKG--------------VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKA 159 (350)
Q Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------------~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~ 159 (350)
+++.+++.+++||||+++|+|.+++..+. ...+++.++..++.|++.||+||| +.+++||||||
T Consensus 96 g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH--~~~iiHRDLK~ 173 (308)
T 4gt4_A 96 GVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS--SHHVVHKDLAT 173 (308)
T ss_dssp EEECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSG
T ss_pred eEEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH--hCCCCCCCccc
Confidence 99999999999999999999999996532 235899999999999999999999 89999999999
Q ss_pred CceEEcCCCcEEEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCccccc
Q 018785 160 SNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRG 238 (350)
Q Consensus 160 ~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~ 238 (350)
+|||++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||+| |..||.+...
T Consensus 174 ~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~ 253 (308)
T 4gt4_A 174 RNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN 253 (308)
T ss_dssp GGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH
T ss_pred cceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999976444333333444678999999999999999999999999999999998 8999977553
Q ss_pred CcchhhhhhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 018785 239 GLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 307 (350)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~ 307 (350)
.... ..+......+.+..+++.+.+|+.+||+.||.+|||+.+|+++|+..
T Consensus 254 ~~~~------------------~~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 254 QDVV------------------EMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HHHH------------------HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HHHH------------------HHHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 2211 12222233345677889999999999999999999999999999865
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-56 Score=385.35 Aligned_cols=247 Identities=26% Similarity=0.404 Sum_probs=198.7
Q ss_pred hcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch---hhHHHHHHHHHHHhccCCCcccceeeEEe
Q 018785 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (350)
Q Consensus 21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (350)
++|++.+.||+|+||+||+| .+..+|+.||||++..... .....+.+|+.+++.++||||+++++++.
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~---------~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~ 83 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLA---------YHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIK 83 (275)
T ss_dssp -CCEEEEEEEC---CCEEEE---------ECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEE---------EECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEE
Confidence 58999999999999999999 7777899999999976532 23456889999999999999999999999
Q ss_pred ecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccc
Q 018785 98 ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL 177 (350)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~ 177 (350)
+++.+|+||||+ +|+|.+++.+++ .+++.++..++.||+.||+||| ++||+||||||+||+++.++.+||+|||+
T Consensus 84 ~~~~~~ivmEy~-~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~ylH--~~~IiHRDiKP~NILl~~~~~vkl~DFGl 158 (275)
T 3hyh_A 84 SKDEIIMVIEYA-GNELFDYIVQRD--KMSEQEARRFFQQIISAVEYCH--RHKIVHRDLKPENLLLDEHLNVKIADFGL 158 (275)
T ss_dssp CSSEEEEEEECC-CEEHHHHHHHSC--SCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCTTTEEECTTCCEEECCSSC
T ss_pred ECCEEEEEEeCC-CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCcccccCChHHeEECCCCCEEEeecCC
Confidence 999999999999 789999998775 7999999999999999999999 99999999999999999999999999999
Q ss_pred cccCCCCCCCcccccccCCCcccCccccccCCC-CCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhh
Q 018785 178 ARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHL-TPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDS 256 (350)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 256 (350)
|...... .......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+.......+.
T Consensus 159 a~~~~~~---~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~---------- 225 (275)
T 3hyh_A 159 SNIMTDG---NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNIS---------- 225 (275)
T ss_dssp C------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH----------
T ss_pred CeecCCC---CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH----------
Confidence 9754322 22334679999999999988876 579999999999999999999997644222111111
Q ss_pred HHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 257 RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
.. ....+..+++++.+||.+||+.||++|||++++++|
T Consensus 226 -------~~--~~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 226 -------NG--VYTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp -------HT--CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred -------cC--CCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 11 123455678899999999999999999999999986
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-56 Score=407.24 Aligned_cols=252 Identities=24% Similarity=0.353 Sum_probs=215.4
Q ss_pred hhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceeeEEeec
Q 018785 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (350)
Q Consensus 20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (350)
.++|++.+.||+|+||.||+| .+..+|+.||||++........+.+.+|+.+|+.++||||++++++|.++
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a---------~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~ 220 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIA---------TVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVG 220 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEE---------EETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred hHhcEeeeEeccCcCcEEEEE---------EECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEEC
Confidence 357999999999999999999 66778999999999876655566788999999999999999999999999
Q ss_pred CceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccccc
Q 018785 100 DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR 179 (350)
Q Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~ 179 (350)
+.+||||||++||+|.+++... .+++.++..++.||+.||+||| ++||+||||||+|||++.+|.+||+|||++.
T Consensus 221 ~~~~iVmEy~~gG~L~~~i~~~---~l~e~~~~~~~~qil~aL~ylH--~~~IiHRDiKp~NILl~~~g~vKl~DFGla~ 295 (423)
T 4fie_A 221 DELWVVMEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLH--AQGVIHRDIKSDSILLTHDGRVKLSDFGFCA 295 (423)
T ss_dssp TEEEEEEECCTTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSTTTEEECTTCCEEECCCTTCE
T ss_pred CEEEEEEeCCCCCcHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHH--HCCeecccCCHHHEEEcCCCCEEEecCccce
Confidence 9999999999999999999765 5999999999999999999999 9999999999999999999999999999997
Q ss_pred cCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhHHH
Q 018785 180 DGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRV 259 (350)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (350)
...... ......+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.........+...
T Consensus 296 ~~~~~~--~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~----------- 362 (423)
T 4fie_A 296 QVSKEV--PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN----------- 362 (423)
T ss_dssp ECCSSC--CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS-----------
T ss_pred ECCCCC--ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcC-----------
Confidence 643322 2234467999999999999999999999999999999999999999765432222221111
Q ss_pred HHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 260 LRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
..........+++++.+||.+||..||.+|||+.++++|
T Consensus 363 -----~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 363 -----LPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp -----CCCCCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -----CCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 011122344678899999999999999999999999986
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-55 Score=385.80 Aligned_cols=266 Identities=28% Similarity=0.417 Sum_probs=211.6
Q ss_pred hhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccc--hhhHHHHHHHHHHHhccCCCccccee
Q 018785 16 SKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES--FQGHKEWLTEVIYLGQLRHENLVKLI 93 (350)
Q Consensus 16 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~ 93 (350)
+++..+++++.++||+|+||+||+|+++ ..||||+++... ....+.+.+|+.++++++||||++++
T Consensus 31 Wei~~~~l~l~~~iG~G~fG~Vy~~~~~------------~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~ 98 (307)
T 3omv_A 31 WEIEASEVMLSTRIGSGSFGTVYKGKWH------------GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFM 98 (307)
T ss_dssp CBCCTTSCCEEEECCCCSSSEEEEEESS------------SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred cEEcHHHeEEeeEEeeCCCcEEEEEEEC------------CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEE
Confidence 4566788999999999999999999653 248999986543 33456789999999999999999999
Q ss_pred eEEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEc
Q 018785 94 GYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLS 173 (350)
Q Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~ 173 (350)
+++.+ +.++|||||+++|+|.+++.... ..+++.++..++.|++.||+||| +++|+||||||+|||++.++.+||+
T Consensus 99 g~~~~-~~~~iVmEy~~gGsL~~~l~~~~-~~l~~~~~~~i~~qia~gL~yLH--~~~IiHRDlKp~NILl~~~~~~Ki~ 174 (307)
T 3omv_A 99 GYMTK-DNLAIVTQWCEGSSLYKHLHVQE-TKFQMFQLIDIARQTAQGMDYLH--AKNIIHRDMKSNNIFLHEGLTVKIG 174 (307)
T ss_dssp EEECS-SSCEEEEECCSSCBHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHH--HTTCBCSCCCSSSEEEETTEEEEEC
T ss_pred EEEEC-CeEEEEEEcCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHH--HCCccCCccCHHHEEECCCCcEEEe
Confidence 98765 57899999999999999997654 36999999999999999999999 8999999999999999999999999
Q ss_pred cccccccCCCCCCCcccccccCCCcccCcccccc---CCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcc
Q 018785 174 DFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT---GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD 250 (350)
Q Consensus 174 Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~---~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~ 250 (350)
|||+|................||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+..+.........
T Consensus 175 DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~--- 251 (307)
T 3omv_A 175 DFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVG--- 251 (307)
T ss_dssp CCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHH---
T ss_pred eccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHh---
Confidence 9999986544333333445679999999999864 3588999999999999999999999976543221111110
Q ss_pred hhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcC
Q 018785 251 PFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 310 (350)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 310 (350)
...........+..+++++.+|+.+||+.||++|||+.+++++|+.+...
T Consensus 252 ----------~~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~ 301 (307)
T 3omv_A 252 ----------RGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHS 301 (307)
T ss_dssp ----------TTCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTT
T ss_pred ----------cCCCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcc
Confidence 00111111234567889999999999999999999999999999998755
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-54 Score=380.78 Aligned_cols=249 Identities=25% Similarity=0.392 Sum_probs=203.1
Q ss_pred hcc-cccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccc--hhhHHHHHHHHHHHhccCCCcccceeeEEe
Q 018785 21 KNF-CSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES--FQGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (350)
Q Consensus 21 ~~y-~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (350)
++| ++.++||+|+||+||+| .+..++..||+|.+.... ......+.+|+.++++++||||+++++++.
T Consensus 25 gr~~~~~~~iG~G~fg~Vy~a---------~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~ 95 (290)
T 3fpq_A 25 GRFLKFDIEIGRGSFKTVYKG---------LDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWE 95 (290)
T ss_dssp SSEEEEEEEEEECSSEEEEEE---------EETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred CceEEeeeEEecCcCcEEEEE---------EECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEe
Confidence 444 78889999999999999 666779999999986543 233467899999999999999999999987
Q ss_pred e----cCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC--eeeCCCCCCceEEcC-CCcE
Q 018785 98 E----SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDAN--VIYRDLKASNVLLDS-NFNA 170 (350)
Q Consensus 98 ~----~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~--i~H~di~~~Nili~~-~~~~ 170 (350)
. ++.+|+||||++||+|.+++.+.. .+++..+..++.||+.||+||| ++| |+||||||+|||++. ++.+
T Consensus 96 ~~~~~~~~~~lvmEy~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~ylH--~~~~~IiHRDlKp~NILl~~~~g~v 171 (290)
T 3fpq_A 96 STVKGKKCIVLVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLH--TRTPPIIHRDLKCDNIFITGPTGSV 171 (290)
T ss_dssp EEETTEEEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH--TSSSCCCCCCCCGGGEEESSTTSCE
T ss_pred eccCCCcEEEEEEeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--HCCCCEEecccChhheeEECCCCCE
Confidence 5 356899999999999999998765 7999999999999999999999 788 999999999999974 7899
Q ss_pred EEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcc
Q 018785 171 KLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD 250 (350)
Q Consensus 171 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~ 250 (350)
||+|||+|..... .......||+.|+|||++.+ .|+.++|||||||++|+|++|+.||.+..+.....
T Consensus 172 Kl~DFGla~~~~~----~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~------- 239 (290)
T 3fpq_A 172 KIGDLGLATLKRA----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIY------- 239 (290)
T ss_dssp EECCTTGGGGCCT----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHH-------
T ss_pred EEEeCcCCEeCCC----CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHH-------
Confidence 9999999975322 22334679999999998865 69999999999999999999999997543211110
Q ss_pred hhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 251 PFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
..+.....+...+..+++++.+||.+||+.||.+|||++++++|
T Consensus 240 ---------~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 240 ---------RRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp ---------HHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ---------HHHHcCCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 01111111122334456789999999999999999999999875
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-55 Score=389.52 Aligned_cols=254 Identities=24% Similarity=0.323 Sum_probs=206.7
Q ss_pred hhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch--hhHHHHHHHHHHHhccCCCcccceeeEE
Q 018785 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLRHENLVKLIGYC 96 (350)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (350)
..++|++.+.||+|+||+||+|+.. .+..+++.||||++..... .....+.+|+.++++++||||+++++++
T Consensus 22 ~p~~Y~i~~~lG~G~fg~Vy~a~~~------~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~ 95 (304)
T 3ubd_A 22 DPSQFELLKVLGQGSFGKVFLVKKI------SGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAF 95 (304)
T ss_dssp CGGGEEEEEEEECGGGCEEEEEEEC------SSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEE
T ss_pred CccccEEEEEEecCCCeEEEEEEEc------cCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEE
Confidence 3478999999999999999999543 2345688999999875432 2234577899999999999999999999
Q ss_pred eecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcccc
Q 018785 97 SESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFG 176 (350)
Q Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg 176 (350)
.+++.+|+||||++||+|.+++.+.+ .+++.++..++.|++.||+||| ++||+||||||+|||++.+|.+||+|||
T Consensus 96 ~~~~~~~ivmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH--~~~IiHRDlKp~NILl~~~g~vKl~DFG 171 (304)
T 3ubd_A 96 QTEGKLYLILDFLRGGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLH--SLGIIYRDLKPENILLDEEGHIKLTDFG 171 (304)
T ss_dssp EETTEEEEEECCCTTCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH--HTTCCCSSCCGGGEEECTTSCEEEESSE
T ss_pred EECCEEEEEEEcCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--HCCCcCCCCCHHHeEEcCCCCEEecccc
Confidence 99999999999999999999998765 7999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhh
Q 018785 177 LARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDS 256 (350)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 256 (350)
+|....... .......||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+.......+.
T Consensus 172 la~~~~~~~--~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~---------- 239 (304)
T 3ubd_A 172 LSKESIDHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMIL---------- 239 (304)
T ss_dssp EEEC-------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH----------
T ss_pred cceeccCCC--ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHH----------
Confidence 997533222 22334679999999999999999999999999999999999999998755322222221
Q ss_pred HHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 018785 257 RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPS-----MVDVLTS 303 (350)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-----~~~ll~~ 303 (350)
.. ....+..+++++.+||.+||+.||.+||| ++++++|
T Consensus 240 -------~~--~~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H 282 (304)
T 3ubd_A 240 -------KA--KLGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH 282 (304)
T ss_dssp -------HC--CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred -------cC--CCCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence 11 12345668899999999999999999998 4788765
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-54 Score=387.65 Aligned_cols=272 Identities=26% Similarity=0.362 Sum_probs=225.2
Q ss_pred hhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch-hhHHHHHHHHHHHhccCC-Cccccee
Q 018785 16 SKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRH-ENLVKLI 93 (350)
Q Consensus 16 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h-~~i~~~~ 93 (350)
+++..++|++.+.||+|+||+||+|++... .+..+++.||||.+..... ...+.+.+|+.+++++.| |||++++
T Consensus 59 wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~----~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~ 134 (353)
T 4ase_A 59 WEFPRDRLKLGKPLGRGAFGQVIEADAFGI----DKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 134 (353)
T ss_dssp HBCCGGGEEEEEEEEECSSEEEEEEEEETS----SSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cEecHHHeEEeeEEecCCCeEEEEEEEcCC----CcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence 345568999999999999999999977643 3445678899999876543 334678999999999965 9999999
Q ss_pred eEEeec-CceEEEEEcCCCCChhhHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCC
Q 018785 94 GYCSES-DNRLLVYEFMPKGSLENHLFRKG--------------VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLK 158 (350)
Q Consensus 94 ~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~--------------~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~ 158 (350)
+++.+. +.+++||||+++|+|.+++.... ...+++..+..++.|++.||+||| +++++|||||
T Consensus 135 g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH--~~~iiHRDLK 212 (353)
T 4ase_A 135 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA--SRKCIHRDLA 212 (353)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCS
T ss_pred EEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh--hCCeecCccC
Confidence 998664 57899999999999999997532 235899999999999999999999 8999999999
Q ss_pred CCceEEcCCCcEEEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccc
Q 018785 159 ASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDR 237 (350)
Q Consensus 159 ~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~ 237 (350)
|+|||++.++.+||+|||+|+...............||+.|+|||++.+..|+.++|||||||++|||++ |..||.+..
T Consensus 213 ~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~ 292 (353)
T 4ase_A 213 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 292 (353)
T ss_dssp GGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred ccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999986554444444445678999999999999999999999999999999998 899997654
Q ss_pred cCcchhhhhhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcC
Q 018785 238 GGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 310 (350)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 310 (350)
.... ....+....+...+..+++++.+|+.+||+.||.+|||+.+++++|+.+..+
T Consensus 293 ~~~~-----------------~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~ 348 (353)
T 4ase_A 293 IDEE-----------------FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 348 (353)
T ss_dssp CSHH-----------------HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHH-----------------HHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence 3211 1222223333455667889999999999999999999999999999988654
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-52 Score=367.75 Aligned_cols=252 Identities=23% Similarity=0.372 Sum_probs=190.9
Q ss_pred hcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh-hHHHHHHHHHHHhccCCCcccceeeEEeec
Q 018785 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ-GHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (350)
Q Consensus 21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (350)
++|++.+.||+|+||+||+| .+..+|+.||||.+...... ..+.+.+|+.++++++||||+++++++.+.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a---------~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~ 75 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEA---------KNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEK 75 (299)
T ss_dssp HHEEEEEEEEECC--EEEEE---------EETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEE
T ss_pred hhCEEeeEEecCCCeEEEEE---------EECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEec
Confidence 57999999999999999999 66677999999998765433 346688999999999999999999998765
Q ss_pred Cc------------eEEEEEcCCCCChhhHHhhcCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcC
Q 018785 100 DN------------RLLVYEFMPKGSLENHLFRKGV-QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS 166 (350)
Q Consensus 100 ~~------------~~lv~e~~~~~~L~~~l~~~~~-~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~ 166 (350)
+. +|+||||+++++|.+++..+.. ...+...++.++.||++||+||| ++||+||||||+|||++.
T Consensus 76 ~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH--~~~IiHRDlKp~NILl~~ 153 (299)
T 4g31_A 76 NTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLH--SKGLMHRDLKPSNIFFTM 153 (299)
T ss_dssp C----------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECT
T ss_pred CccccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHH--HCcCccccCcHHHeEECC
Confidence 43 6899999999999999976542 23445668899999999999999 899999999999999999
Q ss_pred CCcEEEccccccccCCCCCCC----------cccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCccc
Q 018785 167 NFNAKLSDFGLARDGPTGDNT----------HVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDED 236 (350)
Q Consensus 167 ~~~~~l~Dfg~~~~~~~~~~~----------~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~ 236 (350)
++.+||+|||++......... .......||+.|+|||++.+..|+.++|||||||++|+|++ ||...
T Consensus 154 ~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~ 230 (299)
T 4g31_A 154 DDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ 230 (299)
T ss_dssp TCCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH
T ss_pred CCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc
Confidence 999999999999765433221 11233579999999999999999999999999999999996 66432
Q ss_pred ccCcchhhhhhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 237 RGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
... .. ...... ...........++.+.+||.+||+.||.+|||+.++++|
T Consensus 231 ~~~--~~--------------~~~~~~-~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 231 MER--VR--------------TLTDVR-NLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp HHH--HH--------------HHHHHH-TTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred cHH--HH--------------HHHHHh-cCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 110 00 000000 000011123445678899999999999999999999875
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-51 Score=366.34 Aligned_cols=274 Identities=24% Similarity=0.326 Sum_probs=204.1
Q ss_pred hhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceeeEEeec
Q 018785 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (350)
Q Consensus 20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (350)
.++|.+.+.||+|+||+||+|++. |+.||||++...... ......|+..+.+++||||+++++++.++
T Consensus 2 ar~i~L~~~iG~G~fG~Vy~~~~~-----------g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~ 69 (303)
T 3hmm_A 2 ARTIVLQESIGKGRFGEVWRGKWR-----------GEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKD 69 (303)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEET-----------TEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEEC-----------CEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEec
Confidence 468999999999999999999653 788999998765422 22234566677788999999999999876
Q ss_pred C----ceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCC--------CeeeCCCCCCceEEcCC
Q 018785 100 D----NRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDA--------NVIYRDLKASNVLLDSN 167 (350)
Q Consensus 100 ~----~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~--------~i~H~di~~~Nili~~~ 167 (350)
+ .+||||||+++|+|.+++... .++...+..++.|++.||+||| ++ +|+||||||+|||++.+
T Consensus 70 ~~~~~~~~lV~Ey~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gl~ylH--~~~~~~~~~~~IiHRDlKp~NILl~~~ 144 (303)
T 3hmm_A 70 NGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLH--MEIVGTQGKPAIAHRDLKSKNILVKKN 144 (303)
T ss_dssp CSSSEEEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHH--CCBCSTTCBCCEECSCCCGGGEEECTT
T ss_pred CCCceEEEEEecCCCCCcHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHH--HhhhhccCCCCEeeccCCcccEEECCC
Confidence 4 479999999999999999875 5899999999999999999999 65 99999999999999999
Q ss_pred CcEEEccccccccCCCCCCC--cccccccCCCcccCccccccC------CCCCccchhhHHHHHHHHHhCCCCCcccccC
Q 018785 168 FNAKLSDFGLARDGPTGDNT--HVSTRIVGTRGYAAPEYVATG------HLTPKSDVYSFGVVLLELLSGRRALDEDRGG 239 (350)
Q Consensus 168 ~~~~l~Dfg~~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~------~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~ 239 (350)
+.+||+|||++......... .......||+.|+|||++.+. .++.++|||||||++|||++|..||......
T Consensus 145 ~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~ 224 (303)
T 3hmm_A 145 GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY 224 (303)
T ss_dssp SCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCC
T ss_pred CCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccc
Confidence 99999999999754333221 122335799999999998764 3567899999999999999998887654332
Q ss_pred cchhhhhhhcchhhhhhHHHHHhhhcccCCCC-----cHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcCCC
Q 018785 240 LAEQTLVEWADPFLRDSRRVLRIMDTRLGGQY-----SKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKD 312 (350)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~ 312 (350)
.....-.....+... ...........+... ...+++.+.+|+.+||+.||++|||+.++++.|+++....+
T Consensus 225 ~~p~~~~~~~~~~~~--~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~~ 300 (303)
T 3hmm_A 225 QLPYYDLVPSDPSVE--EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 300 (303)
T ss_dssp CCTTTTTSCSSCCHH--HHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred cccchhcccccchHH--HHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHcC
Confidence 111000000000000 011111222222222 23466789999999999999999999999999999987644
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-51 Score=376.17 Aligned_cols=276 Identities=24% Similarity=0.324 Sum_probs=213.7
Q ss_pred hhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch--hhHHHHHHHHHHHhccCCCcccceeeEEe
Q 018785 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (350)
Q Consensus 20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (350)
+++|++.+.||+|+||+||+| .+..+|+.||||++..... .....+.+|+.+|+.++||||+++++++.
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a---------~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 123 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSA---------RRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILR 123 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEE---------EETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECC
T ss_pred CCCeEEEEEEecccCeEEEEE---------EECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeee
Confidence 468999999999999999999 6777899999999975432 33456789999999999999999999876
Q ss_pred e------cCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEE
Q 018785 98 E------SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAK 171 (350)
Q Consensus 98 ~------~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~ 171 (350)
. .+.+|+||||+. |+|.+++.... .+++..+..++.||+.||.||| ++||+||||||+|||++.++.+|
T Consensus 124 ~~~~~~~~~~~~ivmE~~~-g~L~~~i~~~~--~l~~~~~~~~~~qil~al~ylH--~~~iiHRDlKP~NIl~~~~~~~K 198 (398)
T 4b99_A 124 PTVPYGEFKSVYVVLDLME-SDLHQIIHSSQ--PLTLEHVRYFLYQLLRGLKYMH--SAQVIHRDLKPSNLLVNENCELK 198 (398)
T ss_dssp CSSCTTTCCCEEEEEECCS-EEHHHHHTSSS--CCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCCGGGEEECTTCCEE
T ss_pred cccccccCCEEEEEEeCCC-CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--HCcCcCCCcCccccccCCCCCEE
Confidence 4 367899999995 68999997654 7999999999999999999999 99999999999999999999999
Q ss_pred EccccccccCCCCC--CCcccccccCCCcccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhh
Q 018785 172 LSDFGLARDGPTGD--NTHVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEW 248 (350)
Q Consensus 172 l~Dfg~~~~~~~~~--~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~ 248 (350)
|+|||++....... .........||+.|+|||++.+. .++.++||||+||++|+|++|+.||.+.+.......+...
T Consensus 199 i~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~ 278 (398)
T 4b99_A 199 IGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMV 278 (398)
T ss_dssp ECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHH
T ss_pred EeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHh
Confidence 99999997643322 12223446899999999998875 5699999999999999999999999887655544444432
Q ss_pred cchhhhhh------HHHHHhhhccc-CCC-----CcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHhhhc
Q 018785 249 ADPFLRDS------RRVLRIMDTRL-GGQ-----YSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS--LEQLHT 309 (350)
Q Consensus 249 ~~~~~~~~------~~~~~~~~~~~-~~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~--L~~~~~ 309 (350)
........ ........... ... ....+++++.+||.+||..||.+|||+.++|+| +.+...
T Consensus 279 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 353 (398)
T 4b99_A 279 LGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHD 353 (398)
T ss_dssp HCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCC
T ss_pred cCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCC
Confidence 21111000 00001111000 000 112457889999999999999999999999987 544443
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-50 Score=365.03 Aligned_cols=270 Identities=21% Similarity=0.288 Sum_probs=204.4
Q ss_pred hhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhcc-CCCcccceeeEEe
Q 018785 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQL-RHENLVKLIGYCS 97 (350)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~ 97 (350)
..++|++.+.||+|+||+||+|+.+ .+..+++.||+|.+.... ....+.+|+.+++.+ +||||+++++++.
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~------~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~ 90 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQ------LQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFR 90 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEE------BTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEE
T ss_pred ccCcEEEEEEEecccCcEEEEEEEc------ccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEE
Confidence 4578999999999999999999643 234568899999886654 345677899999988 6999999999999
Q ss_pred ecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCC-CcEEEcccc
Q 018785 98 ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSN-FNAKLSDFG 176 (350)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~-~~~~l~Dfg 176 (350)
+.+.+|+||||+++++|.+++. .+++.+++.++.||+.||+||| ++||+||||||+|||++.+ +.+||+|||
T Consensus 91 ~~~~~~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH--~~gIiHRDiKPeNiLl~~~~~~~kl~DFG 163 (361)
T 4f9c_A 91 KNDHVVIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIH--QFGIVHRDVKPSNFLYNRRLKKYALVDFG 163 (361)
T ss_dssp ETTEEEEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred ECCEEEEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHH--HCCeEeCcCCHHHeEEeCCCCeEEECcCC
Confidence 9999999999999999999883 5899999999999999999999 9999999999999999876 799999999
Q ss_pred ccccCCCCCCC--------------------------cccccccCCCcccCccccccC-CCCCccchhhHHHHHHHHHhC
Q 018785 177 LARDGPTGDNT--------------------------HVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSG 229 (350)
Q Consensus 177 ~~~~~~~~~~~--------------------------~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~ll~~ll~g 229 (350)
+|......... .......||+.|+|||++.+. .++.++||||+||++|+|++|
T Consensus 164 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G 243 (361)
T 4f9c_A 164 LAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSG 243 (361)
T ss_dssp TCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHT
T ss_pred CCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHC
Confidence 99754322111 112235699999999999775 589999999999999999999
Q ss_pred CCCCcccccC-cchhhhhhhcchh-h-------------------hhhHHHHHhh---------------hcccCCCCcH
Q 018785 230 RRALDEDRGG-LAEQTLVEWADPF-L-------------------RDSRRVLRIM---------------DTRLGGQYSK 273 (350)
Q Consensus 230 ~~pf~~~~~~-~~~~~~~~~~~~~-~-------------------~~~~~~~~~~---------------~~~~~~~~~~ 273 (350)
+.||....+. .....+....... . .+........ ..........
T Consensus 244 ~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~ 323 (361)
T 4f9c_A 244 RYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWN 323 (361)
T ss_dssp CSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CT
T ss_pred CCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccc
Confidence 9999644332 1112221111100 0 0000000000 0000111234
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 274 KEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 274 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
.+++++.+||.+||..||.+|||++++++|
T Consensus 324 ~is~~a~DLl~~lL~~dP~~R~ta~eaL~H 353 (361)
T 4f9c_A 324 EVPDEAYDLLDKLLDLNPASRITAEEALLH 353 (361)
T ss_dssp TCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred cCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 567889999999999999999999999976
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=382.53 Aligned_cols=254 Identities=23% Similarity=0.320 Sum_probs=216.1
Q ss_pred hhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceeeEEeec
Q 018785 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (350)
Q Consensus 20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (350)
.++|++.+.||+|+||+||+| .+..+|+.||+|.+..........+.+|+.+|+.++||||++++++|.+.
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~---------~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 226 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRV---------TERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD 226 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEE---------EETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECS
T ss_pred ccccEEEEEEeeccCeEEEEE---------EECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 468999999999999999999 67778999999999877666677889999999999999999999999999
Q ss_pred CceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCC--CcEEEccccc
Q 018785 100 DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSN--FNAKLSDFGL 177 (350)
Q Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~--~~~~l~Dfg~ 177 (350)
+.+|+||||++||+|.+++.... ..+++.++..++.||+.||.||| ++||+||||||+|||++.+ +.+||+|||+
T Consensus 227 ~~~~iv~E~~~gg~L~~~i~~~~-~~l~e~~~~~~~~qi~~al~ylH--~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~ 303 (573)
T 3uto_A 227 NEMVMIYEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMH--ENNYVHLDLKPENIMFTTKRSNELKLIDFGL 303 (573)
T ss_dssp SEEEEEEECCCCCBHHHHHTCTT-SCEEHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEESSSSCCCEEECCCSS
T ss_pred CEEEEEEeecCCCcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHH--HCCeeeccCChhhccccCCCCCCEEEeeccc
Confidence 99999999999999999986543 36999999999999999999999 9999999999999999854 8899999999
Q ss_pred cccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhH
Q 018785 178 ARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSR 257 (350)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 257 (350)
+...... .......||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.........+....
T Consensus 304 a~~~~~~---~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~-------- 372 (573)
T 3uto_A 304 TAHLDPK---QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCD-------- 372 (573)
T ss_dssp CEECCTT---SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTC--------
T ss_pred eeEccCC---CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCC--------
Confidence 9865332 22334679999999999999999999999999999999999999998765432222222111
Q ss_pred HHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 258 RVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
..........+++++.+||.+||+.||.+|||+.++++|
T Consensus 373 -------~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 373 -------WNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp -------CCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -------CCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111122334678899999999999999999999999986
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-49 Score=377.73 Aligned_cols=252 Identities=25% Similarity=0.372 Sum_probs=208.8
Q ss_pred hhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh---hHH---HHHHHHHHHhccCCCcccce
Q 018785 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ---GHK---EWLTEVIYLGQLRHENLVKL 92 (350)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~---~~~~e~~~l~~l~h~~i~~~ 92 (350)
.-++|++.++||+|+||+||+| .+..+|+.||+|++...... ... ..+.++.+++.++||||+++
T Consensus 187 slddf~i~k~LG~G~fG~V~la---------~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l 257 (689)
T 3v5w_A 187 TMNDFSVHRIIGRGGFGEVYGC---------RKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCM 257 (689)
T ss_dssp CGGGEEEEEEEEECSSEEEEEE---------EETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCE
T ss_pred chHHeEEEEEEecccCeEEEEE---------EECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEE
Confidence 3578999999999999999999 67778999999999754321 122 23445677788899999999
Q ss_pred eeEEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEE
Q 018785 93 IGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKL 172 (350)
Q Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l 172 (350)
+++|.+.+.+|+||||++||+|.+++...+ .+++..++.++.||+.||.||| ++||+||||||+|||++.+|.+||
T Consensus 258 ~~~f~~~~~lylVmEy~~GGdL~~~l~~~~--~l~E~~a~~y~~qIl~aL~yLH--~~gIiHRDLKPeNILld~~G~vKL 333 (689)
T 3v5w_A 258 SYAFHTPDKLSFILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMH--NRFVVYRDLKPANILLDEHGHVRI 333 (689)
T ss_dssp EEEEECSSEEEEEECCCCSCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH--TTTEECCCCSGGGEEECTTSCEEE
T ss_pred EEEEEECCEEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--HCCccccCCchHHeEEeCCCCEEe
Confidence 999999999999999999999999998775 7999999999999999999999 999999999999999999999999
Q ss_pred ccccccccCCCCCCCcccccccCCCcccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcch
Q 018785 173 SDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADP 251 (350)
Q Consensus 173 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~ 251 (350)
+|||+|....... ....+||+.|+|||++.+ ..|+.++|+|||||++|+|++|..||.+........ +.
T Consensus 334 ~DFGlA~~~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~-i~----- 403 (689)
T 3v5w_A 334 SDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-ID----- 403 (689)
T ss_dssp CCCTTCEECSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHH-HH-----
T ss_pred cccceeeecCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH-HH-----
Confidence 9999997643322 233579999999999964 579999999999999999999999997654322111 00
Q ss_pred hhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 018785 252 FLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPS-----MVDVLTS 303 (350)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-----~~~ll~~ 303 (350)
..+.. .....+..+++++.+||.+||+.||.+|++ ++++++|
T Consensus 404 --------~~i~~--~~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 404 --------RMTLT--MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp --------HHHHH--CCCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred --------HhhcC--CCCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence 01111 112345678899999999999999999998 6899887
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-48 Score=341.82 Aligned_cols=253 Identities=23% Similarity=0.373 Sum_probs=215.3
Q ss_pred hhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceeeEEee
Q 018785 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (350)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (350)
..++|++.+.||+|+||+||+| .+..+++.||+|.+........+.+.+|+.+++.++||||+++++++..
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 88 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTA---------MDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV 88 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEE---------EBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEE---------EECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEE
Confidence 4579999999999999999999 6667799999999987766667788999999999999999999999999
Q ss_pred cCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcccccc
Q 018785 99 SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 178 (350)
Q Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~ 178 (350)
.+..++||||+++++|.+++... .+++..+..++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++
T Consensus 89 ~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~ 163 (297)
T 3fxz_A 89 GDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLH--SNQVIHRDIKSDNILLGMDGSVKLTDFGFC 163 (297)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTCCEEECCCTTC
T ss_pred CCEEEEEEECCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHH--hCCceeCCCCHHHEEECCCCCEEEeeCCCc
Confidence 99999999999999999999775 5899999999999999999999 899999999999999999999999999998
Q ss_pred ccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhHH
Q 018785 179 RDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRR 258 (350)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (350)
........ ......|++.|+|||.+.+..++.++||||||+++|+|++|..||.+.........+.
T Consensus 164 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~------------ 229 (297)
T 3fxz_A 164 AQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA------------ 229 (297)
T ss_dssp EECCSTTC--CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH------------
T ss_pred eecCCccc--ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH------------
Confidence 76433222 2334568999999999999999999999999999999999999997644321111111
Q ss_pred HHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 259 VLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
.........+..+++.+.+||.+||+.||.+|||+.++++|
T Consensus 230 ----~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 230 ----TNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp ----HHCSCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ----hCCCCCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 11111223355678899999999999999999999999875
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-47 Score=342.14 Aligned_cols=249 Identities=24% Similarity=0.365 Sum_probs=211.5
Q ss_pred hhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch--hhHHHHHHHHHHHhccCCCcccceeeEEe
Q 018785 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (350)
Q Consensus 20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (350)
.++|++.+.||+|+||.||+| .+..+|+.||||++..... .....+.+|+.+++.++||||+++++++.
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 84 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLA---------RHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIE 84 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEE---------EETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEE---------EECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 568999999999999999999 6667799999999876532 34466889999999999999999999999
Q ss_pred ecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccc
Q 018785 98 ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL 177 (350)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~ 177 (350)
..+..++||||+++++|.+++.... .+++..+..++.|++.||.||| +.|++|+||||+||+++.++.++|+|||+
T Consensus 85 ~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH--~~~ivHrDlkp~NIll~~~~~~kl~DFG~ 160 (328)
T 3fe3_A 85 TEKTLYLIMEYASGGEVFDYLVAHG--RMKEKEARSKFRQIVSAVQYCH--QKRIVHRDLKAENLLLDADMNIKIADFGF 160 (328)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTTSCEEECSTTC
T ss_pred ECCEEEEEEECCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCEeccCCCHHHEEEcCCCCEEEeeccC
Confidence 9999999999999999999998765 6999999999999999999999 89999999999999999999999999999
Q ss_pred cccCCCCCCCcccccccCCCcccCccccccCCCC-CccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhh
Q 018785 178 ARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLT-PKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDS 256 (350)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~-~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 256 (350)
+....... ......|++.|+|||++.+..+. .++|||||||++|+|++|..||.+.........+.
T Consensus 161 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~---------- 227 (328)
T 3fe3_A 161 SNEFTVGG---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVL---------- 227 (328)
T ss_dssp CGGGSSSC---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH----------
T ss_pred ceecCCCC---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH----------
Confidence 97543322 23345789999999999888775 78999999999999999999997654322211111
Q ss_pred HHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 257 RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
.. ....+..+++++.+|+.+||..||.+|||++++++|
T Consensus 228 -------~~--~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 228 -------RG--KYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp -------HC--CCCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred -------hC--CCCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 11 112344577899999999999999999999999987
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=337.30 Aligned_cols=279 Identities=40% Similarity=0.664 Sum_probs=226.8
Q ss_pred hhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceeeEEee
Q 018785 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (350)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (350)
..++|++.+.||+|+||+||+|++ .+++.||||.+..........+.+|+..++.++||||+++++++..
T Consensus 37 ~~~~y~~~~~lg~G~~g~Vy~~~~----------~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 106 (321)
T 2qkw_B 37 ATNNFDHKFLIGHGVFGKVYKGVL----------RDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDE 106 (321)
T ss_dssp CCCCCSCCCCSCBCSSSEEEEEEC----------TTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCC
T ss_pred HHhccCccceeecCCCeeEEEEEE----------CCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC
Confidence 468999999999999999999943 2478999999887766666788999999999999999999999999
Q ss_pred cCceEEEEEcCCCCChhhHHhhcC--CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcccc
Q 018785 99 SDNRLLVYEFMPKGSLENHLFRKG--VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFG 176 (350)
Q Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg 176 (350)
.+..++||||+++++|.+++.... ...+++..++.++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||
T Consensus 107 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH--~~~ivH~dlkp~Nil~~~~~~~kl~Dfg 184 (321)
T 2qkw_B 107 RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH--TRAIIHRDVKSINILLDENFVPKITDFG 184 (321)
T ss_dssp TTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCSTTEEECTTCCEEECCCT
T ss_pred CCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhc--CCCeecCCCCHHHEEECCCCCEEEeecc
Confidence 999999999999999999996543 235899999999999999999999 8999999999999999999999999999
Q ss_pred ccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhh
Q 018785 177 LARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDS 256 (350)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 256 (350)
++................|++.|+|||.+.+..++.++||||||+++|+|++|+.||.............. ... ....
T Consensus 185 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~-~~~-~~~~ 262 (321)
T 2qkw_B 185 ISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEW-AVE-SHNN 262 (321)
T ss_dssp TCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHH-THH-HHTT
T ss_pred cccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHH-hhh-cccc
Confidence 99764433333333345678999999999999999999999999999999999999986654433221111 000 0001
Q ss_pred HHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcCC
Q 018785 257 RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSK 311 (350)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~ 311 (350)
...............+..++..+.+++.+||+.||++|||+.+++++|+.+....
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~ 317 (321)
T 2qkw_B 263 GQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQ 317 (321)
T ss_dssp TCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred ccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhcc
Confidence 1111222233334556788999999999999999999999999999999887653
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=342.98 Aligned_cols=272 Identities=25% Similarity=0.390 Sum_probs=222.9
Q ss_pred hhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch-hhHHHHHHHHHHHhcc-CCCcccceee
Q 018785 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQL-RHENLVKLIG 94 (350)
Q Consensus 17 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~ 94 (350)
++..++|++.+.||+|+||.||+|++.... .....++..||||++..... .....+.+|+.+++.+ +||||+++++
T Consensus 77 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~--~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~ 154 (370)
T 2psq_A 77 EFPRDKLTLGKPLGEGCFGQVVMAEAVGID--KDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLG 154 (370)
T ss_dssp BCCGGGEEEEEEESCCSSSEEEEEEEETCS--TTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEE
T ss_pred cccHHHCEeeeEEeeCCCeeEEEEEEeccc--CcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence 345689999999999999999999764211 02345678899999976532 3446788999999999 8999999999
Q ss_pred EEeecCceEEEEEcCCCCChhhHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCC
Q 018785 95 YCSESDNRLLVYEFMPKGSLENHLFRKG--------------VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKAS 160 (350)
Q Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------------~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~ 160 (350)
++.+.+.+|+||||+++++|.+++.... ...++..+++.++.|++.||.||| +.|++|+||||+
T Consensus 155 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH--~~~ivHrDlkp~ 232 (370)
T 2psq_A 155 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA--SQKCIHRDLAAR 232 (370)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGG
T ss_pred EEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH--hCCeeccccchh
Confidence 9999999999999999999999997653 235889999999999999999999 899999999999
Q ss_pred ceEEcCCCcEEEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccccC
Q 018785 161 NVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGG 239 (350)
Q Consensus 161 Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~ 239 (350)
||+++.++.++|+|||++................+++.|+|||++.+..++.++|||||||++|+|++ |..||.+....
T Consensus 233 NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~ 312 (370)
T 2psq_A 233 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 312 (370)
T ss_dssp GEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred hEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 99999999999999999986544333333333456788999999999999999999999999999999 99999765432
Q ss_pred cchhhhhhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcC
Q 018785 240 LAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 310 (350)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 310 (350)
.... .+........+..+++.+.++|.+||+.||.+|||+.+++++|+.+...
T Consensus 313 ~~~~------------------~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~ 365 (370)
T 2psq_A 313 ELFK------------------LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 365 (370)
T ss_dssp GHHH------------------HHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHH------------------HHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 2211 1122222344567788999999999999999999999999999998754
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-47 Score=334.98 Aligned_cols=275 Identities=26% Similarity=0.379 Sum_probs=219.6
Q ss_pred hhhhhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch---hhHHHHHHHHHHHhccCCCcc
Q 018785 13 SMISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENL 89 (350)
Q Consensus 13 ~~~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i 89 (350)
.+++++..++|++.+.||+|+||.||+| .+..++..||+|.+..... .....+.+|+..+++++||||
T Consensus 3 ~~~g~~~~~~y~i~~~lg~G~~g~V~~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i 73 (294)
T 4eqm_A 3 HMIGKIINERYKIVDKLGGGGMSTVYLA---------EDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNI 73 (294)
T ss_dssp -CCSSCEETTEEEEEEEEEETTEEEEEE---------EETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTB
T ss_pred cchhhHhhccEEEEEEEccCCCEEEEEE---------EECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCC
Confidence 3567788899999999999999999999 5666789999998854332 334668899999999999999
Q ss_pred cceeeEEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCc
Q 018785 90 VKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFN 169 (350)
Q Consensus 90 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~ 169 (350)
+++++++...+..++||||+++++|.+++.... .+++..++.++.|++.||.||| +.|++|+||||+||+++.++.
T Consensus 74 v~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~Dlkp~Nil~~~~~~ 149 (294)
T 4eqm_A 74 VSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHG--PLSVDTAINFTNQILDGIKHAH--DMRIVHRDIKPQNILIDSNKT 149 (294)
T ss_dssp CCEEEEEECSSEEEEEEECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTTSC
T ss_pred ceEEEeeeeCCeEEEEEeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEECCCCC
Confidence 999999999999999999999999999998765 7999999999999999999999 899999999999999999999
Q ss_pred EEEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhc
Q 018785 170 AKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWA 249 (350)
Q Consensus 170 ~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~ 249 (350)
++|+|||++........ .......|++.|+|||.+.+..++.++||||||+++|+|++|+.||.+..............
T Consensus 150 ~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~ 228 (294)
T 4eqm_A 150 LKIFDFGIAKALSETSL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDS 228 (294)
T ss_dssp EEECCCSSSTTC--------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSC
T ss_pred EEEEeCCCccccccccc-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcc
Confidence 99999999976433221 12233568999999999999999999999999999999999999997654321111111100
Q ss_pred chhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCC-CHHHHHHHHHhhhcCCCCCC
Q 018785 250 DPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRP-SMVDVLTSLEQLHTSKDMPR 315 (350)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-s~~~ll~~L~~~~~~~~~~~ 315 (350)
.+. ........+++.+.+++.+||+.||.+|| +++++.+.|..+.......+
T Consensus 229 ~~~--------------~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~~~~ 281 (294)
T 4eqm_A 229 VPN--------------VTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRANE 281 (294)
T ss_dssp CCC--------------HHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSSTTC
T ss_pred CCC--------------cchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhccCCc
Confidence 000 00112345678899999999999999998 99999999998876654443
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=334.84 Aligned_cols=268 Identities=30% Similarity=0.456 Sum_probs=210.8
Q ss_pred hhhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch--hhHHHHHHHHHHHhccCCCcccce
Q 018785 15 ISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLRHENLVKL 92 (350)
Q Consensus 15 ~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~ 92 (350)
..++..++|++.+.||+|+||+||+|++ +|..||+|++..... .....+.+|+.++++++||||+++
T Consensus 31 ~~~i~~~~y~i~~~lG~G~~g~V~~~~~-----------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~ 99 (309)
T 3p86_A 31 DMDIPWCDLNIKEKIGAGSFGTVHRAEW-----------HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLF 99 (309)
T ss_dssp -CBCCGGGEEEEEEEEECSSEEEEEEEE-----------TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cccCChhHceeeeEeecCCCeEEEEEEE-----------CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeE
Confidence 3455678999999999999999999954 367899999876542 334568899999999999999999
Q ss_pred eeEEeecCceEEEEEcCCCCChhhHHhhcCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCC--eeeCCCCCCceEEcCCCc
Q 018785 93 IGYCSESDNRLLVYEFMPKGSLENHLFRKGV-QPISWPTRVKIAIDVARGLSFLHGLDAN--VIYRDLKASNVLLDSNFN 169 (350)
Q Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~l~~~~~~~i~~ql~~al~~lh~~~~~--i~H~di~~~Nili~~~~~ 169 (350)
++++...+..++||||+++++|.+++..... ..+++..++.++.|++.||+||| +.| ++|+||||+||+++.++.
T Consensus 100 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH--~~~~~ivH~Dikp~NIll~~~~~ 177 (309)
T 3p86_A 100 MGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH--NRNPPIVHRNLKSPNLLVDKKYT 177 (309)
T ss_dssp EEEECSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHH--TSSSCCCCTTCCGGGEEECTTCC
T ss_pred EEEEEECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH--cCCCCEECCCCChhhEEEeCCCc
Confidence 9999999999999999999999999976531 23899999999999999999999 889 999999999999999999
Q ss_pred EEEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhc
Q 018785 170 AKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWA 249 (350)
Q Consensus 170 ~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~ 249 (350)
++|+|||++...... ........|++.|+|||++.+..++.++||||||+++|+|++|..||.........
T Consensus 178 ~kL~Dfg~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~------- 248 (309)
T 3p86_A 178 VKVCDFGLSRLKAST--FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVV------- 248 (309)
T ss_dssp EEECCCC-------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHH-------
T ss_pred EEECCCCCCcccccc--ccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-------
Confidence 999999999753222 11223356899999999999999999999999999999999999999765422111
Q ss_pred chhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcCCCCC
Q 018785 250 DPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDMP 314 (350)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~~ 314 (350)
............+..+++.+.+||.+||+.||.+|||+.++++.|+.+......|
T Consensus 249 ----------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~ 303 (309)
T 3p86_A 249 ----------AAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPP 303 (309)
T ss_dssp ----------HHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-----
T ss_pred ----------HHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCC
Confidence 1111122233456678889999999999999999999999999999998875444
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=335.89 Aligned_cols=287 Identities=26% Similarity=0.369 Sum_probs=236.8
Q ss_pred ccccccCCCCchhhhhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch-hhHHHHHHHHHH
Q 018785 2 YLLIAMSDPSASMISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIY 80 (350)
Q Consensus 2 ~~~~~~~~~~~~~~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~ 80 (350)
|..++-+..+.....++..++|++.+.||+|+||.||+|++... .+..++..||+|.+..... .....+.+|+.+
T Consensus 4 ~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~ 79 (313)
T 1t46_A 4 YVYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGL----IKSDAAMTVAVKMLKPSAHLTEREALMSELKV 79 (313)
T ss_dssp TCCCCTTTSCCCGGGBCCGGGEEEEEEEEECSSEEEEEEEEESS----SSTTCEEEEEEEEECTTCCHHHHHHHHHHHHH
T ss_pred eEEeccccCCCccccccChhhhhHHHhhCccCCcceEEEEEeec----cccchhhhhHHHhcCcchhHHHHHHHHHHHHH
Confidence 56677777777777888899999999999999999999965422 2556789999999976543 344678899999
Q ss_pred Hhcc-CCCcccceeeEEeecCceEEEEEcCCCCChhhHHhhcCC----------------CCCCHHHHHHHHHHHHHHHH
Q 018785 81 LGQL-RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGV----------------QPISWPTRVKIAIDVARGLS 143 (350)
Q Consensus 81 l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~----------------~~l~~~~~~~i~~ql~~al~ 143 (350)
++++ +||||+++++++...+..++||||+++++|.+++..... ..+++..++.++.|++.||.
T Consensus 80 l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~ 159 (313)
T 1t46_A 80 LSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMA 159 (313)
T ss_dssp HHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHH
T ss_pred HhhcccCCCeeeEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHH
Confidence 9999 899999999999999999999999999999999976542 24899999999999999999
Q ss_pred HhhcCCCCeeeCCCCCCceEEcCCCcEEEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHH
Q 018785 144 FLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVL 223 (350)
Q Consensus 144 ~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll 223 (350)
||| +.|++|+||+|+||+++.++.++|+|||++................+++.|+|||.+.+..++.++||||||+++
T Consensus 160 ~lH--~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 237 (313)
T 1t46_A 160 FLA--SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFL 237 (313)
T ss_dssp HHH--HTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred HHH--HCCeecCCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHH
Confidence 999 899999999999999999999999999999865544433333344567789999999999999999999999999
Q ss_pred HHHHh-CCCCCcccccCcchhhhhhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018785 224 LELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLT 302 (350)
Q Consensus 224 ~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 302 (350)
|+|++ |..||.+........ ...........+..+++.+.+++.+||..||.+|||+.++++
T Consensus 238 ~ellt~g~~p~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 300 (313)
T 1t46_A 238 WELFSLGSSPYPGMPVDSKFY-----------------KMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (313)
T ss_dssp HHHHTTTCCSSTTCCSSHHHH-----------------HHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHhCCCCCCCcccchhHHH-----------------HHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 99998 999997654322111 111122222334567789999999999999999999999999
Q ss_pred HHHhhhcCC
Q 018785 303 SLEQLHTSK 311 (350)
Q Consensus 303 ~L~~~~~~~ 311 (350)
+|+++....
T Consensus 301 ~L~~~~~~~ 309 (313)
T 1t46_A 301 LIEKQISES 309 (313)
T ss_dssp HHHHHHHHT
T ss_pred HHHHHHHHh
Confidence 999887653
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=336.32 Aligned_cols=271 Identities=28% Similarity=0.414 Sum_probs=220.2
Q ss_pred hhhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccc-hhhHHHHHHHHHHHhccCCCccccee
Q 018785 15 ISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES-FQGHKEWLTEVIYLGQLRHENLVKLI 93 (350)
Q Consensus 15 ~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~ 93 (350)
..++..++|++.+.||+|+||+||+|++. .....+..||||.+.... ......+.+|+.+++.++||||++++
T Consensus 43 ~~~~~~~~y~i~~~lG~G~~g~V~~~~~~------~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 116 (325)
T 3kul_A 43 TREIEASRIHIEKIIGSGDSGEVCYGRLR------VPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116 (325)
T ss_dssp CCBCCGGGEEEEEEEEETTTEEEEEEEEC------CTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred ccccChhHeEEeeEEEeCCCcEEEEEEEe------cCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEE
Confidence 34566789999999999999999999654 222345679999997653 33456788999999999999999999
Q ss_pred eEEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEc
Q 018785 94 GYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLS 173 (350)
Q Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~ 173 (350)
+++.+.+..++||||+++++|.+++.... ..++...++.++.|++.||.||| +.|++|+||||+||+++.++.++|+
T Consensus 117 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH--~~~ivH~Dlkp~NIll~~~~~~kl~ 193 (325)
T 3kul_A 117 GVVTRGRLAMIVTEYMENGSLDTFLRTHD-GQFTIMQLVGMLRGVGAGMRYLS--DLGYVHRDLAARNVLVDSNLVCKVS 193 (325)
T ss_dssp EEECGGGCCEEEEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECTTCCEEEC
T ss_pred EEEEeCCccEEEeeCCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHH--HCCeeCCCCCcceEEECCCCCEEEC
Confidence 99999999999999999999999996553 36999999999999999999999 8999999999999999999999999
Q ss_pred cccccccCCCCCCCc-ccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccccCcchhhhhhhcch
Q 018785 174 DFGLARDGPTGDNTH-VSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADP 251 (350)
Q Consensus 174 Dfg~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~ 251 (350)
|||++.......... ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+.......
T Consensus 194 Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~--------- 264 (325)
T 3kul_A 194 DFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVI--------- 264 (325)
T ss_dssp CCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHH---------
T ss_pred CCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHH---------
Confidence 999998654332221 2222345678999999998999999999999999999999 99999765432211
Q ss_pred hhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcCCC
Q 018785 252 FLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKD 312 (350)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~ 312 (350)
..+........+..+++.+.+|+.+||..||.+|||+.++++.|+.+.....
T Consensus 265 ---------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~ 316 (325)
T 3kul_A 265 ---------SSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPE 316 (325)
T ss_dssp ---------HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC
T ss_pred ---------HHHHcCCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcc
Confidence 1112222334455778899999999999999999999999999999987643
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=338.15 Aligned_cols=251 Identities=25% Similarity=0.366 Sum_probs=212.5
Q ss_pred hhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccc---hhhHHHHHHHHHHHhccCCCcccceeeE
Q 018785 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES---FQGHKEWLTEVIYLGQLRHENLVKLIGY 95 (350)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 95 (350)
..++|++.+.||+|+||.||+| .+..+|+.||+|++.... ......+.+|..+++.++||||++++++
T Consensus 3 ~~~~y~~~~~lG~G~fg~V~~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~ 73 (337)
T 1o6l_A 3 TMNDFDYLKLLGKGTFGKVILV---------REKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYA 73 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEE---------EETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEE
T ss_pred ChHHeEEEEEEecCCCeEEEEE---------EECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEE
Confidence 4579999999999999999999 566679999999997653 2345668889999999999999999999
Q ss_pred EeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccc
Q 018785 96 CSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDF 175 (350)
Q Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Df 175 (350)
+.+.+..++||||++|++|.+++.... .+++..++.++.||+.||.||| ++|++|+||||+||+++.++.++|+||
T Consensus 74 ~~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH--~~~ivHrDlkp~NIll~~~g~vkL~DF 149 (337)
T 1o6l_A 74 FQTHDRLCFVMEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLH--SRDVVYRDIKLENLMLDKDGHIKITDF 149 (337)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCCGGGEEECTTSCEEECCC
T ss_pred EEeCCEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--HCCeecCcCCHHHEEECCCCCEEEeec
Confidence 999999999999999999999997764 7999999999999999999999 899999999999999999999999999
Q ss_pred cccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhh
Q 018785 176 GLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRD 255 (350)
Q Consensus 176 g~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 255 (350)
|++....... .......|++.|+|||++.+..++.++|+|||||++|+|++|..||.+.........+
T Consensus 150 G~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i---------- 217 (337)
T 1o6l_A 150 GLCKEGISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI---------- 217 (337)
T ss_dssp TTCBCSCCTT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH----------
T ss_pred cchhhcccCC--CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHH----------
Confidence 9997532222 2233457899999999999999999999999999999999999999764422111111
Q ss_pred hHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 018785 256 SRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRP-----SMVDVLTS 303 (350)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~~ 303 (350)
... ....+..+++++.+||.+||+.||.+|| +++++++|
T Consensus 218 -------~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 218 -------LME--EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp -------HHC--CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred -------HcC--CCCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 111 1234556788999999999999999999 89999987
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=336.94 Aligned_cols=264 Identities=28% Similarity=0.437 Sum_probs=218.0
Q ss_pred hhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceeeEEee
Q 018785 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (350)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (350)
..++|++.+.||+|+||+||+| .+..++..||+|.+..........+.+|+.+++.++||||+++++++.+
T Consensus 8 ~~~~~~~~~~lG~G~~g~V~~~---------~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 78 (310)
T 3s95_A 8 RPSDLIHGEVLGKGCFGQAIKV---------THRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYK 78 (310)
T ss_dssp CGGGEEEEEEEECCSSEEEEEE---------EETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred ChhHeeccceecCCCCEEEEEE---------EECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEec
Confidence 4689999999999999999999 5666789999999877666667789999999999999999999999999
Q ss_pred cCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcccccc
Q 018785 99 SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 178 (350)
Q Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~ 178 (350)
++..++||||+++++|.+++.... ..+++.++..++.|++.||+||| +.|++|+||||+||+++.++.++|+|||++
T Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH--~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 155 (310)
T 3s95_A 79 DKRLNFITEYIKGGTLRGIIKSMD-SQYPWSQRVSFAKDIASGMAYLH--SMNIIHRDLNSHNCLVRENKNVVVADFGLA 155 (310)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHCC-TTSCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSTTSEEECTTSCEEECCCTTC
T ss_pred CCeeEEEEEecCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH--hCCccCCCCCcCeEEECCCCCEEEeecccc
Confidence 999999999999999999998743 36999999999999999999999 899999999999999999999999999999
Q ss_pred ccCCCCCCCcc------------cccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhh
Q 018785 179 RDGPTGDNTHV------------STRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLV 246 (350)
Q Consensus 179 ~~~~~~~~~~~------------~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~ 246 (350)
........... .....|++.|+|||++.+..++.++||||||+++|+|++|..||.............
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~ 235 (310)
T 3s95_A 156 RLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLN 235 (310)
T ss_dssp EECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBC
T ss_pred eecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhh
Confidence 76433322110 113568999999999999999999999999999999999999987544322111100
Q ss_pred hhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcC
Q 018785 247 EWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 310 (350)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 310 (350)
...... ...+..+++.+.+++.+||+.||.+|||+.++++.|+.+...
T Consensus 236 ------------~~~~~~----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~ 283 (310)
T 3s95_A 236 ------------VRGFLD----RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH 283 (310)
T ss_dssp ------------HHHHHH----HTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ------------hhcccc----ccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 000000 112345667899999999999999999999999999998765
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=332.06 Aligned_cols=285 Identities=23% Similarity=0.358 Sum_probs=222.1
Q ss_pred hhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceeeE
Q 018785 16 SKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGY 95 (350)
Q Consensus 16 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 95 (350)
.++..++|++.+.||+|+||+||+|++.. .+..+++.||||.+..........+.+|+.+++.++||||++++++
T Consensus 5 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 79 (295)
T 3ugc_A 5 TQFEERHLKFLQQLGKGNFGSVEMCRYDP-----LQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGV 79 (295)
T ss_dssp -CCCGGGEEEEEEEEECSSEEEEEEEECT-----TCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred CcCCHHHhhhhheeeccCCEEEEEEEEec-----ccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 45678999999999999999999996542 3566799999999987766666788999999999999999999999
Q ss_pred Eee--cCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEc
Q 018785 96 CSE--SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLS 173 (350)
Q Consensus 96 ~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~ 173 (350)
+.. ....++||||+++++|.+++.... ..++...++.++.|++.||.||| +.|++|+||||+||+++.++.++|+
T Consensus 80 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~Dikp~Nil~~~~~~~kl~ 156 (295)
T 3ugc_A 80 CYSAGRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLG--TKRYIHRDLATRNILVENENRVKIG 156 (295)
T ss_dssp ECHHHHTSCEEEEECCTTCBHHHHHHHCG-GGCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEEEETTEEEEC
T ss_pred EecCCCCceEEEEEeCCCCCHHHHHHhcc-cccCHHHHHHHHHHHHHHHHHHh--cCCcccCCCCHhhEEEcCCCeEEEc
Confidence 854 356899999999999999997754 25899999999999999999999 8999999999999999999999999
Q ss_pred cccccccCCCCCCC-cccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchh
Q 018785 174 DFGLARDGPTGDNT-HVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPF 252 (350)
Q Consensus 174 Dfg~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 252 (350)
|||++......... .......++..|+|||.+.+..++.++||||||+++|+|++|..||.......... ..... ..
T Consensus 157 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~-~~~~~-~~ 234 (295)
T 3ugc_A 157 DFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRM-IGNDK-QG 234 (295)
T ss_dssp CCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHH-HCTTC-CT
T ss_pred cCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhh-hcCcc-cc
Confidence 99999865333221 11222346667999999999999999999999999999999999886543211000 00000 00
Q ss_pred hhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcC
Q 018785 253 LRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 310 (350)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 310 (350)
...................+..+++++.+++.+||+.||.+|||+.++++.|+++...
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~ 292 (295)
T 3ugc_A 235 QMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292 (295)
T ss_dssp HHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred chhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 0011122223333334455667889999999999999999999999999999998765
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=340.32 Aligned_cols=255 Identities=24% Similarity=0.323 Sum_probs=212.0
Q ss_pred hhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh------hHHHHHHHHHHHhccCCCcccc
Q 018785 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ------GHKEWLTEVIYLGQLRHENLVK 91 (350)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~ 91 (350)
...++|++.+.||+|+||.||+| .+..+|..||+|++...... ....+.+|+.+++.++||||++
T Consensus 9 ~~~~~y~~~~~LG~G~fg~V~~~---------~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~ 79 (361)
T 2yab_A 9 KVEDFYDIGEELGSGQFAIVKKC---------REKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79 (361)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEE---------EETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCC
T ss_pred ChhhceEEeeEEeeCcCEEEEEE---------EECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCc
Confidence 34678999999999999999999 66677999999998765432 3467889999999999999999
Q ss_pred eeeEEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCC---
Q 018785 92 LIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNF--- 168 (350)
Q Consensus 92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~--- 168 (350)
+++++.+.+..++||||++|++|.+++.... .+++..+..++.|++.||.||| +.|++|+||||+||+++.++
T Consensus 80 l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH--~~givHrDlkp~NIll~~~~~~~ 155 (361)
T 2yab_A 80 LHDVYENRTDVVLILELVSGGELFDFLAQKE--SLSEEEATSFIKQILDGVNYLH--TKKIAHFDLKPENIMLLDKNIPI 155 (361)
T ss_dssp EEEEEECSSEEEEEEECCCSCBHHHHHTTCS--CCBHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEESCTTSSS
T ss_pred EEEEEEeCCEEEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEEeCCCCCc
Confidence 9999999999999999999999999997654 7999999999999999999999 89999999999999998876
Q ss_pred -cEEEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhh
Q 018785 169 -NAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVE 247 (350)
Q Consensus 169 -~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~ 247 (350)
.++|+|||++....... ......|++.|+|||++.+..++.++|+||||+++|+|++|..||.+.........+..
T Consensus 156 ~~vkl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~ 232 (361)
T 2yab_A 156 PHIKLIDFGLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITA 232 (361)
T ss_dssp CCEEECCCSSCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHT
T ss_pred cCEEEEecCCceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 79999999997644322 22335689999999999999999999999999999999999999976543322222221
Q ss_pred hcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 248 WADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
.... ........+++.+.+||.+||..||.+|||+.++++|
T Consensus 233 ~~~~---------------~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 233 VSYD---------------FDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp TCCC---------------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cCCC---------------CCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 1100 0001123467889999999999999999999999975
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=340.89 Aligned_cols=275 Identities=26% Similarity=0.354 Sum_probs=224.7
Q ss_pred hhhhhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch-hhHHHHHHHHHHHhcc-CCCccc
Q 018785 13 SMISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQL-RHENLV 90 (350)
Q Consensus 13 ~~~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~ 90 (350)
....++..++|++.+.||+|+||.||+|++... .+..+++.||||.+..... .....+.+|+.+++++ +||||+
T Consensus 14 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv 89 (359)
T 3vhe_A 14 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGI----DKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89 (359)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESS----SSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred cccccccccceeeceeecCCCCceEEEEEeccc----cccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCccee
Confidence 345567789999999999999999999965432 3567789999999976533 3346688999999999 799999
Q ss_pred ceeeEEeecCc-eEEEEEcCCCCChhhHHhhcCC----------------------------------------------
Q 018785 91 KLIGYCSESDN-RLLVYEFMPKGSLENHLFRKGV---------------------------------------------- 123 (350)
Q Consensus 91 ~~~~~~~~~~~-~~lv~e~~~~~~L~~~l~~~~~---------------------------------------------- 123 (350)
++++++.+.+. .++||||+.+++|.+++.....
T Consensus 90 ~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (359)
T 3vhe_A 90 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVE 169 (359)
T ss_dssp CEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------
T ss_pred eeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccc
Confidence 99999887654 8999999999999999976532
Q ss_pred ------------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccccccCCCCC
Q 018785 124 ------------------QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGD 185 (350)
Q Consensus 124 ------------------~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~~~~~~~ 185 (350)
..+++..++.++.|++.||+||| +.|++|+||||+||+++.++.++|+|||++.......
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH--~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 247 (359)
T 3vhe_A 170 EKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA--SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 247 (359)
T ss_dssp --------------CTTTTCBCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred ccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHH--HCCcccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence 12889999999999999999999 8999999999999999999999999999998654444
Q ss_pred CCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccccCcchhhhhhhcchhhhhhHHHHHhhh
Q 018785 186 NTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMD 264 (350)
Q Consensus 186 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (350)
.........+++.|+|||++.+..++.++||||||+++|+|++ |..||.+....... ...+.
T Consensus 248 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~-----------------~~~~~ 310 (359)
T 3vhe_A 248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF-----------------CRRLK 310 (359)
T ss_dssp TCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH-----------------HHHHH
T ss_pred cchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHH-----------------HHHHH
Confidence 3334444667888999999999999999999999999999998 99999765532211 11122
Q ss_pred cccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcC
Q 018785 265 TRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 310 (350)
Q Consensus 265 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 310 (350)
.......+..+++++.+++.+||+.||.+|||+.+++++|+.+..+
T Consensus 311 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 311 EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence 2223344556788999999999999999999999999999988654
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-46 Score=333.92 Aligned_cols=272 Identities=27% Similarity=0.373 Sum_probs=223.7
Q ss_pred hhhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccc-hhhHHHHHHHHHHHhccCCCccccee
Q 018785 15 ISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES-FQGHKEWLTEVIYLGQLRHENLVKLI 93 (350)
Q Consensus 15 ~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~ 93 (350)
..+...++|++.+.||+|+||.||+|+.... ....++..||+|.+.... ......+.+|+.+++.++||||++++
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~ 92 (314)
T 2ivs_A 17 KWEFPRKNLVLGKTLGEGEFGKVVKATAFHL----KGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLY 92 (314)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEETG----GGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred ccccchhheeeeeeecccCCeeEEEEEEecc----CcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEE
Confidence 3456688999999999999999999965321 224467899999997653 23446788999999999999999999
Q ss_pred eEEeecCceEEEEEcCCCCChhhHHhhcCC----------------------CCCCHHHHHHHHHHHHHHHHHhhcCCCC
Q 018785 94 GYCSESDNRLLVYEFMPKGSLENHLFRKGV----------------------QPISWPTRVKIAIDVARGLSFLHGLDAN 151 (350)
Q Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~----------------------~~l~~~~~~~i~~ql~~al~~lh~~~~~ 151 (350)
+++.+.+..++||||+++++|.+++..... ..+++..++.++.|++.||.||| +.|
T Consensus 93 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH--~~~ 170 (314)
T 2ivs_A 93 GACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA--EMK 170 (314)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH--HTT
T ss_pred EEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH--HCC
Confidence 999999999999999999999999986542 24889999999999999999999 899
Q ss_pred eeeCCCCCCceEEcCCCcEEEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CC
Q 018785 152 VIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GR 230 (350)
Q Consensus 152 i~H~di~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~ 230 (350)
++|+||||+||+++.++.++|+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |.
T Consensus 171 ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~ 250 (314)
T 2ivs_A 171 LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGG 250 (314)
T ss_dssp EECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSC
T ss_pred CcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999999976544333323333456778999999999999999999999999999999 99
Q ss_pred CCCcccccCcchhhhhhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcC
Q 018785 231 RALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 310 (350)
Q Consensus 231 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 310 (350)
.||.+......... +........+..+++.+.+++.+||+.||.+|||+.+++++|+++...
T Consensus 251 ~p~~~~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 251 NPYPGIPPERLFNL------------------LKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp CSSTTCCGGGHHHH------------------HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCCCCCHHHHHHH------------------hhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 99976553222211 111222334556788999999999999999999999999999998654
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=343.00 Aligned_cols=274 Identities=27% Similarity=0.393 Sum_probs=220.4
Q ss_pred hhhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccc-hhhHHHHHHHHHHHhccCCCccccee
Q 018785 15 ISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES-FQGHKEWLTEVIYLGQLRHENLVKLI 93 (350)
Q Consensus 15 ~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~ 93 (350)
+.++..++|++.+.||+|+||+||+|++... .+..++..||||.+.... ......+.+|+.++++++||||++++
T Consensus 65 ~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~ 140 (367)
T 3l9p_A 65 LKEVPRKNITLIRGLGHGAFGEVYEGQVSGM----PNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCI 140 (367)
T ss_dssp SCBCCGGGEEEEEECCCCSSSCEEEEEECC---------CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred hhhcCHhHeEEeeEeeeCCCEEEEEEEEccC----CCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEE
Confidence 4456678999999999999999999976532 255678899999987543 23445688899999999999999999
Q ss_pred eEEeecCceEEEEEcCCCCChhhHHhhcCC-----CCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCC
Q 018785 94 GYCSESDNRLLVYEFMPKGSLENHLFRKGV-----QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNF 168 (350)
Q Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-----~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~ 168 (350)
+++......++||||+++++|.+++..... ..++...++.++.|++.||+||| ++|++|+||||+||+++.++
T Consensus 141 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH--~~~ivHrDlkp~NIll~~~~ 218 (367)
T 3l9p_A 141 GVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE--ENHFIHRDIAARNCLLTCPG 218 (367)
T ss_dssp EEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEESCSS
T ss_pred EEEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHH--hCCeeCCCCChhhEEEecCC
Confidence 999999999999999999999999976531 35899999999999999999999 89999999999999999655
Q ss_pred ---cEEEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccccCcchhh
Q 018785 169 ---NAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQT 244 (350)
Q Consensus 169 ---~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~~~~ 244 (350)
.++|+|||++................+++.|+|||++.+..++.++|||||||++|+|++ |..||.........
T Consensus 219 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~-- 296 (367)
T 3l9p_A 219 PGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL-- 296 (367)
T ss_dssp TTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH--
T ss_pred CCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH--
Confidence 499999999964322222222333557889999999999999999999999999999998 99999765432211
Q ss_pred hhhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcCCC
Q 018785 245 LVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKD 312 (350)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~ 312 (350)
..+........+..+++.+.+|+.+||+.||.+|||+.+++++|+.+....+
T Consensus 297 ----------------~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~ 348 (367)
T 3l9p_A 297 ----------------EFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD 348 (367)
T ss_dssp ----------------HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred ----------------HHHHcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChh
Confidence 1122222233455678899999999999999999999999999999887643
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-46 Score=333.27 Aligned_cols=275 Identities=28% Similarity=0.372 Sum_probs=213.7
Q ss_pred hhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceeeEEe
Q 018785 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (350)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (350)
+..++|++.++||+|+||+||+|++. ++.||||++...... ......|+..+++++||||+++++++.
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-----------~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~ 88 (322)
T 3soc_A 21 FQSMPLQLLEVKARGRFGCVWKAQLL-----------NEYVAVKIFPIQDKQ-SWQNEYEVYSLPGMKHENILQFIGAEK 88 (322)
T ss_dssp ETTEEEEEEEEEECSTTCEEEEEEET-----------TEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEE
T ss_pred cchhhchhhheecccCceEEEEEEEC-----------CCEEEEEEeecCchH-HHHHHHHHHHHhcCCCCCchhhcceec
Confidence 34679999999999999999999542 678999999765433 344566888999999999999999998
Q ss_pred ecCc----eEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCC----------CeeeCCCCCCceE
Q 018785 98 ESDN----RLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDA----------NVIYRDLKASNVL 163 (350)
Q Consensus 98 ~~~~----~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~----------~i~H~di~~~Nil 163 (350)
.... +++||||+++++|.+++... .+++..++.++.|++.||.||| +. |++|+||||+||+
T Consensus 89 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~al~~LH--~~~~~l~~~~~~~ivH~Dlkp~Nil 163 (322)
T 3soc_A 89 RGTSVDVDLWLITAFHEKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLH--EDIPGLKDGHKPAISHRDIKSKNVL 163 (322)
T ss_dssp EECSSSEEEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHT--CCEEEETTEEECEEECSCCSGGGEE
T ss_pred cCCCCCceEEEEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHH--hhccccccccCCCEEeCCCChHhEE
Confidence 7554 69999999999999999775 5899999999999999999999 88 9999999999999
Q ss_pred EcCCCcEEEccccccccCCCCCCCcccccccCCCcccCccccccC-----CCCCccchhhHHHHHHHHHhCCCCCccccc
Q 018785 164 LDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG-----HLTPKSDVYSFGVVLLELLSGRRALDEDRG 238 (350)
Q Consensus 164 i~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-----~~~~~~DiwslG~ll~~ll~g~~pf~~~~~ 238 (350)
++.++.++|+|||++................|++.|+|||++.+. .++.++|||||||++|+|++|+.||.+...
T Consensus 164 l~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~ 243 (322)
T 3soc_A 164 LKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVD 243 (322)
T ss_dssp ECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCC
T ss_pred ECCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcc
Confidence 999999999999999765444333333345789999999998763 455688999999999999999999987654
Q ss_pred Ccchhhhhhhcc-hhhhhhHHHHHhhhcccCCCC-----cHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcCC
Q 018785 239 GLAEQTLVEWAD-PFLRDSRRVLRIMDTRLGGQY-----SKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSK 311 (350)
Q Consensus 239 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~ 311 (350)
............ +..... ............. ....++.+.+|+.+||+.||.+|||+.++++.|+++....
T Consensus 244 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~~ 320 (322)
T 3soc_A 244 EYMLPFEEEIGQHPSLEDM--QEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRLT 320 (322)
T ss_dssp CCCCTTHHHHCSSCCHHHH--HHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred hhccchhhhhccCCchhhh--hhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 332222211111 111111 1111111111111 2245678999999999999999999999999999987653
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-46 Score=337.36 Aligned_cols=273 Identities=25% Similarity=0.348 Sum_probs=220.7
Q ss_pred hhhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch-hhHHHHHHHHHHHhccCCCccccee
Q 018785 15 ISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLVKLI 93 (350)
Q Consensus 15 ~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~ 93 (350)
..++..++|++.+.||+|+||.||+|++... ....++..||+|.+..... .....+.+|+.+++.++||||++++
T Consensus 41 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~ 116 (343)
T 1luf_A 41 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGL----LPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLL 116 (343)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETS----STTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred eeEecHHHCeeeeeeeecCCeeEEEEEecCc----CCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEE
Confidence 3456678999999999999999999976532 2235678999999976543 3346788999999999999999999
Q ss_pred eEEeecCceEEEEEcCCCCChhhHHhhcC----------------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCC
Q 018785 94 GYCSESDNRLLVYEFMPKGSLENHLFRKG----------------------VQPISWPTRVKIAIDVARGLSFLHGLDAN 151 (350)
Q Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------------~~~l~~~~~~~i~~ql~~al~~lh~~~~~ 151 (350)
+++.+.+..++||||+++++|.+++.... ...+++.+++.++.|++.||.||| +.|
T Consensus 117 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH--~~~ 194 (343)
T 1luf_A 117 GVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS--ERK 194 (343)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH--HTT
T ss_pred EEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH--hCC
Confidence 99999999999999999999999997642 146899999999999999999999 899
Q ss_pred eeeCCCCCCceEEcCCCcEEEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CC
Q 018785 152 VIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GR 230 (350)
Q Consensus 152 i~H~di~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~ 230 (350)
++|+||||+||+++.++.++|+|||++................+++.|+|||.+.+..++.++|+||||+++|+|++ |.
T Consensus 195 ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~ 274 (343)
T 1luf_A 195 FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 274 (343)
T ss_dssp CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred eecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCC
Confidence 99999999999999999999999999875332222222233457888999999999999999999999999999999 99
Q ss_pred CCCcccccCcchhhhhhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcC
Q 018785 231 RALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 310 (350)
Q Consensus 231 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 310 (350)
.||.+......... +........+..+++.+.+++.+||+.||.+|||+.+++++|+++...
T Consensus 275 ~p~~~~~~~~~~~~------------------~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~ 336 (343)
T 1luf_A 275 QPYYGMAHEEVIYY------------------VRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER 336 (343)
T ss_dssp CTTTTSCHHHHHHH------------------HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred CcCCCCChHHHHHH------------------HhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence 99976442211111 111112234556788999999999999999999999999999998775
Q ss_pred C
Q 018785 311 K 311 (350)
Q Consensus 311 ~ 311 (350)
.
T Consensus 337 ~ 337 (343)
T 1luf_A 337 A 337 (343)
T ss_dssp -
T ss_pred h
Confidence 4
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=339.12 Aligned_cols=281 Identities=25% Similarity=0.370 Sum_probs=228.6
Q ss_pred hhhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch-hhHHHHHHHHHHHhcc-CCCcccce
Q 018785 15 ISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQL-RHENLVKL 92 (350)
Q Consensus 15 ~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~ 92 (350)
..++..++|++.+.||+|+||+||+|++.... ......+..||+|++..... .....+.+|+.+++.+ +||||+++
T Consensus 63 ~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~--~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~ 140 (382)
T 3tt0_A 63 RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLD--KDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINL 140 (382)
T ss_dssp TTBCCGGGEEEEEEEEECSSEEEEEEEEETSS--TTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccchhheEeeeEEecCCCeEEEEEEEcccc--ccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhh
Confidence 45667889999999999999999999764321 02334567899999876533 3346788999999999 89999999
Q ss_pred eeEEeecCceEEEEEcCCCCChhhHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCC
Q 018785 93 IGYCSESDNRLLVYEFMPKGSLENHLFRKG--------------VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLK 158 (350)
Q Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------------~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~ 158 (350)
++++...+..++||||+++++|.+++.... ...+++..++.++.|++.||.||| +.|++|+|||
T Consensus 141 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dlk 218 (382)
T 3tt0_A 141 LGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA--SKKCIHRDLA 218 (382)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCC
T ss_pred eeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH--hCCEecCCCC
Confidence 999999999999999999999999998754 235999999999999999999999 8999999999
Q ss_pred CCceEEcCCCcEEEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccc
Q 018785 159 ASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDR 237 (350)
Q Consensus 159 ~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~ 237 (350)
|+||+++.++.++|+|||++................+++.|+|||++.+..++.++||||||+++|+|++ |..||.+..
T Consensus 219 p~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~ 298 (382)
T 3tt0_A 219 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 298 (382)
T ss_dssp GGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred cceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999986544333333334556788999999999999999999999999999999 999997654
Q ss_pred cCcchhhhhhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcCCCCCCCC
Q 018785 238 GGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDMPRTP 317 (350)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~~~~~ 317 (350)
... ....+........+..+++++.+|+.+||+.||.+|||+.+++++|+.+..........
T Consensus 299 ~~~------------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~~ 360 (382)
T 3tt0_A 299 VEE------------------LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQEMG 360 (382)
T ss_dssp HHH------------------HHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC--
T ss_pred HHH------------------HHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCCCC
Confidence 221 11222222233345567889999999999999999999999999999998776554433
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-46 Score=337.61 Aligned_cols=276 Identities=28% Similarity=0.389 Sum_probs=221.2
Q ss_pred hhhhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch-hhHHHHHHHHHHHhcc-CCCcccc
Q 018785 14 MISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQL-RHENLVK 91 (350)
Q Consensus 14 ~~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~ 91 (350)
...++..++|++.+.||+|+||+||+|++... ....++..||+|.+..... .....+.+|+.+++++ +||||++
T Consensus 38 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~ 113 (344)
T 1rjb_A 38 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGI----SKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVN 113 (344)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESC----SSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCC
T ss_pred cCcccCHHHceeeeeecCCCCceeEEeeeecc----ccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeee
Confidence 34566788999999999999999999965322 2345688999999875432 2346788999999999 8999999
Q ss_pred eeeEEeecCceEEEEEcCCCCChhhHHhhcCC---------------------CCCCHHHHHHHHHHHHHHHHHhhcCCC
Q 018785 92 LIGYCSESDNRLLVYEFMPKGSLENHLFRKGV---------------------QPISWPTRVKIAIDVARGLSFLHGLDA 150 (350)
Q Consensus 92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------------------~~l~~~~~~~i~~ql~~al~~lh~~~~ 150 (350)
+++++...+..++||||+++++|.+++..... ..++...++.++.|++.||.||| +.
T Consensus 114 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH--~~ 191 (344)
T 1rjb_A 114 LLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE--FK 191 (344)
T ss_dssp EEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH--HT
T ss_pred EEEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH--hC
Confidence 99999999999999999999999999976542 23789999999999999999999 89
Q ss_pred CeeeCCCCCCceEEcCCCcEEEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-C
Q 018785 151 NVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-G 229 (350)
Q Consensus 151 ~i~H~di~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g 229 (350)
|++|+||+|+||+++.++.++|+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |
T Consensus 192 ~ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g 271 (344)
T 1rjb_A 192 SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLG 271 (344)
T ss_dssp TEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTS
T ss_pred CcccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCC
Confidence 999999999999999999999999999976544333333334556788999999999999999999999999999998 9
Q ss_pred CCCCcccccCcchhhhhhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhc
Q 018785 230 RRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHT 309 (350)
Q Consensus 230 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 309 (350)
..||.+....... ...+........+..+++++.+|+.+||..||.+|||+.+++++|+.+..
T Consensus 272 ~~p~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 334 (344)
T 1rjb_A 272 VNPYPGIPVDANF-----------------YKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLA 334 (344)
T ss_dssp CCSSTTCCCSHHH-----------------HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred CCCcccCCcHHHH-----------------HHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence 9999765432211 11122222233455678899999999999999999999999999999877
Q ss_pred CCC
Q 018785 310 SKD 312 (350)
Q Consensus 310 ~~~ 312 (350)
...
T Consensus 335 ~~~ 337 (344)
T 1rjb_A 335 DAE 337 (344)
T ss_dssp ---
T ss_pred HHH
Confidence 643
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-46 Score=334.98 Aligned_cols=286 Identities=40% Similarity=0.717 Sum_probs=223.2
Q ss_pred hhhhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh-hHHHHHHHHHHHhccCCCcccce
Q 018785 14 MISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ-GHKEWLTEVIYLGQLRHENLVKL 92 (350)
Q Consensus 14 ~~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~ 92 (350)
....+..++|++.+.||+|+||+||+|+. .++..||||.+...... ....+.+|+.+++.++||||+++
T Consensus 23 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~----------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~ 92 (326)
T 3uim_A 23 RELQVASDNFSNKNILGRGGFGKVYKGRL----------ADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL 92 (326)
T ss_dssp HHHHTTTTSSCSTTEEECCSSSEEEEECC----------SSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCC
T ss_pred HHHHHHhhccccceeEecCCCcEEEEEEe----------cCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccce
Confidence 35567789999999999999999999932 24788999998765432 22357899999999999999999
Q ss_pred eeEEeecCceEEEEEcCCCCChhhHHhhcC--CCCCCHHHHHHHHHHHHHHHHHhhcCCC---CeeeCCCCCCceEEcCC
Q 018785 93 IGYCSESDNRLLVYEFMPKGSLENHLFRKG--VQPISWPTRVKIAIDVARGLSFLHGLDA---NVIYRDLKASNVLLDSN 167 (350)
Q Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~l~~~~~~~i~~ql~~al~~lh~~~~---~i~H~di~~~Nili~~~ 167 (350)
++++...+..++||||+.+++|.+++.... ...++...+..++.|++.||.||| +. |++|+||+|+||+++.+
T Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH--~~~~~~ivH~Dlkp~Nil~~~~ 170 (326)
T 3uim_A 93 RGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLH--DHCDPKIIHRDVKAANILLDEE 170 (326)
T ss_dssp CEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHH--HSSSSCEECCCCSGGGEEECTT
T ss_pred EEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH--hCCCCCeEeCCCchhhEEECCC
Confidence 999999999999999999999999997654 234899999999999999999999 78 99999999999999999
Q ss_pred CcEEEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcc-hhhhh
Q 018785 168 FNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLA-EQTLV 246 (350)
Q Consensus 168 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~-~~~~~ 246 (350)
+.++|+|||++........ .......|++.|+|||.+.+..++.++||||||+++|+|++|..||........ .....
T Consensus 171 ~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~ 249 (326)
T 3uim_A 171 FEAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL 249 (326)
T ss_dssp CCEEECCCSSCEECCSSSS-CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHH
T ss_pred CCEEeccCccccccCcccc-cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHH
Confidence 9999999999976433222 223335589999999999899999999999999999999999999963221111 11111
Q ss_pred hhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcCCCC
Q 018785 247 EWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDM 313 (350)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~ 313 (350)
.+...... ................+...+..+.+++.+||+.||.+|||+.+++++|+........
T Consensus 250 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~~~~ 315 (326)
T 3uim_A 250 DWVKGLLK-EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAERW 315 (326)
T ss_dssp HHHTTTTS-SCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCSSSC
T ss_pred HHHHHHhh-chhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchhhhh
Confidence 11111111 1112222333334456678889999999999999999999999999999976555433
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=343.71 Aligned_cols=258 Identities=21% Similarity=0.285 Sum_probs=212.4
Q ss_pred hhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch--hhHHHHHHHHHHHhccCCCccccee
Q 018785 16 SKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLRHENLVKLI 93 (350)
Q Consensus 16 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~ 93 (350)
+....++|++.+.||+|+||+||+| .+..+|+.+|+|++..... .....+.+|+.+++.++||||++++
T Consensus 6 ~~~~~~~Y~i~~~LG~G~fg~V~~~---------~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~ 76 (444)
T 3soa_A 6 CTRFTEEYQLFEELGKGAFSVVRRC---------VKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLH 76 (444)
T ss_dssp -CHHHHHEEEEEEEEEC--CEEEEE---------EETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEE
T ss_pred cccccCCeEEEEEeccCCCeEEEEE---------EECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEE
Confidence 4456789999999999999999999 6677799999999876543 3345688999999999999999999
Q ss_pred eEEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEc---CCCcE
Q 018785 94 GYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLD---SNFNA 170 (350)
Q Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~---~~~~~ 170 (350)
+++.+.+..++||||+.|++|.+++.... .+++..+..++.||+.||.||| +.|++|+||||+||+++ .++.+
T Consensus 77 ~~~~~~~~~~lv~E~~~gg~L~~~i~~~~--~~~e~~~~~i~~qil~aL~~lH--~~givHrDlKp~NIll~~~~~~~~v 152 (444)
T 3soa_A 77 DSISEEGHHYLIFDLVTGGELFEDIVARE--YYSEADASHCIQQILEAVLHCH--QMGVVHRNLKPENLLLASKLKGAAV 152 (444)
T ss_dssp EEEECSSEEEEEECCCBCCBHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCSSTTEEESBSSTTCCE
T ss_pred EEEEECCEEEEEEEeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCccccCCCHHHEEEeccCCCCcE
Confidence 99999999999999999999999998775 7999999999999999999999 89999999999999998 46789
Q ss_pred EEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcc
Q 018785 171 KLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD 250 (350)
Q Consensus 171 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~ 250 (350)
+|+|||++....... .......|++.|+|||++.+..++.++|||||||++|+|++|..||.+.........+...
T Consensus 153 kL~DFG~a~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~-- 228 (444)
T 3soa_A 153 KLADFGLAIEVEGEQ--QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAG-- 228 (444)
T ss_dssp EECCCSSCBCCCTTC--CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT--
T ss_pred EEccCceeEEecCCC--ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhC--
Confidence 999999997643322 2223457899999999999989999999999999999999999999765432222221110
Q ss_pred hhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 251 PFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
...........+++++.+||.+||+.||.+|||+.++++|
T Consensus 229 -------------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 229 -------------AYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp -------------CCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred -------------CCCCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 0011112234578899999999999999999999999987
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-45 Score=326.78 Aligned_cols=283 Identities=21% Similarity=0.317 Sum_probs=217.0
Q ss_pred hhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch-hhHHHHHHHHHHHhccCCCcccceeeEE
Q 018785 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLVKLIGYC 96 (350)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (350)
...++|++.++||+|+||+||+| .+..+++.||||++..... .....+.+|+.+++.++||||+++++++
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~---------~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 76 (319)
T 4euu_A 6 TSNHLWLLSDILGQGATANVFRG---------RHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIE 76 (319)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEE---------EETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CCCCCEEEEEEecCCCCeEEEEE---------EECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEe
Confidence 45789999999999999999999 5556789999999876543 3356678999999999999999999998
Q ss_pred eecC--ceEEEEEcCCCCChhhHHhhcCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEE----cCCCc
Q 018785 97 SESD--NRLLVYEFMPKGSLENHLFRKGV-QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLL----DSNFN 169 (350)
Q Consensus 97 ~~~~--~~~lv~e~~~~~~L~~~l~~~~~-~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili----~~~~~ 169 (350)
...+ ..++||||+++++|.+++..... ..+++..++.++.|++.||.||| +.|++|+||||+||++ +.++.
T Consensus 77 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH--~~~ivH~Dlkp~NIll~~~~~~~~~ 154 (319)
T 4euu_A 77 EETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR--ENGIVHRNIKPGNIMRVIGEDGQSV 154 (319)
T ss_dssp ECTTTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEEEECTTSCEE
T ss_pred ecCCCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH--HCCEecCCCCHHHEEEeccCCCCce
Confidence 8765 77999999999999999976532 23999999999999999999999 8999999999999999 77788
Q ss_pred EEEccccccccCCCCCCCcccccccCCCcccCccccc--------cCCCCCccchhhHHHHHHHHHhCCCCCcccccCcc
Q 018785 170 AKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVA--------TGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLA 241 (350)
Q Consensus 170 ~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~--------~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~ 241 (350)
++|+|||++........ .....+++.|+|||++. +..++.++|||||||++|+|++|..||........
T Consensus 155 ~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~ 231 (319)
T 4euu_A 155 YKLTDFGAARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR 231 (319)
T ss_dssp EEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGG
T ss_pred EEEccCCCceecCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccch
Confidence 99999999976443322 22346899999999886 57889999999999999999999999975443222
Q ss_pred hhhhhh-hcc--h--hhhhhHHH----HH-hhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcCC
Q 018785 242 EQTLVE-WAD--P--FLRDSRRV----LR-IMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSK 311 (350)
Q Consensus 242 ~~~~~~-~~~--~--~~~~~~~~----~~-~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~ 311 (350)
...+.. ... + ........ .. ..........+..++..+.++|.+||+.||.+|||++++++|..+....-
T Consensus 232 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~~~ 311 (319)
T 4euu_A 232 NKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRG 311 (319)
T ss_dssp CHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC--
T ss_pred hHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhhcC
Confidence 211111 000 0 00000000 00 00011222456788999999999999999999999999999998776554
Q ss_pred CCC
Q 018785 312 DMP 314 (350)
Q Consensus 312 ~~~ 314 (350)
+.|
T Consensus 312 ~~~ 314 (319)
T 4euu_A 312 NSH 314 (319)
T ss_dssp ---
T ss_pred Ccc
Confidence 433
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=339.30 Aligned_cols=254 Identities=26% Similarity=0.402 Sum_probs=207.2
Q ss_pred hhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch---hhHHHHHHHHHHHhcc-CCCcccc
Q 018785 16 SKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQL-RHENLVK 91 (350)
Q Consensus 16 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l-~h~~i~~ 91 (350)
..+..++|++.+.||+|+||.||+| .+..+++.||+|++..... .....+..|..+++.+ +||||++
T Consensus 18 ~~~~~~~y~~~~~lG~G~fg~V~~~---------~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~ 88 (353)
T 3txo_A 18 NRLGIDNFEFIRVLGKGSFGKVMLA---------RVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 88 (353)
T ss_dssp -----CCEEEEEEEEEETTEEEEEE---------EETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCC
T ss_pred CCCchhheEEEEEEeeCCCEEEEEE---------EEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceee
Confidence 3455689999999999999999999 5566789999999976532 3345677899999988 7999999
Q ss_pred eeeEEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEE
Q 018785 92 LIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAK 171 (350)
Q Consensus 92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~ 171 (350)
+++++.+.+.+|+||||++|++|.+++.... .+++..++.++.||+.||+||| +.|++||||||+||+++.++.++
T Consensus 89 l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH--~~givHrDlkp~NILl~~~g~ik 164 (353)
T 3txo_A 89 LFCCFQTPDRLFFVMEFVNGGDLMFHIQKSR--RFDEARARFYAAEIISALMFLH--DKGIIYRDLKLDNVLLDHEGHCK 164 (353)
T ss_dssp EEEEEECSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCCGGGEEECTTSCEE
T ss_pred EEEEEEeCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCCcccCCCHHHEEECCCCCEE
Confidence 9999999999999999999999999998765 6999999999999999999999 89999999999999999999999
Q ss_pred EccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcch
Q 018785 172 LSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADP 251 (350)
Q Consensus 172 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~ 251 (350)
|+|||++....... .......|++.|+|||++.+..++.++|+|||||++|+|++|..||.+.........+.
T Consensus 165 L~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~----- 237 (353)
T 3txo_A 165 LADFGMCKEGICNG--VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAIL----- 237 (353)
T ss_dssp ECCCTTCBCSCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-----
T ss_pred EccccceeecccCC--ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHH-----
Confidence 99999997532221 22334578999999999999999999999999999999999999997655322222221
Q ss_pred hhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCH------HHHHHH
Q 018785 252 FLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSM------VDVLTS 303 (350)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~------~~ll~~ 303 (350)
.. ....+..+++.+.+||.+||..||.+||++ +++++|
T Consensus 238 ------------~~--~~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h 281 (353)
T 3txo_A 238 ------------ND--EVVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH 281 (353)
T ss_dssp ------------HC--CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred ------------cC--CCCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence 11 122345577889999999999999999998 888876
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-46 Score=335.32 Aligned_cols=256 Identities=25% Similarity=0.323 Sum_probs=208.9
Q ss_pred hhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh-hHHHHHHHHHHHhccCCCcccceeeEEee
Q 018785 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ-GHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (350)
Q Consensus 20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (350)
.++|++.+.||+|+||+||+| .+..+++.||+|++...... ....+.+|+.+++.++||||+++++++.+
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~---------~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 76 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLA---------VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE 76 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEE---------EETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhceeeeEEecCCCEEEEEE---------EECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence 478999999999999999999 55667899999998655432 23567899999999999999999999999
Q ss_pred cCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcccccc
Q 018785 99 SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 178 (350)
Q Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~ 178 (350)
++..++||||+++++|.+++.... .+++..++.++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++
T Consensus 77 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH--~~givH~Dlkp~NIll~~~~~~kl~Dfg~a 152 (323)
T 3tki_A 77 GNIQYLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLH--GIGITHRDIKPENLLLDERDNLKISDFGLA 152 (323)
T ss_dssp SSEEEEEEECCTTEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred CCeEEEEEEcCCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHH--HCCccccccchHHEEEeCCCCEEEEEeecc
Confidence 999999999999999999997654 6999999999999999999999 899999999999999999999999999999
Q ss_pred ccCCCCCCCcccccccCCCcccCccccccCCC-CCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhH
Q 018785 179 RDGPTGDNTHVSTRIVGTRGYAAPEYVATGHL-TPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSR 257 (350)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 257 (350)
................|++.|+|||++.+..+ +.++||||||+++|+|++|..||............
T Consensus 153 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~------------ 220 (323)
T 3tki_A 153 TVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD------------ 220 (323)
T ss_dssp EECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHH------------
T ss_pred ceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHH------------
Confidence 75433333233334678999999999987765 77899999999999999999999765432211111
Q ss_pred HHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018785 258 RVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL 304 (350)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 304 (350)
.............+++.+.+||.+||..||.+|||+.+++++-
T Consensus 221 ----~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~ 263 (323)
T 3tki_A 221 ----WKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDR 263 (323)
T ss_dssp ----HHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCT
T ss_pred ----HhcccccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhCh
Confidence 1111111122345778899999999999999999999999763
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=332.23 Aligned_cols=255 Identities=24% Similarity=0.344 Sum_probs=211.1
Q ss_pred hhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh------hHHHHHHHHHHHhccCCCcccc
Q 018785 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ------GHKEWLTEVIYLGQLRHENLVK 91 (350)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~ 91 (350)
...++|++.+.||+|+||.||+| .+..+|..||+|.+...... ....+.+|+.+++.++||||++
T Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~---------~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~ 78 (326)
T 2y0a_A 8 NVDDYYDTGEELGSGQFAVVKKC---------REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78 (326)
T ss_dssp CHHHHEEEEEEEECCSSEEEEEE---------EETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCC
T ss_pred CcccceEeceEEeeCCCeEEEEE---------EECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 34678999999999999999999 66667899999998765322 3567889999999999999999
Q ss_pred eeeEEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCC---
Q 018785 92 LIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNF--- 168 (350)
Q Consensus 92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~--- 168 (350)
+++++...+..++||||+++++|.+++.... .+++..++.++.|++.||.||| +.|++|+||+|+||+++.++
T Consensus 79 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH--~~~ivH~Dlkp~NIll~~~~~~~ 154 (326)
T 2y0a_A 79 LHEVYENKTDVILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLH--SLQIAHFDLKPENIMLLDRNVPK 154 (326)
T ss_dssp EEEEEECSSEEEEEEECCCSCBHHHHHTTSS--CCBHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEESCSSSSS
T ss_pred EEEEEEeCCEEEEEEEcCCCCCHHHHHHhcC--CcCHHHHHHHHHHHHHHHHHHH--HCCeEcCCCCHHHEEEecCCCCC
Confidence 9999999999999999999999999997654 7999999999999999999999 89999999999999998887
Q ss_pred -cEEEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhh
Q 018785 169 -NAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVE 247 (350)
Q Consensus 169 -~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~ 247 (350)
.++|+|||++........ .....|++.|+|||++.+..++.++||||||+++|+|++|..||.+.........+..
T Consensus 155 ~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~ 231 (326)
T 2y0a_A 155 PRIKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSA 231 (326)
T ss_dssp CCEEECCCTTCEECCTTSC---CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHH
T ss_pred CCEEEEECCCCeECCCCCc---cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHh
Confidence 799999999976533221 2235689999999999989999999999999999999999999976543222221111
Q ss_pred hcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 248 WADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
... .........++..+.+||.+||..||.+|||+.++++|
T Consensus 232 ~~~---------------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 232 VNY---------------EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp TCC---------------CCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred cCC---------------CcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 100 00001122456789999999999999999999999986
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=343.78 Aligned_cols=264 Identities=26% Similarity=0.401 Sum_probs=216.1
Q ss_pred hhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch-hhHHHHHHHHHHHhccCCCcccceeeE
Q 018785 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLVKLIGY 95 (350)
Q Consensus 17 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~ 95 (350)
.+..++|++.+.||+|+||.||+|+ ...++..||||.+..... .....+.+|+.+++.++||||++++++
T Consensus 110 ~~~~~~~~~~~~lG~G~~g~V~~~~---------~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 180 (377)
T 3cbl_A 110 VLNHEDLVLGEQIGRGNFGEVFSGR---------LRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 180 (377)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEE---------ETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEE
T ss_pred EEchHHeEEeeEeccCCCCeEEEEE---------EecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 4456899999999999999999994 445688999999875532 233457889999999999999999999
Q ss_pred EeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccc
Q 018785 96 CSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDF 175 (350)
Q Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Df 175 (350)
+...+..++||||+++++|.+++.... ..++...+..++.|++.||+||| +.|++|+||+|+||+++.++.++|+||
T Consensus 181 ~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH--~~~ivHrDlkp~Nil~~~~~~~kl~Df 257 (377)
T 3cbl_A 181 CTQKQPIYIVMELVQGGDFLTFLRTEG-ARLRVKTLLQMVGDAAAGMEYLE--SKCCIHRDLAARNCLVTEKNVLKISDF 257 (377)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECTTCCEEECCG
T ss_pred EecCCCcEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH--HCCcCCcccCHHHEEEcCCCcEEECcC
Confidence 999999999999999999999997653 25899999999999999999999 899999999999999999999999999
Q ss_pred cccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccccCcchhhhhhhcchhhh
Q 018785 176 GLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLR 254 (350)
Q Consensus 176 g~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~ 254 (350)
|++................++..|+|||.+.+..++.++||||||+++|+|++ |..||.+......
T Consensus 258 G~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~------------- 324 (377)
T 3cbl_A 258 GMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQT------------- 324 (377)
T ss_dssp GGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHH-------------
T ss_pred CCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH-------------
Confidence 99975322211111111234567999999998899999999999999999998 9999976543211
Q ss_pred hhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcC
Q 018785 255 DSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 310 (350)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 310 (350)
...+........+..+++.+.+|+.+||+.||.+|||+.++++.|+++...
T Consensus 325 -----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 325 -----REFVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp -----HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -----HHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 112222223344566788999999999999999999999999999998754
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-46 Score=333.38 Aligned_cols=256 Identities=20% Similarity=0.260 Sum_probs=212.3
Q ss_pred hhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceeeEEee
Q 018785 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (350)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (350)
..++|++.+.||+|+||+||+| .+..++..||+|.+.... .....+.+|+.+++.++||||+++++++.+
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~---------~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 72 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRC---------VETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFES 72 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEE---------EETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEE
T ss_pred hhhceEeeeEEecCCCeEEEEE---------EECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEec
Confidence 3579999999999999999999 666779999999987654 334668899999999999999999999999
Q ss_pred cCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcC--CCcEEEcccc
Q 018785 99 SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS--NFNAKLSDFG 176 (350)
Q Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~--~~~~~l~Dfg 176 (350)
.+..++||||+++++|.+++.... ..+++..++.++.|++.||.||| +.|++|+||||+||+++. ++.++|+|||
T Consensus 73 ~~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH--~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg 149 (321)
T 1tki_A 73 MEELVMIFEFISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLH--SHNIGHFDIRPENIIYQTRRSSTIKIIEFG 149 (321)
T ss_dssp TTEEEEEECCCCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEESSSSCCCEEECCCT
T ss_pred CCEEEEEEEeCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH--HCCCCcCCCCHHHEEEccCCCCCEEEEECC
Confidence 999999999999999999996543 36999999999999999999999 899999999999999987 7899999999
Q ss_pred ccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhh
Q 018785 177 LARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDS 256 (350)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 256 (350)
++....... ......+++.|+|||++.+..++.++||||||+++|+|++|..||.+.........+.......
T Consensus 150 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~---- 222 (321)
T 1tki_A 150 QARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTF---- 222 (321)
T ss_dssp TCEECCTTC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCC----
T ss_pred CCeECCCCC---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCC----
Confidence 998653322 2334568999999999988889999999999999999999999997655332222222111000
Q ss_pred HHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018785 257 RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 305 (350)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~ 305 (350)
.......+++++.+|+.+||..||.+|||+.++++|-.
T Consensus 223 -----------~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~ 260 (321)
T 1tki_A 223 -----------DEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPW 260 (321)
T ss_dssp -----------CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred -----------ChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChh
Confidence 00011246788999999999999999999999998743
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=329.73 Aligned_cols=249 Identities=26% Similarity=0.388 Sum_probs=211.9
Q ss_pred hhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch---hhHHHHHHHHHHHhccCCCcccceee
Q 018785 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLVKLIG 94 (350)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~ 94 (350)
+..++|++.+.||+|+||.||+| .+..+|+.||+|++..... .....+.+|..+++.++||||+++++
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~~---------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~ 73 (318)
T 1fot_A 3 YSLQDFQILRTLGTGSFGRVHLI---------RSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWG 73 (318)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEE---------EETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEE
T ss_pred CChHHcEEEEEEeeCCCEEEEEE---------EECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeE
Confidence 34579999999999999999999 5666799999999876532 34566788999999999999999999
Q ss_pred EEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcc
Q 018785 95 YCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSD 174 (350)
Q Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~D 174 (350)
++.+.+..|+||||+++++|.+++.... .+++..++.++.|++.||.||| +.|++|+||||+||+++.++.++|+|
T Consensus 74 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH--~~~ivHrDlkp~NIll~~~g~~kL~D 149 (318)
T 1fot_A 74 TFQDAQQIFMIMDYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLH--SKDIIYRDLKPENILLDKNGHIKITD 149 (318)
T ss_dssp EEECSSEEEEEECCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHH--TTTEECCCCCGGGEEECTTSCEEECC
T ss_pred EEEeCCEEEEEEeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCccccCCChheEEEcCCCCEEEee
Confidence 9999999999999999999999998765 6999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhh
Q 018785 175 FGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLR 254 (350)
Q Consensus 175 fg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~ 254 (350)
||++...... .....|++.|+|||++.+..++.++|+|||||++|+|++|..||...........
T Consensus 150 fg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~---------- 214 (318)
T 1fot_A 150 FGFAKYVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEK---------- 214 (318)
T ss_dssp CSSCEECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH----------
T ss_pred cCcceecCCc-----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHH----------
Confidence 9999764321 2235689999999999999999999999999999999999999976443211111
Q ss_pred hhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 018785 255 DSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRP-----SMVDVLTS 303 (350)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~~ 303 (350)
+.... ...+..+++++.++|.+||..||.+|| +++++++|
T Consensus 215 -------i~~~~--~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 215 -------ILNAE--LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp -------HHHCC--CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred -------HHhCC--CCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 11111 223456778999999999999999999 89999977
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-46 Score=337.38 Aligned_cols=259 Identities=25% Similarity=0.400 Sum_probs=210.0
Q ss_pred CchhhhhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch---hhHHHHHHHHHHHhcc-CC
Q 018785 11 SASMISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQL-RH 86 (350)
Q Consensus 11 ~~~~~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l-~h 86 (350)
.......+..++|++.+.||+|+||.||+| .+..+|+.||+|++..... .....+..|..+++.+ +|
T Consensus 7 ~~~~~~~~~~~~y~~~~~lG~G~fg~V~~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~h 77 (345)
T 1xjd_A 7 RPSLQIKLKIEDFILHKMLGKGSFGKVFLA---------EFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 77 (345)
T ss_dssp ---------CTTEEEEEEEEECSSSEEEEE---------EETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTC
T ss_pred CCCccCCCChHHeEEEEEEeeCCCeEEEEE---------EECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCC
Confidence 333445667889999999999999999999 5566799999999976532 3345677888888876 89
Q ss_pred CcccceeeEEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcC
Q 018785 87 ENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS 166 (350)
Q Consensus 87 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~ 166 (350)
|||+++++++.+.+..|+||||++|++|.+++.... .+++..+..++.|++.||.||| +.|++|+||||+||+++.
T Consensus 78 p~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH--~~~ivHrDlkp~NIll~~ 153 (345)
T 1xjd_A 78 PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLH--SKGIVYRDLKLDNILLDK 153 (345)
T ss_dssp TTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCCGGGEEECT
T ss_pred CCCCcEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCeEeCCCChhhEEECC
Confidence 999999999999999999999999999999998764 6999999999999999999999 899999999999999999
Q ss_pred CCcEEEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhh
Q 018785 167 NFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLV 246 (350)
Q Consensus 167 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~ 246 (350)
++.++|+|||++....... .......|++.|+|||++.+..++.++|+|||||++|+|++|..||.+.........+.
T Consensus 154 ~g~vkL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~ 231 (345)
T 1xjd_A 154 DGHIKIADFGMCKENMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIR 231 (345)
T ss_dssp TSCEEECCCTTCBCCCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred CCCEEEeEChhhhhcccCC--CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence 9999999999997532222 12334678999999999999999999999999999999999999997654322211111
Q ss_pred hhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHH-HHHHH
Q 018785 247 EWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMV-DVLTS 303 (350)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~-~ll~~ 303 (350)
.. ....+..+++++.+||.+||..||.+||++. ++++|
T Consensus 232 -----------------~~--~~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~h 270 (345)
T 1xjd_A 232 -----------------MD--NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH 270 (345)
T ss_dssp -----------------HC--CCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred -----------------hC--CCCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcC
Confidence 11 1223456788999999999999999999997 77655
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=321.71 Aligned_cols=261 Identities=27% Similarity=0.405 Sum_probs=215.5
Q ss_pred hhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceeeEE
Q 018785 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYC 96 (350)
Q Consensus 17 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (350)
++..++|++.+.||+|+||.||+|++. ++..||+|.+..... ....+.+|+..+++++||||+++++++
T Consensus 4 ~l~~~~y~~~~~lg~G~~g~V~~~~~~----------~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~ 72 (268)
T 3sxs_A 4 ELKREEITLLKELGSGQFGVVKLGKWK----------GQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVC 72 (268)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEET----------TTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred EechhheeeeeeeccCCCceEEEEEec----------CceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 456789999999999999999999543 356799999876543 346688999999999999999999999
Q ss_pred eecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcccc
Q 018785 97 SESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFG 176 (350)
Q Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg 176 (350)
...+..++||||+++++|.+++.... ..+++..++.++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||
T Consensus 73 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH--~~~i~H~dikp~Nil~~~~~~~~l~Dfg 149 (268)
T 3sxs_A 73 SKEYPIYIVTEYISNGCLLNYLRSHG-KGLEPSQLLEMCYDVCEGMAFLE--SHQFIHRDLAARNCLVDRDLCVKVSDFG 149 (268)
T ss_dssp CSSSSEEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHH--HTTEEESSCSGGGEEECTTCCEEECCTT
T ss_pred ccCCceEEEEEccCCCcHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCcCcceEEECCCCCEEEccCc
Confidence 99999999999999999999997653 25899999999999999999999 8999999999999999999999999999
Q ss_pred ccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccccCcchhhhhhhcchhhhh
Q 018785 177 LARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRD 255 (350)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 255 (350)
++........ .......+++.|+|||.+.+..++.++|+||||+++|+|++ |..||...........
T Consensus 150 ~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~----------- 217 (268)
T 3sxs_A 150 MTRYVLDDQY-VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLK----------- 217 (268)
T ss_dssp CEEECCTTCE-EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH-----------
T ss_pred cceecchhhh-hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHH-----------
Confidence 9976433221 11223445677999999999899999999999999999999 9999975543211111
Q ss_pred hHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcC
Q 018785 256 SRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 310 (350)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 310 (350)
.........+..+++.+.+++.+||+.||.+|||+.+++++|+.+...
T Consensus 218 -------~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 218 -------VSQGHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp -------HHTTCCCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred -------HHcCCCCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 111112233445678899999999999999999999999999998765
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=326.84 Aligned_cols=266 Identities=25% Similarity=0.399 Sum_probs=224.3
Q ss_pred hhhhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCccccee
Q 018785 14 MISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLI 93 (350)
Q Consensus 14 ~~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 93 (350)
.-.++..++|++.+.||+|++|+||+| .+..++..||+|.+.... .....+.+|+.+++.++||||++++
T Consensus 6 ~~~~~~~~~~~~~~~lg~G~~g~V~~~---------~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~ 75 (288)
T 3kfa_A 6 DKWEMERTDITMKHKLGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLL 75 (288)
T ss_dssp CTTBCCGGGEEEEEESGGGTTCSEEEE---------EEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred hcccccccceeEEeecCCCCceeEEEe---------EecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEE
Confidence 345677899999999999999999999 445568899999987654 3456788999999999999999999
Q ss_pred eEEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEc
Q 018785 94 GYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLS 173 (350)
Q Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~ 173 (350)
+++.+.+..++|||++++++|.+++.......++...++.++.|++.||.||| +.|++|+||+|+||+++.++.++|+
T Consensus 76 ~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH--~~~i~H~dikp~Nil~~~~~~~~l~ 153 (288)
T 3kfa_A 76 GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVA 153 (288)
T ss_dssp EEECSSSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHH--HHTCCCSCCSGGGEEECGGGCEEEC
T ss_pred EEEccCCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHH--HCCccCCCCCcceEEEcCCCCEEEc
Confidence 99999999999999999999999998876667999999999999999999999 8999999999999999999999999
Q ss_pred cccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccccCcchhhhhhhcchh
Q 018785 174 DFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPF 252 (350)
Q Consensus 174 Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~ 252 (350)
|||++....... ........+++.|+|||.+.+..++.++||||||+++|+|++ |..||..........
T Consensus 154 Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~--------- 223 (288)
T 3kfa_A 154 DFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE--------- 223 (288)
T ss_dssp CCCGGGTSCSSS-SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH---------
T ss_pred cCccceeccCCc-cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH---------
Confidence 999997643322 222233456778999999999999999999999999999999 899997654322211
Q ss_pred hhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcC
Q 018785 253 LRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 310 (350)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 310 (350)
.+........+..+++.+.+|+.+||..||.+|||+.++++.|+.+...
T Consensus 224 ---------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~ 272 (288)
T 3kfa_A 224 ---------LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 272 (288)
T ss_dssp ---------HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---------HHhccCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence 1122222344556788999999999999999999999999999988764
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=322.73 Aligned_cols=261 Identities=28% Similarity=0.430 Sum_probs=215.6
Q ss_pred hhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceeeEE
Q 018785 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYC 96 (350)
Q Consensus 17 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (350)
.+..++|++.+.||+|+||+||+|++. ++..||+|.+..... ..+.+.+|+.++++++||||+++++++
T Consensus 6 ~i~~~~y~~~~~lg~G~~g~V~~~~~~----------~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~ 74 (269)
T 4hcu_A 6 VIDPSELTFVQEIGSGQFGLVHLGYWL----------NKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVC 74 (269)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEET----------TTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred EeChhhceeeheecCCCccEEEEEEec----------CCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 345689999999999999999999542 366799999876543 346788999999999999999999999
Q ss_pred eecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcccc
Q 018785 97 SESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFG 176 (350)
Q Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg 176 (350)
.+.+..++||||+++++|.+++.... ..++...++.++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||
T Consensus 75 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH--~~~i~H~dikp~Nil~~~~~~~kl~Dfg 151 (269)
T 4hcu_A 75 LEQAPICLVFEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLE--EACVIHRDLAARNCLVGENQVIKVSDFG 151 (269)
T ss_dssp CSSSSEEEEEECCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECGGGCEEECCTT
T ss_pred ecCCceEEEEEeCCCCcHHHHHHhcC-cccCHHHHHHHHHHHHHHHHHHH--hCCeecCCcchheEEEcCCCCEEecccc
Confidence 99999999999999999999997654 36899999999999999999999 8999999999999999999999999999
Q ss_pred ccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccccCcchhhhhhhcchhhhh
Q 018785 177 LARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRD 255 (350)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 255 (350)
++....... ........+++.|+|||.+.+..++.++|+||||+++|+|++ |..||...........
T Consensus 152 ~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~----------- 219 (269)
T 4hcu_A 152 MTRFVLDDQ-YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVED----------- 219 (269)
T ss_dssp GGGGBCCHH-HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH-----------
T ss_pred ccccccccc-cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHH-----------
Confidence 997532221 111222445678999999998999999999999999999999 8999976543221111
Q ss_pred hHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcC
Q 018785 256 SRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 310 (350)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 310 (350)
+........+..+++.+.+++.+||+.||.+|||+.+++++|+++...
T Consensus 220 -------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 220 -------ISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp -------HHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred -------HhcCccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 111222333455678899999999999999999999999999998764
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=338.31 Aligned_cols=279 Identities=19% Similarity=0.223 Sum_probs=212.5
Q ss_pred hhhcccccceeccc--CceeEEeecccCCCcCCCCCCCCcEEEEEEccccch--hhHHHHHHHHHHHhccCCCcccceee
Q 018785 19 ATKNFCSDYLLGEG--GFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLRHENLVKLIG 94 (350)
Q Consensus 19 ~~~~y~i~~~lg~G--~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~ 94 (350)
.+++|++.++||+| +||+||+| .+..+|+.||||.+..... .....+.+|+.+++.++||||+++++
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~---------~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 93 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLA---------RYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRA 93 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEE---------EETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CCCcEEEEecccCCcCCceEEEEE---------EEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeE
Confidence 46899999999999 99999999 5666799999999976542 33466888999999999999999999
Q ss_pred EEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcc
Q 018785 95 YCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSD 174 (350)
Q Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~D 174 (350)
++.+.+..++||||+++++|.+++.......+++..++.++.||+.||.||| +.|++|+||||+||+++.++.++|+|
T Consensus 94 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH--~~~ivHrDlkp~NIll~~~~~~kl~d 171 (389)
T 3gni_B 94 TFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH--HMGYVHRSVKASHILISVDGKVYLSG 171 (389)
T ss_dssp EEEETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTCCEEECC
T ss_pred EEEECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEEcCCCCEEEcc
Confidence 9999999999999999999999998875567999999999999999999999 89999999999999999999999999
Q ss_pred ccccccCCCCCC-----CcccccccCCCcccCcccccc--CCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhh
Q 018785 175 FGLARDGPTGDN-----THVSTRIVGTRGYAAPEYVAT--GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVE 247 (350)
Q Consensus 175 fg~~~~~~~~~~-----~~~~~~~~~~~~~~aPE~~~~--~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~ 247 (350)
||.+........ ........|++.|+|||++.+ ..++.++|||||||++|+|++|..||.+............
T Consensus 172 fg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 251 (389)
T 3gni_B 172 LRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLN 251 (389)
T ss_dssp GGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC--
T ss_pred cccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc
Confidence 998754321111 111222467888999999987 5789999999999999999999999987554433322221
Q ss_pred hcchhhhhhHH---------------------------HHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 018785 248 WADPFLRDSRR---------------------------VLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDV 300 (350)
Q Consensus 248 ~~~~~~~~~~~---------------------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l 300 (350)
...+...+... .............+..+++.+.+||.+||+.||.+|||+.++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~el 331 (389)
T 3gni_B 252 GTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTL 331 (389)
T ss_dssp ------------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHH
T ss_pred CCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHH
Confidence 11110000000 000000001112345567889999999999999999999999
Q ss_pred HHH--HHhhh
Q 018785 301 LTS--LEQLH 308 (350)
Q Consensus 301 l~~--L~~~~ 308 (350)
++| +.++.
T Consensus 332 l~hp~f~~~~ 341 (389)
T 3gni_B 332 LNHSFFKQIK 341 (389)
T ss_dssp TTSGGGGGC-
T ss_pred hcCHHHHHHh
Confidence 987 44443
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=330.96 Aligned_cols=271 Identities=28% Similarity=0.414 Sum_probs=201.1
Q ss_pred hhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccc--hhhHHHHHHHHHHHhccCCCcccceeeE
Q 018785 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES--FQGHKEWLTEVIYLGQLRHENLVKLIGY 95 (350)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 95 (350)
+..++|++.+.||+|+||+||+|++.. .......||||.+.... ......+.+|+.++++++||||++++++
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 93 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQ------EDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGV 93 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEE
T ss_pred cChhHeEEeceecccCCeEEEEEEEcc------cCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhce
Confidence 457899999999999999999995432 11122489999997653 2345678899999999999999999999
Q ss_pred EeecCce------EEEEEcCCCCChhhHHhhcC----CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEc
Q 018785 96 CSESDNR------LLVYEFMPKGSLENHLFRKG----VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLD 165 (350)
Q Consensus 96 ~~~~~~~------~lv~e~~~~~~L~~~l~~~~----~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~ 165 (350)
+...... ++||||+.+++|.+++.... ...+++..++.++.|++.||.||| +.|++|+||||+||+++
T Consensus 94 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH--~~~ivH~Dikp~NIli~ 171 (323)
T 3qup_A 94 SLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS--SRNFIHRDLAARNCMLA 171 (323)
T ss_dssp EECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEEC
T ss_pred eeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHH--cCCcccCCCCcceEEEc
Confidence 9877655 99999999999999996542 125899999999999999999999 89999999999999999
Q ss_pred CCCcEEEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccccCcchhh
Q 018785 166 SNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQT 244 (350)
Q Consensus 166 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~~~~ 244 (350)
.++.++|+|||++................+++.|+|||.+.+..++.++|||||||++|+|++ |..||.+.........
T Consensus 172 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~ 251 (323)
T 3qup_A 172 EDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNY 251 (323)
T ss_dssp TTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH
T ss_pred CCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHH
Confidence 999999999999976544333333333456778999999999999999999999999999999 8999976554322222
Q ss_pred hhhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcCCCCC
Q 018785 245 LVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDMP 314 (350)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~~ 314 (350)
+. .......+..+++.+.+|+.+||+.||.+|||+.++++.|+++.......
T Consensus 252 ~~------------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~ 303 (323)
T 3qup_A 252 LI------------------GGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVL 303 (323)
T ss_dssp HH------------------TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC----
T ss_pred Hh------------------cCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhc
Confidence 11 11122334567789999999999999999999999999999988764443
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=333.95 Aligned_cols=255 Identities=21% Similarity=0.314 Sum_probs=211.1
Q ss_pred hhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch--hhHHHHHHHHHHHhccCCCcccceeeE
Q 018785 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLRHENLVKLIGY 95 (350)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~ 95 (350)
...++|++.+.||+|+||.||+| .+..+|..||+|++..... .....+.+|+.+++.++||||++++++
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~~---------~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~ 96 (362)
T 2bdw_A 26 KFSDNYDVKEELGKGAFSVVRRC---------VHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 96 (362)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEE---------EETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CcccCeEEeeEEecCCCeEEEEE---------EECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 44679999999999999999999 5666789999999876532 344668899999999999999999999
Q ss_pred EeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCC---cEEE
Q 018785 96 CSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNF---NAKL 172 (350)
Q Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~---~~~l 172 (350)
+.+.+..++||||+.+++|.+++.... .+++..+..++.|++.||.||| +.|++|+||||+||+++.++ .++|
T Consensus 97 ~~~~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH--~~~ivH~Dlkp~NIll~~~~~~~~~kl 172 (362)
T 2bdw_A 97 IQEESFHYLVFDLVTGGELFEDIVARE--FYSEADASHCIQQILESIAYCH--SNGIVHRNLKPENLLLASKAKGAAVKL 172 (362)
T ss_dssp EECSSEEEEEECCCCSCBHHHHHTTCS--CCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCSGGGEEESCSSTTCCEEE
T ss_pred EEeCCEEEEEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCeEeccCchHHEEEecCCCCCCEEE
Confidence 999999999999999999999997654 7999999999999999999999 89999999999999998654 5999
Q ss_pred ccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchh
Q 018785 173 SDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPF 252 (350)
Q Consensus 173 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 252 (350)
+|||++....... ......|++.|+|||++.+..++.++|||||||++|+|++|..||.+.........+...
T Consensus 173 ~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~---- 245 (362)
T 2bdw_A 173 ADFGLAIEVNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG---- 245 (362)
T ss_dssp CCCTTCBCCTTCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT----
T ss_pred eecCcceEecCCc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC----
Confidence 9999997644322 223356899999999999989999999999999999999999999765432221111110
Q ss_pred hhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 253 LRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
...........+++++.+||.+||..||.+|||+.++++|
T Consensus 246 -----------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 246 -----------AYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp -----------CCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred -----------CCCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0011112234578899999999999999999999999987
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=329.08 Aligned_cols=251 Identities=24% Similarity=0.331 Sum_probs=210.0
Q ss_pred cccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceeeEEeecCc
Q 018785 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSESDN 101 (350)
Q Consensus 22 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 101 (350)
.|...+.||+|+||.||+| .+..+|+.||||++........+.+.+|+..++.++||||+++++++...+.
T Consensus 46 ~~~~~~~lg~G~~g~V~~a---------~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLA---------REKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEE 116 (321)
T ss_dssp HEEEEEEEEEETTEEEEEE---------EETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTE
T ss_pred hhhccEEeccCCCeEEEEE---------EECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCE
Confidence 4788889999999999999 5556789999999987666666778999999999999999999999999999
Q ss_pred eEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccccccC
Q 018785 102 RLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDG 181 (350)
Q Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~~~ 181 (350)
.++||||+++++|.+++... .+++..+..++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||++...
T Consensus 117 ~~lv~e~~~~~~L~~~l~~~---~l~~~~~~~i~~qi~~~L~~LH--~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~ 191 (321)
T 2c30_A 117 LWVLMEFLQGGALTDIVSQV---RLNEEQIATVCEAVLQALAYLH--AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQI 191 (321)
T ss_dssp EEEEECCCCSCBHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEECCCCcEEEeeeeeeeec
Confidence 99999999999999988654 6999999999999999999999 899999999999999999999999999998764
Q ss_pred CCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhHHHHH
Q 018785 182 PTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLR 261 (350)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (350)
..... ......|++.|+|||.+.+..++.++||||||+++|+|++|..||...........+....
T Consensus 192 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~------------ 257 (321)
T 2c30_A 192 SKDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSP------------ 257 (321)
T ss_dssp CSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSS------------
T ss_pred ccCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC------------
Confidence 33221 2233568999999999999999999999999999999999999997644322111111110
Q ss_pred hhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018785 262 IMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL 304 (350)
Q Consensus 262 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 304 (350)
.........+++.+.+++.+||+.||.+|||+.++++|-
T Consensus 258 ----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp 296 (321)
T 2c30_A 258 ----PPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHP 296 (321)
T ss_dssp ----CCCCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred ----CCCcCccccCCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 001122345678899999999999999999999999863
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=336.91 Aligned_cols=258 Identities=22% Similarity=0.306 Sum_probs=202.1
Q ss_pred hhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceeeEE
Q 018785 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYC 96 (350)
Q Consensus 17 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (350)
....++|++.+.||+|+||+||++ .+..+++.||+|++...... ...+.+|+..++.++||||+++++++
T Consensus 16 ~~~~~~y~~~~~lG~G~~g~V~~~---------~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~ 85 (361)
T 3uc3_A 16 MHDSDRYDFVKDIGSGNFGVARLM---------RDKLTKELVAVKYIERGAAI-DENVQREIINHRSLRHPNIVRFKEVI 85 (361)
T ss_dssp CCCTTTEEEEEEESSSTTSSEEEE---------EETTTCCEEEEEEEESSTTS-CHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CCCCCcEEEEEEeccCCCEEEEEE---------EECCCCcEEEEEEEecCccc-cHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 345689999999999999999999 66677999999998765432 35678999999999999999999999
Q ss_pred eecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCc--EEEcc
Q 018785 97 SESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFN--AKLSD 174 (350)
Q Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~--~~l~D 174 (350)
.+.+..++||||+.+++|.+++.... .+++..++.++.|++.||.||| +.|++|+||||+||+++.++. ++|+|
T Consensus 86 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~ql~~~L~~LH--~~~ivH~Dlkp~Nill~~~~~~~~kl~D 161 (361)
T 3uc3_A 86 LTPTHLAIIMEYASGGELYERICNAG--RFSEDEARFFFQQLLSGVSYCH--SMQICHRDLKLENTLLDGSPAPRLKICD 161 (361)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH--HTTCCSCCCCGGGEEECSSSSCCEEECC
T ss_pred eeCCEEEEEEEeCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEEcCCCCceEEEee
Confidence 99999999999999999999997765 6999999999999999999999 999999999999999987765 99999
Q ss_pred ccccccCCCCCCCcccccccCCCcccCccccccCCCCCc-cchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhh
Q 018785 175 FGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPK-SDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 253 (350)
Q Consensus 175 fg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~-~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 253 (350)
||++...... .......|++.|+|||++.+..++.+ +|||||||++|+|++|+.||.+............
T Consensus 162 fg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~------ 232 (361)
T 3uc3_A 162 FGYSKSSVLH---SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQ------ 232 (361)
T ss_dssp CCCC------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHH------
T ss_pred cCcccccccc---CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHH------
Confidence 9998742221 12233568999999999988887655 8999999999999999999986554322221111
Q ss_pred hhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018785 254 RDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL 304 (350)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 304 (350)
..............+++.+.+||.+||..||.+|||+.++++|=
T Consensus 233 -------~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp 276 (361)
T 3uc3_A 233 -------RILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHS 276 (361)
T ss_dssp -------HHHTTCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSH
T ss_pred -------HHhcCCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCc
Confidence 11111111122224678899999999999999999999999883
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-45 Score=334.50 Aligned_cols=268 Identities=29% Similarity=0.443 Sum_probs=208.5
Q ss_pred hhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccc-hhhHHHHHHHHHHHhccCCCcccceee
Q 018785 16 SKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES-FQGHKEWLTEVIYLGQLRHENLVKLIG 94 (350)
Q Consensus 16 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~ 94 (350)
.++..++|.+.+.||+|+||.||+|++. ....++..||||.+.... ......+.+|+.++++++||||+++++
T Consensus 40 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 113 (373)
T 2qol_A 40 KELDATNISIDKVVGAGEFGEVCSGRLK------LPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEG 113 (373)
T ss_dssp CBCCGGGCCCCEEEEECSSSEEEEC-CB------CTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred hhcCHhhceeeeEEeeCCCeEEEEEEEe------cCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 3455679999999999999999999654 223467889999997653 234567899999999999999999999
Q ss_pred EEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcc
Q 018785 95 YCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSD 174 (350)
Q Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~D 174 (350)
++.+.+..++||||+++++|.+++.... ..++...++.++.|++.||.||| +.|++|+||||+||+++.++.++|+|
T Consensus 114 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dlkp~NIll~~~~~~kl~D 190 (373)
T 2qol_A 114 VVTKSKPVMIVTEYMENGSLDSFLRKHD-AQFTVIQLVGMLRGIASGMKYLS--DMGYVHRDLAARNILINSNLVCKVSD 190 (373)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTTCCEEECC
T ss_pred EEeeCCceEEEEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH--HCCeeCCCCCcceEEEcCCCCEEECc
Confidence 9999999999999999999999997653 36899999999999999999999 89999999999999999999999999
Q ss_pred ccccccCCCCCCCc-ccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccccCcchhhhhhhcchh
Q 018785 175 FGLARDGPTGDNTH-VSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPF 252 (350)
Q Consensus 175 fg~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~ 252 (350)
||++.......... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.........
T Consensus 191 fg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~---------- 260 (373)
T 2qol_A 191 FGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI---------- 260 (373)
T ss_dssp C----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHH----------
T ss_pred CccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHH----------
Confidence 99997643322111 1112234667999999999999999999999999999998 99999765432111
Q ss_pred hhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcC
Q 018785 253 LRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 310 (350)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 310 (350)
..+........+..++..+.+++.+||+.||.+||++.++++.|+.+...
T Consensus 261 --------~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 261 --------KAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp --------HHHHTTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred --------HHHHcCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 11112222233456778999999999999999999999999999998765
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=332.99 Aligned_cols=254 Identities=24% Similarity=0.316 Sum_probs=207.6
Q ss_pred hhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch-----hhHHHHHHHHHHHhccCCCccccee
Q 018785 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-----QGHKEWLTEVIYLGQLRHENLVKLI 93 (350)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~ 93 (350)
..++|++.+.||+|+||+||+| .+..+++.||||++..... .....+.+|+.+++.++||||++++
T Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~---------~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~ 92 (351)
T 3c0i_A 22 FEDVYELCEVIGKGPFSVVRRC---------INRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELL 92 (351)
T ss_dssp HHHHEEEEEEEEECSSEEEEEE---------EETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccceEEeeEEeeCCCEEEEEE---------EECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEE
Confidence 4679999999999999999999 6666789999999865432 1356788999999999999999999
Q ss_pred eEEeecCceEEEEEcCCCCChhhHHhhc--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCc--
Q 018785 94 GYCSESDNRLLVYEFMPKGSLENHLFRK--GVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFN-- 169 (350)
Q Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~-- 169 (350)
+++.+.+..|+||||+++++|.+++... ....+++..++.++.|++.||.||| ++|++|+||||+||+++.++.
T Consensus 93 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH--~~~ivHrDlkp~NIl~~~~~~~~ 170 (351)
T 3c0i_A 93 ETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH--DNNIIHRDVKPHCVLLASKENSA 170 (351)
T ss_dssp EEEEETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECSSSTTC
T ss_pred EEEEeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH--HCCceeccCChHHeEEecCCCCC
Confidence 9999999999999999999999888653 2335899999999999999999999 899999999999999987655
Q ss_pred -EEEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhh
Q 018785 170 -AKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEW 248 (350)
Q Consensus 170 -~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~ 248 (350)
++|+|||++....... .......|++.|+|||++.+..++.++|||||||++|+|++|..||.+.... ....+
T Consensus 171 ~vkl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~i--- 244 (351)
T 3c0i_A 171 PVKLGGFGVAIQLGESG--LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKER-LFEGI--- 244 (351)
T ss_dssp CEEECCCTTCEECCTTS--CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHH-HHHHH---
T ss_pred cEEEecCcceeEecCCC--eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHH-HHHHH---
Confidence 9999999997643322 2223456899999999999999999999999999999999999999764311 00000
Q ss_pred cchhhhhhHHHHHhhhcccCC--CCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 249 ADPFLRDSRRVLRIMDTRLGG--QYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
....... .....+++++.+||.+||..||.+|||+.++++|
T Consensus 245 --------------~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 245 --------------IKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp --------------HHTCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred --------------HcCCCCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 1100000 0112457889999999999999999999999976
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=337.10 Aligned_cols=263 Identities=24% Similarity=0.348 Sum_probs=210.1
Q ss_pred hhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhh---HHHHHHHHHHHhcc-CCCcccc
Q 018785 16 SKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQG---HKEWLTEVIYLGQL-RHENLVK 91 (350)
Q Consensus 16 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~l-~h~~i~~ 91 (350)
..+..++|++.++||+|+||.||+| .+..+++.||+|++....... ...+..|..+++++ +||||++
T Consensus 47 ~~~~~~~y~~~~~LG~G~fG~V~~~---------~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~ 117 (396)
T 4dc2_A 47 SSLGLQDFDLLRVIGRGSYAKVLLV---------RLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 117 (396)
T ss_dssp --CCGGGEEEEEEEEECSSEEEEEE---------EETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCC
T ss_pred cCCChhHcEEEEEEeeCCCeEEEEE---------EECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCe
Confidence 3455679999999999999999999 556678999999997654322 23467888888877 8999999
Q ss_pred eeeEEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEE
Q 018785 92 LIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAK 171 (350)
Q Consensus 92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~ 171 (350)
+++++.+.+.+++||||+++++|.+++.... .+++..++.++.||+.||.||| +.||+||||||+||+++.++.++
T Consensus 118 l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH--~~givHrDLKp~NILl~~~g~ik 193 (396)
T 4dc2_A 118 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLH--ERGIIYRDLKLDNVLLDSEGHIK 193 (396)
T ss_dssp EEEEEECSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCCGGGEEECTTSCEE
T ss_pred eEEEEEECCEEEEEEEcCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCEEeccCCHHHEEECCCCCEE
Confidence 9999999999999999999999999998765 7999999999999999999999 89999999999999999999999
Q ss_pred EccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcch
Q 018785 172 LSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADP 251 (350)
Q Consensus 172 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~ 251 (350)
|+|||++....... .......||+.|+|||++.+..++.++|+|||||++|+|++|..||............
T Consensus 194 L~DFGla~~~~~~~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~------ 265 (396)
T 4dc2_A 194 LTDYGMCKEGLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN------ 265 (396)
T ss_dssp ECCCTTCBCCCCTT--CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------C------
T ss_pred EeecceeeecccCC--CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchh------
Confidence 99999997532222 2233467899999999999999999999999999999999999999653321110000
Q ss_pred hhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCH------HHHHHH
Q 018785 252 FLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSM------VDVLTS 303 (350)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~------~~ll~~ 303 (350)
........+.. .....+..+++++.+||.+||+.||.+||++ +++++|
T Consensus 266 --~~~~~~~~i~~--~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H 319 (396)
T 4dc2_A 266 --TEDYLFQVILE--KQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 319 (396)
T ss_dssp --CHHHHHHHHHH--CCCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred --hHHHHHHHHhc--cccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence 00000111111 1223456688899999999999999999985 678776
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=331.84 Aligned_cols=283 Identities=24% Similarity=0.344 Sum_probs=224.8
Q ss_pred hhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceeeEEe
Q 018785 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (350)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (350)
+..++|++.+.||+|+||.||+|++.. .+..++..||+|.+........+.+.+|+.++++++||||+++++++.
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 94 (327)
T 3lxl_A 20 FEERHLKYISQLGKGNFGSVELCRYDP-----LGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSY 94 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECT-----TSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred hchhhhhhhhhccCCCCeEEEEEEecc-----CCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEe
Confidence 446899999999999999999996532 356679999999998877666677899999999999999999999886
Q ss_pred --ecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccc
Q 018785 98 --ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDF 175 (350)
Q Consensus 98 --~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Df 175 (350)
.....++||||+++++|.+++.... ..+++..++.++.|++.||+||| +.|++|+||||+||+++.++.++|+||
T Consensus 95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH--~~~ivH~Dikp~NIl~~~~~~~kl~Df 171 (327)
T 3lxl_A 95 GPGRQSLRLVMEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLG--SRRCVHRDLAARNILVESEAHVKIADF 171 (327)
T ss_dssp CSSSCEEEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEEEETTEEEECCG
T ss_pred cCCCceEEEEEeecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHH--hCCccCCCCChhhEEECCCCCEEEccc
Confidence 4566899999999999999997643 25899999999999999999999 899999999999999999999999999
Q ss_pred cccccCCCCCCCc-ccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhh
Q 018785 176 GLARDGPTGDNTH-VSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLR 254 (350)
Q Consensus 176 g~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~ 254 (350)
|++.......... ......++..|+|||.+.+..++.++||||||+++|+|++|..||.............. ....
T Consensus 172 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~---~~~~ 248 (327)
T 3lxl_A 172 GLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCE---RDVP 248 (327)
T ss_dssp GGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC-------CC
T ss_pred ccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccc---cccc
Confidence 9998654333221 22234577789999999999999999999999999999999999865432211110000 1111
Q ss_pred hhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcCC
Q 018785 255 DSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSK 311 (350)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~ 311 (350)
.................+..+++.+.+|+.+||+.||.+|||+.+++++|+.+....
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 305 (327)
T 3lxl_A 249 ALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305 (327)
T ss_dssp HHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred cHHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 122333334444445556778899999999999999999999999999999987653
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-46 Score=335.54 Aligned_cols=253 Identities=25% Similarity=0.351 Sum_probs=211.0
Q ss_pred hhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh---hHHHHHHHHHHHhccCCCccccee
Q 018785 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ---GHKEWLTEVIYLGQLRHENLVKLI 93 (350)
Q Consensus 17 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~ 93 (350)
...-++|++.+.||+|+||.||+| .+..+++.||+|++...... ....+.+|+.+++.++||||++++
T Consensus 5 ~~~i~~Y~i~~~lG~G~~g~V~~a---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~ 75 (336)
T 3h4j_B 5 KRHIGPYIIRETLGEGSFGKVKLA---------THYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLY 75 (336)
T ss_dssp CSEETTEEEEEEEEEETTEEEEEE---------EETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEE
T ss_pred ccccCCEEEEEEEecCCCeEEEEE---------EECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 344579999999999999999999 66677899999998754322 235688999999999999999999
Q ss_pred eEEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEc
Q 018785 94 GYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLS 173 (350)
Q Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~ 173 (350)
+++...+..++||||+ +++|.+++.... .+++.+++.++.|++.||.||| +.|++|+||||+||+++.++.++|+
T Consensus 76 ~~~~~~~~~~lv~E~~-~g~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH--~~givH~Dlkp~NIll~~~~~~kl~ 150 (336)
T 3h4j_B 76 DVITTPTDIVMVIEYA-GGELFDYIVEKK--RMTEDEGRRFFQQIICAIEYCH--RHKIVHRDLKPENLLLDDNLNVKIA 150 (336)
T ss_dssp EEEECSSEEEEEECCC-CEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHH--HHTCCCCCCSTTTEEECTTCCEEEC
T ss_pred EEEEeCCEEEEEEECC-CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCeEecCCchhhEEEcCCCCEEEE
Confidence 9999999999999999 789999987765 7999999999999999999999 8999999999999999999999999
Q ss_pred cccccccCCCCCCCcccccccCCCcccCccccccCCC-CCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchh
Q 018785 174 DFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHL-TPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPF 252 (350)
Q Consensus 174 Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 252 (350)
|||++....... ......|++.|+|||++.+..+ +.++||||||+++|+|++|..||.+.........+..
T Consensus 151 DFG~s~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~----- 222 (336)
T 3h4j_B 151 DFGLSNIMTDGN---FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNS----- 222 (336)
T ss_dssp CSSCTBTTTTSB---TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCS-----
T ss_pred EeccceeccCCc---ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHc-----
Confidence 999997643322 2233568999999999988776 6899999999999999999999976543222211111
Q ss_pred hhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018785 253 LRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 305 (350)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~ 305 (350)
.....+..+++.+.+||.+||..||.+|||++++++|-.
T Consensus 223 --------------~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~ 261 (336)
T 3h4j_B 223 --------------CVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPW 261 (336)
T ss_dssp --------------SCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHH
T ss_pred --------------CCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChh
Confidence 011234457789999999999999999999999998743
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=325.45 Aligned_cols=281 Identities=28% Similarity=0.378 Sum_probs=221.9
Q ss_pred hhhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch-hhHHHHHHHHHHHhccCCCccccee
Q 018785 15 ISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLVKLI 93 (350)
Q Consensus 15 ~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~ 93 (350)
......++|++.+.||+|+||.||+|++.. .+..+++.||+|.+..... .....+.+|+.+++.++||||++++
T Consensus 15 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 89 (302)
T 4e5w_A 15 PTHFEKRFLKRIRDLGEGHFGKVELCRYDP-----EGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYK 89 (302)
T ss_dssp TTBCCGGGEEEEEEEEECSSEEEEEEEECT-----TSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred hhhhhhhhhhhhhccCCCCceEEEEEEEcc-----ccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeee
Confidence 445557889999999999999999996542 3566799999999875532 3346788999999999999999999
Q ss_pred eEEeec--CceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEE
Q 018785 94 GYCSES--DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAK 171 (350)
Q Consensus 94 ~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~ 171 (350)
+++... +..++||||+++++|.+++.... ..++...++.++.|++.||+||| +.|++|+||+|+||+++.++.++
T Consensus 90 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dikp~Nil~~~~~~~k 166 (302)
T 4e5w_A 90 GICTEDGGNGIKLIMEFLPSGSLKEYLPKNK-NKINLKQQLKYAVQICKGMDYLG--SRQYVHRDLAARNVLVESEHQVK 166 (302)
T ss_dssp EEEEC---CCEEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEEEETTEEE
T ss_pred eEEecCCCceEEEEEEeCCCCcHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHhh--cCCcccCCCchheEEEcCCCCEE
Confidence 999876 67899999999999999996554 36999999999999999999999 89999999999999999999999
Q ss_pred EccccccccCCCCCCC-cccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhc-
Q 018785 172 LSDFGLARDGPTGDNT-HVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWA- 249 (350)
Q Consensus 172 l~Dfg~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~- 249 (350)
|+|||++......... .......++..|+|||.+.+..++.++|+||||+++|+|++|..|+...... .....
T Consensus 167 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~~~ 241 (302)
T 4e5w_A 167 IGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMAL-----FLKMIG 241 (302)
T ss_dssp ECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH-----HHHHHC
T ss_pred ECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhH-----HhhccC
Confidence 9999999765443322 1223355777899999999999999999999999999999999986533211 00000
Q ss_pred -chhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 018785 250 -DPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLH 308 (350)
Q Consensus 250 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 308 (350)
......................+..+++.+.+|+.+||+.||.+|||+.++++.|+.+.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 242 PTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp SCCGGGHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CcccccCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 01111222333334444445566778899999999999999999999999999999874
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-45 Score=322.17 Aligned_cols=262 Identities=31% Similarity=0.546 Sum_probs=212.4
Q ss_pred chhhhhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhh-------HHHHHHHHHHHhcc
Q 018785 12 ASMISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQG-------HKEWLTEVIYLGQL 84 (350)
Q Consensus 12 ~~~~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~-------~~~~~~e~~~l~~l 84 (350)
...+..+..++|++.+.||+|+||+||+| .+..+++.||+|.+....... ...+.+|+.+++.+
T Consensus 10 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 80 (287)
T 4f0f_A 10 KSRLPTLADNEIEYEKQIGKGGFGLVHKG---------RLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL 80 (287)
T ss_dssp --CCCBCCSTTEEEEEECCCCSSSCEEEE---------EETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTC
T ss_pred chhhhhhhhccceehhccccCCceeEEEE---------EEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhC
Confidence 34456677899999999999999999999 555678999999986543221 15688999999999
Q ss_pred CCCcccceeeEEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC--eeeCCCCCCce
Q 018785 85 RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDAN--VIYRDLKASNV 162 (350)
Q Consensus 85 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~--i~H~di~~~Ni 162 (350)
+||||+++++++.+.. ++||||+++++|.+++.... ..+++..++.++.|++.||.||| +.| ++|+||||+||
T Consensus 81 ~h~~i~~~~~~~~~~~--~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH--~~~~~ivH~dikp~Ni 155 (287)
T 4f0f_A 81 NHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKA-HPIKWSVKLRLMLDIALGIEYMQ--NQNPPIVHRDLRSPNI 155 (287)
T ss_dssp CCTTBCCEEEEETTTT--EEEEECCTTCBHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHH--TSSSCCBCSCCSGGGE
T ss_pred CCCCchhhheeecCCC--eEEEEecCCCCHHHHHhccc-CCccHHHHHHHHHHHHHHHHHHH--hCCCCeecCCCCcceE
Confidence 9999999999987654 79999999999999886554 37999999999999999999999 889 99999999999
Q ss_pred EEcCCCc-----EEEccccccccCCCCCCCcccccccCCCcccCccccc--cCCCCCccchhhHHHHHHHHHhCCCCCcc
Q 018785 163 LLDSNFN-----AKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVA--TGHLTPKSDVYSFGVVLLELLSGRRALDE 235 (350)
Q Consensus 163 li~~~~~-----~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~--~~~~~~~~DiwslG~ll~~ll~g~~pf~~ 235 (350)
+++.++. ++|+|||++..... ......+++.|+|||.+. +..++.++||||||+++|+|++|..||..
T Consensus 156 l~~~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 230 (287)
T 4f0f_A 156 FLQSLDENAPVCAKVADFGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDE 230 (287)
T ss_dssp EESCCCTTCSCCEEECCCTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred EEeccCCCCceeEEeCCCCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCcc
Confidence 9988776 99999999974222 233356899999999983 45678899999999999999999999976
Q ss_pred cccCcchhhhhhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 018785 236 DRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 307 (350)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~ 307 (350)
....... ..............+..+++.+.+++.+||+.||.+|||+.++++.|+++
T Consensus 231 ~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 231 YSYGKIK---------------FINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp CCCCHHH---------------HHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred ccccHHH---------------HHHHHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 5432110 11112222333445667788999999999999999999999999999864
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-45 Score=321.93 Aligned_cols=265 Identities=24% Similarity=0.357 Sum_probs=206.0
Q ss_pred hhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch-hhHHHHHHHHHHHhccCCCcccceee
Q 018785 16 SKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLVKLIG 94 (350)
Q Consensus 16 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~ 94 (350)
.++..++|++.+.||+|+||.||+|++. .....+..|++|.+..... ...+.+.+|+..+++++||||+++++
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 83 (281)
T 1mp8_A 10 YEIQRERIELGRCIGEGQFGDVHQGIYM------SPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIG 83 (281)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEEC------CC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred eEEehHHeEEEeEeeecCCeeEEEEEEe------cCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEE
Confidence 4566889999999999999999999654 2233567899999876432 33466889999999999999999999
Q ss_pred EEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcc
Q 018785 95 YCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSD 174 (350)
Q Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~D 174 (350)
++. ++..++||||+.+++|.+++.... ..+++..++.++.|++.||.||| +.|++|+||||+||+++.++.++|+|
T Consensus 84 ~~~-~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dlkp~Nil~~~~~~~kl~D 159 (281)
T 1mp8_A 84 VIT-ENPVWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLE--SKRFVHRDIAARNVLVSSNDCVKLGD 159 (281)
T ss_dssp EEC-SSSCEEEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEEEETTEEEECC
T ss_pred EEc-cCccEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH--hCCeecccccHHHEEECCCCCEEECc
Confidence 985 567899999999999999997654 36899999999999999999999 89999999999999999999999999
Q ss_pred ccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccccCcchhhhhhhcchhh
Q 018785 175 FGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFL 253 (350)
Q Consensus 175 fg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~ 253 (350)
||++........ .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+.........+.
T Consensus 160 fg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~------- 231 (281)
T 1mp8_A 160 FGLSRYMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE------- 231 (281)
T ss_dssp --------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-------
T ss_pred cccccccCcccc-cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHH-------
Confidence 999976433221 11222345678999999998999999999999999999996 899997654332221111
Q ss_pred hhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhc
Q 018785 254 RDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHT 309 (350)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 309 (350)
.......+..+++.+.+++.+||..||.+|||+.+++++|+++..
T Consensus 232 -----------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 276 (281)
T 1mp8_A 232 -----------NGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 276 (281)
T ss_dssp -----------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----------cCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 111223455678899999999999999999999999999998764
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-45 Score=324.09 Aligned_cols=273 Identities=17% Similarity=0.190 Sum_probs=219.9
Q ss_pred hhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhcc-CCCcccceee
Q 018785 16 SKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQL-RHENLVKLIG 94 (350)
Q Consensus 16 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~ 94 (350)
.++.+++|++.+.||+|++|.||+| .+..+++.||+|++.... ....+.+|+..++.+ +|++++++++
T Consensus 5 ~~~~~~~y~~~~~lg~G~~g~V~~~---------~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~ 73 (298)
T 1csn_A 5 NNVVGVHYKVGRRIGEGSFGVIFEG---------TNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYY 73 (298)
T ss_dssp -CEETTTEEEEEEEEECSSCEEEEE---------EETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEE
T ss_pred CcccccceEEEEEEeecCCEEEEEE---------EECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEe
Confidence 4566889999999999999999999 556678999999986543 234567899999999 7999999999
Q ss_pred EEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCc-----
Q 018785 95 YCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFN----- 169 (350)
Q Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~----- 169 (350)
++......++|||++ +++|.+++.... ..+++..+..++.|++.||.||| +.|++|+||||+||+++.++.
T Consensus 74 ~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH--~~~ivH~Dlkp~NIl~~~~~~~~~~~ 149 (298)
T 1csn_A 74 FGQEGLHNVLVIDLL-GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIH--EKSLVYRDIKPDNFLIGRPNSKNANM 149 (298)
T ss_dssp EEEETTEEEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHH--TTTEECCCCCGGGEEECCSSSTTTTC
T ss_pred ecCCCceeEEEEEec-CCCHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHH--hCCEecCCCCHHHEEeccCCCCCCCe
Confidence 999999999999999 999999998654 36999999999999999999999 999999999999999987766
Q ss_pred EEEccccccccCCCCCCC-----cccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhh
Q 018785 170 AKLSDFGLARDGPTGDNT-----HVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQT 244 (350)
Q Consensus 170 ~~l~Dfg~~~~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~ 244 (350)
++|+|||++......... .......|++.|+|||.+.+..++.++||||||+++|+|++|+.||.+.........
T Consensus 150 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 229 (298)
T 1csn_A 150 IYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQK 229 (298)
T ss_dssp EEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHH
T ss_pred EEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHH
Confidence 999999999765433221 112345689999999999999999999999999999999999999987554333222
Q ss_pred hhhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcCCCCC
Q 018785 245 LVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDMP 314 (350)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~~ 314 (350)
+........ ..........+++++.+++.+||+.||.+|||++++++.|+++.......
T Consensus 230 ~~~~~~~~~-----------~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~ 288 (298)
T 1csn_A 230 YERIGEKKQ-----------STPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTT 288 (298)
T ss_dssp HHHHHHHHH-----------HSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred HHHHHhhcc-----------CccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCC
Confidence 221110000 00000112246789999999999999999999999999999998875544
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-45 Score=332.13 Aligned_cols=248 Identities=25% Similarity=0.332 Sum_probs=211.6
Q ss_pred hhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch---hhHHHHHHHHHHHhccCCCcccceeeE
Q 018785 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLVKLIGY 95 (350)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~ 95 (350)
..++|++.+.||+|+||.||+| .+..+|+.||+|++..... .....+.+|+.+++.++||||++++++
T Consensus 39 ~~~~y~~~~~lG~G~~g~V~~~---------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 109 (350)
T 1rdq_E 39 QLDQFDRIKTLGTGSFGRVMLV---------KHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 109 (350)
T ss_dssp CGGGEEEEEEEEECSSCEEEEE---------EETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred CHHHCEEEEEeecCcCcEEEEE---------EECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 4579999999999999999999 5666789999999876532 344678889999999999999999999
Q ss_pred EeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccc
Q 018785 96 CSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDF 175 (350)
Q Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Df 175 (350)
+.+.+..|+||||+++++|.+++.... .+++..++.++.|++.||.||| +.|++|+||||+||+++.++.++|+||
T Consensus 110 ~~~~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH--~~~ivHrDlkp~NIll~~~g~~kL~DF 185 (350)
T 1rdq_E 110 FKDNSNLYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLH--SLDLIYRDLKPENLLIDQQGYIQVTDF 185 (350)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTSCEEECCC
T ss_pred EEcCCEEEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCcccccCccceEEECCCCCEEEccc
Confidence 999999999999999999999998765 6999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhh
Q 018785 176 GLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRD 255 (350)
Q Consensus 176 g~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 255 (350)
|++...... .....|++.|+|||++.+..++.++|+|||||++|+|++|..||.+.........+.
T Consensus 186 g~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~--------- 251 (350)
T 1rdq_E 186 GFAKRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIV--------- 251 (350)
T ss_dssp TTCEECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH---------
T ss_pred ccceeccCC-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHH---------
Confidence 999764322 223568999999999999999999999999999999999999997654322211111
Q ss_pred hHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 018785 256 SRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPS-----MVDVLTS 303 (350)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-----~~~ll~~ 303 (350)
... ...+..+++++.+||.+||+.||.+||+ ++++++|
T Consensus 252 --------~~~--~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 252 --------SGK--VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp --------HCC--CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred --------cCC--CCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 111 2234567889999999999999999998 8999876
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-45 Score=326.53 Aligned_cols=273 Identities=23% Similarity=0.282 Sum_probs=208.9
Q ss_pred hhhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh--hHHHHHHHHHHHhccCCCcccce
Q 018785 15 ISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ--GHKEWLTEVIYLGQLRHENLVKL 92 (350)
Q Consensus 15 ~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~ 92 (350)
..+...++|++.+.||+|+||+||+|+. .+|+.||+|.+...... ....+.+|+.+++.++||||+++
T Consensus 15 ~~q~l~~~y~~~~~lG~G~~g~V~~~~~----------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~ 84 (311)
T 3niz_A 15 YFQGLMEKYQKLEKVGEGTYGVVYKAKD----------SQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSL 84 (311)
T ss_dssp CEECSSCEEEEEEEEEECSSCEEEEEEE----------TTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred eecchHhhhHhhhhccCCCCeEEEEEEE----------CCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeee
Confidence 4455678999999999999999999943 23789999998755322 23567899999999999999999
Q ss_pred eeEEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEE
Q 018785 93 IGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKL 172 (350)
Q Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l 172 (350)
++++.+.+..++||||+. ++|.+++.... ..+++..++.++.|++.||.||| +.|++|+||||+||+++.++.++|
T Consensus 85 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH--~~~ivH~Dikp~NIl~~~~~~~kl 160 (311)
T 3niz_A 85 IDVIHSERCLTLVFEFME-KDLKKVLDENK-TGLQDSQIKIYLYQLLRGVAHCH--QHRILHRDLKPQNLLINSDGALKL 160 (311)
T ss_dssp EEEECCSSCEEEEEECCS-EEHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTCCEEE
T ss_pred eeEEccCCEEEEEEcCCC-CCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCchHhEEECCCCCEEE
Confidence 999999999999999996 58888887654 36999999999999999999999 899999999999999999999999
Q ss_pred ccccccccCCCCCCCcccccccCCCcccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcch
Q 018785 173 SDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADP 251 (350)
Q Consensus 173 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~ 251 (350)
+|||++....... .......+++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+......
T Consensus 161 ~Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~ 238 (311)
T 3niz_A 161 ADFGLARAFGIPV--RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGT 238 (311)
T ss_dssp CCCTTCEETTSCC--C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCC
T ss_pred ccCcCceecCCCc--ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCC
Confidence 9999997643222 22233567899999999876 56899999999999999999999999877665554444332111
Q ss_pred hh----hhhHHHHHhhhcc---cC----CCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 252 FL----RDSRRVLRIMDTR---LG----GQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 252 ~~----~~~~~~~~~~~~~---~~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
.. ............. .. ......+++++.+||.+||+.||.+|||++++++|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 239 PNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp CCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 00 0000000000000 00 00122356789999999999999999999999975
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-45 Score=327.39 Aligned_cols=272 Identities=19% Similarity=0.218 Sum_probs=218.9
Q ss_pred hhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhcc-CCCcccceeeEE
Q 018785 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQL-RHENLVKLIGYC 96 (350)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~ 96 (350)
+.+++|++.+.||+|+||+||+| .+..+++.||||++..... ...+..|+.+++.+ +||||+++++++
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~---------~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~ 74 (330)
T 2izr_A 6 MVGPNFRVGKKIGCGNFGELRLG---------KNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFG 74 (330)
T ss_dssp EETTTEEEEEECCC-CTTSEEEE---------EETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEE
T ss_pred EEcCCeEEEEEeeccCCceEEEE---------EECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEE
Confidence 35789999999999999999999 5666799999999875532 23577899999999 899999999999
Q ss_pred eecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCc-----EE
Q 018785 97 SESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFN-----AK 171 (350)
Q Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~-----~~ 171 (350)
...+..++|||++ +++|.+++.... ..+++..++.++.|++.||+||| +.|++|+||||+||+++.++. ++
T Consensus 75 ~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH--~~~iiHrDlkp~Nill~~~~~~~~~~~k 150 (330)
T 2izr_A 75 PCGKYNAMVLELL-GPSLEDLFDLCD-RTFSLKTVLMIAIQLISRMEYVH--SKNLIYRDVKPENFLIGRPGNKTQQVIH 150 (330)
T ss_dssp EETTEEEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECCGGGTCTTSEE
T ss_pred ecCCccEEEEEeC-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHH--hCCeeccCCCHHHeeeccCCCCCCceEE
Confidence 9999999999999 999999998653 37999999999999999999999 899999999999999998887 99
Q ss_pred EccccccccCCCCCCCc-----ccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhh
Q 018785 172 LSDFGLARDGPTGDNTH-----VSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLV 246 (350)
Q Consensus 172 l~Dfg~~~~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~ 246 (350)
|+|||++.......... ......|++.|+|||.+.+..++.++||||||+++|+|++|..||.+.........+.
T Consensus 151 l~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~ 230 (330)
T 2izr_A 151 IIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQ 230 (330)
T ss_dssp ECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHH
T ss_pred EEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHH
Confidence 99999997643332211 1234678999999999999999999999999999999999999998765443332222
Q ss_pred hhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcCCCCCCC
Q 018785 247 EWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDMPRT 316 (350)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~~~~ 316 (350)
.......... ........+ ++.+++.+||..||.+||++.++++.|+++.........
T Consensus 231 ~i~~~~~~~~-----------~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~~~ 288 (330)
T 2izr_A 231 KIGDTKRATP-----------IEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMFD 288 (330)
T ss_dssp HHHHHHHHSC-----------HHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCCS
T ss_pred HHHhhhccCC-----------HHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCCCC
Confidence 2111000000 000011234 899999999999999999999999999999887655533
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-45 Score=334.56 Aligned_cols=257 Identities=23% Similarity=0.328 Sum_probs=213.0
Q ss_pred hhhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch---hhHHHHHHHHHHHhccCCCcccc
Q 018785 15 ISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLVK 91 (350)
Q Consensus 15 ~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~ 91 (350)
-.++..++|++.+.||+|+||.||+| .+..+++.||+|++..... .....+.+|+.+++.++||||++
T Consensus 9 ~~~v~~~~y~i~~~LG~G~fG~V~~~---------~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~ 79 (384)
T 4fr4_A 9 NEDVNFDHFEILRAIGKGSFGKVCIV---------QKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVN 79 (384)
T ss_dssp CCCCCGGGEEEEEEEECCTTCCEEEE---------EETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCC
T ss_pred CCCCChHHeEEEEEEeeCCCeEEEEE---------EECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCc
Confidence 34566789999999999999999999 5666789999999875432 33467889999999999999999
Q ss_pred eeeEEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEE
Q 018785 92 LIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAK 171 (350)
Q Consensus 92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~ 171 (350)
+++++.+.+..|+||||+.|++|.+++.... .+++..++.++.|++.||.||| +.|++|+||||+||+++.++.++
T Consensus 80 l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH--~~givHrDlkp~NIll~~~g~vk 155 (384)
T 4fr4_A 80 LWYSFQDEEDMFMVVDLLLGGDLRYHLQQNV--HFKEETVKLFICELVMALDYLQ--NQRIIHRDMKPDNILLDEHGHVH 155 (384)
T ss_dssp EEEEEECSSEEEEEECCCTTEEHHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTSCEE
T ss_pred EEEEEEeCCEEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--HCCceeccCcHHHeEECCCCCEE
Confidence 9999999999999999999999999998764 7999999999999999999999 89999999999999999999999
Q ss_pred EccccccccCCCCCCCcccccccCCCcccCcccccc---CCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhh
Q 018785 172 LSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT---GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEW 248 (350)
Q Consensus 172 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~---~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~ 248 (350)
|+|||++....... ......|++.|+|||++.+ ..++.++|+|||||++|+|++|..||..............
T Consensus 156 L~DFG~a~~~~~~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~- 231 (384)
T 4fr4_A 156 ITDFNIAAMLPRET---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHT- 231 (384)
T ss_dssp ECCCTTCEECCTTC---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHH-
T ss_pred EeccceeeeccCCC---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHH-
Confidence 99999997643322 2334578999999999864 4689999999999999999999999975543222111111
Q ss_pred cchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCC-HHHHHHH
Q 018785 249 ADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPS-MVDVLTS 303 (350)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-~~~ll~~ 303 (350)
+. ......+..+++.+.+||.+||+.||.+||+ ++++++|
T Consensus 232 -------------~~--~~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~h 272 (384)
T 4fr4_A 232 -------------FE--TTVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNF 272 (384)
T ss_dssp -------------HH--HCCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTS
T ss_pred -------------Hh--hcccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcC
Confidence 00 1112345567889999999999999999998 7777764
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-45 Score=334.77 Aligned_cols=254 Identities=21% Similarity=0.303 Sum_probs=212.4
Q ss_pred hhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceeeEEeec
Q 018785 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (350)
Q Consensus 20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (350)
.++|++.+.||+|+||.||+| .+..+|+.||+|.+..........+.+|+.+++.++||||+++++++.+.
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~---------~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~ 120 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRC---------VEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDK 120 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEE---------EETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECS
T ss_pred ccceEEEEEEecCCCEEEEEE---------EECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeC
Confidence 468999999999999999999 56667899999999877655667789999999999999999999999999
Q ss_pred CceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcC--CCcEEEccccc
Q 018785 100 DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS--NFNAKLSDFGL 177 (350)
Q Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~--~~~~~l~Dfg~ 177 (350)
+..++||||+.+++|.+++.... ..+++..++.++.|++.||.||| +.|++|+||||+||+++. ++.++|+|||+
T Consensus 121 ~~~~lv~E~~~gg~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH--~~givHrDlkp~NIll~~~~~~~vkL~DFG~ 197 (387)
T 1kob_A 121 YEMVLILEFLSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMH--EHSIVHLDIKPENIMCETKKASSVKIIDFGL 197 (387)
T ss_dssp SEEEEEEECCCCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEESSTTCCCEEECCCTT
T ss_pred CEEEEEEEcCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHH--hCCeeecccchHHeEEecCCCCceEEEeccc
Confidence 99999999999999999987543 36899999999999999999999 899999999999999974 46799999999
Q ss_pred cccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhH
Q 018785 178 ARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSR 257 (350)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 257 (350)
+....... ......+++.|+|||++.+..++.++|||||||++|+|++|..||.+.........+..
T Consensus 198 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~---------- 264 (387)
T 1kob_A 198 ATKLNPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKR---------- 264 (387)
T ss_dssp CEECCTTS---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHH----------
T ss_pred ceecCCCc---ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHh----------
Confidence 98643322 22335689999999999999999999999999999999999999976543221111111
Q ss_pred HHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 258 RVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
............+++++.+||.+||..||.+|||+.++++|
T Consensus 265 -----~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 265 -----CDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp -----CCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred -----CCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 01111222334678899999999999999999999999986
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-45 Score=330.37 Aligned_cols=274 Identities=27% Similarity=0.379 Sum_probs=220.9
Q ss_pred hhhhhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch-hhHHHHHHHHHHHhcc-CCCccc
Q 018785 13 SMISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQL-RHENLV 90 (350)
Q Consensus 13 ~~~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~ 90 (350)
....+...++|++.+.||+|+||.||+|+.... ........||+|.+..... .....+.+|+.+++.+ +||||+
T Consensus 38 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv 113 (333)
T 2i1m_A 38 NEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGL----GKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113 (333)
T ss_dssp CGGGBCCTTSEEEEEEEEECSSEEEEEEEETTC----SSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred cccccCCHHHceeeeEeccCCCcceEEEEecCC----CcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCee
Confidence 335666788999999999999999999965432 1233456899999876543 3446688999999999 899999
Q ss_pred ceeeEEeecCceEEEEEcCCCCChhhHHhhcC------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCC
Q 018785 91 KLIGYCSESDNRLLVYEFMPKGSLENHLFRKG------------VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLK 158 (350)
Q Consensus 91 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~ 158 (350)
++++++...+..++||||+++++|.+++.... ...++...++.++.|++.||.||| +.|++|+||+
T Consensus 114 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~Dlk 191 (333)
T 2i1m_A 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA--SKNCIHRDVA 191 (333)
T ss_dssp CEEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCS
T ss_pred eEEEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh--cCCcccCCcc
Confidence 99999999999999999999999999997542 236899999999999999999999 8999999999
Q ss_pred CCceEEcCCCcEEEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccc
Q 018785 159 ASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDR 237 (350)
Q Consensus 159 ~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~ 237 (350)
|+||+++.++.++|+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+..
T Consensus 192 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 271 (333)
T 2i1m_A 192 ARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGIL 271 (333)
T ss_dssp GGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred cceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccc
Confidence 9999999999999999999975433333222333456778999999999999999999999999999998 889997654
Q ss_pred cCcchhhhhhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhc
Q 018785 238 GGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHT 309 (350)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 309 (350)
..... ............+..+++.+.+++.+||+.||.+|||+.+++++|+++..
T Consensus 272 ~~~~~-----------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~ 326 (333)
T 2i1m_A 272 VNSKF-----------------YKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ 326 (333)
T ss_dssp SSHHH-----------------HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhHHH-----------------HHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHH
Confidence 32211 11112222223345567889999999999999999999999999998764
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-45 Score=332.18 Aligned_cols=253 Identities=27% Similarity=0.412 Sum_probs=210.7
Q ss_pred hhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch---hhHHHHHHHHHHHhcc-CCCcccce
Q 018785 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQL-RHENLVKL 92 (350)
Q Consensus 17 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l-~h~~i~~~ 92 (350)
.+..++|++.+.||+|+||.||+| .+..+++.||+|++..... .....+..|..++..+ .||+|+++
T Consensus 16 ~~~~~~y~~~~~lG~G~fg~V~~~---------~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l 86 (353)
T 2i0e_A 16 RMKLTDFNFLMVLGKGSFGKVMLS---------ERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 86 (353)
T ss_dssp ---CTTEEEEEEEEEETTEEEEEE---------EETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCE
T ss_pred CCchHHcEEEEEEeeCCCEEEEEE---------EECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeE
Confidence 455689999999999999999999 5566789999999876532 3346678899999888 79999999
Q ss_pred eeEEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEE
Q 018785 93 IGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKL 172 (350)
Q Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l 172 (350)
++++.+.+..|+||||++|++|.+++.... .+++..++.++.|++.||.||| +.|++||||||+||+++.++.++|
T Consensus 87 ~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH--~~givHrDlkp~NIll~~~g~vkL 162 (353)
T 2i0e_A 87 HSCFQTMDRLYFVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQ--SKGIIYRDLKLDNVMLDSEGHIKI 162 (353)
T ss_dssp EEEEECSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCCGGGEEECTTSCEEE
T ss_pred EEEEEcCCEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--HCCEEeccCCHHHEEEcCCCcEEE
Confidence 999999999999999999999999998765 6999999999999999999999 899999999999999999999999
Q ss_pred ccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchh
Q 018785 173 SDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPF 252 (350)
Q Consensus 173 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 252 (350)
+|||++....... .......|++.|+|||++.+..++.++|+|||||++|+|++|..||.+.........+.
T Consensus 163 ~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~------ 234 (353)
T 2i0e_A 163 ADFGMCKENIWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM------ 234 (353)
T ss_dssp CCCTTCBCCCCTT--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------
T ss_pred EeCCcccccccCC--cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHH------
Confidence 9999997532222 22334578999999999999999999999999999999999999997654322221111
Q ss_pred hhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 018785 253 LRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPS-----MVDVLTS 303 (350)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-----~~~ll~~ 303 (350)
.. ....+..+++++.+||.+||..||.+||+ ++++++|
T Consensus 235 -----------~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 235 -----------EH--NVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp -----------HC--CCCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred -----------hC--CCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 11 12345567889999999999999999995 5888876
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=330.59 Aligned_cols=269 Identities=24% Similarity=0.387 Sum_probs=211.6
Q ss_pred hhhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch-hhHHHHHHHHHHHhccCCCccccee
Q 018785 15 ISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLVKLI 93 (350)
Q Consensus 15 ~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~ 93 (350)
...+..++|++.+.||+|+||+||+|++... ...-..+|++|.+..... .....+.+|+.++++++||||++++
T Consensus 9 ~~~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 83 (327)
T 3poz_A 9 LRILKETEFKKIKVLGSGAFGTVYKGLWIPE-----GEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLL 83 (327)
T ss_dssp SEECCGGGEEEEEEEEEETTEEEEEEEECC---------CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEE
T ss_pred HhhcCHHHcccceEEeeCCCeEEEEEEEcCC-----CceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEE
Confidence 4445678999999999999999999964321 111233568888764432 3456788999999999999999999
Q ss_pred eEEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEc
Q 018785 94 GYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLS 173 (350)
Q Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~ 173 (350)
+++..+ ..++|++++.+++|.+++.... ..++...++.++.|++.||.||| +.|++|+||||+||+++.++.++|+
T Consensus 84 ~~~~~~-~~~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH--~~~ivH~Dikp~NIll~~~~~~kl~ 159 (327)
T 3poz_A 84 GICLTS-TVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKIT 159 (327)
T ss_dssp EEEESS-SEEEEEECCTTCBHHHHHHHST-TSCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEEEETTEEEEC
T ss_pred EEEecC-CeEEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHh--hCCeeCCCCChheEEECCCCCEEEc
Confidence 999875 4789999999999999998754 36999999999999999999999 8999999999999999999999999
Q ss_pred cccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccccCcchhhhhhhcchh
Q 018785 174 DFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPF 252 (350)
Q Consensus 174 Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~ 252 (350)
|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||.+........
T Consensus 160 Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~--------- 230 (327)
T 3poz_A 160 DFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS--------- 230 (327)
T ss_dssp CTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH---------
T ss_pred cCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHH---------
Confidence 9999976544433333333456778999999999999999999999999999999 999997655322221
Q ss_pred hhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcC
Q 018785 253 LRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 310 (350)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 310 (350)
.+........+..++..+.+++.+||+.||.+|||+.+++++|+.+...
T Consensus 231 ---------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 231 ---------ILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp ---------HHHTTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred ---------HHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 1222222334556778999999999999999999999999999988654
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-45 Score=328.47 Aligned_cols=257 Identities=25% Similarity=0.357 Sum_probs=204.4
Q ss_pred hhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch----hhHHHHHHHHHHHhccCCCcccc
Q 018785 16 SKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF----QGHKEWLTEVIYLGQLRHENLVK 91 (350)
Q Consensus 16 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~ 91 (350)
.++..++|++.+.||+|+||.||+|+.. .+..+++.||+|++..... .....+.+|+.+++.++||||++
T Consensus 12 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~ 85 (327)
T 3a62_A 12 EKIRPECFELLRVLGKGGYGKVFQVRKV------TGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVD 85 (327)
T ss_dssp -CCCGGGEEEEEEEEEETTEEEEEEEEC------SSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCC
T ss_pred CCCCHHHeEEEEEEEeCCCEEEEEEEEe------ccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccc
Confidence 3456789999999999999999999543 2345789999999876532 23355778999999999999999
Q ss_pred eeeEEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEE
Q 018785 92 LIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAK 171 (350)
Q Consensus 92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~ 171 (350)
+++++...+..++||||+++++|.+++.... .+++..+..++.|++.||.||| +.|++|+||||+||+++.++.++
T Consensus 86 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH--~~~ivH~Dlkp~Nill~~~~~~k 161 (327)
T 3a62_A 86 LIYAFQTGGKLYLILEYLSGGELFMQLEREG--IFMEDTACFYLAEISMALGHLH--QKGIIYRDLKPENIMLNHQGHVK 161 (327)
T ss_dssp EEEEEECSSCEEEEEECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCTTTEEECTTSCEE
T ss_pred eeEEEEcCCEEEEEEeCCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHH--hCCEEcccCCHHHeEECCCCcEE
Confidence 9999999999999999999999999998765 6899999999999999999999 89999999999999999999999
Q ss_pred EccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcch
Q 018785 172 LSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADP 251 (350)
Q Consensus 172 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~ 251 (350)
|+|||++....... .......|++.|+|||++.+..++.++|+||||+++|+|++|..||.+.........+.
T Consensus 162 l~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~----- 234 (327)
T 3a62_A 162 LTDFGLCKESIHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKIL----- 234 (327)
T ss_dssp ECCCSCC------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH-----
T ss_pred EEeCCcccccccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHH-----
Confidence 99999987532221 12233568999999999999999999999999999999999999997654322111111
Q ss_pred hhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 018785 252 FLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRP-----SMVDVLTS 303 (350)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~~ 303 (350)
.. ....+..+++++.+||.+||..||.+|| ++.++++|
T Consensus 235 ------------~~--~~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 235 ------------KC--KLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp ------------HT--CCCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred ------------hC--CCCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 11 1233456788999999999999999999 78899886
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-45 Score=329.04 Aligned_cols=260 Identities=24% Similarity=0.354 Sum_probs=210.4
Q ss_pred hhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch---hhHHHHHHHHHHHhcc-CCCccccee
Q 018785 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQL-RHENLVKLI 93 (350)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l-~h~~i~~~~ 93 (350)
+..++|++.+.||+|+||.||+| .+..+++.||+|++..... .....+..|..+++++ +||||++++
T Consensus 6 ~~~~~y~~~~~lG~G~fg~V~~~---------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~ 76 (345)
T 3a8x_A 6 LGLQDFDLLRVIGRGSYAKVLLV---------RLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 76 (345)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEE---------EETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEE
T ss_pred CchhheEEEEEEEecCCeEEEEE---------EECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEE
Confidence 45679999999999999999999 5566789999999976532 2345678899999887 899999999
Q ss_pred eEEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEc
Q 018785 94 GYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLS 173 (350)
Q Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~ 173 (350)
+++.+.+..|+||||+++++|.+++.... .+++..++.++.|++.||.||| +.|++|+||||+||+++.++.++|+
T Consensus 77 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH--~~~ivHrDlkp~NIll~~~g~~kL~ 152 (345)
T 3a8x_A 77 SCFQTESRLFFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLH--ERGIIYRDLKLDNVLLDSEGHIKLT 152 (345)
T ss_dssp EEEECSSEEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCCGGGEEECTTSCEEEC
T ss_pred EEEEeCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCceecCCCHHHEEECCCCCEEEE
Confidence 99999999999999999999999998764 6999999999999999999999 8999999999999999999999999
Q ss_pred cccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhh
Q 018785 174 DFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 253 (350)
Q Consensus 174 Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 253 (350)
|||++....... .......|++.|+|||++.+..++.++|+|||||++|+|++|..||.......... .
T Consensus 153 DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~---------~ 221 (345)
T 3a8x_A 153 DYGMCKEGLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD---------Q 221 (345)
T ss_dssp CGGGCBCSCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC---------------
T ss_pred eccccccccCCC--CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccc---------c
Confidence 999997532222 22334578999999999999999999999999999999999999996532211000 0
Q ss_pred hhhH-HHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCH------HHHHHH
Q 018785 254 RDSR-RVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSM------VDVLTS 303 (350)
Q Consensus 254 ~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~------~~ll~~ 303 (350)
.... ....+... ....+..++.++.+||.+||..||.+||++ .++++|
T Consensus 222 ~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h 276 (345)
T 3a8x_A 222 NTEDYLFQVILEK--QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 276 (345)
T ss_dssp -CHHHHHHHHHHC--CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred ccHHHHHHHHHcC--CCCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence 0000 01111111 123456678899999999999999999995 788776
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=323.87 Aligned_cols=268 Identities=27% Similarity=0.435 Sum_probs=207.9
Q ss_pred hhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccc--hhhHHHHHHHHHHHhccCCCcccceee
Q 018785 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES--FQGHKEWLTEVIYLGQLRHENLVKLIG 94 (350)
Q Consensus 17 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~ 94 (350)
.+..++|.+.+.||+|+||.||+|++. .+..++..||+|.+.... ......+.+|+..+++++||||+++++
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 103 (313)
T 3brb_A 30 VIDRNLLILGKILGEGEFGSVMEGNLK------QEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLG 103 (313)
T ss_dssp BCCGGGEEEEEEEEC-CCCCEEEEEEE------CTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCE
T ss_pred ccCHHHeeeccceeecCCeEEEEEEEe------ccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeE
Confidence 345789999999999999999999664 334567899999987653 233466889999999999999999999
Q ss_pred EEeecC-----ceEEEEEcCCCCChhhHHhhc----CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEc
Q 018785 95 YCSESD-----NRLLVYEFMPKGSLENHLFRK----GVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLD 165 (350)
Q Consensus 95 ~~~~~~-----~~~lv~e~~~~~~L~~~l~~~----~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~ 165 (350)
++...+ ..++||||+++++|.+++... ....+++..++.++.|++.||.||| +.|++|+||+|+||+++
T Consensus 104 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~dikp~NIli~ 181 (313)
T 3brb_A 104 VCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS--NRNFLHRDLAARNCMLR 181 (313)
T ss_dssp EEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH--TTTCCCCCCSGGGEEEC
T ss_pred EEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCcceEEEc
Confidence 987755 359999999999999998532 2346999999999999999999999 99999999999999999
Q ss_pred CCCcEEEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccccCcchhh
Q 018785 166 SNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQT 244 (350)
Q Consensus 166 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~~~~ 244 (350)
.++.++|+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||...........
T Consensus 182 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 261 (313)
T 3brb_A 182 DDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDY 261 (313)
T ss_dssp TTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH
T ss_pred CCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHH
Confidence 999999999999976543332222333456778999999999999999999999999999999 8889876543222111
Q ss_pred hhhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcC
Q 018785 245 LVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 310 (350)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 310 (350)
+ ........+..+++.+.+++.+||..||.+|||+.+++++|+.+...
T Consensus 262 ~------------------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~ 309 (313)
T 3brb_A 262 L------------------LHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLES 309 (313)
T ss_dssp H------------------HTTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred H------------------HcCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 1 11112234556778999999999999999999999999999998765
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-45 Score=327.85 Aligned_cols=277 Identities=25% Similarity=0.379 Sum_probs=221.9
Q ss_pred hhhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch-hhHHHHHHHHHHHhcc-CCCcccce
Q 018785 15 ISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQL-RHENLVKL 92 (350)
Q Consensus 15 ~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~ 92 (350)
..++..++|++.+.||+|+||.||+|++.... .....++..||+|.+..... .....+.+|+.+++.+ +||||+++
T Consensus 29 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~--~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 106 (334)
T 2pvf_A 29 KWEFPRDKLTLGKPLGEGAFGQVVMAEAVGID--KDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINL 106 (334)
T ss_dssp TTBCCGGGEEEEEEEEECSSCEEEEEEETTCS--TTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cccCCHhHeEEeeEEeecCceeEEEeEecccc--ccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeE
Confidence 34667899999999999999999999764311 02335688999999976532 3346788999999999 89999999
Q ss_pred eeEEeecCceEEEEEcCCCCChhhHHhhcCC--------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCC
Q 018785 93 IGYCSESDNRLLVYEFMPKGSLENHLFRKGV--------------QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLK 158 (350)
Q Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------------~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~ 158 (350)
++++...+..++||||+++++|.+++..... ..++...++.++.|++.||.||| +.|++|+|||
T Consensus 107 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dlk 184 (334)
T 2pvf_A 107 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA--SQKCIHRDLA 184 (334)
T ss_dssp EEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCS
T ss_pred EEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH--hCCeeCCCCc
Confidence 9999999999999999999999999976531 24889999999999999999999 8999999999
Q ss_pred CCceEEcCCCcEEEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccc
Q 018785 159 ASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDR 237 (350)
Q Consensus 159 ~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~ 237 (350)
|+||+++.++.++|+|||++................+++.|+|||++.+..++.++||||||+++|+|++ |..||.+..
T Consensus 185 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 264 (334)
T 2pvf_A 185 ARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 264 (334)
T ss_dssp GGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred cceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCC
Confidence 9999999999999999999976544332222333456778999999988899999999999999999999 999997644
Q ss_pred cCcchhhhhhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcCCCC
Q 018785 238 GGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDM 313 (350)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~ 313 (350)
..... ..+........+..++..+.+++.+||..||.+|||+.+++++|+.+......
T Consensus 265 ~~~~~------------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~ 322 (334)
T 2pvf_A 265 VEELF------------------KLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 322 (334)
T ss_dssp HHHHH------------------HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred HHHHH------------------HHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcccc
Confidence 22111 11111122334556788999999999999999999999999999999876443
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-45 Score=319.31 Aligned_cols=253 Identities=23% Similarity=0.325 Sum_probs=210.4
Q ss_pred hhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceeeEEee
Q 018785 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (350)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (350)
..++|++.+.||+|+||+||+| .+..++..+++|.+..........+.+|+.+++.++||||+++++++.+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~---------~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 77 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIA---------VQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFED 77 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEE---------EETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred hhhhEEeeeEEeecCCEEEEEE---------EeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 4678999999999999999999 5666788999999987766667889999999999999999999999999
Q ss_pred cCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEE---cCCCcEEEccc
Q 018785 99 SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLL---DSNFNAKLSDF 175 (350)
Q Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili---~~~~~~~l~Df 175 (350)
.+..++||||+++++|.+++.... .+++..++.++.|++.||.||| +.|++|+||+|+||++ +.++.++|+||
T Consensus 78 ~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH--~~~i~H~dlkp~Nil~~~~~~~~~~~l~Df 153 (277)
T 3f3z_A 78 NTDIYLVMELCTGGELFERVVHKR--VFRESDAARIMKDVLSAVAYCH--KLNVAHRDLKPENFLFLTDSPDSPLKLIDF 153 (277)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEESSSSTTCCEEECCC
T ss_pred CCeEEEEEeccCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCccCCCCCHHHEEEecCCCCCcEEEEec
Confidence 999999999999999999997765 6999999999999999999999 8999999999999999 78889999999
Q ss_pred cccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhh
Q 018785 176 GLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRD 255 (350)
Q Consensus 176 g~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 255 (350)
|++....... ......+++.|+|||.+.+. ++.++||||||+++|+|++|..||...........+.......
T Consensus 154 g~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--- 226 (277)
T 3f3z_A 154 GLAARFKPGK---MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTF--- 226 (277)
T ss_dssp TTCEECCTTS---CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC---
T ss_pred ccceeccCcc---chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCC---
Confidence 9997643322 22335689999999988654 8999999999999999999999997654322222211110000
Q ss_pred hHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 256 SRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
.......+++.+.+++.+||+.||.+|||+.++++|
T Consensus 227 ------------~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 227 ------------PEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp ------------CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred ------------CchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000011457899999999999999999999999976
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-45 Score=326.64 Aligned_cols=273 Identities=26% Similarity=0.355 Sum_probs=222.0
Q ss_pred hhhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch-hhHHHHHHHHHHHhcc-CCCcccce
Q 018785 15 ISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQL-RHENLVKL 92 (350)
Q Consensus 15 ~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~ 92 (350)
..+...++|++.+.||+|+||+||+|++... .+..+++.||||.+..... .....+.+|+.+++.+ +||||+++
T Consensus 21 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 21 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGI----DKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp HHBCCGGGEEEEEEEEECSSEEEEEEEEESS----SSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ceecchhheeeeeEEcCCCceeEEEEEEecC----CccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 4456688999999999999999999965432 2456789999999876543 3345688999999999 69999999
Q ss_pred eeEEeecC-ceEEEEEcCCCCChhhHHhhcCC--------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCC
Q 018785 93 IGYCSESD-NRLLVYEFMPKGSLENHLFRKGV--------------QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDL 157 (350)
Q Consensus 93 ~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~--------------~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di 157 (350)
++++...+ ..++||||+++++|.+++..... ..+++..++.++.|++.||.||| +.|++|+||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH--~~~i~H~di 174 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA--SRKCIHRDL 174 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH--HTTCCCSCC
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH--hCCcccccC
Confidence 99987754 48999999999999999976542 12889999999999999999999 899999999
Q ss_pred CCCceEEcCCCcEEEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCccc
Q 018785 158 KASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDED 236 (350)
Q Consensus 158 ~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~ 236 (350)
+|+||+++.++.++|+|||++................+++.|+|||++.+..++.++||||||+++|+|++ |..||.+.
T Consensus 175 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~ 254 (316)
T 2xir_A 175 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 254 (316)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred ccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCccc
Confidence 99999999999999999999986544443333444567888999999999999999999999999999998 99999765
Q ss_pred ccCcchhhhhhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcC
Q 018785 237 RGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 310 (350)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 310 (350)
...... ...+........+..+++.+.+++.+||+.||.+|||+.+++++|+.+...
T Consensus 255 ~~~~~~-----------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 311 (316)
T 2xir_A 255 KIDEEF-----------------CRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 311 (316)
T ss_dssp CCSHHH-----------------HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred chhHHH-----------------HHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence 432111 111111122233455778999999999999999999999999999988754
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-45 Score=319.41 Aligned_cols=254 Identities=31% Similarity=0.487 Sum_probs=200.8
Q ss_pred hhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh----hHHHHHHHHHHHhccCCCcccce
Q 018785 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ----GHKEWLTEVIYLGQLRHENLVKL 92 (350)
Q Consensus 17 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~ 92 (350)
++..++|++.+.||+|+||+||+|++. +..||+|++...... ..+.+.+|+.+++.++||||+++
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-----------~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 71 (271)
T 3dtc_A 3 EIDFAELTLEEIIGIGGFGKVYRAFWI-----------GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71 (271)
T ss_dssp BCCTTSEEEEEEEEEETTEEEEEEEET-----------TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccchhheeeeeeeccCCCeEEEEEEEc-----------CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeE
Confidence 345689999999999999999999532 678999998765332 24668899999999999999999
Q ss_pred eeEEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC---eeeCCCCCCceEEcC---
Q 018785 93 IGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDAN---VIYRDLKASNVLLDS--- 166 (350)
Q Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~---i~H~di~~~Nili~~--- 166 (350)
++++...+..++||||+++++|.+++... .+++..++.++.|++.||.||| +.| ++|+||+|+||+++.
T Consensus 72 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~i~~~l~~~l~~lH--~~~~~~i~H~dikp~Nil~~~~~~ 146 (271)
T 3dtc_A 72 RGVCLKEPNLCLVMEFARGGPLNRVLSGK---RIPPDILVNWAVQIARGMNYLH--DEAIVPIIHRDLKSSNILILQKVE 146 (271)
T ss_dssp EEEECCC--CEEEEECCTTEEHHHHHTSS---CCCHHHHHHHHHHHHHHHHHHH--HSSSSCCCCSCCSGGGEEESSCCS
T ss_pred EEEEecCCceEEEEEcCCCCCHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHH--hCCCCceeecCCchHHEEEecccc
Confidence 99999999999999999999999988543 6999999999999999999999 888 899999999999986
Q ss_pred -----CCcEEEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcc
Q 018785 167 -----NFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLA 241 (350)
Q Consensus 167 -----~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~ 241 (350)
++.++|+|||++........ ....+++.|+|||.+.+..++.++|+||||+++|+|++|+.||.+......
T Consensus 147 ~~~~~~~~~kl~Dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~ 222 (271)
T 3dtc_A 147 NGDLSNKILKITDFGLAREWHRTTK----MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAV 222 (271)
T ss_dssp SSCCSSCCEEECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHH
T ss_pred cccccCcceEEccCCcccccccccc----cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 67799999999975433221 234688999999999999999999999999999999999999976442111
Q ss_pred hhhhhhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 018785 242 EQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 307 (350)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~ 307 (350)
.............+..+++.+.+++.+||+.||.+|||+.+++++|+++
T Consensus 223 -----------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 223 -----------------AYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp -----------------HHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred -----------------HHhhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 1112222233344567788999999999999999999999999999864
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-45 Score=324.58 Aligned_cols=274 Identities=26% Similarity=0.339 Sum_probs=204.8
Q ss_pred hhhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh-----hHHHHHHHHHHHhcc---CC
Q 018785 15 ISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ-----GHKEWLTEVIYLGQL---RH 86 (350)
Q Consensus 15 ~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~e~~~l~~l---~h 86 (350)
++++..++|++.+.||+|+||+||+| .+..+++.||+|.+...... ....+.+|+..++.+ .|
T Consensus 3 ~g~~~~~~y~~~~~lg~G~~g~V~~~---------~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h 73 (308)
T 3g33_A 3 LGSMATSRYEPVAEIGVGAYGTVYKA---------RDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEH 73 (308)
T ss_dssp -------CCEEEEEECCSSSCCEEEE---------ECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCC
T ss_pred CCcccccceEEEEEEecCCCeEEEEE---------EECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCC
Confidence 45677899999999999999999999 66778999999998754311 123455666666655 59
Q ss_pred CcccceeeEEeecC-----ceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCc
Q 018785 87 ENLVKLIGYCSESD-----NRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASN 161 (350)
Q Consensus 87 ~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~N 161 (350)
|||+++++++.... ..++|||++. ++|.+++.......+++..++.++.|++.||+||| +.|++|+||||+|
T Consensus 74 ~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH--~~~ivH~Dlkp~N 150 (308)
T 3g33_A 74 PNVVRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLH--ANCIVHRDLKPEN 150 (308)
T ss_dssp TTBCCEEEEEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCTTT
T ss_pred CCeEEeeeeeeccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHH
Confidence 99999999998765 4789999995 69999998876556999999999999999999999 8999999999999
Q ss_pred eEEcCCCcEEEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcc
Q 018785 162 VLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLA 241 (350)
Q Consensus 162 ili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~ 241 (350)
|+++.++.++|+|||++....... ......+++.|+|||++.+..++.++|||||||++|+|++|..||.+......
T Consensus 151 il~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~ 227 (308)
T 3g33_A 151 ILVTSGGTVKLADFGLARIYSYQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ 227 (308)
T ss_dssp EEECTTSCEEECSCSCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHH
T ss_pred EEEcCCCCEEEeeCccccccCCCc---ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 999999999999999997543322 22345689999999999999999999999999999999999999987654433
Q ss_pred hhhhhhhcchhhh-hhHHHHH----hhhcccC---CCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 242 EQTLVEWADPFLR-DSRRVLR----IMDTRLG---GQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 242 ~~~~~~~~~~~~~-~~~~~~~----~~~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
...+......... ....... ....... ......+++.+.+||.+||+.||.+|||+.++++|
T Consensus 228 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 228 LGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp HHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 3333221110000 0000000 0000000 00112456889999999999999999999999976
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-45 Score=324.81 Aligned_cols=269 Identities=26% Similarity=0.327 Sum_probs=205.2
Q ss_pred hhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh--hHHHHHHHHHHHhccCCCcccceeeEEe
Q 018785 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ--GHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (350)
Q Consensus 20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (350)
.++|++.+.||+|++|+||+| .+..+|+.||+|.+...... ....+.+|+.++++++||||+++++++.
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~---------~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 72 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKC---------RNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFR 72 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEE---------EETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEE---------EeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheee
Confidence 368999999999999999999 56667899999988655432 2456788999999999999999999999
Q ss_pred ecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccc
Q 018785 98 ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL 177 (350)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~ 177 (350)
..+..++||||+.+++|.+++.... .+++..+..++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||+
T Consensus 73 ~~~~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~i~~~l~~~l~~lH--~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 148 (311)
T 4agu_A 73 RKRRLHLVFEYCDHTVLHELDRYQR--GVPEHLVKSITWQTLQAVNFCH--KHNCIHRDVKPENILITKHSVIKLCDFGF 148 (311)
T ss_dssp ETTEEEEEEECCSEEHHHHHHHTSS--CCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred cCCeEEEEEEeCCCchHHHHHhhhc--CCCHHHHHHHHHHHHHHHHHHH--HCCCcCCCCChhhEEEcCCCCEEEeeCCC
Confidence 9999999999999989988876654 6999999999999999999999 89999999999999999999999999999
Q ss_pred cccCCCCCCCcccccccCCCcccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhh
Q 018785 178 ARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDS 256 (350)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 256 (350)
+........ ......+++.|+|||.+.+ ..++.++||||||+++|+|++|..||.+.........+...........
T Consensus 149 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 226 (311)
T 4agu_A 149 ARLLTGPSD--YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRH 226 (311)
T ss_dssp CEECC--------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred chhccCccc--ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccc
Confidence 976432221 2233568889999999876 5789999999999999999999999987665433333322211111111
Q ss_pred HHHHHh---hh---cccCCC------CcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 257 RRVLRI---MD---TRLGGQ------YSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 257 ~~~~~~---~~---~~~~~~------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
...... .. ...... ....++..+.+|+.+||+.||.+|||++++++|
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 227 QQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp HHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred ccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 000000 00 000000 012467789999999999999999999999976
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-45 Score=328.19 Aligned_cols=276 Identities=27% Similarity=0.392 Sum_probs=216.0
Q ss_pred hhhhhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccc-hhhHHHHHHHHHHHhccCCCcccc
Q 018785 13 SMISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES-FQGHKEWLTEVIYLGQLRHENLVK 91 (350)
Q Consensus 13 ~~~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~ 91 (350)
..+.++..++|++.+.||+|+||.||+|++... .+..++..||||.+.... ......+.+|+.+++.++||||++
T Consensus 22 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 97 (327)
T 2yfx_A 22 SDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGM----PNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97 (327)
T ss_dssp GGSCBCCGGGCEEEEECC--CSSCEEEEEC------------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred hhcccCChhheEEEEEEcCCCCeeEEEEEEcCC----CCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCe
Confidence 345667889999999999999999999965432 245678899999997543 234466889999999999999999
Q ss_pred eeeEEeecCceEEEEEcCCCCChhhHHhhcCC-----CCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcC
Q 018785 92 LIGYCSESDNRLLVYEFMPKGSLENHLFRKGV-----QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS 166 (350)
Q Consensus 92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-----~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~ 166 (350)
+++++...+..++||||+++++|.+++..... ..++...++.++.|++.||.||| +.|++|+||+|+||+++.
T Consensus 98 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH--~~~i~H~dlkp~NIli~~ 175 (327)
T 2yfx_A 98 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE--ENHFIHRDIAARNCLLTC 175 (327)
T ss_dssp EEEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEESC
T ss_pred EEEEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHh--hCCeecCcCCHhHEEEec
Confidence 99999999999999999999999999987542 35889999999999999999999 899999999999999984
Q ss_pred C---CcEEEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccccCcch
Q 018785 167 N---FNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAE 242 (350)
Q Consensus 167 ~---~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~~ 242 (350)
+ ..++|+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||.........
T Consensus 176 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~ 255 (327)
T 2yfx_A 176 PGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL 255 (327)
T ss_dssp SSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred CCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHH
Confidence 4 4599999999864333222222334567888999999999999999999999999999998 88998764422111
Q ss_pred hhhhhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcCCC
Q 018785 243 QTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKD 312 (350)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~ 312 (350)
..+........+..+++.+.+++.+||+.||.+|||+.+++++|+.+....+
T Consensus 256 ------------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~ 307 (327)
T 2yfx_A 256 ------------------EFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD 307 (327)
T ss_dssp ------------------HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred ------------------HHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCHH
Confidence 1111112223445677899999999999999999999999999999877643
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-45 Score=326.59 Aligned_cols=268 Identities=25% Similarity=0.301 Sum_probs=205.0
Q ss_pred hhhccccc-ceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhcc-CCCcccceeeEE
Q 018785 19 ATKNFCSD-YLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQL-RHENLVKLIGYC 96 (350)
Q Consensus 19 ~~~~y~i~-~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~ 96 (350)
..++|++. +.||+|+||+||+| .+..+++.||||++..........+.+|+..++++ +||||+++++++
T Consensus 10 ~~~~y~i~~~~lg~G~~g~V~~~---------~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~ 80 (316)
T 2ac3_A 10 FEDVYQLQEDVLGEGAHARVQTC---------INLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80 (316)
T ss_dssp TTTSCEECCCCCCCCSSEEEEEE---------ECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cceeEEecCceecCCceEEEEEE---------EEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 45789985 78999999999999 66677899999999776555567788999999885 799999999999
Q ss_pred eecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCc---EEEc
Q 018785 97 SESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFN---AKLS 173 (350)
Q Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~---~~l~ 173 (350)
.+.+..++||||+++++|.+++.... .+++..++.++.|++.||+||| +.|++|+||||+||+++.++. ++|+
T Consensus 81 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH--~~~ivH~dlkp~Nil~~~~~~~~~~kl~ 156 (316)
T 2ac3_A 81 EEEDRFYLVFEKMRGGSILSHIHKRR--HFNELEASVVVQDVASALDFLH--NKGIAHRDLKPENILCEHPNQVSPVKIC 156 (316)
T ss_dssp EETTEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEESCSSSSCSEEEC
T ss_pred eeCCEEEEEEEcCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHH--hCCceeCCCCHHHEEEccCCCcCceEEE
Confidence 99999999999999999999998764 6999999999999999999999 899999999999999988776 9999
Q ss_pred cccccccCCCCCCC-----cccccccCCCcccCcccccc-----CCCCCccchhhHHHHHHHHHhCCCCCcccccCcchh
Q 018785 174 DFGLARDGPTGDNT-----HVSTRIVGTRGYAAPEYVAT-----GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQ 243 (350)
Q Consensus 174 Dfg~~~~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~-----~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~ 243 (350)
|||++......... .......|++.|+|||++.+ ..++.++|||||||++|+|++|..||.+........
T Consensus 157 Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~ 236 (316)
T 2ac3_A 157 DFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGW 236 (316)
T ss_dssp CTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC
T ss_pred EccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccc
Confidence 99998754322111 11123458999999999865 568899999999999999999999998655432111
Q ss_pred hhhhhcchhhhhhHHHHHhhhcccCCCCc----HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 244 TLVEWADPFLRDSRRVLRIMDTRLGGQYS----KKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
......... .......+..... ..+ ..+++.+.+||.+||..||.+|||+.++++|
T Consensus 237 ~~~~~~~~~--~~~~~~~i~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 237 DRGEACPAC--QNMLFESIQEGKY--EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp ----CCHHH--HHHHHHHHHHCCC--CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred cccccchhH--HHHHHHHHhccCc--ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 110000000 0000111111111 111 2467889999999999999999999999986
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-45 Score=326.30 Aligned_cols=279 Identities=31% Similarity=0.428 Sum_probs=220.0
Q ss_pred hhhcc-cccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch-hhHHHHHHHHHHHhccCCCcccceeeEE
Q 018785 19 ATKNF-CSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLVKLIGYC 96 (350)
Q Consensus 19 ~~~~y-~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (350)
..++| ++.+.||+|+||+||++++.. .+..+++.||||++..... .....+.+|+.+++.++||||+++++++
T Consensus 28 ~~~r~~~~~~~lG~G~~g~V~~~~~~~-----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 102 (318)
T 3lxp_A 28 FHKRYLKKIRDLGEGHFGKVSLYCYDP-----TNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCC 102 (318)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECS-----CC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ecHHHHhhhheecCCCCeEEEEEEEcc-----CCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEE
Confidence 34455 999999999999998876543 5666899999999976543 3346688999999999999999999999
Q ss_pred eec--CceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcc
Q 018785 97 SES--DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSD 174 (350)
Q Consensus 97 ~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~D 174 (350)
.+. ...++||||+++++|.+++... .+++..++.++.|++.||.||| +.|++|+||+|+||+++.++.++|+|
T Consensus 103 ~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~i~~~l~~~l~~LH--~~~ivH~Dikp~Nil~~~~~~~kl~D 177 (318)
T 3lxp_A 103 EDAGAASLQLVMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLH--AQHYIHRDLAARNVLLDNDRLVKIGD 177 (318)
T ss_dssp EETTTTEEEEEECCCTTCBHHHHGGGS---CCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECTTCCEEECC
T ss_pred ecCCCceEEEEEecccCCcHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHH--hCCccCCCCchheEEEcCCCCEEECC
Confidence 874 5789999999999999999765 4899999999999999999999 89999999999999999999999999
Q ss_pred ccccccCCCCCCC-cccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhh
Q 018785 175 FGLARDGPTGDNT-HVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 253 (350)
Q Consensus 175 fg~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 253 (350)
||++......... .......++..|+|||.+.+..++.++||||||+++|+|++|..||......... ...... ..
T Consensus 178 fg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~--~~~~~~-~~ 254 (318)
T 3lxp_A 178 FGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLE--LIGIAQ-GQ 254 (318)
T ss_dssp GGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHH--HHCSCC-HH
T ss_pred ccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhh--hhcccc-cc
Confidence 9999865443321 1122345677899999999989999999999999999999999998654321100 000000 01
Q ss_pred hhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcC
Q 018785 254 RDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 310 (350)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 310 (350)
..................+..+++.+.+||.+||+.||.+|||+.++++.|+.+...
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 311 (318)
T 3lxp_A 255 MTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEK 311 (318)
T ss_dssp HHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hhHHHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHh
Confidence 111223333444444555677889999999999999999999999999999988765
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-45 Score=324.09 Aligned_cols=253 Identities=22% Similarity=0.350 Sum_probs=201.2
Q ss_pred hhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh--------------------------hH
Q 018785 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ--------------------------GH 71 (350)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--------------------------~~ 71 (350)
+..++|++.+.||+|+||.||+| .+..+++.||||++...... ..
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~a---------~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (298)
T 2zv2_A 10 VQLNQYTLKDEIGKGSYGVVKLA---------YNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80 (298)
T ss_dssp CEETTEEEEEEEEC--CCEEEEE---------EETTTTEEEEEEEEECC-------------------------------
T ss_pred eeecceEEEeEEeecCCEEEEEE---------EECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchH
Confidence 44679999999999999999999 56667899999998654321 12
Q ss_pred HHHHHHHHHHhccCCCcccceeeEEee--cCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCC
Q 018785 72 KEWLTEVIYLGQLRHENLVKLIGYCSE--SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLD 149 (350)
Q Consensus 72 ~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~ 149 (350)
..+.+|+.+++.++||||+++++++.+ .+..++||||+++++|.+++.. ..+++..++.++.|++.||.||| +
T Consensus 81 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH--~ 155 (298)
T 2zv2_A 81 EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL---KPLSEDQARFYFQDLIKGIEYLH--Y 155 (298)
T ss_dssp CHHHHHHHHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS---SCCCHHHHHHHHHHHHHHHHHHH--H
T ss_pred HHHHHHHHHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHH--H
Confidence 457889999999999999999999986 5678999999999999886543 36999999999999999999999 8
Q ss_pred CCeeeCCCCCCceEEcCCCcEEEccccccccCCCCCCCcccccccCCCcccCccccccCC---CCCccchhhHHHHHHHH
Q 018785 150 ANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGH---LTPKSDVYSFGVVLLEL 226 (350)
Q Consensus 150 ~~i~H~di~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~---~~~~~DiwslG~ll~~l 226 (350)
.|++|+||||+||+++.++.++|+|||++....... .......|++.|+|||.+.+.. ++.++||||||+++|+|
T Consensus 156 ~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l 233 (298)
T 2zv2_A 156 QKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSD--ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCF 233 (298)
T ss_dssp TTEECCCCCGGGEEECTTSCEEECCCTTCEECSSSS--CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHH
T ss_pred CCeeccCCCHHHEEECCCCCEEEecCCCcccccccc--ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHH
Confidence 999999999999999999999999999997643322 1223356899999999987665 36789999999999999
Q ss_pred HhCCCCCcccccCcchhhhhhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 227 LSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 227 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
++|..||.......... ..............+++.+.+||.+||+.||.+|||+.++++|
T Consensus 234 ~~g~~pf~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 234 VFGQCPFMDERIMCLHS-----------------KIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp HHSSCSSCCSSHHHHHH-----------------HHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred HHCCCCCCCccHHHHHH-----------------HHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 99999997543211111 1111111112234567889999999999999999999999875
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-45 Score=323.99 Aligned_cols=268 Identities=24% Similarity=0.305 Sum_probs=204.8
Q ss_pred hcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch--hhHHHHHHHHHHHhccCCCcccceeeEEee
Q 018785 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (350)
Q Consensus 21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (350)
++|++.+.||+|+||+||+| .+..+++.||+|.+..... .....+.+|+.++++++||||+++++++.+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~---------~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 72 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKA---------KNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS 72 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEE---------EETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEE---------EECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEe
Confidence 58999999999999999999 5666789999999875533 234667899999999999999999999999
Q ss_pred cCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcccccc
Q 018785 99 SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 178 (350)
Q Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~ 178 (350)
++..++||||+.+ ++.+++.... ..+++..++.++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++
T Consensus 73 ~~~~~lv~e~~~~-~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH--~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~ 148 (292)
T 3o0g_A 73 DKKLTLVFEFCDQ-DLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCH--SRNVLHRDLKPQNLLINRNGELKLANFGLA 148 (292)
T ss_dssp TTEEEEEEECCSE-EHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred CCEEEEEEecCCC-CHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEEcCCCCEEEeecccc
Confidence 9999999999965 6767665533 37999999999999999999999 899999999999999999999999999999
Q ss_pred ccCCCCCCCcccccccCCCcccCccccccCC-CCCccchhhHHHHHHHHHhCCCCCc-ccccCcchhhhhhhcc-hhhhh
Q 018785 179 RDGPTGDNTHVSTRIVGTRGYAAPEYVATGH-LTPKSDVYSFGVVLLELLSGRRALD-EDRGGLAEQTLVEWAD-PFLRD 255 (350)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~DiwslG~ll~~ll~g~~pf~-~~~~~~~~~~~~~~~~-~~~~~ 255 (350)
...... ........+++.|+|||++.+.. ++.++|||||||++|+|++|..||. +.........+..... +....
T Consensus 149 ~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~ 226 (292)
T 3o0g_A 149 RAFGIP--VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQ 226 (292)
T ss_dssp EECCSC--CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred eecCCc--cccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhh
Confidence 764322 22223356789999999987765 8999999999999999999888864 3222222222211110 00000
Q ss_pred hHHHHHhhh---------cccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 256 SRRVLRIMD---------TRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 256 ~~~~~~~~~---------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
......... ..........+++.+.+||.+||+.||.+|||++++++|
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 227 WPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 000000000 000111234567899999999999999999999999975
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-45 Score=320.01 Aligned_cols=253 Identities=25% Similarity=0.417 Sum_probs=210.2
Q ss_pred hhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh---hHHHHHHHHHHHhccCCCccccee
Q 018785 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ---GHKEWLTEVIYLGQLRHENLVKLI 93 (350)
Q Consensus 17 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~ 93 (350)
.+..++|++.+.||+|++|+||+| .+..++..||+|++...... ....+.+|+.+++.++||||++++
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~---------~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 75 (279)
T 3fdn_A 5 QWALEDFEIGRPLGKGKFGNVYLA---------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 75 (279)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEE---------EETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred eeecccEEEeeEEecCCCeEEEEE---------EEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchh
Confidence 345689999999999999999999 56667889999998654322 245688999999999999999999
Q ss_pred eEEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEc
Q 018785 94 GYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLS 173 (350)
Q Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~ 173 (350)
+++.+.+..++||||+++++|.+++.... .+++..++.++.|++.||.||| +.|++|+||+|+||+++.++.++|+
T Consensus 76 ~~~~~~~~~~lv~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~qi~~~l~~LH--~~~i~H~dlkp~Nili~~~~~~~l~ 151 (279)
T 3fdn_A 76 GYFHDATRVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCH--SKRVIHRDIKPENLLLGSAGELKIA 151 (279)
T ss_dssp EEEECSSEEEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH--TTTCEECCCCGGGEEECTTSCEEEC
T ss_pred heEecCCEEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--hCCEecccCChHhEEEcCCCCEEEE
Confidence 99999999999999999999999998765 6999999999999999999999 9999999999999999999999999
Q ss_pred cccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhh
Q 018785 174 DFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 253 (350)
Q Consensus 174 Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 253 (350)
|||++....... .....+++.|+|||.+.+..++.++||||||+++|+|++|..||...........+..
T Consensus 152 Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~------ 221 (279)
T 3fdn_A 152 DFGWSVHAPSSR----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR------ 221 (279)
T ss_dssp SCCEESCC------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH------
T ss_pred eccccccCCccc----ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHh------
Confidence 999986432221 2334688999999999999999999999999999999999999976442221111111
Q ss_pred hhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018785 254 RDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 305 (350)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~ 305 (350)
.....+..+++.+.+||.+||+.||.+|||+.++++|-.
T Consensus 222 -------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~ 260 (279)
T 3fdn_A 222 -------------VEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 260 (279)
T ss_dssp -------------TCCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHH
T ss_pred -------------CCCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCcc
Confidence 112334557788999999999999999999999998844
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-45 Score=322.35 Aligned_cols=263 Identities=25% Similarity=0.379 Sum_probs=214.0
Q ss_pred hhhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceee
Q 018785 15 ISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIG 94 (350)
Q Consensus 15 ~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 94 (350)
..++..++|++.+.||+|+||+||+|++. ++..||+|++...... ...+.+|+.+++.++||||+++++
T Consensus 18 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~----------~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~ 86 (283)
T 3gen_A 18 SWEIDPKDLTFLKELGTGQFGVVKYGKWR----------GQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYG 86 (283)
T ss_dssp TTBCCGGGEEEEEECC---CEEEEEEEET----------TTEEEEEEEECTTSBC-HHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred CccCCHHHHHhHhhcCCCCCceEEEEEEc----------CCCeEEEEEecCCCCC-HHHHHHHHHHHhcCCCCCEeeEEE
Confidence 44567889999999999999999999543 3667999999766433 466889999999999999999999
Q ss_pred EEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcc
Q 018785 95 YCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSD 174 (350)
Q Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~D 174 (350)
++.+.+..++||||+++++|.+++.... ..+++..++.++.|++.||.||| +.|++|+||+|+||+++.++.++|+|
T Consensus 87 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH--~~~i~H~dikp~Nili~~~~~~kl~D 163 (283)
T 3gen_A 87 VCTKQRPIFIITEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLE--SKQFLHRDLAARNCLVNDQGVVKVSD 163 (283)
T ss_dssp EECSSSSEEEEECCCTTCBHHHHHHCGG-GCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSSCSGGGEEECTTSCEEECS
T ss_pred EEecCCCeEEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHH--HCCccCCCCccceEEEcCCCCEEEcc
Confidence 9999999999999999999999997633 36999999999999999999999 89999999999999999999999999
Q ss_pred ccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccccCcchhhhhhhcchhh
Q 018785 175 FGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFL 253 (350)
Q Consensus 175 fg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~ 253 (350)
||++....... ........+++.|+|||.+.+..++.++|+||||+++|+|++ |..||...........+
T Consensus 164 fg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~-------- 234 (283)
T 3gen_A 164 FGLSRYVLDDE-YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI-------- 234 (283)
T ss_dssp TTGGGGBCCHH-HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH--------
T ss_pred ccccccccccc-cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHH--------
Confidence 99997542221 111122345678999999998999999999999999999998 99999765432222111
Q ss_pred hhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcC
Q 018785 254 RDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 310 (350)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 310 (350)
........+..+++.+.+++.+||+.||.+|||+.+++++|.++...
T Consensus 235 ----------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 235 ----------AQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp ----------HTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----------hcccCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 11222333455678899999999999999999999999999988754
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=316.16 Aligned_cols=256 Identities=23% Similarity=0.342 Sum_probs=212.9
Q ss_pred hhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccc--hhhHHHHHHHHHHHhccCCCcccceee
Q 018785 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES--FQGHKEWLTEVIYLGQLRHENLVKLIG 94 (350)
Q Consensus 17 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~ 94 (350)
.+..++|++.+.||+|+||+||+|++. +..||+|++.... ......+.+|+.++++++||||+++++
T Consensus 6 ~i~~~~y~~~~~lg~G~~g~V~~~~~~-----------~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 74 (271)
T 3kmu_A 6 GIDFKQLNFLTKLNENHSGELWKGRWQ-----------GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74 (271)
T ss_dssp CCCGGGCEEEEEEEEETTEEEEEEEET-----------TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEE
T ss_pred CCCHHHhHHHHHhcCCCcceEEEEEEC-----------CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEE
Confidence 345689999999999999999999542 6789999987653 233467889999999999999999999
Q ss_pred EEeec--CceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC--eeeCCCCCCceEEcCCCcE
Q 018785 95 YCSES--DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDAN--VIYRDLKASNVLLDSNFNA 170 (350)
Q Consensus 95 ~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~--i~H~di~~~Nili~~~~~~ 170 (350)
++... +..++||||+++++|.+++.......+++..++.++.|++.||.||| +.| ++|+||+|+||+++.++.+
T Consensus 75 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH--~~~~~i~H~dikp~Nil~~~~~~~ 152 (271)
T 3kmu_A 75 ACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH--TLEPLIPRHALNSRSVMIDEDMTA 152 (271)
T ss_dssp EECTTTSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHT--TSSSCCTTCCCSGGGEEECTTSCE
T ss_pred EEccCCCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh--cCCCceecCCCccceEEEcCCcce
Confidence 99887 78899999999999999998776556999999999999999999999 888 9999999999999999999
Q ss_pred EEccccccccCCCCCCCcccccccCCCcccCccccccCCCCC---ccchhhHHHHHHHHHhCCCCCcccccCcchhhhhh
Q 018785 171 KLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTP---KSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVE 247 (350)
Q Consensus 171 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~---~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~ 247 (350)
++.|||+...... ....+++.|+|||.+.+..++. ++||||||+++|+|++|+.||........
T Consensus 153 ~l~~~~~~~~~~~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------ 219 (271)
T 3kmu_A 153 RISMADVKFSFQS-------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEI------ 219 (271)
T ss_dssp EEEGGGSCCTTSC-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHH------
T ss_pred eEEeccceeeecc-------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHH------
Confidence 9998887753211 1245788999999998765554 79999999999999999999975442111
Q ss_pred hcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhc
Q 018785 248 WADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHT 309 (350)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 309 (350)
.............+..+++.+.+++.+||+.||.+|||++++++.|+++..
T Consensus 220 -----------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 220 -----------GMKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp -----------HHHHHHSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred -----------HHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 122222333344566788899999999999999999999999999998864
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=338.34 Aligned_cols=255 Identities=31% Similarity=0.452 Sum_probs=214.6
Q ss_pred hhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceeeEEe
Q 018785 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (350)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (350)
+..++|++.+.||+|+||.||+|.+. +..||||.+.... ....+.+|+.++++++||||+++++++.
T Consensus 190 i~~~~~~~~~~lG~G~fg~V~~~~~~-----------~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~ 256 (450)
T 1k9a_A 190 LNMKELKLLQTIGKGEFGDVMLGDYR-----------GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIV 256 (450)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET-----------TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred cChHHeEEEeeecCcCCeeEEEEEec-----------CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEE
Confidence 45678999999999999999999543 6689999997654 4567889999999999999999999987
Q ss_pred ecC-ceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcccc
Q 018785 98 ESD-NRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFG 176 (350)
Q Consensus 98 ~~~-~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg 176 (350)
..+ ..++||||+++++|.+++.......++...++.++.|++.||+||| ++|++|+||+|+||+++.++.++|+|||
T Consensus 257 ~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH--~~~ivHrDlkp~Nill~~~~~~kl~DfG 334 (450)
T 1k9a_A 257 EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE--GNNFVHRDLAARNVLVSEDNVAKVSDFG 334 (450)
T ss_dssp CTTSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGGGEEECTTSCEEECCCT
T ss_pred cCCCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--hCCeeCCCCCHhhEEECCCCCEEEeeCC
Confidence 665 7899999999999999998776556899999999999999999999 8999999999999999999999999999
Q ss_pred ccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccccCcchhhhhhhcchhhhh
Q 018785 177 LARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRD 255 (350)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 255 (350)
++....... ....++..|+|||.+.+..++.++||||||+++|+|++ |..||.+.........+
T Consensus 335 ~a~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i---------- 399 (450)
T 1k9a_A 335 LTKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV---------- 399 (450)
T ss_dssp TCEECC-----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHH----------
T ss_pred Ccccccccc-----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH----------
Confidence 997532211 12246778999999999999999999999999999998 99999765543222211
Q ss_pred hHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcC
Q 018785 256 SRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 310 (350)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 310 (350)
........+..+++.+.+||.+||+.||.+|||+.++++.|+++...
T Consensus 400 --------~~~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 400 --------EKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp --------HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred --------HcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 12223344567889999999999999999999999999999998765
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=325.91 Aligned_cols=271 Identities=25% Similarity=0.358 Sum_probs=210.9
Q ss_pred hhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceeeE
Q 018785 16 SKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGY 95 (350)
Q Consensus 16 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 95 (350)
.++..++|++.+.||+|+||+||+|+...... .....+..|++|.+..........+.+|+.+++.++||||++++++
T Consensus 3 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~--~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 80 (289)
T 4fvq_A 3 HKIRNEDLIFNESLGQGTFTKIFKGVRREVGD--YGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGV 80 (289)
T ss_dssp CBCCGGGEEEEEEEEEETTEEEEEEEEEEECG--GGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEE
T ss_pred EEechhHeeeeeeeccCCCceEEEEEEecccc--cccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEE
Confidence 35667899999999999999999995542100 0011235799999987766667889999999999999999999999
Q ss_pred EeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCc------
Q 018785 96 CSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFN------ 169 (350)
Q Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~------ 169 (350)
+..++..++||||+++++|.+++.... ..+++..++.++.|++.||.||| +.|++|+||||+||+++.++.
T Consensus 81 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH--~~~ivH~Dlkp~NIll~~~~~~~~~~~ 157 (289)
T 4fvq_A 81 CVCGDENILVQEFVKFGSLDTYLKKNK-NCINILWKLEVAKQLAAAMHFLE--ENTLIHGNVCAKNILLIREEDRKTGNP 157 (289)
T ss_dssp ECCTTCCEEEEECCTTCBHHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEEEECCBGGGTBC
T ss_pred EEeCCCCEEEEECCCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHh--hCCeECCCcCcceEEEecCCccccccc
Confidence 999999999999999999999997754 24899999999999999999999 899999999999999988877
Q ss_pred --EEEccccccccCCCCCCCcccccccCCCcccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhh
Q 018785 170 --AKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLV 246 (350)
Q Consensus 170 --~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~ 246 (350)
++|+|||++..... .....+++.|+|||.+.+ ..++.++||||||+++|+|++|..|+.........
T Consensus 158 ~~~kl~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~---- 227 (289)
T 4fvq_A 158 PFIKLSDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRK---- 227 (289)
T ss_dssp CEEEECCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH----
T ss_pred ceeeeccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHH----
Confidence 99999999864321 122457788999999987 67899999999999999999965544322211000
Q ss_pred hhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcCCCCCCC
Q 018785 247 EWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDMPRT 316 (350)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~~~~ 316 (350)
...... ....+...++++.+|+.+||+.||.+|||+.+++++|+++.+....+..
T Consensus 228 -------------~~~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~~~~~ 282 (289)
T 4fvq_A 228 -------------LQFYED--RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVPRG 282 (289)
T ss_dssp -------------HHHHHT--TCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--------
T ss_pred -------------HHHhhc--cCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCCCCC
Confidence 000000 1222334467899999999999999999999999999999987665543
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=321.92 Aligned_cols=273 Identities=24% Similarity=0.344 Sum_probs=207.8
Q ss_pred hhhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccc---hhhHHHHHHHHHHHhccCCCcccc
Q 018785 15 ISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES---FQGHKEWLTEVIYLGQLRHENLVK 91 (350)
Q Consensus 15 ~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~ 91 (350)
++....++|++.+.||+|+||.||+| .+..+|..||+|.+.... ......+.+|+..++.++||||++
T Consensus 26 ~~~~~~~~y~~~~~lg~G~~g~Vy~~---------~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 96 (310)
T 2wqm_A 26 MGYNTLANFRIEKKIGRGQFSEVYRA---------ACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIK 96 (310)
T ss_dssp GTTSSGGGEEEEEEEECC--CEEEEE---------EETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCC
T ss_pred cccccccceEEEEeecCCCCceEEEE---------EEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEee
Confidence 34455679999999999999999999 555668999999987532 234566889999999999999999
Q ss_pred eeeEEeecCceEEEEEcCCCCChhhHHhhc--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCc
Q 018785 92 LIGYCSESDNRLLVYEFMPKGSLENHLFRK--GVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFN 169 (350)
Q Consensus 92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~ 169 (350)
+++++...+..++|||++++++|.+++... ....+++..++.++.|++.||.||| +.|++|+||+|+||+++.++.
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH--~~~i~H~dl~p~NIl~~~~~~ 174 (310)
T 2wqm_A 97 YYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH--SRRVMHRDIKPANVFITATGV 174 (310)
T ss_dssp EEEEEEETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTTSC
T ss_pred EEEEEEcCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHh--hCCeeCCCCcHHHEEEcCCCC
Confidence 999999999999999999999999998642 2346899999999999999999999 899999999999999999999
Q ss_pred EEEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhc
Q 018785 170 AKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWA 249 (350)
Q Consensus 170 ~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~ 249 (350)
++|+|||++....... .......+++.|+|||.+.+..++.++||||||+++|+|++|..||.+...... .+
T Consensus 175 ~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~---- 246 (310)
T 2wqm_A 175 VKLGDLGLGRFFSSKT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY--SL---- 246 (310)
T ss_dssp EEECCC--------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHH--HH----
T ss_pred EEEEeccceeeecCCC--ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHH--HH----
Confidence 9999999987543222 112234678899999999999999999999999999999999999975432110 00
Q ss_pred chhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcCCCCCC
Q 018785 250 DPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDMPR 315 (350)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~~~ 315 (350)
................+++++.+++.+||..||.+|||+.++++.|.++......|.
T Consensus 247 ---------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~~ 303 (310)
T 2wqm_A 247 ---------CKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSL 303 (310)
T ss_dssp ---------HHHHHTTCSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC---
T ss_pred ---------HHHhhcccCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhhh
Confidence 001111111111234567899999999999999999999999999999998865553
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=318.09 Aligned_cols=264 Identities=26% Similarity=0.410 Sum_probs=213.3
Q ss_pred hhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccc-hhhHHHHHHHHHHHhccCCCcccceeeE
Q 018785 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES-FQGHKEWLTEVIYLGQLRHENLVKLIGY 95 (350)
Q Consensus 17 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 95 (350)
.+..++|++.+.||+|+||+||+|++. .+..++..||+|.+.... ......+.+|+.+++.++||||++++++
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 81 (281)
T 3cc6_A 8 GIAREDVVLNRILGEGFFGEVYEGVYT------NHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGI 81 (281)
T ss_dssp SCCGGGEEEEEEEEECSSSEEEEEEEE------CTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEE
T ss_pred eecccceEEEEEEEecCCeeEEEeEEc------CCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEE
Confidence 456789999999999999999999764 234456789999987653 3345678899999999999999999999
Q ss_pred EeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccc
Q 018785 96 CSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDF 175 (350)
Q Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Df 175 (350)
+.+ +..++|||++.+++|.+++.... ..++...+..++.|++.||.||| +.|++|+||+|+||+++.++.++|+||
T Consensus 82 ~~~-~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dlkp~Nil~~~~~~~kl~Df 157 (281)
T 3cc6_A 82 IEE-EPTWIIMELYPYGELGHYLERNK-NSLKVLTLVLYSLQICKAMAYLE--SINCVHRDIAVRNILVASPECVKLGDF 157 (281)
T ss_dssp ECS-SSCEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCSGGGEEEEETTEEEECCC
T ss_pred EcC-CCCEEEEecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCccceEEECCCCcEEeCcc
Confidence 875 46789999999999999997654 36899999999999999999999 899999999999999999999999999
Q ss_pred cccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccccCcchhhhhhhcchhhh
Q 018785 176 GLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLR 254 (350)
Q Consensus 176 g~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~ 254 (350)
|++........ .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||...........+
T Consensus 158 g~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~--------- 227 (281)
T 3cc6_A 158 GLSRYIEDEDY-YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVL--------- 227 (281)
T ss_dssp CGGGCC----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHH---------
T ss_pred CCCcccccccc-cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHH---------
Confidence 99976433221 11223446778999999988999999999999999999998 99999754432222111
Q ss_pred hhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhc
Q 018785 255 DSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHT 309 (350)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 309 (350)
........+..+++.+.+++.+||..||.+|||+.+++++|+++..
T Consensus 228 ---------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 273 (281)
T 3cc6_A 228 ---------EKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ 273 (281)
T ss_dssp ---------HHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---------hcCCCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence 1111223344577889999999999999999999999999998764
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-45 Score=345.16 Aligned_cols=264 Identities=25% Similarity=0.403 Sum_probs=221.6
Q ss_pred hhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceeeE
Q 018785 16 SKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGY 95 (350)
Q Consensus 16 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 95 (350)
.++...+|++.+.||+|+||.||+|++ ..++..||||.+.... .....+.+|+.++++++||||++++++
T Consensus 215 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~---------~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~ 284 (495)
T 1opk_A 215 WEMERTDITMKHKLGGGQYGEVYEGVW---------KKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGV 284 (495)
T ss_dssp CBCCGGGEEEEEESGGGTTSSEEEEEE---------GGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccCHHHceeeeEecCCCCeEEEEEEE---------cCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEE
Confidence 345677899999999999999999954 4457899999997654 345778999999999999999999999
Q ss_pred EeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccc
Q 018785 96 CSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDF 175 (350)
Q Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Df 175 (350)
+...+..++||||+++++|.+++.......++...++.++.|++.||+||| ++|++|+||||+||+++.++.++|+||
T Consensus 285 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH--~~~ivHrDlkp~NIll~~~~~~kl~DF 362 (495)
T 1opk_A 285 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE--KKNFIHRNLAARNCLVGENHLVKVADF 362 (495)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECGGGCEEECCT
T ss_pred EecCCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCChhhEEECCCCcEEEeec
Confidence 999999999999999999999998766667999999999999999999999 899999999999999999999999999
Q ss_pred cccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccccCcchhhhhhhcchhhh
Q 018785 176 GLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLR 254 (350)
Q Consensus 176 g~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~ 254 (350)
|++....... ........++..|+|||++.+..++.++||||||+++|+|++ |..||.+.......
T Consensus 363 G~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~------------ 429 (495)
T 1opk_A 363 GLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY------------ 429 (495)
T ss_dssp TCEECCTTCC-EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH------------
T ss_pred ccceeccCCc-eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHH------------
Confidence 9998643221 111222345678999999998999999999999999999999 89999765532221
Q ss_pred hhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcC
Q 018785 255 DSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 310 (350)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 310 (350)
..+........+..+++.+.+||.+||+.||.+|||+.++++.|+.+...
T Consensus 430 ------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~ 479 (495)
T 1opk_A 430 ------ELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 479 (495)
T ss_dssp ------HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred ------HHHHcCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence 11222233345567788999999999999999999999999999988654
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-45 Score=326.84 Aligned_cols=270 Identities=23% Similarity=0.356 Sum_probs=195.2
Q ss_pred hhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh-hHHHHHHHHHHHhccCCCcccceeeEEee
Q 018785 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ-GHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (350)
Q Consensus 20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (350)
.++|++.+.||+|+||+||+| .+..+|+.||+|.+...... ....+.+|+.+++.++||||+++++++..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 74 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKG---------LNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHT 74 (317)
T ss_dssp ---------------CEEEEE---------ECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECC
T ss_pred ccceeEeeEECCCCCEEEEEE---------EECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEE
Confidence 468999999999999999999 66677899999998765432 33567889999999999999999999999
Q ss_pred cCceEEEEEcCCCCChhhHHhhcC----CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcc
Q 018785 99 SDNRLLVYEFMPKGSLENHLFRKG----VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSD 174 (350)
Q Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~----~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~D 174 (350)
++..++||||++ ++|.+++.... ...+++..+..++.|++.||.||| +.|++|+||||+||+++.++.++|+|
T Consensus 75 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH--~~~ivH~Dlkp~NIl~~~~~~~kl~D 151 (317)
T 2pmi_A 75 ENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH--ENKILHRDLKPQNLLINKRGQLKLGD 151 (317)
T ss_dssp TTEEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTCCEEECC
T ss_pred CCeEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH--HCCeeeCCCChHHeEEcCCCCEEECc
Confidence 999999999996 59999886542 235899999999999999999999 89999999999999999999999999
Q ss_pred ccccccCCCCCCCcccccccCCCcccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchh-
Q 018785 175 FGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPF- 252 (350)
Q Consensus 175 fg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~- 252 (350)
||++........ ......+++.|+|||++.+. .++.++|||||||++|+|++|..||.+.........+.......
T Consensus 152 fg~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~ 229 (317)
T 2pmi_A 152 FGLARAFGIPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPN 229 (317)
T ss_dssp CSSCEETTSCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCC
T ss_pred CccceecCCCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 999976432221 22335688999999998764 68999999999999999999999998765443333332211100
Q ss_pred ---hhhhHHHHHh---hhcc--------cCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 253 ---LRDSRRVLRI---MDTR--------LGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 253 ---~~~~~~~~~~---~~~~--------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
+......... .... ........+++++.+||.+||+.||.+|||+.++++|
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 230 ESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp TTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 0000000000 0000 0001122456789999999999999999999999976
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=317.17 Aligned_cols=255 Identities=21% Similarity=0.315 Sum_probs=210.8
Q ss_pred hhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch--hhHHHHHHHHHHHhccCCCcccceeeEE
Q 018785 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLRHENLVKLIGYC 96 (350)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (350)
..++|++.+.||+|+||.||+| .+..++..||+|++..... .....+.+|+.++++++||||+++++++
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~---------~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 74 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRC---------VHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI 74 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEE---------EETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEE---------EEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEE
Confidence 4689999999999999999999 5666789999999876542 3346688999999999999999999999
Q ss_pred eecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCc---EEEc
Q 018785 97 SESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFN---AKLS 173 (350)
Q Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~---~~l~ 173 (350)
...+..++|||++.+++|.+++.... .+++..+..++.|++.||.||| +.|++|+||+|+||+++.++. ++|+
T Consensus 75 ~~~~~~~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dikp~Nil~~~~~~~~~~kl~ 150 (284)
T 3kk8_A 75 QEESFHYLVFDLVTGGELFEDIVARE--FYSEADASHCIQQILESIAYCH--SNGIVHRNLKPENLLLASKAKGAAVKLA 150 (284)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGGGEEESSSSTTCCEEEC
T ss_pred EcCCEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--HCCcCcCCCCHHHEEEecCCCCCcEEEe
Confidence 99999999999999999999987765 6999999999999999999999 899999999999999987655 9999
Q ss_pred cccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhh
Q 018785 174 DFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 253 (350)
Q Consensus 174 Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 253 (350)
|||.+....... ......+++.|+|||.+.+..++.++||||||+++|+|++|..||.+.........+...
T Consensus 151 Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~----- 222 (284)
T 3kk8_A 151 DFGLAIEVNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG----- 222 (284)
T ss_dssp CCTTCEECCSSC---BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT-----
T ss_pred eceeeEEcccCc---cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhc-----
Confidence 999997543322 223356889999999999999999999999999999999999999765432222111110
Q ss_pred hhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018785 254 RDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL 304 (350)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 304 (350)
...........+++++.+|+.+||+.||.+|||+.++++|-
T Consensus 223 ----------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~ 263 (284)
T 3kk8_A 223 ----------AYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVP 263 (284)
T ss_dssp ----------CCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSH
T ss_pred ----------cccCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCc
Confidence 01111122245678899999999999999999999999863
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=316.05 Aligned_cols=269 Identities=39% Similarity=0.649 Sum_probs=213.4
Q ss_pred ccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccc----hhhHHHHHHHHHHHhccCCCcccceeeEEee
Q 018785 23 FCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES----FQGHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (350)
Q Consensus 23 y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (350)
|...+.||+|+||+||+|++ ++..||+|.+.... ......+.+|+.+++.++||||+++++++.+
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~-----------~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 101 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV-----------NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSD 101 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES-----------SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cccCCccccCCCeEEEEEEE-----------CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEec
Confidence 33448999999999999943 36789999886532 2335678899999999999999999999999
Q ss_pred cCceEEEEEcCCCCChhhHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccc
Q 018785 99 SDNRLLVYEFMPKGSLENHLFRKG-VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL 177 (350)
Q Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~ 177 (350)
.+..++||||+++++|.+++.... ...++...++.++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||+
T Consensus 102 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH--~~~i~H~dlkp~Nili~~~~~~kl~Dfg~ 179 (307)
T 2nru_A 102 GDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH--ENHHIHRDIKSANILLDEAFTAKISDFGL 179 (307)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGGGEEECTTCCEEECCCTT
T ss_pred CCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh--cCCeecCCCCHHHEEEcCCCcEEEeeccc
Confidence 999999999999999999987432 346999999999999999999999 89999999999999999999999999999
Q ss_pred cccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhH
Q 018785 178 ARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSR 257 (350)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 257 (350)
+................|++.|+|||.+.+ .++.++|+||||+++|+|++|..||...........+..... ....
T Consensus 180 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~ 255 (307)
T 2nru_A 180 ARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIE---DEEK 255 (307)
T ss_dssp CEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHH---TTSC
T ss_pred ccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhh---hhhh
Confidence 976544333333334568999999998765 578999999999999999999999987665443333222110 0001
Q ss_pred HHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhc
Q 018785 258 RVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHT 309 (350)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 309 (350)
.....+... ....+...+..+.+++.+||+.||.+|||+.+++++|+++..
T Consensus 256 ~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 256 TIEDYIDKK-MNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp CHHHHSCSS-CSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred hhhhhcccc-ccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 111112221 133466788999999999999999999999999999998864
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-45 Score=327.02 Aligned_cols=274 Identities=24% Similarity=0.387 Sum_probs=220.4
Q ss_pred hhhhhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch-hhHHHHHHHHHHHhccCCCcccc
Q 018785 13 SMISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLVK 91 (350)
Q Consensus 13 ~~~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~ 91 (350)
....++..++|++.+.||+|+||.||+|++... ....++..||+|.+..... .....+.+|+.+++.++||||++
T Consensus 17 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~----~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 92 (322)
T 1p4o_A 17 PDEWEVAREKITMSRELGQGSFGMVYEGVAKGV----VKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92 (322)
T ss_dssp CCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEE----ETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCC
T ss_pred hhhhcchhhheeeeeEeccCCceEEEeeeecCc----cCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEee
Confidence 345567789999999999999999999965421 2234578899999875532 33456889999999999999999
Q ss_pred eeeEEeecCceEEEEEcCCCCChhhHHhhcC--------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceE
Q 018785 92 LIGYCSESDNRLLVYEFMPKGSLENHLFRKG--------VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVL 163 (350)
Q Consensus 92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nil 163 (350)
+++++.+.+..++|||++++++|.+++.... ...++...++.++.|++.||.||| +.|++|+||+|+||+
T Consensus 93 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH--~~~i~H~dikp~NIl 170 (322)
T 1p4o_A 93 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN--ANKFVHRDLAARNCM 170 (322)
T ss_dssp EEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH--HTTCBCSCCSGGGEE
T ss_pred eEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH--HCCCccCCCccceEE
Confidence 9999999999999999999999999996532 135789999999999999999999 899999999999999
Q ss_pred EcCCCcEEEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccccCcch
Q 018785 164 LDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAE 242 (350)
Q Consensus 164 i~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~~ 242 (350)
++.++.++|+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+.......
T Consensus 171 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~ 250 (322)
T 1p4o_A 171 VAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL 250 (322)
T ss_dssp ECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHH
T ss_pred EcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHH
Confidence 99999999999999975433222222233456788999999999999999999999999999999 88898764422111
Q ss_pred hhhhhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcC
Q 018785 243 QTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 310 (350)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 310 (350)
.. +........+..+++.+.+++.+||+.||.+|||+.+++++|+++...
T Consensus 251 ~~------------------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~ 300 (322)
T 1p4o_A 251 RF------------------VMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 300 (322)
T ss_dssp HH------------------HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred HH------------------HHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhcc
Confidence 11 111111233456788999999999999999999999999999887553
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=320.14 Aligned_cols=269 Identities=27% Similarity=0.408 Sum_probs=202.8
Q ss_pred chhhhhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccc--hhhHHHHHHHHHHHhccCCCcc
Q 018785 12 ASMISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES--FQGHKEWLTEVIYLGQLRHENL 89 (350)
Q Consensus 12 ~~~~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i 89 (350)
.....++..++|++.+.||+|+||+||+|++. ..||+|++.... ......+.+|+.+++.++||||
T Consensus 15 ~~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~------------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 82 (289)
T 3og7_A 15 AADDWEIPDGQITVGQRIGSGSFGTVYKGKWH------------GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 82 (289)
T ss_dssp ---CCBCCTTSCEEEEEEEECSSEEEEEEESS------------SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTB
T ss_pred CCCCCccCccceeeeeEecCCCCeEEEEEEEc------------CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcE
Confidence 34456788999999999999999999999542 248999886543 2344678899999999999999
Q ss_pred cceeeEEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCc
Q 018785 90 VKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFN 169 (350)
Q Consensus 90 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~ 169 (350)
++++++. .....++||||+.+++|.+++.... ..++...++.++.|++.||.||| +.|++|+||||+||+++.++.
T Consensus 83 v~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~lH--~~~i~H~Dlkp~Nil~~~~~~ 158 (289)
T 3og7_A 83 LLFMGYS-TAPQLAIVTQWCEGSSLYHHLHASE-TKFEMKKLIDIARQTARGMDYLH--AKSIIHRDLKSNNIFLHEDNT 158 (289)
T ss_dssp CCEEEEE-CSSSCEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEEETTTE
T ss_pred EEEEeec-cCCccEEEEEecCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHH--hCCcccccCccceEEECCCCC
Confidence 9999954 5567899999999999999996543 46999999999999999999999 899999999999999999999
Q ss_pred EEEccccccccCCCCCCCcccccccCCCcccCccccc---cCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhh
Q 018785 170 AKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVA---TGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLV 246 (350)
Q Consensus 170 ~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~ 246 (350)
++|+|||++................|++.|+|||.+. +..++.++||||||+++|+|++|+.||.............
T Consensus 159 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~ 238 (289)
T 3og7_A 159 VKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMV 238 (289)
T ss_dssp EEECCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHH
T ss_pred EEEccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHh
Confidence 9999999997544333333334456899999999986 5678889999999999999999999997654321111111
Q ss_pred hhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhc
Q 018785 247 EWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHT 309 (350)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 309 (350)
. ..............+++.+.+|+.+||+.||.+|||+.++++.|+++..
T Consensus 239 ~-------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 239 G-------------RGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp H-------------HTSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred c-------------ccccCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 0 0000111122344678899999999999999999999999999998754
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-45 Score=327.36 Aligned_cols=269 Identities=24% Similarity=0.380 Sum_probs=209.6
Q ss_pred hhhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccc-hhhHHHHHHHHHHHhccCCCccccee
Q 018785 15 ISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES-FQGHKEWLTEVIYLGQLRHENLVKLI 93 (350)
Q Consensus 15 ~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~ 93 (350)
...+..++|++.+.||+|+||+||+|++... ...-..+|++|.+.... ......+.+|+.+++.++||||++++
T Consensus 9 ~~~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~-----~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~ 83 (327)
T 3lzb_A 9 LRILKETEFKKIKVLGSGAFGTVYKGLWIPE-----GEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLL 83 (327)
T ss_dssp CEECCTTTEEEEEEEEECSSEEEEEEEECCT-----TCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCC
T ss_pred hcccCHhHceEEEEeeeCCCeEEEEEEEcCC-----CceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEE
Confidence 3445578999999999999999999954321 11112346777775432 23457788999999999999999999
Q ss_pred eEEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEc
Q 018785 94 GYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLS 173 (350)
Q Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~ 173 (350)
+++.... .++|++++.+++|.+++.... ..+++..++.++.|++.||.||| +.|++|+||||+||+++.++.++|+
T Consensus 84 ~~~~~~~-~~~v~~~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dikp~NIl~~~~~~~kL~ 159 (327)
T 3lzb_A 84 GICLTST-VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKIT 159 (327)
T ss_dssp EEEESSS-EEEEECCCSSCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEEEETTEEEEC
T ss_pred EEEecCC-ceEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHh--hCCCcCCCCCHHHEEEcCCCCEEEc
Confidence 9998754 789999999999999997754 36999999999999999999999 8999999999999999999999999
Q ss_pred cccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccccCcchhhhhhhcchh
Q 018785 174 DFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPF 252 (350)
Q Consensus 174 Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~ 252 (350)
|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+........
T Consensus 160 DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~--------- 230 (327)
T 3lzb_A 160 DFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS--------- 230 (327)
T ss_dssp CTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH---------
T ss_pred cCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH---------
Confidence 9999986544333333333456778999999999999999999999999999999 999997655432221
Q ss_pred hhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcC
Q 018785 253 LRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 310 (350)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 310 (350)
.+........+..++.++.+++.+||..||.+|||+.++++.|+.+...
T Consensus 231 ---------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 231 ---------ILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp ---------HHHTTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred ---------HHHcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 1222222334556788999999999999999999999999999998754
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=318.38 Aligned_cols=271 Identities=27% Similarity=0.368 Sum_probs=218.5
Q ss_pred hhhhcccccc-eecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch-hhHHHHHHHHHHHhccCCCcccceeeE
Q 018785 18 IATKNFCSDY-LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLVKLIGY 95 (350)
Q Consensus 18 ~~~~~y~i~~-~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~ 95 (350)
+..++|.+.. .||+|+||.||+|++. ...++..||+|.+..... .....+.+|+.+++.++||||++++++
T Consensus 6 ~~~~~~~i~~~~lg~G~~g~Vy~~~~~-------~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 78 (287)
T 1u59_A 6 LKRDNLLIADIELGCGNFGSVRQGVYR-------MRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGV 78 (287)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC----------CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccHHHhhhhhccccccCceeEEEeEec-------cCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEE
Confidence 3456777777 9999999999999642 334578999999976532 345678899999999999999999999
Q ss_pred EeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccc
Q 018785 96 CSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDF 175 (350)
Q Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Df 175 (350)
+ ..+..++|||++.+++|.+++.... ..+++..++.++.|++.||.||| +.|++|+||+|+||+++.++.++|+||
T Consensus 79 ~-~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dlkp~Nili~~~~~~kl~Df 154 (287)
T 1u59_A 79 C-QAEALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLE--EKNFVHRDLAARNVLLVNRHYAKISDF 154 (287)
T ss_dssp E-ESSSEEEEEECCTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEEEETTEEEECCC
T ss_pred e-cCCCcEEEEEeCCCCCHHHHHHhCC-ccCCHHHHHHHHHHHHHHHHHHH--HCCEeeCCCchheEEEcCCCCEEECcc
Confidence 9 5567999999999999999986543 36999999999999999999999 899999999999999999999999999
Q ss_pred cccccCCCCCCCc-ccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccccCcchhhhhhhcchhh
Q 018785 176 GLARDGPTGDNTH-VSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFL 253 (350)
Q Consensus 176 g~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~ 253 (350)
|++.......... ......+++.|+|||.+.+..++.++|+||||+++|+|++ |..||..........
T Consensus 155 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~---------- 224 (287)
T 1u59_A 155 GLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMA---------- 224 (287)
T ss_dssp TTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHH----------
T ss_pred cceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHH----------
Confidence 9997653332211 1222345788999999988899999999999999999998 999997654322111
Q ss_pred hhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcCCCCCCCC
Q 018785 254 RDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDMPRTP 317 (350)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~~~~~ 317 (350)
.+........+..+++.+.+++.+||..||.+|||+.+++++|+.+..+...+...
T Consensus 225 --------~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~~~ 280 (287)
T 1u59_A 225 --------FIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEG 280 (287)
T ss_dssp --------HHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTCSS
T ss_pred --------HHhcCCcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCcccC
Confidence 11112223445677889999999999999999999999999999998876655443
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=324.60 Aligned_cols=255 Identities=24% Similarity=0.329 Sum_probs=210.8
Q ss_pred hhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh------hHHHHHHHHHHHhccCCCcccc
Q 018785 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ------GHKEWLTEVIYLGQLRHENLVK 91 (350)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~ 91 (350)
...++|++.+.||+|+||.||+| .+..+|..||+|.+...... ....+.+|+.+++.++||||++
T Consensus 9 ~~~~~y~~~~~lg~G~~g~V~~~---------~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 79 (321)
T 2a2a_A 9 KVEDFYDIGEELGSGQFAIVKKC---------REKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79 (321)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEE---------EETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCC
T ss_pred hhhccEEEeeEeeecCCEEEEEE---------EECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcce
Confidence 35689999999999999999999 56667899999998765332 3567889999999999999999
Q ss_pred eeeEEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCC---
Q 018785 92 LIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNF--- 168 (350)
Q Consensus 92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~--- 168 (350)
+++++.+.+..++||||+++++|.+++.... .+++..++.++.|++.||.||| +.|++|+||+|+||+++.++
T Consensus 80 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH--~~~ivH~dikp~NIl~~~~~~~~ 155 (321)
T 2a2a_A 80 LHDVYENRTDVVLILELVSGGELFDFLAQKE--SLSEEEATSFIKQILDGVNYLH--TKKIAHFDLKPENIMLLDKNIPI 155 (321)
T ss_dssp EEEEEECSSEEEEEECCCCSCBHHHHHHTCS--CEEHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEESCTTSSS
T ss_pred EEEEEecCCEEEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCChHHEEEecCCCCc
Confidence 9999999999999999999999999997654 7899999999999999999999 89999999999999999887
Q ss_pred -cEEEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhh
Q 018785 169 -NAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVE 247 (350)
Q Consensus 169 -~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~ 247 (350)
.++|+|||++........ .....|++.|+|||.+.+..++.++|+||||+++|+|++|..||.+.........+..
T Consensus 156 ~~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~ 232 (321)
T 2a2a_A 156 PHIKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITS 232 (321)
T ss_dssp CCEEECCCTTCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHT
T ss_pred CCEEEccCccceecCcccc---ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHh
Confidence 799999999976443221 2234689999999999999999999999999999999999999976543222221111
Q ss_pred hcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 248 WADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
... .........+++.+.+||.+||..||.+|||+.++++|
T Consensus 233 ~~~---------------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 233 VSY---------------DFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp TCC---------------CCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred ccc---------------ccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 100 00001112456789999999999999999999999975
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=329.58 Aligned_cols=266 Identities=25% Similarity=0.391 Sum_probs=210.9
Q ss_pred hhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch-hhHHHHHHHHHHHhccCCCcccceeeEE
Q 018785 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLVKLIGYC 96 (350)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (350)
...++|++.+.||+|+||+||+|++... ...-..+|++|.+..... .....+.+|+..++.++||||+++++++
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~-----~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 84 (325)
T 3kex_A 10 FKETELRKLKVLGSGVFGTVHKGVWIPE-----GESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLC 84 (325)
T ss_dssp CCTTTEEEEEEEECCSSCEEEEEEECCT-----TCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEE
T ss_pred cCHhHceeeeeeeecCCceEEEEEEcCC-----CceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEE
Confidence 3467999999999999999999955321 111233478887754432 2224466789999999999999999988
Q ss_pred eecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcccc
Q 018785 97 SESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFG 176 (350)
Q Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg 176 (350)
. ++..++||||+.+++|.+++.... ..+++..++.++.|++.||.||| +.|++|+||||+||+++.++.++|+|||
T Consensus 85 ~-~~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~Dikp~Nil~~~~~~~kl~Dfg 160 (325)
T 3kex_A 85 P-GSSLQLVTQYLPLGSLLDHVRQHR-GALGPQLLLNWGVQIAKGMYYLE--EHGMVHRNLAARNVLLKSPSQVQVADFG 160 (325)
T ss_dssp C-BSSEEEEEECCTTCBSHHHHHSSG-GGSCTTHHHHHHHHHHHHHHHHH--HTTCCCSCCSSTTEEESSSSCEEECSCS
T ss_pred c-CCccEEEEEeCCCCCHHHHHHHcc-ccCCHHHHHHHHHHHHHHHHHHH--hCCCCCCccchheEEECCCCeEEECCCC
Confidence 6 567899999999999999997652 36899999999999999999999 8999999999999999999999999999
Q ss_pred ccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccccCcchhhhhhhcchhhhh
Q 018785 177 LARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRD 255 (350)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 255 (350)
++................++..|+|||.+.+..++.++||||||+++|+|++ |..||.+.........+
T Consensus 161 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~---------- 230 (325)
T 3kex_A 161 VADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLL---------- 230 (325)
T ss_dssp GGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHH----------
T ss_pred cccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHH----------
Confidence 9987655444434444567788999999999999999999999999999999 99999865533222211
Q ss_pred hHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcC
Q 018785 256 SRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 310 (350)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 310 (350)
........+..++.++.+++.+||..||.+|||+.+++++|..+...
T Consensus 231 --------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~ 277 (325)
T 3kex_A 231 --------EKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277 (325)
T ss_dssp --------HTTCBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred --------HcCCCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 11122233445677889999999999999999999999999998654
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=331.03 Aligned_cols=271 Identities=23% Similarity=0.288 Sum_probs=211.8
Q ss_pred hhhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccC-----CCcc
Q 018785 15 ISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLR-----HENL 89 (350)
Q Consensus 15 ~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-----h~~i 89 (350)
.+.+..++|++.++||+|+||+||+| .+..+++.||||++.... ........|+.+++.+. ||||
T Consensus 29 ~g~~~~~~y~~~~~lG~G~~g~V~~~---------~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~h~~i 98 (360)
T 3llt_A 29 KGMLLNNAFLVIRKMGDGTFGRVLLC---------QHIDNKKYYAVKVVRNIK-KYTRSAKIEADILKKIQNDDINNNNI 98 (360)
T ss_dssp TTCEETTTEEEEEEEEECSSEEEEEE---------EETTTCCEEEEEEECSCH-HHHHHHHHHHHHHHHTCCCSTTGGGB
T ss_pred cceEecCEEEEEEEEcccCCeEEEEE---------EECCCCeEEEEEEeccch-hhhhhhHHHHHHHHHhcccCCCCCCe
Confidence 44566789999999999999999999 555678999999987543 33455677899998886 9999
Q ss_pred cceeeEEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcC---
Q 018785 90 VKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS--- 166 (350)
Q Consensus 90 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~--- 166 (350)
+++++++...+..++|||++ +++|.+++.......++...++.++.||+.||.||| +.|++|+||||+||+++.
T Consensus 99 v~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH--~~~ivHrDlkp~NIll~~~~~ 175 (360)
T 3llt_A 99 VKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLR--KMSLTHTDLKPENILLDDPYF 175 (360)
T ss_dssp CCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEESCTTC
T ss_pred ecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--HCCeeeCCCCcccEEEccccc
Confidence 99999999999999999999 999999998877667999999999999999999999 899999999999999975
Q ss_pred ----------------------CCcEEEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHH
Q 018785 167 ----------------------NFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLL 224 (350)
Q Consensus 167 ----------------------~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~ 224 (350)
++.++|+|||++....... ....|++.|+|||++.+..++.++|||||||++|
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 250 (360)
T 3llt_A 176 EKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH-----GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLA 250 (360)
T ss_dssp CEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC-----CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHH
T ss_pred cccccchhcccccccccccccCCCCEEEEeccCceecCCCC-----cCccCcccccCcHHHcCCCCCCccchHHHHHHHH
Confidence 7889999999997533222 2356889999999999999999999999999999
Q ss_pred HHHhCCCCCcccccCcchhhhhhhcchhhhhhHHHHH------hhhc---------------------ccCCCCcHHHHH
Q 018785 225 ELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLR------IMDT---------------------RLGGQYSKKEAQ 277 (350)
Q Consensus 225 ~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~---------------------~~~~~~~~~~~~ 277 (350)
+|++|+.||...........+.....+.......... .... ..........++
T Consensus 251 ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (360)
T 3llt_A 251 ELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHE 330 (360)
T ss_dssp HHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCH
T ss_pred HHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHH
Confidence 9999999998765443333333322211111000000 0000 000000111236
Q ss_pred HHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 278 AVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 278 ~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
.+.+||.+||+.||.+|||+.++++|
T Consensus 331 ~l~~li~~~L~~dP~~Rpta~elL~h 356 (360)
T 3llt_A 331 LFCDFLYSILQIDPTLRPSPAELLKH 356 (360)
T ss_dssp HHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 78899999999999999999999865
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=324.55 Aligned_cols=271 Identities=24% Similarity=0.313 Sum_probs=213.9
Q ss_pred hhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceeeE
Q 018785 16 SKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGY 95 (350)
Q Consensus 16 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 95 (350)
..+..++|++.+.||+|+||.||+| .+..+++.||+|.+..........+.+|+.+++.++||||++++++
T Consensus 24 ~~i~~~~y~~~~~lg~G~~g~V~~~---------~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 94 (317)
T 2buj_A 24 VIIDNKHYLFIQKLGEGGFSYVDLV---------EGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAY 94 (317)
T ss_dssp EEETTEEEEEEEEEEC--CEEEEEE---------EETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEE
T ss_pred EEECCeEEEEEEEecCCCCeEEEEE---------EecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 3456789999999999999999999 5566789999999877666666788999999999999999999999
Q ss_pred Eee----cCceEEEEEcCCCCChhhHHhhc--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCc
Q 018785 96 CSE----SDNRLLVYEFMPKGSLENHLFRK--GVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFN 169 (350)
Q Consensus 96 ~~~----~~~~~lv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~ 169 (350)
+.. ....++||||+.+++|.+++... ....+++..++.++.|++.||.||| +.|++|+||+|+||+++.++.
T Consensus 95 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH--~~~ivH~dlkp~NIl~~~~~~ 172 (317)
T 2buj_A 95 CLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH--AKGYAHRDLKPTNILLGDEGQ 172 (317)
T ss_dssp EEEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTSC
T ss_pred EEeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHHEEEcCCCC
Confidence 863 34788999999999999999753 2347999999999999999999999 899999999999999999999
Q ss_pred EEEccccccccCCCCCCCc-------ccccccCCCcccCccccccCC---CCCccchhhHHHHHHHHHhCCCCCcccccC
Q 018785 170 AKLSDFGLARDGPTGDNTH-------VSTRIVGTRGYAAPEYVATGH---LTPKSDVYSFGVVLLELLSGRRALDEDRGG 239 (350)
Q Consensus 170 ~~l~Dfg~~~~~~~~~~~~-------~~~~~~~~~~~~aPE~~~~~~---~~~~~DiwslG~ll~~ll~g~~pf~~~~~~ 239 (350)
++|+|||++.......... ......+++.|+|||++.+.. ++.++||||||+++|+|++|..||......
T Consensus 173 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~ 252 (317)
T 2buj_A 173 PVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQK 252 (317)
T ss_dssp EEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHT
T ss_pred EEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcc
Confidence 9999999886532211110 011245688999999987553 689999999999999999999999643211
Q ss_pred cchhhhhhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcCCCC
Q 018785 240 LAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDM 313 (350)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~ 313 (350)
.. .................++..+.++|.+||+.||.+|||+.+++++|+.+......
T Consensus 253 ~~----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~ 310 (317)
T 2buj_A 253 GD----------------SVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPG 310 (317)
T ss_dssp TS----------------CHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCCC
T ss_pred cc----------------hhhHHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCCC
Confidence 00 00011111111222345678999999999999999999999999999998766443
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=340.51 Aligned_cols=253 Identities=27% Similarity=0.418 Sum_probs=212.4
Q ss_pred hhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch---hhHHHHHHHHHHHhccCCCcccce
Q 018785 16 SKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLVKL 92 (350)
Q Consensus 16 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~ 92 (350)
+.+..++|.+.+.||+|+||.||+| .+..+|+.||||++..... .....+.+|+.+++.++||||+++
T Consensus 11 ~~~~~~~Y~l~~~LG~G~fg~V~~a---------~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l 81 (476)
T 2y94_A 11 GRVKIGHYILGDTLGVGTFGKVKVG---------KHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL 81 (476)
T ss_dssp SCCEETTEEEEEEEECCSSSCEEEE---------EETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCE
T ss_pred CCceecCEEEEEEEeeCCCeEEEEE---------EECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcE
Confidence 3455689999999999999999999 6666799999999976532 234578899999999999999999
Q ss_pred eeEEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEE
Q 018785 93 IGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKL 172 (350)
Q Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l 172 (350)
++++...+..++||||+++++|.+++.... .+++..++.++.|++.||.||| +.|++|+||||+||+++.++.++|
T Consensus 82 ~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH--~~givHrDLkp~NIll~~~~~vkL 157 (476)
T 2y94_A 82 YQVISTPSDIFMVMEYVSGGELFDYICKNG--RLDEKESRRLFQQILSGVDYCH--RHMVVHRDLKPENVLLDAHMNAKI 157 (476)
T ss_dssp EEEEECSSEEEEEEECCSSEEHHHHTTSSS--SCCHHHHHHHHHHHHHHHHHHH--TTTEECSCCSGGGEEECTTCCEEE
T ss_pred EEEEEECCEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--HCCCCcccccHHHEEEecCCCeEE
Confidence 999999999999999999999999997654 7999999999999999999999 999999999999999999999999
Q ss_pred ccccccccCCCCCCCcccccccCCCcccCccccccCCC-CCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcch
Q 018785 173 SDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHL-TPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADP 251 (350)
Q Consensus 173 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~ 251 (350)
+|||++....... ......|++.|+|||++.+..+ +.++|||||||++|+|++|..||.+.........+.
T Consensus 158 ~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~----- 229 (476)
T 2y94_A 158 ADFGLSNMMSDGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKIC----- 229 (476)
T ss_dssp CCCSSCEECCTTC---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHH-----
T ss_pred Eeccchhhccccc---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHh-----
Confidence 9999998643322 2233568999999999988765 689999999999999999999997654322211111
Q ss_pred hhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 252 FLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
... ...+..+++++.+||.+||..||.+|||+.++++|
T Consensus 230 ------------~~~--~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 230 ------------DGI--FYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp ------------TTC--CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred ------------cCC--cCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence 111 12344567889999999999999999999999986
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=320.42 Aligned_cols=257 Identities=24% Similarity=0.370 Sum_probs=209.6
Q ss_pred hhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceeeE
Q 018785 16 SKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGY 95 (350)
Q Consensus 16 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 95 (350)
.....++|++.+.||+|+||.||+| .+..+|+.||+|.+..........+.+|+..++.++||||++++++
T Consensus 4 ~~~~~~~y~~~~~lg~G~~g~V~~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 74 (304)
T 2jam_A 4 TTNIRKTFIFMEVLGSGAFSEVFLV---------KQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDI 74 (304)
T ss_dssp --CHHHHEEEEEEEEECSSEEEEEE---------EETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccchhccceeeeeccCCCCceEEEE---------EECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhh
Confidence 3456789999999999999999999 5566789999999987654455678899999999999999999999
Q ss_pred EeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEE---cCCCcEEE
Q 018785 96 CSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLL---DSNFNAKL 172 (350)
Q Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili---~~~~~~~l 172 (350)
+.+.+..++|||++++++|.+++.... .+++..+..++.|++.||.||| +.|++|+||+|+||++ +.++.++|
T Consensus 75 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dikp~NIl~~~~~~~~~~kl 150 (304)
T 2jam_A 75 YESTTHYYLVMQLVSGGELFDRILERG--VYTEKDASLVIQQVLSAVKYLH--ENGIVHRDLKPENLLYLTPEENSKIMI 150 (304)
T ss_dssp EECSSEEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH--HTTCCCCSCCGGGCEESSSSTTCCEEB
T ss_pred cccCCEEEEEEEcCCCccHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCccccCCCHHHEEEecCCCCCCEEE
Confidence 999999999999999999999997765 6899999999999999999999 8999999999999999 77889999
Q ss_pred ccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchh
Q 018785 173 SDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPF 252 (350)
Q Consensus 173 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 252 (350)
+|||++...... ......+++.|+|||.+.+..++.++||||||+++|+|++|..||...........+...
T Consensus 151 ~Dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~---- 222 (304)
T 2jam_A 151 TDFGLSKMEQNG----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEG---- 222 (304)
T ss_dssp CSCSTTCCCCCB----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHC----
T ss_pred ccCCcceecCCC----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC----
Confidence 999998653221 223356899999999999999999999999999999999999999765432211111110
Q ss_pred hhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018785 253 LRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL 304 (350)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 304 (350)
...........+++.+.++|.+||..||.+|||+.++++|-
T Consensus 223 -----------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~ 263 (304)
T 2jam_A 223 -----------YYEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHP 263 (304)
T ss_dssp -----------CCCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSH
T ss_pred -----------CCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCc
Confidence 00111223346778999999999999999999999999863
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-44 Score=323.12 Aligned_cols=270 Identities=27% Similarity=0.440 Sum_probs=212.6
Q ss_pred hhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch-hhHHHHHHHHHHHhccCCCcccceee
Q 018785 16 SKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLVKLIG 94 (350)
Q Consensus 16 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~ 94 (350)
.++..++|.+.+.||+|+||+||+|++.. .....+..||+|.+..... .....+.+|+.+++.++||||+++++
T Consensus 39 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~-----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 113 (333)
T 1mqb_A 39 TEIHPSCVTRQKVIGAGEFGEVYKGMLKT-----SSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEG 113 (333)
T ss_dssp CBCCTTTEEEEEEEEECSSSEEEEEEEEC--------CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred ccCChHHhhcccEEecCCCeEEEEEEEec-----CCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEE
Confidence 35567899999999999999999996643 1223456799999876532 33456889999999999999999999
Q ss_pred EEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcc
Q 018785 95 YCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSD 174 (350)
Q Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~D 174 (350)
++...+..++|||++++++|.+++.... ..++...++.++.|++.||.||| +.|++|+||+|+||+++.++.++|+|
T Consensus 114 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dikp~NIl~~~~~~~kl~D 190 (333)
T 1mqb_A 114 VISKYKPMMIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLA--NMNYVHRDLAARNILVNSNLVCKVSD 190 (333)
T ss_dssp EECSSSSEEEEEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTTCCEEECC
T ss_pred EEecCCCcEEEEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH--hCCeeCCCCChheEEECCCCcEEECC
Confidence 9999999999999999999999997653 36999999999999999999999 89999999999999999999999999
Q ss_pred ccccccCCCCCCCc-ccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccccCcchhhhhhhcchh
Q 018785 175 FGLARDGPTGDNTH-VSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPF 252 (350)
Q Consensus 175 fg~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~ 252 (350)
||++.......... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.........
T Consensus 191 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~---------- 260 (333)
T 1mqb_A 191 FGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVM---------- 260 (333)
T ss_dssp CCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH----------
T ss_pred CCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHH----------
Confidence 99997643322111 1122345678999999998999999999999999999998 99999654421111
Q ss_pred hhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcCC
Q 018785 253 LRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSK 311 (350)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~ 311 (350)
..+........+..+++.+.+++.+||+.||.+||++.+++++|+++....
T Consensus 261 --------~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 311 (333)
T 1mqb_A 261 --------KAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 311 (333)
T ss_dssp --------HHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred --------HHHHCCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 111112222334567889999999999999999999999999999987653
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-45 Score=342.24 Aligned_cols=252 Identities=27% Similarity=0.375 Sum_probs=203.9
Q ss_pred hhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch---hhHHHHHHHHHHHhccCCCcccceee
Q 018785 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLVKLIG 94 (350)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~ 94 (350)
+..++|++.+.||+|+||.||+| .+..+|+.||||++..... .....+.+|+.+++.++||||+++++
T Consensus 145 ~~~~~y~~~~~lG~G~~g~V~~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~ 215 (446)
T 4ejn_A 145 VTMNEFEYLKLLGKGTFGKVILV---------KEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 215 (446)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEE---------EETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEE
T ss_pred CChHHcEEeEEEeeCcCEEEEEE---------EEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEE
Confidence 44578999999999999999999 6667799999999876432 23355678999999999999999999
Q ss_pred EEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCC-CCeeeCCCCCCceEEcCCCcEEEc
Q 018785 95 YCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLD-ANVIYRDLKASNVLLDSNFNAKLS 173 (350)
Q Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~-~~i~H~di~~~Nili~~~~~~~l~ 173 (350)
++...+..++||||+++++|.+++.... .+++..+..++.|++.||+||| + .||+|+||||+||+++.++.++|+
T Consensus 216 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH--~~~giiHrDlkp~NIll~~~~~~kl~ 291 (446)
T 4ejn_A 216 SFQTHDRLCFVMEYANGGELFFHLSRER--VFSEDRARFYGAEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKIT 291 (446)
T ss_dssp EEEETTEEEEEECCCSSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH--HHTCCCCCCCCGGGEEECSSSCEEEC
T ss_pred EEeeCCEEEEEEeeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHh--hcCCEEECCCCHHHEEECCCCCEEEc
Confidence 9999999999999999999999997765 7999999999999999999999 7 899999999999999999999999
Q ss_pred cccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhh
Q 018785 174 DFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 253 (350)
Q Consensus 174 Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 253 (350)
|||++....... .......|++.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+.
T Consensus 292 DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~------- 362 (446)
T 4ejn_A 292 DFGLCKEGIKDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL------- 362 (446)
T ss_dssp CCCCCCTTCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-------
T ss_pred cCCCceeccCCC--cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHH-------
Confidence 999997532222 22334678999999999999999999999999999999999999997654322211111
Q ss_pred hhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 018785 254 RDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRP-----SMVDVLTS 303 (350)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~~ 303 (350)
.. ....+..+++++.+||.+||+.||.+|| +++++++|
T Consensus 363 ----------~~--~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 363 ----------ME--EIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp ----------HC--CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ----------hC--CCCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 11 1223456788999999999999999999 99999986
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-45 Score=325.25 Aligned_cols=266 Identities=24% Similarity=0.351 Sum_probs=204.8
Q ss_pred hhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh---hHHHHHHHHHHHhccCCCccccee
Q 018785 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ---GHKEWLTEVIYLGQLRHENLVKLI 93 (350)
Q Consensus 17 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~ 93 (350)
....++|++.+.||+|+||.||+| .+..+++.||||++...... ....+.+|+..+++++||||++++
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~V~~~---------~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~ 78 (311)
T 3ork_A 8 SHLSDRYELGEILGFGGMSEVHLA---------RDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78 (311)
T ss_dssp SEETTTEEEEEEEEECSSEEEEEE---------EETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEE
T ss_pred ceecCcEEEEEEEccCCCEEEEEE---------EECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEE
Confidence 455789999999999999999999 56667999999999765332 235678999999999999999999
Q ss_pred eEEeecCce----EEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCc
Q 018785 94 GYCSESDNR----LLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFN 169 (350)
Q Consensus 94 ~~~~~~~~~----~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~ 169 (350)
+++...... ++||||+++++|.+++.... .+++..++.++.|++.||.||| +.|++|+||||+||+++.++.
T Consensus 79 ~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~dlkp~Nil~~~~~~ 154 (311)
T 3ork_A 79 DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSH--QNGIIHRDVKPANIMISATNA 154 (311)
T ss_dssp EEEEEEETTEEEEEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEEETTSC
T ss_pred EeeeccCCCCcccEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--HCCCCcCCCCHHHEEEcCCCC
Confidence 998776544 99999999999999998765 6999999999999999999999 899999999999999999999
Q ss_pred EEEccccccccCCCCCCC-cccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhh
Q 018785 170 AKLSDFGLARDGPTGDNT-HVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEW 248 (350)
Q Consensus 170 ~~l~Dfg~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~ 248 (350)
++|+|||++......... .......|++.|+|||.+.+..++.++||||||+++|+|++|+.||.+.............
T Consensus 155 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~ 234 (311)
T 3ork_A 155 VKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVRE 234 (311)
T ss_dssp EEECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHC
T ss_pred EEEeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcC
Confidence 999999999754333222 1223356899999999999999999999999999999999999999765432211111110
Q ss_pred cchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHH-HHHHhhhcC
Q 018785 249 ADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL-TSLEQLHTS 310 (350)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll-~~L~~~~~~ 310 (350)
.. .........+++++.++|.+||+.||.+||+..+++ +.|..+...
T Consensus 235 ~~---------------~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~ 282 (311)
T 3ork_A 235 DP---------------IPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNG 282 (311)
T ss_dssp CC---------------CCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTT
T ss_pred CC---------------CCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcC
Confidence 00 000001224678899999999999999999666555 556666554
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=328.72 Aligned_cols=252 Identities=25% Similarity=0.380 Sum_probs=194.7
Q ss_pred hhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceeeEEe
Q 018785 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (350)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (350)
...++|++.+.||+|+||+||+| .+..+++.||||++.... ..+.+.+|+.++++++||||+++++++.
T Consensus 50 ~~~~~y~~~~~lG~G~~g~Vy~~---------~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~ 118 (349)
T 2w4o_A 50 ALSDFFEVESELGRGATSIVYRC---------KQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFE 118 (349)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEE---------EETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEE
T ss_pred cccCcEEEeeEEeeCCCEEEEEE---------EECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEe
Confidence 44678999999999999999999 555668899999987653 3456788999999999999999999999
Q ss_pred ecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcC---CCcEEEcc
Q 018785 98 ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS---NFNAKLSD 174 (350)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~---~~~~~l~D 174 (350)
..+..++||||+++++|.+++.... .+++.+++.++.|++.||.||| +.|++|+||||+||+++. ++.++|+|
T Consensus 119 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~LH--~~~ivH~Dikp~NIll~~~~~~~~~kl~D 194 (349)
T 2w4o_A 119 TPTEISLVLELVTGGELFDRIVEKG--YYSERDAADAVKQILEAVAYLH--ENGIVHRDLKPENLLYATPAPDAPLKIAD 194 (349)
T ss_dssp CSSEEEEEECCCCSCBHHHHHTTCS--SCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEESSSSTTCCEEECC
T ss_pred cCCeEEEEEEeCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--HCCeEecCCCcccEEEecCCCCCCEEEcc
Confidence 9999999999999999999997654 6999999999999999999999 899999999999999975 78899999
Q ss_pred ccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhh
Q 018785 175 FGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLR 254 (350)
Q Consensus 175 fg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~ 254 (350)
||++....... ......|++.|+|||++.+..++.++|||||||++|+|++|..||.........
T Consensus 195 fg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~------------ 259 (349)
T 2w4o_A 195 FGLSKIVEHQV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFM------------ 259 (349)
T ss_dssp CC-------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHH------------
T ss_pred CccccccCccc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHH------------
Confidence 99997543221 123356899999999999999999999999999999999999999754432100
Q ss_pred hhHHHHHhhhcc--cCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 255 DSRRVLRIMDTR--LGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 255 ~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
...+.... ........++.++.+||.+||..||.+|||+.++++|
T Consensus 260 ----~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 260 ----FRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp ----HHHHHTTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ----HHHHHhCCCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00111111 1112234577899999999999999999999999975
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=317.88 Aligned_cols=263 Identities=28% Similarity=0.403 Sum_probs=212.7
Q ss_pred hhhhcccccc-eecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh--hHHHHHHHHHHHhccCCCcccceee
Q 018785 18 IATKNFCSDY-LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ--GHKEWLTEVIYLGQLRHENLVKLIG 94 (350)
Q Consensus 18 ~~~~~y~i~~-~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~ 94 (350)
+..++|++.+ .||+|+||+||+|.+. ...++..||||++...... ....+.+|+.+++.++||||+++++
T Consensus 13 ~~~~~y~~~~~~lg~G~~g~Vy~~~~~-------~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 85 (291)
T 1xbb_A 13 LDRKLLTLEDKELGSGNFGTVKKGYYQ-------MKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIG 85 (291)
T ss_dssp CCGGGEEEEEEEEEECSSEEEEEEEEE-------CSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred ecchhhhhccCccccccCeeeEeeeec-------CCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence 3467899998 9999999999999652 3345789999998765332 2467889999999999999999999
Q ss_pred EEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcc
Q 018785 95 YCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSD 174 (350)
Q Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~D 174 (350)
++ ..+..++|||++++++|.+++.... .+++..++.++.|++.||.||| +.|++|+||+|+||+++.++.++|+|
T Consensus 86 ~~-~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH--~~~i~H~dikp~Nil~~~~~~~kl~D 160 (291)
T 1xbb_A 86 IC-EAESWMLVMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLE--ESNFVHRDLAARNVLLVTQHYAKISD 160 (291)
T ss_dssp EE-ESSSEEEEEECCTTEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEEEETTEEEECC
T ss_pred EE-CCCCcEEEEEeCCCCCHHHHHHhCc--CCCHHHHHHHHHHHHHHHHHHH--hCCeEcCCCCcceEEEeCCCcEEEcc
Confidence 99 5678899999999999999998764 6999999999999999999999 89999999999999999999999999
Q ss_pred ccccccCCCCCCCc-ccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccccCcchhhhhhhcchh
Q 018785 175 FGLARDGPTGDNTH-VSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPF 252 (350)
Q Consensus 175 fg~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~ 252 (350)
||++.......... ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.........
T Consensus 161 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~---------- 230 (291)
T 1xbb_A 161 FGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT---------- 230 (291)
T ss_dssp CTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH----------
T ss_pred CCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHH----------
Confidence 99997654332211 1122345678999999988889999999999999999999 99999765432111
Q ss_pred hhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcC
Q 018785 253 LRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 310 (350)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 310 (350)
..+........+..+++.+.+++.+||+.||.+|||+.++++.|+++...
T Consensus 231 --------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 280 (291)
T 1xbb_A 231 --------AMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 280 (291)
T ss_dssp --------HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred --------HHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 11112222334556788999999999999999999999999999988754
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=318.19 Aligned_cols=257 Identities=27% Similarity=0.403 Sum_probs=211.3
Q ss_pred hhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceeeE
Q 018785 16 SKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGY 95 (350)
Q Consensus 16 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 95 (350)
.+..+.+|++.+.||+|+||.||+| .+..+++.||+|.+.... ..+.+|+.+++.++||||++++++
T Consensus 6 ~~~~~~~y~~~~~lg~G~~g~V~~~---------~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~ 72 (284)
T 2a19_B 6 DKRFGMDFKEIELIGSGGFGQVFKA---------KHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGC 72 (284)
T ss_dssp CHHHHHHEEEEEEEECSSSCCEEEE---------EETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEE
T ss_pred cchhccccceeeeeccCCceEEEEE---------EEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeee
Confidence 4566789999999999999999999 555668999999987654 235679999999999999999998
Q ss_pred Eee----------------cCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCC
Q 018785 96 CSE----------------SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKA 159 (350)
Q Consensus 96 ~~~----------------~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~ 159 (350)
+.. ....++||||+++++|.+++.......+++..++.++.|++.||.||| +.|++|+||+|
T Consensus 73 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH--~~~i~H~dlkp 150 (284)
T 2a19_B 73 WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIH--SKKLINRDLKP 150 (284)
T ss_dssp EEEEEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSG
T ss_pred EeccccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH--hCCeeeccCCH
Confidence 854 455899999999999999998765557999999999999999999999 89999999999
Q ss_pred CceEEcCCCcEEEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccC
Q 018785 160 SNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGG 239 (350)
Q Consensus 160 ~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~ 239 (350)
+||+++.++.++|+|||++........ .....+++.|+|||.+.+..++.++|+||||+++|+|++|..|+.....
T Consensus 151 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~- 226 (284)
T 2a19_B 151 SNIFLVDTKQVKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK- 226 (284)
T ss_dssp GGEEEEETTEEEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHH-
T ss_pred HHEEEcCCCCEEECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHH-
Confidence 999999999999999999876433322 2234588999999999999999999999999999999999988743210
Q ss_pred cchhhhhhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcCCCC
Q 018785 240 LAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDM 313 (350)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~ 313 (350)
..... .....+..++..+.+++.+||..||.+|||+.+++++|+.+......
T Consensus 227 ------------------~~~~~----~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~ 278 (284)
T 2a19_B 227 ------------------FFTDL----RDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEK 278 (284)
T ss_dssp ------------------HHHHH----HTTCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC----
T ss_pred ------------------HHHHh----hcccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCc
Confidence 00000 11123345677899999999999999999999999999998876443
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=328.02 Aligned_cols=259 Identities=24% Similarity=0.354 Sum_probs=204.8
Q ss_pred hhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch--hhHHHHHHHHHHHhccCC--Ccccc
Q 018785 16 SKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLRH--ENLVK 91 (350)
Q Consensus 16 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h--~~i~~ 91 (350)
..+.+++|++.+.||+|+||.||+|+ + .+++.||||.+..... .....+.+|+.+++.+.| |||++
T Consensus 4 i~~~~~~y~i~~~lG~G~~g~Vy~~~---------~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~ 73 (343)
T 3dbq_A 4 ISVKGRIYSILKQIGSGGSSKVFQVL---------N-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 73 (343)
T ss_dssp EESSSCEEEEEEEESCCSSEEEEEEE---------C-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCC
T ss_pred eeeecCEEEEEEEEecCCCeEEEEEE---------e-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEE
Confidence 35678899999999999999999993 3 3478899999875432 334668899999999976 99999
Q ss_pred eeeEEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEE
Q 018785 92 LIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAK 171 (350)
Q Consensus 92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~ 171 (350)
+++++..++..++|||+ .+++|.+++.... .+++.++..++.|++.||.||| +.|++|+||||+||+++ ++.++
T Consensus 74 ~~~~~~~~~~~~lv~e~-~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH--~~~iiHrDikp~NIll~-~~~~k 147 (343)
T 3dbq_A 74 LYDYEITDQYIYMVMEC-GNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIH--QHGIVHSDLKPANFLIV-DGMLK 147 (343)
T ss_dssp EEEEEECSSEEEEEECC-CSEEHHHHHHHSC--CCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEEE-TTEEE
T ss_pred EeeeEeeCCEEEEEEeC-CCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCcceEEEE-CCcEE
Confidence 99999999999999995 5889999998765 7999999999999999999999 89999999999999996 67899
Q ss_pred EccccccccCCCCCCCcccccccCCCcccCcccccc-----------CCCCCccchhhHHHHHHHHHhCCCCCcccccCc
Q 018785 172 LSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-----------GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGL 240 (350)
Q Consensus 172 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-----------~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~ 240 (350)
|+|||++................|++.|+|||++.+ ..++.++|||||||++|+|++|..||......
T Consensus 148 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~- 226 (343)
T 3dbq_A 148 LIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ- 226 (343)
T ss_dssp ECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-
T ss_pred EeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH-
Confidence 999999986544433333344678999999999865 67888999999999999999999999653321
Q ss_pred chhhhhhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 018785 241 AEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQ 306 (350)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 306 (350)
................+...+..+.+|+.+||+.||.+|||+.++++|-.-
T Consensus 227 ---------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~ 277 (343)
T 3dbq_A 227 ---------------ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 277 (343)
T ss_dssp ---------------HHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred ---------------HHHHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccc
Confidence 111222222233334455566789999999999999999999999988543
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=316.76 Aligned_cols=256 Identities=25% Similarity=0.331 Sum_probs=209.3
Q ss_pred hhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch-hhHHHHHHHHHHHhccCCCcccceeeEEe
Q 018785 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (350)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (350)
..++|++.+.||+|++|.||+| .+..+++.||+|.+..... .....+.+|+.+++.++||||+++++++.
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~---------~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 75 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLA---------VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR 75 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEE---------EETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred eecceEEEEEeecCCCcEEEEE---------EECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEE
Confidence 3579999999999999999999 5566788999999875533 33467889999999999999999999999
Q ss_pred ecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccc
Q 018785 98 ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL 177 (350)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~ 177 (350)
+++..++|||++++++|.+++.... .+++..+..++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||.
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dl~p~Nil~~~~~~~kl~dfg~ 151 (276)
T 2yex_A 76 EGNIQYLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLH--GIGITHRDIKPENLLLDERDNLKISDFGL 151 (276)
T ss_dssp ETTEEEEEEECCTTEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred cCCEEEEEEEecCCCcHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHH--hCCeeccCCChHHEEEccCCCEEEeeCCC
Confidence 9999999999999999999986553 6999999999999999999999 89999999999999999999999999999
Q ss_pred cccCCCCCCCcccccccCCCcccCccccccCCC-CCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhh
Q 018785 178 ARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHL-TPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDS 256 (350)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 256 (350)
+................+++.|+|||.+.+..+ +.++|+||||+++|+|++|..||...........
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~------------ 219 (276)
T 2yex_A 152 ATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS------------ 219 (276)
T ss_dssp CEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHH------------
T ss_pred ccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHH------------
Confidence 975433222222334568899999999987765 6789999999999999999999976543211110
Q ss_pred HHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 257 RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
..............+++.+.+||.+||..||.+|||+.++++|
T Consensus 220 ----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 220 ----DWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp ----HHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ----HhhhcccccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 0001111111234567889999999999999999999999875
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=320.91 Aligned_cols=267 Identities=22% Similarity=0.324 Sum_probs=202.6
Q ss_pred hcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh--hHHHHHHHHHHHhccCCCcccceeeEEee
Q 018785 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ--GHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (350)
Q Consensus 21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (350)
++|++.+.||+|+||+||+|+ + .+|+.||+|.+...... ....+.+|+.+++.++||||+++++++..
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~---------~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 71 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQ---------N-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT 71 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEE---------E-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEE---------c-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEcc
Confidence 589999999999999999994 3 35789999998655432 23667899999999999999999999999
Q ss_pred cCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcccccc
Q 018785 99 SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 178 (350)
Q Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~ 178 (350)
.+..++|||++.+ +|.+++.... ..+++..+..++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++
T Consensus 72 ~~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 147 (288)
T 1ob3_A 72 KKRLVLVFEHLDQ-DLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCH--DRRVLHRDLKPQNLLINREGELKIADFGLA 147 (288)
T ss_dssp SSCEEEEEECCSE-EHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTTSCEEECCTTHH
T ss_pred CCeEEEEEEecCC-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEEcCCCCEEEeECccc
Confidence 9999999999965 9999887653 36899999999999999999999 899999999999999999999999999998
Q ss_pred ccCCCCCCCcccccccCCCcccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcc-hhhhhh
Q 018785 179 RDGPTGDNTHVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD-PFLRDS 256 (350)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~ 256 (350)
....... .......+++.|+|||++.+. .++.++|||||||++|+|++|..||.+.........+..... +.....
T Consensus 148 ~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 225 (288)
T 1ob3_A 148 RAFGIPV--RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNW 225 (288)
T ss_dssp HHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred cccCccc--cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhc
Confidence 7532211 122334678999999998764 589999999999999999999999987554333222221110 000000
Q ss_pred HHHHHh--hh-------cccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 257 RRVLRI--MD-------TRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 257 ~~~~~~--~~-------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
...... .. ..........+++++.+||.+||+.||.+|||+.++++|
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 226 PNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp TTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 000000 00 000011223467889999999999999999999999875
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=338.25 Aligned_cols=267 Identities=30% Similarity=0.421 Sum_probs=215.6
Q ss_pred hhhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceee
Q 018785 15 ISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIG 94 (350)
Q Consensus 15 ~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 94 (350)
..++..++|++.+.||+|+||.||+|++.. +..||||.+.... ...+.+.+|+.++++++||||+++++
T Consensus 178 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~----------~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~ 246 (452)
T 1fmk_A 178 AWEIPRESLRLEVKLGQGCFGEVWMGTWNG----------TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYA 246 (452)
T ss_dssp CSBCCGGGEEEEEEEEECSSCEEEEEEETT----------TEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccccChhHceeeeeecCCCCeEEEEEEECC----------CceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEE
Confidence 345667899999999999999999996532 4569999998654 33567899999999999999999999
Q ss_pred EEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcc
Q 018785 95 YCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSD 174 (350)
Q Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~D 174 (350)
++.+ +..++||||+++++|.+++.......++...+..++.|++.||+||| ++|++|+||+|+||+++.++.++|+|
T Consensus 247 ~~~~-~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH--~~~ivHrDlkp~Nill~~~~~~kl~D 323 (452)
T 1fmk_A 247 VVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE--RMNYVHRDLRAANILVGENLVCKVAD 323 (452)
T ss_dssp EECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEECGGGCEEECC
T ss_pred EEcC-CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--hCCeeCCCCChhhEEECCCCCEEECC
Confidence 9876 67899999999999999997644346999999999999999999999 89999999999999999999999999
Q ss_pred ccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccccCcchhhhhhhcchhh
Q 018785 175 FGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFL 253 (350)
Q Consensus 175 fg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~ 253 (350)
||++....... ........++..|+|||.+.+..++.++||||||+++|+|++ |..||.+.......
T Consensus 324 fG~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~----------- 391 (452)
T 1fmk_A 324 FGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL----------- 391 (452)
T ss_dssp CCTTC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH-----------
T ss_pred CccceecCCCc-eecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHH-----------
Confidence 99997643221 111222345678999999999999999999999999999999 89999765432111
Q ss_pred hhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcCCCCC
Q 018785 254 RDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDMP 314 (350)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~~ 314 (350)
..+........+..+++.+.+||.+||+.||.+|||++++++.|+.+......+
T Consensus 392 -------~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~~ 445 (452)
T 1fmk_A 392 -------DQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 445 (452)
T ss_dssp -------HHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCC
T ss_pred -------HHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCcc
Confidence 111222233445677889999999999999999999999999999998775544
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=320.77 Aligned_cols=268 Identities=22% Similarity=0.293 Sum_probs=205.8
Q ss_pred hhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh---hHHHHHHHHHHHhccCCCcccceee
Q 018785 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ---GHKEWLTEVIYLGQLRHENLVKLIG 94 (350)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~ 94 (350)
...++|++.+.||+|+||.||+| .+..+++.||+|++...... ....+.+|+..++.++||||+++++
T Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~ 101 (309)
T 2h34_A 31 TQFGPYRLRRLVGRGGMGDVYEA---------EDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHD 101 (309)
T ss_dssp ---CCEEEEEEEEECSSSEEEEE---------EETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred cEeccEEEEEEEcCCCCeeEEEE---------EEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEE
Confidence 33579999999999999999999 55667899999999765432 2366889999999999999999999
Q ss_pred EEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcc
Q 018785 95 YCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSD 174 (350)
Q Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~D 174 (350)
++..++..++|||++++++|.+++.... .+++..++.++.|++.||.||| +.|++|+||+|+||+++.++.++|+|
T Consensus 102 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH--~~~i~H~dlkp~NIl~~~~~~~kl~D 177 (309)
T 2h34_A 102 FGEIDGQLYVDMRLINGVDLAAMLRRQG--PLAPPRAVAIVRQIGSALDAAH--AAGATHRDVKPENILVSADDFAYLVD 177 (309)
T ss_dssp EEEETTEEEEEEECCCCEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTTSCEEECS
T ss_pred EEeeCCeEEEEEEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--HCcCCcCCCChHHEEEcCCCCEEEec
Confidence 9999999999999999999999998764 6999999999999999999999 89999999999999999999999999
Q ss_pred ccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhh
Q 018785 175 FGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLR 254 (350)
Q Consensus 175 fg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~ 254 (350)
||++........ .......+++.|+|||.+.+..++.++||||||+++|+|++|..||...........+..
T Consensus 178 fg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~------- 249 (309)
T 2h34_A 178 FGIASATTDEKL-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQ------- 249 (309)
T ss_dssp CCC-----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHS-------
T ss_pred CccCcccccccc-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhcc-------
Confidence 999875433221 122235688899999999999999999999999999999999999976442211111100
Q ss_pred hhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCC-CHHHHHHHHHhhhcCCCCCC
Q 018785 255 DSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRP-SMVDVLTSLEQLHTSKDMPR 315 (350)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-s~~~ll~~L~~~~~~~~~~~ 315 (350)
........+..+++.+.++|.+||..||.+|| |++++++.|.++....+.+.
T Consensus 250 ---------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~~~~ 302 (309)
T 2h34_A 250 ---------AIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATADQDR 302 (309)
T ss_dssp ---------CCCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC------
T ss_pred ---------CCCCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhcccc
Confidence 00011123446778899999999999999999 99999999999887765544
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=340.38 Aligned_cols=266 Identities=26% Similarity=0.421 Sum_probs=218.4
Q ss_pred hhhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceee
Q 018785 15 ISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIG 94 (350)
Q Consensus 15 ~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 94 (350)
..++..++|++.+.||+|+||+||+|++. .+..||||.+.... ...+.+.+|+.+++.++||||+++++
T Consensus 182 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~~----------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~ 250 (454)
T 1qcf_A 182 AWEIPRESLKLEKKLGAGQFGEVWMATYN----------KHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHA 250 (454)
T ss_dssp CSBCCGGGEEEEEEEECCSSEEEEEEEET----------TTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred ceeechHHeEEEEEcccCCceEEEEEEEC----------CccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEE
Confidence 34566789999999999999999999653 25679999997654 34678899999999999999999999
Q ss_pred EEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcc
Q 018785 95 YCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSD 174 (350)
Q Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~D 174 (350)
++. .+..++||||+.+++|.+++.......++...+..++.|++.||+||| ++|++|+||||+||+++.++.++|+|
T Consensus 251 ~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH--~~~ivHrDlkp~Nill~~~~~~kl~D 327 (454)
T 1qcf_A 251 VVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE--QRNYIHRDLRAANILVSASLVCKIAD 327 (454)
T ss_dssp EEC-SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHH--HTTCCCSSCSGGGEEECTTCCEEECS
T ss_pred EEe-CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH--hCCccCCCCCHHHEEECCCCcEEEee
Confidence 986 567899999999999999997654346889999999999999999999 89999999999999999999999999
Q ss_pred ccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccccCcchhhhhhhcchhh
Q 018785 175 FGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFL 253 (350)
Q Consensus 175 fg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~ 253 (350)
||++....... ........++..|+|||++.+..++.++||||||+++|+|++ |..||.+........
T Consensus 328 FG~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~---------- 396 (454)
T 1qcf_A 328 FGLARVIEDNE-YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIR---------- 396 (454)
T ss_dssp TTGGGGBCCHH-HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH----------
T ss_pred CCCceEcCCCc-eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHH----------
Confidence 99997542211 111122345678999999998999999999999999999999 999997654322111
Q ss_pred hhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcCCCC
Q 018785 254 RDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDM 313 (350)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~ 313 (350)
.+........+..+++++.+||.+||..||.+|||++++++.|+++......
T Consensus 397 --------~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~~~ 448 (454)
T 1qcf_A 397 --------ALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATES 448 (454)
T ss_dssp --------HHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSSCC
T ss_pred --------HHHcCCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcccc
Confidence 1112222334567788999999999999999999999999999999876543
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=318.11 Aligned_cols=260 Identities=23% Similarity=0.361 Sum_probs=216.1
Q ss_pred CchhhhhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccc---hhhHHHHHHHHHHHhccCCC
Q 018785 11 SASMISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES---FQGHKEWLTEVIYLGQLRHE 87 (350)
Q Consensus 11 ~~~~~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~ 87 (350)
+.........++|++.+.||+|+||.||+| .+..+++.||+|++.... ......+.+|+.+++.++||
T Consensus 5 p~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~---------~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ 75 (294)
T 2rku_A 5 PEVLVDPRSRRRYVRGRFLGKGGFAKCFEI---------SDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ 75 (294)
T ss_dssp CSEEEETTTTEEEEEEEEEEEETTEEEEEE---------EETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCT
T ss_pred cceeeCCCcccceEEEEEEeecCCEEEEEE---------EECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCC
Confidence 334445567899999999999999999999 566678999999987653 23446688899999999999
Q ss_pred cccceeeEEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCC
Q 018785 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSN 167 (350)
Q Consensus 88 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~ 167 (350)
||+++++++.+.+..++|||++++++|.+++.... .+++..++.++.|++.||.||| +.|++|+||+|+||+++.+
T Consensus 76 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH--~~~i~H~dl~p~Nil~~~~ 151 (294)
T 2rku_A 76 HVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLH--RNRVIHRDLKLGNLFLNED 151 (294)
T ss_dssp TBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTT
T ss_pred CEeeeeeeeccCCEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--HCCccccCCChHhEEEcCC
Confidence 99999999999999999999999999999987764 7999999999999999999999 8999999999999999999
Q ss_pred CcEEEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhh
Q 018785 168 FNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVE 247 (350)
Q Consensus 168 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~ 247 (350)
+.++|+|||++........ ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||...........
T Consensus 152 ~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~--- 226 (294)
T 2rku_A 152 LEVKIGDFGLATKVEYDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLR--- 226 (294)
T ss_dssp CCEEECCCTTCEECCSTTC--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH---
T ss_pred CCEEEEeccCceecccCcc--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---
Confidence 9999999999976432222 22335688999999999988999999999999999999999999976442111111
Q ss_pred hcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018785 248 WADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL 304 (350)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 304 (350)
.... ....+..+++.+.+++.+||+.||.+|||+++++++-
T Consensus 227 --------------~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~ 267 (294)
T 2rku_A 227 --------------IKKN--EYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDE 267 (294)
T ss_dssp --------------HHTT--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred --------------Hhhc--cCCCccccCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence 1111 1223456678899999999999999999999999873
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=314.04 Aligned_cols=260 Identities=28% Similarity=0.425 Sum_probs=214.3
Q ss_pred hhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceeeEEe
Q 018785 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (350)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (350)
+..++|++.+.||+|++|.||+|++. ++..||+|.+..... ..+.+.+|+..++.++||||+++++++.
T Consensus 5 i~~~~y~~~~~lg~G~~g~V~~~~~~----------~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 73 (267)
T 3t9t_A 5 IDPSELTFVQEIGSGQFGLVHLGYWL----------NKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCL 73 (267)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET----------TTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred EchhheeeeeEecCCCceeEEEEEec----------CCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEc
Confidence 45689999999999999999999542 367899999976543 3467889999999999999999999999
Q ss_pred ecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccc
Q 018785 98 ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL 177 (350)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~ 177 (350)
+.+..++|||++++++|.+++.... ..++...+..++.|++.||.+|| +.|++|+||+|+||+++.++.++|+|||+
T Consensus 74 ~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dl~p~Nili~~~~~~kl~dfg~ 150 (267)
T 3t9t_A 74 EQAPICLVTEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLE--EACVIHRDLAARNCLVGENQVIKVSDFGM 150 (267)
T ss_dssp SSSSCEEEECCCTTCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSSCCGGGEEECGGGCEEECCTTG
T ss_pred cCCCeEEEEeCCCCCcHHHHHhhCc-ccCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCchheEEECCCCCEEEccccc
Confidence 9999999999999999999997653 36899999999999999999999 89999999999999999999999999999
Q ss_pred cccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccccCcchhhhhhhcchhhhhh
Q 018785 178 ARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDS 256 (350)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 256 (350)
+....... ........++..|+|||.+.+..++.++|+||||+++|+|++ |..||...........
T Consensus 151 ~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~------------ 217 (267)
T 3t9t_A 151 TRFVLDDQ-YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVED------------ 217 (267)
T ss_dssp GGGBCCHH-HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH------------
T ss_pred cccccccc-ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHH------------
Confidence 97532211 111122446678999999998899999999999999999999 8999976442211111
Q ss_pred HHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcC
Q 018785 257 RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 310 (350)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 310 (350)
+........+..++..+.+++.+||..||.+|||+.+++++|+++...
T Consensus 218 ------i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 218 ------ISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp ------HHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ------HhcCCcCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 111112233445678899999999999999999999999999998754
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-44 Score=321.36 Aligned_cols=253 Identities=25% Similarity=0.371 Sum_probs=199.6
Q ss_pred hhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch-hhHHHHHHHHHHHhccCCCcccceeeEEee
Q 018785 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (350)
Q Consensus 20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (350)
.++|++.+.||+|+||.||+| .+..+|+.||||++..... .....+.+|+.++++++||||+++++++.+
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a---------~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 75 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEA---------KNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLE 75 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEE---------EETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEE
T ss_pred hhcCceeeEecCCCCeEEEEE---------EEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEE
Confidence 478999999999999999999 5566789999999875543 345678999999999999999999999865
Q ss_pred cCc---------------------------------------------------------eEEEEEcCCCCChhhHHhhc
Q 018785 99 SDN---------------------------------------------------------RLLVYEFMPKGSLENHLFRK 121 (350)
Q Consensus 99 ~~~---------------------------------------------------------~~lv~e~~~~~~L~~~l~~~ 121 (350)
... .++||||+++++|.+++...
T Consensus 76 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 155 (332)
T 3qd2_B 76 TPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRR 155 (332)
T ss_dssp CCSCHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTC
T ss_pred eccchhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcc
Confidence 432 79999999999999999865
Q ss_pred CC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccccccCCCCCCC----------ccc
Q 018785 122 GV-QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNT----------HVS 190 (350)
Q Consensus 122 ~~-~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~----------~~~ 190 (350)
.. ...+...++.++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++......... ...
T Consensus 156 ~~~~~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~ 233 (332)
T 3qd2_B 156 CSLEDREHGVCLHIFIQIAEAVEFLH--SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATH 233 (332)
T ss_dssp CSGGGSCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CC
T ss_pred cCccchhhHHHHHHHHHHHHHHHHHH--hCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccc
Confidence 42 23455568999999999999999 899999999999999999999999999999765443211 112
Q ss_pred ccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhHHHHHhhhcccCCC
Q 018785 191 TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQ 270 (350)
Q Consensus 191 ~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (350)
....|++.|+|||.+.+..++.++||||||+++|+|++|..|+.... .............
T Consensus 234 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~--------------------~~~~~~~~~~~~~ 293 (332)
T 3qd2_B 234 TGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERV--------------------RIITDVRNLKFPL 293 (332)
T ss_dssp CSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHH--------------------HHHHHHHTTCCCH
T ss_pred cccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHH--------------------HHHHHhhccCCCc
Confidence 33568999999999999999999999999999999999877643211 0001111111111
Q ss_pred CcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 271 YSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 271 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
.....++++.+|+.+||+.||.+|||+.++++|
T Consensus 294 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 294 LFTQKYPQEHMMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred ccccCChhHHHHHHHHccCCCCcCCCHHHHhhc
Confidence 223556788999999999999999999999975
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=330.48 Aligned_cols=253 Identities=23% Similarity=0.338 Sum_probs=204.1
Q ss_pred hcccc--cceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceeeEEee
Q 018785 21 KNFCS--DYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (350)
Q Consensus 21 ~~y~i--~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (350)
..|.+ .+.||+|+||.||+| .+..+|..||+|++..........+.+|+.++++++||||+++++++..
T Consensus 87 ~~~~~~~~~~lG~G~~g~Vy~a---------~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 157 (373)
T 2x4f_A 87 SFYTVSKTEILGGGRFGQVHKC---------EETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFES 157 (373)
T ss_dssp GTEEEEEEEECC-----CEEEE---------EETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred cceeeecceEEecCcCEEEEEE---------EEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 34554 668999999999999 5666789999999988766667789999999999999999999999999
Q ss_pred cCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEE--cCCCcEEEcccc
Q 018785 99 SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLL--DSNFNAKLSDFG 176 (350)
Q Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili--~~~~~~~l~Dfg 176 (350)
.+..++||||+++++|.+++.... ..+++..++.++.|++.||.||| +.|++|+||||+||++ +.++.++|+|||
T Consensus 158 ~~~~~lv~E~~~~~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG 234 (373)
T 2x4f_A 158 KNDIVLVMEYVDGGELFDRIIDES-YNLTELDTILFMKQICEGIRHMH--QMYILHLDLKPENILCVNRDAKQIKIIDFG 234 (373)
T ss_dssp SSEEEEEEECCTTCEEHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEEEETTTTEEEECCCS
T ss_pred CCEEEEEEeCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH--HCCcccccCCHHHEEEecCCCCcEEEEeCC
Confidence 999999999999999999887543 36899999999999999999999 8999999999999999 567889999999
Q ss_pred ccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhh
Q 018785 177 LARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDS 256 (350)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 256 (350)
++........ .....|++.|+|||++.+..++.++|||||||++|+|++|..||.+.........+.....
T Consensus 235 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~------ 305 (373)
T 2x4f_A 235 LARRYKPREK---LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRW------ 305 (373)
T ss_dssp SCEECCTTCB---CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC------
T ss_pred CceecCCccc---cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC------
Confidence 9986433222 2234689999999999888999999999999999999999999976553222222211100
Q ss_pred HHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 257 RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
.........+++++.+||.+||+.||.+|||+.++++|
T Consensus 306 ---------~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 306 ---------DLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKH 343 (373)
T ss_dssp ---------CSCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ---------CCChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 01111223567899999999999999999999999986
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-45 Score=331.91 Aligned_cols=272 Identities=25% Similarity=0.351 Sum_probs=214.3
Q ss_pred hhhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch-hhHHHHHHHHHHHhccCCCccccee
Q 018785 15 ISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLVKLI 93 (350)
Q Consensus 15 ~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~ 93 (350)
.+++..++|++.+.||+|+||+||+| .+..++..||+|++..... .....+.+|+.+++.++||||++++
T Consensus 27 ~~~~~~~~y~~~~~lg~G~~g~V~~~---------~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 97 (360)
T 3eqc_A 27 VGELKDDDFEKISELGAGNGGVVFKV---------SHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFY 97 (360)
T ss_dssp CCCCCGGGEEEEEEEEECSSCEEEEE---------EETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEE
T ss_pred ccccccccceeeeeecCCCCeEEEEE---------EECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEe
Confidence 45666789999999999999999999 5666789999999876532 3346788999999999999999999
Q ss_pred eEEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCC-CeeeCCCCCCceEEcCCCcEEE
Q 018785 94 GYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDA-NVIYRDLKASNVLLDSNFNAKL 172 (350)
Q Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~-~i~H~di~~~Nili~~~~~~~l 172 (350)
+++..++..++||||+++++|.+++.... .+++..+..++.|++.||.||| +. |++|+||+|+||+++.++.++|
T Consensus 98 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lh--~~~~i~H~dlkp~Nil~~~~~~~kl 173 (360)
T 3eqc_A 98 GAFYSDGEISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKL 173 (360)
T ss_dssp EEEEETTEEEEEECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH--HHHCCCCSCCSGGGEEECTTCCEEE
T ss_pred EEEEECCEEEEEEECCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HhCCEEcCCccHHHEEECCCCCEEE
Confidence 99999999999999999999999998765 6899999999999999999999 75 9999999999999999999999
Q ss_pred ccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhh----
Q 018785 173 SDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEW---- 248 (350)
Q Consensus 173 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~---- 248 (350)
+|||++...... ......+++.|+|||++.+..++.++||||||+++|+|++|..||...............
T Consensus 174 ~Dfg~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 249 (360)
T 3eqc_A 174 CDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGD 249 (360)
T ss_dssp CCCCCCHHHHHH----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------
T ss_pred EECCCCcccccc----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccccccc
Confidence 999998542111 122346889999999999999999999999999999999999999765432221111000
Q ss_pred ---------------------cchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 249 ---------------------ADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 249 ---------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
..+.......................++.++.+||.+||+.||.+|||+.++++|
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 325 (360)
T 3eqc_A 250 AAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325 (360)
T ss_dssp ------------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred CCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 0000000111112222222222234567899999999999999999999999987
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=323.02 Aligned_cols=284 Identities=23% Similarity=0.358 Sum_probs=221.2
Q ss_pred hhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceeeE
Q 018785 16 SKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGY 95 (350)
Q Consensus 16 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 95 (350)
..+..++|++.+.||+|+||.||+|++.. .+..+++.||+|.+..........+.+|+.+++.++||||++++++
T Consensus 36 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 110 (326)
T 2w1i_A 36 TQFEERHLKFLQQLGKGNFGSVEMCRYDP-----LQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGV 110 (326)
T ss_dssp -CCCGGGEEEEEEEECCSSEEEEEEEECT-----TSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred cccCHHHceeeeeeccCCCeEEEEEEecc-----ccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEE
Confidence 44567889999999999999999996532 3556799999999987766666788999999999999999999999
Q ss_pred EeecC--ceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEc
Q 018785 96 CSESD--NRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLS 173 (350)
Q Consensus 96 ~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~ 173 (350)
+...+ ..++|||++++++|.+++.... ..++...++.++.|++.||.+|| +.|++|+||+|+||+++.++.++|+
T Consensus 111 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~dikp~NIli~~~~~~kL~ 187 (326)
T 2w1i_A 111 CYSAGRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLG--TKRYIHRDLATRNILVENENRVKIG 187 (326)
T ss_dssp ECC----CCEEEECCCTTCBHHHHHHHST-TSSCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGGGEEEEETTEEEEC
T ss_pred EEecCCCceEEEEECCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHH--hCCEeccCCCcceEEEcCCCcEEEe
Confidence 86644 7899999999999999998764 36899999999999999999999 8999999999999999999999999
Q ss_pred cccccccCCCCCCCcc-cccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchh
Q 018785 174 DFGLARDGPTGDNTHV-STRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPF 252 (350)
Q Consensus 174 Dfg~~~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 252 (350)
|||++........... .....++..|+|||.+.+..++.++||||||+++|+|++|..||......... .... ....
T Consensus 188 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~-~~~~-~~~~ 265 (326)
T 2w1i_A 188 DFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMR-MIGN-DKQG 265 (326)
T ss_dssp CCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHH-HHCT-TCCT
T ss_pred cCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHH-hhcc-ccch
Confidence 9999986543322111 12234667799999998888999999999999999999999988643211000 0000 0000
Q ss_pred hhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhc
Q 018785 253 LRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHT 309 (350)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 309 (350)
..........+........+..+++++.++|.+||+.||.+|||+.++++.|+++..
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~ 322 (326)
T 2w1i_A 266 QMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 322 (326)
T ss_dssp HHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 000111222222222334456788999999999999999999999999999998865
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=325.87 Aligned_cols=255 Identities=26% Similarity=0.352 Sum_probs=186.0
Q ss_pred hccccc---ceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccC-CCcccceeeEE
Q 018785 21 KNFCSD---YLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLR-HENLVKLIGYC 96 (350)
Q Consensus 21 ~~y~i~---~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~ 96 (350)
++|.+. +.||+|+||+||+| .+..+++.||||++.... ...+.+|+..++.+. ||||+++++++
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~---------~~~~~~~~vavK~~~~~~---~~~~~~e~~~l~~l~~h~niv~~~~~~ 75 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKC---------VHKKSNQAFAVKIISKRM---EANTQKEITALKLCEGHPNIVKLHEVF 75 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEE---------EETTTCCEEEEEEEEGGG---HHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred hccccccCCCccccCCCeEEEEE---------EECCCCCEEEEEEEChhh---hhhHHHHHHHHHHhcCCCCeeEEEEEE
Confidence 566665 78999999999999 566678999999986543 455678999999996 99999999999
Q ss_pred eecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCC---cEEEc
Q 018785 97 SESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNF---NAKLS 173 (350)
Q Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~---~~~l~ 173 (350)
.+.+..++||||+++++|.+++.... .+++..+..++.|++.||.||| +.|++|+||||+||+++.++ .++|+
T Consensus 76 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH--~~~ivH~Dlkp~NIll~~~~~~~~~kl~ 151 (325)
T 3kn6_A 76 HDQLHTFLVMELLNGGELFERIKKKK--HFSETEASYIMRKLVSAVSHMH--DVGVVHRDLKPENLLFTDENDNLEIKII 151 (325)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEEEC----CEEEEC
T ss_pred EcCCEEEEEEEccCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--HCCCeecCCCHHHEEEecCCCcccEEEe
Confidence 99999999999999999999998764 7999999999999999999999 89999999999999997765 79999
Q ss_pred cccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhh
Q 018785 174 DFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 253 (350)
Q Consensus 174 Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 253 (350)
|||++....... .......+++.|+|||++.+..++.++||||||+++|+|++|..||.............
T Consensus 152 Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~------- 222 (325)
T 3kn6_A 152 DFGFARLKPPDN--QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAV------- 222 (325)
T ss_dssp CCTTCEECCC------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHH-------
T ss_pred ccccceecCCCC--CcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHH-------
Confidence 999997543322 22233567899999999999999999999999999999999999997654321111110
Q ss_pred hhhHHHHHhhhccc--CCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 254 RDSRRVLRIMDTRL--GGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 254 ~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
.....+..... .......+++++.+||.+||..||.+|||+.++++|
T Consensus 223 ---~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 223 ---EIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp ---HHHHHHTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred ---HHHHHHHcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 00111111111 111123568899999999999999999999999866
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=316.15 Aligned_cols=265 Identities=26% Similarity=0.411 Sum_probs=215.8
Q ss_pred hhhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceee
Q 018785 15 ISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIG 94 (350)
Q Consensus 15 ~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 94 (350)
..++..++|++.+.||+|+||.||+|++. ++..||+|.+.... .....+.+|+.+++.++||||+++++
T Consensus 7 ~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~----------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~ 75 (279)
T 1qpc_A 7 EWEVPRETLKLVERLGAGQFGEVWMGYYN----------GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYA 75 (279)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEET----------TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred hcccCHHhhhheeeecCCCCeEEEEEEEc----------CCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEE
Confidence 34567789999999999999999999532 35689999987654 23567889999999999999999999
Q ss_pred EEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcc
Q 018785 95 YCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSD 174 (350)
Q Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~D 174 (350)
++.. +..++|||++.+++|.+++.......++...+..++.|++.||.||| +.|++|+||+|+||+++.++.++|+|
T Consensus 76 ~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH--~~~i~H~dikp~Nil~~~~~~~kl~D 152 (279)
T 1qpc_A 76 VVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--ERNYIHRDLRAANILVSDTLSCKIAD 152 (279)
T ss_dssp EECS-SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECTTSCEEECC
T ss_pred EEcC-CCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH--HCCeeccCCCHhhEEEcCCCCEEECC
Confidence 9874 56899999999999999997543336899999999999999999999 89999999999999999999999999
Q ss_pred ccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccccCcchhhhhhhcchhh
Q 018785 175 FGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFL 253 (350)
Q Consensus 175 fg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~ 253 (350)
||++........ .......++..|+|||.+.+..++.++||||||+++|+|++ |..||.+.......
T Consensus 153 fg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~----------- 220 (279)
T 1qpc_A 153 FGLARLIEDNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI----------- 220 (279)
T ss_dssp CTTCEECSSSCE-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH-----------
T ss_pred CcccccccCccc-ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHH-----------
Confidence 999976433221 11222446778999999988889999999999999999999 89999764432111
Q ss_pred hhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcCCC
Q 018785 254 RDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKD 312 (350)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~ 312 (350)
..+........+..+++.+.+++.+||..||.+|||+.++++.|+++.....
T Consensus 221 -------~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 272 (279)
T 1qpc_A 221 -------QNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATE 272 (279)
T ss_dssp -------HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred -------HHHhcccCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhcc
Confidence 1111122233445678899999999999999999999999999999887643
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=333.92 Aligned_cols=282 Identities=23% Similarity=0.381 Sum_probs=205.2
Q ss_pred hhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEcccc--chhhHHHHHHHHHHHhccC-CCcccce
Q 018785 16 SKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAE--SFQGHKEWLTEVIYLGQLR-HENLVKL 92 (350)
Q Consensus 16 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~ 92 (350)
.....++|++.+.||+|+||+||+| .+..+|+.||||.+... .......+.+|+..++.+. ||||+++
T Consensus 4 ~~~~~~~y~~~~~lG~G~~g~V~~~---------~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l 74 (388)
T 3oz6_A 4 DRHVLRKYELVKKLGKGAYGIVWKS---------IDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNL 74 (388)
T ss_dssp CHHHHTTEEEEEC-------CEEEE---------EETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCE
T ss_pred cCcccCceEEEEEeeeCCCeEEEEE---------EECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCee
Confidence 4556789999999999999999999 66677999999988643 2334466788999999997 9999999
Q ss_pred eeEEeecC--ceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcE
Q 018785 93 IGYCSESD--NRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNA 170 (350)
Q Consensus 93 ~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~ 170 (350)
++++...+ ..|+||||+. ++|.+++... .++...+..++.|++.||.||| +.|++||||||+||+++.++.+
T Consensus 75 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH--~~~ivHrDlkp~NIll~~~~~~ 148 (388)
T 3oz6_A 75 LNVLRADNDRDVYLVFDYME-TDLHAVIRAN---ILEPVHKQYVVYQLIKVIKYLH--SGGLLHRDMKPSNILLNAECHV 148 (388)
T ss_dssp EEEEECTTSSCEEEEEECCS-EEHHHHHHHT---CCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTCCE
T ss_pred eeEEecCCCCEEEEEecccC-cCHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH--hCCEEeCCCCHHHeEEcCCCCE
Confidence 99997554 6899999995 6999988764 6899999999999999999999 8999999999999999999999
Q ss_pred EEccccccccCCCCC-------------------CCcccccccCCCcccCcccccc-CCCCCccchhhHHHHHHHHHhCC
Q 018785 171 KLSDFGLARDGPTGD-------------------NTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGR 230 (350)
Q Consensus 171 ~l~Dfg~~~~~~~~~-------------------~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~ll~~ll~g~ 230 (350)
+|+|||++....... .........||+.|+|||++.+ ..++.++|||||||++|+|++|+
T Consensus 149 kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~ 228 (388)
T 3oz6_A 149 KVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228 (388)
T ss_dssp EECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred EecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCC
Confidence 999999997543211 1111233578999999999877 67899999999999999999999
Q ss_pred CCCcccccCcchhhhhhhcc-hhhhhh--------HHHHHhh-------hcccCC------------CCcHHHHHHHHHH
Q 018785 231 RALDEDRGGLAEQTLVEWAD-PFLRDS--------RRVLRIM-------DTRLGG------------QYSKKEAQAVAAV 282 (350)
Q Consensus 231 ~pf~~~~~~~~~~~~~~~~~-~~~~~~--------~~~~~~~-------~~~~~~------------~~~~~~~~~l~~l 282 (350)
.||.+.........+..... |..... ....... ...... .....+++++.+|
T Consensus 229 ~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dl 308 (388)
T 3oz6_A 229 PIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDL 308 (388)
T ss_dssp CSCCCSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHH
Confidence 99987665444333332211 100000 0000000 000000 0011456789999
Q ss_pred HHHhhccCCCCCCCHHHHHHH--HHhhhcCCC
Q 018785 283 VLQCLHMDPKNRPSMVDVLTS--LEQLHTSKD 312 (350)
Q Consensus 283 i~~~l~~dp~~Rps~~~ll~~--L~~~~~~~~ 312 (350)
|.+||..||.+|||++++++| +..+....+
T Consensus 309 l~~~L~~dP~~R~t~~e~l~Hp~~~~~~~~~~ 340 (388)
T 3oz6_A 309 LDKLLQFNPNKRISANDALKHPFVSIFHNPNE 340 (388)
T ss_dssp HHHHCCSSGGGSCCHHHHTTSTTTTTTCCGGG
T ss_pred HHHhhccCcccCCCHHHHhCCHHHHHhcCCcc
Confidence 999999999999999999988 555544433
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-44 Score=325.43 Aligned_cols=289 Identities=16% Similarity=0.215 Sum_probs=217.6
Q ss_pred hhhhhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhH-----------HHHHHHHHHH
Q 018785 13 SMISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGH-----------KEWLTEVIYL 81 (350)
Q Consensus 13 ~~~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~-----------~~~~~e~~~l 81 (350)
..+.+...++|++.+.||+|+||+||+|++..+ .....++.||||++........ .....|+..+
T Consensus 27 ~~i~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~ 102 (364)
T 3op5_A 27 EIITDMAAAAWKVGLPIGQGGFGCIYLADMNSS----ESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102 (364)
T ss_dssp CEEECTTCCEEEEEEECCCC-CCEEEEEEECCS----SCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHH
T ss_pred cEeeccCCCeEEEEEEEecCCCeEEEEeeecCc----cccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHH
Confidence 344556677999999999999999999976543 2334578999999876542211 1234566677
Q ss_pred hccCCCcccceeeEEeec----CceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCC
Q 018785 82 GQLRHENLVKLIGYCSES----DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDL 157 (350)
Q Consensus 82 ~~l~h~~i~~~~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di 157 (350)
+.++||||+++++++... ...++||||+ +++|.+++.... ..+++..++.++.|++.||.||| +.|++|+||
T Consensus 103 ~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH--~~~iiHrDl 178 (364)
T 3op5_A 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA-KRFSRKTVLQLSLRILDILEYIH--EHEYVHGDI 178 (364)
T ss_dssp TTCSCCCSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCC
T ss_pred hhccCCCCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH--HCCeEEecC
Confidence 788999999999998765 4589999999 999999997753 37999999999999999999999 899999999
Q ss_pred CCCceEEc--CCCcEEEccccccccCCCCCCCc-----ccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCC
Q 018785 158 KASNVLLD--SNFNAKLSDFGLARDGPTGDNTH-----VSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR 230 (350)
Q Consensus 158 ~~~Nili~--~~~~~~l~Dfg~~~~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~ 230 (350)
||+||+++ .++.++|+|||++.......... ......|++.|+|||.+.+..++.++|||||||++|+|++|.
T Consensus 179 kp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~ 258 (364)
T 3op5_A 179 KASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGH 258 (364)
T ss_dssp CGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSC
T ss_pred CHHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCC
Confidence 99999998 88999999999997543322111 112345899999999999999999999999999999999999
Q ss_pred CCCcccccCcchhhhhhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcC
Q 018785 231 RALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 310 (350)
Q Consensus 231 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 310 (350)
.||.+.............. . ............ ....+++++.+++.+||..||.+||++.++++.|.++...
T Consensus 259 ~Pf~~~~~~~~~~~~~~~~---~--~~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~ 330 (364)
T 3op5_A 259 LPWEDNLKDPKYVRDSKIR---Y--RENIASLMDKCF---PAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKA 330 (364)
T ss_dssp CTTGGGTTCHHHHHHHHHH---H--HHCHHHHHHHHS---CTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred CCccccccCHHHHHHHHHH---h--hhhHHHHHHHhc---ccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Confidence 9998644322211111100 0 000111111100 0134578899999999999999999999999999999887
Q ss_pred CCCCCCC
Q 018785 311 KDMPRTP 317 (350)
Q Consensus 311 ~~~~~~~ 317 (350)
...+...
T Consensus 331 ~~~~~~~ 337 (364)
T 3op5_A 331 IGSKDDG 337 (364)
T ss_dssp TTCCCCC
T ss_pred cCCCcCC
Confidence 6665443
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-44 Score=320.13 Aligned_cols=253 Identities=24% Similarity=0.281 Sum_probs=198.8
Q ss_pred hhhhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch--hhHHHHHHHHHHHhcc-CCCccc
Q 018785 14 MISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQL-RHENLV 90 (350)
Q Consensus 14 ~~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l-~h~~i~ 90 (350)
..+++..++|++.++||+|+||+||+| .+..+|+.||||++..... ........|...+..+ .||||+
T Consensus 50 ~~~~~~~~~y~~~~~LG~G~~g~Vy~~---------~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv 120 (311)
T 3p1a_A 50 RPESFFQQSFQRLSRLGHGSYGEVFKV---------RSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCV 120 (311)
T ss_dssp SSSCHHHHHEEEEEEEEEETTEEEEEE---------EETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred CccchhhhheeeeheeccCCCeEEEEE---------EECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEE
Confidence 345666789999999999999999999 5556789999998765432 2223344455555444 899999
Q ss_pred ceeeEEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcE
Q 018785 91 KLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNA 170 (350)
Q Consensus 91 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~ 170 (350)
++++++.+++..++|||++ +++|.+++.... ..+++..++.++.|++.||+||| +.|++|+||||+||+++.++.+
T Consensus 121 ~l~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dikp~NIll~~~~~~ 196 (311)
T 3p1a_A 121 RLEQAWEEGGILYLQTELC-GPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLH--SQGLVHLDVKPANIFLGPRGRC 196 (311)
T ss_dssp CEEEEEEETTEEEEEEECC-CCBHHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECGGGCE
T ss_pred EEEEEEEeCCEEEEEEecc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH--HCCEecCCCCHHHEEECCCCCE
Confidence 9999999999999999999 779999887664 36999999999999999999999 8999999999999999999999
Q ss_pred EEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcc
Q 018785 171 KLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD 250 (350)
Q Consensus 171 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~ 250 (350)
+|+|||++....... ......|++.|+|||++.+ .++.++||||||+++|+|++|..|+.+... ..
T Consensus 197 kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~---~~------- 262 (311)
T 3p1a_A 197 KLGDFGLLVELGTAG---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG---WQ------- 262 (311)
T ss_dssp EECCCTTCEECC---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH---HH-------
T ss_pred EEccceeeeecccCC---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH---HH-------
Confidence 999999987643322 2233458999999998876 789999999999999999999776643221 00
Q ss_pred hhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 251 PFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
...........+..+++++.+++.+||+.||.+|||+.++++|
T Consensus 263 ----------~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 263 ----------QLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp ----------HHTTTCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ----------HHhccCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 0011111111223467889999999999999999999999875
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=325.78 Aligned_cols=256 Identities=21% Similarity=0.323 Sum_probs=205.5
Q ss_pred hhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhcc-CCCcccceeeEEe
Q 018785 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQL-RHENLVKLIGYCS 97 (350)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~ 97 (350)
..++|++.+.||+|+||.||+| .+..+++.||+|++...... ..+|+.++.++ +||||+++++++.
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~---------~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~ 86 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRC---------IHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYD 86 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEE---------EETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEE---------EECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEE
Confidence 4678999999999999999999 66677999999999765432 24577777777 7999999999999
Q ss_pred ecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCC----CcEEEc
Q 018785 98 ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSN----FNAKLS 173 (350)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~----~~~~l~ 173 (350)
+.+..|+||||++|++|.+++.... .+++..+..++.|++.||.||| +.|++|+||||+||++... +.++|+
T Consensus 87 ~~~~~~lv~E~~~gg~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH--~~givHrDlkp~NIl~~~~~~~~~~~kl~ 162 (342)
T 2qr7_A 87 DGKYVYVVTELMKGGELLDKILRQK--FFSEREASAVLFTITKTVEYLH--AQGVVHRDLKPSNILYVDESGNPESIRIC 162 (342)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHTCT--TCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGGGEEESSSSCSGGGEEEC
T ss_pred cCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCcEeccCCHHHEEEecCCCCcCeEEEE
Confidence 9999999999999999999997764 7999999999999999999999 8999999999999998543 349999
Q ss_pred cccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhh
Q 018785 174 DFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 253 (350)
Q Consensus 174 Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 253 (350)
|||++........ ......+++.|+|||++.+..++.++|+|||||++|+|++|..||.+.............
T Consensus 163 Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i----- 235 (342)
T 2qr7_A 163 DFGFAKQLRAENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARI----- 235 (342)
T ss_dssp CCTTCEECBCTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHH-----
T ss_pred ECCCcccCcCCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHH-----
Confidence 9999976433221 223356899999999998888999999999999999999999999754322111111100
Q ss_pred hhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018785 254 RDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 305 (350)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~ 305 (350)
...........+..+++++.+||.+||..||.+|||+.++++|-.
T Consensus 236 -------~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~ 280 (342)
T 2qr7_A 236 -------GSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPW 280 (342)
T ss_dssp -------HHCCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHH
T ss_pred -------ccCCcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCe
Confidence 000011112233567889999999999999999999999998744
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-44 Score=314.50 Aligned_cols=250 Identities=22% Similarity=0.398 Sum_probs=210.6
Q ss_pred hhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch---hhHHHHHHHHHHHhccCCCcccceee
Q 018785 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLVKLIG 94 (350)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~ 94 (350)
+..++|++.+.||+|++|.||+| .+..++..||+|.+..... .....+.+|+.+++.++||||+++++
T Consensus 11 ~~~~~y~~~~~lg~G~~g~Vy~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 81 (284)
T 2vgo_A 11 FTIDDFDIGRPLGKGKFGNVYLA---------REKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81 (284)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEE---------EETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred hhhhhceeeheecCCCCeEEEEE---------EEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEE
Confidence 44579999999999999999999 5566788999999865432 22466889999999999999999999
Q ss_pred EEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcc
Q 018785 95 YCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSD 174 (350)
Q Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~D 174 (350)
++.+.+..++|||++++++|.+++.... .+++..+..++.|++.||.||| +.|++|+||+|+||+++.++.++|+|
T Consensus 82 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dl~p~Nil~~~~~~~kl~D 157 (284)
T 2vgo_A 82 YFHDRKRIYLMLEFAPRGELYKELQKHG--RFDEQRSATFMEELADALHYCH--ERKVIHRDIKPENLLMGYKGELKIAD 157 (284)
T ss_dssp EEECSSEEEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH--TTTEECCCCSGGGEEECTTCCEEECC
T ss_pred EEEcCCEEEEEEEeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--HCCceecCCCHHHEEEcCCCCEEEec
Confidence 9999999999999999999999998765 6999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhh
Q 018785 175 FGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLR 254 (350)
Q Consensus 175 fg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~ 254 (350)
||++....... .....+++.|+|||.+.+..++.++|+||||+++|+|++|..||...........+
T Consensus 158 fg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~--------- 224 (284)
T 2vgo_A 158 FGWSVHAPSLR----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRI--------- 224 (284)
T ss_dssp CTTCEECSSSC----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH---------
T ss_pred ccccccCcccc----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHH---------
Confidence 99986533221 22346889999999999999999999999999999999999999764422111111
Q ss_pred hhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 255 DSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
.. .....+..+++.+.++|.+||+.||.+|||+.++++|
T Consensus 225 --------~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 225 --------VN--VDLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp --------HT--TCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred --------hc--cccCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence 11 1123345677899999999999999999999999976
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=316.05 Aligned_cols=251 Identities=27% Similarity=0.406 Sum_probs=188.6
Q ss_pred hhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch---hhHHHHHHHHHHHhccCCCcccceeeEE
Q 018785 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLVKLIGYC 96 (350)
Q Consensus 20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (350)
.++|++.+.||+|+||.||+| .+..+|+.||+|.+..... .....+.+|+.+++.++||||+++++++
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~---------~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 80 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRA---------ESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYF 80 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEE---------EETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEE
T ss_pred cccceeeeeecCCCceEEEEE---------EEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEE
Confidence 468999999999999999999 5556789999999865432 2236688999999999999999999999
Q ss_pred eecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcccc
Q 018785 97 SESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFG 176 (350)
Q Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg 176 (350)
.+.+..++||||+++++|.+++.... ..+++..++.++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||
T Consensus 81 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dl~p~Nili~~~~~~kl~dfg 157 (278)
T 3cok_A 81 EDSNYVYLVLEMCHNGEMNRYLKNRV-KPFSENEARHFMHQIITGMLYLH--SHGILHRDLTLSNLLLTRNMNIKIADFG 157 (278)
T ss_dssp ECSSEEEEEEECCTTEEHHHHHHTCS-SCCCHHHHHHHHHHHHHHHHHHH--HTTEECSSCCGGGEEECTTCCEEECCCT
T ss_pred ccCCeEEEEEecCCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEEcCCCCEEEEeec
Confidence 99999999999999999999997653 36899999999999999999999 8999999999999999999999999999
Q ss_pred ccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhh
Q 018785 177 LARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDS 256 (350)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 256 (350)
++........ ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||...........+.
T Consensus 158 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~---------- 225 (278)
T 3cok_A 158 LATQLKMPHE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVV---------- 225 (278)
T ss_dssp TCEECC------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CC----------
T ss_pred ceeeccCCCC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHh----------
Confidence 9976432221 1223467889999999998899999999999999999999999997654322111110
Q ss_pred HHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 257 RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
. .....+..++.++.+++.+||+.||.+|||+.++++|
T Consensus 226 -------~--~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 226 -------L--ADYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp -------S--SCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred -------h--cccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence 0 0112344567889999999999999999999999875
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-43 Score=316.61 Aligned_cols=271 Identities=24% Similarity=0.372 Sum_probs=206.8
Q ss_pred chhhhhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhc--cCCCcc
Q 018785 12 ASMISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQ--LRHENL 89 (350)
Q Consensus 12 ~~~~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~--l~h~~i 89 (350)
+........++|++.+.||+|+||.||+|++. ++.||||++.... ......|.+++.. ++||||
T Consensus 28 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-----------~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i 93 (337)
T 3mdy_A 28 PLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-----------GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENI 93 (337)
T ss_dssp CHHHHTTHHHHCEEEEEEEEETTEEEEEEEET-----------TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTB
T ss_pred CcccccccccceEEEeEeecCCCeEEEEEEEC-----------CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCe
Confidence 34456677889999999999999999999532 7889999986543 2233444455444 489999
Q ss_pred cceeeEEeec----CceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCC--------CeeeCCC
Q 018785 90 VKLIGYCSES----DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDA--------NVIYRDL 157 (350)
Q Consensus 90 ~~~~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~--------~i~H~di 157 (350)
+++++++... ...++||||+++++|.+++... .+++..++.++.|++.||.||| +. |++|+||
T Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH--~~~~~~~~~~~ivH~Di 168 (337)
T 3mdy_A 94 LGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLH--TEIFSTQGKPAIAHRDL 168 (337)
T ss_dssp CCEEEEEEESCGGGCEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHH--SCBCSTTCBCCEECSCC
T ss_pred eeEEEEEccCCCCCCceEEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHH--HhhhhhccCCCEEeccc
Confidence 9999999877 6789999999999999999765 5899999999999999999999 78 9999999
Q ss_pred CCCceEEcCCCcEEEccccccccCCCCCCCc--ccccccCCCcccCccccccCCCCCc------cchhhHHHHHHHHHhC
Q 018785 158 KASNVLLDSNFNAKLSDFGLARDGPTGDNTH--VSTRIVGTRGYAAPEYVATGHLTPK------SDVYSFGVVLLELLSG 229 (350)
Q Consensus 158 ~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~------~DiwslG~ll~~ll~g 229 (350)
||+||+++.++.++|+|||++.......... ......|++.|+|||++.+..+... +|||||||++|+|++|
T Consensus 169 kp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg 248 (337)
T 3mdy_A 169 KSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARR 248 (337)
T ss_dssp CGGGEEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTT
T ss_pred chHHEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhc
Confidence 9999999999999999999997543332221 1223568999999999988776665 9999999999999999
Q ss_pred ----------CCCCcccccCcchhhhhhhcchhhhhhHHHHHhhhcccCCCC-----cHHHHHHHHHHHHHhhccCCCCC
Q 018785 230 ----------RRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQY-----SKKEAQAVAAVVLQCLHMDPKNR 294 (350)
Q Consensus 230 ----------~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~~l~~dp~~R 294 (350)
+.||......... ..... ............ ...+++++.+|+.+||+.||.+|
T Consensus 249 ~~~~~~~~~~~~p~~~~~~~~~~----------~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R 316 (337)
T 3mdy_A 249 CVSGGIVEEYQLPYHDLVPSDPS----------YEDMR--EIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASR 316 (337)
T ss_dssp BCBTTBCCCCCCTTTTTSCSSCC----------HHHHH--HHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGS
T ss_pred cCcccccccccccHhhhcCCCCc----------hhhhH--HHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhC
Confidence 4555432221111 00000 001111111122 23788899999999999999999
Q ss_pred CCHHHHHHHHHhhhcCCCC
Q 018785 295 PSMVDVLTSLEQLHTSKDM 313 (350)
Q Consensus 295 ps~~~ll~~L~~~~~~~~~ 313 (350)
||+.+++++|+.+....++
T Consensus 317 ps~~ell~~L~~l~~~~~~ 335 (337)
T 3mdy_A 317 LTALRVKKTLAKMSESQDI 335 (337)
T ss_dssp CCHHHHHHHHHHHHHTTTC
T ss_pred CCHHHHHHHHHHHHhhccc
Confidence 9999999999999887653
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=338.27 Aligned_cols=265 Identities=24% Similarity=0.296 Sum_probs=202.1
Q ss_pred hhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccc--hhhHHHHHHHHHHHhccCCCcccceeeEEe
Q 018785 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES--FQGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (350)
Q Consensus 20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (350)
.++|++.+.||+|+||+||+| .+..+++.||||++.... ......+.+|+.+++.++||||+++++++.
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a---------~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 131 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAA---------YDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFT 131 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEE---------EETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred cCCeEEEEEeecCCCeEEEEE---------EECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEc
Confidence 578999999999999999999 666779999999997652 234566889999999999999999999996
Q ss_pred ecC------ceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEE
Q 018785 98 ESD------NRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAK 171 (350)
Q Consensus 98 ~~~------~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~ 171 (350)
..+ ..|+||||+.+ +|.+.+.. .+++..+..++.|++.||+||| +.||+||||||+||+++.++.++
T Consensus 132 ~~~~~~~~~~~~lv~E~~~~-~l~~~~~~----~l~~~~~~~~~~qil~aL~~lH--~~~iiHrDlkp~NIll~~~~~~k 204 (464)
T 3ttj_A 132 PQKTLEEFQDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLH--SAGIIHRDLKPSNIVVKSDCTLK 204 (464)
T ss_dssp SCCSTTTCCEEEEEEECCSE-EHHHHHTS----CCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTTSCEE
T ss_pred cCCccccCCeEEEEEeCCCC-CHHHHHhh----cCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCChHhEEEeCCCCEE
Confidence 553 46999999955 67776643 4899999999999999999999 89999999999999999999999
Q ss_pred EccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcch
Q 018785 172 LSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADP 251 (350)
Q Consensus 172 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~ 251 (350)
|+|||++...... .......|++.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+......
T Consensus 205 l~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~ 281 (464)
T 3ttj_A 205 ILDFGLARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGT 281 (464)
T ss_dssp ECCCCCC-----C---CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCS
T ss_pred EEEEEeeeecCCC---cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 9999999754322 2233457899999999999999999999999999999999999999876654433333322111
Q ss_pred h-h---hhh-HHHHHhhhccc------------------CCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 252 F-L---RDS-RRVLRIMDTRL------------------GGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 252 ~-~---~~~-~~~~~~~~~~~------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
. . ... ........... ........++++.+||.+||..||.+|||++++++|
T Consensus 282 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 282 PCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp CCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 0 000 00001111000 000112237789999999999999999999999987
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=342.26 Aligned_cols=257 Identities=28% Similarity=0.433 Sum_probs=215.7
Q ss_pred hhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch---hhHHHHHHHHHHHhccCCCcccceee
Q 018785 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLVKLIG 94 (350)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~ 94 (350)
+..++|++.+.||+|+||.||+| .+..+|+.||+|++..... .....+.+|+.+++.++||||+++++
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a---------~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~ 251 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCAC---------QVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 251 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEE---------EETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccccceEEEEEEeeCCCEEEEEE---------EECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEE
Confidence 55788999999999999999999 5666799999999876432 23456788999999999999999999
Q ss_pred EEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcc
Q 018785 95 YCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSD 174 (350)
Q Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~D 174 (350)
++.+.+.+++||||++|++|.+++.......+++..++.++.||+.||.||| +.||+|+||||+||+++.++.++|+|
T Consensus 252 ~~~~~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH--~~gIvHrDLKPeNILld~~g~vKL~D 329 (576)
T 2acx_A 252 AYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH--RERIVYRDLKPENILLDDHGHIRISD 329 (576)
T ss_dssp EEECSSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTSCEEECC
T ss_pred EEeeCCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--HCCEeccCCchheEEEeCCCCeEEEe
Confidence 9999999999999999999999998766556999999999999999999999 89999999999999999999999999
Q ss_pred ccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhh
Q 018785 175 FGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLR 254 (350)
Q Consensus 175 fg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~ 254 (350)
||++....... ......|++.|+|||++.+..++.++|+|||||++|+|++|..||...........+...
T Consensus 330 FGla~~~~~~~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~------ 400 (576)
T 2acx_A 330 LGLAVHVPEGQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERL------ 400 (576)
T ss_dssp CTTCEECCTTC---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHH------
T ss_pred cccceecccCc---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHH------
Confidence 99997643322 223357899999999999989999999999999999999999999865433222212110
Q ss_pred hhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 018785 255 DSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRP-----SMVDVLTS 303 (350)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~~ 303 (350)
+. ......+..+++++.+||.+||..||.+|| +++++++|
T Consensus 401 --------i~-~~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 401 --------VK-EVPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp --------HH-HCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred --------hh-cccccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 00 111234556788999999999999999999 78999887
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=326.77 Aligned_cols=260 Identities=22% Similarity=0.236 Sum_probs=204.5
Q ss_pred hhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccc-----hhhHHHHHHHHHHHhccCCCcccce
Q 018785 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES-----FQGHKEWLTEVIYLGQLRHENLVKL 92 (350)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~ 92 (350)
...++|++.+.||+|+||+||+| .+..++..||+|++.... ......+.+|+.+++.++||||+++
T Consensus 23 ~~~~~y~~~~~lG~G~~g~V~~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~ 93 (345)
T 3hko_A 23 ELQKKYHLKGAIGQGSYGVVRVA---------IENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93 (345)
T ss_dssp HHHHHEEEEEEEEECSSCEEEEE---------EETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred hhhhheeecceeeecCCeEEEEE---------EECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCccee
Confidence 34689999999999999999999 566678999999987542 2344678899999999999999999
Q ss_pred eeEEeecCceEEEEEcCCCCChhhHHhhcC--------------------------------------CCCCCHHHHHHH
Q 018785 93 IGYCSESDNRLLVYEFMPKGSLENHLFRKG--------------------------------------VQPISWPTRVKI 134 (350)
Q Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------------------------------------~~~l~~~~~~~i 134 (350)
++++.+.+..++||||+++++|.+++.... ...+++..++.+
T Consensus 94 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 173 (345)
T 3hko_A 94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNI 173 (345)
T ss_dssp EEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHH
T ss_pred ehhhccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHH
Confidence 999999999999999999999999885210 112356778899
Q ss_pred HHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCC--cEEEccccccccCCCCCC--CcccccccCCCcccCcccccc--C
Q 018785 135 AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNF--NAKLSDFGLARDGPTGDN--THVSTRIVGTRGYAAPEYVAT--G 208 (350)
Q Consensus 135 ~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~--~~~l~Dfg~~~~~~~~~~--~~~~~~~~~~~~~~aPE~~~~--~ 208 (350)
+.|++.||+||| +.|++|+||+|+||+++.++ .++|+|||++........ ........+++.|+|||.+.+ .
T Consensus 174 ~~qi~~~l~~LH--~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 251 (345)
T 3hko_A 174 MRQIFSALHYLH--NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNE 251 (345)
T ss_dssp HHHHHHHHHHHH--HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSS
T ss_pred HHHHHHHHHHHH--HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCC
Confidence 999999999999 89999999999999998776 799999999975322211 112334568999999999865 6
Q ss_pred CCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhc
Q 018785 209 HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLH 288 (350)
Q Consensus 209 ~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 288 (350)
.++.++||||||+++|+|++|..||.+.........+..... .........+++.+.+||.+||+
T Consensus 252 ~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~li~~~l~ 316 (345)
T 3hko_A 252 SYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKL---------------CFENPNYNVLSPLARDLLSNLLN 316 (345)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC---------------CTTSGGGGGSCHHHHHHHHHHSC
T ss_pred CCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhccc---------------ccCCcccccCCHHHHHHHHHHcC
Confidence 788999999999999999999999976553222222211100 00111123467899999999999
Q ss_pred cCCCCCCCHHHHHHH
Q 018785 289 MDPKNRPSMVDVLTS 303 (350)
Q Consensus 289 ~dp~~Rps~~~ll~~ 303 (350)
.||.+|||+.++++|
T Consensus 317 ~~p~~Rps~~~~l~h 331 (345)
T 3hko_A 317 RNVDERFDAMRALQH 331 (345)
T ss_dssp SCTTTSCCHHHHHHS
T ss_pred CChhHCCCHHHHhcC
Confidence 999999999999986
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=324.38 Aligned_cols=271 Identities=27% Similarity=0.430 Sum_probs=206.5
Q ss_pred hhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh--hHHHHHHHHHHHhccCCCcccceeeE
Q 018785 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ--GHKEWLTEVIYLGQLRHENLVKLIGY 95 (350)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~ 95 (350)
...++|++.+.||+|+||.||+| .+..+|+.||+|.+...... ....+.+|+.+++.++||||++++++
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~---------~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 92 (331)
T 4aaa_A 22 QSMEKYENLGLVGEGSYGMVMKC---------RNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEV 92 (331)
T ss_dssp BCGGGEEEEEEGGGGTTSSEEEE---------EETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred hhhhhheeeeEEeecCCEEEEEE---------EECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEE
Confidence 34579999999999999999999 56667899999988654332 23557889999999999999999999
Q ss_pred EeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccc
Q 018785 96 CSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDF 175 (350)
Q Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Df 175 (350)
+...+..++||||+.+++|.++..... .+++..+..++.|++.||.||| +.|++|+||+|+||+++.++.++|+||
T Consensus 93 ~~~~~~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~qi~~~l~~LH--~~~ivH~dlkp~Nil~~~~~~~kl~Df 168 (331)
T 4aaa_A 93 CKKKKRWYLVFEFVDHTILDDLELFPN--GLDYQVVQKYLFQIINGIGFCH--SHNIIHRDIKPENILVSQSGVVKLCDF 168 (331)
T ss_dssp EEETTEEEEEEECCSEEHHHHHHHSTT--CCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTTSCEEECCC
T ss_pred eecCCEEEEEEecCCcchHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHH--HCCEEccCcChheEEEcCCCcEEEEeC
Confidence 999999999999999888888765544 6999999999999999999999 899999999999999999999999999
Q ss_pred cccccCCCCCCCcccccccCCCcccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhh
Q 018785 176 GLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLR 254 (350)
Q Consensus 176 g~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~ 254 (350)
|++....... .......+++.|+|||.+.+. .++.++||||||+++|+|++|..||.+.........+.........
T Consensus 169 g~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 246 (331)
T 4aaa_A 169 GFARTLAAPG--EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIP 246 (331)
T ss_dssp TTC--------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCH
T ss_pred CCceeecCCc--cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCh
Confidence 9997543322 122335688999999998775 7899999999999999999999999876544333332222111111
Q ss_pred hhHHHHHh---hhc-c---cCC-----CCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 255 DSRRVLRI---MDT-R---LGG-----QYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 255 ~~~~~~~~---~~~-~---~~~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
........ ... . ... .....+++.+.+||.+||+.||.+|||+.++++|
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 247 RHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp HHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred hhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 10000000 000 0 000 0112467889999999999999999999999976
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-44 Score=315.44 Aligned_cols=262 Identities=24% Similarity=0.364 Sum_probs=211.0
Q ss_pred hhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh------hHHHHHHHHHHHhccCCCcccc
Q 018785 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ------GHKEWLTEVIYLGQLRHENLVK 91 (350)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~ 91 (350)
+..++|++.+.||+|+||+||+| .+..+++.||+|.+...... ....+.+|+.+++.++||||++
T Consensus 2 ~~~~~y~~~~~lg~G~~g~V~~~---------~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 72 (283)
T 3bhy_A 2 MVEDHYEMGEELGSGQFAIVRKC---------RQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72 (283)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEE---------EETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCC
T ss_pred chhhhhhhHHhhcccCceEEEEE---------EEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeee
Confidence 34688999999999999999999 55667899999998765322 3567889999999999999999
Q ss_pred eeeEEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCC---
Q 018785 92 LIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNF--- 168 (350)
Q Consensus 92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~--- 168 (350)
+++++...+..++|||++++++|.+++.... .+++..++.++.|++.||.||| +.|++|+||+|+||+++.++
T Consensus 73 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dl~p~Nil~~~~~~~~ 148 (283)
T 3bhy_A 73 LHDIFENKTDVVLILELVSGGELFDFLAEKE--SLTEDEATQFLKQILDGVHYLH--SKRIAHFDLKPENIMLLDKNVPN 148 (283)
T ss_dssp EEEEEECSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEESCSSSSS
T ss_pred hhheecCCCeEEEEEeecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--hCCccCCCCChHHEEEecCCCCC
Confidence 9999999999999999999999999997654 6999999999999999999999 89999999999999998877
Q ss_pred -cEEEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhh
Q 018785 169 -NAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVE 247 (350)
Q Consensus 169 -~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~ 247 (350)
.++|+|||++........ .....+++.|+|||.+.+..++.++|+||||+++|+|++|..||...........+..
T Consensus 149 ~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 225 (283)
T 3bhy_A 149 PRIKLIDFGIAHKIEAGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISA 225 (283)
T ss_dssp CCEEECCCTTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT
T ss_pred CceEEEecccceeccCCCc---ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHh
Confidence 799999999976433221 2234588899999999989999999999999999999999999976543222111111
Q ss_pred hcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHhhhcC
Q 018785 248 WADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS--LEQLHTS 310 (350)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~--L~~~~~~ 310 (350)
.. ..........+++.+.+++.+||..||.+|||+.++++| +..+...
T Consensus 226 ~~---------------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~ 275 (283)
T 3bhy_A 226 VN---------------YDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRR 275 (283)
T ss_dssp TC---------------CCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHC
T ss_pred cc---------------cCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHH
Confidence 00 000001112456789999999999999999999999985 5555544
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-44 Score=322.28 Aligned_cols=266 Identities=28% Similarity=0.417 Sum_probs=213.3
Q ss_pred hhhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEE--EEEEccccc-hhhHHHHHHHHHHHhcc-CCCccc
Q 018785 15 ISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVV--AIKRLKAES-FQGHKEWLTEVIYLGQL-RHENLV 90 (350)
Q Consensus 15 ~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~v--aiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~ 90 (350)
...+..++|++.+.||+|+||.||+|+ +..++..+ ++|.+.... ......+.+|+.+++++ +||||+
T Consensus 19 ~p~~~~~~y~~~~~lg~G~~g~Vy~~~---------~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv 89 (327)
T 1fvr_A 19 YPVLDWNDIKFQDVIGEGNFGQVLKAR---------IKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89 (327)
T ss_dssp SSBCCGGGCEEEEEEECGGGCEEEEEE---------EEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBC
T ss_pred cccccHHHccceeeeecCCCceEEEEE---------EccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchh
Confidence 334556899999999999999999994 34446544 889886532 23345688999999999 899999
Q ss_pred ceeeEEeecCceEEEEEcCCCCChhhHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCC
Q 018785 91 KLIGYCSESDNRLLVYEFMPKGSLENHLFRKG--------------VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRD 156 (350)
Q Consensus 91 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------------~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~d 156 (350)
++++++.+.+..++||||+++++|.+++.... ...+++..++.++.|++.||.||| +.|++|+|
T Consensus 90 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~d 167 (327)
T 1fvr_A 90 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS--QKQFIHRD 167 (327)
T ss_dssp CEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH--HTTEECSC
T ss_pred hhceeeeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH--hCCccCCC
Confidence 99999999999999999999999999997643 246899999999999999999999 89999999
Q ss_pred CCCCceEEcCCCcEEEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcc
Q 018785 157 LKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDE 235 (350)
Q Consensus 157 i~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~ 235 (350)
|+|+||+++.++.++|+|||++....... ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+
T Consensus 168 lkp~NIl~~~~~~~kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~ 244 (327)
T 1fvr_A 168 LAARNILVGENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG 244 (327)
T ss_dssp CSGGGEEECGGGCEEECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred CccceEEEcCCCeEEEcccCcCccccccc---cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCC
Confidence 99999999999999999999987422211 1222346778999999988889999999999999999998 9999976
Q ss_pred cccCcchhhhhhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcCCC
Q 018785 236 DRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKD 312 (350)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~ 312 (350)
........ .+........+..+++.+.+|+.+||..||.+|||+.+++++|..+.....
T Consensus 245 ~~~~~~~~------------------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 303 (327)
T 1fvr_A 245 MTCAELYE------------------KLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 303 (327)
T ss_dssp CCHHHHHH------------------HGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred CcHHHHHH------------------HhhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhc
Confidence 54321111 111112223455678899999999999999999999999999999988744
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-44 Score=337.37 Aligned_cols=257 Identities=25% Similarity=0.318 Sum_probs=209.9
Q ss_pred hhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccc--hhhHHHHHHHHHHHhccCCCcccceee
Q 018785 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES--FQGHKEWLTEVIYLGQLRHENLVKLIG 94 (350)
Q Consensus 17 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~ 94 (350)
....++|++.+.||+|+||+||+| .+..+++.||||++.... ......+.+|+.++++++||||+++++
T Consensus 18 g~~~~~y~~~~~lG~G~~g~V~~~---------~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 88 (486)
T 3mwu_A 18 GTFAERYNIVCMLGKGSFGEVLKC---------KDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88 (486)
T ss_dssp CHHHHHEEEEEEEECCSSSEEEEE---------EETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CChhcceEEeEEEeecCCEEEEEE---------EECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 345689999999999999999999 566678999999986543 234567889999999999999999999
Q ss_pred EEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEc---CCCcEE
Q 018785 95 YCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLD---SNFNAK 171 (350)
Q Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~---~~~~~~ 171 (350)
++.+.+..++||||+.+++|.+++.... .+++..++.++.|++.||.||| +.|++|+||||+||+++ .++.++
T Consensus 89 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~al~~lH--~~~ivH~Dlkp~Nil~~~~~~~~~~k 164 (486)
T 3mwu_A 89 ILEDSSSFYIVGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMH--KHNIVHRDLKPENILLESKEKDCDIK 164 (486)
T ss_dssp EEECSSEEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEESSSSTTCCEE
T ss_pred EEEcCCEEEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--HCCeEeccCchHHEEEecCCCCCCEE
Confidence 9999999999999999999999997765 7999999999999999999999 89999999999999995 456799
Q ss_pred EccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcch
Q 018785 172 LSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADP 251 (350)
Q Consensus 172 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~ 251 (350)
|+|||++....... ......|++.|+|||++.+ .++.++|||||||++|+|++|..||.+.........+....
T Consensus 165 l~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~-- 238 (486)
T 3mwu_A 165 IIDFGLSTCFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGK-- 238 (486)
T ss_dssp ECSCSCTTTBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC--
T ss_pred EEECCcCeECCCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--
Confidence 99999997543322 2233568999999999865 58999999999999999999999997654322222111110
Q ss_pred hhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018785 252 FLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 305 (350)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~ 305 (350)
..........+++++.+||.+||..||.+|||+.++++|-.
T Consensus 239 -------------~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~ 279 (486)
T 3mwu_A 239 -------------YAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPW 279 (486)
T ss_dssp -------------CCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHH
T ss_pred -------------CCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHh
Confidence 01111223467889999999999999999999999998833
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-44 Score=328.19 Aligned_cols=257 Identities=24% Similarity=0.353 Sum_probs=203.0
Q ss_pred hhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccc--hhhHHHHHHHHHHHhccC--CCcccce
Q 018785 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES--FQGHKEWLTEVIYLGQLR--HENLVKL 92 (350)
Q Consensus 17 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~--h~~i~~~ 92 (350)
.+.+.+|++.+.||+|+||.||+| .+.. ++.||||++.... ......+.+|+.+++.+. ||||+++
T Consensus 52 ~~~~~~y~~~~~LG~G~fg~Vy~~---------~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~ 121 (390)
T 2zmd_A 52 SVKGRIYSILKQIGSGGSSKVFQV---------LNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121 (390)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEE---------ECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCE
T ss_pred cccCCceEEEEEEccCCCeEEEEE---------EcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEE
Confidence 345678999999999999999999 3333 7899999986543 234467889999999996 5999999
Q ss_pred eeEEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEE
Q 018785 93 IGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKL 172 (350)
Q Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l 172 (350)
++++...+..++||| +.+++|.+++.... .+++.++..++.||+.||.||| +.||+|+||||+||+++ ++.++|
T Consensus 122 ~~~~~~~~~~~lv~E-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH--~~~ivHrDlkp~NIll~-~~~~kl 195 (390)
T 2zmd_A 122 YDYEITDQYIYMVME-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIH--QHGIVHSDLKPANFLIV-DGMLKL 195 (390)
T ss_dssp EEEEECSSEEEEEEE-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHH--TTTCCCCCCCGGGEEES-SSCEEE
T ss_pred EEEEecCCEEEEEEe-cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--HCCeeecCCCHHHEEEE-CCeEEE
Confidence 999999999999999 55889999998765 7899999999999999999999 99999999999999995 578999
Q ss_pred ccccccccCCCCCCCcccccccCCCcccCcccccc-----------CCCCCccchhhHHHHHHHHHhCCCCCcccccCcc
Q 018785 173 SDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-----------GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLA 241 (350)
Q Consensus 173 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-----------~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~ 241 (350)
+|||++................|++.|+|||++.+ ..++.++|||||||++|+|++|..||......
T Consensus 196 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-- 273 (390)
T 2zmd_A 196 IDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-- 273 (390)
T ss_dssp CCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH--
T ss_pred EecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH--
Confidence 99999986544333323344579999999999865 36888999999999999999999999653321
Q ss_pred hhhhhhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018785 242 EQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 305 (350)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~ 305 (350)
................+...+.++.+||.+||..||.+|||+.++++|-.
T Consensus 274 --------------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~ 323 (390)
T 2zmd_A 274 --------------ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPY 323 (390)
T ss_dssp --------------HHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred --------------HHHHHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcC
Confidence 01111222222223334445678999999999999999999999998743
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=314.24 Aligned_cols=266 Identities=27% Similarity=0.425 Sum_probs=209.5
Q ss_pred hhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch-hhHHHHHHHHHHHhccCCCcccceeeEE-
Q 018785 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLVKLIGYC- 96 (350)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~- 96 (350)
...+|++.+.||+|+||+||+|++.. ...+...+++|.+..... .....+.+|+.++++++||||+++++++
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 96 (298)
T 3f66_A 23 SSLIVHFNEVIGRGHFGCVYHGTLLD------NDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL 96 (298)
T ss_dssp GGEEEEEEEEEEEETTEEEEEEEEC-----------CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEC
T ss_pred cceehhhcceeeecCCceEEEEEEec------CCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEE
Confidence 45689999999999999999996542 233456789998876432 3446788999999999999999999985
Q ss_pred eecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcccc
Q 018785 97 SESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFG 176 (350)
Q Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg 176 (350)
..++..++||||+.+++|.+++.... ..++...++.++.|++.||.||| +.|++|+||||+||+++.++.++|+|||
T Consensus 97 ~~~~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH--~~~i~H~dikp~Nil~~~~~~~kl~Dfg 173 (298)
T 3f66_A 97 RSEGSPLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKYLA--SKKFVHRDLAARNCMLDEKFTVKVADFG 173 (298)
T ss_dssp CSSSCCEEEEECCTTCBHHHHHHCTT-CCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEECTTCCEEECSCG
T ss_pred cCCCceEEEEeCCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHH--hCCccCCCCchheEEECCCCCEEECccc
Confidence 55668899999999999999997543 46899999999999999999999 8999999999999999999999999999
Q ss_pred ccccCCCCCCC--cccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhC-CCCCcccccCcchhhhhhhcchhh
Q 018785 177 LARDGPTGDNT--HVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSG-RRALDEDRGGLAEQTLVEWADPFL 253 (350)
Q Consensus 177 ~~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g-~~pf~~~~~~~~~~~~~~~~~~~~ 253 (350)
++......... .......+++.|+|||.+.+..++.++|+||||+++|+|++| ..||...........+.
T Consensus 174 ~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~------- 246 (298)
T 3f66_A 174 LARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL------- 246 (298)
T ss_dssp GGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHH-------
T ss_pred ccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHh-------
Confidence 99754332211 112234567789999999999999999999999999999994 55665444322221111
Q ss_pred hhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcCC
Q 018785 254 RDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSK 311 (350)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~ 311 (350)
.......+..+++.+.+++.+||+.||.+|||+.++++.|+.+....
T Consensus 247 -----------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 293 (298)
T 3f66_A 247 -----------QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 293 (298)
T ss_dssp -----------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred -----------cCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 11122234456788999999999999999999999999999998764
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=327.37 Aligned_cols=286 Identities=18% Similarity=0.229 Sum_probs=211.4
Q ss_pred ccCCCCchhhhhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhh-----------HHHH
Q 018785 6 AMSDPSASMISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQG-----------HKEW 74 (350)
Q Consensus 6 ~~~~~~~~~~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~-----------~~~~ 74 (350)
+..-+....+.+..+++|++.+.||+|+||.||+|++.. ...++..+|+|.+....... ...+
T Consensus 22 ~~~l~~g~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~ 95 (345)
T 2v62_A 22 SMPFPEGKVLDDMEGNQWVLGKKIGSGGFGLIYLAFPTN------KPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDC 95 (345)
T ss_dssp ---CCTTCEEECTTSCEEEEEEEC------CEEEEEESS------SCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHH
T ss_pred cCcCCCCCeeccccCceEEEEeeEeecCCeEEEEEEecC------CCCccceEEEEeeecCCcchHHHHHHHHHHhhhHH
Confidence 334455666777888999999999999999999996542 12357889999987653211 1235
Q ss_pred HHHHHHHhccCCCcccceeeEEee----cCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCC
Q 018785 75 LTEVIYLGQLRHENLVKLIGYCSE----SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDA 150 (350)
Q Consensus 75 ~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~ 150 (350)
.+|+..++.++||||+++++++.. ....++|||++ +++|.+++.... .+++..++.++.|++.||+||| +.
T Consensus 96 ~~e~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH--~~ 170 (345)
T 2v62_A 96 IKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIH--EN 170 (345)
T ss_dssp HHHHHHHHTCSCCCCCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHH--HT
T ss_pred HHHHHhhccccccCcceeecccccccCCCcEEEEEEecc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--hC
Confidence 678888999999999999999887 67889999999 999999997765 7999999999999999999999 89
Q ss_pred CeeeCCCCCCceEEcCCC--cEEEccccccccCCCCCC-----CcccccccCCCcccCccccccCCCCCccchhhHHHHH
Q 018785 151 NVIYRDLKASNVLLDSNF--NAKLSDFGLARDGPTGDN-----THVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVL 223 (350)
Q Consensus 151 ~i~H~di~~~Nili~~~~--~~~l~Dfg~~~~~~~~~~-----~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll 223 (350)
|++|+||||+||+++.++ .++|+|||++........ ........|++.|+|||++.+..++.++||||||+++
T Consensus 171 ~ivH~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il 250 (345)
T 2v62_A 171 EYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCM 250 (345)
T ss_dssp TEECSCCSGGGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHH
T ss_pred CeeCCCcCHHHEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHH
Confidence 999999999999998887 999999999975432211 1112335789999999999999999999999999999
Q ss_pred HHHHhCCCCCcccccCcchhhhhhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 224 LELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 224 ~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
|+|++|..||.............. .......... ... ......+++++.+++.+||..||.+|||++++++.
T Consensus 251 ~ell~g~~pf~~~~~~~~~~~~~~--~~~~~~~~~~---~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 322 (345)
T 2v62_A 251 LRWLCGKLPWEQNLKDPVAVQTAK--TNLLDELPQS---VLK---WAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKI 322 (345)
T ss_dssp HHHHHSSCTTGGGTTCHHHHHHHH--HHHHHTTTHH---HHH---HSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred HHHHhCCCCccccccccHHHHHHH--HhhcccccHH---HHh---hccccccHHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence 999999999965332211110000 0000000000 000 00011467799999999999999999999999999
Q ss_pred HHhhhcC
Q 018785 304 LEQLHTS 310 (350)
Q Consensus 304 L~~~~~~ 310 (350)
|+++...
T Consensus 323 L~~~~~~ 329 (345)
T 2v62_A 323 LNPHGIP 329 (345)
T ss_dssp HCTTCCC
T ss_pred HhccCCc
Confidence 9987653
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=329.04 Aligned_cols=253 Identities=25% Similarity=0.367 Sum_probs=202.1
Q ss_pred hhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh---hHHHHHHHHHH-HhccCCCcccce
Q 018785 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ---GHKEWLTEVIY-LGQLRHENLVKL 92 (350)
Q Consensus 17 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~-l~~l~h~~i~~~ 92 (350)
....++|++.+.||+|+||.||+| .+..++..||+|++...... ....+..|... ++.++||||+++
T Consensus 34 ~~~~~~y~~~~~lG~G~fg~V~~~---------~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l 104 (373)
T 2r5t_A 34 HAKPSDFHFLKVIGKGSFGKVLLA---------RHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 104 (373)
T ss_dssp TCCGGGEEEEEEEECCTTCEEEEE---------EETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCE
T ss_pred CCChhheEEEEEEeeCCCeEEEEE---------EEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCE
Confidence 455689999999999999999999 55667899999999765432 22345556655 566899999999
Q ss_pred eeEEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEE
Q 018785 93 IGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKL 172 (350)
Q Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l 172 (350)
++++.+.+.+|+||||+.|++|.+++.... .+++..++.++.||+.||.||| +.|++||||||+||+++.+|.++|
T Consensus 105 ~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH--~~givHrDlkp~NIll~~~g~ikL 180 (373)
T 2r5t_A 105 HFSFQTADKLYFVLDYINGGELFYHLQRER--CFLEPRARFYAAEIASALGYLH--SLNIVYRDLKPENILLDSQGHIVL 180 (373)
T ss_dssp EEEEECSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTTSCEEE
T ss_pred EEEEEeCCEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--HCCceecCCCHHHEEECCCCCEEE
Confidence 999999999999999999999999998764 6899999999999999999999 899999999999999999999999
Q ss_pred ccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchh
Q 018785 173 SDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPF 252 (350)
Q Consensus 173 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 252 (350)
+|||++....... .......|++.|+|||++.+..++.++|+|||||++|+|++|..||.+.........+
T Consensus 181 ~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i------- 251 (373)
T 2r5t_A 181 TDFGLCKENIEHN--STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNI------- 251 (373)
T ss_dssp CCCCBCGGGBCCC--CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHH-------
T ss_pred eeCccccccccCC--CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHH-------
Confidence 9999997532221 1233457899999999999999999999999999999999999999765432222111
Q ss_pred hhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCH----HHHHHH
Q 018785 253 LRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSM----VDVLTS 303 (350)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~----~~ll~~ 303 (350)
.... ...+..++..+.+||.+||+.||.+||++ .++++|
T Consensus 252 ----------~~~~--~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h 294 (373)
T 2r5t_A 252 ----------LNKP--LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSH 294 (373)
T ss_dssp ----------HHSC--CCCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTS
T ss_pred ----------Hhcc--cCCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCC
Confidence 1111 12345677899999999999999999997 455554
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=333.70 Aligned_cols=256 Identities=21% Similarity=0.236 Sum_probs=209.1
Q ss_pred hhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch---hhHHHHHHHHHHHhccCCCcccceee
Q 018785 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLVKLIG 94 (350)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~ 94 (350)
...++|++.+.||+|+||+||+| .+..+++.||+|++..... .....+.+|..+++.++||||+++++
T Consensus 66 ~~~~~y~~~~~LG~G~fG~V~~~---------~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~ 136 (410)
T 3v8s_A 66 MKAEDYEVVKVIGRGAFGEVQLV---------RHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 136 (410)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEE---------EETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEE
T ss_pred cCccccEEEEEEEcCCCEEEEEE---------EECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 34679999999999999999999 5666789999999865322 12234778999999999999999999
Q ss_pred EEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcc
Q 018785 95 YCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSD 174 (350)
Q Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~D 174 (350)
++.+.+.+|+||||++|++|.+++... .+++..++.++.|++.||.||| +.|++||||||+||+++.++.++|+|
T Consensus 137 ~~~~~~~~~lV~E~~~gg~L~~~l~~~---~~~e~~~~~~~~qi~~aL~~LH--~~givHrDLKp~NILl~~~g~ikL~D 211 (410)
T 3v8s_A 137 AFQDDRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIH--SMGFIHRDVKPDNMLLDKSGHLKLAD 211 (410)
T ss_dssp EEECSSEEEEEECCCTTEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTSCEEECC
T ss_pred EEEECCEEEEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH--HCCeEeccCCHHHeeECCCCCEEEec
Confidence 999999999999999999999999765 5899999999999999999999 89999999999999999999999999
Q ss_pred ccccccCCCCCCCcccccccCCCcccCccccccCC----CCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcc
Q 018785 175 FGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGH----LTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD 250 (350)
Q Consensus 175 fg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~----~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~ 250 (350)
||++....... ........|++.|+|||++.+.. ++.++|+|||||++|+|++|..||.+.........+....
T Consensus 212 FG~a~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~- 289 (410)
T 3v8s_A 212 FGTCMKMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHK- 289 (410)
T ss_dssp CTTCEECCTTS-EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH-
T ss_pred cceeEeeccCC-cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhcc-
Confidence 99997643322 11223467999999999997765 7899999999999999999999997654322222221100
Q ss_pred hhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 018785 251 PFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKN--RPSMVDVLTS 303 (350)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~--Rps~~~ll~~ 303 (350)
..........+++++.+||.+||..+|.+ ||+++++++|
T Consensus 290 --------------~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 290 --------------NSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp --------------HHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred --------------ccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 00111112356789999999999999988 9999999987
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-44 Score=322.19 Aligned_cols=255 Identities=23% Similarity=0.367 Sum_probs=213.2
Q ss_pred hhhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccc---hhhHHHHHHHHHHHhccCCCcccc
Q 018785 15 ISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES---FQGHKEWLTEVIYLGQLRHENLVK 91 (350)
Q Consensus 15 ~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~ 91 (350)
......++|++.+.||+|+||.||++ .+..+++.|++|++.... ......+.+|+.+++.++||||++
T Consensus 35 ~~~~~~~~y~~~~~lg~G~~g~Vy~~---------~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 105 (335)
T 2owb_A 35 VDPRSRRRYVRGRFLGKGGFAKCFEI---------SDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVG 105 (335)
T ss_dssp EETTTTEEEEEEEEEEEETTEEEEEE---------EETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCC
T ss_pred cCcccCCceEEEEEEeeCCCeEEEEE---------EECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCe
Confidence 34456789999999999999999999 556678999999987553 234566889999999999999999
Q ss_pred eeeEEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEE
Q 018785 92 LIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAK 171 (350)
Q Consensus 92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~ 171 (350)
+++++.+.+..++||||+.+++|.+++.... .+++.+++.++.|++.||.||| +.|++|+||+|+||+++.++.++
T Consensus 106 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH--~~~ivH~dlkp~NIl~~~~~~~k 181 (335)
T 2owb_A 106 FHGFFEDNDFVFVVLELCRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLH--RNRVIHRDLKLGNLFLNEDLEVK 181 (335)
T ss_dssp EEEEEECSSEEEEEECCCTTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGGGEEECTTCCEE
T ss_pred EEEEEecCCeEEEEEecCCCCCHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHH--HCCCEecCCCchhEEEcCCCCEE
Confidence 9999999999999999999999999987764 7999999999999999999999 89999999999999999999999
Q ss_pred EccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcch
Q 018785 172 LSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADP 251 (350)
Q Consensus 172 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~ 251 (350)
|+|||++........ ......+++.|+|||++.+..++.++||||||+++|+|++|..||...........+
T Consensus 182 l~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~------ 253 (335)
T 2owb_A 182 IGDFGLATKVEYDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI------ 253 (335)
T ss_dssp ECCCTTCEECCSTTC--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH------
T ss_pred EeeccCceecccCcc--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHH------
Confidence 999999976432221 223356889999999999999999999999999999999999999754421111111
Q ss_pred hhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 252 FLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
... ....+..+++.+.+||.+||+.||.+|||+.+++++
T Consensus 254 -----------~~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 254 -----------KKN--EYSIPKHINPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp -----------HHT--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred -----------hcC--CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111 112344567889999999999999999999999986
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-44 Score=336.12 Aligned_cols=275 Identities=24% Similarity=0.348 Sum_probs=192.2
Q ss_pred hhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccc--hhhHHHHHHHHHHHhccCCCcccceeeEEe
Q 018785 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES--FQGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (350)
Q Consensus 20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (350)
.++|++.+.||+|+||+||+| .+..+++.||||++.... ......+.+|+.+++.++||||+++++++.
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~---------~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 122 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEA---------YDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVI 122 (458)
T ss_dssp CTTEEECCC-------CEEEE---------EECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECC
T ss_pred CCCeEEeeEeeecCCeEEEEE---------EECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEe
Confidence 478999999999999999999 566678999999986542 234467889999999999999999999984
Q ss_pred e-----cCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEE
Q 018785 98 E-----SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKL 172 (350)
Q Consensus 98 ~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l 172 (350)
. ...+|+|||++ +++|.+++.... .+++..++.++.||+.||.||| +.||+||||||+|||++.++.++|
T Consensus 123 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH--~~~iiHrDlKp~NILl~~~~~~kl 197 (458)
T 3rp9_A 123 PKDVEKFDELYVVLEIA-DSDFKKLFRTPV--YLTELHIKTLLYNLLVGVKYVH--SAGILHRDLKPANCLVNQDCSVKV 197 (458)
T ss_dssp CSCTTTCCCEEEEECCC-SEEHHHHHHSSC--CCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCCGGGEEECTTCCEEE
T ss_pred cCCcccCceEEEEEecc-ccchhhhcccCC--CCCHHHHHHHHHHHHHHHHHHH--hCCcCCCCCChhhEEECCCCCEee
Confidence 3 35789999998 679999987654 7999999999999999999999 899999999999999999999999
Q ss_pred ccccccccCCCCCCC-------------------------cccccccCCCcccCcccc-ccCCCCCccchhhHHHHHHHH
Q 018785 173 SDFGLARDGPTGDNT-------------------------HVSTRIVGTRGYAAPEYV-ATGHLTPKSDVYSFGVVLLEL 226 (350)
Q Consensus 173 ~Dfg~~~~~~~~~~~-------------------------~~~~~~~~~~~~~aPE~~-~~~~~~~~~DiwslG~ll~~l 226 (350)
+|||++......... .......||+.|+|||++ .+..++.++|||||||++|+|
T Consensus 198 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~el 277 (458)
T 3rp9_A 198 CDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAEL 277 (458)
T ss_dssp CCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHH
T ss_pred cccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHH
Confidence 999999865332211 122335679999999976 456799999999999999999
Q ss_pred Hh-----------CCCCCcccccCcc--------------------hhhhhhh-cchhhhh--------hHHHHHhhhcc
Q 018785 227 LS-----------GRRALDEDRGGLA--------------------EQTLVEW-ADPFLRD--------SRRVLRIMDTR 266 (350)
Q Consensus 227 l~-----------g~~pf~~~~~~~~--------------------~~~~~~~-~~~~~~~--------~~~~~~~~~~~ 266 (350)
++ |+.+|.+...... ...+... ..+.... ...........
T Consensus 278 ltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~ 357 (458)
T 3rp9_A 278 LNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKR 357 (458)
T ss_dssp HTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCC
T ss_pred HHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCC
Confidence 98 6666655431100 0000000 0000000 00000000000
Q ss_pred cC---CCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHhhh
Q 018785 267 LG---GQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS--LEQLH 308 (350)
Q Consensus 267 ~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~--L~~~~ 308 (350)
.. ......+++++.+||.+||..||.+|||++++++| +..+.
T Consensus 358 ~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~ 404 (458)
T 3rp9_A 358 EGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVR 404 (458)
T ss_dssp CCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred CCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcC
Confidence 00 01123457889999999999999999999999987 44443
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-44 Score=316.56 Aligned_cols=255 Identities=25% Similarity=0.316 Sum_probs=202.5
Q ss_pred hhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch-hhHHHHHHHHHHHhccCCCcccceeeEE
Q 018785 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLVKLIGYC 96 (350)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (350)
...++|++.+.||+|+||+||+| .+..++..+|+|.+..... .....+.+|+.+++.++||||+++++++
T Consensus 19 ~i~~~y~~~~~lg~G~~g~V~~~---------~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 89 (285)
T 3is5_A 19 TIDDLFIFKRKLGSGAFGDVHLV---------EERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89 (285)
T ss_dssp CHHHHEEEEEEEEECSSCEEEEE---------EETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ChhhheeecceeccCCCeEEEEE---------EEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHhe
Confidence 34589999999999999999999 5566789999999876542 3457788999999999999999999999
Q ss_pred eecCceEEEEEcCCCCChhhHHhhc--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEE---cCCCcEE
Q 018785 97 SESDNRLLVYEFMPKGSLENHLFRK--GVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLL---DSNFNAK 171 (350)
Q Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili---~~~~~~~ 171 (350)
.+.+..++||||+++++|.+++... ....+++..++.++.|++.||.||| +.|++|+||+|+||++ +.++.++
T Consensus 90 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH--~~~ivH~dikp~NIl~~~~~~~~~~k 167 (285)
T 3is5_A 90 EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH--SQHVVHKDLKPENILFQDTSPHSPIK 167 (285)
T ss_dssp ECSSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCSGGGEEESSSSTTCCEE
T ss_pred ecCCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHH--hCCEEECCCCHHHEEEecCCCCCCEE
Confidence 9999999999999999999988543 2247999999999999999999999 8999999999999999 4567899
Q ss_pred EccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcch
Q 018785 172 LSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADP 251 (350)
Q Consensus 172 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~ 251 (350)
|+|||++....... ......+++.|+|||.+. ..++.++||||||+++|+|++|..||.+............
T Consensus 168 l~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~---- 239 (285)
T 3is5_A 168 IIDFGLAELFKSDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATY---- 239 (285)
T ss_dssp ECCCCCCCC-------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH----
T ss_pred EEeeecceecCCcc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhcc----
Confidence 99999997543322 223356889999999874 5688999999999999999999999976543221111110
Q ss_pred hhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 252 FLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
. ..........+++.+.+|+.+||+.||.+|||+.++++|
T Consensus 240 -----------~-~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 240 -----------K-EPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp -----------C-CCCCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred -----------C-CcccccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 000001112356789999999999999999999999865
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=312.10 Aligned_cols=252 Identities=24% Similarity=0.376 Sum_probs=203.9
Q ss_pred hhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccc--hhhHHHHHHHHHHHhccCCCcccceeeE
Q 018785 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES--FQGHKEWLTEVIYLGQLRHENLVKLIGY 95 (350)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 95 (350)
..+..|++.+.||+|+||+||+| .+..++..|++|.+.... ......+.+|+.+++.++||||++++++
T Consensus 23 ~~~~~~~~~~~lg~G~~g~Vy~~---------~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 93 (290)
T 1t4h_A 23 NDGRFLKFDIEIGRGSFKTVYKG---------LDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 93 (290)
T ss_dssp TTSCEEEEEEEEEECSSEEEEEE---------EETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred cCceeEEeeeeccCCCCeEEEEe---------EecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeee
Confidence 34667999999999999999999 566678999999987543 2345678899999999999999999999
Q ss_pred Eee----cCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC--eeeCCCCCCceEEc-CCC
Q 018785 96 CSE----SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDAN--VIYRDLKASNVLLD-SNF 168 (350)
Q Consensus 96 ~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~--i~H~di~~~Nili~-~~~ 168 (350)
+.. ....++||||+++++|.+++.... .++...++.++.|++.||.||| +.| ++|+||+|+||+++ .++
T Consensus 94 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH--~~~~~i~H~dikp~Nil~~~~~~ 169 (290)
T 1t4h_A 94 WESTVKGKKCIVLVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLH--TRTPPIIHRDLKCDNIFITGPTG 169 (290)
T ss_dssp EEEESSSCEEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH--TSSSCCCCSCCCGGGEEESSTTS
T ss_pred eccccCCCceEEEEEEecCCCCHHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHH--cCCCCEEECCCCHHHEEEECCCC
Confidence 875 355899999999999999998764 6899999999999999999999 888 99999999999997 788
Q ss_pred cEEEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhh
Q 018785 169 NAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEW 248 (350)
Q Consensus 169 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~ 248 (350)
.++|+|||++...... ......+++.|+|||.+. ..++.++||||||+++|+|++|+.||..........
T Consensus 170 ~~kl~Dfg~~~~~~~~----~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~----- 239 (290)
T 1t4h_A 170 SVKIGDLGLATLKRAS----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIY----- 239 (290)
T ss_dssp CEEECCTTGGGGCCTT----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHH-----
T ss_pred CEEEeeCCCccccccc----ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHH-----
Confidence 9999999999753222 223356899999999876 458999999999999999999999997543211110
Q ss_pred cchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 249 ADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
............+...++++.++|.+||+.||.+|||+.++++|
T Consensus 240 -----------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 240 -----------RRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp -----------HHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred -----------HHHhccCCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 11111111112233455789999999999999999999999975
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-45 Score=327.70 Aligned_cols=268 Identities=23% Similarity=0.320 Sum_probs=201.0
Q ss_pred hcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhH-HHHHHHHHHHhccCCCcccceeeEEeec
Q 018785 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGH-KEWLTEVIYLGQLRHENLVKLIGYCSES 99 (350)
Q Consensus 21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (350)
++|++.+.||+|+||+||+| .+..+++.||+|.+........ ..+.+|+.+++.++||||+++++++...
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~---------~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 72 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKG---------KSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTE 72 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEE---------EETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECS
T ss_pred CceEEEEEEcCCCCEEEEEE---------EECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeC
Confidence 58999999999999999999 5566789999999875543221 1345689999999999999999999999
Q ss_pred CceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccccc
Q 018785 100 DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR 179 (350)
Q Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~ 179 (350)
+..++||||+. ++|.+++.... ..+++..++.++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++.
T Consensus 73 ~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH--~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~ 148 (324)
T 3mtl_A 73 KSLTLVFEYLD-KDLKQYLDDCG-NIINMHNVKLFLFQLLRGLAYCH--RQKVLHRDLKPQNLLINERGELKLADFGLAR 148 (324)
T ss_dssp SCEEEEEECCS-EEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHH--HTTEEESSCCGGGEEECTTCCEEECSSSEEE
T ss_pred CEEEEEecccc-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH--HCCccCCCcCHHHEEECCCCCEEEccCcccc
Confidence 99999999995 59999887654 36899999999999999999999 8999999999999999999999999999997
Q ss_pred cCCCCCCCcccccccCCCcccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhh----h
Q 018785 180 DGPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL----R 254 (350)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~----~ 254 (350)
...... .......+++.|+|||++.+ ..++.++||||||+++|+|++|..||.+.........+........ .
T Consensus 149 ~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 226 (324)
T 3mtl_A 149 AKSIPT--KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWP 226 (324)
T ss_dssp CC--------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred cccCCc--cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhch
Confidence 533222 22233467899999999876 5689999999999999999999999987665443333332211000 0
Q ss_pred ---hhHHHHHhhhcccCC----CCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 255 ---DSRRVLRIMDTRLGG----QYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 255 ---~~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
............... .....+++++.+||.+||+.||.+|||++++++|
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 282 (324)
T 3mtl_A 227 GILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282 (324)
T ss_dssp TGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 000000000000000 0112456789999999999999999999999986
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=313.77 Aligned_cols=268 Identities=26% Similarity=0.350 Sum_probs=212.8
Q ss_pred hhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch-hhHHHHHHHHHHHhccCCCcccceeeEE
Q 018785 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLVKLIGYC 96 (350)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (350)
...-.|.+.++||+|+||+||+|++.. ...++..||+|.+..... ...+.+.+|+.+++.++||||+++++++
T Consensus 18 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 91 (298)
T 3pls_A 18 HERVVTHSDRVIGKGHFGVVYHGEYID------QAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIM 91 (298)
T ss_dssp GGGEEEEEEEEEEEETTEEEEEEEEEC------SSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred ccceEEccCceeccCCCceEEEEEEec------CCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence 334567778999999999999996542 333456899999876443 3446788999999999999999999999
Q ss_pred eecCce-EEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccc
Q 018785 97 SESDNR-LLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDF 175 (350)
Q Consensus 97 ~~~~~~-~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Df 175 (350)
.+.+.. ++|||++.+++|.+++.... ..++...++.++.|++.||.||| +.|++|+||||+||+++.++.++|+||
T Consensus 92 ~~~~~~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH--~~~i~H~dikp~Nili~~~~~~kl~Df 168 (298)
T 3pls_A 92 LPPEGLPHVLLPYMCHGDLLQFIRSPQ-RNPTVKDLISFGLQVARGMEYLA--EQKFVHRDLAARNCMLDESFTVKVADF 168 (298)
T ss_dssp CCSSSCCEEEECCCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEECTTCCEEECCT
T ss_pred ecCCCCcEEEEecccCCCHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCcceEEEcCCCcEEeCcC
Confidence 876665 99999999999999997643 46899999999999999999999 899999999999999999999999999
Q ss_pred cccccCCCCC--CCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCc-ccccCcchhhhhhhcchh
Q 018785 176 GLARDGPTGD--NTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALD-EDRGGLAEQTLVEWADPF 252 (350)
Q Consensus 176 g~~~~~~~~~--~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~-~~~~~~~~~~~~~~~~~~ 252 (350)
|++....... .........+++.|+|||.+.+..++.++||||||+++|+|++|..|+. .......
T Consensus 169 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~----------- 237 (298)
T 3pls_A 169 GLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDL----------- 237 (298)
T ss_dssp TSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGH-----------
T ss_pred CCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHH-----------
Confidence 9997543221 1112223456788999999999999999999999999999999666543 3222111
Q ss_pred hhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcCCC
Q 018785 253 LRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKD 312 (350)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~ 312 (350)
...+........+..+++.+.+++.+||..||.+|||+.++++.|+++.....
T Consensus 238 -------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~ 290 (298)
T 3pls_A 238 -------THFLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALL 290 (298)
T ss_dssp -------HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred -------HHHhhcCCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHh
Confidence 11111222233345677899999999999999999999999999999887643
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-44 Score=320.84 Aligned_cols=259 Identities=20% Similarity=0.293 Sum_probs=210.4
Q ss_pred hhhhhhccccc-ceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch--hhHHHHHHHHHHHhcc-CCCcccc
Q 018785 16 SKIATKNFCSD-YLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQL-RHENLVK 91 (350)
Q Consensus 16 ~~~~~~~y~i~-~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l-~h~~i~~ 91 (350)
.+...++|.+. +.||+|+||.||+| .+..+++.||+|++..... .....+.+|+.+++.+ .||||++
T Consensus 23 ~~~~~~~y~~~~~~lG~G~~g~V~~~---------~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~ 93 (327)
T 3lm5_A 23 MENFNNFYILTSKELGRGKFAVVRQC---------ISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVIN 93 (327)
T ss_dssp HHHHHHHEEEEEEEEEEETTEEEEEE---------EETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCC
T ss_pred HHhhhhEEeeccceeCCCCCeEEEEE---------EECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEE
Confidence 45566788887 89999999999999 5666789999999876543 2356788999999999 5799999
Q ss_pred eeeEEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcC---CC
Q 018785 92 LIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS---NF 168 (350)
Q Consensus 92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~---~~ 168 (350)
+++++...+..++||||+.+++|.+++.......+++..++.++.|++.||+||| +.|++|+||+|+||+++. ++
T Consensus 94 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH--~~givH~Dikp~NIl~~~~~~~~ 171 (327)
T 3lm5_A 94 LHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH--QNNIVHLDLKPQNILLSSIYPLG 171 (327)
T ss_dssp EEEEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGGGEEESCBTTBC
T ss_pred EEEEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH--HCCeecCcCChHHEEEecCCCCC
Confidence 9999999999999999999999999997665567999999999999999999999 899999999999999987 78
Q ss_pred cEEEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhh
Q 018785 169 NAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEW 248 (350)
Q Consensus 169 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~ 248 (350)
.++|+|||++........ .....+++.|+|||++.+..++.++||||||+++|+|++|..||...........+..
T Consensus 172 ~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~- 247 (327)
T 3lm5_A 172 DIKIVDFGMSRKIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQ- 247 (327)
T ss_dssp CEEECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-
T ss_pred cEEEeeCccccccCCccc---cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHh-
Confidence 999999999976433221 2235689999999999999999999999999999999999999976543222211111
Q ss_pred cchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 249 ADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
............+++.+.+||.+||+.||.+|||++++++|
T Consensus 248 --------------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 248 --------------VNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp --------------TCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred --------------cccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 11112223334677889999999999999999999999876
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=334.58 Aligned_cols=259 Identities=19% Similarity=0.214 Sum_probs=209.5
Q ss_pred hhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh---hHHHHHHHHHHHhccCCCcccceee
Q 018785 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ---GHKEWLTEVIYLGQLRHENLVKLIG 94 (350)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~ 94 (350)
+..++|++.++||+|+||+||+| .+..+++.||+|++...... ....+.+|..++..++||||+++++
T Consensus 71 ~~~~~y~~~~~LG~G~fG~V~~~---------~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~ 141 (437)
T 4aw2_A 71 LHREDFEILKVIGRGAFGEVAVV---------KLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHY 141 (437)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEE---------EETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEE
T ss_pred CChhheEEEEEEEeCCCEEEEEE---------EEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence 34579999999999999999999 55567899999998754321 1233788999999999999999999
Q ss_pred EEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcc
Q 018785 95 YCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSD 174 (350)
Q Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~D 174 (350)
++.+.+.+|+||||+.+++|.+++.... ..+++..++.++.|++.||.||| +.||+||||||+||+++.++.++|+|
T Consensus 142 ~~~~~~~~~lV~Ey~~gg~L~~~l~~~~-~~l~e~~~~~~~~qi~~aL~~LH--~~giiHrDLKp~NILl~~~g~vkL~D 218 (437)
T 4aw2_A 142 AFQDDNNLYLVMDYYVGGDLLTLLSKFE-DRLPEEMARFYLAEMVIAIDSVH--QLHYVHRDIKPDNILMDMNGHIRLAD 218 (437)
T ss_dssp EEECSSEEEEEECCCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTSCEEECC
T ss_pred EEeeCCEEEEEEecCCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHH--hCCeEecccCHHHeeEcCCCCEEEcc
Confidence 9999999999999999999999997643 36999999999999999999999 89999999999999999999999999
Q ss_pred ccccccCCCCCCCcccccccCCCcccCccccc-----cCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhc
Q 018785 175 FGLARDGPTGDNTHVSTRIVGTRGYAAPEYVA-----TGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWA 249 (350)
Q Consensus 175 fg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~ 249 (350)
||++........ .......||+.|+|||++. +..++.++|+|||||++|+|++|+.||.+.........+....
T Consensus 219 FGla~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~ 297 (437)
T 4aw2_A 219 FGSCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHK 297 (437)
T ss_dssp CTTCEECCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH
T ss_pred hhhhhhcccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcc
Confidence 999975433222 2223357999999999986 4578999999999999999999999998655332222222100
Q ss_pred chhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 018785 250 DPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKN--RPSMVDVLTS 303 (350)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~--Rps~~~ll~~ 303 (350)
...........+++++.+||.+||..+|++ |++++++++|
T Consensus 298 --------------~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 298 --------------ERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp --------------HHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred --------------ccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 000001112347889999999999888888 9999999987
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-44 Score=329.59 Aligned_cols=257 Identities=21% Similarity=0.284 Sum_probs=197.0
Q ss_pred hhccccc-ceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHh-ccCCCcccceeeEEe
Q 018785 20 TKNFCSD-YLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLG-QLRHENLVKLIGYCS 97 (350)
Q Consensus 20 ~~~y~i~-~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~ 97 (350)
.++|.+. ++||+|+||+||+| .+..+++.||||++... ..+.+|+.++. ..+||||+++++++.
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~---------~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~ 125 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQI---------FNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYE 125 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEE---------EETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred cccceeccceeeeccCeEEEEE---------EECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEe
Confidence 3566665 79999999999999 66667999999998633 34556777764 458999999999987
Q ss_pred e----cCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcC---CCcE
Q 018785 98 E----SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS---NFNA 170 (350)
Q Consensus 98 ~----~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~---~~~~ 170 (350)
. ...+|+||||+++++|.+++.......+++..++.++.|++.||.||| +.|++|+||||+||+++. ++.+
T Consensus 126 ~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH--~~~ivHrDlkp~Nill~~~~~~~~~ 203 (400)
T 1nxk_A 126 NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH--SINIAHRDVKPENLLYTSKRPNAIL 203 (400)
T ss_dssp EEETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEESSSSTTCCE
T ss_pred ecccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH--HCCccccCcCcceEEEecCCCCccE
Confidence 6 567899999999999999998766557999999999999999999999 899999999999999987 7889
Q ss_pred EEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcc
Q 018785 171 KLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD 250 (350)
Q Consensus 171 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~ 250 (350)
+|+|||++....... ......|++.|+|||++.+..++.++|||||||++|+|++|..||..............
T Consensus 204 kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~--- 277 (400)
T 1nxk_A 204 KLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT--- 277 (400)
T ss_dssp EECCCTTCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHH---
T ss_pred EEEecccccccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHH---
Confidence 999999997543222 22345689999999999999999999999999999999999999976543221111100
Q ss_pred hhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 018785 251 PFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQ 306 (350)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 306 (350)
................+++++.+||.+||..||.+|||+.++++|-.-
T Consensus 278 --------~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~ 325 (400)
T 1nxk_A 278 --------RIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 325 (400)
T ss_dssp --------HHHHTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHH
T ss_pred --------HHHcCcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccc
Confidence 000000011111224578899999999999999999999999998543
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=315.28 Aligned_cols=254 Identities=20% Similarity=0.269 Sum_probs=205.9
Q ss_pred hhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch----hhHHHHHHHHHHHhccCCCcccceeeE
Q 018785 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF----QGHKEWLTEVIYLGQLRHENLVKLIGY 95 (350)
Q Consensus 20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~ 95 (350)
.++|++.+.||+|+||.||+| .+..++..||+|++..... .....+.+|+.+++.++||||++++++
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~---------~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 74 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEV---------LDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDV 74 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEE---------EBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred ccceeEeeEEecCCCeEEEEE---------EECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEE
Confidence 479999999999999999999 6666789999999876532 234678899999999999999999999
Q ss_pred E--eecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEc
Q 018785 96 C--SESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLS 173 (350)
Q Consensus 96 ~--~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~ 173 (350)
+ .+.+..++||||+.++ |.+++.......+++..+..++.|++.||.||| +.|++|+||+|+||+++.++.++|+
T Consensus 75 ~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH--~~~i~H~dlkp~NIl~~~~~~~kl~ 151 (305)
T 2wtk_C 75 LYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLH--SQGIVHKDIKPGNLLLTTGGTLKIS 151 (305)
T ss_dssp EECC---CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECTTCCEEEC
T ss_pred EEcCCCCeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHH--HCCeeecCCCcccEEEcCCCcEEee
Confidence 8 4556889999999664 888887766668999999999999999999999 8999999999999999999999999
Q ss_pred cccccccCCCCCCCcccccccCCCcccCccccccCC--CCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcch
Q 018785 174 DFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGH--LTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADP 251 (350)
Q Consensus 174 Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~--~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~ 251 (350)
|||++................+++.|+|||++.+.. ++.++||||||+++|+|++|..||.+.........+.
T Consensus 152 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~----- 226 (305)
T 2wtk_C 152 ALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIG----- 226 (305)
T ss_dssp CCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH-----
T ss_pred ccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHh-----
Confidence 999998654433333334456899999999987643 3779999999999999999999997644211111111
Q ss_pred hhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018785 252 FLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL 304 (350)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 304 (350)
.. ....+..+++.+.+++.+||..||.+|||+.++++|-
T Consensus 227 ------------~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~ 265 (305)
T 2wtk_C 227 ------------KG--SYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHS 265 (305)
T ss_dssp ------------HC--CCCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSH
T ss_pred ------------cC--CCCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCc
Confidence 01 1123446778899999999999999999999999873
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-44 Score=331.74 Aligned_cols=270 Identities=23% Similarity=0.290 Sum_probs=210.0
Q ss_pred hhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhcc------CCCcc
Q 018785 16 SKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQL------RHENL 89 (350)
Q Consensus 16 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l------~h~~i 89 (350)
.+....+|++.+.||+|+||+||+| .+..+++.||||++.... .....+.+|+.+++.+ +|+||
T Consensus 92 ~~~~~~ry~~~~~LG~G~fg~V~~a---------~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~i 161 (429)
T 3kvw_A 92 HDHVAYRYEVLKVIGKGSFGQVVKA---------YDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNV 161 (429)
T ss_dssp TCEETTTEEEEEEEEESSSEEEEEE---------EETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCB
T ss_pred CCcccCcEEEEEEcccCccEEEEEE---------EECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCE
Confidence 3455678999999999999999999 566678999999997653 2235566777777766 57899
Q ss_pred cceeeEEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCc
Q 018785 90 VKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFN 169 (350)
Q Consensus 90 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~ 169 (350)
+++++++...+..++|||++ +++|.+++.......+++..++.++.||+.||+||| +.|++|+||||+||+++.++.
T Consensus 162 v~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH--~~~ivHrDlKp~NILl~~~~~ 238 (429)
T 3kvw_A 162 IHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH--KNRIIHCDLKPENILLKQQGR 238 (429)
T ss_dssp CCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH--HHTEECSCCSGGGEEESSTTS
T ss_pred EEEEeecccCCeEEEEEecc-CCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHeEEccCCC
Confidence 99999999999999999999 569999998877667999999999999999999999 899999999999999999887
Q ss_pred --EEEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhh
Q 018785 170 --AKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVE 247 (350)
Q Consensus 170 --~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~ 247 (350)
++|+|||++...... .....+++.|+|||++.+..++.++|||||||++|+|++|..||.+.........+..
T Consensus 239 ~~vkL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~ 313 (429)
T 3kvw_A 239 SGIKVIDFGSSCYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIE 313 (429)
T ss_dssp CCEEECCCTTCEETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred cceEEeecccceecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 999999999753322 2234688999999999999999999999999999999999999987665443333332
Q ss_pred hcchhh----hhhHHHHHhhhccc-------------------------------CC-----CCcHHHHHHHHHHHHHhh
Q 018785 248 WADPFL----RDSRRVLRIMDTRL-------------------------------GG-----QYSKKEAQAVAAVVLQCL 287 (350)
Q Consensus 248 ~~~~~~----~~~~~~~~~~~~~~-------------------------------~~-----~~~~~~~~~l~~li~~~l 287 (350)
...... ........++.... .. ......++.+.+||.+||
T Consensus 314 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L 393 (429)
T 3kvw_A 314 LLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCL 393 (429)
T ss_dssp HHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHT
T ss_pred HcCCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHC
Confidence 211110 00000111110000 00 011123678999999999
Q ss_pred ccCCCCCCCHHHHHHH
Q 018785 288 HMDPKNRPSMVDVLTS 303 (350)
Q Consensus 288 ~~dp~~Rps~~~ll~~ 303 (350)
+.||.+|||+.++++|
T Consensus 394 ~~dP~~Rpta~e~L~H 409 (429)
T 3kvw_A 394 EWDPAVRMTPGQALRH 409 (429)
T ss_dssp CSSTTTSCCHHHHHTS
T ss_pred CCChhhCCCHHHHhCC
Confidence 9999999999999976
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-44 Score=332.15 Aligned_cols=262 Identities=24% Similarity=0.327 Sum_probs=201.4
Q ss_pred CCchhhhhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh--------hHHHHHHHHHHH
Q 018785 10 PSASMISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ--------GHKEWLTEVIYL 81 (350)
Q Consensus 10 ~~~~~~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--------~~~~~~~e~~~l 81 (350)
...........++|++.+.||+|+||+||+| .+..+++.||+|++...... ....+.+|+.++
T Consensus 124 ~~~~~~~~~~~~~y~~~~~LG~G~~g~V~~a---------~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l 194 (419)
T 3i6u_A 124 DDQSVYPKALRDEYIMSKTLGSGACGEVKLA---------FERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 194 (419)
T ss_dssp SCGGGSCHHHHTTEEEEEEEEECSSSEEEEE---------EETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHH
T ss_pred ccccccchhhhccEEEEeEEeeCCCeEEEEE---------EECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHH
Confidence 3344455667889999999999999999999 66667899999998754321 112477899999
Q ss_pred hccCCCcccceeeEEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCc
Q 018785 82 GQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASN 161 (350)
Q Consensus 82 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~N 161 (350)
++++||||+++++++.. +..++||||+++++|.+++.... .+++..++.++.|++.||+||| +.|++|+||||+|
T Consensus 195 ~~l~hpniv~l~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH--~~~ivHrDlkp~N 269 (419)
T 3i6u_A 195 KKLNHPCIIKIKNFFDA-EDYYIVLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQYLH--ENGIIHRDLKPEN 269 (419)
T ss_dssp HHCCCTTBCCCCEEEES-SEEEEEEECCTTCBGGGGTSSSC--CCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGG
T ss_pred HhCCCCCEeeEEEEEec-CceEEEEEcCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHH--HCCccccCCChHh
Confidence 99999999999999865 45899999999999999887654 7999999999999999999999 8999999999999
Q ss_pred eEEcCCC---cEEEccccccccCCCCCCCcccccccCCCcccCcccccc---CCCCCccchhhHHHHHHHHHhCCCCCcc
Q 018785 162 VLLDSNF---NAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT---GHLTPKSDVYSFGVVLLELLSGRRALDE 235 (350)
Q Consensus 162 ili~~~~---~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~---~~~~~~~DiwslG~ll~~ll~g~~pf~~ 235 (350)
|+++.++ .++|+|||++...... .......|++.|+|||++.+ ..++.++||||||+++|+|++|..||..
T Consensus 270 Ill~~~~~~~~~kl~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~ 346 (419)
T 3i6u_A 270 VLLSSQEEDCLIKITDFGHSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE 346 (419)
T ss_dssp EEESSSSSSCCEEECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred EEEecCCCcceEEEeecccceecCCC---ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 9997654 4999999999864322 22234568999999999854 5678899999999999999999999976
Q ss_pred cccCcchh-hhhhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 236 DRGGLAEQ-TLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 236 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
........ .+........ ......+++.+.+||.+||+.||.+|||+.++++|
T Consensus 347 ~~~~~~~~~~i~~~~~~~~---------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 347 HRTQVSLKDQITSGKYNFI---------------PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp CSSSCCHHHHHHTTCCCCC---------------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CcchHHHHHHHhcCCCCCC---------------chhhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 54332211 1111000000 00112457889999999999999999999999986
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=316.25 Aligned_cols=259 Identities=26% Similarity=0.356 Sum_probs=214.6
Q ss_pred hhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch-hhHHHHHHHHHHHhccCCCcccceeeE
Q 018785 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLVKLIGY 95 (350)
Q Consensus 17 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~ 95 (350)
....++|++.+.||+|+||.||+| .+..+++.||+|++..... .....+.+|+.+++.++||||++++++
T Consensus 18 ~~~~~~y~~~~~lg~G~~g~V~~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 88 (303)
T 3a7i_A 18 ADPEELFTKLEKIGKGSFGEVFKG---------IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 88 (303)
T ss_dssp ECGGGTEEEEEEEEECSSSEEEEE---------EETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CChHHHHHHhhhhcccCCeEEEEE---------EECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEE
Confidence 345678999999999999999999 5566789999999876542 345778899999999999999999999
Q ss_pred EeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccc
Q 018785 96 CSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDF 175 (350)
Q Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Df 175 (350)
+...+..++||||+++++|.+++... .++...+..++.|++.||.||| +.|++|+||+|+||+++.++.++|+||
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dl~p~Nil~~~~~~~kl~Df 163 (303)
T 3a7i_A 89 YLKDTKLWIIMEYLGGGSALDLLEPG---PLDETQIATILREILKGLDYLH--SEKKIHRDIKAANVLLSEHGEVKLADF 163 (303)
T ss_dssp EEETTEEEEEEECCTTEEHHHHHTTS---CCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTSCEEECCC
T ss_pred EecCCeEEEEEEeCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH--HCCCccCCCChheEEECCCCCEEEeec
Confidence 99999999999999999999998653 6999999999999999999999 899999999999999999999999999
Q ss_pred cccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhh
Q 018785 176 GLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRD 255 (350)
Q Consensus 176 g~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 255 (350)
|++....... .......+++.|+|||.+.+..++.++|+||||+++|+|++|..||..........
T Consensus 164 g~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~------------ 229 (303)
T 3a7i_A 164 GVAGQLTDTQ--IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLF------------ 229 (303)
T ss_dssp TTCEECBTTB--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH------------
T ss_pred ccceecCccc--cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHH------------
Confidence 9997543222 12233568889999999999999999999999999999999999997543211111
Q ss_pred hHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhc
Q 018785 256 SRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHT 309 (350)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 309 (350)
.+........+..++..+.+|+.+||..||.+|||+.+++++..-...
T Consensus 230 ------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 277 (303)
T 3a7i_A 230 ------LIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRN 277 (303)
T ss_dssp ------HHHHSCCCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHH
T ss_pred ------HhhcCCCCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcC
Confidence 111112223445677889999999999999999999999987654433
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-44 Score=315.04 Aligned_cols=256 Identities=31% Similarity=0.447 Sum_probs=206.0
Q ss_pred hhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceeeEE
Q 018785 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYC 96 (350)
Q Consensus 17 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (350)
.+..++|++.+.||+|++|+||+|++ +|..||+|.+.... ..+.+.+|+..++.++||||+++++++
T Consensus 17 ~~~~~~y~~~~~lg~G~~g~V~~~~~-----------~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~ 83 (278)
T 1byg_A 17 ALNMKELKLLQTIGKGEFGDVMLGDY-----------RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVI 83 (278)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEE-----------TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEE
T ss_pred cCChhhceEEeEEecCCCceEEEEEE-----------cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 45678999999999999999999943 27789999997654 456788999999999999999999986
Q ss_pred ee-cCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccc
Q 018785 97 SE-SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDF 175 (350)
Q Consensus 97 ~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Df 175 (350)
.+ .+..++|||++++++|.+++.......+++..+..++.|++.||.||| +.|++|+||+|+||+++.++.++|+||
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dlkp~Nil~~~~~~~~l~Df 161 (278)
T 1byg_A 84 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE--GNNFVHRDLAARNVLVSEDNVAKVSDF 161 (278)
T ss_dssp CCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEECTTSCEEECCC
T ss_pred EcCCCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH--hCCccccCCCcceEEEeCCCcEEEeec
Confidence 54 457899999999999999997664334889999999999999999999 899999999999999999999999999
Q ss_pred cccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccccCcchhhhhhhcchhhh
Q 018785 176 GLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLR 254 (350)
Q Consensus 176 g~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~ 254 (350)
|++....... ....+++.|+|||.+.+..++.++|+||||+++|+|++ |..||...........
T Consensus 162 g~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~---------- 226 (278)
T 1byg_A 162 GLTKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR---------- 226 (278)
T ss_dssp CC-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHH----------
T ss_pred cccccccccc-----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH----------
Confidence 9987532221 12346778999999999999999999999999999998 9999976543221111
Q ss_pred hhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcC
Q 018785 255 DSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 310 (350)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 310 (350)
+........+..+++.+.+++.+||+.||.+|||+.++++.|+++...
T Consensus 227 --------~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 227 --------VEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp --------HTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --------HhcCCCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 111122334556788999999999999999999999999999998764
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-44 Score=316.90 Aligned_cols=271 Identities=28% Similarity=0.405 Sum_probs=207.6
Q ss_pred hhhhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccc---hhhHHHHHHHHHHHhccCCCccc
Q 018785 14 MISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES---FQGHKEWLTEVIYLGQLRHENLV 90 (350)
Q Consensus 14 ~~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~ 90 (350)
....+..++|++.+.||+|+||+||+|++.. ....+..||+|.+.... ......+.+|+..++.++||||+
T Consensus 11 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~ 84 (291)
T 1u46_A 11 LTCLIGEKDLRLLEKLGDGSFGVVRRGEWDA------PSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84 (291)
T ss_dssp CCEECCGGGEEEEEECC----CCCEEEEEEC------TTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBC
T ss_pred cccccchhHeeeeeeecCCCceeEEEEEecc------CCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcc
Confidence 3445668899999999999999999996542 22334579999887643 23346788999999999999999
Q ss_pred ceeeEEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcE
Q 018785 91 KLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNA 170 (350)
Q Consensus 91 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~ 170 (350)
++++++.... .++|+|++.+++|.+++.... ..+++..+..++.|++.||.||| +.|++|+||+|+||+++.++.+
T Consensus 85 ~~~~~~~~~~-~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dikp~Nili~~~~~~ 160 (291)
T 1u46_A 85 RLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLE--SKRFIHRDLAARNLLLATRDLV 160 (291)
T ss_dssp CEEEEECSSS-CEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGGGEEEEETTEE
T ss_pred cEEEEEccCC-ceeeEecccCCCHHHHHHhcc-CCcCHHHHHHHHHHHHHHHHHHH--hCCcccCCCchheEEEcCCCCE
Confidence 9999998754 899999999999999997653 36899999999999999999999 8999999999999999999999
Q ss_pred EEccccccccCCCCCCCc-ccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccccCcchhhhhhh
Q 018785 171 KLSDFGLARDGPTGDNTH-VSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEW 248 (350)
Q Consensus 171 ~l~Dfg~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~ 248 (350)
+|+|||++.......... ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||..........
T Consensus 161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~----- 235 (291)
T 1u46_A 161 KIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILH----- 235 (291)
T ss_dssp EECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH-----
T ss_pred EEccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHH-----
Confidence 999999997654333221 1223456778999999988889999999999999999999 999997654321111
Q ss_pred cchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcCC
Q 018785 249 ADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSK 311 (350)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~ 311 (350)
...........+..+++.+.+++.+||..||.+|||+.+++++|.++....
T Consensus 236 ------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 286 (291)
T 1u46_A 236 ------------KIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTD 286 (291)
T ss_dssp ------------HHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred ------------HHHccCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCccc
Confidence 111122222334567889999999999999999999999999999987654
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-44 Score=332.69 Aligned_cols=281 Identities=23% Similarity=0.308 Sum_probs=206.0
Q ss_pred hhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccc--hhhHHHHHHHHHHHhccCCCcccceeeEE
Q 018785 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES--FQGHKEWLTEVIYLGQLRHENLVKLIGYC 96 (350)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (350)
..++|++.+.||+|+||.||+| .+..+++.||||++.... ......+.+|+.+++.++||||+++++++
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a---------~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~ 94 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLA---------YDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLI 94 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEE---------EETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEEC
T ss_pred ecCCEEEEEEEeecCCEEEEEE---------EECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEE
Confidence 4689999999999999999999 566679999999997542 23446788999999999999999999999
Q ss_pred eec-----CceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEE
Q 018785 97 SES-----DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAK 171 (350)
Q Consensus 97 ~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~ 171 (350)
... +..|+|||++ +++|.+++.... .+++..++.++.||+.||.||| +.|++||||||+||+++.++.++
T Consensus 95 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~--~l~~~~~~~i~~qil~aL~~LH--~~givHrDlkp~NILl~~~~~~k 169 (432)
T 3n9x_A 95 IPDDLLKFDELYIVLEIA-DSDLKKLFKTPI--FLTEEHIKTILYNLLLGENFIH--ESGIIHRDLKPANCLLNQDCSVK 169 (432)
T ss_dssp CCSCTTTCCCEEEEEECC-SEEHHHHHHSSC--CCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTCCEE
T ss_pred ecCCCCcCCeEEEEEecC-CcCHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHH--HCCCCCCCCCHHHeEECCCCCEE
Confidence 776 5789999998 569999997654 6999999999999999999999 89999999999999999999999
Q ss_pred EccccccccCCCCCCC--------------------cccccccCCCcccCcccc-ccCCCCCccchhhHHHHHHHHHhCC
Q 018785 172 LSDFGLARDGPTGDNT--------------------HVSTRIVGTRGYAAPEYV-ATGHLTPKSDVYSFGVVLLELLSGR 230 (350)
Q Consensus 172 l~Dfg~~~~~~~~~~~--------------------~~~~~~~~~~~~~aPE~~-~~~~~~~~~DiwslG~ll~~ll~g~ 230 (350)
|+|||++......... .......||+.|+|||++ .+..++.++|||||||++|+|++|.
T Consensus 170 L~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~ 249 (432)
T 3n9x_A 170 VCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNML 249 (432)
T ss_dssp ECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTC
T ss_pred EccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcc
Confidence 9999999865433211 122446789999999986 5567999999999999999999865
Q ss_pred CCCc-----------ccccC-----------------cchhhhhh-hcchhhhh-----hHHHHHhhhccc-CCC-----
Q 018785 231 RALD-----------EDRGG-----------------LAEQTLVE-WADPFLRD-----SRRVLRIMDTRL-GGQ----- 270 (350)
Q Consensus 231 ~pf~-----------~~~~~-----------------~~~~~~~~-~~~~~~~~-----~~~~~~~~~~~~-~~~----- 270 (350)
.||. +.... .....+.. ...+.... .......+.... ...
T Consensus 250 ~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (432)
T 3n9x_A 250 QSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQ 329 (432)
T ss_dssp TTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHH
T ss_pred cccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHH
Confidence 5543 22110 00000000 00010000 000111111100 000
Q ss_pred CcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHhhhcCCCC
Q 018785 271 YSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS--LEQLHTSKDM 313 (350)
Q Consensus 271 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~--L~~~~~~~~~ 313 (350)
....+++++.+||.+||..||.+|||++++++| +..+......
T Consensus 330 ~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~e 374 (432)
T 3n9x_A 330 KYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKKLE 374 (432)
T ss_dssp HSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCCTTTC
T ss_pred HCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhccCcccC
Confidence 013467899999999999999999999999987 5555544333
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=323.74 Aligned_cols=272 Identities=24% Similarity=0.276 Sum_probs=200.1
Q ss_pred hhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhh--HHHHHHHHHHHhccCCCccccee
Q 018785 16 SKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQG--HKEWLTEVIYLGQLRHENLVKLI 93 (350)
Q Consensus 16 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~ 93 (350)
.....++|++.+.||+|+||+||+| .+..+++.||||.+....... ...+.+|+.+++.++||||++++
T Consensus 29 ~~~~~~~y~~~~~lg~G~~g~V~~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 99 (329)
T 3gbz_A 29 SATSIDRYRRITKLGEGTYGEVYKA---------IDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELK 99 (329)
T ss_dssp ---CGGGEEEEEEEEECSSSEEEEE---------EETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEE
T ss_pred cccchhhEEEEEEEEecCCeEEEEE---------EECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEE
Confidence 3445679999999999999999999 666779999999997654322 34567899999999999999999
Q ss_pred eEEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEc-----CCC
Q 018785 94 GYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLD-----SNF 168 (350)
Q Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~-----~~~ 168 (350)
+++...+..++||||+. ++|.+++.... .+++..++.++.||+.||.||| +.|++|+||||+||+++ .++
T Consensus 100 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~--~~~~~~~~~i~~ql~~~l~~LH--~~~ivH~Dlkp~NIll~~~~~~~~~ 174 (329)
T 3gbz_A 100 SVIHHNHRLHLIFEYAE-NDLKKYMDKNP--DVSMRVIKSFLYQLINGVNFCH--SRRCLHRDLKPQNLLLSVSDASETP 174 (329)
T ss_dssp EEEEETTEEEEEEECCS-EEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEEEC-----CC
T ss_pred EEEecCCEEEEEEecCC-CCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHH--hCCEECCCCCHHHEEEecCCCCccc
Confidence 99999999999999996 59999998775 6999999999999999999999 89999999999999994 445
Q ss_pred cEEEccccccccCCCCCCCcccccccCCCcccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhh
Q 018785 169 NAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVE 247 (350)
Q Consensus 169 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~ 247 (350)
.++|+|||++....... .......+++.|+|||++.+. .++.++|||||||++|+|++|..||.+.........+..
T Consensus 175 ~~kl~Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~ 252 (329)
T 3gbz_A 175 VLKIGDFGLARAFGIPI--RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFE 252 (329)
T ss_dssp EEEECCTTHHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred eEEECcCCCccccCCcc--cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHH
Confidence 59999999997532221 122334678999999998775 589999999999999999999999977654333222221
Q ss_pred hcc-hhhhhhHHHH------HhhhcccC----CCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 248 WAD-PFLRDSRRVL------RIMDTRLG----GQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 248 ~~~-~~~~~~~~~~------~~~~~~~~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
... +......... ........ ......+++++.+||.+||+.||.+|||+.++++|
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 319 (329)
T 3gbz_A 253 VLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319 (329)
T ss_dssp HHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence 110 0000000000 00000000 00112356889999999999999999999999875
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=327.64 Aligned_cols=280 Identities=21% Similarity=0.322 Sum_probs=217.2
Q ss_pred hhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch-hhHHHHHHHHHHHhccCCCcccceeeEE
Q 018785 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLVKLIGYC 96 (350)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (350)
..+++|++.++||+|+||+||+| .+..+|+.||||++..... .....+.+|+.+++.++||||+++++++
T Consensus 6 ~~~~~y~i~~~LG~G~~g~Vy~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~ 76 (396)
T 4eut_A 6 TSNHLWLLSDILGQGATANVFRG---------RHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIE 76 (396)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEE---------EETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CCCCceEEEEEEEcCCCeEEEEE---------EECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEee
Confidence 45789999999999999999999 5566789999999876543 3356678999999999999999999999
Q ss_pred eecC--ceEEEEEcCCCCChhhHHhhcCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEE----cCCCc
Q 018785 97 SESD--NRLLVYEFMPKGSLENHLFRKGV-QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLL----DSNFN 169 (350)
Q Consensus 97 ~~~~--~~~lv~e~~~~~~L~~~l~~~~~-~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili----~~~~~ 169 (350)
...+ ..++||||+++++|.+++..... ..+++..++.++.|++.||+||| +.|++|+||||+||++ +.++.
T Consensus 77 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dlkp~NIll~~~~~~~~~ 154 (396)
T 4eut_A 77 EETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR--ENGIVHRNIKPGNIMRVIGEDGQSV 154 (396)
T ss_dssp ECTTTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEEEECTTSCEE
T ss_pred ccCCCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH--HCCEEECCcCHHHEEEeecCCCcee
Confidence 8765 77999999999999999976432 23999999999999999999999 8999999999999999 77778
Q ss_pred EEEccccccccCCCCCCCcccccccCCCcccCcccccc--------CCCCCccchhhHHHHHHHHHhCCCCCcccccCcc
Q 018785 170 AKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT--------GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLA 241 (350)
Q Consensus 170 ~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--------~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~ 241 (350)
++|+|||++....... ......|++.|+|||++.+ ..++.++|||||||++|+|++|+.||........
T Consensus 155 ~kL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~ 231 (396)
T 4eut_A 155 YKLTDFGAARELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR 231 (396)
T ss_dssp EEECCGGGCEECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTT
T ss_pred EEEecCCCceEccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccc
Confidence 9999999997643322 2223568999999999865 5677899999999999999999999975443222
Q ss_pred hhhhh-hhcc--h--hhhhhHHH----HH-hhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcCC
Q 018785 242 EQTLV-EWAD--P--FLRDSRRV----LR-IMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSK 311 (350)
Q Consensus 242 ~~~~~-~~~~--~--~~~~~~~~----~~-~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~ 311 (350)
...+. .... + ........ .. ..........+..++..+.+++.+||+.||++|||+.++++.+.++....
T Consensus 232 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~~ 311 (396)
T 4eut_A 232 NKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRM 311 (396)
T ss_dssp CHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTCE
T ss_pred hHHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhce
Confidence 11111 1000 0 00000000 00 00011122355788999999999999999999999999999999987764
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=312.34 Aligned_cols=271 Identities=20% Similarity=0.254 Sum_probs=214.9
Q ss_pred hhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceeeEE-e
Q 018785 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYC-S 97 (350)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~ 97 (350)
.+++|++.+.||+|+||.||+| .+..+++.||+|++..... ...+.+|+.+++.+.|++++..+..+ .
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~---------~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~ 75 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLG---------TDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGA 75 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEE---------EETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEE
T ss_pred eccEEEEEEEEccCCCeEEEEE---------EEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccC
Confidence 4689999999999999999999 5566789999999876543 24578899999999988877666555 5
Q ss_pred ecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEc---CCCcEEEcc
Q 018785 98 ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLD---SNFNAKLSD 174 (350)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~---~~~~~~l~D 174 (350)
..+..++||||+ +++|.+++.... ..+++..++.++.|++.||.||| +.|++|+||||+||+++ .++.++|+|
T Consensus 76 ~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH--~~~ivH~dlkp~NIl~~~~~~~~~~kl~D 151 (296)
T 3uzp_A 76 EGDYNVMVMELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIH--SKNFIHRDVKPDNFLMGLGKKGNLVYIID 151 (296)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGGGEEECCGGGTTCEEECC
T ss_pred CCCceEEEEEec-CCCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHH--hCCeeeCCCCHHHeEEecCCCCCeEEEee
Confidence 667789999999 999999997543 36999999999999999999999 89999999999999994 788999999
Q ss_pred ccccccCCCCCCCc-----ccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhc
Q 018785 175 FGLARDGPTGDNTH-----VSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWA 249 (350)
Q Consensus 175 fg~~~~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~ 249 (350)
||++.......... ......+++.|+|||.+.+..++.++||||||+++|+|++|+.||...........+....
T Consensus 152 fg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 231 (296)
T 3uzp_A 152 FGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS 231 (296)
T ss_dssp CTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHH
T ss_pred CCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhc
Confidence 99997644432211 1234568999999999999999999999999999999999999998755433222222111
Q ss_pred chhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcCCCCCC
Q 018785 250 DPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDMPR 315 (350)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~~~ 315 (350)
...... ........+++++.+++.+||+.||.+|||+.++++.|+++......+.
T Consensus 232 ~~~~~~-----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~ 286 (296)
T 3uzp_A 232 EKKMST-----------PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSY 286 (296)
T ss_dssp HHHHHS-----------CHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCCS
T ss_pred ccccCC-----------chHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCcc
Confidence 100000 0001123457889999999999999999999999999999988866553
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=314.10 Aligned_cols=272 Identities=19% Similarity=0.247 Sum_probs=211.1
Q ss_pred hhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceeeEE-
Q 018785 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYC- 96 (350)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~- 96 (350)
..+++|++.+.||+|+||+||+| .+..+++.||+|++...... ..+..|+.+++.++|++++..+..+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~---------~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~ 74 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLG---------TDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCG 74 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEE---------EETTTTEEEEEEEEEC---C--CCHHHHHHHHHHHTTSTTCCCEEEEE
T ss_pred ccCCceEEeeeecCCCCeEEEEE---------EEcCCCceEEEEeecccccc--hHHHHHHHHHHHhcCCCCCCeeeeec
Confidence 34689999999999999999999 56667899999986554322 3467899999999888777766655
Q ss_pred eecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEE---cCCCcEEEc
Q 018785 97 SESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLL---DSNFNAKLS 173 (350)
Q Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili---~~~~~~~l~ 173 (350)
...+..++|||++ +++|.+++.... ..+++..++.++.|++.||.||| +.|++|+||||+||++ +.++.++|+
T Consensus 75 ~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH--~~~ivH~Dlkp~NIl~~~~~~~~~~kL~ 150 (296)
T 4hgt_A 75 AEGDYNVMVMELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIH--SKNFIHRDVKPDNFLMGLGKKGNLVYII 150 (296)
T ss_dssp EETTEEEEEEECC-CCBHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECCGGGTTCEEEC
T ss_pred CCCCceEEEEEcc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHeeeeccCCCCeEEEe
Confidence 6677889999999 999999997543 36999999999999999999999 8999999999999999 788999999
Q ss_pred cccccccCCCCCCC-----cccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhh
Q 018785 174 DFGLARDGPTGDNT-----HVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEW 248 (350)
Q Consensus 174 Dfg~~~~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~ 248 (350)
|||++......... .......+++.|+|||.+.+..++.++||||||+++|+|++|+.||.+.........+...
T Consensus 151 Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 230 (296)
T 4hgt_A 151 DFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERI 230 (296)
T ss_dssp CCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHH
T ss_pred cCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhh
Confidence 99999765443221 1223456899999999999999999999999999999999999999876554333332221
Q ss_pred cchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcCCCCCC
Q 018785 249 ADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDMPR 315 (350)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~~~ 315 (350)
........ .......+++++.+++.+||+.||.+|||+.++++.|+++........
T Consensus 231 ~~~~~~~~-----------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~ 286 (296)
T 4hgt_A 231 SEKKMSTP-----------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSY 286 (296)
T ss_dssp HHHHHHSC-----------HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCCT
T ss_pred hcccccch-----------hhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCCc
Confidence 11100000 000112356789999999999999999999999999999998766543
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=320.90 Aligned_cols=276 Identities=25% Similarity=0.350 Sum_probs=191.2
Q ss_pred CCCCchhhhhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch-hhHHHHHHHHHHHhccCC
Q 018785 8 SDPSASMISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRH 86 (350)
Q Consensus 8 ~~~~~~~~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h 86 (350)
+..+...-..+..++|++.+.||+|++|.||+| .+..+++.||||.+..... .....+.+|+..++.++|
T Consensus 2 ~~~s~~~p~~i~~~~y~~~~~lg~G~~g~V~~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h 72 (303)
T 2vwi_A 2 SEDSSALPWSINRDDYELQEVIGSGATAVVQAA---------YCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHH 72 (303)
T ss_dssp -----------CCCCCEEEEECC---CCCEEEE---------EC----CEEEEECCC----------------CCCCCCC
T ss_pred CCcccccccccchhhhhhhheeccccceEEEEE---------EECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCC
Confidence 344444556677899999999999999999999 5666789999999876532 234567889999999999
Q ss_pred CcccceeeEEeecCceEEEEEcCCCCChhhHHhhc------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCC
Q 018785 87 ENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRK------GVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKAS 160 (350)
Q Consensus 87 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~------~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~ 160 (350)
|||+++++++...+..++||||+++++|.+++... ....+++..++.++.|++.||.||| +.|++|+||+|+
T Consensus 73 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH--~~~i~H~dl~p~ 150 (303)
T 2vwi_A 73 PNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH--KNGQIHRDVKAG 150 (303)
T ss_dssp TTBCCEEEEEESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCSGG
T ss_pred CCEeeEEEEEeecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHH--hCCCCCCCCChh
Confidence 99999999999999999999999999999998641 2346899999999999999999999 899999999999
Q ss_pred ceEEcCCCcEEEccccccccCCCCCCC---cccccccCCCcccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCccc
Q 018785 161 NVLLDSNFNAKLSDFGLARDGPTGDNT---HVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRALDED 236 (350)
Q Consensus 161 Nili~~~~~~~l~Dfg~~~~~~~~~~~---~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~ll~~ll~g~~pf~~~ 236 (350)
||+++.++.++|+|||++......... .......+++.|+|||.+.+ ..++.++||||||+++|+|++|..||...
T Consensus 151 Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 230 (303)
T 2vwi_A 151 NILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKY 230 (303)
T ss_dssp GEEECTTCCEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred hEEEcCCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccC
Confidence 999999999999999998754332211 11223568899999999866 57899999999999999999999999765
Q ss_pred ccCcchhhhhhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 237 RGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
..............+... ...........++.++.+++.+||+.||.+|||+.++++|
T Consensus 231 ~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 231 PPMKVLMLTLQNDPPSLE---------TGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp CGGGHHHHHHTSSCCCTT---------C-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred chhhHHHHHhccCCCccc---------cccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 433222111110000000 0000112233466789999999999999999999999975
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=317.65 Aligned_cols=258 Identities=25% Similarity=0.355 Sum_probs=203.8
Q ss_pred hhhhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCccccee
Q 018785 14 MISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLI 93 (350)
Q Consensus 14 ~~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 93 (350)
.+.+...++|++.+.||+|+||.||+| .+..+|+.||+|.+.... ....+.+|+.+++.++||||++++
T Consensus 22 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~---------~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~ 90 (314)
T 3com_A 22 SLTKQPEEVFDVLEKLGEGSYGSVYKA---------IHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYY 90 (314)
T ss_dssp --------CEEEEEECC----CEEEEE---------EETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEE
T ss_pred hhhhcchhhhhhheeeccCCCeEEEEE---------EECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEE
Confidence 355666789999999999999999999 555678999999987653 345678899999999999999999
Q ss_pred eEEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEc
Q 018785 94 GYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLS 173 (350)
Q Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~ 173 (350)
+++...+..++||||+.+++|.+++.... ..++...++.++.|++.||.||| +.|++|+||+|+||+++.++.++|+
T Consensus 91 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH--~~~i~H~dl~p~Nil~~~~~~~kl~ 167 (314)
T 3com_A 91 GSYFKNTDLWIVMEYCGAGSVSDIIRLRN-KTLTEDEIATILQSTLKGLEYLH--FMRKIHRDIKAGNILLNTEGHAKLA 167 (314)
T ss_dssp EEEEETTEEEEEEECCTTEEHHHHHHHHT-CCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTCCEEEC
T ss_pred EEEEeCCEEEEEeecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH--hCCCcCCCcCHHHEEECCCCCEEEe
Confidence 99999999999999999999999987433 37999999999999999999999 8999999999999999999999999
Q ss_pred cccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhh
Q 018785 174 DFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 253 (350)
Q Consensus 174 Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 253 (350)
|||++....... .......+++.|+|||.+.+..++.++||||||+++|+|++|..||...........+..
T Consensus 168 dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~------ 239 (314)
T 3com_A 168 DFGVAGQLTDTM--AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPT------ 239 (314)
T ss_dssp CCTTCEECBTTB--SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH------
T ss_pred ecccchhhhhhc--cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhc------
Confidence 999997543221 122335688899999999998999999999999999999999999975442111111000
Q ss_pred hhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 254 RDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
........+..+++.+.+||.+||..||.+|||+.++++|
T Consensus 240 ----------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 240 ----------NPPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQH 279 (314)
T ss_dssp ----------SCCCCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred ----------CCCcccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 1111112344567899999999999999999999999976
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=323.64 Aligned_cols=275 Identities=23% Similarity=0.346 Sum_probs=205.8
Q ss_pred hhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccc--hhhHHHHHHHHHHHhccCCCcccceeeEEe
Q 018785 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES--FQGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (350)
Q Consensus 20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (350)
.++|++.+.||+|+||.||+| .+..+|+.||||.+.... ......+.+|+.+++.++||||+++++++.
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 94 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSA---------VDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFT 94 (367)
T ss_dssp BSSEEEEEEC------CEEEE---------EETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEEC
T ss_pred cceEEEeEEeeecCCeEEEEE---------EECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEe
Confidence 578999999999999999999 666779999999986543 233466789999999999999999999998
Q ss_pred ecC------ceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEE
Q 018785 98 ESD------NRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAK 171 (350)
Q Consensus 98 ~~~------~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~ 171 (350)
..+ ..|+|||++ +++|.+++... .+++..+..++.|++.||.||| +.|++|+||||+||+++.++.++
T Consensus 95 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~---~l~~~~~~~~~~qi~~~L~~LH--~~~ivH~Dlkp~NIll~~~~~~k 168 (367)
T 1cm8_A 95 PDETLDDFTDFYLVMPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIH--AAGIIHRDLKPGNLAVNEDCELK 168 (367)
T ss_dssp SCSSTTTCCCCEEEEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTCCEE
T ss_pred cCCccccCceEEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH--HCCccccCcCHHHEEEcCCCCEE
Confidence 763 459999999 88999998764 6899999999999999999999 89999999999999999999999
Q ss_pred EccccccccCCCCCCCcccccccCCCcccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcc
Q 018785 172 LSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD 250 (350)
Q Consensus 172 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~ 250 (350)
|+|||++...... .....+++.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+.....
T Consensus 169 l~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g 243 (367)
T 1cm8_A 169 ILDFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTG 243 (367)
T ss_dssp ECCCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred EEeeecccccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 9999999864322 223567899999999877 6899999999999999999999999987665433333332211
Q ss_pred hhhhh---------hHHHHHhhhcccC---CCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHhhhcCCCCC
Q 018785 251 PFLRD---------SRRVLRIMDTRLG---GQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS--LEQLHTSKDMP 314 (350)
Q Consensus 251 ~~~~~---------~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~--L~~~~~~~~~~ 314 (350)
..... ............. .......++.+.+||.+||..||.+|||++++++| +..+....+.|
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~~~~~ 321 (367)
T 1cm8_A 244 TPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEP 321 (367)
T ss_dssp CCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC------
T ss_pred CCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCCccCC
Confidence 11000 0000011111000 11234567899999999999999999999999987 55555544433
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=336.62 Aligned_cols=256 Identities=25% Similarity=0.321 Sum_probs=207.5
Q ss_pred hhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch-------------hhHHHHHHHHHHHhcc
Q 018785 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-------------QGHKEWLTEVIYLGQL 84 (350)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-------------~~~~~~~~e~~~l~~l 84 (350)
...++|++.++||+|+||+||+| .+..++..||+|++..... ...+.+.+|+.+++.+
T Consensus 33 ~i~~~Y~~~~~lG~G~~g~V~~~---------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 103 (504)
T 3q5i_A 33 KIGESYFKVRKLGSGAYGEVLLC---------KEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103 (504)
T ss_dssp CGGGTEEEEEEEEC--CEEEEEE---------EETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTC
T ss_pred CcccceEEEeEecccCCeEEEEE---------EECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhC
Confidence 35689999999999999999999 5666789999999876432 2245688999999999
Q ss_pred CCCcccceeeEEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEE
Q 018785 85 RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLL 164 (350)
Q Consensus 85 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili 164 (350)
+||||+++++++.+.+..++||||+++++|.+++.... .+++..++.++.|++.||.||| +.|++|+||||+||++
T Consensus 104 ~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH--~~~ivH~Dlkp~Nil~ 179 (504)
T 3q5i_A 104 DHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRH--KFDECDAANIMKQILSGICYLH--KHNIVHRDIKPENILL 179 (504)
T ss_dssp CCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEE
T ss_pred CCCCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCeEeCCCcHHHEEE
Confidence 99999999999999999999999999999999997765 6999999999999999999999 8999999999999999
Q ss_pred cCCC---cEEEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcc
Q 018785 165 DSNF---NAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLA 241 (350)
Q Consensus 165 ~~~~---~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~ 241 (350)
+.++ .++|+|||++....... ......|++.|+|||++. ..++.++|||||||++|+|++|..||.+......
T Consensus 180 ~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 255 (504)
T 3q5i_A 180 ENKNSLLNIKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDI 255 (504)
T ss_dssp SSTTCCSSEEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred ecCCCCccEEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 8776 69999999997643322 223356899999999876 5689999999999999999999999987554322
Q ss_pred hhhhhhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018785 242 EQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 305 (350)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~ 305 (350)
...+....... .......+++++.+||.+||..||.+|||++++++|-.
T Consensus 256 ~~~i~~~~~~~---------------~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~ 304 (504)
T 3q5i_A 256 IKKVEKGKYYF---------------DFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRW 304 (504)
T ss_dssp HHHHHHCCCCC---------------CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred HHHHHcCCCCC---------------CccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHh
Confidence 22222111000 00011346788999999999999999999999998743
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-44 Score=312.70 Aligned_cols=253 Identities=26% Similarity=0.409 Sum_probs=202.7
Q ss_pred hhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch---hhHHHHHHHHHHHhccCCCcccce
Q 018785 16 SKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLVKL 92 (350)
Q Consensus 16 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~ 92 (350)
+.+..++|++.+.||+|++|.||+| .+..+|+.||+|.+..... .....+.+|+..++.++||||+++
T Consensus 6 g~~~~~~y~i~~~lg~G~~g~V~~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 76 (276)
T 2h6d_A 6 GRVKIGHYVLGDTLGVGTFGKVKIG---------EHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76 (276)
T ss_dssp -CCEETTEEEEEEEEECSSEEEEEE---------EETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCE
T ss_pred CcceeccEEEEeeecCCCCeEEEEE---------EECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEE
Confidence 4556789999999999999999999 5556789999999875432 234578899999999999999999
Q ss_pred eeEEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEE
Q 018785 93 IGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKL 172 (350)
Q Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l 172 (350)
++++...+..++|||++++++|.+++.... .+++..+..++.|++.||.||| +.|++|+||+|+||+++.++.++|
T Consensus 77 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dl~p~Nil~~~~~~~~l 152 (276)
T 2h6d_A 77 YQVISTPTDFFMVMEYVSGGELFDYICKHG--RVEEMEARRLFQQILSAVDYCH--RHMVVHRDLKPENVLLDAHMNAKI 152 (276)
T ss_dssp EEEEECSSEEEEEEECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHH--HHCSSCCCCCGGGEEECTTSCEEE
T ss_pred EEEEecCCeEEEEEeccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHH--HCCCccCCCChhhEEECCCCCEEE
Confidence 999999999999999999999999998765 6899999999999999999999 899999999999999999999999
Q ss_pred ccccccccCCCCCCCcccccccCCCcccCccccccCCC-CCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcch
Q 018785 173 SDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHL-TPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADP 251 (350)
Q Consensus 173 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~ 251 (350)
+|||++....... ......+++.|+|||.+.+..+ +.++|+||||+++|+|++|..||...........+.
T Consensus 153 ~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~----- 224 (276)
T 2h6d_A 153 ADFGLSNMMSDGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIR----- 224 (276)
T ss_dssp CCCCGGGCCCC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-----
T ss_pred eecccccccCCCc---ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhh-----
Confidence 9999997643322 1223467889999999987765 589999999999999999999997543211111110
Q ss_pred hhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 252 FLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
.. ....+..++..+.+++.+||+.||.+|||+.++++|
T Consensus 225 ------------~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 225 ------------GG--VFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp ------------HC--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred ------------cC--cccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 00 112344567889999999999999999999999986
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-43 Score=312.22 Aligned_cols=257 Identities=29% Similarity=0.455 Sum_probs=204.7
Q ss_pred hhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceeeEEe
Q 018785 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (350)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (350)
+..++|++.+.||+|+||+||+|++. +..||+|.+.... ....+.+|+..+++++||||+++++++.
T Consensus 5 i~~~~~~~~~~lg~G~~g~V~~~~~~-----------~~~vavK~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 71 (307)
T 2eva_A 5 IDYKEIEVEEVVGRGAFGVVCKAKWR-----------AKDVAIKQIESES--ERKAFIVELRQLSRVNHPNIVKLYGACL 71 (307)
T ss_dssp CCGGGEEEEEEEECCSSSEEEEEEET-----------TEEEEEEECSSTT--HHHHHHHHHHHHHHCCCTTBCCEEEBCT
T ss_pred CCHhHeeeeeEeecCCCceEEEEEEC-----------CeeEEEEEecChh--HHHHHHHHHHHHhcCCCCCcCeEEEEEc
Confidence 34679999999999999999999542 5789999986543 4567889999999999999999999887
Q ss_pred ecCceEEEEEcCCCCChhhHHhhcCC-CCCCHHHHHHHHHHHHHHHHHhhcCC---CCeeeCCCCCCceEEcCCCc-EEE
Q 018785 98 ESDNRLLVYEFMPKGSLENHLFRKGV-QPISWPTRVKIAIDVARGLSFLHGLD---ANVIYRDLKASNVLLDSNFN-AKL 172 (350)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~-~~l~~~~~~~i~~ql~~al~~lh~~~---~~i~H~di~~~Nili~~~~~-~~l 172 (350)
+..++||||+++++|.+++..... ..++...++.++.|+++||.||| + +|++|+||||+||+++.++. ++|
T Consensus 72 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH--~~~~~~ivH~dlkp~NIll~~~~~~~kl 147 (307)
T 2eva_A 72 --NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLH--SMQPKALIHRDLKPPNLLLVAGGTVLKI 147 (307)
T ss_dssp --TTTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHH--TCSSSCCCCCCCSGGGEEEETTTTEEEE
T ss_pred --CCcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHH--hCCCCCeecCCCChhHEEEeCCCCEEEE
Confidence 458999999999999999976542 24788899999999999999999 7 89999999999999998886 799
Q ss_pred ccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchh
Q 018785 173 SDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPF 252 (350)
Q Consensus 173 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 252 (350)
+|||++...... .....|++.|+|||.+.+..++.++||||||+++|+|++|+.||.........
T Consensus 148 ~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~---------- 212 (307)
T 2eva_A 148 CDFGTACDIQTH-----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR---------- 212 (307)
T ss_dssp CCCCC-----------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHH----------
T ss_pred cccccccccccc-----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHH----------
Confidence 999999753221 12245889999999999999999999999999999999999999754321110
Q ss_pred hhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcCCC
Q 018785 253 LRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKD 312 (350)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~ 312 (350)
................+++.+.+++.+||+.||.+|||+.++++.|+.+.....
T Consensus 213 ------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 266 (307)
T 2eva_A 213 ------IMWAVHNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFP 266 (307)
T ss_dssp ------HHHHHHTTCCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCC
T ss_pred ------HHHHHhcCCCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhcc
Confidence 000111112233445678899999999999999999999999999999876543
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=321.30 Aligned_cols=253 Identities=28% Similarity=0.371 Sum_probs=207.3
Q ss_pred hhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch---hhHHHHHHHHHHHhccCCCcccceeeE
Q 018785 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLVKLIGY 95 (350)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~ 95 (350)
..++|++.+.||+|+||+||+| .+..+++.||||.+..... .....+.+|+.+++.++||||++++++
T Consensus 52 ~~~~y~~~~~lG~G~~g~Vy~a---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 122 (348)
T 1u5q_A 52 PEKLFSDLREIGHGSFGAVYFA---------RDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGC 122 (348)
T ss_dssp HHHHEEEEEEEEECSSEEEEEE---------EETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred hhhheeeeeEEccCCCEEEEEE---------EEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 3467999999999999999999 5566789999999875432 234568899999999999999999999
Q ss_pred EeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccc
Q 018785 96 CSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDF 175 (350)
Q Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Df 175 (350)
+...+..++||||+. ++|.+++.... ..+++..+..++.|++.||.||| +.|++|+||||+||+++.++.++|+||
T Consensus 123 ~~~~~~~~lv~e~~~-g~l~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dlkp~NIll~~~~~~kL~Df 198 (348)
T 1u5q_A 123 YLREHTAWLVMEYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLH--SHNMIHRDVKAGNILLSEPGLVKLGDF 198 (348)
T ss_dssp EEETTEEEEEEECCS-EEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCSGGGEEEETTTEEEECCC
T ss_pred EEECCeEEEEEecCC-CCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH--hCCeeeCCCCHHHEEECCCCCEEEeec
Confidence 999999999999995 68888886543 37999999999999999999999 899999999999999999999999999
Q ss_pred cccccCCCCCCCcccccccCCCcccCccccc---cCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchh
Q 018785 176 GLARDGPTGDNTHVSTRIVGTRGYAAPEYVA---TGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPF 252 (350)
Q Consensus 176 g~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 252 (350)
|++...... ....|++.|+|||++. +..++.++|||||||++|+|++|..||.+........
T Consensus 199 G~a~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~--------- 263 (348)
T 1u5q_A 199 GSASIMAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY--------- 263 (348)
T ss_dssp TTCBSSSSB------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH---------
T ss_pred cCceecCCC------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH---------
Confidence 999754321 2346899999999885 5678999999999999999999999997544211111
Q ss_pred hhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 018785 253 LRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 307 (350)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~ 307 (350)
...........+..+++.+.+||.+||+.||.+|||+++++++..-.
T Consensus 264 --------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~ 310 (348)
T 1u5q_A 264 --------HIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVL 310 (348)
T ss_dssp --------HHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHH
T ss_pred --------HHHhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhh
Confidence 11111112222345678899999999999999999999999875543
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-44 Score=322.03 Aligned_cols=268 Identities=24% Similarity=0.366 Sum_probs=198.7
Q ss_pred hhhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccC-CCccccee
Q 018785 15 ISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLR-HENLVKLI 93 (350)
Q Consensus 15 ~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~ 93 (350)
..++...+|++.+.||+|+||.||+| .+..+++.||+|.+..........+.+|+..++++. ||||++++
T Consensus 22 ~~~~~~~~y~~~~~lg~G~~g~V~~~---------~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~ 92 (337)
T 3ll6_A 22 TVELGELRLRVRRVLAEGGFAFVYEA---------QDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFC 92 (337)
T ss_dssp EEEETTEEEEEEEEEECCSSEEEEEE---------EETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEE
T ss_pred eeeccCceEEEEEEEccCCceEEEEE---------EECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcc
Confidence 34556779999999999999999999 556678999999987766666677889999999995 99999999
Q ss_pred eEEe--------ecCceEEEEEcCCCCChhhHHhhc-CCCCCCHHHHHHHHHHHHHHHHHhhcCCCC--eeeCCCCCCce
Q 018785 94 GYCS--------ESDNRLLVYEFMPKGSLENHLFRK-GVQPISWPTRVKIAIDVARGLSFLHGLDAN--VIYRDLKASNV 162 (350)
Q Consensus 94 ~~~~--------~~~~~~lv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~i~~ql~~al~~lh~~~~~--i~H~di~~~Ni 162 (350)
+++. .....++||||+ +++|.+++... ....+++..++.++.|++.||.||| +.| ++|+||||+||
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~-~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH--~~~~~ivH~Dikp~NI 169 (337)
T 3ll6_A 93 SAASIGKEESDTGQAEFLLLTELC-KGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH--RQKPPIIHRDLKVENL 169 (337)
T ss_dssp EEEEECTTTSTTSSEEEEEEEECC-SEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHH--TSSSCCBCCCCCGGGC
T ss_pred ccccccccccccCCceEEEEEEec-CCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH--hCCCCEEEccCCcccE
Confidence 9984 334578999999 57999988652 2346999999999999999999999 888 99999999999
Q ss_pred EEcCCCcEEEccccccccCCCCCCCc----------ccccccCCCcccCcccc---ccCCCCCccchhhHHHHHHHHHhC
Q 018785 163 LLDSNFNAKLSDFGLARDGPTGDNTH----------VSTRIVGTRGYAAPEYV---ATGHLTPKSDVYSFGVVLLELLSG 229 (350)
Q Consensus 163 li~~~~~~~l~Dfg~~~~~~~~~~~~----------~~~~~~~~~~~~aPE~~---~~~~~~~~~DiwslG~ll~~ll~g 229 (350)
+++.++.++|+|||++.......... ......+++.|+|||++ .+..++.++||||||+++|+|++|
T Consensus 170 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g 249 (337)
T 3ll6_A 170 LLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFR 249 (337)
T ss_dssp EECTTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHS
T ss_pred EECCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhC
Confidence 99999999999999997644332211 11134588899999988 566788999999999999999999
Q ss_pred CCCCcccccCcchhhhhhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhc
Q 018785 230 RRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHT 309 (350)
Q Consensus 230 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 309 (350)
..||........ .............+..+.+|+.+||+.||.+|||+.+++++|+.+..
T Consensus 250 ~~p~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~ 308 (337)
T 3ll6_A 250 QHPFEDGAKLRI---------------------VNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAA 308 (337)
T ss_dssp SCCC---------------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCcchhHHHh---------------------hcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 999965432111 11111112223345568899999999999999999999999999987
Q ss_pred CCCCCC
Q 018785 310 SKDMPR 315 (350)
Q Consensus 310 ~~~~~~ 315 (350)
......
T Consensus 309 ~~~~~~ 314 (337)
T 3ll6_A 309 ARNVNP 314 (337)
T ss_dssp HTTCCT
T ss_pred ccCCCC
Confidence 755443
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-44 Score=323.41 Aligned_cols=245 Identities=22% Similarity=0.315 Sum_probs=205.5
Q ss_pred hhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh--------hHHHHHHHHHHHhccCCCcc
Q 018785 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ--------GHKEWLTEVIYLGQLRHENL 89 (350)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--------~~~~~~~e~~~l~~l~h~~i 89 (350)
...++|++.+.||+|+||+||+| .+..+++.||||.+...... ....+.+|+.+++.++||||
T Consensus 21 ~~~~~y~~~~~lG~G~~g~Vy~a---------~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~I 91 (335)
T 3dls_A 21 EYSQKYSTMSPLGSGAFGFVWTA---------VDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91 (335)
T ss_dssp HHHHHEEEEEECSSSSSCSEEEE---------EETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTB
T ss_pred ccccceEEEeEEEecCCEEEEEE---------EECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCE
Confidence 34579999999999999999999 56667999999998765321 22345679999999999999
Q ss_pred cceeeEEeecCceEEEEEcCCCC-ChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCC
Q 018785 90 VKLIGYCSESDNRLLVYEFMPKG-SLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNF 168 (350)
Q Consensus 90 ~~~~~~~~~~~~~~lv~e~~~~~-~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~ 168 (350)
+++++++.+.+..++|||++.++ +|.+++.... .+++..++.++.|++.||.||| +.|++|+||||+||+++.++
T Consensus 92 v~~~~~~~~~~~~~lv~e~~~~g~~l~~~~~~~~--~l~~~~~~~i~~qi~~~L~~LH--~~~ivH~Dlkp~NIll~~~~ 167 (335)
T 3dls_A 92 IKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHP--RLDEPLASYIFRQLVSAVGYLR--LKDIIHRDIKDENIVIAEDF 167 (335)
T ss_dssp CCEEEEEECSSEEEEEEECCTTSCBHHHHHHTCC--CCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECTTS
T ss_pred eeEEEEEeeCCEEEEEEEeCCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--hCCeEEeccCHHHEEEcCCC
Confidence 99999999999999999998666 9999997765 6999999999999999999999 89999999999999999999
Q ss_pred cEEEccccccccCCCCCCCcccccccCCCcccCccccccCCC-CCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhh
Q 018785 169 NAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHL-TPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVE 247 (350)
Q Consensus 169 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~ 247 (350)
.++|+|||++........ .....|++.|+|||++.+..+ +.++||||||+++|+|++|..||.......
T Consensus 168 ~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~------- 237 (335)
T 3dls_A 168 TIKLIDFGSAAYLERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV------- 237 (335)
T ss_dssp CEEECCCTTCEECCTTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT-------
T ss_pred cEEEeecccceECCCCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH-------
Confidence 999999999976433322 233568999999999988876 788999999999999999999996532100
Q ss_pred hcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 248 WADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
.. ....+..+++++.+||.+||+.||.+|||+.+++++
T Consensus 238 ----------------~~--~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 238 ----------------EA--AIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp ----------------TT--CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred ----------------hh--ccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 011233467889999999999999999999999987
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-44 Score=338.03 Aligned_cols=258 Identities=26% Similarity=0.337 Sum_probs=213.1
Q ss_pred hhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccc---hhhHHHHHHHHHHHhccCCCcccce
Q 018785 16 SKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES---FQGHKEWLTEVIYLGQLRHENLVKL 92 (350)
Q Consensus 16 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~ 92 (350)
.....++|++.+.||+|+||.||+| .+..+|+.||||++.... ......+.+|+.++++++||||+++
T Consensus 21 ~~~~~~~y~~~~~lg~G~~g~V~~~---------~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~ 91 (484)
T 3nyv_A 21 TAIFSDRYKGQRVLGKGSFGEVILC---------KDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 91 (484)
T ss_dssp CCCHHHHEEEEEEEEEETTEEEEEE---------EETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCE
T ss_pred CCcccCceEEeeEEecCCCEEEEEE---------EECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcE
Confidence 3456789999999999999999999 666779999999986543 2345778999999999999999999
Q ss_pred eeEEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEE---cCCCc
Q 018785 93 IGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLL---DSNFN 169 (350)
Q Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili---~~~~~ 169 (350)
++++.+.+..++|||++.+++|.+++.... .+++..++.++.|++.||.||| +.|++|+||||+||++ +.++.
T Consensus 92 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH--~~~ivH~Dlkp~Nil~~~~~~~~~ 167 (484)
T 3nyv_A 92 YEFFEDKGYFYLVGEVYTGGELFDEIISRK--RFSEVDAARIIRQVLSGITYMH--KNKIVHRDLKPENLLLESKSKDAN 167 (484)
T ss_dssp EEEEECSSEEEEEECCCCSCBHHHHHHTCS--CCBHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEESSSSTTCC
T ss_pred EEEEEeCCEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--HCCeeeCCCCHHHEEEecCCCCCc
Confidence 999999999999999999999999997765 7999999999999999999999 8999999999999999 56788
Q ss_pred EEEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhc
Q 018785 170 AKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWA 249 (350)
Q Consensus 170 ~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~ 249 (350)
++|+|||++....... ......|++.|+|||++.+ .++.++|||||||++|+|++|..||.+.........+....
T Consensus 168 ~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~ 243 (484)
T 3nyv_A 168 IRIIDFGLSTHFEASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGK 243 (484)
T ss_dssp EEECCTTHHHHBCCCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC
T ss_pred EEEEeeeeeEEccccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC
Confidence 9999999997543322 2334568999999998866 68999999999999999999999998755322222221110
Q ss_pred chhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018785 250 DPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 305 (350)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~ 305 (350)
..........+++++.+||.+||+.||.+|||+.++++|-.
T Consensus 244 ---------------~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~ 284 (484)
T 3nyv_A 244 ---------------YTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEW 284 (484)
T ss_dssp ---------------CCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHH
T ss_pred ---------------CCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChh
Confidence 00111223467889999999999999999999999998743
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=336.44 Aligned_cols=258 Identities=27% Similarity=0.427 Sum_probs=213.2
Q ss_pred hhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch---hhHHHHHHHHHHHhccCCCcccceee
Q 018785 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLVKLIG 94 (350)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~ 94 (350)
+..++|++.+.||+|+||.||+| .+..+|+.||+|++..... .....+..|..+++.++||||+++++
T Consensus 182 ~~~~~f~~~~~LG~G~fG~Vy~a---------~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~ 252 (543)
T 3c4z_A 182 MGEDWFLDFRVLGRGGFGEVFAC---------QMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252 (543)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEE---------EETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CChhheEEEEEEeeCCCeEEEEE---------EECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence 45689999999999999999999 5666799999999976532 23456788999999999999999999
Q ss_pred EEeecCceEEEEEcCCCCChhhHHhhcC--CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEE
Q 018785 95 YCSESDNRLLVYEFMPKGSLENHLFRKG--VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKL 172 (350)
Q Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l 172 (350)
++.+.+.+|+||||++|++|.+++.... ...+++..++.++.||+.||.||| +.|++|+||||+||+++.+|.++|
T Consensus 253 ~~~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH--~~gIvHrDLKP~NILl~~~g~vkL 330 (543)
T 3c4z_A 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH--QRNIIYRDLKPENVLLDDDGNVRI 330 (543)
T ss_dssp EEECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTSCEEE
T ss_pred EEeeCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHH--HcCCcccCCChHHEEEeCCCCEEE
Confidence 9999999999999999999999987643 346999999999999999999999 899999999999999999999999
Q ss_pred ccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchh
Q 018785 173 SDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPF 252 (350)
Q Consensus 173 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 252 (350)
+|||++........ ......||+.|+|||++.+..++.++|+|||||++|+|++|..||...........+..
T Consensus 331 ~DFGla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~----- 403 (543)
T 3c4z_A 331 SDLGLAVELKAGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQ----- 403 (543)
T ss_dssp CCCTTCEECCTTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHH-----
T ss_pred eecceeeeccCCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHH-----
Confidence 99999976433322 12335789999999999999999999999999999999999999976543222111111
Q ss_pred hhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCH-----HHHHHH
Q 018785 253 LRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSM-----VDVLTS 303 (350)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-----~~ll~~ 303 (350)
.+... ....+..+++.+.+||.+||+.||.+||++ +++++|
T Consensus 404 --------~i~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~H 449 (543)
T 3c4z_A 404 --------RVLEQ--AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTH 449 (543)
T ss_dssp --------HHHHC--CCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTS
T ss_pred --------HHhhc--ccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcC
Confidence 11111 123455678899999999999999999964 778765
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=334.80 Aligned_cols=253 Identities=26% Similarity=0.351 Sum_probs=204.2
Q ss_pred hhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch--hhHHHHHHHHHHHhccCCCcccceeeEE
Q 018785 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLRHENLVKLIGYC 96 (350)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (350)
..++|++.+.||+|+||+||+| .+..++..||+|++..... .....+.+|+.+++.++||||+++++++
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~---------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 105 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLC---------RDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFF 105 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEE---------EETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEE---------EECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 4568999999999999999999 5666789999999876532 2346788999999999999999999999
Q ss_pred eecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCC---CcEEEc
Q 018785 97 SESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSN---FNAKLS 173 (350)
Q Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~---~~~~l~ 173 (350)
.+.+..++||||+.+++|.+++.... .+++..++.++.|++.||.||| +.|++|+||||+||+++.. +.++|+
T Consensus 106 ~~~~~~~lv~e~~~~g~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH--~~~ivH~Dlkp~Nil~~~~~~~~~~kl~ 181 (494)
T 3lij_A 106 EDKRNYYLVMECYKGGELFDEIIHRM--KFNEVDAAVIIKQVLSGVTYLH--KHNIVHRDLKPENLLLESKEKDALIKIV 181 (494)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEESCSSTTCCEEEC
T ss_pred EeCCEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCceeccCChhhEEEeCCCCCCcEEEE
Confidence 99999999999999999999987765 6999999999999999999999 8999999999999999764 459999
Q ss_pred cccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhh
Q 018785 174 DFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 253 (350)
Q Consensus 174 Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 253 (350)
|||++....... ......|++.|+|||++. ..++.++|||||||++|+|++|..||.+.........+....
T Consensus 182 DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~---- 253 (494)
T 3lij_A 182 DFGLSAVFENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGK---- 253 (494)
T ss_dssp CCTTCEECBTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC----
T ss_pred ECCCCeECCCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC----
Confidence 999997643322 223356899999999875 568999999999999999999999998755432222221110
Q ss_pred hhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 254 RDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
..........+++.+.+||.+||+.||.+|||+.++++|
T Consensus 254 -----------~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 254 -----------YTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp -----------CCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred -----------CCCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 001111223567899999999999999999999999977
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=315.60 Aligned_cols=258 Identities=24% Similarity=0.325 Sum_probs=208.5
Q ss_pred hhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccc--hhhHHHHHHHHHHHhccCCCcccceeeEEe
Q 018785 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES--FQGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (350)
Q Consensus 20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (350)
.++|++.+.||+|+||.||+| .+..+++.||+|.+.... ......+.+|+..+++++||||+++++++.
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 75 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKI---------RRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRII 75 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEE---------EETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hhheeeehhccCCCCcEEEEE---------EECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEe
Confidence 579999999999999999999 556678999999987543 234567889999999999999999999874
Q ss_pred --ecCceEEEEEcCCCCChhhHHhhcC--CCCCCHHHHHHHHHHHHHHHHHhhcCCCC-----eeeCCCCCCceEEcCCC
Q 018785 98 --ESDNRLLVYEFMPKGSLENHLFRKG--VQPISWPTRVKIAIDVARGLSFLHGLDAN-----VIYRDLKASNVLLDSNF 168 (350)
Q Consensus 98 --~~~~~~lv~e~~~~~~L~~~l~~~~--~~~l~~~~~~~i~~ql~~al~~lh~~~~~-----i~H~di~~~Nili~~~~ 168 (350)
.....++||||+++++|.+++.... ...+++..++.++.|++.||.||| +.| ++|+||+|+||+++.++
T Consensus 76 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH--~~~~~~~~ivH~dl~p~NIl~~~~~ 153 (279)
T 2w5a_A 76 DRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH--RRSDGGHTVLHRDLKPANVFLDGKQ 153 (279)
T ss_dssp EGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH--HHC------CCCCCSGGGEEECSSS
T ss_pred cCCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHh--cccCCCCeeEEeccchhhEEEcCCC
Confidence 4578899999999999999997542 335999999999999999999999 788 99999999999999999
Q ss_pred cEEEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhh
Q 018785 169 NAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEW 248 (350)
Q Consensus 169 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~ 248 (350)
.++|+|||++....... .......+++.|+|||.+.+..++.++||||||+++|+|++|..||...........+
T Consensus 154 ~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i--- 228 (279)
T 2w5a_A 154 NVKLGDFGLARILNHDT--SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI--- 228 (279)
T ss_dssp CEEECCCCHHHHC---C--HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---
T ss_pred CEEEecCchheeecccc--ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHH---
Confidence 99999999997543221 1222356889999999999889999999999999999999999999765421111111
Q ss_pred cchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 018785 249 ADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLH 308 (350)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 308 (350)
........+..+++++.+++.+||+.||.+|||+.++++++....
T Consensus 229 ---------------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~ 273 (279)
T 2w5a_A 229 ---------------REGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273 (279)
T ss_dssp ---------------HHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCG
T ss_pred ---------------hhcccccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhh
Confidence 111112344567889999999999999999999999998765443
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-44 Score=341.02 Aligned_cols=267 Identities=30% Similarity=0.421 Sum_probs=218.7
Q ss_pred hhhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceee
Q 018785 15 ISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIG 94 (350)
Q Consensus 15 ~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 94 (350)
..++..++|++.+.||+|+||.||+|++.. +..||||++.... ...+.+.+|+.++++++||||+++++
T Consensus 261 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~----------~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~ 329 (535)
T 2h8h_A 261 AWEIPRESLRLEVKLGQGCFGEVWMGTWNG----------TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYA 329 (535)
T ss_dssp CSBCCGGGEEEEEEEEECSSEEEEEEEETT----------TEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ceecchhhhhhheecccCCCeEEEEEEECC----------CceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEE
Confidence 345667899999999999999999996542 4569999997654 33567899999999999999999999
Q ss_pred EEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcc
Q 018785 95 YCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSD 174 (350)
Q Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~D 174 (350)
++.+ +..++||||+.+++|.+++.......++...++.++.||+.||.||| ++|++|+||+|+|||++.++.++|+|
T Consensus 330 ~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH--~~~ivHrDlkp~NIll~~~~~~kl~D 406 (535)
T 2h8h_A 330 VVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE--RMNYVHRDLRAANILVGENLVCKVAD 406 (535)
T ss_dssp EECS-SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEECGGGCEEECC
T ss_pred EEee-ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH--hCCeeCCCCCHhhEEEcCCCcEEEcc
Confidence 9876 67899999999999999997644346899999999999999999999 89999999999999999999999999
Q ss_pred ccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccccCcchhhhhhhcchhh
Q 018785 175 FGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFL 253 (350)
Q Consensus 175 fg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~ 253 (350)
||++....... ........++..|+|||++.+..++.++||||||+++|+|++ |..||.+.......
T Consensus 407 FG~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~----------- 474 (535)
T 2h8h_A 407 FGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL----------- 474 (535)
T ss_dssp TTSTTTCCCHH-HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHH-----------
T ss_pred cccceecCCCc-eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH-----------
Confidence 99997543211 111122345678999999999999999999999999999999 89999765432111
Q ss_pred hhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcCCCCC
Q 018785 254 RDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDMP 314 (350)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~~ 314 (350)
..+........+..+++.+.+||.+||+.||++|||++++++.|+.+.......
T Consensus 475 -------~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~~ 528 (535)
T 2h8h_A 475 -------DQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 528 (535)
T ss_dssp -------HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCSCS
T ss_pred -------HHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccCcc
Confidence 111222233445677889999999999999999999999999999998775543
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-44 Score=329.79 Aligned_cols=258 Identities=21% Similarity=0.240 Sum_probs=207.9
Q ss_pred hhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh---hHHHHHHHHHHHhccCCCcccceee
Q 018785 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ---GHKEWLTEVIYLGQLRHENLVKLIG 94 (350)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~ 94 (350)
+..++|++.+.||+|+||.||+| .+..+|+.||+|++...... ....+.+|..++..++||+|+++++
T Consensus 58 ~~~~~f~~~~~lG~G~fG~V~~~---------~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~ 128 (412)
T 2vd5_A 58 LQRDDFEILKVIGRGAFSEVAVV---------KMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHF 128 (412)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEE---------EETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEE
T ss_pred CChhhEEEEEEEeeCCCeEEEEE---------EECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEE
Confidence 45689999999999999999999 55667999999999754321 2234778999999999999999999
Q ss_pred EEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcc
Q 018785 95 YCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSD 174 (350)
Q Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~D 174 (350)
++.+.+.+|+||||++|++|.+++...+ ..+++..++.++.|++.||.||| +.|++||||||+||+++.++.++|+|
T Consensus 129 ~~~~~~~~~lVmE~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~LH--~~giiHrDLKp~NILld~~g~vkL~D 205 (412)
T 2vd5_A 129 AFQDENYLYLVMEYYVGGDLLTLLSKFG-ERIPAEMARFYLAEIVMAIDSVH--RLGYVHRDIKPDNILLDRCGHIRLAD 205 (412)
T ss_dssp EEECSSEEEEEECCCCSCBHHHHHHHHS-SCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTSCEEECC
T ss_pred EEeeCCEEEEEEcCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH--HCCeeecccCHHHeeecCCCCEEEee
Confidence 9999999999999999999999997653 36999999999999999999999 89999999999999999999999999
Q ss_pred ccccccCCCCCCCcccccccCCCcccCccccc-------cCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhh
Q 018785 175 FGLARDGPTGDNTHVSTRIVGTRGYAAPEYVA-------TGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVE 247 (350)
Q Consensus 175 fg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-------~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~ 247 (350)
||++........ .......||+.|+|||++. +..++.++|+|||||++|+|++|+.||...........+..
T Consensus 206 FGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~ 284 (412)
T 2vd5_A 206 FGSCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVH 284 (412)
T ss_dssp CTTCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT
T ss_pred chhheeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 999976433221 1222357899999999987 35789999999999999999999999976553322222221
Q ss_pred hcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCC---CCHHHHHHH
Q 018785 248 WADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNR---PSMVDVLTS 303 (350)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R---ps~~~ll~~ 303 (350)
.. ...........+++++.+||.+||. +|.+| |+++++++|
T Consensus 285 ~~--------------~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 285 YK--------------EHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp HH--------------HHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred cc--------------cCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 00 0000011124578899999999999 99998 599999887
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=322.92 Aligned_cols=267 Identities=28% Similarity=0.432 Sum_probs=204.9
Q ss_pred hhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccc-hhhHHHHHHHHHHHhccCCCcccceeeEEe-
Q 018785 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES-FQGHKEWLTEVIYLGQLRHENLVKLIGYCS- 97 (350)
Q Consensus 20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~- 97 (350)
..+|++.+.||+|+||+||+|++.. ....+..||+|.+.... ......+.+|+.++++++||||+++++++.
T Consensus 88 ~~~~~~~~~LG~G~fg~Vy~~~~~~------~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~ 161 (373)
T 3c1x_A 88 SLIVHFNEVIGRGHFGCVYHGTLLD------NDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR 161 (373)
T ss_dssp TEEEEEEEEEECCSSSEEEEEEEEE------TTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECC
T ss_pred hceeecCcEeeeCCCeEEEEEEEEC------CCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEc
Confidence 3468889999999999999996542 22235678999886543 234567889999999999999999999864
Q ss_pred ecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccc
Q 018785 98 ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL 177 (350)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~ 177 (350)
.++..++||||+++++|.+++.... ..++...++.++.|++.||.||| +.|++|+||||+||+++.++.++|+|||+
T Consensus 162 ~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH--~~~ivHrDlkp~NIll~~~~~~kL~DFG~ 238 (373)
T 3c1x_A 162 SEGSPLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLA--SKKFVHRDLAARNCMLDEKFTVKVADFGL 238 (373)
T ss_dssp CSSCCEEEEECCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTTCCEEECCC--
T ss_pred CCCCeEEEEECCCCCCHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHH--HCCEecCccchheEEECCCCCEEEeeccc
Confidence 4568899999999999999997543 36889999999999999999999 89999999999999999999999999999
Q ss_pred cccCCCCCCC--cccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccccCcchhhhhhhcchhhh
Q 018785 178 ARDGPTGDNT--HVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLR 254 (350)
Q Consensus 178 ~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~ 254 (350)
+......... .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||...........+..
T Consensus 239 a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~------- 311 (373)
T 3c1x_A 239 ARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ------- 311 (373)
T ss_dssp -------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHT-------
T ss_pred cccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHc-------
Confidence 9754332211 11223456778999999999999999999999999999999 6777765543322221111
Q ss_pred hhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcCCCC
Q 018785 255 DSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDM 313 (350)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~ 313 (350)
......+..+++.+.+++.+||+.||.+|||+.++++.|+.+......
T Consensus 312 -----------~~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~ 359 (373)
T 3c1x_A 312 -----------GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 359 (373)
T ss_dssp -----------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred -----------CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhccc
Confidence 111223456778999999999999999999999999999999887543
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-44 Score=318.78 Aligned_cols=257 Identities=23% Similarity=0.347 Sum_probs=204.6
Q ss_pred hhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceeeEE
Q 018785 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYC 96 (350)
Q Consensus 17 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (350)
....++|++.+.||+|+||.||+| .+..++..|++|.+..........+.+|+.+++.++||||+++++++
T Consensus 15 ~~~~~~y~i~~~lg~G~~g~V~~~---------~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 85 (302)
T 2j7t_A 15 LDPNEVWEIVGELGDGAFGKVYKA---------KNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 85 (302)
T ss_dssp SCGGGTEEEEEEEECSTTCCEEEE---------EETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cCCccceeecceeccCCCeEEEEE---------EEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeee
Confidence 345789999999999999999999 55567899999999877666677889999999999999999999999
Q ss_pred eecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcccc
Q 018785 97 SESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFG 176 (350)
Q Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg 176 (350)
...+..++||||+++++|.+++.... ..+++..++.++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||
T Consensus 86 ~~~~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dlkp~Nil~~~~~~~kl~Dfg 162 (302)
T 2j7t_A 86 YHDGKLWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVVCRQMLEALNFLH--SKRIIHRDLKAGNVLMTLEGDIRLADFG 162 (302)
T ss_dssp ECC-CEEEEEECCTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCSGGGEEECTTSCEEECCCH
T ss_pred eeCCeEEEEEEeCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHh--cCCcccCCCCHHHEEECCCCCEEEEECC
Confidence 99999999999999999999887643 36999999999999999999999 8999999999999999999999999999
Q ss_pred ccccCCCCCCCcccccccCCCcccCccccc-----cCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcch
Q 018785 177 LARDGPTGDNTHVSTRIVGTRGYAAPEYVA-----TGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADP 251 (350)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~ 251 (350)
++...... ........+++.|+|||.+. +..++.++|+||||+++|+|++|..||...........+..
T Consensus 163 ~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---- 236 (302)
T 2j7t_A 163 VSAKNLKT--LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK---- 236 (302)
T ss_dssp HHHHHHHH--HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH----
T ss_pred CCcccccc--ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhc----
Confidence 87421100 01112245788999999883 56788999999999999999999999976442211111110
Q ss_pred hhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 252 FLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
........+..++..+.+++.+||..||.+|||+.++++|
T Consensus 237 ------------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 237 ------------SDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp ------------SCCCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred ------------cCCcccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 0111112345677899999999999999999999999875
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=321.10 Aligned_cols=264 Identities=17% Similarity=0.180 Sum_probs=210.1
Q ss_pred hhhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccC---CCcccc
Q 018785 15 ISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLR---HENLVK 91 (350)
Q Consensus 15 ~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~ 91 (350)
..++..++|++.+.||+|+||+||+|++... .+..+++.||+|++..... ..+..|...++.+. |++|++
T Consensus 59 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~----~~~~~~~~vavK~~~~~~~---~~~~~e~~~~~~l~~~~~~~iv~ 131 (365)
T 3e7e_A 59 EFQLGSKLVYVHHLLGEGAFAQVYEATQGDL----NDAKNKQKFVLKVQKPANP---WEFYIGTQLMERLKPSMQHMFMK 131 (365)
T ss_dssp EEECSSSEEEEEEEEEECSSEEEEEEEC-----------CCCCEEEEEESSCCH---HHHHHHHHHHHHSCGGGGGGBCC
T ss_pred eEEECCEEEEEEEEeeccCCEEEEEEEecCC----cccccCcEEEEEEeCCCCh---hHHHHHHHHHHHhhhhhhhhhhh
Confidence 3455678999999999999999999965432 2456789999999976643 34556666666665 999999
Q ss_pred eeeEEeecCceEEEEEcCCCCChhhHHhhc---CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcC--
Q 018785 92 LIGYCSESDNRLLVYEFMPKGSLENHLFRK---GVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS-- 166 (350)
Q Consensus 92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~-- 166 (350)
+++++...+..++||||+++++|.+++... ....+++..++.++.|++.||+||| +.||+||||||+||+++.
T Consensus 132 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH--~~~ivHrDiKp~NIll~~~~ 209 (365)
T 3e7e_A 132 FYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH--DCEIIHGDIKPDNFILGNGF 209 (365)
T ss_dssp EEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH--TTTEECCCCSGGGEEECGGG
T ss_pred hheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh--hCCeecCCCCHHHEEecccc
Confidence 999999999999999999999999999742 2347999999999999999999999 999999999999999988
Q ss_pred ---------CCcEEEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccc
Q 018785 167 ---------NFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDR 237 (350)
Q Consensus 167 ---------~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~ 237 (350)
++.++|+|||++................||+.|+|||++.+..++.++|||||||++|+|++|+.||....
T Consensus 210 ~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 289 (365)
T 3e7e_A 210 LEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNE 289 (365)
T ss_dssp TCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEE
T ss_pred cCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCC
Confidence 89999999999965433333334455679999999999999999999999999999999999999996543
Q ss_pred cCcchhhhhhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCC-CCHHHHHHHHHhhhcC
Q 018785 238 GGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNR-PSMVDVLTSLEQLHTS 310 (350)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R-ps~~~ll~~L~~~~~~ 310 (350)
..... +. ... . ....++.+.+++..||+.+|.+| |+++++.+.|+.+...
T Consensus 290 ~~~~~--~~------------------~~~-~--~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~ 340 (365)
T 3e7e_A 290 GGECK--PE------------------GLF-R--RLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ 340 (365)
T ss_dssp TTEEE--EC------------------SCC-T--TCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred CCcee--ec------------------hhc-c--ccCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence 32110 00 000 0 00235678899999999999999 7888888888887765
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=326.99 Aligned_cols=273 Identities=22% Similarity=0.302 Sum_probs=211.4
Q ss_pred hhhhhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccC-------
Q 018785 13 SMISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLR------- 85 (350)
Q Consensus 13 ~~~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~------- 85 (350)
...+++..++|++.++||+|+||+||+| .+..+++.||||++.... .....+.+|+.+++.+.
T Consensus 29 ~~~g~~~~~~y~~~~~lg~G~~g~V~~~---------~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~ 98 (397)
T 1wak_A 29 VKIGDLFNGRYHVIRKLGWGHFSTVWLS---------WDIQGKKFVAMKVVKSAE-HYTETALDEIRLLKSVRNSDPNDP 98 (397)
T ss_dssp SCTTCEETTTEEEEEEEEECSSEEEEEE---------EETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHSCTTCG
T ss_pred EehhhhcCCeEEEEEEeeecCCeeEEEE---------EecCCCeEEEEEEEecCC-cchHHHHHHHHHHHHHhhcCCCCC
Confidence 3456677899999999999999999999 566678999999997543 33466788999998884
Q ss_pred -CCcccceeeEEe----ecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCC-CeeeCCCCC
Q 018785 86 -HENLVKLIGYCS----ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDA-NVIYRDLKA 159 (350)
Q Consensus 86 -h~~i~~~~~~~~----~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~-~i~H~di~~ 159 (350)
|+||+++++++. .....++|||++ +++|.+++.......+++..++.++.||+.||.||| ++ |++|+||||
T Consensus 99 ~~~~iv~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH--~~~givHrDikp 175 (397)
T 1wak_A 99 NREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLH--TKCRIIHTDIKP 175 (397)
T ss_dssp GGGGBCCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH--HTTCEECCCCSG
T ss_pred CcceeeeeecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH--HhCCEecCCCCH
Confidence 788999999987 556889999999 778888887765557999999999999999999999 87 999999999
Q ss_pred CceEEcCCC-------------------------------------------------cEEEccccccccCCCCCCCccc
Q 018785 160 SNVLLDSNF-------------------------------------------------NAKLSDFGLARDGPTGDNTHVS 190 (350)
Q Consensus 160 ~Nili~~~~-------------------------------------------------~~~l~Dfg~~~~~~~~~~~~~~ 190 (350)
+||+++.++ .++|+|||++...... .
T Consensus 176 ~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~ 250 (397)
T 1wak_A 176 ENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----F 250 (397)
T ss_dssp GGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----S
T ss_pred HHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----C
Confidence 999998775 7999999999764322 2
Q ss_pred ccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhh------hhhhcchhhhh----hHHHH
Q 018785 191 TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQT------LVEWADPFLRD----SRRVL 260 (350)
Q Consensus 191 ~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~------~~~~~~~~~~~----~~~~~ 260 (350)
....+++.|+|||++.+..++.++|||||||++|+|++|..||........... +.......... .....
T Consensus 251 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~ 330 (397)
T 1wak_A 251 TEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSK 330 (397)
T ss_dssp CSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGG
T ss_pred ccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccc
Confidence 234689999999999999999999999999999999999999986554322111 11100000000 00000
Q ss_pred Hhhh-------------------cccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 261 RIMD-------------------TRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 261 ~~~~-------------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
.... .......+...+..+.+||.+||+.||.+|||+.++++|
T Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 331 EFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp GTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred cccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 0000 000113456788999999999999999999999999975
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=320.39 Aligned_cols=254 Identities=26% Similarity=0.375 Sum_probs=206.5
Q ss_pred hhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch--------hhHHHHHHHHHHHhcc-CCC
Q 018785 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--------QGHKEWLTEVIYLGQL-RHE 87 (350)
Q Consensus 17 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~e~~~l~~l-~h~ 87 (350)
....++|++.+.||+|++|.||+| .+..+|+.||||++..... .....+.+|+.+++.+ +||
T Consensus 90 ~~~~~~y~~~~~lg~G~~g~Vy~a---------~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp 160 (365)
T 2y7j_A 90 KEFYQKYDPKDVIGRGVSSVVRRC---------VHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHP 160 (365)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEE---------EETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCT
T ss_pred hhhhhhcccceEEecCCCEEEEEE---------EECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 444578999999999999999999 5556689999999865431 1134578899999999 799
Q ss_pred cccceeeEEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCC
Q 018785 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSN 167 (350)
Q Consensus 88 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~ 167 (350)
||+++++++...+..++||||+++++|.+++.... .+++..+..++.|++.||.||| +.|++|+||+|+||+++.+
T Consensus 161 ~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH--~~gi~H~Dlkp~NIl~~~~ 236 (365)
T 2y7j_A 161 HIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKV--ALSEKETRSIMRSLLEAVSFLH--ANNIVHRDLKPENILLDDN 236 (365)
T ss_dssp TBCCEEEEEEBSSEEEEEECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECTT
T ss_pred CEeEEEEEEeeCCEEEEEEEeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEECCC
Confidence 99999999999999999999999999999998764 6999999999999999999999 8999999999999999999
Q ss_pred CcEEEccccccccCCCCCCCcccccccCCCcccCcccccc------CCCCCccchhhHHHHHHHHHhCCCCCcccccCcc
Q 018785 168 FNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT------GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLA 241 (350)
Q Consensus 168 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~------~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~ 241 (350)
+.++|+|||++....... ......|++.|+|||++.+ ..++.++||||||+++|+|++|..||........
T Consensus 237 ~~ikl~DfG~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~ 313 (365)
T 2y7j_A 237 MQIRLSDFGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILM 313 (365)
T ss_dssp CCEEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred CCEEEEecCcccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHH
Confidence 999999999987644322 2233568999999998864 3588899999999999999999999976442211
Q ss_pred hhhhhhhcchhhhhhHHHHHhhhcccCCC--CcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 242 EQTLVEWADPFLRDSRRVLRIMDTRLGGQ--YSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
...+.. ...... ....++..+.+||.+||+.||.+|||+.++++|
T Consensus 314 ~~~i~~-----------------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 314 LRMIME-----------------GQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp HHHHHH-----------------TCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHh-----------------CCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 111111 000000 012356789999999999999999999999975
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=312.20 Aligned_cols=262 Identities=23% Similarity=0.376 Sum_probs=200.2
Q ss_pred hhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhc--cCCCccccee
Q 018785 16 SKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQ--LRHENLVKLI 93 (350)
Q Consensus 16 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~--l~h~~i~~~~ 93 (350)
.....++|++.+.||+|+||+||+|++ +++.||||++.... ...+..|.+++.. ++||||++++
T Consensus 3 ~~~~~~~y~~~~~lg~G~~g~V~~~~~-----------~~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~niv~~~ 68 (301)
T 3q4u_A 3 QRTVARDITLLECVGKGRYGEVWRGSW-----------QGENVAVKIFSSRD---EKSWFRETELYNTVMLRHENILGFI 68 (301)
T ss_dssp -CCCGGGCEEEEEEEECSSEEEEEEEE-----------TTEEEEEEEECGGG---HHHHHHHHHHHHHTCCCCTTBCCEE
T ss_pred cccccCcEEEEEeeccCCCcEEEEEEE-----------CCEEEEEEEecccc---chhhHHHHHHHHHhhccCcCeeeEE
Confidence 456689999999999999999999954 37889999987553 3344455555555 7999999999
Q ss_pred eEEee----cCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcC------CCCeeeCCCCCCceE
Q 018785 94 GYCSE----SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL------DANVIYRDLKASNVL 163 (350)
Q Consensus 94 ~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~------~~~i~H~di~~~Nil 163 (350)
+++.. ....++||||+++++|.+++... .+++..++.++.|++.||.|||+. +.|++|+||||+||+
T Consensus 69 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nil 145 (301)
T 3q4u_A 69 ASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT---TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNIL 145 (301)
T ss_dssp EEEEEEETTEEEEEEEECCCTTCBHHHHHTTC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEE
T ss_pred EeeccccCCCceeEEehhhccCCCHHHHHhhc---ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEE
Confidence 98654 34578999999999999999544 699999999999999999999932 469999999999999
Q ss_pred EcCCCcEEEccccccccCCCCCCCc--ccccccCCCcccCccccccC------CCCCccchhhHHHHHHHHHhC------
Q 018785 164 LDSNFNAKLSDFGLARDGPTGDNTH--VSTRIVGTRGYAAPEYVATG------HLTPKSDVYSFGVVLLELLSG------ 229 (350)
Q Consensus 164 i~~~~~~~l~Dfg~~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~------~~~~~~DiwslG~ll~~ll~g------ 229 (350)
++.++.++|+|||++.......... ......|++.|+|||++.+. .++.++||||||+++|+|++|
T Consensus 146 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~ 225 (301)
T 3q4u_A 146 VKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGI 225 (301)
T ss_dssp ECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTB
T ss_pred EcCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccc
Confidence 9999999999999986533222211 11224689999999999776 445689999999999999999
Q ss_pred ----CCCCcccccCcch-hhhhhhcchhhhhhHHHHHhhhcccCCC-----CcHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 018785 230 ----RRALDEDRGGLAE-QTLVEWADPFLRDSRRVLRIMDTRLGGQ-----YSKKEAQAVAAVVLQCLHMDPKNRPSMVD 299 (350)
Q Consensus 230 ----~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ 299 (350)
..||......... ..+.. .......... .+..+++.+.+|+.+||+.||.+|||+.+
T Consensus 226 ~~~~~~pf~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~ 292 (301)
T 3q4u_A 226 VEDYKPPFYDVVPNDPSFEDMRK-------------VVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALR 292 (301)
T ss_dssp CCCCCCTTTTTSCSSCCHHHHHH-------------HHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred cccccccccccCCCCcchhhhhH-------------HHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHH
Confidence 7777543322111 11110 0000111111 23457889999999999999999999999
Q ss_pred HHHHHHhh
Q 018785 300 VLTSLEQL 307 (350)
Q Consensus 300 ll~~L~~~ 307 (350)
+++.|+++
T Consensus 293 i~~~L~~i 300 (301)
T 3q4u_A 293 IKKTLTKI 300 (301)
T ss_dssp HHHHHHHH
T ss_pred HHHHHhcc
Confidence 99999876
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=317.68 Aligned_cols=254 Identities=28% Similarity=0.363 Sum_probs=201.7
Q ss_pred hhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhcc-CCCcccceeeEEe
Q 018785 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQL-RHENLVKLIGYCS 97 (350)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~ 97 (350)
..++|++.+.||+|+||.||+| .+..+++.||||++.... .....+.+|+..++++ .||||+++++++.
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~---------~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 91 (326)
T 2x7f_A 22 PAGIFELVELVGNGTYGQVYKG---------RHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFI 91 (326)
T ss_dssp CTTTEEEEEEEEEETTEEEEEE---------EETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEE---------EECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEe
Confidence 4679999999999999999999 555678999999987654 2346788899999999 7999999999997
Q ss_pred e------cCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEE
Q 018785 98 E------SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAK 171 (350)
Q Consensus 98 ~------~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~ 171 (350)
. .+..++||||+++++|.+++.......+++..++.++.|++.||.||| +.|++|+||+|+||+++.++.++
T Consensus 92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH--~~~ivH~dlkp~NIl~~~~~~~k 169 (326)
T 2x7f_A 92 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH--QHKVIHRDIKGQNVLLTENAEVK 169 (326)
T ss_dssp ECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCSGGGEEECTTCCEE
T ss_pred eccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH--HCCccccCCcHHHEEEcCCCCEE
Confidence 6 467899999999999999998765457999999999999999999999 89999999999999999999999
Q ss_pred EccccccccCCCCCCCcccccccCCCcccCccccc-----cCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhh
Q 018785 172 LSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVA-----TGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLV 246 (350)
Q Consensus 172 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~ 246 (350)
|+|||++....... .......+++.|+|||++. +..++.++||||||+++|+|++|..||..........
T Consensus 170 l~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~--- 244 (326)
T 2x7f_A 170 LVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF--- 244 (326)
T ss_dssp ECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH---
T ss_pred EeeCcCceecCcCc--cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHH---
Confidence 99999987543221 1122346889999999986 5678899999999999999999999996544211111
Q ss_pred hhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 247 EWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
..............+++.+.+||.+||..||.+|||+.++++|
T Consensus 245 --------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 245 --------------LIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp --------------HHHHSCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred --------------HhhcCccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 1111111122234567899999999999999999999999986
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=310.99 Aligned_cols=252 Identities=25% Similarity=0.395 Sum_probs=202.0
Q ss_pred ccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceeeEEeecCce
Q 018785 23 FCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSESDNR 102 (350)
Q Consensus 23 y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 102 (350)
|....+||+|+||.||+| .+..++..||+|.+..........+.+|+.+++.++||||+++++++...+..
T Consensus 24 ~~~~~~lg~G~~g~Vy~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 94 (295)
T 2clq_A 24 NGDRVVLGKGTYGIVYAG---------RDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFI 94 (295)
T ss_dssp TSSBCEEEECSSSEEEEE---------EETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred CCCcEEEeecCcEEEEEE---------EECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcE
Confidence 334449999999999999 55667899999999876655567789999999999999999999999999999
Q ss_pred EEEEEcCCCCChhhHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcC-CCcEEEcccccccc
Q 018785 103 LLVYEFMPKGSLENHLFRKG-VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS-NFNAKLSDFGLARD 180 (350)
Q Consensus 103 ~lv~e~~~~~~L~~~l~~~~-~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~-~~~~~l~Dfg~~~~ 180 (350)
++|||++++++|.+++.... ...+++..+..++.|++.||.||| +.|++|+||+|+||+++. ++.++|+|||++..
T Consensus 95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~ 172 (295)
T 2clq_A 95 KIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH--DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKR 172 (295)
T ss_dssp EEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEEETTTCCEEECCTTTCEE
T ss_pred EEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHH--hCCEEccCCChhhEEEECCCCCEEEeecccccc
Confidence 99999999999999997653 235678889999999999999999 899999999999999987 88999999999976
Q ss_pred CCCCCCCcccccccCCCcccCccccccCC--CCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhHH
Q 018785 181 GPTGDNTHVSTRIVGTRGYAAPEYVATGH--LTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRR 258 (350)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~--~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (350)
...... ......+++.|+|||++.+.. ++.++|+||||+++|+|++|..||.........
T Consensus 173 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---------------- 234 (295)
T 2clq_A 173 LAGINP--CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAA---------------- 234 (295)
T ss_dssp SCC-------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHH----------------
T ss_pred cCCCCC--cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHH----------------
Confidence 433221 122356888999999987653 788999999999999999999999654321100
Q ss_pred HHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 259 VLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
.............+..+++++.+++.+||..||.+|||+.+++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 235 MFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp HHHHHHHCCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred HHhhccccccccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 000011112234456678899999999999999999999999865
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=323.00 Aligned_cols=283 Identities=12% Similarity=0.146 Sum_probs=212.2
Q ss_pred hhhhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccc--
Q 018785 14 MISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVK-- 91 (350)
Q Consensus 14 ~~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~-- 91 (350)
.+.+..+++|++.+.||+|+||.||+|+....... .....++.||+|.+... ..+.+|+.++++++||||++
T Consensus 35 ~i~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~-~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~ 108 (352)
T 2jii_A 35 VLTDKSGRQWKLKSFQTRDNQGILYEAAPTSTLTC-DSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKW 108 (352)
T ss_dssp EEECTTSCEEEEEEEEEEETTEEEEEEEECC------------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHH
T ss_pred eeecccCCeEEEEEEecCCCCeEEEEEeecCCccc-cccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhh
Confidence 34445578999999999999999999965421000 00114789999998654 34678999999999999887
Q ss_pred -------------eeeEEee-cCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCC
Q 018785 92 -------------LIGYCSE-SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDL 157 (350)
Q Consensus 92 -------------~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di 157 (350)
+++++.. ++..++||||+ +++|.+++.......+++..++.++.|++.||.||| +.|++|+||
T Consensus 109 ~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH--~~~ivH~Di 185 (352)
T 2jii_A 109 KKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLH--ENEYVHGNV 185 (352)
T ss_dssp HHHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH--HTTCBCSCC
T ss_pred hhhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHH--hCCccCCCC
Confidence 5667665 67889999999 999999998764457999999999999999999999 899999999
Q ss_pred CCCceEEcCCC--cEEEccccccccCCCCCCC-----cccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCC
Q 018785 158 KASNVLLDSNF--NAKLSDFGLARDGPTGDNT-----HVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR 230 (350)
Q Consensus 158 ~~~Nili~~~~--~~~l~Dfg~~~~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~ 230 (350)
||+||+++.++ .++|+|||++......... .......|++.|+|||.+.+..++.++||||||+++|+|++|+
T Consensus 186 kp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~ 265 (352)
T 2jii_A 186 TAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGF 265 (352)
T ss_dssp CGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSC
T ss_pred CHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCC
Confidence 99999999998 8999999999754332211 1112346899999999999989999999999999999999999
Q ss_pred CCCcccccCcchhhhhhhcchhhhhhHHHHHhhhcc-cCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhc
Q 018785 231 RALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTR-LGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHT 309 (350)
Q Consensus 231 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 309 (350)
.||........ .+... ........... ........+++.+.+|+.+||..||.+|||++++++.|+++..
T Consensus 266 ~pf~~~~~~~~--~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 336 (352)
T 2jii_A 266 LPWTNCLPNTE--DIMKQ-------KQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQ 336 (352)
T ss_dssp CTTGGGTTCHH--HHHHH-------HHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred CCcccCCcCHH--HHHHH-------HHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHH
Confidence 99986542111 01000 00000000000 0001112457899999999999999999999999999999987
Q ss_pred CCCCC
Q 018785 310 SKDMP 314 (350)
Q Consensus 310 ~~~~~ 314 (350)
.....
T Consensus 337 ~~~~~ 341 (352)
T 2jii_A 337 DLRVS 341 (352)
T ss_dssp HTTCC
T ss_pred hcCCC
Confidence 76544
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=323.48 Aligned_cols=269 Identities=24% Similarity=0.328 Sum_probs=209.1
Q ss_pred hhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch-hhHHHHHHHHHHHhccCCCcccceeeEEee
Q 018785 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (350)
Q Consensus 20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (350)
+++|++.+.||+|+||.||+| .+..++..||||.+..... .....+.+|+.++++++||||+++++++..
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 96 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSA---------YDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRA 96 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEE---------EETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECC
T ss_pred cccEEEEEEeecCCCeEEEEE---------EECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEec
Confidence 479999999999999999999 5666789999999875432 334668899999999999999999999876
Q ss_pred c-----CceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEc
Q 018785 99 S-----DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLS 173 (350)
Q Consensus 99 ~-----~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~ 173 (350)
. ...++|||++. ++|.+++... .+++..++.++.|++.||.||| +.|++|+||||+||+++.++.++|+
T Consensus 97 ~~~~~~~~~~iv~e~~~-~~L~~~l~~~---~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dikp~NIl~~~~~~~kl~ 170 (364)
T 3qyz_A 97 PTIEQMKDVYIVQDLME-TDLYKLLKTQ---HLSNDHICYFLYQILRGLKYIH--SANVLHRDLKPSNLLLNTTCDLKIC 170 (364)
T ss_dssp SSTTTCCCEEEEEECCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTCCEEEC
T ss_pred CCccccceEEEEEcccC-cCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCChHhEEECCCCCEEEE
Confidence 5 36899999995 5999998765 5999999999999999999999 8999999999999999999999999
Q ss_pred cccccccCCCCCCCc-ccccccCCCcccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcch
Q 018785 174 DFGLARDGPTGDNTH-VSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADP 251 (350)
Q Consensus 174 Dfg~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~ 251 (350)
|||++.......... ......|++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+......
T Consensus 171 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~ 250 (364)
T 3qyz_A 171 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGS 250 (364)
T ss_dssp CCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCS
T ss_pred eCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCC
Confidence 999997643322211 1233578999999998755 45899999999999999999999999877655544444332211
Q ss_pred hhhh-hH-----HHHHhh-hcccCCC-----CcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 252 FLRD-SR-----RVLRIM-DTRLGGQ-----YSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 252 ~~~~-~~-----~~~~~~-~~~~~~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
.... .. ...... ....... ....+++++.+||.+||..||.+|||+.++++|
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 251 PSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp CCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 1110 00 000000 0000000 113456789999999999999999999999986
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=320.74 Aligned_cols=271 Identities=24% Similarity=0.321 Sum_probs=205.5
Q ss_pred hhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh--hHHHHHHHHHHHhccCCCcccceeeEEe
Q 018785 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ--GHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (350)
Q Consensus 20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (350)
.++|++.+.||+|+||+||+| .+..+|+.||+|.+...... ....+.+|+.+++.++||||+++++++.
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 86 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKA---------RHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICR 86 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEE---------EETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred ccceeEEEEEecCCCcEEEEE---------EECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheee
Confidence 479999999999999999999 56667899999988655432 2356778999999999999999999988
Q ss_pred e--------cCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCc
Q 018785 98 E--------SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFN 169 (350)
Q Consensus 98 ~--------~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~ 169 (350)
. .+..++||||+. ++|.+.+.... ..+++..++.++.|++.||.||| +.|++|+||||+||+++.++.
T Consensus 87 ~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH--~~~ivH~Dlkp~NIl~~~~~~ 162 (351)
T 3mi9_A 87 TKASPYNRCKGSIYLVFDFCE-HDLAGLLSNVL-VKFTLSEIKRVMQMLLNGLYYIH--RNKILHRDMKAANVLITRDGV 162 (351)
T ss_dssp EC--------CEEEEEEECCS-EEHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTSC
T ss_pred ccccccccCCceEEEEEeccC-CCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHH--HCCeeCCCCCHHHEEEcCCCC
Confidence 7 346899999995 48888776543 36999999999999999999999 899999999999999999999
Q ss_pred EEEccccccccCCCCCC--CcccccccCCCcccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhh
Q 018785 170 AKLSDFGLARDGPTGDN--THVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLV 246 (350)
Q Consensus 170 ~~l~Dfg~~~~~~~~~~--~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~ 246 (350)
++|+|||++........ ........+++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+.
T Consensus 163 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~ 242 (351)
T 3mi9_A 163 LKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALIS 242 (351)
T ss_dssp EEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred EEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 99999999976443222 122234567999999998876 468999999999999999999999998766544333333
Q ss_pred hhcchhhh----hhHHHH--HhhhcccC--CCCcH-----HHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 247 EWADPFLR----DSRRVL--RIMDTRLG--GQYSK-----KEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 247 ~~~~~~~~----~~~~~~--~~~~~~~~--~~~~~-----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
........ ...... ........ ..... ..++.+.+||.+||+.||.+|||++++++|
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 243 QLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp HHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 22111100 000000 00000000 00000 125678999999999999999999999987
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=312.55 Aligned_cols=256 Identities=24% Similarity=0.316 Sum_probs=194.6
Q ss_pred hhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh--hHHHHHHHHHHHhccCCCcccceee
Q 018785 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ--GHKEWLTEVIYLGQLRHENLVKLIG 94 (350)
Q Consensus 17 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~ 94 (350)
++..++|++.+.||+|+||+||+| .+..+|+.||+|.+...... ....+.++...++.++||||+++++
T Consensus 3 ~i~~~~y~~~~~lg~G~~g~V~~~---------~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~ 73 (290)
T 3fme_A 3 EVKADDLEPIMELGRGAYGVVEKM---------RHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYG 73 (290)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEE---------EETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred cccHHhhhhHHhcCCCCCeEEEEE---------EecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEee
Confidence 456789999999999999999999 56667999999998765322 2234455666688889999999999
Q ss_pred EEeecCceEEEEEcCCCCChhhHHhhc--CCCCCCHHHHHHHHHHHHHHHHHhhcCCC-CeeeCCCCCCceEEcCCCcEE
Q 018785 95 YCSESDNRLLVYEFMPKGSLENHLFRK--GVQPISWPTRVKIAIDVARGLSFLHGLDA-NVIYRDLKASNVLLDSNFNAK 171 (350)
Q Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~i~~ql~~al~~lh~~~~-~i~H~di~~~Nili~~~~~~~ 171 (350)
++.+.+..++||||++ ++|.+++... ....+++..++.++.|++.||.||| ++ |++|+||||+||+++.++.++
T Consensus 74 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH--~~~~i~H~dlkp~Nil~~~~~~~k 150 (290)
T 3fme_A 74 ALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVK 150 (290)
T ss_dssp EEECSSSEEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH--HHSCCCCCCCSGGGCEECTTCCEE
T ss_pred eeeccCCEEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh--hcCCeecCCCCHHHEEECCCCCEE
Confidence 9999999999999995 5888877542 3347999999999999999999999 87 999999999999999999999
Q ss_pred EccccccccCCCCCCCcccccccCCCcccCcccc----ccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhh
Q 018785 172 LSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYV----ATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVE 247 (350)
Q Consensus 172 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~----~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~ 247 (350)
|+|||++....... ......+++.|+|||.+ .+..++.++||||||+++|+|++|..||......
T Consensus 151 l~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------- 219 (290)
T 3fme_A 151 MCDFGISGYLVDDV---AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP-------- 219 (290)
T ss_dssp BCCC------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCH--------
T ss_pred EeecCCcccccccc---cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCch--------
Confidence 99999997543322 12224688999999996 4567889999999999999999999999753221
Q ss_pred hcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 248 WADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
...................+++++.+++.+||+.||.+|||+.++++|
T Consensus 220 --------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h 267 (290)
T 3fme_A 220 --------FQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQH 267 (290)
T ss_dssp --------HHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred --------HHHHHHHhccCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence 111112222222222334577899999999999999999999999985
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=318.70 Aligned_cols=271 Identities=25% Similarity=0.305 Sum_probs=201.7
Q ss_pred hhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhh-----HHHHHHHHHHHhccCCCccccee
Q 018785 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQG-----HKEWLTEVIYLGQLRHENLVKLI 93 (350)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~ 93 (350)
..++|++.+.||+|+||.||+| .+..+|+.||+|.+....... ...+.+|+.+++.++||||++++
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~---------~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 78 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKA---------RDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLL 78 (346)
T ss_dssp -----CEEEEEEEETTEEEEEE---------ECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEE
T ss_pred HhcccEEEeEEeecCCEEEEEE---------EECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEE
Confidence 4679999999999999999999 666678999999987543221 23577899999999999999999
Q ss_pred eEEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEc
Q 018785 94 GYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLS 173 (350)
Q Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~ 173 (350)
+++...+..++||||+++ +|.+++.... ..+++..+..++.|++.||.||| +.|++|+||||+||+++.++.++|+
T Consensus 79 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~Dlkp~Nil~~~~~~~kl~ 154 (346)
T 1ua2_A 79 DAFGHKSNISLVFDFMET-DLEVIIKDNS-LVLTPSHIKAYMLMTLQGLEYLH--QHWILHRDLKPNNLLLDENGVLKLA 154 (346)
T ss_dssp EEECCTTCCEEEEECCSE-EHHHHHTTCC-SSCCSSHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred EEEeeCCceEEEEEcCCC-CHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHH--HCCEECCCCCHHHEEEcCCCCEEEE
Confidence 999999999999999965 8988886543 36899999999999999999999 8999999999999999999999999
Q ss_pred cccccccCCCCCCCcccccccCCCcccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhc-ch
Q 018785 174 DFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWA-DP 251 (350)
Q Consensus 174 Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~-~~ 251 (350)
|||++....... .......+++.|+|||++.+. .++.++|||||||++|+|++|..||.+.........+.... .+
T Consensus 155 Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~ 232 (346)
T 1ua2_A 155 DFGLAKSFGSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTP 232 (346)
T ss_dssp CCGGGSTTTSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred ecccceeccCCc--ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCC
Confidence 999997643222 222335689999999998664 58899999999999999999999997765433322222111 00
Q ss_pred hhhhhHH---HHHhhhcccCCC-----CcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018785 252 FLRDSRR---VLRIMDTRLGGQ-----YSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL 304 (350)
Q Consensus 252 ~~~~~~~---~~~~~~~~~~~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 304 (350)
....... ............ ....+++++.+||.+||..||.+|||+.++++|-
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~ 293 (346)
T 1ua2_A 233 TEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK 293 (346)
T ss_dssp CTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSG
T ss_pred ChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcCh
Confidence 0000000 000000000000 1134568899999999999999999999999873
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=309.40 Aligned_cols=256 Identities=25% Similarity=0.339 Sum_probs=207.8
Q ss_pred hhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccc---------hhhHHHHHHHHHHHhccC-C
Q 018785 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES---------FQGHKEWLTEVIYLGQLR-H 86 (350)
Q Consensus 17 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---------~~~~~~~~~e~~~l~~l~-h 86 (350)
....++|++.+.||+|++|.||+| .+..+|+.||||.+.... ....+.+.+|+.+++++. |
T Consensus 13 ~~~~~~y~~~~~lg~G~~g~V~~~---------~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h 83 (298)
T 1phk_A 13 HGFYENYEPKEILGRGVSSVVRRC---------IHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 83 (298)
T ss_dssp --CTTTEEEEEEEEECSSEEEEEE---------EETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred cchhhccceeeeecCCCceEEEEE---------EEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 345689999999999999999999 566678999999986543 122356788999999995 9
Q ss_pred CcccceeeEEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcC
Q 018785 87 ENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS 166 (350)
Q Consensus 87 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~ 166 (350)
|||+++++++...+..++|||++++++|.+++.... .+++..++.++.|++.||.||| +.|++|+||+|+||+++.
T Consensus 84 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dl~p~Nil~~~ 159 (298)
T 1phk_A 84 PNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALH--KLNIVHRDLKPENILLDD 159 (298)
T ss_dssp TTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECT
T ss_pred CCEeeeeeeeccCCeEEEEEeccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCcceEEEcC
Confidence 999999999999999999999999999999998764 6999999999999999999999 899999999999999999
Q ss_pred CCcEEEccccccccCCCCCCCcccccccCCCcccCccccc------cCCCCCccchhhHHHHHHHHHhCCCCCcccccCc
Q 018785 167 NFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVA------TGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGL 240 (350)
Q Consensus 167 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~------~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~ 240 (350)
++.++|+|||++....... ......+++.|+|||++. ...++.++||||||+++|+|++|..||.......
T Consensus 160 ~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~ 236 (298)
T 1phk_A 160 DMNIKLTDFGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML 236 (298)
T ss_dssp TCCEEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred CCcEEEecccchhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHH
Confidence 9999999999997643322 223356888999999885 4568899999999999999999999997644221
Q ss_pred chhhhhhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 241 AEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
....+... ...........+++.+.+++.+||..||.+|||+.++++|
T Consensus 237 ~~~~~~~~---------------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (298)
T 1phk_A 237 MLRMIMSG---------------NYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 284 (298)
T ss_dssp HHHHHHHT---------------CCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HHHHHhcC---------------CcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence 11111110 0011112234678899999999999999999999999874
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=311.47 Aligned_cols=248 Identities=22% Similarity=0.310 Sum_probs=202.3
Q ss_pred hhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch--hhHHHHHHHHHHHhcc-CCCcccceee
Q 018785 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQL-RHENLVKLIG 94 (350)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l-~h~~i~~~~~ 94 (350)
...++|++.+.||+|+||+||+| .+..+++.||+|.+..... .....+.+|+..+..+ +||||+++++
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~ 78 (289)
T 1x8b_A 8 RYTTEFHELEKIGSGEFGSVFKC---------VKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFS 78 (289)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEE---------EETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEE
T ss_pred cccchhhhhhhhcCCCceEEEEE---------EEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeee
Confidence 34689999999999999999999 5566789999999876432 3345678889999988 8999999999
Q ss_pred EEeecCceEEEEEcCCCCChhhHHhhcC--CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCC-----
Q 018785 95 YCSESDNRLLVYEFMPKGSLENHLFRKG--VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSN----- 167 (350)
Q Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~----- 167 (350)
++.+.+..++||||+++++|.+++.... ...+++..++.++.|++.||.||| +.|++|+||||+||+++.+
T Consensus 79 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH--~~~ivH~Dikp~NIl~~~~~~~~~ 156 (289)
T 1x8b_A 79 AWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH--SMSLVHMDIKPSNIFISRTSIPNA 156 (289)
T ss_dssp EEEETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEEC-------
T ss_pred eeecCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHH--hCCEeecCCCHHHEEEcCCCCCcc
Confidence 9999999999999999999999997642 136899999999999999999999 8999999999999999844
Q ss_pred --------------CcEEEccccccccCCCCCCCcccccccCCCcccCccccccC-CCCCccchhhHHHHHHHHHhCCCC
Q 018785 168 --------------FNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRA 232 (350)
Q Consensus 168 --------------~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~ll~~ll~g~~p 232 (350)
..++|+|||.+....... ...+++.|+|||.+.+. .++.++||||||+++|+|++|..+
T Consensus 157 ~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~ 230 (289)
T 1x8b_A 157 ASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL 230 (289)
T ss_dssp -------------CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCC
T ss_pred cccccccccccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCC
Confidence 479999999997643322 23488899999998766 566899999999999999999877
Q ss_pred CcccccCcchhhhhhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 233 LDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 233 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
+..... . ..+........+..+++.+.+++.+||+.||.+|||+.++++|
T Consensus 231 ~~~~~~---~------------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 231 PRNGDQ---W------------------HEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp CSSSHH---H------------------HHHHTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred CcchhH---H------------------HHHHcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 643211 0 0011111223445678899999999999999999999999876
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=329.92 Aligned_cols=241 Identities=17% Similarity=0.217 Sum_probs=192.0
Q ss_pred hhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEcccc---chhhHHHHHHHH---HHHhccCCCccccee
Q 018785 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAE---SFQGHKEWLTEV---IYLGQLRHENLVKLI 93 (350)
Q Consensus 20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~---~~l~~l~h~~i~~~~ 93 (350)
.++|++.+.||+|+||+||+| .+..+|+.||||++... .....+.+.+|+ ..++.++||||++++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a---------~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~ 142 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEA---------TDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVH 142 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEE---------EC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHH
T ss_pred CceEEEcceeecCCCEEEEEE---------EECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHH
Confidence 578999999999999999999 56667899999998743 223456788899 455556899999998
Q ss_pred -------eEEeecCc-----------------eEEEEEcCCCCChhhHHhhcCCCCCCH-------HHHHHHHHHHHHHH
Q 018785 94 -------GYCSESDN-----------------RLLVYEFMPKGSLENHLFRKGVQPISW-------PTRVKIAIDVARGL 142 (350)
Q Consensus 94 -------~~~~~~~~-----------------~~lv~e~~~~~~L~~~l~~~~~~~l~~-------~~~~~i~~ql~~al 142 (350)
+++...+. .|+||||+ +|+|.+++.... .+++ ..++.++.|++.||
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~--~~~~~~~~l~~~~~~~i~~qi~~aL 219 (377)
T 3byv_A 143 LRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLL--SHSSTHKSLVHHARLQLTLQVIRLL 219 (377)
T ss_dssp HCBCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHH--HTTTTTHHHHHHHHHHHHHHHHHHH
T ss_pred hhhhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhcc--ccccccccccHHHHHHHHHHHHHHH
Confidence 66665543 78999999 679999997653 3444 78888999999999
Q ss_pred HHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccccccCCCCCCCcccccccCCCcccCccccccC-----------CCC
Q 018785 143 SFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG-----------HLT 211 (350)
Q Consensus 143 ~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-----------~~~ 211 (350)
+||| +.|++|+||||+||+++.++.++|+|||++..... ......| +.|+|||++.+. .++
T Consensus 220 ~~LH--~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~ 291 (377)
T 3byv_A 220 ASLH--HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMT 291 (377)
T ss_dssp HHHH--HTTEECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECC
T ss_pred HHHH--hCCeecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCC
Confidence 9999 89999999999999999999999999999975221 2233456 889999999887 899
Q ss_pred CccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCC
Q 018785 212 PKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDP 291 (350)
Q Consensus 212 ~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 291 (350)
.++|||||||++|+|++|..||.+.........+.. ....+++++.+||.+||+.||
T Consensus 292 ~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~li~~~L~~dp 348 (377)
T 3byv_A 292 FSFDAWALGLVIYWIWCADLPITKDAALGGSEWIFR-----------------------SCKNIPQPVRALLEGFLRYPK 348 (377)
T ss_dssp HHHHHHHHHHHHHHHHHSSCCC------CCSGGGGS-----------------------SCCCCCHHHHHHHHHHTCSSG
T ss_pred hhhhHHHHHHHHHHHHHCCCCCcccccccchhhhhh-----------------------hccCCCHHHHHHHHHHcCCCc
Confidence 999999999999999999999976553322221111 112456789999999999999
Q ss_pred CCCCCHHHHHHH
Q 018785 292 KNRPSMVDVLTS 303 (350)
Q Consensus 292 ~~Rps~~~ll~~ 303 (350)
.+|||+.++++|
T Consensus 349 ~~Rpt~~e~l~h 360 (377)
T 3byv_A 349 EDRLLPLQAMET 360 (377)
T ss_dssp GGCCCHHHHHTS
T ss_pred hhCCCHHHHhhC
Confidence 999999999975
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-43 Score=321.22 Aligned_cols=265 Identities=23% Similarity=0.299 Sum_probs=198.3
Q ss_pred hhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccc--hhhHHHHHHHHHHHhccCCCcccceeeEEe
Q 018785 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES--FQGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (350)
Q Consensus 20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (350)
.++|++.+.||+|+||.||+| .+..+++.||||.+.... ......+.+|+.+++.++||||+++++++.
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~---------~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 94 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAA---------YDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFT 94 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEE---------EETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hhheeEeeeeEecCCEEEEEE---------EECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeec
Confidence 579999999999999999999 566678999999987542 233456789999999999999999999997
Q ss_pred ecC------ceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEE
Q 018785 98 ESD------NRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAK 171 (350)
Q Consensus 98 ~~~------~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~ 171 (350)
..+ ..++||||+. ++|.+++.. .+++..+..++.|++.||.||| +.|++|+||||+||+++.++.++
T Consensus 95 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH--~~~ivH~Dlkp~NIl~~~~~~~k 167 (371)
T 2xrw_A 95 PQKSLEEFQDVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLH--SAGIIHRDLKPSNIVVKSDCTLK 167 (371)
T ss_dssp SCCSTTTCCEEEEEEECCS-EEHHHHHHS----CCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTTSCEE
T ss_pred cccccccccceEEEEEcCC-CCHHHHHhh----ccCHHHHHHHHHHHHHHHHHHH--HCCeecccCCHHHEEEcCCCCEE
Confidence 665 6799999995 588888852 5899999999999999999999 89999999999999999999999
Q ss_pred EccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcch
Q 018785 172 LSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADP 251 (350)
Q Consensus 172 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~ 251 (350)
|+|||++...... .......+++.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+......
T Consensus 168 l~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~ 244 (371)
T 2xrw_A 168 ILDFGLARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGT 244 (371)
T ss_dssp ECCCCC-------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCC
T ss_pred EEEeecccccccc---cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 9999999754322 1223356889999999999999999999999999999999999999876543332222211110
Q ss_pred h----hhhh-HHHHHhhhcc------------------cCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 252 F----LRDS-RRVLRIMDTR------------------LGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 252 ~----~~~~-~~~~~~~~~~------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
. .... .......... .........+.++.+||.+||..||.+|||++++++|
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 245 PCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp CCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 0 0000 0000000000 0001123457889999999999999999999999987
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-43 Score=315.24 Aligned_cols=272 Identities=22% Similarity=0.309 Sum_probs=211.9
Q ss_pred hhhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCC------c
Q 018785 15 ISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHE------N 88 (350)
Q Consensus 15 ~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~------~ 88 (350)
.+++..++|++.+.||+|+||+||+|+.. ..+++.||+|++.... .....+.+|+.+++.++|+ +
T Consensus 8 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~--------~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~ 78 (339)
T 1z57_A 8 SGDVLSARYEIVDTLGEGAFGKVVECIDH--------KAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFR 78 (339)
T ss_dssp TTCEETTTEEEEEEEEEETTEEEEEEEET--------TTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTC
T ss_pred cCCCccCceEEEEEEecCCCeEEEEEEec--------CCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCcee
Confidence 45677889999999999999999999431 3468899999987543 3346678888888888654 5
Q ss_pred ccceeeEEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcC--
Q 018785 89 LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS-- 166 (350)
Q Consensus 89 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~-- 166 (350)
++++++++...+..++|||++ +++|.+++.......+++..+..++.|++.||+||| +.|++|+||||+||+++.
T Consensus 79 i~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~Dlkp~Nil~~~~~ 155 (339)
T 1z57_A 79 CVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLH--SNKLTHTDLKPENILFVQSD 155 (339)
T ss_dssp BCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEESCCC
T ss_pred eEeeecccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHH--HCCCcCCCCCHHHEEEeccc
Confidence 999999999999999999999 889999998876667999999999999999999999 899999999999999987
Q ss_pred -----------------CCcEEEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhC
Q 018785 167 -----------------NFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSG 229 (350)
Q Consensus 167 -----------------~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g 229 (350)
++.++|+|||++...... .....+++.|+|||++.+..++.++||||||+++|+|++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g 230 (339)
T 1z57_A 156 YTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLG 230 (339)
T ss_dssp EEEEEC----CEEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHS
T ss_pred cccccCCccccccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhC
Confidence 667999999999753322 1234688999999999999999999999999999999999
Q ss_pred CCCCcccccCcchhhhhhhcchhhhhh------------------------HHHHHhhhc-ccCCCCcHHHHHHHHHHHH
Q 018785 230 RRALDEDRGGLAEQTLVEWADPFLRDS------------------------RRVLRIMDT-RLGGQYSKKEAQAVAAVVL 284 (350)
Q Consensus 230 ~~pf~~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~-~~~~~~~~~~~~~l~~li~ 284 (350)
..||...........+.....+..... ......... ..........++.+.+||.
T Consensus 231 ~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 310 (339)
T 1z57_A 231 FTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQ 310 (339)
T ss_dssp SCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHH
T ss_pred CCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHH
Confidence 999987654333322222111100000 000000000 0011223456889999999
Q ss_pred HhhccCCCCCCCHHHHHHH
Q 018785 285 QCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 285 ~~l~~dp~~Rps~~~ll~~ 303 (350)
+||+.||.+|||+.++++|
T Consensus 311 ~~L~~dP~~Rpt~~ell~h 329 (339)
T 1z57_A 311 KMLEYDPAKRITLREALKH 329 (339)
T ss_dssp HHTCSSTTTSCCHHHHTTS
T ss_pred HHhCcCcccccCHHHHhcC
Confidence 9999999999999999976
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-43 Score=316.38 Aligned_cols=278 Identities=22% Similarity=0.324 Sum_probs=203.0
Q ss_pred hhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceeeEE
Q 018785 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYC 96 (350)
Q Consensus 17 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (350)
.+..++|++.+.||+|+||+||+|++ +++.||||++....... .....++..+..++||||+++++.+
T Consensus 9 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-----------~~~~vavK~~~~~~~~~-~~~e~~~~~~~~~~h~~i~~~~~~~ 76 (336)
T 3g2f_A 9 SLDLDNLKLLELIGRGRYGAVYKGSL-----------DERPVAVKVFSFANRQN-FINEKNIYRVPLMEHDNIARFIVGD 76 (336)
T ss_dssp CCCTTSEEEEEEEEECSSEEEEEEEE-----------TTEEEEEEEEEGGGHHH-HHHHHHHHTSTTCCCTTBCCEEEEE
T ss_pred CcChHHhheeeecccCCCeEEEEEEE-----------CCeEEEEEEeeccchhh-HHHHHHHHHHHhccCcchhhheecc
Confidence 45568999999999999999999943 36889999987554221 1223344445568999999999865
Q ss_pred ee-----cCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCC---------CeeeCCCCCCce
Q 018785 97 SE-----SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDA---------NVIYRDLKASNV 162 (350)
Q Consensus 97 ~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~---------~i~H~di~~~Ni 162 (350)
.. ....++||||+++++|.+++.... .+...++.++.|++.||.||| +. |++|+||||+||
T Consensus 77 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~i~~qi~~~L~~LH--~~~~~~~~~~~~ivH~Dikp~Ni 151 (336)
T 3g2f_A 77 ERVTADGRMEYLLVMEYYPNGSLXKYLSLHT---SDWVSSCRLAHSVTRGLAYLH--TELPRGDHYKPAISHRDLNSRNV 151 (336)
T ss_dssp EEECTTSCEEEEEEECCCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHH--CCBCCGGGCBCCEECSSCSGGGE
T ss_pred cccccCCCceEEEEEecCCCCcHHHHHhhcc---cchhHHHHHHHHHHHHHHHHH--hhhccccccccceeecccccceE
Confidence 42 235689999999999999997764 688899999999999999999 88 999999999999
Q ss_pred EEcCCCcEEEccccccccCCCCCC------CcccccccCCCcccCcccccc-------CCCCCccchhhHHHHHHHHHhC
Q 018785 163 LLDSNFNAKLSDFGLARDGPTGDN------THVSTRIVGTRGYAAPEYVAT-------GHLTPKSDVYSFGVVLLELLSG 229 (350)
Q Consensus 163 li~~~~~~~l~Dfg~~~~~~~~~~------~~~~~~~~~~~~~~aPE~~~~-------~~~~~~~DiwslG~ll~~ll~g 229 (350)
+++.++.++|+|||++........ ........|++.|+|||++.+ ..++.++|||||||++|+|++|
T Consensus 152 ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g 231 (336)
T 3g2f_A 152 LVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMR 231 (336)
T ss_dssp EECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhc
Confidence 999999999999999976443221 111223568999999999876 3566789999999999999999
Q ss_pred CCCCcccccCcc-hhhhhh--hcchhhhhhHHHHHhhhcccCCC------CcHHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 018785 230 RRALDEDRGGLA-EQTLVE--WADPFLRDSRRVLRIMDTRLGGQ------YSKKEAQAVAAVVLQCLHMDPKNRPSMVDV 300 (350)
Q Consensus 230 ~~pf~~~~~~~~-~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l 300 (350)
..||........ ...... ...+........ ......... ....+++.+.+||.+||+.||.+|||+.++
T Consensus 232 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~ 309 (336)
T 3g2f_A 232 CTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVL--VSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXA 309 (336)
T ss_dssp BGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHH--HTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred CCcCCCccchhHHHHhhhcccCCCchHHHHHhh--hcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHH
Confidence 877643332211 111110 111111111111 111111111 123577899999999999999999999999
Q ss_pred HHHHHhhhcCCCC
Q 018785 301 LTSLEQLHTSKDM 313 (350)
Q Consensus 301 l~~L~~~~~~~~~ 313 (350)
++.|+++...-..
T Consensus 310 l~~L~~ll~~~~~ 322 (336)
T 3g2f_A 310 EERMAELMMIWER 322 (336)
T ss_dssp HHHHHHHHHCCCC
T ss_pred HHHHHHHHHHHHh
Confidence 9999999876443
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=344.19 Aligned_cols=252 Identities=27% Similarity=0.412 Sum_probs=211.5
Q ss_pred hhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch---hhHHHHHHHHHHHhcc-CCCccccee
Q 018785 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQL-RHENLVKLI 93 (350)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l-~h~~i~~~~ 93 (350)
+..++|++.++||+|+||.||+| .+..+++.||||++..... .....+..|..++..+ +||+|++++
T Consensus 338 ~~~~~f~~~~~LG~G~fG~V~~~---------~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~ 408 (674)
T 3pfq_A 338 MKLTDFNFLMVLGKGSFGKVMLS---------ERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 408 (674)
T ss_dssp --CTTEEEEEESSBTTTBCEEEE---------EESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEE
T ss_pred ccccceEEEEEEccCCCEEEEEE---------EECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEE
Confidence 34578999999999999999999 5566789999999875422 2345677888999887 799999999
Q ss_pred eEEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEc
Q 018785 94 GYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLS 173 (350)
Q Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~ 173 (350)
+++.+.+.+|+||||+++++|.+++.... .+++..++.++.||+.||.||| +.||+||||||+|||++.++.++|+
T Consensus 409 ~~~~~~~~~~lV~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH--~~gIiHrDLKp~NILl~~~g~ikL~ 484 (674)
T 3pfq_A 409 SCFQTMDRLYFVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQ--SKGIIYRDLKLDNVMLDSEGHIKIA 484 (674)
T ss_dssp EECBCSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH--HTSEECCCCCSTTEEECSSSCEEEC
T ss_pred EEEEeCCEEEEEEeCcCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--hCCeEeccCChhhEEEcCCCcEEEe
Confidence 99999999999999999999999998765 6999999999999999999999 8999999999999999999999999
Q ss_pred cccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhh
Q 018785 174 DFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 253 (350)
Q Consensus 174 Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 253 (350)
|||++....... .......||+.|+|||++.+..++.++|+||||+++|+|++|..||.+.+.......+.
T Consensus 485 DFGla~~~~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~------- 555 (674)
T 3pfq_A 485 DFGMCKENIWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM------- 555 (674)
T ss_dssp CCTTCEECCCTT--CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-------
T ss_pred ecceeeccccCC--cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHH-------
Confidence 999997532222 22334679999999999999999999999999999999999999998755322222221
Q ss_pred hhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCH-----HHHHHH
Q 018785 254 RDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSM-----VDVLTS 303 (350)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-----~~ll~~ 303 (350)
.. ...++..+++++.+||.+||+.||.+||++ +++++|
T Consensus 556 ----------~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h 598 (674)
T 3pfq_A 556 ----------EH--NVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 598 (674)
T ss_dssp ----------SS--CCCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred ----------hC--CCCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence 11 123456788899999999999999999998 888876
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-44 Score=323.76 Aligned_cols=271 Identities=19% Similarity=0.229 Sum_probs=208.5
Q ss_pred hhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhh-----------------HHHHHHHH
Q 018785 16 SKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQG-----------------HKEWLTEV 78 (350)
Q Consensus 16 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~-----------------~~~~~~e~ 78 (350)
.+...++|++.+.||+|+||.||+|+ + +++.||+|.+....... ...+.+|+
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~V~~~~---------~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~ 94 (348)
T 2pml_X 26 KDKYINDYRIIRTLNQGKFNKIILCE---------K--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNEL 94 (348)
T ss_dssp SCEEETTEEEEEEEECCSSCCEEEEE---------E--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHH
T ss_pred cccccCceEEEEEEcCCCCeEEEEEE---------c--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHH
Confidence 34456899999999999999999994 3 58999999987653321 16788999
Q ss_pred HHHhccCCCcccceeeEEeecCceEEEEEcCCCCChhhH------HhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCC-CC
Q 018785 79 IYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENH------LFRKGVQPISWPTRVKIAIDVARGLSFLHGLD-AN 151 (350)
Q Consensus 79 ~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~------l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~-~~ 151 (350)
.+++.++||||+++++++.+.+..++||||+++++|.++ +.......+++..++.++.|++.||.||| + .|
T Consensus 95 ~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH--~~~~ 172 (348)
T 2pml_X 95 QIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIH--NEKN 172 (348)
T ss_dssp HHHTTCCCTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHH--HTSC
T ss_pred HHHHhCCCCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHh--ccCC
Confidence 999999999999999999999999999999999999998 65543568999999999999999999999 7 99
Q ss_pred eeeCCCCCCceEEcCCCcEEEccccccccCCCCCCCcccccccCCCcccCccccccC-CCCC-ccchhhHHHHHHHHHhC
Q 018785 152 VIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG-HLTP-KSDVYSFGVVLLELLSG 229 (350)
Q Consensus 152 i~H~di~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~-~~DiwslG~ll~~ll~g 229 (350)
++|+||+|+||+++.++.++|+|||.+...... ......+++.|+|||.+.+. .++. ++||||||+++|+|++|
T Consensus 173 i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g 248 (348)
T 2pml_X 173 ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYN 248 (348)
T ss_dssp EECCCCCGGGEEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHS
T ss_pred EeecCCChHhEEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhC
Confidence 999999999999999999999999999764322 23345688999999999877 6665 99999999999999999
Q ss_pred CCCCcccccC-cchhhhhhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 230 RRALDEDRGG-LAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 230 ~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
..||...... .....+.............................+++.+.+|+.+||+.||.+|||+.++++|
T Consensus 249 ~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 249 VVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp SCSSCCSSCSHHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred CCCCCCCCcHHHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 9999865542 1111111110000000000000000000001124567899999999999999999999999975
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-43 Score=315.08 Aligned_cols=255 Identities=26% Similarity=0.344 Sum_probs=201.5
Q ss_pred hhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch--------hhHHHHHHHHHHHhccCCCc
Q 018785 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--------QGHKEWLTEVIYLGQLRHEN 88 (350)
Q Consensus 17 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~e~~~l~~l~h~~ 88 (350)
....++|++.+.||+|+||.||+| .+..+++.||||.+..... .....+.+|+.+++.++|||
T Consensus 6 ~~l~~~y~~~~~lg~G~~g~V~~~---------~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 76 (322)
T 2ycf_A 6 KALRDEYIMSKTLGSGACGEVKLA---------FERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76 (322)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEE---------EETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTT
T ss_pred hhhhhceeEeeEEecCCCEEEEEE---------EEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCC
Confidence 456789999999999999999999 5666789999999865432 12234788999999999999
Q ss_pred ccceeeEEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCC
Q 018785 89 LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNF 168 (350)
Q Consensus 89 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~ 168 (350)
|+++++++...+ .++||||+++++|.+++.... .+++..++.++.|++.||.||| +.|++|+||+|+||+++.++
T Consensus 77 i~~~~~~~~~~~-~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~dlkp~NIl~~~~~ 151 (322)
T 2ycf_A 77 IIKIKNFFDAED-YYIVLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQYLH--ENGIIHRDLKPENVLLSSQE 151 (322)
T ss_dssp BCCEEEEEESSS-EEEEEECCTTEETHHHHSTTC--CCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEESSSS
T ss_pred CceEeeEEcCCc-eEEEEecCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHH--HCCeeccCCCHHHEEEecCC
Confidence 999999987654 899999999999999987654 7999999999999999999999 89999999999999998766
Q ss_pred c---EEEccccccccCCCCCCCcccccccCCCcccCccccc---cCCCCCccchhhHHHHHHHHHhCCCCCcccccCcch
Q 018785 169 N---AKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVA---TGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAE 242 (350)
Q Consensus 169 ~---~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~ 242 (350)
. ++|+|||++..... ........+++.|+|||++. +..++.++||||||+++|+|++|..||.........
T Consensus 152 ~~~~~kl~Dfg~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~ 228 (322)
T 2ycf_A 152 EDCLIKITDFGHSKILGE---TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL 228 (322)
T ss_dssp SSCCEEECCCTTCEECCC---CHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCH
T ss_pred CCCeEEEccCccceeccc---ccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHH
Confidence 5 99999999976422 11223356899999999874 467889999999999999999999999765433221
Q ss_pred -hhhhhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 243 -QTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 243 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
..+........ ......+++.+.+|+.+||..||.+|||+.++++|
T Consensus 229 ~~~~~~~~~~~~---------------~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 229 KDQITSGKYNFI---------------PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp HHHHHHTCCCCC---------------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHhCccccC---------------chhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 11111000000 00112457789999999999999999999999864
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=324.24 Aligned_cols=264 Identities=23% Similarity=0.341 Sum_probs=191.3
Q ss_pred hhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccc--hhhHHHHHHHHHHHhccCCCcccceeeEEe
Q 018785 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES--FQGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (350)
Q Consensus 20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (350)
.++|++.+.||+|+||.||+| .+..+|+.||||.+.... ......+.+|+.+++.++||||+++++++.
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 98 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAA---------FDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT 98 (367)
T ss_dssp ETTEEEEEECC----CCEEEE---------EETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred CCceEEeeEEeecCCeEEEEE---------EECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEe
Confidence 579999999999999999999 666779999999986542 234466789999999999999999999986
Q ss_pred ec------CceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEE
Q 018785 98 ES------DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAK 171 (350)
Q Consensus 98 ~~------~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~ 171 (350)
.. ...++|++++ +++|.+++... .+++..+..++.||+.||.||| +.|++|+||||+||+++.++.++
T Consensus 99 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH--~~givH~Dlkp~NIll~~~~~~k 172 (367)
T 2fst_X 99 PARSLEEFNDVYLVTHLM-GADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIH--SADIIHRDLKPSNLAVNEDCELK 172 (367)
T ss_dssp SCSSGGGCCCCEEEEECC-CEECC-----C---CCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTTCCEE
T ss_pred cCCccccCCeEEEEeccc-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH--HCCeeeCCCCHhhEEECCCCCEE
Confidence 54 5679999998 78999988653 6999999999999999999999 89999999999999999999999
Q ss_pred EccccccccCCCCCCCcccccccCCCcccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcc
Q 018785 172 LSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD 250 (350)
Q Consensus 172 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~ 250 (350)
|+|||++...... .....+++.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+.....
T Consensus 173 L~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g 247 (367)
T 2fst_X 173 ILDFGLARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG 247 (367)
T ss_dssp ECC--------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred Eeecccccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 9999999753221 233568899999999877 6789999999999999999999999987665433333332211
Q ss_pred hhhhh------hHHHHHhhhc---ccCCC---CcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 251 PFLRD------SRRVLRIMDT---RLGGQ---YSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 251 ~~~~~------~~~~~~~~~~---~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
..... .......... ..... .....++.+.+||.+||..||.+|||+.++++|
T Consensus 248 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 248 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp SCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 11000 0000111111 00000 112346789999999999999999999999987
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-43 Score=321.22 Aligned_cols=274 Identities=22% Similarity=0.316 Sum_probs=205.0
Q ss_pred hhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceeeEE
Q 018785 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYC 96 (350)
Q Consensus 17 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (350)
+...++|++.+.||+|+||+||+| .+..+|+.||||.+...... ..+|+.+++.++||||+++++++
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a---------~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~ 69 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEV---------FDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYF 69 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEE---------EETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEE
T ss_pred ccccceEEEEEEEEeccCEEEEEE---------EECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhhee
Confidence 345689999999999999999999 66677999999988654322 23689999999999999999998
Q ss_pred eec--------------------------------------CceEEEEEcCCCCChhhHHhh--cCCCCCCHHHHHHHHH
Q 018785 97 SES--------------------------------------DNRLLVYEFMPKGSLENHLFR--KGVQPISWPTRVKIAI 136 (350)
Q Consensus 97 ~~~--------------------------------------~~~~lv~e~~~~~~L~~~l~~--~~~~~l~~~~~~~i~~ 136 (350)
... ...++||||+. ++|.+.+.. .....+++..++.++.
T Consensus 70 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~ 148 (383)
T 3eb0_A 70 YTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIY 148 (383)
T ss_dssp EEC-------------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHH
T ss_pred eecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHH
Confidence 443 34789999996 588877753 2334799999999999
Q ss_pred HHHHHHHHhhcCCCCeeeCCCCCCceEEc-CCCcEEEccccccccCCCCCCCcccccccCCCcccCccccccC-CCCCcc
Q 018785 137 DVARGLSFLHGLDANVIYRDLKASNVLLD-SNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG-HLTPKS 214 (350)
Q Consensus 137 ql~~al~~lh~~~~~i~H~di~~~Nili~-~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~ 214 (350)
||+.||.||| +.|++|+||||+||+++ .++.++|+|||++........ .....+++.|+|||++.+. .++.++
T Consensus 149 qi~~aL~~LH--~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~ 223 (383)
T 3eb0_A 149 QLFRAVGFIH--SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGATEYTPSI 223 (383)
T ss_dssp HHHHHHHHHH--TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCSSCCTHH
T ss_pred HHHHHHHHHH--HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCCCCCCcch
Confidence 9999999999 99999999999999997 688999999999976433322 2234678899999998775 589999
Q ss_pred chhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcc-hhhhhhHHHHHhhh---------cccCCCCcHHHHHHHHHHHH
Q 018785 215 DVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD-PFLRDSRRVLRIMD---------TRLGGQYSKKEAQAVAAVVL 284 (350)
Q Consensus 215 DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~l~~li~ 284 (350)
||||+||++|+|++|+.||.+.........+..... +............. .......+..+++++.+||.
T Consensus 224 DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 303 (383)
T 3eb0_A 224 DLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLE 303 (383)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHH
T ss_pred hhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHH
Confidence 999999999999999999987665444333332211 11111100000000 00000123456788999999
Q ss_pred HhhccCCCCCCCHHHHHHH--HHhhhc
Q 018785 285 QCLHMDPKNRPSMVDVLTS--LEQLHT 309 (350)
Q Consensus 285 ~~l~~dp~~Rps~~~ll~~--L~~~~~ 309 (350)
+||..||.+|||+.++++| +..+..
T Consensus 304 ~~L~~dP~~R~t~~e~l~hp~f~~~~~ 330 (383)
T 3eb0_A 304 QILRYEPDLRINPYEAMAHPFFDHLRN 330 (383)
T ss_dssp HHCCSSGGGSCCHHHHHTSGGGHHHHH
T ss_pred HHccCChhhCCCHHHHhcCHHHHHHHh
Confidence 9999999999999999976 555443
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=320.90 Aligned_cols=261 Identities=26% Similarity=0.370 Sum_probs=209.1
Q ss_pred hhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch----hhHHHHHHHHHHHhcc-CCCcccce
Q 018785 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF----QGHKEWLTEVIYLGQL-RHENLVKL 92 (350)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~e~~~l~~l-~h~~i~~~ 92 (350)
+..++|++.+.||+|+||.||+|+.. ....+++.||||++..... .....+..|+.+++.+ +||||+++
T Consensus 51 ~~~~~y~~~~~lG~G~~g~Vy~~~~~------~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~ 124 (355)
T 1vzo_A 51 VGIENFELLKVLGTGAYGKVFLVRKI------SGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTL 124 (355)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEEC------SSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCE
T ss_pred ccccceEEEEEeccCCCEEEEEEEEc------ccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEE
Confidence 34579999999999999999999653 2245789999999875431 2234566789999999 69999999
Q ss_pred eeEEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEE
Q 018785 93 IGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKL 172 (350)
Q Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l 172 (350)
++++...+..++||||+++++|.+++.... .+++..+..++.|++.||.||| +.|++|+||||+||+++.++.++|
T Consensus 125 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH--~~~ivH~Dlkp~NIll~~~~~~kl 200 (355)
T 1vzo_A 125 HYAFQTETKLHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLH--KLGIIYRDIKLENILLDSNGHVVL 200 (355)
T ss_dssp EEEEEETTEEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTTSCEEE
T ss_pred EEEEeeCceEEEEeecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEECCCCcEEE
Confidence 999999999999999999999999998765 6999999999999999999999 899999999999999999999999
Q ss_pred ccccccccCCCCCCCcccccccCCCcccCccccccC--CCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcc
Q 018785 173 SDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG--HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD 250 (350)
Q Consensus 173 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~ 250 (350)
+|||++....... ........|++.|+|||++.+. .++.++|||||||++|+|++|..||...........+..
T Consensus 201 ~DfG~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~--- 276 (355)
T 1vzo_A 201 TDFGLSKEFVADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR--- 276 (355)
T ss_dssp SCSSEEEECCGGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHH---
T ss_pred eeCCCCeecccCC-CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHH---
Confidence 9999997543221 1122335689999999998763 578899999999999999999999976543322221111
Q ss_pred hhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHHH
Q 018785 251 PFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRP-----SMVDVLTSL 304 (350)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~~L 304 (350)
.... .....+..++..+.+||.+||..||.+|| |++++++|.
T Consensus 277 ----------~~~~--~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 277 ----------RILK--SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp ----------HHHH--CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred ----------HHhc--cCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 0011 11234556778899999999999999999 999999874
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=335.81 Aligned_cols=264 Identities=27% Similarity=0.374 Sum_probs=210.5
Q ss_pred hcccccc-eecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch-hhHHHHHHHHHHHhccCCCcccceeeEEee
Q 018785 21 KNFCSDY-LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (350)
Q Consensus 21 ~~y~i~~-~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (350)
.++.+.. .||+|+||.||+|.+.. ..++..||||++..... .....+.+|+.++++++||||+++++++..
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~-------~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~ 407 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRM-------RKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA 407 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEEC-------SSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES
T ss_pred cceeEcCcEEecCCCcEEEEEEEec-------CCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc
Confidence 3444444 89999999999996642 23467899999976532 346778999999999999999999999976
Q ss_pred cCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcccccc
Q 018785 99 SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 178 (350)
Q Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~ 178 (350)
+..++||||+.+++|.+++.... ..+++..+..++.|++.||+||| ++|++|+||||+||+++.++.++|+|||++
T Consensus 408 -~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH--~~~iiHrDlkp~NILl~~~~~vkL~DFGla 483 (613)
T 2ozo_A 408 -EALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLE--EKNFVHRNLAARNVLLVNRHYAKISDFGLS 483 (613)
T ss_dssp -SSEEEEEECCTTCBHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEEEETTEEEECCCSTT
T ss_pred -CCeEEEEEeCCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHH--HCCEEcCcCCHHHEEEcCCCcEEEeeccCc
Confidence 57999999999999999996543 46999999999999999999999 899999999999999999999999999999
Q ss_pred ccCCCCCCCc-ccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccccCcchhhhhhhcchhhhhh
Q 018785 179 RDGPTGDNTH-VSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDS 256 (350)
Q Consensus 179 ~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 256 (350)
.......... ......+++.|+|||++.+..++.++||||||+++|+|++ |..||.+.......
T Consensus 484 ~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~-------------- 549 (613)
T 2ozo_A 484 KALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM-------------- 549 (613)
T ss_dssp TTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHH--------------
T ss_pred ccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH--------------
Confidence 7643322211 1122335678999999999999999999999999999998 99999875542221
Q ss_pred HHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcCCCC
Q 018785 257 RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDM 313 (350)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~ 313 (350)
..+........+..+++++.+||.+||..||.+|||+.++++.|+.+......
T Consensus 550 ----~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~ 602 (613)
T 2ozo_A 550 ----AFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 602 (613)
T ss_dssp ----HHHHTTCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSC
T ss_pred ----HHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhcc
Confidence 11222223345567889999999999999999999999999999998766433
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-42 Score=310.72 Aligned_cols=272 Identities=24% Similarity=0.377 Sum_probs=212.0
Q ss_pred CCchhhhhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhc--cCCC
Q 018785 10 PSASMISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQ--LRHE 87 (350)
Q Consensus 10 ~~~~~~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~--l~h~ 87 (350)
..+........++|++.+.||+|+||.||+|++ +++.||||.+.... ...+..|.++++. ++||
T Consensus 31 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-----------~~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~ 96 (342)
T 1b6c_B 31 GLPLLVQRTIARTIVLQESIGKGRFGEVWRGKW-----------RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHE 96 (342)
T ss_dssp SSCHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-----------TTEEEEEEEECGGG---HHHHHHHHHHHHHSCCCCT
T ss_pred CCceeecccccccEEEEeeecCCCCcEEEEEEE-----------cCccEEEEEeCchh---HHHHHHHHHHHHHhhcCCC
Confidence 444556777789999999999999999999943 37899999986543 3456677887777 6899
Q ss_pred cccceeeEEeecC----ceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcC------CCCeeeCCC
Q 018785 88 NLVKLIGYCSESD----NRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL------DANVIYRDL 157 (350)
Q Consensus 88 ~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~------~~~i~H~di 157 (350)
||+++++++.... ..++||||+++++|.+++... .+++..++.++.|++.||.|||+. +.|++|+||
T Consensus 97 ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dl 173 (342)
T 1b6c_B 97 NILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDL 173 (342)
T ss_dssp TBCCEEEEEECCCSSCCCEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCC
T ss_pred cEEEEEeeecccCCccceeEEEEeecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCC
Confidence 9999999998876 789999999999999999765 589999999999999999999932 369999999
Q ss_pred CCCceEEcCCCcEEEccccccccCCCCCCCc--ccccccCCCcccCccccccCC------CCCccchhhHHHHHHHHHhC
Q 018785 158 KASNVLLDSNFNAKLSDFGLARDGPTGDNTH--VSTRIVGTRGYAAPEYVATGH------LTPKSDVYSFGVVLLELLSG 229 (350)
Q Consensus 158 ~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~------~~~~~DiwslG~ll~~ll~g 229 (350)
||+||+++.++.++|+|||++.......... ......+++.|+|||++.+.. ++.++||||||+++|+|++|
T Consensus 174 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg 253 (342)
T 1b6c_B 174 KSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 253 (342)
T ss_dssp SGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CHHHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhc
Confidence 9999999999999999999997543322211 123356889999999987652 33689999999999999999
Q ss_pred ----------CCCCcccccCcc-hhhhhhhcchhhhhhHHHHHhhhcccCCCC-----cHHHHHHHHHHHHHhhccCCCC
Q 018785 230 ----------RRALDEDRGGLA-EQTLVEWADPFLRDSRRVLRIMDTRLGGQY-----SKKEAQAVAAVVLQCLHMDPKN 293 (350)
Q Consensus 230 ----------~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~~l~~dp~~ 293 (350)
..||........ ...+. ............ ...+++.+.+|+.+||+.||.+
T Consensus 254 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~ 320 (342)
T 1b6c_B 254 CSIGGIHEDYQLPYYDLVPSDPSVEEMR-------------KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAA 320 (342)
T ss_dssp BCBTTBCCCCCCTTTTTSCSSCCHHHHH-------------HHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGG
T ss_pred cCcCCcccccccCccccCcCcccHHHHH-------------HHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhh
Confidence 667754432211 11111 011111111112 2367789999999999999999
Q ss_pred CCCHHHHHHHHHhhhcCC
Q 018785 294 RPSMVDVLTSLEQLHTSK 311 (350)
Q Consensus 294 Rps~~~ll~~L~~~~~~~ 311 (350)
|||+.+++++|+++....
T Consensus 321 Rps~~~i~~~L~~i~~~~ 338 (342)
T 1b6c_B 321 RLTALRIKKTLSQLSQQE 338 (342)
T ss_dssp SCCHHHHHHHHHHHHHTT
T ss_pred CCCHHHHHHHHHHHHHHh
Confidence 999999999999998764
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=326.39 Aligned_cols=271 Identities=20% Similarity=0.266 Sum_probs=215.2
Q ss_pred hhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCC-CcccceeeEE
Q 018785 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRH-ENLVKLIGYC 96 (350)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~ 96 (350)
..+++|++.++||+|+||.||+| .+..+++.||||++...... ..+..|+.+++.+.| +++..+..++
T Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a---------~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~ 72 (483)
T 3sv0_A 4 RVGNKFRLGRKIGSGSFGEIYLG---------TNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFG 72 (483)
T ss_dssp EETTTEECCCCCEECSSCEEEEE---------EETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEE
T ss_pred CcCCcEEEEEEEeeCCCEEEEEE---------EECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEE
Confidence 45789999999999999999999 55567899999987655422 346789999999976 5555666666
Q ss_pred eecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEE---cCCCcEEEc
Q 018785 97 SESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLL---DSNFNAKLS 173 (350)
Q Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili---~~~~~~~l~ 173 (350)
...+..++||||+ +++|.+++.... ..+++..++.++.||+.||.||| +.||+|+||||+|||+ +.++.++|+
T Consensus 73 ~~~~~~~lvme~~-g~sL~~ll~~~~-~~l~~~~~~~i~~qi~~aL~yLH--~~gIvHrDIKP~NILl~~~~~~~~vkL~ 148 (483)
T 3sv0_A 73 VEGDYNVLVMDLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVH--SKSFLHRDIKPDNFLMGLGRRANQVYII 148 (483)
T ss_dssp EETTEEEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECCGGGTTCEEEC
T ss_pred eeCCEEEEEEECC-CCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHH--HCCEeecccCcceEEEecCCCCCeEEEE
Confidence 7778889999999 999999997543 36999999999999999999999 8999999999999999 578899999
Q ss_pred cccccccCCCCCCCc-----ccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhh
Q 018785 174 DFGLARDGPTGDNTH-----VSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEW 248 (350)
Q Consensus 174 Dfg~~~~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~ 248 (350)
|||++.......... ......|++.|+|||.+.+..++.++|||||||++|+|++|+.||.+.........+...
T Consensus 149 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i 228 (483)
T 3sv0_A 149 DFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI 228 (483)
T ss_dssp CCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHH
T ss_pred eCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHH
Confidence 999997654433211 122467899999999999999999999999999999999999999876654433333322
Q ss_pred cchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcCCCCC
Q 018785 249 ADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDMP 314 (350)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~~ 314 (350)
......... ......+++++.+|+.+||+.||.+||++.+|++.|+++......+
T Consensus 229 ~~~~~~~~~-----------~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~~ 283 (483)
T 3sv0_A 229 SEKKVATSI-----------EALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQ 283 (483)
T ss_dssp HHHHHHSCH-----------HHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred hhccccccH-----------HHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCCC
Confidence 111111000 0111245678999999999999999999999999999997765444
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=307.29 Aligned_cols=256 Identities=25% Similarity=0.343 Sum_probs=208.5
Q ss_pred hhhhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch--hhHHHHHHHHHHHhccCCCcccc
Q 018785 14 MISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLRHENLVK 91 (350)
Q Consensus 14 ~~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~ 91 (350)
.......++|++.+.||+|++|.||+| .+..+++.||+|++..... .....+.+|+.++++++||||++
T Consensus 15 ~~~~~~~~~y~i~~~lg~G~~g~V~~~---------~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 85 (287)
T 2wei_A 15 YFQGTFAERYNIVCMLGKGSFGEVLKC---------KDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMK 85 (287)
T ss_dssp HHTHHHHHHEEEEEEEEEETTEEEEEE---------EETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCC
T ss_pred hHHHHHhhcceeeEEEcCCCCEEEEEE---------EEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccE
Confidence 345556789999999999999999999 5556789999999865432 34567889999999999999999
Q ss_pred eeeEEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCC---C
Q 018785 92 LIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSN---F 168 (350)
Q Consensus 92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~---~ 168 (350)
+++++...+..++|||++.+++|.+++.... .+++..++.++.|++.||.+|| +.|++|+||+|+||+++.+ +
T Consensus 86 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH--~~~i~H~dl~p~NIlv~~~~~~~ 161 (287)
T 2wei_A 86 LFEILEDSSSFYIVGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMH--KHNIVHRDLKPENILLESKEKDC 161 (287)
T ss_dssp EEEEEECSSEEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEESCSSTTC
T ss_pred EEEEEeCCCeEEEEEEccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--HCCeeccCCChhhEEEecCCCcc
Confidence 9999999999999999999999999987664 6999999999999999999999 8999999999999999764 4
Q ss_pred cEEEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhh
Q 018785 169 NAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEW 248 (350)
Q Consensus 169 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~ 248 (350)
.++|+|||++........ .....+++.|+|||.+.+ .++.++|+||||+++|+|++|..||.+.........+.
T Consensus 162 ~~kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~-- 235 (287)
T 2wei_A 162 DIKIIDFGLSTCFQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVE-- 235 (287)
T ss_dssp CEEECSTTGGGTBCCCSS---CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--
T ss_pred cEEEeccCcceeecCCCc---cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH--
Confidence 699999999875433221 122347788999998865 48999999999999999999999997654321111111
Q ss_pred cchhhhhhHHHHHhhhcccC--CCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 249 ADPFLRDSRRVLRIMDTRLG--GQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
..... ......+++++.++|.+||..||.+|||+.+++++
T Consensus 236 ---------------~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 236 ---------------TGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp ---------------HCCCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred ---------------cCCCCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence 11111 11123567899999999999999999999999985
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=310.28 Aligned_cols=262 Identities=19% Similarity=0.260 Sum_probs=203.0
Q ss_pred hhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccC-CCcccceeeEEee
Q 018785 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLR-HENLVKLIGYCSE 98 (350)
Q Consensus 20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~ 98 (350)
.++|++.+.||+|+||+||+| .+..+++.||+|++.... ...+.+|+.+++.+. ||||+++++++..
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~---------~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~ 102 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEA---------INITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKD 102 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEE---------EETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEEC
T ss_pred CCceEEEEEecccCCeEEEEE---------EECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeecc
Confidence 578999999999999999999 566678999999987543 456789999999997 9999999999987
Q ss_pred --cCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCC-cEEEccc
Q 018785 99 --SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNF-NAKLSDF 175 (350)
Q Consensus 99 --~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~-~~~l~Df 175 (350)
....++|||++.+++|.+++. .+++..+..++.|++.||.||| +.|++|+||||+||+++.++ .++|+||
T Consensus 103 ~~~~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~Dikp~Nil~~~~~~~~kl~Df 175 (330)
T 3nsz_A 103 PVSRTPALVFEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCH--SMGIMHRDVKPHNVMIDHEHRKLRLIDW 175 (330)
T ss_dssp TTTCCEEEEEECCCCCCHHHHGG-----GCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEEETTTTEEEECCC
T ss_pred CCCCceEEEEeccCchhHHHHHH-----hCCHHHHHHHHHHHHHHHHHHH--hCCeeeCCCCHHHEEEcCCCCEEEEEeC
Confidence 667899999999999999884 3889999999999999999999 89999999999999999776 8999999
Q ss_pred cccccCCCCCCCcccccccCCCcccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCcccccC-cchhhhhhhcc-hh
Q 018785 176 GLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRALDEDRGG-LAEQTLVEWAD-PF 252 (350)
Q Consensus 176 g~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~-~~~~~~~~~~~-~~ 252 (350)
|++........ .....+++.|+|||.+.+ ..++.++|||||||++|+|++|..||...... .....+..... +.
T Consensus 176 g~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~ 252 (330)
T 3nsz_A 176 GLAEFYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED 252 (330)
T ss_dssp TTCEECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHH
T ss_pred CCceEcCCCCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCch
Confidence 99976433322 223467888999999877 67899999999999999999999999543321 11111111100 00
Q ss_pred hhhh---------HHHHHhh--------hcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 253 LRDS---------RRVLRIM--------DTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 253 ~~~~---------~~~~~~~--------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
..+. ....... ...........+++++.+||.+||+.||.+|||++++++|
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 253 LYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp HHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred hhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0000 0000000 0011112233468899999999999999999999999976
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=337.14 Aligned_cols=253 Identities=28% Similarity=0.408 Sum_probs=206.3
Q ss_pred ceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch--hhHHHHHHHHHHHhccCCCcccceeeEEeecCceEE
Q 018785 27 YLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLRHENLVKLIGYCSESDNRLL 104 (350)
Q Consensus 27 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 104 (350)
+.||+|+||+||+|.+. ...++..||||++..... .....+.+|+.++++++||||+++++++.. +..++
T Consensus 375 ~~LG~G~fG~Vy~~~~~-------~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~l 446 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQ-------MKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWML 446 (635)
T ss_dssp EEEEECSSEEEEEEEEE-------CSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred CEeccCCCEEEEEEEEc-------CCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEE
Confidence 47999999999999653 334578999999976543 235778999999999999999999999964 56899
Q ss_pred EEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccccccCCCC
Q 018785 105 VYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTG 184 (350)
Q Consensus 105 v~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~~~~~~ 184 (350)
||||+.+++|.+++.... .+++..++.++.||+.||+||| +.||+|+||||+||+++.++.++|+|||++......
T Consensus 447 v~E~~~~g~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~yLH--~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~ 522 (635)
T 4fl3_A 447 VMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLE--ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD 522 (635)
T ss_dssp EEECCTTEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-
T ss_pred EEEccCCCCHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHHH--HCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccC
Confidence 999999999999997664 7999999999999999999999 899999999999999999999999999999765433
Q ss_pred CCC-cccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccccCcchhhhhhhcchhhhhhHHHHHh
Q 018785 185 DNT-HVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRI 262 (350)
Q Consensus 185 ~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (350)
... .......+++.|+|||++.+..++.++||||||+++|+|++ |..||.+...... ...
T Consensus 523 ~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~------------------~~~ 584 (635)
T 4fl3_A 523 ENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV------------------TAM 584 (635)
T ss_dssp ------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH------------------HHH
T ss_pred ccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH------------------HHH
Confidence 221 12222345678999999999999999999999999999998 9999976553221 222
Q ss_pred hhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhc
Q 018785 263 MDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHT 309 (350)
Q Consensus 263 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 309 (350)
+........+..+++++.+||.+||+.||.+|||+.++++.|+++..
T Consensus 585 i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~ 631 (635)
T 4fl3_A 585 LEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 631 (635)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 22233344566788999999999999999999999999999998764
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-43 Score=313.72 Aligned_cols=271 Identities=24% Similarity=0.341 Sum_probs=201.6
Q ss_pred hhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceeeEEe
Q 018785 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (350)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (350)
..+++|++.+.||+|++|.||+| .+..+++.||+|.+..........+.+|+.+++.++||||+++++++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 78 (320)
T 2i6l_A 8 DLGSRYMDLKPLGCGGNGLVFSA---------VDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILG 78 (320)
T ss_dssp EETTTEEEEEECC-----CEEEE---------EETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred ccCCceeEEEEeccCCCeEEEEE---------EECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecc
Confidence 34789999999999999999999 566678999999998776666678899999999999999999999874
Q ss_pred --------------ecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceE
Q 018785 98 --------------ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVL 163 (350)
Q Consensus 98 --------------~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nil 163 (350)
+.+..++||||+. ++|.+++... .+++..++.++.|++.||+||| +.|++|+||+|+||+
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dlkp~Nil 152 (320)
T 2i6l_A 79 PSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQG---PLLEEHARLFMYQLLRGLKYIH--SANVLHRDLKPANLF 152 (320)
T ss_dssp TTSCBCCC----CCSCSEEEEEEECCS-EEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCSGGGEE
T ss_pred ccccccccccccccccCceeEEeeccC-CCHHHHhhcC---CccHHHHHHHHHHHHHHHHHHH--hCCEecCCCCHHHEE
Confidence 3467899999996 6999988653 6899999999999999999999 899999999999999
Q ss_pred Ec-CCCcEEEccccccccCCCCCC-CcccccccCCCcccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCcccccCc
Q 018785 164 LD-SNFNAKLSDFGLARDGPTGDN-THVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGL 240 (350)
Q Consensus 164 i~-~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~ 240 (350)
++ .++.++|+|||++........ ........++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.+.....
T Consensus 153 ~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 232 (320)
T 2i6l_A 153 INTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELE 232 (320)
T ss_dssp EETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred EcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHH
Confidence 97 567899999999976432211 111223456888999998865 678999999999999999999999998765433
Q ss_pred chhhhhhhcchhhh-hhHHHHHh----hhcccC------CCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 241 AEQTLVEWADPFLR-DSRRVLRI----MDTRLG------GQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 241 ~~~~~~~~~~~~~~-~~~~~~~~----~~~~~~------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
....+......... ........ ...... ......++.++.+||.+||+.||.+|||+.++++|
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 233 QMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp HHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 33322221111000 00000000 000000 00123467899999999999999999999999986
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=313.29 Aligned_cols=275 Identities=21% Similarity=0.279 Sum_probs=211.6
Q ss_pred CchhhhhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCC-cEEEEEEccccchhhHHHHHHHHHHHhccCCCc-
Q 018785 11 SASMISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSG-IVVAIKRLKAESFQGHKEWLTEVIYLGQLRHEN- 88 (350)
Q Consensus 11 ~~~~~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~-~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~- 88 (350)
.....+++..++|++.+.||+|+||+||+|+ +..++ ..||+|++.... .....+..|+.+++.+.|++
T Consensus 9 ~~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~---------~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~ 78 (355)
T 2eu9_A 9 LVCRIGDWLQERYEIVGNLGEGTFGKVVECL---------DHARGKSQVALKIIRNVG-KYREAARLEINVLKKIKEKDK 78 (355)
T ss_dssp BCCCTTCEETTTEEEEEEEEEETTEEEEEEE---------ETTTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHHCT
T ss_pred cccccCceecccEEEEEEeeccCCeEEEEEE---------ecCCCceEEEEEEEcccc-cchhHHHHHHHHHHHHhhcCC
Confidence 3445677888999999999999999999994 43344 789999987543 33466778899888886555
Q ss_pred -----ccceeeEEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceE
Q 018785 89 -----LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVL 163 (350)
Q Consensus 89 -----i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nil 163 (350)
++.+++++...+..++|||++ ++++.+++.......+++..++.++.||+.||.||| +.|++|+||||+||+
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH--~~~ivH~Dlkp~NIl 155 (355)
T 2eu9_A 79 ENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLH--ENQLTHTDLKPENIL 155 (355)
T ss_dssp TSCSCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH--TTTEECCCCCGGGEE
T ss_pred CCceeEEEeeeeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEE
Confidence 899999999999999999999 778888887776567999999999999999999999 999999999999999
Q ss_pred E-------------------cCCCcEEEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHH
Q 018785 164 L-------------------DSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLL 224 (350)
Q Consensus 164 i-------------------~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~ 224 (350)
+ +.++.++|+|||++....... ....|++.|+|||++.+..++.++||||||+++|
T Consensus 156 l~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ 230 (355)
T 2eu9_A 156 FVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHH-----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILF 230 (355)
T ss_dssp ESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSCC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHH
T ss_pred EecccccccccccccccccccCCCcEEEeecCccccccccc-----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHH
Confidence 9 567889999999997533221 2346889999999999999999999999999999
Q ss_pred HHHhCCCCCcccccCcchhhhhhhcchhhhhh--------------------HHHHHhhhc-----ccCCCCcHHHHHHH
Q 018785 225 ELLSGRRALDEDRGGLAEQTLVEWADPFLRDS--------------------RRVLRIMDT-----RLGGQYSKKEAQAV 279 (350)
Q Consensus 225 ~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~~-----~~~~~~~~~~~~~l 279 (350)
+|++|..||...........+.....+..... ......... ..........+.++
T Consensus 231 el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 310 (355)
T 2eu9_A 231 EYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQL 310 (355)
T ss_dssp HHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHH
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHH
Confidence 99999999987654333222222111100000 000000000 00011233557799
Q ss_pred HHHHHHhhccCCCCCCCHHHHHHH
Q 018785 280 AAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 280 ~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
.+||.+||+.||.+|||+.++++|
T Consensus 311 ~~li~~~L~~dP~~Rpt~~e~l~h 334 (355)
T 2eu9_A 311 FDLMRRMLEFDPAQRITLAEALLH 334 (355)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred HHHHHHHhcCChhhCcCHHHHhcC
Confidence 999999999999999999999875
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=309.47 Aligned_cols=259 Identities=24% Similarity=0.349 Sum_probs=202.5
Q ss_pred hhhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccc--hhhHHHHHHHHHHHhccC--CCccc
Q 018785 15 ISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES--FQGHKEWLTEVIYLGQLR--HENLV 90 (350)
Q Consensus 15 ~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~--h~~i~ 90 (350)
...+.+++|++.+.||+|+||.||+|+ +. +++.||+|.+.... ......+.+|+..++++. ||||+
T Consensus 22 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~---------~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv 91 (313)
T 3cek_A 22 SMSVKGRIYSILKQIGSGGSSKVFQVL---------NE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKII 91 (313)
T ss_dssp EEEETTEEEEEEEEEECCSSEEEEEEE---------CT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBC
T ss_pred eeeeccceEEEEEEecCCCCEEEEEEE---------cC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceE
Confidence 345668899999999999999999993 32 37889999986543 234467889999999996 59999
Q ss_pred ceeeEEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcE
Q 018785 91 KLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNA 170 (350)
Q Consensus 91 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~ 170 (350)
++++++...+..++||| +.+++|.+++.... .++...++.++.|++.||.||| +.|++|+||+|+||+++. +.+
T Consensus 92 ~~~~~~~~~~~~~lv~e-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~dlkp~NIl~~~-~~~ 165 (313)
T 3cek_A 92 RLYDYEITDQYIYMVME-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIH--QHGIVHSDLKPANFLIVD-GML 165 (313)
T ss_dssp CEEEEEECSSEEEEEEC-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEEET-TEE
T ss_pred EEEEEeecCCEEEEEEe-cCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--HCCceecCCCcccEEEEC-CeE
Confidence 99999999999999999 45889999998765 7899999999999999999999 899999999999999964 799
Q ss_pred EEccccccccCCCCCCCcccccccCCCcccCcccccc-----------CCCCCccchhhHHHHHHHHHhCCCCCcccccC
Q 018785 171 KLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-----------GHLTPKSDVYSFGVVLLELLSGRRALDEDRGG 239 (350)
Q Consensus 171 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-----------~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~ 239 (350)
+|+|||++................+++.|+|||.+.+ ..++.++||||||+++|+|++|..||......
T Consensus 166 kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 245 (313)
T 3cek_A 166 KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ 245 (313)
T ss_dssp EECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH
T ss_pred EEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH
Confidence 9999999976544333323334568999999999865 46788999999999999999999999654321
Q ss_pred cchhhhhhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018785 240 LAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 305 (350)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~ 305 (350)
................+...+..+.+++.+||+.||.+|||+.+++++-.
T Consensus 246 ----------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~ 295 (313)
T 3cek_A 246 ----------------ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPY 295 (313)
T ss_dssp ----------------HHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred ----------------HHHHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCcc
Confidence 01111222222223344455778999999999999999999999998743
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=315.34 Aligned_cols=273 Identities=22% Similarity=0.237 Sum_probs=208.3
Q ss_pred hhhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccC-CC-----c
Q 018785 15 ISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLR-HE-----N 88 (350)
Q Consensus 15 ~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~-----~ 88 (350)
.++...++|++.+.||+|+||+||+| .+..+++.||||++.... .....+..|+.+++.+. |+ +
T Consensus 48 ~~~~~~~~y~~~~~lG~G~~g~V~~~---------~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~ 117 (382)
T 2vx3_A 48 NGEKWMDRYEIDSLIGKGSFGQVVKA---------YDRVEQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYY 117 (382)
T ss_dssp TTCEETTTEEEEEEEEEETTEEEEEE---------EETTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGG
T ss_pred cCCEeeeeEEEEEEEeecCCEEEEEE---------EEcCCCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhccccccee
Confidence 34455689999999999999999999 566678999999997543 23455667888877774 44 5
Q ss_pred ccceeeEEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEc--C
Q 018785 89 LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLD--S 166 (350)
Q Consensus 89 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~--~ 166 (350)
|+++++++...+..++|||++. ++|.+++.......+++..+..++.|++.||.|||+...||+|+||||+||+++ .
T Consensus 118 iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~ 196 (382)
T 2vx3_A 118 IVHLKRHFMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPK 196 (382)
T ss_dssp BCCEEEEEEETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTT
T ss_pred EEEeeeeeccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCC
Confidence 9999999999999999999995 599999988765679999999999999999999994347999999999999995 4
Q ss_pred CCcEEEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhh
Q 018785 167 NFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLV 246 (350)
Q Consensus 167 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~ 246 (350)
++.++|+|||++...... .....+++.|+|||++.+..++.++|||||||++|+|++|..||.+.........+.
T Consensus 197 ~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~ 271 (382)
T 2vx3_A 197 RSAIKIVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIV 271 (382)
T ss_dssp SCCEEECCCTTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred CCcEEEEeccCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 678999999999764322 223568899999999999999999999999999999999999998766544333333
Q ss_pred hhcchhh----hhhHHHHHhhhccc-----------------------------------------CCCCcHHHHHHHHH
Q 018785 247 EWADPFL----RDSRRVLRIMDTRL-----------------------------------------GGQYSKKEAQAVAA 281 (350)
Q Consensus 247 ~~~~~~~----~~~~~~~~~~~~~~-----------------------------------------~~~~~~~~~~~l~~ 281 (350)
....... .........+.... ........++++.+
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 351 (382)
T 2vx3_A 272 EVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKD 351 (382)
T ss_dssp HHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHH
T ss_pred HHhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHH
Confidence 2211100 00000000100000 00112234568999
Q ss_pred HHHHhhccCCCCCCCHHHHHHH
Q 018785 282 VVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 282 li~~~l~~dp~~Rps~~~ll~~ 303 (350)
||.+||+.||.+|||+.++++|
T Consensus 352 li~~mL~~dP~~Rpta~e~L~h 373 (382)
T 2vx3_A 352 LILRMLDYDPKTRIQPYYALQH 373 (382)
T ss_dssp HHHHHTCSCTTTSCCHHHHTTS
T ss_pred HHHHhcCCChhhCCCHHHHhcC
Confidence 9999999999999999999875
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=317.34 Aligned_cols=263 Identities=24% Similarity=0.354 Sum_probs=202.8
Q ss_pred hhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch--hhHHHHHHHHHHHhccCCCcccceeeEEe
Q 018785 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (350)
Q Consensus 20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (350)
.++|++.+.||+|+||+||+| .+..+|+.||||.+..... .....+.+|+.+++.++||||+++++++.
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 111 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSA---------IDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFT 111 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEE---------EETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred cccEEEEeEEecCCCeEEEEE---------EECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhhee
Confidence 579999999999999999999 6667799999999876432 23466889999999999999999999998
Q ss_pred ecCce------EEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEE
Q 018785 98 ESDNR------LLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAK 171 (350)
Q Consensus 98 ~~~~~------~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~ 171 (350)
..+.. ++|||++. ++|.+++.. .+++..+..++.|++.||.||| +.|++|+||||+||+++.++.++
T Consensus 112 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dikp~NIll~~~~~~k 184 (371)
T 4exu_A 112 PASSLRNFYDFYLVMPFMQ-TDLQKIMGM----EFSEEKIQYLVYQMLKGLKYIH--SAGVVHRDLKPGNLAVNEDCELK 184 (371)
T ss_dssp SCSSSTTCCCCEEEEECCC-EEHHHHTTS----CCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTTCCEE
T ss_pred ccCCcccceeEEEEEcccc-ccHHHHhhc----CCCHHHHHHHHHHHHHHHHHHH--HCCCcCCCcCHHHeEECCCCCEE
Confidence 87665 99999995 688887732 5899999999999999999999 89999999999999999999999
Q ss_pred EccccccccCCCCCCCcccccccCCCcccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcc
Q 018785 172 LSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD 250 (350)
Q Consensus 172 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~ 250 (350)
|+|||++...... .....+++.|+|||.+.+ ..++.++|||||||++|+|++|..||.+.........+.....
T Consensus 185 L~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~ 259 (371)
T 4exu_A 185 ILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTG 259 (371)
T ss_dssp ECSTTCC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred EEecCcccccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence 9999999753222 223467899999999877 6889999999999999999999999987654333333322111
Q ss_pred hhhhh---------hHHHHHhhhcccCCC---CcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 251 PFLRD---------SRRVLRIMDTRLGGQ---YSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 251 ~~~~~---------~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
..... ............... ....+++.+.+||.+||+.||.+|||+.++++|
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 260 VPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp CCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 10000 000011111111100 122457899999999999999999999999987
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=311.05 Aligned_cols=271 Identities=26% Similarity=0.362 Sum_probs=205.0
Q ss_pred hhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhh--HHHHHHHHHHHhcc---CCCccccee
Q 018785 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQG--HKEWLTEVIYLGQL---RHENLVKLI 93 (350)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l---~h~~i~~~~ 93 (350)
..++|++.+.||+|+||.||+|+.. ..+|+.||+|.+....... ...+.+|+..++.+ .||||++++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~--------~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~ 80 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDL--------KNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLF 80 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEET--------TTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEE
T ss_pred chhceeeeeeecccccEEEEEEEec--------CCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeee
Confidence 4589999999999999999999432 2458899999987543221 12345566666655 899999999
Q ss_pred eEEe-----ecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCC
Q 018785 94 GYCS-----ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNF 168 (350)
Q Consensus 94 ~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~ 168 (350)
+++. .....++|||++. ++|.+++.......+++..++.++.|++.||.||| +.|++|+||+|+||+++.++
T Consensus 81 ~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH--~~gi~H~dlkp~Nili~~~~ 157 (326)
T 1blx_A 81 DVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH--SHRVVHRDLKPQNILVTSSG 157 (326)
T ss_dssp EEEEEEECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTTC
T ss_pred eeeeecccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH--HCCceeccCCHHHeEEcCCC
Confidence 9987 5567899999996 69999998876567999999999999999999999 89999999999999999999
Q ss_pred cEEEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhh
Q 018785 169 NAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEW 248 (350)
Q Consensus 169 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~ 248 (350)
.++|+|||++...... .......+++.|+|||.+.+..++.++||||||+++|+|++|..||.+.........+...
T Consensus 158 ~~kl~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~ 234 (326)
T 1blx_A 158 QIKLADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDV 234 (326)
T ss_dssp CEEECSCCSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred CEEEecCcccccccCC---CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence 9999999999753321 1223356889999999999999999999999999999999999999876543332222211
Q ss_pred cc-hhhhhhHH----HHHhhh---cccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 249 AD-PFLRDSRR----VLRIMD---TRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 249 ~~-~~~~~~~~----~~~~~~---~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
.. +....... ...... ..........++..+.+||.+||..||.+|||+.++++|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 235 IGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp HCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 00 00000000 000000 000112234567899999999999999999999999865
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=332.32 Aligned_cols=266 Identities=24% Similarity=0.353 Sum_probs=213.3
Q ss_pred hhhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch-hhHHHHHHHHHHHhccCCCccccee
Q 018785 15 ISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLVKLI 93 (350)
Q Consensus 15 ~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~ 93 (350)
..++..++|++.+.||+|+||.||+|++.. ....+..||+|.+..... ...+.+.+|+.++++++||||++++
T Consensus 384 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~------~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~ 457 (656)
T 2j0j_A 384 DYEIQRERIELGRCIGEGQFGDVHQGIYMS------PENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457 (656)
T ss_dssp GTBCCGGGEEEEEEEECCSSCCEEEEEECC------SSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccccccccEEEeeEEeeCCCEEEEEEEEec------CCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 345567899999999999999999997642 233467899999875432 3346788999999999999999999
Q ss_pred eEEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEc
Q 018785 94 GYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLS 173 (350)
Q Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~ 173 (350)
+++. ++..++||||+++++|.+++.... ..++...++.++.|++.||.||| +.|++|+||||+||+++.++.++|+
T Consensus 458 ~~~~-~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH--~~givHrDikp~NILl~~~~~vkL~ 533 (656)
T 2j0j_A 458 GVIT-ENPVWIIMELCTLGELRSFLQVRK-FSLDLASLILYAYQLSTALAYLE--SKRFVHRDIAARNVLVSSNDCVKLG 533 (656)
T ss_dssp EEEC-SSSCEEEEECCTTCBHHHHHHHTT-TTCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEEEETTEEEEC
T ss_pred EEEe-cCceEEEEEcCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH--hCCccccccchHhEEEeCCCCEEEE
Confidence 9985 467899999999999999997654 36899999999999999999999 8999999999999999999999999
Q ss_pred cccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccccCcchhhhhhhcchh
Q 018785 174 DFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPF 252 (350)
Q Consensus 174 Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~ 252 (350)
|||++........ .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+.........
T Consensus 534 DFG~a~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~-------- 604 (656)
T 2j0j_A 534 DFGLSRYMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR-------- 604 (656)
T ss_dssp CCCCCCSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH--------
T ss_pred ecCCCeecCCCcc-eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHH--------
Confidence 9999976433221 11223446678999999998999999999999999999997 8999976543221111
Q ss_pred hhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhc
Q 018785 253 LRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHT 309 (350)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 309 (350)
+........+..+++.+.+++.+||..||.+|||+.++++.|+++..
T Consensus 605 ----------i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~ 651 (656)
T 2j0j_A 605 ----------IENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 651 (656)
T ss_dssp ----------HHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----------HHcCCCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 11112233456778899999999999999999999999999998854
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=316.80 Aligned_cols=271 Identities=25% Similarity=0.321 Sum_probs=205.5
Q ss_pred hhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch-hhHHHHHHHHHHHhccCCCcccceeeEE
Q 018785 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLVKLIGYC 96 (350)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (350)
...++|++.+.||+|+||.||+| .+..+|+.||||.+..... .....+.+|+.+++.++||||+++++++
T Consensus 8 ~i~~~y~~~~~lg~G~~g~V~~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 78 (353)
T 2b9h_A 8 NISSDFQLKSLLGEGAYGVVCSA---------THKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQ 78 (353)
T ss_dssp CSCTTEEEEEEEEECSSEEEEEE---------EETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEC
T ss_pred ccccceEEeeEEcCCCCeEEEEE---------EECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeee
Confidence 45689999999999999999999 5566789999999865432 2345678899999999999999999987
Q ss_pred eec-----CceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEE
Q 018785 97 SES-----DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAK 171 (350)
Q Consensus 97 ~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~ 171 (350)
... ...++|||++. ++|.+++... .++...+..++.|++.||.||| +.|++|+||+|+||+++.++.++
T Consensus 79 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH--~~~ivH~Dlkp~Nil~~~~~~~k 152 (353)
T 2b9h_A 79 RPDSFENFNEVYIIQELMQ-TDLHRVISTQ---MLSDDHIQYFIYQTLRAVKVLH--GSNVIHRDLKPSNLLINSNCDLK 152 (353)
T ss_dssp CCSCSTTCCCEEEEECCCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGGGEEECTTCCEE
T ss_pred cccccCccceEEEEEeccC-ccHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHeEEcCCCcEE
Confidence 654 67899999995 6999988764 6999999999999999999999 89999999999999999999999
Q ss_pred EccccccccCCCCCCCc--------ccccccCCCcccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCcccccCcch
Q 018785 172 LSDFGLARDGPTGDNTH--------VSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAE 242 (350)
Q Consensus 172 l~Dfg~~~~~~~~~~~~--------~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~ 242 (350)
|+|||++.......... ......|++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.......
T Consensus 153 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~ 232 (353)
T 2b9h_A 153 VCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQL 232 (353)
T ss_dssp ECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred EEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH
Confidence 99999997643322111 1122467899999998765 67899999999999999999999999876543222
Q ss_pred hhhhhhcchhh-h------hhHHHHHhhhccc---CC---CCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 243 QTLVEWADPFL-R------DSRRVLRIMDTRL---GG---QYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 243 ~~~~~~~~~~~-~------~~~~~~~~~~~~~---~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
..+........ . ............. .. .....+++++.+||.+||..||.+|||+.++++|
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 233 LLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp HHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 22221111000 0 0000001111000 00 0123567889999999999999999999999986
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=318.01 Aligned_cols=271 Identities=25% Similarity=0.320 Sum_probs=199.9
Q ss_pred hhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh-----------hHHHHHHHHHHHhcc
Q 018785 16 SKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ-----------GHKEWLTEVIYLGQL 84 (350)
Q Consensus 16 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-----------~~~~~~~e~~~l~~l 84 (350)
.....++|++.+.||+|+||.||+|+ +. .|..||||.+...... ....+.+|+.+++.+
T Consensus 17 ~~~~~~~y~~~~~lg~G~~g~V~~~~---------~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 86 (362)
T 3pg1_A 17 LHAMQSPYTVQRFISSGSYGAVCAGV---------DS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHF 86 (362)
T ss_dssp HHHTTCSCEEEEEEEEETTEEEEEEE---------CT-TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHC
T ss_pred HHHhccceEEeEEeccCCCEEEEEEE---------CC-CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhC
Confidence 34557899999999999999999993 33 3889999988653221 236788999999999
Q ss_pred CCCcccceeeEEeec-----CceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCC
Q 018785 85 RHENLVKLIGYCSES-----DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKA 159 (350)
Q Consensus 85 ~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~ 159 (350)
+||||+++++++... ...++|||++. ++|.+++.... ..++...+..++.|++.||.||| +.|++|+||||
T Consensus 87 ~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~Dlkp 162 (362)
T 3pg1_A 87 HHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR-IVISPQHIQYFMYHILLGLHVLH--EAGVVHRDLHP 162 (362)
T ss_dssp CCTTBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCG
T ss_pred CCcCccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHH--HCcCEecCCCh
Confidence 999999999998543 35799999996 68888887543 36999999999999999999999 89999999999
Q ss_pred CceEEcCCCcEEEccccccccCCCCCCCcccccccCCCcccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCccccc
Q 018785 160 SNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRALDEDRG 238 (350)
Q Consensus 160 ~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~ 238 (350)
+||+++.++.++|+|||++....... ......+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||.+...
T Consensus 163 ~NIl~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~ 239 (362)
T 3pg1_A 163 GNILLADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTF 239 (362)
T ss_dssp GGEEECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred HHEEEcCCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCH
Confidence 99999999999999999997432222 2233567888999999877 6789999999999999999999999987654
Q ss_pred Ccchhhhhhhcch-hhhh-----hHHHHHhhhcccCC-------CCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 239 GLAEQTLVEWADP-FLRD-----SRRVLRIMDTRLGG-------QYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 239 ~~~~~~~~~~~~~-~~~~-----~~~~~~~~~~~~~~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
......+...... .... .............. .....+++.+.+||.+||+.||.+|||+.++++|
T Consensus 240 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 240 YNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp HHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 4333333322111 1100 00001111110000 0122446789999999999999999999999986
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=312.38 Aligned_cols=258 Identities=21% Similarity=0.283 Sum_probs=180.6
Q ss_pred hhhhcccccc-eecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceeeEE
Q 018785 18 IATKNFCSDY-LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYC 96 (350)
Q Consensus 18 ~~~~~y~i~~-~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (350)
...++|++.+ +||+|+||+||+| .+..+++.||||++.... ....+....++.+.||||+++++++
T Consensus 25 ~~~~~y~i~~~~lG~G~~g~V~~~---------~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~ 91 (336)
T 3fhr_A 25 AVTDDYQLSKQVLGLGVNGKVLEC---------FHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVY 91 (336)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEE---------EETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEE
T ss_pred cccceeEecceeeeeCCCeEEEEE---------EECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHH
Confidence 4568899955 6999999999999 566678999999986542 1222333445667999999999998
Q ss_pred ee----cCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCC---Cc
Q 018785 97 SE----SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSN---FN 169 (350)
Q Consensus 97 ~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~---~~ 169 (350)
.. ....++||||+++++|.+++.......+++..++.++.|++.||.||| +.|++|+||+|+||+++.+ +.
T Consensus 92 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH--~~~ivH~dlkp~NIll~~~~~~~~ 169 (336)
T 3fhr_A 92 ENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH--SHNIAHRDVKPENLLYTSKEKDAV 169 (336)
T ss_dssp EEEETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEESCSSTTCC
T ss_pred hhccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEEEecCCCce
Confidence 76 455899999999999999998876667999999999999999999999 8999999999999999764 45
Q ss_pred EEEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhc
Q 018785 170 AKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWA 249 (350)
Q Consensus 170 ~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~ 249 (350)
++|+|||++....... .....+++.|+|||.+.+..++.++||||||+++|+|++|..||...............
T Consensus 170 ~kl~Dfg~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~- 244 (336)
T 3fhr_A 170 LKLTDFGFAKETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRR- 244 (336)
T ss_dssp EEECCCTTCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----------------
T ss_pred EEEeccccceeccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHh-
Confidence 9999999997543221 22346789999999998888999999999999999999999999765432221111100
Q ss_pred chhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018785 250 DPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 305 (350)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~ 305 (350)
...............+++++.+||.+||..||.+|||+.++++|-.
T Consensus 245 ----------~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 290 (336)
T 3fhr_A 245 ----------IRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPW 290 (336)
T ss_dssp ----------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHH
T ss_pred ----------hhccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcc
Confidence 0000011111223457789999999999999999999999998643
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=302.94 Aligned_cols=255 Identities=24% Similarity=0.397 Sum_probs=196.9
Q ss_pred hhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceeeEEee
Q 018785 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (350)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (350)
..++|++.+.||+|+||.||+| .+..+++.||||.+.... .....+.+|+.+++.++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~---------~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 73 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKA---------RNALDSRYYAIKKIRHTE-EKLSTILSEVMLLASLNHQYVVRYYAAWLE 73 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEE---------EETTTCCEEEEEEEEEEH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred ccccchhhheeccCCcEEEEEE---------EEcCCCeEEEEEEEeccH-HHHHHHHHHHHHHHhcCchHHHHHHHHHHh
Confidence 3579999999999999999999 556678999999986543 345678899999999999999999998754
Q ss_pred -------------cCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEc
Q 018785 99 -------------SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLD 165 (350)
Q Consensus 99 -------------~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~ 165 (350)
.+..++||||+++++|.+++.... ..++...++.++.|++.||+||| +.|++|+||+|+||+++
T Consensus 74 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH--~~~i~H~dlkp~Nil~~ 150 (303)
T 1zy4_A 74 RRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN-LNQQRDEYWRLFRQILEALSYIH--SQGIIHRDLKPMNIFID 150 (303)
T ss_dssp CCCCCC------CEEEEEEEEECCCSCBHHHHHHHSC-GGGCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEEC
T ss_pred hcchhhhhcccccCCceEEEEecCCCCCHHHhhhccc-cccchHHHHHHHHHHHHHHHHHH--hCCeecccCCHHhEEEc
Confidence 456799999999999999997654 35788899999999999999999 89999999999999999
Q ss_pred CCCcEEEccccccccCCCCCC------------CcccccccCCCcccCccccccC-CCCCccchhhHHHHHHHHHhCCCC
Q 018785 166 SNFNAKLSDFGLARDGPTGDN------------THVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRA 232 (350)
Q Consensus 166 ~~~~~~l~Dfg~~~~~~~~~~------------~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~ll~~ll~g~~p 232 (350)
.++.++|+|||++........ ........+++.|+|||.+.+. .++.++||||||+++|+|++ |
T Consensus 151 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p 227 (303)
T 1zy4_A 151 ESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---P 227 (303)
T ss_dssp TTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---C
T ss_pred CCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---c
Confidence 999999999999976432211 1122335688899999998765 68999999999999999998 4
Q ss_pred CcccccCcchhhhhhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 233 LDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 233 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
|...... .. ................+...++.+.+++.+||+.||.+|||+.++++|
T Consensus 228 ~~~~~~~--~~------------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 228 FSTGMER--VN------------ILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp CSSHHHH--HH------------HHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred cCCchhH--HH------------HHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 4321100 00 000011111122233455667889999999999999999999999975
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-42 Score=318.43 Aligned_cols=271 Identities=24% Similarity=0.345 Sum_probs=201.1
Q ss_pred hhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceeeEEeec
Q 018785 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (350)
Q Consensus 20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (350)
..+|++.+.||+|+||.||+| .+..+|+.||||.+..... ...+|+.+++.++||||+++++++...
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~---------~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~ 119 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQA---------KLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSS 119 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEE---------EETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEE
T ss_pred cceEEeeeEEeeCCCEEEEEE---------EECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEecc
Confidence 347999999999999999999 5556789999998865432 234689999999999999999988542
Q ss_pred ------CceEEEEEcCCCCChhhHHhh--cCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCC-CcE
Q 018785 100 ------DNRLLVYEFMPKGSLENHLFR--KGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSN-FNA 170 (350)
Q Consensus 100 ------~~~~lv~e~~~~~~L~~~l~~--~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~-~~~ 170 (350)
..+++||||+.+ ++.+++.. .....+++..++.++.||+.||.||| +.||+|+||||+||+++.+ +.+
T Consensus 120 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH--~~~ivHrDlkp~NILl~~~~~~~ 196 (420)
T 1j1b_A 120 GEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH--SFGICHRDIKPQNLLLDPDTAVL 196 (420)
T ss_dssp ETTTTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH--TTTEECSCCSGGGEEEETTTTEE
T ss_pred CCCCcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH--HCCccccCCChhhEEEeCCCCeE
Confidence 236799999954 77776643 23347999999999999999999999 9999999999999999965 568
Q ss_pred EEccccccccCCCCCCCcccccccCCCcccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhh-
Q 018785 171 KLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEW- 248 (350)
Q Consensus 171 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~- 248 (350)
||+|||++........ .....+++.|+|||++.+. .++.++|||||||++|+|++|+.||.+.........+...
T Consensus 197 kl~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~l 273 (420)
T 1j1b_A 197 KLCDFGSAKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL 273 (420)
T ss_dssp EECCCTTCEECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred EeccchhhhhcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 9999999976433222 2234689999999998765 7899999999999999999999999876543333333221
Q ss_pred cchhhhhhHHHHHhhhc-ccC--------CCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHhhhc
Q 018785 249 ADPFLRDSRRVLRIMDT-RLG--------GQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS--LEQLHT 309 (350)
Q Consensus 249 ~~~~~~~~~~~~~~~~~-~~~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~--L~~~~~ 309 (350)
..+.............. ... ..++..+++++.+||.+||..||.+|||+.++++| +..+..
T Consensus 274 g~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 345 (420)
T 1j1b_A 274 GTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 345 (420)
T ss_dssp CSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred CCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccccc
Confidence 11111111100000000 000 00123457899999999999999999999999976 444443
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=315.43 Aligned_cols=268 Identities=20% Similarity=0.309 Sum_probs=204.1
Q ss_pred hhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccC-----------C
Q 018785 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLR-----------H 86 (350)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-----------h 86 (350)
+..++|++.+.||+|+||+||+| .+..+++.||||++.... .....+.+|+.+++++. |
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~---------~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~ 85 (373)
T 1q8y_A 16 YKDARYILVRKLGWGHFSTVWLA---------KDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGA 85 (373)
T ss_dssp ETTTTEEEEEEEEECSSEEEEEE---------EETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHH
T ss_pred ccCCeEEEEEeeeecCCeEEEEE---------EecCCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhcccc
Confidence 35679999999999999999999 566678999999987543 23456778888888875 8
Q ss_pred CcccceeeEEeecC----ceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCC-CeeeCCCCCCc
Q 018785 87 ENLVKLIGYCSESD----NRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDA-NVIYRDLKASN 161 (350)
Q Consensus 87 ~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~-~i~H~di~~~N 161 (350)
|||+++++++...+ ..++|||++ +++|.+++.......+++..+..++.||+.||.||| ++ |++|+||||+|
T Consensus 86 ~~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH--~~~~ivH~Dikp~N 162 (373)
T 1q8y_A 86 NHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMH--RRCGIIHTDIKPEN 162 (373)
T ss_dssp TTBCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH--HTTCEECSCCSGGG
T ss_pred chHHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHH--hcCCEEecCCChHH
Confidence 99999999988654 789999999 899999998866567999999999999999999999 87 99999999999
Q ss_pred eEEc------CCCcEEEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcc
Q 018785 162 VLLD------SNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDE 235 (350)
Q Consensus 162 ili~------~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~ 235 (350)
|+++ ..+.++|+|||++...... .....+++.|+|||++.+..++.++||||||+++|+|++|..||..
T Consensus 163 Ill~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 237 (373)
T 1q8y_A 163 VLMEIVDSPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEP 237 (373)
T ss_dssp EEEEEEETTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC--
T ss_pred eEEeccCCCcCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 9994 3447999999999764322 2234688999999999999999999999999999999999999986
Q ss_pred cccCcch------hhhhhhcch----hhhhhHHHHHhhh-------------------cccCCCCcHHHHHHHHHHHHHh
Q 018785 236 DRGGLAE------QTLVEWADP----FLRDSRRVLRIMD-------------------TRLGGQYSKKEAQAVAAVVLQC 286 (350)
Q Consensus 236 ~~~~~~~------~~~~~~~~~----~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~l~~li~~~ 286 (350)
....... ..+...... ............. .......+..+++++.+||.+|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 317 (373)
T 1q8y_A 238 DEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPM 317 (373)
T ss_dssp -------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGG
T ss_pred CcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHH
Confidence 5432111 111110000 0000000000000 0011234578899999999999
Q ss_pred hccCCCCCCCHHHHHHH
Q 018785 287 LHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 287 l~~dp~~Rps~~~ll~~ 303 (350)
|+.||.+|||+.++++|
T Consensus 318 L~~dP~~Rpt~~ell~h 334 (373)
T 1q8y_A 318 LQLDPRKRADAGGLVNH 334 (373)
T ss_dssp GCSSTTTCBCHHHHHTC
T ss_pred hccCccccCCHHHHhhC
Confidence 99999999999999986
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=310.33 Aligned_cols=263 Identities=25% Similarity=0.357 Sum_probs=202.6
Q ss_pred hhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch--hhHHHHHHHHHHHhccCCCcccceeeEEe
Q 018785 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (350)
Q Consensus 20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (350)
.++|.+.+.||+|+||.||+| .+..+|+.||||.+..... .....+.+|+.+++.++||||+++++++.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 93 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSA---------IDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFT 93 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEE---------EETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred CceEEEeeeEecCCCeEEEEE---------EECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEe
Confidence 478999999999999999999 5666799999999876432 23456789999999999999999999998
Q ss_pred ecCc------eEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEE
Q 018785 98 ESDN------RLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAK 171 (350)
Q Consensus 98 ~~~~------~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~ 171 (350)
..+. .++|||++. ++|.+++.. .+++..+..++.|++.||.||| +.|++|+||+|+||+++.++.++
T Consensus 94 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~LH--~~~ivH~dlkp~NIl~~~~~~~k 166 (353)
T 3coi_A 94 PASSLRNFYDFYLVMPFMQ-TDLQKIMGL----KFSEEKIQYLVYQMLKGLKYIH--SAGVVHRDLKPGNLAVNEDCELK 166 (353)
T ss_dssp SCSSGGGCCCCEEEEECCS-EEGGGTTTS----CCCHHHHHHHHHHHHHHHHHHH--HTTCCCSSCCGGGEEECTTCCEE
T ss_pred cccccccceeEEEEecccc-CCHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEeECCCCcEE
Confidence 7654 499999995 588887742 5899999999999999999999 89999999999999999999999
Q ss_pred EccccccccCCCCCCCcccccccCCCcccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcc
Q 018785 172 LSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD 250 (350)
Q Consensus 172 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~ 250 (350)
|+|||++...... .....+++.|+|||.+.+ ..++.++||||||+++|+|++|..||.+.........+.....
T Consensus 167 l~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~ 241 (353)
T 3coi_A 167 ILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTG 241 (353)
T ss_dssp ECSTTCTTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHC
T ss_pred EeecccccCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 9999999753221 223467899999999877 6789999999999999999999999987654333222222111
Q ss_pred hhhh-------h--hHHHHHhhhcccC---CCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 251 PFLR-------D--SRRVLRIMDTRLG---GQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 251 ~~~~-------~--~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
.... + ............. ......+++.+.+||.+||..||.+|||+.++++|
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 242 VPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp BCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0000 0 0000111111111 12234668899999999999999999999999976
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=308.68 Aligned_cols=283 Identities=24% Similarity=0.325 Sum_probs=199.2
Q ss_pred hhhhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCccccee
Q 018785 14 MISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLI 93 (350)
Q Consensus 14 ~~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 93 (350)
.......++|++.+.||+|+||+||+| .+..+|+.||||.+..... ......+++..++.++||||++++
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~---------~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~ 85 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLG---------KEKSTGMSVAIKKVIQDPR-FRNRELQIMQDLAVLHHPNIVQLQ 85 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEE---------EETTTCCEEEEEEEECCTT-CCCHHHHHHHHHHHHCCTTBCCEE
T ss_pred hhchhhccceEEEEEEecCCCeEEEEE---------EECCCCCEEEEEEEecCcc-ccHHHHHHHHHHHhcCCCCcccHH
Confidence 345566789999999999999999999 5666789999998865432 233456778888889999999999
Q ss_pred eEEeecCc-------eEEEEEcCCCCChhhHHhh--cCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEE
Q 018785 94 GYCSESDN-------RLLVYEFMPKGSLENHLFR--KGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLL 164 (350)
Q Consensus 94 ~~~~~~~~-------~~lv~e~~~~~~L~~~l~~--~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili 164 (350)
+++...+. .++||||+.+ +|.+.+.. .....++...+..++.|++.||.|||..+.|++|+||||+||++
T Consensus 86 ~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll 164 (360)
T 3e3p_A 86 SYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLV 164 (360)
T ss_dssp EEEEEECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEE
T ss_pred HhhhccccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEE
Confidence 99876443 7899999965 66555432 23347899999999999999999999556899999999999999
Q ss_pred cC-CCcEEEccccccccCCCCCCCcccccccCCCcccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCcccccCcch
Q 018785 165 DS-NFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAE 242 (350)
Q Consensus 165 ~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~ 242 (350)
+. ++.++|+|||++........ .....+++.|+|||++.+. .++.++|||||||++|+|++|..||.+.......
T Consensus 165 ~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~ 241 (360)
T 3e3p_A 165 NEADGTLKLCDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQL 241 (360)
T ss_dssp ETTTTEEEECCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred eCCCCcEEEeeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHH
Confidence 97 89999999999986443322 2234678999999998665 4899999999999999999999999876654433
Q ss_pred hhhhhhcchhhhhh-HHHH------Hhhh------cccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHhh
Q 018785 243 QTLVEWADPFLRDS-RRVL------RIMD------TRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS--LEQL 307 (350)
Q Consensus 243 ~~~~~~~~~~~~~~-~~~~------~~~~------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~--L~~~ 307 (350)
..+........... .... .... ...........++++.+||.+||+.||.+|||+.++++| +.++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 321 (360)
T 3e3p_A 242 HEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDEL 321 (360)
T ss_dssp HHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGG
T ss_pred HHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCcccccc
Confidence 33332211110000 0000 0000 000011122367899999999999999999999999987 5555
Q ss_pred hcC
Q 018785 308 HTS 310 (350)
Q Consensus 308 ~~~ 310 (350)
...
T Consensus 322 ~~~ 324 (360)
T 3e3p_A 322 HDP 324 (360)
T ss_dssp GCT
T ss_pred CCc
Confidence 443
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=318.16 Aligned_cols=255 Identities=12% Similarity=0.040 Sum_probs=184.7
Q ss_pred hhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch---hhHHHHHHHH---HHHhccCCCccccee
Q 018785 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEV---IYLGQLRHENLVKLI 93 (350)
Q Consensus 20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~---~~l~~l~h~~i~~~~ 93 (350)
..+|++.+.||+|+||+||+| .+..+|+.||||++..... .....+.+|+ ..++. +||||++++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~---------~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~ 130 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLV---------RDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDR 130 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEE---------EETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------
T ss_pred ceeeeeeeeccCCCCEEEEEE---------EECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhc
Confidence 456999999999999999999 5566789999999987543 2345567774 45555 799988754
Q ss_pred -------eEEeecC-----------------ceEEEEEcCCCCChhhHHhhcCCCCCCHHHH------HHHHHHHHHHHH
Q 018785 94 -------GYCSESD-----------------NRLLVYEFMPKGSLENHLFRKGVQPISWPTR------VKIAIDVARGLS 143 (350)
Q Consensus 94 -------~~~~~~~-----------------~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~------~~i~~ql~~al~ 143 (350)
+++...+ ..++||||++ ++|.+++..... .++...+ ..++.|++.||+
T Consensus 131 ~~~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~vk~~i~~qi~~aL~ 208 (371)
T 3q60_A 131 RRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF-VYVFRGDEGILALHILTAQLIRLAA 208 (371)
T ss_dssp -CBCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred eeEEeeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc-ccchhhhhhhhhHHHHHHHHHHHHH
Confidence 4554332 3799999997 899999976531 3455555 677899999999
Q ss_pred HhhcCCCCeeeCCCCCCceEEcCCCcEEEccccccccCCCCCCCcccccccCCCcccCcccccc--CCCCCccchhhHHH
Q 018785 144 FLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT--GHLTPKSDVYSFGV 221 (350)
Q Consensus 144 ~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~DiwslG~ 221 (350)
||| +.|++|+||||+||+++.++.++|+|||++..... ......+++.|+|||++.+ ..++.++|||||||
T Consensus 209 ~LH--~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~ 281 (371)
T 3q60_A 209 NLQ--SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT-----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGL 281 (371)
T ss_dssp HHH--HTTEEETTCSGGGEEECTTSCEEECCGGGEEETTC-----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHH
T ss_pred HHH--HCCCccCcCCHHHEEECCCCCEEEEecceeeecCC-----CccCccCCcCCcChhhccCCCCCcCccccHHHHHH
Confidence 999 89999999999999999999999999999975321 1113456689999999987 67999999999999
Q ss_pred HHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 018785 222 VLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL 301 (350)
Q Consensus 222 ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll 301 (350)
++|+|++|+.||.+........... . .................+++.+.+||.+||+.||.+|||+.+++
T Consensus 282 il~elltg~~Pf~~~~~~~~~~~~~----~------~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l 351 (371)
T 3q60_A 282 SIYRVWCLFLPFGLVTPGIKGSWKR----P------SLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAM 351 (371)
T ss_dssp HHHHHHHSSCSTTBCCTTCTTCCCB----C------CTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHT
T ss_pred HHHHHHhCCCCCCCcCcccccchhh----h------hhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHh
Confidence 9999999999998764321110000 0 00000001111112236688999999999999999999999998
Q ss_pred HH
Q 018785 302 TS 303 (350)
Q Consensus 302 ~~ 303 (350)
+|
T Consensus 352 ~h 353 (371)
T 3q60_A 352 ET 353 (371)
T ss_dssp TS
T ss_pred cC
Confidence 65
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-42 Score=317.92 Aligned_cols=272 Identities=19% Similarity=0.257 Sum_probs=187.0
Q ss_pred hhcccc-cceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceeeEEee
Q 018785 20 TKNFCS-DYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (350)
Q Consensus 20 ~~~y~i-~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (350)
.+.|++ .++||+|+||+||+|+.. +..++..||||.+..... ...+.+|+.+++.++||||+++++++..
T Consensus 19 ~~~y~~~g~~lG~G~~g~Vy~~~~~-------~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~ 89 (405)
T 3rgf_A 19 EDLFEYEGCKVGRGTYGHVYKAKRK-------DGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLS 89 (405)
T ss_dssp HHHEECSSCCCC-----EEEEEEES-------SSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEE
T ss_pred hhhhhhcCcEeeecCCeEEEEEEEc-------cCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEec
Confidence 456777 558999999999999542 334678999999976542 2457789999999999999999999954
Q ss_pred --cCceEEEEEcCCCCChhhHHhhcC-------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEE----c
Q 018785 99 --SDNRLLVYEFMPKGSLENHLFRKG-------VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLL----D 165 (350)
Q Consensus 99 --~~~~~lv~e~~~~~~L~~~l~~~~-------~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili----~ 165 (350)
....++||||+. ++|.+++.... ...+++..++.++.||+.||.||| +.||+|+||||+||++ +
T Consensus 90 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH--~~~ivH~Dlkp~NIll~~~~~ 166 (405)
T 3rgf_A 90 HADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH--ANWVLHRDLKPANILVMGEGP 166 (405)
T ss_dssp TTTTEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECCSST
T ss_pred CCCCeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH--hCCEeCCCcCHHHeEEecCCC
Confidence 678899999994 58888875321 124899999999999999999999 8999999999999999 6
Q ss_pred CCCcEEEccccccccCCCCCC-CcccccccCCCcccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCcccccCcc--
Q 018785 166 SNFNAKLSDFGLARDGPTGDN-THVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLA-- 241 (350)
Q Consensus 166 ~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~-- 241 (350)
.++.++|+|||++........ ........|++.|+|||++.+. .++.++|||||||++|+|++|..||.+......
T Consensus 167 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~ 246 (405)
T 3rgf_A 167 ERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTS 246 (405)
T ss_dssp TTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------
T ss_pred CCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcccccccc
Confidence 778999999999976533221 1222345789999999998874 589999999999999999999999976543210
Q ss_pred -------hhhhhh-hcchhhh---------hhHHHHHhhhcccCCC---------CcHHHHHHHHHHHHHhhccCCCCCC
Q 018785 242 -------EQTLVE-WADPFLR---------DSRRVLRIMDTRLGGQ---------YSKKEAQAVAAVVLQCLHMDPKNRP 295 (350)
Q Consensus 242 -------~~~~~~-~~~~~~~---------~~~~~~~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rp 295 (350)
...+.. ...+... ................ .....++.+.+||.+||..||.+||
T Consensus 247 ~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ 326 (405)
T 3rgf_A 247 NPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRI 326 (405)
T ss_dssp CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSC
T ss_pred ccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCC
Confidence 011110 0000000 0000000000000000 0011256789999999999999999
Q ss_pred CHHHHHHH
Q 018785 296 SMVDVLTS 303 (350)
Q Consensus 296 s~~~ll~~ 303 (350)
|++++++|
T Consensus 327 ta~e~L~h 334 (405)
T 3rgf_A 327 TSEQAMQD 334 (405)
T ss_dssp CHHHHHTS
T ss_pred CHHHHhcC
Confidence 99999987
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=313.94 Aligned_cols=276 Identities=22% Similarity=0.341 Sum_probs=202.1
Q ss_pred hhhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceee
Q 018785 15 ISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIG 94 (350)
Q Consensus 15 ~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 94 (350)
.++....+|++.++||+|+||+||+|+. ..++. +|+|.+...... ..+|+.+++.++||||+++++
T Consensus 34 ~~~~~~~~Y~~~~~lG~G~~g~V~~a~~---------~~~~~-~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~ 99 (394)
T 4e7w_A 34 TGEQREIAYTNCKVIGNGSFGVVFQAKL---------VESDE-VAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKA 99 (394)
T ss_dssp SCCEEEEEEEEEEEEEEETTEEEEEEEE---------TTTEE-EEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEE
T ss_pred CCCcccceEEEeEEEeeCCCeEEEEEEE---------CCCCe-EEEEEEecCcch----HHHHHHHHHhCCCCCcceEEE
Confidence 3445567899999999999999999943 33444 788877543221 236899999999999999999
Q ss_pred EEeecCc------eEEEEEcCCCCChhhHHhh--cCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEc-
Q 018785 95 YCSESDN------RLLVYEFMPKGSLENHLFR--KGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLD- 165 (350)
Q Consensus 95 ~~~~~~~------~~lv~e~~~~~~L~~~l~~--~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~- 165 (350)
++...+. .++||||+.+ ++.+.+.. .....+++..++.++.|++.||+||| +.|++|+||||+||+++
T Consensus 100 ~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH--~~~ivHrDlkp~Nill~~ 176 (394)
T 4e7w_A 100 FFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH--SIGICHRDIKPQNLLLDP 176 (394)
T ss_dssp EEEEESSSSSCEEEEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEEET
T ss_pred EEEecCCCCCceEEEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH--HCCccCCCCCHHHEEEcC
Confidence 9865443 7899999965 55444432 12347999999999999999999999 89999999999999998
Q ss_pred CCCcEEEccccccccCCCCCCCcccccccCCCcccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCcccccCcchhh
Q 018785 166 SNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQT 244 (350)
Q Consensus 166 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~ 244 (350)
.++.++|+|||++........ .....+++.|+|||++.+. .++.++|||||||++|+|++|+.||.+.........
T Consensus 177 ~~~~~kL~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~ 253 (394)
T 4e7w_A 177 PSGVLKLIDFGSAKILIAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVE 253 (394)
T ss_dssp TTTEEEECCCTTCEECCTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred CCCcEEEeeCCCcccccCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 789999999999976433322 2234678899999998765 589999999999999999999999987665433333
Q ss_pred hhhhcc-hhhhhhHHHH-HhhhcccC--------CCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHhhhcC
Q 018785 245 LVEWAD-PFLRDSRRVL-RIMDTRLG--------GQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS--LEQLHTS 310 (350)
Q Consensus 245 ~~~~~~-~~~~~~~~~~-~~~~~~~~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~--L~~~~~~ 310 (350)
+..... +......... ........ ...+..+++++.+||.+||..||.+|||+.++++| +..+...
T Consensus 254 i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 331 (394)
T 4e7w_A 254 IIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTG 331 (394)
T ss_dssp HHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTSS
T ss_pred HHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhccc
Confidence 332211 1111110000 00000000 01123467899999999999999999999999987 5555443
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=306.84 Aligned_cols=248 Identities=25% Similarity=0.421 Sum_probs=195.0
Q ss_pred hhhhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh------hHHHHHHHHHHHhcc---
Q 018785 14 MISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ------GHKEWLTEVIYLGQL--- 84 (350)
Q Consensus 14 ~~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~e~~~l~~l--- 84 (350)
...+...++|++.+.||+|+||.||+| .+..+++.||||.+...... ....+.+|+..++++
T Consensus 24 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~---------~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~ 94 (312)
T 2iwi_A 24 KDREAFEAEYRLGPLLGKGGFGTVFAG---------HRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAG 94 (312)
T ss_dssp ---------CEEEEEEEEETTEEEEEE---------ECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSS
T ss_pred cchhhhhhceEEeeEEEcCCCEEEEEE---------EEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhccc
Confidence 345666789999999999999999999 66667899999999765432 122345688888888
Q ss_pred -CCCcccceeeEEeecCceEEEEEc-CCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCce
Q 018785 85 -RHENLVKLIGYCSESDNRLLVYEF-MPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNV 162 (350)
Q Consensus 85 -~h~~i~~~~~~~~~~~~~~lv~e~-~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Ni 162 (350)
+||||+++++++...+..++|+|+ +.+++|.+++.... .+++..++.++.|++.||.||| +.|++|+||+|+||
T Consensus 95 ~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dlkp~Ni 170 (312)
T 2iwi_A 95 GGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKG--PLGEGPSRCFFGQVVAAIQHCH--SRGVVHRDIKDENI 170 (312)
T ss_dssp CCCSSBCCEEEEC-----CEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHH--HHTEECCCCSGGGE
T ss_pred CCCCCeeeEEEEEecCCeEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--HCCeeecCCChhhE
Confidence 899999999999999999999999 78899999998765 6999999999999999999999 89999999999999
Q ss_pred EEc-CCCcEEEccccccccCCCCCCCcccccccCCCcccCccccccCCCC-CccchhhHHHHHHHHHhCCCCCcccccCc
Q 018785 163 LLD-SNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLT-PKSDVYSFGVVLLELLSGRRALDEDRGGL 240 (350)
Q Consensus 163 li~-~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~-~~~DiwslG~ll~~ll~g~~pf~~~~~~~ 240 (350)
+++ .++.++|+|||++....... .....++..|+|||++.+..+. .++||||||+++|+|++|+.||.....
T Consensus 171 l~~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-- 244 (312)
T 2iwi_A 171 LIDLRRGCAKLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE-- 244 (312)
T ss_dssp EEETTTTEEEECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--
T ss_pred EEeCCCCeEEEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH--
Confidence 999 78999999999997643322 2234588899999998777664 589999999999999999999964321
Q ss_pred chhhhhhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 241 AEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
+. . .....+..++..+.++|.+||+.||.+|||+.+++++
T Consensus 245 ----~~-----------------~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 245 ----IL-----------------E--AELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp ----HH-----------------H--TCCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ----Hh-----------------h--hccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 0 0112344567889999999999999999999999986
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-42 Score=308.20 Aligned_cols=260 Identities=25% Similarity=0.332 Sum_probs=184.8
Q ss_pred hhhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch-hhHHHHHHHHH-HHhccCCCcccce
Q 018785 15 ISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVI-YLGQLRHENLVKL 92 (350)
Q Consensus 15 ~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~-~l~~l~h~~i~~~ 92 (350)
..++..++|++.+.||+|+||.||+| .+..+|+.||||.+..... .....+..|.. +++.++||||+++
T Consensus 16 ~~~~~~~~y~~~~~lg~G~~g~Vy~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~ 86 (327)
T 3aln_A 16 HWDFTAEDLKDLGEIGRGAYGSVNKM---------VHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQF 86 (327)
T ss_dssp EECCCSCSEEC-CEEEECSSEEEEEE---------EETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCE
T ss_pred hcccCHHHhhehheeccCCCEEEEEE---------EEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeee
Confidence 44566789999999999999999999 5566789999999876532 22334445555 7777899999999
Q ss_pred eeEEeecCceEEEEEcCCCCChhhHHhh---cCCCCCCHHHHHHHHHHHHHHHHHhhcCCC-CeeeCCCCCCceEEcCCC
Q 018785 93 IGYCSESDNRLLVYEFMPKGSLENHLFR---KGVQPISWPTRVKIAIDVARGLSFLHGLDA-NVIYRDLKASNVLLDSNF 168 (350)
Q Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~l~~~~~~~i~~ql~~al~~lh~~~~-~i~H~di~~~Nili~~~~ 168 (350)
++++...+..++||||+.+ +|.+++.. .....+++..+..++.|++.||.||| +. |++|+||+|+||+++.++
T Consensus 87 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH--~~~~ivH~dlkp~NIll~~~~ 163 (327)
T 3aln_A 87 YGALFREGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK--ENLKIIHRDIKPSNILLDRSG 163 (327)
T ss_dssp EEEEECSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHH--HHHSCCCSCCCGGGEEEETTT
T ss_pred eeEEEeCCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHh--ccCCEeECCCCHHHEEEcCCC
Confidence 9999999999999999964 88887753 22347999999999999999999999 88 999999999999999999
Q ss_pred cEEEccccccccCCCCCCCcccccccCCCcccCcccc----ccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcc-hh
Q 018785 169 NAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYV----ATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLA-EQ 243 (350)
Q Consensus 169 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~----~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~-~~ 243 (350)
.++|+|||++....... ......|++.|+|||.+ .+..++.++||||||+++|+|++|..||........ ..
T Consensus 164 ~~kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~ 240 (327)
T 3aln_A 164 NIKLCDFGISGQLVDSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLT 240 (327)
T ss_dssp EEEECCCSSSCC---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------C
T ss_pred CEEEccCCCceeccccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHH
Confidence 99999999997543222 12224688899999998 456789999999999999999999999975432100 00
Q ss_pred hhhhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 244 TLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
.+... ............+++.+.+|+.+||..||.+|||+.+++++
T Consensus 241 ~~~~~--------------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 241 QVVKG--------------DPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp CCCCS--------------CCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHhcC--------------CCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 00000 00001111223567899999999999999999999999876
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=307.54 Aligned_cols=266 Identities=21% Similarity=0.304 Sum_probs=203.8
Q ss_pred hhhhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch--hhHHHHHHHHHHHhccCCCcccc
Q 018785 14 MISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLRHENLVK 91 (350)
Q Consensus 14 ~~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~ 91 (350)
...++..++|++.+.||+|+||.||+|++. ..+++|.+..... .....+.+|+..++.++||||++
T Consensus 26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~------------~~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~ 93 (319)
T 2y4i_B 26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWH------------GEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVL 93 (319)
T ss_dssp GGSSSCCSCEECCCBCCCSSSSEEEEEEES------------SSEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCC
T ss_pred ccccCCHHHeEEeeEeccCCceEEEEEEEc------------CeEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeE
Confidence 344556789999999999999999999543 2389998875432 22344667899999999999999
Q ss_pred eeeEEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEE
Q 018785 92 LIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAK 171 (350)
Q Consensus 92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~ 171 (350)
+++++...+..++||||+++++|.+++.... ..+++..++.++.|++.||.||| +.|++|+||+|+||+++ ++.++
T Consensus 94 ~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH--~~~i~H~dlkp~NIl~~-~~~~~ 169 (319)
T 2y4i_B 94 FMGACMSPPHLAIITSLCKGRTLYSVVRDAK-IVLDVNKTRQIAQEIVKGMGYLH--AKGILHKDLKSKNVFYD-NGKVV 169 (319)
T ss_dssp CCEEEECSSCEEEECBCCCSEEHHHHTTSSC-CCCCSHHHHHHHHHHHHHHHHHH--HTTCCCCCCCSTTEEEC---CCE
T ss_pred EEEEEecCCceEEEeecccCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH--hCCccccCCChhhEEEe-CCCEE
Confidence 9999999999999999999999999997653 36899999999999999999999 89999999999999998 67999
Q ss_pred EccccccccCCCCC---CCcccccccCCCcccCcccccc---------CCCCCccchhhHHHHHHHHHhCCCCCcccccC
Q 018785 172 LSDFGLARDGPTGD---NTHVSTRIVGTRGYAAPEYVAT---------GHLTPKSDVYSFGVVLLELLSGRRALDEDRGG 239 (350)
Q Consensus 172 l~Dfg~~~~~~~~~---~~~~~~~~~~~~~~~aPE~~~~---------~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~ 239 (350)
|+|||++....... .........|++.|+|||.+.+ ..++.++||||||+++|+|++|..||......
T Consensus 170 l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~ 249 (319)
T 2y4i_B 170 ITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE 249 (319)
T ss_dssp ECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH
T ss_pred EeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 99999986532211 1122223457889999999864 35788999999999999999999999765432
Q ss_pred cchhhhhhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcCCC
Q 018785 240 LAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKD 312 (350)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~ 312 (350)
.....+. ...........++.++.+++.+||..||.+|||+.++++.|+++.....
T Consensus 250 ~~~~~~~-----------------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~ 305 (319)
T 2y4i_B 250 AIIWQMG-----------------TGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNR 305 (319)
T ss_dssp HHHHHHH-----------------TTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-----
T ss_pred HHHHHhc-----------------cCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhc
Confidence 2111111 1111111223466789999999999999999999999999999987743
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=309.24 Aligned_cols=248 Identities=22% Similarity=0.403 Sum_probs=202.6
Q ss_pred hhhhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh------hHHHHHHHHHHHhccC--
Q 018785 14 MISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ------GHKEWLTEVIYLGQLR-- 85 (350)
Q Consensus 14 ~~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~e~~~l~~l~-- 85 (350)
...+...++|++.+.||+|+||.||+| .+..+++.||||.+...... ....+..|+.+++.+.
T Consensus 36 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~---------~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 106 (320)
T 3a99_A 36 KEKEPLESQYQVGPLLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 106 (320)
T ss_dssp ----CCTTTEEEEEECSSSSSCEEEEE---------EETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSS
T ss_pred cccCCccCceEEEEEEeeCCCeEEEEE---------EECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccC
Confidence 355566789999999999999999999 55667899999998765322 1234567889999986
Q ss_pred CCcccceeeEEeecCceEEEEEcCCC-CChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEE
Q 018785 86 HENLVKLIGYCSESDNRLLVYEFMPK-GSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLL 164 (350)
Q Consensus 86 h~~i~~~~~~~~~~~~~~lv~e~~~~-~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili 164 (350)
||||+++++++...+..++|+|++.+ ++|.+++.... .+++..++.++.|++.||.||| +.|++|+||+|+||++
T Consensus 107 ~~~i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH--~~~ivH~Dlkp~NIll 182 (320)
T 3a99_A 107 FSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCH--NCGVLHRDIKDENILI 182 (320)
T ss_dssp SCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEE
T ss_pred CCCceEEEEEEecCCcEEEEEEcCCCCccHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHH--HCCcEeCCCCHHHEEE
Confidence 69999999999999999999999875 89999998764 7999999999999999999999 8999999999999999
Q ss_pred c-CCCcEEEccccccccCCCCCCCcccccccCCCcccCccccccCCC-CCccchhhHHHHHHHHHhCCCCCcccccCcch
Q 018785 165 D-SNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHL-TPKSDVYSFGVVLLELLSGRRALDEDRGGLAE 242 (350)
Q Consensus 165 ~-~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~ 242 (350)
+ .++.++|+|||++....... .....+++.|+|||++.+..+ +.++||||||+++|+|++|..||.....
T Consensus 183 ~~~~~~~kL~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~---- 254 (320)
T 3a99_A 183 DLNRGELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE---- 254 (320)
T ss_dssp ETTTTEEEECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH----
T ss_pred eCCCCCEEEeeCcccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh----
Confidence 8 77899999999997643321 223458899999999887766 6789999999999999999999964321
Q ss_pred hhhhhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 243 QTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
+. .. ....+..+++++.+||.+||+.||.+|||+++++++
T Consensus 255 --~~-----------------~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 255 --II-----------------RG--QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp --HH-----------------HC--CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred --hh-----------------cc--cccccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 00 011234567889999999999999999999999875
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-41 Score=299.46 Aligned_cols=254 Identities=22% Similarity=0.326 Sum_probs=184.7
Q ss_pred hhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh--hHHHHHHHHHHHhccCCCcccceeeE
Q 018785 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ--GHKEWLTEVIYLGQLRHENLVKLIGY 95 (350)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~ 95 (350)
...++|++.+.||+|+||.||+| .+..+|+.||||.+...... ....+.++..+++.++||||++++++
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~---------~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 92 (318)
T 2dyl_A 22 AEINDLENLGEMGSGTCGQVWKM---------RFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92 (318)
T ss_dssp CCGGGEEEEEEC------CEEEE---------EETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred hhhccccccceeeecCCeeEEEE---------EEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEE
Confidence 34578999999999999999999 55567899999998765432 22334555567888899999999999
Q ss_pred EeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCC-CeeeCCCCCCceEEcCCCcEEEcc
Q 018785 96 CSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDA-NVIYRDLKASNVLLDSNFNAKLSD 174 (350)
Q Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~-~i~H~di~~~Nili~~~~~~~l~D 174 (350)
+...+..++||||+ ++.+..+.... ...+++..++.++.|++.||.||| ++ |++|+||+|+||+++.++.++|+|
T Consensus 93 ~~~~~~~~lv~e~~-~~~~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH--~~~~i~H~dlkp~Nil~~~~~~~kl~d 168 (318)
T 2dyl_A 93 FITNTDVFIAMELM-GTCAEKLKKRM-QGPIPERILGKMTVAIVKALYYLK--EKHGVIHRDVKPSNILLDERGQIKLCD 168 (318)
T ss_dssp EECSSEEEEEECCC-SEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHH--HHHCCCCCCCCGGGEEECTTSCEEECC
T ss_pred EecCCcEEEEEecc-CCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHH--hhCCEEeCCCCHHHEEECCCCCEEEEE
Confidence 99999999999999 65665555432 247999999999999999999999 75 999999999999999999999999
Q ss_pred ccccccCCCCCCCcccccccCCCcccCccccc-----cCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhc
Q 018785 175 FGLARDGPTGDNTHVSTRIVGTRGYAAPEYVA-----TGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWA 249 (350)
Q Consensus 175 fg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~ 249 (350)
||++....... ......+++.|+|||.+. +..++.++||||||+++|+|++|..||........
T Consensus 169 fg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-------- 237 (318)
T 2dyl_A 169 FGISGRLVDDK---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFE-------- 237 (318)
T ss_dssp CTTC-----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHH--------
T ss_pred CCCchhccCCc---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHH--------
Confidence 99986543322 122346889999999984 45788999999999999999999999975332100
Q ss_pred chhhhhhHHHHHhhhcc-cCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 250 DPFLRDSRRVLRIMDTR-LGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 250 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
......... ........+++++.+++.+||+.||.+|||+.++++|
T Consensus 238 --------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 238 --------VLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp --------HHHHHHHSCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred --------HHHHHhccCCCCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 001111111 1111123467889999999999999999999999976
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=292.27 Aligned_cols=241 Identities=16% Similarity=0.118 Sum_probs=191.9
Q ss_pred hhh-hhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh---hHHHHHHHHHHHhccCCCccc
Q 018785 15 ISK-IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ---GHKEWLTEVIYLGQLRHENLV 90 (350)
Q Consensus 15 ~~~-~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~ 90 (350)
.++ +..++|++.+.||+|+||.||+| .+..+++.||||++...... ....+.+|+..++.++||||+
T Consensus 24 ~g~~~~~~~y~i~~~lg~G~~g~Vy~a---------~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv 94 (286)
T 3uqc_A 24 PGARIANGRYRLLIFHGGVPPLQFWQA---------LDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVA 94 (286)
T ss_dssp TTCEETTTTEEEEEEEEBSTTCEEEEE---------EETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBC
T ss_pred CCCEEecCcEEEEEEEcccCCeEEEEE---------EecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcc
Confidence 444 66789999999999999999999 56667899999999766432 236788999999999999999
Q ss_pred ceeeEEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcE
Q 018785 91 KLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNA 170 (350)
Q Consensus 91 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~ 170 (350)
++++++...+..|+||||++|++|.+++... ....++..++.|++.||.||| +.|++|+||||+||+++.++.+
T Consensus 95 ~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~----~~~~~~~~i~~ql~~aL~~lH--~~givH~Dikp~NIll~~~g~~ 168 (286)
T 3uqc_A 95 RVLDVVHTRAGGLVVAEWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAH--RAGVALSIDHPSRVRVSIDGDV 168 (286)
T ss_dssp CEEEEEEETTEEEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCSGGGEEEETTSCE
T ss_pred eeeEEEEECCcEEEEEEecCCCCHHHHHhcC----CChHHHHHHHHHHHHHHHHHH--HCCCccCCCCcccEEEcCCCCE
Confidence 9999999999999999999999999998542 456678999999999999999 8999999999999999999999
Q ss_pred EEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcc
Q 018785 171 KLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD 250 (350)
Q Consensus 171 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~ 250 (350)
+|++++ |++ .++.++|||||||++|+|++|+.||.+...............
T Consensus 169 kl~~~~----------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~ 219 (286)
T 3uqc_A 169 VLAYPA----------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTA 219 (286)
T ss_dssp EECSCC----------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTT
T ss_pred EEEecc----------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhc
Confidence 997443 222 367899999999999999999999987654321110000000
Q ss_pred hhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcCCC
Q 018785 251 PFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKD 312 (350)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~ 312 (350)
...... ......+++++.++|.+||+.||.+| |+.++++.|.++.....
T Consensus 220 ~~~~~~------------~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~ 268 (286)
T 3uqc_A 220 GQPIEP------------ADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVAD 268 (286)
T ss_dssp SCBCCH------------HHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC---
T ss_pred cCCCCh------------hhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCC
Confidence 000000 01123467889999999999999999 99999999999987644
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=319.92 Aligned_cols=284 Identities=23% Similarity=0.314 Sum_probs=207.9
Q ss_pred hhhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccc-hhhHHHHHHHHHHHhccCCCccccee
Q 018785 15 ISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES-FQGHKEWLTEVIYLGQLRHENLVKLI 93 (350)
Q Consensus 15 ~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~ 93 (350)
......++|++.+.||+|+||+||+| .+..+|..||||.+.... ......+.+|+.+++.++||||++++
T Consensus 8 ~pg~~~grY~i~~~LG~G~fG~Vyla---------~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~ 78 (676)
T 3qa8_A 8 LPTQTCGPWEMKERLGTGGFGYVLRW---------IHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAR 78 (676)
T ss_dssp ---------CCCCCCCBCSSSBCCCC---------CCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEE
T ss_pred CCCCCCCCeEEEEEEeeCCCeEEEEE---------EECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCcee
Confidence 33445589999999999999999999 677789999999987653 33456688999999999999999999
Q ss_pred eEEee------cCceEEEEEcCCCCChhhHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcC
Q 018785 94 GYCSE------SDNRLLVYEFMPKGSLENHLFRKG-VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS 166 (350)
Q Consensus 94 ~~~~~------~~~~~lv~e~~~~~~L~~~l~~~~-~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~ 166 (350)
+++.. .+..++||||+++++|.+++.... ...+++..++.++.|++.||.||| +.|++|+||+|+||+++.
T Consensus 79 ~v~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLH--s~gIVHrDLKP~NILl~~ 156 (676)
T 3qa8_A 79 EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH--ENRIIHRDLKPENIVLQP 156 (676)
T ss_dssp ECCTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHH--HTTBCCCCCCSTTEEEEC
T ss_pred eeecccccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH--HCCCccCCCCHHHeEeec
Confidence 98765 677899999999999999997643 235899999999999999999999 899999999999999987
Q ss_pred CCc---EEEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchh
Q 018785 167 NFN---AKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQ 243 (350)
Q Consensus 167 ~~~---~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~ 243 (350)
++. ++|+|||++........ .....+++.|+|||.+.+..++.++||||||+++|+|++|..||..........
T Consensus 157 ~g~~~~vKL~DFG~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~ 233 (676)
T 3qa8_A 157 GPQRLIHKIIDLGYAKELDQGEL---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWH 233 (676)
T ss_dssp CSSSCEEEECSCCCCCBTTSCCC---CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSS
T ss_pred CCCceeEEEcccccccccccccc---cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhh
Confidence 765 89999999986533322 233568999999999999999999999999999999999999996532110000
Q ss_pred h-hhhhcch---hhhhhHHHHHh-hhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHH-----HHHHHHhhhcCCC
Q 018785 244 T-LVEWADP---FLRDSRRVLRI-MDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVD-----VLTSLEQLHTSKD 312 (350)
Q Consensus 244 ~-~~~~~~~---~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~-----ll~~L~~~~~~~~ 312 (350)
. +...... ........... ............+++.+.++|.+||..||.+|||+.+ +.+.+.++...+-
T Consensus 234 ~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~ki 312 (676)
T 3qa8_A 234 GKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSLKL 312 (676)
T ss_dssp TTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCCCE
T ss_pred hhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhccc
Confidence 0 0000000 00000000000 0001122345678999999999999999999999988 5566777766653
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=307.89 Aligned_cols=257 Identities=23% Similarity=0.335 Sum_probs=190.0
Q ss_pred hhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhcc-CCCcccceeeE
Q 018785 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQL-RHENLVKLIGY 95 (350)
Q Consensus 17 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~ 95 (350)
....+.|.+.++||+|+||+||.+ ...+|+.||||.+.... ...+.+|+.+++++ +||||++++++
T Consensus 11 ~~l~~~~~~~~~LG~G~~g~V~~~----------~~~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~ 77 (434)
T 2rio_A 11 QSLKNLVVSEKILGYGSSGTVVFQ----------GSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCS 77 (434)
T ss_dssp CSCSSCEEEEEEEEECSTTCEEEE----------EESSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEE
T ss_pred hhhhheeeccCeEeeCCCeEEEEE----------EEECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEE
Confidence 345677888999999999999864 12348899999886543 34567899999876 89999999999
Q ss_pred EeecCceEEEEEcCCCCChhhHHhhcCCCC-----CCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCC---
Q 018785 96 CSESDNRLLVYEFMPKGSLENHLFRKGVQP-----ISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSN--- 167 (350)
Q Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~-----l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~--- 167 (350)
+.+++..++|||++. ++|.+++....... .++..++.++.|++.||+||| +.|++|+||||+||+++.+
T Consensus 78 ~~~~~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH--~~~ivHrDLkp~NILl~~~~~~ 154 (434)
T 2rio_A 78 ETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH--SLKIIHRDLKPQNILVSTSSRF 154 (434)
T ss_dssp EECSSEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEEECCHHH
T ss_pred EecCCeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHH--HCCccccCCChHhEEEecCccc
Confidence 999999999999995 69999997654211 133356789999999999999 8999999999999999754
Q ss_pred ----------CcEEEccccccccCCCCCCCc--ccccccCCCcccCcccccc-------CCCCCccchhhHHHHHHHHHh
Q 018785 168 ----------FNAKLSDFGLARDGPTGDNTH--VSTRIVGTRGYAAPEYVAT-------GHLTPKSDVYSFGVVLLELLS 228 (350)
Q Consensus 168 ----------~~~~l~Dfg~~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~-------~~~~~~~DiwslG~ll~~ll~ 228 (350)
+.++|+|||++.......... ......|++.|+|||++.+ ..++.++|||||||++|+|++
T Consensus 155 ~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt 234 (434)
T 2rio_A 155 TADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILS 234 (434)
T ss_dssp HSCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHT
T ss_pred ccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHh
Confidence 479999999998654432211 1233568999999999865 568899999999999999998
Q ss_pred -CCCCCcccccCcchhhhhhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 229 -GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 229 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
|..||....... ..+.... .............+++++.+||.+||+.||.+|||+.++++|
T Consensus 235 ~g~~Pf~~~~~~~--~~i~~~~------------~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 296 (434)
T 2rio_A 235 KGKHPFGDKYSRE--SNIIRGI------------FSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296 (434)
T ss_dssp TSCCTTCSTTTHH--HHHHHTC------------CCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCCCCCCCchhhH--HHHhcCC------------CCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence 899996543211 0110000 000001112245788999999999999999999999999874
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=308.49 Aligned_cols=255 Identities=25% Similarity=0.350 Sum_probs=190.1
Q ss_pred hhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhcc-CCCcccceee
Q 018785 16 SKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQL-RHENLVKLIG 94 (350)
Q Consensus 16 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~ 94 (350)
..+...+|.+.++||+|+||+||.. ...+++.||||.+...... .+.+|+.+++.+ +||||+++++
T Consensus 19 ~~i~~~~y~~~~~LG~G~~G~V~~~----------~~~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~ 85 (432)
T 3p23_A 19 VIVGKISFCPKDVLGHGAEGTIVYR----------GMFDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFC 85 (432)
T ss_dssp EEETTEEEEEEEEEEECGGGCEEEE----------EESSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEE
T ss_pred EEEccEEEecCCeeecCcCEEEEEE----------EEeCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEE
Confidence 4455678999999999999996542 2234788999998765433 245789999999 7999999999
Q ss_pred EEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCC-----Cc
Q 018785 95 YCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSN-----FN 169 (350)
Q Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~-----~~ 169 (350)
++.+.+..|+|||++. ++|.+++..... .+....+..++.|++.||.||| +.|++|+||||+||+++.+ ..
T Consensus 86 ~~~~~~~~~lv~E~~~-g~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH--~~~ivHrDlKp~NIll~~~~~~~~~~ 161 (432)
T 3p23_A 86 TEKDRQFQYIAIELCA-ATLQEYVEQKDF-AHLGLEPITLLQQTTSGLAHLH--SLNIVHRDLKPHNILISMPNAHGKIK 161 (432)
T ss_dssp EEEETTEEEEEEECCS-EEHHHHHHSSSC-CCCSSCHHHHHHHHHHHHHHHH--HTTCCCCCCSTTSEEECCCBTTTBCC
T ss_pred EEecCCEEEEEEECCC-CCHHHHHHhcCC-CccchhHHHHHHHHHHHHHHHH--HCcCEeCCCCHHHEEEecCCCCCcee
Confidence 9999999999999994 699999976642 4555677899999999999999 8999999999999999532 35
Q ss_pred EEEccccccccCCCCCCC-cccccccCCCcccCccccc---cCCCCCccchhhHHHHHHHHHh-CCCCCcccccCcchhh
Q 018785 170 AKLSDFGLARDGPTGDNT-HVSTRIVGTRGYAAPEYVA---TGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQT 244 (350)
Q Consensus 170 ~~l~Dfg~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~---~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~~~~ 244 (350)
++|+|||++......... .......|++.|+|||++. +..++.++|||||||++|+|++ |..||...........
T Consensus 162 ~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~ 241 (432)
T 3p23_A 162 AMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANIL 241 (432)
T ss_dssp EEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHH
T ss_pred EEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHH
Confidence 789999999765433211 2233456899999999987 4567789999999999999999 8888854332111100
Q ss_pred hhhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 245 LVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
... ............+..+.+||.+||+.||.+|||+.++++|
T Consensus 242 ~~~----------------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h 284 (432)
T 3p23_A 242 LGA----------------CSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH 284 (432)
T ss_dssp TTC----------------CCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hcc----------------CCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence 000 0000011123567788999999999999999999999965
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=289.26 Aligned_cols=231 Identities=20% Similarity=0.290 Sum_probs=182.5
Q ss_pred hhccccc-ceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHH-hccCCCcccceeeEEe
Q 018785 20 TKNFCSD-YLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYL-GQLRHENLVKLIGYCS 97 (350)
Q Consensus 20 ~~~y~i~-~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l-~~l~h~~i~~~~~~~~ 97 (350)
.++|.+. +.||+|+||.||+| .+..+++.||+|.+... ....+|+..+ +.++||||+++++++.
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~---------~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~ 81 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQI---------FNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYE 81 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEE---------EETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred ccchhhcCcccccCCCeEEEEE---------EEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhh
Confidence 4566666 88999999999999 56667899999998643 3455777777 5568999999999988
Q ss_pred e----cCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcC---CCcE
Q 018785 98 E----SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS---NFNA 170 (350)
Q Consensus 98 ~----~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~---~~~~ 170 (350)
. ....++||||+++++|.+++.......+++..++.++.|++.||.||| +.|++|+||+|+||+++. ++.+
T Consensus 82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH--~~~i~H~dlkp~Nil~~~~~~~~~~ 159 (299)
T 3m2w_A 82 NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH--SINIAHRDVKPENLLYTSKRPNAIL 159 (299)
T ss_dssp EEETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEESSSSTTCCE
T ss_pred hhcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHHEEEecCCCCCcE
Confidence 7 678899999999999999998876667999999999999999999999 899999999999999998 7889
Q ss_pred EEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcc
Q 018785 171 KLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD 250 (350)
Q Consensus 171 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~ 250 (350)
+|+|||++.... +..++.++|||||||++|+|++|..||.................
T Consensus 160 kl~Dfg~a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~ 215 (299)
T 3m2w_A 160 KLTDFGFAKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR 215 (299)
T ss_dssp EECCCTTCEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSC
T ss_pred EEeccccccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHh
Confidence 999999885321 24467789999999999999999999976543221111100000
Q ss_pred hhhhhhHHHHHhhhcccCCCCc----HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018785 251 PFLRDSRRVLRIMDTRLGGQYS----KKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 305 (350)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~ 305 (350)
. .....+ ..+++++.+|+.+||+.||.+|||+.++++|-.
T Consensus 216 -------------~--~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~ 259 (299)
T 3m2w_A 216 -------------M--GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW 259 (299)
T ss_dssp -------------T--TCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred -------------h--ccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChh
Confidence 0 000111 346789999999999999999999999998733
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=316.02 Aligned_cols=246 Identities=21% Similarity=0.329 Sum_probs=195.7
Q ss_pred hhhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch-hhHHHHHHHHHHHhccCCCccccee
Q 018785 15 ISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLVKLI 93 (350)
Q Consensus 15 ~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~ 93 (350)
.+++..++|++.+.||+|+||+||+|++.. .+++.||||.+..... .....+.+|+.++++++||||++++
T Consensus 74 ~g~~~~~~y~i~~~lg~G~~g~Vy~a~~~~--------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~ 145 (681)
T 2pzi_A 74 PGDIVAGQYEVKGCIAHGGLGWIYLALDRN--------VNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145 (681)
T ss_dssp TTCEETTTEEEEEEEEEETTEEEEEEEEGG--------GTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEE
T ss_pred CCCEeCCceEEEEEEeeCCCeEEEEEEEcC--------CCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEe
Confidence 345667899999999999999999994421 1578999998865432 3345678999999999999999999
Q ss_pred eEEeecCc-----eEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCC
Q 018785 94 GYCSESDN-----RLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNF 168 (350)
Q Consensus 94 ~~~~~~~~-----~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~ 168 (350)
+++...+. .|+||||++|++|.+++.. .+++..++.++.|++.||.||| +.||+|+||||+||+++.+
T Consensus 146 ~~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH--~~giiHrDlkp~NIll~~~- 218 (681)
T 2pzi_A 146 NFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLH--SIGLVYNDLKPENIMLTEE- 218 (681)
T ss_dssp EEEEEECTTSCEEEEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECSS-
T ss_pred eeEeecCCCCCceeEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHH--HCCCeecccChHHeEEeCC-
Confidence 99988766 7999999999999987644 5899999999999999999999 8999999999999999875
Q ss_pred cEEEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhh
Q 018785 169 NAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEW 248 (350)
Q Consensus 169 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~ 248 (350)
.++|+|||++...... ....|++.|+|||++.+.. +.++||||||+++|+|++|..||.+.......
T Consensus 219 ~~kl~DFG~a~~~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~------ 285 (681)
T 2pzi_A 219 QLKLIDLGAVSRINSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGLP------ 285 (681)
T ss_dssp CEEECCCTTCEETTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSCC------
T ss_pred cEEEEecccchhcccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccccc------
Confidence 8999999999764332 3356899999999886654 88999999999999999999888653321110
Q ss_pred cchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCC-HHHHHHHHHhh
Q 018785 249 ADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPS-MVDVLTSLEQL 307 (350)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-~~~ll~~L~~~ 307 (350)
........++.+.++|.+||+.||.+||+ .+++.+.|..+
T Consensus 286 -------------------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 286 -------------------EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp -------------------TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred -------------------ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 00011234578999999999999999995 55565655544
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=300.84 Aligned_cols=243 Identities=17% Similarity=0.222 Sum_probs=182.8
Q ss_pred hhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh---hHHHHHHHHHHHhccCC-Cc-------
Q 018785 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ---GHKEWLTEVIYLGQLRH-EN------- 88 (350)
Q Consensus 20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h-~~------- 88 (350)
..+|.+.++||+|+||+||+| .+..+|+.||||++...... ..+.+.+|+..++.+.| ++
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a---------~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~ 147 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEA---------TDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVH 147 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEE---------EETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHH
T ss_pred ceeEEEecccccCCCEEEEEE---------EecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHh
Confidence 346889999999999999999 56667899999998743322 24668899999999876 21
Q ss_pred --ccceeeE------------Eee-----cCceEEEEEcCCCCChhhHHh-----hcCCCCCCHHHHHHHHHHHHHHHHH
Q 018785 89 --LVKLIGY------------CSE-----SDNRLLVYEFMPKGSLENHLF-----RKGVQPISWPTRVKIAIDVARGLSF 144 (350)
Q Consensus 89 --i~~~~~~------------~~~-----~~~~~lv~e~~~~~~L~~~l~-----~~~~~~l~~~~~~~i~~ql~~al~~ 144 (350)
++...+. +.. ....+++|+.. +++|.+++. ......+++..++.++.|++.||+|
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~ 226 (413)
T 3dzo_A 148 LRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLAS 226 (413)
T ss_dssp TCBCCCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHH
T ss_pred cccccchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHH
Confidence 1111111 111 22456777766 789999885 2223357788899999999999999
Q ss_pred hhcCCCCeeeCCCCCCceEEcCCCcEEEccccccccCCCCCCCcccccccCCCcccCcccc----------ccCCCCCcc
Q 018785 145 LHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYV----------ATGHLTPKS 214 (350)
Q Consensus 145 lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~----------~~~~~~~~~ 214 (350)
|| +.||+||||||+||+++.++.++|+|||++...... .....| +.|+|||++ .+..++.++
T Consensus 227 LH--~~~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~ 298 (413)
T 3dzo_A 227 LH--HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAF 298 (413)
T ss_dssp HH--HTTEECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHH
T ss_pred HH--hCCcccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchh
Confidence 99 899999999999999999999999999998753222 233456 899999998 555688899
Q ss_pred chhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCC
Q 018785 215 DVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNR 294 (350)
Q Consensus 215 DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R 294 (350)
|||||||++|+|++|+.||...........+. . ....+++.+.+||.+||+.||.+|
T Consensus 299 DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~-----------------~------~~~~~~~~~~~li~~~l~~dP~~R 355 (413)
T 3dzo_A 299 DTWTLGLAIYWIWCADLPNTDDAALGGSEWIF-----------------R------SCKNIPQPVRALLEGFLRYPKEDR 355 (413)
T ss_dssp HHHHHHHHHHHHHHSSCCCCTTGGGSCSGGGG-----------------S------SCCCCCHHHHHHHHHHTCSSGGGS
T ss_pred hHHHHHHHHHHHHHCCCCCCCcchhhhHHHHH-----------------h------hcccCCHHHHHHHHHHccCChhhC
Confidence 99999999999999999997654322211111 0 011356789999999999999999
Q ss_pred CCHHHHHHH
Q 018785 295 PSMVDVLTS 303 (350)
Q Consensus 295 ps~~~ll~~ 303 (350)
||+.+++++
T Consensus 356 pt~~~~l~~ 364 (413)
T 3dzo_A 356 LLPLQAMET 364 (413)
T ss_dssp CCHHHHTTS
T ss_pred cCHHHHHhC
Confidence 997777654
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=285.15 Aligned_cols=246 Identities=20% Similarity=0.185 Sum_probs=184.6
Q ss_pred hhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch--------hhHHHHHHHHHHHhccC---
Q 018785 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--------QGHKEWLTEVIYLGQLR--- 85 (350)
Q Consensus 17 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~e~~~l~~l~--- 85 (350)
....++|++.+.||+|+||+||+|++ +|+.||||++..... .....+.+|+.+++.++
T Consensus 16 ~~~~~~y~~~~~lG~G~~g~V~~~~~-----------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~ 84 (336)
T 2vuw_A 16 CLPTEKLQRCEKIGEGVFGEVFQTIA-----------DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLS 84 (336)
T ss_dssp HSCHHHHHTCEEEEEETTEEEEEEEE-----------TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGG
T ss_pred hcccccchheeeecccCceEEEEEEe-----------CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhh
Confidence 35578999999999999999999943 478999999976532 22366788888888875
Q ss_pred ------CCcccceee-----------------EEee-------------cCceEEEEEcCCCCChhhHHhhcCCCCCCHH
Q 018785 86 ------HENLVKLIG-----------------YCSE-------------SDNRLLVYEFMPKGSLENHLFRKGVQPISWP 129 (350)
Q Consensus 86 ------h~~i~~~~~-----------------~~~~-------------~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~ 129 (350)
||||+++.+ ++.+ .+..++||||+++|++.+.+.. ..+++.
T Consensus 85 ~~~~~~h~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~ 161 (336)
T 2vuw_A 85 GEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLA 161 (336)
T ss_dssp GCSSSBCCCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHH
T ss_pred ccccccCCchhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHH
Confidence 555555554 4443 6889999999999977776644 368999
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCC--------------------cEEEccccccccCCCCCCCcc
Q 018785 130 TRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNF--------------------NAKLSDFGLARDGPTGDNTHV 189 (350)
Q Consensus 130 ~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~--------------------~~~l~Dfg~~~~~~~~~~~~~ 189 (350)
.++.++.||+.||.|||+ +.||+||||||+|||++.++ .++|+|||++.....
T Consensus 162 ~~~~i~~qi~~aL~~lH~-~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~------ 234 (336)
T 2vuw_A 162 TAKSILHQLTASLAVAEA-SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD------ 234 (336)
T ss_dssp HHHHHHHHHHHHHHHHHH-HHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET------
T ss_pred HHHHHHHHHHHHHHHHHH-hCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC------
Confidence 999999999999999993 37999999999999999887 899999999975432
Q ss_pred cccccCCCcccCccccccCCCCCccchhhHHHH-HHHHHhCCCCCcccccCcchhhhhhhcchhhhhhHHHHHh--hhcc
Q 018785 190 STRIVGTRGYAAPEYVATGHLTPKSDVYSFGVV-LLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRI--MDTR 266 (350)
Q Consensus 190 ~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~l-l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 266 (350)
....|++.|+|||++.+.. +.++||||||++ .++++.|..||...... ..+ ....... ....
T Consensus 235 -~~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~---~~~----------~~~~~~~~~~~~~ 299 (336)
T 2vuw_A 235 -GIVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWL---HYL----------TDKMLKQMTFKTK 299 (336)
T ss_dssp -TEEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHH---HHH----------HHHHHHTCCCSSC
T ss_pred -CcEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhh---hHH----------HHhhhhhhccCcc
Confidence 1346899999999998776 889999998777 77788899888532100 000 0000000 0111
Q ss_pred cCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHH-HH
Q 018785 267 LGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL-TS 303 (350)
Q Consensus 267 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll-~~ 303 (350)
........+++++.+||.+||+.| |+++++ +|
T Consensus 300 ~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~H 332 (336)
T 2vuw_A 300 CNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQH 332 (336)
T ss_dssp CCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHC
T ss_pred cchhhhhhcCHHHHHHHHHHhccC-----CHHHHHhcC
Confidence 111224578999999999999976 999998 64
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=5.4e-31 Score=252.83 Aligned_cols=171 Identities=20% Similarity=0.123 Sum_probs=128.1
Q ss_pred CCCcEEEEEEccccc----------hhhHHHHHHHHHHHhcc-CCCcccceeeEEeecCceEEEEEcCCCCChhhHHhhc
Q 018785 53 GSGIVVAIKRLKAES----------FQGHKEWLTEVIYLGQL-RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRK 121 (350)
Q Consensus 53 ~~~~~vaiK~~~~~~----------~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 121 (350)
..|+.+++|.+.... ....+.+.+|+++|+++ .|+||+++++++++++.+||||||++|++|.+++...
T Consensus 257 ~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~~ 336 (569)
T 4azs_A 257 FFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAAG 336 (569)
T ss_dssp EECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHTT
T ss_pred cccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHhC
Confidence 357889999986542 12335689999999999 6999999999999999999999999999999999876
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccccccCCCCCCCcccccccCCCcccC
Q 018785 122 GVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAA 201 (350)
Q Consensus 122 ~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~a 201 (350)
+ +++.. .|+.||+.||+|+| ++||+||||||+|||++.+|.+||+|||+++...... .......||+.|+|
T Consensus 337 ~--~l~~~---~I~~QIl~AL~ylH--~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~--~~~~t~vGTp~YmA 407 (569)
T 4azs_A 337 E--EIDRE---KILGSLLRSLAALE--KQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC--SWPTNLVQSFFVFV 407 (569)
T ss_dssp C--CCCHH---HHHHHHHHHHHHHH--HTTCEESCCCGGGEEECTTSCEEECCCTTEESCC-----CCSHHHHHHHHHHH
T ss_pred C--CCCHH---HHHHHHHHHHHHHH--HCCceeccCchHhEEECCCCCEEEeecccCeeCCCCC--ccccCceechhhcc
Confidence 5 56654 57899999999999 9999999999999999999999999999997643322 22344679999999
Q ss_pred ccccccCCCCCccchhhHHHHHHHHHhCCCCC
Q 018785 202 PEYVATGHLTPKSDVYSFGVVLLELLSGRRAL 233 (350)
Q Consensus 202 PE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf 233 (350)
||++.+. +..++|+|++|++++.+.++..++
T Consensus 408 PE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 408 NELFAEN-KSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp HHHC------------------CCCCTTHHHH
T ss_pred HHHhCCC-CCCcccccccccchhhhccccchh
Confidence 9998654 567899999999998887765543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2e-26 Score=219.94 Aligned_cols=185 Identities=17% Similarity=0.220 Sum_probs=140.9
Q ss_pred cccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh--------hHHHHHHHHHHHhccCCCcccceeeE
Q 018785 24 CSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ--------GHKEWLTEVIYLGQLRHENLVKLIGY 95 (350)
Q Consensus 24 ~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--------~~~~~~~e~~~l~~l~h~~i~~~~~~ 95 (350)
...++||+|+||.||+|.+. +..+++|........ ..+.+.+|+.++++++||||+++..+
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~~-----------~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~ 407 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSYL-----------DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIF 407 (540)
T ss_dssp ---------CCEEEEEEECS-----------SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEE
T ss_pred CCCCEEeeCCCEEEEEEEEC-----------CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEE
Confidence 34568999999999998432 567888875433211 13457899999999999999966666
Q ss_pred EeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccc
Q 018785 96 CSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDF 175 (350)
Q Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Df 175 (350)
+...+..++||||+++++|.+++.. +..++.|++++|.||| ++|++|+||||+||+++. .++|+||
T Consensus 408 ~~~~~~~~lVmE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH--~~gIiHrDiKp~NILl~~--~~kL~DF 473 (540)
T 3en9_A 408 DVDLDNKRIMMSYINGKLAKDVIED----------NLDIAYKIGEIVGKLH--KNDVIHNDLTTSNFIFDK--DLYIIDF 473 (540)
T ss_dssp EEETTTTEEEEECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHH--HTTEECTTCCTTSEEESS--SEEECCC
T ss_pred EEeCCccEEEEECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHH--HCcCccCCCCHHHEEECC--eEEEEEC
Confidence 6677888999999999999999865 5689999999999999 899999999999999998 9999999
Q ss_pred cccccCCCCCCCc-----ccccccCCCcccCcccccc--CCCCCccchhhHHHHHHHHHhCCCCC
Q 018785 176 GLARDGPTGDNTH-----VSTRIVGTRGYAAPEYVAT--GHLTPKSDVYSFGVVLLELLSGRRAL 233 (350)
Q Consensus 176 g~~~~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~--~~~~~~~DiwslG~ll~~ll~g~~pf 233 (350)
|++.......... ......||+.|+|||++.+ ..|+...|+|+..+-..+-+.++.+|
T Consensus 474 Gla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 474 GLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp TTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred ccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 9998653321111 1134678999999999976 56788889999988888777776654
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=8e-24 Score=185.84 Aligned_cols=146 Identities=15% Similarity=0.091 Sum_probs=115.7
Q ss_pred hhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch------------------hhHHHHHHHHHHH
Q 018785 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF------------------QGHKEWLTEVIYL 81 (350)
Q Consensus 20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~------------------~~~~~~~~e~~~l 81 (350)
+..|.+.+.||+|++|.||+| .+ .+|+.||+|.+..... .....+.+|+.++
T Consensus 89 ~~~~~~~~~iG~G~~g~Vy~~---------~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l 158 (282)
T 1zar_A 89 GKVDAIGKLMGEGKESAVFNC---------YS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRAL 158 (282)
T ss_dssp TSCSEEEEEEEECSSEEEEEE---------EE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHH
T ss_pred CeEEEecCEeccCCCceEEEE---------Ee-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHH
Confidence 334556699999999999999 44 5688999999865322 1245678999999
Q ss_pred hccCCCcccceeeEEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCc
Q 018785 82 GQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASN 161 (350)
Q Consensus 82 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~N 161 (350)
+.++ | +++.+++.. +..++||||++|++|.+ +. . .....++.|++.||.+|| +.|++|+||||+|
T Consensus 159 ~~l~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~------~--~~~~~i~~qi~~~l~~lH--~~giiHrDlkp~N 223 (282)
T 1zar_A 159 QKLQ--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VR------V--ENPDEVLDMILEEVAKFY--HRGIVHGDLSQYN 223 (282)
T ss_dssp HHTT--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CC------C--SCHHHHHHHHHHHHHHHH--HTTEECSCCSTTS
T ss_pred Hhcc--C-CCcCeEEec-cceEEEEEecCCCcHHH-cc------h--hhHHHHHHHHHHHHHHHH--HCCCEeCCCCHHH
Confidence 9998 4 666665544 56799999999999998 42 1 235579999999999999 9999999999999
Q ss_pred eEEcCCCcEEEccccccccCCCCCCCcccccccCCCcccCccccc
Q 018785 162 VLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVA 206 (350)
Q Consensus 162 ili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 206 (350)
|+++ ++.++|+|||++.. +..+.|||.+.
T Consensus 224 ILl~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~ 252 (282)
T 1zar_A 224 VLVS-EEGIWIIDFPQSVE---------------VGEEGWREILE 252 (282)
T ss_dssp EEEE-TTEEEECCCTTCEE---------------TTSTTHHHHHH
T ss_pred EEEE-CCcEEEEECCCCeE---------------CCCCCHHHHHH
Confidence 9999 99999999999963 23367888763
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=1.5e-19 Score=156.67 Aligned_cols=138 Identities=18% Similarity=0.109 Sum_probs=104.8
Q ss_pred cccccceecccCceeEEeecccCCCcCCCCCCCCcE--EEEEEccccchh------------------------hHHHHH
Q 018785 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIV--VAIKRLKAESFQ------------------------GHKEWL 75 (350)
Q Consensus 22 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~--vaiK~~~~~~~~------------------------~~~~~~ 75 (350)
-|.+.+.||+|++|.||+|++ ..+|+. ||||++...... ....+.
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~---------~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 118 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADG---------VFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTE 118 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEE---------EETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEE---------cCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHH
Confidence 477899999999999999943 345778 999987543211 113577
Q ss_pred HHHHHHhccCCCcc--cceeeEEeecCceEEEEEcCCC-C----ChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcC
Q 018785 76 TEVIYLGQLRHENL--VKLIGYCSESDNRLLVYEFMPK-G----SLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL 148 (350)
Q Consensus 76 ~e~~~l~~l~h~~i--~~~~~~~~~~~~~~lv~e~~~~-~----~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~ 148 (350)
.|+..++.+.|+++ ..+++. +..++||||+.+ | +|.++... .++..+..++.|++.+|.+||.
T Consensus 119 ~E~~~l~~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~- 188 (258)
T 1zth_A 119 KEFRNLERAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQ- 188 (258)
T ss_dssp HHHHHHHHHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHH-
T ss_pred HHHHHHHHHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHH-
Confidence 89999999987764 333332 367899999932 3 67665432 2345688999999999999994
Q ss_pred CCCeeeCCCCCCceEEcCCCcEEEcccccccc
Q 018785 149 DANVIYRDLKASNVLLDSNFNAKLSDFGLARD 180 (350)
Q Consensus 149 ~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~~ 180 (350)
+.|++|+||||.|||++. .++|+|||++..
T Consensus 189 ~~givHrDlkp~NILl~~--~~~liDFG~a~~ 218 (258)
T 1zth_A 189 EAELVHADLSEYNIMYID--KVYFIDMGQAVT 218 (258)
T ss_dssp TSCEECSSCSTTSEEESS--SEEECCCTTCEE
T ss_pred HCCEEeCCCCHHHEEEcC--cEEEEECccccc
Confidence 479999999999999988 899999999964
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.69 E-value=8.9e-18 Score=151.58 Aligned_cols=136 Identities=12% Similarity=0.102 Sum_probs=97.9
Q ss_pred ccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh--------------hHH--------HHHHHHHH
Q 018785 23 FCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ--------------GHK--------EWLTEVIY 80 (350)
Q Consensus 23 y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--------------~~~--------~~~~e~~~ 80 (350)
|++.+.||.|++|.||+|. + .+|+.||||+++..... ... ....|...
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~---------d-~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~n 166 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVA---------D-EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAF 166 (397)
T ss_dssp SEEEEEEEECSSEEEEEEE---------C-TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHH
T ss_pred EEecCEeeeCCceEEEEEE---------C-CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHH
Confidence 8999999999999999993 3 35889999987532100 001 12346666
Q ss_pred HhccCCCcccceeeEEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCC
Q 018785 81 LGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKAS 160 (350)
Q Consensus 81 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~ 160 (350)
|.++.+.++....-+.. ...++||||++|.+|.++.. ......++.|++.+|.+|| +.|++||||||.
T Consensus 167 L~rL~~~gv~vp~p~~~--~~~~LVME~i~G~~L~~l~~--------~~~~~~l~~qll~~l~~lH--~~gIVHrDLKp~ 234 (397)
T 4gyi_A 167 MKALYEEGFPVPEPIAQ--SRHTIVMSLVDALPMRQVSS--------VPDPASLYADLIALILRLA--KHGLIHGDFNEF 234 (397)
T ss_dssp HHHHHHTTCSCCCEEEE--ETTEEEEECCSCEEGGGCCC--------CSCHHHHHHHHHHHHHHHH--HTTEECSCCSTT
T ss_pred HHHHHhcCCCCCeeeec--cCceEEEEecCCccHhhhcc--------cHHHHHHHHHHHHHHHHHH--HCCCcCCCCCHH
Confidence 66664444332221211 22379999999888866431 2245678899999999999 899999999999
Q ss_pred ceEEcCCC----------cEEEcccccccc
Q 018785 161 NVLLDSNF----------NAKLSDFGLARD 180 (350)
Q Consensus 161 Nili~~~~----------~~~l~Dfg~~~~ 180 (350)
|||++.++ .+.++||+.+..
T Consensus 235 NILl~~dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 235 NILIREEKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp SEEEEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred HEEEeCCCCcccccccccceEEEEeCCccc
Confidence 99998776 389999998864
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.43 E-value=4.3e-13 Score=116.10 Aligned_cols=141 Identities=13% Similarity=-0.007 Sum_probs=109.6
Q ss_pred hcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccC-CCcccceeeEEeec
Q 018785 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLR-HENLVKLIGYCSES 99 (350)
Q Consensus 21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~ 99 (350)
..|++...++.|+.+.||++. .. +..+++|............+.+|+..++.+. +..+.++++++...
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~---------~~--~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~ 82 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLV---------GE--NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHD 82 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEE---------CS--SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEET
T ss_pred ccceeEeeccCCCCCeEEEEE---------CC--CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecC
Confidence 469999999999999999983 22 5689999887532223345778999998884 67788899999988
Q ss_pred CceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCC------------------------------
Q 018785 100 DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLD------------------------------ 149 (350)
Q Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~------------------------------ 149 (350)
+..|+|||+++|.+|.+.+. +......++.+++++|..||+..
T Consensus 83 ~~~~lv~e~i~G~~l~~~~~-------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (263)
T 3tm0_A 83 GWSNLLMSEADGVLCSEEYE-------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDC 155 (263)
T ss_dssp TEEEEEEECCSSEEHHHHCC-------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSG
T ss_pred CceEEEEEecCCeehhhccC-------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccc
Confidence 89999999999999987631 12234577889999999999410
Q ss_pred ---------------------------CCeeeCCCCCCceEEcCCCcEEEccccccc
Q 018785 150 ---------------------------ANVIYRDLKASNVLLDSNFNAKLSDFGLAR 179 (350)
Q Consensus 150 ---------------------------~~i~H~di~~~Nili~~~~~~~l~Dfg~~~ 179 (350)
..++|+|+++.||+++.++.+.|+||+.+.
T Consensus 156 ~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 156 ENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp GGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 458999999999999876556799998774
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.21 E-value=3.3e-11 Score=103.82 Aligned_cols=136 Identities=16% Similarity=0.081 Sum_probs=96.4
Q ss_pred hcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCc--ccceeeEEee
Q 018785 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHEN--LVKLIGYCSE 98 (350)
Q Consensus 21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~~~~ 98 (350)
..|.+..+.+.|..+.||++.. .+|..+++|...... ...+..|+..++.+.+.+ +.+++++...
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~----------~~g~~~vlK~~~~~~---~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~ 86 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSA----------QGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTE 86 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEEC----------TTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEEC
T ss_pred CCCceEecccCCCCceEEEEec----------CCCCeEEEEeCCccc---chhhhHHHHHHHHHHhCCCCCCeEEEeccC
Confidence 3466655545666789999732 245678999876542 234667888888885333 5668888888
Q ss_pred cCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCC-----------------------------
Q 018785 99 SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLD----------------------------- 149 (350)
Q Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~----------------------------- 149 (350)
++..++|||+++|.++. .. ..+ ...++.+++..|..||+..
T Consensus 87 ~~~~~~v~e~i~G~~l~--~~-----~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (264)
T 1nd4_A 87 AGRDWLLLGEVPGQDLL--SS-----HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQD 156 (264)
T ss_dssp SSCEEEEEECCSSEETT--TS-----CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTT
T ss_pred CCCCEEEEEecCCcccC--cC-----cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccch
Confidence 88899999999998884 21 112 2356677888888888321
Q ss_pred ---------------------------CCeeeCCCCCCceEEcCCCcEEEccccccc
Q 018785 150 ---------------------------ANVIYRDLKASNVLLDSNFNAKLSDFGLAR 179 (350)
Q Consensus 150 ---------------------------~~i~H~di~~~Nili~~~~~~~l~Dfg~~~ 179 (350)
.+++|+|++|.||+++.++.+.|+||+.+.
T Consensus 157 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 157 DLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp SCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 129999999999999876556799999875
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.14 E-value=2.8e-10 Score=103.06 Aligned_cols=142 Identities=15% Similarity=0.185 Sum_probs=104.0
Q ss_pred cccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEcc--ccc-hhhHHHHHHHHHHHhccC--CCcccceeeEEee
Q 018785 24 CSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLK--AES-FQGHKEWLTEVIYLGQLR--HENLVKLIGYCSE 98 (350)
Q Consensus 24 ~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~--~~~-~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~ 98 (350)
...+.|+.|.++.||++... +..+++|... ... ......+.+|+.+++.+. +..+.+++.++.+
T Consensus 41 ~~~~~l~~G~sn~~y~v~~~-----------~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~ 109 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVTP-----------GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCED 109 (359)
T ss_dssp CEEEECCC-CCSCEEEEECS-----------SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECC
T ss_pred ceEEEcCCcccceEEEEEEC-----------CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCC
Confidence 34567899999999998321 3568888776 332 122356778999999886 4567888888876
Q ss_pred c---CceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcC---------------------------
Q 018785 99 S---DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL--------------------------- 148 (350)
Q Consensus 99 ~---~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~--------------------------- 148 (350)
. +..|+|||+++|.++.+... ..++..+...++.+++.+|+.||+.
T Consensus 110 ~~~~g~~~~vme~v~G~~l~~~~~----~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 185 (359)
T 3dxp_A 110 ESVIGRAFYIMEFVSGRVLWDQSL----PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQ 185 (359)
T ss_dssp TTTTSSCEEEEECCCCBCCCCTTC----TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHH
T ss_pred CCccCCeEEEEEecCCeecCCCcc----ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHH
Confidence 6 45899999999888755221 2467888889999999999999942
Q ss_pred -----------------------------CCCeeeCCCCCCceEEcCCCc--EEEcccccccc
Q 018785 149 -----------------------------DANVIYRDLKASNVLLDSNFN--AKLSDFGLARD 180 (350)
Q Consensus 149 -----------------------------~~~i~H~di~~~Nili~~~~~--~~l~Dfg~~~~ 180 (350)
...++|+|+++.||+++.++. +.++||+.+..
T Consensus 186 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 186 YKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 157899999999999987753 68999998864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.10 E-value=1.1e-10 Score=103.19 Aligned_cols=185 Identities=19% Similarity=0.199 Sum_probs=119.3
Q ss_pred cceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhcc-CCCc--ccceeeEEeecC--
Q 018785 26 DYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQL-RHEN--LVKLIGYCSESD-- 100 (350)
Q Consensus 26 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~--i~~~~~~~~~~~-- 100 (350)
.+.++.|....||++ +..+++|+.... .....+..|...++.+ .+.. +.+++......+
T Consensus 25 i~~~~~G~~n~v~~v--------------~~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~ 88 (304)
T 3sg8_A 25 IEISGEGNDCIAYEI--------------NRDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETY 88 (304)
T ss_dssp CCEEEECSSEEEEES--------------TTSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSC
T ss_pred eEecCCCCcceEEEE--------------CCEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCC
Confidence 456899999999997 245888986533 3346688899999887 3332 334444433333
Q ss_pred -ceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcC-------------------------------
Q 018785 101 -NRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL------------------------------- 148 (350)
Q Consensus 101 -~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~------------------------------- 148 (350)
..|+||++++|.++.+.... .++..+...++.+++..++.||+.
T Consensus 89 ~~~~~vm~~i~G~~l~~~~~~----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (304)
T 3sg8_A 89 QMSFAGFTKIKGVPLTPLLLN----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRE 164 (304)
T ss_dssp SCSCEEEECCCCEECCHHHHH----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTT
T ss_pred CcceEEEcccCCeECCccccc----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhccc
Confidence 34899999999888764432 467777778888888888888731
Q ss_pred -------------------------CCCeeeCCCCCCceEEcC--CCcEEEccccccccCCCCCCCcccccccCCCcccC
Q 018785 149 -------------------------DANVIYRDLKASNVLLDS--NFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAA 201 (350)
Q Consensus 149 -------------------------~~~i~H~di~~~Nili~~--~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~a 201 (350)
...++|+|+++.||+++. .+.+.++||+.+........ .........-..
T Consensus 165 ~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~D---l~~~~~~~~~~~ 241 (304)
T 3sg8_A 165 LKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDND---FISLMEDDEEYG 241 (304)
T ss_dssp SCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHH---HHTTCCTTTSCC
T ss_pred CCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHH---HHHHHhhccccC
Confidence 134799999999999988 45578999998865322110 000000000012
Q ss_pred cccccc-----CC---------CCCccchhhHHHHHHHHHhCCCCC
Q 018785 202 PEYVAT-----GH---------LTPKSDVYSFGVVLLELLSGRRAL 233 (350)
Q Consensus 202 PE~~~~-----~~---------~~~~~DiwslG~ll~~ll~g~~pf 233 (350)
|+.... .. .....+.|++|.++|.+.+|..+|
T Consensus 242 ~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 242 MEFVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 222110 01 112358999999999999998765
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.75 E-value=8.7e-08 Score=82.86 Aligned_cols=133 Identities=18% Similarity=0.133 Sum_probs=94.4
Q ss_pred ecccCce-eEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccC-CCcccceeeEEeecCceEEEE
Q 018785 29 LGEGGFG-CVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLR-HENLVKLIGYCSESDNRLLVY 106 (350)
Q Consensus 29 lg~G~~g-~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~ 106 (350)
+..|..+ .||+. .....+..+++|.-... ....+..|...|+.+. +-.+.+++.++.+.+..|+||
T Consensus 32 ~~~G~S~~~v~rl---------~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvm 99 (272)
T 4gkh_A 32 DNVGQSGATIYRL---------YGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLT 99 (272)
T ss_dssp EECSSSSCEEEEE---------ECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred ccCCCcCCeEEEE---------EecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEE
Confidence 4455555 68886 34444667889976543 3456778999888884 444778888888889999999
Q ss_pred EcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcC--------------------------------------
Q 018785 107 EFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL-------------------------------------- 148 (350)
Q Consensus 107 e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~-------------------------------------- 148 (350)
++++|.++.+..... ......++.++...|..||+.
T Consensus 100 e~l~G~~~~~~~~~~------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (272)
T 4gkh_A 100 TAIPGKTAFQVLEEY------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNG 173 (272)
T ss_dssp ECCCSEEHHHHHHHC------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTT
T ss_pred EeeCCccccccccCC------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccc
Confidence 999998887765432 123344556666666666621
Q ss_pred ------------------CCCeeeCCCCCCceEEcCCCcEEEccccccc
Q 018785 149 ------------------DANVIYRDLKASNVLLDSNFNAKLSDFGLAR 179 (350)
Q Consensus 149 ------------------~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~ 179 (350)
...++|+|+++.||+++.++.+-|+||+.+.
T Consensus 174 ~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 174 WPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp CCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred hHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 0115899999999999887767799998885
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.64 E-value=3.3e-07 Score=80.82 Aligned_cols=135 Identities=19% Similarity=0.135 Sum_probs=91.2
Q ss_pred cceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCC---cccceeeEEe-ecCc
Q 018785 26 DYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHE---NLVKLIGYCS-ESDN 101 (350)
Q Consensus 26 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~---~i~~~~~~~~-~~~~ 101 (350)
.+.++.|....||+. |..+++|+-.. ......+..|...++.+.+. .+.+++.+.. ..+.
T Consensus 24 v~~l~~G~~n~v~~v--------------g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~ 87 (306)
T 3tdw_A 24 VESLGEGFRNYAILV--------------NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGN 87 (306)
T ss_dssp EEEEEECSSEEEEEE--------------TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSC
T ss_pred eeecCCCcceeEEEE--------------CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCc
Confidence 456788888899987 45688887432 23346688999999998642 3556666664 4456
Q ss_pred eEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcC---------------------------------
Q 018785 102 RLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL--------------------------------- 148 (350)
Q Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~--------------------------------- 148 (350)
.++||++++|.++.+.... .++..+...++.++...|..||+.
T Consensus 88 ~~~v~e~i~G~~l~~~~~~----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~ 163 (306)
T 3tdw_A 88 PFVGYRKVQGQILGEDGMA----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPL 163 (306)
T ss_dssp EEEEEECCCSEECHHHHHT----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGG
T ss_pred eEEEEeccCCeECchhhhh----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccc
Confidence 7899999999888763211 234444444444444444444421
Q ss_pred -------------------------CCCeeeCCCCCCceEEcC---CCc-EEEcccccccc
Q 018785 149 -------------------------DANVIYRDLKASNVLLDS---NFN-AKLSDFGLARD 180 (350)
Q Consensus 149 -------------------------~~~i~H~di~~~Nili~~---~~~-~~l~Dfg~~~~ 180 (350)
...++|+|+++.||+++. ++. +.|+||+.+..
T Consensus 164 l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 164 LDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp SCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred cchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 345699999999999987 455 47999998864
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.28 E-value=2.4e-06 Score=76.89 Aligned_cols=89 Identities=2% Similarity=-0.127 Sum_probs=54.4
Q ss_pred cccee-cccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccc---hhhHHHHHHHHHHHhccC-C--CcccceeeEEe
Q 018785 25 SDYLL-GEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES---FQGHKEWLTEVIYLGQLR-H--ENLVKLIGYCS 97 (350)
Q Consensus 25 i~~~l-g~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~-h--~~i~~~~~~~~ 97 (350)
..+.| +.|....+|+....... .....+..+++|...... ......+..|+..++.+. + -.+.+++.+..
T Consensus 24 ~~~~l~~~G~~n~~y~v~~~~~~---~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~ 100 (357)
T 3ats_A 24 VESGVDSTGMSSETIILTARWQQ---DGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIET 100 (357)
T ss_dssp EEEEECTTSSEEEEEEEEEEEEE---TTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEEC
T ss_pred EEEECCCCCccceEEEEEEeccc---CCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEcc
Confidence 34677 88888999987432000 000015678889865433 101234567777777773 2 35677777766
Q ss_pred ec---CceEEEEEcCCCCChhh
Q 018785 98 ES---DNRLLVYEFMPKGSLEN 116 (350)
Q Consensus 98 ~~---~~~~lv~e~~~~~~L~~ 116 (350)
+. +..|+|||+++|.++.+
T Consensus 101 ~~~~~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 101 TGDVLGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp SSTTTSSCEEEEECCCCBCCCB
T ss_pred CCCccCCceEEEEecCCCChhh
Confidence 54 35689999998877653
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=98.15 E-value=1.6e-05 Score=65.07 Aligned_cols=138 Identities=14% Similarity=0.052 Sum_probs=93.3
Q ss_pred CChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccccccCCCCCCCcccc
Q 018785 112 GSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVST 191 (350)
Q Consensus 112 ~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~ 191 (350)
.+|.+.+...+ .+++++++|.++.|.+.+|..+-. .+.-...=+.|..|++..+|.|.+.+ ..+.
T Consensus 33 vSL~eIL~~~~-~PlsEEqaWALc~Qc~~~L~~~~~-~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------ 97 (229)
T 2yle_A 33 LSLEEILRLYN-QPINEEQAWAVCYQCCGSLRAAAR-RRQPRHRVRSAAQIRVWRDGAVTLAP-AADD------------ 97 (229)
T ss_dssp EEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCSGGGEEEETTSCEEECC-C---------------
T ss_pred ccHHHHHHHcC-CCcCHHHHHHHHHHHHHHHHhhhh-cccCCceecCCcceEEecCCceeccc-cccc------------
Confidence 37899887766 489999999999999999887621 12212344467999999999998864 1110
Q ss_pred cccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhHHHHHhhhcccCCCC
Q 018785 192 RIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQY 271 (350)
Q Consensus 192 ~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (350)
.....+.|||.. ....+.+.=|||||+++|.-+--..|-. .
T Consensus 98 --~~~~~~~~pe~~-~~~~te~~~IysLG~tLY~ALDygL~e~------------------------------------e 138 (229)
T 2yle_A 98 --AGEPPPVAGKLG-YSQCMETEVIESLGIIIYKALDYGLKEN------------------------------------E 138 (229)
T ss_dssp -----------CCS-SSSSCHHHHHHHHHHHHHHHHTTTCCTT------------------------------------E
T ss_pred --ccccCCCChhhc-cccchHHHHHHHHHHHHHHHhhcCCCcc------------------------------------c
Confidence 012236788865 2345577889999999999998766422 2
Q ss_pred cHHHHHHHHHHHHHhhcc-------------------------CCCCCCCHHHHHHH
Q 018785 272 SKKEAQAVAAVVLQCLHM-------------------------DPKNRPSMVDVLTS 303 (350)
Q Consensus 272 ~~~~~~~l~~li~~~l~~-------------------------dp~~Rps~~~ll~~ 303 (350)
+..+++.|-.||..|... .+..|+++++|++.
T Consensus 139 E~eLS~~LE~LL~~Mt~~~~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~~ 195 (229)
T 2yle_A 139 ERELSPPLEQLIDHMANTVEADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMKL 195 (229)
T ss_dssp EECCCHHHHHHHHHHTTCCC--------------------CCSCCCCCCSHHHHHHH
T ss_pred chhhCHHHHHHHHHHHhcccccccccccccccccccccccccccccCcCCHHHHHHH
Confidence 345678888899888765 24578899888754
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.13 E-value=2.2e-05 Score=71.74 Aligned_cols=77 Identities=13% Similarity=0.053 Sum_probs=47.3
Q ss_pred ccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch-------hhHHHHHHHHHHHhccC--CC-cccceee
Q 018785 25 SDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-------QGHKEWLTEVIYLGQLR--HE-NLVKLIG 94 (350)
Q Consensus 25 i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~e~~~l~~l~--h~-~i~~~~~ 94 (350)
..+.||.|..+.||+++ ...++..+++|....... .....+..|...++.+. .+ .+.+++.
T Consensus 34 ~~~~lg~G~~n~vyrv~---------~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~ 104 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIY---------DQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFY 104 (397)
T ss_dssp EEEECCSSSSEEEEEEE---------C----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEE
T ss_pred EEEECCCCceEEEEEEE---------ECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEE
Confidence 35688999999999983 333467899997643211 11234566888887763 23 3445554
Q ss_pred EEeecCceEEEEEcCCCC
Q 018785 95 YCSESDNRLLVYEFMPKG 112 (350)
Q Consensus 95 ~~~~~~~~~lv~e~~~~~ 112 (350)
+ +.+..++|||++.+.
T Consensus 105 ~--d~~~~~lvmE~l~g~ 120 (397)
T 2olc_A 105 S--DTEMAVTVMEDLSHL 120 (397)
T ss_dssp E--ETTTTEEEECCCTTS
T ss_pred E--cCCccEEEEEeCCCc
Confidence 3 345678999999764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.01 E-value=5.8e-05 Score=67.13 Aligned_cols=31 Identities=23% Similarity=0.249 Sum_probs=28.2
Q ss_pred CCCeeeCCCCCCceEEcCCCcEEEccccccc
Q 018785 149 DANVIYRDLKASNVLLDSNFNAKLSDFGLAR 179 (350)
Q Consensus 149 ~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~ 179 (350)
..+++|+|+++.||+++.++.+.++||+.+.
T Consensus 221 ~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 221 SPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp SCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred cCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 5789999999999999888889999999775
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.87 E-value=6.6e-05 Score=65.27 Aligned_cols=87 Identities=14% Similarity=0.198 Sum_probs=60.9
Q ss_pred hhhhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccC-C--Cccc
Q 018785 14 MISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLR-H--ENLV 90 (350)
Q Consensus 14 ~~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h--~~i~ 90 (350)
.+.++.+.+..-.+.+|.|..+.||+.+. .+|+.|++|+...........+..|+..|+.|. . -.+.
T Consensus 8 ~~~~l~G~~v~~v~~~g~G~~~~vyrv~l----------~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP 77 (288)
T 3f7w_A 8 RVTELTGREVAAVAERGHSHRWHLYRVEL----------ADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVP 77 (288)
T ss_dssp HHHHHHCCCEEEEEEEEEETTEEEEEEEE----------TTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSC
T ss_pred HHHHhcCCCeEEEEecCCCCCeEEEEEEE----------CCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcc
Confidence 35566778888889999999999999843 347889999876554333445778988888874 2 2344
Q ss_pred ceeeEEeecCceEEEEEcCCCCCh
Q 018785 91 KLIGYCSESDNRLLVYEFMPKGSL 114 (350)
Q Consensus 91 ~~~~~~~~~~~~~lv~e~~~~~~L 114 (350)
++++. +..++|||++++...
T Consensus 78 ~v~~~----~~~~lv~e~l~~~~~ 97 (288)
T 3f7w_A 78 QVAGW----DDRTLAMEWVDERPP 97 (288)
T ss_dssp CEEEE----ETTEEEEECCCCCCC
T ss_pred eEEec----cCceEEEEeecccCC
Confidence 44443 234789999876643
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.82 E-value=0.00025 Score=62.29 Aligned_cols=75 Identities=16% Similarity=0.067 Sum_probs=57.3
Q ss_pred cceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccC---CCcccceeeEEeecCce
Q 018785 26 DYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLR---HENLVKLIGYCSESDNR 102 (350)
Q Consensus 26 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~ 102 (350)
.+.|+.|....+|+.. . .+..+++|..... ....+..|+..|+.|. ...+.+++.+....+..
T Consensus 41 ~~~l~gG~~n~~y~v~---------~--~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~ 106 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIN---------D--EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHS 106 (312)
T ss_dssp EEEECCSSSSEEEEEE---------S--SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEE
T ss_pred eEEeCCccceeeeEEE---------E--CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCce
Confidence 4578999999999973 2 2567888987543 2456778888888873 46788888888877889
Q ss_pred EEEEEcCCCCCh
Q 018785 103 LLVYEFMPKGSL 114 (350)
Q Consensus 103 ~lv~e~~~~~~L 114 (350)
++|||+++|..+
T Consensus 107 ~lvme~l~G~~~ 118 (312)
T 3jr1_A 107 FLLLEALNKSKN 118 (312)
T ss_dssp EEEEECCCCCCC
T ss_pred EEEEEeccCCCC
Confidence 999999988765
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.73 E-value=0.00033 Score=64.41 Aligned_cols=31 Identities=16% Similarity=0.216 Sum_probs=28.1
Q ss_pred CCCeeeCCCCCCceEEcCCCcEEEcccccccc
Q 018785 149 DANVIYRDLKASNVLLDSNFNAKLSDFGLARD 180 (350)
Q Consensus 149 ~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~~ 180 (350)
...++|||+++.||+++.++ +.++||+.+..
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~ 261 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFY 261 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence 78899999999999998776 99999998875
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.57 E-value=0.00037 Score=62.96 Aligned_cols=151 Identities=17% Similarity=0.194 Sum_probs=83.1
Q ss_pred hcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccC-CCcccceeeEEeec
Q 018785 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLR-HENLVKLIGYCSES 99 (350)
Q Consensus 21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~ 99 (350)
+... .+.|..|....+|++...+.. ......+..+++|+.... ......+.+|..+++.+. +.-..++++.+.+
T Consensus 51 ~~l~-v~~lsGG~TN~~y~v~~~~~~--~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~- 125 (379)
T 3feg_A 51 EELR-VYPVSGGLSNLLFRCSLPDHL--PSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE- 125 (379)
T ss_dssp GGCC-CEEC-----CCEEEEECCTTS--CCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT-
T ss_pred CceE-EEEcCCcccccEEEEEeCCCc--cccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC-
Confidence 3444 346777888899998543210 011223578999986442 223456668888888874 3223566666553
Q ss_pred CceEEEEEcCCCCChhhH--------------Hh---hcC---CCCCC--HHHHHHHHHHHHH-----------------
Q 018785 100 DNRLLVYEFMPKGSLENH--------------LF---RKG---VQPIS--WPTRVKIAIDVAR----------------- 140 (350)
Q Consensus 100 ~~~~lv~e~~~~~~L~~~--------------l~---~~~---~~~l~--~~~~~~i~~ql~~----------------- 140 (350)
.+|+||++|.+|..- +. ... .+... ..++..+..++-.
T Consensus 126 ---g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l 202 (379)
T 3feg_A 126 ---GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSL 202 (379)
T ss_dssp ---EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTH
T ss_pred ---ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHH
Confidence 299999987655321 00 000 11111 2344444443321
Q ss_pred --HHH----Hhh--cCCCCeeeCCCCCCceEEcCC----CcEEEccccccc
Q 018785 141 --GLS----FLH--GLDANVIYRDLKASNVLLDSN----FNAKLSDFGLAR 179 (350)
Q Consensus 141 --al~----~lh--~~~~~i~H~di~~~Nili~~~----~~~~l~Dfg~~~ 179 (350)
.+. .|. .....++|+|+.+.||+++.+ +.+.++||..+.
T Consensus 203 ~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 203 KDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 112 122 114568999999999999876 689999999885
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.49 E-value=0.00042 Score=60.51 Aligned_cols=136 Identities=13% Similarity=0.086 Sum_probs=73.4
Q ss_pred ccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcc-cceeeEEeecCceE
Q 018785 25 SDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENL-VKLIGYCSESDNRL 103 (350)
Q Consensus 25 i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~ 103 (350)
-.+.|+.|....+|++ ..+++|+....... ......|+..++.+...++ .+++.+ +.+..+
T Consensus 22 ~i~~l~gG~tN~~~~~---------------~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~ 83 (301)
T 3dxq_A 22 GPLERLGGLTNLVFRA---------------GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHV--DPATGV 83 (301)
T ss_dssp SCEEEESCSSEEEEEE---------------TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCC
T ss_pred ceeEcCCcccccccee---------------eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCE
Confidence 3778899999999996 23788887653211 1112456666666632222 445543 334457
Q ss_pred EEEEcC-CCCChhhHHhh----------------cC-CCCC----CH----------------------HHHHHHHHHHH
Q 018785 104 LVYEFM-PKGSLENHLFR----------------KG-VQPI----SW----------------------PTRVKIAIDVA 139 (350)
Q Consensus 104 lv~e~~-~~~~L~~~l~~----------------~~-~~~l----~~----------------------~~~~~i~~ql~ 139 (350)
++++|+ +|.++...... +. ...+ +. ......+..+.
T Consensus 84 ~v~e~i~~g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~ 163 (301)
T 3dxq_A 84 MVTRYIAGAQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVR 163 (301)
T ss_dssp EEEECCTTCEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHH
T ss_pred EEEeecCCCccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHH
Confidence 899999 66555321000 00 0001 10 01111111111
Q ss_pred HHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcccccccc
Q 018785 140 RGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD 180 (350)
Q Consensus 140 ~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~~ 180 (350)
..+... .....++|+|+.+.||+ ..++.+.++||+.+..
T Consensus 164 ~~l~~~-~~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 164 SALAAH-PLPLAACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp HHHHSS-CCCCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHhc-CCCceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 111111 11455899999999999 5667789999998864
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.35 E-value=0.0036 Score=55.15 Aligned_cols=140 Identities=14% Similarity=0.088 Sum_probs=76.6
Q ss_pred ceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCC--CcccceeeE-----Eeec
Q 018785 27 YLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRH--ENLVKLIGY-----CSES 99 (350)
Q Consensus 27 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~-----~~~~ 99 (350)
..++ |....||++.. .+|+.+++|...... .....+..|...++.+.. -.+.+++.. ...+
T Consensus 32 ~~l~-g~~n~~y~v~~----------~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~ 99 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQD----------EDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQ 99 (328)
T ss_dssp EEEC-CSSSEEEEECC----------TTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEET
T ss_pred Eeec-CcccceEEEEc----------CCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEEC
Confidence 3466 77788998722 235578899886432 123455667777766631 113333332 2234
Q ss_pred CceEEEEEcCCCCChh-----h------HH---hh----cC---CCCCCHHH----------------------HHHHHH
Q 018785 100 DNRLLVYEFMPKGSLE-----N------HL---FR----KG---VQPISWPT----------------------RVKIAI 136 (350)
Q Consensus 100 ~~~~lv~e~~~~~~L~-----~------~l---~~----~~---~~~l~~~~----------------------~~~i~~ 136 (350)
+..++++++++|.++. . .+ .. .. ....+... ....+.
T Consensus 100 g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 179 (328)
T 1zyl_A 100 GFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATD 179 (328)
T ss_dssp TEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHH
T ss_pred CEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHH
Confidence 5567899999775432 1 11 00 00 00111111 011222
Q ss_pred HHHHHHHHhhc--CCCCeeeCCCCCCceEEcCCCcEEEcccccccc
Q 018785 137 DVARGLSFLHG--LDANVIYRDLKASNVLLDSNFNAKLSDFGLARD 180 (350)
Q Consensus 137 ql~~al~~lh~--~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~~ 180 (350)
.++..+..+-. ....++|+|+++.||+++ + .+.++||+.+..
T Consensus 180 ~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 180 ELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp HHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 22333322210 156789999999999998 4 899999988753
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.30 E-value=0.0017 Score=57.49 Aligned_cols=32 Identities=28% Similarity=0.297 Sum_probs=28.0
Q ss_pred CCCeeeCCCCCCceEEcCC----CcEEEcccccccc
Q 018785 149 DANVIYRDLKASNVLLDSN----FNAKLSDFGLARD 180 (350)
Q Consensus 149 ~~~i~H~di~~~Nili~~~----~~~~l~Dfg~~~~ 180 (350)
...++|+|+++.||+++.+ +.+.++||+.+..
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 5689999999999999874 6799999998864
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.29 E-value=0.00093 Score=61.50 Aligned_cols=81 Identities=15% Similarity=0.083 Sum_probs=48.6
Q ss_pred cceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCc-ccceeeEEeecCceEE
Q 018785 26 DYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHEN-LVKLIGYCSESDNRLL 104 (350)
Q Consensus 26 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~l 104 (350)
.+.|+.|....+|++...+... .....+..+++|+..... ....+..|+.+++.+...+ ..++++.+.+ .+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~--~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~ 149 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYP--PIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GR 149 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSC--CSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EE
T ss_pred EEEeCCCcccceEEEEeCCCcc--ccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CE
Confidence 4567888889999985432110 011235788999884421 1134557888888774222 3566665543 38
Q ss_pred EEEcCCCCCh
Q 018785 105 VYEFMPKGSL 114 (350)
Q Consensus 105 v~e~~~~~~L 114 (350)
|++|++|.++
T Consensus 150 v~e~l~G~~l 159 (429)
T 1nw1_A 150 LEEYIPSRPL 159 (429)
T ss_dssp EECCCCEEEC
T ss_pred EEEEeCCccc
Confidence 9999976444
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.25 E-value=0.001 Score=61.64 Aligned_cols=75 Identities=15% Similarity=0.009 Sum_probs=44.9
Q ss_pred cceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcc-cceeeEEeecCceEE
Q 018785 26 DYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENL-VKLIGYCSESDNRLL 104 (350)
Q Consensus 26 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~l 104 (350)
.+.|+.|....+|++... ..+..+++|+....... .-....|+.+++.|...++ .++++++. + .+
T Consensus 113 i~~lsgG~tN~~y~v~~~---------~~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~ 178 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDM---------SKQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFFT--N--GR 178 (458)
T ss_dssp EEEECC--CEEEEEEEET---------TTTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EE
T ss_pred EEEcCCCeEeEEEEEEEC---------CCCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eE
Confidence 456788888899998432 23467889987543211 1112468888888854333 56666663 2 36
Q ss_pred EEEcCCCCCh
Q 018785 105 VYEFMPKGSL 114 (350)
Q Consensus 105 v~e~~~~~~L 114 (350)
|++|++|.+|
T Consensus 179 v~e~I~G~~l 188 (458)
T 2qg7_A 179 IEEFMDGYAL 188 (458)
T ss_dssp EEECCCSEEC
T ss_pred EEEeeCCccC
Confidence 9999987544
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.96 E-value=0.01 Score=51.98 Aligned_cols=31 Identities=35% Similarity=0.296 Sum_probs=26.3
Q ss_pred CCCeeeCCCCCCceEEcCCCcEEEccccccc
Q 018785 149 DANVIYRDLKASNVLLDSNFNAKLSDFGLAR 179 (350)
Q Consensus 149 ~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~ 179 (350)
..+++|+|+++.||+++.++.+.++||+.+.
T Consensus 186 ~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 186 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred CcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 3579999999999999877556799998775
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.96 E-value=0.0026 Score=57.16 Aligned_cols=83 Identities=10% Similarity=-0.022 Sum_probs=42.8
Q ss_pred cceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCc-ccceeeEEeecCceEE
Q 018785 26 DYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHEN-LVKLIGYCSESDNRLL 104 (350)
Q Consensus 26 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~l 104 (350)
.+.|+.|....+|++...+... ......+..+++|+....... ......|...++.+...+ +.++++.. . .++
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~-~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~ 111 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETA-NNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGR 111 (369)
T ss_dssp EEEC----CCEEEEEEECHHHH-TTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEE
T ss_pred EEEeCCcccceEEEEEeCCCCc-ccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec--C--CcE
Confidence 4467788888999984321000 000112367889987653221 112346777777764222 44565544 2 368
Q ss_pred EEEcCCCCCh
Q 018785 105 VYEFMPKGSL 114 (350)
Q Consensus 105 v~e~~~~~~L 114 (350)
|++|++|.++
T Consensus 112 v~e~i~G~~l 121 (369)
T 3c5i_A 112 IEEWLYGDPL 121 (369)
T ss_dssp EEECCCSEEC
T ss_pred EEEEecCCcC
Confidence 9999987543
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.73 E-value=0.013 Score=51.95 Aligned_cols=32 Identities=19% Similarity=0.163 Sum_probs=27.8
Q ss_pred CCCeeeCCCCCCceEEcCCCcEEEcccccccc
Q 018785 149 DANVIYRDLKASNVLLDSNFNAKLSDFGLARD 180 (350)
Q Consensus 149 ~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~~ 180 (350)
...++|+|+.+.||+++.++.+.++||+.+..
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 35789999999999998888899999987753
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.02 E-value=0.027 Score=51.49 Aligned_cols=82 Identities=11% Similarity=-0.040 Sum_probs=46.4
Q ss_pred cceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccC-CCcccceeeEEeecCceEE
Q 018785 26 DYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLR-HENLVKLIGYCSESDNRLL 104 (350)
Q Consensus 26 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l 104 (350)
.+.|..|-...+|++....... .....+..+++++..... ...-+..+|..+++.+. +.-..++++.+. .++
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~--~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~ 147 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESM--SLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADFP----EGR 147 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-------CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEE
T ss_pred EEEcCCCcccceEEEEeCCCcc--cccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCE
Confidence 4466778888999985432100 001125788999875532 11112346777777773 222445554332 378
Q ss_pred EEEcCCCCCh
Q 018785 105 VYEFMPKGSL 114 (350)
Q Consensus 105 v~e~~~~~~L 114 (350)
|++|++|.+|
T Consensus 148 I~efI~G~~l 157 (424)
T 3mes_A 148 IEEFIDGEPL 157 (424)
T ss_dssp EEECCCSEEC
T ss_pred EEEEeCCccC
Confidence 9999988664
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=95.41 E-value=0.14 Score=46.41 Aligned_cols=30 Identities=23% Similarity=0.259 Sum_probs=25.1
Q ss_pred CeeeCCCCCCceEE------cCCCcEEEcccccccc
Q 018785 151 NVIYRDLKASNVLL------DSNFNAKLSDFGLARD 180 (350)
Q Consensus 151 ~i~H~di~~~Nili------~~~~~~~l~Dfg~~~~ 180 (350)
.++|+|+.+.||++ +.++.+.++||..+..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 46899999999999 3456799999998863
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=90.99 E-value=1.2 Score=36.18 Aligned_cols=117 Identities=7% Similarity=0.073 Sum_probs=78.9
Q ss_pred CCCcccceeeEEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEE
Q 018785 85 RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLL 164 (350)
Q Consensus 85 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili 164 (350)
.||+++.. .+-++++.+.+.++. ..+...|-.-. .++....++++.+|+....+++ .=+|--++|+|+++
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~--~~~~~~f~~ik---~~~~~eKlr~l~ni~~l~~~~~----~r~tf~L~P~NL~f 112 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDI--NDNHTPFDNIK---SFTKNEKLRYLLNIKNLEEVNR----TRYTFVLAPDELFF 112 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECC--CTTSEEGGGGG---GSCHHHHHHHHHHGGGGGGGGG----SSEECCCSGGGEEE
T ss_pred cCCcccce-EEEEcccEEEEEEEc--CcccCCHHHHH---hcCHHHHHHHHHHHHHHHHHhc----CceEEEEecceEEE
Confidence 58888877 466666655555554 33344444322 5788899999999998875555 34678899999999
Q ss_pred cCCCcEEEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcc
Q 018785 165 DSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDE 235 (350)
Q Consensus 165 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~ 235 (350)
+.++.+++.-.|+... ++|. .++...-+-.+=|++..+++++..|..
T Consensus 113 ~~~~~p~i~~RGik~~-------------------l~P~-----~~~ee~fL~qyKAliiall~~K~~Fe~ 159 (215)
T 4ann_A 113 TRDGLPIAKTRGLQNV-------------------VDPL-----PVSEAEFLTRYKALVICAFNEKQSFDA 159 (215)
T ss_dssp CTTSCEEESCCEETTT-------------------BSCC-----CCCHHHHHHHHHHHHHHHHCTTCCHHH
T ss_pred cCCCCEEEEEccCccC-------------------CCCC-----CCCHHHHHHHHHHHHHHHHcCCCCHHH
Confidence 9999999976665422 2332 122222345677888999999888753
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=89.57 E-value=1.7 Score=35.45 Aligned_cols=116 Identities=11% Similarity=0.121 Sum_probs=76.8
Q ss_pred CCCcccceeeEEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHH-HhhcCCCCeeeCCCCCCceE
Q 018785 85 RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLS-FLHGLDANVIYRDLKASNVL 163 (350)
Q Consensus 85 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~-~lh~~~~~i~H~di~~~Nil 163 (350)
.||++ -..+-.+++.+.+.++.-+++.-+..+ + .++..+.++++.+|+.... +++ .-+|--++|+|++
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i--~---~~~~~eKlrll~nl~~L~~~~~~----~r~tf~l~P~NL~ 116 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI--R---KTTLLSRIRAAIHLVSKVKHHSA----RRLIFIVCPENLM 116 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH--H---TSCHHHHHHHHHHHHHHHSSCCS----SSEECCCCGGGEE
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH--H---hcCHHHHHHHHHHHHHHHHHhhh----CceeEEEeCceEE
Confidence 57777 444556666666666654333222333 2 5788899999999888766 444 5577889999999
Q ss_pred EcCCCcEEEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcc
Q 018785 164 LDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDE 235 (350)
Q Consensus 164 i~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~ 235 (350)
++.++.+++.-.|+-.. ++|.. ++..-=+-.+=|++..++.++..|..
T Consensus 117 f~~~~~p~i~hRGi~~~-------------------lpP~e-----~~ee~fl~qyKali~all~~K~~Fe~ 164 (219)
T 4ano_A 117 FNRALEPFFLHVGVKES-------------------LPPDE-----WDDERLLREVKATVLALTEGEYRFDE 164 (219)
T ss_dssp ECTTCCEEESCCEETTT-------------------BSSCS-----CCHHHHHHHHHHHHHHHTTCSSCHHH
T ss_pred EeCCCcEEEEEcCCccc-------------------CCCCC-----CCHHHHHHHHHHHHHHHHcCCCCHHH
Confidence 99999999986665432 23321 11122244667888889998887743
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 350 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-75 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 8e-68 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-67 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-66 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 5e-66 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 5e-66 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 6e-66 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 8e-66 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-65 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-65 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 5e-65 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 6e-65 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 9e-65 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-64 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-64 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-64 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 5e-63 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 7e-63 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 8e-63 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-62 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 9e-62 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 9e-62 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 6e-61 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 8e-61 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-60 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 4e-59 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 6e-59 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-58 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 8e-57 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-56 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-55 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-55 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-54 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-52 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-52 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 9e-50 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-49 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-49 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-48 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-48 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-48 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-47 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-45 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-45 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 5e-45 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 6e-45 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 8e-45 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-43 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 8e-43 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-42 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-42 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-42 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-42 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 9e-41 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-40 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-39 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 8e-38 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-35 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 9e-34 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-33 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-32 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 5e-29 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-15 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 231 bits (591), Expect = 2e-75
Identities = 71/291 (24%), Positives = 128/291 (43%), Gaps = 32/291 (10%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHE 87
+G G FG V+KG K + V + + A + Q + + EV L + RH
Sbjct: 15 RIGSGSFGTVYKG----------KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 64
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHG 147
N++ +GY + +V ++ SL +HL + IA A+G+ +LH
Sbjct: 65 NILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLH- 121
Query: 148 LDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT 207
++I+RDLK++N+ L + K+ DFGLA +H ++ G+ + APE +
Sbjct: 122 -AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 180
Query: 208 ---GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMD 264
+ +SDVY+FG+VL EL++G+ +Q + +L
Sbjct: 181 QDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN--RDQIIFMVGRGYLSPDLS------ 232
Query: 265 TRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDMPR 315
+ +A+ ++ +CL RP +L S+E L ++ +P+
Sbjct: 233 -----KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELL--ARSLPK 276
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 213 bits (542), Expect = 8e-68
Identities = 70/297 (23%), Positives = 132/297 (44%), Gaps = 30/297 (10%)
Query: 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTE 77
+ + + LG G +G V++G + VA+K LK ++ + +E+L E
Sbjct: 14 MERTDITMKHKLGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKE 63
Query: 78 VIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAID 137
+ +++H NLV+L+G C+ ++ EFM G+L ++L Q +S + +A
Sbjct: 64 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ 123
Query: 138 VARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR 197
++ + +L N I+RDL A N L+ N K++DFGL+R GD
Sbjct: 124 ISSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPI 180
Query: 198 GYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSR 257
+ APE +A + KSDV++FGV+L E+ + + D
Sbjct: 181 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-----------------IDLS 223
Query: 258 RVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDMP 314
+V +++ + + + V ++ C +P +RPS ++ + E + +
Sbjct: 224 QVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSIS 280
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (536), Expect = 3e-67
Identities = 70/283 (24%), Positives = 124/283 (43%), Gaps = 32/283 (11%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHE 87
LG G FG V+ G+ + VA+K LK S +L E + QL+H+
Sbjct: 20 RLGAGQFGEVWMGYYN----------GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQ 68
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHG 147
LV+L ++ + ++ E+M GSL + L ++ + +A +A G++F+
Sbjct: 69 RLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE- 126
Query: 148 LDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT 207
+ N I+RDL+A+N+L+ + K++DFGLAR + + APE +
Sbjct: 127 -ERNYIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFPIKWTAPEAINY 184
Query: 208 GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRL 267
G T KSDV+SFG++L E+++ R +E +R
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD----------- 233
Query: 268 GGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 310
+ + ++ C P++RP+ + + LE T+
Sbjct: 234 ------NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (531), Expect = 2e-66
Identities = 80/285 (28%), Positives = 128/285 (44%), Gaps = 38/285 (13%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHE 87
+G+G FG V G G VA+K +K ++ + +L E + QLRH
Sbjct: 14 TIGKGEFGDVMLGDYR-----------GNKVAVKCIKNDATA--QAFLAEASVMTQLRHS 60
Query: 88 NLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLH 146
NLV+L+G E L +V E+M KGSL ++L +G + +K ++DV + +L
Sbjct: 61 NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 120
Query: 147 GLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVA 206
N ++RDL A NVL+ + AK+SDFGL ++ + +T + APE +
Sbjct: 121 --GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG-----KLPVKWTAPEALR 173
Query: 207 TGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTR 266
+ KSDV+SFG++L E+ S R + V+ ++
Sbjct: 174 EKKFSTKSDVWSFGILLWEIYSFGRVPYPR-----------------IPLKDVVPRVEKG 216
Query: 267 LGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSK 311
AV V+ C H+D RPS + + LE + T +
Sbjct: 217 YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 261
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (529), Expect = 5e-66
Identities = 85/312 (27%), Positives = 139/312 (44%), Gaps = 36/312 (11%)
Query: 10 PSASMISK----IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKA 65
P ++K I ++ + LG+G FG V+ G + T VAIK LK
Sbjct: 2 PQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTT----------RVAIKTLK- 50
Query: 66 ESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQP 125
+ +L E + +LRHE LV+L SE + +V E+M KGSL + L + +
Sbjct: 51 PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKY 109
Query: 126 ISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGD 185
+ P V +A +A G++++ N ++RDL+A+N+L+ N K++DFGLAR +
Sbjct: 110 LRLPQLVDMAAQIASGMAYVE--RMNYVHRDLRAANILVGENLVCKVADFGLARLIE-DN 166
Query: 186 NTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTL 245
+ APE G T KSDV+SFG++L EL + R
Sbjct: 167 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG--------- 217
Query: 246 VEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 305
+R VL ++ + +++ ++ QC +P+ RP+ + LE
Sbjct: 218 --------MVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 269
Query: 306 QLHTSKDMPRTP 317
TS + P
Sbjct: 270 DYFTSTEPQYQP 281
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (529), Expect = 5e-66
Identities = 78/315 (24%), Positives = 130/315 (41%), Gaps = 38/315 (12%)
Query: 18 IATKNFC-SDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGH-KEWL 75
+ N +D LG G FG V +G I VAIK LK + + +E +
Sbjct: 5 LKRDNLLIADIELGCGNFGSVRQGVYRMR-------KKQIDVAIKVLKQGTEKADTEEMM 57
Query: 76 TEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIA 135
E + QL + +V+LIG C +++ +LV E G L L K + I ++
Sbjct: 58 REAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELL 115
Query: 136 IDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD-GPTGDNTHVSTRIV 194
V+ G+ +L + N ++RDL A NVLL + AK+SDFGL++ G +
Sbjct: 116 HQVSMGMKYLE--EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 173
Query: 195 GTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLR 254
+ APE + + +SDV+S+GV + E LS + P+ +
Sbjct: 174 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK------------------PYKK 215
Query: 255 DS-RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDM 313
V+ ++ + + + A++ C ++RP + V + +
Sbjct: 216 MKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR--ACYYSL 273
Query: 314 PRTPPPAKLHHHHHH 328
HHHHHH
Sbjct: 274 ASKVEG---HHHHHH 285
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (526), Expect = 6e-66
Identities = 66/280 (23%), Positives = 112/280 (40%), Gaps = 34/280 (12%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHEN 88
LG G FG V G VAIK +K E E++ E + L HE
Sbjct: 12 LGTGQFGVVKYGKWR----------GQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEK 60
Query: 89 LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL 148
LV+L G C++ ++ E+M G L N+L +++ DV + +L
Sbjct: 61 LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLE-- 117
Query: 149 DANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG 208
++RDL A N L++ K+SDFGL+R D S ++ PE +
Sbjct: 118 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD-DEYTSSVGSKFPVRWSPPEVLMYS 176
Query: 209 HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDS-RRVLRIMDTRL 267
+ KSD+++FGV++ E+ S + P+ R + + L
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGKM------------------PYERFTNSETAEHIAQGL 218
Query: 268 GGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 307
++ V ++ C H RP+ +L+++ +
Sbjct: 219 RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 208 bits (529), Expect = 8e-66
Identities = 75/302 (24%), Positives = 134/302 (44%), Gaps = 39/302 (12%)
Query: 19 ATKNFCSDY---------LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAE-SF 68
A + F + ++G G FG V G + I VAIK LK+ +
Sbjct: 15 AVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPG------KREIFVAIKTLKSGYTE 68
Query: 69 QGHKEWLTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISW 128
+ +++L+E +GQ H N++ L G ++S +++ EFM GSL+ R+ +
Sbjct: 69 KQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLD-SFLRQNDGQFTV 127
Query: 129 PTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTH 188
V + +A G+ +L D N ++RDL A N+L++SN K+SDFGL+R +
Sbjct: 128 IQLVGMLRGIAAGMKYLA--DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDP 185
Query: 189 VSTRIVG---TRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTL 245
T +G + APE + T SDV+S+G+V+ E++S D
Sbjct: 186 TYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWD--------- 236
Query: 246 VEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 305
++ V+ ++ A+ ++L C D +RP ++ +L+
Sbjct: 237 --------MTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLD 288
Query: 306 QL 307
++
Sbjct: 289 KM 290
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (529), Expect = 2e-65
Identities = 69/310 (22%), Positives = 121/310 (39%), Gaps = 42/310 (13%)
Query: 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQG-HKEWLT 76
+ +F LG G G VFK + SG+V+A K + E + +
Sbjct: 3 LKDDDFEKISELGAGNGGVVFKV---------SHKPSGLVMARKLIHLEIKPAIRNQIIR 53
Query: 77 EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 136
E+ L + +V G + E M GSL+ L + G I K++I
Sbjct: 54 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSI 111
Query: 137 DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 196
V +GL++L +++RD+K SN+L++S KL DFG++ ++ VGT
Sbjct: 112 AVIKGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGT 166
Query: 197 RGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTL----------- 245
R Y +PE + H + +SD++S G+ L+E+ GR + E
Sbjct: 167 RSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAET 226
Query: 246 ----------VEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAA----VVLQCLHMDP 291
+ R + ++D + K + + V +CL +P
Sbjct: 227 PPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNP 286
Query: 292 KNRPSMVDVL 301
R + ++
Sbjct: 287 AERADLKQLM 296
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (526), Expect = 2e-65
Identities = 67/306 (21%), Positives = 131/306 (42%), Gaps = 36/306 (11%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHEN 88
+G+G FG V++G G VA+K + + E+ LRHEN
Sbjct: 11 IGKGRFGEVWRGKWR-----------GEEVAVKIFSSREER-SWFREAEIYQTVMLRHEN 58
Query: 89 LVKLIGYCSESDNRL----LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSF 144
++ I ++ + LV ++ GSL ++L R ++ +K+A+ A GL+
Sbjct: 59 ILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAH 115
Query: 145 LH------GLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNT--HVSTRIVGT 196
LH + +RDLK+ N+L+ N ++D GLA + +T VGT
Sbjct: 116 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 175
Query: 197 RGYAAPEYVAT------GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD 250
+ Y APE + ++D+Y+ G+V E+ + +D
Sbjct: 176 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235
Query: 251 PFLRDSRRVL--RIMDTRLGGQYSKKEA-QAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 307
P + + R+V+ + + + ++ EA + +A ++ +C + + R + + + +L QL
Sbjct: 236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295
Query: 308 HTSKDM 313
+ +
Sbjct: 296 SQQEGI 301
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (525), Expect = 5e-65
Identities = 80/287 (27%), Positives = 130/287 (45%), Gaps = 30/287 (10%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGH-KEWLTEVIYLGQLRH 86
++G G FGCV+ G + N G I A+K L + G ++LTE I + H
Sbjct: 34 VIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87
Query: 87 ENLVKLIGYCSESDNR-LLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFL 145
N++ L+G C S+ L+V +M G L N + + P + + + VA+G+ FL
Sbjct: 88 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKFL 146
Query: 146 HGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD--GPTGDNTHVSTRIVGTRGYAAPE 203
++RDL A N +LD F K++DFGLARD D+ H T + A E
Sbjct: 147 A--SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 204
Query: 204 YVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIM 263
+ T T KSDV+SFGV+L EL++ D + L+ R +
Sbjct: 205 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD------VNTFDITVYLLQGRRLLQ--- 255
Query: 264 DTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 310
+ + V+L+C H + RPS ++++ + + ++
Sbjct: 256 --------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (525), Expect = 6e-65
Identities = 77/303 (25%), Positives = 126/303 (41%), Gaps = 49/303 (16%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKE-WLTEVIYLGQL-R 85
+LG G FG V + K G I VA+K LK ++ +E ++E+ + QL
Sbjct: 44 VLGSGAFGKVMNATAYGIS----KTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGS 99
Query: 86 HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKG---------------------VQ 124
HEN+V L+G C+ S L++E+ G L N+L K +
Sbjct: 100 HENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN 159
Query: 125 PISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTG 184
+++ + A VA+G+ FL + ++RDL A NVL+ K+ DFGLARD +
Sbjct: 160 VLTFEDLLCFAYQVAKGMEFLE--FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 217
Query: 185 DNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQT 244
N V + APE + G T KSDV+S+G++L E+ S
Sbjct: 218 SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN------------ 265
Query: 245 LVEWADPFLRDSRR--VLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLT 302
P+ +++ + + ++ C D + RPS ++ +
Sbjct: 266 ------PYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTS 319
Query: 303 SLE 305
L
Sbjct: 320 FLG 322
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (521), Expect = 9e-65
Identities = 73/303 (24%), Positives = 140/303 (46%), Gaps = 27/303 (8%)
Query: 16 SKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHK-EW 74
++I ++G G FG V+KG + + + VAIK LKA + + ++
Sbjct: 2 TEIHPSCVTRQKVIGAGEFGEVYKGMLKT-----SSGKKEVPVAIKTLKAGYTEKQRVDF 56
Query: 75 LTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 134
L E +GQ H N+++L G S+ +++ E+M G+ + R+ S V +
Sbjct: 57 LGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGA-LDKFLREKDGEFSVLQLVGM 115
Query: 135 AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD-GPTGDNTHVSTRI 193
+A G+ +L + N ++RDL A N+L++SN K+SDFGL+R + T+ ++
Sbjct: 116 LRGIAAGMKYLA--NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGG 173
Query: 194 VGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 253
+ APE ++ T SDV+SFG+V+ E+++ +
Sbjct: 174 KIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE----------------- 216
Query: 254 RDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDM 313
+ V++ ++ A+ +++QC + RP D+++ L++L + D
Sbjct: 217 LSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDS 276
Query: 314 PRT 316
+T
Sbjct: 277 LKT 279
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (523), Expect = 1e-64
Identities = 73/298 (24%), Positives = 118/298 (39%), Gaps = 40/298 (13%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKE-WLTEVIYLGQL-R 85
LG G FG V + + K + + VA+K LK + +E ++E+ L L
Sbjct: 30 TLGAGAFGKVVEATA----YGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 85
Query: 86 HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQ----------------PISWP 129
H N+V L+G C+ L++ E+ G L N L RK +
Sbjct: 86 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 145
Query: 130 TRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHV 189
+ + VA+G++FL N I+RDL A N+LL K+ DFGLARD N V
Sbjct: 146 DLLSFSYQVAKGMAFLA--SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 203
Query: 190 STRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWA 249
+ APE + T +SDV+S+G+ L EL S +
Sbjct: 204 KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM------------ 251
Query: 250 DPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 307
+ +++ + + ++ C DP RP+ ++ +E+
Sbjct: 252 ----PVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (518), Expect = 1e-64
Identities = 78/279 (27%), Positives = 126/279 (45%), Gaps = 32/279 (11%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHEN 88
+G G FG V G+ + VAIK ++ E ++++ E + +L H
Sbjct: 13 IGSGQFGLVHLGYWL----------NKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPK 61
Query: 89 LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL 148
LV+L G C E LV+EFM G L ++ R + T + + +DV G+++L
Sbjct: 62 LVQLYGVCLEQAPICLVFEFMEHGCLSDY-LRTQRGLFAAETLLGMCLDVCEGMAYLE-- 118
Query: 149 DANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG 208
+A VI+RDL A N L+ N K+SDFG+ R D ST +A+PE +
Sbjct: 119 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFSFS 177
Query: 209 HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLG 268
+ KSDV+SFGV++ E+ S + E+R + D R+ RL
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGKIPYENR----------SNSEVVEDISTGFRLYKPRL- 226
Query: 269 GQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 307
+ V ++ C P++RP+ +L L ++
Sbjct: 227 ------ASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 204 bits (520), Expect = 2e-64
Identities = 69/302 (22%), Positives = 123/302 (40%), Gaps = 46/302 (15%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQG-HKEWLTEVIYLGQLRHE 87
+GEG FG VF+ +VA+K LK E+ ++ E + + +
Sbjct: 21 IGEGAFGRVFQARAPGLLPYEP----FTMVAVKMLKEEASADMQADFQREAALMAEFDNP 76
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKG----------------------VQP 125
N+VKL+G C+ L++E+M G L L P
Sbjct: 77 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 136
Query: 126 ISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGD 185
+S ++ IA VA G+++L + ++RDL N L+ N K++DFGL+R+ + D
Sbjct: 137 LSCAEQLCIARQVAAGMAYLS--ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 194
Query: 186 NTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTL 245
+ PE + T +SDV+++GVVL E+ S G+A + +
Sbjct: 195 YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY---GMAHEEV 251
Query: 246 VEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 305
+ + +RD + + + ++ C P +RPS + L+
Sbjct: 252 IYY----VRDGNIL----------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQ 297
Query: 306 QL 307
++
Sbjct: 298 RM 299
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (512), Expect = 5e-63
Identities = 64/288 (22%), Positives = 128/288 (44%), Gaps = 31/288 (10%)
Query: 25 SDY----LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLK-AESFQGHKEWLTEVI 79
+++ +LG G FG V+KG + P I VAIK L+ A S + +KE L E
Sbjct: 9 TEFKKIKVLGSGAFGTVYKG-----LWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 63
Query: 80 YLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVA 139
+ + + ++ +L+G C L+ + MP G L +++ I + + +A
Sbjct: 64 VMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIA 121
Query: 140 RGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGY 199
+G+++L D +++RDL A NVL+ + + K++DFGLA+ + + + +
Sbjct: 122 KGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 179
Query: 200 AAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRV 259
A E + T +SDV+S+GV + EL++ + + +
Sbjct: 180 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG-----------------IPASEI 222
Query: 260 LRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 307
I++ V ++++C +D +RP +++ ++
Sbjct: 223 SSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (509), Expect = 7e-63
Identities = 60/278 (21%), Positives = 111/278 (39%), Gaps = 35/278 (12%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHEN 88
LG+G FG V+K + ++ A K + +S + ++++ E+ L H N
Sbjct: 20 LGDGAFGKVYKA---------QNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70
Query: 89 LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL 148
+VKL+ +N ++ EF G+++ + +P++ + L++LH
Sbjct: 71 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELE-RPLTESQIQVVCKQTLDALNYLH-- 127
Query: 149 DANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT- 207
D +I+RDLKA N+L + + KL+DFG++ +GT + APE V
Sbjct: 128 DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR--DSFIGTPYWMAPEVVMCE 185
Query: 208 ----GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIM 263
K+DV+S G+ L+E+ E + + P L R
Sbjct: 186 TSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRW---- 241
Query: 264 DTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL 301
+ + +CL + R + +L
Sbjct: 242 ------------SSNFKDFLKKCLEKNVDARWTTSQLL 267
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (507), Expect = 8e-63
Identities = 66/285 (23%), Positives = 114/285 (40%), Gaps = 35/285 (12%)
Query: 23 FCSDY----LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRL-KAESFQGHKEWLTE 77
F D+ LGEG +G V + VA+K + + + E
Sbjct: 3 FVEDWDLVQTLGEGAYGEVQLA---------VNRVTEEAVAVKIVDMKRAVDCPENIKKE 53
Query: 78 VIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAID 137
+ L HEN+VK G+ E + + L E+ G L + + + P +
Sbjct: 54 ICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQ 111
Query: 138 VARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR 197
+ G+ +LH + +RD+K N+LLD N K+SDFGLA + + ++ GT
Sbjct: 112 LMAGVVYLH--GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 169
Query: 198 GYAAPEYVATGHL-TPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDS 256
Y APE + DV+S G+VL +L+G D+ E + + +L
Sbjct: 170 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW 229
Query: 257 RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL 301
+++ A A++ + L +P R ++ D+
Sbjct: 230 KKI----------------DSAPLALLHKILVENPSARITIPDIK 258
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 4e-62
Identities = 74/285 (25%), Positives = 121/285 (42%), Gaps = 34/285 (11%)
Query: 26 DYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQG--HKEWLTEVIYLGQ 83
D LG G FG V KG+ VA+K LK E+ E L E + Q
Sbjct: 12 DKELGSGNFGTVKKGYYQMK-------KVVKTVAVKILKNEANDPALKDELLAEANVMQQ 64
Query: 84 LRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLS 143
L + +V++IG C E+++ +LV E G L +L + + +++ V+ G+
Sbjct: 65 LDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMK 121
Query: 144 FLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTH-VSTRIVGTRGYAAP 202
+L ++N ++RDL A NVLL + AK+SDFGL++ +N + T + AP
Sbjct: 122 YLE--ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAP 179
Query: 203 EYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDS-RRVLR 261
E + + KSDV+SFGV++ E S + P+ V
Sbjct: 180 ECINYYKFSSKSDVWSFGVLMWEAFSYGQK------------------PYRGMKGSEVTA 221
Query: 262 IMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQ 306
+++ + + ++ C D +NRP V L
Sbjct: 222 MLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 9e-62
Identities = 66/289 (22%), Positives = 115/289 (39%), Gaps = 44/289 (15%)
Query: 21 KNFC-SDY----LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHK 72
+ + D+ LG+G FG V+ + S ++A+K L
Sbjct: 1 RQWALEDFEIGRPLGKGKFGNVYLA---------REKQSKFILALKVLFKAQLEKAGVEH 51
Query: 73 EWLTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRV 132
+ EV LRH N+++L GY ++ L+ E+ P G++ L +
Sbjct: 52 QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS--KFDEQRTA 109
Query: 133 KIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR 192
++A LS+ H VI+RD+K N+LL S K++DFG + P+ T +
Sbjct: 110 TYITELANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTL--- 164
Query: 193 IVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPF 252
GT Y PE + K D++S GV+ E L G+ PF
Sbjct: 165 -CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP-------------------PF 204
Query: 253 LRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL 301
++ + +R+ + + ++ + L +P RP + +VL
Sbjct: 205 EANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 253
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 197 bits (503), Expect = 9e-62
Identities = 70/279 (25%), Positives = 111/279 (39%), Gaps = 42/279 (15%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEW---LTEVIYLGQLR 85
+G G FG V+ + VVAIK++ Q +++W + EV +L +LR
Sbjct: 23 IGHGSFGAVYFA---------RDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 86 HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFL 145
H N ++ G LV E+ + + K P+ + +GL++L
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK--PLQEVEIAAVTHGALQGLAYL 131
Query: 146 HGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYV 205
H N+I+RD+KA N+LL KL DFG A + VGT + APE +
Sbjct: 132 H--SHNMIHRDVKAGNILLSEPGLVKLGDFGSASI------MAPANSFVGTPYWMAPEVI 183
Query: 206 AT---GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRI 262
G K DV+S G+ +EL + L A + + P L+
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQ-------- 235
Query: 263 MDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL 301
S ++ V CL P++RP+ +L
Sbjct: 236 ---------SGHWSEYFRNFVDSCLQKIPQDRPTSEVLL 265
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 6e-61
Identities = 61/283 (21%), Positives = 104/283 (36%), Gaps = 39/283 (13%)
Query: 26 DYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQ 83
D +G G F V+KG + + VA L+ + + E L
Sbjct: 14 DIEIGRGSFKTVYKG---------LDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKG 64
Query: 84 LRHENLVKLIGYCSES----DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVA 139
L+H N+V+ + +LV E M G+L+ +L R + +
Sbjct: 65 LQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQIL 122
Query: 140 RGLSFLHGLDANVIYRDLKASNVLLDS-NFNAKLSDFGLARDGPTGDNTHVSTRIVGTRG 198
+GL FLH +I+RDLK N+ + + K+ D GLA + ++GT
Sbjct: 123 KGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAKAVIGTPE 178
Query: 199 YAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRR 258
+ APE DVY+FG+ +LE+ + E + +
Sbjct: 179 FMAPEMY-EEKYDESVDVYAFGMCMLEMATSEYPYSECQN---AAQIYR----------- 223
Query: 259 VLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL 301
R+ + K V ++ C+ + R S+ D+L
Sbjct: 224 --RVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLL 264
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 8e-61
Identities = 80/311 (25%), Positives = 128/311 (41%), Gaps = 45/311 (14%)
Query: 13 SMISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAE-SFQGH 71
++ + + ++GEG FG V K I ++ G + AIKR+K S H
Sbjct: 2 TIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKD-------GLRMDAAIKRMKEYASKDDH 54
Query: 72 KEWLTEVIYLGQL-RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGV------- 123
+++ E+ L +L H N++ L+G C L E+ P G+L + L + V
Sbjct: 55 RDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAF 114
Query: 124 -------QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFG 176
+S + A DVARG+ +L I+RDL A N+L+ N+ AK++DFG
Sbjct: 115 AIANSTASTLSSQQLLHFAADVARGMDYLS--QKQFIHRDLAARNILVGENYVAKIADFG 172
Query: 177 LARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDED 236
L+R T + A E + T SDV+S+GV+L E++S
Sbjct: 173 LSRGQEVYVKK---TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG 229
Query: 237 RGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPS 296
T E + + R + V ++ QC P RPS
Sbjct: 230 ------MTCAELYEKLPQGYRL-----------EKPLNCDDEVYDLMRQCWREKPYERPS 272
Query: 297 MVDVLTSLEQL 307
+L SL ++
Sbjct: 273 FAQILVSLNRM 283
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 1e-60
Identities = 77/294 (26%), Positives = 123/294 (41%), Gaps = 30/294 (10%)
Query: 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEW 74
I K+ LG+G FG V +G D + G + VA+K LK + + ++
Sbjct: 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPS------GKTVSVAVKCLKPDVLSQPEAMDDF 58
Query: 75 LTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 134
+ EV + L H NL++L G +V E P GSL + L + T +
Sbjct: 59 IREVNAMHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRY 116
Query: 135 AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHV-STRI 193
A+ VA G+ +L I+RDL A N+LL + K+ DFGL R P D+ +V
Sbjct: 117 AVQVAEGMGYLE--SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHR 174
Query: 194 VGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 253
+ APE + T + SD + FGV L E+ + + +
Sbjct: 175 KVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL------NGSQILHKID 228
Query: 254 RDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 307
++ R+ R D Q + V++QC P++RP+ V + L +
Sbjct: 229 KEGERLPRPEDC----------PQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (482), Expect = 4e-59
Identities = 68/283 (24%), Positives = 116/283 (40%), Gaps = 38/283 (13%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLR 85
+G G +G K + G ++ K L S + ++EV L +L+
Sbjct: 11 TIGTGSYGRCQKI---------RRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK 61
Query: 86 HENLVKLIGYCSESDNRLL--VYEFMPKGSLENHLFR--KGVQPISWPTRVKIAIDVARG 141
H N+V+ + N L V E+ G L + + + K Q + +++ +
Sbjct: 62 HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 121
Query: 142 LSFLH---GLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRG 198
L H V++RDLK +NV LD N KL DFGLAR +T + VGT
Sbjct: 122 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHDTSFAKAFVGTPY 179
Query: 199 YAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRR 258
Y +PE + KSD++S G +L EL + + E A +
Sbjct: 180 YMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF-------SQKELA-------GK 225
Query: 259 VLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL 301
+ R+ +YS + ++ + L++ +RPS+ ++L
Sbjct: 226 IREGKFRRIPYRYSD----ELNEIITRMLNLKDYHRPSVEEIL 264
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (483), Expect = 6e-59
Identities = 58/274 (21%), Positives = 114/274 (41%), Gaps = 32/274 (11%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHE 87
+G+G G V+ +G VAI+++ + + + E++ + + ++
Sbjct: 27 KIGQGASGTVYTA---------MDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNP 77
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHG 147
N+V + D +V E++ GSL + + + + + + L FLH
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLH- 133
Query: 148 LDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT 207
VI+RD+K+ N+LL + + KL+DFG + +VGT + APE V
Sbjct: 134 -SNQVIHRDIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAPEVVTR 190
Query: 208 GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRL 267
PK D++S G++ +E++ G + A + P L++ ++
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKL-------- 242
Query: 268 GGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL 301
+ + +CL MD + R S ++L
Sbjct: 243 --------SAIFRDFLNRCLDMDVEKRGSAKELL 268
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 2e-58
Identities = 73/299 (24%), Positives = 134/299 (44%), Gaps = 32/299 (10%)
Query: 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRL-KAESFQGHKEWLT 76
+A + LG+G FG V++G K VAIK + +A S + E+L
Sbjct: 17 VAREKITMSRELGQGSFGMVYEGVAKGVV----KDEPETRVAIKTVNEAASMRERIEFLN 72
Query: 77 EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKG--------VQPISW 128
E + + ++V+L+G S+ L++ E M +G L+++L + P S
Sbjct: 73 EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL 132
Query: 129 PTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTH 188
+++A ++A G+++L+ ++RDL A N ++ +F K+ DFG+ RD D
Sbjct: 133 SKMIQMAGEIADGMAYLN--ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 190
Query: 189 VSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEW 248
+ + + +PE + G T SDV+SFGVVL E+ + + EQ L
Sbjct: 191 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS--NEQVLRFV 248
Query: 249 ADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 307
+ L D + ++ C +PK RPS +++++S+++
Sbjct: 249 MEGGLLD---------------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 8e-57
Identities = 64/281 (22%), Positives = 112/281 (39%), Gaps = 29/281 (10%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKE-WLTEVIYLGQLRH 86
+GEG FG V +G + VAIK K + +E +L E + + Q H
Sbjct: 14 CIGEGQFGDVHQGIYMSPE------NPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 67
Query: 87 ENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLH 146
++VKLIG +E + ++ E G L + L + + + + A ++ L++L
Sbjct: 68 PHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLE 125
Query: 147 GLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVA 206
++RD+ A NVL+ SN KL DFGL+R + +++ + APE +
Sbjct: 126 --SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST-YYKASKGKLPIKWMAPESIN 182
Query: 207 TGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTR 266
T SDV+ FGV + E+L + +E +
Sbjct: 183 FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL-------------- 228
Query: 267 LGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 307
+ +++ +C DP RP ++ L +
Sbjct: 229 ---PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (464), Expect = 3e-56
Identities = 70/296 (23%), Positives = 125/296 (42%), Gaps = 37/296 (12%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGH-KEWLTEVIYLGQL-R 85
LGEG FG V KP VA+K LK+++ + + ++E+ + + +
Sbjct: 20 PLGEGAFGQVVLAE--AIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 77
Query: 86 HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKG--------------VQPISWPTR 131
H+N++ L+G C++ ++ E+ KG+L +L + + +S
Sbjct: 78 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 137
Query: 132 VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVST 191
V A VARG+ +L I+RDL A NVL+ + K++DFGLARD D +T
Sbjct: 138 VSCAYQVARGMEYLA--SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 195
Query: 192 RIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADP 251
+ APE + T +SDV+SFGV+L E+ + +
Sbjct: 196 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG--------------- 240
Query: 252 FLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 307
+ +++ + ++ C H P RP+ ++ L+++
Sbjct: 241 --VPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (461), Expect = 1e-55
Identities = 75/297 (25%), Positives = 122/297 (41%), Gaps = 39/297 (13%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQG-HKEWLTEVIYLGQLRH 86
LG G FG V + F K + VA+K LK + H+ ++E+ L + H
Sbjct: 20 PLGRGAFGQVIEADA----FGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 75
Query: 87 E-NLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQ--------------PISWPT 130
N+V L+G C++ L ++ EF G+L +L K + ++
Sbjct: 76 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 135
Query: 131 RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 190
+ + VA+G+ FL I+RDL A N+LL K+ DFGLARD +
Sbjct: 136 LICYSFQVAKGMEFLA--SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 193
Query: 191 TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD 250
+ APE + T +SDV+SFGV+L E+ S + + E
Sbjct: 194 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG------VKIDEEFC 247
Query: 251 PFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 307
L++ R+ + + +L C H +P RP+ +++ L L
Sbjct: 248 RRLKEGTRM----------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 182 bits (464), Expect = 2e-55
Identities = 72/327 (22%), Positives = 116/327 (35%), Gaps = 34/327 (10%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHE 87
LG G FG V + T+ +G A K + + E+ + LRH
Sbjct: 33 ELGTGAFGVVHRV---------TERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHP 83
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHG 147
LV L + + +++YEFM G L + + +S V+ V +GL +H
Sbjct: 84 TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMH- 141
Query: 148 LDANVIYRDLKASNVLLDSNFN--AKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYV 205
+ N ++ DLK N++ + + KL DFGL + V+T GT +AAPE
Sbjct: 142 -ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPEVA 197
Query: 206 ATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDT 265
+ +D++S GV+ LLSG + D LR+ + MD
Sbjct: 198 EGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN-----------DDETLRNVKSCDWNMDD 246
Query: 266 RLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS--LEQLHTSKDMPRTPPPAKLH 323
S + + + L DP R ++ L L + + P
Sbjct: 247 SAFSGIS----EDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTK 302
Query: 324 HHHHHHNHHQGIKHTNPPRKTSITNSK 350
+ PP S
Sbjct: 303 IRDSIKTKYDAWPEPLPPLGRISNYSS 329
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 1e-54
Identities = 55/295 (18%), Positives = 104/295 (35%), Gaps = 35/295 (11%)
Query: 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKE 73
K ++F +LGEG F V + + AIK L+
Sbjct: 4 KKRPEDFKFGKILGEGSFSTVVLA---------RELATSREYAIKILEKRHIIKENKVPY 54
Query: 74 WLTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVK 133
E + +L H VKL + + + G L ++ + G
Sbjct: 55 VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG--SFDETCTRF 112
Query: 134 IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRI 193
++ L +LH +I+RDLK N+LL+ + + +++DFG A+ +
Sbjct: 113 YTAEIVSALEYLH--GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSF 170
Query: 194 VGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 253
VGT Y +PE + SD+++ G ++ +L++G PF
Sbjct: 171 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLP-------------------PFR 211
Query: 254 RDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLH 308
+ ++ +L + +K +V + L +D R ++
Sbjct: 212 AGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKA 266
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 175 bits (445), Expect = 1e-52
Identities = 62/326 (19%), Positives = 114/326 (34%), Gaps = 36/326 (11%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHE 87
LG G FG V + + +G V K + E+ + QL H
Sbjct: 36 ELGSGAFGVVHRC---------VEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHP 86
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHG 147
L+ L + +L+ EF+ G L + + + +S + GL +H
Sbjct: 87 KLINLHDAFEDKYEMVLILEFLSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMH- 144
Query: 148 LDANVIYRDLKASNVLLDSNFNA--KLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYV 205
+ ++++ D+K N++ ++ + K+ DFGLA + T +AAPE V
Sbjct: 145 -EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK---VTTATAEFAAPEIV 200
Query: 206 ATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDT 265
+ +D+++ GV+ LLSG + L + V R
Sbjct: 201 DREPVGFYTDMWAIGVLGYVLLSGLSPF--------------AGEDDLETLQNVKRCDWE 246
Query: 266 RLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS--LEQLHTSKDMPRTPPPAKLH 323
+S +A + L +P+ R ++ D L L+ H ++ P ++ +
Sbjct: 247 FDEDAFSSVSPEAK-DFIKNLLQKEPRKRLTVHDALEHPWLKGDH--SNLTSRIPSSRYN 303
Query: 324 HHHHHHNHHQGIKHTNPPRKTSITNS 349
P I N
Sbjct: 304 KIRQKIKEKYADWPAPQPAIGRIANF 329
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 173 bits (439), Expect = 1e-52
Identities = 66/290 (22%), Positives = 123/290 (42%), Gaps = 37/290 (12%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQG---HKEWLTEVIYLGQL 84
+LG GG V VA+K L+A+ + + + E L
Sbjct: 14 ILGFGGMSEVHLA---------RDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL 64
Query: 85 RHENLVKLIGYCSESDNRL----LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVAR 140
H +V + +V E++ +L + + +G P++ +++ D +
Sbjct: 65 NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQ 122
Query: 141 GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD-GPTGDNTHVSTRIVGTRGY 199
L+F H +I+RD+K +N+++ + K+ DFG+AR +G++ + ++GT Y
Sbjct: 123 ALNFSH--QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 180
Query: 200 AAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRV 259
+PE + +SDVYS G VL E+L+G D + V A +R+
Sbjct: 181 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD-------SPVSVAYQHVREDPIP 233
Query: 260 LRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRP-SMVDVLTSLEQLH 308
L + + AVVL+ L +P+NR + ++ L ++H
Sbjct: 234 PSARHEGL--------SADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 9e-50
Identities = 62/278 (22%), Positives = 102/278 (36%), Gaps = 38/278 (13%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKE----WLTEVIYLGQ 83
+LG+G FG VF + AIK LK + + + + +
Sbjct: 9 MLGKGSFGKVFLA---------EFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA 59
Query: 84 LRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLS 143
H L + +N V E++ G L H+ A ++ GL
Sbjct: 60 WEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQ 117
Query: 144 FLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPE 203
FLH ++YRDLK N+LLD + + K++DFG+ ++ GD GT Y APE
Sbjct: 118 FLH--SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NTFCGTPDYIAPE 173
Query: 204 YVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIM 263
+ D +SFGV+L E+L G+ PF L
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQS-------------------PFHGQDEEELFHS 214
Query: 264 DTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL 301
Y + + ++++ +P+ R + +
Sbjct: 215 IRMDNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDI 252
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 165 bits (419), Expect = 2e-49
Identities = 64/294 (21%), Positives = 114/294 (38%), Gaps = 47/294 (15%)
Query: 20 TKNFCSDY----LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKE-W 74
++ Y +LG G F V + +VAIK + ++ +G +
Sbjct: 4 AEDIRDIYDFRDVLGTGAFSEVILA---------EDKRTQKLVAIKCIAKKALEGKEGSM 54
Query: 75 LTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 134
E+ L +++H N+V L + L+ + + G L + + KG + ++
Sbjct: 55 ENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG--FYTERDASRL 112
Query: 135 AIDVARGLSFLHGLDANVIYRDLKASNVLL---DSNFNAKLSDFGLARDGPTGDNTHVST 191
V + +LH D +++RDLK N+L D + +SDFGL++ D V +
Sbjct: 113 IFQVLDAVKYLH--DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK---MEDPGSVLS 167
Query: 192 RIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADP 251
GT GY APE +A + D +S GV+ LL G P
Sbjct: 168 TACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYP-------------------P 208
Query: 252 FLRDSRRVL--RIM--DTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL 301
F ++ L +I+ + Y + + + + DP+ R + L
Sbjct: 209 FYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQAL 262
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (420), Expect = 3e-49
Identities = 61/334 (18%), Positives = 120/334 (35%), Gaps = 53/334 (15%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHE 87
LG G FG V + + S K +K + E+ L RH
Sbjct: 12 DLGRGEFGIVHRC---------VETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHR 61
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHG 147
N++ L + ++++EF+ + + ++ V V L FLH
Sbjct: 62 NILHLHESFESMEELVMIFEFISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLH- 119
Query: 148 LDANVIYRDLKASNVLLDSNFNA--KLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYV 205
N+ + D++ N++ + ++ K+ +FG AR GDN + + Y APE
Sbjct: 120 -SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTAPEYYAPEVH 175
Query: 206 ATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVL--RIM 263
++ +D++S G ++ LLSG PFL ++ + + IM
Sbjct: 176 QHDVVSTATDMWSLGTLVYVLLSGIN-------------------PFLAETNQQIIENIM 216
Query: 264 DTRLG--GQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLT------SLEQLHTSKDMPR 315
+ + K+ + V + L + K+R + + L +E++ T
Sbjct: 217 NAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTK----- 271
Query: 316 TPPPAKLHHHHHHHNHHQGIKHTNPPRKTSITNS 349
H ++H + + + S +
Sbjct: 272 -VIRTLKHRRYYHTLIKKDLNMVVSAARISCGGA 304
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 1e-48
Identities = 71/309 (22%), Positives = 110/309 (35%), Gaps = 32/309 (10%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKE-----WLTEVIYLG 82
LGEG F V+K + +VAIK++K K+ L E+ L
Sbjct: 5 FLGEGQFATVYKA---------RDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQ 55
Query: 83 QLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGL 142
+L H N++ L+ N LV++FM ++ + +GL
Sbjct: 56 ELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSL--VLTPSHIKAYMLMTLQGL 113
Query: 143 SFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAP 202
+LH +++RDLK +N+LLD N KL+DFGLA+ G T V TR Y AP
Sbjct: 114 EYLH--QHWILHRDLKPNNLLLDENGVLKLADFGLAKS--FGSPNRAYTHQVVTRWYRAP 169
Query: 203 EYVATGHL-TPKSDVYSFGVVLLELLSGRRALDED---------RGGLAEQTLVEWADPF 252
E + + D+++ G +L ELL L D L T +W D
Sbjct: 170 ELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMC 229
Query: 253 LRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS--LEQLHTS 310
+ + ++ +P R + L
Sbjct: 230 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGP 289
Query: 311 KDMPRTPPP 319
+ P P
Sbjct: 290 TPGCQLPRP 298
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 3e-48
Identities = 77/316 (24%), Positives = 128/316 (40%), Gaps = 29/316 (9%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGH-KEWLTEVIYLGQLRH 86
+GEG +G V + + + VAIK++ Q + + L E+ L + RH
Sbjct: 15 YIGEGAYGMVCSAY---------DNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRH 65
Query: 87 ENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRK-GVQPISWPTRVKIAIDVARGLSFL 145
EN++ + + ++ + L++ Q +S + RGL ++
Sbjct: 66 ENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYI 125
Query: 146 HGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD-GPTGDNTHVSTRIVGTRGYAAPEY 204
H ANV++RDLK SN+LL++ + K+ DFGLAR P D+T T V TR Y APE
Sbjct: 126 H--SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183
Query: 205 VATGHL-TPKSDVYSFGVVLLELLSGR------------RALDEDRGGLAEQTLVEWADP 251
+ T D++S G +L E+LS R + G +++ L +
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243
Query: 252 FLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS--LEQLHT 309
R+ L + + ++ + L +P R + L LEQ +
Sbjct: 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 303
Query: 310 SKDMPRTPPPAKLHHH 325
D P P K
Sbjct: 304 PSDEPIAEAPFKFDME 319
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 161 bits (409), Expect = 3e-48
Identities = 68/303 (22%), Positives = 116/303 (38%), Gaps = 59/303 (19%)
Query: 23 FCSDY----LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---------Q 69
F +Y +LG G V + + A+K + +
Sbjct: 1 FYENYEPKEILGRGVSSVVRRC---------IHKPTCKEYAVKIIDVTGGGSFSAEEVQE 51
Query: 70 GHKEWLTEVIYLGQLR-HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISW 128
+ L EV L ++ H N+++L + LV++ M KG L ++L K +S
Sbjct: 52 LREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV--TLSE 109
Query: 129 PTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTH 188
KI + + LH N+++RDLK N+LLD + N KL+DFG + D
Sbjct: 110 KETRKIMRALLEVICALH--KLNIVHRDLKPENILLDDDMNIKLTDFGFSC---QLDPGE 164
Query: 189 VSTRIVGTRGYAAPEYVATGHL------TPKSDVYSFGVVLLELLSGRRALDEDRGGLAE 242
+ GT Y APE + + D++S GV++ LL+G
Sbjct: 165 KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP----------- 213
Query: 243 QTLVEWADPFLRDSRRVL--RIM--DTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMV 298
PF + ++ IM + + G + V +V + L + P+ R +
Sbjct: 214 --------PFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAE 265
Query: 299 DVL 301
+ L
Sbjct: 266 EAL 268
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 162 bits (412), Expect = 1e-47
Identities = 65/283 (22%), Positives = 104/283 (36%), Gaps = 40/283 (14%)
Query: 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEV 78
+F ++G GGFG V+ K +G + A+K L + QG L E
Sbjct: 5 DFSVHRIIGRGGFGEVYGC---------RKADTGKMYAMKCLDKKRIKMKQGETLALNER 55
Query: 79 I---YLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIA 135
I + +V + D + + M G L HL + G S A
Sbjct: 56 IMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG--VFSEADMRFYA 113
Query: 136 IDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVG 195
++ GL +H + V+YRDLK +N+LLD + + ++SD GLA D VG
Sbjct: 114 AEIILGLEHMH--NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VG 167
Query: 196 TRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLR 254
T GY APE + G +D +S G +L +LL G + + + +
Sbjct: 168 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE 227
Query: 255 DSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSM 297
+ + +++ L D R
Sbjct: 228 LPDSF----------------SPELRSLLEGLLQRDVNRRLGC 254
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 1e-45
Identities = 55/298 (18%), Positives = 111/298 (37%), Gaps = 43/298 (14%)
Query: 17 KIATKNFCSDY-----LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGH 71
+I DY +LG G G V + + A+K L+
Sbjct: 3 QIKKNAIIDDYKVTSQVLGLGINGKVLQI---------FNKRTQEKFALKMLQ-----DC 48
Query: 72 KEWLTEV-IYLGQLRHENLVKLIGYC----SESDNRLLVYEFMPKGSLENHLFRKGVQPI 126
+ EV ++ + ++V+++ + L+V E + G L + + +G Q
Sbjct: 49 PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF 108
Query: 127 SWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFN---AKLSDFGLARDGPT 183
+ +I + + +LH N+ +RD+K N+L S KL+DFG A++ +
Sbjct: 109 TEREASEIMKSIGEAIQYLH--SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 166
Query: 184 GDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQ 243
++ T Y APE + D++S GV++ LL G + G
Sbjct: 167 HNSLT---TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP 223
Query: 244 TLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL 301
+ + +R+ + ++ V ++ L +P R ++ + +
Sbjct: 224 GM-----------KTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFM 270
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 3e-45
Identities = 64/308 (20%), Positives = 116/308 (37%), Gaps = 45/308 (14%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEW------LTEVIYL 81
LG G F V K + +G+ A K +K + + EV L
Sbjct: 17 ELGSGQFAVVKKC---------REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 67
Query: 82 GQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARG 141
+++H N++ L + +L+ E + G L + L K ++ + + G
Sbjct: 68 KEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNG 125
Query: 142 LSFLHGLDANVIYRDLKASNVLLDSN----FNAKLSDFGLARDGPTGDNTHVSTRIVGTR 197
+ +LH + + DLK N++L K+ DFGLA G+ I GT
Sbjct: 126 VYYLH--SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTP 180
Query: 198 GYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSR 257
+ APE V L ++D++S GV+ LLSG D +++
Sbjct: 181 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT---------------KQETL 225
Query: 258 RVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS--LEQLHTSKDMPR 315
+ ++ +Y + + + L DPK R ++ D L ++ T + +
Sbjct: 226 ANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSS 285
Query: 316 --TPPPAK 321
+ P +
Sbjct: 286 AWSHPQFE 293
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 154 bits (390), Expect = 5e-45
Identities = 68/281 (24%), Positives = 115/281 (40%), Gaps = 48/281 (17%)
Query: 25 SDY----LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKE---WLTE 77
D+ LG G FG V +G A+K LK E K+ E
Sbjct: 4 QDFQILRTLGTGSFGRVHLI---------RSRHNGRYYAMKVLKKEIVVRLKQVEHTNDE 54
Query: 78 VIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAID 137
+ L + H ++++ G ++ ++ +++ G L + L + Q P A +
Sbjct: 55 RLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKS--QRFPNPVAKFYAAE 112
Query: 138 VARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR 197
V L +LH ++IYRDLK N+LLD N + K++DFG A+ P T + GT
Sbjct: 113 VCLALEYLH--SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT-----LCGTP 165
Query: 198 GYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSR 257
Y APE V+T D +SFG+++ E+L+G PF +
Sbjct: 166 DYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYT-------------------PFYDSNT 206
Query: 258 RVL--RIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPS 296
+I++ L ++ + V ++ + + D R
Sbjct: 207 MKTYEKILNAEL--RFPPFFNEDVKDLLSRLITRDLSQRLG 245
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 6e-45
Identities = 70/290 (24%), Positives = 114/290 (39%), Gaps = 30/290 (10%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQG--HKEWLTEVI---YLGQ 83
+GEG +G VFK +N G VA+KR++ ++ + + EV +L
Sbjct: 15 IGEGAYGKVFKARDLKNG--------GRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 66
Query: 84 LRHENLVKLIGYCSESDNRLLVYEFMP----KGSLENHLFRKGVQPISWPTRVKIAIDVA 139
H N+V+L C+ S + L +L + + T + +
Sbjct: 67 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 126
Query: 140 RGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGY 199
RGL FLH V++RDLK N+L+ S+ KL+DFGLAR T +V T Y
Sbjct: 127 RGLDFLH--SHRVVHRDLKPQNILVTSSGQIKLADFGLAR---IYSFQMALTSVVVTLWY 181
Query: 200 AAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL-DEDRGGLAEQTLVEWADPFLRDSRR 258
APE + D++S G + E+ + + L P D R
Sbjct: 182 RAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR 241
Query: 259 VLRIMDTRLGGQYSKKEAQAVAAV-------VLQCLHMDPKNRPSMVDVL 301
+ + + ++ + V + +L+CL +P R S L
Sbjct: 242 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL 291
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 153 bits (388), Expect = 8e-45
Identities = 54/289 (18%), Positives = 96/289 (33%), Gaps = 35/289 (12%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHE 87
+G G FG ++ G T +G VAIK ++ H + E ++
Sbjct: 14 KIGSGSFGDIYLG---------TDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGG 62
Query: 88 NLVKLIGYC-SESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLH 146
+ I +C +E D ++V E + + F S T + +A + + ++H
Sbjct: 63 VGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSR--KFSLKTVLLLADQMISRIEYIH 120
Query: 147 GLDANVIYRDLKASNVL---LDSNFNAKLSDFGLAR-----DGPTGDNTHVSTRIVGTRG 198
N I+RD+K N L + DFGLA+ + + GT
Sbjct: 121 --SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTAR 178
Query: 199 YAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRR 258
YA+ + + D+ S G VL+ G + Q ++ +
Sbjct: 179 YASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 238
Query: 259 VLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 307
VL K A + C + ++P + L
Sbjct: 239 VLC-----------KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 1e-43
Identities = 63/309 (20%), Positives = 118/309 (38%), Gaps = 57/309 (18%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKE------WLTEVIYL 81
LLG GGFG V+ G + + VAIK ++ + E EV+ L
Sbjct: 11 LLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 61
Query: 82 GQLR--HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVA 139
++ +++L+ + D+ +L+ E + + V
Sbjct: 62 KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVL 120
Query: 140 RGLSFLHGLDANVIYRDLKASNVLLDSN-FNAKLSDFGLARDGPTGDNTHVSTRIVGTRG 198
+ H + V++RD+K N+L+D N KL DFG V T GTR
Sbjct: 121 EAVRHCH--NCGVLHRDIKDENILIDLNRGELKLIDFGSGAL----LKDTVYTDFDGTRV 174
Query: 199 YAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSR 257
Y+ PE++ + + V+S G++L +++ G PF D
Sbjct: 175 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDI-------------------PFEHDE- 214
Query: 258 RVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHT-SKDMPRT 316
I+ ++ + ++ + ++ CL + P +RP+ ++ H +D+
Sbjct: 215 ---EIIRGQV--FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN-----HPWMQDVLLP 264
Query: 317 PPPAKLHHH 325
A++H H
Sbjct: 265 QETAEIHLH 273
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 8e-43
Identities = 64/286 (22%), Positives = 116/286 (40%), Gaps = 25/286 (8%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLR 85
+GEG +G V+K +G VVA+K+++ ++ + E+ L +L
Sbjct: 9 KIGEGTYGVVYKA---------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 59
Query: 86 HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFL 145
H N+VKL+ + LV+EF+ + L+ + + I P + +GL+F
Sbjct: 60 HPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 146 HGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYV 205
H V++RDLK N+L+++ KL+DFGLAR + +V A +
Sbjct: 119 H--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVVTLWYRAPEILL 175
Query: 206 ATGHLTPKSDVYSFGVVLLELLSGRRALDED----------RGGLAEQTLVEWADPFLRD 255
+ + D++S G + E+++ R D R +V + D
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 235
Query: 256 SRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL 301
+ + + + +++ Q LH DP R S L
Sbjct: 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAAL 281
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 2e-42
Identities = 64/299 (21%), Positives = 117/299 (39%), Gaps = 39/299 (13%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQG--HKEWLTEVIYLGQLRH 86
+G+G FG VFK +G VA+K++ E+ + L E+ L L+H
Sbjct: 18 IGQGTFGEVFKA---------RHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 68
Query: 87 ENLVKLIGYCSESDNR--------LLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDV 138
EN+V LI C + LV++F + ++ +
Sbjct: 69 ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV--KFTLSEIKRVMQML 126
Query: 139 ARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS--TRIVGT 196
GL ++H +++RD+KA+NVL+ + KL+DFGLAR N+ + T V T
Sbjct: 127 LNGLYYIH--RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVT 184
Query: 197 RGYAAPEYVATGHL-TPKSDVYSFGVVLLELLSGRRALDEDR------------GGLAEQ 243
Y PE + P D++ G ++ E+ + + + G + +
Sbjct: 185 LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 244
Query: 244 TLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAA-VVLQCLHMDPKNRPSMVDVL 301
+ L + +++ ++ + A ++ + L +DP R D L
Sbjct: 245 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDAL 303
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 146 bits (370), Expect = 3e-42
Identities = 46/290 (15%), Positives = 89/290 (30%), Gaps = 35/290 (12%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHE 87
+GEG FG +F+G T + VAIK S + E L
Sbjct: 12 RIGEGSFGVIFEG---------TNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGC 60
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHG 147
+ + Y + ++ + SLE+ L G + S T A + + +H
Sbjct: 61 TGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIH- 118
Query: 148 LDANVIYRDLKASNVLLDSNFN-----AKLSDFGLAR-----DGPTGDNTHVSTRIVGTR 197
+ +++YRD+K N L+ + + DFG+ + + GT
Sbjct: 119 -EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 177
Query: 198 GYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSR 257
Y + + + D+ + G V + L G + +Q +
Sbjct: 178 RYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL 237
Query: 258 RVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 307
R L + + ++ P + ++
Sbjct: 238 RELC-----------AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (373), Expect = 3e-42
Identities = 69/284 (24%), Positives = 109/284 (38%), Gaps = 37/284 (13%)
Query: 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEW-- 74
K+ +F LLG+G FG V + +G A+K L+ E E
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILV---------REKATGRYYAMKILRKEVIIAKDEVAH 51
Query: 75 -LTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVK 133
+TE L RH L L D V E+ G L HL R+ + +
Sbjct: 52 TVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE--RVFTEERARF 109
Query: 134 IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRI 193
++ L +LH +V+YRD+K N++LD + + K++DFGL ++G + T
Sbjct: 110 YGAEIVSALEYLH--SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KTF 165
Query: 194 VGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 253
GT Y APE + D + GVV+ E++ GR PF
Sbjct: 166 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL-------------------PFY 206
Query: 254 RDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSM 297
L + ++ + + +++ L DPK R
Sbjct: 207 NQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGG 250
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 146 bits (368), Expect = 4e-42
Identities = 57/285 (20%), Positives = 110/285 (38%), Gaps = 27/285 (9%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLRH 86
+GEG +G V+K + G A+K+++ E + E+ L +L+H
Sbjct: 10 IGEGTYGVVYKAQNN----------YGETFALKKIRLEKEDEGIPSTTIREISILKELKH 59
Query: 87 ENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLH 146
N+VKL +LV+E + + + +G + T + + G+++ H
Sbjct: 60 SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEG--GLESVTAKSFLLQLLNGIAYCH 117
Query: 147 GLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVA 206
D V++RDLK N+L++ K++DFGLAR + IV A +
Sbjct: 118 --DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT-HEIVTLWYRAPDVLMG 174
Query: 207 TGHLTPKSDVYSFGVVLLELLSGRRALDEDRG---------GLAEQTLVEWADPF-LRDS 256
+ + D++S G + E+++G L W + L
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234
Query: 257 RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL 301
+ + + K ++ ++ + L +DP R + L
Sbjct: 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQAL 279
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 9e-41
Identities = 64/316 (20%), Positives = 116/316 (36%), Gaps = 38/316 (12%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHE 87
++G G FG V++ SG +VAIK++ Q + E+ + +L H
Sbjct: 27 VIGNGSFGVVYQA---------KLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHC 73
Query: 88 NLVKLIGYCSESDNR------LLVYEFMPKGSLENHL-FRKGVQPISWPTRVKIAIDVAR 140
N+V+L + S + LV +++P+ + + Q + + R
Sbjct: 74 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 141 GLSFLHGLDANVIYRDLKASNVLLDSN-FNAKLSDFGLARDGPTGDNTHVSTRIVGTRGY 199
L+++H + +RD+K N+LLD + KL DFG A+ + I
Sbjct: 134 SLAYIH--SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ--LVRGEPNVSYICSRYYR 189
Query: 200 AAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRV 259
A T DV+S G VL ELL G+ D G +++ R+ R
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249
Query: 260 L----------RIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS--LEQL 307
+ +I + + A+ + L P R + ++ ++L
Sbjct: 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309
Query: 308 HT-SKDMPRTPPPAKL 322
+ +P L
Sbjct: 310 RDPNVKLPNGRDTPAL 325
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 3e-40
Identities = 67/287 (23%), Positives = 107/287 (37%), Gaps = 29/287 (10%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLRH 86
+GEG +G VFK + +VA+KR++ + L E+ L +L+H
Sbjct: 10 IGEGTYGTVFKA---------KNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKH 60
Query: 87 ENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLH 146
+N+V+L LV+EF + + G + +GL F H
Sbjct: 61 KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLD--PEIVKSFLFQLLKGLGFCH 118
Query: 147 GLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPE-YV 205
NV++RDLK N+L++ N KL++FGLAR + + V T Y P+
Sbjct: 119 --SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY--SAEVVTLWYRPPDVLF 174
Query: 206 ATGHLTPKSDVYSFGVVLLELLSGRRALDEDRG----------GLAEQTLVEWADPF-LR 254
+ D++S G + EL + R L L T +W L
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234
Query: 255 DSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL 301
D + T K ++ L +P R S + L
Sbjct: 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEAL 281
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 1e-39
Identities = 61/314 (19%), Positives = 124/314 (39%), Gaps = 41/314 (13%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLK--AESFQGHKEWLTEVIYLGQLR 85
+G G +G V +G VAIK+L +S K E+ L +R
Sbjct: 25 PVGSGAYGAVCSA---------VDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMR 75
Query: 86 HENLVKLIGYCSESDNR------LLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVA 139
HEN++ L+ + + LV FM G+ L + + + +
Sbjct: 76 HENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHE--KLGEDRIQFLVYQML 131
Query: 140 RGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGY 199
+GL ++H A +I+RDLK N+ ++ + K+ DFGLAR ++ ++ +V
Sbjct: 132 KGLRYIH--AAGIIHRDLKPGNLAVNEDCELKILDFGLARQA----DSEMTGYVVTRWYR 185
Query: 200 AAPEYVATGHLTPKSDVYSFGVVLLELLSGR------------RALDEDRGGLAEQTLVE 247
A + T D++S G ++ E+++G+ + + + G + +
Sbjct: 186 APEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR 245
Query: 248 WADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS--LE 305
++ + L ++ + + ++ + L +D + R + + L E
Sbjct: 246 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFE 305
Query: 306 QLHTSKDMPRTPPP 319
LH ++D P+
Sbjct: 306 SLHDTEDEPQVQKY 319
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 136 bits (343), Expect = 8e-38
Identities = 62/270 (22%), Positives = 100/270 (37%), Gaps = 40/270 (14%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEW---LTEVIYLGQLR 85
LG G FG V SG A+K L + K+ L E L +
Sbjct: 49 LGTGSFGRVMLV---------KHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 86 HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFL 145
LVKL ++ N +V E++ G + +HL R G S P A + +L
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYL 157
Query: 146 HGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYV 205
H ++IYRDLK N+L+D +++DFG A+ T + GT APE +
Sbjct: 158 H--SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-----LCGTPEALAPEII 210
Query: 206 ATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDT 265
+ D ++ GV++ E+ +G PF D +
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYP-------------------PFFADQPIQIYEKIV 251
Query: 266 RLGGQYSKKEAQAVAAVVLQCLHMDPKNRP 295
++ + + ++ L +D R
Sbjct: 252 SGKVRFPSHFSSDLKDLLRNLLQVDLTKRF 281
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 128 bits (323), Expect = 4e-35
Identities = 51/298 (17%), Positives = 104/298 (34%), Gaps = 46/298 (15%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLR-H 86
LG G + VF+ + V +K LK K+ E+ L LR
Sbjct: 42 KLGRGKYSEVFEA---------INITNNEKVVVKILKPVK---KKKIKREIKILENLRGG 89
Query: 87 ENLVKLIGYCSESDNRL--LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSF 144
N++ L + +R LV+E + + Q ++ ++ + L +
Sbjct: 90 PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDY 144
Query: 145 LHGLDANVIYRDLKASNVLLDS-NFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPE 203
H +++RD+K NV++D + +L D+GLA G V +R + PE
Sbjct: 145 CH--SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY---NVRVASRYFKGPE 199
Query: 204 YVAT-GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLV------EWADPFLRDS 256
+ D++S G +L ++ + + + E ++
Sbjct: 200 LLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 259
Query: 257 RRVLRIMDTRLGGQYSKKEAQAVAA-------------VVLQCLHMDPKNRPSMVDVL 301
L + G++S+K + + + L D ++R + + +
Sbjct: 260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAM 317
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 9e-34
Identities = 65/311 (20%), Positives = 121/311 (38%), Gaps = 37/311 (11%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLK--AESFQGHKEWLTEVIYLGQLR 85
+G G +G V + +G+ VA+K+L +S K E+ L ++
Sbjct: 25 PVGSGAYGSVCAAF---------DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 75
Query: 86 HENLVKLIGYCSES----DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARG 141
HEN++ L+ + + + + G+ N++ + ++ + + RG
Sbjct: 76 HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQILRG 133
Query: 142 LSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAA 201
L ++H A++I+RDLK SN+ ++ + K+ DFGLAR +V+TR A
Sbjct: 134 LKYIH--SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRW----YRAP 187
Query: 202 PEYVATGHLTPKSDVYSFGVVLLELLSGR------------RALDEDRGGLAEQTLVEWA 249
+ H D++S G ++ ELL+GR + + G + L + +
Sbjct: 188 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 247
Query: 250 DPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS--LEQL 307
R+ + L M ++ + L +D R + L Q
Sbjct: 248 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307
Query: 308 HTSKDMPRTPP 318
H D P P
Sbjct: 308 HDPDDEPVADP 318
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (309), Expect = 3e-33
Identities = 71/292 (24%), Positives = 116/292 (39%), Gaps = 41/292 (14%)
Query: 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLK----AESFQGHK 72
K+ +NF +LG G +G VF + +G + A+K LK + + +
Sbjct: 20 KVGIENFELLKVLGTGAYGKVFLVR------KISGHDTGKLYAMKVLKKATIVQKAKTTE 73
Query: 73 EWLTEVIYLGQLRHE-NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTR 131
TE L +R LV L L+ +++ G L HL ++ + +
Sbjct: 74 HTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR--ERFTEHEV 131
Query: 132 VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVST 191
++ L LH +IYRD+K N+LLDSN + L+DFGL+++ + +
Sbjct: 132 QIYVGEIVLALEHLH--KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER-AY 188
Query: 192 RIVGTRGYAAPEYVATGH--LTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWA 249
GT Y AP+ V G D +S GV++ ELL+G
Sbjct: 189 DFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGAS------------------ 230
Query: 250 DPFLRDSRR--VLRIMDTRLGGQ--YSKKEAQAVAAVVLQCLHMDPKNRPSM 297
PF D + I L + Y ++ + ++ + L DPK R
Sbjct: 231 -PFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGC 281
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 2e-32
Identities = 63/325 (19%), Positives = 117/325 (36%), Gaps = 52/325 (16%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAE--SFQGHKEWLTEVIYLGQLR 85
+G G G V + VAIK+L + K E++ + +
Sbjct: 24 PIGSGAQGIVCAAY---------DAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN 74
Query: 86 HENLVKLIGYCS------ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVA 139
H+N++ L+ + E + LV E M + + + +
Sbjct: 75 HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ-----MELDHERMSYLLYQML 129
Query: 140 RGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGY 199
G+ LH A +I+RDLK SN+++ S+ K+ DFGLAR T + + T V TR Y
Sbjct: 130 CGIKHLH--SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYY 184
Query: 200 AAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDS--- 256
APE + D++S G ++ E++ + ++E +
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244
Query: 257 --------------------RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPS 296
++ +++K +A ++ + L +DP R S
Sbjct: 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 304
Query: 297 MVDVLTS--LEQLHTSKDMPRTPPP 319
+ D L + + ++ PP
Sbjct: 305 VDDALQHPYINVWYDPAEVEAPPPQ 329
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 112 bits (281), Expect = 5e-29
Identities = 53/318 (16%), Positives = 108/318 (33%), Gaps = 55/318 (17%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHE 87
LG G F V+ + VA+K ++ + + E+ L ++
Sbjct: 20 KLGWGHFSTVWLAK---------DMVNNTHVAMKIVRGDKVY-TEAAEDEIKLLQRVNDA 69
Query: 88 NLVKLIGYCSESDNRLL-VYEFMPKGSLENHLF-------------RKGVQPISWPTRVK 133
+ K + +LL + + + + + I +
Sbjct: 70 DNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQ 129
Query: 134 IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSN-FNAKLSDFGLARDGPTGDNTHVSTR 192
I+ + GL ++H +I+ D+K NVL++ L +A G T
Sbjct: 130 ISKQLLLGLDYMHR-RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTN 188
Query: 193 IVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRR----------ALDEDRGGLAE 242
+ TR Y +PE + +D++S ++ EL++G D+D
Sbjct: 189 SIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQII 248
Query: 243 QTLVEWADPFLRDSRRVLRIMDTR-------------------LGGQYSKKEAQAVAAVV 283
+ L E LR+ + ++R ++SK EA+ ++ +
Sbjct: 249 ELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFL 308
Query: 284 LQCLHMDPKNRPSMVDVL 301
L +DP+ R ++
Sbjct: 309 SPMLQLDPRKRADAGGLV 326
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 72.5 bits (177), Expect = 1e-15
Identities = 24/163 (14%), Positives = 45/163 (27%), Gaps = 28/163 (17%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES----------FQGHKEWLTE 77
L+GEG VF +K K G +
Sbjct: 7 LMGEGKESAVFNC----------YSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVL 56
Query: 78 VIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAID 137
I + L KL G Y + L + K + + ++
Sbjct: 57 AIRSARNEFRALQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVENPDEVLDM 111
Query: 138 VARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD 180
+ ++ + +++ DL NVL+ + DF + +
Sbjct: 112 ILEEVAKFY--HRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVE 151
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 350 | |||
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.88 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.72 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.27 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.12 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.22 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.16 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.76 |
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-55 Score=387.83 Aligned_cols=252 Identities=23% Similarity=0.372 Sum_probs=215.7
Q ss_pred hhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceeeEEeec
Q 018785 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (350)
Q Consensus 20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (350)
.++|++.+.||+|+||+||+| .+..+|+.||||++........+.+.+|+.+++.++||||+++++++.++
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a---------~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~ 89 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTA---------MDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG 89 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEE---------EBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred ccccEEEEEEecCcCcEEEEE---------EECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEEC
Confidence 358999999999999999999 66777999999999877666677899999999999999999999999999
Q ss_pred CceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccccc
Q 018785 100 DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR 179 (350)
Q Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~ 179 (350)
+..|+||||++|++|.+++..+ .+++.+++.++.||+.||.||| ++||+||||||+|||++.++.+||+|||++.
T Consensus 90 ~~~~ivmEy~~gg~L~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH--~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~ 164 (293)
T d1yhwa1 90 DELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLH--SNQVIHRDIKSDNILLGMDGSVKLTDFGFCA 164 (293)
T ss_dssp TEEEEEEECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred CEEEEEEEecCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHH--HCCCcccCCcHHHeEECCCCcEeeccchhhe
Confidence 9999999999999999988765 5999999999999999999999 8999999999999999999999999999998
Q ss_pred cCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhHHH
Q 018785 180 DGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRV 259 (350)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (350)
...... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+.
T Consensus 165 ~~~~~~--~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~------------- 229 (293)
T d1yhwa1 165 QITPEQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA------------- 229 (293)
T ss_dssp ECCSTT--CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH-------------
T ss_pred eecccc--ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHH-------------
Confidence 643322 22344679999999999999999999999999999999999999997644321111111
Q ss_pred HHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 260 LRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
.........+..+++++.+||.+||+.||.+|||++++++|
T Consensus 230 ---~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 230 ---TNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp ---HHCSCCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred ---hCCCCCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11112233456788999999999999999999999999875
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-56 Score=385.41 Aligned_cols=254 Identities=26% Similarity=0.329 Sum_probs=210.1
Q ss_pred hcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh-hHHHHHHHHHHHhccCCCcccceeeEEeec
Q 018785 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ-GHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (350)
Q Consensus 21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (350)
++|++.+.||+|+||+||+| .+..+|+.||||++...... ..+.+.+|+.++++++||||+++++++.++
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~---------~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~ 75 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLA---------VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREG 75 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEE---------EETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred cceEEEEEEecCcCeEEEEE---------EECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccC
Confidence 58999999999999999999 66677999999998765432 335688999999999999999999999999
Q ss_pred CceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccccc
Q 018785 100 DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR 179 (350)
Q Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~ 179 (350)
+..|+||||+++++|.+++..+. .+++.+++.++.|+++||.||| ++||+||||||+||+++.++.+||+|||++.
T Consensus 76 ~~~~ivmEy~~gg~L~~~l~~~~--~l~e~~~~~i~~qi~~al~ylH--~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~ 151 (271)
T d1nvra_ 76 NIQYLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLH--GIGITHRDIKPENLLLDERDNLKISDFGLAT 151 (271)
T ss_dssp TEEEEEEECCTTEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred ceeEEEEeccCCCcHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHH--HcCCccCcccHHHEEECCCCCEEEccchhhe
Confidence 99999999999999999997654 7999999999999999999999 8999999999999999999999999999998
Q ss_pred cCCCCCCCcccccccCCCcccCccccccCCC-CCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhHH
Q 018785 180 DGPTGDNTHVSTRIVGTRGYAAPEYVATGHL-TPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRR 258 (350)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (350)
...............||+.|+|||++.+..+ +.++|||||||++|+|++|+.||............
T Consensus 152 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~------------- 218 (271)
T d1nvra_ 152 VFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD------------- 218 (271)
T ss_dssp ECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHH-------------
T ss_pred eeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHH-------------
Confidence 6544333333445679999999999988876 57899999999999999999999765432211111
Q ss_pred HHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 259 VLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
.............+++++.+||.+||+.||++|||++++++|
T Consensus 219 ---~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 219 ---WKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp ---HHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ---HhcCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 111111122234678899999999999999999999999864
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-55 Score=379.37 Aligned_cols=248 Identities=25% Similarity=0.424 Sum_probs=212.7
Q ss_pred hhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch---hhHHHHHHHHHHHhccCCCcccceeeEE
Q 018785 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLVKLIGYC 96 (350)
Q Consensus 20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (350)
-++|++.+.||+|+||+||+| .+..+++.||+|++..... .....+.+|+.+++.++||||+++++++
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~---------~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~ 75 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLA---------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 75 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEE---------EETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hhHeEEEEEEecCCCcEEEEE---------EECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEE
Confidence 468999999999999999999 6667799999999875432 2346688999999999999999999999
Q ss_pred eecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcccc
Q 018785 97 SESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFG 176 (350)
Q Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg 176 (350)
.+++..|+||||+++|+|.+++.... .+++..++.++.||++||+||| ++|++||||||+||+++.++.+||+|||
T Consensus 76 ~~~~~~~ivmEy~~~g~L~~~l~~~~--~l~e~~~~~i~~qi~~al~~lH--~~~ivHrDiKp~Nill~~~~~~kl~DFG 151 (263)
T d2j4za1 76 HDATRVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFG 151 (263)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTTSCEEECCCC
T ss_pred EECCEEEEEEeecCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHH--HCCeeeeeeccccceecCCCCEeecccc
Confidence 99999999999999999999998765 7999999999999999999999 8999999999999999999999999999
Q ss_pred ccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhh
Q 018785 177 LARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDS 256 (350)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 256 (350)
++...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+.
T Consensus 152 ~a~~~~~~----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~---------- 217 (263)
T d2j4za1 152 WSVHAPSS----RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS---------- 217 (263)
T ss_dssp SCSCCCCC----CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH----------
T ss_pred eeeecCCC----cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHH----------
Confidence 99754332 2234568999999999999999999999999999999999999997654322211111
Q ss_pred HHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 257 RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
. .....+..+++++.+||.+||+.||.+|||++++++|
T Consensus 218 -------~--~~~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 218 -------R--VEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp -------T--TCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred -------c--CCCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence 1 1123455678899999999999999999999999975
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-55 Score=382.57 Aligned_cols=253 Identities=23% Similarity=0.333 Sum_probs=212.2
Q ss_pred hcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceeeEEeecC
Q 018785 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSESD 100 (350)
Q Consensus 21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 100 (350)
+.|++.+.||+|+||+||+| .+..+|..||||++........+.+.+|+.++++++||||+++++++.+++
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~---------~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~ 82 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKA---------QNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYEN 82 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEE---------EETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred cCeEEeEEEeeCCCcEEEEE---------EECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC
Confidence 46999999999999999999 666778999999998766666677889999999999999999999999999
Q ss_pred ceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcccccccc
Q 018785 101 NRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD 180 (350)
Q Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~~ 180 (350)
..++||||+++|+|.+++.... ..+++.++..++.||+.||.||| ++||+||||||+|||++.++.+||+|||++..
T Consensus 83 ~~~lvmEy~~~g~L~~~~~~~~-~~l~e~~~~~i~~qi~~gL~ylH--~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~ 159 (288)
T d2jfla1 83 NLWILIEFCAGGAVDAVMLELE-RPLTESQIQVVCKQTLDALNYLH--DNKIIHRDLKAGNILFTLDGDIKLADFGVSAK 159 (288)
T ss_dssp EEEEEEECCTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred eEEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH--HCCEEEeecChhheeECCCCCEEEEechhhhc
Confidence 9999999999999999886543 36999999999999999999999 89999999999999999999999999999864
Q ss_pred CCCCCCCcccccccCCCcccCccccc-----cCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhh
Q 018785 181 GPTGDNTHVSTRIVGTRGYAAPEYVA-----TGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRD 255 (350)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 255 (350)
.... ........||+.|+|||++. +..++.++|||||||++|+|++|+.||.+.........+...
T Consensus 160 ~~~~--~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~------- 230 (288)
T d2jfla1 160 NTRT--IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKS------- 230 (288)
T ss_dssp CHHH--HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHS-------
T ss_pred cCCC--cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC-------
Confidence 2111 11223467899999999884 456889999999999999999999999876543322222211
Q ss_pred hHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 256 SRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
.......+..+++++.+||.+||+.||.+|||++++++|
T Consensus 231 ---------~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 231 ---------EPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp ---------CCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred ---------CCCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111223345678899999999999999999999999875
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.3e-54 Score=377.61 Aligned_cols=266 Identities=25% Similarity=0.399 Sum_probs=224.0
Q ss_pred hhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceeeE
Q 018785 16 SKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGY 95 (350)
Q Consensus 16 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 95 (350)
+++..++|++.+.||+|+||+||+| .+..+++.||||+++... ...+.+.+|+.++++++||||++++++
T Consensus 12 wei~~~~~~~~~~iG~G~fg~Vy~a---------~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~ 81 (287)
T d1opja_ 12 WEMERTDITMKHKLGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGV 81 (287)
T ss_dssp TBCCGGGEEEEEETTTTTTSSEEEE---------EEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cEecHHHeEEeeEEeeCCCeEEEEE---------EECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCcc
Confidence 4567789999999999999999999 445568899999987654 345678999999999999999999999
Q ss_pred EeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccc
Q 018785 96 CSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDF 175 (350)
Q Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Df 175 (350)
+.+++..++||||+++|+|.+++.......+++..++.++.|++.||+||| ++||+||||||+|||++.++.+||+||
T Consensus 82 ~~~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH--~~~iiHrDlKp~NILl~~~~~~Kl~DF 159 (287)
T d1opja_ 82 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVADF 159 (287)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEECGGGCEEECCC
T ss_pred EeeCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHH--HCCcccCccccCeEEECCCCcEEEccc
Confidence 999999999999999999999998776678999999999999999999999 899999999999999999999999999
Q ss_pred cccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhh
Q 018785 176 GLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRD 255 (350)
Q Consensus 176 g~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 255 (350)
|++....... ........|++.|+|||++.+..++.++|||||||++|+|++|+.||....+.
T Consensus 160 G~a~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~---------------- 222 (287)
T d1opja_ 160 GLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---------------- 222 (287)
T ss_dssp CCTTTCCSSS-SEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCH----------------
T ss_pred cceeecCCCC-ceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchH----------------
Confidence 9998643322 22233345788899999999999999999999999999999987766432211
Q ss_pred hHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcCC
Q 018785 256 SRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSK 311 (350)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~ 311 (350)
......+........+..+++++.+|+.+||+.||++|||++++++.|+.+....
T Consensus 223 -~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~~ 277 (287)
T d1opja_ 223 -SQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 277 (287)
T ss_dssp -HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSSS
T ss_pred -HHHHHHHhcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhC
Confidence 1112223333344556678899999999999999999999999999999886554
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-55 Score=381.95 Aligned_cols=254 Identities=21% Similarity=0.302 Sum_probs=212.0
Q ss_pred hhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch---hhHHHHHHHHHHHhccCCCcccceeeEE
Q 018785 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLVKLIGYC 96 (350)
Q Consensus 20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (350)
.++|++.+.||+|+||+||+| .+..+|+.||||++..... .....+.+|+.++++++||||+++++++
T Consensus 7 p~dy~i~~~lG~G~fg~Vy~a---------~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~ 77 (288)
T d1uu3a_ 7 PEDFKFGKILGEGSFSTVVLA---------RELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTF 77 (288)
T ss_dssp GGGEEEEEEEEECSSCEEEEE---------EETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEE
T ss_pred CCCCEEEEEEeeCCCeEEEEE---------EECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEE
Confidence 368999999999999999999 6667799999999875432 3346788999999999999999999999
Q ss_pred eecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcccc
Q 018785 97 SESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFG 176 (350)
Q Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg 176 (350)
.+++..|+||||++||+|.+++...+ .+++..++.++.|++.||.||| ++||+||||||+||+++.++.++|+|||
T Consensus 78 ~~~~~~~ivmEy~~gg~L~~~~~~~~--~l~e~~~~~~~~qi~~al~ylH--~~~iiHrDiKp~NIll~~~~~vkl~DFG 153 (288)
T d1uu3a_ 78 QDDEKLYFGLSYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLH--GKGIIHRDLKPENILLNEDMHIQITDFG 153 (288)
T ss_dssp ECSSEEEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECTTSCEEECCCT
T ss_pred EECCEEEEEEEccCCCCHHHhhhccC--CCCHHHHHHHHHHHHHHHHhhc--cccEEcCcCCccccccCCCceEEecccc
Confidence 99999999999999999999988765 7999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhh
Q 018785 177 LARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDS 256 (350)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 256 (350)
++................||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+
T Consensus 154 ~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i----------- 222 (288)
T d1uu3a_ 154 TAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI----------- 222 (288)
T ss_dssp TCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-----------
T ss_pred cceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHH-----------
Confidence 998655444443444567999999999999999999999999999999999999999765432221111
Q ss_pred HHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018785 257 RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 305 (350)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~ 305 (350)
... ....+..+++++.+||.+||+.||.+|||+++++++-.
T Consensus 223 ------~~~--~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~ 263 (288)
T d1uu3a_ 223 ------IKL--EYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGP 263 (288)
T ss_dssp ------HTT--CCCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHH
T ss_pred ------HcC--CCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHH
Confidence 111 12345567889999999999999999999999876543
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-54 Score=373.19 Aligned_cols=265 Identities=28% Similarity=0.407 Sum_probs=209.8
Q ss_pred hhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccc--hhhHHHHHHHHHHHhccCCCcccceee
Q 018785 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES--FQGHKEWLTEVIYLGQLRHENLVKLIG 94 (350)
Q Consensus 17 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~ 94 (350)
++..++|++.+.||+|+||+||+|+++ ..||||++.... ....+.+.+|+.++++++||||+++++
T Consensus 4 ei~~~~~~~~~~lG~G~fg~Vy~~~~~------------~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~ 71 (276)
T d1uwha_ 4 EIPDGQITVGQRIGSGSFGTVYKGKWH------------GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71 (276)
T ss_dssp BCCTTCCCCCSEEEECSSCEEEEEESS------------SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred ccccccEEEEEEEeeCCCcEEEEEEEC------------CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeE
Confidence 345689999999999999999999542 249999987543 344577899999999999999999999
Q ss_pred EEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcc
Q 018785 95 YCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSD 174 (350)
Q Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~D 174 (350)
++. ++.+++||||+++|+|.+++.... ..+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|
T Consensus 72 ~~~-~~~~~lv~Ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~gl~yLH--~~~ivHrDlKp~NiLl~~~~~~Kl~D 147 (276)
T d1uwha_ 72 YST-APQLAIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLH--AKSIIHRDLKSNNIFLHEDLTVKIGD 147 (276)
T ss_dssp EEC-SSSCEEEEECCCEEEHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEEETTSSEEECC
T ss_pred EEe-ccEEEEEEecCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHh--cCCEeccccCHHHEEEcCCCCEEEcc
Confidence 865 467899999999999999997654 36999999999999999999999 89999999999999999999999999
Q ss_pred ccccccCCCCCCCcccccccCCCcccCccccccC---CCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcch
Q 018785 175 FGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG---HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADP 251 (350)
Q Consensus 175 fg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~---~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~ 251 (350)
||++................||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+............
T Consensus 148 FGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~---- 223 (276)
T d1uwha_ 148 FGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG---- 223 (276)
T ss_dssp CCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHH----
T ss_pred ccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHh----
Confidence 9999765444433344456789999999998643 578899999999999999999999986543221111111
Q ss_pred hhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcC
Q 018785 252 FLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 310 (350)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 310 (350)
...........+..+++++.+|+.+||+.||.+|||+.+++++|+.+..+
T Consensus 224 ---------~~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~ 273 (276)
T d1uwha_ 224 ---------RGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273 (276)
T ss_dssp ---------HTSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ---------cCCCCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence 00111111233456788999999999999999999999999999998865
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-54 Score=375.53 Aligned_cols=253 Identities=24% Similarity=0.345 Sum_probs=200.1
Q ss_pred hhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch--hhHHHHHHHHHHHhccCCCcccceeeEEe
Q 018785 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (350)
Q Consensus 20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (350)
.++|++.+.||+|+||+||+| .+..+|+.||+|.+..... .....+.+|+.++++++||||+++++++.
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~---------~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~ 73 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKI---------RRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRII 73 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEE---------EETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEE
T ss_pred chhCEEeEEEecCCCeEEEEE---------EECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEE
Confidence 368999999999999999999 6667799999999876543 33466889999999999999999999985
Q ss_pred e--cCceEEEEEcCCCCChhhHHhhc--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCC-----eeeCCCCCCceEEcCCC
Q 018785 98 E--SDNRLLVYEFMPKGSLENHLFRK--GVQPISWPTRVKIAIDVARGLSFLHGLDAN-----VIYRDLKASNVLLDSNF 168 (350)
Q Consensus 98 ~--~~~~~lv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~i~~ql~~al~~lh~~~~~-----i~H~di~~~Nili~~~~ 168 (350)
+ ++.+|+||||+++|+|.+++... ....+++..++.++.|++.||.||| +.| |+||||||+|||++.++
T Consensus 74 ~~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH--~~~~~~~~IiHrDiKp~NIll~~~~ 151 (269)
T d2java1 74 DRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH--RRSDGGHTVLHRDLKPANVFLDGKQ 151 (269)
T ss_dssp C----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH--HHCC---------CCGGGEEECTTS
T ss_pred eCCCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH--HhcCCCCCEEeCcCchhhcCcCCCC
Confidence 4 46789999999999999998643 2347999999999999999999999 655 99999999999999999
Q ss_pred cEEEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhh
Q 018785 169 NAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEW 248 (350)
Q Consensus 169 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~ 248 (350)
.+||+|||++....... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+
T Consensus 152 ~vkl~DFG~a~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i--- 226 (269)
T d2java1 152 NVKLGDFGLARILNHDT--SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI--- 226 (269)
T ss_dssp CEEECCHHHHHHC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH---
T ss_pred cEEEeeccceeecccCC--CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHH---
Confidence 99999999998643322 2223467899999999999999999999999999999999999999765432211111
Q ss_pred cchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 249 ADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
........+..+++++.+||.+||+.||.+|||++++++|
T Consensus 227 ---------------~~~~~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 227 ---------------REGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp ---------------HHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ---------------HcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 1111223455678899999999999999999999999875
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-54 Score=385.38 Aligned_cols=274 Identities=25% Similarity=0.346 Sum_probs=215.8
Q ss_pred hhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch-hhHHHHHHHHHHHhccCCCcccceeeEE
Q 018785 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLVKLIGYC 96 (350)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (350)
+..++|++.+.||+|+||+||+| .+..+|+.||+|++..... .....+.+|+.++++++||||+++++++
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~---------~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 73 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKV---------SHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 73 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEE---------EETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEE
T ss_pred CCccCCEEEEEEecCCCeEEEEE---------EECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 45789999999999999999999 6667799999999876533 3346788999999999999999999999
Q ss_pred eecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCC-CCeeeCCCCCCceEEcCCCcEEEccc
Q 018785 97 SESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLD-ANVIYRDLKASNVLLDSNFNAKLSDF 175 (350)
Q Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~-~~i~H~di~~~Nili~~~~~~~l~Df 175 (350)
.+.+..++||||++|++|.+++.+.+ .+++..++.++.|++.||.||| + +||+||||||+|||++.++.+||+||
T Consensus 74 ~~~~~~~iVmEy~~gg~L~~~l~~~~--~l~~~~~~~~~~qil~aL~yLH--~~~~IiHRDiKP~NILl~~~~~vkl~DF 149 (322)
T d1s9ja_ 74 YSDGEISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDF 149 (322)
T ss_dssp ECSSEEEEEEECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH--HHHCCCCSCCSGGGEEECTTCCEEECCC
T ss_pred EECCEEEEEEEcCCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHH--HhCCEEccccCHHHeeECCCCCEEEeeC
Confidence 99999999999999999999998765 6999999999999999999999 6 49999999999999999999999999
Q ss_pred cccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhc------
Q 018785 176 GLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWA------ 249 (350)
Q Consensus 176 g~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~------ 249 (350)
|+|...... ......||+.|+|||++.+..|+.++||||+||++|+|++|+.||.+.+............
T Consensus 150 Gla~~~~~~----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~ 225 (322)
T d1s9ja_ 150 GVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAE 225 (322)
T ss_dssp CCCHHHHHH----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------
T ss_pred CCccccCCC----ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCccc
Confidence 999753221 1233579999999999999999999999999999999999999997654332111100000
Q ss_pred -------------------chhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHhhh
Q 018785 250 -------------------DPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS--LEQLH 308 (350)
Q Consensus 250 -------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~--L~~~~ 308 (350)
.+.......................++.++.+||.+||..||.+|||++++++| +.+..
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~ 305 (322)
T d1s9ja_ 226 TPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD 305 (322)
T ss_dssp --------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred CCcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCC
Confidence 000000111111112222222223467899999999999999999999999987 55443
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-53 Score=377.39 Aligned_cols=254 Identities=22% Similarity=0.368 Sum_probs=198.5
Q ss_pred hhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh-hHHHHHHHHHHHhccCCCcccceeeEEe
Q 018785 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ-GHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (350)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (350)
..++|++.+.||+|+||+||+| .+..+|+.||||++...... ....+.+|+.+++.++||||+++++++.
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~---------~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 77 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILA---------EDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYE 77 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEE---------EETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEE
T ss_pred CccceEEEEEEeeccCeEEEEE---------EECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 4577999999999999999999 66677999999999765433 2345778999999999999999999999
Q ss_pred ecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEc---CCCcEEEcc
Q 018785 98 ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLD---SNFNAKLSD 174 (350)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~---~~~~~~l~D 174 (350)
+++.+|+||||++|++|.+++...+ .+++.++..++.||+.||+||| ++|++||||||+||++. .++.++|+|
T Consensus 78 ~~~~~~lvmE~~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~al~ylH--~~~iiHrDiKp~Nil~~~~~~~~~vkl~D 153 (307)
T d1a06a_ 78 SGGHLYLIMQLVSGGELFDRIVEKG--FYTERDASRLIFQVLDAVKYLH--DLGIVHRDLKPENLLYYSLDEDSKIMISD 153 (307)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHTCS--CCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEESSSSTTCCEEECC
T ss_pred ECCEEEEEEeccCCCcHHHhhhccc--CCCHHHHHHHHHHHHHHHHhhh--hceeeeEEecccceeecccCCCceEEEec
Confidence 9999999999999999999997764 7999999999999999999999 99999999999999995 478899999
Q ss_pred ccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhh
Q 018785 175 FGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLR 254 (350)
Q Consensus 175 fg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~ 254 (350)
||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.........+...
T Consensus 154 FG~a~~~~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~------ 224 (307)
T d1a06a_ 154 FGLSKMEDPGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKA------ 224 (307)
T ss_dssp C---------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTT------
T ss_pred cceeEEccCCC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhcc------
Confidence 99997543222 223457999999999999999999999999999999999999999765432222221110
Q ss_pred hhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 255 DSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
...........+++++.+||.+||+.||.+|||++++++|
T Consensus 225 ---------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 225 ---------EYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp ---------CCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred ---------CCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 1111223345678899999999999999999999999986
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-53 Score=366.49 Aligned_cols=248 Identities=25% Similarity=0.385 Sum_probs=201.7
Q ss_pred cccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccc--hhhHHHHHHHHHHHhccCCCcccceeeEEee-
Q 018785 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES--FQGHKEWLTEVIYLGQLRHENLVKLIGYCSE- 98 (350)
Q Consensus 22 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~- 98 (350)
.|++.++||+|+||+||+| .+..++..||+|.+.... ....+.+.+|++++++++||||+++++++..
T Consensus 10 y~~~~~~iG~G~fg~Vy~~---------~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~ 80 (270)
T d1t4ha_ 10 FLKFDIEIGRGSFKTVYKG---------LDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWEST 80 (270)
T ss_dssp EEEEEEEEEECSSEEEEEE---------EETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEE
T ss_pred EEEeeeEEecCcCcEEEEE---------EECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeec
Confidence 3478889999999999999 666678999999987653 2344668899999999999999999999865
Q ss_pred ---cCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC--eeeCCCCCCceEEc-CCCcEEE
Q 018785 99 ---SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDAN--VIYRDLKASNVLLD-SNFNAKL 172 (350)
Q Consensus 99 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~--i~H~di~~~Nili~-~~~~~~l 172 (350)
...+|+||||+++++|.+++.+.. .+++..++.++.||+.||+||| +++ |+||||||+|||++ .++.+||
T Consensus 81 ~~~~~~~~ivmE~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~gl~yLH--~~~~~IiHrDiKp~NILl~~~~~~~Kl 156 (270)
T d1t4ha_ 81 VKGKKCIVLVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLH--TRTPPIIHRDLKCDNIFITGPTGSVKI 156 (270)
T ss_dssp SSSCEEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH--TSSSCCCCSCCCGGGEEESSTTSCEEE
T ss_pred cccCCEEEEEEeCCCCCcHHHHHhccc--cccHHHHHHHHHHHHHHHHHHH--HCCCCEEeCCcChhhceeeCCCCCEEE
Confidence 345799999999999999998765 7999999999999999999999 788 99999999999996 5789999
Q ss_pred ccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchh
Q 018785 173 SDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPF 252 (350)
Q Consensus 173 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 252 (350)
+|||++...... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+..+.....
T Consensus 157 ~DFGla~~~~~~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~--------- 222 (270)
T d1t4ha_ 157 GDLGLATLKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIY--------- 222 (270)
T ss_dssp CCTTGGGGCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHH---------
T ss_pred eecCcceeccCC----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHH---------
Confidence 999999753221 2234579999999998865 59999999999999999999999997544221110
Q ss_pred hhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 253 LRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
..+.........+...++++.+||.+||+.||++|||++++++|
T Consensus 223 -------~~i~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 223 -------RRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp -------HHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred -------HHHHcCCCCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence 01111111122334567789999999999999999999999875
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=5.7e-53 Score=379.76 Aligned_cols=256 Identities=23% Similarity=0.321 Sum_probs=215.8
Q ss_pred hhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceeeEEe
Q 018785 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (350)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (350)
...++|++.+.||+|+||+||+| .+..+|+.||||++........+.+.+|+.++++++||||+++++++.
T Consensus 23 ~il~~Y~i~~~lG~G~fg~Vy~~---------~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~ 93 (350)
T d1koaa2 23 HVLDHYDIHEELGTGAFGVVHRV---------TERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 93 (350)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEE---------EETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEE
T ss_pred CCccCeEEEEEEecCcCeEEEEE---------EECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 34578999999999999999999 666779999999998777666778899999999999999999999999
Q ss_pred ecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcC--CCcEEEccc
Q 018785 98 ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS--NFNAKLSDF 175 (350)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~--~~~~~l~Df 175 (350)
+++.+|+||||++||+|.+++.... ..+++.++..++.||+.||.||| ++|++||||||+|||++. ++.+||+||
T Consensus 94 ~~~~~~ivmE~~~gg~L~~~l~~~~-~~l~e~~~~~i~~qi~~aL~ylH--~~~iiHrDiKp~NIll~~~~~~~vkL~DF 170 (350)
T d1koaa2 94 DDNEMVMIYEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMH--ENNYVHLDLKPENIMFTTKRSNELKLIDF 170 (350)
T ss_dssp ETTEEEEEECCCCSCBHHHHHTCTT-SCBCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEESSTTSCCEEECCC
T ss_pred ECCEEEEEEEcCCCCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHH--hcCCeeeeechhHeeeccCCCCeEEEeec
Confidence 9999999999999999999986443 36999999999999999999999 999999999999999964 578999999
Q ss_pred cccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhh
Q 018785 176 GLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRD 255 (350)
Q Consensus 176 g~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 255 (350)
|++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+...
T Consensus 171 G~a~~~~~~~---~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~------- 240 (350)
T d1koaa2 171 GLTAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSC------- 240 (350)
T ss_dssp TTCEECCTTS---CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT-------
T ss_pred chheeccccc---ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhC-------
Confidence 9997643322 233467899999999999999999999999999999999999999765432222222111
Q ss_pred hHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 256 SRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
...........+++++.+||.+||..||.+|||++++++|
T Consensus 241 --------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 241 --------DWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp --------CCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred --------CCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1111122234678899999999999999999999999987
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-53 Score=377.37 Aligned_cols=266 Identities=29% Similarity=0.410 Sum_probs=217.6
Q ss_pred hhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch-hhHHHHHHHHHHHhcc-CCCcccceee
Q 018785 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQL-RHENLVKLIG 94 (350)
Q Consensus 17 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~ 94 (350)
++..++|++.++||+|+||+||+|++... ........||+|.+..... .....+.+|+.+++++ +||||+++++
T Consensus 33 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~ 108 (325)
T d1rjba_ 33 EFPRENLEFGKVLGSGAFGKVMNATAYGI----SKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLG 108 (325)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESC----SSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cCCHHHeEEeeEEeeCCCeEEEEEEEcCC----CcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEE
Confidence 34557899999999999999999976543 2334456799998865432 2335688899999998 8999999999
Q ss_pred EEeecCceEEEEEcCCCCChhhHHhhcCC---------------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCee
Q 018785 95 YCSESDNRLLVYEFMPKGSLENHLFRKGV---------------------QPISWPTRVKIAIDVARGLSFLHGLDANVI 153 (350)
Q Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------------------~~l~~~~~~~i~~ql~~al~~lh~~~~~i~ 153 (350)
++.+.+.+++||||+++|+|.+++..+.. ..+++..++.++.|++.||+||| +++|+
T Consensus 109 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH--~~~Ii 186 (325)
T d1rjba_ 109 ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE--FKSCV 186 (325)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH--HTTEE
T ss_pred EEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH--hCCee
Confidence 99999999999999999999999976531 35889999999999999999999 89999
Q ss_pred eCCCCCCceEEcCCCcEEEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCC
Q 018785 154 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRA 232 (350)
Q Consensus 154 H~di~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~p 232 (350)
||||||+||+++.++.+||+|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..|
T Consensus 187 HRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~P 266 (325)
T d1rjba_ 187 HRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 266 (325)
T ss_dssp ETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred eccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCC
Confidence 999999999999999999999999976544444434445668999999999999999999999999999999997 8999
Q ss_pred CcccccCcchhhhhhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018785 233 LDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 305 (350)
Q Consensus 233 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~ 305 (350)
|.+....... ...+....+...+..+++++.+||.+||+.||++|||+++|+++|.
T Consensus 267 f~~~~~~~~~-----------------~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 267 YPGIPVDANF-----------------YKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp STTCCCSHHH-----------------HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCCHHHHH-----------------HHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 9765533221 1222233334456678899999999999999999999999999996
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=5.5e-53 Score=380.19 Aligned_cols=254 Identities=21% Similarity=0.301 Sum_probs=215.6
Q ss_pred hhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceeeEEeec
Q 018785 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (350)
Q Consensus 20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (350)
.++|++.+.||+|+||+||+| .+..+|+.||||++..........+.+|+.++++++||||+++++++.++
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a---------~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~ 98 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRC---------VEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDK 98 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEE---------EETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECS
T ss_pred ccceEEEEEEecCCCeEEEEE---------EECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence 367999999999999999999 66677999999999877666667788999999999999999999999999
Q ss_pred CceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEc--CCCcEEEccccc
Q 018785 100 DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLD--SNFNAKLSDFGL 177 (350)
Q Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~--~~~~~~l~Dfg~ 177 (350)
+.+|+||||++|++|.+++.... ..+++.+++.++.||+.||.||| ++||+||||||+|||++ .++.++|+|||+
T Consensus 99 ~~~~ivmE~~~gg~L~~~~~~~~-~~l~e~~~~~i~~qi~~aL~ylH--~~~iiHRDiKp~NILl~~~~~~~vkL~DFGl 175 (352)
T d1koba_ 99 YEMVLILEFLSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMH--EHSIVHLDIKPENIMCETKKASSVKIIDFGL 175 (352)
T ss_dssp SEEEEEEECCCCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEESSTTCCCEEECCCTT
T ss_pred CEEEEEEEcCCCChHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH--HCCeeecccccccccccccCCCeEEEeeccc
Confidence 99999999999999999876543 36999999999999999999999 99999999999999997 568899999999
Q ss_pred cccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhH
Q 018785 178 ARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSR 257 (350)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 257 (350)
+....... ......|++.|+|||++.+..++.++|||||||++|+|++|..||.+.........+..
T Consensus 176 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~---------- 242 (352)
T d1koba_ 176 ATKLNPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKR---------- 242 (352)
T ss_dssp CEECCTTS---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHH----------
T ss_pred ceecCCCC---ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh----------
Confidence 98654322 23345789999999999999999999999999999999999999986553222222211
Q ss_pred HHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 258 RVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
............+++++.+||.+||+.||.+|||+.++++|
T Consensus 243 -----~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 243 -----CDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp -----CCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred -----CCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11112233345678899999999999999999999999986
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-53 Score=366.27 Aligned_cols=257 Identities=28% Similarity=0.423 Sum_probs=204.6
Q ss_pred hhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceeeEEeec
Q 018785 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (350)
Q Consensus 20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (350)
.++|++.+.||+|+||+||+|++. +++.||||.+.... ...+.+.+|+.++++++||||+++++++..+
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~----------~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~ 72 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWL----------NKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 72 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEET----------TTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hHHcEEEEEEeeCCCeEEEEEEEC----------CCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccC
Confidence 468999999999999999999543 35689999997654 3356789999999999999999999999999
Q ss_pred CceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccccc
Q 018785 100 DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR 179 (350)
Q Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~ 179 (350)
+..++||||+++|+|.+++.... ..+++..++.++.|++.||.||| +++++||||||+||+++.++.+||+|||++.
T Consensus 73 ~~~~lv~E~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qia~gl~~lH--~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~ 149 (263)
T d1sm2a_ 73 APICLVFEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLE--EACVIHRDLAARNCLVGENQVIKVSDFGMTR 149 (263)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHH--HTTCCCTTCSGGGEEECGGGCEEECSCC---
T ss_pred CceEEEEEecCCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHhhh--ccceeecccchhheeecCCCCeEecccchhe
Confidence 99999999999999999987653 36889999999999999999999 8999999999999999999999999999997
Q ss_pred cCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCC-CCcccccCcchhhhhhhcchhhhhhHH
Q 018785 180 DGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRR-ALDEDRGGLAEQTLVEWADPFLRDSRR 258 (350)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~-pf~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (350)
........ ......|++.|+|||++.+..++.++|||||||++|+|++++. ||........
T Consensus 150 ~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~----------------- 211 (263)
T d1sm2a_ 150 FVLDDQYT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV----------------- 211 (263)
T ss_dssp ----------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHH-----------------
T ss_pred eccCCCce-eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHH-----------------
Confidence 64333222 2233568899999999999999999999999999999999644 4443322111
Q ss_pred HHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhc
Q 018785 259 VLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHT 309 (350)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 309 (350)
...+........+..+++++.+|+.+||+.||++|||+++++++|+++..
T Consensus 212 -~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 212 -VEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp -HHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -HHHHHhcCCCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 11122222334456678899999999999999999999999999999864
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.5e-52 Score=369.96 Aligned_cols=265 Identities=27% Similarity=0.423 Sum_probs=207.4
Q ss_pred hhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch-hhHHHHHHHHHHHhccCCCcccceeeEE
Q 018785 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLVKLIGYC 96 (350)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (350)
+..++|++.++||+|+||+||+|++.. .......||||.+..... ...+.+.+|+.++++++||||+++++++
T Consensus 23 i~~~~~~~~~~lG~G~fg~Vy~~~~~~------~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~ 96 (299)
T d1jpaa_ 23 IDISCVKIEQVIGAGEFGEVCSGHLKL------PGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVV 96 (299)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECC---------CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred hChhhcEEeeEEeeCCCeEEEEEEEeC------CCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEE
Confidence 345789999999999999999996542 122345789998865433 3456789999999999999999999999
Q ss_pred eecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcccc
Q 018785 97 SESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFG 176 (350)
Q Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg 176 (350)
..++..++||||+++|+|.+++.... ..+++.+++.++.|++.||.||| +++++||||||+|||++.++.+||+|||
T Consensus 97 ~~~~~~~iv~Ey~~~g~L~~~~~~~~-~~l~~~~~~~i~~qia~gl~yLH--~~~iiHrDlKp~NILl~~~~~~Kl~DFG 173 (299)
T d1jpaa_ 97 TKSTPVMIITEFMENGSLDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLA--DMNYVHRDLAARNILVNSNLVCKVSDFG 173 (299)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTTCCEEECCC-
T ss_pred eeCCEEEEEEEecCCCcceeeecccc-CCCCHHHHHHHHHHHHHHHHHHh--hCCCccCccccceEEECCCCcEEECCcc
Confidence 99999999999999999999887644 36899999999999999999999 8999999999999999999999999999
Q ss_pred ccccCCCCCCCcc---cccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccccCcchhhhhhhcchh
Q 018785 177 LARDGPTGDNTHV---STRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPF 252 (350)
Q Consensus 177 ~~~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~ 252 (350)
++........... .....+++.|+|||.+.+..++.++|||||||++|+|++ |..||.+.......
T Consensus 174 la~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~---------- 243 (299)
T d1jpaa_ 174 LSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVI---------- 243 (299)
T ss_dssp ----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH----------
T ss_pred cceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHH----------
Confidence 9976543322211 122457889999999999999999999999999999998 89999765432111
Q ss_pred hhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhc
Q 018785 253 LRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHT 309 (350)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 309 (350)
..+........+..+++++.+|+.+||+.||.+|||+.++++.|+++..
T Consensus 244 --------~~i~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 244 --------NAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp --------HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred --------HHHHcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 1122222334556788899999999999999999999999999998754
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-53 Score=368.72 Aligned_cols=265 Identities=26% Similarity=0.404 Sum_probs=217.0
Q ss_pred hhhhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCccccee
Q 018785 14 MISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLI 93 (350)
Q Consensus 14 ~~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 93 (350)
.-+++..++|++.+.||+|+||+||+|+++ ++..||||.+.... ...+.+.+|+.++++++||||++++
T Consensus 6 ~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~----------~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~ 74 (272)
T d1qpca_ 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYN----------GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLY 74 (272)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEET----------TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCeecCHHHeEEeEEEecCCCcEEEEEEEC----------CCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEE
Confidence 344566789999999999999999999543 35689999997654 3456789999999999999999999
Q ss_pred eEEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEc
Q 018785 94 GYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLS 173 (350)
Q Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~ 173 (350)
+++.+ +..++||||+++|+|.+++.......+++..++.++.|+++||.||| +++++||||||+||+++.++.+||+
T Consensus 75 g~~~~-~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH--~~~ivHrDiKp~NIll~~~~~~Kl~ 151 (272)
T d1qpca_ 75 AVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--ERNYIHRDLRAANILVSDTLSCKIA 151 (272)
T ss_dssp EEECS-SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECTTSCEEEC
T ss_pred eeecc-CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH--hCCcccCccchhheeeecccceeec
Confidence 98754 57799999999999999886554446999999999999999999999 8999999999999999999999999
Q ss_pred cccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCc-ccccCcchhhhhhhcchh
Q 018785 174 DFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALD-EDRGGLAEQTLVEWADPF 252 (350)
Q Consensus 174 Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~-~~~~~~~~~~~~~~~~~~ 252 (350)
|||++....... ........+++.|+|||++.+..++.++|||||||++|+|++|+.|+. .....
T Consensus 152 DFGla~~~~~~~-~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~------------- 217 (272)
T d1qpca_ 152 DFGLARLIEDNE-YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP------------- 217 (272)
T ss_dssp CCTTCEECSSSC-EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-------------
T ss_pred cccceEEccCCc-cccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHH-------------
Confidence 999998653322 122233568889999999998999999999999999999999766553 32211
Q ss_pred hhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcCC
Q 018785 253 LRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSK 311 (350)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~ 311 (350)
.....+........+..+++++.+|+.+||+.||++|||++++++.|+.+.+++
T Consensus 218 -----~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ftst 271 (272)
T d1qpca_ 218 -----EVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 271 (272)
T ss_dssp -----HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred -----HHHHHHHhcCCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhcC
Confidence 111222223334455678889999999999999999999999999999987653
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-52 Score=370.25 Aligned_cols=254 Identities=24% Similarity=0.341 Sum_probs=211.8
Q ss_pred hhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch------hhHHHHHHHHHHHhccCCCcccce
Q 018785 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF------QGHKEWLTEVIYLGQLRHENLVKL 92 (350)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~ 92 (350)
..++|++.+.||+|+||+||+| .+..+|+.||||++..... ...+.+.+|+.++++++||||+++
T Consensus 8 i~d~Y~~~~~lG~G~fg~Vy~~---------~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~ 78 (293)
T d1jksa_ 8 VDDYYDTGEELGSGQFAVVKKC---------REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITL 78 (293)
T ss_dssp GGGTEEEEEEEEECSSEEEEEE---------EETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cccCEEEeEEEecCCCeEEEEE---------EECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcE
Confidence 3578999999999999999999 6667799999999865432 235678899999999999999999
Q ss_pred eeEEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCC----
Q 018785 93 IGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNF---- 168 (350)
Q Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~---- 168 (350)
++++.+.+.+|+||||+++++|.+++.... .+++..++.++.|++.||+||| +.|++||||||+||+++.++
T Consensus 79 ~~~~~~~~~~~iv~E~~~gg~L~~~i~~~~--~l~~~~~~~~~~qi~~al~yLH--~~~ivHrDiKp~Nill~~~~~~~~ 154 (293)
T d1jksa_ 79 HEVYENKTDVILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLH--SLQIAHFDLKPENIMLLDRNVPKP 154 (293)
T ss_dssp EEEEECSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEESCSSSSSC
T ss_pred EEEEEECCEEEEEEEcCCCccccchhcccc--ccchhHHHHHHHHHHHHHHhhh--hcceeecccccceEEEecCCCccc
Confidence 999999999999999999999999998765 7999999999999999999999 99999999999999998776
Q ss_pred cEEEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhh
Q 018785 169 NAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEW 248 (350)
Q Consensus 169 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~ 248 (350)
.++++|||++....... ......+++.|+|||++.+..++.++||||+||++|+|++|+.||.+.+.......+...
T Consensus 155 ~vkl~DfG~a~~~~~~~---~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~ 231 (293)
T d1jksa_ 155 RIKIIDFGLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 231 (293)
T ss_dssp CEEECCCTTCEECTTSC---BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTT
T ss_pred ceEecchhhhhhcCCCc---cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhc
Confidence 49999999997643322 223356889999999999999999999999999999999999999875543322222211
Q ss_pred cchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 249 ADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
.. ......+..+++++.+||.+||+.||.+|||++++++|
T Consensus 232 ~~---------------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 232 NY---------------EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp CC---------------CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CC---------------CCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 10 00011123467889999999999999999999999875
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-52 Score=374.21 Aligned_cols=251 Identities=25% Similarity=0.370 Sum_probs=215.1
Q ss_pred hhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch---hhHHHHHHHHHHHhccCCCcccceeeE
Q 018785 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLVKLIGY 95 (350)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~ 95 (350)
.-++|++.+.||+|+||.||+| .+..+|+.||||++..... .....+.+|+.+++.++||||++++++
T Consensus 3 ~l~dy~~~~~lG~G~fg~V~~~---------~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~ 73 (337)
T d1o6la_ 3 TMNDFDYLKLLGKGTFGKVILV---------REKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYA 73 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEE---------EETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEE
T ss_pred chHhcEEEEEEecCcCeEEEEE---------EECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEee
Confidence 3578999999999999999999 6677899999999976532 345678899999999999999999999
Q ss_pred EeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccc
Q 018785 96 CSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDF 175 (350)
Q Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Df 175 (350)
+.+.+.+|+||||++||+|.+++.... .+++..++.++.||+.||+||| ++|++||||||+||+++.+|.+||+||
T Consensus 74 ~~~~~~~~iv~ey~~gg~L~~~~~~~~--~~~e~~~~~~~~qil~al~ylH--~~~iiHRDlKP~NILl~~~g~vkl~DF 149 (337)
T d1o6la_ 74 FQTHDRLCFVMEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLH--SRDVVYRDIKLENLMLDKDGHIKITDF 149 (337)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCCGGGEEECTTSCEEECCC
T ss_pred eccccccccceeccCCCchhhhhhccc--CCcHHHHHHHHHHHhhhhhhhh--hcCccccccCHHHeEecCCCCEEEeec
Confidence 999999999999999999999998775 7999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhh
Q 018785 176 GLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRD 255 (350)
Q Consensus 176 g~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 255 (350)
|++....... .......||+.|+|||++.+..|+.++|+|||||++|+|++|+.||.+.+.......+.
T Consensus 150 G~a~~~~~~~--~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~--------- 218 (337)
T d1o6la_ 150 GLCKEGISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL--------- 218 (337)
T ss_dssp TTCBCSCCTT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH---------
T ss_pred ccccccccCC--cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHh---------
Confidence 9998543322 22344679999999999999999999999999999999999999998765322211111
Q ss_pred hHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 018785 256 SRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPS-----MVDVLTS 303 (350)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-----~~~ll~~ 303 (350)
.. ....+..+++++.+||.+||+.||.+|++ ++++++|
T Consensus 219 --------~~--~~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 219 --------ME--EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp --------HC--CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred --------cC--CCCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 11 12345678899999999999999999994 8999886
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-52 Score=371.70 Aligned_cols=248 Identities=28% Similarity=0.373 Sum_probs=207.8
Q ss_pred hhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch---hhHHHHHHHHHHHhccCCCcccceeeEE
Q 018785 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLVKLIGYC 96 (350)
Q Consensus 20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (350)
.+.|++.+.||+|+||+||+| .+..+|+.||||++..... .....+.+|+.++++++||||+++++++
T Consensus 14 ~~~y~~l~~lG~G~fg~Vy~a---------~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~ 84 (309)
T d1u5ra_ 14 EKLFSDLREIGHGSFGAVYFA---------RDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCY 84 (309)
T ss_dssp HHHEEEEEEEEECSSSEEEEE---------EETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred HHhcEeeEEEecCCCeEEEEE---------EECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEE
Confidence 356999999999999999999 6667799999999876543 2335688999999999999999999999
Q ss_pred eecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcccc
Q 018785 97 SESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFG 176 (350)
Q Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg 176 (350)
.+++..|+||||+.+++|..++..+. .+++.+++.++.||+.||.||| ++||+||||||+|||++.++.+||+|||
T Consensus 85 ~~~~~~~iv~E~~~~g~l~~~~~~~~--~l~e~~~~~i~~qi~~aL~yLH--~~~iiHrDiKp~NILl~~~~~~Kl~DFG 160 (309)
T d1u5ra_ 85 LREHTAWLVMEYCLGSASDLLEVHKK--PLQEVEIAAVTHGALQGLAYLH--SHNMIHRDVKAGNILLSEPGLVKLGDFG 160 (309)
T ss_dssp EETTEEEEEEECCSEEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCSGGGEEEETTTEEEECCCT
T ss_pred EECCEEEEEEEecCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHH--hCCEeccCCCcceEEECCCCCEEEeecc
Confidence 99999999999999988877666554 7999999999999999999999 8999999999999999999999999999
Q ss_pred ccccCCCCCCCcccccccCCCcccCcccccc---CCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhh
Q 018785 177 LARDGPTGDNTHVSTRIVGTRGYAAPEYVAT---GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 253 (350)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~---~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 253 (350)
++..... .....||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.+.......
T Consensus 161 ~a~~~~~------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~----------- 223 (309)
T d1u5ra_ 161 SASIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL----------- 223 (309)
T ss_dssp TCBSSSS------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH-----------
T ss_pred cccccCC------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHH-----------
Confidence 9975332 223569999999999864 45889999999999999999999999764422111
Q ss_pred hhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 254 RDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
............+..+++++.+||.+||+.||.+|||++++++|
T Consensus 224 ------~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 224 ------YHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp ------HHHHHSCCCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred ------HHHHhCCCCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence 11222222223344678899999999999999999999999875
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-52 Score=358.92 Aligned_cols=255 Identities=26% Similarity=0.394 Sum_probs=215.6
Q ss_pred hhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceeeEEeec
Q 018785 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (350)
Q Consensus 20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (350)
.++|++.+.||+|+||+||+|+++ ++..||||.++.... ..+.+.+|+.++++++||||+++++++.++
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~----------~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~ 71 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWR----------GQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 71 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEET----------TTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCS
T ss_pred hHHCEEeEEEecCCCeEEEEEEEC----------CCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeC
Confidence 478999999999999999999543 467899999987653 356789999999999999999999999999
Q ss_pred CceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccccc
Q 018785 100 DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR 179 (350)
Q Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~ 179 (350)
+.+++||||+++|+|.+++.... ..+++..+..++.|+++||+||| +.|++|+||||+||+++.++.+||+|||++.
T Consensus 72 ~~~~iv~Ey~~~g~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~~LH--~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~ 148 (258)
T d1k2pa_ 72 RPIFIITEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLE--SKQFLHRDLAARNCLVNDQGVVKVSDFGLSR 148 (258)
T ss_dssp SSEEEEEECCTTEEHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHH--HTTBCCSCCSGGGEEECTTCCEEECCCSSCC
T ss_pred CceEEEEEccCCCcHHHhhhccc-cCCcHHHHHHHHHHHHHHHHHHh--hcCcccccccceeEEEcCCCcEEECcchhhe
Confidence 99999999999999999876543 36899999999999999999999 8999999999999999999999999999997
Q ss_pred cCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccccCcchhhhhhhcchhhhhhHH
Q 018785 180 DGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRR 258 (350)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (350)
........ ......+++.|+|||.+.+..++.++||||||+++|+|++ |+.||.+........
T Consensus 149 ~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~--------------- 212 (258)
T d1k2pa_ 149 YVLDDEYT-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAE--------------- 212 (258)
T ss_dssp BCSSSSCC-CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHH---------------
T ss_pred eccCCCce-eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHH---------------
Confidence 54433222 2333568889999999999999999999999999999998 798997665322221
Q ss_pred HHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 018785 259 VLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 307 (350)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~ 307 (350)
.+....+...+..+++++.+|+.+||+.||++|||+++++++|.++
T Consensus 213 ---~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 213 ---HIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp ---HHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred ---HHHhCCCCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 1222333445667788999999999999999999999999999653
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-52 Score=362.90 Aligned_cols=262 Identities=27% Similarity=0.392 Sum_probs=214.1
Q ss_pred hhcccccce-ecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccc-hhhHHHHHHHHHHHhccCCCcccceeeEEe
Q 018785 20 TKNFCSDYL-LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES-FQGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (350)
Q Consensus 20 ~~~y~i~~~-lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (350)
.++|.+... ||+|+||+||+|++. ...++..||||.+.... ....+.+.+|+.++++++||||+++++++.
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~-------~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~ 79 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYR-------MRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ 79 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC----------CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred ccCeEECCcEEecccCeEEEEEEEe-------cCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeec
Confidence 467888884 999999999999653 23346789999987654 334567899999999999999999999986
Q ss_pred ecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccc
Q 018785 98 ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL 177 (350)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~ 177 (350)
. +..++||||+++|+|.+++.... ..+++..+..++.|++.||+||| ++|++||||||+||+++.++.+||+|||+
T Consensus 80 ~-~~~~lvmE~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~gL~ylH--~~~iiHrDlKp~Nill~~~~~~Kl~DFGl 155 (285)
T d1u59a_ 80 A-EALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLE--EKNFVHRDLAARNVLLVNRHYAKISDFGL 155 (285)
T ss_dssp S-SSEEEEEECCTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEEEETTEEEECCCTT
T ss_pred c-CeEEEEEEeCCCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHHHH--hCCeecCcCchhheeeccCCceeeccchh
Confidence 5 57899999999999999875543 37999999999999999999999 89999999999999999999999999999
Q ss_pred cccCCCCCCCc-ccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccccCcchhhhhhhcchhhhh
Q 018785 178 ARDGPTGDNTH-VSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRD 255 (350)
Q Consensus 178 ~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 255 (350)
+.......... ......|++.|+|||++.+..++.++|||||||++|||++ |+.||.+.......
T Consensus 156 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~------------- 222 (285)
T d1u59a_ 156 SKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM------------- 222 (285)
T ss_dssp CEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHH-------------
T ss_pred hhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHH-------------
Confidence 98654433221 1223457889999999999999999999999999999998 89999765432211
Q ss_pred hHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcC
Q 018785 256 SRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 310 (350)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 310 (350)
..+....+...+..+++++.+|+.+||+.||++|||+.++++.|+.+..+
T Consensus 223 -----~~i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 223 -----AFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp -----HHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -----HHHHcCCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 11222333455677889999999999999999999999999999876643
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-52 Score=361.03 Aligned_cols=252 Identities=29% Similarity=0.408 Sum_probs=205.9
Q ss_pred ceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch--hhHHHHHHHHHHHhccCCCcccceeeEEeecCceEE
Q 018785 27 YLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLRHENLVKLIGYCSESDNRLL 104 (350)
Q Consensus 27 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 104 (350)
++||+|+||+||+|.+. ...+++.||||++..... ...+.+.+|+.++++++||||+++++++.. +..++
T Consensus 13 k~iG~G~fG~Vy~~~~~-------~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~l 84 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQ-------MKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWML 84 (277)
T ss_dssp EEEEECSSEEEEEEEEE-------CSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEE
T ss_pred CCcccCCCeEEEEEEEc-------cCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEE
Confidence 57999999999999653 234578899999865432 234678999999999999999999999865 56799
Q ss_pred EEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccccccCCCC
Q 018785 105 VYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTG 184 (350)
Q Consensus 105 v~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~~~~~~ 184 (350)
||||+++|+|.+++.... .+++..+..++.||+.||+||| +++++||||||+||+++.++.++|+|||++......
T Consensus 85 vmE~~~~g~L~~~l~~~~--~l~~~~~~~i~~qi~~gl~ylH--~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~ 160 (277)
T d1xbba_ 85 VMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLE--ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD 160 (277)
T ss_dssp EEECCTTEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred EEEcCCCCcHHHHHhhcc--CCCHHHHHHHHHHHHHHHhhHH--hCCcccCCCcchhhcccccCcccccchhhhhhcccc
Confidence 999999999999998765 7999999999999999999999 899999999999999999999999999999865443
Q ss_pred CCCc-ccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccccCcchhhhhhhcchhhhhhHHHHHh
Q 018785 185 DNTH-VSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRI 262 (350)
Q Consensus 185 ~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (350)
.... ......|++.|+|||.+.+..++.++|||||||++|+|++ |+.||.+...... ...
T Consensus 161 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~------------------~~~ 222 (277)
T d1xbba_ 161 ENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV------------------TAM 222 (277)
T ss_dssp CSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH------------------HHH
T ss_pred ccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHH------------------HHH
Confidence 3222 2233568889999999999999999999999999999997 8999976543211 112
Q ss_pred hhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 018785 263 MDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLH 308 (350)
Q Consensus 263 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 308 (350)
+....+...+..+|+++.+|+.+||+.||.+|||++++++.|+...
T Consensus 223 i~~~~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 268 (277)
T d1xbba_ 223 LEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 268 (277)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred HHcCCCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHH
Confidence 2223334556678899999999999999999999999998887754
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.4e-51 Score=365.98 Aligned_cols=247 Identities=26% Similarity=0.387 Sum_probs=212.0
Q ss_pred hhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch---hhHHHHHHHHHHHhccCCCcccceeeEE
Q 018785 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLVKLIGYC 96 (350)
Q Consensus 20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (350)
-++|++.+.||+|+||+||+| .+..+|+.||||++..... ...+.+.+|+.+++.++||||+++++++
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a---------~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~ 73 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLI---------RSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTF 73 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEE---------EETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEE
T ss_pred hhHeEEEEEEecCcCcEEEEE---------EECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeE
Confidence 468999999999999999999 6667799999999875432 3356788999999999999999999999
Q ss_pred eecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcccc
Q 018785 97 SESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFG 176 (350)
Q Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg 176 (350)
.+.+.+|+||||++|++|..++.... .+++..++.++.||+.||.||| ++||+||||||+|||++.+|.+||+|||
T Consensus 74 ~~~~~~~ivmE~~~gg~l~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH--~~~iiHrDiKp~NILl~~~g~vkL~DFG 149 (316)
T d1fota_ 74 QDAQQIFMIMDYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLH--SKDIIYRDLKPENILLDKNGHIKITDFG 149 (316)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHH--TTTEECCCCCGGGEEECTTSCEEECCCS
T ss_pred eeCCeeeeEeeecCCccccccccccc--cccccHHHHHHHHHHHhhhhhc--cCcEEccccCchheeEcCCCCEEEecCc
Confidence 99999999999999999999988776 6899999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhh
Q 018785 177 LARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDS 256 (350)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 256 (350)
++...... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+
T Consensus 150 ~a~~~~~~-----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i----------- 213 (316)
T d1fota_ 150 FAKYVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI----------- 213 (316)
T ss_dssp SCEECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH-----------
T ss_pred cceEeccc-----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHH-----------
Confidence 99864332 22357999999999999999999999999999999999999999765432221111
Q ss_pred HHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 018785 257 RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRP-----SMVDVLTS 303 (350)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~~ 303 (350)
... ....+..+++++.+++.+||..||.+|+ |++++++|
T Consensus 214 ------~~~--~~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 214 ------LNA--ELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp ------HHC--CCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred ------HcC--CCCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 111 1234556788999999999999999996 99999987
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-51 Score=360.08 Aligned_cols=269 Identities=27% Similarity=0.429 Sum_probs=211.7
Q ss_pred hhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch-hhHHHHHHHHHHHhccCCCcccceeeE
Q 018785 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLVKLIGY 95 (350)
Q Consensus 17 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~ 95 (350)
++..+.|++.++||+|+||+||+|++... .......||||.+..... .....+.+|+.++++++||||++++++
T Consensus 3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~-----~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~ 77 (283)
T d1mqba_ 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTS-----SGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGV 77 (283)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC--------CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred cCCHHHeEeeeEEeeCCCeEEEEEEEeCC-----CCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEE
Confidence 34567899999999999999999976532 223346799999876543 334568899999999999999999999
Q ss_pred EeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccc
Q 018785 96 CSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDF 175 (350)
Q Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Df 175 (350)
+.+.+..++|||++.++++.+++.... ..++..++..++.|++.||.||| +.+++||||||+|||++.++.+||+||
T Consensus 78 ~~~~~~~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~~i~~gl~~lH--~~~iiHrDlKp~NILl~~~~~~Kl~DF 154 (283)
T d1mqba_ 78 ISKYKPMMIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLA--NMNYVHRDLAARNILVNSNLVCKVSDF 154 (283)
T ss_dssp ECSSSSEEEEEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTTCCEEECCC
T ss_pred EecCCceEEEEEecccCcchhhhhccc-ccccHHHHHHHHHHHHHhhhhcc--ccccccCccccceEEECCCCeEEEccc
Confidence 999999999999999999999886654 37999999999999999999999 899999999999999999999999999
Q ss_pred cccccCCCCCCC-cccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhh
Q 018785 176 GLARDGPTGDNT-HVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLR 254 (350)
Q Consensus 176 g~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~ 254 (350)
|++......... .......|++.|+|||.+.+..++.++|||||||++|+|++|..||......
T Consensus 155 Gla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~--------------- 219 (283)
T d1mqba_ 155 GLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN--------------- 219 (283)
T ss_dssp CC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---------------
T ss_pred chhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH---------------
Confidence 999764433222 1223346788999999999999999999999999999999976665432211
Q ss_pred hhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcC
Q 018785 255 DSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 310 (350)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 310 (350)
......+........+..++..+.+|+.+||+.||++|||+.++++.|+.+...
T Consensus 220 --~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 220 --HEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp --HHHHHHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred --HHHHHHHhccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 111222333334455667889999999999999999999999999999987654
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.8e-51 Score=359.93 Aligned_cols=264 Identities=24% Similarity=0.358 Sum_probs=209.5
Q ss_pred hhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh---hHHHHHHHHHHHhccCCCcccceee
Q 018785 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ---GHKEWLTEVIYLGQLRHENLVKLIG 94 (350)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~ 94 (350)
...++|++.+.||+|+||+||+| .+..+|+.||||++...... ....+.+|+.+++.++||||+++++
T Consensus 4 ~l~drY~i~~~lG~G~fg~Vy~a---------~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~ 74 (277)
T d1o6ya_ 4 HLSDRYELGEILGFGGMSEVHLA---------RDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 74 (277)
T ss_dssp EETTTEEEEEEEEECSSEEEEEE---------EETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred CccceeEEeEEEeeCCCeEEEEE---------EECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccc
Confidence 34678999999999999999999 66778999999999765432 2356889999999999999999999
Q ss_pred EEeecCc----eEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcE
Q 018785 95 YCSESDN----RLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNA 170 (350)
Q Consensus 95 ~~~~~~~----~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~ 170 (350)
++...+. .|+||||++|++|.+++...+ .+++.+++.++.||+.||+||| ++|++||||||+||+++.++..
T Consensus 75 ~~~~~~~~~~~~~lvmE~~~g~~L~~~~~~~~--~l~~~~~~~i~~qi~~al~~lH--~~~iiHrDiKP~NIll~~~~~~ 150 (277)
T d1o6ya_ 75 TGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSH--QNGIIHRDVKPANIMISATNAV 150 (277)
T ss_dssp EEEEECSSSEEEEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEEETTSCE
T ss_pred eeeeccCCCceEEEEEECCCCCEehhhhcccC--CCCHHHHHHHHHHHHHHHHHHH--hCCccCccccCcccccCccccc
Confidence 9887543 789999999999999997775 7999999999999999999999 8999999999999999999999
Q ss_pred EEccccccccCCCCCC-CcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhc
Q 018785 171 KLSDFGLARDGPTGDN-THVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWA 249 (350)
Q Consensus 171 ~l~Dfg~~~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~ 249 (350)
+++|||.+........ ........||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+...
T Consensus 151 ~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~- 229 (277)
T d1o6ya_ 151 KVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVRE- 229 (277)
T ss_dssp EECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHC-
T ss_pred eeehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhc-
Confidence 9999998865433222 22233467899999999999999999999999999999999999999765432221111110
Q ss_pred chhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCC-CHHHHHHHHHhhhc
Q 018785 250 DPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRP-SMVDVLTSLEQLHT 309 (350)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-s~~~ll~~L~~~~~ 309 (350)
...........+|+++.++|.+||+.||.+|| |++++++.|.++..
T Consensus 230 --------------~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~n 276 (277)
T d1o6ya_ 230 --------------DPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276 (277)
T ss_dssp --------------CCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHC
T ss_pred --------------CCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHhC
Confidence 00011122345788999999999999999998 89999999988753
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-51 Score=357.62 Aligned_cols=263 Identities=24% Similarity=0.361 Sum_probs=206.4
Q ss_pred hhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh-hHHHHHHHHHHHhccCCCcccceeeEE
Q 018785 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ-GHKEWLTEVIYLGQLRHENLVKLIGYC 96 (350)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (350)
+..++|++.+.||+|+||.||+|++. .....+..||||.+...... ....+.+|+.++++++||||+++++++
T Consensus 4 i~~~~~~l~~~iG~G~fg~Vy~a~~~------~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~ 77 (273)
T d1mp8a_ 4 IQRERIELGRCIGEGQFGDVHQGIYM------SPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI 77 (273)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEC------CC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cCHHHeEEEEEEeeCCCcEEEEEEEe------cCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 44679999999999999999999654 22344678999998654433 346789999999999999999999998
Q ss_pred eecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcccc
Q 018785 97 SESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFG 176 (350)
Q Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg 176 (350)
. ++..++||||+++++|.+++.... ..+++..++.++.|+++||.||| +++++||||||+||+++.++.+||+|||
T Consensus 78 ~-~~~~~iv~E~~~~g~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH--~~~iiHrDlKp~NIll~~~~~~Kl~DfG 153 (273)
T d1mp8a_ 78 T-ENPVWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLE--SKRFVHRDIAARNVLVSSNDCVKLGDFG 153 (273)
T ss_dssp C-SSSCEEEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEEEETTEEEECC--
T ss_pred e-cCeEEEEEEeccCCcHHhhhhccC-CCCCHHHHHHHHHHHHHHhhhhc--ccCeeccccchhheeecCCCcEEEccch
Confidence 6 468899999999999999876554 36899999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccccCcchhhhhhhcchhhhh
Q 018785 177 LARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRD 255 (350)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 255 (350)
++....... ........+++.|+|||.+.+..++.++|||||||++|+|++ |..||.+.........+.
T Consensus 154 ~a~~~~~~~-~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~--------- 223 (273)
T d1mp8a_ 154 LSRYMEDST-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE--------- 223 (273)
T ss_dssp ------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH---------
T ss_pred hheeccCCc-ceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHH---------
Confidence 997643322 222333567889999999999999999999999999999998 888987665433222221
Q ss_pred hHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhc
Q 018785 256 SRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHT 309 (350)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 309 (350)
.......+..+|+++.+||.+||..||.+|||+.+++++|+++..
T Consensus 224 ---------~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 268 (273)
T d1mp8a_ 224 ---------NGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268 (273)
T ss_dssp ---------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---------cCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 122234566788999999999999999999999999999998754
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=7e-51 Score=354.88 Aligned_cols=253 Identities=25% Similarity=0.344 Sum_probs=210.3
Q ss_pred hhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh---------hHHHHHHHHHHHhccC-CCcc
Q 018785 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ---------GHKEWLTEVIYLGQLR-HENL 89 (350)
Q Consensus 20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---------~~~~~~~e~~~l~~l~-h~~i 89 (350)
.++|++.+.||+|+||+||+| .+..+|+.||||++...... ....+.+|+.++++++ ||||
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~---------~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnI 72 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRC---------IHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNI 72 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEE---------EETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTB
T ss_pred cccCEEceEEecCcCeEEEEE---------EECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCe
Confidence 478999999999999999999 56667999999998764321 1235778999999997 9999
Q ss_pred cceeeEEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCc
Q 018785 90 VKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFN 169 (350)
Q Consensus 90 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~ 169 (350)
+++++++.+++..|+||||+++++|.+++..++ .+++.+++.++.||++||+||| ++|++||||||+||+++.++.
T Consensus 73 v~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~~lH--~~~ivHrDlkp~Nill~~~~~ 148 (277)
T d1phka_ 73 IQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALH--KLNIVHRDLKPENILLDDDMN 148 (277)
T ss_dssp CCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECTTCC
T ss_pred EEEEeecccCcceEEEEEcCCCchHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--HcCCcccccccceEEEcCCCC
Confidence 999999999999999999999999999998765 7999999999999999999999 899999999999999999999
Q ss_pred EEEccccccccCCCCCCCcccccccCCCcccCcccccc------CCCCCccchhhHHHHHHHHHhCCCCCcccccCcchh
Q 018785 170 AKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT------GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQ 243 (350)
Q Consensus 170 ~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~------~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~ 243 (350)
+||+|||++....... ......|++.|.|||.+.+ ..++.++||||+||++|+|++|+.||.+........
T Consensus 149 ~kl~DFG~a~~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~ 225 (277)
T d1phka_ 149 IKLTDFGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLR 225 (277)
T ss_dssp EEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred eEEccchheeEccCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHH
Confidence 9999999998643322 2234568999999998854 346789999999999999999999998755322222
Q ss_pred hhhhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 244 TLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
.+... ...........+|+++.+|+.+||+.||.+|||++++++|
T Consensus 226 ~i~~~---------------~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 226 MIMSG---------------NYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp HHHHT---------------CCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HHHhC---------------CCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 22110 1111223345788999999999999999999999999875
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-51 Score=358.13 Aligned_cols=265 Identities=31% Similarity=0.452 Sum_probs=212.4
Q ss_pred hhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceeeE
Q 018785 16 SKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGY 95 (350)
Q Consensus 16 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 95 (350)
+++..++|++.+.||+|+||+||+|+++ . +..||||++..... ..+.+.+|+.++++++||||++++++
T Consensus 12 ~~i~~~~~~i~~~iG~G~fg~Vy~~~~~---------~-~~~vAiK~l~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~g~ 80 (285)
T d1fmka3 12 WEIPRESLRLEVKLGQGCFGEVWMGTWN---------G-TTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAV 80 (285)
T ss_dssp SBCCGGGEEEEEEEEECSSCEEEEEEET---------T-TEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred eEcCHHHEEEeeEEeeCCCeEEEEEEEC---------C-CCEEEEEEECcccC-CHHHHHHHHHHHHhcccCCEeEEEEE
Confidence 3455789999999999999999999543 2 35799999976543 45678999999999999999999999
Q ss_pred EeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccc
Q 018785 96 CSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDF 175 (350)
Q Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Df 175 (350)
+.+ +..++||||+++|+|.+++.......+++.+++.++.|++.||+||| ++|++||||||+||+++.++.+||+||
T Consensus 81 ~~~-~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH--~~~ivH~DlKp~NIll~~~~~~kl~Df 157 (285)
T d1fmka3 81 VSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE--RMNYVHRDLRAANILVGENLVCKVADF 157 (285)
T ss_dssp ECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEECGGGCEEECCC
T ss_pred Eec-CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHh--hhheecccccceEEEECCCCcEEEccc
Confidence 854 56899999999999999987654457999999999999999999999 899999999999999999999999999
Q ss_pred cccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhh
Q 018785 176 GLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRD 255 (350)
Q Consensus 176 g~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 255 (350)
|++........ .......+++.|+|||.+.+..++.++||||||+++|+|++|+.||......
T Consensus 158 Gla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~---------------- 220 (285)
T d1fmka3 158 GLARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---------------- 220 (285)
T ss_dssp CTTC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH----------------
T ss_pred chhhhccCCCc-eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH----------------
Confidence 99976433222 2223356889999999999999999999999999999999977665432211
Q ss_pred hHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcCCC
Q 018785 256 SRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKD 312 (350)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~ 312 (350)
......+........+..+++++.+|+.+||+.||++|||+++|++.|+...+...
T Consensus 221 -~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~ 276 (285)
T d1fmka3 221 -REVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 276 (285)
T ss_dssp -HHHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred -HHHHHHHHhcCCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCC
Confidence 11112222233344566788999999999999999999999999999999887754
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-51 Score=365.26 Aligned_cols=254 Identities=19% Similarity=0.256 Sum_probs=211.5
Q ss_pred hhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceeeEEee
Q 018785 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (350)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (350)
..++|++.+.||+|+||+||+| .+..+|+.||||.+...... ...+.+|+.+|+.++||||+++++++.+
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~---------~~~~~~~~~AiK~i~~~~~~-~~~~~~Ei~il~~l~HpnIv~~~~~~~~ 72 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRC---------VETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESFES 72 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEE---------EETTTTEEEEEEEECCCTHH-HHHHHHHHHHHHHSCCTTBCCEEEEEEE
T ss_pred CccceEEEEEEecCCCeEEEEE---------EECCCCcEEEEEEEcCCccc-HHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 3578999999999999999999 66777999999999876533 4567899999999999999999999999
Q ss_pred cCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCC--CcEEEcccc
Q 018785 99 SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSN--FNAKLSDFG 176 (350)
Q Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~--~~~~l~Dfg 176 (350)
++.+|+||||++|++|.+++...+ ..+++.+++.++.||++||.||| +.||+||||||+||+++.+ ..++|+|||
T Consensus 73 ~~~~~lvmE~~~gg~L~~~i~~~~-~~l~e~~~~~i~~qi~~al~yLH--~~~iiHrDlKp~NIll~~~~~~~ikl~DFG 149 (321)
T d1tkia_ 73 MEELVMIFEFISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLH--SHNIGHFDIRPENIIYQTRRSSTIKIIEFG 149 (321)
T ss_dssp TTEEEEEECCCCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEESSSSCCCEEECCCT
T ss_pred CCEEEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH--HcCCCcccccccceeecCCCceEEEEcccc
Confidence 999999999999999999997654 36999999999999999999999 8999999999999999854 479999999
Q ss_pred ccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhh
Q 018785 177 LARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDS 256 (350)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 256 (350)
++...... .......+++.|+|||...+..++.++|||||||++|+|++|..||.+.........+......
T Consensus 150 ~~~~~~~~---~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~----- 221 (321)
T d1tkia_ 150 QARQLKPG---DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYT----- 221 (321)
T ss_dssp TCEECCTT---CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC-----
T ss_pred hhhccccC---CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-----
Confidence 99764332 2233456889999999999999999999999999999999999999876543322222211100
Q ss_pred HHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 257 RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
........+++++.+||.+||..||.+|||++++++|
T Consensus 222 ----------~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 222 ----------FDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp ----------CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ----------CChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0001112467889999999999999999999999986
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5e-51 Score=367.31 Aligned_cols=246 Identities=25% Similarity=0.332 Sum_probs=211.3
Q ss_pred hcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch---hhHHHHHHHHHHHhccCCCcccceeeEEe
Q 018785 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (350)
Q Consensus 21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (350)
++|++.+.||+|+||.||+| .+..+|+.||||++..... .....+.+|+.+++.++||||+++++++.
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a---------~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~ 111 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLV---------KHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEE---------EETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEE---------EECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccc
Confidence 68999999999999999999 6667799999999875432 33466889999999999999999999999
Q ss_pred ecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccc
Q 018785 98 ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL 177 (350)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~ 177 (350)
+.+..++|||++.+++|.+++...+ .+++..++.++.||+.||.||| ++||+||||||+|||++.++.+||+|||+
T Consensus 112 ~~~~~~~v~e~~~~g~l~~~l~~~~--~l~e~~~~~i~~qi~~aL~yLH--~~~iiHRDIKP~NILl~~~g~ikL~DFG~ 187 (350)
T d1rdqe_ 112 DNSNLYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLH--SLDLIYRDLKPENLLIDQQGYIQVTDFGF 187 (350)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred cccccccccccccccchhhhHhhcC--CCCHHHHHHHHHHHHHHHHHHH--hCCEecCcCCHHHcccCCCCCEEeeecee
Confidence 9999999999999999999998775 7999999999999999999999 99999999999999999999999999999
Q ss_pred cccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhH
Q 018785 178 ARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSR 257 (350)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 257 (350)
+...... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+.
T Consensus 188 a~~~~~~-----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~----------- 251 (350)
T d1rdqe_ 188 AKRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIV----------- 251 (350)
T ss_dssp CEECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-----------
T ss_pred eeecccc-----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHh-----------
Confidence 9864332 223568999999999999999999999999999999999999997654322211111
Q ss_pred HHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 018785 258 RVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRP-----SMVDVLTS 303 (350)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~~ 303 (350)
.. ....+..+++++.+||.+||..||.+|+ |++++++|
T Consensus 252 ------~~--~~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 252 ------SG--KVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp ------HC--CCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred ------cC--CCCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence 11 1223456788999999999999999994 89999986
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-51 Score=359.31 Aligned_cols=272 Identities=26% Similarity=0.347 Sum_probs=211.4
Q ss_pred hhhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch-hhHHHHHHHHHHHhcc-CCCcccce
Q 018785 15 ISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQL-RHENLVKL 92 (350)
Q Consensus 15 ~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~ 92 (350)
-+++..++|++.++||+|+||.||+|++... .+..+++.||||.+..... ...+.+..|...+.++ +|+||+.+
T Consensus 7 ~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~----~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~ 82 (299)
T d1ywna1 7 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGI----DKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 82 (299)
T ss_dssp HHBCCGGGEEEEEEEEECSSCEEEEEEEEST----TSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cccccHHHEEEeeEEeecCCeEEEEEEEcCC----CcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEe
Confidence 3445668999999999999999999976543 3456788999999875433 3345677777777777 68999999
Q ss_pred eeEEeec-CceEEEEEcCCCCChhhHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCC
Q 018785 93 IGYCSES-DNRLLVYEFMPKGSLENHLFRKG--------------VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDL 157 (350)
Q Consensus 93 ~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~--------------~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di 157 (350)
++++... +.+++||||+++|+|.+++.... ...+++..+..++.|++.||+||| +++|+||||
T Consensus 83 ~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH--~~~ivHrDl 160 (299)
T d1ywna1 83 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA--SRKCIHRDL 160 (299)
T ss_dssp EEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH--HTTCCCSCC
T ss_pred eeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH--hCCCcCCcC
Confidence 9987654 56899999999999999996542 235889999999999999999999 899999999
Q ss_pred CCCceEEcCCCcEEEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCC-CCCccc
Q 018785 158 KASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR-RALDED 236 (350)
Q Consensus 158 ~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~-~pf~~~ 236 (350)
||+||+++.++.+||+|||++................||+.|+|||.+.+..++.++||||+||++|+|++|. .||.+.
T Consensus 161 Kp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~ 240 (299)
T d1ywna1 161 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 240 (299)
T ss_dssp CGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred CccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999997654444444444567899999999999999999999999999999999875 577654
Q ss_pred ccCcchhhhhhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhc
Q 018785 237 RGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHT 309 (350)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 309 (350)
..... ....+........+..+++++.+|+.+||+.||.+|||+++++++|+++-.
T Consensus 241 ~~~~~-----------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 241 KIDEE-----------------FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp CCSHH-----------------HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CHHHH-----------------HHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 43211 112222233344566778899999999999999999999999999998754
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-51 Score=354.70 Aligned_cols=255 Identities=31% Similarity=0.446 Sum_probs=206.9
Q ss_pred hhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceeeEE
Q 018785 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYC 96 (350)
Q Consensus 17 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (350)
++..++|++.+.||+|+||.||+|+++ |..||||+++... ..+.+.+|+.++++++||||+++++++
T Consensus 3 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~-----------~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~ 69 (262)
T d1byga_ 3 ALNMKELKLLQTIGKGEFGDVMLGDYR-----------GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVI 69 (262)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEET-----------TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEE
T ss_pred ccCHHHeEEeEEEecCCCeEEEEEEEC-----------CeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 345678999999999999999999653 6689999997654 446789999999999999999999988
Q ss_pred ee-cCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccc
Q 018785 97 SE-SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDF 175 (350)
Q Consensus 97 ~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Df 175 (350)
.+ .+.+++||||+++|+|.+++.......++...++.++.|++.||.||| +.+++|+||+|+||+++.++.++|+||
T Consensus 70 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH--~~~ivH~dlkp~Nil~~~~~~~kl~df 147 (262)
T d1byga_ 70 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE--GNNFVHRDLAARNVLVSEDNVAKVSDF 147 (262)
T ss_dssp CCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEECTTSCEEECCC
T ss_pred EecCCcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccc--cCceeccccchHhheecCCCCEeeccc
Confidence 54 567899999999999999997654446899999999999999999999 899999999999999999999999999
Q ss_pred cccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccccCcchhhhhhhcchhhh
Q 018785 176 GLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLR 254 (350)
Q Consensus 176 g~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~ 254 (350)
|++....... ....++..|+|||.+.+..++.++||||||+++|+|++ |..||..........
T Consensus 148 g~s~~~~~~~-----~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~----------- 211 (262)
T d1byga_ 148 GLTKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP----------- 211 (262)
T ss_dssp CC-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHH-----------
T ss_pred ccceecCCCC-----ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHH-----------
Confidence 9997533222 22456788999999999999999999999999999998 677776544322221
Q ss_pred hhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhc
Q 018785 255 DSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHT 309 (350)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 309 (350)
.+......+.+..+++++.+||.+||..||.+|||+.+++++|+++.+
T Consensus 212 -------~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 212 -------RVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp -------HHTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -------HHHcCCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 122233345566778899999999999999999999999999998865
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.1e-50 Score=366.94 Aligned_cols=251 Identities=25% Similarity=0.366 Sum_probs=206.6
Q ss_pred hhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh---hHHHH---HHHHHHHhccCCCccccee
Q 018785 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ---GHKEW---LTEVIYLGQLRHENLVKLI 93 (350)
Q Consensus 20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~---~~e~~~l~~l~h~~i~~~~ 93 (350)
-++|++.++||+|+||.||+| .+..+|+.||||++...... ....+ ..++.+++.++||||++++
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~---------~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~ 73 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGC---------RKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMS 73 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEE---------EETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEE
T ss_pred HHhCeeeeEEecCCCeEEEEE---------EECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEE
Confidence 368999999999999999999 66677999999998654321 11223 3457778888999999999
Q ss_pred eEEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEc
Q 018785 94 GYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLS 173 (350)
Q Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~ 173 (350)
+++.+.+.+|+||||++|++|.+++.... .+++..++.++.||+.||.||| ++|++||||||+|||++.+|.+||+
T Consensus 74 ~~~~~~~~~~ivmE~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~ylH--~~~iiHrDlKP~NILl~~~g~iKl~ 149 (364)
T d1omwa3 74 YAFHTPDKLSFILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMH--NRFVVYRDLKPANILLDEHGHVRIS 149 (364)
T ss_dssp EEEECSSEEEEEECCCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECSSSCEEEC
T ss_pred EEEEECCEEEEEEEecCCCcHHHHHHhcc--cccHHHHHHHHHHHHHHHHHHH--HCCccceeeccceeEEcCCCcEEEe
Confidence 99999999999999999999999998775 7899999999999999999999 9999999999999999999999999
Q ss_pred cccccccCCCCCCCcccccccCCCcccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchh
Q 018785 174 DFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPF 252 (350)
Q Consensus 174 Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 252 (350)
|||++....... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+...........
T Consensus 150 DFGla~~~~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~------ 219 (364)
T d1omwa3 150 DLGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR------ 219 (364)
T ss_dssp CCTTCEECSSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHH------
T ss_pred eeceeeecCCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHH------
Confidence 999998643322 233569999999999864 568999999999999999999999998654332211111
Q ss_pred hhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 018785 253 LRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPS-----MVDVLTS 303 (350)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-----~~~ll~~ 303 (350)
.........+..+++++.+||.+||+.||.+||| ++++++|
T Consensus 220 ----------~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 220 ----------MTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp ----------HSSSCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred ----------hcccCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 0111122345567889999999999999999999 6999876
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-51 Score=364.36 Aligned_cols=249 Identities=25% Similarity=0.404 Sum_probs=208.0
Q ss_pred hcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch---hhHHHHHHHHHHH-hccCCCcccceeeEE
Q 018785 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYL-GQLRHENLVKLIGYC 96 (350)
Q Consensus 21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l-~~l~h~~i~~~~~~~ 96 (350)
++|++.+.||+|+||+||+| .+..+|+.||||++..... ...+.+..|...+ +.++||||+++++++
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~---------~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~ 72 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLA---------EFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF 72 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEE---------EETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEE---------EECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEE
Confidence 57999999999999999999 6677899999999975432 2334455565555 468999999999999
Q ss_pred eecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcccc
Q 018785 97 SESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFG 176 (350)
Q Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg 176 (350)
.+++.+|+||||+++|+|.+++.... .+++.+++.++.||+.||.||| ++|++||||||+|||++.++.++|+|||
T Consensus 73 ~~~~~~yivmEy~~~g~L~~~i~~~~--~~~e~~~~~~~~qi~~al~ylH--~~~iiHrDikp~NiL~~~~~~~kl~DFG 148 (320)
T d1xjda_ 73 QTKENLFFVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLH--SKGIVYRDLKLDNILLDKDGHIKIADFG 148 (320)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCCGGGEEECTTSCEEECCCT
T ss_pred ccCCceeEEEeecCCCcHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHH--hCCeeeccCcccceeecCCCceeccccc
Confidence 99999999999999999999998765 7999999999999999999999 8999999999999999999999999999
Q ss_pred ccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhh
Q 018785 177 LARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDS 256 (350)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 256 (350)
++....... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+.
T Consensus 149 ~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~---------- 216 (320)
T d1xjda_ 149 MCKENMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIR---------- 216 (320)
T ss_dssp TCBCCCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH----------
T ss_pred hhhhccccc--ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHH----------
Confidence 997543322 22334678999999999999999999999999999999999999998755322221111
Q ss_pred HHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHH-HHHHH
Q 018785 257 RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMV-DVLTS 303 (350)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~-~ll~~ 303 (350)
.. ....+..+++++.+||.+||..||.+|||+. ++++|
T Consensus 217 -------~~--~~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~h 255 (320)
T d1xjda_ 217 -------MD--NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH 255 (320)
T ss_dssp -------HC--CCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred -------cC--CCCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhC
Confidence 11 1234556788999999999999999999995 78764
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-50 Score=360.98 Aligned_cols=263 Identities=25% Similarity=0.390 Sum_probs=210.1
Q ss_pred hhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccc-hhhHHHHHHHHHHHhccCCCcccceeeEEee
Q 018785 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES-FQGHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (350)
Q Consensus 20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (350)
..+|++.++||+|+||+||+|++..+ ......+||+|.+.... ....+.+.+|+.++++++||||+++++++.+
T Consensus 8 ~~dy~~~~~lG~G~fG~Vy~~~~~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~ 82 (317)
T d1xkka_ 8 ETEFKKIKVLGSGAFGTVYKGLWIPE-----GEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT 82 (317)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECC---------CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred HHHCEEeeEEecCCCeEEEEEEEcCC-----CCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 45799999999999999999965321 11223478999886543 2345778999999999999999999999986
Q ss_pred cCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcccccc
Q 018785 99 SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 178 (350)
Q Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~ 178 (350)
+ ..+++++++.+++|.+++.... ..+++..++.++.|++.||+||| ++|++||||||+||+++.++.+||+|||++
T Consensus 83 ~-~~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~yLH--~~~iiHrDlKp~NIll~~~~~~kl~DFGla 158 (317)
T d1xkka_ 83 S-TVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLA 158 (317)
T ss_dssp S-SEEEEEECCTTCBHHHHHHHTS-SSCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEEEETTEEEECCCSHH
T ss_pred C-CeeEEEEeccCCcccccccccc-cCCCHHHHHHHHHHHHHHHHHHH--HcCcccCcchhhcceeCCCCCeEeeccccc
Confidence 4 6778889999999999887654 47999999999999999999999 899999999999999999999999999999
Q ss_pred ccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccccCcchhhhhhhcchhhhhhH
Q 018785 179 RDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSR 257 (350)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 257 (350)
................|++.|+|||.+.+..++.++|||||||++|+|++ |..||.+........
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~-------------- 224 (317)
T d1xkka_ 159 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS-------------- 224 (317)
T ss_dssp HHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHH--------------
T ss_pred eecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHH--------------
Confidence 87554444333344568999999999999999999999999999999998 788887655322221
Q ss_pred HHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhc
Q 018785 258 RVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHT 309 (350)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 309 (350)
.+....+...+..+++++.+|+.+||..||.+|||+.+++++|..+..
T Consensus 225 ----~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 225 ----ILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp ----HHHHTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----HHHcCCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 222223334556788899999999999999999999999999988754
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.8e-50 Score=357.45 Aligned_cols=268 Identities=25% Similarity=0.348 Sum_probs=219.8
Q ss_pred hhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh-hHHHHHHHHHHHhccCCCcccceeeE
Q 018785 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ-GHKEWLTEVIYLGQLRHENLVKLIGY 95 (350)
Q Consensus 17 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~ 95 (350)
++..++|++.+.||+|+||+||+|++.+. .+..++..||||++...... ....+.+|+.++++++||||++++++
T Consensus 9 e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~----~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~ 84 (301)
T d1lufa_ 9 EYPRNNIEYVRDIGEGAFGRVFQARAPGL----LPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV 84 (301)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETS----STTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred cCCHHHcEEeEEEeeCCCeEEEEEEECCC----ccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceee
Confidence 34467899999999999999999987543 34566889999999765433 34668999999999999999999999
Q ss_pred EeecCceEEEEEcCCCCChhhHHhhcC----------------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCee
Q 018785 96 CSESDNRLLVYEFMPKGSLENHLFRKG----------------------VQPISWPTRVKIAIDVARGLSFLHGLDANVI 153 (350)
Q Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------------~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~ 153 (350)
+...+..+++||++.+++|.+++.... ...++...++.++.|++.||+||| +.+++
T Consensus 85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH--~~~iv 162 (301)
T d1lufa_ 85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS--ERKFV 162 (301)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH--HTTCC
T ss_pred eccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc--cCCeE
Confidence 999999999999999999999996532 235888999999999999999999 99999
Q ss_pred eCCCCCCceEEcCCCcEEEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCC-CC
Q 018785 154 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR-RA 232 (350)
Q Consensus 154 H~di~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~-~p 232 (350)
||||||+||+++.++.+||+|||++................+++.|+|||.+.+..++.++|||||||++|+|++|. .|
T Consensus 163 HrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p 242 (301)
T d1lufa_ 163 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 242 (301)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred eeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCC
Confidence 99999999999999999999999997543333333334456888999999999999999999999999999999986 56
Q ss_pred CcccccCcchhhhhhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 018785 233 LDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLH 308 (350)
Q Consensus 233 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 308 (350)
|.+....+... .+........+..+++++.+|+.+||+.||++|||+.+|++.|+++-
T Consensus 243 ~~~~~~~e~~~------------------~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 243 YYGMAHEEVIY------------------YVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TTTSCHHHHHH------------------HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCCHHHHHH------------------HHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 76544322211 12222233456678889999999999999999999999999999874
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-50 Score=352.09 Aligned_cols=262 Identities=29% Similarity=0.414 Sum_probs=206.0
Q ss_pred hhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch---hhHHHHHHHHHHHhccCCCcccceeeE
Q 018785 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLVKLIGY 95 (350)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~ 95 (350)
..++|++.+.||+|+||+||+|++.. ..+....||||++..... ...+.+.+|+.++++++||||++++++
T Consensus 6 ~~~d~~~~~~iG~G~fg~Vy~~~~~~------~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~ 79 (273)
T d1u46a_ 6 GEKDLRLLEKLGDGSFGVVRRGEWDA------PSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGV 79 (273)
T ss_dssp CGGGEEEEEECC----CCCEEEEEEC------TTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred chHHeEEEEEEecCCCeEEEEEEEEC------CCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 35789999999999999999997652 333456899998875432 234678999999999999999999999
Q ss_pred EeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccc
Q 018785 96 CSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDF 175 (350)
Q Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Df 175 (350)
+.+ +..++||||++++++.+++..+. ..+++..++.++.|++.||.||| ++|++||||||+||+++.++.+||+||
T Consensus 80 ~~~-~~~~lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH--~~~iiHrDikp~NIll~~~~~vkl~Df 155 (273)
T d1u46a_ 80 VLT-PPMKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLE--SKRFIHRDLAARNLLLATRDLVKIGDF 155 (273)
T ss_dssp ECS-SSCEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGGGEEEEETTEEEECCC
T ss_pred Eee-cchheeeeeecCcchhhhhhccc-CCCCHHHHHHHHHHHHHHHHHhh--hCCEeeeeecHHHhccccccceeeccc
Confidence 976 57789999999999999887654 26999999999999999999999 899999999999999999999999999
Q ss_pred cccccCCCCCCCcc-cccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCcccccCcchhhhhhhcchhh
Q 018785 176 GLARDGPTGDNTHV-STRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFL 253 (350)
Q Consensus 176 g~~~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~ 253 (350)
|++........... .....++..|+|||.+.+..++.++||||||+++|+|++ |..||.+.+.....
T Consensus 156 Gl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~----------- 224 (273)
T d1u46a_ 156 GLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQIL----------- 224 (273)
T ss_dssp TTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH-----------
T ss_pred hhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHH-----------
Confidence 99987544433322 223456778999999999999999999999999999998 89999765432221
Q ss_pred hhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 018785 254 RDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 307 (350)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~ 307 (350)
..+.......+.+..+|+++.+|+.+||..||++|||+.++++.|.++
T Consensus 225 ------~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 225 ------HKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp ------HHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------HHHHhCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 222223333345567888999999999999999999999999999875
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-50 Score=362.29 Aligned_cols=254 Identities=21% Similarity=0.292 Sum_probs=202.7
Q ss_pred hhcccccc-eecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhc-cCCCcccceeeEEe
Q 018785 20 TKNFCSDY-LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQ-LRHENLVKLIGYCS 97 (350)
Q Consensus 20 ~~~y~i~~-~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~ 97 (350)
-++|++.. .||+|+||+||+| .+..+++.||||++... ..+.+|+.++.+ .+||||++++++|.
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a---------~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~ 75 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQI---------FNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYE 75 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEE---------EETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEE---------EECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEe
Confidence 46898865 6999999999999 66667899999998643 345678887655 48999999999987
Q ss_pred e----cCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcC---CCcE
Q 018785 98 E----SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS---NFNA 170 (350)
Q Consensus 98 ~----~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~---~~~~ 170 (350)
+ +..+|+||||++||+|.+++..++...+++.+++.++.||+.||+||| +.|++||||||+||+++. ++.+
T Consensus 76 ~~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH--~~~iiHRDiKp~NIll~~~~~~~~~ 153 (335)
T d2ozaa1 76 NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH--SINIAHRDVKPENLLYTSKRPNAIL 153 (335)
T ss_dssp EEETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEESCSSTTCCE
T ss_pred ecccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHH--HcCCccccccccccccccccccccc
Confidence 5 467899999999999999998776568999999999999999999999 999999999999999975 4569
Q ss_pred EEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcc
Q 018785 171 KLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD 250 (350)
Q Consensus 171 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~ 250 (350)
+|+|||++........ .....|++.|+|||++.+..|+.++|||||||++|+|++|+.||.+.........+.....
T Consensus 154 Kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~ 230 (335)
T d2ozaa1 154 KLTDFGFAKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR 230 (335)
T ss_dssp EECCCTTCEECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCC
T ss_pred cccccceeeeccCCCc---cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHh
Confidence 9999999976443322 2345799999999999999999999999999999999999999987654333222211100
Q ss_pred hhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 251 PFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
.............+++++.+||.+||+.||.+|||+.++++|
T Consensus 231 -----------~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 231 -----------MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp -----------SCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred -----------cCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 000001111224578899999999999999999999999987
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-50 Score=353.11 Aligned_cols=272 Identities=26% Similarity=0.389 Sum_probs=218.8
Q ss_pred hhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch-hhHHHHHHHHHHHhcc-CCCccccee
Q 018785 16 SKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQL-RHENLVKLI 93 (350)
Q Consensus 16 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~ 93 (350)
+++.-++|++.+.||+|+||.||+|+...... ....++..||||++..... .....+.+|...+.++ +||||++++
T Consensus 8 ~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~--~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~ 85 (299)
T d1fgka_ 8 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDK--DKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLL 85 (299)
T ss_dssp TBCCGGGEEEEEECC-----CEEEEEEECC------CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CcccHHHeEEeeEEeecCCcEEEEEEEcCCCc--ccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecc
Confidence 34557899999999999999999997653210 1234567899999976653 3346778888888888 799999999
Q ss_pred eEEeecCceEEEEEcCCCCChhhHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCC
Q 018785 94 GYCSESDNRLLVYEFMPKGSLENHLFRKG--------------VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKA 159 (350)
Q Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------------~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~ 159 (350)
+++.+++..++||||+++|+|.+++.... ...+++.+++.++.||+.||.||| +.+++||||||
T Consensus 86 ~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH--~~~ivHrDiKp 163 (299)
T d1fgka_ 86 GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA--SKKCIHRDLAA 163 (299)
T ss_dssp EEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSG
T ss_pred cccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh--hCCEEeeeecc
Confidence 99999999999999999999999997553 246899999999999999999999 99999999999
Q ss_pred CceEEcCCCcEEEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCccccc
Q 018785 160 SNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRG 238 (350)
Q Consensus 160 ~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~-g~~pf~~~~~ 238 (350)
+||+++.++.++|+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+...
T Consensus 164 ~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~ 243 (299)
T d1fgka_ 164 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 243 (299)
T ss_dssp GGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred cceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH
Confidence 999999999999999999986555444444455678889999999999999999999999999999998 6888865442
Q ss_pred CcchhhhhhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhc
Q 018785 239 GLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHT 309 (350)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 309 (350)
.. ....+........+..+++++.+||.+||+.||.+|||+.++++.|+++..
T Consensus 244 ~~------------------~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 244 EE------------------LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp HH------------------HHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HH------------------HHHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 21 112223333445566788899999999999999999999999999998854
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-49 Score=353.03 Aligned_cols=271 Identities=27% Similarity=0.377 Sum_probs=224.3
Q ss_pred hhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch-hhHHHHHHHHHHHhcc-CCCccccee
Q 018785 16 SKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQL-RHENLVKLI 93 (350)
Q Consensus 16 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~ 93 (350)
+++..++|++.++||+|+||.||+|++... .+..++..||||.+..... .....+.+|+.+++.+ +||||++++
T Consensus 18 ~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~----~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~ 93 (311)
T d1t46a_ 18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGL----IKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLL 93 (311)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESS----SSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccCCHHHeEEeeEEeecCCeEEEEEEEecc----ccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEE
Confidence 445678999999999999999999977543 3456789999999976543 3445688999999999 699999999
Q ss_pred eEEeecCceEEEEEcCCCCChhhHHhhcC----------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCC
Q 018785 94 GYCSESDNRLLVYEFMPKGSLENHLFRKG----------------VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDL 157 (350)
Q Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di 157 (350)
+++.+.+..++||||+++++|.+++.... ...+++..+..++.||+.||+||| +++++||||
T Consensus 94 g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH--~~~ivHrDL 171 (311)
T d1t46a_ 94 GACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA--SKNCIHRDL 171 (311)
T ss_dssp EEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCC
T ss_pred EEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH--hCCeeeccc
Confidence 99999999999999999999999997543 235899999999999999999999 899999999
Q ss_pred CCCceEEcCCCcEEEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCC-CCCccc
Q 018785 158 KASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR-RALDED 236 (350)
Q Consensus 158 ~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~-~pf~~~ 236 (350)
||+||+++.++.++++|||.+................+++.|+|||.+.+..++.++||||||+++|+|++++ .||...
T Consensus 172 Kp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~ 251 (311)
T d1t46a_ 172 AARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM 251 (311)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred ccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999998765554444445567899999999999999999999999999999999954 445443
Q ss_pred ccCcchhhhhhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhc
Q 018785 237 RGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHT 309 (350)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 309 (350)
..... ....+........+..+++.+.+||.+||+.||.+|||+.++++.|++...
T Consensus 252 ~~~~~-----------------~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~ 307 (311)
T d1t46a_ 252 PVDSK-----------------FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (311)
T ss_dssp CSSHH-----------------HHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CHHHH-----------------HHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhc
Confidence 32211 222233334444556678899999999999999999999999999986543
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-50 Score=354.71 Aligned_cols=273 Identities=26% Similarity=0.355 Sum_probs=208.1
Q ss_pred hcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh--hHHHHHHHHHHHhccCCCcccceeeEEee
Q 018785 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ--GHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (350)
Q Consensus 21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (350)
++|++.+.||+|+||+||+| .+..+|+.||||++...... ....+.+|+.++++++||||+++++++.+
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~---------~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~ 72 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKA---------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT 72 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEE---------EETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEE---------EECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccccc
Confidence 58999999999999999999 66778999999999665432 24668899999999999999999999999
Q ss_pred cCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcccccc
Q 018785 99 SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 178 (350)
Q Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~ 178 (350)
++..|+||||+. +.+.+++.......+++..+..++.|++.||.||| ++||+||||||+||+++.++.++|+|||.+
T Consensus 73 ~~~~~iv~e~~~-~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH--~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a 149 (298)
T d1gz8a_ 73 ENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLA 149 (298)
T ss_dssp TTEEEEEEECCS-EEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTTSCEEECSTTHH
T ss_pred ccceeEEEeecC-CchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhh--cCCEEccccCchheeecccCcceeccCCcc
Confidence 999999999994 56667776665568999999999999999999999 999999999999999999999999999999
Q ss_pred ccCCCCCCCcccccccCCCcccCccccccCC-CCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhc-chhhhhh
Q 018785 179 RDGPTGDNTHVSTRIVGTRGYAAPEYVATGH-LTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWA-DPFLRDS 256 (350)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~ 256 (350)
...... ........|++.|+|||.+.... ++.++|+||+||++|+|++|+.||.+.+.......+.... .+.....
T Consensus 150 ~~~~~~--~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 227 (298)
T d1gz8a_ 150 RAFGVP--VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVW 227 (298)
T ss_dssp HHHCCC--SBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred eeccCC--cccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhc
Confidence 754322 22333457899999999877665 5789999999999999999999998655432222222111 0000000
Q ss_pred HHHHHhhhcc------cCC---CCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHhh
Q 018785 257 RRVLRIMDTR------LGG---QYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS--LEQL 307 (350)
Q Consensus 257 ~~~~~~~~~~------~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~--L~~~ 307 (350)
.......... ... .....+++++.+||.+||..||.+|||++++++| ++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 228 PGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289 (298)
T ss_dssp TTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred cccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence 0000000000 000 0112456789999999999999999999999987 5444
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-50 Score=355.06 Aligned_cols=264 Identities=24% Similarity=0.270 Sum_probs=198.8
Q ss_pred ccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhh-----HHHHHHHHHHHhccCCCcccceeeEEeec
Q 018785 25 SDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQG-----HKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (350)
Q Consensus 25 i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (350)
..++||+|+||+||+| .+..+|+.||||++....... ...+.+|+.++++++||||+++++++..+
T Consensus 2 ~l~~lG~G~fg~Vy~~---------~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~ 72 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKA---------RDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK 72 (299)
T ss_dssp EEEEEEEETTEEEEEE---------ECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred cceEeccCcCeEEEEE---------EECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccC
Confidence 3578999999999999 677789999999987654322 23578899999999999999999999999
Q ss_pred CceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccccc
Q 018785 100 DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR 179 (350)
Q Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~ 179 (350)
+..|+||||+.++++..+.... ..+++..+..++.||+.||+||| ++|++||||||+||+++.++.+||+|||++.
T Consensus 73 ~~~~ivmE~~~~~~~~~~~~~~--~~l~~~~~~~~~~qil~aL~~lH--~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~ 148 (299)
T d1ua2a_ 73 SNISLVFDFMETDLEVIIKDNS--LVLTPSHIKAYMLMTLQGLEYLH--QHWILHRDLKPNNLLLDENGVLKLADFGLAK 148 (299)
T ss_dssp TCCEEEEECCSEEHHHHHTTCC--SSCCSSHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred CceeehhhhhcchHHhhhhhcc--cCCCHHHHHHHHHHHHHHHHHhh--ccceecccCCcceEEecCCCccccccCcccc
Confidence 9999999999877666555433 37999999999999999999999 9999999999999999999999999999997
Q ss_pred cCCCCCCCcccccccCCCcccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcch-hhhhh-
Q 018785 180 DGPTGDNTHVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADP-FLRDS- 256 (350)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~- 256 (350)
....... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.........+...... .....
T Consensus 149 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~ 226 (299)
T d1ua2a_ 149 SFGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWP 226 (299)
T ss_dssp TTTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSS
T ss_pred ccCCCcc--cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhcc
Confidence 6433222 22335689999999988654 6799999999999999999999999876544333333221110 00000
Q ss_pred --HHHHHhhhcccCCC-----CcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 257 --RRVLRIMDTRLGGQ-----YSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 257 --~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
.............. ....+++++.+||.+||+.||++|||++++++|
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 227 DMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp STTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred chhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 00000000000000 112456789999999999999999999999976
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-50 Score=351.17 Aligned_cols=242 Identities=23% Similarity=0.432 Sum_probs=200.6
Q ss_pred hhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh------hHHHHHHHHHHHhccC--CCcccc
Q 018785 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ------GHKEWLTEVIYLGQLR--HENLVK 91 (350)
Q Consensus 20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~e~~~l~~l~--h~~i~~ 91 (350)
.++|++.++||+|+||+||+| .+..+|+.||||++...... ....+.+|+.++++++ ||||++
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a---------~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~ 73 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIR 73 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEE---------EETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCC
T ss_pred CCeEEEeEEEeeCCCeEEEEE---------EECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccE
Confidence 578999999999999999999 66677999999998754321 1123567999999986 899999
Q ss_pred eeeEEeecCceEEEEEcCCC-CChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCC-Cc
Q 018785 92 LIGYCSESDNRLLVYEFMPK-GSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSN-FN 169 (350)
Q Consensus 92 ~~~~~~~~~~~~lv~e~~~~-~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~-~~ 169 (350)
+++++.+.+..++|||++.+ +++.+++..+. .+++.+++.++.|+++||.||| ++|++||||||+||+++.+ +.
T Consensus 74 ~~~~~~~~~~~~lv~e~~~~~~~l~~~~~~~~--~l~e~~~~~~~~qi~~al~~lH--~~~iiHrDiKp~NIll~~~~~~ 149 (273)
T d1xwsa_ 74 LLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCH--NCGVLHRDIKDENILIDLNRGE 149 (273)
T ss_dssp EEEEEECSSEEEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEEETTTTE
T ss_pred EEEEEeeCCeEEEEEEeccCcchHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHH--HCCCccccCcccceEEecCCCe
Confidence 99999999999999999875 57888887665 7999999999999999999999 9999999999999999854 78
Q ss_pred EEEccccccccCCCCCCCcccccccCCCcccCccccccCCC-CCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhh
Q 018785 170 AKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHL-TPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEW 248 (350)
Q Consensus 170 ~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~ 248 (350)
++|+|||++...... ......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||..... +..
T Consensus 150 vkl~DFG~a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------i~~- 218 (273)
T d1xwsa_ 150 LKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIR- 218 (273)
T ss_dssp EEECCCTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHH-
T ss_pred EEECccccceecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH------Hhh-
Confidence 999999999764322 2234568999999999987765 5778999999999999999999965321 100
Q ss_pred cchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 249 ADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
. ....+..+|+++.+||.+||..||.+|||++++++|
T Consensus 219 ----------------~--~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 219 ----------------G--QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp ----------------C--CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ----------------c--ccCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 0 112334567899999999999999999999999876
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-48 Score=343.77 Aligned_cols=264 Identities=28% Similarity=0.428 Sum_probs=209.2
Q ss_pred ccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEcccc-chhhHHHHHHHHHHHhccCCCcccceeeEEee-cCce
Q 018785 25 SDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAE-SFQGHKEWLTEVIYLGQLRHENLVKLIGYCSE-SDNR 102 (350)
Q Consensus 25 i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 102 (350)
..++||+|+||+||+|++.. ...+...||||.++.. .......+.+|++++++++||||+++++++.+ ++..
T Consensus 31 ~~~~iG~G~fg~Vyk~~~~~------~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~ 104 (311)
T d1r0pa_ 31 FNEVIGRGHFGCVYHGTLLD------NDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 104 (311)
T ss_dssp EEEEEEEETTEEEEEEEECC----------CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEE
T ss_pred cceEEeecCCeEEEEEEEEC------CCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCce
Confidence 36789999999999997642 2233557999998753 33445779999999999999999999999765 4578
Q ss_pred EEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEccccccccCC
Q 018785 103 LLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGP 182 (350)
Q Consensus 103 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~~~~ 182 (350)
++||||+++++|.+++.... ..++...+..++.|++.||.|+| +.+++||||||+||+++.++.+||+|||++....
T Consensus 105 ~lv~E~~~~g~l~~~~~~~~-~~~~~~~~~~i~~qia~gL~~lH--~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~ 181 (311)
T d1r0pa_ 105 LVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLA--SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY 181 (311)
T ss_dssp EEEEECCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTT
T ss_pred EEEEEEeecCchhhhhcccc-ccchHHHHHHHHHHHHHhhhhhc--ccCcccCCccHHhEeECCCCCEEEecccchhhcc
Confidence 99999999999999886554 36788889999999999999999 9999999999999999999999999999998654
Q ss_pred CCCCC--cccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcchhhhhhHHHH
Q 018785 183 TGDNT--HVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVL 260 (350)
Q Consensus 183 ~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (350)
..... .......|++.|+|||.+.+..++.++||||||+++|+|++|+.||......... .
T Consensus 182 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~-----------------~ 244 (311)
T d1r0pa_ 182 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI-----------------T 244 (311)
T ss_dssp TTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------C-----------------H
T ss_pred ccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHH-----------------H
Confidence 43322 2223356889999999999999999999999999999999988887643321110 1
Q ss_pred HhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcCCCCC
Q 018785 261 RIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDMP 314 (350)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~~ 314 (350)
..+....+...+..+++++.+|+.+||+.||++|||+.+++++|+++..+-..+
T Consensus 245 ~~i~~g~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~~ 298 (311)
T d1r0pa_ 245 VYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 298 (311)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSC
T ss_pred HHHHcCCCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhhh
Confidence 111111223345567889999999999999999999999999999998764433
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-49 Score=347.97 Aligned_cols=260 Identities=29% Similarity=0.414 Sum_probs=209.8
Q ss_pred hhhcccccceecccCceeEEeecccCCCcCCCCCCCCc--EEEEEEccccc-hhhHHHHHHHHHHHhcc-CCCcccceee
Q 018785 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGI--VVAIKRLKAES-FQGHKEWLTEVIYLGQL-RHENLVKLIG 94 (350)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~--~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~ 94 (350)
.-++|++.++||+|+||+||+|++. .+|. .||||.+.... ....+.+.+|+.+++++ +||||+++++
T Consensus 8 ~~~~~~~~~~iG~G~fg~Vy~~~~~---------~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~ 78 (309)
T d1fvra_ 8 DWNDIKFQDVIGEGNFGQVLKARIK---------KDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLG 78 (309)
T ss_dssp CGGGCEEEEEEECGGGCEEEEEEEE---------ETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEE
T ss_pred CHHHcEEEEEEeeCCCcEEEEEEEC---------CCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEE
Confidence 3489999999999999999999553 3344 57778775433 23445789999999999 6999999999
Q ss_pred EEeecCceEEEEEcCCCCChhhHHhhc--------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCC
Q 018785 95 YCSESDNRLLVYEFMPKGSLENHLFRK--------------GVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKAS 160 (350)
Q Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~--------------~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~ 160 (350)
++.+++.+++||||+++|+|.+++..+ ....+++..+..++.|++.||.|+| +.+++||||||+
T Consensus 79 ~~~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH--~~~iiHrDlkp~ 156 (309)
T d1fvra_ 79 ACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS--QKQFIHRDLAAR 156 (309)
T ss_dssp EEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGG
T ss_pred EEecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh--cCCccccccccc
Confidence 999999999999999999999999654 2357999999999999999999999 899999999999
Q ss_pred ceEEcCCCcEEEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCC-CCcccccC
Q 018785 161 NVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRR-ALDEDRGG 239 (350)
Q Consensus 161 Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~-pf~~~~~~ 239 (350)
|||++.++.+||+|||++........ .....++..|+|||.+.+..++.++||||||+++|+|++|.. ||.+.+..
T Consensus 157 NIL~~~~~~~kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~ 233 (309)
T d1fvra_ 157 NILVGENYVAKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA 233 (309)
T ss_dssp GEEECGGGCEEECCTTCEESSCEECC---C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH
T ss_pred eEEEcCCCceEEcccccccccccccc---ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHH
Confidence 99999999999999999975332222 123457889999999999999999999999999999999765 66554422
Q ss_pred cchhhhhhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcC
Q 018785 240 LAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 310 (350)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 310 (350)
... ..+....+...+..+++++.+||.+||+.||++|||+++++++|+++...
T Consensus 234 ~~~------------------~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 286 (309)
T d1fvra_ 234 ELY------------------EKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 286 (309)
T ss_dssp HHH------------------HHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHH------------------HHHHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 211 11222223445667889999999999999999999999999999998764
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-49 Score=347.12 Aligned_cols=270 Identities=24% Similarity=0.392 Sum_probs=220.8
Q ss_pred hhhhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch-hhHHHHHHHHHHHhccCCCcccceee
Q 018785 16 SKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLVKLIG 94 (350)
Q Consensus 16 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~ 94 (350)
+++..++|++.+.||+|+||+||+|.++.. .+..++..||||.++.... .....+.+|+.++++++||||+++++
T Consensus 15 ~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~----~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~ 90 (308)
T d1p4oa_ 15 WEVAREKITMSRELGQGSFGMVYEGVAKGV----VKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLG 90 (308)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEEEE----ETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred eeecHHHeEEeeEEeeCCCeEEEEEEECCc----ccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeee
Confidence 456678999999999999999999976532 2234467899999975433 33456889999999999999999999
Q ss_pred EEeecCceEEEEEcCCCCChhhHHhhc--------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcC
Q 018785 95 YCSESDNRLLVYEFMPKGSLENHLFRK--------GVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS 166 (350)
Q Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~--------~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~ 166 (350)
++..++..++||||+.+|+|.+++... ....++...+..++.|++.||.||| +++++||||||+||+++.
T Consensus 91 ~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH--~~~ivHrDlk~~NiLld~ 168 (308)
T d1p4oa_ 91 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN--ANKFVHRDLAARNCMVAE 168 (308)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH--HTTCBCSCCSGGGEEECT
T ss_pred EEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh--hCCeeeceEcCCceeecC
Confidence 999999999999999999999998643 1235788899999999999999999 899999999999999999
Q ss_pred CCcEEEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCC-CCCcccccCcchhhh
Q 018785 167 NFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR-RALDEDRGGLAEQTL 245 (350)
Q Consensus 167 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~-~pf~~~~~~~~~~~~ 245 (350)
++.+||+|||++................+++.|+|||.+.+..++.++||||+|+++|+|++|. .||.+........
T Consensus 169 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~-- 246 (308)
T d1p4oa_ 169 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR-- 246 (308)
T ss_dssp TCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHH--
T ss_pred CceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHH--
Confidence 9999999999997654444333344456889999999999999999999999999999999985 6676544322111
Q ss_pred hhhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhc
Q 018785 246 VEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHT 309 (350)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 309 (350)
.+........+..+++.+.+||.+||+.||++|||+++++++|++...
T Consensus 247 ----------------~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 247 ----------------FVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp ----------------HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred ----------------HHHhCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 112222334456778899999999999999999999999999987644
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-48 Score=346.84 Aligned_cols=269 Identities=25% Similarity=0.355 Sum_probs=201.3
Q ss_pred hhcccccceecccCceeEEeecccCCCcCCCCCC-CCcEEEEEEccccchhh--HHHHHHHHHHHhcc---CCCccccee
Q 018785 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPG-SGIVVAIKRLKAESFQG--HKEWLTEVIYLGQL---RHENLVKLI 93 (350)
Q Consensus 20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~-~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l---~h~~i~~~~ 93 (350)
.++|++.+.||+|+||+||+| .+.. +++.||||++....... ...+.+|+.+++.+ +||||++++
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a---------~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~ 76 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKA---------RDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLF 76 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEE---------EETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEE
T ss_pred cCCEEEEEEEecccCeEEEEE---------EEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceee
Confidence 479999999999999999999 4433 36789999986543221 22345566666555 799999999
Q ss_pred eEEee-----cCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCC
Q 018785 94 GYCSE-----SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNF 168 (350)
Q Consensus 94 ~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~ 168 (350)
+++.. ....+++||++.++.+. +........+++..++.++.|++.||+||| ++||+||||||+|||++.++
T Consensus 77 ~~~~~~~~~~~~~~~~~~e~~~~~~~~-~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH--~~~ivHrDiKp~NILi~~~~ 153 (305)
T d1blxa_ 77 DVCTVSRTDRETKLTLVFEHVDQDLTT-YLDKVPEPGVPTETIKDMMFQLLRGLDFLH--SHRVVHRDLKPQNILVTSSG 153 (305)
T ss_dssp EEEEEEECSSEEEEEEEEECCSCBHHH-HHHHSCTTCSCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTTC
T ss_pred eeecccccccCceEEEEEEeccCCchh-hhhhccCCCCCHHHHHHHHHHHHHHHHHHH--hCCEEecCCCccEEEEcCCC
Confidence 99853 34678999999765554 444444457999999999999999999999 99999999999999999999
Q ss_pred cEEEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhh
Q 018785 169 NAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEW 248 (350)
Q Consensus 169 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~ 248 (350)
.++|+|||++..... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+...
T Consensus 154 ~~kl~dfg~~~~~~~---~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~ 230 (305)
T d1blxa_ 154 QIKLADFGLARIYSF---QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDV 230 (305)
T ss_dssp CEEECSCCSCCCCCG---GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred Ceeecchhhhhhhcc---cccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHh
Confidence 999999999874322 22334567999999999999999999999999999999999999999876644333333221
Q ss_pred cchh-hhhh-------HHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 249 ADPF-LRDS-------RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 249 ~~~~-~~~~-------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
.... .... ..................+++.+.+||.+||+.||.+|||++++++|
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 231 IGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp HCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 1100 0000 00000000011112334567889999999999999999999999987
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=6e-49 Score=345.50 Aligned_cols=267 Identities=21% Similarity=0.303 Sum_probs=201.6
Q ss_pred hcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchh--hHHHHHHHHHHHhccCCCcccceeeEEee
Q 018785 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ--GHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (350)
Q Consensus 21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (350)
++|++.++||+|+||+||+|++ .+|+.||||++...... ....+.+|+.++++++||||+++++.+..
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~----------~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~ 71 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQN----------NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT 71 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE----------TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEe----------CCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeeccc
Confidence 6899999999999999999943 25789999998765432 24678899999999999999999999999
Q ss_pred cCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcccccc
Q 018785 99 SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 178 (350)
Q Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~ 178 (350)
++..+++++++.++.+..+.... ..+++..+..++.||+.||+||| +.||+||||||+||+++.++.++++|||.+
T Consensus 72 ~~~~~i~~e~~~~~~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH--~~~IvHrDiKp~NIll~~~~~~kl~DfG~a 147 (286)
T d1ob3a_ 72 KKRLVLVFEHLDQDLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCH--DRRVLHRDLKPQNLLINREGELKIADFGLA 147 (286)
T ss_dssp SSCEEEEEECCSEEHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTTSCEEECCTTHH
T ss_pred CCceeEEEEeehhhhHHHHHhhc--CCcchhhhHHHHHHHHHHHHHhc--cCcEEecCCCCceeeEcCCCCEEecccccc
Confidence 99999999999665555554433 37999999999999999999999 899999999999999999999999999999
Q ss_pred ccCCCCCCCcccccccCCCcccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhc-chhhhhh
Q 018785 179 RDGPTGDNTHVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWA-DPFLRDS 256 (350)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~ 256 (350)
....... .......+++.|.|||.+.+. .++.++|+|||||++|+|++|+.||.+.........+.... .+.....
T Consensus 148 ~~~~~~~--~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 225 (286)
T d1ob3a_ 148 RAFGIPV--RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNW 225 (286)
T ss_dssp HHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred eecccCc--cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhc
Confidence 7643222 222334688899999998764 56899999999999999999999997655433322222111 1100000
Q ss_pred HHHHHh---------hhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 257 RRVLRI---------MDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 257 ~~~~~~---------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
...... ............+++++.+||.+||+.||++|||++++++|
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 226 PNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp TTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000000 00000011234567899999999999999999999999865
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-48 Score=341.01 Aligned_cols=275 Identities=24% Similarity=0.322 Sum_probs=204.2
Q ss_pred hhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceeeEEeec
Q 018785 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (350)
Q Consensus 20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (350)
.++|.+.+.||+|+||.||+|++ +|+.||||++...... ......|+..++.++||||+++++++.+.
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~-----------~g~~vAvK~~~~~~~~-~~~~e~ei~~~~~~~HpnIv~~~~~~~~~ 69 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKW-----------RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKD 69 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE-----------TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE-----------CCEEEEEEEECccchh-HHHHHHHHHHHhhCCCCcCcceEEEEEeC
Confidence 57899999999999999999954 3789999998755422 22233456666778999999999998765
Q ss_pred C----ceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcC------CCCeeeCCCCCCceEEcCCCc
Q 018785 100 D----NRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL------DANVIYRDLKASNVLLDSNFN 169 (350)
Q Consensus 100 ~----~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~------~~~i~H~di~~~Nili~~~~~ 169 (350)
+ .+++||||+++++|.+++.+. .++...++.++.|++.||+|+|+. ++||+||||||+||+++.++.
T Consensus 70 ~~~~~~~~lv~Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~ 146 (303)
T d1vjya_ 70 NGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT 146 (303)
T ss_dssp CSSSEEEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSC
T ss_pred CCcceEEEEEEecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCC
Confidence 4 578999999999999999875 589999999999999999999932 269999999999999999999
Q ss_pred EEEccccccccCCCCCCC--cccccccCCCcccCccccccCC------CCCccchhhHHHHHHHHHhCCCCCcccccCcc
Q 018785 170 AKLSDFGLARDGPTGDNT--HVSTRIVGTRGYAAPEYVATGH------LTPKSDVYSFGVVLLELLSGRRALDEDRGGLA 241 (350)
Q Consensus 170 ~~l~Dfg~~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~------~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~ 241 (350)
+||+|||++......... .......||+.|+|||++.+.. ++.++|||||||++|+|++|..||........
T Consensus 147 ~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~ 226 (303)
T d1vjya_ 147 CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL 226 (303)
T ss_dssp EEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCC
T ss_pred eEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCccccccc
Confidence 999999999764333222 1223467899999999986653 55689999999999999999988765443222
Q ss_pred hhhhhhhcchhhhhhHHHHHhhhcccCCCC-----cHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcCC
Q 018785 242 EQTLVEWADPFLRDSRRVLRIMDTRLGGQY-----SKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSK 311 (350)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~ 311 (350)
.........+..... .........+... ....+..+.+|+.+||+.||.+|||+.++++.|+++....
T Consensus 227 ~~~~~~~~~~~~~~~--~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 299 (303)
T d1vjya_ 227 PYYDLVPSDPSVEEM--RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp TTTTTSCSSCCHHHH--HHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred chhhcccccchHHHH--HHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhc
Confidence 111111011111111 1111111111111 2345677999999999999999999999999999987653
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-48 Score=347.42 Aligned_cols=277 Identities=23% Similarity=0.346 Sum_probs=205.8
Q ss_pred hhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch--hhHHHHHHHHHHHhccCCCcccceeeEE
Q 018785 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLRHENLVKLIGYC 96 (350)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (350)
..++|++.++||+|+||+||+| .+..+|+.||||++..... .....+.+|+.+|+.++||||+++++++
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~---------~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~ 86 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSA---------VDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVF 86 (346)
T ss_dssp CBSSEEEEEEC------CEEEE---------EETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEE
T ss_pred cCCcEEEEEEEecCCCeEEEEE---------EECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEe
Confidence 3689999999999999999999 6667799999999975432 3345688999999999999999999999
Q ss_pred eecC------ceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcE
Q 018785 97 SESD------NRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNA 170 (350)
Q Consensus 97 ~~~~------~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~ 170 (350)
...+ .+|+||||+ +.+|..+.... .+++..++.++.||+.||.||| ++||+||||||+|||++.++.+
T Consensus 87 ~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH--~~~IiHrDiKp~NIL~~~~~~~ 160 (346)
T d1cm8a_ 87 TPDETLDDFTDFYLVMPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIH--AAGIIHRDLKPGNLAVNEDCEL 160 (346)
T ss_dssp CSCSSTTTCCCCEEEEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTCCE
T ss_pred ccCccccccceEEEEEecc-cccHHHHHHhc---cccHHHHHHHHHHHHHHHHHHH--hCCCcccccCcchhhccccccc
Confidence 7654 469999999 77888777554 6999999999999999999999 9999999999999999999999
Q ss_pred EEccccccccCCCCCCCcccccccCCCcccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhc
Q 018785 171 KLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWA 249 (350)
Q Consensus 171 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~ 249 (350)
+++|||++...... .....+++.|+|||.+.+. .++.++||||+||++|+|++|..||.+.+.......+....
T Consensus 161 kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~ 235 (346)
T d1cm8a_ 161 KILDFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVT 235 (346)
T ss_dssp EECCCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred ccccccceeccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhcc
Confidence 99999999864332 2335689999999998764 56899999999999999999999998765433322222211
Q ss_pred chhhh---------hhHHHHHhhhcccC---CCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHhhhcCCCCCC
Q 018785 250 DPFLR---------DSRRVLRIMDTRLG---GQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS--LEQLHTSKDMPR 315 (350)
Q Consensus 250 ~~~~~---------~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~--L~~~~~~~~~~~ 315 (350)
..... .............. ......+++++.+||.+||..||.+|||++++|+| ++.+....+.|.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~~~~~~ 315 (346)
T d1cm8a_ 236 GTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQ 315 (346)
T ss_dssp CCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC------C
T ss_pred CCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCcccccc
Confidence 11000 00001111111111 11234567889999999999999999999999998 776665544443
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=4.2e-47 Score=334.34 Aligned_cols=271 Identities=17% Similarity=0.184 Sum_probs=216.3
Q ss_pred hhhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccC-CCcccceeeEE
Q 018785 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLR-HENLVKLIGYC 96 (350)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~ 96 (350)
+.+++|++.+.||+|+||+||+| .+..+|+.||||++..... ...+.+|++.++.+. |++++.+++++
T Consensus 2 vig~~Y~i~~~iG~G~fG~Vy~a---------~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~ 70 (293)
T d1csna_ 2 VVGVHYKVGRRIGEGSFGVIFEG---------TNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFG 70 (293)
T ss_dssp EETTTEEEEEEEEECSSCEEEEE---------EETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEE
T ss_pred CCCCceEEEEEEecCCCeEEEEE---------EECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEe
Confidence 56789999999999999999999 5666799999998865432 234677888999886 48999999999
Q ss_pred eecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcC-----CCcEE
Q 018785 97 SESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS-----NFNAK 171 (350)
Q Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~-----~~~~~ 171 (350)
..+...++|||++ +++|.+++.... ..++...+..++.|++.||.||| +.|++||||||+||+++. ++.++
T Consensus 71 ~~~~~~~~vme~~-~~~l~~~~~~~~-~~~~~~~~~~i~~q~~~~l~~lH--~~giiHrDiKp~Nili~~~~~~~~~~vk 146 (293)
T d1csna_ 71 QEGLHNVLVIDLL-GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIH--EKSLVYRDIKPDNFLIGRPNSKNANMIY 146 (293)
T ss_dssp EETTEEEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHH--TTTEECCCCCGGGEEECCSSSTTTTCEE
T ss_pred ecCCccEEEEEec-CCCHHHHHHhhc-cchhhHHHHHHHHHHHHHHHHHH--HCCceeccCCccceeecCcccccCCceE
Confidence 9999999999999 789999887654 46999999999999999999999 999999999999999964 56799
Q ss_pred EccccccccCCCCCCC-----cccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhh
Q 018785 172 LSDFGLARDGPTGDNT-----HVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLV 246 (350)
Q Consensus 172 l~Dfg~~~~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~ 246 (350)
|+|||++......... .......||+.|+|||++.+..++.++||||||+++|+|++|..||.+...........
T Consensus 147 l~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~ 226 (293)
T d1csna_ 147 VVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYE 226 (293)
T ss_dssp ECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHH
T ss_pred EcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHH
Confidence 9999999865433221 12234579999999999999999999999999999999999999998765543332222
Q ss_pred hhcchhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcCCCCC
Q 018785 247 EWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDMP 314 (350)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~~ 314 (350)
...... .......+...+|+++.+++..|+..+|++||+++.+.+.|+++..+....
T Consensus 227 ~i~~~~-----------~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~~ 283 (293)
T d1csna_ 227 RIGEKK-----------QSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTT 283 (293)
T ss_dssp HHHHHH-----------HHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred HHHhcc-----------CCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCCC
Confidence 111000 000001112346778999999999999999999999999998877654443
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-47 Score=344.90 Aligned_cols=277 Identities=25% Similarity=0.332 Sum_probs=204.6
Q ss_pred hhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch-hhHHHHHHHHHHHhccCCCcccceeeEEee
Q 018785 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (350)
Q Consensus 20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (350)
+.+|++.++||+|+||+||+| .+..+|+.||||++..... .....+.+|+.+|++++||||+++++++..
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~---------~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~ 77 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSA---------YDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRA 77 (345)
T ss_dssp CTTEEEEEECC---CCCEEEE---------EETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECC
T ss_pred CCCeEEEEEEeeccCeEEEEE---------EECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEee
Confidence 468999999999999999999 6677799999999975442 334568899999999999999999999876
Q ss_pred cCc----eEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcc
Q 018785 99 SDN----RLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSD 174 (350)
Q Consensus 99 ~~~----~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~D 174 (350)
... .+++++++.+++|.+++..+ .+++..++.++.|++.||+||| ++||+||||||+||+++.++.++|+|
T Consensus 78 ~~~~~~~~~~l~~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH--~~~iiHRDIKp~NILl~~~~~~kl~D 152 (345)
T d1pmea_ 78 PTIEQMKDVYLVTHLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIH--SANVLHRDLKPSNLLLNTTCDLKICD 152 (345)
T ss_dssp SSTTTCCCEEEEEECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTCCEEECC
T ss_pred ccccccceEEEEEeecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHH--HCCCcCCCCCcceEEECCCCCEEEcc
Confidence 532 24445556699999999765 5999999999999999999999 89999999999999999999999999
Q ss_pred ccccccCCCCCCC-cccccccCCCcccCccccc-cCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhc-ch
Q 018785 175 FGLARDGPTGDNT-HVSTRIVGTRGYAAPEYVA-TGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWA-DP 251 (350)
Q Consensus 175 fg~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~-~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~-~~ 251 (350)
||++......... .......|++.|+|||++. +..++.++||||+||++|+|++|+.||.+.............. .+
T Consensus 153 fG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~ 232 (345)
T d1pmea_ 153 FGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP 232 (345)
T ss_dssp CTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSC
T ss_pred cCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCC
Confidence 9999754333221 1233466899999999884 4567899999999999999999999997665432222222111 11
Q ss_pred hhhh--------hHHHHHhhhcccCC---CCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHhhhcC
Q 018785 252 FLRD--------SRRVLRIMDTRLGG---QYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS--LEQLHTS 310 (350)
Q Consensus 252 ~~~~--------~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~--L~~~~~~ 310 (350)
.... .............. .....+++++.+|+.+||..||.+|||++++++| |++....
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~ 304 (345)
T d1pmea_ 233 SQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 304 (345)
T ss_dssp CHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCG
T ss_pred ChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCC
Confidence 0000 00000000000000 0122456789999999999999999999999987 5544443
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-47 Score=340.35 Aligned_cols=271 Identities=23% Similarity=0.310 Sum_probs=199.1
Q ss_pred hhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch--hhHHHHHHHHHHHhccCCCcccceeeEEe
Q 018785 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (350)
Q Consensus 20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (350)
-++|++.+.||+|+||+||+| .+..+|+.||||++..... .....+.+|+.+++.++||||+++++++.
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a---------~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~ 79 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKA---------RHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICR 79 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEE---------EETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred cCCEEEEEEEecCcCeEEEEE---------EECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeee
Confidence 389999999999999999999 5667799999999865432 23456789999999999999999999875
Q ss_pred e--------cCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCc
Q 018785 98 E--------SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFN 169 (350)
Q Consensus 98 ~--------~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~ 169 (350)
. .+..++|||++.++.+..+... ...+++..++.++.|+++||.||| ++||+||||||+||+++.++.
T Consensus 80 ~~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~--~~~~~~~~~~~i~~qil~~l~~lH--~~~ivHrDlKp~NILl~~~~~ 155 (318)
T d3blha1 80 TKASPYNRCKGSIYLVFDFCEHDLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIH--RNKILHRDMKAANVLITRDGV 155 (318)
T ss_dssp C----------CEEEEEECCCEEHHHHHTCT--TCCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTSC
T ss_pred cccccccccCceEEEEEeccCCCccchhhhc--ccccccHHHHHHHHHHHHHHHHhc--cCCEEecCcCchheeecCCCc
Confidence 4 3568999999976555443332 347999999999999999999999 999999999999999999999
Q ss_pred EEEccccccccCCCCCCC--cccccccCCCcccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhh
Q 018785 170 AKLSDFGLARDGPTGDNT--HVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLV 246 (350)
Q Consensus 170 ~~l~Dfg~~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~ 246 (350)
++++|||++......... .......||+.|+|||++.+. .++.++||||+||++|+|++|+.||.+.........+.
T Consensus 156 ~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~ 235 (318)
T d3blha1 156 LKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALIS 235 (318)
T ss_dssp EEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred EEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHH
Confidence 999999999754432221 122335689999999998765 68999999999999999999999998765444333333
Q ss_pred hhcchhhhhh------HHHHHhhhcccCCC--Cc-----HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 247 EWADPFLRDS------RRVLRIMDTRLGGQ--YS-----KKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 247 ~~~~~~~~~~------~~~~~~~~~~~~~~--~~-----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
.......... .............. .. ...++.+.+||.+||+.||++|||++++++|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 236 QLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp HHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 2211110000 00000000000000 00 1224678899999999999999999999976
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2e-46 Score=331.47 Aligned_cols=266 Identities=19% Similarity=0.214 Sum_probs=205.2
Q ss_pred hhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcc-cceeeEEee
Q 018785 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENL-VKLIGYCSE 98 (350)
Q Consensus 20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~ 98 (350)
+++|++.+.||+|+||+||+| .+..+|+.||||++...... ..+..|.++++.++|+++ +.+..++.+
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a---------~~~~~~~~vAvK~~~~~~~~--~~~~~E~~i~~~l~~~~~i~~~~~~~~~ 74 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLG---------TDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAE 74 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEE---------EETTTTEEEEEEEEESCTTS--CCHHHHHHHHHHSTTSTTCCCEEEEEEE
T ss_pred CCEEEEeEEEeeCCCcEEEEE---------EECCCCCEEEEEEEchhccC--HHHHHHHHHHHHccCCCcccEEEEEEec
Confidence 578999999999999999999 56667899999988765422 346789999999976665 455666677
Q ss_pred cCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcC---CCcEEEccc
Q 018785 99 SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS---NFNAKLSDF 175 (350)
Q Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~---~~~~~l~Df 175 (350)
.+..++|||++ ++++.+.+.... ..+++..+..++.|++.||+||| ++|++||||||+||+++. +..++|+||
T Consensus 75 ~~~~~ivme~~-~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH--~~~iiHrDiKp~NIl~~~~~~~~~vkl~DF 150 (299)
T d1ckia_ 75 GDYNVMVMELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIH--SKNFIHRDVKPDNFLMGLGKKGNLVYIIDF 150 (299)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGGGEEECCGGGTTCEEECCC
T ss_pred CCEEEEEEEEc-CCchhhhhhhcc-CCCcHHHHHHHHHHHHHHHHHHH--HCCeeeccCCHhhccccccCCCceeeeecc
Confidence 88889999998 667777765543 47999999999999999999999 899999999999999864 456999999
Q ss_pred cccccCCCCCCC-----cccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcc
Q 018785 176 GLARDGPTGDNT-----HVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD 250 (350)
Q Consensus 176 g~~~~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~ 250 (350)
|++......... .......||+.|+|||.+.+..++.++|||||||++|+|++|+.||...........+.....
T Consensus 151 G~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~ 230 (299)
T d1ckia_ 151 GLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE 230 (299)
T ss_dssp SSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHH
T ss_pred CcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhc
Confidence 999865443322 122345799999999999999999999999999999999999999987655433333222111
Q ss_pred hhhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhcCC
Q 018785 251 PFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSK 311 (350)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~ 311 (350)
..... ........+|+++.+++.+||+.||++||+++++.+.|+++....
T Consensus 231 ~~~~~-----------~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~ 280 (299)
T d1ckia_ 231 KKMST-----------PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280 (299)
T ss_dssp HHHHS-----------CHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred ccCCC-----------ChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence 10000 000112356788999999999999999999999999888876543
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-47 Score=338.84 Aligned_cols=259 Identities=26% Similarity=0.353 Sum_probs=210.6
Q ss_pred hhhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch----hhHHHHHHHHHHHhccCC-Cccccee
Q 018785 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF----QGHKEWLTEVIYLGQLRH-ENLVKLI 93 (350)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~e~~~l~~l~h-~~i~~~~ 93 (350)
.-++|++.+.||+|+||+||+|+.. ....+|+.||||.+..... .....+.+|+.++++++| |||++++
T Consensus 22 ~l~~y~~~~~IG~G~fg~Vy~~~~~------~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~ 95 (322)
T d1vzoa_ 22 GIENFELLKVLGTGAYGKVFLVRKI------SGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLH 95 (322)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEEC------SSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEE
T ss_pred chhceEEEEEEecCCCeEEEEEEEC------ccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEee
Confidence 3478999999999999999999543 3456799999999865432 223457789999999966 8999999
Q ss_pred eEEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEc
Q 018785 94 GYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLS 173 (350)
Q Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~ 173 (350)
+++.+....+++|||+.+++|.+++.... .+++..+..++.||+.||.|+| +++++||||||+||+++.++.++|+
T Consensus 96 ~~~~~~~~~~~v~e~~~~~~L~~~i~~~~--~~~e~~~~~~~~Qi~~al~~lH--~~~ivHrDiKp~Nill~~~~~vkL~ 171 (322)
T d1vzoa_ 96 YAFQTETKLHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLH--KLGIIYRDIKLENILLDSNGHVVLT 171 (322)
T ss_dssp EEEEETTEEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTTSCEEES
T ss_pred eeeccCCceeeeeecccccHHHHHHHhcc--cccHHHHHHHHHHHHHHHHHhh--cCCEEeccCCccceeecCCCCEEEe
Confidence 99999999999999999999999998776 6889999999999999999999 9999999999999999999999999
Q ss_pred cccccccCCCCCCCcccccccCCCcccCccccccC--CCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcch
Q 018785 174 DFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG--HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADP 251 (350)
Q Consensus 174 Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~ 251 (350)
|||++....... ........|++.|++||.+.+. .++.++|||||||++|+|++|+.||.+.........+....
T Consensus 172 DFG~a~~~~~~~-~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~-- 248 (322)
T d1vzoa_ 172 DFGLSKEFVADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI-- 248 (322)
T ss_dssp CSSEEEECCGGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHH--
T ss_pred eccchhhhcccc-cccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc--
Confidence 999997543322 2223346789999999998765 46789999999999999999999998766544333332210
Q ss_pred hhhhhHHHHHhhhcccCCCCcHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 018785 252 FLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRP-----SMVDVLTS 303 (350)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~~ 303 (350)
.......+..+++++.+||.+||..||.+|| |++++++|
T Consensus 249 -------------~~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 249 -------------LKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp -------------HHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred -------------ccCCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence 0111234557889999999999999999999 47899875
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-47 Score=333.56 Aligned_cols=268 Identities=23% Similarity=0.279 Sum_probs=207.6
Q ss_pred hcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch--hhHHHHHHHHHHHhccCCCcccceeeEEee
Q 018785 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (350)
Q Consensus 21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (350)
++|++.+.||+|+||+||+| .+..+++.||||+++.... .....+.+|+.+++.++||||+++++++..
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~---------~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~ 72 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKA---------KNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS 72 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEE---------EETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred CCCEeeeEEecCcCeEEEEE---------EECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccccc
Confidence 58999999999999999999 6667799999999865543 335678899999999999999999999999
Q ss_pred cCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEEcccccc
Q 018785 99 SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 178 (350)
Q Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~ 178 (350)
....++|++++.++++..++.... .+++..+..++.|+++||+||| ++||+||||||+||+++.++.++|+|||.+
T Consensus 73 ~~~~~iv~~~~~~~~l~~~~~~~~--~~~~~~~~~~~~q~~~aL~~lH--~~~IvHrDiKP~NIli~~~~~~kl~DFG~a 148 (292)
T d1unla_ 73 DKKLTLVFEFCDQDLKKYFDSCNG--DLDPEIVKSFLFQLLKGLGFCH--SRNVLHRDLKPQNLLINRNGELKLANFGLA 148 (292)
T ss_dssp SSEEEEEEECCSEEHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTCCEEECCCTTC
T ss_pred ccceeEEeeecccccccccccccc--ccchhHHHHHHHHHHHHHHHhh--cCCEeeecccCcccccccCCceeeeecchh
Confidence 999999999998888887776554 7899999999999999999999 899999999999999999999999999999
Q ss_pred ccCCCCCCCcccccccCCCcccCccccccCC-CCCccchhhHHHHHHHHHhCCCCCcccccC-cchhhhhhhcch-hhhh
Q 018785 179 RDGPTGDNTHVSTRIVGTRGYAAPEYVATGH-LTPKSDVYSFGVVLLELLSGRRALDEDRGG-LAEQTLVEWADP-FLRD 255 (350)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~DiwslG~ll~~ll~g~~pf~~~~~~-~~~~~~~~~~~~-~~~~ 255 (350)
........ ......+++.|.|||.+.+.. ++.++|||||||++|+|++|+.||....+. .....+...... ....
T Consensus 149 ~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (292)
T d1unla_ 149 RAFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQ 226 (292)
T ss_dssp EECCSCCS--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred hcccCCCc--cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhh
Confidence 86443322 222345677899999887664 689999999999999999999997543321 111111111110 0000
Q ss_pred hHHHHHhh---------hcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 256 SRRVLRIM---------DTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 256 ~~~~~~~~---------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
........ ............++.+.+||.+||+.||.+|||++++++|
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 227 WPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00000000 0111112334567889999999999999999999999876
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-47 Score=340.48 Aligned_cols=270 Identities=24% Similarity=0.338 Sum_probs=202.0
Q ss_pred hcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccCCCcccceeeEEeec-
Q 018785 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSES- 99 (350)
Q Consensus 21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~- 99 (350)
-+|+..++||+|+||+||+| .+..+|+.||||++...... ..+|+.++++++||||+++++++...
T Consensus 20 ~~Y~~~k~LG~G~fg~Vy~a---------~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~ 86 (350)
T d1q5ka_ 20 VSYTDTKVIGNGSFGVVYQA---------KLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSG 86 (350)
T ss_dssp EEEEEEEEEEEETTEEEEEE---------EETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC-
T ss_pred CCcEeeeEEeeCcCeEEEEE---------EECCCCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecC
Confidence 37999999999999999999 66677999999998765422 24689999999999999999998542
Q ss_pred -----CceEEEEEcCCCCChhhHHhh--cCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCC-cEE
Q 018785 100 -----DNRLLVYEFMPKGSLENHLFR--KGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNF-NAK 171 (350)
Q Consensus 100 -----~~~~lv~e~~~~~~L~~~l~~--~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~-~~~ 171 (350)
..+++||||+.++ +.+.+.. .....+++..++.++.|++.||+||| ++||+||||||+|||++.++ .+|
T Consensus 87 ~~~~~~~~~lv~Ey~~~~-~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH--~~~IiHrDiKp~NILl~~~~~~~k 163 (350)
T d1q5ka_ 87 EKKDEVYLNLVLDYVPET-VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH--SFGICHRDIKPQNLLLDPDTAVLK 163 (350)
T ss_dssp -CCSCCEEEEEEECCSEE-HHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH--TTTEECCCCCGGGEEECTTTCCEE
T ss_pred ccCCceEEEEEEeccCCc-cHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHH--hcCCcccCCCcceEEEecCCCcee
Confidence 3478999999654 4444422 23347999999999999999999999 99999999999999999775 799
Q ss_pred EccccccccCCCCCCCcccccccCCCcccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcc
Q 018785 172 LSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD 250 (350)
Q Consensus 172 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~ 250 (350)
|+|||++....... ......|++.|+|||.+.+ ..++.++||||+||++|+|++|..||...........+.....
T Consensus 164 l~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g 240 (350)
T d1q5ka_ 164 LCDFGSAKQLVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLG 240 (350)
T ss_dssp ECCCTTCEECCTTS---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHC
T ss_pred EecccchhhccCCc---ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhC
Confidence 99999997643322 2233568999999998875 4789999999999999999999999987654433333322211
Q ss_pred -hhhhhhHHHHHhh-hcc--------cCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHhhhc
Q 018785 251 -PFLRDSRRVLRIM-DTR--------LGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS--LEQLHT 309 (350)
Q Consensus 251 -~~~~~~~~~~~~~-~~~--------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~--L~~~~~ 309 (350)
+............ ... .........++++.+||.+||..||.+|||+.++++| ++++..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 311 (350)
T d1q5ka_ 241 TPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 311 (350)
T ss_dssp CCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred CChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccC
Confidence 1111110000000 000 0011223567889999999999999999999999987 555544
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=6.1e-46 Score=332.55 Aligned_cols=262 Identities=19% Similarity=0.259 Sum_probs=201.7
Q ss_pred hhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccC-CCcccceeeEEee
Q 018785 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLR-HENLVKLIGYCSE 98 (350)
Q Consensus 20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~ 98 (350)
.++|++.++||+|+||+||+| .+..+|+.||||+++... ...+.+|+.+|+.++ ||||+++++++..
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a---------~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~ 101 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEA---------INITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKD 101 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEE---------EETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEEC
T ss_pred CcCeEEEEEEecCcCeEEEEE---------EECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEe
Confidence 468999999999999999999 666789999999987543 456788999999995 9999999999974
Q ss_pred --cCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCC-cEEEccc
Q 018785 99 --SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNF-NAKLSDF 175 (350)
Q Consensus 99 --~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~-~~~l~Df 175 (350)
...+++||||+.+++|..+. +.+++..++.++.||+.||.||| ++||+||||||+|||++.++ .++|+||
T Consensus 102 ~~~~~~~~v~e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH--~~gIvHrDiKp~NILi~~~~~~vkl~DF 174 (328)
T d3bqca1 102 PVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCH--SMGIMHRDVKPHNVMIDHEHRKLRLIDW 174 (328)
T ss_dssp TTTCSEEEEEECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEEETTTTEEEECCG
T ss_pred cCCCceeEEEeecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHh--hcccccccccccceEEcCCCCeeeeccc
Confidence 45689999999999987753 26999999999999999999999 99999999999999998655 5899999
Q ss_pred cccccCCCCCCCcccccccCCCcccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCcccccCcc-hhhhhhhcc-hh
Q 018785 176 GLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLA-EQTLVEWAD-PF 252 (350)
Q Consensus 176 g~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~-~~~~~~~~~-~~ 252 (350)
|++........ .....+|+.|+|||.+.+. .++.++|+||+||++|+|++|+.||........ ...+..... +.
T Consensus 175 G~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~ 251 (328)
T d3bqca1 175 GLAEFYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED 251 (328)
T ss_dssp GGCEECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHH
T ss_pred ccceeccCCCc---ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCch
Confidence 99976443322 2335688999999998765 579999999999999999999999976543221 111111111 00
Q ss_pred hhhhHH---------HHHhh--------hcccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 253 LRDSRR---------VLRIM--------DTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 253 ~~~~~~---------~~~~~--------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
...... ..... ...........+++++.+||.+||..||.+|||++++|+|
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 252 LYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp HHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000000 00000 0011112234567899999999999999999999999875
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-46 Score=337.08 Aligned_cols=265 Identities=24% Similarity=0.305 Sum_probs=196.3
Q ss_pred hhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch--hhHHHHHHHHHHHhccCCCcccceeeEEe
Q 018785 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (350)
Q Consensus 20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (350)
.++|++.++||+|+||+||+| .+..+|+.||||++..... .....+.+|+.++++++||||++++++|.
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~---------~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~ 86 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAA---------YDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFT 86 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEE---------EETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred cCCeEEEEEeecCcCeEEEEE---------EECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEe
Confidence 368999999999999999999 6667799999999976532 33456889999999999999999999996
Q ss_pred e------cCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEE
Q 018785 98 E------SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAK 171 (350)
Q Consensus 98 ~------~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~ 171 (350)
. ...+|+||||+.+ ++.+.+. ..+++..++.++.|++.||.||| ++|++|+||||+||+++.++.++
T Consensus 87 ~~~~~~~~~~~~iv~Ey~~~-~l~~~~~----~~~~~~~i~~~~~qil~gl~~LH--~~giiHrDlKP~Nil~~~~~~~k 159 (355)
T d2b1pa1 87 PQKTLEEFQDVYLVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLH--SAGIIHRDLKPSNIVVKSDCTLK 159 (355)
T ss_dssp SCCSTTTCCEEEEEEECCSE-EHHHHHT----SCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTTCCEE
T ss_pred cccccccCceeEEEEeccch-HHHHhhh----cCCCHHHHHHHHHHHHHHHHHhh--hcccccccCCcccccccccccee
Confidence 4 3678999999955 5555553 25899999999999999999999 89999999999999999999999
Q ss_pred EccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcc-
Q 018785 172 LSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD- 250 (350)
Q Consensus 172 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~- 250 (350)
++|||++....... ......+|+.|+|||.+.+..++.++||||+||++++|++|+.||.+.+.......+.....
T Consensus 160 l~df~~~~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~ 236 (355)
T d2b1pa1 160 ILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGT 236 (355)
T ss_dssp ECCCCC------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred eechhhhhcccccc---ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccC
Confidence 99999987543322 23345688999999999999999999999999999999999999987654333322221111
Q ss_pred hh---hhh-hHHHHHhhhc------------------ccCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018785 251 PF---LRD-SRRVLRIMDT------------------RLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 303 (350)
Q Consensus 251 ~~---~~~-~~~~~~~~~~------------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 303 (350)
+. ... .......... ..........++++.+||.+||..||++|||++++|+|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 237 PCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp CCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00 000 0000000000 00111134568899999999999999999999999977
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-46 Score=336.25 Aligned_cols=271 Identities=23% Similarity=0.320 Sum_probs=204.0
Q ss_pred hhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch--hhHHHHHHHHHHHhccCCCcccceeeEEe
Q 018785 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (350)
Q Consensus 20 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (350)
.++|++.+.||+|+||+||+| .+..+|+.||||++..... .....+.+|+.++++++|||++++++++.
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a---------~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~ 87 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAA---------FDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT 87 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEE---------EETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred CCCeEEEEEEecCCCeEEEEE---------EECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 578999999999999999999 6667899999999976532 33456789999999999999999999986
Q ss_pred ec-----CceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEEcCCCcEEE
Q 018785 98 ES-----DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKL 172 (350)
Q Consensus 98 ~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili~~~~~~~l 172 (350)
.. ...+++++++.+++|.+++..+ .+++.+++.++.||+.||+||| ++||+||||||+||+++.++.+++
T Consensus 88 ~~~~~~~~~~~~i~~~~~gg~L~~~~~~~---~l~e~~~~~i~~qil~aL~~LH--~~giiHrDiKp~NILi~~~~~~kl 162 (348)
T d2gfsa1 88 PARSLEEFNDVYLVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIH--SADIIHRDLKPSNLAVNEDCELKI 162 (348)
T ss_dssp SCSSTTTCCCCEEEEECCSEEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTTCCEEE
T ss_pred eccccccCceEEEEEeecCCchhhhcccc---cccHHHHHHHHHHHHHHHHHHH--hCCCcccccCCccccccccccccc
Confidence 43 3345666777799999998654 6999999999999999999999 899999999999999999999999
Q ss_pred ccccccccCCCCCCCcccccccCCCcccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCcccccCcchhhhhhhcch
Q 018785 173 SDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADP 251 (350)
Q Consensus 173 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~ 251 (350)
+|||.+..... ......|++.|+|||.+.+. .++.++|||||||++|+|++|+.||.+.+.......+......
T Consensus 163 ~dfg~a~~~~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~ 237 (348)
T d2gfsa1 163 LDFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 237 (348)
T ss_dssp CCC----CCTG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred cccchhcccCc-----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 99999975322 22335678889999987765 4688999999999999999999999876654443333322111
Q ss_pred hhhh------hHHHHHhhh---cccCCC---CcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHhhhc
Q 018785 252 FLRD------SRRVLRIMD---TRLGGQ---YSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS--LEQLHT 309 (350)
Q Consensus 252 ~~~~------~~~~~~~~~---~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~--L~~~~~ 309 (350)
.... ......... ...... ....+++++.+||.+||..||.+|||+.++++| +.++..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~ 309 (348)
T d2gfsa1 238 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 309 (348)
T ss_dssp CCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred CChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCC
Confidence 1000 000000000 000000 112457889999999999999999999999986 555443
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=8e-41 Score=303.30 Aligned_cols=279 Identities=20% Similarity=0.286 Sum_probs=198.9
Q ss_pred hhhhhhh-hhcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccC------
Q 018785 13 SMISKIA-TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLR------ 85 (350)
Q Consensus 13 ~~~~~~~-~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~------ 85 (350)
..+++.. .+||+++++||+|+||+||+| .+..+|+.||||+++.... ..+.+.+|+.+++.++
T Consensus 4 ~~~g~~~~~~rY~i~~~LG~G~fg~Vy~~---------~~~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~ 73 (362)
T d1q8ya_ 4 AFKGEPYKDARYILVRKLGWGHFSTVWLA---------KDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTK 73 (362)
T ss_dssp CCTTCEETTTTEEEEEEEEECSSEEEEEE---------EETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSH
T ss_pred CCCCCCccCCcEEEEEEEeeCCCeEEEEE---------EECCCCCEEEEEEEecccc-chHHHHHHHHHHHHhcchhhhh
Confidence 3456654 467999999999999999999 6667799999999986643 2355677888887764
Q ss_pred -----CCcccceeeEEeec--CceEEEEEcCCCC-ChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCC
Q 018785 86 -----HENLVKLIGYCSES--DNRLLVYEFMPKG-SLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDL 157 (350)
Q Consensus 86 -----h~~i~~~~~~~~~~--~~~~lv~e~~~~~-~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di 157 (350)
|+||+++++++... ...++++.+.... .............+++..++.++.|++.||.|||+ ..||+||||
T Consensus 74 ~~~~~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~-~~~IvHrDl 152 (362)
T d1q8ya_ 74 EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR-RCGIIHTDI 152 (362)
T ss_dssp HHHHHHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH-TTCEECSCC
T ss_pred hhhcCcCceEEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhh-hcCcccccC
Confidence 58899999887654 4455666654333 44455555555689999999999999999999993 389999999
Q ss_pred CCCceEEcCCCc------EEEccccccccCCCCCCCcccccccCCCcccCccccccCCCCCccchhhHHHHHHHHHhCCC
Q 018785 158 KASNVLLDSNFN------AKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRR 231 (350)
Q Consensus 158 ~~~Nili~~~~~------~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll~g~~ 231 (350)
||+|||++.++. ++++|||.+....... ....|++.|+|||++.+..++.++|+||+||++++|++|+.
T Consensus 153 Kp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~ 227 (362)
T d1q8ya_ 153 KPENVLMEIVDSPENLIQIKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDF 227 (362)
T ss_dssp SGGGEEEEEEETTTTEEEEEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred ChhHeeeeccCcccccceeeEeeccccccccccc-----ccccccccccChhhccccCCCccccccchHHHHHHHHHCCC
Confidence 999999976553 9999999987543222 23568999999999999999999999999999999999999
Q ss_pred CCcccccCcchh---hhhh---h-cc---hhhhhhHHHHHhhhc-------------------ccCCCCcHHHHHHHHHH
Q 018785 232 ALDEDRGGLAEQ---TLVE---W-AD---PFLRDSRRVLRIMDT-------------------RLGGQYSKKEAQAVAAV 282 (350)
Q Consensus 232 pf~~~~~~~~~~---~~~~---~-~~---~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~l~~l 282 (350)
||.......... .+.. . .. ............... ..........++++.+|
T Consensus 228 pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dl 307 (362)
T d1q8ya_ 228 LFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDF 307 (362)
T ss_dssp CC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHH
T ss_pred CCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHH
Confidence 997544321111 1100 0 00 000000000000000 01123456788999999
Q ss_pred HHHhhccCCCCCCCHHHHHHH--HHhh
Q 018785 283 VLQCLHMDPKNRPSMVDVLTS--LEQL 307 (350)
Q Consensus 283 i~~~l~~dp~~Rps~~~ll~~--L~~~ 307 (350)
|.+||..||.+|||++++|+| +.+.
T Consensus 308 l~~mL~~dP~~Rpta~e~L~Hp~f~~~ 334 (362)
T d1q8ya_ 308 LSPMLQLDPRKRADAGGLVNHPWLKDT 334 (362)
T ss_dssp HGGGGCSSTTTCBCHHHHHTCGGGTTC
T ss_pred HHHHCCCChhHCcCHHHHhcCcccCCC
Confidence 999999999999999999986 5544
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.88 E-value=1e-23 Score=172.55 Aligned_cols=164 Identities=14% Similarity=0.079 Sum_probs=117.6
Q ss_pred ccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccch------------------hhHHHHHHHHHHHhcc
Q 018785 23 FCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF------------------QGHKEWLTEVIYLGQL 84 (350)
Q Consensus 23 y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~------------------~~~~~~~~e~~~l~~l 84 (350)
+.+.++||+|+||+||+|+ + .+|+.||||++..... ........|+..+.++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~---------~-~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l 71 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCY---------S-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL 71 (191)
T ss_dssp SEEEEEEEECSSEEEEEEE---------E-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT
T ss_pred chhCCEeeeCcceEEEEEE---------C-CCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHc
Confidence 4578899999999999994 3 2478999998753211 0112345678889999
Q ss_pred CCCcccceeeEEeecCceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCceEE
Q 018785 85 RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLL 164 (350)
Q Consensus 85 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~~~~i~H~di~~~Nili 164 (350)
.|++++..+++.. .+++||++++..+.+ ++...+..++.|++.++.+|| +.|++|+||||+|||+
T Consensus 72 ~~~~v~~~~~~~~----~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH--~~giiHrDiKP~NILv 136 (191)
T d1zara2 72 QGLAVPKVYAWEG----NAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFY--HRGIVHGDLSQYNVLV 136 (191)
T ss_dssp TTSSSCCEEEEET----TEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHH--HTTEECSCCSTTSEEE
T ss_pred cCCCcceEEEecC----CEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHh--hCCEEEccCChhheee
Confidence 9999988876532 379999997755433 344567789999999999999 8999999999999999
Q ss_pred cCCCcEEEccccccccCCCCCCCcccccccCCCcccCcc-----ccccCCCCCccchhhHHHH
Q 018785 165 DSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPE-----YVATGHLTPKSDVYSFGVV 222 (350)
Q Consensus 165 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE-----~~~~~~~~~~~DiwslG~l 222 (350)
+.+ .++|+|||.+......... .|.... .+....|+.++|+||+.--
T Consensus 137 ~~~-~~~liDFG~a~~~~~~~~~----------~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 137 SEE-GIWIIDFPQSVEVGEEGWR----------EILERDVRNIITYFSRTYRTEKDINSAIDR 188 (191)
T ss_dssp ETT-EEEECCCTTCEETTSTTHH----------HHHHHHHHHHHHHHHHHHCCCCCHHHHHHH
T ss_pred eCC-CEEEEECCCcccCCCCCcH----------HHHHHHHHHHHHHHcCCCCCcccHHHHHHH
Confidence 865 5899999998753222111 011110 1234678889999997543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.72 E-value=3.9e-08 Score=82.58 Aligned_cols=141 Identities=12% Similarity=-0.007 Sum_probs=93.3
Q ss_pred hcccccceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccC-CCcccceeeEEeec
Q 018785 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLR-HENLVKLIGYCSES 99 (350)
Q Consensus 21 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~ 99 (350)
+.|+..+..+.+..+.||+... .+..+++|............+.+|...++.+. +-.+.+++.+...+
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~~-----------~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~ 82 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLVG-----------ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHD 82 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEEC-----------SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEET
T ss_pred hceEEEEcCCCCCCCcEEEEEe-----------CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecC
Confidence 5677666655555578998632 24567888876554444445667888877763 44467778888888
Q ss_pred CceEEEEEcCCCCChhhHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcC-------------------------------
Q 018785 100 DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL------------------------------- 148 (350)
Q Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~al~~lh~~------------------------------- 148 (350)
+..++||++++|.++.+..... .....++.++...+..||+.
T Consensus 83 ~~~~lv~~~l~G~~~~~~~~~~-------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (263)
T d1j7la_ 83 GWSNLLMSEADGVLCSEEYEDE-------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDC 155 (263)
T ss_dssp TEEEEEEECCSSEEHHHHTTTC-------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCG
T ss_pred CceEEEEEeccccccccccccc-------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhh
Confidence 8999999999888876544211 11222344444444444421
Q ss_pred --------------------------CCCeeeCCCCCCceEEcCCCcEEEccccccc
Q 018785 149 --------------------------DANVIYRDLKASNVLLDSNFNAKLSDFGLAR 179 (350)
Q Consensus 149 --------------------------~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~ 179 (350)
...++|+|+.|.||++++++.+-|+||+.+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 156 ENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp GGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred hcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1125899999999999877666799998875
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.27 E-value=1.3e-05 Score=70.84 Aligned_cols=78 Identities=15% Similarity=0.073 Sum_probs=46.6
Q ss_pred cceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEcccc------c-hhhHHHHHHHHHHHhccC-C--CcccceeeE
Q 018785 26 DYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAE------S-FQGHKEWLTEVIYLGQLR-H--ENLVKLIGY 95 (350)
Q Consensus 26 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~------~-~~~~~~~~~e~~~l~~l~-h--~~i~~~~~~ 95 (350)
.+.||.|....||++ ....+++.+++|.-... . .........|+..|+.+. + ..+.+++.+
T Consensus 31 ~~eig~G~~N~vfrV---------~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~ 101 (392)
T d2pula1 31 CQEIGDGNLNYVFHI---------YDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS 101 (392)
T ss_dssp EEECCSSSSEEEEEE---------EC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE
T ss_pred EEEeCCCceEeEEEE---------EeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE
Confidence 457899999999998 45555778999964321 1 111223456777777662 2 334455543
Q ss_pred EeecCceEEEEEcCCCCCh
Q 018785 96 CSESDNRLLVYEFMPKGSL 114 (350)
Q Consensus 96 ~~~~~~~~lv~e~~~~~~L 114 (350)
+.+..++|||++.+..+
T Consensus 102 --d~~~~~lvmE~L~~~~~ 118 (392)
T d2pula1 102 --DTEMAVTVMEDLSHLKI 118 (392)
T ss_dssp --ETTTTEEEECCCTTSEE
T ss_pred --cCCCCEEEEeccCCccc
Confidence 45567899999976543
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.12 E-value=9.4e-06 Score=67.10 Aligned_cols=76 Identities=17% Similarity=0.115 Sum_probs=50.2
Q ss_pred eecccCc-eeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccC--CCcccceeeEEeecCceEE
Q 018785 28 LLGEGGF-GCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLR--HENLVKLIGYCSESDNRLL 104 (350)
Q Consensus 28 ~lg~G~~-g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~l 104 (350)
.+..|.. +.||+.. ...+..+++|........ .+..|...++.+. .-.+.+++.+..+.+..++
T Consensus 17 ~~~~G~s~~~v~r~~----------~~~~~~~vlK~~~~~~~~---~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~ 83 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLS----------AQGRPVLFVKTDLSGALN---ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWL 83 (255)
T ss_dssp ECSCTTSSCEEEEEE----------CTTSCCEEEEEECSCTTS---CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEE
T ss_pred EcCCcccCCeEEEEE----------eCCCCEEEEEeCCccCHh---HHHHHHHHHHHHHhcCCCCCceeeecccccceEE
Confidence 3445554 5789863 234666888976655432 3556777776663 3336777888888889999
Q ss_pred EEEcCCCCChhh
Q 018785 105 VYEFMPKGSLEN 116 (350)
Q Consensus 105 v~e~~~~~~L~~ 116 (350)
||++++|.++.+
T Consensus 84 v~~~i~G~~~~~ 95 (255)
T d1nd4a_ 84 LLGEVPGQDLLS 95 (255)
T ss_dssp EEECCSSEETTT
T ss_pred EEEeeecccccc
Confidence 999998876543
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.22 E-value=0.00075 Score=59.24 Aligned_cols=81 Identities=15% Similarity=0.066 Sum_probs=51.8
Q ss_pred cceecccCceeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccC-CCcccceeeEEeecCceEE
Q 018785 26 DYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLR-HENLVKLIGYCSESDNRLL 104 (350)
Q Consensus 26 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l 104 (350)
.+.|+.|-.-.+|++....... ........|++++..... ......+|..+++.+. +.-..++++++.. ++
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~--~~~~~~~~vllRi~g~~~--~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~ 118 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYP--PIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GR 118 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSC--CSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EE
T ss_pred EEEcCCccccceEEEEeCCCCc--cccCCCCcEEEEecCCcc--hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ce
Confidence 3567888888999986553321 112345678888776332 2344567888888874 4434577777653 58
Q ss_pred EEEcCCCCCh
Q 018785 105 VYEFMPKGSL 114 (350)
Q Consensus 105 v~e~~~~~~L 114 (350)
|++|++|.++
T Consensus 119 I~efi~g~~l 128 (395)
T d1nw1a_ 119 LEEYIPSRPL 128 (395)
T ss_dssp EECCCCEEEC
T ss_pred EEEEeccccC
Confidence 9999977554
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.16 E-value=0.0025 Score=54.18 Aligned_cols=133 Identities=14% Similarity=0.070 Sum_probs=74.2
Q ss_pred eeEEeecccCCCcCCCCCCCCcEEEEEEccccchhhHHHHHHHHHHHhccC---CC--cccce--eeEEeecCceEEEEE
Q 018785 35 GCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLR---HE--NLVKL--IGYCSESDNRLLVYE 107 (350)
Q Consensus 35 g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~---h~--~i~~~--~~~~~~~~~~~lv~e 107 (350)
-.||+++ ..+|..+++|+..... .+...+..|...+..|. -| ..+.. -..+..++..+.+++
T Consensus 36 N~vy~v~----------~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~ 104 (325)
T d1zyla1 36 NRVYQFQ----------DEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFP 104 (325)
T ss_dssp SEEEEEC----------CTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEE
T ss_pred ceeEEEE----------cCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEe
Confidence 4788873 2357789999987653 34556777887777763 12 11111 112345566788999
Q ss_pred cCCCCChh-----hHH-------------hhcC----------------------CCCCCHH---HHHHHHHHHHHHHHH
Q 018785 108 FMPKGSLE-----NHL-------------FRKG----------------------VQPISWP---TRVKIAIDVARGLSF 144 (350)
Q Consensus 108 ~~~~~~L~-----~~l-------------~~~~----------------------~~~l~~~---~~~~i~~ql~~al~~ 144 (350)
++.|..+. .+. .... ...++.. .....+..+...+..
T Consensus 105 ~~~G~~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~ 184 (325)
T d1zyla1 105 SVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTA 184 (325)
T ss_dssp CCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHH
T ss_pred ecCCcCCCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHH
Confidence 88654321 110 0000 0111111 222333444444433
Q ss_pred h--hcCCCCeeeCCCCCCceEEcCCCcEEEcccccccc
Q 018785 145 L--HGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD 180 (350)
Q Consensus 145 l--h~~~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~~ 180 (350)
. .....+++|+|+++.||+++.+ ..++||+-+..
T Consensus 185 ~~~~~~p~~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 185 HWREDFTVLRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp HCCSCSCCEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred hccccCCceeecCCCCcccEEEeCC--ceEEechhccc
Confidence 2 1124678999999999999743 45899998864
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.76 E-value=0.034 Score=46.37 Aligned_cols=31 Identities=35% Similarity=0.296 Sum_probs=27.8
Q ss_pred CCCeeeCCCCCCceEEcCCCcEEEccccccc
Q 018785 149 DANVIYRDLKASNVLLDSNFNAKLSDFGLAR 179 (350)
Q Consensus 149 ~~~i~H~di~~~Nili~~~~~~~l~Dfg~~~ 179 (350)
..|++|+|+.++|++++.+...-++||+.+.
T Consensus 182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 182 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccccccCCcchhhhhcccccceeEecccccc
Confidence 6789999999999999988777899999885
|